Citrus Sinensis ID: 041143
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 973 | 2.2.26 [Sep-21-2011] | |||||||
| P43298 | 942 | Probable receptor protein | no | no | 0.914 | 0.944 | 0.447 | 0.0 | |
| Q9ZWC8 | 1166 | Serine/threonine-protein | no | no | 0.806 | 0.673 | 0.298 | 1e-77 | |
| Q8GUQ5 | 1207 | Brassinosteroid LRR recep | N/A | no | 0.779 | 0.628 | 0.313 | 1e-76 | |
| Q9LJF3 | 1164 | Receptor-like protein kin | no | no | 0.816 | 0.682 | 0.291 | 2e-76 | |
| Q8L899 | 1207 | Systemin receptor SR160 O | N/A | no | 0.771 | 0.622 | 0.312 | 2e-75 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.765 | 0.676 | 0.3 | 1e-74 | |
| Q9LYN8 | 1192 | Leucine-rich repeat recep | no | no | 0.817 | 0.666 | 0.308 | 2e-73 | |
| Q8LPB4 | 1021 | Phytosulfokine receptor 1 | N/A | no | 0.771 | 0.735 | 0.289 | 5e-69 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.803 | 0.624 | 0.283 | 1e-68 | |
| Q9FN37 | 1036 | Phytosulfokine receptor 2 | no | no | 0.786 | 0.738 | 0.283 | 8e-68 |
| >sp|P43298|TMK1_ARATH Probable receptor protein kinase TMK1 OS=Arabidopsis thaliana GN=TMK1 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 740 bits (1910), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 439/982 (44%), Positives = 584/982 (59%), Gaps = 92/982 (9%)
Query: 22 ATDPNDLKILNDFKNGLENPELLKWPANGDDPCGPPPWPHVFCSG-NRVTQIQVQNLGLK 80
A DL + K L P W + DPC W H+ C+G RVT+IQ+ + GL+
Sbjct: 23 ADSDGDLSAMLSLKKSLNPPSSFGW--SDPDPC---KWTHIVCTGTKRVTRIQIGHSGLQ 77
Query: 81 GPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSV 140
G L + L++L L LQ N +G +P+ SGL+ L+ L N FD+IPSD F GL+S+
Sbjct: 78 GTLSPDLRNLSELERLELQWNNISGPVPSLSGLASLQVLMLSNNNFDSIPSDVFQGLTSL 137
Query: 141 RVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLG--TLPSLAALKLS 198
+ + +D NPF W IP+SL N+ L N S + N+ G LP FLG P L+ L L+
Sbjct: 138 QSVEIDNNPFKS---WEIPESLRNASALQNFSANSANVSGSLPGFLGPDEFPGLSILHLA 194
Query: 199 YNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPED 258
+N L G +P S S +Q LWLN Q +TG I V+ M L ++WLH N+F+G +P D
Sbjct: 195 FNNLEGELPMSLAGSQVQSLWLNGQK---LTGDITVLQNMTGLKEVWLHSNKFSGPLP-D 250
Query: 259 IGALSSLKDLNLNRNQLVGLIPKSLANMELDNLV-LNNNLLMGPIPKFKAG---NVTYDS 314
L L+ L+L N G +P SL ++E +V L NN L GP+P FK+ ++ DS
Sbjct: 251 FSGLKELESLSLRDNSFTGPVPASLLSLESLKVVNLTNNHLQGPVPVFKSSVSVDLDKDS 310
Query: 315 NSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSII 374
NSFC S PG EC P V LL +YP L W GNDPC W+G++C SN +++I
Sbjct: 311 NSFCLSSPG-ECDPRVKSLLLIASSFDYPPRLAESWKGNDPCTN-WIGIAC-SNGNITVI 367
Query: 375 NLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLP 434
+L + LTGT+SP F +KSL+ + + NN+ +P
Sbjct: 368 SLEKMELTGTISP------------------------EFGAIKSLQRIILGINNLTGMIP 403
Query: 435 EFHDTV----KLVIDGNPLLVGGINHTQAPTSPGPVSSPTPPGSQSPSNHTSSGRGQSPS 490
+ T+ L + N L G V PG +S ++G +P
Sbjct: 404 QELTTLPNLKTLDVSSNKLF-------------GKV-----PGFRSNVVVNTNG---NPD 442
Query: 491 SGNSPPSPITHPNSNHSS-----IHVQPQRKSTKRLKLL-VVVGISVVVTVVLVVILLCI 544
G S + +S+ S I+ R+ K + ++VG + + + +I L +
Sbjct: 443 IGKDKSSLSSPGSSSPSGGSGSGINGDKDRRGMKSSTFIGIIVGSVLGGLLSIFLIGLLV 502
Query: 545 YCC-KKRKGTL---EAPGSIVVHPRDPSDPENMVKIAVSNDTARSLS-SQTVASSGSTNS 599
+C KKR+ E+ ++VVHPR VKI V+ + S T G++
Sbjct: 503 FCWYKKRQKRFSGSESSNAVVVHPRHSGSDNESVKITVAGSSVSVGGISDTYTLPGTSEV 562
Query: 600 GATENSHVIESGTLVISVQVLRKVTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEA 659
G +N ++E+G ++IS+QVLR VT NF+ +N LG GGFG VYKGEL DGTKIAVKRME
Sbjct: 563 G--DNIQMVEAGNMLISIQVLRSVTNNFSSDNILGSGGFGVVYKGELHDGTKIAVKRMEN 620
Query: 660 GVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEK 719
GV K EF+SEIAVL+KVRHRHLV+LLGY ++GNE+LLVYEYMP G LSRHLF W +
Sbjct: 621 GVIAGKGFAEFKSEIAVLTKVRHRHLVTLLGYCLDGNEKLLVYEYMPQGTLSRHLFEWSE 680
Query: 720 LQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK 779
LKPL W +RL++ALDVARG+EYLH LA Q+FIHRDLK SNILL DD RAKV+DFGLV+
Sbjct: 681 EGLKPLLWKQRLTLALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 740
Query: 780 LAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEE 839
LAP+G+ S+ TR+AGTFGYLAPEYAV G++TTK DV+S+GV+LMEL+TG +LDE +PEE
Sbjct: 741 LAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVYSFGVILMELITGRKSLDESQPEE 800
Query: 840 SRYLAEWFWRIKSSKE-KFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGH 898
S +L WF R+ +KE FK AID ++++EET S+ VAELAGHC AREPY RPDMGH
Sbjct: 801 SIHLVSWFKRMYINKEASFKKAIDTTIDLDEETLASVHTVAELAGHCCAREPYQRPDMGH 860
Query: 899 VVNVLSPLVEKWRPITDESECCSGIDYSLPLPQMLKVWQEAESK-------EISYPNLED 951
VN+LS LVE W+P E GID + LPQ LK WQ E + P+L++
Sbjct: 861 AVNILSSLVELWKPSDQNPEDIYGIDLDMSLPQALKKWQAYEGRSDLESSTSSLLPSLDN 920
Query: 952 SKGSIPARPTGFAESFTSSDGR 973
++ SIP RP GFAESFTS DGR
Sbjct: 921 TQMSIPTRPYGFAESFTSVDGR 942
|
Probable receptor. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9ZWC8|BRL1_ARATH Serine/threonine-protein kinase BRI1-like 1 OS=Arabidopsis thaliana GN=BRL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 291 bits (746), Expect = 1e-77, Method: Compositional matrix adjust.
Identities = 265/887 (29%), Positives = 411/887 (46%), Gaps = 102/887 (11%)
Query: 79 LKGPLPQNFNQLTKLYNLGLQRNKFNGKL--PTFSGLSELEFAYLDFNEFDTIPSDFFDG 136
G LP F L NL L N +G S ++ + + Y+ +N
Sbjct: 314 FSGELPSQFTACVWLQNLNLGNNYLSGDFLNTVVSKITGITYLYVAYNNISGSVPISLTN 373
Query: 137 LSSVRVLALDYNPF-----------------------NKTFGWSIPDSLANSVQLTNLSL 173
S++RVL L N F N ++P L L + L
Sbjct: 374 CSNLRVLDLSSNGFTGNVPSGFCSLQSSPVLEKILIANNYLSGTVPMELGKCKSLKTIDL 433
Query: 174 INCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASF---GQSLMQILWLNDQDAGGMTG 230
L GP+P + LP+L+ L + N L+G IP G +L ++ N+ +TG
Sbjct: 434 SFNELTGPIPKEIWMLPNLSDLVMWANNLTGTIPEGVCVKGGNLETLILNNNL----LTG 489
Query: 231 PI-DVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANME-L 288
I + +++ ++ + L N+ TG IP IG LS L L L N L G +P+ L N + L
Sbjct: 490 SIPESISRCTNMIWISLSSNRLTGKIPSGIGNLSKLAILQLGNNSLSGNVPRQLGNCKSL 549
Query: 289 DNLVLNNNLLMGPIPKFKA--------GNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGV 340
L LN+N L G +P A G+V+ +F ++E G +C L++F G
Sbjct: 550 IWLDLNSNNLTGDLPGELASQAGLVMPGSVSGKQFAFVRNEGGTDCR-GAGGLVEFEGIR 608
Query: 341 NYPVN---LVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIE 397
+ +V P G + + ++N + ++ + ++G + P N+ L
Sbjct: 609 AERLERLPMVHSCPATRIYSGMTM-YTFSANGSMIYFDISYNAVSGFIPPGYGNMGYLQV 667
Query: 398 IRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLPEFHDTVKLVIDGNPLLVGGINHT 457
+ LG N I+GT+P++F LK++ +LD+S NN++ LP ++ + D L V N T
Sbjct: 668 LNLGHNRITGTIPDSFGGLKAIGVLDLSHNNLQGYLPGSLGSLSFLSD---LDVSNNNLT 724
Query: 458 QAPTSPGPVSSPTPPGSQSPSNHTSSGRGQSPSSGNSPPSPITHPNSNHSSIHVQPQRKS 517
G ++ T P S+ +N G P G++P PIT S IH + Q +
Sbjct: 725 GPIPFGGQLT--TFPVSRYANNSGLCGVPLRPC-GSAPRRPIT------SRIHAKKQTVA 775
Query: 518 TKRLKLLVVVGISVVVTVVLVVILLCIYCCKKRKGTLEAPGSIVVHPRDPSDPENMVKIA 577
T V+ GI+ + V++++ +Y +K V ++ + + +
Sbjct: 776 TA-----VIAGIAFSF-MCFVMLVMALYRVRK------------VQKKEQKREKYIESLP 817
Query: 578 VSNDTARSLSSQTVASSGSTNSGATENSHVIESGTLVISVQVLRKVTQNFAQENELGRGG 637
S + LSS S N E ++ L + T F+ E +G GG
Sbjct: 818 TSGSCSWKLSSVPEPLS--------INVATFEKPLRKLTFAHLLEATNGFSAETMVGSGG 869
Query: 638 FGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNE 697
FG VYK +L DG+ +A+K++ T + EF +E+ + K++HR+LV LLGY G E
Sbjct: 870 FGEVYKAQLRDGSVVAIKKLIR--ITGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGEE 927
Query: 698 RLLVYEYMPHGALSRHLFRWEKLQLKP---LSWTRRLSIALDVARGMEYLHCLARQTFIH 754
RLLVYEYM G+L L EK K L+W R IA+ ARG+ +LH IH
Sbjct: 928 RLLVYEYMKWGSLETVLH--EKSSKKGGIYLNWAARKKIAIGAARGLAFLHHSCIPHIIH 985
Query: 755 RDLKSSNILLDDDYRAKVSDFGLVKL--APDGEKSVVTRLAGTFGYLAPEYAVMGKITTK 812
RD+KSSN+LLD+D+ A+VSDFG+ +L A D SV T LAGT GY+ PEY + T K
Sbjct: 986 RDMKSSNVLLDEDFEARVSDFGMARLVSALDTHLSVST-LAGTPGYVPPEYYQSFRCTAK 1044
Query: 813 ADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI-DPALEVNEET 871
DV+SYGV+L+ELL+G +D E L W ++ +EK A I DP L ++
Sbjct: 1045 GDVYSYGVILLELLSGKKPIDPGEFGEDNNLVGWAKQLY--REKRGAEILDPELVTDKSG 1102
Query: 872 FESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPITDESE 918
+ ++A C P+ RP M L + ++ + T+E E
Sbjct: 1103 DVELFHYLKIASQCLDDRPFKRPTMIQ----LMAMFKEMKADTEEDE 1145
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. Binds brassinolide. May be involved in cell growth and vascular differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GUQ5|BRI1_SOLLC Brassinosteroid LRR receptor kinase OS=Solanum lycopersicum GN=CURL3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 288 bits (737), Expect = 1e-76, Method: Compositional matrix adjust.
Identities = 278/886 (31%), Positives = 411/886 (46%), Gaps = 128/886 (14%)
Query: 64 CSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLD 122
CS + I N K P+ ++L+ + + L NKF G LP +FS L +LE +
Sbjct: 351 CSSLELVDISYNNFSGKLPV-DTLSKLSNIKTMVLSFNKFVGGLPDSFSNLLKLETLDMS 409
Query: 123 FNEFD-TIPSDFF-DGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVG 180
N IPS D +++++VL L N F IPDSL+N QL +L L L G
Sbjct: 410 SNNLTGVIPSGICKDPMNNLKVLYLQ----NNLFKGPIPDSLSNCSQLVSLDLSFNYLTG 465
Query: 181 PLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQ--DAGGMTGPIDV-VAK 237
+P LG+L L L L N+LSG IP Q LM + L + D +TGPI ++
Sbjct: 466 SIPSSLGSLSKLKDLILWLNQLSGEIP----QELMYLQALENLILDFNDLTGPIPASLSN 521
Query: 238 MVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANME-LDNLVLNNN 296
L + L NQ +G IP +G LS+L L L N + G IP L N + L L LN N
Sbjct: 522 CTKLNWISLSNNQLSGEIPASLGRLSNLAILKLGNNSISGNIPAELGNCQSLIWLDLNTN 581
Query: 297 LLMGPIPK--FK-AGNV-----TYDSNSFCQSEPGIECAPDVNVLLDFLGGVN------- 341
L G IP FK +GN+ T + +++ EC N LL+F GG+
Sbjct: 582 FLNGSIPPPLFKQSGNIAVALLTGKRYVYIKNDGSKECHGAGN-LLEF-GGIRQEQLDRI 639
Query: 342 ---YPVNLVSQWPG-NDPC---QGPWLGLSCTSNS-------------KVSIINLPRHNL 381
+P N + G P G + L + N +SI+NL ++L
Sbjct: 640 STRHPCNFTRVYRGITQPTFNHNGSMIFLDLSYNKLEGSIPKELGAMYYLSILNLGHNDL 699
Query: 382 TGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLPEF--HDT 439
+G + + L ++ + L N +GT+PN+ T L L +D+S+NN+ +PE DT
Sbjct: 700 SGMIPQQLGGLKNVAILDLSYNRFNGTIPNSLTSLTLLGEIDLSNNNLSGMIPESAPFDT 759
Query: 440 VKLVIDGNPLLVGGINHTQAPTSPGPVSSPTPPGSQSPSN-HTSSGRGQSPSSGNSPPSP 498
N L G P P+ P G +S +N H S R Q+ +G+
Sbjct: 760 FPDYRFANNSLCG---------YPLPI--PCSSGPKSDANQHQKSHRRQASLAGS----- 803
Query: 499 ITHPNSNHSSIHVQPQRKSTKRLKLLVVVGISVVVTVVLVVILLCIYCCKKRKGTLEAPG 558
V +G+ + + +I++ I KKR+ EA
Sbjct: 804 --------------------------VAMGLLFSLFCIFGLIIVAIET-KKRRRKKEAAL 836
Query: 559 SIVVHPRDPSDPENMVKIAVSNDTARSLSSQTVASSGSTNSGATENSHVIESGTLVISVQ 618
A + + S ++ + S + N E ++
Sbjct: 837 E-----------------AYMDGHSHSATANSAWKFTSAREALSINLAAFEKPLRKLTFA 879
Query: 619 VLRKVTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLS 678
L + T F ++ +G GGFG VYK +L+DG+ +A+K++ + + EF +E+ +
Sbjct: 880 DLLEATNGFHNDSLVGSGGFGDVYKAQLKDGSVVAIKKLIH--VSGQGDREFTAEMETIG 937
Query: 679 KVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVA 738
K++HR+LV LLGY G ERLLVYEYM +G+L L +K+ +K L+W R IA+ A
Sbjct: 938 KIKHRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVLHDRKKIGIK-LNWPARRKIAIGAA 996
Query: 739 RGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKL--APDGEKSVVTRLAGTF 796
RG+ +LH IHRD+KSSN+LLD++ A+VSDFG+ +L A D SV T LAGT
Sbjct: 997 RGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHLSVST-LAGTP 1055
Query: 797 GYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEK 856
GY+ PEY + +TK DV+SYGVVL+ELLTG D ++ + W +K K
Sbjct: 1056 GYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKQPTDSADFGDNNLVG---WVKLHAKGK 1112
Query: 857 FKAAIDPALEVNEETFESISIVAELAGHCTAREPYH--RPDMGHVV 900
D L + + E I ++ L C + H RP M V+
Sbjct: 1113 ITDVFDRELLKEDASIE-IELLQHLKVACACLDDRHWKRPTMIQVM 1157
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. May be involved in a feedback regulation of brassinosteroid biosynthesis. May be also involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. Solanum lycopersicum (taxid: 4081) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LJF3|BRL3_ARATH Receptor-like protein kinase BRI1-like 3 OS=Arabidopsis thaliana GN=BRL3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 288 bits (736), Expect = 2e-76, Method: Compositional matrix adjust.
Identities = 263/902 (29%), Positives = 413/902 (45%), Gaps = 108/902 (11%)
Query: 57 PPWPHVFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKL--PTFSGLS 114
PP + C V + +L G LPQ+F L +L L NK +G S LS
Sbjct: 294 PPELSLLCRTLEVLDLSGNSL--TGQLPQSFTSCGSLQSLNLGNNKLSGDFLSTVVSKLS 351
Query: 115 ELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPD---SLANSVQLTNL 171
+ YL FN S++RVL L N F +P SL +S L L
Sbjct: 352 RITNLYLPFNNISGSVPISLTNCSNLRVLDLSSNEFTG----EVPSGFCSLQSSSVLEKL 407
Query: 172 SLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPA---SFGQSLMQILWLNDQDAGG- 227
+ N L G +P LG SL + LS+N L+G+IP + + ++W N+ G
Sbjct: 408 LIANNYLSGTVPVELGKCKSLKTIDLSFNALTGLIPKEIWTLPKLSDLVMWANNLTGGIP 467
Query: 228 -------------------MTGPI-DVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKD 267
+TG + + ++K ++ + L N TG IP IG L L
Sbjct: 468 ESICVDGGNLETLILNNNLLTGSLPESISKCTNMLWISLSSNLLTGEIPVGIGKLEKLAI 527
Query: 268 LNLNRNQLVGLIPKSLANMELDNLV---LNNNLLMGPIPKFKA--------GNVTYDSNS 316
L L N L G IP L N + NL+ LN+N L G +P A G+V+ +
Sbjct: 528 LQLGNNSLTGNIPSELGNCK--NLIWLDLNSNNLTGNLPGELASQAGLVMPGSVSGKQFA 585
Query: 317 FCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGP--WLGLSC---TSNSKV 371
F ++E G +C L++F G + +P C + G++ +SN +
Sbjct: 586 FVRNEGGTDCR-GAGGLVEFEG---IRAERLEHFPMVHSCPKTRIYSGMTMYMFSSNGSM 641
Query: 372 SIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKP 431
++L + ++G++ + L + LG N ++GT+P++F LK++ +LD+S N+++
Sbjct: 642 IYLDLSYNAVSGSIPLGYGAMGYLQVLNLGHNLLTGTIPDSFGGLKAIGVLDLSHNDLQG 701
Query: 432 PLPEFHDTVKLVIDGNPLLVGGINH-TQAPTSPGPVSSPTPPGSQSPSNHTSSGRGQSPS 490
LP +GG++ + S ++ P P G Q + + S
Sbjct: 702 FLPGS--------------LGGLSFLSDLDVSNNNLTGPIPFGGQLTTFPLTRYANNSGL 747
Query: 491 SGNSPPSPITHPNSNHSSIHVQPQRKSTKRLKLLVVVGISV-VVTVVLVVILLCIYCCKK 549
G P P S + H P+++S + G+S +V + +++L + +
Sbjct: 748 CG--VPLPPCSSGSRPTRSHAHPKKQS-------IATGMSAGIVFSFMCIVMLIMALYRA 798
Query: 550 RKGTLEAPGSIVVHPRDPSDPENMVKIAVSNDTARSLSSQTVASSGSTNSGATENSHVIE 609
RK V ++ + + + S + S + + N E
Sbjct: 799 RK----------VQKKEKQREKYIESLPTS--------GSSSWKLSSVHEPLSINVATFE 840
Query: 610 SGTLVISVQVLRKVTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDE 669
++ L + T F+ ++ +G GGFG VYK +L DG+ +A+K++ T + E
Sbjct: 841 KPLRKLTFAHLLEATNGFSADSMIGSGGFGDVYKAKLADGSVVAIKKLIQ--VTGQGDRE 898
Query: 670 FQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTR 729
F +E+ + K++HR+LV LLGY G ERLLVYEYM +G+L L K L W+
Sbjct: 899 FMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKYGSLETVLHEKTKKGGIFLDWSA 958
Query: 730 RLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKL--APDGEKS 787
R IA+ ARG+ +LH IHRD+KSSN+LLD D+ A+VSDFG+ +L A D S
Sbjct: 959 RKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDQDFVARVSDFGMARLVSALDTHLS 1018
Query: 788 VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWF 847
V T LAGT GY+ PEY + T K DV+SYGV+L+ELL+G +D E E L W
Sbjct: 1019 VST-LAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSGKKPIDPEEFGEDNNLVGWA 1077
Query: 848 WRIKSSKEKFKAAI-DPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPL 906
++ +EK A I DP L ++ + ++A C P+ RP M V+ + L
Sbjct: 1078 KQLY--REKRGAEILDPELVTDKSGDVELLHYLKIASQCLDDRPFKRPTMIQVMTMFKEL 1135
Query: 907 VE 908
V+
Sbjct: 1136 VQ 1137
|
Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Binds brassinolide. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. May be involved in cell growth and vascular differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8L899|BRI1_SOLPE Systemin receptor SR160 OS=Solanum peruvianum PE=1 SV=1 | Back alignment and function description |
|---|
Score = 285 bits (728), Expect = 2e-75, Method: Compositional matrix adjust.
Identities = 275/879 (31%), Positives = 406/879 (46%), Gaps = 128/879 (14%)
Query: 72 IQVQNLGLKGPLP-QNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFD-T 128
+ + N G LP +L+ + + L NKF G LP +FS L +LE + N
Sbjct: 357 VDISNNNFSGKLPVDTLLKLSNIKTMVLSFNKFVGGLPDSFSNLPKLETLDMSSNNLTGI 416
Query: 129 IPSDFF-DGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLG 187
IPS D +++++VL L N F IPDSL+N QL +L L L G +P LG
Sbjct: 417 IPSGICKDPMNNLKVLYLQ----NNLFKGPIPDSLSNCSQLVSLDLSFNYLTGSIPSSLG 472
Query: 188 TLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQ--DAGGMTGPIDV-VAKMVSLTQL 244
+L L L L N+LSG IP Q LM + L + D +TGPI ++ L +
Sbjct: 473 SLSKLKDLILWLNQLSGEIP----QELMYLQALENLILDFNDLTGPIPASLSNCTKLNWI 528
Query: 245 WLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANME-LDNLVLNNNLLMGPIP 303
L NQ +G IP +G LS+L L L N + G IP L N + L L LN N L G IP
Sbjct: 529 SLSNNQLSGEIPASLGRLSNLAILKLGNNSISGNIPAELGNCQSLIWLDLNTNFLNGSIP 588
Query: 304 K--FK-AGNV-----TYDSNSFCQSEPGIECAPDVNVLLDFLGGVN----------YPVN 345
FK +GN+ T + +++ EC N LL+F GG+ +P N
Sbjct: 589 PPLFKQSGNIAVALLTGKRYVYIKNDGSKECHGAGN-LLEF-GGIRQEQLDRISTRHPCN 646
Query: 346 LVSQWPG-NDPC---QGPWLGLSCTSNS-------------KVSIINLPRHNLTGTLSPS 388
+ G P G + L + N +SI+NL ++L+G +
Sbjct: 647 FTRVYRGITQPTFNHNGSMIFLDLSYNKLEGSIPKELGAMYYLSILNLGHNDLSGMIPQQ 706
Query: 389 IANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLPEF--HDTVKLVIDG 446
+ L ++ + L N +GT+PN+ T L L +D+S+NN+ +PE DT
Sbjct: 707 LGGLKNVAILDLSYNRFNGTIPNSLTSLTLLGEIDLSNNNLSGMIPESAPFDTFPDYRFA 766
Query: 447 NPLLVGGINHTQAPTSPGPVSSPTPPGSQSPSN-HTSSGRGQSPSSGNSPPSPITHPNSN 505
N L G P+ P G +S +N H S R Q+ +G+
Sbjct: 767 NNSLCGY-----------PLPLPCSSGPKSDANQHQKSHRRQASLAGS------------ 803
Query: 506 HSSIHVQPQRKSTKRLKLLVVVGISVVVTVVLVVILLCIYCCKKRKGTLEAPGSIVVHPR 565
V +G+ + + +I++ I KKR+ EA
Sbjct: 804 -------------------VAMGLLFSLFCIFGLIIVAIET-KKRRRKKEAALE------ 837
Query: 566 DPSDPENMVKIAVSNDTARSLSSQTVASSGSTNSGATENSHVIESGTLVISVQVLRKVTQ 625
A + + S ++ + S + N E ++ L + T
Sbjct: 838 -----------AYMDGHSHSATANSAWKFTSAREALSINLAAFEKPLRKLTFADLLEATN 886
Query: 626 NFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHL 685
F ++ +G GGFG VYK +L+DG+ +A+K++ + + EF +E+ + K++HR+L
Sbjct: 887 GFHNDSLVGSGGFGDVYKAQLKDGSVVAIKKLIH--VSGQGDREFTAEMETIGKIKHRNL 944
Query: 686 VSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLH 745
V LLGY G ERLLVYEYM +G+L L +K +K L+W R IA+ ARG+ +LH
Sbjct: 945 VPLLGYCKVGEERLLVYEYMKYGSLEDVLHDRKKTGIK-LNWPARRKIAIGAARGLAFLH 1003
Query: 746 CLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKL--APDGEKSVVTRLAGTFGYLAPEY 803
IHRD+KSSN+LLD++ A+VSDFG+ +L A D SV T LAGT GY+ PEY
Sbjct: 1004 HNCIPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHLSVST-LAGTPGYVPPEY 1062
Query: 804 AVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDP 863
+ +TK DV+SYGVVL+ELLTG D ++ + W +K K D
Sbjct: 1063 YQSFRCSTKGDVYSYGVVLLELLTGKQPTDSADFGDNNLVG---WVKLHAKGKITDVFDR 1119
Query: 864 ALEVNEETFESISIVAELAGHCTAREPYH--RPDMGHVV 900
L + + E I ++ L C + H RP M V+
Sbjct: 1120 ELLKEDASIE-IELLQHLKVACACLDDRHWKRPTMIQVM 1157
|
Receptor with a serine/threonine-protein kinase activity. Involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. May also regulate, in response to brassinosteroid binding, a signaling cascade involved in plant development. Solanum peruvianum (taxid: 4082) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 281 bits (720), Expect = 1e-74, Method: Compositional matrix adjust.
Identities = 264/880 (30%), Positives = 400/880 (45%), Gaps = 135/880 (15%)
Query: 81 GPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDT---IPSDF---- 133
G +P+ +LTK+ L L N+ G++P G + ++ A +DF+E IP +F
Sbjct: 273 GSIPREIGKLTKMKRLYLYTNQLTGEIPREIG-NLIDAAEIDFSENQLTGFIPKEFGHIL 331
Query: 134 -------------------FDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLI 174
L+ + L L N N T IP L L +L L
Sbjct: 332 NLKLLHLFENILLGPIPRELGELTLLEKLDLSINRLNGT----IPQELQFLPYLVDLQLF 387
Query: 175 NCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDV 234
+ L G +P +G + + L +S N LSG IPA F + Q L L + ++G I
Sbjct: 388 DNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCR--FQTLILLSLGSNKLSGNIPR 445
Query: 235 VAKMV-SLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANME-LDNLV 292
K SLT+L L NQ TGS+P ++ L +L L L++N L G I L ++ L+ L
Sbjct: 446 DLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALELHQNWLSGNISADLGKLKNLERLR 505
Query: 293 LNNNLLMGPIPKFKAGNVT------YDSNSFCQSEPGIECAPDVNV-LLDFLGGVNYPVN 345
L NN G IP + GN+T SN P E V + LD G N
Sbjct: 506 LANNNFTGEIPP-EIGNLTKIVGFNISSNQLTGHIPK-ELGSCVTIQRLDLSG------N 557
Query: 346 LVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSI 405
S + + Q +L I+ L + LTG + S +L L+E++LG N +
Sbjct: 558 KFSGYIAQELGQLVYL----------EILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLL 607
Query: 406 SGTVPNNFTELKSLRL-LDVSDNNIKPPLPEFHDTVKLV----IDGNPL----------- 449
S +P +L SL++ L++S NN+ +P+ ++++ ++ N L
Sbjct: 608 SENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNL 667
Query: 450 ---LVGGI-NHTQAPTSPGPVSSPTPPGSQSPSNHTSSGRGQSPSSGNSPPSPITHPNSN 505
L+ I N+ T P S NH G S S P P
Sbjct: 668 MSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNH---GLCNSQRSHCQPLVP------- 717
Query: 506 HSSIHVQPQRKSTKRLKLLVVVGISVVVTVVLVVILLCIYCCKKRKGTLEAPGSIVVHPR 565
HS + ++R K+L + I V+ +V L+ L + K+R+ P + +
Sbjct: 718 HSDSKLNWLINGSQRQKILTITCI-VIGSVFLITFLGLCWTIKRRE-----PAFVALE-- 769
Query: 566 DPSDPENMVKIAVSNDTARSLSSQTVASSGSTNSGATENSHVIESGTLVISVQVLRKVTQ 625
D + P+ M S G T G + T+
Sbjct: 770 DQTKPDVM-------------DSYYFPKKGFTYQGLVD-------------------ATR 797
Query: 626 NFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHL 685
NF+++ LGRG GTVYK E+ G IAVK++ + + + F++EI+ L K+RHR++
Sbjct: 798 NFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSRGEGASSDNSFRAEISTLGKIRHRNI 857
Query: 686 VSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLH 745
V L G+ N LL+YEYM G+L L R EK L L W R IAL A G+ YLH
Sbjct: 858 VKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCL--LDWNARYRIALGAAEGLCYLH 915
Query: 746 CLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAV 805
R +HRD+KS+NILLD+ ++A V DFGL KL ++ +AG++GY+APEYA
Sbjct: 916 HDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMSAVAGSYGYIAPEYAY 975
Query: 806 MGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPAL 865
K+T K D++S+GVVL+EL+TG + + E+ L W R + D L
Sbjct: 976 TMKVTEKCDIYSFGVVLLELITGKPPV--QPLEQGGDLVNWVRRSIRNMIPTIEMFDARL 1033
Query: 866 EVNEE-TFESISIVAELAGHCTAREPYHRPDMGHVVNVLS 904
+ N++ T +S+V ++A CT+ P RP M VV +++
Sbjct: 1034 DTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAMIT 1073
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function description |
|---|
Score = 278 bits (710), Expect = 2e-73, Method: Compositional matrix adjust.
Identities = 270/875 (30%), Positives = 400/875 (45%), Gaps = 80/875 (9%)
Query: 81 GPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFDTIPSDFFDGLSS 139
G +P L +L L N +G +P G LE L N + FDG SS
Sbjct: 343 GEIPHEIEDCPMLKHLSLASNLLSGSIPRELCGSGSLEAIDLSGNLLSGTIEEVFDGCSS 402
Query: 140 VRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSY 199
+ L L N N SIP+ L + L L L + N G +P L +L SY
Sbjct: 403 LGELLLTNNQING----SIPEDLWK-LPLMALDLDSNNFTGEIPKSLWKSTNLMEFTASY 457
Query: 200 NRLSGVIPASFGQSL-MQILWLNDQDAGGMTGPI-DVVAKMVSLTQLWLHGNQFTGSIPE 257
NRL G +PA G + ++ L L+D +TG I + K+ SL+ L L+ N F G IP
Sbjct: 458 NRLEGYLPAEIGNAASLKRLVLSDNQ---LTGEIPREIGKLTSLSVLNLNANMFQGKIPV 514
Query: 258 DIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGPI---PKFKAGNVTYD 313
++G +SL L+L N L G IP + + +L LVL+ N L G I P +
Sbjct: 515 ELGDCTSLTTLDLGSNNLQGQIPDKITALAQLQCLVLSYNNLSGSIPSKPSAYFHQIEMP 574
Query: 314 SNSFCQ------------SEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWL 361
SF Q S P E + VL++ N+ L + P +
Sbjct: 575 DLSFLQHHGIFDLSYNRLSGPIPEELGECLVLVEISLSNNH---LSGEIPASLSRLTNLT 631
Query: 362 GLSCTSNS-------------KVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGT 408
L + N+ K+ +NL + L G + S L SL+++ L KN + G
Sbjct: 632 ILDLSGNALTGSIPKEMGNSLKLQGLNLANNQLNGHIPESFGLLGSLVKLNLTKNKLDGP 691
Query: 409 VPNNFTELKSLRLLDVSDNNIK----PPLPEFHDTVKLVIDGN------PLLVGGINHTQ 458
VP + LK L +D+S NN+ L V L I+ N P +G + +
Sbjct: 692 VPASLGNLKELTHMDLSFNNLSGELSSELSTMEKLVGLYIEQNKFTGEIPSELGNLTQLE 751
Query: 459 -APTSPGPVSSPTP------PGSQSPSNHTSSGRGQSPSSG--NSPPSPITHPNSNHSSI 509
S +S P P + + ++ RG+ PS G P + N
Sbjct: 752 YLDVSENLLSGEIPTKICGLPNLEFLNLAKNNLRGEVPSDGVCQDPSKALLSGNKELCGR 811
Query: 510 HVQPQRKSTKRLKLLVVVGISVVVTVVLVVILLCIYCCKKRKGTLEAPGSIVVHPRDPSD 569
V K + KL GI+ ++ +++ + ++ ++ T V RD D
Sbjct: 812 VVGSDCK-IEGTKLRSAWGIAGLMLGFTIIVFVFVFSLRRWAMTKR------VKQRD--D 862
Query: 570 PENMVKIAVSNDTARSLSSQTVASSGSTNSGATENSHVIESGTLVISVQVLRKVTQNFAQ 629
PE M + + ++L S + + N + E L + + + + T +F++
Sbjct: 863 PERMEESRLKGFVDQNL---YFLSGSRSREPLSINIAMFEQPLLKVRLGDIVEATDHFSK 919
Query: 630 ENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLL 689
+N +G GGFGTVYK L +AVK++ T+ EF +E+ L KV+H +LVSLL
Sbjct: 920 KNIIGDGGFGTVYKACLPGEKTVAVKKLSE--AKTQGNREFMAEMETLGKVKHPNLVSLL 977
Query: 690 GYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLAR 749
GY E+LLVYEYM +G+L H R + L+ L W++RL IA+ ARG+ +LH
Sbjct: 978 GYCSFSEEKLLVYEYMVNGSLD-HWLRNQTGMLEVLDWSKRLKIAVGAARGLAFLHHGFI 1036
Query: 750 QTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKI 809
IHRD+K+SNILLD D+ KV+DFGL +L E V T +AGTFGY+ PEY +
Sbjct: 1037 PHIIHRDIKASNILLDGDFEPKVADFGLARLISACESHVSTVIAGTFGYIPPEYGQSARA 1096
Query: 810 TTKADVFSYGVVLMELLTGLAALDEERPE-ESRYLAEWFWRIKSSKEKFKAAIDPALEVN 868
TTK DV+S+GV+L+EL+TG + E E L W + K ++ K IDP L V+
Sbjct: 1097 TTKGDVYSFGVILLELVTGKEPTGPDFKESEGGNLVGWAIQ-KINQGKAVDVIDPLL-VS 1154
Query: 869 EETFESISIVAELAGHCTAREPYHRPDMGHVVNVL 903
S + ++A C A P RP+M V+ L
Sbjct: 1155 VALKNSQLRLLQIAMLCLAETPAKRPNMLDVLKAL 1189
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8LPB4|PSKR1_DAUCA Phytosulfokine receptor 1 OS=Daucus carota GN=PSKR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 263 bits (672), Expect = 5e-69, Method: Compositional matrix adjust.
Identities = 251/867 (28%), Positives = 392/867 (45%), Gaps = 116/867 (13%)
Query: 69 VTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFD 127
++ + +QN L G L +L+ L L + NKF+GK+P F L++L + N F+
Sbjct: 232 LSVLALQNNRLSGALSSKLGKLSNLGRLDISSNKFSGKIPDVFLELNKLWYFSAQSNLFN 291
Query: 128 TIPSDFFDGLSSVRVLALDYNPFN--------------------KTFGWSIPDSLANSVQ 167
S+ +L+L N + +F SIP +L N ++
Sbjct: 292 GEMPRSLSNSRSISLLSLRNNTLSGQIYLNCSAMTNLTSLDLASNSFSGSIPSNLPNCLR 351
Query: 168 LTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPA----SFGQSLMQ-ILWLND 222
L ++ + +P+ SL +L S + + + A Q+L +L LN
Sbjct: 352 LKTINFAKIKFIAQIPESFKNFQSLTSLSFSNSSIQNISSALEILQHCQNLKTLVLTLNF 411
Query: 223 QDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKS 282
Q + P + +L L + Q G++P+ + SL+ L+L+ NQL G IP
Sbjct: 412 QKEELPSVP---SLQFKNLKVLIIASCQLRGTVPQWLSNSPSLQLLDLSWNQLSGTIPPW 468
Query: 283 LANM-ELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDF---LG 338
L ++ L L L+NN +G IP + S EP +PD G
Sbjct: 469 LGSLNSLFYLDLSNNTFIGEIPHSLTSLQSLVSKENAVEEP----SPDFPFFKKKNTNAG 524
Query: 339 GVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEI 398
G+ Y N P P +I+L ++L G++ P +L L +
Sbjct: 525 GLQY----------NQPSSFP------------PMIDLSYNSLNGSIWPEFGDLRQLHVL 562
Query: 399 RLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLPEFHDTVKLVIDGNPLLVGGINHTQ 458
L N++SG +P N + + SL +LD+S NN+ +P P LV +
Sbjct: 563 NLKNNNLSGNIPANLSGMTSLEVLDLSHNNLSGNIP-------------PSLVKLSFLST 609
Query: 459 APTSPGPVSSPTPPGSQSPSNHTSSGRGQSPSSG-NSPPSPITHPNSNHSSIHVQPQRKS 517
+ +S P P G Q + SS G G ++ P IT + + S++ KS
Sbjct: 610 FSVAYNKLSGPIPTGVQFQTFPNSSFEGNQGLCGEHASPCHITDQSPHGSAV------KS 663
Query: 518 TKRLKLLVVVGISVVVTVVLVVILLCIYCCKKRKGTLEAPGSIVVHPRDPSDPENMVKIA 577
K ++ +V V + + V ++ + + + R DPE K A
Sbjct: 664 KKNIRKIVAVAVGTGLGTVFLLTVTLLIILRTTS-------------RGEVDPE---KKA 707
Query: 578 VSNDTARSLSSQTVASSGSTNSGATENSHVIESGTLVISVQVLRKVTQNFAQENELGRGG 637
+++ L S++V + +S +S+ + K T +F Q N +G GG
Sbjct: 708 DADEI--ELGSRSVVLFHNKDSNNE------------LSLDDILKSTSSFNQANIIGCGG 753
Query: 638 FGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNE 697
FG VYK L DGTK+A+KR+ T + EFQ+E+ LS+ +H +LV LLGY N+
Sbjct: 754 FGLVYKATLPDGTKVAIKRLSG--DTGQMDREFQAEVETLSRAQHPNLVHLLGYCNYKND 811
Query: 698 RLLVYEYMPHGALSRHLFRWEKLQLKP-LSWTRRLSIALDVARGMEYLHCLARQTFIHRD 756
+LL+Y YM +G+L L EK+ P L W RL IA A G+ YLH +HRD
Sbjct: 812 KLLIYSYMDNGSLDYWLH--EKVDGPPSLDWKTRLRIARGAAEGLAYLHQSCEPHILHRD 869
Query: 757 LKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVF 816
+KSSNILL D + A ++DFGL +L + V T L GT GY+ PEY T K DV+
Sbjct: 870 IKSSNILLSDTFVAHLADFGLARLILPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVY 929
Query: 817 SYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESIS 876
S+GVVL+ELLTG +D +P SR L W ++K+ K + DP + +++ E +
Sbjct: 930 SFGVVLLELLTGRRPMDVCKPRGSRDLISWVLQMKTEKRE-SEIFDPFI-YDKDHAEEML 987
Query: 877 IVAELAGHCTAREPYHRPDMGHVVNVL 903
+V E+A C P RP +V+ L
Sbjct: 988 LVLEIACRCLGENPKTRPTTQQLVSWL 1014
|
Phytosulfokine receptor with a serine/threonine-protein kinase activity. Regulates, in response to phytosulfokine binding, a signaling cascade involved in plant cell differentiation, organogenesis and somatic embryogenesis. Daucus carota (taxid: 4039) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 261 bits (668), Expect = 1e-68, Method: Compositional matrix adjust.
Identities = 265/935 (28%), Positives = 418/935 (44%), Gaps = 153/935 (16%)
Query: 68 RVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSG-LSELEFAYLDFNEF 126
+T + + N L+G L + + LT L L N GK+P G L +LE YL N F
Sbjct: 386 ELTNLYLNNNSLEGTLSSSISNLTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRF 445
Query: 127 D-TIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDF 185
+P + + R+ +D+ + IP S+ LT L L LVG +P
Sbjct: 446 SGEMPVEIGN---CTRLQEIDW--YGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPAS 500
Query: 186 LGTLPSLAALKLSYNRLSGVIPASFG--------------------------QSLMQILW 219
LG + + L+ N+LSG IP+SFG ++L +I +
Sbjct: 501 LGNCHQMTVIDLADNQLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSLINLKNLTRINF 560
Query: 220 LNDQDAG-------------------GMTGPIDV-VAKMVSLTQLWLHGNQFTGSIPEDI 259
+++ G G G I + + K +L +L L NQFTG IP
Sbjct: 561 SSNKFNGSISPLCGSSSYLSFDVTENGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTF 620
Query: 260 GALSSLKDLNLNRNQLVGLIPKSLA-NMELDNLVLNNNLLMGPIPKFKA-----GNVTYD 313
G +S L L+++RN L G+IP L +L ++ LNNN L G IP + G +
Sbjct: 621 GKISELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLS 680
Query: 314 SNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSI 373
SN F S P E N+L FL G N + Q GN ++
Sbjct: 681 SNKFVGSLP-TEIFSLTNILTLFLDG-NSLNGSIPQEIGNLQA--------------LNA 724
Query: 374 INLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLR-LLDVSDNNIKPP 432
+NL + L+G L +I L L E+RL +N+++G +P +L+ L+ LD+S NN
Sbjct: 725 LNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGR 784
Query: 433 LPEFHDTVKLVIDGNPLLVGGINHTQ-APTSPGPVSSPTPPGSQSPSNHTSSGRGQSPSS 491
+P T+ L ++H Q PG + G + S + G+ + S
Sbjct: 785 IPSTISTLP------KLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKKQFS 838
Query: 492 --------GNSP--PSPITHPNSNHSSIHVQPQRKSTKRLKLLVVVGISVVVTVVLVVIL 541
GN+ SP++H N S ++S ++++ IS + + L+V++
Sbjct: 839 RWQADAFVGNAGLCGSPLSHCNRAGSK-----NQRSLSPKTVVIISAISSLAAIALMVLV 893
Query: 542 LCIYCCKKRKGTLEAPGSIVVHPRDPSDPENMVKIAVSNDTARSLSSQTVASSGSTNSGA 601
+ ++ + ++ K ++A S +S + + +N GA
Sbjct: 894 IILFFKQNH---------------------DLFKKVRGGNSAFSSNSSSSQAPLFSNGGA 932
Query: 602 TENSHVIESGTLVISVQVLRKVTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRM--EA 659
+ I + + T +E +G GG G VYK EL++G IAVK++ +
Sbjct: 933 KSD----------IKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKILWKD 982
Query: 660 GVTTTKALDEFQSEIAVLSKVRHRHLVSLLGY--SIEGNERLLVYEYMPHGALSRHLFRW 717
+ + K+ F E+ L +RHRHLV L+GY S LL+YEYM +G++ L
Sbjct: 983 DLMSNKS---FNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHAN 1039
Query: 718 EKLQLKP-LSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFG 776
E + K L W RL IAL +A+G+EYLH +HRD+KSSN+LLD + A + DFG
Sbjct: 1040 ENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFG 1099
Query: 777 LVKLAP---DGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALD 833
L K+ D T AG++GY+APEYA K T K+DV+S G+VLME++TG +
Sbjct: 1100 LAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTE 1159
Query: 834 EERPEESRYLAEWFWRI------KSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTA 887
EE+ + W + ++EK + +L EE E+ V E+A CT
Sbjct: 1160 AMFDEETD-MVRWVETVLDTPPGSEAREKLIDSELKSLLPCEE--EAAYQVLEIALQCTK 1216
Query: 888 REPYHRPD----MGHVVNVLSPLVEKWRPITDESE 918
P RP +++NV + +R + +++
Sbjct: 1217 SYPQERPSSRQASEYLLNVFNNRAASYREMQTDTD 1251
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FN37|PSKR2_ARATH Phytosulfokine receptor 2 OS=Arabidopsis thaliana GN=PSKR2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 259 bits (662), Expect = 8e-68, Method: Compositional matrix adjust.
Identities = 251/886 (28%), Positives = 391/886 (44%), Gaps = 121/886 (13%)
Query: 60 PHVFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEF 118
P S + Q+ + L G L +N + L+ L +L + N+F+ +P F L++LE
Sbjct: 225 PDYLYSIRELEQLSLSGNYLSGELSKNLSNLSGLKSLLISENRFSDVIPDVFGNLTQLEH 284
Query: 119 AYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNL 178
+ N+F S +RVL L N + SI + L L L + +
Sbjct: 285 LDVSSNKFSGRFPPSLSQCSKLRVLDLR----NNSLSGSINLNFTGFTDLCVLDLASNHF 340
Query: 179 VGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQ-SLMQILWLNDQDAGGMTGPIDVVAK 237
GPLPD LG P + L L+ N G IP +F + L L++ + ++V+
Sbjct: 341 SGPLPDSLGHCPKMKILSLAKNEFRGKIPDTFKNLQSLLFLSLSNNSFVDFSETMNVLQH 400
Query: 238 MVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANME-LDNLVLNNN 296
+L+ L L N IP ++ +L L L L G IP L N + L+ L L+ N
Sbjct: 401 CRNLSTLILSKNFIGEEIPNNVTGFDNLAILALGNCGLRGQIPSWLLNCKKLEVLDLSWN 460
Query: 297 LLMGPIPKFKAG-----NVTYDSNSFCQSEPG--------IECAPDVNVLLDFLGGVNY- 342
G IP + + + +N+ + P I + + D G Y
Sbjct: 461 HFYGTIPHWIGKMESLFYIDFSNNTLTGAIPVAITELKNLIRLNGTASQMTDSSGIPLYV 520
Query: 343 ---------PVNLVSQWP-----GNDPCQG---PWLGLSCTSNSKVSIINLPRHNLTGTL 385
P N VS++P N+ G P +G ++ +++L R+N TGT+
Sbjct: 521 KRNKSSNGLPYNQVSRFPPSIYLNNNRLNGTILPEIG----RLKELHMLDLSRNNFTGTI 576
Query: 386 SPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLP---EFHDTVKL 442
SI+ LD+L + L N + G++P +F L L V+ N + +P +F+
Sbjct: 577 PDSISGLDNLEVLDLSYNHLYGSIPLSFQSLTFLSRFSVAYNRLTGAIPSGGQFYSFPHS 636
Query: 443 VIDGNPLLVGGINHTQAPTSPGPVSSPTPPGSQSPSNHTSSGRGQSPSSGNSPPSPITHP 502
+GN L I+ +P + P GS +N+
Sbjct: 637 SFEGNLGLCRAID---SPCDVLMSNMLNPKGSSRRNNNGG-------------------- 673
Query: 503 NSNHSSIHVQPQRKSTKRLKLLVVVGISVVVTVVLVVILLCIYCCKKRKGTLEAPGSIVV 562
+ R S L + + +GI+++++V+L+ I
Sbjct: 674 ---------KFGRSSIVVLTISLAIGITLLLSVILLRI---------------------- 702
Query: 563 HPRDPSDPENMVKIAVSNDTARSLSSQTVASSGSTNSGATENSHVIESGTLVISVQVLRK 622
+D D N V + +++L + S G +SV+ L K
Sbjct: 703 SRKDVDDRINDVDEETISGVSKALGPSKIVLFHSC-------------GCKDLSVEELLK 749
Query: 623 VTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRH 682
T NF+Q N +G GGFG VYK DG+K AVKR+ + EFQ+E+ LS+ H
Sbjct: 750 STNNFSQANIIGCGGFGLVYKANFPDGSKAAVKRLSGDCGQMER--EFQAEVEALSRAEH 807
Query: 683 RHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGME 742
++LVSL GY GN+RLL+Y +M +G+L L + L W RL IA ARG+
Sbjct: 808 KNLVSLQGYCKHGNDRLLIYSFMENGSLDYWLHERVDGNM-TLIWDVRLKIAQGAARGLA 866
Query: 743 YLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPE 802
YLH + IHRD+KSSNILLD+ + A ++DFGL +L + V T L GT GY+ PE
Sbjct: 867 YLHKVCEPNVIHRDVKSSNILLDEKFEAHLADFGLARLLRPYDTHVTTDLVGTLGYIPPE 926
Query: 803 YAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862
Y+ T + DV+S+GVVL+EL+TG ++ + + R L +++K+ K + ID
Sbjct: 927 YSQSLIATCRGDVYSFGVVLLELVTGRRPVEVCKGKSCRDLVSRVFQMKAEKRE-AELID 985
Query: 863 PALE--VNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPL 906
+ VNE T + + E+A C EP RP + VV L L
Sbjct: 986 TTIRENVNERT---VLEMLEIACKCIDHEPRRRPLIEEVVTWLEDL 1028
|
Phytosulfokine receptor with a serine/threonine-protein kinase activity. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 973 | ||||||
| 224059228 | 936 | predicted protein [Populus trichocarpa] | 0.945 | 0.982 | 0.727 | 0.0 | |
| 359479100 | 994 | PREDICTED: probable receptor protein kin | 0.960 | 0.940 | 0.707 | 0.0 | |
| 356542042 | 988 | PREDICTED: probable receptor protein kin | 0.968 | 0.953 | 0.679 | 0.0 | |
| 296084035 | 917 | unnamed protein product [Vitis vinifera] | 0.933 | 0.990 | 0.679 | 0.0 | |
| 359482053 | 960 | PREDICTED: probable receptor protein kin | 0.967 | 0.980 | 0.679 | 0.0 | |
| 356542792 | 933 | PREDICTED: probable receptor protein kin | 0.948 | 0.989 | 0.673 | 0.0 | |
| 356541378 | 926 | PREDICTED: probable receptor protein kin | 0.944 | 0.992 | 0.675 | 0.0 | |
| 224104561 | 870 | predicted protein [Populus trichocarpa] | 0.893 | 0.998 | 0.706 | 0.0 | |
| 255583590 | 961 | Serine/threonine-protein kinase PBS1, pu | 0.951 | 0.963 | 0.663 | 0.0 | |
| 224091435 | 948 | predicted protein [Populus trichocarpa] | 0.965 | 0.990 | 0.652 | 0.0 |
| >gi|224059228|ref|XP_002299778.1| predicted protein [Populus trichocarpa] gi|222847036|gb|EEE84583.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1404 bits (3635), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 698/959 (72%), Positives = 785/959 (81%), Gaps = 39/959 (4%)
Query: 16 VGVANSATDPNDLKILNDFKNGLENPELLKWPANGDDPCGPPPWPHVFCSGNRVTQIQVQ 75
V + S TDPNDLKIL DF+ GLENPELLKWPANGDDPCGPP WPHVFCS RVTQIQVQ
Sbjct: 16 VTLGYSVTDPNDLKILLDFQKGLENPELLKWPANGDDPCGPPLWPHVFCSDGRVTQIQVQ 75
Query: 76 NLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFD 135
++GLKGPLPQNFNQL+KLYN+GLQRN F GKLPTF GLSELEFA+LD+N FDTIPSDFF
Sbjct: 76 SMGLKGPLPQNFNQLSKLYNIGLQRNNFTGKLPTFKGLSELEFAFLDYNNFDTIPSDFFV 135
Query: 136 GLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAAL 195
GLSS+RVLALD NP N++ GWS+P LA+SVQLTNLS+ + NL G LPDFLG++ SL+ L
Sbjct: 136 GLSSIRVLALDSNPLNESTGWSLPSELADSVQLTNLSVSSSNLAGSLPDFLGSMQSLSNL 195
Query: 196 KLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSI 255
+LSYNRLSG IPASFG+SLM L LN+Q+ GGM+GPIDV+A M SL+QLWLHGN FTG+I
Sbjct: 196 RLSYNRLSGEIPASFGKSLMSTLLLNNQEGGGMSGPIDVIASMTSLSQLWLHGNSFTGTI 255
Query: 256 PEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMGPIPKFKAGNVTYDSN 315
PE+IG LS L+DLNLN N+LVGL+P+SLA+M LD+L LNNN LMGP+PKFKAG V+Y+SN
Sbjct: 256 PENIGGLSLLRDLNLNGNKLVGLVPQSLADMPLDDLDLNNNQLMGPVPKFKAGKVSYESN 315
Query: 316 SFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIIN 375
FCQS+PG+ECAP+VN LLDFLGGVNYP L SQW GNDPCQG WLGL+C SNSKVS+IN
Sbjct: 316 PFCQSKPGVECAPEVNALLDFLGGVNYPSILTSQWSGNDPCQGSWLGLNCDSNSKVSVIN 375
Query: 376 LPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLPE 435
L RHNLTGTLSPSIA LDSLIEI LG NSI GT+P+NFT L SLRLLDVS NN+ PPLP+
Sbjct: 376 LLRHNLTGTLSPSIARLDSLIEIDLGGNSIKGTIPSNFTNLNSLRLLDVSGNNLGPPLPK 435
Query: 436 FHDTVKLVIDGNPLLVGGINHTQAPTSPGPVSSPTPPGSQSPSNHTSSGRGQSPSSGNSP 495
F +VKLV+DGNPLL ++P G++P
Sbjct: 436 FRTSVKLVVDGNPLL-----------------------------------DENPPRGSAP 460
Query: 496 PSPITHPNSNHSSIHVQPQRKSTKRLKLLVVVGISVVVTVVLVVILLCIYCC-KKRKGTL 554
PSP T P S S + + +R KL++V GI + +V+I L +YCC KKRK T
Sbjct: 461 PSPSTMPFSPPSPTSIS---NTNQRTKLVIVGGIFAGSLLAIVLIALSLYCCFKKRKETS 517
Query: 555 EAPGSIVVHPRDPSDPENMVKIAVSNDTARSLSSQTVASSGSTNSGATENSHVIESGTLV 614
P SIVVHPRDPSD EN+VKIA SN+T RSLS+QT SS S S TENS ++ESG +V
Sbjct: 518 NPPSSIVVHPRDPSDRENIVKIAFSNNTIRSLSTQTGISSVSNTSNLTENSSLVESGNVV 577
Query: 615 ISVQVLRKVTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEI 674
ISVQVLRKVT NFAQ+N+LG GGFG VYKGELEDGTKIAVKRMEAGV +KA DEFQ+EI
Sbjct: 578 ISVQVLRKVTDNFAQKNQLGSGGFGIVYKGELEDGTKIAVKRMEAGVMGSKAGDEFQAEI 637
Query: 675 AVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIA 734
AVLSKVRHRHLVSLLGYSIEGNERLLVYEYMP GALS HLF W+KL L+PLSW RRLSIA
Sbjct: 638 AVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPQGALSMHLFHWKKLNLEPLSWMRRLSIA 697
Query: 735 LDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAG 794
LDVARG+EYLH LARQTFIHRDLKSSNILL DD+ AKVSDFGLVKLAPD E+SV TRLAG
Sbjct: 698 LDVARGVEYLHSLARQTFIHRDLKSSNILLGDDFHAKVSDFGLVKLAPDREQSVATRLAG 757
Query: 795 TFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSK 854
TFGYLAPEYAVMGKITTK DVFSYGVVLMELLTGL ALDEERPEESRYLAEWFWRIKSSK
Sbjct: 758 TFGYLAPEYAVMGKITTKVDVFSYGVVLMELLTGLTALDEERPEESRYLAEWFWRIKSSK 817
Query: 855 EKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPIT 914
EK AAIDPAL VN+ETFESIS +AELAGHCT+R+P HRPDMGH VNVL PLVEKW+P+
Sbjct: 818 EKLMAAIDPALNVNDETFESISSIAELAGHCTSRDPNHRPDMGHAVNVLVPLVEKWKPVN 877
Query: 915 DESECCSGIDYSLPLPQMLKVWQEAESKEISYPNLEDSKGSIPARPTGFAESFTSSDGR 973
DESE GIDYS PLP+MLKVWQ+A+S +SY +L DSKGSIPARP GFAESFTS+DGR
Sbjct: 878 DESEDFYGIDYSQPLPEMLKVWQDADSTGLSYTSLSDSKGSIPARPAGFAESFTSADGR 936
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359479100|ref|XP_002274506.2| PREDICTED: probable receptor protein kinase TMK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1396 bits (3613), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 688/973 (70%), Positives = 785/973 (80%), Gaps = 38/973 (3%)
Query: 2 DHVRFSVVLVLYFVVGVANSATDPNDLKILNDFKNGLENPELLKWPANGDDPCGPPPWPH 61
D + VVL+L + VA+ ATDP+D+KILNDF+ GLEN ELLKWP +GDDPCGPP WPH
Sbjct: 59 DQSKLWVVLILC-IFRVAHCATDPSDMKILNDFRKGLENSELLKWPDDGDDPCGPPLWPH 117
Query: 62 VFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYL 121
VFCSG+RV QIQV+ LGLKGPLPQNFNQL+ LYNLGLQRN FNGKLP+F GLSEL+FA+L
Sbjct: 118 VFCSGDRVAQIQVEGLGLKGPLPQNFNQLSMLYNLGLQRNHFNGKLPSFRGLSELQFAFL 177
Query: 122 DFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGP 181
D+NEFDTIP+DFFDGL+S+R+LAL+ NPFN T GWSIPD L SVQLT LSL NCNLVGP
Sbjct: 178 DYNEFDTIPADFFDGLTSIRILALNDNPFNATTGWSIPDELQKSVQLTTLSLGNCNLVGP 237
Query: 182 LPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSL 241
LP+FLGTLPSL LKL YNRLSG IPASFGQSLMQILWLNDQD GGM+GP+DV+ MVSL
Sbjct: 238 LPEFLGTLPSLTTLKLPYNRLSGEIPASFGQSLMQILWLNDQDGGGMSGPMDVIGSMVSL 297
Query: 242 TQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMGP 301
TQLWLHGNQFTG+IPE IG L+SL+DLNLN N+LVGL+P+SLANMEL L LNNN LMGP
Sbjct: 298 TQLWLHGNQFTGTIPESIGDLTSLRDLNLNGNKLVGLVPESLANMELQKLDLNNNHLMGP 357
Query: 302 IPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWL 361
IPKF +GNV+Y SNSFCQSEPG++C+P+VN LLDFL VNYP+ L S+W GNDPC+ PWL
Sbjct: 358 IPKFTSGNVSYASNSFCQSEPGLQCSPEVNALLDFLAAVNYPLGLASEWSGNDPCEQPWL 417
Query: 362 GLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRL 421
GL C NSKVSI+NLP L GTLSPSI NLDSL+EIRLG N+++GT+P N T+L SL+
Sbjct: 418 GLGCNPNSKVSIVNLPNFRLNGTLSPSIGNLDSLVEIRLGGNNLTGTIPMNLTKLTSLKK 477
Query: 422 LDVSDNNIKPPLPEFHDTVKLVIDGNPLLVGGINHTQAPTSPGPVSSPTPPGSQSPSNHT 481
LDVS NN +PP+P F ++VK++ +GN P G+Q+ +
Sbjct: 478 LDVSGNNFEPPVPRFQESVKVITNGN---------------------PRLAGNQTEPSPP 516
Query: 482 SSGRGQSPSSGNSPPSPITHPNSNHSSIHVQPQRKSTKRLK-LLVVVGISVVVTVVLVVI 540
+P + ++KRLK +++V IS + ++VI
Sbjct: 517 PGSPPSP--------------PPGSPPSPFKP-KSTSKRLKTVIIVAAISAFAILAMLVI 561
Query: 541 LLCIYCCKKRKGTLEAPGSIVVHPRDPSDPENMVKIAVSNDTARSLSSQTVASSGSTNSG 600
LL +YC KKRK +EAP SIVVHPRDP DP+NMVKIAVS++T SL +QT +S S +S
Sbjct: 562 LLTLYCRKKRKDQVEAPSSIVVHPRDPFDPDNMVKIAVSSNTTGSLFTQTGSSIESRDSS 621
Query: 601 ATENSHVIESGTLVISVQVLRKVTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAG 660
NSH IESG L+ISVQVLRKVT NFA ENELGRGGFG VYKGELEDGTKIAVKRMEAG
Sbjct: 622 GVHNSHKIESGNLIISVQVLRKVTDNFAPENELGRGGFGAVYKGELEDGTKIAVKRMEAG 681
Query: 661 VTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKL 720
V + ALDEFQ+EIAVLSKVRHRHLVSLLG+SIEGNERLLVYE+M HGALSRHLF W+ L
Sbjct: 682 VVSNTALDEFQAEIAVLSKVRHRHLVSLLGHSIEGNERLLVYEFMSHGALSRHLFHWKNL 741
Query: 721 QLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKL 780
+L+PLSW RLSIALDVARGMEYLH LAR++FIHRDLKSSNILL DD+RAKV+DFGLVKL
Sbjct: 742 KLEPLSWKMRLSIALDVARGMEYLHGLARESFIHRDLKSSNILLGDDFRAKVADFGLVKL 801
Query: 781 APDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEES 840
APD KSV TRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDE R EE
Sbjct: 802 APDRGKSVATRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEGRSEEC 861
Query: 841 RYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVV 900
RYLAEWFWRIKSSKEK AA+DPA+ EETFESIS+VAELAGHCTAREP HRPDMGH V
Sbjct: 862 RYLAEWFWRIKSSKEKLMAAVDPAIGATEETFESISVVAELAGHCTAREPSHRPDMGHAV 921
Query: 901 NVLSPLVEKWRPITDESECCSGIDYSLPLPQMLKVWQEAESKEISYPNLEDSKGSIPARP 960
NVLSPLVEKW+P +E+E SGIDYSLPLPQMLK WQEAE+K+ S+ +LEDSKGSIPARP
Sbjct: 922 NVLSPLVEKWKPFDNETESYSGIDYSLPLPQMLKGWQEAETKDFSHTSLEDSKGSIPARP 981
Query: 961 TGFAESFTSSDGR 973
GFAESFTSSDGR
Sbjct: 982 AGFAESFTSSDGR 994
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356542042|ref|XP_003539480.1| PREDICTED: probable receptor protein kinase TMK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1316 bits (3407), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 663/976 (67%), Positives = 784/976 (80%), Gaps = 34/976 (3%)
Query: 8 VVLVLYF--VVGVANSATDPNDLKILNDFKNGLENPELLKWPANGDDPCGPPPWPHVFCS 65
VV +L F ++ ++ AT+PND+K+LNDF+ GLENPELLKWP GDDPCGPP WP V+CS
Sbjct: 37 VVFLLCFGLIITMSYGATNPNDVKVLNDFRKGLENPELLKWPEEGDDPCGPPLWPFVYCS 96
Query: 66 GNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNE 125
G+RVTQIQ ++LGL+G LP NFNQL++L+NLGLQRN +G LPTFSGLS+L++A+LD+N
Sbjct: 97 GDRVTQIQAKDLGLRGTLPHNFNQLSELFNLGLQRNNLSGMLPTFSGLSKLKYAFLDYNA 156
Query: 126 FDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDF 185
FD IP+DFFDGLSS+ VL L+ NP N + GWS P L SVQLTNLSL CNLVGPLPDF
Sbjct: 157 FDAIPADFFDGLSSLMVLTLEKNPLNVSSGWSFPMDLEKSVQLTNLSLAFCNLVGPLPDF 216
Query: 186 LGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLW 245
LG LPSL L LS N+L+G IPA+F QS +Q LWLN+Q+ GG++GPIDV+A M+ L +
Sbjct: 217 LGRLPSLTQLSLSGNKLTGAIPATFAQSSIQDLWLNNQEGGGLSGPIDVIASMILLRHVL 276
Query: 246 LHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMGPIPKF 305
LHGNQFTG IP++IG L+SL++LNLN NQLVGLIP+SLA+MEL+ LVLNNN+LMGPIP+F
Sbjct: 277 LHGNQFTGPIPQNIGNLTSLQELNLNSNQLVGLIPESLAHMELEILVLNNNMLMGPIPEF 336
Query: 306 KAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQ---GPWLG 362
KA NV+YD+N FCQ EPG+EC+P V LLDFL +NYP L+S W G++PC G W G
Sbjct: 337 KAANVSYDNNLFCQPEPGLECSPQVAALLDFLDKLNYPSFLISDWVGDEPCTRSTGSWFG 396
Query: 363 LSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLL 422
LSC SNS+VS+INLPRH L GTLSPS+A LDSL+EIRL N+I+G+VP NFT+LKSLRLL
Sbjct: 397 LSCNSNSEVSVINLPRHKLNGTLSPSLAKLDSLLEIRLAGNNITGSVPGNFTDLKSLRLL 456
Query: 423 DVSDNNIKPPLPEFHDTVKLVIDGNPLLVGGINHTQAPTSPGPVSSPTPPGSQSPSNHTS 482
D+SDNN++PPLP+FH+ K+V GNPLL N T SP P+++P P Q+PS+
Sbjct: 457 DLSDNNLEPPLPKFHNDPKVVTVGNPLLP---NQTGGSPSPMPINNP--PSPQNPSH--- 508
Query: 483 SGRGQSPSSGNSPPSPITHPNSNHSSIHVQPQRKSTKRLKLLVVVGISVVVTVVLVVILL 542
P S + P P SN S LK+ VGI V V VV LL
Sbjct: 509 ------PPSSHESPVPDQSSRSNQSK---------PNDLKIFKAVGIVAGVAVFAVVALL 553
Query: 543 CIY---CCKK-RKGTLEAPGSIVVHPRDPSDPENMVKIAVSNDTARSLSSQTVASSGSTN 598
+Y CC+K +K +L+AP SI+VHPRDPSD +NMVKI VSN T SLS++T SS S
Sbjct: 554 VVYPFLCCRKNKKASLDAPSSIMVHPRDPSDSDNMVKITVSNATG-SLSTKTGTSSQSNI 612
Query: 599 SGATENSHVIESGTLVISVQVLRKVTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRME 658
SG T+NSH+IE G LVIS+QVLRKVT +FA ENELGRGGFGTVYKGELEDGTKIAVKRME
Sbjct: 613 SGETQNSHIIEDGNLVISIQVLRKVTNDFASENELGRGGFGTVYKGELEDGTKIAVKRME 672
Query: 659 AGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWE 718
GV ++KAL+EFQ+EIAVLSKVRHRHLVSLLGYSI+GNERLLVYEYM GALS+HLF W+
Sbjct: 673 HGVISSKALEEFQAEIAVLSKVRHRHLVSLLGYSIDGNERLLVYEYMSLGALSQHLFHWK 732
Query: 719 KLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLV 778
L+L+PLSW++RL+IALDVARGMEYLH LARQTFIHRDLKSSNILL DD+RAK+SDFGLV
Sbjct: 733 SLKLEPLSWSQRLAIALDVARGMEYLHSLARQTFIHRDLKSSNILLGDDFRAKISDFGLV 792
Query: 779 KLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPE 838
K APD EKSV T+LAGTFGYLAPEYAVMGKITTK DVFSYGVVLMELLTGL ALDE RPE
Sbjct: 793 KHAPDSEKSVATKLAGTFGYLAPEYAVMGKITTKVDVFSYGVVLMELLTGLVALDESRPE 852
Query: 839 ESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGH 898
ESRYLAEWFWRIKSSKEK AAIDP LE +EETFESI+IVAELAGHCTARE +HRPDMGH
Sbjct: 853 ESRYLAEWFWRIKSSKEKLMAAIDPVLEASEETFESITIVAELAGHCTAREAHHRPDMGH 912
Query: 899 VVNVLSPLVEKWRPITDESECCSGIDYSLPLPQMLKVWQEAESKEISYPN-LEDSKGSIP 957
VNVL+ LVEKW+P+ DE +C SGIDY+ PLPQMLK+W+EAES E SY + LE+S+ SI
Sbjct: 913 AVNVLAALVEKWKPVDDELDCYSGIDYTRPLPQMLKIWKEAESGEFSYASCLENSRSSIA 972
Query: 958 ARPTGFAESFTSSDGR 973
ARP+GFA+SFTS+D R
Sbjct: 973 ARPSGFADSFTSADAR 988
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296084035|emb|CBI24423.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1316 bits (3406), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 665/978 (67%), Positives = 755/978 (77%), Gaps = 70/978 (7%)
Query: 2 DHVRFSVVLVLYFVVGVANSATDPNDLKILNDFKNGLENPELLKWPANGDDPCGPPPWPH 61
D + VVL+L + VA+ ATDP+D+KILNDF+ GLEN ELLKWP +GDDPCGPP WPH
Sbjct: 4 DQSKLWVVLILC-IFRVAHCATDPSDMKILNDFRKGLENSELLKWPDDGDDPCGPPLWPH 62
Query: 62 VFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYL 121
VFCSG+RV QIQV+ LGLKGPLPQNFNQL+ LYNLGLQRN FNGKLP+F GLSEL+FA+L
Sbjct: 63 VFCSGDRVAQIQVEGLGLKGPLPQNFNQLSMLYNLGLQRNHFNGKLPSFRGLSELQFAFL 122
Query: 122 DFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGP 181
D+NEFDTIP+DFFDGL+S+R+LAL+ NPFN T GWSIPD L SVQLT LSL NCNLVGP
Sbjct: 123 DYNEFDTIPADFFDGLTSIRILALNDNPFNATTGWSIPDELQKSVQLTTLSLGNCNLVGP 182
Query: 182 LPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSL 241
LP+FLGTLPSL LKL YNRLSG IPASFGQSLMQILWLNDQD GGM+GP+DV+ MVSL
Sbjct: 183 LPEFLGTLPSLTTLKLPYNRLSGEIPASFGQSLMQILWLNDQDGGGMSGPMDVIGSMVSL 242
Query: 242 TQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMGP 301
TQLWLHGNQFTG+IPE IG L+SL+DLNLN N+LVGL+P+SLANMEL L LNNN LMGP
Sbjct: 243 TQLWLHGNQFTGTIPESIGDLTSLRDLNLNGNKLVGLVPESLANMELQKLDLNNNHLMGP 302
Query: 302 IPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWL 361
IPKF +GNV+Y SNSFCQSEPG++C+P+VN LLDFL VNYP+ L S+W GNDPC+ PWL
Sbjct: 303 IPKFTSGNVSYASNSFCQSEPGLQCSPEVNALLDFLAAVNYPLGLASEWSGNDPCEQPWL 362
Query: 362 GLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRL 421
GL C NSKVSI+NLP L +GT+ + L SL
Sbjct: 363 GLGCNPNSKVSIVNLPNFRL------------------------NGTLSPSIGNLDSLVE 398
Query: 422 LDVSDNNIKPPLP----EFHDTVKLVIDGNPLLVGGINHTQAPTSPGPVSSPTPPGSQSP 477
+ + NN+ +P + KL + GN P P Q
Sbjct: 399 IRLGGNNLTGTIPMNLTKLTSLKKLDVSGNNF------------------EPPVPRFQES 440
Query: 478 SNHTSSGRGQSPSSGNSPPSPITHPNSNHSSIHVQPQRKST-KRLK-LLVVVGISVVVTV 535
++G + + V P+ KST KRLK +++V IS +
Sbjct: 441 VKVITNG---------------------NPRLAVHPEPKSTSKRLKTVIIVAAISAFAIL 479
Query: 536 VLVVILLCIYCCKKRKGTLEAPGSIVVHPRDPSDPENMVKIAVSNDTARSLSSQTVASSG 595
++VILL +YC KKRK +EAP SIVVHPRDP DP+NMVKIAVS++T SL +QT +S
Sbjct: 480 AMLVILLTLYCRKKRKDQVEAPSSIVVHPRDPFDPDNMVKIAVSSNTTGSLFTQTGSSIE 539
Query: 596 STNSGATENSHVIESGTLVISVQVLRKVTQNFAQENELGRGGFGTVYKGELEDGTKIAVK 655
S +S NSH IESG L+ISVQVLRKVT NFA ENELGRGGFG VYKGELEDGTKIAVK
Sbjct: 540 SRDSSGVHNSHKIESGNLIISVQVLRKVTDNFAPENELGRGGFGAVYKGELEDGTKIAVK 599
Query: 656 RMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLF 715
RMEAGV + ALDEFQ+EIAVLSKVRHRHLVSLLG+SIEGNERLLVYE+M HGALSRHLF
Sbjct: 600 RMEAGVVSNTALDEFQAEIAVLSKVRHRHLVSLLGHSIEGNERLLVYEFMSHGALSRHLF 659
Query: 716 RWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDF 775
W+ L+L+PLSW RLSIALDVARGMEYLH LAR++FIHRDLKSSNILL DD+RAKV+DF
Sbjct: 660 HWKNLKLEPLSWKMRLSIALDVARGMEYLHGLARESFIHRDLKSSNILLGDDFRAKVADF 719
Query: 776 GLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEE 835
GLVKLAPD KSV TRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDE
Sbjct: 720 GLVKLAPDRGKSVATRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEG 779
Query: 836 RPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPD 895
R EE RYLAEWFWRIKSSKEK AA+DPA+ EETFESIS+VAELAGHCTAREP HRPD
Sbjct: 780 RSEECRYLAEWFWRIKSSKEKLMAAVDPAIGATEETFESISVVAELAGHCTAREPSHRPD 839
Query: 896 MGHVVNVLSPLVEKWRPITDESECCSGIDYSLPLPQMLKVWQEAESKEISYPNLEDSKGS 955
MGH VNVLSPLVEKW+P +E+E SGIDYSLPLPQMLK WQEAE+K+ S+ +LEDSKGS
Sbjct: 840 MGHAVNVLSPLVEKWKPFDNETESYSGIDYSLPLPQMLKGWQEAETKDFSHTSLEDSKGS 899
Query: 956 IPARPTGFAESFTSSDGR 973
IPARP GFAESFTSSDGR
Sbjct: 900 IPARPAGFAESFTSSDGR 917
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359482053|ref|XP_002274910.2| PREDICTED: probable receptor protein kinase TMK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1301 bits (3367), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 654/963 (67%), Positives = 761/963 (79%), Gaps = 22/963 (2%)
Query: 11 VLYFVVGVANSATDPNDLKILNDFKNGLENPELLKWPANGDDPCGPPPWPHVFCSGNRVT 70
VL+ +V V +ATDPNDL ILN F+ GL+NPELL WP NGDDPCG P W HVFCSG+RV+
Sbjct: 20 VLFSLVAVVFTATDPNDLAILNQFRKGLKNPELLNWPENGDDPCGIPRWDHVFCSGSRVS 79
Query: 71 QIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIP 130
QIQVQNLGLKGPLPQN NQL+ L +LGLQRN+F+G+LP+ SGLSEL +AY DFNEFD+IP
Sbjct: 80 QIQVQNLGLKGPLPQNLNQLSMLTSLGLQRNQFSGQLPSLSGLSELRYAYFDFNEFDSIP 139
Query: 131 SDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLP 190
SDFFDGL ++ VL LD N N T GWS+P L NS QL NL+L+N NLVGPLP+FLG +
Sbjct: 140 SDFFDGLVNLEVLELDNNNLNVTTGWSLPSQLQNSAQLRNLTLVNSNLVGPLPEFLGNMS 199
Query: 191 SLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQ 250
SLA LKLS N +SG IPASF S ++ILWLN+Q G MTGPIDVVA M+SLT LWLHGN+
Sbjct: 200 SLAVLKLSMNTISGGIPASFKDSNLEILWLNNQKGGQMTGPIDVVATMLSLTTLWLHGNK 259
Query: 251 FTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMGPIPKFKAGNV 310
F+G IPE+IG L+SLKDLNLN NQLVGLIP SLA++EL++L LNNN LMGPIP FKA NV
Sbjct: 260 FSGPIPENIGDLTSLKDLNLNSNQLVGLIPDSLASLELNSLDLNNNQLMGPIPNFKAVNV 319
Query: 311 TYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSK 370
+YDSN CQS+PG+ CA +V VLL+FLGG+NYP +LVS W GNDPC+GPWLGLSC ++ K
Sbjct: 320 SYDSNQLCQSKPGVPCAKEVMVLLEFLGGLNYPNHLVSSWSGNDPCEGPWLGLSC-ADQK 378
Query: 371 VSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIK 430
VSIINLP+ GTLSPS+ANL+SL +IRL N+I+G VP N+T LKSL LD+S NNI
Sbjct: 379 VSIINLPKFGFNGTLSPSLANLESLSQIRLPSNNITGQVPTNWTSLKSLTYLDLSGNNIS 438
Query: 431 PPLPEFHDTVKLVIDGNPLLVGGINHTQAPTSPGPVSSPTPPGSQSPSNHTSSGRGQSPS 490
PP P F TVKLV+ GNPLL + Q+ T SS S ++ T G +
Sbjct: 439 PPFPNFSKTVKLVLYGNPLL----SSNQSTTPGNSPSSGGSQSSSGSASPT---MGSNSG 491
Query: 491 SGNSPPSPITHPNSNHSSIHVQPQRKSTKRLKLLVVVGISVVVTVVLVVILLCIYCCKKR 550
+ +S P + NS + +++VV ++ +V +V L IY CKKR
Sbjct: 492 TSDSSEEPTKNKNSKGPKL-------------VVIVVPLASFALLVFLVAPLSIYYCKKR 538
Query: 551 KGTLEAPGSIVVHPRDPSDPENMVKIAVSNDTARSLSSQTVASSGSTNSGATENSHVIES 610
K T +A S+V+HPRDPSD ENMVKI V+N S+S+ A SGS NS T SHVIE+
Sbjct: 539 KNTNQASSSLVIHPRDPSDSENMVKIVVANSNNGSVSTLG-ACSGSRNSSGTGESHVIEA 597
Query: 611 GTLVISVQVLRKVTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEF 670
G LVISVQVLR VT+NFA EN LGRGGFG VYKGEL+DGTKIAVKRMEAG+ ++KALDEF
Sbjct: 598 GNLVISVQVLRNVTKNFAPENVLGRGGFGVVYKGELDDGTKIAVKRMEAGIISSKALDEF 657
Query: 671 QSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRR 730
Q+EIAVLSKVRHRHLVSLLGYS+EGNER+LVYEYMP GALS+HLF W+ L+L+PLSW RR
Sbjct: 658 QAEIAVLSKVRHRHLVSLLGYSVEGNERILVYEYMPQGALSKHLFHWKSLKLEPLSWKRR 717
Query: 731 LSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVT 790
L+IALDVARGMEYLH LA QTFIHRDLKSSNILL DDYRAKVSDFGLVKLAPDGEKSVVT
Sbjct: 718 LNIALDVARGMEYLHTLAHQTFIHRDLKSSNILLGDDYRAKVSDFGLVKLAPDGEKSVVT 777
Query: 791 RLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRI 850
+LAGTFGYLAPEYAV GKIT K DVFS+GVVLMELLTGL ALDE+RPEES+YLA WFW I
Sbjct: 778 KLAGTFGYLAPEYAVTGKITVKVDVFSFGVVLMELLTGLMALDEDRPEESQYLAAWFWHI 837
Query: 851 KSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKW 910
KS+KEK AAIDP L+ EET ESIS +AELAGHCTAREP RP+MGH VNVL+PLVEKW
Sbjct: 838 KSNKEKLMAAIDPVLDKKEETLESISTIAELAGHCTAREPSQRPEMGHAVNVLAPLVEKW 897
Query: 911 RPITDESECCSGIDYSLPLPQMLKVWQEAESKEISYPNLEDSKGSIPARPTGFAESFTSS 970
+P D++E SGIDYSLPL QM+K WQEAE K+ SY +LEDSKGSIPARPTGFA+SFTS+
Sbjct: 898 KPFDDDTEEYSGIDYSLPLNQMVKGWQEAEGKDFSYLDLEDSKGSIPARPTGFADSFTSA 957
Query: 971 DGR 973
DGR
Sbjct: 958 DGR 960
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356542792|ref|XP_003539849.1| PREDICTED: probable receptor protein kinase TMK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1298 bits (3359), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 641/952 (67%), Positives = 751/952 (78%), Gaps = 29/952 (3%)
Query: 23 TDPNDLKILNDFKNGLENPELLKWPANGDDPCGPPPWPHVFCSGNRVTQIQVQNLGLKGP 82
T+PNDL+ILNDF+ GL+NPELLKWP NG+DPCGPP W +V+CSG RVTQIQ +NLGL+G
Sbjct: 10 TNPNDLRILNDFRKGLKNPELLKWPDNGNDPCGPPSWSYVYCSGGRVTQIQTKNLGLEGS 69
Query: 83 LPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRV 142
LP NFNQL +L NLGLQRN +G+LPTFSGLS+L++A+LD+NEFD+IPSDFF+GL+S++V
Sbjct: 70 LPPNFNQLYELQNLGLQRNNLSGRLPTFSGLSKLQYAFLDYNEFDSIPSDFFNGLNSIKV 129
Query: 143 LALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRL 202
L+L+ NP N T GW P L NSVQL NLSL+NCNLVG LPDFLGTLPSL L+LS NRL
Sbjct: 130 LSLEVNPLNATTGWYFPKDLENSVQLINLSLVNCNLVGTLPDFLGTLPSLTNLRLSGNRL 189
Query: 203 SGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGAL 262
+G IPASF +S +Q+LWLNDQ+ GGMTGPIDVVA M L Q+WLHGNQF+G+IP++IG L
Sbjct: 190 TGAIPASFNRSSIQVLWLNDQEGGGMTGPIDVVASMTFLRQVWLHGNQFSGTIPQNIGNL 249
Query: 263 SSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEP 322
+SL++LNLN NQLVGLIP SLANM+L LVLNNN MGPIPKFKA V+YDSN FCQS+P
Sbjct: 250 TSLQELNLNSNQLVGLIPDSLANMDLQILVLNNNGFMGPIPKFKADKVSYDSNLFCQSKP 309
Query: 323 GIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLT 382
G+ECAP V LLDFL +NYP L S+W GNDPC W GLSC NSKVSIINLPR L
Sbjct: 310 GLECAPQVTALLDFLNNLNYPSGLASKWSGNDPCGESWFGLSCDQNSKVSIINLPRQQLN 369
Query: 383 GTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLPEFHDTVKL 442
GTLS S+A LDSL+EIRL +N+I+G VP+ FTELKSLRLLD+ DNN++PPLP FH VK+
Sbjct: 370 GTLSSSLAKLDSLLEIRLAENNITGKVPSKFTELKSLRLLDLRDNNVEPPLPNFHSGVKV 429
Query: 443 VIDGNPLLVGGINHTQAPTSPGPVSSPTPPGSQSPSNHTSSGRGQSPSSGNSPPSPITHP 502
+I+GNP L N + SP P +S PP S PS H S QS
Sbjct: 430 IIEGNPRLG---NQPVSSPSPTPFTS-RPPSSAQPSPHDPSNSNQS-------------- 471
Query: 503 NSNHSSIHVQPQRKSTKRLKLL-VVVGISVVVTVVLVVILLCIYCCKKRKGTLEAPGSIV 561
SS+ ++P R KR K + +V G ++ V L+V L I C KK K + +V
Sbjct: 472 ----SSVRLKPHRNGFKRFKTVAIVAGAAIFAFVALLVTSLLICCLKKEKAS-----KVV 522
Query: 562 VHPRDPSDPENMVKIAVSNDTARSLSSQTVASSGSTNSGATENSHVIESGTLVISVQVLR 621
VH +DPS PE M+K AV + T SLS++T SS + SG TE+SHVIE + IS+Q LR
Sbjct: 523 VHTKDPSYPEKMIKFAVMDSTTGSLSTKTGISSLTNISGETESSHVIEDRNIAISIQDLR 582
Query: 622 KVTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR 681
KVT NFA ENELG GGFGTVYKGELE+G KIAVKRME G +++AL+EFQ+EIAVLSKVR
Sbjct: 583 KVTNNFASENELGHGGFGTVYKGELENGKKIAVKRMECGAVSSRALEEFQAEIAVLSKVR 642
Query: 682 HRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGM 741
HRHLVSLLGYSIEGNER+LVYEYMP GALSRHLF W+ L+L+PLS ++RL+IALDVAR M
Sbjct: 643 HRHLVSLLGYSIEGNERILVYEYMPMGALSRHLFHWKNLKLEPLSLSQRLTIALDVARAM 702
Query: 742 EYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAP 801
EYLH LARQTFIHRDLKSSNILL DD+ AKVSDFGLVKLAPDG+KSV T+LAGTFGYLAP
Sbjct: 703 EYLHGLARQTFIHRDLKSSNILLGDDFHAKVSDFGLVKLAPDGQKSVATKLAGTFGYLAP 762
Query: 802 EYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861
EYAVMGKITTK DVFSYGVVLMELLTGL ALDE R EESRYLAEWFW+IKSSKE AAI
Sbjct: 763 EYAVMGKITTKVDVFSYGVVLMELLTGLMALDESRSEESRYLAEWFWQIKSSKETLMAAI 822
Query: 862 DPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPITDESECCS 921
DPALE +EE FESISIVAELAGHCT+R+ HRPDM H V+VLS LVEKWRP+ +E + S
Sbjct: 823 DPALEASEEAFESISIVAELAGHCTSRDASHRPDMSHAVSVLSALVEKWRPVDEEFDYGS 882
Query: 922 GIDYSLPLPQMLKVWQEAESKEISYPNLEDSKGSIPARPTGFAESFTSSDGR 973
GID+S PLPQ+LK W+E+E KE SY + S+GSIPARPTGFA+SFTS+D R
Sbjct: 883 GIDFSQPLPQLLKDWKESEGKESSYTSAH-SEGSIPARPTGFADSFTSADAR 933
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356541378|ref|XP_003539154.1| PREDICTED: probable receptor protein kinase TMK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1295 bits (3350), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 643/952 (67%), Positives = 752/952 (78%), Gaps = 33/952 (3%)
Query: 23 TDPNDLKILNDFKNGLENPELLKWPANGDDPCGPPPWPHVFCSGNRVTQIQVQNLGLKGP 82
T+PNDLKILNDF+ ++NPELLKWP NG+DPCGPP WP+V+CSG RVTQIQ QNLGL+G
Sbjct: 7 TNPNDLKILNDFRKRMKNPELLKWPDNGNDPCGPPSWPYVYCSGGRVTQIQTQNLGLEGS 66
Query: 83 LPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRV 142
LP NFNQL++L NLGLQRN +G LPTFSGLS LE+A+LD+NEFD IPSDFF+GL++++
Sbjct: 67 LPPNFNQLSELTNLGLQRNNLSGTLPTFSGLSNLEYAFLDYNEFDKIPSDFFNGLNNIKF 126
Query: 143 LALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRL 202
L+L+ NP N T GW P L NSVQLTNLSL+NCNLVG LPDFLGTLPSL L+LS NRL
Sbjct: 127 LSLEVNPLNATTGWYFPKDLENSVQLTNLSLVNCNLVGTLPDFLGTLPSLKNLRLSGNRL 186
Query: 203 SGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGAL 262
+G IP+SF QSL+Q+LWLNDQ GGMTGPIDV+A M L Q+WLHGNQF+G+IP++IG L
Sbjct: 187 TGTIPSSFNQSLIQVLWLNDQKGGGMTGPIDVIASMTFLRQVWLHGNQFSGTIPQNIGNL 246
Query: 263 SSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEP 322
+SL++LNLN NQLVGLIP SLANM+L LVLNNN MGPIPKFKA ++YDSN FCQS+P
Sbjct: 247 TSLQELNLNSNQLVGLIPDSLANMDLQILVLNNNGFMGPIPKFKAAKISYDSNLFCQSKP 306
Query: 323 GIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLT 382
G+ECAP+V LLDFL +NYP L S+W GNDPC W GLSC NSKVSIINLPR L
Sbjct: 307 GLECAPEVTALLDFLNNLNYPSGLASKWSGNDPCGESWFGLSCGQNSKVSIINLPRQQLN 366
Query: 383 GTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLPEFHDTVKL 442
GTLSPS+A LDSL+EIRL +NSI+G VP+NFT+LKSLRLLD+SDNN +PPLP FH VK+
Sbjct: 367 GTLSPSLAKLDSLLEIRLAENSITGKVPSNFTQLKSLRLLDLSDNNFEPPLPNFHSGVKV 426
Query: 443 VIDGNPLLVGGINHTQAPTSPGPVSSPTPPGSQSPSNHTSSGRGQSPSSGNSPPSPITHP 502
+I+GN L +G N + SP P++S TPP S PS H S
Sbjct: 427 IIEGN-LRLG--NQPVSSPSPMPITS-TPPSSAQPSPHNPSRSLSP-------------- 468
Query: 503 NSNHSSIHVQPQRKSTKRLKLL-VVVGISVVVTVVLVVILLCIYCCKKRKGTLEAPGSIV 561
S H+QP ++R K + +V G ++ +V L+V L + C KK K + ++V
Sbjct: 469 ----PSSHMQP----SQRFKTVAIVAGAAIFASVALLVTSLFLCCLKKEKAS-----NVV 515
Query: 562 VHPRDPSDPENMVKIAVSNDTARSLSSQTVASSGSTNSGATENSHVIESGTLVISVQVLR 621
VH +DPS PE M+K+AV + T SLS++T S + SG TENSHVIE G + IS+Q LR
Sbjct: 516 VHTKDPSYPEKMIKVAVMDSTTESLSTKTGISFLTNISGETENSHVIEDGNIAISIQDLR 575
Query: 622 KVTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR 681
KVT NFA ENELG GGFGTVYKGELE+G KIAVKRME G +++AL+EF +EIAVLSKVR
Sbjct: 576 KVTNNFASENELGHGGFGTVYKGELENGIKIAVKRMECGAVSSRALEEFHAEIAVLSKVR 635
Query: 682 HRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGM 741
HRHLVSLLGYSIEGNERLLVYEYMP GALSRHLF W+ L+L+PLS + RL+IALDVAR M
Sbjct: 636 HRHLVSLLGYSIEGNERLLVYEYMPMGALSRHLFNWKTLKLEPLSLSHRLTIALDVARAM 695
Query: 742 EYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAP 801
EYLH LARQTFIHRDLKSSNILL DDYRAKVSDFGLVKLAPDGEKSV T+LAGTFGYLAP
Sbjct: 696 EYLHGLARQTFIHRDLKSSNILLGDDYRAKVSDFGLVKLAPDGEKSVATKLAGTFGYLAP 755
Query: 802 EYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861
EYAVMGKITTK DVFSYGVVLMELLTGL ALDE R EESRYLAEWFW+IKSSKE AAI
Sbjct: 756 EYAVMGKITTKVDVFSYGVVLMELLTGLMALDERRSEESRYLAEWFWQIKSSKETLMAAI 815
Query: 862 DPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPITDESECCS 921
DPALE + ETFESISIVAELAGHCT+R+ HRPDM H V VLS LVEKWRP+ +E + S
Sbjct: 816 DPALEASGETFESISIVAELAGHCTSRDASHRPDMSHAVGVLSALVEKWRPVDEEFDYGS 875
Query: 922 GIDYSLPLPQMLKVWQEAESKEISYPNLEDSKGSIPARPTGFAESFTSSDGR 973
GID + PLPQ+LK W+E+E KE SY + S+GS+PARPTGFA+SFTS+D R
Sbjct: 876 GIDLTQPLPQLLKAWKESEGKESSYTSAH-SEGSMPARPTGFADSFTSADAR 926
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224104561|ref|XP_002313480.1| predicted protein [Populus trichocarpa] gi|222849888|gb|EEE87435.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1276 bits (3302), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 634/898 (70%), Positives = 726/898 (80%), Gaps = 29/898 (3%)
Query: 77 LGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDG 136
+GLKGPLPQNFNQL+KLYN+GLQRN FNGKLPTF GLSEL +A+L+ N FDTIPSDFF+G
Sbjct: 1 MGLKGPLPQNFNQLSKLYNIGLQRNNFNGKLPTFKGLSELVYAFLNGNNFDTIPSDFFEG 60
Query: 137 LSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALK 196
LSS+ VLALD N N++ GWS+P LA+SVQLTN S+ +CNL GPLPDFLG++PSL+ L+
Sbjct: 61 LSSIAVLALDGNSLNESTGWSLPSELASSVQLTNFSVSSCNLAGPLPDFLGSMPSLSNLE 120
Query: 197 LSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIP 256
LSYNRLSG IPASFGQSLM IL LN+Q+ GGM+G IDV+A M SL+QLWLHGN F+G+IP
Sbjct: 121 LSYNRLSGEIPASFGQSLMSILLLNNQEGGGMSGSIDVIANMTSLSQLWLHGNSFSGTIP 180
Query: 257 EDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMGPIPKFKAGNVTYDSNS 316
E IG LS L+DLNLN N+LVG IP+SLA+M+L+NL LNNN LMGP+P FKAG V+YDSN
Sbjct: 181 EKIGDLSLLRDLNLNGNKLVGYIPQSLADMQLENLDLNNNQLMGPVPVFKAGKVSYDSNP 240
Query: 317 FCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINL 376
CQS+PG+ECAP+V LLDFL GVNYP N+ QW GNDPC GPWLGL+C SNSKVS+INL
Sbjct: 241 LCQSKPGVECAPEVYALLDFLSGVNYPSNIAPQWSGNDPCHGPWLGLNCDSNSKVSVINL 300
Query: 377 PRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLPEF 436
PR NLTGTL+PSIA LDSL++I LG N I GT+P+N T LKSLRL DVS+NN+ PPLP+F
Sbjct: 301 PRRNLTGTLNPSIAKLDSLVQIGLGGNDIEGTIPSNLTNLKSLRLFDVSENNLGPPLPKF 360
Query: 437 HDTVKLVIDGNPLLVGGINHTQAPTSPGPVSSPTPPGSQSPSNHTSSGRGQSPSSGNSPP 496
++VKLV+DGNPLLVG ++ + S P
Sbjct: 361 RNSVKLVVDGNPLLVG----------------------------SAQPSPFTMPSSPPSP 392
Query: 497 SPITHPNSNHSSIHVQPQRKSTKRLKLLVVVGISVVVTVVLVVILLCIYCC-KKRKGTLE 555
+ +H N + S+ +++ +R KL++V GI + +V+I LC+Y C KK+K T
Sbjct: 393 TSSSHANRSTSTKVPAQTKRNFERTKLVIVGGILAGSLLAVVLIALCLYSCFKKKKETSN 452
Query: 556 APGSIVVHPRDPSDPENMVKIAVSNDTARSLSSQTVASSGSTNSGATENSHVIESGTLVI 615
P SIVVHPRDPSD EN VKIAVS++ SLS+QT SS S S TENS IE+G ++I
Sbjct: 453 PPCSIVVHPRDPSDSENFVKIAVSDNITGSLSTQTGTSSVSNTSSLTENSRAIEAGNVII 512
Query: 616 SVQVLRKVTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIA 675
SVQVLRKVT NFAQ+N+LG GGFGTVYKGELEDGTKIAVKRMEAGV + KA+DEFQ+EIA
Sbjct: 513 SVQVLRKVTDNFAQKNQLGSGGFGTVYKGELEDGTKIAVKRMEAGVVSGKAVDEFQAEIA 572
Query: 676 VLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIAL 735
VLSKVRHRHLVSLLGYSIEGNERLLVYEY+ GALS HLF W+KL L+PLSWTRRLSIAL
Sbjct: 573 VLSKVRHRHLVSLLGYSIEGNERLLVYEYLSEGALSMHLFHWKKLNLEPLSWTRRLSIAL 632
Query: 736 DVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGT 795
DVARGMEYLH LARQTFIHRDLKSSNILL DD+RAKVSDFGLVKLAPDGEKSVVTRLAGT
Sbjct: 633 DVARGMEYLHSLARQTFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDGEKSVVTRLAGT 692
Query: 796 FGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKE 855
FGYLAPEYAVMGKITTKADVFSYGVVLMELLTGL ALDEER EESRYLAEWFW+IKSSKE
Sbjct: 693 FGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLTALDEERSEESRYLAEWFWKIKSSKE 752
Query: 856 KFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPITD 915
K AAIDP L +EE FESI +AELAGHCT REP HRPDMGH VNVL+PLVEKW+PI D
Sbjct: 753 KLMAAIDPTLNASEEIFESIYTIAELAGHCTLREPNHRPDMGHAVNVLAPLVEKWKPIND 812
Query: 916 ESECCSGIDYSLPLPQMLKVWQEAESKEISYPNLEDSKGSIPARPTGFAESFTSSDGR 973
ESE SGIDYSLPLP+MLKVWQ+ ES SY +L DSK SIPARP GFAESFTS+DGR
Sbjct: 813 ESEDFSGIDYSLPLPEMLKVWQDGESTGRSYTSLNDSKSSIPARPAGFAESFTSADGR 870
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255583590|ref|XP_002532551.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] gi|223527740|gb|EEF29845.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1246 bits (3223), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 634/956 (66%), Positives = 743/956 (77%), Gaps = 30/956 (3%)
Query: 21 SATDPNDLKILNDFKNGLENPELLKWPANGD-DPCGPPPWPHVFCSGNRVTQIQVQNLGL 79
S TDPNDL IL F++GLENPELL+WPA+GD DPCG W HV C +RVTQIQV+N+ L
Sbjct: 33 SDTDPNDLAILKAFRDGLENPELLEWPASGDEDPCGQS-WKHVHCVDSRVTQIQVENMRL 91
Query: 80 KGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSS 139
KGPLP+N NQLT L NLGLQRN+F G LP+FSGLS L+FAYLD+N+FDTIPSDFF GL +
Sbjct: 92 KGPLPENLNQLTMLVNLGLQRNQFTGPLPSFSGLSNLQFAYLDYNQFDTIPSDFFTGLVN 151
Query: 140 VRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSY 199
++VLALD NPFN T GW+ L +S QLTNLS ++CNLVGPLPDFLG+L SL LKLS
Sbjct: 152 LQVLALDGNPFNATTGWTFSKDLQDSSQLTNLSCMSCNLVGPLPDFLGSLVSLQNLKLSG 211
Query: 200 NRLSGVIPASF-GQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPED 258
N LSG IP SF G +Q LWLN+Q GG++G ID+VA M S+T LWLHGNQFTG IPE
Sbjct: 212 NNLSGEIPPSFKGGMSLQNLWLNNQKGGGLSGTIDLVATMESVTVLWLHGNQFTGKIPES 271
Query: 259 IGALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFC 318
IG L+ LKDLNLN N+LVGL+P SLAN+ L++L LNNN LMGPIPKFKA V+ SN FC
Sbjct: 272 IGRLTQLKDLNLNGNKLVGLVPDSLANLPLEHLDLNNNQLMGPIPKFKATKVSCTSNPFC 331
Query: 319 QSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPR 378
QS G+ CAP+V LL+FL G++YP LVS W NDPC W+G+ C SN KV I LP
Sbjct: 332 QSTAGVSCAPEVMALLEFLDGLSYPPRLVSSWTSNDPCSS-WMGVECVSN-KVYSIALPN 389
Query: 379 HNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLPEFHD 438
NL+GTLSPS+ANL SL +I+LG N++SG VP N+T L SL LD+S+NNI PP P+F
Sbjct: 390 QNLSGTLSPSVANLGSLHQIKLGGNNLSGQVPTNWTNLASLETLDLSNNNILPPFPKFSS 449
Query: 439 TVKLVIDGNPLLVGGINHTQAPTSPGPVSSPTPPGSQSPSNHTSSGRGQSPSSGNSPPSP 498
TV +VI GNP+L GG T+P P P SPS S +G S S
Sbjct: 450 TVNVVIAGNPMLNGG------KTAPSPDKYPPSGSRDSPS---SQAKGTQSSPAGSSAES 500
Query: 499 ITHPNSNHSSIHVQPQRKSTKRLKLLVVVG-ISVVVTVVLVVILLCIYCCKKRKGTLEAP 557
IT +KS KR L+ V+ ++ V V +++I L IY CKKR+ T++AP
Sbjct: 501 IT--------------QKSPKRSTLVAVIAPLASVAVVAILIIPLSIYFCKKRRDTIQAP 546
Query: 558 GSIVVHPRDPSDPENMVKIAVSNDTARSLSSQTVASSGSTNSGATENSHVIESGTLVISV 617
S+V+HPRDPSD N VKI V++ T S S++T + S S NS SHVIE+G+LVISV
Sbjct: 547 SSLVIHPRDPSDSNN-VKIVVAHHTNGSTSTRTGSDSASINSSGIGESHVIEAGSLVISV 605
Query: 618 QVLRKVTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVL 677
QVLR VT+NFA +NELGRGGFG VYKGEL+DGTKIAVKRME+GV ++KALDEFQ+EIAVL
Sbjct: 606 QVLRNVTKNFAPDNELGRGGFGVVYKGELDDGTKIAVKRMESGVISSKALDEFQAEIAVL 665
Query: 678 SKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDV 737
SKVRHRHLVSLLGYSIEGNER+LVYEYMP GALS+HLF W+ +L+PLSW RRL+IALDV
Sbjct: 666 SKVRHRHLVSLLGYSIEGNERILVYEYMPQGALSKHLFHWKSFELEPLSWKRRLNIALDV 725
Query: 738 ARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFG 797
ARGMEYLH LA ++FIHRDLKSSNILL DD+RAKVSDFGLVKLAPDG+KSVVTRLAGTFG
Sbjct: 726 ARGMEYLHNLAHRSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDGDKSVVTRLAGTFG 785
Query: 798 YLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKF 857
YLAPEYAV GKITTKADVFS+GVVLMELLTGL ALDE+RPEE++YLA WFW I S K+K
Sbjct: 786 YLAPEYAVTGKITTKADVFSFGVVLMELLTGLVALDEDRPEETQYLAAWFWHISSDKQKL 845
Query: 858 KAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPITDES 917
+AAIDPAL+V +ETFESISI+AELAGHCTAREP RPDM H VNVL+PLVEKW+P D++
Sbjct: 846 RAAIDPALDVKDETFESISIIAELAGHCTAREPNQRPDMSHAVNVLAPLVEKWKPSGDDT 905
Query: 918 ECCSGIDYSLPLPQMLKVWQEAESKEISYPNLEDSKGSIPARPTGFAESFTSSDGR 973
E GIDYSLPL QM+K WQEAE K+ SY +LEDSKGSIPARPTGFAESFTS+DGR
Sbjct: 906 EEYCGIDYSLPLNQMVKGWQEAEGKDFSYVDLEDSKGSIPARPTGFAESFTSADGR 961
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224091435|ref|XP_002309250.1| predicted protein [Populus trichocarpa] gi|222855226|gb|EEE92773.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1233 bits (3191), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 632/968 (65%), Positives = 747/968 (77%), Gaps = 29/968 (2%)
Query: 8 VVLVLYFVVGVANSATDPNDLKILNDFKNGLENPELLKWPANGDD-PCGPPPWPHVFCSG 66
+VL L+ + V SATDPND I+ F+ GLENPELL+WPA+GDD PCG W HVFCSG
Sbjct: 8 LVLALFSLFTVVFSATDPNDFAIIKAFREGLENPELLEWPADGDDDPCGQS-WKHVFCSG 66
Query: 67 NRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEF 126
+RVTQIQVQN+ LKG LPQN NQLTKL LGLQRN+F G LP+ SGLSEL+ YLDFN+F
Sbjct: 67 SRVTQIQVQNMSLKGTLPQNLNQLTKLQRLGLQRNQFTGALPSLSGLSELQSVYLDFNQF 126
Query: 127 DTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFL 186
D+IPSD FD L S++ LALD N FN + GWS P+ L +S QLTNLS + CNL GPLP FL
Sbjct: 127 DSIPSDCFDRLVSLQSLALDKNNFNASTGWSFPEGLQDSAQLTNLSCMFCNLAGPLPYFL 186
Query: 187 GTLPSLAALKLSYNRLSGVIPASFGQSL-MQILWLNDQDAGGMTGPIDVVAKMVSLTQLW 245
G L SL L+LS N LSG IPASF +S +Q LWLNDQ+ GG++G +DVV M S+ LW
Sbjct: 187 GALSSLQNLRLSGNNLSGEIPASFKRSTSLQNLWLNDQNGGGLSGTLDVVTTMDSVNVLW 246
Query: 246 LHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMGPIPKF 305
LHGNQFTG+IPE IG L+ L+DLNLN N+LVG +P SLA M L++L LNNN LMGPIP F
Sbjct: 247 LHGNQFTGTIPESIGNLTVLQDLNLNGNKLVGFVPDSLAKMPLEHLDLNNNQLMGPIPNF 306
Query: 306 KAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSC 365
KA V+Y SN+FCQS PG+ CAP+V LL+FLG +NYP LVS W GNDPC WLGL+C
Sbjct: 307 KATEVSYASNAFCQSTPGVPCAPEVMALLEFLGSLNYPSRLVSSWTGNDPCS--WLGLAC 364
Query: 366 TSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVS 425
N V+ I LP NL+GTLSPS+A L SLI+I+LG N++SG VP N+T L SL+ LD+S
Sbjct: 365 -HNGNVNSIALPSSNLSGTLSPSVATLGSLIQIKLGSNNLSGQVPENWTSLTSLKTLDLS 423
Query: 426 DNNIKPPLPEFHDTVKLVIDGNPLLVGGINHTQAPTSPGPVSSPTPPGSQSPSNHTSSGR 485
NNI PPLP+F DTV +V GNPLL GG P+ S + S + + G
Sbjct: 424 TNNISPPLPKFADTVNVVTVGNPLLTGGSPSNPNPSP----GSGSSGSPPSNPSSPTKGT 479
Query: 486 GQSPSSGNSPPSPITHPNSNHSSIHVQPQRKSTKRLKLLVVVGISVVVTVVLVVILLCIY 545
G SP + P V+P+R + + ++ ++ VV V L+ I L IY
Sbjct: 480 GSSPGDSSEP---------------VKPKRSTL----VAIIAPVASVVVVALLAIPLSIY 520
Query: 546 CCKKRKGTLEAPGSIVVHPRDPSDPENMVKIAVSNDTARSLSSQTVASSGSTNSGATENS 605
C KKRK T +AP S+V+HPRDPSD +N VKI V+++T S S+ T + S S NS S
Sbjct: 521 CYKKRKDTFQAPSSLVIHPRDPSDSDNTVKIVVASNTNGSASTITGSGSASRNSSGVGES 580
Query: 606 HVIESGTLVISVQVLRKVTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTK 665
HVIE+G LVISVQVLR VT+NFA ENELGRGGFG VYKGEL+DGTKIAVKRME+GV ++K
Sbjct: 581 HVIEAGNLVISVQVLRNVTKNFASENELGRGGFGVVYKGELDDGTKIAVKRMESGVISSK 640
Query: 666 ALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPL 725
A+DEFQ+EIAVLSKVRHRHLVSLLGYS+EG ER+LVYEYMP GALS+HLF W+ +L+PL
Sbjct: 641 AIDEFQAEIAVLSKVRHRHLVSLLGYSVEGYERILVYEYMPQGALSKHLFHWKSSKLEPL 700
Query: 726 SWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGE 785
SW RRL+IALDVARGMEYLH LA ++FIHRDLKSSNILL DD+RAKVSDFGLVKLAPDGE
Sbjct: 701 SWKRRLNIALDVARGMEYLHNLAHRSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDGE 760
Query: 786 KSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAE 845
KS+VTRLAGTFGYLAPEYAV GKITTK DVFS+G+VLMELLTGL ALDE+RPEES+YLA
Sbjct: 761 KSMVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGIVLMELLTGLMALDEDRPEESQYLAA 820
Query: 846 WFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSP 905
WFWRIKS K+K +AAIDPAL+V +ETFESISI+AELAGHCTAREP RPDMGH VNVL+P
Sbjct: 821 WFWRIKSDKQKLRAAIDPALDVKDETFESISIIAELAGHCTAREPNQRPDMGHAVNVLAP 880
Query: 906 LVEKWRPITDESECCSGIDYSLPLPQMLKVWQEAESKEISYPNLEDSKGSIPARPTGFAE 965
LVEKW+P+ D++E GIDYSLPL QM+K WQEAE K++SY +LEDSK SIPARPTGFAE
Sbjct: 881 LVEKWKPMDDDTEDYCGIDYSLPLNQMVKGWQEAEGKDLSYVDLEDSKSSIPARPTGFAE 940
Query: 966 SFTSSDGR 973
SFTS+DGR
Sbjct: 941 SFTSADGR 948
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 973 | ||||||
| TAIR|locus:2059703 | 943 | AT2G01820 [Arabidopsis thalian | 0.438 | 0.452 | 0.591 | 1.7e-213 | |
| TAIR|locus:2013825 | 942 | TMK1 "transmembrane kinase 1" | 0.434 | 0.449 | 0.589 | 4.1e-213 | |
| TAIR|locus:2095188 | 928 | AT3G23750 [Arabidopsis thalian | 0.417 | 0.437 | 0.571 | 1.5e-199 | |
| TAIR|locus:2024016 | 886 | AT1G24650 [Arabidopsis thalian | 0.402 | 0.442 | 0.568 | 2.7e-193 | |
| UNIPROTKB|Q8RZV7 | 1294 | P0413C03.22 "Putative extra sp | 0.304 | 0.228 | 0.421 | 3.2e-80 | |
| TAIR|locus:2205260 | 1047 | AT1G56120 [Arabidopsis thalian | 0.284 | 0.264 | 0.459 | 2.5e-75 | |
| TAIR|locus:2203718 | 1035 | AT1G53440 [Arabidopsis thalian | 0.349 | 0.328 | 0.367 | 1.3e-74 | |
| TAIR|locus:2019863 | 971 | AT1G79620 [Arabidopsis thalian | 0.309 | 0.309 | 0.406 | 7.2e-74 | |
| TAIR|locus:2160791 | 1102 | AT5G63930 [Arabidopsis thalian | 0.316 | 0.279 | 0.359 | 2.6e-73 | |
| TAIR|locus:2205250 | 1032 | AT1G56130 [Arabidopsis thalian | 0.294 | 0.278 | 0.433 | 3.7e-73 |
| TAIR|locus:2059703 AT2G01820 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1319 (469.4 bits), Expect = 1.7e-213, Sum P(2) = 1.7e-213
Identities = 263/445 (59%), Positives = 333/445 (74%)
Query: 543 CIYCCK-KRKGTLEAPGS-IVVHPRDPSDPENMVKIAVSNDTARSLSSQTVASSGSTNSG 600
C+Y K KR +++P S +V+HP D ++ +K+ V+ A SL+S + S S +
Sbjct: 503 CLYAKKRKRPARVQSPSSNMVIHPHHSGDNDD-IKLTVA---ASSLNSGGGSDSYSHSGS 558
Query: 601 ATENSHVIESGTLVISVQVLRKVTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAG 660
A + HV+E+G LVIS+QVLR VT NF++EN LGRGGFGTVYKGEL DGTKIAVKRME+
Sbjct: 559 AASDIHVVEAGNLVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMESS 618
Query: 661 VTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKL 720
V + K L EF+SEI VL+K+RHRHLV+LLGY ++GNERLLVYEYMP G LS+HLF W++
Sbjct: 619 VVSDKGLTEFKSEITVLTKMRHRHLVALLGYCLDGNERLLVYEYMPQGTLSQHLFHWKEE 678
Query: 721 QLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKL 780
KPL WTRRL+IALDVARG+EYLH LA Q+FIHRDLK SNILL DD RAKVSDFGLV+L
Sbjct: 679 GRKPLDWTRRLAIALDVARGVEYLHTLAHQSFIHRDLKPSNILLGDDMRAKVSDFGLVRL 738
Query: 781 APDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEES 840
APDG+ S+ TR+AGTFGYLAPEYAV G++TTK D+FS GV+LMEL+TG ALDE +PE+S
Sbjct: 739 APDGKYSIETRVAGTFGYLAPEYAVTGRVTTKVDIFSLGVILMELITGRKALDETQPEDS 798
Query: 841 RYLAEWFWRIKSSKEK--FKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGH 898
+L WF R+ +SK++ FK AIDP + ++++T SI V ELAGHC AREPY RPDM H
Sbjct: 799 VHLVTWFRRVAASKDENAFKNAIDPNISLDDDTVASIEKVWELAGHCCAREPYQRPDMAH 858
Query: 899 VVNVLSPLVEKWRPITDESECCSGIDYSLPLPQMLKVWQEAE----------SKEISYPN 948
+VNVLS L +W+P + + GIDY +PLPQ+LK WQ E S +Y +
Sbjct: 859 IVNVLSSLTVQWKPTETDPDDVYGIDYDMPLPQVLKKWQAFEGLSQTADDSGSSSSAYGS 918
Query: 949 LEDSKGSIPARPTGFAESFTSSDGR 973
++++ SIP RP+GFA+SFTS DGR
Sbjct: 919 KDNTQTSIPTRPSGFADSFTSVDGR 943
|
|
| TAIR|locus:2013825 TMK1 "transmembrane kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1277 (454.6 bits), Expect = 4.1e-213, Sum P(3) = 4.1e-213
Identities = 257/436 (58%), Positives = 318/436 (72%)
Query: 548 KKRKGTLEAPGSIVVHPRDPSDPENMVKIAVSNDTARSLS--SQTVASSGSTNSGATENS 605
+KR E+ ++VVHPR VKI V+ + S+ S T G++ G +N
Sbjct: 510 QKRFSGSESSNAVVVHPRHSGSDNESVKITVAGSSV-SVGGISDTYTLPGTSEVG--DNI 566
Query: 606 HVIESGTLVISVQVLRKVTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTK 665
++E+G ++IS+QVLR VT NF+ +N LG GGFG VYKGEL DGTKIAVKRME GV K
Sbjct: 567 QMVEAGNMLISIQVLRSVTNNFSSDNILGSGGFGVVYKGELHDGTKIAVKRMENGVIAGK 626
Query: 666 ALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPL 725
EF+SEIAVL+KVRHRHLV+LLGY ++GNE+LLVYEYMP G LSRHLF W + LKPL
Sbjct: 627 GFAEFKSEIAVLTKVRHRHLVTLLGYCLDGNEKLLVYEYMPQGTLSRHLFEWSEEGLKPL 686
Query: 726 SWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGE 785
W +RL++ALDVARG+EYLH LA Q+FIHRDLK SNILL DD RAKV+DFGLV+LAP+G+
Sbjct: 687 LWKQRLTLALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 746
Query: 786 KSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAE 845
S+ TR+AGTFGYLAPEYAV G++TTK DV+S+GV+LMEL+TG +LDE +PEES +L
Sbjct: 747 GSIETRIAGTFGYLAPEYAVTGRVTTKVDVYSFGVILMELITGRKSLDESQPEESIHLVS 806
Query: 846 WFWRIKSSKE-KFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLS 904
WF R+ +KE FK AID ++++EET S+ VAELAGHC AREPY RPDMGH VN+LS
Sbjct: 807 WFKRMYINKEASFKKAIDTTIDLDEETLASVHTVAELAGHCCAREPYQRPDMGHAVNILS 866
Query: 905 PLVEKWRPITDESECCSGIDYSLPLPQMLKVWQEAESK---EIS----YPNLEDSKGSIP 957
LVE W+P E GID + LPQ LK WQ E + E S P+L++++ SIP
Sbjct: 867 SLVELWKPSDQNPEDIYGIDLDMSLPQALKKWQAYEGRSDLESSTSSLLPSLDNTQMSIP 926
Query: 958 ARPTGFAESFTSSDGR 973
RP GFAESFTS DGR
Sbjct: 927 TRPYGFAESFTSVDGR 942
|
|
| TAIR|locus:2095188 AT3G23750 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1191 (424.3 bits), Expect = 1.5e-199, Sum P(2) = 1.5e-199
Identities = 240/420 (57%), Positives = 297/420 (70%)
Query: 568 SDPENMVKIAVSNDTARSLSSQTVASSG----------STNSGATENSHVIESGTLVISV 617
+DPE + KI VS+ + S ++G S +SG + ++E G++ I +
Sbjct: 509 TDPEKVGKILVSDAVSNGGSGNGGYANGHGANNFNALNSPSSGDNSDRFLLEGGSVTIPM 568
Query: 618 QVLRKVTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVL 677
+VLR+VT NF+++N LGRGGFG VY GEL DGTK AVKRME K + EFQ+EIAVL
Sbjct: 569 EVLRQVTNNFSEDNILGRGGFGVVYAGELHDGTKTAVKRMECAAMGNKGMSEFQAEIAVL 628
Query: 678 SKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDV 737
+KVRHRHLV+LLGY + GNERLLVYEYMP G L +HLF W +L PL+W +R+SIALDV
Sbjct: 629 TKVRHRHLVALLGYCVNGNERLLVYEYMPQGNLGQHLFEWSELGYSPLTWKQRVSIALDV 688
Query: 738 ARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFG 797
ARG+EYLH LA+Q+FIHRDLK SNILL DD RAKV+DFGLVK APDG+ SV TRLAGTFG
Sbjct: 689 ARGVEYLHSLAQQSFIHRDLKPSNILLGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFG 748
Query: 798 YLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKF 857
YLAPEYA G++TTK DV+++GVVLME+LTG ALD+ P+E +L WF RI +KE
Sbjct: 749 YLAPEYAATGRVTTKVDVYAFGVVLMEILTGRKALDDSLPDERSHLVTWFRRILINKENI 808
Query: 858 KAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPITDES 917
A+D LE +EET ESI VAELAGHCTAREP RPDMGH VNVL PLVEKW+P E
Sbjct: 809 PKALDQTLEADEETMESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEKWKPSCQEE 868
Query: 918 ECCSGIDYSLPLPQMLKVWQ-EAESKEISYP---NLEDSKGSIPARPTGFAESFTSSDGR 973
E GID ++ LPQ L+ WQ E S + + ++ SIP + +GF +F S+DGR
Sbjct: 869 EESFGIDVNMSLPQALQRWQNEGTSSSTMFHGDFSYSQTQSSIPPKASGFPNTFDSADGR 928
|
|
| TAIR|locus:2024016 AT1G24650 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1142 (407.1 bits), Expect = 2.7e-193, Sum P(2) = 2.7e-193
Identities = 236/415 (56%), Positives = 298/415 (71%)
Query: 562 VHPRDPSDPENMVKIAVSNDTARSLSSQTVASSGSTNSGATEN-SHVIESGTLVISVQVL 620
+HP+ S ++ KI + N +G + SG + N +H+ E+G +VIS+QVL
Sbjct: 492 MHPQQQSSDQDAFKITIEN-----------LCTGVSESGFSGNDAHLGEAGNIVISIQVL 540
Query: 621 RKVTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV 680
R T NF ++N LGRGGFG VYKGEL DGTKIAVKRME+ + + K LDEF+SEIAVL++V
Sbjct: 541 RDATYNFDEKNILGRGGFGIVYKGELHDGTKIAVKRMESSIISGKGLDEFKSEIAVLTRV 600
Query: 681 RHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARG 740
RHR+LV L GY +EGNERLLVY+YMP G LSRH+F W++ L+PL WTRRL IALDVARG
Sbjct: 601 RHRNLVVLHGYCLEGNERLLVYQYMPQGTLSRHIFYWKEEGLRPLEWTRRLIIALDVARG 660
Query: 741 MEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLA 800
+EYLH LA Q+FIHRDLK SNILL DD AKV+DFGLV+LAP+G +S+ T++AGTFGYLA
Sbjct: 661 VEYLHTLAHQSFIHRDLKPSNILLGDDMHAKVADFGLVRLAPEGTQSIETKIAGTFGYLA 720
Query: 801 PEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAA 860
PEYAV G++TTK DV+S+GV+LMELLTG ALD R EE +LA WF R+ +K F A
Sbjct: 721 PEYAVTGRVTTKVDVYSFGVILMELLTGRKALDVARSEEEVHLATWFRRMFINKGSFPKA 780
Query: 861 IDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPI--TDESE 918
ID A+EVNEET SI+IVAELA C++REP RPDM HVVNVL LV +W+P + +SE
Sbjct: 781 IDEAMEVNEETLRSINIVAELANQCSSREPRDRPDMNHVVNVLVSLVVQWKPTERSSDSE 840
Query: 919 CCSGIDYSLPLPQMLKVWQEAESKEISYPNLEDSKGSIPARPTGFAESFTSSDGR 973
GIDY PLPQ++ +S +++ SIP+RP+ +F S GR
Sbjct: 841 DIYGIDYDTPLPQLI-----LDSCFFG----DNTLTSIPSRPSELESTFKSGQGR 886
|
|
| UNIPROTKB|Q8RZV7 P0413C03.22 "Putative extra sporogenous cells" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 568 (205.0 bits), Expect = 3.2e-80, Sum P(2) = 3.2e-80
Identities = 127/301 (42%), Positives = 176/301 (58%)
Query: 604 NSHVIESGTLVISVQVLRKVTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTT 663
N E L ++ + K T+NF++ + +G GGFGTVYK L +G ++A+KR+ G
Sbjct: 979 NLATFEHALLRVTADDILKATENFSKVHIIGDGGFGTVYKAALPEGRRVAIKRLHGG-HQ 1037
Query: 664 TKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLK 723
+ EF +E+ + KV+H +LV LLGY + G+ER L+YEYM +G+L L R L+
Sbjct: 1038 FQGDREFLAEMETIGKVKHPNLVPLLGYCVCGDERFLIYEYMENGSLEMWL-RNRADALE 1096
Query: 724 PLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783
L W RL I L ARG+ +LH IHRD+KSSNILLD+++ +VSDFGL ++
Sbjct: 1097 ALGWPDRLKICLGSARGLAFLHHGFVPHIIHRDMKSSNILLDENFEPRVSDFGLARIISA 1156
Query: 784 GEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYL 843
E V T +AGTFGY+ PEY + K TTK DV+S+GVV++ELLTG +E + L
Sbjct: 1157 CETHVSTDIAGTFGYIPPEYGLTMKSTTKGDVYSFGVVMLELLTGRPPTGQEEVQGGGNL 1216
Query: 844 AEWF-WRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNV 902
W W I K+ DP L V+ E ++ V +A CTA EP+ RP M VV
Sbjct: 1217 VGWVRWMIARGKQN--ELFDPCLPVSSVWREQMARVLAIARDCTADEPFKRPTMLEVVKG 1274
Query: 903 L 903
L
Sbjct: 1275 L 1275
|
|
| TAIR|locus:2205260 AT1G56120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 595 (214.5 bits), Expect = 2.5e-75, Sum P(2) = 2.5e-75
Identities = 131/285 (45%), Positives = 173/285 (60%)
Query: 620 LRKVTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSK 679
L+ TQ+F N+LG GGFG VYKG L DG ++AVK++ G K +F +EI +S
Sbjct: 703 LKNATQDFDLSNKLGEGGFGAVYKGNLNDGREVAVKQLSIGSRQGKG--QFVAEIIAISS 760
Query: 680 VRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVAR 739
V HR+LV L G EG+ RLLVYEY+P+G+L + LF + L L W+ R I L VAR
Sbjct: 761 VLHRNLVKLYGCCFEGDHRLLVYEYLPNGSLDQALFGDKSLHL---DWSTRYEICLGVAR 817
Query: 740 GMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYL 799
G+ YLH A IHRD+K+SNILLD + KVSDFGL KL D + + TR+AGT GYL
Sbjct: 818 GLVYLHEEASVRIIHRDVKASNILLDSELVPKVSDFGLAKLYDDKKTHISTRVAGTIGYL 877
Query: 800 APEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKA 859
APEYA+ G +T K DV+++GVV +EL++G DE E +YL EW W + K +
Sbjct: 878 APEYAMRGHLTEKTDVYAFGVVALELVSGRKNSDENLEEGKKYLLEWAWNLHE-KNRDVE 936
Query: 860 AIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLS 904
ID E++E E + + +A CT RP M VV +LS
Sbjct: 937 LIDD--ELSEYNMEEVKRMIGIALLCTQSSYALRPPMSRVVAMLS 979
|
|
| TAIR|locus:2203718 AT1G53440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 576 (207.8 bits), Expect = 1.3e-74, Sum P(2) = 1.3e-74
Identities = 128/348 (36%), Positives = 208/348 (59%)
Query: 608 IESGTLVISVQVLRKVTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKAL 667
+++G+ + Q+ ++ T NF EN++G GGFG VYKG L DG IAVK++ + + +
Sbjct: 650 LQTGSFTLK-QI-KRATNNFDPENKIGEGGFGPVYKGVLADGMTIAVKQLSS--KSKQGN 705
Query: 668 DEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSW 727
EF +EI ++S ++H +LV L G IEG E LLVYEY+ + +L+R LF EK +L L W
Sbjct: 706 REFVTEIGMISALQHPNLVKLYGCCIEGKELLLVYEYLENNSLARALFGTEKQRLH-LDW 764
Query: 728 TRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKS 787
+ R + + +A+G+ YLH +R +HRD+K++N+LLD AK+SDFGL KL +
Sbjct: 765 STRNKVCIGIAKGLAYLHEESRLKIVHRDIKATNVLLDLSLNAKISDFGLAKLDEEENTH 824
Query: 788 VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWF 847
+ TR+AGT GY+APEYA+ G +T KADV+S+GVV +E+++G + + EE YL +W
Sbjct: 825 ISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGVVCLEIVSGKSNTNYRPKEEFIYLLDWA 884
Query: 848 WRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLV 907
+ ++ + +DP L + E++ ++ +A CT P RP M VV++L +
Sbjct: 885 YVLQEQGSLLEL-VDPDLGTSFSKKEAMRML-NIALLCTNPSPTLRPPMSSVVSMLQGKI 942
Query: 908 EKWRPITDESECCSGIDYSLPLPQMLKVWQEAESKEISYPNLEDSKGS 955
+ P+ SG ++ + + Q++ES+ +Y ++ K S
Sbjct: 943 KVQPPLVKREADPSG-SAAMRFKALEHLSQDSESQVSTYTRNKEHKSS 989
|
|
| TAIR|locus:2019863 AT1G79620 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 537 (194.1 bits), Expect = 7.2e-74, Sum P(2) = 7.2e-74
Identities = 131/322 (40%), Positives = 188/322 (58%)
Query: 592 ASSGSTNSGATENSHVIESGTLVISVQVLRKVTQNFAQENELGRGGFGTVYKGELEDGTK 651
ASSG + GA + G S + L+K+T NF+ +ELG GG+G VYKG L+DG
Sbjct: 608 ASSGKDSGGAPQLK-----GARWFSYEELKKITNNFSVSSELGYGGYGKVYKGMLQDGHM 662
Query: 652 IAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALS 711
+A+KR + G +T L EF++EI +LS+V H++LV L+G+ E E++LVYEYM +G+L
Sbjct: 663 VAIKRAQQG-STQGGL-EFKTEIELLSRVHHKNLVGLVGFCFEQGEQILVYEYMSNGSLK 720
Query: 712 RHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAK 771
L + L W RRL +AL ARG+ YLH LA IHRD+KS+NILLD++ AK
Sbjct: 721 DSLTGRSGITL---DWKRRLRVALGSARGLAYLHELADPPIIHRDVKSTNILLDENLTAK 777
Query: 772 VSDFGLVKLAPDGEKS-VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLA 830
V+DFGL KL D K V T++ GT GYL PEY K+T K+DV+S+GVV+MEL+T
Sbjct: 778 VADFGLSKLVSDCTKGHVSTQVKGTLGYLDPEYYTTQKLTEKSDVYSFGVVMMELITAKQ 837
Query: 831 ALDEERPEESRYLAEWFWRIKS-SKEKF---KAAIDPALEVNEETFESISIVAELAGHCT 886
+ E+ +Y+ + + S + F + +D +L + T + ELA C
Sbjct: 838 PI-----EKGKYIVREIKLVMNKSDDDFYGLRDKMDRSLR-DVGTLPELGRYMELALKCV 891
Query: 887 AREPYHRPDMGHVVNVLSPLVE 908
RP M VV + +++
Sbjct: 892 DETADERPTMSEVVKEIEIIIQ 913
|
|
| TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 466 (169.1 bits), Expect = 2.6e-73, Sum P(2) = 2.6e-73
Identities = 115/320 (35%), Positives = 171/320 (53%)
Query: 589 QTVASSGSTNSGATENSHVIESGTLVISVQVLRKVTQNFAQENELGRGGFGTVYKGELED 648
+TVASS + + + + Q L T NF + +GRG GTVYK L
Sbjct: 766 RTVASSAQDGQPSEMSLDIYFPPKEGFTFQDLVAATDNFDESFVVGRGACGTVYKAVLPA 825
Query: 649 GTKIAVKRMEA---GVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYM 705
G +AVK++ + G + F++EI L +RHR++V L G+ LL+YEYM
Sbjct: 826 GYTLAVKKLASNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYM 885
Query: 706 PHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLD 765
P G+L L L W++R IAL A+G+ YLH + HRD+KS+NILLD
Sbjct: 886 PKGSLGEILHD----PSCNLDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLD 941
Query: 766 DDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMEL 825
D + A V DFGL K+ ++ +AG++GY+APEYA K+T K+D++SYGVVL+EL
Sbjct: 942 DKFEAHVGDFGLAKVIDMPHSKSMSAIAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLLEL 1001
Query: 826 LTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI-DPALEVNEETFESISI-VAELAG 883
LTG A + + ++ + W R ++ + + D L + +E S + V ++A
Sbjct: 1002 LTGKAPV--QPIDQGGDVVNWV-RSYIRRDALSSGVLDARLTLEDERIVSHMLTVLKIAL 1058
Query: 884 HCTAREPYHRPDMGHVVNVL 903
CT+ P RP M VV +L
Sbjct: 1059 LCTSVSPVARPSMRQVVLML 1078
|
|
| TAIR|locus:2205250 AT1G56130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 583 (210.3 bits), Expect = 3.7e-73, Sum P(2) = 3.7e-73
Identities = 128/295 (43%), Positives = 171/295 (57%)
Query: 614 VISVQVLRKVTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSE 673
+ + L+ TQ+F N+LG GGFG VYKG L DG +AVK + G K +F +E
Sbjct: 681 IFTYSELKSATQDFDPSNKLGEGGFGPVYKGNLNDGRVVAVKLLSVGSRQGKG--QFVAE 738
Query: 674 IAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSI 733
I +S V HR+LV L G EG R+LVYEY+P+G+L + LF + L L W+ R I
Sbjct: 739 IVAISSVLHRNLVKLYGCCFEGEHRMLVYEYLPNGSLDQALFGDKTLHL---DWSTRYEI 795
Query: 734 ALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLA 793
L VARG+ YLH A +HRD+K+SNILLD ++SDFGL KL D + + TR+A
Sbjct: 796 CLGVARGLVYLHEEASVRIVHRDVKASNILLDSRLVPQISDFGLAKLYDDKKTHISTRVA 855
Query: 794 GTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSS 853
GT GYLAPEYA+ G +T K DV+++GVV +EL++G DE EE +YL EW W +
Sbjct: 856 GTIGYLAPEYAMRGHLTEKTDVYAFGVVALELVSGRPNSDENLEEEKKYLLEWAWNLHEK 915
Query: 854 KEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908
+ D + N E + + +A L CT RP M VV +LS VE
Sbjct: 916 SRDIELIDDKLTDFNMEEAKRMIGIALL---CTQTSHALRPPMSRVVAMLSGDVE 967
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 973 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-54 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-54 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-53 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-52 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 9e-52 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-50 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-46 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 8e-43 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 8e-35 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-34 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-34 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-34 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-34 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-32 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-32 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-32 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-31 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-30 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-30 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-30 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-29 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-29 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-29 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-29 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-28 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-28 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-28 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-28 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-28 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 9e-28 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-27 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-27 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-27 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-27 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-27 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-27 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 9e-27 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-26 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-26 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-26 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-26 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-26 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-26 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-26 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-25 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-25 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-25 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-25 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-25 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-25 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 8e-25 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-25 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-24 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-24 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-24 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-24 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 8e-24 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 9e-24 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-23 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-23 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-22 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-22 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-22 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-22 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-22 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-22 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-22 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 8e-22 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-21 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-21 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-21 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-21 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-21 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-21 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-21 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-21 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-21 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-21 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-21 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-21 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-21 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-20 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-20 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-20 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-20 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-20 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-20 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 9e-20 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-19 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-19 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-19 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-19 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-19 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-19 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-19 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-19 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-19 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-19 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-19 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-19 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-18 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-18 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-18 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-18 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-18 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-18 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-18 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-18 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-18 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-18 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-18 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-18 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-17 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-17 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-17 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-17 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-17 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 9e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 9e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-16 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-16 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-16 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-16 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-16 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-16 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-16 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-16 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-16 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 8e-16 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-15 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-15 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-15 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-15 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-15 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-15 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 7e-15 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-14 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-14 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-14 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-14 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-14 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-14 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-14 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-14 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-14 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-14 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-14 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 6e-14 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 8e-14 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 8e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-14 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 9e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-13 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-13 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-13 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-12 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-12 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-12 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 7e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-11 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-11 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-11 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-11 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 8e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-10 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 9e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-09 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-09 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-09 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 7e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-08 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-08 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 8e-08 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 9e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-07 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-07 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 6e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 9e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-06 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 6e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 2e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 4e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-04 | |
| COG0478 | 304 | COG0478, COG0478, RIO-like serine/threonine protei | 4e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 5e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 6e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.003 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.004 | |
| cd05144 | 198 | cd05144, RIO2_C, RIO kinase family; RIO2, C-termin | 0.004 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 7e-54
Identities = 77/203 (37%), Positives = 114/203 (56%), Gaps = 12/203 (5%)
Query: 630 ENELGRGGFGTVYKGELEDG-----TKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRH 684
+LG G FG VYKG L+ ++AVK ++ + + ++EF E ++ K+ H +
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKED-ASEQQIEEFLREARIMRKLDHPN 62
Query: 685 LVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYL 744
+V LLG E ++V EYMP G L +L K + K LS + LS AL +ARGMEYL
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYL---RKNRPKELSLSDLLSFALQIARGMEYL 119
Query: 745 HCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYA 804
+ FIHRDL + N L+ ++ K+SDFGL + D + V ++APE
Sbjct: 120 E---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESL 176
Query: 805 VMGKITTKADVFSYGVVLMELLT 827
GK T+K+DV+S+GV+L E+ T
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 7e-54
Identities = 73/203 (35%), Positives = 110/203 (54%), Gaps = 13/203 (6%)
Query: 630 ENELGRGGFGTVYKGELED-----GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRH 684
+LG G FG VYKG+L+ ++AVK ++ + + ++EF E ++ K+ H +
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKED-ASEQQIEEFLREARIMRKLDHPN 62
Query: 685 LVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYL 744
+V LLG E +V EYM G L +L + LS + LS AL +ARGMEYL
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYL----RKNRPKLSLSDLLSFALQIARGMEYL 118
Query: 745 HCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYA 804
+ FIHRDL + N L+ ++ K+SDFGL + D + ++APE
Sbjct: 119 E---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESL 175
Query: 805 VMGKITTKADVFSYGVVLMELLT 827
GK T+K+DV+S+GV+L E+ T
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 7e-53
Identities = 78/196 (39%), Positives = 107/196 (54%), Gaps = 12/196 (6%)
Query: 633 LGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGY 691
LG GGFGTVY + G K+A+K ++ ++ L+E EI +L K+ H ++V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKE-DSSSLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 692 SIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQT 751
+ N LV EY G+L L E LS L I L + G+EYLH
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENE----GKLSEDEILRILLQILEGLEYLH---SNG 112
Query: 752 FIHRDLKSSNILLD-DDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPE-YAVMGKI 809
IHRDLK NILLD D+ + K++DFGL KL KS++ + GT Y+APE G
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD-KSLLKTIVGTPAYMAPEVLLGKGYY 171
Query: 810 TTKADVFSYGVVLMEL 825
+ K+D++S GV+L EL
Sbjct: 172 SEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 182 bits (465), Expect = 5e-52
Identities = 73/205 (35%), Positives = 112/205 (54%), Gaps = 18/205 (8%)
Query: 632 ELGRGGFGTVYKGEL-----EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLV 686
+LG G FG VYKG L TK+AVK ++ G + + +EF E +++ K+ H ++V
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEG-ASEEEREEFLEEASIMKKLSHPNIV 64
Query: 687 SLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHC 746
LLG +G +V EYMP G L L + + L+ L +AL +A+GMEYL
Sbjct: 65 RLLGVCTQGEPLYIVTEYMPGGDLLDFL----RKHGEKLTLKDLLQMALQIAKGMEYLE- 119
Query: 747 LARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFG---YLAPEY 803
+ F+HRDL + N L+ ++ K+SDFGL + + + G ++APE
Sbjct: 120 --SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG--GGKLPIKWMAPES 175
Query: 804 AVMGKITTKADVFSYGVVLMELLTG 828
GK T+K+DV+S+GV+L E+ T
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 9e-52
Identities = 73/209 (34%), Positives = 108/209 (51%), Gaps = 19/209 (9%)
Query: 631 NELGRGGFGTVYKGELEDG----TKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLV 686
+LG G FG VYKG+L+ T++AVK ++ + + +F E V+ K+ H ++V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKED-ASEEERKDFLKEARVMKKLGHPNVV 59
Query: 687 SLLGYSIEGNERLLVYEYMPHGALSRHL----FRWEKLQLKPLSWTRRLSIALDVARGME 742
LLG E LV EYM G L +L + + LS LS A+ +A+GME
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 743 YLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFG----Y 798
YL + F+HRDL + N L+ +D K+SDFG L+ D R +
Sbjct: 120 YLA---SKKFVHRDLAARNCLVGEDLVVKISDFG---LSRDVYDDDYYRKKTGGKLPIRW 173
Query: 799 LAPEYAVMGKITTKADVFSYGVVLMELLT 827
+APE G T+K+DV+S+GV+L E+ T
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 4e-50
Identities = 91/272 (33%), Positives = 127/272 (46%), Gaps = 25/272 (9%)
Query: 633 LGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGY 691
LG G FGTVYK G +AVK ++ +K + EI +L ++ H ++V L+
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 692 SIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQT 751
+ + LV EY G L +L + PLS IAL + RG+EYLH
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYL-----SRGGPLSEDEAKKIALQILRGLEYLH---SNG 118
Query: 752 FIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGK-IT 810
IHRDLK NILLD++ K++DFGL K S +T GT Y+APE + G
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 811 TKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEE 870
K DV+S GV+L ELLTG E I + + + P LE +E
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGE-------------NILDQLQLIRRILGPPLEFDEP 224
Query: 871 TFESISIVA-ELAGHCTAREPYHRPDMGHVVN 901
+ S S A +L C ++P RP ++
Sbjct: 225 KWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 5e-46
Identities = 67/199 (33%), Positives = 98/199 (49%), Gaps = 12/199 (6%)
Query: 631 NELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLL 689
+LG G FG VY + + G +A+K ++ K + EI +L K++H ++V L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKK-KKIKKDRERILREIKILKKLKHPNIVRLY 63
Query: 690 GYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLAR 749
+ ++ LV EY G L L + +L R + +EYLH
Sbjct: 64 DVFEDEDKLYLVMEYCEGGDLFDLLKKRGRL---SEDEAR--FYLRQILSALEYLH---S 115
Query: 750 QTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKI 809
+ +HRDLK NILLD+D K++DFGL + GEK T GT Y+APE +
Sbjct: 116 KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL--TTFVGTPEYMAPEVLLGKGY 173
Query: 810 TTKADVFSYGVVLMELLTG 828
D++S GV+L ELLTG
Sbjct: 174 GKAVDIWSLGVILYELLTG 192
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 8e-43
Identities = 68/202 (33%), Positives = 106/202 (52%), Gaps = 16/202 (7%)
Query: 633 LGRGGFGTVYKGELED-GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLG- 690
LGRG FG+VY +D G +AVK +E + + L+ + EI +LS ++H ++V G
Sbjct: 8 LGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGS 67
Query: 691 -YSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPL--SWTRRLSIALDVARGMEYLHCL 747
E N + EY+ G+LS L ++ KL +P+ +TR + G+ YLH
Sbjct: 68 ERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLP-EPVIRKYTR------QILEGLAYLH-- 118
Query: 748 ARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTR-LAGTFGYLAPEYAVM 806
+HRD+K +NIL+D D K++DFG K D E T + GT ++APE
Sbjct: 119 -SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177
Query: 807 GKITTKADVFSYGVVLMELLTG 828
+ AD++S G ++E+ TG
Sbjct: 178 EEYGRAADIWSLGCTVIEMATG 199
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 8e-35
Identities = 70/215 (32%), Positives = 110/215 (51%), Gaps = 26/215 (12%)
Query: 632 ELGRGGFGTVYKGEL------EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHL 685
ELG G FG V+ GE D +AVK ++ + A +F+ E +L+ +H ++
Sbjct: 12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTLK-ETASNDARKDFEREAELLTNFQHENI 70
Query: 686 VSLLGYSIEGNERLLVYEYMPHGALSRHLFR---------WEKLQLKPLSWTRRLSIALD 736
V G EG+ ++V+EYM HG L++ L + L+ ++ L IA+
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 737 VARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGT- 795
+A GM Y LA Q F+HRDL + N L+ D K+ DFG+ + D + R+ G
Sbjct: 131 IASGMVY---LASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR---DVYTTDYYRVGGHT 184
Query: 796 ---FGYLAPEYAVMGKITTKADVFSYGVVLMELLT 827
++ PE + K TT++DV+S+GVVL E+ T
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 76/195 (38%), Positives = 113/195 (57%), Gaps = 18/195 (9%)
Query: 633 LGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYS 692
+G+G FG V G+ G K+AVK ++ T A F +E +V++ +RH +LV LLG
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVV 69
Query: 693 IEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTF 752
++GN +V EYM G+L +L R + ++ ++L ALDV GMEYL + F
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYL-RSRGRAV--ITLAQQLGFALDVCEGMEYLE---EKNF 123
Query: 753 IHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTF--GYLAPEYAVMGKIT 810
+HRDL + N+L+ +D AKVSDFGL K A G+ S G + APE K +
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDS------GKLPVKWTAPEALREKKFS 177
Query: 811 TKADVFSYGVVLMEL 825
TK+DV+S+G++L E+
Sbjct: 178 TKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 2e-34
Identities = 73/199 (36%), Positives = 107/199 (53%), Gaps = 17/199 (8%)
Query: 633 LGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYS 692
LG G FG V+ G TK+AVK ++ G + +A F E ++ K+RH LV L
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEA---FLQEAQIMKKLRHDKLVQLYAVC 70
Query: 693 IEGNERLLVYEYMPHGALSRHLFRWE--KLQLKPLSWTRRLSIALDVARGMEYLHCLARQ 750
E +V EYM G+L L E KL+L L + +A +A GM YL +
Sbjct: 71 SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQL-----VDMAAQIAEGMAYLE---SR 122
Query: 751 TFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTF--GYLAPEYAVMGK 808
+IHRDL + NIL+ ++ K++DFGL +L D E + R F + APE A G+
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT--AREGAKFPIKWTAPEAANYGR 180
Query: 809 ITTKADVFSYGVVLMELLT 827
T K+DV+S+G++L E++T
Sbjct: 181 FTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 59/199 (29%), Positives = 104/199 (52%), Gaps = 14/199 (7%)
Query: 632 ELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLG 690
++G+GGFG VYK G ++A+K ++ + + + ++ +EI +L K +H ++V G
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIK--LESKEKKEKIINEIQILKKCKHPNIVKYYG 64
Query: 691 YSIEGNERLLVYEYMPHGALSRHL-FRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLAR 749
++ +E +V E+ G+L L + L +++ + ++ +G+EYLH
Sbjct: 65 SYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAY-----VCKELLKGLEYLH---S 116
Query: 750 QTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKI 809
IHRD+K++NILL D K+ DFGL D + + GT ++APE
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKAR--NTMVGTPYWMAPEVINGKPY 174
Query: 810 TTKADVFSYGVVLMELLTG 828
KAD++S G+ +EL G
Sbjct: 175 DYKADIWSLGITAIELAEG 193
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 6e-34
Identities = 73/234 (31%), Positives = 107/234 (45%), Gaps = 19/234 (8%)
Query: 633 LGRGGFGTVYK-GELEDGTKIAVKRME-AGVTTTKALDEFQSEIAVLSKVRHRHLVSLLG 690
LG+G FG V + + G A+K ++ + K ++ +E +LS++ H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 691 YSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLAR 749
Y+ + E+L LV EY P G L HL + + R A ++ +EYLH
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGRF---SEERARF--YAAEIVLALEYLH---S 111
Query: 750 QTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKI 809
I+RDLK NILLD D K++DFGL K T GT YLAPE +
Sbjct: 112 LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEVLLGKGY 170
Query: 810 TTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDP 863
D +S GV+L E+LTG P + E + +I +F + P
Sbjct: 171 GKAVDWWSLGVLLYEMLTGKP------PFYAEDRKEIYEKILKDPLRFPEFLSP 218
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 1e-32
Identities = 63/202 (31%), Positives = 103/202 (50%), Gaps = 16/202 (7%)
Query: 631 NELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLL 689
+ +GRG FG VYKG LE G +A+K++ +AL EI +L ++H ++V +
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 690 GYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIAL--DVARGMEYLHCL 747
G + ++ EY +G+L + + ++ L V +G+ YLH
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIKKFGPFP-------ESLVAVYVYQVLQGLAYLH-- 116
Query: 748 ARQTFIHRDLKSSNILLDDDYRAKVSDFGL-VKLAPDGEKSVVTRLAGTFGYLAPEYAVM 806
Q IHRD+K++NIL D K++DFG+ KL + + GT ++APE M
Sbjct: 117 -EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD--ASVVGTPYWMAPEVIEM 173
Query: 807 GKITTKADVFSYGVVLMELLTG 828
+T +D++S G ++ELLTG
Sbjct: 174 SGASTASDIWSLGCTVIELLTG 195
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 66/207 (31%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 631 NELGRGGFGTVYKGELE---DGT--KIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHL 685
+LG G FG V + D T ++AVK + + +F+ EI +L + H ++
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHS-GEEQHRSDFEREIEILRTLDHENI 68
Query: 686 VSLLG--YSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEY 743
V G G L+ EY+P G+L R + + Q+ + R L + + +GM+Y
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSL-RDYLQRHRDQI---NLKRLLLFSSQICKGMDY 124
Query: 744 LHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAG---TFGYLA 800
L Q +IHRDL + NIL++ + K+SDFGL K+ P+ + + G F Y A
Sbjct: 125 LG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-A 180
Query: 801 PEYAVMGKITTKADVFSYGVVLMELLT 827
PE K ++ +DV+S+GV L EL T
Sbjct: 181 PECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 6e-32
Identities = 70/205 (34%), Positives = 106/205 (51%), Gaps = 17/205 (8%)
Query: 627 FAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLV 686
F E +LG G FG V++G ++ ++A+K +++ +FQ E+ L ++RH+HL+
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKS--DDLLKQQDFQKEVQALKRLRHKHLI 65
Query: 687 SLLGYSIEGNERLLVYEYMPHGALSRHLFRWE--KLQLKPLSWTRRLSIALDVARGMEYL 744
SL G ++ E M G+L L E L + L + +A VA GM YL
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASL-----IDMACQVAEGMAYL 120
Query: 745 HCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGY--LAPE 802
Q IHRDL + NIL+ +D KV+DFGL +L + V Y APE
Sbjct: 121 E---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE---DVYLSSDKKIPYKWTAPE 174
Query: 803 YAVMGKITTKADVFSYGVVLMELLT 827
A G +TK+DV+S+G++L E+ T
Sbjct: 175 AASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 68/208 (32%), Positives = 109/208 (52%), Gaps = 17/208 (8%)
Query: 633 LGRGGFGTVYKGEL--EDGT--KIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSL 688
LG G FG+V +G+L +DG+ K+AVK M+ + T ++EF SE A + H +++ L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 689 LGYSIEGNER------LLVYEYMPHGALSRHLFRWEKLQLKPLSWTRR--LSIALDVARG 740
+G E + +++ +M HG L L +L P + L +D+A G
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLY-SRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 741 MEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGT-FGYL 799
MEYL + + FIHRDL + N +L +D V+DFGL K G+ R+A ++
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 800 APEYAVMGKITTKADVFSYGVVLMELLT 827
A E T+K+DV+++GV + E+ T
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 3e-30
Identities = 80/273 (29%), Positives = 127/273 (46%), Gaps = 27/273 (9%)
Query: 632 ELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGY 691
E+G G FG V+ G + K+A+K + G + ++F E V+ K+ H LV L G
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE---EDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 692 SIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQT 751
E + LV+E+M HG LS +L + Q S L + LDV GM YL
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYL----RAQRGKFSQETLLGMCLDVCEGMAYLE---SSN 120
Query: 752 FIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITT 811
IHRDL + N L+ ++ KVSDFG+ + D + + T + +PE K ++
Sbjct: 121 VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSS 180
Query: 812 KADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEET 871
K+DV+S+GV++ E+ + + + P E+R +E I + +K +
Sbjct: 181 KSDVWSFGVLMWEVFS-----EGKTPYENRSNSEVVETINAGFRLYKPRLAS-------- 227
Query: 872 FESISIVAELAGHCTAREPYHRPDMGHVVNVLS 904
V EL HC P RP +++ L+
Sbjct: 228 ----QSVYELMQHCWKERPEDRPSFSLLLHQLA 256
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 5e-30
Identities = 84/330 (25%), Positives = 133/330 (40%), Gaps = 26/330 (7%)
Query: 632 ELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDE-FQSEIAVLSKVRH-RHLVSLL 689
+LG G FG VY D +A+K + + + E F EI +L+ + H ++V L
Sbjct: 7 KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 690 GYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLAR 749
+ + LV EY+ G+L L + + PLS + L I + +EYLH
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLL--KKIGRKGPLSESEALFILAQILSALEYLH---S 119
Query: 750 QTFIHRDLKSSNILLD-DDYRAKVSDFGLVKLAPDGEKSVVTR-----LAGTFGYLAPEY 803
+ IHRD+K NILLD D K+ DFGL KL PD + GT GY+APE
Sbjct: 120 KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV 179
Query: 804 A---VMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAA 860
+ ++ +D++S G+ L ELLTG P E + + +
Sbjct: 180 LLGLSLAYASSSSDIWSLGITLYELLTG------LPPFEGEKNSSATSQTLKIILELPTP 233
Query: 861 IDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPITDESECC 920
+ ++L A++P +R ++ L+ + +
Sbjct: 234 SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSS--SSDLSHDLLAHLKLKESDLSDL 291
Query: 921 SGIDYSLPLPQMLKVWQEAESKEISYPNLE 950
D S PL L EA ++ +
Sbjct: 292 LKPDDSAPLRLSLPPSLEALISSLNSLAIS 321
|
Length = 384 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 76/289 (26%), Positives = 140/289 (48%), Gaps = 42/289 (14%)
Query: 630 ENELGRGGFGTVYKGEL----EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHL 685
E +G G FG V +G L + +A+K ++AG ++ K +F +E +++ + H ++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG-SSDKQRLDFLTEASIMGQFDHPNI 67
Query: 686 VSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLH 745
+ L G + +++ EYM +G+L + L + + + + + +A GM+YL
Sbjct: 68 IRLEGVVTKSRPVMIITEYMENGSLDKFLRENDG----KFTVGQLVGMLRGIASGMKYL- 122
Query: 746 CLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFG--YLAPEY 803
+ ++HRDL + NIL++ + KVSDFGL + D E + T+ G + APE
Sbjct: 123 --SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK-GGKIPIRWTAPEA 179
Query: 804 AVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862
K T+ +DV+S+G+V+ E+++ G ERP Y W S+++ KA D
Sbjct: 180 IAYRKFTSASDVWSFGIVMWEVMSYG------ERP----Y---WDM---SNQDVIKAVED 223
Query: 863 ----PALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLV 907
P + S + +L C ++ RP +V+ L ++
Sbjct: 224 GYRLPPPM------DCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 7e-30
Identities = 67/200 (33%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 632 ELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGY 691
ELG G FG V+ G+ +A+K + G + D+F E V+ K+ H +LV L G
Sbjct: 11 ELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE---DDFIEEAKVMMKLSHPNLVQLYGV 67
Query: 692 SIEGNERLLVYEYMPHGALSRHL-FRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQ 750
+ +V EYM +G L +L R KL + L L + DV MEYL
Sbjct: 68 CTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWL-----LDMCSDVCEAMEYLE---SN 119
Query: 751 TFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGE--KSVVTRLAGTFGYLAPEYAVMGK 808
FIHRDL + N L+ +D KVSDFGL + D + S T+ + PE +
Sbjct: 120 GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFP--VKWAPPEVFDYSR 177
Query: 809 ITTKADVFSYGVVLMELLTG 828
++K+DV+S+GV++ E+ +
Sbjct: 178 FSSKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 79/206 (38%), Positives = 114/206 (55%), Gaps = 22/206 (10%)
Query: 633 LGRGGFGTVYKGEL--EDGTKI--AVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSL 688
+G+G FG VY G L DG KI AVK + +T + +++F E ++ H +++SL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNR-ITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 689 LGYSI--EGNERLLVYEYMPHGALSRHLFRWEKLQ--LKPLSWTRRLSIALDVARGMEYL 744
LG + EG+ L+V YM HG L R+ R E +K L + L VA+GMEYL
Sbjct: 62 LGICLPSEGSP-LVVLPYMKHGDL-RNFIRSETHNPTVKDL-----IGFGLQVAKGMEYL 114
Query: 745 HCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGT---FGYLAP 801
A + F+HRDL + N +LD+ + KV+DFGL + D E V G ++A
Sbjct: 115 ---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMAL 171
Query: 802 EYAVMGKITTKADVFSYGVVLMELLT 827
E K TTK+DV+S+GV+L EL+T
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 76/195 (38%), Positives = 109/195 (55%), Gaps = 16/195 (8%)
Query: 633 LGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYS 692
+G G FG V +GE G K+AVK ++ VT L+E AV++K+ H++LV LLG
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQAFLEE----TAVMTKLHHKNLVRLLGV- 67
Query: 693 IEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTF 752
I N +V E M G L L R L + + L +LDVA GMEYL +
Sbjct: 68 ILHNGLYIVMELMSKGNLVNFL-RTRGRALVSVI--QLLQFSLDVAEGMEYLE---SKKL 121
Query: 753 IHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTK 812
+HRDL + NIL+ +D AKVSDFGL ++ G + ++L + APE K ++K
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDN--SKLP--VKWTAPEALKHKKFSSK 177
Query: 813 ADVFSYGVVLMELLT 827
+DV+SYGV+L E+ +
Sbjct: 178 SDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 6e-29
Identities = 66/212 (31%), Positives = 108/212 (50%), Gaps = 19/212 (8%)
Query: 616 SVQVLRKVTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIA 675
S+Q+LRK LG G FG V++G + T +AVK ++ G T +F +E
Sbjct: 7 SIQLLRK----------LGAGQFGEVWEGLWNNTTPVAVKTLKPG---TMDPKDFLAEAQ 53
Query: 676 VLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIAL 735
++ K+RH L+ L +V E M +G+L +L LK + + +A
Sbjct: 54 IMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALK---LPQLIDMAA 110
Query: 736 DVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGT 795
VA GM YL Q +IHRDL + N+L+ ++ KV+DFGL ++ +
Sbjct: 111 QVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFP 167
Query: 796 FGYLAPEYAVMGKITTKADVFSYGVVLMELLT 827
+ APE A+ + + K+DV+S+G++L E++T
Sbjct: 168 IKWTAPEAALYNRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 7e-29
Identities = 73/199 (36%), Positives = 109/199 (54%), Gaps = 12/199 (6%)
Query: 630 ENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLL 689
+LG G FG V+ G TK+AVK ++ G + ++ F E ++ K+RH LV L
Sbjct: 11 IKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES---FLEEAQIMKKLRHDKLVQL- 66
Query: 690 GYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLA 748
Y++ E + +V EYM G+L L E LK + +A VA GM Y+
Sbjct: 67 -YAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALK---LPNLVDMAAQVAAGMAYIE--- 119
Query: 749 RQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGK 808
R +IHRDL+S+NIL+ D K++DFGL +L D E + + APE A+ G+
Sbjct: 120 RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 179
Query: 809 ITTKADVFSYGVVLMELLT 827
T K+DV+S+G++L EL+T
Sbjct: 180 FTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 71/249 (28%), Positives = 109/249 (43%), Gaps = 50/249 (20%)
Query: 626 NFAQENELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRH 684
+ ++G+G FG VY DG +K ++ + K ++ +E+ +L K+ H +
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 685 LVSLLGYSIEGNERLL-VYEYMPHGALSRHLFRWEKLQLKP---------LSWTRRLSIA 734
++ S E +L V EY G LS+ + K Q K L W +L +A
Sbjct: 61 IIKYYE-SFEEKGKLCIVMEYADGGDLSQKI----KKQKKEGKPFPEEQILDWFVQLCLA 115
Query: 735 LDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK-LAPDGE--KSVVTR 791
L YLH + +HRD+K NI L + K+ DFG+ K L+ + K+VV
Sbjct: 116 LK------YLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-- 164
Query: 792 LAGTFGYLAPE------YAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAE 845
GT YL+PE Y K+D++S G VL EL T + P E L E
Sbjct: 165 --GTPYYLSPELCQNKPY------NYKSDIWSLGCVLYELCTL------KHPFEGENLLE 210
Query: 846 WFWRIKSSK 854
+I +
Sbjct: 211 LALKILKGQ 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 68/201 (33%), Positives = 101/201 (50%), Gaps = 15/201 (7%)
Query: 633 LGRGGFGTVYKG---ELEDGTKI--AVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVS 687
LG G FGTVYKG + KI A+K + T+ KA E E V++ V H H+V
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE-TSPKANKEILDEAYVMASVDHPHVVR 73
Query: 688 LLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCL 747
LLG + ++ L+ + MP G L ++ R K + L+ + +A+GM YL
Sbjct: 74 LLGICL-SSQVQLITQLMPLGCLLDYV-RNHKDNIGSQYL---LNWCVQIAKGMSYLE-- 126
Query: 748 ARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGT-FGYLAPEYAVM 806
+ +HRDL + N+L+ K++DFGL KL EK ++A E +
Sbjct: 127 -EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH 185
Query: 807 GKITTKADVFSYGVVLMELLT 827
T K+DV+SYGV + EL+T
Sbjct: 186 RIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-28
Identities = 70/199 (35%), Positives = 112/199 (56%), Gaps = 12/199 (6%)
Query: 630 ENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLL 689
E +LG+G FG V+ G T++A+K ++ G + +A F E V+ K+RH LV L
Sbjct: 11 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQL- 66
Query: 690 GYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLA 748
Y++ E + +V EYM G+L L + K L + + +A +A GM Y+
Sbjct: 67 -YAVVSEEPIYIVTEYMSKGSLLDFL---KGEMGKYLRLPQLVDMAAQIASGMAYVE--- 119
Query: 749 RQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGK 808
R ++HRDL+++NIL+ ++ KV+DFGL +L D E + + APE A+ G+
Sbjct: 120 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 179
Query: 809 ITTKADVFSYGVVLMELLT 827
T K+DV+S+G++L EL T
Sbjct: 180 FTIKSDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 71/217 (32%), Positives = 109/217 (50%), Gaps = 32/217 (14%)
Query: 632 ELGRGGFGTVYKGEL------EDGTKIAVK--RMEAGVTTTKALDEFQSEIAVLSKVRHR 683
ELG G FG VYKGEL T +A+K + A K EF+ E ++S ++H
Sbjct: 12 ELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP---KVQQEFRQEAELMSDLQHP 68
Query: 684 HLVSLLGYSIEGNERLLVYEYMPHGALSRHLFR-----------WEKLQLKPLSWTRRLS 732
++V LLG + +++EY+ HG L L R ++ L + L
Sbjct: 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 733 IALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRL 792
IA+ +A GMEY L+ F+HRDL + N L+ + K+SDFGL + D + R+
Sbjct: 129 IAIQIAAGMEY---LSSHHFVHRDLAARNCLVGEGLTVKISDFGLSR---DIYSADYYRV 182
Query: 793 AGT----FGYLAPEYAVMGKITTKADVFSYGVVLMEL 825
++ PE + GK TT++D++S+GVVL E+
Sbjct: 183 QSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 8e-28
Identities = 67/198 (33%), Positives = 105/198 (53%), Gaps = 11/198 (5%)
Query: 633 LGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDE-FQSEIAVLSKVRHRHLVSLLGY 691
+G+G FG VYKG L+ T++AVK T L F E +L + H ++V L+G
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCR--STLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 692 SIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQT 751
++ +V E +P G+L L R +K +L + L ++LD A GMEYL +
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFL-RKKKNRLTV---KKLLQMSLDAAAGMEYLE---SKN 113
Query: 752 FIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGT-FGYLAPEYAVMGKIT 810
IHRDL + N L+ ++ K+SDFG+ + G +V L + APE G+ T
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYT 173
Query: 811 TKADVFSYGVVLMELLTG 828
+++DV+SYG++L E +
Sbjct: 174 SESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 9e-28
Identities = 86/295 (29%), Positives = 131/295 (44%), Gaps = 45/295 (15%)
Query: 629 QENELGRGGFGTVYKGEL------EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRH 682
ELG+G FG VY+G E T++A+K + + + + EF +E +V+ +
Sbjct: 10 LIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI-EFLNEASVMKEFNC 68
Query: 683 RHLVSLLGYSIEGNERLLVYEYMPHGALSRHL--FRWEKLQ---LKPLSWTRRLSIALDV 737
H+V LLG G L+V E M G L +L R E L P + + + +A ++
Sbjct: 69 HHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEI 128
Query: 738 ARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA-------PDGEKSVVT 790
A GM YL F+HRDL + N ++ +D K+ DFG+ + G+ +
Sbjct: 129 ADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 791 RLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRI 850
R ++APE G TTK+DV+S+GVVL E+ T LAE ++
Sbjct: 186 R------WMAPESLKDGVFTTKSDVWSFGVVLWEMAT---------------LAEQPYQG 224
Query: 851 KSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSP 905
S++E K ID E + EL C P RP +V+ L
Sbjct: 225 LSNEEVLKFVIDGGHLDLPENCP--DKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 74/206 (35%), Positives = 114/206 (55%), Gaps = 22/206 (10%)
Query: 633 LGRGGFGTVYK---GELEDGTK--IAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVS 687
LG+G FG+V L+D T +AVK+++ +T + L +F+ EI +L ++H ++V
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQH--STAEHLRDFEREIEILKSLQHDNIVK 69
Query: 688 LLG--YSIEGNERLLVYEYMPHGALSRHLFR-WEKLQLKPLSWTRRLSIALDVARGMEYL 744
G YS LV EY+P+G+L +L + E+L + L L A + +GMEYL
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKL-----LLYASQICKGMEYL 124
Query: 745 HCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAG---TFGYLAP 801
+ ++HRDL + NIL++ + R K+ DFGL K+ P ++ R G F Y AP
Sbjct: 125 ---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-AP 180
Query: 802 EYAVMGKITTKADVFSYGVVLMELLT 827
E K + +DV+S+GVVL EL T
Sbjct: 181 ESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 69/216 (31%), Positives = 108/216 (50%), Gaps = 28/216 (12%)
Query: 632 ELGRGGFGTVYKGEL------EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHL 685
ELG G FG V+ E +D +AVK ++ + A +FQ E +L+ ++H+H+
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE--ASESARQDFQREAELLTVLQHQHI 69
Query: 686 VSLLGYSIEGNERLLVYEYMPHGALSR---------HLFRWEKLQ-LKPLSWTRRLSIAL 735
V G EG L+V+EYM HG L+R + + L+ + L+IA
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 736 DVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAG- 794
+A GM YL L F+HRDL + N L+ K+ DFG+ + D + R+ G
Sbjct: 130 QIASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSR---DIYSTDYYRVGGR 183
Query: 795 ---TFGYLAPEYAVMGKITTKADVFSYGVVLMELLT 827
++ PE + K TT++D++S+GVVL E+ T
Sbjct: 184 TMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 79/286 (27%), Positives = 140/286 (48%), Gaps = 31/286 (10%)
Query: 628 AQENELGRGGFGTVYKGELEDGTK----IAVKRMEAGVTTTKALDEFQSEIAVLSKVRHR 683
++ +G G FG V++G L+ + +A+K ++ G T + D F SE +++ + H
Sbjct: 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQD-FLSEASIMGQFSHH 66
Query: 684 HLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEY 743
+++ L G + +++ EYM +GAL ++L R + L +A GM+Y
Sbjct: 67 NIIRLEGVVTKFKPAMIITEYMENGALDKYL-RDHDGEFSSYQLVGMLR---GIAAGMKY 122
Query: 744 LHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFG--YLAP 801
L + ++HRDL + NIL++ + KVSDFGL ++ D + T G + AP
Sbjct: 123 L---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAP 179
Query: 802 EYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861
E K T+ +DV+S+G+V+ E+++ ERP +W + S+ E K AI
Sbjct: 180 EAIAYRKFTSASDVWSFGIVMWEVMSF-----GERP---------YWDM-SNHEVMK-AI 223
Query: 862 DPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLV 907
+ + + S V +L C ++ RP +VN+L L+
Sbjct: 224 NDGFRL-PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 4e-27
Identities = 69/199 (34%), Positives = 112/199 (56%), Gaps = 12/199 (6%)
Query: 630 ENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLL 689
+ +LG+G FG V+ G TK+A+K ++ G +A F E ++ K+RH LV L
Sbjct: 11 DVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA---FLQEAQIMKKLRHDKLVPL- 66
Query: 690 GYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLA 748
Y++ E + +V E+M G+L L + K L + + +A +A GM Y+
Sbjct: 67 -YAVVSEEPIYIVTEFMGKGSLLDFLKEGDG---KYLKLPQLVDMAAQIADGMAYIE--- 119
Query: 749 RQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGK 808
R +IHRDL+++NIL+ D+ K++DFGL +L D E + + APE A+ G+
Sbjct: 120 RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 179
Query: 809 ITTKADVFSYGVVLMELLT 827
T K+DV+S+G++L EL+T
Sbjct: 180 FTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 66/196 (33%), Positives = 100/196 (51%), Gaps = 10/196 (5%)
Query: 632 ELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGY 691
ELG G FG V+ G+ K+A+K + G + ++F E V+ K+ H LV L G
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSE---EDFIEEAKVMMKLSHPKLVQLYGV 67
Query: 692 SIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQT 751
+ +V E+M +G L +L R + +L LS+ DV GMEYL R +
Sbjct: 68 CTQQKPLYIVTEFMENGCLLNYL-RQRQGKLSK---DMLLSMCQDVCEGMEYLE---RNS 120
Query: 752 FIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITT 811
FIHRDL + N L+ KVSDFG+ + D E + + + PE K ++
Sbjct: 121 FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSS 180
Query: 812 KADVFSYGVVLMELLT 827
K+DV+S+GV++ E+ T
Sbjct: 181 KSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 63/202 (31%), Positives = 108/202 (53%), Gaps = 16/202 (7%)
Query: 630 ENELGRGGFGTVYKGELED-GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSL 688
+++LG G +G VY+G + +AVK ++ T ++EF E AV+ +++H +LV L
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQL 67
Query: 689 LGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLA 748
LG ++ E+M +G L +L + ++ + L +A ++ MEYL
Sbjct: 68 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL---LYMATQISSAMEYLE--- 121
Query: 749 RQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGT---FGYLAPEYAV 805
++ FIHRDL + N L+ +++ KV+DFGL +L T AG + APE
Sbjct: 122 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAPESLA 178
Query: 806 MGKITTKADVFSYGVVLMELLT 827
K + K+DV+++GV+L E+ T
Sbjct: 179 YNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 9e-27
Identities = 76/213 (35%), Positives = 109/213 (51%), Gaps = 25/213 (11%)
Query: 633 LGRGGFGTVYKG----ELEDGT---KIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHL 685
LG G FG VY+G L G+ ++AVK + G T + EF E ++S H ++
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK-EFLKEAHLMSNFNHPNI 61
Query: 686 VSLLGYSIEGNERLLVYEYMPHGALSRHL--FRWEKLQLKPLSWTRRLSIALDVARGMEY 743
V LLG + + ++ E M G L +L R E+ L+ L I LDVA+G Y
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 744 LHCLARQTFIHRDLKSSNILL-----DDDYRAKVSDFGLVKLAPDGEKSVVTRLAGT--- 795
L + FIHRDL + N L+ D D K+ DFGL + D KS R G
Sbjct: 122 LE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR---DIYKSDYYRKEGEGLL 175
Query: 796 -FGYLAPEYAVMGKITTKADVFSYGVVLMELLT 827
++APE + GK TT++DV+S+GV++ E+LT
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 71/194 (36%), Positives = 105/194 (54%), Gaps = 16/194 (8%)
Query: 633 LGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYS 692
+G+G FG V G+ G K+AVK ++ T F +E +V++++RH +LV LLG
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATA----QAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 693 IEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQT 751
+E L +V EYM G+L +L + L L +LDV MEYL
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEA---NN 122
Query: 752 FIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITT 811
F+HRDL + N+L+ +D AKVSDFGL K A + + + T APE K +T
Sbjct: 123 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFST 178
Query: 812 KADVFSYGVVLMEL 825
K+DV+S+G++L E+
Sbjct: 179 KSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 65/202 (32%), Positives = 99/202 (49%), Gaps = 14/202 (6%)
Query: 632 ELGRGGFGTVYKGE----LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVS 687
+LG G FG V +GE +AVK +++ + +D+F E A++ + H +L+
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIR 60
Query: 688 LLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCL 747
L G + + ++V E P G+L L R K L + A+ +A GM YL
Sbjct: 61 LYGVVLT-HPLMMVTELAPLGSL---LDRLRKDALGHFLISTLCDYAVQIANGMRYLE-- 114
Query: 748 ARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVT--RLAGTFGYLAPEYAV 805
+ FIHRDL + NILL D + K+ DFGL++ P E V L F + APE
Sbjct: 115 -SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLR 173
Query: 806 MGKITTKADVFSYGVVLMELLT 827
+ +DV+ +GV L E+ T
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 91/306 (29%), Positives = 148/306 (48%), Gaps = 60/306 (19%)
Query: 630 ENELGRGGFGTVYKGEL-EDGTKI--AVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHL 685
++ +G G FG V K + +DG ++ A+KRM+ + D F E+ VL K+ H ++
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD-FAGELEVLCKLGHHPNI 70
Query: 686 VSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKP-----------LSWTRRLSIA 734
++LLG L EY PHG L L + L+ P LS + L A
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130
Query: 735 LDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAG 794
DVARGM+YL +++ FIHRDL + NIL+ ++Y AK++DFGL + G++ V + G
Sbjct: 131 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMG 183
Query: 795 TFG--YLAPEYAVMGKITTKADVFSYGVVLMELLT-------GL--AALDEERPEESRYL 843
++A E TT +DV+SYGV+L E+++ G+ A L E+ P+ R
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR-- 241
Query: 844 AEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVL 903
++ L ++E + +L C +PY RP ++ L
Sbjct: 242 -----------------LEKPLNCDDEVY-------DLMRQCWREKPYERPSFAQILVSL 277
Query: 904 SPLVEK 909
+ ++E+
Sbjct: 278 NRMLEE 283
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 68/203 (33%), Positives = 108/203 (53%), Gaps = 16/203 (7%)
Query: 631 NELGRGGFGTVYKG--ELEDGTKI--AVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLV 686
ELG G FG+V KG ++ G ++ AVK ++ EF E +V++++ H +V
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGK-KEFLREASVMAQLDHPCIV 59
Query: 687 SLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHC 746
L+G +G +LV E P G L ++L + ++ + L +A VA GM YL
Sbjct: 60 RLIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDL-----KELAHQVAMGMAYLE- 112
Query: 747 LARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTF--GYLAPEYA 804
+ F+HRDL + N+LL + ++AK+SDFG+ + G AG + + APE
Sbjct: 113 --SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECI 170
Query: 805 VMGKITTKADVFSYGVVLMELLT 827
GK ++K+DV+SYGV L E +
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 4e-26
Identities = 129/471 (27%), Positives = 201/471 (42%), Gaps = 88/471 (18%)
Query: 7 SVVLVLYFVVGVANSATDPNDLKILNDFKNGLENPELLKWPANGDDPCGPPPWPHVFCSG 66
++ + F + + S +L++L FK+ + +P LK+ +N + W + C+
Sbjct: 10 PYLIFMLFFLFLNFSMLHAEELELLLSFKSSINDP--LKYLSNWNSSADVCLWQGITCNN 67
Query: 67 -NRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP--TFSGLSELEFAYLDF 123
+RV I + + G + +L + + L N+ +G +P F+ S L + L
Sbjct: 68 SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSN 127
Query: 124 NEFD-TIPSDFFDGL---------------------SSVRVLALDYNPFNKTFGWSIPDS 161
N F +IP L SS++VL L N IP+S
Sbjct: 128 NNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVG----KIPNS 183
Query: 162 LANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLN 221
L N L L+L + LVG +P LG + SL + L YN LSG IP G
Sbjct: 184 LTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGG--------- 234
Query: 222 DQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPK 281
+ SL L L N TG IP +G L +L+ L L +N+L G IP
Sbjct: 235 ----------------LTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPP 278
Query: 282 SLANME-LDNLVLNNNLLMGPIPKFKAGNVTYD-----SNSFCQSEPGIECA-PDVNVLL 334
S+ +++ L +L L++N L G IP+ + SN+F P + P + VL
Sbjct: 279 SIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQ 338
Query: 335 ----DFLGGVNYPVNLVSQWPGNDPCQGPWLGLS------------CTSNSKVSIINLPR 378
F G + P NL N+ L LS C+S + +I L
Sbjct: 339 LWSNKFSGEI--PKNLGKH---NNLTV---LDLSTNNLTGEIPEGLCSSGNLFKLI-LFS 389
Query: 379 HNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNI 429
++L G + S+ SL +RL NS SG +P+ FT+L + LD+S+NN+
Sbjct: 390 NSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNL 440
|
Length = 968 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 68/230 (29%), Positives = 120/230 (52%), Gaps = 14/230 (6%)
Query: 626 NFAQENELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRH 684
+F +LG+G +G+VYK + L D A+K ++ G + K ++ +EI +L+ V H +
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 685 LVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYL 744
++S ++GN+ +V EY P G LS+ + + +K + K + I + + RG++ L
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKR-KLIPEQEIWRIFIQLLRGLQAL 119
Query: 745 HCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYA 804
H Q +HRDLKS+NILL + K+ D G+ K+ GT Y+APE
Sbjct: 120 H---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI---GTPHYMAPEVW 173
Query: 805 VMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSK 854
+ K+D++S G +L E+ T P E+R + + ++++ K
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATF------APPFEARSMQDLRYKVQRGK 217
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 7e-26
Identities = 69/232 (29%), Positives = 110/232 (47%), Gaps = 40/232 (17%)
Query: 626 NFAQENELGRGGFGTVYKGEL------EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSK 679
N ++G+G FG V++ E T +AVK ++ + D FQ E A++++
Sbjct: 6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD-FQREAALMAE 64
Query: 680 VRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHL-----------------FRWEKLQL 722
H ++V LLG G L++EYM +G L+ L R L
Sbjct: 65 FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 723 KPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK--- 779
PLS T +L IA VA GM Y L+ + F+HRDL + N L+ ++ K++DFGL +
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAY---LSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181
Query: 780 ----LAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT 827
++ R ++ PE + TT++DV++YGVVL E+ +
Sbjct: 182 SADYYKASENDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 73/269 (27%), Positives = 127/269 (47%), Gaps = 32/269 (11%)
Query: 614 VISVQVLRKVTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQS 672
++S R++ +N + +G G G VYK + G ++A+K+M + + +
Sbjct: 11 IVSEGDPRELYKNLEK---IGEGASGEVYKATDRATGKEVAIKKMR---LRKQNKELIIN 64
Query: 673 EIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWT-RRL 731
EI ++ +H ++V + G+E +V EYM G+L + + + ++
Sbjct: 65 EILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSL------TDIITQNFVRMNEPQI 118
Query: 732 S-IALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL-VKLAPDGEK--S 787
+ + +V +G+EYLH Q IHRD+KS NILL D K++DFG +L + K S
Sbjct: 119 AYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS 175
Query: 788 VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYL--AE 845
VV GT ++APE K D++S G++ +E+ G E P + +L +
Sbjct: 176 VV----GTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK 231
Query: 846 WFWRIK----SSKEKFKAAIDPALEVNEE 870
+K S E FK ++ L + E
Sbjct: 232 GIPPLKNPEKWSPE-FKDFLNKCLVKDPE 259
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 71/221 (32%), Positives = 113/221 (51%), Gaps = 26/221 (11%)
Query: 625 QNFAQENELGRGGFGTVYKGEL------EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLS 678
N + ELG G FG V+ E +D +AVK ++ + A +F E +L+
Sbjct: 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLT 62
Query: 679 KVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHL--------FRWEKLQLKPLSWTRR 730
++H H+V G +EG+ ++V+EYM HG L++ L E + L+ ++
Sbjct: 63 NLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQM 122
Query: 731 LSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVT 790
L IA +A GM Y LA Q F+HRDL + N L+ ++ K+ DFG+ + D +
Sbjct: 123 LHIAQQIAAGMVY---LASQHFVHRDLATRNCLVGENLLVKIGDFGMSR---DVYSTDYY 176
Query: 791 RLAG----TFGYLAPEYAVMGKITTKADVFSYGVVLMELLT 827
R+ G ++ PE + K TT++DV+S GVVL E+ T
Sbjct: 177 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 83/272 (30%), Positives = 135/272 (49%), Gaps = 42/272 (15%)
Query: 633 LGRGGFGTVYKG-ELEDGTKIAVKRM---EAGVTTTKALDEFQSEIAVLSKVRHRHLVSL 688
LG G FG+VY+G L+DG AVK + + G T +A+ + + EIA+LSK++H ++V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 689 LGYSIEGNERLLVY-EYMPHGALSRHLFRWEKLQLKPL--SWTRRLSIALDVARGMEYLH 745
LG E + L ++ E +P G+L++ L ++ +P+ +TR++ L G+EYLH
Sbjct: 68 LGTEREE-DNLYIFLELVPGGSLAKLLKKYGSFP-EPVIRLYTRQI---LL---GLEYLH 119
Query: 746 CLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK--LAPDGEKSVVTRLAGTFGYLAPEY 803
+ +HRD+K +NIL+D + K++DFG+ K + KS G+ ++APE
Sbjct: 120 ---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFK----GSPYWMAPEV 172
Query: 804 AV-MGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862
G AD++S G ++E+ TG + P ++I SKE I
Sbjct: 173 IAQQGGYGLAADIWSLGCTVLEMATG------KPPWSQLEGVAAVFKIGRSKE--LPPIP 224
Query: 863 PALEVNEETFESISIVAELAGHCTAREPYHRP 894
L + F C R+P RP
Sbjct: 225 DHLSDEAKDFILK---------CLQRDPSLRP 247
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 4e-25
Identities = 72/206 (34%), Positives = 101/206 (49%), Gaps = 21/206 (10%)
Query: 632 ELGRGGFGTV----YKGELED-GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLV 686
LG G FG V Y + G +AVK ++ + ++ EI +L + H ++V
Sbjct: 11 VLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRE-CGQQNTSGWKKEINILKTLYHENIV 69
Query: 687 SLLGYSIEGNER--LLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYL 744
G E + L+ EY+P G+L +L + KL L L L A + GM YL
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK-HKLNLAQL-----LLFAQQICEGMAYL 123
Query: 745 HCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAG---TFGYLAP 801
H Q +IHRDL + N+LLD+D K+ DFGL K P+G + R G F Y A
Sbjct: 124 HS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AV 179
Query: 802 EYAVMGKITTKADVFSYGVVLMELLT 827
E K + +DV+S+GV L ELLT
Sbjct: 180 ECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 78/282 (27%), Positives = 124/282 (43%), Gaps = 30/282 (10%)
Query: 633 LGRGGFGTVYKG-----ELEDG-TKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLV 686
LGRG FG V+ E E G T + VK ++ EF+ E+ + K+ H+++V
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQK-TKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 687 SLLGYSIEGNERLLVYEYMPHGALSRHLF----RWEKLQLKPLSWTRRLSIALDVARGME 742
LLG E ++ EY G L + L + EKL+ PLS +++++ +A GM+
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 743 YLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPE 802
+L + F+HRDL + N L+ KVS L K + E + +LAPE
Sbjct: 132 HL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE 188
Query: 803 YAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862
+TK+DV+S+GV++ E+ T E P E R+++ K +
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFT-----QGELPFYGLSDEEVLNRLQAGKLELPVP-- 241
Query: 863 PALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLS 904
E + +L C A P RP +V+ L
Sbjct: 242 ------EGCPSRLY---KLMTRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 71/219 (32%), Positives = 112/219 (51%), Gaps = 29/219 (13%)
Query: 630 ENELGRGGFGTVYKGE------LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHR 683
+ ELG G FG V+ E +D +AVK ++ T A +FQ E +L+ ++H
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD--PTLAARKDFQREAELLTNLQHE 67
Query: 684 HLVSLLGYSIEGNERLLVYEYMPHGALSRH----------LFRWEKLQLK-PLSWTRRLS 732
H+V G +G+ ++V+EYM HG L++ L + Q K L ++ L
Sbjct: 68 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 733 IALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRL 792
IA +A GM Y LA Q F+HRDL + N L+ + K+ DFG+ + D + R+
Sbjct: 128 IASQIASGMVY---LASQHFVHRDLATRNCLVGANLLVKIGDFGMSR---DVYSTDYYRV 181
Query: 793 AG----TFGYLAPEYAVMGKITTKADVFSYGVVLMELLT 827
G ++ PE + K TT++DV+S+GV+L E+ T
Sbjct: 182 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 62/199 (31%), Positives = 111/199 (55%), Gaps = 12/199 (6%)
Query: 630 ENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLL 689
+LG G FG V+ G TK+A+K ++ G + + + F +E ++ +++H LV L
Sbjct: 11 VKKLGAGQFGEVWMGYYNGHTKVAIKSLKQG---SMSPEAFLAEANLMKQLQHPRLVRL- 66
Query: 690 GYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLA 748
Y++ E + ++ EYM +G+L L E ++L + + +A +A GM ++
Sbjct: 67 -YAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLT---INKLIDMAAQIAEGMAFIE--- 119
Query: 749 RQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGK 808
R+ +IHRDL+++NIL+ + K++DFGL +L D E + + APE G
Sbjct: 120 RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 179
Query: 809 ITTKADVFSYGVVLMELLT 827
T K+DV+S+G++L E++T
Sbjct: 180 FTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 60/208 (28%), Positives = 94/208 (45%), Gaps = 15/208 (7%)
Query: 628 AQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLV 686
+ N++G G FG VY L+ G +AVK + K + E E+ VL ++H +LV
Sbjct: 3 QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV 62
Query: 687 SLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHC 746
G + + + EY G L L E ++ R ++ L G+ YLH
Sbjct: 63 KYYGVEVHREKVYIFMEYCSGGTLEELL---EHGRILDEHVIRVYTLQL--LEGLAYLH- 116
Query: 747 LARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFG---YLAPEY 803
+HRD+K +NI LD + K+ DFG + ++ + G Y+APE
Sbjct: 117 --SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174
Query: 804 AVMGKITTK---ADVFSYGVVLMELLTG 828
GK AD++S G V++E+ TG
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATG 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 70/235 (29%), Positives = 113/235 (48%), Gaps = 38/235 (16%)
Query: 633 LGRGGFGTVY------------KGELEDGTK-----IAVKRMEAGVTTTKALDEFQSEIA 675
LG G FG V+ K E+ +AVK + + A ++F E+
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDN-AREDFLKEVK 71
Query: 676 VLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWE------KLQLKPLSWTR 729
+LS++ ++ LLG ++ EYM +G L++ L + K LS++
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 730 RLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVV 789
L +A +A GM YL L F+HRDL + N L+ +Y K++DFG+ + + S
Sbjct: 132 LLYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSR---NLYSSDY 185
Query: 790 TRLAGT----FGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEES 840
R+ G ++A E ++GK TTK+DV+++GV L E+LT L E+P E
Sbjct: 186 YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT----LCREQPYEH 236
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 34/217 (15%)
Query: 631 NELGRGGFGTVYKGE-LEDGTKIAVK--RMEAG-----VTTTKALDEFQSEIAVLSKVRH 682
++G G +G VYK + G +A+K RME +T + EI +L K+RH
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR-------EIKLLQKLRH 57
Query: 683 RHLVSLLG--YSIEGNERLLVYEYMPH---GALSRHLFRWEKLQLKPLSWTRRLSIALDV 737
++V L S +V+EYM H G L ++ + Q+K +
Sbjct: 58 PNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIK--------CYMKQL 109
Query: 738 ARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFG 797
G++YLH +HRD+K SNIL+++D K++DFGL + + T T
Sbjct: 110 LEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLW 166
Query: 798 YLAPEYAVMG--KITTKADVFSYGVVLMELLTGLAAL 832
Y PE ++G + + D++S G +L EL G
Sbjct: 167 YRPPEL-LLGATRYGPEVDMWSVGCILAELFLGKPIF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 64/207 (30%), Positives = 111/207 (53%), Gaps = 16/207 (7%)
Query: 633 LGRGGFGTVYKGEL---EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLL 689
LG G FG+V +G+L + K+AVK M+ + T +++F SE + + H +++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 690 GYSIEGNER------LLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIAL--DVARGM 741
G ++ E +++ +M HG L L + +L P ++ + D+A GM
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLL-YSRLGDCPQYLPTQMLVKFMTDIASGM 125
Query: 742 EYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGT-FGYLA 800
EYL + ++FIHRDL + N +L+++ V+DFGL K +G+ R+A ++A
Sbjct: 126 EYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIA 182
Query: 801 PEYAVMGKITTKADVFSYGVVLMELLT 827
E TTK+DV+S+GV + E+ T
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 7e-24
Identities = 62/198 (31%), Positives = 104/198 (52%), Gaps = 13/198 (6%)
Query: 632 ELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGY 691
+LG G FG V+ G + TK+AVK ++ G + +A F E ++ ++H LV L
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA---FLEEANLMKTLQHDKLVRLYAV 69
Query: 692 SIEGNERLLVYEYMPHGALSRHLFRWE--KLQLKPLSWTRRLSIALDVARGMEYLHCLAR 749
+ ++ EYM G+L L E K+ L L + + +A GM Y+ R
Sbjct: 70 VTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKL-----IDFSAQIAEGMAYIE---R 121
Query: 750 QTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKI 809
+ +IHRDL+++N+L+ + K++DFGL ++ D E + + APE G
Sbjct: 122 KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF 181
Query: 810 TTKADVFSYGVVLMELLT 827
T K+DV+S+G++L E++T
Sbjct: 182 TIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 80/294 (27%), Positives = 142/294 (48%), Gaps = 51/294 (17%)
Query: 630 ENELGRGGFGTVYKGELEDGTK----IAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHL 685
E +G G FG V G L+ K +A+K ++AG T + D F SE +++ + H ++
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRD-FLSEASIMGQFDHPNI 67
Query: 686 VSLLGYSIEGNERLLVYEYMPHGALS----RHLFRWEKLQLKPLSWTRRLSIALDVARGM 741
+ L G + ++V EYM +G+L +H ++ +QL + + +A GM
Sbjct: 68 IHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL--------VGMLRGIASGM 119
Query: 742 EYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFG--YL 799
+YL + ++HRDL + NIL++ + KVSDFGL ++ D ++ T G +
Sbjct: 120 KYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 176
Query: 800 APEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWR------IKSS 853
APE K T+ +DV+SYG+V+ E+++ ERP +W IK+
Sbjct: 177 APEAIAYRKFTSASDVWSYGIVMWEVMSY-----GERP---------YWEMSNQDVIKAI 222
Query: 854 KEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLV 907
+E ++ PA + + + +L C ++ RP +V++L L+
Sbjct: 223 EEGYRL---PA------PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 70/207 (33%), Positives = 106/207 (51%), Gaps = 15/207 (7%)
Query: 632 ELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGY 691
ELG G FG V G+ +A+K ++ G + + DEF E V+ K+ H LV L G
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEG---SMSEDEFIEEAKVMMKLSHEKLVQLYGV 67
Query: 692 SIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQT 751
+ +V EYM +G L +L + K ++ L + DV GM YL +
Sbjct: 68 CTKQRPIYIVTEYMSNGCLLNYL----REHGKRFQPSQLLEMCKDVCEGMAYLE---SKQ 120
Query: 752 FIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGE--KSVVTRLAGTFGYLAPEYAVMGKI 809
FIHRDL + N L+DD KVSDFGL + D E SV ++ + PE + K
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFP--VRWSPPEVLLYSKF 178
Query: 810 TTKADVFSYGVVLMELLTGLAALDEER 836
++K+DV+++GV++ E+ + L + ER
Sbjct: 179 SSKSDVWAFGVLMWEVYS-LGKMPYER 204
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-23
Identities = 115/379 (30%), Positives = 168/379 (44%), Gaps = 38/379 (10%)
Query: 70 TQIQVQNLG---LKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSG-LSELEFAYLDFNE 125
+ ++V +LG L G +P + LT L L L N+ G++P G + L++ YL +N
Sbjct: 164 SSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNN 223
Query: 126 FD-TIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPD 184
IP + GL+S+ L L YN IP SL N L L L L GP+P
Sbjct: 224 LSGEIPYEI-GGLTSLNHLDLVYNNLTG----PIPSSLGNLKNLQYLFLYQNKLSGPIPP 278
Query: 185 FLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDV-VAKMVSLTQ 243
+ +L L +L LS N LSG IP Q +Q L + + TG I V + + L
Sbjct: 279 SIFSLQKLISLDLSDNSLSGEIPELVIQ--LQNLEILHLFSNNFTGKIPVALTSLPRLQV 336
Query: 244 LWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGPI 302
L L N+F+G IP+++G ++L L+L+ N L G IP+ L + L L+L +N L G I
Sbjct: 337 LQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEI 396
Query: 303 PKFKAG-----NVTYDSNSFCQSEP-GIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPC 356
PK V NSF P P V LD + N + S+
Sbjct: 397 PKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVY-FLD-ISNNNLQGRINSR------- 447
Query: 357 QGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTEL 416
W + +++L R+ G L P L + L +N SG VP L
Sbjct: 448 --KW------DMPSLQMLSLARNKFFGGL-PDSFGSKRLENLDLSRNQFSGAVPRKLGSL 498
Query: 417 KSLRLLDVSDNNIKPPLPE 435
L L +S+N + +P+
Sbjct: 499 SELMQLKLSENKLSGEIPD 517
|
Length = 968 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 4e-23
Identities = 65/203 (32%), Positives = 97/203 (47%), Gaps = 20/203 (9%)
Query: 633 LGRGGFGTVY------KGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLV 686
LG+GGFG V G++ K+ KR++ AL+E + +L KV R +V
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKK----ILEKVSSRFIV 56
Query: 687 SLLGYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLH 745
SL Y+ E + L LV M G L H++ + R + A + G+E+LH
Sbjct: 57 SL-AYAFETKDDLCLVMTLMNGGDLKYHIY---NVGEPGFPEARAIFYAAQIICGLEHLH 112
Query: 746 CLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAV 805
++ ++RDLK N+LLDD ++SD GL G+K + AGT GY+APE
Sbjct: 113 ---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTPGYMAPEVLQ 167
Query: 806 MGKITTKADVFSYGVVLMELLTG 828
D F+ G L E++ G
Sbjct: 168 GEVYDFSVDWFALGCTLYEMIAG 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-22
Identities = 91/361 (25%), Positives = 158/361 (43%), Gaps = 49/361 (13%)
Query: 79 LKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEF-DTIPSDFFDG 136
L G +P LT L +L L N G +P + L L++ +L N+ IP F
Sbjct: 224 LSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIF-- 281
Query: 137 LSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALK 196
S ++++LD + + + IP+ + L L L + N G +P L +LP L L+
Sbjct: 282 -SLQKLISLDLS--DNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQ 338
Query: 197 LSYNRLSGVIPASFG-QSLMQILWLNDQDAGGMTGPI-DVVAKMVSLTQLWLHGNQFTGS 254
L N+ SG IP + G + + +L D +TG I + + +L +L L N G
Sbjct: 339 LWSNKFSGEIPKNLGKHNNLTVL---DLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGE 395
Query: 255 IPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDN-LVLNNNLLMGPIPKFKAGNVTYD 313
IP+ +GA SL+ + L N G +P + L L ++NN L G I
Sbjct: 396 IPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRI----------- 444
Query: 314 SNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSI 373
NS P ++ +L +++ G P + ++
Sbjct: 445 -NSRKWDMPSLQ-------MLSLA---------RNKFFGGLP--------DSFGSKRLEN 479
Query: 374 INLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPL 433
++L R+ +G + + +L L++++L +N +SG +P+ + K L LD+S N + +
Sbjct: 480 LDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQI 539
Query: 434 P 434
P
Sbjct: 540 P 540
|
Length = 968 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 1e-22
Identities = 63/210 (30%), Positives = 116/210 (55%), Gaps = 21/210 (10%)
Query: 633 LGRGGFGTVYKGEL--EDGT--KIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSL 688
LG+G FG+V + +L EDG+ K+AVK ++A + ++ ++EF E A + + H +++ L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 689 LGYSIEGNER------LLVYEYMPHGALSRHLFRWEKLQLKPLSWTRR--LSIALDVARG 740
+G S+ + +++ +M HG L L ++ +P + + + +D+A G
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLM-SRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 741 MEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGE---KSVVTRLAGTFG 797
MEYL + + FIHRDL + N +L+++ V+DFGL K G+ + ++L
Sbjct: 126 MEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLP--VK 180
Query: 798 YLAPEYAVMGKITTKADVFSYGVVLMELLT 827
+LA E TT +DV+++GV + E++T
Sbjct: 181 WLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 62/199 (31%), Positives = 103/199 (51%), Gaps = 17/199 (8%)
Query: 633 LGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGY 691
LG G +G+VYK E G +A+K + + L E EI++L + ++V G
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVP----VEEDLQEIIKEISILKQCDSPYIVKYYGS 66
Query: 692 SIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQT 751
+ + +V EY G++S + K+ K L+ +I +G+EYLH
Sbjct: 67 YFKNTDLWIVMEYCGAGSVSDIM----KITNKTLTEEEIAAILYQTLKGLEYLH---SNK 119
Query: 752 FIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKI-- 809
IHRD+K+ NILL+++ +AK++DFG+ D T + GT ++APE V+ +I
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAPE--VIQEIGY 176
Query: 810 TTKADVFSYGVVLMELLTG 828
KAD++S G+ +E+ G
Sbjct: 177 NNKADIWSLGITAIEMAEG 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 2e-22
Identities = 62/201 (30%), Positives = 103/201 (51%), Gaps = 15/201 (7%)
Query: 633 LGRGGFGTVYKG-ELEDGTKI----AVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVS 687
LG G FGTV+KG + +G I A+K ++ + + E + + + H ++V
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQ-DRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 688 LLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCL 747
LLG G LV + P G+L H+ R + L P R L+ + +A+GM YL
Sbjct: 74 LLGIC-PGASLQLVTQLSPLGSLLDHV-RQHRDSLDP---QRLLNWCVQIAKGMYYLE-- 126
Query: 748 ARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA-PDGEKSVVTRLAGTFGYLAPEYAVM 806
+HR+L + NILL D +++DFG+ L PD +K + ++A E +
Sbjct: 127 -EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILF 185
Query: 807 GKITTKADVFSYGVVLMELLT 827
G+ T ++DV+SYGV + E+++
Sbjct: 186 GRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 3e-22
Identities = 64/196 (32%), Positives = 103/196 (52%), Gaps = 10/196 (5%)
Query: 633 LGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYS 692
LG+G FG V+KG L+D T +AVK + + + +F SE +L + H ++V L+G
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKI-KFLSEARILKQYDHPNIVKLIGVC 61
Query: 693 IEGNERLLVYEYMPHGALSRHLFR-WEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQT 751
+ +V E +P G L + ++L+ K L + ALD A GM YL +
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQL-----VKFALDAAAGMAYLES---KN 113
Query: 752 FIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITT 811
IHRDL + N L+ ++ K+SDFG+ + DG S + APE G+ ++
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSS 173
Query: 812 KADVFSYGVVLMELLT 827
++DV+SYG++L E +
Sbjct: 174 ESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 4e-22
Identities = 71/236 (30%), Positives = 123/236 (52%), Gaps = 31/236 (13%)
Query: 625 QNFAQENELGRGGFGTVYKGE-------LEDGTK--------IAVKRMEAGVTTTKALDE 669
Q + +LG G FG V+ E L +G +AVK + A VT T A ++
Sbjct: 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKT-ARND 63
Query: 670 FQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWE-------KLQL 722
F EI ++S++++ +++ LLG + + ++ EYM +G L++ L + E +
Sbjct: 64 FLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNI 123
Query: 723 KPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782
+S L +A+ +A GM+YL L F+HRDL + N L+ + Y K++DFG+ +
Sbjct: 124 PSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCLVGNHYTIKIADFGMSRNLY 180
Query: 783 DGE-KSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERP 837
G+ + R ++A E ++GK TT +DV+++GV L E+ T L +E+P
Sbjct: 181 SGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT----LCKEQP 232
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 6e-22
Identities = 67/211 (31%), Positives = 110/211 (52%), Gaps = 22/211 (10%)
Query: 632 ELGRGGFGTVYKG------ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHL 685
ELG+G FG VY+G + E T++A+K + + + + EF +E +V+ + H+
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEASVMKEFNCHHV 71
Query: 686 VSLLGYSIEGNERLLVYEYMPHGALSRHL--FRWEKLQ---LKPLSWTRRLSIALDVARG 740
V LLG +G L++ E M G L +L R E P S + + +A ++A G
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 741 MEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGT----F 796
M YL+ F+HRDL + N ++ +D+ K+ DFG+ + D ++ R G
Sbjct: 132 MAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR---DIYETDYYRKGGKGLLPV 185
Query: 797 GYLAPEYAVMGKITTKADVFSYGVVLMELLT 827
+++PE G TT +DV+S+GVVL E+ T
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 6e-22
Identities = 77/286 (26%), Positives = 137/286 (47%), Gaps = 33/286 (11%)
Query: 630 ENELGRGGFGTVYKGELEDGTK----IAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHL 685
E +G G FG V +G L+ K +A+K +++G T K +F SE +++ + H ++
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTE-KQRRDFLSEASIMGQFDHPNI 67
Query: 686 VSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLH 745
+ L G + +++ E+M +GAL L R Q + L +A GM+YL
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFL-RQNDGQFTVIQLVGMLR---GIAAGMKYL- 122
Query: 746 CLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG--EKSVVTRLAGTFG--YLAP 801
+ ++HRDL + NIL++ + KVSDFGL + D + + + L G + AP
Sbjct: 123 --SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 802 EYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861
E K T+ +DV+SYG+V+ E+++ ERP +W + S + AI
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMSY-----GERP---------YWDM--SNQDVINAI 224
Query: 862 DPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLV 907
+ + + + + +L C ++ RP G +V+ L ++
Sbjct: 225 EQDYRL-PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 8e-22
Identities = 73/244 (29%), Positives = 117/244 (47%), Gaps = 22/244 (9%)
Query: 627 FAQENELGRGGFGTV------YKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV 680
F Q LG+GGFG V G++ K+ KR++ + AL+E Q +L KV
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQ----ILEKV 57
Query: 681 RHRHLVSLLGYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVAR 739
R +VSL Y+ E + L LV M G L H++ + + R + A ++
Sbjct: 58 NSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEE---GRAVFYAAEICC 113
Query: 740 GMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYL 799
G+E LH ++ ++RDLK NILLDD ++SD GL P+G+ + GT GY+
Sbjct: 114 GLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--TIKGRVGTVGYM 168
Query: 800 APEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKA 859
APE + T D ++ G +L E++ G + + + + R E +K +E++
Sbjct: 169 APEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL--VKEVQEEYSE 226
Query: 860 AIDP 863
P
Sbjct: 227 KFSP 230
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 9e-22
Identities = 104/382 (27%), Positives = 164/382 (42%), Gaps = 74/382 (19%)
Query: 79 LKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFD-TIPSDFFDG 136
L G +P+ QL L L L N F GK+P + L L+ L N+F IP +
Sbjct: 296 LSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNL-GK 354
Query: 137 LSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALK 196
+++ VL L N IP+ L +S L L L + +L G +P LG SL ++
Sbjct: 355 HNNLTVLDLSTNNLTG----EIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVR 410
Query: 197 LSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVA-KMVSLTQLWLHGNQFTGSI 255
L N SG +P+ F + + +++ D + G I+ M SL L L N+F G +
Sbjct: 411 LQDNSFSGELPSEFTK--LPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGL 468
Query: 256 PEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGPIPKFKAGNVTYDS 314
P+ G+ L++L+L+RNQ G +P+ L ++ EL L L+ N L G IP D
Sbjct: 469 PDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIP---------DE 518
Query: 315 NSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSII 374
S C+ LVS +
Sbjct: 519 LSSCK-------------------------KLVS-------------------------L 528
Query: 375 NLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLP 434
+L + L+G + S + + L ++ L +N +SG +P N ++SL +++S N++ LP
Sbjct: 529 DLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP 588
Query: 435 E---FHDTVKLVIDGNPLLVGG 453
F + GN L GG
Sbjct: 589 STGAFLAINASAVAGNIDLCGG 610
|
Length = 968 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 24/228 (10%)
Query: 634 GRGGFGTVYKGELEDGTKI-AVKRM-EAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGY 691
G+G FG V + D K+ A+K M + ++ +E +L ++ H LV+L Y
Sbjct: 9 GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLW-Y 67
Query: 692 SIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQ 750
S + E + LV + + G L HL Q S + ++ +EYLH +
Sbjct: 68 SFQDEENMYLVVDLLLGGDLRYHL-----SQKVKFSEEQVKFWICEIVLALEYLH---SK 119
Query: 751 TFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKIT 810
IHRD+K NILLD+ ++DF + + T +GT GY+APE + +
Sbjct: 120 GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST--SGTPGYMAPE-VLCRQGY 176
Query: 811 TKA-DVFSYGVVLMELLTGLAALDEERPEE--SRYLAEWFWRIKSSKE 855
+ A D +S GV E L G +RP SR + + + + +
Sbjct: 177 SVAVDWWSLGVTAYECLRG------KRPYRGHSRTIRDQIRAKQETAD 218
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 59/203 (29%), Positives = 93/203 (45%), Gaps = 20/203 (9%)
Query: 632 ELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTT--KALDEFQSEIAVLSKVRHRHLVSL 688
LG+G G VYK G A+K++ K L E+ L ++V
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLL---RELKTLRSCESPYVVKC 64
Query: 689 LGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLA 748
G + E +V EYM G+L+ L + K+ L+ IA + +G++YLH
Sbjct: 65 YGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLA-----YIARQILKGLDYLHTKR 119
Query: 749 RQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP---DGEKSVVTRLAGTFGYLAPEYAV 805
IHRD+K SN+L++ K++DFG+ K+ D + V GT Y++PE
Sbjct: 120 HI--IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV----GTVTYMSPERIQ 173
Query: 806 MGKITTKADVFSYGVVLMELLTG 828
+ AD++S G+ L+E G
Sbjct: 174 GESYSYAADIWSLGLTLLECALG 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 1e-21
Identities = 67/211 (31%), Positives = 108/211 (51%), Gaps = 22/211 (10%)
Query: 632 ELGRGGFGTVYKGELED------GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHL 685
ELG+G FG VY+G D T++AVK + + + + EF +E +V+ H+
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHHV 71
Query: 686 VSLLGYSIEGNERLLVYEYMPHGALSRHLFRW----EKLQLKPLSWTRRL-SIALDVARG 740
V LLG +G L+V E M HG L +L E +P + + +A ++A G
Sbjct: 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 741 MEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGT----F 796
M YL+ + F+HRDL + N ++ D+ K+ DFG+ + D ++ R G
Sbjct: 132 MAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTR---DIYETDYYRKGGKGLLPV 185
Query: 797 GYLAPEYAVMGKITTKADVFSYGVVLMELLT 827
++APE G TT +D++S+GVVL E+ +
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 73/221 (33%), Positives = 111/221 (50%), Gaps = 27/221 (12%)
Query: 633 LGRGGFGTVY---KGELEDGTKIAVKRMEAGVTTTK-ALDEFQSEIAVLSKVRHRHLVSL 688
+ +G +G V+ K D A+K ++ K +D+ +E +LS+ + ++V L
Sbjct: 1 ISKGAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 689 LGYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCL 747
YS +G + L LV EY+P G L+ L E + R + IA ++ +EYLH
Sbjct: 59 Y-YSFQGKKNLYLVMEYLPGGDLASLL---ENVGSLDEDVAR-IYIA-EIVLALEYLH-- 110
Query: 748 ARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKL--------APDGEKSVVTRLAGTFGYL 799
IHRDLK NIL+D + K++DFGL K+ D EK R+ GT Y+
Sbjct: 111 -SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDK-RIVGTPDYI 168
Query: 800 APEYAVMGKITTKA-DVFSYGVVLMELLTGLAALDEERPEE 839
APE ++G+ +K D +S G +L E L G+ E PEE
Sbjct: 169 APE-VILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE 208
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 2e-21
Identities = 88/305 (28%), Positives = 140/305 (45%), Gaps = 60/305 (19%)
Query: 630 ENELGRGGFGTVYKGELE-DGTKI--AVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHL 685
E+ +G G FG V + ++ DG K+ A+K ++ + D F E+ VL K+ H ++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRD-FAGELEVLCKLGHHPNI 65
Query: 686 VSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKP-----------LSWTRRLSIA 734
++LLG + EY P+G L L + L+ P L+ + L A
Sbjct: 66 INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125
Query: 735 LDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAG 794
DVA GM+YL + + FIHRDL + N+L+ ++ +K++DFGL + GE+ V + G
Sbjct: 126 SDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVKKTMG 178
Query: 795 TFG--YLAPEYAVMGKITTKADVFSYGVVLMELLT-------GL--AALDEERPEESRYL 843
++A E TTK+DV+S+GV+L E+++ G+ A L E+ P+ R
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRM- 237
Query: 844 AEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVL 903
EK + D V EL C PY RP + L
Sbjct: 238 -----------EKPRNCDDE--------------VYELMRQCWRDRPYERPPFAQISVQL 272
Query: 904 SPLVE 908
S ++E
Sbjct: 273 SRMLE 277
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 71/222 (31%), Positives = 111/222 (50%), Gaps = 39/222 (17%)
Query: 633 LGRGGFGTVYKGEL------EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHL 685
LG G FG V K E + + +AVK M T K L + SE+ ++ + +H+++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVK-MLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 686 VSLLGYSIEGNERLLVYEYMPHGALSRHLFR----------------WEKLQLKPLSWTR 729
++LLG + +V EY HG L L E L K L
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL---- 134
Query: 730 RLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGE---K 786
+S A VARGME+L A + IHRDL + N+L+ +D+ K++DFGL + + K
Sbjct: 135 -VSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRK 190
Query: 787 SVVTRLAGTFGYLAPEYAVMGKI-TTKADVFSYGVVLMELLT 827
+ RL ++APE A+ ++ T ++DV+S+GV+L E+ T
Sbjct: 191 TTNGRLP--VKWMAPE-ALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 3e-21
Identities = 67/214 (31%), Positives = 107/214 (50%), Gaps = 31/214 (14%)
Query: 627 FAQENELGRGGFGTVYKG-ELEDGTKIAVKRM-----EAGVTTTKALDEFQSEIAVLSKV 680
+ + +LG G +G VYK + + G +A+K++ E G+ +T AL EI++L ++
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPST-AL----REISLLKEL 55
Query: 681 RHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARG 740
+H ++V LL + LV+EY L ++L + PLS SI + RG
Sbjct: 56 KHPNIVKLLDVIHTERKLYLVFEYCDMD-LKKYL----DKRPGPLSPNLIKSIMYQLLRG 110
Query: 741 MEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA--PDGE--KSVVTRLAGTF 796
+ Y H +HRDLK NIL++ D K++DFGL + P VV T
Sbjct: 111 LAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-----TL 162
Query: 797 GYLAPEYAVMG--KITTKADVFSYGVVLMELLTG 828
Y APE ++G +T D++S G + E++TG
Sbjct: 163 WYRAPE-ILLGSKHYSTAVDIWSVGCIFAEMITG 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 3e-21
Identities = 65/210 (30%), Positives = 109/210 (51%), Gaps = 21/210 (10%)
Query: 631 NELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLL 689
+G G VY L + K+A+KR++ T +DE + E+ +S+ H ++V
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTS-VDELRKEVQAMSQCNHPNVVKYY 65
Query: 690 GYSIEGNERLLVYEYMPHGALS---RHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHC 746
+ G+E LV Y+ G+L + + L ++ ++ +V +G+EYLH
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIA-----TVLKEVLKGLEYLH- 119
Query: 747 LARQTFIHRDLKSSNILLDDDYRAKVSDFGL-VKLAPDGEKSVVTR--LAGTFGYLAPEY 803
IHRD+K+ NILL +D K++DFG+ LA G+++ R GT ++APE
Sbjct: 120 --SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE- 176
Query: 804 AVMGKI---TTKADVFSYGVVLMELLTGLA 830
VM ++ KAD++S+G+ +EL TG A
Sbjct: 177 -VMEQVHGYDFKADIWSFGITAIELATGAA 205
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.2 bits (235), Expect = 3e-21
Identities = 62/210 (29%), Positives = 103/210 (49%), Gaps = 26/210 (12%)
Query: 627 FAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDE---FQSEIAVLSKVRH 682
F +G+G FG VYK + +A+K + +A DE Q EI LS+ R
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKV----IDLEEAEDEIEDIQQEIQFLSQCRS 58
Query: 683 RHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGME 742
++ G ++G++ ++ EY G+ L + KL ++ I +V G+E
Sbjct: 59 PYITKYYGSFLKGSKLWIIMEYCGGGSC-LDLLKPGKLDETYIA-----FILREVLLGLE 112
Query: 743 YLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGE-KSVVTRL---AGTFGY 798
YLH + IHRD+K++NILL ++ K++DFG+ G+ S +++ GT +
Sbjct: 113 YLHE---EGKIHRDIKAANILLSEEGDVKLADFGV-----SGQLTSTMSKRNTFVGTPFW 164
Query: 799 LAPEYAVMGKITTKADVFSYGVVLMELLTG 828
+APE KAD++S G+ +EL G
Sbjct: 165 MAPEVIKQSGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 5e-21
Identities = 66/211 (31%), Positives = 112/211 (53%), Gaps = 25/211 (11%)
Query: 633 LGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKA-------LDEFQSEIAVLSKVRHRH 684
+G G FG+VY G G +AVK++E + + LD EIA+L +++H +
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 685 LVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPL--SWTRRLSIALDVARGME 742
+V LG S++ + + EY+P G+++ L + + + L ++ R+ + +G+
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFE-ETLVRNFVRQ------ILKGLN 120
Query: 743 YLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTR-----LAGTFG 797
YLH + IHRD+K +NIL+D+ K+SDFG+ K S T L G+
Sbjct: 121 YLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVF 177
Query: 798 YLAPEYAVMGKITTKADVFSYGVVLMELLTG 828
++APE T KAD++S G +++E+LTG
Sbjct: 178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLTG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 5e-21
Identities = 76/288 (26%), Positives = 136/288 (47%), Gaps = 41/288 (14%)
Query: 630 ENELGRGGFGTVYKGELEDGTK----IAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHL 685
E LG G FG + +G L+ +K +A+ + AG + + F +E L + H ++
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRG-FLAEALTLGQFDHSNI 68
Query: 686 VSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLH 745
V L G GN ++V EYM +GAL L + E L + + + +A GM+Y
Sbjct: 69 VRLEGVITRGNTMMIVTEYMSNGALDSFLRKHE----GQLVAGQLMGMLPGLASGMKY-- 122
Query: 746 CLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYL--APEY 803
L+ ++H+ L + +L++ D K+S F +L D +++ T ++G L APE
Sbjct: 123 -LSEMGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEA 179
Query: 804 AVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID- 862
++ +DV+S+G+V+ E+++ ERP +W + S ++ KA D
Sbjct: 180 IQYHHFSSASDVWSFGIVMWEVMSY-----GERP---------YWDM-SGQDVIKAVEDG 224
Query: 863 ---PALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLV 907
PA N +++ +L C +E RP + ++LS +V
Sbjct: 225 FRLPA-PRNCP-----NLLHQLMLDCWQKERGERPRFSQIHSILSKMV 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 6e-21
Identities = 67/206 (32%), Positives = 111/206 (53%), Gaps = 19/206 (9%)
Query: 632 ELGRGGFGTV----YKGELED-GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLV 686
+LG G FG V Y E ++ G ++AVK ++ + + + + EI +L + H ++V
Sbjct: 11 DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE-SGGNHIADLKKEIEILRNLYHENIV 69
Query: 687 SLLGYSIE--GNERLLVYEYMPHGALSRHLFR-WEKLQLKPLSWTRRLSIALDVARGMEY 743
G E GN L+ E++P G+L +L R K+ LK L A+ + +GM+Y
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQ-----LKYAVQICKGMDY 124
Query: 744 LHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEK--SVVTRLAGTFGYLAP 801
L +RQ ++HRDL + N+L++ +++ K+ DFGL K ++ +V L + AP
Sbjct: 125 LG--SRQ-YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAP 181
Query: 802 EYAVMGKITTKADVFSYGVVLMELLT 827
E + K +DV+S+GV L ELLT
Sbjct: 182 ECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 8e-21
Identities = 66/222 (29%), Positives = 106/222 (47%), Gaps = 32/222 (14%)
Query: 633 LGRGGFGTVYKGE------LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLV 686
LG G FG V K T +AVK ++ ++++ D SE +L +V H H++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRD-LLSEFNLLKQVNHPHVI 66
Query: 687 SLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQ-------------------LKPLSW 727
L G + LL+ EY +G+L L K+ + L+
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 728 TRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKS 787
+S A ++RGM+YL A +HRDL + N+L+ + + K+SDFGL + + E S
Sbjct: 127 GDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYE-EDS 182
Query: 788 VVTRLAGTF--GYLAPEYAVMGKITTKADVFSYGVVLMELLT 827
V R G ++A E TT++DV+S+GV+L E++T
Sbjct: 183 YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 1e-20
Identities = 66/203 (32%), Positives = 108/203 (53%), Gaps = 20/203 (9%)
Query: 630 ENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLL 689
E +LG G FG V+ TK+AVK M+ G + +A F +E V+ ++H LV L
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA---FLAEANVMKTLQHDKLVKL- 66
Query: 690 GYSIEGNERL-LVYEYMPHGALSRHLFRWE--KLQLKPLSWTRRLSIALDVARGMEYLHC 746
+++ E + ++ E+M G+L L E K L L + + +A GM ++
Sbjct: 67 -HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKL-----IDFSAQIAEGMAFIE- 119
Query: 747 LARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTF--GYLAPEYA 804
++ +IHRDL+++NIL+ K++DFGL ++ D E R F + APE
Sbjct: 120 --QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE--YTAREGAKFPIKWTAPEAI 175
Query: 805 VMGKITTKADVFSYGVVLMELLT 827
G T K+DV+S+G++LME++T
Sbjct: 176 NFGSFTIKSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 1e-20
Identities = 67/210 (31%), Positives = 100/210 (47%), Gaps = 22/210 (10%)
Query: 633 LGRGGFGTVYKGEL----EDGTK--IAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLV 686
LG G FG VY+G D + +AVK + + D F E ++SK H+++V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESD-FLMEALIMSKFNHQNIV 72
Query: 687 SLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRR--LSIALDVARGMEYL 744
L+G S E R ++ E M G L L +P S T + L A DVA+G
Sbjct: 73 RLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKG---C 129
Query: 745 HCLARQTFIHRDLKSSNILLDD---DYRAKVSDFGLVKLAPDGEKSVVTRLAGT----FG 797
L FIHRD+ + N LL AK++DFG+ + D ++ R G
Sbjct: 130 KYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR---DIYRASYYRKGGRAMLPIK 186
Query: 798 YLAPEYAVMGKITTKADVFSYGVVLMELLT 827
++ PE + G T+K DV+S+GV+L E+ +
Sbjct: 187 WMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 3e-20
Identities = 58/235 (24%), Positives = 96/235 (40%), Gaps = 48/235 (20%)
Query: 625 QNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRME-AGVTTTKALDEFQSEIAVLSKV-R 681
+F +G G F TV E E + A+K ++ + K + + E VL+++
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 682 HRHLVSLLGYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVAR- 739
H ++ L Y+ + E L V EY P+G L + ++ + S+ R
Sbjct: 61 HPGIIKLY-YTFQDEENLYFVLEYAPNGEL------LQYIR-------KYGSLDEKCTRF 106
Query: 740 -------GMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRL 792
+EYLH + IHRDLK NILLD D K++DFG K+ +
Sbjct: 107 YAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKG 163
Query: 793 A-------------------GTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTG 828
GT Y++PE +D+++ G ++ ++LTG
Sbjct: 164 DATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTG 218
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 61/199 (30%), Positives = 96/199 (48%), Gaps = 12/199 (6%)
Query: 633 LGRGGFGTVYK-GELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGY 691
+G G G V+K + E G +A+K++ ++ EI L +H ++V LL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 692 SIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQT 751
G+ +LV EYMP LS L E+ PL + S + +G+ Y+H
Sbjct: 68 FPHGSGFVLVMEYMPSD-LSEVLRDEER----PLPEAQVKSYMRMLLKGVAYMHANG--- 119
Query: 752 FIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMG--KI 809
+HRDLK +N+L+ D K++DFGL +L + E + + T Y APE + G K
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPEL-LYGARKY 178
Query: 810 TTKADVFSYGVVLMELLTG 828
D+++ G + ELL G
Sbjct: 179 DPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 6e-20
Identities = 61/214 (28%), Positives = 106/214 (49%), Gaps = 22/214 (10%)
Query: 632 ELGRGGFGTVYKGEL-----EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLV 686
ELG FG +YKG L + +A+K ++ + + EFQ E ++++++ H ++V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLK-DINNPQQWGEFQQEASLMAELHHPNIV 70
Query: 687 SLLGYSIEGNERLLVYEYMPHGALSRHLFRW-----------EKLQLKP-LSWTRRLSIA 734
LLG + +++EY+ G L L E +K L L IA
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 735 LDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK-LAPDGEKSVVTRLA 793
+ +A GMEYL + F+H+DL + NIL+ + K+SD GL + + V +
Sbjct: 131 IQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187
Query: 794 GTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT 827
++ PE + GK ++ +D++S+GVVL E+ +
Sbjct: 188 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 6e-20
Identities = 59/206 (28%), Positives = 94/206 (45%), Gaps = 13/206 (6%)
Query: 631 NELGRGGFGTVYK-GELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLL 689
+G+G FGTV K DG + K ++ G T K + SE+ +L +++H ++V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 690 GYSI-EGNERL-LVYEYMPHGALSRHLFRWEKLQLK---PLSW--TRRLSIALDVARGME 742
I N+ L +V EY G L++ + + +K + W +L +AL
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125
Query: 743 YLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPE 802
T +HRDLK +NI LD + K+ DFGL K+ S GT Y++PE
Sbjct: 126 D----PGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD-SSFAKTYVGTPYYMSPE 180
Query: 803 YAVMGKITTKADVFSYGVVLMELLTG 828
K+D++S G ++ EL
Sbjct: 181 QLNHMSYDEKSDIWSLGCLIYELCAL 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 8e-20
Identities = 73/240 (30%), Positives = 117/240 (48%), Gaps = 22/240 (9%)
Query: 627 FAQENELGRGGFGTV------YKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV 680
F Q LG+GGFG V G++ ++ KR++ + AL+E Q +L KV
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQ----ILEKV 57
Query: 681 RHRHLVSLLGYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVAR 739
+ +V+L Y+ E + L LV M G L H++ + R L A ++
Sbjct: 58 NSQFVVNL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEE---ERALFYAAEILC 113
Query: 740 GMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYL 799
G+E LH R+ ++RDLK NILLDD ++SD GL P+GE S+ R+ GT GY+
Sbjct: 114 GLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-SIRGRV-GTVGYM 168
Query: 800 APEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKA 859
APE + T D + G ++ E++ G + + + R + R+ ++E + A
Sbjct: 169 APEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD--RRVLETEEVYSA 226
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 9e-20
Identities = 67/230 (29%), Positives = 117/230 (50%), Gaps = 32/230 (13%)
Query: 632 ELGRGGFGTVYKGELEDGTK-----------------IAVKRMEAGVTTTKALDEFQSEI 674
+LG G FG V+ E E K +AVK + A ++F EI
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED-ANKNARNDFLKEI 70
Query: 675 AVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWE------KLQLKPLSWT 728
++S+++ +++ LL I + ++ EYM +G L++ L R E K + +S++
Sbjct: 71 KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYS 130
Query: 729 RRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGE-KS 787
+ +A +A GM+YL L F+HRDL + N L+ +Y K++DFG+ + G+
Sbjct: 131 TLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYR 187
Query: 788 VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERP 837
+ R +++ E ++GK TT +DV+++GV L E+LT L +E+P
Sbjct: 188 IQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT----LCKEQP 233
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-19
Identities = 64/213 (30%), Positives = 102/213 (47%), Gaps = 24/213 (11%)
Query: 626 NFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQS---EIAVLSKVR 681
N+ + LG+G FG VY +++ G ++AVK++ + + E + EI +L ++
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 682 HRHLVSLLGYSIEGNERLLVY-EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARG 740
H +V G + +E L ++ EYMP G++ L L+ T + G
Sbjct: 63 HERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQL-----KAYGALTETVTRKYTRQILEG 116
Query: 741 MEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK------LAPDGEKSVVTRLAG 794
+EYLH +HRD+K +NIL D K+ DFG K + G KSV G
Sbjct: 117 VEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT----G 169
Query: 795 TFGYLAPEYAVMGKITTKADVFSYGVVLMELLT 827
T +++PE KADV+S G ++E+LT
Sbjct: 170 TPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 1e-19
Identities = 66/223 (29%), Positives = 110/223 (49%), Gaps = 35/223 (15%)
Query: 627 FAQENELGRGGFGTVYKG---ELEDGTKIAVKRMEAGVTTTKALDEFQS---EIAVLSKV 680
+ E +GRG +G VYK +DG + A+K+ + + QS EIA+L ++
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGIS--QSACREIALLREL 59
Query: 681 RHRHLVSLLGYSIEGNERL--LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRL--SIALD 736
+H ++VSL+ +E ++ L+++Y H + ++ + Q K +S + S+
Sbjct: 60 KHENVVSLVEVFLEHADKSVYLLFDYAEHDLW--QIIKFHR-QAKRVSIPPSMVKSLLWQ 116
Query: 737 VARGMEYLHCLARQTFIHRDLKSSNILL----DDDYRAKVSDFGLVKL--AP-----DGE 785
+ G+ YLH +HRDLK +NIL+ + K+ D GL +L AP D +
Sbjct: 117 ILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD 173
Query: 786 KSVVTRLAGTFGYLAPEYAVMGKITTKA-DVFSYGVVLMELLT 827
VV T Y APE + + TKA D+++ G + ELLT
Sbjct: 174 PVVV-----TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 55/206 (26%), Positives = 95/206 (46%), Gaps = 27/206 (13%)
Query: 633 LGRGGFGTVYKG-ELEDGTKIAVKRM----EAGVTTTKALDEFQSEIAVLSKVRHRHLVS 687
+G G +G VYK + G +A+K++ E+ AL EI +L ++ H +++
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTAL----REIKLLKELNHPNIIK 62
Query: 688 LLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCL 747
LL + LV+E+M L++ K + + L + S + +G+ + H
Sbjct: 63 LLDVFRHKGDLYLVFEFMDT-----DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH-- 115
Query: 748 ARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK-LAPDGE---KSVVTRLAGTFGYLAPEY 803
+HRDLK N+L++ + K++DFGL + VVTR Y APE
Sbjct: 116 -SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRW-----YRAPEL 169
Query: 804 AV-MGKITTKADVFSYGVVLMELLTG 828
+ +T D++S G + ELL+
Sbjct: 170 LLGDKGYSTPVDIWSVGCIFAELLSR 195
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 2e-19
Identities = 65/210 (30%), Positives = 95/210 (45%), Gaps = 19/210 (9%)
Query: 631 NELGRGGFGTVYKGELEDGTKIA---VKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVS 687
+E+G G FG V GE G A VK + A T F E+ ++ H +++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNVLQ 59
Query: 688 LLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLS-IALDVARGMEYLHC 746
LG IE LLV E+ P G L +L R + + ++ L +A +VA G+ +LH
Sbjct: 60 CLGQCIESIPYLLVLEFCPLGDLKNYL-RSNRGMVAQMAQKDVLQRMACEVASGLLWLH- 117
Query: 747 LARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVT--RLAGTFGYLAPEYA 804
+ FIH DL N L D K+ D+GL L E +T A +LAPE
Sbjct: 118 --QADFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELV 174
Query: 805 -------VMGKITTKADVFSYGVVLMELLT 827
+ T K++++S GV + EL T
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 2e-19
Identities = 65/227 (28%), Positives = 113/227 (49%), Gaps = 36/227 (15%)
Query: 632 ELGRGGFGTVYKGELEDGTK-----------------IAVKRMEAGVTTTKALDEFQSEI 674
+LG G FG V+ E+ + +AVK + A ++F E+
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD-ANKNARNDFLKEV 70
Query: 675 AVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGAL-----SRHLFRWEK---------L 720
+LS+++ +++ LLG ++ + ++ EYM +G L S HL E+
Sbjct: 71 KILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAH 130
Query: 721 QLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKL 780
L +S++ L +AL +A GM+YL L F+HRDL + N L+ ++ K++DFG+ +
Sbjct: 131 CLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDLATRNCLVGENLTIKIADFGMSRN 187
Query: 781 APDGE-KSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELL 826
G+ + R ++A E +MGK TT +DV+++GV L E+L
Sbjct: 188 LYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 60/209 (28%), Positives = 103/209 (49%), Gaps = 22/209 (10%)
Query: 633 LGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQ--------SEIAVLSKVRHR 683
+G+G +G VY + G +AVK++E T D Q SEI L + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 684 HLVSLLGYSIEGNERLLVY-EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGME 742
++V LG+ E L ++ EY+P G++ L + + + + + V G+
Sbjct: 69 NIVQYLGFE-TTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVR-----FFTEQVLEGLA 122
Query: 743 YLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVV-TRLAGTFGYLAP 801
YLH + +HRDLK+ N+L+D D K+SDFG+ K + D + + G+ ++AP
Sbjct: 123 YLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179
Query: 802 E--YAVMGKITTKADVFSYGVVLMELLTG 828
E ++ + K D++S G V++E+ G
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 63/206 (30%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 633 LGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGY 691
LG+G +G VY +L +IA+K + ++ + EIA+ S ++HR++V LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIP--ERDSRYVQPLHEEIALHSYLKHRNIVQYLGS 73
Query: 692 SIEGNERLLVYEYMPHGALSRHL-FRWEKLQLKPLS---WTRRLSIALDVARGMEYLHCL 747
E + E +P G+LS L +W L+ + +T++ + G++YLH
Sbjct: 74 DSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQ------ILEGLKYLH-- 125
Query: 748 ARQTFIHRDLKSSNILLDDDYRA--KVSDFGLVK-LAPDGEKSVVTRLAGTFGYLAPEYA 804
+HRD+K N+L+ + Y K+SDFG K LA G GT Y+APE
Sbjct: 126 -DNQIVHRDIKGDNVLV-NTYSGVVKISDFGTSKRLA--GINPCTETFTGTLQYMAPEVI 181
Query: 805 VMGK--ITTKADVFSYGVVLMELLTG 828
G AD++S G ++E+ TG
Sbjct: 182 DKGPRGYGAPADIWSLGCTIVEMATG 207
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 2e-19
Identities = 62/223 (27%), Positives = 104/223 (46%), Gaps = 48/223 (21%)
Query: 626 NFAQENELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQS-----------E 673
+ + +LG G + VYK E G +A+K+++ G E + E
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLG--------ERKEAKDGINFTALRE 52
Query: 674 IAVLSKVRHRHLVSLLG-YSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPL---SWTR 729
I +L +++H +++ LL + + N L V+E+M L + + + + L P S+
Sbjct: 53 IKLLQELKHPNIIGLLDVFGHKSNINL-VFEFM-ETDL-EKVIKDKSIVLTPADIKSYML 109
Query: 730 RLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKL--APDGEKS 787
RG+EYLH +HRDLK +N+L+ D K++DFGL + +P+ + +
Sbjct: 110 MT------LRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMT 160
Query: 788 --VVTRLAGTFGYLAPEYAVMG--KITTKADVFSYGVVLMELL 826
VVTR Y APE + G D++S G + ELL
Sbjct: 161 HQVVTRW-----YRAPEL-LFGARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 3e-19
Identities = 91/302 (30%), Positives = 145/302 (48%), Gaps = 60/302 (19%)
Query: 633 LGRGGFGTVYKGELE-DGTKI--AVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSL 688
+G G FG V K ++ DG ++ A+KRM+ + D F E+ VL K+ H ++++L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD-FAGELEVLCKLGHHPNIINL 61
Query: 689 LGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKP-----------LSWTRRLSIALDV 737
LG L EY PHG L L + L+ P LS + L A DV
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 738 ARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFG 797
ARGM+YL +++ FIHRDL + NIL+ ++Y AK++DFGL + G++ V + G
Sbjct: 122 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMGRLP 174
Query: 798 --YLAPEYAVMGKITTKADVFSYGVVLMELLT-------GL--AALDEERPEESRYLAEW 846
++A E TT +DV+SYGV+L E+++ G+ A L E+ P+ R
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR----- 229
Query: 847 FWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPL 906
++ L ++E + +L C +PY RP ++ L+ +
Sbjct: 230 --------------LEKPLNCDDEVY-------DLMRQCWREKPYERPSFAQILVSLNRM 268
Query: 907 VE 908
+E
Sbjct: 269 LE 270
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-19
Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 10/212 (4%)
Query: 626 NFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRH 684
+F N++G+G FG V+K D A+K+++ + +E E VL+K+ +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 685 LVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLK-PLSWTRRLSIALDVARGMEY 743
++ ++ + +V EY +G L + L K+Q PL + + + G+ +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLL----KMQRGRPLPEDQVWRFFIQILLGLAH 116
Query: 744 LHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEY 803
LH + +HRD+KS N+ LD K+ D G+ KL D T + GT YL+PE
Sbjct: 117 LH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT-IVGTPYYLSPEL 172
Query: 804 AVMGKITTKADVFSYGVVLMELLTGLAALDEE 835
K+DV++ GVVL E TG D
Sbjct: 173 CEDKPYNEKSDVWALGVVLYECCTGKHPFDAN 204
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 4e-19
Identities = 83/273 (30%), Positives = 130/273 (47%), Gaps = 38/273 (13%)
Query: 164 NSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQ 223
NS ++ ++ L N+ G + + LP + + LS N+LSG IP + + +LN
Sbjct: 67 NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLS 126
Query: 224 DAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSL 283
+ TG I + +L L L N +G IP DIG+ SSLK L+L N LVG IP SL
Sbjct: 127 N-NNFTGSIPR-GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSL 184
Query: 284 ANM-ELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNY 342
N+ L+ L L +N L+G IP+ E ++ +LG N
Sbjct: 185 TNLTSLEFLTLASNQLVGQIPR--------------------ELGQMKSLKWIYLGYNNL 224
Query: 343 PVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGK 402
G P + L + ++ ++L +NLTG + S+ NL +L + L +
Sbjct: 225 --------SGEIPYEIGGL-------TSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQ 269
Query: 403 NSISGTVPNNFTELKSLRLLDVSDNNIKPPLPE 435
N +SG +P + L+ L LD+SDN++ +PE
Sbjct: 270 NKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPE 302
|
Length = 968 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 4e-19
Identities = 64/224 (28%), Positives = 100/224 (44%), Gaps = 44/224 (19%)
Query: 633 LGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEF----QSEIAVLSKVRHRHLVS 687
LG G FG VYK +++ G +A+K+ + D F EI +L K++H ++V
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKK----ILMHNEKDGFPITALREIKILKKLKHPNVVP 71
Query: 688 LLGYSIE-----GNERLLVY---EYMPH---GALSRHLFRWEKLQLKPLSWTRRLSIALD 736
L+ ++E +R VY YM H G L + + Q+K L
Sbjct: 72 LIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIK--------CYMLQ 123
Query: 737 VARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKL----------APDGEK 786
+ G+ YLH +HRD+K++NIL+D+ K++DFGL + G
Sbjct: 124 LLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGT 180
Query: 787 SVVTRLAGTFGYLAPEYAVMG--KITTKADVFSYGVVLMELLTG 828
T L T Y PE ++G + TT D++ G V E+ T
Sbjct: 181 RKYTNLVVTRWYRPPEL-LLGERRYTTAVDIWGIGCVFAEMFTR 223
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 5e-19
Identities = 74/245 (30%), Positives = 114/245 (46%), Gaps = 22/245 (8%)
Query: 627 FAQENELGRGGFGTV------YKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV 680
F LG+GGFG V G++ K+ KR++ AL+E Q +L KV
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ----ILEKV 57
Query: 681 RHRHLVSLLGYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVAR 739
R +VSL Y+ E + L LV M G L H++ + R + A ++
Sbjct: 58 NSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIY---NMGNPGFDEERAVFYAAEITC 113
Query: 740 GMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYL 799
G+E LH R+ ++RDLK NILLDD ++SD GL P+GE + GT GY+
Sbjct: 114 GLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRVGTVGYM 168
Query: 800 APEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKA 859
APE + T D + G ++ E++ G + + + + R E R+K +E++
Sbjct: 169 APEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVE--RRVKEDQEEYSE 226
Query: 860 AIDPA 864
A
Sbjct: 227 KFSEA 231
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 7e-19
Identities = 66/219 (30%), Positives = 101/219 (46%), Gaps = 39/219 (17%)
Query: 627 FAQENELGRGGFGTVYKG-ELEDGTKI----AVKRMEAGVTTTKALDEFQSEIAVLSKVR 681
F + LG G FGTVYKG + +G K+ A+K + T+ KA E E V++ V
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVD 67
Query: 682 HRHLVSLLGYSIEGNERLLVYEYMPHGAL------------SRHLFRWEKLQLKPLSWTR 729
+ H+ LLG + +L + + MP G L S++L W
Sbjct: 68 NPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNW------------ 114
Query: 730 RLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVV 789
+ +A+GM YL + +HRDL + N+L+ K++DFGL KL EK
Sbjct: 115 ----CVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYH 167
Query: 790 TRLAGT-FGYLAPEYAVMGKITTKADVFSYGVVLMELLT 827
++A E + T ++DV+SYGV + EL+T
Sbjct: 168 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 7e-19
Identities = 59/206 (28%), Positives = 94/206 (45%), Gaps = 13/206 (6%)
Query: 625 QNFAQENELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHR 683
+ ELG G G V K G +AVK + + + E+ +L K
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQ-KQILRELDILHKCNSP 59
Query: 684 HLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEK-LQLKPLSWTRRLSIALDVARGME 742
++V G + + EYM G+L + L + + + L IA+ V +G+
Sbjct: 60 YIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLT 114
Query: 743 YLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPE 802
YLH + IHRD+K SNIL++ + K+ DFG+ + S+ GT Y+APE
Sbjct: 115 YLH--EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN---SLAKTFVGTSSYMAPE 169
Query: 803 YAVMGKITTKADVFSYGVVLMELLTG 828
+ K+D++S G+ L+EL TG
Sbjct: 170 RIQGNDYSVKSDIWSLGLSLIELATG 195
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 9e-19
Identities = 85/302 (28%), Positives = 139/302 (46%), Gaps = 30/302 (9%)
Query: 629 QENELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVS 687
+EN + RG G YKG+ +++G + VK + ++ SEIA + K++H ++V
Sbjct: 694 EENVISRGKKGASYKGKSIKNGMQFVVKEIN----DVNSIPS--SEIADMGKLQHPNIVK 747
Query: 688 LLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCL 747
L+G L++EY+ LS L+ LSW RR IA+ +A+ + +LHC
Sbjct: 748 LIGLCRSEKGAYLIHEYIEGKNLSE--------VLRNLSWERRRKIAIGIAKALRFLHCR 799
Query: 748 ARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMG 807
+ +L I++D D ++L+ G T+ + Y+APE
Sbjct: 800 CSPAVVVGNLSPEKIIID------GKDEPHLRLSLPGLLCTDTKCFISSAYVAPETRETK 853
Query: 808 KITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEV 867
IT K+D++ +G++L+ELLTG + D E + EW R S IDP++
Sbjct: 854 DITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWA-RYCYSDCHLDMWIDPSIRG 911
Query: 868 NEETFES-ISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPITDESECCSGIDYS 926
+ ++ I V LA HCTA +P RP V+ L S C +G+ +S
Sbjct: 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA------SRSSSSCVTGLKFS 965
Query: 927 LP 928
Sbjct: 966 SL 967
|
Length = 968 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 76/284 (26%), Positives = 128/284 (45%), Gaps = 28/284 (9%)
Query: 624 TQNFAQENELGRGGFGTVYKGE-LEDGTKIAVKRMEA-GVTTTKALDEFQSEIAVLSKVR 681
NF E ++G+G F VYK L DG +A+K+++ + KA + EI +L ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 682 HRHLVSLLGYSIEGNERLLVYEYMPHGALSR---HLFRWEKLQLKPLSWTRRLSIALDVA 738
H +++ L IE NE +V E G LSR H + ++L + W + +
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWK----YFVQLC 116
Query: 739 RGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGY 798
+E++H + +HRD+K +N+ + K+ D GL + + + L GT Y
Sbjct: 117 SALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPYY 172
Query: 799 LAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFK 858
++PE K+D++S G +L E +AAL + L +I EK
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYE----MAALQSPFYGDKMNLYSLCKKI----EKCD 224
Query: 859 AAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNV 902
PA +EE + +L C +P RPD+ +V+ V
Sbjct: 225 YPPLPADHYSEE-------LRDLVSRCINPDPEKRPDISYVLQV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (216), Expect = 1e-18
Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 29/207 (14%)
Query: 632 ELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQS--EIAVLSKV-RHRHLVS 687
+LG G FG+VY E G +A+K+M+ + +E + E+ L K+ H ++V
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMK---KKFYSWEECMNLREVKSLRKLNEHPNIVK 62
Query: 688 LLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCL 747
L E +E V+EYM G L L + + KP S + SI + +G+ ++H
Sbjct: 63 LKEVFRENDELYFVFEYM-EGNL-YQLMK--DRKGKPFSESVIRSIIYQILQGLAHIH-- 116
Query: 748 ARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPE----- 802
+ F HRDLK N+L+ K++DFGL + + T T Y APE
Sbjct: 117 -KHGFFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVSTRWYRAPEILLRS 173
Query: 803 --YAVMGKITTKADVFSYGVVLMELLT 827
Y ++ D+++ G ++ EL T
Sbjct: 174 TSY------SSPVDIWALGCIMAELYT 194
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-18
Identities = 74/249 (29%), Positives = 113/249 (45%), Gaps = 23/249 (9%)
Query: 626 NFAQENELGRGGFGTVY----KGELEDGTKIAVK--RMEAGVTTTKALDEFQSEIAVLSK 679
NF LG G +G V+ G + G A+K + V K + ++E VL
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 680 VRHRHLVSLLGYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVA 738
VR + L Y+ + + +L L+ +Y+ G L HL++ E + R+ IA ++
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEV----RVYIA-EIV 115
Query: 739 RGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGY 798
+++LH L I+RD+K NILLD + ++DFGL K E+ GT Y
Sbjct: 116 LALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEY 172
Query: 799 LAPEYAVMGKI--TTKADVFSYGVVLMELLTGLA--ALDEERPEESRYLAEWFWRIKSSK 854
+APE G D +S GV+ ELLTG + +D E+ +S E RI SK
Sbjct: 173 MAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQS----EISRRILKSK 228
Query: 855 EKFKAAIDP 863
F +
Sbjct: 229 PPFPKTMSA 237
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 1e-18
Identities = 66/207 (31%), Positives = 104/207 (50%), Gaps = 23/207 (11%)
Query: 633 LGRGGFGTVYK------GELEDGTKIAVKRME--AGVTTTKALDEFQSEIAVLSKV-RHR 683
LG G FG V + + + K+AVK ++ A + +AL SE+ ++S + H
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREAL---MSELKIMSHLGNHE 99
Query: 684 HLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEY 743
++V+LLG G L++ EY +G L L R + L+ LS + VA+GM +
Sbjct: 100 NIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRE---SFLTLEDLLSFSYQVAKGMAF 156
Query: 744 LHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVV---TRLAGTFGYLA 800
L A + IHRDL + N+LL K+ DFGL + + VV RL ++A
Sbjct: 157 L---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLP--VKWMA 211
Query: 801 PEYAVMGKITTKADVFSYGVVLMELLT 827
PE T ++DV+SYG++L E+ +
Sbjct: 212 PESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (216), Expect = 2e-18
Identities = 69/216 (31%), Positives = 100/216 (46%), Gaps = 34/216 (15%)
Query: 625 QNFAQENELGRGGFGTVYKGELEDGTKI-AVKRME-AGVTTTKALDEFQSEIAVLSKVRH 682
+F LG G FG V + K A+K + A + K ++ +E +L +RH
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 683 RHLVSLLGYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVAR-- 739
LV+L G S + + L LV EY+P G L HL + + R VAR
Sbjct: 61 PFLVNLYG-SFQDDSNLYLVMEYVPGGELFSHLRK-----------SGRFP--EPVARFY 106
Query: 740 ------GMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLA 793
+EYLH ++RDLK N+LLD D K++DFG K + L
Sbjct: 107 AAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYT----LC 159
Query: 794 GTFGYLAPEYAVMGKITTKA-DVFSYGVVLMELLTG 828
GT YLAPE ++ K KA D ++ G+++ E+L G
Sbjct: 160 GTPEYLAPE-IILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 72/232 (31%), Positives = 110/232 (47%), Gaps = 22/232 (9%)
Query: 633 LGRGGFGTV------YKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLV 686
LG+GGFG V G++ K+ KR++ AL+E + +L KV R +V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKR----ILEKVNSRFVV 63
Query: 687 SLLGYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLH 745
SL Y+ E + L LV M G L H++ + R + A ++ G+E L
Sbjct: 64 SL-AYAYETKDALCLVLTIMNGGDLKFHIY---NMGNPGFDEQRAIFYAAELCCGLEDLQ 119
Query: 746 CLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAV 805
R+ ++RDLK NILLDD ++SD GL P+GE V GT GY+APE
Sbjct: 120 ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRVGTVGYMAPEVIN 174
Query: 806 MGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKF 857
K T D + G ++ E++ G + + + R E R+K +E++
Sbjct: 175 NEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR--EEVDRRVKEDQEEY 224
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 3e-18
Identities = 73/247 (29%), Positives = 113/247 (45%), Gaps = 34/247 (13%)
Query: 60 PHVFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFA 119
P CS + ++ + + L+G +P++ L + LQ N F+G+LP S ++L
Sbjct: 373 PEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELP--SEFTKLPLV 430
Query: 120 YLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLV 179
Y F I ++ G + R W +P L LSL
Sbjct: 431 Y-----FLDISNNNLQGRINSR-------------KWDMP-------SLQMLSLARNKFF 465
Query: 180 GPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQ--SLMQILWLNDQDAGGMTGPIDVVAK 237
G LPD G+ L L LS N+ SG +P G LMQ+ ++ +G + + K
Sbjct: 466 GGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKK 524
Query: 238 MVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANME-LDNLVLNNN 296
+VSL L NQ +G IP + L L+L++NQL G IPK+L N+E L + +++N
Sbjct: 525 LVSLD---LSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHN 581
Query: 297 LLMGPIP 303
L G +P
Sbjct: 582 HLHGSLP 588
|
Length = 968 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 64/201 (31%), Positives = 94/201 (46%), Gaps = 18/201 (8%)
Query: 633 LGRGGFGTVYKGELE-DGTKIAVKRM-EAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLG 690
LG GGFG V +++ A+K + + + T + SE +L + H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 691 YSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPL--SWTRRLSIALDVARGMEYLHCLA 748
+ ++ EY G L W L+ + L +T R IA V EYLH
Sbjct: 61 TFKDKKYIYMLMEYCLGGEL------WTILRDRGLFDEYTARFYIAC-VVLAFEYLH--- 110
Query: 749 RQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGK 808
+ I+RDLK N+LLD + K+ DFG K G+K+ GT Y+APE ++ K
Sbjct: 111 NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT--FCGTPEYVAPE-IILNK 167
Query: 809 -ITTKADVFSYGVVLMELLTG 828
D +S G++L ELLTG
Sbjct: 168 GYDFSVDYWSLGILLYELLTG 188
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 3e-18
Identities = 62/216 (28%), Positives = 110/216 (50%), Gaps = 22/216 (10%)
Query: 631 NELGRGGFGTVYKGELEDGTKIAVKRMEAG----VTTTKALDEFQSEIAVLSKVRHRHLV 686
LG+G +GTVY G G IAVK++E + K ++ Q E+ +L ++H ++V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 687 SLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKL-QLKPLSWTRRLSIALDVARGMEYLH 745
LG ++ N + E++P G++S L R+ L + +T++ + G+ YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQ------ILDGVAYLH 119
Query: 746 CLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK----LAPDGEKSVVTR-LAGTFGYLA 800
+HRD+K +N++L + K+ DFG + + G S + + + GT ++A
Sbjct: 120 ---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176
Query: 801 PEYAVMGKITTKADVFSYGVVLMELLTG---LAALD 833
PE K+D++S G + E+ TG LA++D
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMD 212
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 4e-18
Identities = 64/200 (32%), Positives = 100/200 (50%), Gaps = 13/200 (6%)
Query: 633 LGRGGFGTVYKG-ELEDGTKIAVK---RMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSL 688
LG G FGTVYKG + +G + + ++ T KA EF E +++ + H HLV L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 689 LGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLA 748
LG + +L V + MPHG L ++ + + L+ + +A+GM YL
Sbjct: 75 LGVCLSPTIQL-VTQLMPHGCLLDYVHEHKD----NIGSQLLLNWCVQIAKGMMYLE--- 126
Query: 749 RQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGT-FGYLAPEYAVMG 807
+ +HRDL + N+L+ K++DFGL +L EK ++A E
Sbjct: 127 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR 186
Query: 808 KITTKADVFSYGVVLMELLT 827
K T ++DV+SYGV + EL+T
Sbjct: 187 KFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 4e-18
Identities = 60/204 (29%), Positives = 107/204 (52%), Gaps = 14/204 (6%)
Query: 627 FAQENELGRGGFGTVYKGELEDGTK--IAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRH 684
F + +G+G FG VYKG +++ TK +A+K ++ +++ Q EI VLS+ +
Sbjct: 6 FTKLERIGKGSFGEVYKG-IDNRTKEVVAIKIIDLE-EAEDEIEDIQQEITVLSQCDSPY 63
Query: 685 LVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYL 744
+ G ++G + ++ EY+ G+ + L+ PL T +I ++ +G++YL
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGS------ALDLLKPGPLEETYIATILREILKGLDYL 117
Query: 745 HCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYA 804
H + IHRD+K++N+LL + K++DFG+ D + T GT ++APE
Sbjct: 118 HSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVI 173
Query: 805 VMGKITTKADVFSYGVVLMELLTG 828
KAD++S G+ +EL G
Sbjct: 174 KQSAYDFKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 4e-18
Identities = 62/221 (28%), Positives = 116/221 (52%), Gaps = 15/221 (6%)
Query: 625 QNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHR 683
+ + + ++G+G GTVY ++ G ++A+K+M K L +EI V+ + +H
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKEL--IINEILVMRENKHP 76
Query: 684 HLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEY 743
++V+ L + G+E +V EY+ G+L+ + + + + ++ + + +E+
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSLT------DVVTETCMDEGQIAAVCRECLQALEF 130
Query: 744 LHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL-VKLAPDGEKSVVTRLAGTFGYLAPE 802
LH + Q IHRD+KS NILL D K++DFG ++ P E+S + + GT ++APE
Sbjct: 131 LH--SNQV-IHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPE 185
Query: 803 YAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYL 843
K D++S G++ +E++ G E P + YL
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL 226
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 4e-18
Identities = 62/198 (31%), Positives = 102/198 (51%), Gaps = 14/198 (7%)
Query: 632 ELGRGGFGTVYKG--ELEDGTK-IAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSL 688
ELG G FGTV KG +++ K +AVK ++ DE E V+ ++ + ++V +
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 689 LGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLA 748
+G E +LV E G L++ L + + + K ++ + V+ GM+YL
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNIT-----ELVHQVSMGMKYLE--- 112
Query: 749 RQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTF--GYLAPEYAVM 806
F+HRDL + N+LL + AK+SDFGL K E + G + + APE
Sbjct: 113 ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY 172
Query: 807 GKITTKADVFSYGVVLME 824
K ++K+DV+S+GV++ E
Sbjct: 173 YKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 6e-18
Identities = 61/204 (29%), Positives = 96/204 (47%), Gaps = 18/204 (8%)
Query: 627 FAQENELGRGGFGTVYKG-ELEDGTKIAVKRME-AGVTTTKALDEFQSEIAVLSKVRHRH 684
F E+G G FG VY ++ +A+K+M +G + + + E+ L ++RH +
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 685 LVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYL 744
+ G + + LV EY G+ S L ++ KPL +I +G+ YL
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCL-GSASDIL----EVHKKPLQEVEIAAICHGALQGLAYL 131
Query: 745 HCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYA 804
H R IHRD+K+ NILL + K++DFG L V GT ++APE
Sbjct: 132 HSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVI 183
Query: 805 VM---GKITTKADVFSYGVVLMEL 825
+ G+ K DV+S G+ +EL
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 1e-17
Identities = 57/217 (26%), Positives = 106/217 (48%), Gaps = 10/217 (4%)
Query: 627 FAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLV 686
F + ++G+G FG V+KG K+ ++ +++ Q EI VLS+ ++
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 687 SLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHC 746
G ++ + ++ EY+ G+ + L+ PL T+ +I ++ +G++YLH
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGS------ALDLLEPGPLDETQIATILREILKGLDYLHS 119
Query: 747 LARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVM 806
+ IHRD+K++N+LL + K++DFG+ D + GT ++APE
Sbjct: 120 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-RNTFVGTPFWMAPEVIKQ 175
Query: 807 GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYL 843
+KAD++S G+ +EL G E P + +L
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL 212
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 61/200 (30%), Positives = 102/200 (51%), Gaps = 16/200 (8%)
Query: 632 ELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLG 690
+LG G G+V K + + GT +A K + G + + E+ ++ + R ++VS G
Sbjct: 12 DLGAGNGGSVSKVKHIPTGTVMAKKVVHIG-AKSSVRKQILRELQIMHECRSPYIVSFYG 70
Query: 691 YSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQ 750
+ N + E+M G+L R + + ++ L IA+ V G+ YL+ + R
Sbjct: 71 AFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYLYNVHR- 124
Query: 751 TFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGE--KSVVTRLAGTFGYLAPEYAVMGK 808
+HRD+K SNIL++ + K+ DFG+ GE S+ GT Y++PE GK
Sbjct: 125 -IMHRDIKPSNILVNSRGQIKLCDFGV-----SGELINSIADTFVGTSTYMSPERIQGGK 178
Query: 809 ITTKADVFSYGVVLMELLTG 828
T K+DV+S G+ ++EL G
Sbjct: 179 YTVKSDVWSLGISIIELALG 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 59/204 (28%), Positives = 102/204 (50%), Gaps = 24/204 (11%)
Query: 631 NELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLL 689
+G G +G VYK ++ G +A+K ++ + + Q EI++L + RH ++V+
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIK--LEPGDDFEIIQQEISMLKECRHPNIVAYF 66
Query: 690 GYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIAL---DVARGMEYLHC 746
G + ++ +V EY G+L ++ PLS L IA + +G+ YLH
Sbjct: 67 GSYLRRDKLWIVMEYCGGGSLQDIY----QVTRGPLS---ELQIAYVCRETLKGLAYLHE 119
Query: 747 LARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTR--LAGTFGYLAPEYA 804
+ IHRD+K +NILL +D K++DFG ++ ++ R GT ++APE A
Sbjct: 120 TGK---IHRDIKGANILLTEDGDVKLADFG---VSAQLTATIAKRKSFIGTPYWMAPEVA 173
Query: 805 ---VMGKITTKADVFSYGVVLMEL 825
G K D+++ G+ +EL
Sbjct: 174 AVERKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 2e-17
Identities = 56/205 (27%), Positives = 103/205 (50%), Gaps = 17/205 (8%)
Query: 633 LGRGGFGTVYKG-ELEDGTKIAVKRM----EAGVTTTKALDEFQSEIAVLSKVRHRHLVS 687
LG G F + Y+ +++ GT +AVK++ + ++ + EI +++++ H H++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 688 LLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCL 747
+LG + E + L E+M G++S L ++ ++ + RG+ YLH
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKY-----GAFKEAVIINYTEQLLRGLSYLH-- 120
Query: 748 ARQTFIHRDLKSSNILLDDD-YRAKVSDFG-LVKLAPD--GEKSVVTRLAGTFGYLAPEY 803
IHRD+K +N+L+D R +++DFG +LA G +L GT ++APE
Sbjct: 121 -ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179
Query: 804 AVMGKITTKADVFSYGVVLMELLTG 828
+ DV+S G V++E+ T
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMATA 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 2e-17
Identities = 71/201 (35%), Positives = 96/201 (47%), Gaps = 14/201 (6%)
Query: 633 LGRGGFGTVYKGE-LEDGTKIAVKRME-AGVTTTKALDEFQSEIAVLSK-VRHRHLVSLL 689
+G+G FG V + DG AVK ++ + K +E VL K V+H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 690 GYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLA 748
YS + ++L V +Y+ G L HL R E+ +P R A ++A + YLH L
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQR-ERSFPEP----RARFYAAEIASALGYLHSL- 115
Query: 749 RQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGK 808
I+RDLK NILLD ++DFGL K + K+ T GT YLAPE
Sbjct: 116 --NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST-FCGTPEYLAPEVLRKQP 172
Query: 809 ITTKADVFSYGVVLMELLTGL 829
D + G VL E+L GL
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGL 193
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 62/218 (28%), Positives = 103/218 (47%), Gaps = 30/218 (13%)
Query: 632 ELGRGGFGTVYKGEL------EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHL 685
ELG FG VYKG L E +A+K ++ +EF+ E + S+++H ++
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGP-LREEFKHEAMMRSRLQHPNI 70
Query: 686 VSLLGYSIEGNERLLVYEYMPHGALSRHLF--------------RWEKLQLKPLSWTRRL 731
V LLG + +++ Y H L L + K L+P + +
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADF---V 127
Query: 732 SIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK--LAPDGEKSVV 789
I +A GME+L + +H+DL + N+L+ D K+SD GL + A D K +
Sbjct: 128 HIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMG 184
Query: 790 TRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT 827
L +++PE + GK + +D++SYGVVL E+ +
Sbjct: 185 NSLL-PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 2e-17
Identities = 68/218 (31%), Positives = 108/218 (49%), Gaps = 29/218 (13%)
Query: 633 LGRGGFGTVYKGEL--------EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHR 683
LG G FG V E +AVK ++ T K L + SE+ ++ + +H+
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHK 78
Query: 684 HLVSLLGYSIEGNERLLVYEYMPHGALSRHL-----------FRWEKLQLKPLSWTRRLS 732
++++LLG + ++ EY G L +L F KL + L++ +S
Sbjct: 79 NIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVS 138
Query: 733 IALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGE---KSVV 789
A VARGMEYL A Q IHRDL + N+L+ +D K++DFGL + + + K+
Sbjct: 139 CAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN 195
Query: 790 TRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT 827
RL ++APE T ++DV+S+GV+L E+ T
Sbjct: 196 GRLP--VKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 24/204 (11%)
Query: 632 ELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLL- 689
ELG G FG VYK + E G A K ++ + + L++F EI +LS+ +H ++V L
Sbjct: 12 ELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYE 69
Query: 690 GYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLAR 749
Y E +L+ E+ GAL + E+ L+ + + + + +LH
Sbjct: 70 AYFYENKLWILI-EFCDGGALDSIMLELER----GLTEPQIRYVCRQMLEALNFLH---S 121
Query: 750 QTFIHRDLKSSNILLDDDYRAKVSDFGL-VKLAPDGEKSVVTRLAGTFGYLAPEYAVMGK 808
IHRDLK+ NILL D K++DFG+ K +K GT ++APE V+
Sbjct: 122 HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR--DTFIGTPYWMAPE--VVAC 177
Query: 809 IT-------TKADVFSYGVVLMEL 825
T KAD++S G+ L+EL
Sbjct: 178 ETFKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-17
Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 632 ELGRGGFGTVYKGELEDGTK---IAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSL 688
ELG G FG V KG + K +A+K ++ DE E ++ ++ + ++V +
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE-NEKSVRDEMMREAEIMHQLDNPYIVRM 60
Query: 689 LGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLA 748
+G E +LV E G L + F K +S + + V+ GM+YL
Sbjct: 61 IGVC-EAEALMLVMEMASGGPL--NKFLSGKKDEITVS--NVVELMHQVSMGMKYLE--- 112
Query: 749 RQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTF--GYLAPEYAVM 806
+ F+HRDL + N+LL + + AK+SDFGL K + R AG + + APE
Sbjct: 113 GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF 172
Query: 807 GKITTKADVFSYGVVLMELLT 827
K ++++DV+SYG+ + E +
Sbjct: 173 RKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 4e-17
Identities = 55/204 (26%), Positives = 107/204 (52%), Gaps = 14/204 (6%)
Query: 627 FAQENELGRGGFGTVYKGELEDGTK--IAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRH 684
F + +G+G FG V+KG +++ T+ +A+K ++ +++ Q EI VLS+ +
Sbjct: 6 FTKLERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLE-EAEDEIEDIQQEITVLSQCDSPY 63
Query: 685 LVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYL 744
+ G ++G + ++ EY+ G+ + L+ P + ++ ++ +G++YL
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGS------ALDLLRAGPFDEFQIATMLKEILKGLDYL 117
Query: 745 HCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYA 804
H + IHRD+K++N+LL + K++DFG+ D + T GT ++APE
Sbjct: 118 HSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVI 173
Query: 805 VMGKITTKADVFSYGVVLMELLTG 828
+KAD++S G+ +EL G
Sbjct: 174 QQSAYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 4e-17
Identities = 61/218 (27%), Positives = 109/218 (50%), Gaps = 29/218 (13%)
Query: 633 LGRGGFGTVYKGEL--------EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHR 683
LG G FG V E ++ +AVK ++ T K L + SE+ ++ + +H+
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHK 81
Query: 684 HLVSLLGYSIEGNERLLVYEYMPHGALSRHL-----------FRWEKLQLKPLSWTRRLS 732
++++LLG + ++ EY G L +L + ++ + +++ +S
Sbjct: 82 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVS 141
Query: 733 IALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGE---KSVV 789
VARGMEYL A Q IHRDL + N+L+ ++ K++DFGL + + + K+
Sbjct: 142 CTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTN 198
Query: 790 TRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT 827
RL ++APE T ++DV+S+GV++ E+ T
Sbjct: 199 GRLP--VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 9e-17
Identities = 54/199 (27%), Positives = 97/199 (48%), Gaps = 14/199 (7%)
Query: 633 LGRGGFG--TVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLG 690
LG+G FG T+Y+ ED + + K + + K + +EI +LS ++H ++++
Sbjct: 8 LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 691 YSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIAL--DVARGMEYLHCLA 748
+ ++ N L+ EY G L + R + + + + + + Y+H
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFE-----EEMVLWYLFQIVSAVSYIH--- 118
Query: 749 RQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGK 808
+ +HRD+K+ NI L K+ DFG+ K+ E S+ + GT Y++PE K
Sbjct: 119 KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGS-EYSMAETVVGTPYYMSPELCQGVK 177
Query: 809 ITTKADVFSYGVVLMELLT 827
K+D+++ G VL ELLT
Sbjct: 178 YNFKSDIWALGCVLYELLT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 9e-17
Identities = 71/231 (30%), Positives = 109/231 (47%), Gaps = 31/231 (13%)
Query: 626 NFAQENELGRGGFGTVYKG-ELEDGTKIAVKRME---AGVTTTKALDEFQSEIAVLSKVR 681
N+ LGRG FG VY + + G ++AVK++ T+K ++ + EI +L +R
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 682 HRHLVSLLGYSIEGNERLL--VYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVAR 739
H +V G + E+ L EYMP G++ L + L TRR + + +
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENV---TRRYT--RQILQ 117
Query: 740 GMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK------LAPDGEKSVVTRLA 793
G+ YLH +HRD+K +NIL D K+ DFG K ++ G KSV
Sbjct: 118 GVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSV----T 170
Query: 794 GTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLA 844
GT +++PE KADV+S ++E+LT E+P + Y A
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT-------EKPPWAEYEA 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 64/201 (31%), Positives = 97/201 (48%), Gaps = 17/201 (8%)
Query: 633 LGRGGFGTVY------KGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLV 686
LG+GGFG V G+L K+ KR++ K + E +L+KV R +V
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLK----KRKGYEGAMVEKRILAKVHSRFIV 56
Query: 687 SLLGYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLH 745
SL Y+ + L LV M G L H++ ++ + R + G+E+LH
Sbjct: 57 SL-AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDE-ENPGFPEPRACFYTAQIISGLEHLH 114
Query: 746 CLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAV 805
++ I+RDLK N+LLD+D ++SD GL DG +S AGT G++APE
Sbjct: 115 ---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG-QSKTKGYAGTPGFMAPELLQ 170
Query: 806 MGKITTKADVFSYGVVLMELL 826
+ D F+ GV L E++
Sbjct: 171 GEEYDFSVDYFALGVTLYEMI 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 1e-16
Identities = 65/218 (29%), Positives = 108/218 (49%), Gaps = 29/218 (13%)
Query: 633 LGRGGFGTVYKGEL--------EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHR 683
LG G FG V + E + +AVK ++ T K L + SE+ ++ + +H+
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN-ATDKDLADLISEMELMKLIGKHK 78
Query: 684 HLVSLLGYSIEGNERLLVYEYMPHGALSRHL-----------FRWEKLQLKPLSWTRRLS 732
++++LLG + ++ EY G L L F K+ + LS+ +S
Sbjct: 79 NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138
Query: 733 IALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGE---KSVV 789
A VARGMEYL + IHRDL + N+L+ +D K++DFGL + D + K+
Sbjct: 139 CAYQVARGMEYL---ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195
Query: 790 TRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT 827
RL ++APE T ++DV+S+G+++ E+ T
Sbjct: 196 GRLP--VKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 1e-16
Identities = 53/194 (27%), Positives = 83/194 (42%), Gaps = 21/194 (10%)
Query: 647 EDGTKIAVKRM-EAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLL-VYEY 704
G ++A+K + F+ E A+ +++ H ++V+LL L V+EY
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 705 MPHGALSRHLFRWEKLQLK-PLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNIL 763
+P L E L L + L V + H Q +HRDLK NI+
Sbjct: 61 VPGRTLR------EVLAADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIM 111
Query: 764 L---DDDYRAKVSDFGLVKLAPDGEKSVVTRLA------GTFGYLAPEYAVMGKITTKAD 814
+ AKV DFG+ L P + V L GT Y APE +T +D
Sbjct: 112 VSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSD 171
Query: 815 VFSYGVVLMELLTG 828
++++G++ +E LTG
Sbjct: 172 LYAWGLIFLECLTG 185
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 18/212 (8%)
Query: 632 ELGRGGFGTVYKGELE-DGTKIAVKRM-EAGVTTTKALDEFQSEIAVLSKVRHRHLVSLL 689
+ +G FG+VY + G A+K + ++ + + ++E A++ V+ L
Sbjct: 3 PISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL 62
Query: 690 GYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLA 748
YS + + L LV EY+ G + + + L P W ++ +V G+E LH
Sbjct: 63 YYSFQSKDYLYLVMEYLNGGDCASLI---KTLGGLPEDWAKQY--IAEVVLGVEDLH--- 114
Query: 749 RQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGK 808
++ IHRD+K N+L+D K++DFGL + G ++ + GT YLAPE ++G
Sbjct: 115 QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRN---GLEN--KKFVGTPDYLAPE-TILGV 168
Query: 809 ITTKA-DVFSYGVVLMELLTGLAALDEERPEE 839
K D +S G V+ E L G E P+
Sbjct: 169 GDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 1e-16
Identities = 64/242 (26%), Positives = 122/242 (50%), Gaps = 18/242 (7%)
Query: 604 NSHVIESGTLVISVQVLRKVTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVT 662
+ ++E ++SV +K F ++G+G GTVY ++ G ++A+++M
Sbjct: 2 DEEILEKLRSIVSVGDPKKKYTRF---EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ 58
Query: 663 TTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQL 722
K L +EI V+ + ++ ++V+ L + G+E +V EY+ G+L+ + +
Sbjct: 59 PKKEL--IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT------DVVTE 110
Query: 723 KPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL-VKLA 781
+ + ++ + + +E+LH IHRD+KS NILL D K++DFG ++
Sbjct: 111 TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167
Query: 782 PDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESR 841
P E+S + + GT ++APE K D++S G++ +E++ G E P +
Sbjct: 168 P--EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL 225
Query: 842 YL 843
YL
Sbjct: 226 YL 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-16
Identities = 68/224 (30%), Positives = 108/224 (48%), Gaps = 31/224 (13%)
Query: 633 LGRGGFGTVYKG-ELEDGTKIAVKRME---AGVTTTKALDEFQSEIAVLSKVRHRHLVSL 688
LG+G FG VY +++ G ++A K+++ T+K + + EI +L ++H +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 689 LGYSIEGNERLLV--YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHC 746
G + E+ L EYMP G++ L + L S TR+ + + GM YLH
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTE---SVTRKYT--RQILEGMSYLH- 123
Query: 747 LARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK------LAPDGEKSVVTRLAGTFGYLA 800
+HRD+K +NIL D K+ DFG K ++ G +SV GT +++
Sbjct: 124 --SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSV----TGTPYWMS 177
Query: 801 PEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLA 844
PE KADV+S G ++E+LT E+P + Y A
Sbjct: 178 PEVISGEGYGRKADVWSLGCTVVEMLT-------EKPPWAEYEA 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-16
Identities = 69/219 (31%), Positives = 114/219 (52%), Gaps = 31/219 (14%)
Query: 633 LGRGGFGTVYKGEL--------EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHR 683
LG G FG V E TK+AVK +++ T K L + SE+ ++ + +H+
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHK 84
Query: 684 HLVSLLGYSIEGNERLLVYEYMPHGALSRHL-----------FRWEKLQLKPLSWTRRLS 732
++++LLG + ++ EY G L +L + ++ + LS+ +S
Sbjct: 85 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS 144
Query: 733 IALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGE---KSVV 789
A VARGMEYL A + IHRDL + N+L+ +D K++DFGL + + K+
Sbjct: 145 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 201
Query: 790 TRLAGTFGYLAPEYAVMGKITT-KADVFSYGVVLMELLT 827
RL ++APE A+ +I T ++DV+S+GV+L E+ T
Sbjct: 202 GRLP--VKWMAPE-ALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 66/211 (31%), Positives = 104/211 (49%), Gaps = 35/211 (16%)
Query: 633 LGRGGFGTVYKG-ELEDGTKI----AVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVS 687
LG G FGTVYKG + DG + A+K + T+ KA E E V++ V ++
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN-TSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 688 LLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKP---LSWTRRLSIALDVARGMEYL 744
LLG + +L V + MP+G L ++ R K ++ L+W + +A+GM YL
Sbjct: 74 LLGICLTSTVQL-VTQLMPYGCLLDYV-RENKDRIGSQDLLNW------CVQIAKGMSYL 125
Query: 745 HCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA--------PDGEKSVVTRLAGTF 796
+HRDL + N+L+ K++DFGL +L DG K +
Sbjct: 126 E---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK------ 176
Query: 797 GYLAPEYAVMGKITTKADVFSYGVVLMELLT 827
++A E + + T ++DV+SYGV + EL+T
Sbjct: 177 -WMALESILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-16
Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 22/203 (10%)
Query: 632 ELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLG 690
ELG G FG VYK + E G A K +E + + L+++ EI +L+ H ++V LLG
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIET--KSEEELEDYMVEIEILATCNHPYIVKLLG 76
Query: 691 YSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQ 750
+ ++ E+ P GA+ + ++ +P I + + +E L L
Sbjct: 77 AFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEP-------QIQVICRQMLEALQYLHSM 129
Query: 751 TFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTR--LAGTFGYLAPEYAVMGK 808
IHRDLK+ N+LL D K++DFG ++ K++ R GT ++APE VM +
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFG---VSAKNVKTLQRRDSFIGTPYWMAPE-VVMCE 185
Query: 809 ITT------KADVFSYGVVLMEL 825
KAD++S G+ L+E+
Sbjct: 186 TMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 3e-16
Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 20/203 (9%)
Query: 633 LGRGGFGTV------YKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLV 686
LG+GGFG V G++ K+ KR++ AL E + +L KV +V
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKE----ILEKVNSPFIV 56
Query: 687 SLLGYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLH 745
+L Y+ E L LV M G L H++ + + L R + + + G+ +LH
Sbjct: 57 NL-AYAFESKTHLCLVMSLMNGGDLKYHIY---NVGERGLEMERVIHYSAQITCGILHLH 112
Query: 746 CLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAV 805
+ ++RD+K N+LLDD ++SD GL DG+ +T+ AGT GY+APE
Sbjct: 113 SMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILK 167
Query: 806 MGKITTKADVFSYGVVLMELLTG 828
+ D F+ G + E++ G
Sbjct: 168 EEPYSYPVDWFAMGCSIYEMVAG 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 3e-16
Identities = 68/220 (30%), Positives = 104/220 (47%), Gaps = 26/220 (11%)
Query: 619 VLRKVTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVK--RMEA---GVTTTKALDEFQS 672
R VT F + N +G G +G VY+ + G +A+K RM+ G+ +
Sbjct: 2 RCRSVT-EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSL-----R 55
Query: 673 EIAVLSKVRHRHLVSLLGYSIEGNER---LLVYEYMPHGALSRHLFRWEKLQLKPLSWTR 729
EI +L +RH ++V L + G LV EY L+ L + + P S ++
Sbjct: 56 EITLLLNLRHPNIVELK-EVVVGKHLDSIFLVMEYCEQD-LASLL---DNMP-TPFSESQ 109
Query: 730 RLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVV 789
+ L + RG++YLH IHRDLK SN+LL D K++DFGL + K +
Sbjct: 110 VKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMT 166
Query: 790 TRLAGTFGYLAPEYAV-MGKITTKADVFSYGVVLMELLTG 828
++ T Y APE + TT D+++ G +L ELL
Sbjct: 167 PKVV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 3e-16
Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 10/205 (4%)
Query: 633 LGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGY 691
+GRG FG V+ D + +K++ T Q+E VL + H +++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 692 SIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQT 751
+E ++V EY P G L+ + +Q + S +I + + LH + +
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEY------IQKRCNSLLDEDTILHFFVQILLALHHVHTKL 121
Query: 752 FIHRDLKSSNILLDDDYR-AKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKIT 810
+HRDLK+ NILLD K+ DFG+ K+ KS + GT Y++PE
Sbjct: 122 ILHRDLKTQNILLDKHKMVVKIGDFGISKIL--SSKSKAYTVVGTPCYISPELCEGKPYN 179
Query: 811 TKADVFSYGVVLMELLTGLAALDEE 835
K+D+++ G VL EL + A +
Sbjct: 180 QKSDIWALGCVLYELASLKRAFEAA 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 3e-16
Identities = 75/265 (28%), Positives = 115/265 (43%), Gaps = 79/265 (29%)
Query: 633 LGRGGFGTVYKGELEDGTK------IAVKRMEAGVTTT--KALDEFQSEIAVLSKV-RHR 683
LGRG FG V + K +AVK ++ G T + KAL +E+ +L + H
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKAL---MTELKILIHIGHHL 71
Query: 684 HLVSLLGYSIEGNERLLV-YEYMPHGALS------RHLF---RWEKLQLK---------- 723
++V+LLG + L+V EY G LS R F R + + +
Sbjct: 72 NVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQ 131
Query: 724 -------------------------------------PLSWTRRLSIALDVARGMEYLHC 746
PL+ +S + VARGME+L
Sbjct: 132 RLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL-- 189
Query: 747 LARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK---LAPDGEKSVVTRLAGTFGYLAPEY 803
A + IHRDL + NILL ++ K+ DFGL + PD + RL ++APE
Sbjct: 190 -ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP--LKWMAPE- 245
Query: 804 AVMGKI-TTKADVFSYGVVLMELLT 827
++ K+ TT++DV+S+GV+L E+ +
Sbjct: 246 SIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 79.8 bits (196), Expect = 4e-16
Identities = 64/242 (26%), Positives = 122/242 (50%), Gaps = 18/242 (7%)
Query: 604 NSHVIESGTLVISVQVLRKVTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVT 662
+ ++E ++SV +K F ++G+G GTVY ++ G ++A+K+M
Sbjct: 1 DEEILEKLRSIVSVGDPKKKYTRF---EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ 57
Query: 663 TTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQL 722
K L +EI V+ + ++ ++V+ L + G+E +V EY+ G+L+ + +
Sbjct: 58 PKKEL--IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT------DVVTE 109
Query: 723 KPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL-VKLA 781
+ + ++ + + +++LH IHRD+KS NILL D K++DFG ++
Sbjct: 110 TCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166
Query: 782 PDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESR 841
P E+S + + GT ++APE K D++S G++ +E++ G E P +
Sbjct: 167 P--EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL 224
Query: 842 YL 843
YL
Sbjct: 225 YL 226
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 4e-16
Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 18/202 (8%)
Query: 633 LGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRH---RHLVSL 688
+GRG +G VY+G + G +A+K + T + + Q E+A+LS++R ++
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLD-TPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 689 LGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSW-TRRLSIALDVARGMEYLHCL 747
G ++G ++ EY G R L + + K +S R + +AL +Y+H
Sbjct: 68 YGSYLKGPRLWIIMEYA-EGGSVRTLMKAGPIAEKYISVIIREVLVAL------KYIH-- 118
Query: 748 ARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMG 807
+ IHRD+K++NIL+ + K+ DFG+ L T GT ++APE G
Sbjct: 119 -KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST-FVGTPYWMAPEVITEG 176
Query: 808 KI-TTKADVFSYGVVLMELLTG 828
K TKAD++S G+ + E+ TG
Sbjct: 177 KYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 4e-16
Identities = 67/212 (31%), Positives = 100/212 (47%), Gaps = 16/212 (7%)
Query: 633 LGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQS---EIAVLSKVRHRHLVSL 688
LG+G FG V+ EL+ A+K ++ V D+ + E VLS ++
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMD--DDVECTMVEKRVLSLAWEHPFLTH 60
Query: 689 LGYSIEGNERLL-VYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCL 747
L + + E L V EY+ G L H+ K L R A ++ G+++LH
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDL-----PRATFYAAEIICGLQFLH-- 113
Query: 748 ARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMG 807
+ ++RDLK NILLD D K++DFG+ K G+ T GT Y+APE +
Sbjct: 114 -SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT-FCGTPDYIAPEILLGQ 171
Query: 808 KITTKADVFSYGVVLMELLTGLAALDEERPEE 839
K T D +S+GV+L E+L G + EE
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 4e-16
Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 50/220 (22%)
Query: 631 NELGRGGFGTVYKG-ELEDGTKIAVKRM-----EAGVTTTKALDEFQSEIAVLSKVR--- 681
E+G G +GTVYK +L G +A+K++ E G+ + EIA+L ++
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTL-----REIALLKQLESFE 59
Query: 682 HRHLVSLL----GYSIEGNERL-LVYEYMPHGALSRHLFR-----WEKLQLKPLSWTRRL 731
H ++V LL G + +L LV+E++ L+ +L + +K L
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMR---- 114
Query: 732 SIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTR 791
+ RG+++LH +HRDLK NIL+ D + K++DFGL ++ + +T
Sbjct: 115 ----QLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARIY--SFEMALTS 165
Query: 792 LAGTFGYLAPE------YAVMGKITTKADVFSYGVVLMEL 825
+ T Y APE YA T D++S G + EL
Sbjct: 166 VVVTLWYRAPEVLLQSSYA------TPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 5e-16
Identities = 69/209 (33%), Positives = 107/209 (51%), Gaps = 31/209 (14%)
Query: 633 LGRGGFGTVY-----KGELEDGTKIAVKRMEAGVTTTKALDEFQS--EIAVLSKVRHRHL 685
LG+G FG V+ G + G A+K ++ T K D ++ E +L++V H +
Sbjct: 4 LGQGSFGKVFLVRKITGP-DAGQLYAMKVLKKA--TLKVRDRVRTKMERDILAEVNHPFI 60
Query: 686 VSLLGYSIEGNERL-LVYEYMPHGALSRHL-----FRWEKLQLKPLSWTRRLSIALDVAR 739
V L Y+ + +L L+ +++ G L L F E ++ + L++ALD
Sbjct: 61 VKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF----YLAELALALD--- 112
Query: 740 GMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYL 799
+LH L I+RDLK NILLD++ K++DFGL K + D EK + GT Y+
Sbjct: 113 ---HLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYM 165
Query: 800 APEYAVMGKITTKADVFSYGVVLMELLTG 828
APE T AD +S+GV++ E+LTG
Sbjct: 166 APEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-16
Identities = 77/281 (27%), Positives = 120/281 (42%), Gaps = 41/281 (14%)
Query: 632 ELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKAL-DEFQSEIAVLSKVRHRHLVSLL 689
+GRG FG V+ G L D T +AVK T L +F E +L + H ++V L+
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRE--TLPPDLKAKFLQEARILKQYSHPNIVRLI 59
Query: 690 GYSIEGNERLLVYEYMPHGALSRHLFRWE--KLQLKPLSWTRRLSIALDVARGMEYL--- 744
G + +V E + G L R E +L++K L + + + A GMEYL
Sbjct: 60 GVCTQKQPIYIVMELVQGGDFLTFL-RTEGPRLKVKEL-----IQMVENAAAGMEYLESK 113
Query: 745 HCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGT-FGYLAPEY 803
HC IHRDL + N L+ + K+SDFG+ + DG + + + APE
Sbjct: 114 HC------IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEA 167
Query: 804 AVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862
G+ ++++DV+S+G++L E + G +++R E R
Sbjct: 168 LNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR------------- 214
Query: 863 PALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVL 903
L E ++ V L C +P RP V L
Sbjct: 215 --LPCPELCPDA---VYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 6e-16
Identities = 68/222 (30%), Positives = 109/222 (49%), Gaps = 38/222 (17%)
Query: 627 FAQENELGRGGFGTVYKGELED-GTKIAVKRM-----EAGVTTTKALDEFQSEIAVLSKV 680
F ++G G +G VYK +D G +A+K++ + G T EI +L ++
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAI-----REIKILRQL 63
Query: 681 RHRHLVSLLGYSIEGNERL----------LVYEYMPH---GALSRHLFRWEKLQLKPLSW 727
HR++V+L + + L LV+EYM H G L L + + +K S+
Sbjct: 64 NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK--SF 121
Query: 728 TRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKS 787
++L L+ G+ Y H ++ F+HRD+K SNILL++ + K++DFGL +L E
Sbjct: 122 MKQL---LE---GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR 172
Query: 788 VVTRLAGTFGYLAPEYAVMG--KITTKADVFSYGVVLMELLT 827
T T Y PE ++G + DV+S G +L EL T
Sbjct: 173 PYTNKVITLWYRPPEL-LLGEERYGPAIDVWSCGCILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 6e-16
Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 633 LGRGGFGTVYKG-ELEDGTKIAVKRME---AGVTTTKALDEFQSEIAVLSKVRHRHLVSL 688
LG+G FG VY + + G ++AVK+++ T+K ++ + EI +L + H +V
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 689 LGYSIEGNERLL--VYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHC 746
G + ER L E+MP G++ L + L TR+ + + G+ YLH
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENV---TRKYT--RQILEGVSYLHS 124
Query: 747 LARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK------LAPDGEKSVVTRLAGTFGYLA 800
+HRD+K +NIL D K+ DFG K L+ G KSV GT +++
Sbjct: 125 ---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSV----TGTPYWMS 177
Query: 801 PEYAVMGKITTKADVFSYGVVLMELLT 827
PE KAD++S G ++E+LT
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 7e-16
Identities = 57/206 (27%), Positives = 84/206 (40%), Gaps = 24/206 (11%)
Query: 632 ELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLG 690
+G G +G V K G +A+K+ + E+ VL ++RH ++V+L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 691 YSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKP--LS--WTRRLSIALDVARGMEYLHC 746
LV+EY+ L E L+ P L R L + + Y H
Sbjct: 68 AFRRKGRLYLVFEYVERTLL-------ELLEASPGGLPPDAVRSYIWQL--LQAIAYCH- 117
Query: 747 LARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAV- 805
IHRD+K NIL+ + K+ DFG + S +T T Y APE V
Sbjct: 118 --SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVG 175
Query: 806 ---MGKITTKADVFSYGVVLMELLTG 828
GK DV++ G ++ ELL G
Sbjct: 176 DTNYGK---PVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 8e-16
Identities = 59/221 (26%), Positives = 117/221 (52%), Gaps = 15/221 (6%)
Query: 625 QNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHR 683
+ + + ++G+G GTV+ ++ G ++A+K++ K L +EI V+ ++++
Sbjct: 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKEL--IINEILVMKELKNP 76
Query: 684 HLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEY 743
++V+ L + G+E +V EY+ G+L+ + + + + ++ + + +E+
Sbjct: 77 NIVNFLDSFLVGDELFVVMEYLAGGSLT------DVVTETCMDEAQIAAVCRECLQALEF 130
Query: 744 LHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL-VKLAPDGEKSVVTRLAGTFGYLAPE 802
LH A Q IHRD+KS N+LL D K++DFG ++ P E+S + + GT ++APE
Sbjct: 131 LH--ANQV-IHRDIKSDNVLLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPE 185
Query: 803 YAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYL 843
K D++S G++ +E++ G E P + YL
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL 226
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-15
Identities = 66/228 (28%), Positives = 111/228 (48%), Gaps = 20/228 (8%)
Query: 613 LVISVQVLRKVTQNFAQENELGRGGFGTV-YKGELEDGTKIAVKRMEAGVTTTKALDEFQ 671
LV+S R+ +F + +G G G V E G ++AVK+M+ + L
Sbjct: 13 LVVSPGDPREYLDSFIK---IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRREL--LF 67
Query: 672 SEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRL 731
+E+ ++ H ++V + + G+E +V E++ GAL+ + + ++ +
Sbjct: 68 NEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT------DIVTHTRMNEEQIA 121
Query: 732 SIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTR 791
++ L V R + YLH Q IHRD+KS +ILL D R K+SDFG K V R
Sbjct: 122 TVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQV---SKEVPKR 175
Query: 792 --LAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERP 837
L GT ++APE T+ D++S G++++E++ G E P
Sbjct: 176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP 223
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 1e-15
Identities = 73/201 (36%), Positives = 101/201 (50%), Gaps = 14/201 (6%)
Query: 633 LGRGGFGTVYKGELE-DGTKIAVKRMEA-GVTTTKALDEFQSEIAVLSK-VRHRHLVSLL 689
+G+G FG V + + DG+ AVK ++ + K + +E VL K ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL- 61
Query: 690 GYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLA 748
YS + E+L V +Y+ G L HL R E+ L+P R A +VA + YLH L
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQR-ERCFLEP----RARFYAAEVASAIGYLHSL- 115
Query: 749 RQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGK 808
I+RDLK NILLD ++DFGL K + E++ T GT YLAPE
Sbjct: 116 --NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST-FCGTPEYLAPEVLRKEP 172
Query: 809 ITTKADVFSYGVVLMELLTGL 829
D + G VL E+L GL
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGL 193
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-15
Identities = 68/254 (26%), Positives = 112/254 (44%), Gaps = 32/254 (12%)
Query: 627 FAQENELGRGGFGTVYKG-ELEDGTKIAVKRME-AGVTTTKALDEFQSEIAVLSKVRHRH 684
F+ E+G G FG VY ++ + +A+K+M +G + + + E+ L K+RH +
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 685 LVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYL 744
+ G + + LV EY G+ S L ++ KPL ++ +G+ YL
Sbjct: 77 TIQYRGCYLREHTAWLVMEYC-LGSASDLL----EVHKKPLQEVEIAAVTHGALQGLAYL 131
Query: 745 HCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYA 804
H IHRD+K+ NILL + K+ DFG + + GT ++APE
Sbjct: 132 H---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM-----APANXFVGTPYWMAPEVI 183
Query: 805 VM---GKITTKADVFSYGVVLMEL---------LTGLAALDEERPEESRYLAEWFWRIKS 852
+ G+ K DV+S G+ +EL + ++AL ES L W
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---- 239
Query: 853 SKEKFKAAIDPALE 866
E F+ +D L+
Sbjct: 240 -SEYFRNFVDSCLQ 252
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 67/226 (29%), Positives = 103/226 (45%), Gaps = 28/226 (12%)
Query: 633 LGRGGFGTVYKGELEDGTKI-AVKRMEAGVTTTKALDEFQS---EIAVLSKVRHRHLVSL 688
LG+G FG V EL+ + A+K ++ V D+ + E VL+ ++
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLED--DDVECTMVERRVLALAWEHPFLTH 60
Query: 689 LGYSIEGNERLL-VYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCL 747
L + + E L V EY+ G L H+ + R A ++ G+++LH
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEA-----RARFYAAEIICGLQFLH-- 113
Query: 748 ARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMG 807
++ I+RDLK N+LLD D K++DFG+ K +GE T GT Y+APE
Sbjct: 114 -KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIAPEILKGQ 171
Query: 808 KITTKADVFSYGVVLMELLTGLAAL---DEERPEESRYLAEWFWRI 850
K D +S+GV+L E+L G + DE+ E F I
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSPFHGEDED---------ELFDSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (194), Expect = 2e-15
Identities = 64/219 (29%), Positives = 96/219 (43%), Gaps = 46/219 (21%)
Query: 633 LGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQS---------EIAVLSKVRH 682
+G G +G V G K+A+K++ + F EI +L +RH
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKIS---------NVFDDLIDAKRILREIKLLRHLRH 58
Query: 683 RHLVSLL-----GYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDV 737
+++ LL + N+ +V E M L + K +PL+ +
Sbjct: 59 ENIIGLLDILRPPSPEDFNDVYIVTELMET-----DLHKVIKSP-QPLTDDHIQYFLYQI 112
Query: 738 ARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA-PDGEKS------VVT 790
RG++YLH IHRDLK SNIL++ + K+ DFGL + PD ++ VVT
Sbjct: 113 LRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVT 169
Query: 791 RLAGTFGYLAPEYAVMGKITTKA-DVFSYGVVLMELLTG 828
R Y APE + TKA D++S G + ELLT
Sbjct: 170 RW-----YRAPELLLSSSRYTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 72/282 (25%), Positives = 130/282 (46%), Gaps = 28/282 (9%)
Query: 626 NFAQENELGRGGFGTVYKGE-LEDGTKIAVKRMEA-GVTTTKALDEFQSEIAVLSKVRHR 683
NF E ++GRG F VY+ L DG +A+K+++ + KA + EI +L ++ H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 684 HLVSLLGYSIEGNERLLVYEYMPHGALS---RHLFRWEKLQLKPLSWTRRLSIALDVARG 740
+++ IE NE +V E G LS +H + ++L + W + +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVW----KYFVQLCSA 118
Query: 741 MEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLA 800
+E++H + +HRD+K +N+ + K+ D GL + + + L GT Y++
Sbjct: 119 LEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPYYMS 174
Query: 801 PEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAA 860
PE K+D++S G +L E +AAL +S + + + S +K +
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYE----MAAL------QSPFYGDKM-NLYSLCKKIEQC 223
Query: 861 IDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNV 902
P L + + E + +L C +P RPD+ +V +V
Sbjct: 224 DYPPLPSDHYSEE----LRQLVNMCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 57/199 (28%), Positives = 93/199 (46%), Gaps = 15/199 (7%)
Query: 633 LGRGGFGTVYKGELED--GTKIAVKRMEAGVTTTKALDE-FQSEIAVLSKVRHRHLVSLL 689
+G G FG VY+G KIAV T+ ++ E F E ++ + H H+V L+
Sbjct: 14 IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLI 73
Query: 690 GYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLAR 749
G I N +V E P G L R + K L S + + ++ + YL
Sbjct: 74 GV-ITENPVWIVMELAPLGEL-RSYLQVNKYSLDLASL---ILYSYQLSTALAYLE---S 125
Query: 750 QTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGE--KSVVTRLAGTFGYLAPEYAVMG 807
+ F+HRD+ + N+L+ K+ DFGL + D K+ +L ++APE
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLP--IKWMAPESINFR 183
Query: 808 KITTKADVFSYGVVLMELL 826
+ T+ +DV+ +GV + E+L
Sbjct: 184 RFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-15
Identities = 76/280 (27%), Positives = 131/280 (46%), Gaps = 24/280 (8%)
Query: 626 NFAQENELGRGGFGTVYKGE-LEDGTKIAVKRMEA-GVTTTKALDEFQSEIAVLSKVRHR 683
NF E ++GRG F VY+ L D +A+K+++ + KA + EI +L ++ H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 684 HLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQ-LKPLSWTRRLSIALDVARGME 742
+++ L IE NE +V E G LS+ + ++K + L P + + L A +E
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA--VE 120
Query: 743 YLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPE 802
++H + +HRD+K +N+ + K+ D GL + + + L GT Y++PE
Sbjct: 121 HMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPYYMSPE 176
Query: 803 YAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862
K+D++S G +L E +AAL +S + + + S +K +
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYE----MAAL------QSPFYGDKM-NLFSLCQKIEQCDY 225
Query: 863 PALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNV 902
P L E E + EL C +P RPD+G+V +
Sbjct: 226 PPLP-TEHYSEKLR---ELVSMCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 77.1 bits (189), Expect = 5e-15
Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 18/204 (8%)
Query: 627 FAQENELGRGGFGTVY-KGELEDGTKIAVKRME-AGVTTTKALDEFQSEIAVLSKVRHRH 684
F E+G G FG VY ++ +A+K+M +G + + + E+ L +++H +
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 685 LVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYL 744
+ G + + LV EY G+ S L ++ KPL +I +G+ YL
Sbjct: 87 SIEYKGCYLREHTAWLVMEYC-LGSASDLL----EVHKKPLQEVEIAAITHGALQGLAYL 141
Query: 745 HCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYA 804
H IHRD+K+ NILL + + K++DFG +A S GT ++APE
Sbjct: 142 H---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIA-----SPANSFVGTPYWMAPEVI 193
Query: 805 VM---GKITTKADVFSYGVVLMEL 825
+ G+ K DV+S G+ +EL
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 5e-15
Identities = 64/234 (27%), Positives = 108/234 (46%), Gaps = 41/234 (17%)
Query: 615 ISVQVLRKVTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTK------ALD 668
I++ R + QE G FG ++ G L D K E V T K +
Sbjct: 1 IAISRDRVTLSDLLQE-----GTFGRIFYGILIDEK--PGKEEEVFVKTVKDHASEIQVT 53
Query: 669 EFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLV-YEYMPHGALSRHLFRWEKLQLKPLSW 727
E +L + H++++ +L IE E V Y YM G L L ++ +L +
Sbjct: 54 LLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFL---QQCRLGEANN 110
Query: 728 TRRLS------IALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK-L 780
+ LS +A+ +A GM YLH ++ IH+D+ + N ++D++ + K++D L + L
Sbjct: 111 PQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDL 167
Query: 781 AP-------DGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT 827
P D E V ++A E V + ++ +DV+S+GV+L EL+T
Sbjct: 168 FPMDYHCLGDNENRPVK-------WMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 7e-15
Identities = 70/214 (32%), Positives = 102/214 (47%), Gaps = 16/214 (7%)
Query: 633 LGRGGFGTVYKGELEDGTKI-AVKRM-EAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLG 690
+G+G FG V + D +I A+K + +A + + + +E VL++V +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL-K 59
Query: 691 YSIEGNERL-LVYEYMPHGALSRHLFRWEKLQL-KPLSWTRRLSIALDVARGMEYLHCLA 748
+S + E+L LV ++ G L HL R + L + +T L AL+ L
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALE---------NLH 110
Query: 749 RQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGK 808
+ I+RDLK NILLD + DFGL KL + T GT YLAPE +
Sbjct: 111 KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT-FCGTPEYLAPELLLGHG 169
Query: 809 ITTKADVFSYGVVLMELLTGLAAL-DEERPEESR 841
T D ++ GV+L E+LTGL DE E R
Sbjct: 170 YTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYR 203
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 7e-15
Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 37/216 (17%)
Query: 626 NFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQS----EIAVLSKVR 681
+ + LG G G+V K L++ I + TT + Q E+ + +
Sbjct: 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALK----TITTDPNPDLQKQILRELEINKSCK 57
Query: 682 HRHLVSLLGYSIEGNERLL--VYEYMPHGALSRHLFRWEKLQLKPLSWTRRLS------I 733
++V G ++ + + EY G+L + + K R+ I
Sbjct: 58 SPYIVKYYGAFLDESSSSIGIAMEYCEGGSL-------DSIYKKVKKRGGRIGEKVLGKI 110
Query: 734 ALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLA 793
A V +G+ YLH +R+ IHRD+K SNILL + K+ DFG+ GE +V LA
Sbjct: 111 AESVLKGLSYLH--SRKI-IHRDIKPSNILLTRKGQVKLCDFGV-----SGE--LVNSLA 160
Query: 794 GTFG----YLAPEYAVMGKITTKADVFSYGVVLMEL 825
GTF Y+APE + +DV+S G+ L+E+
Sbjct: 161 GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 626 NFAQENELGRGGFGTVYKGELEDGT-------KIAVKRMEAGVTT---TKALDEFQSEIA 675
+A LG G FG VYK ++ +I V G K++ + SE+
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 676 VLSK-VRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIA 734
++ + +RH ++V +E N+RL + + GA F K + + + R +I
Sbjct: 61 IIKEQLRHPNIVRYYKTFLE-NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIF 119
Query: 735 LDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAG 794
+ + + YLH + +HRDL +NI+L +D + ++DFGL K +S +T + G
Sbjct: 120 VQMVLALRYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSVVG 175
Query: 795 TFGYLAPEYAVMGKITTKADVFSYGVVLMELLT 827
T Y PE KADV+++G +L ++ T
Sbjct: 176 TILYSCPEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 1e-14
Identities = 67/205 (32%), Positives = 106/205 (51%), Gaps = 21/205 (10%)
Query: 633 LGRGGFGTVYKGELEDGT---KI-AVKRMEAG--VTTTKALDEFQSEIAVLSKVRHRHLV 686
LG+GG+G V++ G KI A+K ++ V K ++E +L V+H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 687 SLLGYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLS--WTRRLSIALDVARGMEY 743
L+ Y+ + +L L+ EY+ G L HL R E + ++ + + +S+AL E+
Sbjct: 64 DLI-YAFQTGGKLYLILEYLSGGELFMHLER-EGIFMEDTACFYLSEISLAL------EH 115
Query: 744 LHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEY 803
LH +Q I+RDLK NILLD K++DFGL K + E +V GT Y+APE
Sbjct: 116 LH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH-EGTVTHTFCGTIEYMAPEI 171
Query: 804 AVMGKITTKADVFSYGVVLMELLTG 828
+ D +S G ++ ++LTG
Sbjct: 172 LMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 60/211 (28%), Positives = 105/211 (49%), Gaps = 27/211 (12%)
Query: 626 NFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRH 684
++G G G V + G ++AVK+M+ + L +E+ ++ +H +
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRREL--LFNEVVIMRDYQHPN 77
Query: 685 LVSLLGYSIEGNERLLVYEYMPHGALS---RHLFRWEKLQLKPLSWTRRLSIALDVARGM 741
+V + + G+E +V E++ GAL+ H R + Q+ ++ L V + +
Sbjct: 78 IVEMYSSYLVGDELWVVMEFLEGGALTDIVTHT-RMNEEQIA--------TVCLAVLKAL 128
Query: 742 EYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFG----LVKLAPDGEKSVVTRLAGTFG 797
+LH Q IHRD+KS +ILL D R K+SDFG + K P KS+V GT
Sbjct: 129 SFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR-RKSLV----GTPY 180
Query: 798 YLAPEYAVMGKITTKADVFSYGVVLMELLTG 828
++APE T+ D++S G++++E++ G
Sbjct: 181 WMAPEVISRLPYGTEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 26/205 (12%)
Query: 632 ELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQS---EIAVLSKVRHRHLVSL 688
ELG G FG VYK + ++ +A A V TK+ +E + EI +L+ H ++V L
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAA----AKVIDTKSEEELEDYMVEIDILASCDHPNIVKL 67
Query: 689 LGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLA 748
L N ++ E+ GA+ + E+ PL+ + + + YLH
Sbjct: 68 LDAFYYENNLWILIEFCAGGAVDAVMLELER----PLTEPQIRVVCKQTLEALNYLH--- 120
Query: 749 RQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTR--LAGTFGYLAPEYAVM 806
IHRDLK+ NIL D K++DFG ++ +++ R GT ++APE VM
Sbjct: 121 ENKIIHRDLKAGNILFTLDGDIKLADFG---VSAKNTRTIQRRDSFIGTPYWMAPE-VVM 176
Query: 807 GKITT------KADVFSYGVVLMEL 825
+ + KADV+S G+ L+E+
Sbjct: 177 CETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 1e-14
Identities = 63/211 (29%), Positives = 109/211 (51%), Gaps = 22/211 (10%)
Query: 632 ELGRGGFGTVYKGELEDG---TKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSL 688
++GRG +G VYK + +DG + A+K++E + A EIA+L +++H ++++L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSAC----REIALLRELKHPNVIAL 63
Query: 689 LGYSIEGNER--LLVYEYMPHGALSRHLF-RWEKLQLKPLSWTRRL--SIALDVARGMEY 743
+ ++R L+++Y H F R K KP+ R + S+ + G+ Y
Sbjct: 64 QKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123
Query: 744 LHCLARQTFIHRDLKSSNILL----DDDYRAKVSDFGLVKL--APDGEKSVVTRLAGTFG 797
LH +HRDLK +NIL+ + R K++D G +L +P + + + TF
Sbjct: 124 LHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180
Query: 798 YLAPEYAVMGKITTKA-DVFSYGVVLMELLT 827
Y APE + + TKA D+++ G + ELLT
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 2e-14
Identities = 59/202 (29%), Positives = 90/202 (44%), Gaps = 17/202 (8%)
Query: 633 LGRGGFGTVYKGELEDGTKI-AVKRMEAG-VTTTKALDEFQSEIAVL---SKVRHRHLVS 687
LGRG FG V E + ++ A+K ++ G + ++ E + + RH LV+
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 688 LLGYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHC 746
L + + + V EY G L H+ S R + A V G++YLH
Sbjct: 67 LFA-CFQTEDHVCFVMEYAAGGDLMMHI------HTDVFSEPRAVFYAACVVLGLQYLH- 118
Query: 747 LARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVM 806
++RDLK N+LLD + K++DFGL K G + GT +LAPE
Sbjct: 119 --ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK-EGMGFGDRTSTFCGTPEFLAPEVLTE 175
Query: 807 GKITTKADVFSYGVVLMELLTG 828
T D + GV++ E+L G
Sbjct: 176 TSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 65/246 (26%), Positives = 105/246 (42%), Gaps = 28/246 (11%)
Query: 625 QNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRME-AGVTTTKALDEFQSEIAVLSKVRH 682
+ + +G G FG V+ + A+K M V K +E VL +V H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 683 RHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGME 742
++ L + ++ EY+P G L +L + S + L A ++ +E
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRF-----SNSTGLFYASEIVCALE 115
Query: 743 YLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTR---LAGTFGYL 799
YLH ++RDLK NILLD + K++DFG K + R L GT YL
Sbjct: 116 YLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFA-------KKLRDRTWTLCGTPEYL 165
Query: 800 APEYAVMGKITTKA-DVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFK 858
APE + K KA D ++ G+++ E+L G ++ P + +I + K +F
Sbjct: 166 APE-VIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI------YEKILAGKLEFP 218
Query: 859 AAIDPA 864
+D
Sbjct: 219 RHLDLY 224
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-14
Identities = 58/210 (27%), Positives = 107/210 (50%), Gaps = 18/210 (8%)
Query: 621 RKVTQNFAQENELGRGGFGTV-YKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSK 679
R + +N+ + +G G G V E G ++AVK M+ + L +E+ ++
Sbjct: 20 RSLLENYIK---IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRREL--LFNEVVIMRD 74
Query: 680 VRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVAR 739
+H+++V + + G E ++ E++ GAL+ + + L+ + ++ V +
Sbjct: 75 YQHQNVVEMYKSYLVGEELWVLMEFLQGGALT------DIVSQTRLNEEQIATVCESVLQ 128
Query: 740 GMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL-VKLAPDGEKSVVTRLAGTFGY 798
+ YLH Q IHRD+KS +ILL D R K+SDFG +++ D K L GT +
Sbjct: 129 ALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR--KSLVGTPYW 183
Query: 799 LAPEYAVMGKITTKADVFSYGVVLMELLTG 828
+APE T+ D++S G++++E++ G
Sbjct: 184 MAPEVISRTPYGTEVDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 2e-14
Identities = 63/223 (28%), Positives = 97/223 (43%), Gaps = 60/223 (26%)
Query: 633 LGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQS---------EIAVLSKVRH 682
+G G +G V + G K+A+K++ FQS E+ +L + H
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKL---------SRPFQSAIHAKRTYRELRLLKHMDH 73
Query: 683 RHLVSLL-----GYSIEG-NERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLS---- 732
+++ LL S+E + LV M GA L + ++LS
Sbjct: 74 ENVIGLLDVFTPASSLEDFQDVYLVTHLM--GA-----------DLNNIVKCQKLSDDHI 120
Query: 733 --IALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKS--V 788
+ + RG++Y+H IHRDLK SNI +++D K+ DFGL + D E + V
Sbjct: 121 QFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHT-DDEMTGYV 176
Query: 789 VTRLAGTFGYLAPEYAVM---GKITTKADVFSYGVVLMELLTG 828
TR Y APE +M D++S G ++ ELLTG
Sbjct: 177 ATRW-----YRAPE--IMLNWMHYNQTVDIWSVGCIMAELLTG 212
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-14
Identities = 65/201 (32%), Positives = 94/201 (46%), Gaps = 17/201 (8%)
Query: 633 LGRGGFGTV-YKGELEDGTKIAVKRMEAGVTTTKALDEFQ---SEIAVLSKVRHRHLVSL 688
LG+G FG V E G A+K + V K DE +E VL RH L +L
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAK--DEVAHTVTESRVLQNTRHPFLTAL 60
Query: 689 LGYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCL 747
Y+ + ++RL V EY G L HL R E++ + R ++ +EYLH
Sbjct: 61 -KYAFQTHDRLCFVMEYANGGELFFHLSR-ERV----FTEERARFYGAEIVSALEYLH-- 112
Query: 748 ARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMG 807
+ ++RD+K N++LD D K++DFGL K ++ T GT YLAPE
Sbjct: 113 -SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDN 170
Query: 808 KITTKADVFSYGVVLMELLTG 828
D + GVV+ E++ G
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCG 191
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 64/211 (30%), Positives = 107/211 (50%), Gaps = 22/211 (10%)
Query: 632 ELGRGGFGTVYKGELEDG---TKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSL 688
++GRG +G VYK + +DG A+K++E + A EIA+L +++H +++SL
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSAC----REIALLRELKHPNVISL 63
Query: 689 LGYSIEGNER--LLVYEYMPHGALSRHLF-RWEKLQLKPLSWTRRL--SIALDVARGMEY 743
+ +R L+++Y H F R K KP+ R + S+ + G+ Y
Sbjct: 64 QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 123
Query: 744 LHCLARQTFIHRDLKSSNILL----DDDYRAKVSDFGLVKL--APDGEKSVVTRLAGTFG 797
LH +HRDLK +NIL+ + R K++D G +L +P + + + TF
Sbjct: 124 LHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180
Query: 798 YLAPEYAVMGKITTKA-DVFSYGVVLMELLT 827
Y APE + + TKA D+++ G + ELLT
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 21/203 (10%)
Query: 633 LGRGGFGTVY--KGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLG 690
+G G FG +Y K + D +K ++ K + + E+ +L+K++H ++V+
Sbjct: 8 IGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 691 YSIEGNERLLVYEYMPHGALSRHLFR-----WEKLQLKPLSWTRRLSIALDVARGMEYLH 745
E +V EY G L + + R + + Q+ LSW ++S+ G++++H
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQI--LSWFVQISL------GLKHIH 118
Query: 746 CLARQTFIHRDLKSSNILLDDDYR-AKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYA 804
+ +HRD+KS NI L + AK+ DFG+ + D + T GT YL+PE
Sbjct: 119 ---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT-CVGTPYYLSPEIC 174
Query: 805 VMGKITTKADVFSYGVVLMELLT 827
K D++S G VL EL T
Sbjct: 175 QNRPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 4e-14
Identities = 68/202 (33%), Positives = 97/202 (48%), Gaps = 18/202 (8%)
Query: 633 LGRGGFGTV-YKGELEDGTKIAVKRMEAGVTTTKALDEFQ---SEIAVLSKVRHRHLVSL 688
LG+G FG V E G A+K ++ V K DE +E VL RH L +L
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK--DEVAHTLTENRVLQNSRHPFLTAL 60
Query: 689 LGYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCL 747
YS + ++RL V EY G L HL R E++ S R ++ ++YLH
Sbjct: 61 -KYSFQTHDRLCFVMEYANGGELFFHLSR-ERV----FSEDRARFYGAEIVSALDYLH-- 112
Query: 748 ARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA-PDGEKSVVTRLAGTFGYLAPEYAVM 806
+ + ++RDLK N++LD D K++DFGL K DG + + GT YLAPE
Sbjct: 113 SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKTFCGTPEYLAPEVLED 170
Query: 807 GKITTKADVFSYGVVLMELLTG 828
D + GVV+ E++ G
Sbjct: 171 NDYGRAVDWWGLGVVMYEMMCG 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 67/227 (29%), Positives = 100/227 (44%), Gaps = 61/227 (26%)
Query: 632 ELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLG 690
ELGRG +G V K GT +AVKR+ A V + + + R L+ L
Sbjct: 8 ELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE---------------QKRLLMDL-- 50
Query: 691 YSIEGNERLLVYEYMPH--GALSRHLFRW----------EKLQLKPLSWTRRL------S 732
+ + R + Y GAL R W +K K +
Sbjct: 51 ---DISMRSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGK 107
Query: 733 IALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVV-TR 791
IA+ + + +EYLH ++ + IHRD+K SN+L++ + + K+ DFG+ D SV T
Sbjct: 108 IAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD---SVAKTI 162
Query: 792 LAGTFGYLAPE----------YAVMGKITTKADVFSYGVVLMELLTG 828
AG Y+APE Y V K+DV+S G+ ++EL TG
Sbjct: 163 DAGCKPYMAPERINPELNQKGYDV------KSDVWSLGITMIELATG 203
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 5e-14
Identities = 78/235 (33%), Positives = 107/235 (45%), Gaps = 24/235 (10%)
Query: 633 LGRGGFGTVYKGELEDGTKI-AVKRMEA-GVTTTKALDEFQSEIAVLSK-VRHRHLVSLL 689
+G+G FG V + K AVK ++ + K SE VL K V+H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL- 61
Query: 690 GYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLA 748
+S + ++L V +Y+ G L HL R E+ L+P R A ++A + YLH L
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQR-ERCFLEP----RARFYAAEIASALGYLHSL- 115
Query: 749 RQTFIHRDLKSSNILLDDDYRAKVSDFGLVK--LAPDGEKSVVTRLAGTFGYLAPEYAVM 806
++RDLK NILLD ++DFGL K + +G S GT YLAPE
Sbjct: 116 --NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST---FCGTPEYLAPEVLHK 170
Query: 807 GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861
D + G VL E+L GL P SR AE + I + + K I
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYGLP------PFYSRNTAEMYDNILNKPLQLKPNI 219
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 5e-14
Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 22/215 (10%)
Query: 633 LGRGGFGTVYKGELEDGTKI-AVKRMEAGVTT-TKALDEFQSEIAVLSKV-RHRHLVSLL 689
LG+G FG V EL+ ++ AVK ++ V ++ +E VL+ +H L L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL- 61
Query: 690 GYS-IEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCL 747
+S + +RL V EY+ G L H+ R + R A ++ G+++LH
Sbjct: 62 -HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDE-----PRARFYAAEIVLGLQFLH-- 113
Query: 748 ARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK--LAPDGEKSVVTR-LAGTFGYLAPEYA 804
+ I+RDLK N+LLD + K++DFG+ K + V T GT Y+APE
Sbjct: 114 -ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG----VTTSTFCGTPDYIAPEIL 168
Query: 805 VMGKITTKADVFSYGVVLMELLTGLAALDEERPEE 839
D ++ GV+L E+L G + + + +E
Sbjct: 169 SYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE 203
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 5e-14
Identities = 70/248 (28%), Positives = 116/248 (46%), Gaps = 21/248 (8%)
Query: 626 NFAQENELGRGGFGTVY---KGELEDGTKI-AVKRMEAG--VTTTKALDEFQSEIAVLSK 679
NF LG G +G V+ K D K+ A+K ++ V K + ++E VL
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 680 VRHRHLVSLLGYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLS-WTRRLSIALDV 737
+R + L Y+ + + +L L+ +Y+ G L HL + E+ + + + ++ + +AL
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLAL-- 118
Query: 738 ARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFG 797
E+LH L I+RD+K NILLD + ++DFGL K + E GT
Sbjct: 119 ----EHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIE 171
Query: 798 YLAPEYAVMGKI--TTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKE 855
Y+AP+ G D +S GV++ ELLTG + + + S+ AE RI S+
Sbjct: 172 YMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKSEP 229
Query: 856 KFKAAIDP 863
+ +
Sbjct: 230 PYPQEMSA 237
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 6e-14
Identities = 68/201 (33%), Positives = 94/201 (46%), Gaps = 17/201 (8%)
Query: 633 LGRGGFGTV-YKGELEDGTKIAVKRMEAGVTTTKALDEFQ---SEIAVLSKVRHRHLVSL 688
LG+G FG V E G A+K ++ V K DE +E VL RH L SL
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAK--DEVAHTLTESRVLKNTRHPFLTSL 60
Query: 689 LGYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCL 747
YS + +RL V EY+ G L HL R E++ S R ++ ++YLH
Sbjct: 61 -KYSFQTKDRLCFVMEYVNGGELFFHLSR-ERV----FSEDRTRFYGAEIVSALDYLH-- 112
Query: 748 ARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMG 807
++RDLK N++LD D K++DFGL K ++ T GT YLAPE
Sbjct: 113 -SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAPEVLEDN 170
Query: 808 KITTKADVFSYGVVLMELLTG 828
D + GVV+ E++ G
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCG 191
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 6e-14
Identities = 68/202 (33%), Positives = 92/202 (45%), Gaps = 19/202 (9%)
Query: 633 LGRGGFGTV-YKGELEDGTKIAVKRMEAGVTTTKALDEFQ---SEIAVLSKVRHRHLVSL 688
LG+G FG V E G A+K ++ V K DE +E VL RH L +L
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAK--DEVAHTLTESRVLQNTRHPFLTAL 60
Query: 689 LGYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCL 747
YS + ++RL V EY G L HL R E++ S R ++ + YLH
Sbjct: 61 -KYSFQTHDRLCFVMEYANGGELFFHLSR-ERV----FSEDRARFYGAEIVSALGYLH-- 112
Query: 748 ARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA-PDGEKSVVTRLAGTFGYLAPEYAVM 806
++RDLK N++LD D K++DFGL K DG GT YLAPE
Sbjct: 113 -SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAPEVLED 169
Query: 807 GKITTKADVFSYGVVLMELLTG 828
D + GVV+ E++ G
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCG 191
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 8e-14
Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 18/204 (8%)
Query: 627 FAQENELGRGGFGTVYKGELEDGTKI-AVKRME-AGVTTTKALDEFQSEIAVLSKVRHRH 684
F +E+G G FG VY ++ AVK+M +G T + + E+ L +++H +
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 685 LVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYL 744
+ G ++ + LV EY G+ S L ++ KPL +I +G+ YL
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYC-LGSASDLL----EVHKKPLQEVEIAAITHGALQGLAYL 137
Query: 745 HCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYA 804
H IHRD+K+ NILL + + K++DFG + S GT ++APE
Sbjct: 138 H---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKS-----SPANSFVGTPYWMAPEVI 189
Query: 805 VM---GKITTKADVFSYGVVLMEL 825
+ G+ K DV+S G+ +EL
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 8e-14
Identities = 63/207 (30%), Positives = 96/207 (46%), Gaps = 17/207 (8%)
Query: 632 ELGRGGFGTVYKGELEDG---TKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSL 688
E+G G FG V GE+ G ++ VK + + + + +F E ++H +L+
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQM-KFLEEAQPYRSLQHSNLLQC 60
Query: 689 LGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLA 748
LG E LLV E+ P G L +L K +L T +A ++A G+ +LH
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH--- 117
Query: 749 RQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVT--RLAGTFGYLAPEYA-- 804
+ FIH DL N LL D K+ D+GL E VT +L ++APE
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYK-EDYYVTPDQLWVPLRWIAPELVDE 176
Query: 805 VMGKI-----TTKADVFSYGVVLMELL 826
V G + T +++V+S GV + EL
Sbjct: 177 VHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 8e-14
Identities = 67/216 (31%), Positives = 102/216 (47%), Gaps = 19/216 (8%)
Query: 633 LGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQS---EIAVLSKVRHRHLVSL 688
LG+G FG V EL+ G AVK ++ V D+ + E VL+ ++
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLID--DDVECTMVEKRVLALAWENPFLTH 60
Query: 689 LGYSIEGNERLL-VYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCL 747
L + + E L V E++ G L H+ + L R A ++ G+++LH
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDL-----YRATFYAAEIVCGLQFLH-- 113
Query: 748 ARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMG 807
+ I+RDLK N++LD D K++DFG+ K G+ T GT Y+APE
Sbjct: 114 -SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEILQGL 171
Query: 808 KITTKADVFSYGVVLMELLTGLAAL---DEERPEES 840
K T D +S+GV+L E+L G + DE+ ES
Sbjct: 172 KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFES 207
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 9e-14
Identities = 76/257 (29%), Positives = 118/257 (45%), Gaps = 38/257 (14%)
Query: 632 ELGRGGFGTVYKGELEDGTKI-AVKRMEAGVTTTKALDEFQ---SEIAVLSKVRHRHLVS 687
++G+GG+G V+ + +D +I A+KRM+ + L+E + +E +L+ + LV
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKK--SLLFKLNEVRHVLTERDILTTTKSEWLVK 65
Query: 688 LLGYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVAR-----GM 741
LL Y+ + +E L L EY+P G R L L+ LS D AR
Sbjct: 66 LL-YAFQDDEYLYLAMEYVPGGDF-RTL----------LNNLGVLS--EDHARFYMAEMF 111
Query: 742 EYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAP 801
E + L +IHRDLK N L+D K++DFGL K SVV G+ Y+AP
Sbjct: 112 EAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV----GSPDYMAP 167
Query: 802 EYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861
E D +S G +L E L G P E+ + +K KE + +
Sbjct: 168 EVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET------WENLKYWKETLQRPV 221
Query: 862 --DPALEVNEETFESIS 876
DP +++E ++ I+
Sbjct: 222 YDDPRFNLSDEAWDLIT 238
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-13
Identities = 38/110 (34%), Positives = 63/110 (57%), Gaps = 4/110 (3%)
Query: 327 APDVNVLLDFLGGVNYPVNLVSQW-PGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTL 385
A ++ +LL F +N P+ +S W D C W G++C ++S+V I+L N++G +
Sbjct: 28 AEELELLLSFKSSINDPLKYLSNWNSSADVCL--WQGITCNNSSRVVSIDLSGKNISGKI 85
Query: 386 SPSIANLDSLIEIRLGKNSISGTVPNN-FTELKSLRLLDVSDNNIKPPLP 434
S +I L + I L N +SG +P++ FT SLR L++S+NN +P
Sbjct: 86 SSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIP 135
|
Length = 968 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 57/210 (27%), Positives = 106/210 (50%), Gaps = 21/210 (10%)
Query: 626 NFAQENELGRGGFGTVYKGE-LEDGTKIAVKRM-----EAGVTTTKALDEFQSEIAVLSK 679
++ + ++G G +G VYKG + G +A+K++ E GV +T EI++L +
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAI-----REISLLKE 55
Query: 680 VRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVAR 739
++H ++V L ++ + L++E++ L ++L K Q + S + +
Sbjct: 56 LQHPNIVCLQDVLMQESRLYLIFEFLSMD-LKKYLDSLPKGQYMDAELVK--SYLYQILQ 112
Query: 740 GMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYL 799
G+ + H + +HRDLK N+L+D+ K++DFGL + A V T T Y
Sbjct: 113 GILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLAR-AFGIPVRVYTHEVVTLWYR 168
Query: 800 APEYAVMG--KITTKADVFSYGVVLMELLT 827
APE ++G + +T D++S G + E+ T
Sbjct: 169 APE-VLLGSPRYSTPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-13
Identities = 67/228 (29%), Positives = 105/228 (46%), Gaps = 24/228 (10%)
Query: 626 NFAQENELGRGGFGTVY---KGELEDGTKI---AVKRMEAGVTTTKALDEFQSEIAVLSK 679
NF LG G +G V+ K D K+ V + A V K ++ ++E VL
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 680 VRHRHLVSLLGYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVA 738
VR + L Y+ + +L L+ +Y+ G + HL++ + + R ++
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEV----RFYSG-EII 115
Query: 739 RGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGY 798
+E+LH L ++RD+K NILLD + ++DFGL K EK GT Y
Sbjct: 116 LALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEY 172
Query: 799 LAPEY----AVMGKITTKADVFSYGVVLMELLTGLA--ALDEERPEES 840
+APE GK D +S G+++ ELLTG + L+ ER +S
Sbjct: 173 MAPEIIRGKGGHGKAV---DWWSLGILIFELLTGASPFTLEGERNTQS 217
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 61/201 (30%), Positives = 92/201 (45%), Gaps = 17/201 (8%)
Query: 633 LGRGGFGTVYK-GELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGY 691
+G G +G V K E G +A+K+ EI +L ++RH +LV+L+
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68
Query: 692 SIEGNERLLVYEYMPHGALSRHLFRWEKLQLKP--LSWTRRLSIALDVARGMEYLHCLAR 749
LV+E++ H L + L+ P L +R + RG+E+ H
Sbjct: 69 FRRKKRLYLVFEFVDHTVL-------DDLEKYPNGLDESRVRKYLFQILRGIEFCH---S 118
Query: 750 QTFIHRDLKSSNILLDDDYRAKVSDFGLVK-LAPDGEKSVVTRLAGTFGYLAPEYAVMGK 808
IHRD+K NIL+ K+ DFG + LA GE V T T Y APE V
Sbjct: 119 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYTDYVATRWYRAPELLVGDT 176
Query: 809 ITTKA-DVFSYGVVLMELLTG 828
+A D+++ G ++ E+LTG
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 2e-13
Identities = 59/218 (27%), Positives = 104/218 (47%), Gaps = 35/218 (16%)
Query: 626 NFAQENELGRGGFGTVYKG-ELEDGTKIAVKR--MEAGVTTTKALDEFQ----SEIAVLS 678
+ + N + G +G VY+ + + G +A+K+ ME K + F EI +L
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKME------KEKEGFPITSLREINILL 59
Query: 679 KVRHRHLVSL----LGYSIEGNERLLVYEYMPH---GALSRHLFRWEKLQLKPLSWTRRL 731
K++H ++V++ +G ++ ++ +V EY+ H + +P +
Sbjct: 60 KLQHPNIVTVKEVVVGSNL--DKIYMVMEYVEHDLKSLMETMK--------QPFLQSEVK 109
Query: 732 SIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTR 791
+ L + G+ +LH +HRDLK+SN+LL++ K+ DFGL + K T+
Sbjct: 110 CLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK-PYTQ 165
Query: 792 LAGTFGYLAPEYAVMGKI-TTKADVFSYGVVLMELLTG 828
L T Y APE + K +T D++S G + ELLT
Sbjct: 166 LVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTK 203
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 2e-13
Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 20/215 (9%)
Query: 623 VTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR 681
V + + +G G +G V G K+A+K++ T + EI +L + +
Sbjct: 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR-EIKILRRFK 61
Query: 682 HRHLVSLLGY----SIEG-NERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALD 736
H +++ +L S E N+ +V E M L++ K Q LS
Sbjct: 62 HENIIGILDIIRPPSFESFNDVYIVQELME-----TDLYKLIKTQ--HLSNDHIQYFLYQ 114
Query: 737 VARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA-PDGE-KSVVTRLAG 794
+ RG++Y+H +HRDLK SN+LL+ + K+ DFGL ++A P+ + +T
Sbjct: 115 ILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA 171
Query: 795 TFGYLAPEYAVMGKITTKA-DVFSYGVVLMELLTG 828
T Y APE + K TKA D++S G +L E+L+
Sbjct: 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 21/215 (9%)
Query: 633 LGRGGFGTVYKGELEDGTKIAV------KRMEAGVTTTKALDEFQSEIAVLSKVRHRHLV 686
+GRGGFG VY D K+ KR++ T AL+E + ++++S +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIMLSLVSTGDCPFIV 60
Query: 687 SLLGYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLH 745
+ Y+ ++L + + M G L HL + K + + A ++ G+E++H
Sbjct: 61 CMT-YAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-----YATEIILGLEHMH 114
Query: 746 CLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAV 805
+ ++RDLK +NILLD+ ++SD G LA D K GT GY+APE
Sbjct: 115 ---NRFVVYRDLKPANILLDEHGHVRISDLG---LACDFSKKKPHASVGTHGYMAPEVLQ 168
Query: 806 MGKI-TTKADVFSYGVVLMELLTGLAALDEERPEE 839
G + AD FS G +L +LL G + + + ++
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 2e-13
Identities = 70/238 (29%), Positives = 98/238 (41%), Gaps = 62/238 (26%)
Query: 633 LGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIA-------VLSKVRHRH 684
+GRG FG V+ + + G A+K + K+ +++IA +L+
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLR------KSDMIKRNQIAHVRAERDILADADSPW 62
Query: 685 LVSLLGYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTR----RLSIALDVAR 739
+V L YS + E L LV EYMP G L L R + P R L +ALD
Sbjct: 63 IVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVF---PEETARFYIAELVLALD--- 115
Query: 740 GMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK------------------LA 781
+H + FIHRD+K NIL+D D K++DFGL K L
Sbjct: 116 ---SVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169
Query: 782 PDGEKSVVTRL----------AGTFGYLAPEYAVMGK-ITTKADVFSYGVVLMELLTG 828
D GT Y+APE + G + D +S GV+L E+L G
Sbjct: 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPE-VLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 3e-13
Identities = 65/218 (29%), Positives = 100/218 (45%), Gaps = 20/218 (9%)
Query: 625 QNFAQENELGRGGFGTV----YKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV 680
+F LG G FG V +KG E +K+ E + K + E ++L ++
Sbjct: 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKRE--ILKMKQVQHVAQEKSILMEL 75
Query: 681 RHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARG 740
H +V+++ + N + E++ G L HL + + P + L +A
Sbjct: 76 SHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRF---PNDVAKFYHAELVLA-- 130
Query: 741 MEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLA 800
EYLH + I+RDLK N+LLD+ KV+DFG K PD + L GT YLA
Sbjct: 131 FEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT----LCGTPEYLA 183
Query: 801 PEYAVMGKITTKA-DVFSYGVVLMELLTGLAALDEERP 837
PE + K KA D ++ GV+L E + G ++ P
Sbjct: 184 PE-VIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP 220
|
Length = 329 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-13
Identities = 60/225 (26%), Positives = 86/225 (38%), Gaps = 62/225 (27%)
Query: 14 FVVGVANSATDPNDLKILNDFKNGLENPELLKWPANGDDPCGPP--PWPHVFCSGNR--- 68
F + A S T ++ L K+ L P W NGD PC P PW C +
Sbjct: 360 FEIITAESKTLLEEVSALQTLKSSLGLPLRFGW--NGD-PCVPQQHPWSGADCQFDSTKG 416
Query: 69 ---VTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNE 125
+ + + N GL+G +P + ++L L ++ L N G +P
Sbjct: 417 KWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIP----------------- 459
Query: 126 FDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDF 185
PS ++S+ VL L YN FN G +P+
Sbjct: 460 ----PS--LGSITSLEVLDLSYNSFN----------------------------GSIPES 485
Query: 186 LGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTG 230
LG L SL L L+ N LSG +PA+ G L+ N D G+ G
Sbjct: 486 LGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCG 530
|
Length = 623 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 4e-13
Identities = 65/206 (31%), Positives = 94/206 (45%), Gaps = 25/206 (12%)
Query: 633 LGRGGFGTVYKGELEDGTKIAV------KRMEAGVTTTKALDEFQSEIAVLSKVRHRH-- 684
+GRGGFG VY D K+ KR++ T AL+E +LS V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNER----IMLSLVSTGDCP 57
Query: 685 LVSLLGYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEY 743
+ + Y+ ++L + + M G L HL Q S A ++ G+E+
Sbjct: 58 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS-----QHGVFSEAEMRFYAAEIILGLEH 112
Query: 744 LHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEY 803
+H + ++RDLK +NILLD+ ++SD G LA D K GT GY+APE
Sbjct: 113 MH---NRFVVYRDLKPANILLDEHGHVRISDLG---LACDFSKKKPHASVGTHGYMAPEV 166
Query: 804 AVMG-KITTKADVFSYGVVLMELLTG 828
G + AD FS G +L +LL G
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 37/213 (17%)
Query: 633 LGRGGFGTVYK-GELEDGTKIAVKRM----EAGVTTTKALDEFQSEIAVLSKVRHRHLVS 687
+G G +G V+K E G +A+K+ + V AL EI +L +++H +LV+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIAL----REIRMLKQLKHPNLVN 64
Query: 688 LLGYSIEGNERL-LVYEYMPHGALS---RHLFRWEKLQLKPLSWTRRLSIALDVARGMEY 743
L+ +L LV+EY H L+ ++ + +K + W + + +
Sbjct: 65 LIEV-FRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIW--------QTLQAVNF 115
Query: 744 LHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKL--APDGEKS--VVTRLAGTFGYL 799
H + IHRD+K NIL+ + K+ DFG ++ P + + V TR Y
Sbjct: 116 CH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRW-----YR 167
Query: 800 APEYAVMG--KITTKADVFSYGVVLMELLTGLA 830
APE V G + DV++ G V ELLTG
Sbjct: 168 APELLV-GDTQYGPPVDVWAIGCVFAELLTGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 5e-13
Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 623 VTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR 681
+T + +G G FG V + G +A+K++ +T E+ +L +R
Sbjct: 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLR 67
Query: 682 HRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGM 741
H +++SL I E + Y L L R L +PL + RG+
Sbjct: 68 HENIISLSDIFISPLEDI----YFVTELLGTDLHRL--LTSRPLEKQFIQYFLYQILRGL 121
Query: 742 EYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAP 801
+Y+H +HRDLK SNIL++++ K+ DFGL ++ + +T T Y AP
Sbjct: 122 KYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTGYVSTRYYRAP 174
Query: 802 EYAVM---GKITTKADVFSYGVVLMELLTG 828
E +M K + D++S G + E+L G
Sbjct: 175 E--IMLTWQKYDVEVDIWSAGCIFAEMLEG 202
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 5e-13
Identities = 58/237 (24%), Positives = 106/237 (44%), Gaps = 39/237 (16%)
Query: 621 RKVTQNFAQ-ENELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQ------- 671
+++ + Q LG G +G V K G +A+K+++ + + Q
Sbjct: 4 FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGI 63
Query: 672 -----SEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLS 726
E+ ++++++H +++ L+ +EG+ LV + M L + + R K++L +
Sbjct: 64 HFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDR--KIRL---T 117
Query: 727 WTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL--------- 777
++ I L + G+ LH + F+HRDL +NI ++ K++DFGL
Sbjct: 118 ESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPY 174
Query: 778 ----VKLAPDGEKSVVTRLAGTFGYLAPEYAVMG--KITTKADVFSYGVVLMELLTG 828
K + +T T Y APE +MG K D++S G + ELLTG
Sbjct: 175 SDTLSKDETMQRREEMTSKVVTLWYRAPEL-LMGAEKYHFAVDMWSVGCIFAELLTG 230
|
Length = 335 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 7e-13
Identities = 70/248 (28%), Positives = 104/248 (41%), Gaps = 36/248 (14%)
Query: 60 PHVFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFA 119
P S R+ +Q+ + G +P+N + L L L N G++P S F
Sbjct: 325 PVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFK 384
Query: 120 YLDF-NEFDT-IPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTN-LSLINC 176
+ F N + IP S+R + L N F+ S + L L + N
Sbjct: 385 LILFSNSLEGEIPKSLGA-CRSLRRVRLQDNSFSGEL-----PSEFTKLPLVYFLDISNN 438
Query: 177 NLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVA 236
NL G + +PSL L L+ N+ G +P SFG
Sbjct: 439 NLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSK----------------------- 475
Query: 237 KMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANME-LDNLVLNN 295
L L L NQF+G++P +G+LS L L L+ N+L G IP L++ + L +L L++
Sbjct: 476 ---RLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSH 532
Query: 296 NLLMGPIP 303
N L G IP
Sbjct: 533 NQLSGQIP 540
|
Length = 968 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 1e-12
Identities = 62/236 (26%), Positives = 94/236 (39%), Gaps = 54/236 (22%)
Query: 632 ELGRGGFGTVYKGELED-GTKIAVKRME-AGVTTTKALDEFQSEIAVLSKVRHRHLVSLL 689
LG+G G V+ L+ G A+K ++ + + +E +L+ + H L +L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67
Query: 690 GYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVAR--------G 740
S + L LV +Y P G L + LQ +P + LS +VAR
Sbjct: 68 A-SFQTETYLCLVMDYCPGGEL------FRLLQRQP---GKCLSE--EVARFYAAEVLLA 115
Query: 741 MEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLA------- 793
+EYLH L ++RDLK NILL + +SDF L K + V L
Sbjct: 116 LEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSS 172
Query: 794 ---------------------GTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTG 828
GT Y+APE + D ++ G++L E+L G
Sbjct: 173 VNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 1e-12
Identities = 67/216 (31%), Positives = 105/216 (48%), Gaps = 24/216 (11%)
Query: 633 LGRGGFGTVYKGELEDGTK--IAVKRMEAGVTTTKALDEFQS---EIAVLSKVRHRHLVS 687
LG+G FG V E GT A+K ++ V D+ + E VL+ ++
Sbjct: 8 LGKGSFGKVMLAE-RKGTDELYAIKILKKDVIIQD--DDVECTMVEKRVLALPGKPPFLT 64
Query: 688 LLGYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHC 746
L + +RL V EY+ G L H+ + K + +P + + A ++A G+ +LH
Sbjct: 65 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFK-EPHA----VFYAAEIAIGLFFLH- 118
Query: 747 LARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPE---Y 803
+ I+RDLK N++LD + K++DFG+ K G K+ T GT Y+APE Y
Sbjct: 119 --SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT-FCGTPDYIAPEIIAY 175
Query: 804 AVMGKITTKADVFSYGVVLMELLTGLAALDEERPEE 839
GK D +++GV+L E+L G D E +E
Sbjct: 176 QPYGK---SVDWWAFGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 17/205 (8%)
Query: 625 QNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHR 683
Q+ + LG G GTVYK L +AVK + +T + + SE+ +L K
Sbjct: 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITV-ELQKQIMSELEILYKCDSP 59
Query: 684 HLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEY 743
+++ G N + E+M G+L + K+ L IA+ V +G+ Y
Sbjct: 60 YIIGFYGAFFVENRISICTEFMDGGSLDV----YRKIPEHVLG-----RIAVAVVKGLTY 110
Query: 744 LHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEY 803
L L +HRD+K SN+L++ + K+ DFG+ + S+ GT Y+APE
Sbjct: 111 LWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN---SIAKTYVGTNAYMAPER 164
Query: 804 AVMGKITTKADVFSYGVVLMELLTG 828
+ +DV+S G+ MEL G
Sbjct: 165 ISGEQYGIHSDVWSLGISFMELALG 189
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 57/209 (27%), Positives = 103/209 (49%), Gaps = 17/209 (8%)
Query: 632 ELGRGGFGTVYKGELED-GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLG 690
++G G G V ++ G +AVK+M+ + L +E+ ++ +H ++V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRREL--LFNEVVIMRDYQHENVVEMYN 84
Query: 691 YSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQ 750
+ G+E +V E++ GAL+ + ++ + ++ ++ L V + + LH Q
Sbjct: 85 SYLVGDELWVVMEFLEGGALT-DIVTHTRMNEEQIA-----AVCLAVLKALSVLHA---Q 135
Query: 751 TFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTR--LAGTFGYLAPEYAVMGK 808
IHRD+KS +ILL D R K+SDFG K V R L GT ++APE
Sbjct: 136 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKSLVGTPYWMAPELISRLP 192
Query: 809 ITTKADVFSYGVVLMELLTGLAALDEERP 837
+ D++S G++++E++ G E P
Sbjct: 193 YGPEVDIWSLGIMVIEMVDGEPPYFNEPP 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 2e-12
Identities = 65/229 (28%), Positives = 108/229 (47%), Gaps = 43/229 (18%)
Query: 621 RKVTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQS------- 672
+ + + + +LG+G +G V+K + +A+K K D F++
Sbjct: 3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALK---------KIFDAFRNATDAQRT 53
Query: 673 --EIAVLSKVR-HRHLVSLLG-YSIEGNERL-LVYEYMP---HGALSRHLFRWEKLQLKP 724
EI L ++ H ++V LL E ++ + LV+EYM H + ++ L+
Sbjct: 54 FREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANI-------LED 106
Query: 725 LSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK----L 780
+ + I + + ++Y+H IHRDLK SNILL+ D R K++DFGL + L
Sbjct: 107 V---HKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160
Query: 781 APDGEKSVVTRLAGTFGYLAPEYAVMGKITTKA-DVFSYGVVLMELLTG 828
+ E V+T T Y APE + TK D++S G +L E+L G
Sbjct: 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG 209
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 55/204 (26%), Positives = 96/204 (47%), Gaps = 10/204 (4%)
Query: 626 NFAQENELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRH 684
NF + ++G G +G VYK G +A+K++ T EI++L ++ H +
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 685 LVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYL 744
+V LL N+ LV+E++ H L + + + L + S + +G+ +
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFM---DASPLSGIPLPLIKSYLFQLLQGLAFC 116
Query: 745 HCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYA 804
H +HRDLK N+L++ + K++DFGL + A T T Y APE
Sbjct: 117 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVVTLWYRAPEIL 172
Query: 805 VMGKI-TTKADVFSYGVVLMELLT 827
+ K +T D++S G + E++T
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 57/221 (25%), Positives = 111/221 (50%), Gaps = 27/221 (12%)
Query: 633 LGRGGFGTVYKG---ELEDG-----TKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRH 684
LG+G F ++KG E+ D T++ +K ++ + + F +++S++ H+H
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDK--SHRNYSESFFEAASMMSQLSHKH 60
Query: 685 LVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEY- 743
LV G + G+E ++V EY+ G+L +L + L +SW L+VA+ + +
Sbjct: 61 LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKK--NKNLINISWK------LEVAKQLAWA 112
Query: 744 LHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG-EKSVVTR--LAGTFGYLA 800
LH L + H ++ + N+LL + K + +KL+ G +V+ + L ++
Sbjct: 113 LHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVP 172
Query: 801 PEYAVMGK-ITTKADVFSYGVVLMELLTG----LAALDEER 836
PE + ++ AD +S+G L E+ +G L+ALD ++
Sbjct: 173 PECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK 213
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 3e-12
Identities = 71/255 (27%), Positives = 122/255 (47%), Gaps = 31/255 (12%)
Query: 633 LGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLG 690
+G G +G VYKG ++ G A+K M+ T +E + EI +L K HR++ + G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQEINMLKKYSHHRNIATYYG 70
Query: 691 YSIEGN------ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYL 744
I+ N + LV E+ G+++ + + LK W I ++ RG+ +L
Sbjct: 71 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE-EWIA--YICREILRGLSHL 127
Query: 745 HCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTR--LAGTFGYLAPE 802
H + IHRD+K N+LL ++ K+ DFG ++ +++V R GT ++APE
Sbjct: 128 H---QHKVIHRDIKGQNVLLTENAEVKLVDFG---VSAQLDRTVGRRNTFIGTPYWMAPE 181
Query: 803 YAVM-----GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEW--FWRIKSSK- 854
K+D++S G+ +E+ G L + P + +L R+KS K
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKW 241
Query: 855 -EKFKAAIDPALEVN 868
+KF++ I+ L N
Sbjct: 242 SKKFQSFIESCLVKN 256
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 4e-12
Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 24/210 (11%)
Query: 627 FAQENELGRGGFG-TVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHL 685
+ + ++G G FG + EDG + +K + + K +E + E+AVLS ++H ++
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61
Query: 686 VSLLGYSIEGNERL-LVYEYMPHGALSRH-------LFRWEKLQLKPLSWTRRLSIALDV 737
V S E N L +V +Y G L + LF +++ L W ++ +AL
Sbjct: 62 VQY-QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQI----LDWFVQICLAL-- 114
Query: 738 ARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFG 797
+++H + +HRD+KS NI L D K+ DFG+ ++ + T + GT
Sbjct: 115 ----KHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPY 166
Query: 798 YLAPEYAVMGKITTKADVFSYGVVLMELLT 827
YL+PE K+D+++ G VL E+ T
Sbjct: 167 YLSPEICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 4e-12
Identities = 58/219 (26%), Positives = 103/219 (47%), Gaps = 35/219 (15%)
Query: 621 RKVTQNFAQENELGRGGFGTVYK------GELEDGTKIAVKRMEAGVTTTKALDEFQSEI 674
R ++F +G G +G VYK GEL I V ++E G + Q EI
Sbjct: 5 RNPQEDFELIQRIGSGTYGDVYKARNVNTGEL---AAIKVIKLEPG----EDFAVVQQEI 57
Query: 675 AVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSR--HLFRWEKLQLKPLSWTRRLS 732
++ +H ++V+ G + ++ + E+ G+L H+ PLS ++
Sbjct: 58 IMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHV-------TGPLSESQIAY 110
Query: 733 IALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL---VKLAPDGEKSVV 789
++ + +G+ YLH + +HRD+K +NILL D+ K++DFG+ + KS +
Sbjct: 111 VSRETLQGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI 167
Query: 790 TRLAGTFGYLAPEYAVM---GKITTKADVFSYGVVLMEL 825
GT ++APE A + G D+++ G+ +EL
Sbjct: 168 ----GTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 5e-12
Identities = 68/201 (33%), Positives = 95/201 (47%), Gaps = 14/201 (6%)
Query: 633 LGRGGFGTVYKGELE-DGTKIAVKRMEAGVT-TTKALDEFQSEIAVLSK-VRHRHLVSLL 689
+G+G FG V + + DG AVK ++ + K +E VL K V+H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 690 GYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLA 748
YS + E+L V +++ G L HL R E+ +P R A ++A + YLH +
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQR-ERSFPEP----RARFYAAEIASALGYLHSI- 115
Query: 749 RQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGK 808
++RDLK NILLD ++DFGL K + T GT YLAPE
Sbjct: 116 --NIVYRDLKPENILLDSQGHVVLTDFGLCKEGI-AQSDTTTTFCGTPEYLAPEVIRKQP 172
Query: 809 ITTKADVFSYGVVLMELLTGL 829
D + G VL E+L GL
Sbjct: 173 YDNTVDWWCLGAVLYEMLYGL 193
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 5e-12
Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 18/213 (8%)
Query: 633 LGRGGFGTVYKGELEDGTKI-AVKRMEAGVTTTKALDEFQS---EIAVLSKVRHRHLVSL 688
LG+G FG V E + ++ A+K ++ V D+ + E VL+ ++
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQD--DDVECTMVEKRVLALQDKPPFLTQ 65
Query: 689 LGYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCL 747
L + +RL V EY+ G L H+ + K + +P + + A +++ G+ +LH
Sbjct: 66 LHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFK-EP----QAVFYAAEISVGLFFLH-- 118
Query: 748 ARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTR-LAGTFGYLAPEYAVM 806
R+ I+RDLK N++LD + K++DFG+ K V TR GT Y+APE
Sbjct: 119 -RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPEIIAY 175
Query: 807 GKITTKADVFSYGVVLMELLTGLAALDEERPEE 839
D ++YGV+L E+L G D E +E
Sbjct: 176 QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 65/220 (29%), Positives = 107/220 (48%), Gaps = 36/220 (16%)
Query: 626 NFAQENELGRGGFGTVYKGE-LEDGTKIAVKRM----EAGVTTTKALDEFQSEIAVLSKV 680
NF Q +LG G + TVYKG G +A+K + E G +T EI+++ ++
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAI-----REISLMKEL 55
Query: 681 RHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHL-FRWEKLQLKPL---SWTRRLSIALD 736
+H ++V L N+ +LV+EYM L +++ + L P S+T +L
Sbjct: 56 KHENIVRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQL----- 109
Query: 737 VARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKL--APDGEKS--VVTRL 792
+G+ + H +HRDLK N+L++ K++DFGL + P S VV
Sbjct: 110 -LKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--- 162
Query: 793 AGTFGYLAPEYAVMGKIT--TKADVFSYGVVLMELLTGLA 830
T Y AP+ ++G T T D++S G ++ E++TG
Sbjct: 163 --TLWYRAPD-VLLGSRTYSTSIDIWSVGCIMAEMITGRP 199
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 6e-12
Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 30/213 (14%)
Query: 626 NFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKAL----------DEFQSEIA 675
+F + ELG G G V K V +G+ + L ++ E+
Sbjct: 2 DFEKLGELGAGNGGVVTK----------VLHRPSGLIMARKLIHLEIKPAIRNQIIRELK 51
Query: 676 VLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIAL 735
VL + ++V G E + E+M G+L + L + ++ P + ++SIA
Sbjct: 52 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI---PENILGKISIA- 107
Query: 736 DVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGT 795
V RG+ YL + +HRD+K SNIL++ K+ DFG+ D S+ GT
Sbjct: 108 -VLRGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGT 161
Query: 796 FGYLAPEYAVMGKITTKADVFSYGVVLMELLTG 828
Y++PE T ++D++S G+ L+E+ G
Sbjct: 162 RSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIG 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 6e-12
Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 16/212 (7%)
Query: 633 LGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQ---SEIAVLSKVRHRHLVSL 688
LG+G FG V L E G AVK ++ V D+ + +E +LS R+ ++
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQD--DDVECTMTEKRILSLARNHPFLTQ 60
Query: 689 LGYSIEGNERLL-VYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCL 747
L + +RL V E++ G L H+ + + R A ++ + +LH
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRF-----DEARARFYAAEITSALMFLH-- 113
Query: 748 ARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMG 807
+ I+RDLK N+LLD + K++DFG+ K K+ T GT Y+APE
Sbjct: 114 -DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST-FCGTPDYIAPEILQEM 171
Query: 808 KITTKADVFSYGVVLMELLTGLAALDEERPEE 839
D ++ GV+L E+L G A + E ++
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 7e-12
Identities = 46/138 (33%), Positives = 75/138 (54%), Gaps = 11/138 (7%)
Query: 695 GNERLLVYEYMPHGALSRHLFR-WEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFI 753
G +L + P + S + + + L PL+ + + VARGME+L A + I
Sbjct: 140 GQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL---ASRKCI 196
Query: 754 HRDLKSSNILLDDDYRAKVSDFGLVK---LAPDGEKSVVTRLAGTFGYLAPEYAVMGKI- 809
HRDL + NILL ++ K+ DFGL + PD + RL ++APE ++ K+
Sbjct: 197 HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP--LKWMAPE-SIFDKVY 253
Query: 810 TTKADVFSYGVVLMELLT 827
TT++DV+S+GV+L E+ +
Sbjct: 254 TTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 8e-12
Identities = 62/222 (27%), Positives = 106/222 (47%), Gaps = 34/222 (15%)
Query: 618 QVLRKVTQ-NFAQENELGRGGFGTVYKG-ELEDGTKIAVK--RMEAGVTTTKALDEF--- 670
+LR+ Q ++ +G G +G VYK L G AVK ++E G D+F
Sbjct: 1 DILRRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG-------DDFSLI 53
Query: 671 QSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSR--HLFRWEKLQLKPLSWT 728
Q EI ++ + +H ++V+ G + + + EY G+L H+ PLS
Sbjct: 54 QQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHV-------TGPLSEL 106
Query: 729 RRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSV 788
+ + + +G+ YLH + +HRD+K +NILL D+ K++DFG +A ++
Sbjct: 107 QIAYVCRETLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFG---VAAKITATI 160
Query: 789 VTR--LAGTFGYLAPEYAVM---GKITTKADVFSYGVVLMEL 825
R GT ++APE A + G D+++ G+ +EL
Sbjct: 161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-11
Identities = 44/135 (32%), Positives = 57/135 (42%), Gaps = 25/135 (18%)
Query: 160 DSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILW 219
DS + L L N L G +P+ + L L ++ LS N + G IP S G
Sbjct: 412 DSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGS------- 464
Query: 220 LNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLI 279
+ SL L L N F GSIPE +G L+SL+ LNLN N L G +
Sbjct: 465 ------------------ITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRV 506
Query: 280 PKSLANMELDNLVLN 294
P +L L N
Sbjct: 507 PAALGGRLLHRASFN 521
|
Length = 623 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 48/195 (24%), Positives = 94/195 (48%), Gaps = 19/195 (9%)
Query: 641 VYKGELEDGTKIAVKRMEAGVTTTKAL-DEFQSEIAVLSKVRHRHLVSLLGYSIEGNERL 699
+YKG + ++ ++ + K L D ++EI L ++ +++ + G+ I+ + L
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 700 ----LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHR 755
L+ EY G L R + EK LS+ +L +A+D +G+ L+ + ++
Sbjct: 95 PRLSLILEYCTRGYL-REVLDKEK----DLSFKTKLDMAIDCCKGLYNLYKYTNKP--YK 147
Query: 756 DLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYA--VMGKITTKA 813
+L S + L+ ++Y+ K+ GL K+ V + Y + + + + T K
Sbjct: 148 NLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV----YFSYKMLNDIFSEYTIKD 203
Query: 814 DVFSYGVVLMELLTG 828
D++S GVVL E+ TG
Sbjct: 204 DIYSLGVVLWEIFTG 218
|
Length = 283 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 20/202 (9%)
Query: 633 LGRGGFGTVYKG-ELEDGTKIAVK--RMEA---GVTTTKALDEFQSEIAVLSKVRHRHLV 686
+G G +G VYK + G +A+K R+E GV +T A+ EI++L ++ H ++V
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPST-AI----REISLLKELNHPNIV 61
Query: 687 SLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHC 746
LL N+ LV+E++ L +++ L P L L +G+ Y H
Sbjct: 62 RLLDVVHSENKLYLVFEFLDLD-LKKYMDSSPLTGLDPPLIKSYLYQLL---QGIAYCH- 116
Query: 747 LARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVM 806
+HRDLK N+L+D + K++DFGL + A T T Y APE +
Sbjct: 117 --SHRVLHRDLKPQNLLIDREGALKLADFGLAR-AFGVPVRTYTHEVVTLWYRAPEILLG 173
Query: 807 GK-ITTKADVFSYGVVLMELLT 827
+ +T D++S G + E++
Sbjct: 174 SRQYSTPVDIWSIGCIFAEMVN 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 1e-11
Identities = 63/230 (27%), Positives = 96/230 (41%), Gaps = 31/230 (13%)
Query: 673 EIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLS 732
E +L V H ++ + + G +V +PH S L+ + + +PL + L
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPH--YSSDLYTYLTKRSRPLPIDQALI 161
Query: 733 IALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKL---APDGEKSVV 789
I + G+ YLH Q IHRD+K+ NI ++D + + D G + AP
Sbjct: 162 IEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA-----F 213
Query: 790 TRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWR 849
LAGT APE K +KAD++S G+VL E+L + + E+ P
Sbjct: 214 LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYV----- 268
Query: 850 IKSSKEKFKAAIDPALEVNEETFES------ISIVAELAGHCTAREPYHR 893
KS I L+V+ E F + E A R+PY R
Sbjct: 269 -KSCHSHLLKIIS-TLKVHPEEFPRDPGSRLVRGFIEYAS--LERQPYTR 314
|
Length = 357 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-11
Identities = 57/199 (28%), Positives = 91/199 (45%), Gaps = 12/199 (6%)
Query: 633 LGRGGFGTVYKGELEDGTKI-AVKRMEAGVTTTKA-LDEFQSEIAVLSKVRHRHLVSLLG 690
LG+G FG V EL+ ++ A+K ++ V +D +E +L+ ++ L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 691 YSIEGNERLL-VYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLAR 749
+ +RL V EY+ G L + R K R A +V + +LH R
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDE-----PRSRFYAAEVTLALMFLH---R 114
Query: 750 QTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKI 809
I+RDLK NILLD + K++DFG+ K + T GT Y+APE +
Sbjct: 115 HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT-FCGTPDYIAPEILQELEY 173
Query: 810 TTKADVFSYGVVLMELLTG 828
D ++ GV++ E++ G
Sbjct: 174 GPSVDWWALGVLMYEMMAG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 3e-11
Identities = 67/254 (26%), Positives = 108/254 (42%), Gaps = 53/254 (20%)
Query: 593 SSGSTNSGATENSHVIESGTLVISVQVLRKVTQNFAQENELGRGGFGTVYKGELEDGTKI 652
SS S++S ++ S S +S L +V N +G G GTVYK ++
Sbjct: 51 SSSSSSSSSSSASGSAPSAAKSLSE--LERV-------NRIGSGAGGTVYKVIHRPTGRL 101
Query: 653 AVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALS- 711
++ G + EI +L V H ++V E ++ E+M G+L
Sbjct: 102 YALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG 161
Query: 712 RHLFRWEKLQLKPLSWTRRLSIALDVAR----GMEYLHCLARQTFIHRDLKSSNILLDDD 767
H+ ++ L DVAR G+ YLH R+ +HRD+K SN+L++
Sbjct: 162 THI--ADEQFLA------------DVARQILSGIAYLH---RRHIVHRDIKPSNLLINSA 204
Query: 768 YRAKVSDFGLVKL---APDGEKSVVTRLAGTFGYLAPEYAVMGKITTK----------AD 814
K++DFG+ ++ D S V GT Y++PE +I T D
Sbjct: 205 KNVKIADFGVSRILAQTMDPCNSSV----GTIAYMSPE-----RINTDLNHGAYDGYAGD 255
Query: 815 VFSYGVVLMELLTG 828
++S GV ++E G
Sbjct: 256 IWSLGVSILEFYLG 269
|
Length = 353 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-11
Identities = 55/195 (28%), Positives = 89/195 (45%), Gaps = 26/195 (13%)
Query: 718 EKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL 777
E L K L+ + + VA+GME+L A + IHRDL + NILL ++ K+ DFGL
Sbjct: 169 EDLYKKVLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGL 225
Query: 778 VK---LAPDGEKSVVTRLAGTFGYLAPEYAVMGKI-TTKADVFSYGVVLMELLTGLAALD 833
+ PD + RL ++APE + ++ T ++DV+S+GV+L E+ + A+
Sbjct: 226 ARDIYKDPDYVRKGDARLP--LKWMAPE-TIFDRVYTIQSDVWSFGVLLWEIFSLGAS-- 280
Query: 834 EERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHR 893
P + E F R + +A E+ + + C EP R
Sbjct: 281 ---PYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD-----------CWHGEPSQR 326
Query: 894 PDMGHVVNVLSPLVE 908
P +V L L++
Sbjct: 327 PTFSELVEHLGNLLQ 341
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-11
Identities = 65/213 (30%), Positives = 95/213 (44%), Gaps = 25/213 (11%)
Query: 633 LGRGGFGTV----YKGELEDGTKIAVKRME-AGVTTTKALDEFQSEIAVLSKVRHRHLVS 687
LG G FG V YK E D +A+KR E + + K +D SE +L+ + H V+
Sbjct: 38 LGTGSFGRVILATYKNE--DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVN 95
Query: 688 LLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCL 747
L G + + LV E++ G L R ++ + A + EYL L
Sbjct: 96 LYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCF-----YAAQIVLIFEYLQSL 150
Query: 748 ARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTR---LAGTFGYLAPEYA 804
++RDLK N+LLD D K++DFG K+ V TR L GT Y+APE
Sbjct: 151 ---NIVYRDLKPENLLLDKDGFIKMTDFGFAKV-------VDTRTYTLCGTPEYIAPEIL 200
Query: 805 VMGKITTKADVFSYGVVLMELLTGLAALDEERP 837
+ AD ++ G+ + E+L G P
Sbjct: 201 LNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233
|
Length = 340 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 4e-11
Identities = 65/217 (29%), Positives = 91/217 (41%), Gaps = 14/217 (6%)
Query: 633 LGRGGFGTV-YKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSL--- 688
LG G GTV + DG AVK ++ + + Q+E+ L +V
Sbjct: 40 LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHED 99
Query: 689 LGYSIEGNERL-----LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEY 743
N LV +Y G L + + K + K R L + +
Sbjct: 100 FAKKDPRNPENVLMIALVLDYANAGDLRQEI----KSRAKTNRTFREHEAGLLFIQVLLA 155
Query: 744 LHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTR-LAGTFGYLAPE 802
+H + + IHRD+KS+NILL + K+ DFG K+ V R GT Y+APE
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215
Query: 803 YAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEE 839
+ KAD+FS GV+L ELLT D E EE
Sbjct: 216 IWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE 252
|
Length = 496 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 5e-11
Identities = 62/214 (28%), Positives = 98/214 (45%), Gaps = 17/214 (7%)
Query: 633 LGRGGFGTVYKGELEDGTKI-AVKRMEAGVTTTK---ALDEFQSEIAVLSKVRHRHLVSL 688
+G+G FG VY+ +D +I A+K + K A + I V + + +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 689 LGYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCL 747
L +S + + L LV +YM G L HL + + + IA ++ +E+LH
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSED----RAKFYIA-ELVLALEHLH-- 113
Query: 748 ARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTR-LAGTFGYLAPEYAVM 806
+ ++RDLK NILLD + DFGL K + + T GT YLAPE +
Sbjct: 114 -KYDIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLLD 170
Query: 807 GKITTK-ADVFSYGVVLMELLTGLAALDEERPEE 839
K TK D +S GV++ E+ G + E ++
Sbjct: 171 EKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ 204
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 68/280 (24%), Positives = 115/280 (41%), Gaps = 51/280 (18%)
Query: 633 LGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALD-------EFQSEIAVLSKVRHRH 684
LG+G F +YKG L V + K L F +++S++ H+H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 685 LVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYL 744
LV L G + +E ++V EY+ G L L R EK + L W +L +A +A + YL
Sbjct: 63 LVKLYGVCVR-DENIMVEEYVKFGPLDVFLHR-EKNNV-SLHW--KLDVAKQLASALHYL 117
Query: 745 HCLARQTFIHRDLKSSNILL---DDDYR----AKVSDFGLVKLAPDGEKSVVTRLAGTFG 797
+ +H ++ NIL+ + K+SD G + + + V R+
Sbjct: 118 E---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG-IPITVLSREERVERIP---- 169
Query: 798 YLAPEYAVMG--KITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKE 855
++APE G +T AD +S+G L+E+ + + E P + +E +
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICS-----NGEEPLSTLSSSE-------KER 217
Query: 856 KFKAA-IDPALEVNEETFESISIVAELAGHCTAREPYHRP 894
++ P + E +A L C +P RP
Sbjct: 218 FYQDQHRLPMPDCAE--------LANLINQCWTYDPTKRP 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 6e-11
Identities = 65/208 (31%), Positives = 91/208 (43%), Gaps = 24/208 (11%)
Query: 632 ELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEI-----AVLSKVRHRHL 685
E+G G G VYK + G +AVK+M T K E I VL ++
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRR--TGNK---EENKRILMDLDVVLKSHDCPYI 76
Query: 686 VSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLH 745
V GY I ++ + E M S L + K P+ + + + + + YL
Sbjct: 77 VKCYGYFITDSDVFICMELM-----STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK 131
Query: 746 CLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEY-- 803
+ IHRD+K SNILLD K+ DFG+ D + TR AG Y+APE
Sbjct: 132 --EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGCAAYMAPERID 187
Query: 804 --AVMGKITTKADVFSYGVVLMELLTGL 829
K +ADV+S G+ L+EL TG
Sbjct: 188 PPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 7e-11
Identities = 56/219 (25%), Positives = 103/219 (47%), Gaps = 22/219 (10%)
Query: 618 QVLRKVTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAV 676
+ + +V + + + +G G +G+V + + G ++AVK++ + E+ +
Sbjct: 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 69
Query: 677 LSKVRHRHLVSLLGYSI------EGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRR 730
L ++H +++ LL E N+ LV M GA ++ + +KL + +
Sbjct: 70 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQF--- 124
Query: 731 LSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVT 790
+ + RG++Y+H IHRDLK SN+ +++D K+ DFGL + D +T
Sbjct: 125 --LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MT 175
Query: 791 RLAGTFGYLAPEYAV-MGKITTKADVFSYGVVLMELLTG 828
T Y APE + D++S G ++ ELLTG
Sbjct: 176 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 7e-11
Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 26/217 (11%)
Query: 622 KVTQNFAQENELGRGGFGTV-YKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV 680
+V + ++G G +GTV + G K+A+K++ + E+ +L +
Sbjct: 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 71
Query: 681 RHRHLVSLLGYSI------EGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIA 734
+H +++ LL ++ LV +M G L + EKL S R +
Sbjct: 72 KHENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKL-----SEDRIQFLV 124
Query: 735 LDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKS--VVTRL 792
+ +G++Y+H IHRDLK N+ +++D K+ DFGL + D E + VVTR
Sbjct: 125 YQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQT-DSEMTGYVVTRW 180
Query: 793 AGTFGYLAPEYAV-MGKITTKADVFSYGVVLMELLTG 828
Y APE + T D++S G ++ E+LTG
Sbjct: 181 -----YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG 212
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 8e-11
Identities = 55/204 (26%), Positives = 96/204 (47%), Gaps = 10/204 (4%)
Query: 625 QNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRH 684
+F + +ELG G G V K + + I +++ ++ E+ VL + +
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 685 LVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYL 744
+V G E + E+M G+L + L +++ P ++SIA V RG+ YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRI---PEEILGKVSIA--VLRGLAYL 119
Query: 745 HCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYA 804
+ +HRD+K SNIL++ K+ DFG+ D S+ GT Y++PE
Sbjct: 120 R--EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRSYMSPERL 174
Query: 805 VMGKITTKADVFSYGVVLMELLTG 828
+ ++D++S G+ L+EL G
Sbjct: 175 QGTHYSVQSDIWSMGLSLVELAIG 198
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 1e-10
Identities = 54/215 (25%), Positives = 94/215 (43%), Gaps = 42/215 (19%)
Query: 633 LGRGGFGTVYKG-ELEDGTKIAVKRM-EAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLG 690
+G G +G V + G K+A+K++ A T A + E+ +L +H +++++
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLR-ELKILRHFKHDNIIAIR- 70
Query: 691 YSI------EGNERLLVYEYMP---H------GALSRHLFRWEKLQLKPLSWTRRLSIAL 735
I + + +V + M H L+ R+ QL
Sbjct: 71 -DILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQL------------- 116
Query: 736 DVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA---PDGEKSVVTRL 792
RG++Y+H IHRDLK SN+L+++D ++ DFG+ + P K +T
Sbjct: 117 --LRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEY 171
Query: 793 AGTFGYLAPEYA-VMGKITTKADVFSYGVVLMELL 826
T Y APE + + TT D++S G + E+L
Sbjct: 172 VATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 56/201 (27%), Positives = 94/201 (46%), Gaps = 12/201 (5%)
Query: 630 ENELGRGGFGTVY-----KGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRH 684
+ LG+G FGTVY K E+ K+ +K + G + E +LSK+ H
Sbjct: 5 QQRLGKGSFGTVYLVKDKKAVAEERLKV-LKEIPVGELNPNETVQANQEAQLLSKLDHPA 63
Query: 685 LVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYL 744
+V +E + ++ EY L L + K LS + + + G+ Y+
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTG-KTLSENQVCEWFIQLLLGVHYM 122
Query: 745 HCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYA 804
H ++ +HRDLK+ NI L ++ K+ DFG+ +L G + T GT Y++PE
Sbjct: 123 H---QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLM-GSCDLATTFTGTPYYMSPEAL 177
Query: 805 VMGKITTKADVFSYGVVLMEL 825
+K+D++S G +L E+
Sbjct: 178 KHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-10
Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 16/206 (7%)
Query: 633 LGRGGFGTVYKGELEDGTKIAVKRM--EAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLG 690
+GRG + V L+ +I ++ + V + +D Q+E V + + + L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 691 YSIEGNERLL-VYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLAR 749
+ RL V EY+ G L H+ R KL P R S + +A + YLH
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKL---PEEHARFYSAEISLA--LNYLH---E 114
Query: 750 QTFIHRDLKSSNILLDDDYRAKVSDFGLVK--LAPDGEKSVVTRLAGTFGYLAPEYAVMG 807
+ I+RDLK N+LLD + K++D+G+ K L P S GT Y+APE
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS---TFCGTPNYIAPEILRGE 171
Query: 808 KITTKADVFSYGVVLMELLTGLAALD 833
D ++ GV++ E++ G + D
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-10
Identities = 58/224 (25%), Positives = 101/224 (45%), Gaps = 36/224 (16%)
Query: 633 LGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKAL-DEFQSEIAVLSKVRHRHLVSLLG 690
+G+GG G VY + ++A+K++ ++ L F E + + + H +V +
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV-- 67
Query: 691 YSIEGNERLLVYEYMPH--GALSRHLFR--WEKLQL-KPL----SWTRRLSIALDVARGM 741
YSI ++ VY MP+ G + L + W+K L K L S LSI + +
Sbjct: 68 YSIC-SDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATI 126
Query: 742 EYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEK--------------- 786
EY+H + +HRDLK NILL + D+G + E+
Sbjct: 127 EYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAA-IFKKLEEEDLLDIDVDERNICY 182
Query: 787 ---SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT 827
++ ++ GT Y+APE + + D+++ GV+L ++LT
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 2e-10
Identities = 49/212 (23%), Positives = 89/212 (41%), Gaps = 25/212 (11%)
Query: 632 ELGR----GGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVS 687
+G+ + K + T +AVK++ + + L Q EI +++H +++
Sbjct: 5 LIGKCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 688 LLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIAL---DVARGMEYL 744
+ I +E +V M +G+ L L L+IA DV ++Y+
Sbjct: 64 YVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP------ELAIAFILKDVLNALDYI 117
Query: 745 HCLARQTFIHRDLKSSNILLDDDYRAKVSDF-GLVKLAPDGEKSVVTRLAGTFG-----Y 798
H + FIHR +K+S+ILL D + +S V + G++ V +
Sbjct: 118 H---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPW 174
Query: 799 LAPE--YAVMGKITTKADVFSYGVVLMELLTG 828
L+PE + K+D++S G+ EL G
Sbjct: 175 LSPEVLQQNLQGYNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 2e-10
Identities = 68/245 (27%), Positives = 117/245 (47%), Gaps = 28/245 (11%)
Query: 625 QNFAQENELGRGGFGTVYKGELEDGTKI-AVKRMEAGVTTTKALDE-FQSEIAVLSKVRH 682
++F +GRG FG V +L++ K+ A+K + +A F+ E VL +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 683 RHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLS--WTRRLSIALDVARG 740
+ + +L + N LV +Y G L L ++E + ++ + + IA+D
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 741 MEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFG-LVKLAPDGEKSVVTRLA-GTFGY 798
+ Y +HRD+K NIL+D + +++DFG +KL DG +V + +A GT Y
Sbjct: 121 LHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG--TVQSSVAVGTPDY 169
Query: 799 LAPEYAVM-----GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSS 853
++PE GK + D +S GV + E+L G E P + L E + +I +
Sbjct: 170 ISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG------ETPFYAESLVETYGKIMNH 223
Query: 854 KEKFK 858
KE+F+
Sbjct: 224 KERFQ 228
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 64/244 (26%), Positives = 112/244 (45%), Gaps = 27/244 (11%)
Query: 615 ISVQVLRKVTQNFAQENELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSE 673
I + LR F +G G +G VYKG ++ G A+K M+ T +E + E
Sbjct: 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTEDEEEEIKLE 62
Query: 674 IAVLSKV-RHRHLVSLLGYSIE------GNERLLVYEYMPHGALSRHLFRWEKLQLKPLS 726
I +L K HR++ + G I+ ++ LV E+ G+++ + + LK
Sbjct: 63 INMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKE-D 121
Query: 727 WTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEK 786
W I ++ RG+ +LH IHRD+K N+LL ++ K+ DFG ++ ++
Sbjct: 122 WIA--YICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFG---VSAQLDR 173
Query: 787 SVVTR--LAGTFGYLAPEYAVM-----GKITTKADVFSYGVVLMELLTGLAALDEERPEE 839
+V R GT ++APE ++D++S G+ +E+ G L + P
Sbjct: 174 TVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR 233
Query: 840 SRYL 843
+ +L
Sbjct: 234 ALFL 237
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 3e-10
Identities = 59/217 (27%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 622 KVTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV 680
+V + + +G G +G+V + K+AVK++ + E+ +L +
Sbjct: 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHM 71
Query: 681 RHRHLVSLL-----GYSIEG-NERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIA 734
+H +++ LL SIE NE LV M GA ++ + +KL + + + +
Sbjct: 72 KHENVIGLLDVFTPATSIENFNEVYLVTNLM--GADLNNIVKCQKLSDEHVQF-----LI 124
Query: 735 LDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAG 794
+ RG++Y+H IHRDLK SN+ +++D ++ DFGL + A D +T
Sbjct: 125 YQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDE----MTGYVA 177
Query: 795 TFGYLAPEYAV-MGKITTKADVFSYGVVLMELLTGLA 830
T Y APE + D++S G ++ ELL G A
Sbjct: 178 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKA 214
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-10
Identities = 53/203 (26%), Positives = 97/203 (47%), Gaps = 10/203 (4%)
Query: 626 NFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHL 685
+F + +ELG G G V+K + I +++ ++ E+ VL + ++
Sbjct: 6 DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65
Query: 686 VSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLH 745
V G E + E+M G+L + L + ++ + L ++SIA V +G+ YL
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG---KVSIA--VIKGLTYLR 120
Query: 746 CLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAV 805
+ +HRD+K SNIL++ K+ DFG+ D S+ GT Y++PE
Sbjct: 121 --EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRSYMSPERLQ 175
Query: 806 MGKITTKADVFSYGVVLMELLTG 828
+ ++D++S G+ L+E+ G
Sbjct: 176 GTHYSVQSDIWSMGLSLVEMAIG 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-10
Identities = 65/256 (25%), Positives = 111/256 (43%), Gaps = 29/256 (11%)
Query: 625 QNFAQENELGRGGFGTVY-KGELEDGTKIAVKRMEAGVTTTK-ALDEFQSEIAVLSKVRH 682
++F ++ +GRG FG V E G A+K M+ V + + F+ E +LS
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 683 RHLVSLLGYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGM 741
+ L Y+ + + L LV EY P G L L R+E + + +A +
Sbjct: 61 PWIPQLQ-YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDM-------AQFYLAELV 112
Query: 742 EYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRL-AGTFGYLA 800
+H + + ++HRD+K N+L+D K++DFG K V ++L GT Y+A
Sbjct: 113 LAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAA-RLTANKMVNSKLPVGTPDYIA 171
Query: 801 PEYAVMGKITT--------KADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKS 852
PE V+ + + D +S GV+ E++ G P A+ + I +
Sbjct: 172 PE--VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYG------RSPFHEGTSAKTYNNIMN 223
Query: 853 SKEKFKAAIDPALEVN 868
+ K DP + +
Sbjct: 224 FQRFLKFPEDPKVSSD 239
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 4e-10
Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 19/220 (8%)
Query: 617 VQVLRKVTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDE--FQSEI 674
++ LR +++ +GRG FG V + K+ ++ + K D F E
Sbjct: 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 675 AVLSKVRHRHLVSLLGYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSI 733
+++ +V L Y+ + + L +V EYMP G L + ++ P W R +
Sbjct: 95 DIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDV----PEKWARFYTA 149
Query: 734 ALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL-VKLAPDGEKSVVTRL 792
+V ++ +H + FIHRD+K N+LLD K++DFG +K+ +G T +
Sbjct: 150 --EVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 204
Query: 793 AGTFGYLAPEYAVM----GKITTKADVFSYGVVLMELLTG 828
GT Y++PE G + D +S GV L E+L G
Sbjct: 205 -GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 4e-10
Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 20/217 (9%)
Query: 633 LGRGGFGTVYKGELEDGTKI-AVKRME-AGVTTTKALDEFQSEIAVLSKVRHRHLVSLLG 690
+GRG + V EL+ +I A+K ++ V + +D Q+E V + + L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 691 YSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLAR 749
+ RL V E++ G L H+ R KL P R S + +A L+ L
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQRQRKL---PEEHARFYSAEISLA-----LNFLHE 114
Query: 750 QTFIHRDLKSSNILLDDDYRAKVSDFGLVK--LAPDGEKSVVTRLAGTFGYLAPEYAVMG 807
+ I+RDLK N+LLD + K++D+G+ K + P S GT Y+APE
Sbjct: 115 RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST---FCGTPNYIAPEILRGE 171
Query: 808 KITTKADVFSYGVVLMELLTGLAALD----EERPEES 840
D ++ GV++ E++ G + D + P+++
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN 208
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 16/206 (7%)
Query: 633 LGRGGFGTVYKGELEDGTKIAVKRM--EAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLG 690
+GRG + V L+ +I ++ + V + +D Q+E V + + L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 691 YSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLAR 749
+ RL LV EY+ G L H+ R KL P R + + +A + +LH
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKL---PEEHARFYAAEICIA--LNFLH---E 114
Query: 750 QTFIHRDLKSSNILLDDDYRAKVSDFGLVK--LAPDGEKSVVTRLAGTFGYLAPEYAVMG 807
+ I+RDLK N+LLD D K++D+G+ K L P S GT Y+APE
Sbjct: 115 RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST---FCGTPNYIAPEILRGE 171
Query: 808 KITTKADVFSYGVVLMELLTGLAALD 833
+ D ++ GV++ E++ G + D
Sbjct: 172 EYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 4e-10
Identities = 60/223 (26%), Positives = 105/223 (47%), Gaps = 39/223 (17%)
Query: 622 KVTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEI------ 674
++ + + ++G G +G+V + G K+A+K++ FQSEI
Sbjct: 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSR---------PFQSEIFAKRAY 62
Query: 675 ---AVLSKVRHRHLVSLLGY---SIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWT 728
+L ++H +++ LL ++ G+E Y MP+ +K+ PLS
Sbjct: 63 RELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD-----LQKIMGHPLSED 117
Query: 729 RRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKS- 787
+ + + G++Y+H IHRDLK N+ +++D K+ DFGL + A D E +
Sbjct: 118 KVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHA-DAEMTG 173
Query: 788 -VVTRLAGTFGYLAPEYAVMGKITTKA-DVFSYGVVLMELLTG 828
VVTR Y APE + + D++S G ++ E+LTG
Sbjct: 174 YVVTRW-----YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTG 211
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 5e-10
Identities = 58/221 (26%), Positives = 97/221 (43%), Gaps = 25/221 (11%)
Query: 632 ELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLL 689
+G G +G VYK + G +A+K M+ +E + E +L K H ++ +
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDI---IEDEEEEIKEEYNILRKYSNHPNIATFY 69
Query: 690 G------YSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEY 743
G ++ LV E G+++ L + + + K L I + RG+ Y
Sbjct: 70 GAFIKKNPPGNDDQLWLVMELCGGGSVTD-LVKGLRKKGKRLKEEWIAYILRETLRGLAY 128
Query: 744 LHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTR--LAGTFGYLAP 801
LH IHRD+K NILL + K+ DFG ++ + ++ R GT ++AP
Sbjct: 129 LH---ENKVIHRDIKGQNILLTKNAEVKLVDFG---VSAQLDSTLGRRNTFIGTPYWMAP 182
Query: 802 EY-AVMGK----ITTKADVFSYGVVLMELLTGLAALDEERP 837
E A + ++DV+S G+ +EL G L + P
Sbjct: 183 EVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP 223
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 9e-10
Identities = 62/251 (24%), Positives = 109/251 (43%), Gaps = 39/251 (15%)
Query: 593 SSGSTNSGATENSHVIESGTLVISVQVLRKVTQNFAQENELGRGGFGTVYKGE-LEDGTK 651
S + + +I++ + R +++ N +G G FG VY+ ++ K
Sbjct: 41 SHNNNAGEDEDEEKMIDN-------DINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEK 93
Query: 652 IAVKRMEAGVTTTKALDEFQ---SEIAVLSKVRHRHLVSLLGY----SIEGNERLL---- 700
+A+K K L + Q E+ ++ + H +++ L Y + NE+ +
Sbjct: 94 VAIK---------KVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV 144
Query: 701 VYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFI-HRDLKS 759
V E++P PL + S L R + Y+H FI HRDLK
Sbjct: 145 VMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQL--CRALAYIH----SKFICHRDLKP 198
Query: 760 SNILLD-DDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMG-KITTKADVFS 817
N+L+D + + K+ DFG K G++S V+ + F Y APE + TT D++S
Sbjct: 199 QNLLIDPNTHTLKLCDFGSAKNLLAGQRS-VSYICSRF-YRAPELMLGATNYTTHIDLWS 256
Query: 818 YGVVLMELLTG 828
G ++ E++ G
Sbjct: 257 LGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 1e-09
Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 21/204 (10%)
Query: 631 NELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQS--EIAVLSKVR-HRHLV 686
++G G F V K + G A+K M+ K+L++ + EI L ++ H +++
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKK---HFKSLEQVNNLREIQALRRLSPHPNIL 61
Query: 687 SLLG--YSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYL 744
L+ + + LV+E M +L+ K + +PL R S + + ++++
Sbjct: 62 RLIEVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHM 116
Query: 745 HCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPE-Y 803
H R HRD+K NIL+ DD K++DFG + K T T Y APE
Sbjct: 117 H---RNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYS--KPPYTEYISTRWYRAPECL 170
Query: 804 AVMGKITTKADVFSYGVVLMELLT 827
G K D+++ G V E+L+
Sbjct: 171 LTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 1e-09
Identities = 65/237 (27%), Positives = 101/237 (42%), Gaps = 45/237 (18%)
Query: 613 LVISVQVLRKVTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQ- 671
+ LR ++F +GRG FG V ++ + V K L +F+
Sbjct: 31 AAEKITKLRMKAEDFDVIKVIGRGAFGEV---------QLVRHKSSKQVYAMKLLSKFEM 81
Query: 672 ---SEIAVLSKVRH------RHLVSLLGYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQ 721
S+ A + R + L Y+ + ++ L +V EYMP G L + ++
Sbjct: 82 IKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDI-- 139
Query: 722 LKPLSWTR----RLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL 777
P W R + +ALD +H + FIHRD+K N+LLD K++DFG
Sbjct: 140 --PEKWARFYTAEVVLALDA------IHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 188
Query: 778 -VKLAPDGEKSVVTRLA-GTFGYLAPEY----AVMGKITTKADVFSYGVVLMELLTG 828
+K+ +G V A GT Y++PE G + D +S GV L E+L G
Sbjct: 189 CMKMDANGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 64/246 (26%), Positives = 116/246 (47%), Gaps = 46/246 (18%)
Query: 633 LGRGGFGTVYKGELEDGTKIAVKRMEAG--VTTTKALDEFQ----SEIAVLSKVRHR--- 683
+GRG FG V AV +M+ + K L++++ +E A + R+
Sbjct: 9 IGRGAFGEV-----------AVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVN 57
Query: 684 ---HLVSLLGYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVAR 739
++ L Y+ + L LV +Y G L L ++E + ++ +A
Sbjct: 58 GDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMA-------RFYIAE 110
Query: 740 GMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFG-LVKLAPDGEKSVVTRLA-GTFG 797
+ +H + + ++HRD+K N+LLD + +++DFG +K+ DG +V + +A GT
Sbjct: 111 MVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG--TVQSSVAVGTPD 168
Query: 798 YLAPEYAV-----MGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKS 852
Y++PE MGK + D +S GV + E+L G E P + L E + +I +
Sbjct: 169 YISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG------ETPFYAESLVETYGKIMN 222
Query: 853 SKEKFK 858
+E+F+
Sbjct: 223 HEERFQ 228
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 25/210 (11%)
Query: 631 NELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLL 689
+ELG+G +G+VYK G +A+K + + +K ++ E+ +L K ++V
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK-FNQIIMELDILHKAVSPYIVDFY 65
Query: 690 G-YSIEGNERLLVY---EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLH 745
G + IEG VY EYM G+L + + P RR I V +G L
Sbjct: 66 GAFFIEGA----VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRR--ITYAVVKG---LK 116
Query: 746 CLARQ-TFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEY- 803
L + IHRD+K +N+L++ + + K+ DFG ++ + S+ G Y+APE
Sbjct: 117 FLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFG---VSGNLVASLAKTNIGCQSYMAPERI 173
Query: 804 -----AVMGKITTKADVFSYGVVLMELLTG 828
T ++DV+S G+ ++E+ G
Sbjct: 174 KSGGPNQNPTYTVQSDVWSLGLSILEMALG 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 67/246 (27%), Positives = 110/246 (44%), Gaps = 47/246 (19%)
Query: 665 KALDEFQSEIAV--------LSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFR 716
K LD +IA+ +S+V H HL + G + G+E ++V E++ HG L R
Sbjct: 50 KVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDV-CLR 108
Query: 717 WEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRA------ 770
EK ++ P++W ++++A +A + YL + +H ++ + NILL A
Sbjct: 109 KEKGRV-PVAW--KITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPF 162
Query: 771 -KVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPE-YAVMGKITTKADVFSYGVVLMELLTG 828
K+SD G V + V R+ ++APE ++T AD +S+G L+E+
Sbjct: 163 IKLSDPG-VSFTALSREERVERIP----WIAPECVPGGNSLSTAADKWSFGTTLLEI--- 214
Query: 829 LAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAR 888
D E P + R +E KE+F + + E S +A L C
Sbjct: 215 --CFDGEVPLKERTPSE--------KERF---YEKKHRLPE---PSCKELATLISQCLTY 258
Query: 889 EPYHRP 894
EP RP
Sbjct: 259 EPTQRP 264
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 59/212 (27%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 632 ELGRGGFGTVYKG---ELEDGTKIAVKRM----EAGVTTTKALDEFQSEIAVLSKVR-HR 683
ELG+G +G V E + +A+K++ + +AL E+ +L R H+
Sbjct: 7 ELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL----RELKLLRHFRGHK 62
Query: 684 HLVSLLGYSI---EGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARG 740
++ L I L +YE + L + + R + PL+ S + G
Sbjct: 63 NITCLYDMDIVFPGNFNELYLYEELMEADLHQ-IIRSGQ----PLTDAHFQSFIYQILCG 117
Query: 741 MEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK---LAPDGEKSVVTRLAGTFG 797
++Y+H +HRDLK N+L++ D K+ DFGL + P +T T
Sbjct: 118 LKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRW 174
Query: 798 YLAPEYAVMGKITTKA-DVFSYGVVLMELLTG 828
Y APE + + TKA DV+S G +L ELL
Sbjct: 175 YRAPEIMLSFQSYTKAIDVWSVGCILAELLGR 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 2e-09
Identities = 64/254 (25%), Positives = 108/254 (42%), Gaps = 61/254 (24%)
Query: 633 LGRGGFGTVYKGELEDGTKI-AVKRMEAGVTTTKALDEFQ-----SEIAVLSKVRHRHLV 686
+GRG FG V + +D I A+K++ ++ L++ Q +E +L++ + +V
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKKLR----KSEMLEKEQVAHVRAERDILAEADNPWVV 64
Query: 687 SLLGYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLH 745
L YS + L L+ EY+P G + L + + + R IA + ++ +H
Sbjct: 65 KLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEE----ETRFYIA-ETILAIDSIH 118
Query: 746 CLARQTFIHRDLKSSNILLDDDYRAKVSDFGL----------------VKLAPDGEKSVV 789
L +IHRD+K N+LLD K+SDFGL P +
Sbjct: 119 KLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFI 175
Query: 790 TR-----------------LA----GTFGYLAPEYAVMGKI--TTKADVFSYGVVLMELL 826
++ LA GT Y+APE V + + D +S GV++ E+L
Sbjct: 176 SKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPE--VFLQTGYNKECDWWSLGVIMYEML 233
Query: 827 TGLAALDEERPEES 840
G + P+E+
Sbjct: 234 VGYPPFCSDNPQET 247
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 68/260 (26%), Positives = 107/260 (41%), Gaps = 54/260 (20%)
Query: 627 FAQENELGRGGFGTVYKGELEDGTKI-AVKRME-AGVTTTKALDEFQSEIAVLSKVRHRH 684
F + +G G FG V D + A+K + A V ++E +L++ +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 685 LVSLLGYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEY 743
+V L YS + + L V +Y+P G + L R + + L+ R IA ++ +E
Sbjct: 63 VVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFE-EDLA---RFYIA-ELTCAIES 116
Query: 744 LHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLV---------------------KLAP 782
+H + FIHRD+K NIL+D D K++DFGL + P
Sbjct: 117 VH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEP 173
Query: 783 DGE---------KSVVTR------------LAGTFGYLAPEYAVMGKITTKADVFSYGVV 821
E K + R L GT Y+APE + T D +S GV+
Sbjct: 174 SEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233
Query: 822 LMELLTGLAALDEERPEESR 841
L E+L G + P E++
Sbjct: 234 LYEMLVGQPPFLADTPAETQ 253
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 20/214 (9%)
Query: 633 LGRGGFGTVYKGELEDGTKI-AVKRMEAGVTTTKALDEFQS---EIAVLSKVRHRHLVSL 688
LG+G FG V E + ++ A+K ++ V D+ + E VL+ ++
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQD--DDVECTMVEKRVLALSGKPPFLTQ 65
Query: 689 LGYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCL 747
L + +RL V EY+ G L + Q+ + A ++A G+ +LH
Sbjct: 66 LHSCFQTMDRLYFVMEYVNGGDLMYQI-----QQVGRFKEPHAVFYAAEIAIGLFFLH-- 118
Query: 748 ARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP-DGEKSVVTR-LAGTFGYLAPEYAV 805
+ I+RDLK N++LD + K++DFG+ K DG V T+ GT Y+APE
Sbjct: 119 -SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG---VTTKTFCGTPDYIAPEIIA 174
Query: 806 MGKITTKADVFSYGVVLMELLTGLAALDEERPEE 839
D +++GV+L E+L G A + E +E
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 67/260 (25%), Positives = 121/260 (46%), Gaps = 42/260 (16%)
Query: 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRM----EAGVTTTKALDEFQSEIAVLSK 679
+ + + ++LG G + TV+KG + +A+K + E G T E+++L
Sbjct: 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-----REVSLLKN 59
Query: 680 VRHRHLVSLLGYSIEGNER--LLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDV 737
++H ++V+L + I ER LV+EY+ L ++L L +S +
Sbjct: 60 LKHANIVTL--HDIIHTERCLTLVFEYL-DSDLKQYLDNCGNL----MSMHNVKIFMFQL 112
Query: 738 ARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAG--- 794
RG+ Y H ++ +HRDLK N+L+++ K++DFGL + KSV T+
Sbjct: 113 LRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLAR-----AKSVPTKTYSNEV 164
Query: 795 -TFGYLAPEYAVMG--KITTKADVFSYGVVLMELLTGLAALDEERPEESRYL-------- 843
T Y P+ ++G + +T D++ G +L E+ TG +E +L
Sbjct: 165 VTLWYRPPD-VLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTP 223
Query: 844 AEWFWRIKSSKEKFKAAIDP 863
E W +S E+F++ + P
Sbjct: 224 TEETWPGITSNEEFRSYLFP 243
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 61/219 (27%), Positives = 99/219 (45%), Gaps = 42/219 (19%)
Query: 632 ELGRGGFGTVYKGELEDGTKIA---VKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSL 688
E+G G FG V E+ T +A VK ++A ++K +EF + ++H +++
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKAN-ASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 689 LGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLS-------IALDVARGM 741
LG +E LLV+EY G L +L + + W RR S +A ++A G+
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQ--------WHRRNSQLLLLQRMACEIAAGV 112
Query: 742 EYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL-------VKLAPDGEKSVVTRLAG 794
++H + F+H DL N L D KV D+G+ + + +K V R
Sbjct: 113 THMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR--- 166
Query: 795 TFGYLAPEY--AVMGKI-----TTKADVFSYGVVLMELL 826
+LAPE G + T ++V++ GV L EL
Sbjct: 167 ---WLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 4e-09
Identities = 53/202 (26%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 633 LGRGGFGTV-YKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGY 691
+G+G +G V DG + +K++ + + + E +LS+++H ++V+
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY-RE 66
Query: 692 SIEGNERLL--VYEYMPHGALSRHLFRWEKLQLKP----LSWTRRLSIALDVARGMEYLH 745
S EG + LL V + G L L + +K +L P + W ++++AL +YLH
Sbjct: 67 SWEGEDGLLYIVMGFCEGGDLYHKL-KEQKGKLLPENQVVEWFVQIAMAL------QYLH 119
Query: 746 CLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAV 805
+ +HRDLK+ N+ L KV D G+ ++ + + + + L GT Y++PE
Sbjct: 120 ---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVL-ENQCDMASTLIGTPYYMSPELFS 175
Query: 806 MGKITTKADVFSYGVVLMELLT 827
K+DV++ G + E+ T
Sbjct: 176 NKPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 41/151 (27%), Positives = 68/151 (45%), Gaps = 20/151 (13%)
Query: 684 HLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKL---QLKPLSWTRRLSIALDVARG 740
++V L Y + + LV ++ G L H+ ++ + +K W + +ALD
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVK--RWAAEMVVALDA--- 100
Query: 741 MEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFG-LVKLAPDGEKSVVTRLAGTFGYL 799
LH R+ + RDL +NILLDD +++ F ++ + V + Y
Sbjct: 101 ---LH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YC 149
Query: 800 APEYAVMGKITTKADVFSYGVVLMELLTGLA 830
APE + + T D +S G +L ELLTG
Sbjct: 150 APEVGGISEETEACDWWSLGAILFELLTGKT 180
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 4e-09
Identities = 38/107 (35%), Positives = 58/107 (54%), Gaps = 8/107 (7%)
Query: 724 PLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783
PL L + VA+GM++L A + IHRD+ + N+LL D AK+ DFGL + +
Sbjct: 208 PLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264
Query: 784 GEKSVV---TRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT 827
VV RL ++APE T ++DV+SYG++L E+ +
Sbjct: 265 DSNYVVKGNARLP--VKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 5e-09
Identities = 38/106 (35%), Positives = 55/106 (51%), Gaps = 21/106 (19%)
Query: 733 IALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLV-KLAPDGEKSVV-T 790
IA+ + + YL + IHRD+K SNILLD + K+ DFG+ +L S+ T
Sbjct: 112 IAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQL----VDSIAKT 165
Query: 791 RLAGTFGYLAPEYAVMGKITT--------KADVFSYGVVLMELLTG 828
R AG Y+APE +I ++DV+S G+ L E+ TG
Sbjct: 166 RDAGCRPYMAPE-----RIDPSARDGYDVRSDVWSLGITLYEVATG 206
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 5e-09
Identities = 61/215 (28%), Positives = 109/215 (50%), Gaps = 24/215 (11%)
Query: 626 NFAQENELGRGGFGTVYKGELE-DGTKIAVK----RMEAGVTTTKALDEFQSEIAVLSKV 680
++ + +LG G + TVYKG+ + +G +A+K + E G T E ++L +
Sbjct: 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI-----REASLLKGL 60
Query: 681 RHRHLVSLLGYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVAR 739
+H ++V LL I E L LV+EY+ H L +++ + L P + L + R
Sbjct: 61 KHANIV-LLHDIIHTKETLTLVFEYV-HTDLCQYMDK-HPGGLHPENVKLFL---FQLLR 114
Query: 740 GMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYL 799
G+ Y+H ++ +HRDLK N+L+ D K++DFGL + A + T Y
Sbjct: 115 GLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYR 170
Query: 800 APEYAVMG--KITTKADVFSYGVVLMELLTGLAAL 832
P+ ++G + +T D++ G + +E++ G+AA
Sbjct: 171 PPD-VLLGSTEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 5e-09
Identities = 37/100 (37%), Positives = 54/100 (54%), Gaps = 8/100 (8%)
Query: 731 LSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVV- 789
LS + VA+GM +L A + IHRDL + NILL K+ DFGL + + VV
Sbjct: 217 LSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVK 273
Query: 790 --TRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT 827
RL ++APE T ++DV+SYG++L E+ +
Sbjct: 274 GNARLP--VKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 66/257 (25%), Positives = 117/257 (45%), Gaps = 44/257 (17%)
Query: 625 QNFAQENELGRGGFGTVYKG--ELEDGTKIAVKRM----EAGVTTTKALDEFQSEIAVLS 678
+ + + ++LG G + TVYKG +L D +A+K + E G T E+++L
Sbjct: 6 ETYIKLDKLGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAI-----REVSLLK 59
Query: 679 KVRHRHLVSLLGYSIEGNER--LLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALD 736
++H ++V+L + I E+ LV+EY L + L ++ ++
Sbjct: 60 DLKHANIVTL--HDIIHTEKSLTLVFEY-----LDKDLKQYLDDCGNSINMHNVKLFLFQ 112
Query: 737 VARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAG-- 794
+ RG+ Y H R+ +HRDLK N+L+++ K++DFGL + KS+ T+
Sbjct: 113 LLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLAR-----AKSIPTKTYSNE 164
Query: 795 --TFGYLAPEYAVMGKI--TTKADVFSYGVVLMELLTGLAALDEERPEESRYL------- 843
T Y P+ ++G +T+ D++ G + E+ TG EE +
Sbjct: 165 VVTLWYRPPD-ILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGT 223
Query: 844 -AEWFWRIKSSKEKFKA 859
E W S E+FK+
Sbjct: 224 PTEETWPGILSNEEFKS 240
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 53/212 (25%), Positives = 100/212 (47%), Gaps = 19/212 (8%)
Query: 625 QNFAQENELGRGGFGTVYKG-ELEDGTK-IAVKRMEAGVTTTKALDEFQSEIAVLSKVR- 681
Q + E+G G +G V+K +L++G + +A+KR+ E+AVL +
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 60
Query: 682 --HRHLVSLLGY-SIEGNER----LLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIA 734
H ++V L ++ +R LV+E++ L+ +L + + + + +
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIK---DMM 116
Query: 735 LDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAG 794
+ RG+++LH +HRDLK NIL+ + K++DFGL ++ + +T +
Sbjct: 117 FQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVV 171
Query: 795 TFGYLAPEYAVMGKITTKADVFSYGVVLMELL 826
T Y APE + T D++S G + E+
Sbjct: 172 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 7e-09
Identities = 66/244 (27%), Positives = 113/244 (46%), Gaps = 44/244 (18%)
Query: 633 LGRGGFGTVYKGELEDGTKI----------AVKRMEAGVTTTKALDEFQSEIAVLSKVRH 682
+GRG FG V ++++ ++ +KR E F+ E VL
Sbjct: 9 IGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETAC--------FREERDVLVN-GD 59
Query: 683 RHLVSLLGYSIEGNERL-LVYEYMPHGALSRHLFRWE-KLQLKPLSWTRRLSIALDVARG 740
R ++ L Y+ + L LV +Y G L L ++E +L P R +A
Sbjct: 60 RRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRL---PEDMAR-----FYLAEM 111
Query: 741 MEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFG-LVKLAPDGEKSVVTRLA-GTFGY 798
+ + + + ++HRD+K N+LLD + +++DFG ++L DG +V + +A GT Y
Sbjct: 112 VLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG--TVQSNVAVGTPDY 169
Query: 799 LAPEY--AV---MGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSS 853
++PE A+ G+ + D +S GV + E+L G E P + L E + +I +
Sbjct: 170 ISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG------ETPFYAESLVETYGKIMNH 223
Query: 854 KEKF 857
KE F
Sbjct: 224 KEHF 227
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 8e-09
Identities = 50/207 (24%), Positives = 95/207 (45%), Gaps = 21/207 (10%)
Query: 626 NFAQENELGRGGFGTVYKG-ELEDGTKIAVKRM-----EAGVTTTKALDEFQSEIAVLSK 679
+ + ++G G +GTV+K E +A+KR+ + GV ++ AL EI +L +
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSS-AL----REICLLKE 55
Query: 680 VRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVAR 739
++H+++V L + LV+EY L ++ + + S + +
Sbjct: 56 LKHKNIVRLYDVLHSDKKLTLVFEYCDQD-LKKYF---DSCNGDIDPEIVK-SFMFQLLK 110
Query: 740 GMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYL 799
G+ + H +HRDLK N+L++ + K++DFGL + + + T Y
Sbjct: 111 GLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYR 166
Query: 800 APEYAVMGKI-TTKADVFSYGVVLMEL 825
P+ K+ +T D++S G + EL
Sbjct: 167 PPDVLFGAKLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-08
Identities = 50/158 (31%), Positives = 76/158 (48%), Gaps = 5/158 (3%)
Query: 671 QSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRR 730
+SE+ L+ H +V ++ LL+ EY G L++ + K +LK +
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI----KQRLKEHLPFQE 168
Query: 731 LSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG-EKSVV 789
+ L + + L + + +HRDLKS+NI L K+ DFG K D V
Sbjct: 169 YEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVA 228
Query: 790 TRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT 827
+ GT YLAPE + + KAD++S GV+L ELLT
Sbjct: 229 SSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 55/202 (27%), Positives = 102/202 (50%), Gaps = 21/202 (10%)
Query: 633 LGRGGFGT--VYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLG 690
+G G FG + + D K A+K + +++ A+++ + E +L+K++H ++V+
Sbjct: 8 VGEGSFGRALLVQHVNSD-QKYAMKEIRLPKSSS-AVEDSRKEAVLLAKMKHPNIVAF-K 64
Query: 691 YSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKP----LSWTRRLSIALDVARGMEYLH 745
S E + L +V EY G L + + + ++ +L P L W ++ + G++++H
Sbjct: 65 ESFEADGHLYIVMEYCDGGDLMQKI-KLQRGKLFPEDTILQWFVQMCL------GVQHIH 117
Query: 746 CLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAV 805
+ +HRD+KS NI L + + K+ DFG +L T + GT Y+ PE
Sbjct: 118 ---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWE 173
Query: 806 MGKITTKADVFSYGVVLMELLT 827
K+D++S G +L EL T
Sbjct: 174 NMPYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 63/254 (24%), Positives = 114/254 (44%), Gaps = 40/254 (15%)
Query: 625 QNFAQENELGRGGFGTVYKG--ELEDGTKIAVKRM----EAGVTTTKALDEFQSEIAVLS 678
+ + + +LG G + TV+KG +L + +A+K + E G T E+++L
Sbjct: 6 ETYIKLEKLGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAI-----REVSLLK 59
Query: 679 KVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVA 738
++H ++V+L LV+EY L + L ++ +S +
Sbjct: 60 DLKHANIVTLHDIVHTDKSLTLVFEY-----LDKDLKQYMDDCGNIMSMHNVKIFLYQIL 114
Query: 739 RGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAG---- 794
RG+ Y H R+ +HRDLK N+L+++ K++DFGL + KSV T+
Sbjct: 115 RGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLAR-----AKSVPTKTYSNEVV 166
Query: 795 TFGYLAPEYAVMG--KITTKADVFSYGVVLMELLTGLAALDEERPEESRYL--------A 844
T Y P+ ++G + +T+ D++ G + E+ +G E+ +L
Sbjct: 167 TLWYRPPD-VLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPT 225
Query: 845 EWFWRIKSSKEKFK 858
E W SS ++FK
Sbjct: 226 EETWPGISSNDEFK 239
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 2e-08
Identities = 35/94 (37%), Positives = 50/94 (53%), Gaps = 13/94 (13%)
Query: 739 RGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGE----KSVVTRLAG 794
RG++Y+H +HRDLK SN+LL+ + K+ DFGL + + + VVTR
Sbjct: 119 RGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRW-- 173
Query: 795 TFGYLAPEYAVM-GKITTKADVFSYGVVLMELLT 827
Y APE + + TT DV+S G + ELL
Sbjct: 174 ---YRAPELLLNCSEYTTAIDVWSVGCIFAELLG 204
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-08
Identities = 34/94 (36%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 739 RGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA-PDGEKSVV-TRLAGTF 796
R ++Y+H HRDLK NIL + D + K+ DFGL ++A D ++ T T
Sbjct: 114 RALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 797 GYLAPEY--AVMGKITTKADVFSYGVVLMELLTG 828
Y APE + K T D++S G + E+LTG
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG 204
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 2e-08
Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 6/92 (6%)
Query: 739 RGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGY 798
RG++YLH A +HRD+K N+L++ + K+ DFGL ++ E +T+ T Y
Sbjct: 114 RGLKYLHS-AG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYY 170
Query: 799 LAPEYAVMG--KITTKADVFSYGVVLMELLTG 828
APE +MG T+ D++S G + ELL
Sbjct: 171 RAPEI-LMGSRHYTSAVDIWSVGCIFAELLGR 201
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 57/216 (26%), Positives = 99/216 (45%), Gaps = 35/216 (16%)
Query: 627 FAQENELGRGGFGTVYKG------ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV 680
+ + ++G G +G VYK E KI +++ + GV +T EI++L ++
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAI-----REISLLKEM 58
Query: 681 RHRHLVSLLGYSIEGNER--LLVYEYMPHGALSRHL-----FRWEKLQLKPLSWTRRLSI 733
+H ++V L + +E+ LV+EY+ L +H+ F +K +
Sbjct: 59 QHGNIVRL--QDVVHSEKRLYLVFEYLDLD-LKKHMDSSPDFAKNPRLIKTYLY------ 109
Query: 734 ALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRA-KVSDFGLVKLAPDGEKSVVTRL 792
+ RG+ Y H +HRDLK N+L+D A K++DFGL + A T
Sbjct: 110 --QILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLAR-AFGIPVRTFTHE 163
Query: 793 AGTFGYLAPEYAVMGK-ITTKADVFSYGVVLMELLT 827
T Y APE + + +T D++S G + E++
Sbjct: 164 VVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-08
Identities = 64/260 (24%), Positives = 110/260 (42%), Gaps = 47/260 (18%)
Query: 625 QNFAQENELGRGGFGTVYKGELED-GTKIAVKRM-EAGVTTTKALDEFQSEIAVLSKVRH 682
++F +GRG FG V + +D G A+K + +A + + + ++E +L +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 683 RHLVSLLGYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGM 741
+V + YS + L L+ E++P G + L + + L + + IA + +
Sbjct: 61 LWVVKMF-YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEE----ETQFYIA-ETVLAI 114
Query: 742 EYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL---VKLAPDGE------------- 785
+ +H L FIHRD+K N+LLD K+SDFGL +K A E
Sbjct: 115 DSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDF 171
Query: 786 ------------------KSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT 827
+ + GT Y+APE + D +S GV++ E+L
Sbjct: 172 TFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231
Query: 828 GLAALDEERPEES-RYLAEW 846
G E P+E+ + + W
Sbjct: 232 GYPPFCSETPQETYKKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 60/205 (29%), Positives = 102/205 (49%), Gaps = 24/205 (11%)
Query: 632 ELGRGGFGTVYKG-ELEDGTKIAVK----RMEAGVTTTKALDEFQSEIAVLSKVRHRHLV 686
+LG G + TVYKG +G +A+K + E GV T E ++L ++H ++V
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAI-----REASLLKGLKHANIV 66
Query: 687 SLLGYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLH 745
LL I E L V+EYM H L++++ + L P + RL + RG+ Y+H
Sbjct: 67 -LLHDIIHTKETLTFVFEYM-HTDLAQYMIQ-HPGGLHP--YNVRL-FMFQLLRGLAYIH 120
Query: 746 CLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAV 805
Q +HRDLK N+L+ K++DFGL + ++ + + T Y P+ +
Sbjct: 121 ---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPD-VL 175
Query: 806 MGKI--TTKADVFSYGVVLMELLTG 828
+G ++ D++ G + +E+L G
Sbjct: 176 LGATDYSSALDIWGAGCIFIEMLQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 24/210 (11%)
Query: 633 LGRGGFGTVYKG-ELEDGTKIAVKRM-----EAGVTTTKALDEFQSEIAVLSKVRHR-HL 685
+G G +G VYK + G +A+K+ E G+ T AL EI++L + ++
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPT-AL----REISLLQMLSESIYI 63
Query: 686 VSLLG--YSIEGNERL---LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARG 740
V LL + E N + LV+EY+ L + + + +PL S + +G
Sbjct: 64 VRLLDVEHVEEKNGKPSLYLVFEYLDSD-LKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122
Query: 741 MEYLHCLARQTFIHRDLKSSNILLDDDY-RAKVSDFGLVKLAPDGEKSVVTRLAGTFGYL 799
+ + H +HRDLK N+L+D K++D GL + KS + T Y
Sbjct: 123 VAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-TLWYR 178
Query: 800 APEYAVMGK-ITTKADVFSYGVVLMELLTG 828
APE + +T D++S G + E+
Sbjct: 179 APEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 60/230 (26%), Positives = 95/230 (41%), Gaps = 37/230 (16%)
Query: 616 SVQVLRK---VTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQ 671
SVQV V + + Q +G G G V + G +AVK++
Sbjct: 9 SVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAY 68
Query: 672 SEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRL 731
E+ +L V H++++SLL + P +L + ++L + + +
Sbjct: 69 RELVLLKCVNHKNIISLLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVI 116
Query: 732 SIALDVAR----------GMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA 781
+ LD R G+++LH IHRDLK SNI++ D K+ DFGL + A
Sbjct: 117 HMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 173
Query: 782 PDG---EKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTG 828
VVTR Y APE + D++S G ++ EL+ G
Sbjct: 174 CTNFMMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 5e-08
Identities = 61/222 (27%), Positives = 98/222 (44%), Gaps = 54/222 (24%)
Query: 633 LGRGGFGTVYKGELE-DGTKIAVK--RMEA--GVTTTKALDEFQSEIAVLSKVRHRHLVS 687
LG G + TVYKG + G +A+K R+E G T E ++L ++H ++V+
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI-----REASLLKDLKHANIVT 67
Query: 688 LLGYSIEGNERLL--VYEYMPH----------GALSRHLFRWEKLQLKPLSWTRRLSIAL 735
L + I ++ L V+EY+ G LS H R QL
Sbjct: 68 L--HDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQL------------- 112
Query: 736 DVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAG- 794
RG+ Y H ++ +HRDLK N+L+ + K++DFGL + KSV ++
Sbjct: 113 --LRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLAR-----AKSVPSKTYSN 162
Query: 795 ---TFGYLAPEYAVMGKI--TTKADVFSYGVVLMELLTGLAA 831
T Y P+ ++G +T D++ G + E+ TG
Sbjct: 163 EVVTLWYRPPD-VLLGSTEYSTSLDMWGVGCIFYEMATGRPL 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 5e-08
Identities = 49/153 (32%), Positives = 82/153 (53%), Gaps = 20/153 (13%)
Query: 635 RGGFGTVYKGELEDGTKI-AVKRMEAGVTTTKAL-DEFQSEIAVLSKVRHRHLVSLLGYS 692
RG FG VY G ++ +K+ AVK ++ K + + Q+E L+ + +V L YS
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLY-YS 72
Query: 693 IE-GNERLLVYEYMPHGALSR--HLFRW--EKLQLKPLSWTRRLSIALDVARGMEYLHCL 747
++ N LV EY+ G + H++ + E++ +K +S +VA ++YLH
Sbjct: 73 LQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYIS---------EVALALDYLH-- 121
Query: 748 ARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKL 780
R IHRDLK N+L+ ++ K++DFGL K+
Sbjct: 122 -RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 5e-08
Identities = 54/223 (24%), Positives = 94/223 (42%), Gaps = 47/223 (21%)
Query: 633 LGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGY 691
LG G G V+ + + ++AVK++ +T +++ EI ++ ++ H ++V +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIV--LTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70
Query: 692 SIEGNERL--------------LVYEYMP--------HGALSRHLFRWEKLQLKPLSWTR 729
L +V EYM G LS R QL
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQL------- 123
Query: 730 RLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLD-DDYRAKVSDFGLVK-LAPDGE-K 786
RG++Y+H +HRDLK +N+ ++ +D K+ DFGL + + P K
Sbjct: 124 --------LRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHK 172
Query: 787 SVVTRLAGTFGYLAPEYAVMGKITTKA-DVFSYGVVLMELLTG 828
++ T Y +P + TKA D+++ G + E+LTG
Sbjct: 173 GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 6e-08
Identities = 63/260 (24%), Positives = 106/260 (40%), Gaps = 49/260 (18%)
Query: 626 NFAQENELGRGGFGTVYKGELEDGTKIAVKRM--EAGVTTTKALDEFQSEIAVLSKVRHR 683
+F +GRG FG V + +D I ++ +A + + + ++E +L +
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA 61
Query: 684 HLVSLLGYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLS-WTRRLSIALDVARGM 741
+V + YS + L L+ E++P G + L + + L + + +A+D
Sbjct: 62 WVVKMF-YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDA---- 116
Query: 742 EYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL---VKLAPDGE------------- 785
+H L FIHRD+K N+LLD K+SDFGL +K A E
Sbjct: 117 --IHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDF 171
Query: 786 ------------------KSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT 827
+ + GT Y+APE + D +S GV++ E+L
Sbjct: 172 SFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231
Query: 828 GLAALDEERPEES-RYLAEW 846
G E P+E+ R + W
Sbjct: 232 GYPPFCSETPQETYRKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 8e-08
Identities = 52/180 (28%), Positives = 78/180 (43%), Gaps = 24/180 (13%)
Query: 731 LSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVT 790
LS VARGME+L A + +HRDL + N+LL K+ DFGL + V
Sbjct: 240 LSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSK 296
Query: 791 RLAGTF---GYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWF 847
TF ++APE TT +DV+SYG++L E+ + +S + +
Sbjct: 297 --GSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF----Y 350
Query: 848 WRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLV 907
+IKS K P E V ++ C EP RP H+ +++ L+
Sbjct: 351 NKIKSGYRMAK----PDHATQE--------VYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 9e-08
Identities = 65/264 (24%), Positives = 104/264 (39%), Gaps = 58/264 (21%)
Query: 627 FAQENELGRGGFGTV-YKGELEDGTKIAVKRM-EAGVTTTKALDEFQSEIAVLSKVRHRH 684
F + LG G FG V +++ A+K + + V + ++E +L++ +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 685 LVSLLGYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEY 743
+V L YS + + L V +Y+P G + L R E P R L +A +E
Sbjct: 63 VVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMEVF---PEVLARFYIAELTLA--IES 116
Query: 744 LHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLV---------------------KLAP 782
+H + FIHRD+K NIL+D D K++DFGL + P
Sbjct: 117 VH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEP 173
Query: 783 DG-------------------------EKSVVTRLAGTFGYLAPEYAVMGKITTKADVFS 817
++ + L GT Y+APE + T D +S
Sbjct: 174 SDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS 233
Query: 818 YGVVLMELLTGLAALDEERPEESR 841
GV+L E+L G P E++
Sbjct: 234 VGVILFEMLVGQPPFLAPTPTETQ 257
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 57/223 (25%), Positives = 95/223 (42%), Gaps = 17/223 (7%)
Query: 613 LVISVQVLRKVTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDE--F 670
+V ++ L+ +++ +GRG FG V + K+ ++ + K D F
Sbjct: 31 IVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFF 90
Query: 671 QSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRR 730
E +++ +V L + +V EYMP G L + ++ + +T
Sbjct: 91 WEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAE 150
Query: 731 LSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL-VKLAPDGEKSVV 789
+ +ALD M IHRD+K N+LLD K++DFG +K+ G
Sbjct: 151 VVLALDAIHSM---------GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCD 201
Query: 790 TRLAGTFGYLAPEYAVM----GKITTKADVFSYGVVLMELLTG 828
T + GT Y++PE G + D +S GV L E+L G
Sbjct: 202 TAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 70/286 (24%), Positives = 117/286 (40%), Gaps = 60/286 (20%)
Query: 633 LGRGGFGTVYKGEL----EDGTKIAVKRMEAGVTTTKALDEFQSEIAV--------LSKV 680
LGRG +Y G L +D E V K LD +I++ + +V
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVIL-KVLDPSHRDISLAFFETASMMRQV 61
Query: 681 RHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARG 740
H+H+V L G + E ++V E++ G L + R + L+ + +A +A
Sbjct: 62 SHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHR----KSDVLTTPWKFKVAKQLASA 117
Query: 741 MEYLHCLARQTFIHRDLKSSNILL-----DDDYRA--KVSDFGLVKLAPDGEKSVVTRLA 793
+ YL + +H ++ + NILL D + K+SD G + + + V R+
Sbjct: 118 LSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG-IPITVLSRQECVERIP 173
Query: 794 GTFGYLAPEYAVMGK-ITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKS 852
++APE K ++ AD +S+G L E+ + E P + + LAE
Sbjct: 174 ----WIAPECVEDSKNLSIAADKWSFGTTLWEI-----CYNGEIPLKDKTLAE------- 217
Query: 853 SKEKFKAA----IDPALEVNEETFESISIVAELAGHCTAREPYHRP 894
KE+F + P S +A+L HC +P RP
Sbjct: 218 -KERFYEGQCMLVTP----------SCKELADLMTHCMNYDPNQRP 252
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-07
Identities = 36/107 (33%), Positives = 57/107 (53%), Gaps = 10/107 (9%)
Query: 725 LSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK-LAPD 783
LS+ + + VA GME+L A + +HRDL + N+L+ + K+ DFGL + + D
Sbjct: 236 LSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRD 292
Query: 784 GEKSVVTRLAGTF---GYLAPEYAVMGKITTKADVFSYGVVLMELLT 827
S TF ++APE TT +DV+S+G++L E+ T
Sbjct: 293 ---SNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 65/264 (24%), Positives = 106/264 (40%), Gaps = 58/264 (21%)
Query: 627 FAQENELGRGGFGTV-YKGELEDGTKIAVKRM-EAGVTTTKALDEFQSEIAVLSKVRHRH 684
F + LG G FG V +++ A+K + + V + ++E +L++ +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 685 LVSLLGYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEY 743
+V L YS + + L V +Y+P G + L R + + P R L A +E
Sbjct: 63 VVRLY-YSFQDKDNLYFVMDYIPGGDMMSLLIR---MGIFPEDLARFYIAELTCA--VES 116
Query: 744 LHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLV------------------------- 778
+H + FIHRD+K NIL+D D K++DFGL
Sbjct: 117 VH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDF 173
Query: 779 --------------KLAP-------DGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFS 817
+L P ++ + L GT Y+APE + T D +S
Sbjct: 174 SNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 233
Query: 818 YGVVLMELLTGLAALDEERPEESR 841
GV+L E+L G + P E++
Sbjct: 234 VGVILYEMLVGQPPFLAQTPLETQ 257
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 33/105 (31%), Positives = 48/105 (45%), Gaps = 3/105 (2%)
Query: 731 LSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVT 790
L+I V R ++YLH IHRD+K+ NI ++ + DFG D +
Sbjct: 185 LAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241
Query: 791 RLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEE 835
AGT APE D++S G+VL E+ T +L E+
Sbjct: 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEK 286
|
Length = 391 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 3e-07
Identities = 34/93 (36%), Positives = 48/93 (51%), Gaps = 13/93 (13%)
Query: 740 GMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG---EKSVVTRLAGTF 796
G+++LH IHRDLK SNI++ D K+ DFGL + A VVTR
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 182
Query: 797 GYLAPEYAV-MGKITTKADVFSYGVVLMELLTG 828
Y APE + MG D++S G ++ E++ G
Sbjct: 183 -YRAPEVILGMG-YKENVDIWSVGCIMGEMIRG 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 52/204 (25%), Positives = 92/204 (45%), Gaps = 18/204 (8%)
Query: 632 ELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR---HRHLVS 687
E+G G +GTVYK + G +A+K + E+A+L ++ H ++V
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 688 LLGY-----SIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGME 742
L+ + + LV+E++ L +L +K+ L + RG++
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQD-LRTYL---DKVPPPGLPAETIKDLMRQFLRGLD 122
Query: 743 YLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPE 802
+LH +HRDLK NIL+ + K++DFGL ++ + +T + T Y APE
Sbjct: 123 FLHA---NCIVHRDLKPENILVTSGGQVKLADFGLARIY--SCQMALTPVVVTLWYRAPE 177
Query: 803 YAVMGKITTKADVFSYGVVLMELL 826
+ T D++S G + E+
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 5e-07
Identities = 35/115 (30%), Positives = 51/115 (44%), Gaps = 11/115 (9%)
Query: 329 DVNVLLDFLGGVNYPVNLVSQWPGNDPC---QGPWLGLSCTSNSK-----VSIINLPRHN 380
+V+ L + P+ W G DPC Q PW G C +S + + L
Sbjct: 373 EVSALQTLKSSLGLPLRF--GWNG-DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQG 429
Query: 381 LTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLPE 435
L G + I+ L L I L NSI G +P + + SL +LD+S N+ +PE
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPE 484
|
Length = 623 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 5e-07
Identities = 52/192 (27%), Positives = 90/192 (46%), Gaps = 36/192 (18%)
Query: 631 NELGRGGFGTVYKG-ELEDGTKIAVKR--ME---AGVTTTKALDEFQSEIAVLSKVRHRH 684
++G+G FG V+K + +A+K+ ME G T AL EI +L ++H +
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPIT-AL----REIKILQLLKHEN 72
Query: 685 LVSLL--------GYSIEGNERLLVYEYMPH---GALSRHLFRWEKLQLKPLSWTRRLSI 733
+V+L+ Y+ LV+E+ H G LS ++ ++K +
Sbjct: 73 VVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIK--------KV 124
Query: 734 ALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK---LAPDGEKSVVT 790
+ G+ Y+H R +HRD+K++NIL+ D K++DFGL + L+ + + + T
Sbjct: 125 MKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT 181
Query: 791 RLAGTFGYLAPE 802
T Y PE
Sbjct: 182 NRVVTLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 6e-07
Identities = 71/272 (26%), Positives = 107/272 (39%), Gaps = 59/272 (21%)
Query: 625 QNFAQENELGRGGFGTVYKGELEDGTKI-AVKRMEAGVTTTK-ALDEFQSEIAVLSKVRH 682
++F +G+G FG V + +D KI A+K + K L ++E VL++
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 683 RHLVSLLGYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGM 741
+VSL YS + + L L+ E++P G L L +++ R +A + +
Sbjct: 61 PWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSED----VTRFYMA-ECVLAI 114
Query: 742 EYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL---------------------VKL 780
E +H L FIHRD+K NIL+D K+SDFGL K
Sbjct: 115 EAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKN 171
Query: 781 APDGEKSVVT--------------------RL-----AGTFGYLAPEYAVMGKITTKADV 815
D SV RL GT Y+APE + + D
Sbjct: 172 RIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDW 231
Query: 816 FSYGVVLMELLTGLAALDEERPEES-RYLAEW 846
+S G ++ E L G E E+ R + W
Sbjct: 232 WSLGAIMFECLIGWPPFCSENSHETYRKIINW 263
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 6e-07
Identities = 36/116 (31%), Positives = 51/116 (43%), Gaps = 23/116 (19%)
Query: 741 MEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLA------- 793
+EYLH +HRDLK N+L+ K++DFGL K+ G S+ T L
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKI---GLMSLTTNLYEGHIEKD 167
Query: 794 ----------GTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEE 839
GT Y+APE + D ++ G++L E L G + PEE
Sbjct: 168 TREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE 223
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 9e-07
Identities = 62/269 (23%), Positives = 103/269 (38%), Gaps = 25/269 (9%)
Query: 566 DPSDPENMVKIAVSNDTAR-SLSSQTVASSGSTNSGATENSHVI--ESGTLVISVQVLRK 622
D SD ++ + T A+ + + + E S
Sbjct: 30 DTSDSKDTTGDKFDDCDELGDSDDVTHATDYDADEESLSPQTDVCQEPCETTSSSDPASV 89
Query: 623 VTQNFAQENELGRGGFGTVY---KGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSK 679
V + + L G G V+ K E K+ VK + G T EI +L
Sbjct: 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTP-------GREIDILKT 142
Query: 680 VRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRH-LFRWEKLQLKPLSWTRRLSIALDVA 738
+ HR +++L+ + +V MP + LF + + PL + ++I +
Sbjct: 143 ISHRAIINLIHAYRWKSTVCMV---MPK---YKCDLFTYVD-RSGPLPLEQAITIQRRLL 195
Query: 739 RGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLV-KLAPDGEKSVVTRLAGTFG 797
+ YLH + IHRD+K+ NI LD+ A + DFG KL + +GT
Sbjct: 196 EALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLE 252
Query: 798 YLAPEYAVMGKITTKADVFSYGVVLMELL 826
+PE + K D++S G+VL E+
Sbjct: 253 TNSPELLALDPYCAKTDIWSAGLVLFEMS 281
|
Length = 392 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 53/222 (23%), Positives = 90/222 (40%), Gaps = 38/222 (17%)
Query: 623 VTQNFAQENELGRGGFGTV---YKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSK 679
V + + +G G G V Y LE +A+K++ E+ ++
Sbjct: 22 VLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKC 79
Query: 680 VRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVAR 739
V H++++ LL + P +L + ++L + + + + LD R
Sbjct: 80 VNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHER 127
Query: 740 ----------GMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG---EK 786
G+++LH IHRDLK SNI++ D K+ DFGL + A
Sbjct: 128 MSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 184
Query: 787 SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTG 828
VVTR Y APE + D++S G ++ E++ G
Sbjct: 185 YVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 51/217 (23%), Positives = 91/217 (41%), Gaps = 32/217 (14%)
Query: 623 VTQNFAQENELGRGGFGTV---YKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSK 679
V + + +G G G V Y L+ +A+K++ E+ ++
Sbjct: 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELVLMKC 72
Query: 680 VRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVAR 739
V H++++SLL + P +L + ++L + + + + LD R
Sbjct: 73 VNHKNIISLLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHER 120
Query: 740 ----------GMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVV 789
G+++LH IHRDLK SNI++ D K+ DFGL + A G ++
Sbjct: 121 MSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMM 175
Query: 790 TRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELL 826
T T Y APE + D++S G ++ E++
Sbjct: 176 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-06
Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 32/210 (15%)
Query: 630 ENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSL- 688
E R G + +G+ + IA KR++AG ++A + ++EI L ++ H +++ +
Sbjct: 174 EEAEARRGVNSTNQGKPKCERLIA-KRVKAG---SRAAIQLENEILALGRLNHENILKIE 229
Query: 689 -------LGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSW-TRRLSIALDVARG 740
Y I +Y +M A F W+ +PL TR + L A
Sbjct: 230 EILRSEANTYMITQKYDFDLYSFMYDEA-----FDWKD---RPLLKQTRAIMKQLLCA-- 279
Query: 741 MEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLA 800
+EY+H + IHRD+K NI L+ D + + DFG EK G G +A
Sbjct: 280 VEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPF---EKEREAFDYGWVGTVA 333
Query: 801 ---PEYAVMGKITTKADVFSYGVVLMELLT 827
PE D++S G++L+++L+
Sbjct: 334 TNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 45/208 (21%), Positives = 83/208 (39%), Gaps = 31/208 (14%)
Query: 633 LGRGGFGTVYKGELEDGTKI-AVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGY 691
+G G +G V K ++ +I A+K+ + + + E+ +L ++ ++V L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 692 SIEGNERLLVYEY-----------MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARG 740
+ LV+EY MP+G + + +K + W + I
Sbjct: 69 FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDI------- 121
Query: 741 MEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLA 800
+HRD+K N+L+ + K+ DFG + +G + T T Y +
Sbjct: 122 ------------VHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRS 169
Query: 801 PEYAVMGKITTKADVFSYGVVLMELLTG 828
PE + D++S G +L EL G
Sbjct: 170 PELLLGAPYGKAVDMWSVGCILGELSDG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 61/247 (24%), Positives = 108/247 (43%), Gaps = 38/247 (15%)
Query: 612 TLVISVQVLRKVTQNFAQENELGRGGFGTVYK-GELEDGTKIAVKRMEAGVTTTKALDEF 670
+ ++ ++ L T + +G+G +G VYK +DG+ AVK ++ + +E
Sbjct: 9 SSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDP---ISDVDEEI 65
Query: 671 QSEIAVLSKV-RHRHLVSLLGY-----SIEGNERLLVYEYMPHGALSRH----LFRWEKL 720
++E +L + H ++V G + G + LV E G+++ L ++L
Sbjct: 66 EAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRL 125
Query: 721 QLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKL 780
+S+ I G+++LH IHRD+K +NILL + K+ DFG+
Sbjct: 126 DEAMISY-----ILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGV--- 174
Query: 781 APDGEKSVVTRL-----AGTFGYLAPEYAVMGK-----ITTKADVFSYGVVLMELLTGLA 830
+ TRL GT ++APE + + DV+S G+ +EL G
Sbjct: 175 ---SAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDP 231
Query: 831 ALDEERP 837
L + P
Sbjct: 232 PLFDMHP 238
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 6e-06
Identities = 37/137 (27%), Positives = 65/137 (47%), Gaps = 10/137 (7%)
Query: 714 LFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVS 773
L+ + +L+PL + ++A + ++Y+H + IHRD+K+ N+L++ +
Sbjct: 246 LYTYLGARLRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLG 302
Query: 774 DFGLVKLAPDGEKSVVTR-LAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAAL 832
DFG A + +AGT APE T D++S G+V+ E A+L
Sbjct: 303 DFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362
Query: 833 ------DEERPEESRYL 843
DE RP +++ L
Sbjct: 363 FSASRGDERRPYDAQIL 379
|
Length = 461 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 1e-05
Identities = 54/216 (25%), Positives = 83/216 (38%), Gaps = 35/216 (16%)
Query: 83 LPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRV 142
LP L L NL L N + S LS L L N+ +P + LS++
Sbjct: 155 LPSPLRNLPNLKNLDLSFNDLSDLPKLLSNLSNLNNLDLSGNKISDLP-PEIELLSALEE 213
Query: 143 LALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRL 202
L L N + SL+N L+ L L N N + LP+ +G L +L L LS N++
Sbjct: 214 LDLSNNSII-----ELLSSLSNLKNLSGLELSN-NKLEDLPESIGNLSNLETLDLSNNQI 267
Query: 203 SGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGAL 262
S I + + +L +L L GN + ++P L
Sbjct: 268 SS---------------------------ISSLGSLTNLRELDLSGNSLSNALPLIALLL 300
Query: 263 SSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLL 298
L+ L L + L ++ L+N +L+N
Sbjct: 301 LLLELLLNLLLTLK-ALELKLNSILLNNNILSNGET 335
|
Length = 394 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 45/187 (24%), Positives = 63/187 (33%), Gaps = 26/187 (13%)
Query: 723 KPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782
+PL+ ++ L + LH A KS NILL D K+ G V
Sbjct: 12 RPLNEEEIWAVCLQCLGALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKT 60
Query: 783 DGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRY 842
E+S ++APE T KAD++S G+ L E L +EER
Sbjct: 61 P-EQSRPDPY-----FMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE----- 109
Query: 843 LAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNV 902
I A DP N E + + C +R P R H +
Sbjct: 110 ----LSAILEILLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAH 165
Query: 903 LSPLVEK 909
L +
Sbjct: 166 CRALFAE 172
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (111), Expect = 3e-05
Identities = 44/163 (26%), Positives = 69/163 (42%), Gaps = 44/163 (26%)
Query: 682 HRHLVSLLGYSIEG-NERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLS------IA 734
+ + + L YS+ +L+ +Y+ G L ++ L+ + +LS I
Sbjct: 68 NPNFIKLY-YSVTTLKGHVLIMDYIKDGDL------FDLLKKE-----GKLSEAEVKKII 115
Query: 735 LDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAK----VSDFGLVKLAPDGEKSVVT 790
+ + LH + IH D+K N+L D RAK + D+GL K+ G S
Sbjct: 116 RQLVEALNDLH---KHNIIHNDIKLENVLYD---RAKDRIYLCDYGLCKII--GTPSC-- 165
Query: 791 RLAGTFGYLAPEYAVMGKITTKA-----DVFSYGVVLMELLTG 828
GT Y +PE KI D ++ GV+ ELLTG
Sbjct: 166 -YDGTLDYFSPE-----KIKGHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 4e-05
Identities = 52/208 (25%), Positives = 95/208 (45%), Gaps = 17/208 (8%)
Query: 632 ELGRG--GFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSL 688
E+GRG +VY GT + V+ + T + L Q+E+ + RH ++++
Sbjct: 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTS 64
Query: 689 LGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLA 748
G+ ++ +M +G+ + L + + +S +I RG+ YLH
Sbjct: 65 WTVFTTGSWLWVISPFMAYGS-ANSLLK--TYFPEGMSEALIGNILFGALRGLNYLH--- 118
Query: 749 RQTFIHRDLKSSNILLDDDYRAKVSDFG-LVKLAPDGEKSVVTRLAGTFG-----YLAPE 802
+ +IHR++K+S+IL+ D +S L L +G+K+ V F +L+PE
Sbjct: 119 QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPE 178
Query: 803 Y--AVMGKITTKADVFSYGVVLMELLTG 828
+ K+D++S G+ EL TG
Sbjct: 179 LLRQDLYGYNVKSDIYSVGITACELATG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 59/226 (26%), Positives = 106/226 (46%), Gaps = 38/226 (16%)
Query: 633 LGRGGFGTVYK-GELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR-HRHLVSLLG 690
+G+G +G V+K ++G+K AVK ++ +E ++E +L + H ++V G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDP---IHDIDEEIEAEYNILKALSDHPNVVKFYG 82
Query: 691 Y-----SIEGNERLLVYEYMPHGALSR----HLFRWEKLQLKPLSWTRRLSIALDVARGM 741
G++ LV E G+++ L R E+++ +++ I + G+
Sbjct: 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY-----ILHEALMGL 137
Query: 742 EYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRL-----AGTF 796
++LH IHRD+K +NILL + K+ DFG+ + TRL GT
Sbjct: 138 QHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGV------SAQLTSTRLRRNTSVGTP 188
Query: 797 GYLAPEY-AVMGKITT----KADVFSYGVVLMELLTGLAALDEERP 837
++APE A ++ + + DV+S G+ +EL G L + P
Sbjct: 189 FWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 40.2 bits (95), Expect = 2e-04
Identities = 20/61 (32%), Positives = 33/61 (54%), Gaps = 3/61 (4%)
Query: 240 SLTQLWLHGNQFTGSIPEDI-GALSSLKDLNLNRNQLVGLIPKSLANME-LDNLVLNNNL 297
+L L L N+ T IP+ L +LK L+L+ N L + P++ + + L +L L+ N
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 298 L 298
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 3e-04
Identities = 46/181 (25%), Positives = 84/181 (46%), Gaps = 28/181 (15%)
Query: 673 EIAVLSKVRHRHLVSLLGYSI-EGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRR 730
E+ V+ +++H+++V + + + N++L ++ E+ G LSR++ + K+ K +
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGK-IEEHAI 120
Query: 731 LSIALDVARGMEYLHCLAR----QTFIHRDLKSSNILLDDDYR----------------- 769
+ I + + Y H L + +HRDLK NI L R
Sbjct: 121 VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180
Query: 770 AKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAV--MGKITTKADVFSYGVVLMELLT 827
AK+ DFGL K G +S+ GT Y +PE + K+D+++ G ++ EL +
Sbjct: 181 AKIGDFGLSKNI--GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCS 238
Query: 828 G 828
G
Sbjct: 239 G 239
|
Length = 1021 |
| >gnl|CDD|223554 COG0478, COG0478, RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 4e-04
Identities = 37/161 (22%), Positives = 56/161 (34%), Gaps = 27/161 (16%)
Query: 631 NELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLG 690
++G G VY G K+AVK G T F+ + + S L
Sbjct: 97 TKIGVGKESDVYVAIDPKGRKVAVKFHRLGRT------SFRKVKRNRDYLADKEHGSWLY 150
Query: 691 YSIEGNERLLVYEYM----PHGAL-------SRHLFRWEKLQLKPLSWTRRL-----SIA 734
S ER +E + P G +RH E ++ L R I
Sbjct: 151 VSRLAAER--EFEALQRLYPEGVKVPKPIAWNRHAVVMEYIEGVELYRLRLDVENPDEIL 208
Query: 735 LDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDF 775
+ +E + R+ +H DL NIL+ +D V D+
Sbjct: 209 DKI---LEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDW 246
|
Length = 304 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 38.7 bits (91), Expect = 5e-04
Identities = 17/61 (27%), Positives = 30/61 (49%), Gaps = 2/61 (3%)
Query: 370 KVSIINLPRHNLTGTLSPSI-ANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNN 428
+ ++L +N + L +L + L N+++ P F+ L SLR LD+S NN
Sbjct: 1 NLKSLDL-SNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 429 I 429
+
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 38.3 bits (90), Expect = 6e-04
Identities = 20/61 (32%), Positives = 27/61 (44%), Gaps = 3/61 (4%)
Query: 92 KLYNLGLQRNKFNGKLP--TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNP 149
L +L L N+ +P F GL L+ L N +I + F GL S+R L L N
Sbjct: 1 NLKSLDLSNNRL-TVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 150 F 150
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 0.002
Identities = 20/64 (31%), Positives = 28/64 (43%), Gaps = 6/64 (9%)
Query: 116 LEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSI-PDSLANSVQLTNLSLI 174
L+ L N IP F GL +++VL L N SI P++ + L +L L
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLT-----SISPEAFSGLPSLRSLDLS 56
Query: 175 NCNL 178
NL
Sbjct: 57 GNNL 60
|
Length = 60 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.003
Identities = 27/85 (31%), Positives = 48/85 (56%), Gaps = 8/85 (9%)
Query: 633 LGRGGFGTVYK------GELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHL 685
LG G FG V + G+ ++ ++AVK ++A T + + SE+ +LS + +H+++
Sbjct: 46 LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDER-EALMSELKILSHLGQHKNI 104
Query: 686 VSLLGYSIEGNERLLVYEYMPHGAL 710
V+LLG G L++ EY +G L
Sbjct: 105 VNLLGACTHGGPVLVITEYCCYGDL 129
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.004
Identities = 31/149 (20%), Positives = 52/149 (34%), Gaps = 19/149 (12%)
Query: 636 GGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVS--LLGYSI 693
G VY +D + +K + K D + E+A+L + + L +L
Sbjct: 9 GLTNRVYLLGTKDEDYV-LKI---NPSREKGAD-REREVAILQLLARKGLPVPKVLASGE 63
Query: 694 EGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFI 753
L+ E++ L + + + IA +A + LH L
Sbjct: 64 SDGWSYLLMEWIE----GETLDEVSEEEKE--------DIAEQLAELLAKLHQLPLLVLC 111
Query: 754 HRDLKSSNILLDDDYRAKVSDFGLVKLAP 782
H DL NIL+DD + D+ P
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|240167 cd05144, RIO2_C, RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Score = 39.0 bits (92), Expect = 0.004
Identities = 36/157 (22%), Positives = 56/157 (35%), Gaps = 20/157 (12%)
Query: 631 NELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLG 690
N++G G VY DG +A+K G T F+ + R S L
Sbjct: 21 NQIGVGKESDVYLALDPDGNPVALKFHRLGRT------SFRKVKRKRDYLGDRKHASWLY 74
Query: 691 YSIEGNERLLVYEYM----PHG-------ALSRHLFRWEKLQLKPLSWTRRLSIALDVA- 738
S ++ + + G +RH E + L R L +V
Sbjct: 75 LSRLAAQK--EFAALKALYEEGFPVPKPIDWNRHAVVMEYIDGVELYRVRVLEDPEEVLD 132
Query: 739 RGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDF 775
+E + + IH DL NIL+DDD + + D+
Sbjct: 133 EILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIIDW 169
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH domains may be involved in RNA recognition. RIO2 is essential for survival and is necessary for rRNA cleavage during 40S ribosomal subunit maturation. The biological substrates of RIO2 are still unknown. Length = 198 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 973 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.98 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.98 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.98 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.98 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.98 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.95 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.93 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.93 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.88 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.85 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.81 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.8 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.8 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.79 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.79 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.78 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.77 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.77 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.75 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.75 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.74 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.74 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.72 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.71 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.71 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.7 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.67 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.66 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.62 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.62 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.61 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.57 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.5 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.48 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.46 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.42 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.4 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.39 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.33 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.29 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.28 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.26 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.24 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.19 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.12 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.11 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.09 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.09 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.08 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.08 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.05 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.04 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.03 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.99 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.97 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.96 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.94 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.93 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.85 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.83 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.81 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.78 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.75 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.74 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.69 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.66 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.59 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.58 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.53 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.48 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.47 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.46 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.39 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.37 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.36 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.35 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.26 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-82 Score=810.09 Aligned_cols=799 Identities=25% Similarity=0.390 Sum_probs=438.2
Q ss_pred ChhHHHHHHHHHhhCCCCc--cCCCCCCCCCCCCCCCcCeEEeeC-CeEEEEEecccCCcccCCcCcccccccceeeccC
Q 041143 24 DPNDLKILNDFKNGLENPE--LLKWPANGDDPCGPPPWPHVFCSG-NRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQR 100 (973)
Q Consensus 24 ~~~~~~~l~~~k~~~~~~~--l~~w~~~~~d~C~~~~w~gv~C~~-~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~ 100 (973)
+++|..||++||+++.++. +.+|+. +.|||. |.||.|+. ++|+.|+|++++++|.++..|..+++|+.|+|++
T Consensus 27 ~~~~~~~l~~~~~~~~~~~~~~~~w~~-~~~~c~---w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~ 102 (968)
T PLN00113 27 HAEELELLLSFKSSINDPLKYLSNWNS-SADVCL---WQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSN 102 (968)
T ss_pred CHHHHHHHHHHHHhCCCCcccCCCCCC-CCCCCc---CcceecCCCCcEEEEEecCCCccccCChHHhCCCCCCEEECCC
Confidence 6789999999999997763 678854 578997 99999974 6899999999999999999999999999999999
Q ss_pred cccCCCCC-C-CCCCCccceeeccCCCCCCC----------------------CccccCCCCCccEEEcccCCCCCccCC
Q 041143 101 NKFNGKLP-T-FSGLSELEFAYLDFNEFDTI----------------------PSDFFDGLSSVRVLALDYNPFNKTFGW 156 (973)
Q Consensus 101 N~l~~~~~-~-~~~l~~L~~L~L~~N~l~~i----------------------~~~~f~~l~~L~~L~Ls~N~l~~~~~~ 156 (973)
|++++.+| . +.++++|++|+|++|+++.. .+..|.++++|++|+|++|.+.+.
T Consensus 103 n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~--- 179 (968)
T PLN00113 103 NQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGK--- 179 (968)
T ss_pred CccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCccccc---
Confidence 99998776 3 44777777777777776532 222334444444444444444432
Q ss_pred CCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhc
Q 041143 157 SIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVA 236 (973)
Q Consensus 157 ~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 236 (973)
+|..+.++++|++|+|++|++++.+|..++++++|++|+|++|++++.+|..+.. +.++..|+...+......+..+.
T Consensus 180 -~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~-l~~L~~L~L~~n~l~~~~p~~l~ 257 (968)
T PLN00113 180 -IPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGG-LTSLNHLDLVYNNLTGPIPSSLG 257 (968)
T ss_pred -CChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhc-CCCCCEEECcCceeccccChhHh
Confidence 4444444444444444444444444444444444444444444444444443322 11111222222221112222333
Q ss_pred CCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcccccCccccccc-ccCeEE-----------------------
Q 041143 237 KMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLV----------------------- 292 (973)
Q Consensus 237 ~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~----------------------- 292 (973)
++++|+.|+|++|++++.+|..+.++++|++|+|++|.+.+.+|..+.++ +|+.|+
T Consensus 258 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L 337 (968)
T PLN00113 258 NLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVL 337 (968)
T ss_pred CCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEE
Confidence 33444444444444433334333333444444444444433333333333 333333
Q ss_pred -ccCCcCcCCCCCCCCCC-----cccccCcccCCCCCcccC------------------CcchhhhhhccCCCCCCcccC
Q 041143 293 -LNNNLLMGPIPKFKAGN-----VTYDSNSFCQSEPGIECA------------------PDVNVLLDFLGGVNYPVNLVS 348 (973)
Q Consensus 293 -l~~N~l~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~l~~l~~~~n~~~ 348 (973)
+++|.+.+.+|..+... +.+..+.+.+..+...+. +.....+..+..+++..|.+.
T Consensus 338 ~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~ 417 (968)
T PLN00113 338 QLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFS 417 (968)
T ss_pred ECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEee
Confidence 33333333333221111 111111111111100000 000000112222222222221
Q ss_pred ------------------------CCCCCCCCC---CC--------ccc--cccCCCCcccEEecCCCcCCCccchhhhC
Q 041143 349 ------------------------QWPGNDPCQ---GP--------WLG--LSCTSNSKVSIINLPRHNLTGTLSPSIAN 391 (973)
Q Consensus 349 ------------------------~~~~~~~~~---~~--------~~~--~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~ 391 (973)
......... .. +.+ -......+|+.|+|++|++.+.+|..+.+
T Consensus 418 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~ 497 (968)
T PLN00113 418 GELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGS 497 (968)
T ss_pred eECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChhhhh
Confidence 100000000 00 000 00011234555555555555555555555
Q ss_pred ccccceEEccCCccccccCccccCcCCCCeeeCCCCcCCCCCCC----CCcccceeecCCccccCCCCCCC-------CC
Q 041143 392 LDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLPE----FHDTVKLVIDGNPLLVGGINHTQ-------AP 460 (973)
Q Consensus 392 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~----~~~~~~~~~~~N~~~c~~~~~~~-------~~ 460 (973)
+++|+.|+|++|+++|.+|..+..+++|++|+|++|.++|.+|. +..+..+++.+|...-..+.... ..
T Consensus 498 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ 577 (968)
T PLN00113 498 LSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVN 577 (968)
T ss_pred hhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEe
Confidence 56666666666666555555555555555566655555555553 23334455555544211110000 00
Q ss_pred CCCCCCCCCCCCCCC----CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccCCccccCCcceeeehHHHHHHHHH
Q 041143 461 TSPGPVSSPTPPGSQ----SPSNHTSSGRGQSPSSGNSPPSPITHPNSNHSSIHVQPQRKSTKRLKLLVVVGISVVVTVV 536 (973)
Q Consensus 461 ~~~~~~~~p~~p~~~----~p~~~~~~~~~~sp~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~iiv~i~v~~~vi 536 (973)
.+.+......|.... ...+.......+.+..+... +.+ ....+. ..+.++++++++++++
T Consensus 578 ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~------~~c--------~~~~~~--~~~~~~~~~~~~~~~~ 641 (968)
T PLN00113 578 ISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGL------PPC--------KRVRKT--PSWWFYITCTLGAFLV 641 (968)
T ss_pred ccCCcceeeCCCcchhcccChhhhcCCccccCCccccCC------CCC--------cccccc--ceeeeehhHHHHHHHH
Confidence 001111100000000 00000000000000000000 000 000011 1222233333333333
Q ss_pred HHHHHhhheeeeecCCCCCCCCccccCCCCCCCchhhhhhcccCCcccccCcccccCCCCCCCCCCCCcccccCCceeec
Q 041143 537 LVVILLCIYCCKKRKGTLEAPGSIVVHPRDPSDPENMVKIAVSNDTARSLSSQTVASSGSTNSGATENSHVIESGTLVIS 616 (973)
Q Consensus 537 ~v~~~l~~~~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~~ 616 (973)
++++++.++++++|+...... ..... ... ... .........+.
T Consensus 642 ~~~~~~~~~~~~~~~~~~~~~-------~~~~~--~~~--------------~~~--------------~~~~~~~~~~~ 684 (968)
T PLN00113 642 LALVAFGFVFIRGRNNLELKR-------VENED--GTW--------------ELQ--------------FFDSKVSKSIT 684 (968)
T ss_pred HHHHHHHHHHHHhhhcccccc-------ccccc--ccc--------------ccc--------------ccccccchhhh
Confidence 333333333333322111000 00000 000 000 00000000122
Q ss_pred HHHHHHHhcCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeC
Q 041143 617 VQVLRKVTQNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEG 695 (973)
Q Consensus 617 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 695 (973)
.+.....|...+.||+|+||.||+|+. .+|..||||+++.... ...+|++++++++|||||+++|+|.+.
T Consensus 685 ---~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~~ 755 (968)
T PLN00113 685 ---INDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCRSE 755 (968)
T ss_pred ---HHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEEcC
Confidence 233445678889999999999999987 5789999999864321 123468899999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeec
Q 041143 696 NERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDF 775 (973)
Q Consensus 696 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 775 (973)
+..++||||+++|+|.++++ .++|.++.+|+.|||+||+|||+.++++|+||||||+||+++.++.+++. |
T Consensus 756 ~~~~lv~Ey~~~g~L~~~l~--------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~ 826 (968)
T PLN00113 756 KGAYLIHEYIEGKNLSEVLR--------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-L 826 (968)
T ss_pred CCCEEEEeCCCCCcHHHHHh--------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-e
Confidence 99999999999999999984 27899999999999999999997777899999999999999999988876 6
Q ss_pred cccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchh
Q 041143 776 GLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKE 855 (973)
Q Consensus 776 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 855 (973)
|.+...... ....||+.|+|||++.+..++.|+|||||||++|||+||+.||+.... ....+.+|.+.... ..
T Consensus 827 ~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~-~~ 899 (968)
T PLN00113 827 SLPGLLCTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYS-DC 899 (968)
T ss_pred ccccccccC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcC-cc
Confidence 655432211 223689999999999999999999999999999999999999965432 23345666654433 23
Q ss_pred HHHhhcCccccCC-cccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 856 KFKAAIDPALEVN-EETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 856 ~~~~~~~~~l~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
.....+|+.+... ....+++.++.+++.+|++.||++||+|+||++.|+++.+.
T Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 900 HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred chhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 4556677766422 23456677889999999999999999999999999988664
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-55 Score=481.38 Aligned_cols=292 Identities=50% Similarity=0.820 Sum_probs=255.0
Q ss_pred CceeecHHHHHHHhcCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeee
Q 041143 611 GTLVISVQVLRKVTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLG 690 (973)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 690 (973)
....|++.+++.+|++|...+.||+|+||.||+|.+.+|+.||||++....... .++|.+|++++.+++|||+|+|+|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlG 138 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLG 138 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEE
Confidence 456799999999999999999999999999999999999999999887653222 456999999999999999999999
Q ss_pred EEEeCC-eEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCC
Q 041143 691 YSIEGN-ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYR 769 (973)
Q Consensus 691 ~~~~~~-~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~ 769 (973)
||.+.+ +++||||||++|+|.++|+..... +++|.+|++||.++|+||+|||+.+.++||||||||+|||+|++++
T Consensus 139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~ 215 (361)
T KOG1187|consen 139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN 215 (361)
T ss_pred EEecCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC
Confidence 999998 599999999999999999873221 8899999999999999999999988889999999999999999999
Q ss_pred EEEeeccccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHH
Q 041143 770 AKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWR 849 (973)
Q Consensus 770 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 849 (973)
+||+|||+|+..+.......+...||.+|+||||+..+..+.|+|||||||+|+||+||+.+.+...+.....+++|++.
T Consensus 216 aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~ 295 (361)
T KOG1187|consen 216 AKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKP 295 (361)
T ss_pred EEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHH
Confidence 99999999986654111212211899999999999999999999999999999999999999997766666679999987
Q ss_pred HhhchhHHHhhcCccccCCccc-HHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 850 IKSSKEKFKAAIDPALEVNEET-FESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 850 ~~~~~~~~~~~~~~~l~~~~~~-~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
... ...+.+++|+.+...... .+++.++..++.+|++.+|++||+|.||+++|+.+..
T Consensus 296 ~~~-~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 296 LLE-EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HHH-CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 776 448999999998733333 3788999999999999999999999999999966543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=408.02 Aligned_cols=260 Identities=36% Similarity=0.553 Sum_probs=214.6
Q ss_pred cccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC-eEEEEEEecC
Q 041143 628 AQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGN-ERLLVYEYMP 706 (973)
Q Consensus 628 ~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~e~~~ 706 (973)
...+.||+|+||+||+|.+.....||||++..........++|.+|+.+|.+++|||||+++|+|.+.. ..++|||||+
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 344559999999999999984444999999876555555789999999999999999999999999987 7999999999
Q ss_pred CCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCC-eeeccCCCCcEEECCCC-CEEEeeccccccCCCC
Q 041143 707 HGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQT-FIHRDLKSSNILLDDDY-RAKVSDFGLVKLAPDG 784 (973)
Q Consensus 707 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~-ivH~Dikp~Nill~~~~-~~kl~DfGla~~~~~~ 784 (973)
+|+|.++++.. ....+++..++++|.|||+||.||| +++ ||||||||+|||++.++ ++||+|||+++.....
T Consensus 124 ~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 124 GGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred CCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 99999999874 3467999999999999999999999 666 99999999999999997 9999999999865543
Q ss_pred CcceecccccccCcccccccc--cCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcC
Q 041143 785 EKSVVTRLAGTFGYLAPEYAV--MGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862 (973)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (973)
. ...+...||+.|||||++. ...|+.|+|||||||++|||+||+.||....+... ...+ . .....
T Consensus 198 ~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~---~~~v---~------~~~~R 264 (362)
T KOG0192|consen 198 K-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV---ASAV---V------VGGLR 264 (362)
T ss_pred c-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH---HHHH---H------hcCCC
Confidence 2 2234468999999999999 66999999999999999999999999998765221 1111 1 01111
Q ss_pred ccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcC
Q 041143 863 PALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWR 911 (973)
Q Consensus 863 ~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~ 911 (973)
+.+. ......+..++.+||+.||++||++.+|+..|+.+.....
T Consensus 265 p~~p-----~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 265 PPIP-----KECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred CCCC-----ccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 1111 1144567889999999999999999999999999877543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=384.78 Aligned_cols=258 Identities=27% Similarity=0.418 Sum_probs=214.6
Q ss_pred ccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC-eEEEEEEe
Q 041143 627 FAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGN-ERLLVYEY 704 (973)
Q Consensus 627 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~e~ 704 (973)
.+..+.||+|..|+|||++++ +++-+|+|++... ......+++.+|++++++++||+||.+||.|.... +..++|||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~-~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN-IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc-CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 344688999999999999876 6788999999543 46667789999999999999999999999999988 59999999
Q ss_pred cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCC
Q 041143 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG 784 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~ 784 (973)
|.+|+|++++... +.+++....+|+.+|++||.|||+ +++||||||||+|||++..|++||||||.++...+.
T Consensus 160 MDgGSLd~~~k~~-----g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 160 MDGGSLDDILKRV-----GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred cCCCCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 9999999998652 568999999999999999999994 489999999999999999999999999999866543
Q ss_pred CcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcC--
Q 041143 785 EKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID-- 862 (973)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 862 (973)
....++||..|||||.+.+..|+.++||||||++++|+.+|+.|+....+.. ....+ -+..+++
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~-~~~~~----------Ll~~Iv~~p 298 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY-LDIFE----------LLCAIVDEP 298 (364)
T ss_pred ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC-CCHHH----------HHHHHhcCC
Confidence 4466899999999999999999999999999999999999999998752111 11111 1222333
Q ss_pred -ccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCC
Q 041143 863 -PALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRP 912 (973)
Q Consensus 863 -~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~ 912 (973)
|.+..+ ..-.++..++..|+++||.+||+++|+++ +.++.+...
T Consensus 299 pP~lP~~----~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~--Hpfi~~~~~ 343 (364)
T KOG0581|consen 299 PPRLPEG----EFSPEFRSFVSCCLRKDPSERPSAKQLLQ--HPFIKKFED 343 (364)
T ss_pred CCCCCcc----cCCHHHHHHHHHHhcCCcccCCCHHHHhc--CHHHhhccc
Confidence 222211 23345889999999999999999999999 888876543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=379.49 Aligned_cols=206 Identities=33% Similarity=0.536 Sum_probs=186.1
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
.+|...+.||+|+||+||+|+.+ ++..||||.+....-..+..+.+..|+++|+.++|||||++++++..++..|||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 57888888999999999999865 58999999997665467778889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCC------CCEEEeeccc
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDD------YRAKVSDFGL 777 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~------~~~kl~DfGl 777 (973)
||.||||..|++.. +.+++.....++.|+|.||++|| +++||||||||+|||++.. -.+||+|||+
T Consensus 90 yC~gGDLs~yi~~~-----~~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRR-----GRLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred eCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 99999999999872 46889999999999999999999 8999999999999999765 4689999999
Q ss_pred cccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhH
Q 041143 778 VKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEES 840 (973)
Q Consensus 778 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~ 840 (973)
|+....+ ......+|++.|||||+++..+|+.|+|+||+|+++|||++|+.||+...+.+-
T Consensus 162 AR~L~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL 222 (429)
T KOG0595|consen 162 ARFLQPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKEL 222 (429)
T ss_pred hhhCCch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHH
Confidence 9987643 345678999999999999999999999999999999999999999998776543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-45 Score=396.63 Aligned_cols=263 Identities=26% Similarity=0.447 Sum_probs=218.7
Q ss_pred cCccccCcccccCccEEEEEEE-CCCCEEEEEEeecC-CCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAG-VTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
.+|...+.||+|||+.||+++. ..|+.||+|++... .......+...+||++.+.|+|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5788899999999999999987 78999999999653 334556778999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
|+|++|+|..++.+ .+++++.++..+..||+.||.||| +.+|||||||..|+++++++++||+|||+|....
T Consensus 98 ELC~~~sL~el~Kr-----rk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le 169 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR-----RKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLE 169 (592)
T ss_pred EecCCccHHHHHHh-----cCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeec
Confidence 99999999988864 478999999999999999999999 8899999999999999999999999999998665
Q ss_pred CCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcC
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (973)
.... ...+++|||.|.|||++.....+..+||||+|||||-|++|++||+...-.+ -+.+++..+..+
T Consensus 170 ~~~E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke------ty~~Ik~~~Y~~----- 237 (592)
T KOG0575|consen 170 YDGE-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE------TYNKIKLNEYSM----- 237 (592)
T ss_pred Cccc-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH------HHHHHHhcCccc-----
Confidence 4322 2456899999999999999999999999999999999999999998764322 122222221111
Q ss_pred ccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhh-hhcCCCCCCC
Q 041143 863 PALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLV-EKWRPITDES 917 (973)
Q Consensus 863 ~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~-~~~~~~~~~~ 917 (973)
|. .......+||.++|+.+|.+|||+++|+. .++. ....|.....
T Consensus 238 P~--------~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~--h~Ff~~g~~p~~lp~ 283 (592)
T KOG0575|consen 238 PS--------HLSAEAKDLIRKLLRPNPSERPSLDEVLD--HPFFKSGFTPARLPS 283 (592)
T ss_pred cc--------ccCHHHHHHHHHHhcCCcccCCCHHHHhc--CHhhhCCCcCCCCCc
Confidence 11 22234679999999999999999999998 7766 3344443333
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=379.98 Aligned_cols=259 Identities=26% Similarity=0.406 Sum_probs=210.2
Q ss_pred HhcCccccCcccccCccEEEEEE-ECCCCEEEEEEeecCCCChH-----HHHHHHHHHHHHHhcCCCceeeeeeEEEeCC
Q 041143 623 VTQNFAQENELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTK-----ALDEFQSEIAVLSKVRHRHLVSLLGYSIEGN 696 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 696 (973)
..+.|...+.||+|+||.|-+|. .++|+.||||++........ .....++|+++|++++|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 34667888999999999999995 56799999999965432221 1234679999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCC---CCEEEe
Q 041143 697 ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDD---YRAKVS 773 (973)
Q Consensus 697 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~---~~~kl~ 773 (973)
..|||||||+||+|.+++.. .+.+.+.....+++|++.|+.||| ++||+||||||+|||+..+ ..+||+
T Consensus 250 s~YmVlE~v~GGeLfd~vv~-----nk~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKIt 321 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA-----NKYLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKIT 321 (475)
T ss_pred ceEEEEEEecCccHHHHHHh-----ccccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEec
Confidence 99999999999999999866 245666777889999999999999 8999999999999999766 779999
Q ss_pred eccccccCCCCCcceecccccccCcccccccccCc---CCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHH
Q 041143 774 DFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGK---ITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRI 850 (973)
Q Consensus 774 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 850 (973)
|||+|+..+. ...+.++|||+.|.|||++.++. +..|+|+||+||+||-+++|.+||.+..... .
T Consensus 322 DFGlAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--s-------- 389 (475)
T KOG0615|consen 322 DFGLAKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--S-------- 389 (475)
T ss_pred ccchhhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--c--------
Confidence 9999998763 45567799999999999998654 3348899999999999999999998665321 0
Q ss_pred hhchhHHHhhcCccccCCcccHH-HHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 851 KSSKEKFKAAIDPALEVNEETFE-SISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 851 ~~~~~~~~~~~~~~l~~~~~~~~-~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
-.+++...++.+....+. ..++..++|.+||..||++||++.|+++ ++|++
T Consensus 390 -----l~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~--hpW~~ 441 (475)
T KOG0615|consen 390 -----LKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN--HPWFK 441 (475)
T ss_pred -----HHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc--Chhhh
Confidence 112223334444433333 3356889999999999999999999998 66655
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=394.24 Aligned_cols=255 Identities=33% Similarity=0.506 Sum_probs=212.4
Q ss_pred cccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEecCC
Q 041143 628 AQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPH 707 (973)
Q Consensus 628 ~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 707 (973)
...+.||+|.||.||.|.++...+||||.++.. ....++|.+|+++|++++|+|||+++|+|..++..+||||||+.
T Consensus 209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~---~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~ 285 (468)
T KOG0197|consen 209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG---SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK 285 (468)
T ss_pred HHHHHhcCCccceEEEEEEcCCCcccceEEecc---ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence 345789999999999999998889999999865 23346788999999999999999999999999999999999999
Q ss_pred CCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCcc
Q 041143 708 GALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKS 787 (973)
Q Consensus 708 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~~ 787 (973)
|+|.+||+. .....+...+.+.++.|||+||+||+ ++++|||||.++||||+++..+||+|||+|+...++...
T Consensus 286 GsLl~yLr~---~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~ 359 (468)
T KOG0197|consen 286 GSLLDYLRT---REGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT 359 (468)
T ss_pred CcHHHHhhh---cCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCCcee
Confidence 999999976 23467889999999999999999999 899999999999999999999999999999966665554
Q ss_pred eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCcccc
Q 041143 788 VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALE 866 (973)
Q Consensus 788 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 866 (973)
......-...|.|||.+..+.++.|||||||||+||||+| |+.|+......+. -+.++...+
T Consensus 360 ~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev-----------------~~~le~GyR 422 (468)
T KOG0197|consen 360 ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV-----------------LELLERGYR 422 (468)
T ss_pred ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH-----------------HHHHhccCc
Confidence 4444556779999999999999999999999999999999 6777776553221 111222222
Q ss_pred CCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 867 VNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 867 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
-+.+..+...+.+|+..||+.+|++|||++.+...|+.+...
T Consensus 423 -lp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 423 -LPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred -CCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 112223445678899999999999999999998888877653
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=362.65 Aligned_cols=261 Identities=28% Similarity=0.414 Sum_probs=213.8
Q ss_pred cCccccCcccccCccEEEEEE-ECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeee-EEEeCCe-EEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLG-YSIEGNE-RLLV 701 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~lV 701 (973)
.+|.++++||+|.||+|||+. ..+|..+|.|.++-+..+.+..++...|+.+|++++|||||++++ .+.++.+ .+||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 467788999999999999995 568999999999877777888889999999999999999999999 4555555 7899
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhcc-CCeeeccCCCCcEEECCCCCEEEeecccccc
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLAR-QTFIHRDLKSSNILLDDDYRAKVSDFGLVKL 780 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~-~~ivH~Dikp~Nill~~~~~~kl~DfGla~~ 780 (973)
|||+..|+|...++.+.+ +.+.+++..+++++.|+++||.++|.... .-|+||||||.||+++.+|.+||+|||+++.
T Consensus 99 mE~c~~GDLsqmIk~~K~-qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKK-QKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHh-ccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 999999999999987655 44789999999999999999999995322 2389999999999999999999999999997
Q ss_pred CCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhh
Q 041143 781 APDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAA 860 (973)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (973)
+.... ......+|||.||+||.+.+..|+.|+||||+||++|||+.-++||.+.. +.+.-.++...+
T Consensus 178 l~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n------~~~L~~KI~qgd------ 244 (375)
T KOG0591|consen 178 LSSKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN------LLSLCKKIEQGD------ 244 (375)
T ss_pred hcchh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc------HHHHHHHHHcCC------
Confidence 76533 33456899999999999999999999999999999999999999998763 222222332210
Q ss_pred cCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHH
Q 041143 861 IDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLS 904 (973)
Q Consensus 861 ~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~ 904 (973)
-+.+ ........+.+||..|+..||++||+...+++.+.
T Consensus 245 -~~~~----p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 245 -YPPL----PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred -CCCC----cHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 0111 11334456889999999999999998655555443
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=408.45 Aligned_cols=263 Identities=31% Similarity=0.471 Sum_probs=214.1
Q ss_pred cCccccCcccccCccEEEEEEEC------CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE------DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNER 698 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 698 (973)
.+....+.||+|.||+||+|+.. +...||||.++.. ...+...+|++|+++++.++|||||+++|+|.+++..
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-AENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc-ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 34455688999999999999753 3457999999875 4555788999999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhhhcc---------CCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCC
Q 041143 699 LLVYEYMPHGALSRHLFRWEKLQ---------LKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYR 769 (973)
Q Consensus 699 ~lV~e~~~~g~L~~~l~~~~~~~---------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~ 769 (973)
+||+|||..|||.+||+...... ..+++..+.+.||.|||.||+||- ++.+|||||..+|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceE
Confidence 99999999999999998643222 123899999999999999999998 889999999999999999999
Q ss_pred EEEeeccccccCCC-CCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHH
Q 041143 770 AKVSDFGLVKLAPD-GEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWF 847 (973)
Q Consensus 770 ~kl~DfGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 847 (973)
|||+|||+++.... +......+-.-..+|||||.|+.++|+++||||||||+|||+++ |+-|+.+...++.. +.+
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI---e~i 718 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI---ECI 718 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH---HHH
Confidence 99999999994433 33222223445779999999999999999999999999999998 78888776543321 111
Q ss_pred HHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 848 WRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 848 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
+ ...+ -.-+..+..++..|+..||+..|++||+++||-..|+.+.+.
T Consensus 719 ~-------------~g~l--L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 719 R-------------AGQL--LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred H-------------cCCc--ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 1 1111 122234456688999999999999999999999999888764
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=368.35 Aligned_cols=244 Identities=28% Similarity=0.406 Sum_probs=203.8
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTT-TKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLV 701 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 701 (973)
.++|+..++||+|+||+||.++.+ +++.+|+|+++..... ....+...+|..+|.+++||+||+++..|++.+..|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 368899999999999999999765 5889999999765333 34577889999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccC
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA 781 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~ 781 (973)
+||+.||.|..+|.+ ...+++..+.-++..|+.||.||| +.+|||||+||+|||+|++|+++|+|||+++..
T Consensus 104 ld~~~GGeLf~hL~~-----eg~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQR-----EGRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred EeccCCccHHHHHHh-----cCCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 999999999999975 356888889999999999999999 899999999999999999999999999999955
Q ss_pred CCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhc
Q 041143 782 PDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861 (973)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (973)
.... .....++||+.|||||++.+..|+..+|.||+||++|||++|.+||...+.. .+...+...+ ...
T Consensus 176 ~~~~-~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~------~~~~~I~~~k----~~~ 244 (357)
T KOG0598|consen 176 LKDG-DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK------KMYDKILKGK----LPL 244 (357)
T ss_pred ccCC-CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH------HHHHHHhcCc----CCC
Confidence 4432 2345589999999999999999999999999999999999999999876632 2233333221 000
Q ss_pred CccccCCcccHHHHHHHHHHHHHhhccCCCCCC
Q 041143 862 DPALEVNEETFESISIVAELAGHCTAREPYHRP 894 (973)
Q Consensus 862 ~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RP 894 (973)
.+. -......+++...+..||++|.
T Consensus 245 ~p~--------~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 245 PPG--------YLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred CCc--------cCCHHHHHHHHHHhccCHHHhc
Confidence 111 1123467999999999999996
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=349.27 Aligned_cols=268 Identities=24% Similarity=0.344 Sum_probs=211.2
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
+.|+...++|+|+||+|||++.+ +|+.||||++.....+....+-..+||++|++++|+|+|.++++|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46788889999999999999876 59999999998776666667778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|++.--| +-|.. .. ..++.....+++.|+++|+.|+| ++++|||||||+|||++.++.+||||||+|+....
T Consensus 82 ~~dhTvL-~eLe~---~p-~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 82 YCDHTVL-HELER---YP-NGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred ecchHHH-HHHHh---cc-CCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 9976433 33333 22 44788889999999999999999 89999999999999999999999999999996654
Q ss_pred CCcceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHH--------HHhhch
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFW--------RIKSSK 854 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~~ 854 (973)
.....+.++.|+.|+|||.+.+ .+|+..+||||+||++.||++|.+-|.+...-+..+.+...- .+....
T Consensus 154 -pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 154 -PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred -CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence 3345678899999999999987 789999999999999999999999998877655544432211 111111
Q ss_pred hHHHhhcCccccC----CcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 855 EKFKAAIDPALEV----NEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 855 ~~~~~~~~~~l~~----~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
..+..+.-|..+- +........-++++++.|++.||.+|++-+|++.
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 1111111121110 0001112234779999999999999999999886
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=363.20 Aligned_cols=274 Identities=23% Similarity=0.306 Sum_probs=215.9
Q ss_pred hcCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeC--CeEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEG--NERLL 700 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 700 (973)
.+.|+.+++||+|.||.||+|+. .+|+.||+|+++.....+....-..+||.+|++++||||++|.+...+. ...||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 45677788999999999999965 6799999999987755566667788999999999999999999998876 68999
Q ss_pred EEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecccccc
Q 041143 701 VYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKL 780 (973)
Q Consensus 701 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~ 780 (973)
|+|||+. ||.-++.. ..-.++..++..++.|++.||+|+| .++|+|||||.+|||||.+|.+||+|||+|++
T Consensus 196 VFeYMdh-DL~GLl~~----p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~ 267 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSS----PGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARF 267 (560)
T ss_pred EEecccc-hhhhhhcC----CCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceee
Confidence 9999966 77776643 2356899999999999999999999 89999999999999999999999999999998
Q ss_pred CCCCCcceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhH---
Q 041143 781 APDGEKSVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEK--- 856 (973)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 856 (973)
+........+..+-|..|+|||++.+ ..|+.++|+||.||||.||++|++.|.+..+.+....+--+-.......+
T Consensus 268 y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 268 YTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred ccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence 77766666788889999999999986 47999999999999999999999999988765543332111110100000
Q ss_pred -HH--hhcCccccCCc----ccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhh
Q 041143 857 -FK--AAIDPALEVNE----ETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLV 907 (973)
Q Consensus 857 -~~--~~~~~~l~~~~----~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~ 907 (973)
+. ..+.+.-.... .........++|+..+|..||.+|.|+.++++ .++.
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~--seyF 403 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ--SEYF 403 (560)
T ss_pred cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc--Cccc
Confidence 00 11111100000 00011134779999999999999999999998 6665
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=338.50 Aligned_cols=238 Identities=29% Similarity=0.420 Sum_probs=204.8
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecC-CCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAG-VTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
++|+..+.||.|+||+|.+++.+ +|..+|+|++... +...++.+....|..+|+.+.||+++++++.+.+.+..||||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 56788899999999999999765 5889999999654 445566778899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||++||.|..++++. ++++...+.-+|.||+.||+||| +.+|++||+||+|||+|.+|.+||+|||+|+...
T Consensus 124 eyv~GGElFS~Lrk~-----~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKS-----GRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred eccCCccHHHHHHhc-----CCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 999999999999873 56888999999999999999999 8899999999999999999999999999999775
Q ss_pred CCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcC
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (973)
.. ..+.||||.|+|||++..+.|..++|.|||||++|||+.|.+||....+. ..+.++...+-.+...+.
T Consensus 196 ~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~------~iY~KI~~~~v~fP~~fs 265 (355)
T KOG0616|consen 196 GR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI------QIYEKILEGKVKFPSYFS 265 (355)
T ss_pred Cc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH------HHHHHHHhCcccCCcccC
Confidence 43 45689999999999999999999999999999999999999999887752 223334443333333333
Q ss_pred ccccCCcccHHHHHHHHHHHHHhhccCCCCC
Q 041143 863 PALEVNEETFESISIVAELAGHCTAREPYHR 893 (973)
Q Consensus 863 ~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~R 893 (973)
+ .+.+|+...++.|-.+|
T Consensus 266 ~-------------~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 266 S-------------DAKDLLKKLLQVDLTKR 283 (355)
T ss_pred H-------------HHHHHHHHHHhhhhHhh
Confidence 3 35589999999999988
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=366.36 Aligned_cols=268 Identities=27% Similarity=0.494 Sum_probs=216.2
Q ss_pred HHHHHHhcCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCe
Q 041143 618 QVLRKVTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNE 697 (973)
Q Consensus 618 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 697 (973)
++.+...+.+...+.||+|.||+||+|++. | .||||++.......+..+.|+.|+.++++-+|.||+-+.|||.....
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh-G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH-G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc-c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 444455566778899999999999999997 3 59999999887788899999999999999999999999999998877
Q ss_pred EEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccc
Q 041143 698 RLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL 777 (973)
Q Consensus 698 ~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGl 777 (973)
.||..+|+|-+|+.++|..+ ..++..+.+.||+|||+||.||| .++|||||||..||++.+++.|||+|||+
T Consensus 463 -AIiTqwCeGsSLY~hlHv~e----tkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQE----TKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred -eeeehhccCchhhhhccchh----hhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccc
Confidence 99999999999999998733 56889999999999999999999 89999999999999999999999999999
Q ss_pred cccCCC-CCcceecccccccCccccccccc---CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhc
Q 041143 778 VKLAPD-GEKSVVTRLAGTFGYLAPEYAVM---GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSS 853 (973)
Q Consensus 778 a~~~~~-~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 853 (973)
+..... ..........|...|||||++.. .+|+..+||||||+|+|||+||..||.....+... +.+-
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIi------fmVG-- 606 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQII------FMVG-- 606 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheE------EEec--
Confidence 863221 11222334568889999999974 46899999999999999999999999844332211 1100
Q ss_pred hhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 854 KEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 854 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
.+. ..+.+ ..........|.+|+..||..++++||.+.+|+..|+.+...
T Consensus 607 rG~----l~pd~--s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 607 RGY----LMPDL--SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred ccc----cCccc--hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 110 01111 111223445688999999999999999999999999888664
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=359.41 Aligned_cols=259 Identities=25% Similarity=0.385 Sum_probs=211.6
Q ss_pred HHHhcCccccCcccccCccEEEEEEE-CCCCEEEEEEeecC-CCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCe
Q 041143 621 RKVTQNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAG-VTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGNE 697 (973)
Q Consensus 621 ~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 697 (973)
.+...+|...+.||+|+|++||+|+. ..++.||||++... ...+...+...+|-++|.+| .||.||+|+..|+++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 34457899999999999999999965 46899999998543 22233345677899999999 79999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccc
Q 041143 698 RLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL 777 (973)
Q Consensus 698 ~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGl 777 (973)
.|+|+||+++|+|.++++++ +.+++.-...+|.+|+.||+||| ++|||||||||+|||+|++|++||+|||.
T Consensus 149 LYFvLe~A~nGdll~~i~K~-----Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGs 220 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKY-----GSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGS 220 (604)
T ss_pred eEEEEEecCCCcHHHHHHHh-----CcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccc
Confidence 99999999999999999874 55788888899999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCcc----------e--ecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHH
Q 041143 778 VKLAPDGEKS----------V--VTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAE 845 (973)
Q Consensus 778 a~~~~~~~~~----------~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~ 845 (973)
|+.+...... . ...++||..|.+||++.....+..+|+|+|||++|+|+.|++||.+..+.-
T Consensus 221 AK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl------ 294 (604)
T KOG0592|consen 221 AKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL------ 294 (604)
T ss_pred cccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH------
Confidence 9865432211 1 145899999999999999999999999999999999999999998765321
Q ss_pred HHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 846 WFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 846 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
.+.++++-.+.+...-. ..+.+|+.+.|..||.+|++..||-+ +.+.+
T Consensus 295 ----------iFqkI~~l~y~fp~~fp---~~a~dLv~KLLv~dp~~Rlt~~qIk~--HpFF~ 342 (604)
T KOG0592|consen 295 ----------IFQKIQALDYEFPEGFP---EDARDLIKKLLVRDPSDRLTSQQIKA--HPFFE 342 (604)
T ss_pred ----------HHHHHHHhcccCCCCCC---HHHHHHHHHHHccCccccccHHHHhh--Ccccc
Confidence 12222222222222211 44679999999999999999988887 44443
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=360.65 Aligned_cols=254 Identities=25% Similarity=0.388 Sum_probs=218.5
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
++|.+.+.||+|.||.||||+.+ +.+.||+|.+.+....++..+.+.+|+++++.++|||||.++++|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888899999999999999765 57899999998777788888999999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+.| +|..+|.. ...+++..+..|+.+++.||.||| +.+|+|||+||.|||++.++.+|+||||+|+.+..
T Consensus 82 ~a~g-~L~~il~~-----d~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~ 152 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ-----DGKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST 152 (808)
T ss_pred hhhh-hHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhccc
Confidence 9966 99999965 356899999999999999999999 89999999999999999999999999999997765
Q ss_pred CCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCc
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDP 863 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (973)
+..+.+.+.|||-|||||+..+..|+..+|+||+||++|||++|++||.... +.+.+..+..+ +
T Consensus 153 -~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~~I~~d---------~ 216 (808)
T KOG0597|consen 153 -NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVKSILKD---------P 216 (808)
T ss_pred -CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHHHHhcC---------C
Confidence 4566788899999999999999999999999999999999999999996432 33333333321 1
Q ss_pred cccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 864 ALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 864 ~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
.. .+......+..++...+.+||.+|.+-.+++. +.+.+.
T Consensus 217 v~----~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~--HpF~k~ 256 (808)
T KOG0597|consen 217 VK----PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG--HPFWKG 256 (808)
T ss_pred CC----CcccccHHHHHHHHHHhhcChhhcccHHHHhc--ChHHhh
Confidence 11 11134455778999999999999999999987 665553
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=378.90 Aligned_cols=258 Identities=28% Similarity=0.499 Sum_probs=220.5
Q ss_pred CccccCcccccCccEEEEEEECC----CCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEE
Q 041143 626 NFAQENELGRGGFGTVYKGELED----GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLV 701 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 701 (973)
...++++||.|.||.||+|+++- ...||||.+|.. ..++...+|..|..||.+++||||++|.|+.......+||
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 44667899999999999998752 357999999986 4677788999999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccC
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA 781 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~ 781 (973)
.|||++|+|+.||+..+ ..+++.+.+.+.++||.||.||- +.++|||||.++|||++.+..+||+|||+++..
T Consensus 709 TEyMENGsLDsFLR~~D----GqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQND----GQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred hhhhhCCcHHHHHhhcC----CceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEeccccceeec
Confidence 99999999999997633 45899999999999999999998 889999999999999999999999999999977
Q ss_pred CCCCcceeccccc--ccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHH
Q 041143 782 PDGEKSVVTRLAG--TFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFK 858 (973)
Q Consensus 782 ~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (973)
.++.....+...| ..+|.|||.+..++++.++|||||||||||.++ |.+|+-+....+ ..
T Consensus 782 edd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd-----------------VI 844 (996)
T KOG0196|consen 782 EDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-----------------VI 844 (996)
T ss_pred ccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH-----------------HH
Confidence 6655444443333 579999999999999999999999999999876 788876654322 22
Q ss_pred hhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 859 AAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 859 ~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
..|+..++ ...++++...+.+|+..||++|-.+||.+.||+..|.+++.+
T Consensus 845 kaIe~gyR-LPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 845 KAIEQGYR-LPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred HHHHhccC-CCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 22333343 345667788899999999999999999999999999999875
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=358.93 Aligned_cols=274 Identities=22% Similarity=0.334 Sum_probs=215.6
Q ss_pred HHhcCccccCcccccCccEEEEEE-ECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeeEEEeCC-eE
Q 041143 622 KVTQNFAQENELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR-HRHLVSLLGYSIEGN-ER 698 (973)
Q Consensus 622 ~~~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~ 698 (973)
...++|...++||.|.||.||+|+ ..+|+.||||+|+.....-++ -.-.||+..|++++ |||||++.+++.+.+ ..
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee-~~nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEE-CMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHH-HHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 345788999999999999999996 457999999999876544332 23468999999998 999999999999988 89
Q ss_pred EEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecccc
Q 041143 699 LLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLV 778 (973)
Q Consensus 699 ~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla 778 (973)
++||||| ..+|++.+..+ .+.+++..+..|+.||++||+|+| ++|+.|||+||+|||+..+..+||+|||+|
T Consensus 86 ~fVfE~M-d~NLYqLmK~R----~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLA 157 (538)
T KOG0661|consen 86 YFVFEFM-DCNLYQLMKDR----NRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLA 157 (538)
T ss_pred eeeHHhh-hhhHHHHHhhc----CCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccc
Confidence 9999999 66999999762 478999999999999999999999 999999999999999999999999999999
Q ss_pred ccCCCCCcceecccccccCcccccccc-cCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhch---
Q 041143 779 KLAPDGEKSVVTRLAGTFGYLAPEYAV-MGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSK--- 854 (973)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 854 (973)
|.... ....+.++.|+.|+|||++. .+.|+.+.||||+|||++|+.+-++-|.+..+.+..+-+--+-.-...+
T Consensus 158 Rev~S--kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~ 235 (538)
T KOG0661|consen 158 REVRS--KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWP 235 (538)
T ss_pred ccccc--CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccch
Confidence 96644 33567789999999999876 5779999999999999999999999998887655433221111000000
Q ss_pred --hHHHhhcCcccc------CCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 855 --EKFKAAIDPALE------VNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 855 --~~~~~~~~~~l~------~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
..+...+.-.+. ...--.....+.++++.+|++.||.+|||++|+++ ..+.+
T Consensus 236 eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~--~pffq 295 (538)
T KOG0661|consen 236 EGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ--HPFFQ 295 (538)
T ss_pred hHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc--Ccccc
Confidence 111122211111 01111224467889999999999999999999998 44444
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=357.32 Aligned_cols=269 Identities=28% Similarity=0.421 Sum_probs=215.0
Q ss_pred HHHHhcCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEE
Q 041143 620 LRKVTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERL 699 (973)
Q Consensus 620 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 699 (973)
.+.......+.++||+|-||.|.++....+.+||||.++.. .......+|.+|+++|.+++|||||+++|+|..++..+
T Consensus 533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~-a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic 611 (807)
T KOG1094|consen 533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPD-ATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC 611 (807)
T ss_pred hhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcc-cchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence 34455677888999999999999999998899999999876 34555689999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccc
Q 041143 700 LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK 779 (973)
Q Consensus 700 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~ 779 (973)
+|+|||++|+|.+|+.+.+.. .+.-...++|+.|||.||+||. +.++|||||.++|+|+|.++++||+|||+++
T Consensus 612 mI~EYmEnGDLnqFl~aheap---t~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR 685 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELP---TAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSR 685 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCc---ccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCccccc
Confidence 999999999999999774332 2455667889999999999999 7899999999999999999999999999999
Q ss_pred cCCCCC-cceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh--CCCCCCCCChhhHHHHHHHHHHHhhchhH
Q 041143 780 LAPDGE-KSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT--GLAALDEERPEESRYLAEWFWRIKSSKEK 856 (973)
Q Consensus 780 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (973)
....++ .....+.+-..+|||||.+..+++++++|||+|||++||+++ ...||.....++ +++...........
T Consensus 686 ~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~~~~~~~~ 762 (807)
T KOG1094|consen 686 NLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGEFFRDQGR 762 (807)
T ss_pred ccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhhhcCCCCc
Confidence 544443 334445667789999999999999999999999999999865 677876554322 22211111111100
Q ss_pred HHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHh
Q 041143 857 FKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPL 906 (973)
Q Consensus 857 ~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~ 906 (973)
+. ....+.-+...+.+++..||+.|-++||+++++...|.+.
T Consensus 763 --~~------~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 763 --QV------VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred --ce------eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 00 1112233456688999999999999999999999877654
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=339.81 Aligned_cols=305 Identities=23% Similarity=0.335 Sum_probs=233.7
Q ss_pred HhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEe-----CC
Q 041143 623 VTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIE-----GN 696 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~ 696 (973)
+...|...+.||+|+||.|+.+... +|+.||||++..........++..+|++++++++|+||+.+++.+.. -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3456666789999999999999764 68999999998766677788899999999999999999999998875 35
Q ss_pred eEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecc
Q 041143 697 ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFG 776 (973)
Q Consensus 697 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG 776 (973)
..|+|+|+| +-+|.+.++. .+.++.....-+.+|+++||.|+| +.+|+|||+||+|++++.+...||+|||
T Consensus 100 DvYiV~elM-etDL~~iik~-----~~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFG 170 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKS-----QQDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFG 170 (359)
T ss_pred eeEEehhHH-hhHHHHHHHc-----CccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEecccc
Confidence 789999999 6789888865 244889999999999999999999 8899999999999999999999999999
Q ss_pred ccccCCC-CCcceecccccccCcccccccc-cCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHh---
Q 041143 777 LVKLAPD-GEKSVVTRLAGTFGYLAPEYAV-MGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIK--- 851 (973)
Q Consensus 777 la~~~~~-~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~--- 851 (973)
+|+.... ......+.++.|..|.|||++. ..+|+.+.||||.||++.||++|++-|.+.+.-+...++...-...
T Consensus 171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e 250 (359)
T KOG0660|consen 171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEE 250 (359)
T ss_pred ceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHH
Confidence 9996543 2233457788999999999876 5679999999999999999999999998887544333321110000
Q ss_pred ----hchhHHHhhcCccccCCccc-----HHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCCCCCCCcccCC
Q 041143 852 ----SSKEKFKAAIDPALEVNEET-----FESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPITDESECCSG 922 (973)
Q Consensus 852 ----~~~~~~~~~~~~~l~~~~~~-----~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~~~~~~~~~~~ 922 (973)
...+..+..+.........+ ...-...++|+.+|+..||.+|+|++|+++ ++++..|+.+++++.+...
T Consensus 251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~--hPYl~~~hdp~dEP~~~~~ 328 (359)
T KOG0660|consen 251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA--HPYLAPYHDPEDEPVCQPI 328 (359)
T ss_pred HHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc--ChhhhhhcCCccCCCCCCC
Confidence 00111111111111100111 122245789999999999999999999999 9999999999999877765
Q ss_pred CCCCCCchhHHHHHHHh
Q 041143 923 IDYSLPLPQMLKVWQEA 939 (973)
Q Consensus 923 ~~~~~~~p~~~~~~~~~ 939 (973)
....... ...++||+.
T Consensus 329 ~~~~~~~-~~~~~~r~~ 344 (359)
T KOG0660|consen 329 FDSFEHE-LTEEELREL 344 (359)
T ss_pred Ccccccc-ccHHHHHHH
Confidence 4421111 334555543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=325.28 Aligned_cols=272 Identities=23% Similarity=0.340 Sum_probs=211.8
Q ss_pred cCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
.+|...+.||+|.||.||+|++ ++|+.||||+++.....+.......+||+.|+.++|+||+.++++|...+..-||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4677889999999999999965 579999999998764444445578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|| ..+|+..++. ....++-.+...++.++++|++||| .+.|+||||||.|+|++.+|.+||+|||+|+.+..
T Consensus 82 fm-~tdLe~vIkd----~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~ 153 (318)
T KOG0659|consen 82 FM-PTDLEVVIKD----KNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGS 153 (318)
T ss_pred ec-cccHHHHhcc----cccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCC
Confidence 99 4589888865 3467889999999999999999999 88999999999999999999999999999997765
Q ss_pred CCcceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhch-hH-----
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSK-EK----- 856 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~----- 856 (973)
..... +..+-|..|+|||.+.+ +.|+..+||||.||++.||+-|.+-|.+...-+.... .+...-... +.
T Consensus 154 p~~~~-~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~--If~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 154 PNRIQ-THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSK--IFRALGTPTPDQWPEMT 230 (318)
T ss_pred CCccc-ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHH--HHHHcCCCCcccCcccc
Confidence 44332 23378999999999886 5699999999999999999999988887765433221 111111000 00
Q ss_pred -HHhhc----CccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 857 -FKAAI----DPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 857 -~~~~~----~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
+.+.+ -|.......-..+.....+++..|+..||.+|++++|+++ +++...
T Consensus 231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~--~~yf~~ 286 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK--HPYFKS 286 (318)
T ss_pred ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc--chhhhc
Confidence 00000 0111101111223345689999999999999999999998 666554
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=353.39 Aligned_cols=257 Identities=29% Similarity=0.467 Sum_probs=201.7
Q ss_pred cCccccCcccccCccEEEEEEECC-CCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC--eEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELED-GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGN--ERLLV 701 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV 701 (973)
.++...+.||+|+||.||++...+ |+..|||.+... .....+.+.+|+.+|.+++|||||+.+|...... .+++.
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~--~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELE--DSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecc--cchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 345667889999999999998764 899999998765 2222677899999999999999999999855544 68999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECC-CCCEEEeecccccc
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDD-DYRAKVSDFGLVKL 780 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~-~~~~kl~DfGla~~ 780 (973)
|||+++|+|.+++.++. . .+++..+.+++.||++||+||| +++||||||||+|||++. ++.+||+|||+++.
T Consensus 95 mEy~~~GsL~~~~~~~g---~-~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~ 167 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYG---G-KLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKK 167 (313)
T ss_pred eeccCCCcHHHHHHHcC---C-CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCccccc
Confidence 99999999999997632 2 5899999999999999999999 899999999999999999 79999999999986
Q ss_pred CCC--CCcceecccccccCcccccccccC-cCCCchhHHhHHHHHHHHHhCCCCCCCC-ChhhHHHHHHHHHHHhhchhH
Q 041143 781 APD--GEKSVVTRLAGTFGYLAPEYAVMG-KITTKADVFSYGVVLMELLTGLAALDEE-RPEESRYLAEWFWRIKSSKEK 856 (973)
Q Consensus 781 ~~~--~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~ 856 (973)
... ........+.||+.|||||++..+ ....++||||+||++.||+||+.||... .. ..++..+....
T Consensus 168 ~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~------~~~~~~ig~~~-- 239 (313)
T KOG0198|consen 168 LESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEE------AEALLLIGRED-- 239 (313)
T ss_pred cccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcch------HHHHHHHhccC--
Confidence 542 112223457899999999999854 3445999999999999999999999763 11 11111111111
Q ss_pred HHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 857 FKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 857 ~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
..|.+. ........+++.+|++.||++|||+.++++ +.+...
T Consensus 240 ----~~P~ip-----~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~--hpf~~~ 281 (313)
T KOG0198|consen 240 ----SLPEIP-----DSLSDEAKDFLRKCFKRDPEKRPTAEELLE--HPFLKQ 281 (313)
T ss_pred ----CCCCCC-----cccCHHHHHHHHHHhhcCcccCcCHHHHhh--Chhhhc
Confidence 111111 112345679999999999999999999998 555443
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=365.05 Aligned_cols=258 Identities=26% Similarity=0.413 Sum_probs=212.6
Q ss_pred HhcCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCC---hHHHHHHHHHHHHHHhcC-CCceeeeeeEEEeCCe
Q 041143 623 VTQNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTT---TKALDEFQSEIAVLSKVR-HRHLVSLLGYSIEGNE 697 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 697 (973)
...+|...+.||+|+||+||+|.. .+|+.||+|++...... ....+.+.+|+.++++++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 346889999999999999999965 46899999977553111 134556778999999998 9999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCC-CCEEEeecc
Q 041143 698 RLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDD-YRAKVSDFG 776 (973)
Q Consensus 698 ~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~-~~~kl~DfG 776 (973)
.++||||+.+|+|.+++.. ..++.+.++.+++.|++.|++||| +++|+||||||+|||+|.+ +.+||+|||
T Consensus 95 ~~ivmEy~~gGdL~~~i~~-----~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN-----KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred EEEEEEecCCccHHHHHHH-----cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEeccc
Confidence 9999999999999999975 256788999999999999999999 8999999999999999999 999999999
Q ss_pred ccccCCCCCcceecccccccCcccccccccCc-CC-CchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhch
Q 041143 777 LVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGK-IT-TKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSK 854 (973)
Q Consensus 777 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 854 (973)
++.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||++.... ..+..+....
T Consensus 167 ~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~------~l~~ki~~~~ 239 (370)
T KOG0583|consen 167 LSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP------NLYRKIRKGE 239 (370)
T ss_pred cccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH------HHHHHHhcCC
Confidence 999764 2334566789999999999999877 86 7899999999999999999999984432 1222233322
Q ss_pred hHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 855 EKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 855 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
-.+...++ -..+..++.+|+..||.+|+++.+|+. .++.+.
T Consensus 240 ~~~p~~~~------------S~~~~~Li~~mL~~~P~~R~t~~~i~~--h~w~~~ 280 (370)
T KOG0583|consen 240 FKIPSYLL------------SPEARSLIEKMLVPDPSTRITLLEILE--HPWFQK 280 (370)
T ss_pred ccCCCCcC------------CHHHHHHHHHHcCCCcccCCCHHHHhh--Chhhcc
Confidence 22222221 234779999999999999999999994 777664
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=363.50 Aligned_cols=256 Identities=24% Similarity=0.446 Sum_probs=212.8
Q ss_pred hcCccccCcccccCccEEEEEE-ECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
...|.....||+|+.|.||.|. ..+++.||||++... .....+-+.+|+.+|+..+|+|||.+++.|..+++.+.||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~--~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLR--KQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEec--cCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 3567778899999999999995 457889999999754 2333456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
|||++|+|.+.+.. ..+++.++..|++++++||+||| .++|+|||||.+|||++.+|.+||+|||++....
T Consensus 350 Eym~ggsLTDvVt~------~~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~ 420 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTK------TRMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQIS 420 (550)
T ss_pred eecCCCchhhhhhc------ccccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccc
Confidence 99999999988865 45899999999999999999999 8999999999999999999999999999987554
Q ss_pred CCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcC
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (973)
.... ....++||+.|||||++....|+.|+||||||++++||+-|++||-.+.+-...+++. ..-.
T Consensus 421 ~~~~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa-------------~ng~ 486 (550)
T KOG0578|consen 421 EEQS-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-------------TNGT 486 (550)
T ss_pred cccC-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh-------------hcCC
Confidence 4332 4566899999999999999999999999999999999999999998766544332221 1111
Q ss_pred ccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 863 PALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 863 ~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
|.++ .....-..+.+++.+||+.|+++||+++|+++ +++++.
T Consensus 487 P~lk---~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~--HpFl~~ 528 (550)
T KOG0578|consen 487 PKLK---NPEKLSPELKDFLDRCLVVDVEQRASAKELLE--HPFLKM 528 (550)
T ss_pred CCcC---CccccCHHHHHHHHHHhhcchhcCCCHHHHhc--Chhhhh
Confidence 2222 11122345779999999999999999999998 666643
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=344.41 Aligned_cols=261 Identities=23% Similarity=0.418 Sum_probs=208.9
Q ss_pred cCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
+.|+..++||.|..++||+|+. ..++.||||++..+..... .+.+++|+..|+.++||||++++..|..+...|+||.
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 5788889999999999999964 5689999999987654444 7889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecccccc-CC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKL-AP 782 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~-~~ 782 (973)
||.+|++.+.+..+-. ..+++..+..|.+++++||.||| .+|.||||||+.|||++.+|.|||+|||.+-. +.
T Consensus 105 fMa~GS~ldIik~~~~---~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYP---DGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred hhcCCcHHHHHHHHcc---ccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 9999999999977443 34889999999999999999999 89999999999999999999999999998663 33
Q ss_pred CCCcce--ecccccccCcccccccc--cCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHH
Q 041143 783 DGEKSV--VTRLAGTFGYLAPEYAV--MGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFK 858 (973)
Q Consensus 783 ~~~~~~--~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (973)
.+.... ...++||+.|||||+++ ...|+.|+||||||++..||.+|+.||....+..... . .+.. .. .
T Consensus 179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl--~---tLqn-~p--p 250 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLL--L---TLQN-DP--P 250 (516)
T ss_pred cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHH--H---HhcC-CC--C
Confidence 332221 24578999999999954 3469999999999999999999999999887654311 0 0000 00 0
Q ss_pred hhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 859 AAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 859 ~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
...-..+. .+.....-..+.+++..|++.||++|||+++++.
T Consensus 251 ~~~t~~~~-~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 251 TLLTSGLD-KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CcccccCC-hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 00000111 1112222335889999999999999999999987
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=368.19 Aligned_cols=265 Identities=27% Similarity=0.424 Sum_probs=207.1
Q ss_pred HhcCccccCcccccCccEEEEEEE------CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeC
Q 041143 623 VTQNFAQENELGRGGFGTVYKGEL------EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEG 695 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 695 (973)
..++|...+.||+|+||.||+|.. .+++.||||+++.. ......+.+.+|++++.++ +|||||+++++|...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG-ATASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc-cchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 346788999999999999999964 23568999998754 2344456799999999999 899999999998764
Q ss_pred C-eEEEEEEecCCCCHHHHHHhhhhc------------------------------------------------------
Q 041143 696 N-ERLLVYEYMPHGALSRHLFRWEKL------------------------------------------------------ 720 (973)
Q Consensus 696 ~-~~~lV~e~~~~g~L~~~l~~~~~~------------------------------------------------------ 720 (973)
+ ..++||||+++|+|.+++......
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4 578999999999999999753210
Q ss_pred ---cCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCcc-eeccccccc
Q 041143 721 ---QLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKS-VVTRLAGTF 796 (973)
Q Consensus 721 ---~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~ 796 (973)
...++++.++..++.||++||+||| +++|+||||||+|||++.++.+||+|||+++........ ......++.
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 0135888999999999999999999 889999999999999999999999999999854332221 122345678
Q ss_pred CcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccCCcccHHHH
Q 041143 797 GYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESI 875 (973)
Q Consensus 797 ~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 875 (973)
.|+|||++.+..++.++|||||||++|||++ |+.||......+. + ...... . ..... .....
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~---~~~~~~-~------~~~~~-----~~~~~ 303 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--F---CQRLKD-G------TRMRA-----PENAT 303 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--H---HHHHhc-C------CCCCC-----CCCCC
Confidence 9999999999999999999999999999997 9999976543211 0 111111 0 00110 01122
Q ss_pred HHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 876 SIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 876 ~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
..+.+++.+|++.||++||++.||++.|+.+.+
T Consensus 304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 304 PEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 357899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=365.83 Aligned_cols=263 Identities=28% Similarity=0.443 Sum_probs=211.1
Q ss_pred cCccccCcccccCccEEEEEEECC--C---CEEEEEEeec-CCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeE
Q 041143 625 QNFAQENELGRGGFGTVYKGELED--G---TKIAVKRMEA-GVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNER 698 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~--g---~~vavK~~~~-~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 698 (973)
++....++||+|+||.||+|+++. + ..||||..+. .........+|..|.++|++++|||||++||++......
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 344455899999999999997653 2 2389999886 335677889999999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecccc
Q 041143 699 LLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLV 778 (973)
Q Consensus 699 ~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla 778 (973)
++|||+|.||+|.+||.+.. ..++..+++.++.++|+||+||| .+++|||||.++|+|++.++.+||+|||++
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~----~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNK----KSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred EEEEEecCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccc
Confidence 99999999999999997622 35899999999999999999999 899999999999999999999999999998
Q ss_pred ccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHH
Q 041143 779 KLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKF 857 (973)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (973)
+.... .........-...|+|||.+..+.|+.++|||||||++||+++ |..|+.+....+. ..++ ..
T Consensus 310 ~~~~~-~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v---~~kI---~~----- 377 (474)
T KOG0194|consen 310 RAGSQ-YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV---KAKI---VK----- 377 (474)
T ss_pred cCCcc-eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHH---HHHH---Hh-----
Confidence 85431 1111111235679999999999999999999999999999999 8889987764322 1111 00
Q ss_pred HhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCC
Q 041143 858 KAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRP 912 (973)
Q Consensus 858 ~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~ 912 (973)
... +..... .....+..++.+|+..+|++||+|.+|.+.++.+.+...+
T Consensus 378 -~~~--r~~~~~---~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 378 -NGY--RMPIPS---KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred -cCc--cCCCCC---CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 000 111111 2334566788899999999999999999999999876543
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=337.43 Aligned_cols=282 Identities=22% Similarity=0.338 Sum_probs=224.8
Q ss_pred hcCccccCcccccCccEEEEEEE-CCCCEEEEEEeecC-CCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAG-VTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLV 701 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 701 (973)
..+|++.+.||+|.||.|-+|.. ..|+.||||.++.. ..+++..-.+.+||+||..++||||+.+|.+|+..+...+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 45788889999999999999965 67999999998654 44556677899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccC
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA 781 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~ 781 (973)
|||..+|.|++|+.. .+.+++.+..+++.||..|+.|+| +++++|||+|.+|||+|.++.+||+|||++..+
T Consensus 132 MEYaS~GeLYDYiSe-----r~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly 203 (668)
T KOG0611|consen 132 MEYASGGELYDYISE-----RGSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLY 203 (668)
T ss_pred EEecCCccHHHHHHH-----hccccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhh
Confidence 999999999999976 356899999999999999999999 999999999999999999999999999999987
Q ss_pred CCCCcceecccccccCcccccccccCcCC-CchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhh
Q 041143 782 PDGEKSVVTRLAGTFGYLAPEYAVMGKIT-TKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAA 860 (973)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (973)
.+. ...+.++|++-|.+||++.+..|. +.+|-||+||+||-|+.|..||++.+.... ++.+.
T Consensus 204 ~~~--kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~l------vrQIs--------- 266 (668)
T KOG0611|consen 204 ADK--KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRL------VRQIS--------- 266 (668)
T ss_pred ccc--cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHH------HHHhh---------
Confidence 664 346789999999999999999884 789999999999999999999998764211 12221
Q ss_pred cCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCCCCCCCcccCCCCCCCCchhHHHHHHH
Q 041143 861 IDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPITDESECCSGIDYSLPLPQMLKVWQE 938 (973)
Q Consensus 861 ~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 938 (973)
...+. .++.......||++|+..+|++|.|..+|..- |.-.|......-+++...+...|....+.+|-+
T Consensus 267 -~GaYr----EP~~PSdA~gLIRwmLmVNP~RRATieDiAsH---WWvNwgy~~~V~~~ea~h~~~~P~~~~m~dw~~ 336 (668)
T KOG0611|consen 267 -RGAYR----EPETPSDASGLIRWMLMVNPERRATIEDIASH---WWVNWGYNMPVIQEEAQHIDHTPGSDSMADWTE 336 (668)
T ss_pred -ccccc----CCCCCchHHHHHHHHHhcCcccchhHHHHhhh---heeecccccccccccccccCCCCcchhhhHHhh
Confidence 11221 11223446689999999999999999999862 222333322222333333333443444555543
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=357.60 Aligned_cols=256 Identities=25% Similarity=0.394 Sum_probs=213.7
Q ss_pred cCccccCcccccCccEEEEEEE-CCCCEEEEEEeecC-CCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAG-VTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
.-|..++.||+|+.|.|-+|+. .+|+.+|||++... .........+.+||-+|+-+.|||++++|+++++..+.|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 4567788999999999999965 57999999998654 233344567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++|-|++++.. .+++...++.+++.||+.|+.|+| ..+|+|||+||+|+|+|.++.+||+|||+|....
T Consensus 92 Eyv~gGELFdylv~-----kG~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~ 163 (786)
T KOG0588|consen 92 EYVPGGELFDYLVR-----KGPLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEV 163 (786)
T ss_pred EecCCchhHHHHHh-----hCCCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeeccc
Confidence 99999999999965 367899999999999999999999 7899999999999999999999999999998655
Q ss_pred CCCcceecccccccCcccccccccCcCC-CchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhc
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMGKIT-TKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (973)
.+ ....+.||++.|.|||++.+..|+ .++||||+|||||.|+||+.||++..- +.+. .++..+...+...
T Consensus 164 ~g--klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi---r~LL---lKV~~G~f~MPs~- 234 (786)
T KOG0588|consen 164 PG--KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI---RVLL---LKVQRGVFEMPSN- 234 (786)
T ss_pred CC--ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH---HHHH---HHHHcCcccCCCc-
Confidence 43 345667999999999999999985 789999999999999999999995442 2222 2222222222222
Q ss_pred CccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcC
Q 041143 862 DPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWR 911 (973)
Q Consensus 862 ~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~ 911 (973)
...++.+|+.+|+..||++|.|++||.. +.++..+.
T Consensus 235 ------------Is~eaQdLLr~ml~VDp~~RiT~~eI~k--HP~l~g~~ 270 (786)
T KOG0588|consen 235 ------------ISSEAQDLLRRMLDVDPSTRITTEEILK--HPFLSGYT 270 (786)
T ss_pred ------------CCHHHHHHHHHHhccCccccccHHHHhh--CchhhcCC
Confidence 2234679999999999999999999999 77776543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=349.57 Aligned_cols=260 Identities=23% Similarity=0.369 Sum_probs=207.7
Q ss_pred HHhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCC-CChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEE
Q 041143 622 KVTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGV-TTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERL 699 (973)
Q Consensus 622 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 699 (973)
...++|+.+.+||+|+||.||+|+.+ +|..+|+|+++... ......+....|-.+|...++|+||+|+..|++.+..|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 35578999999999999999999755 69999999997652 23345677889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccc
Q 041143 700 LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK 779 (973)
Q Consensus 700 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~ 779 (973)
|||||++||++...|.. ...|+...+..++.+++.|++-+| +.|+|||||||+|+|||..|++||+|||++.
T Consensus 218 LiMEylPGGD~mTLL~~-----~~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMR-----KDTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLST 289 (550)
T ss_pred EEEEecCCccHHHHHHh-----cCcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccc
Confidence 99999999999999965 367888889999999999999999 8899999999999999999999999999975
Q ss_pred cCCC-----------------------CCcc----e-------------------ecccccccCcccccccccCcCCCch
Q 041143 780 LAPD-----------------------GEKS----V-------------------VTRLAGTFGYLAPEYAVMGKITTKA 813 (973)
Q Consensus 780 ~~~~-----------------------~~~~----~-------------------~~~~~gt~~y~aPE~~~~~~~~~~~ 813 (973)
.... .... . ....+|||.|||||++.+..|+..+
T Consensus 290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c 369 (550)
T KOG0605|consen 290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC 369 (550)
T ss_pred hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence 2110 0000 0 0125799999999999999999999
Q ss_pred hHHhHHHHHHHHHhCCCCCCCCChhhH-HHHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCC
Q 041143 814 DVFSYGVVLMELLTGLAALDEERPEES-RYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYH 892 (973)
Q Consensus 814 Dv~S~Gvvl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~ 892 (973)
|.||+|||+|||+.|.+||....+.+. +.+..|-..... |. ..+...+..+||.+|+. ||++
T Consensus 370 DwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~f----------P~------~~~~s~eA~DLI~rll~-d~~~ 432 (550)
T KOG0605|consen 370 DWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKF----------PE------EVDLSDEAKDLITRLLC-DPEN 432 (550)
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccC----------CC------cCcccHHHHHHHHHHhc-CHHH
Confidence 999999999999999999998887542 333333221111 10 01111457799999999 9999
Q ss_pred CCC---HhHHHHHHHHhhh
Q 041143 893 RPD---MGHVVNVLSPLVE 908 (973)
Q Consensus 893 RPs---~~~v~~~L~~~~~ 908 (973)
|.- +.||-+ +++.+
T Consensus 433 RLG~~G~~EIK~--HPfF~ 449 (550)
T KOG0605|consen 433 RLGSKGAEEIKK--HPFFK 449 (550)
T ss_pred hcCcccHHHHhc--CCccc
Confidence 985 555555 44443
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=337.54 Aligned_cols=271 Identities=27% Similarity=0.428 Sum_probs=201.8
Q ss_pred cccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHh--cCCCceeeeeeEEEeCC----eEEEE
Q 041143 628 AQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSK--VRHRHLVSLLGYSIEGN----ERLLV 701 (973)
Q Consensus 628 ~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~lV 701 (973)
...++||+|.||.||||.+. ++.||||++ ..+..+.|+.|-+|.+. |+|+||++++++-...+ +++||
T Consensus 213 ~l~eli~~Grfg~V~KaqL~-~~~VAVKif-----p~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLD-NRLVAVKIF-----PEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred hhHHHhhcCccceeehhhcc-CceeEEEec-----CHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 34577999999999999998 589999998 45566788888888775 68999999999877665 88999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhh------ccCCeeeccCCCCcEEECCCCCEEEeec
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCL------ARQTFIHRDLKSSNILLDDDYRAKVSDF 775 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~------~~~~ivH~Dikp~Nill~~~~~~kl~Df 775 (973)
+||.+.|+|.+||.. ..++|....+|+..+++||+|||+. .+++|+|||||++||||.+|+++.|+||
T Consensus 287 t~fh~kGsL~dyL~~------ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKA------NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred eeeccCCcHHHHHHh------ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 999999999999976 6689999999999999999999964 3668999999999999999999999999
Q ss_pred cccccCCCCC-cceecccccccCcccccccccCc-C-----CCchhHHhHHHHHHHHHhCCCCCCC-CChhhHHHHHHHH
Q 041143 776 GLVKLAPDGE-KSVVTRLAGTFGYLAPEYAVMGK-I-----TTKADVFSYGVVLMELLTGLAALDE-ERPEESRYLAEWF 847 (973)
Q Consensus 776 Gla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~-~-----~~~~Dv~S~Gvvl~elltg~~p~~~-~~~~~~~~~~~~~ 847 (973)
|+|..+..+. ......-+||.+|||||++.+.- + -.+.||||+|.|||||+++...++. ..+.-..-..+-+
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 9998554332 12223368999999999987532 2 2368999999999999998766542 1110000000000
Q ss_pred HHHhhchhHH-----HhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcC
Q 041143 848 WRIKSSKEKF-----KAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWR 911 (973)
Q Consensus 848 ~~~~~~~~~~-----~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~ 911 (973)
..... -+.+ ++-..|.+.-.-.....+..+.+.+..||+.||+.|.|+.=|-+.+.++..-+.
T Consensus 441 G~hPt-~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 441 GNHPT-LEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred cCCCC-HHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 00000 0111 111122222111122456678899999999999999999999998888766543
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=360.59 Aligned_cols=245 Identities=27% Similarity=0.404 Sum_probs=204.6
Q ss_pred HhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecC-CCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeEE
Q 041143 623 VTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAG-VTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGNERL 699 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 699 (973)
..++|...++||+|.||+|+++..+ +++.+|||++++. +...+..+....|-+|+... +||.++.++.+++..++.|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 3478999999999999999999876 5789999999876 33455677888999998887 5999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccc
Q 041143 700 LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK 779 (973)
Q Consensus 700 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~ 779 (973)
+||||+.||++..+.+ ...+++.++.-+|..|+.||+||| +++|||||||.+|||+|.+|.+||+|||+++
T Consensus 446 fvmey~~Ggdm~~~~~------~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIH------TDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEecCCCcEEEEEe------cccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEeccccccc
Confidence 9999999999543332 267899999999999999999999 8999999999999999999999999999999
Q ss_pred cCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHh
Q 041143 780 LAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKA 859 (973)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (973)
...... ....+++||+.|||||++.+..|+.++|.|||||+||||+.|+.||.+.++++ -++.
T Consensus 517 e~m~~g-~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee----------------~Fds 579 (694)
T KOG0694|consen 517 EGMGQG-DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE----------------VFDS 579 (694)
T ss_pred ccCCCC-CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH----------------HHHH
Confidence 544222 24667999999999999999999999999999999999999999999776432 1222
Q ss_pred hcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCH
Q 041143 860 AIDPALEVNEETFESISIVAELAGHCTAREPYHRPDM 896 (973)
Q Consensus 860 ~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~ 896 (973)
++.... .++.....+.+.|+++++.++|++|.-+
T Consensus 580 I~~d~~---~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 580 IVNDEV---RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HhcCCC---CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 222111 1222334557899999999999999976
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=318.18 Aligned_cols=255 Identities=27% Similarity=0.437 Sum_probs=211.0
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecC-CCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAG-VTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLV 701 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 701 (973)
.++|+..+.||+|.||.||.|+.+ ++-.||+|++... ........++.+|+++-..++||||+++|+|+.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 468899999999999999999754 6788999998543 22223356799999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccC
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA 781 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~ 781 (973)
+||..+|.+...|+.. ....++......+..|+|.|+.|+| .++||||||||+|+|++.++..|++|||-+...
T Consensus 101 lEya~~gel~k~L~~~---~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEG---RMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EEecCCchHHHHHHhc---ccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 9999999999999752 2356788888999999999999999 899999999999999999999999999998765
Q ss_pred CCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhc
Q 041143 782 PDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861 (973)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (973)
+.+ ....++||..|.+||+..+..++.++|+|++||+.||++.|.+||......+ -++++...+. .
T Consensus 175 p~~---kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e------tYkrI~k~~~-----~ 240 (281)
T KOG0580|consen 175 PSN---KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE------TYKRIRKVDL-----K 240 (281)
T ss_pred CCC---CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH------HHHHHHHccc-----c
Confidence 533 3456799999999999999999999999999999999999999998765221 1222222111 1
Q ss_pred CccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 862 DPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 862 ~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
+| ........++|.+|+..+|.+|....||++ ..++.
T Consensus 241 ~p--------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~--hpwI~ 277 (281)
T KOG0580|consen 241 FP--------STISGGAADLISRLLVKNPIERLALTEVMD--HPWIV 277 (281)
T ss_pred CC--------cccChhHHHHHHHHhccCccccccHHHHhh--hHHHH
Confidence 11 112234679999999999999999999998 55544
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=353.19 Aligned_cols=246 Identities=28% Similarity=0.442 Sum_probs=203.1
Q ss_pred ccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEecC
Q 041143 627 FAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMP 706 (973)
Q Consensus 627 ~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 706 (973)
...++-||.|+.|.||+|+++ ++.||||+++.- -..+|+-|++++|+||+.+.|+|....-++||||||.
T Consensus 126 IsELeWlGSGaQGAVF~Grl~-netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa 195 (904)
T KOG4721|consen 126 ISELEWLGSGAQGAVFLGRLH-NETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCA 195 (904)
T ss_pred hhhhhhhccCcccceeeeecc-CceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccc
Confidence 345677999999999999998 788999987532 2457899999999999999999999999999999999
Q ss_pred CCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCc
Q 041143 707 HGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEK 786 (973)
Q Consensus 707 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~ 786 (973)
.|-|.+.|+. ...++-...+.+..+||.||.||| .+.|||||||.-||||..+..+||+|||-++...+.
T Consensus 196 ~GqL~~VLka-----~~~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-- 265 (904)
T KOG4721|consen 196 QGQLYEVLKA-----GRPITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-- 265 (904)
T ss_pred cccHHHHHhc-----cCccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhh--
Confidence 9999999975 356777888999999999999999 889999999999999999999999999999866543
Q ss_pred ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCcccc
Q 041143 787 SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALE 866 (973)
Q Consensus 787 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 866 (973)
.....++||..|||||++.....++|+||||||||||||+||..||.+.+.... +|.+- ...+.-
T Consensus 266 STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI------IwGVG--sNsL~L------- 330 (904)
T KOG4721|consen 266 STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI------IWGVG--SNSLHL------- 330 (904)
T ss_pred hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee------EEecc--CCcccc-------
Confidence 345568999999999999999999999999999999999999999976543211 11111 111111
Q ss_pred CCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 867 VNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 867 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
..+..+..-+.-|+++||+..|..||++++|+.-|+-....
T Consensus 331 --pvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pe 371 (904)
T KOG4721|consen 331 --PVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPE 371 (904)
T ss_pred --cCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence 11223344577889999999999999999999988765443
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=382.32 Aligned_cols=265 Identities=29% Similarity=0.451 Sum_probs=213.8
Q ss_pred cCccccCcccccCccEEEEEEECC--CC----EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeE
Q 041143 625 QNFAQENELGRGGFGTVYKGELED--GT----KIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNER 698 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~--g~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 698 (973)
.+.+..+.||+|+||.||+|...+ |. .||||.++.. .+.+...+|.+|..+|++++|||||+++|+|.+....
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 344566889999999999997653 43 4899988764 5677788999999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecc
Q 041143 699 LLVYEYMPHGALSRHLFRWEKLQ--LKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFG 776 (973)
Q Consensus 699 ~lV~e~~~~g~L~~~l~~~~~~~--~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG 776 (973)
++++|||++|+|..||++.+... ...++..+.+.++.|||+|+.||+ ++++|||||.++|+||++...|||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccc
Confidence 99999999999999998753322 346889999999999999999999 8899999999999999999999999999
Q ss_pred ccccCCCCCccee-cccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhch
Q 041143 777 LVKLAPDGEKSVV-TRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSK 854 (973)
Q Consensus 777 la~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 854 (973)
+|+...+...... ....-...|||||.+..+.++.|+|||||||++||++| |..||......+.... + .. .
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~--~----~~-g 920 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLD--V----LE-G 920 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHH--H----Hh-C
Confidence 9994433322222 22233579999999999999999999999999999999 7888877654332110 0 00 1
Q ss_pred hHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcC
Q 041143 855 EKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWR 911 (973)
Q Consensus 855 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~ 911 (973)
.++.... .+...+.+++.+||+.+|++||++..|++++..+.....
T Consensus 921 --------gRL~~P~---~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 921 --------GRLDPPS---YCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred --------CccCCCC---CCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 1222222 334567799999999999999999999999988877543
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=346.15 Aligned_cols=250 Identities=21% Similarity=0.325 Sum_probs=200.7
Q ss_pred cCcccccCccEEEEEEECCCCEEEEEEeecCCCCh-HHHHHHHHHHHHHHhcCCCceeeeeeEEEe----CCeEEEEEEe
Q 041143 630 ENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTT-KALDEFQSEIAVLSKVRHRHLVSLLGYSIE----GNERLLVYEY 704 (973)
Q Consensus 630 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~e~ 704 (973)
...||+|++|.||+|.+ +|+.||||+++...... ...+.|.+|++++.+++|||||+++|++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36799999999999998 48899999987543322 235778899999999999999999999877 3467899999
Q ss_pred cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCC
Q 041143 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG 784 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~ 784 (973)
+++|+|.+++.. .+.++|..+..++.+++.||+|||. ..+++||||||+||++++++.+||+|||+++.....
T Consensus 104 ~~~g~L~~~l~~-----~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~ 176 (283)
T PHA02988 104 CTRGYLREVLDK-----EKDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP 176 (283)
T ss_pred CCCCcHHHHHhh-----CCCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc
Confidence 999999999965 2468999999999999999999993 248889999999999999999999999999865432
Q ss_pred CcceecccccccCccccccccc--CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcC
Q 041143 785 EKSVVTRLAGTFGYLAPEYAVM--GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862 (973)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (973)
. ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||......+. ...+.... ..
T Consensus 177 ~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~------~~~i~~~~------~~ 240 (283)
T PHA02988 177 P----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI------YDLIINKN------NS 240 (283)
T ss_pred c----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH------HHHHHhcC------CC
Confidence 1 23468899999999876 6899999999999999999999999986643221 11111100 01
Q ss_pred ccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 863 PALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 863 ~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
+.+. ......+.+++.+||+.||++||+++||++.|+.+..
T Consensus 241 ~~~~-----~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 241 LKLP-----LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred CCCC-----CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 1111 1123458899999999999999999999999988754
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=338.72 Aligned_cols=266 Identities=30% Similarity=0.422 Sum_probs=211.2
Q ss_pred ecHHHHHHHhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCCh------------HHHHHHHHHHHHHHhcC
Q 041143 615 ISVQVLRKVTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTT------------KALDEFQSEIAVLSKVR 681 (973)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~------------~~~~~~~~E~~~l~~l~ 681 (973)
+....-++..++|+..+.||+|.||.|-+|+.. +++.||||++....... ...+...+||.+|++++
T Consensus 87 ~~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~ 166 (576)
T KOG0585|consen 87 YDDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH 166 (576)
T ss_pred ecCcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC
Confidence 333444566789999999999999999999764 68999999985432111 12357899999999999
Q ss_pred CCceeeeeeEEEe--CCeEEEEEEecCCCCHHHHHHhhhhccCCC-CCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCC
Q 041143 682 HRHLVSLLGYSIE--GNERLLVYEYMPHGALSRHLFRWEKLQLKP-LSWTRRLSIALDVARGMEYLHCLARQTFIHRDLK 758 (973)
Q Consensus 682 h~niv~l~~~~~~--~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~-l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dik 758 (973)
|||||+|+++..+ .+..|||+|||..|.+... .. .++ ++..++.+++.+++.||+||| .++|||||||
T Consensus 167 H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~-----p~-d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIK 237 (576)
T KOG0585|consen 167 HPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWC-----PP-DKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIK 237 (576)
T ss_pred CcCeeEEEEeecCcccCceEEEEEeccCCccccC-----CC-CcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccc
Confidence 9999999999876 4678999999999887421 11 234 899999999999999999999 8999999999
Q ss_pred CCcEEECCCCCEEEeeccccccCCCC----CcceecccccccCcccccccccCc----CCCchhHHhHHHHHHHHHhCCC
Q 041143 759 SSNILLDDDYRAKVSDFGLVKLAPDG----EKSVVTRLAGTFGYLAPEYAVMGK----ITTKADVFSYGVVLMELLTGLA 830 (973)
Q Consensus 759 p~Nill~~~~~~kl~DfGla~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~S~Gvvl~elltg~~ 830 (973)
|+|+|++++|++||+|||.+..+..+ ........+|||.|+|||...++. .+.+.||||+||+||.|+.|+.
T Consensus 238 PsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~ 317 (576)
T KOG0585|consen 238 PSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQL 317 (576)
T ss_pred hhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccC
Confidence 99999999999999999998866332 122334578999999999987633 3567899999999999999999
Q ss_pred CCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 831 ALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 831 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
||-+... -+.++.++...+.+... .+....+.+||+++|.+||++|.+..+|.. +.++.
T Consensus 318 PF~~~~~----------------~~l~~KIvn~pL~fP~~-pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~--Hpwvt 376 (576)
T KOG0585|consen 318 PFFDDFE----------------LELFDKIVNDPLEFPEN-PEINEDLKDLIKRLLEKDPEQRITLPDIKL--HPWVT 376 (576)
T ss_pred CcccchH----------------HHHHHHHhcCcccCCCc-ccccHHHHHHHHHHhhcChhheeehhhhee--cceec
Confidence 9986543 22344555556653333 245567889999999999999999999987 55544
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=345.94 Aligned_cols=255 Identities=25% Similarity=0.425 Sum_probs=212.2
Q ss_pred cCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
..|...+.||+|.||.||+|.+ +.++.||+|++... ......+++++|+.++.+++++||.+.||.+..+...+++||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le-~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLE-EAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechh-hcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 4567778999999999999965 46889999999765 344556789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
||.+|++.+.|... ..+++....-|..++..|+.||| .++.+|||||+.|||+..+|.+||+|||.+-....
T Consensus 92 y~~gGsv~~lL~~~-----~~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~ 163 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSG-----NILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTN 163 (467)
T ss_pred HhcCcchhhhhccC-----CCCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeec
Confidence 99999999988652 33366677779999999999999 88999999999999999999999999999876654
Q ss_pred CCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCc
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDP 863 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (973)
.... ...++||+.|||||++....|+.|+||||+|++.+||.+|.+|+....+....+ .+.+-..|
T Consensus 164 ~~~r-r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf-------------lIpk~~PP 229 (467)
T KOG0201|consen 164 TVKR-RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF-------------LIPKSAPP 229 (467)
T ss_pred hhhc-cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE-------------eccCCCCC
Confidence 4333 367899999999999998899999999999999999999999998877632211 12222334
Q ss_pred cccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 864 ALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 864 ~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
.+.. ..-..+.+++..|++.||+.||++.+++. +++++.
T Consensus 230 ~L~~-----~~S~~~kEFV~~CL~k~P~~RpsA~~LLK--h~FIk~ 268 (467)
T KOG0201|consen 230 RLDG-----DFSPPFKEFVEACLDKNPEFRPSAKELLK--HKFIKR 268 (467)
T ss_pred cccc-----ccCHHHHHHHHHHhhcCcccCcCHHHHhh--hHHHHh
Confidence 4431 22234789999999999999999999998 666654
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=348.48 Aligned_cols=265 Identities=27% Similarity=0.429 Sum_probs=204.1
Q ss_pred cCccccCcccccCccEEEEEEECC-----------------CCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceee
Q 041143 625 QNFAQENELGRGGFGTVYKGELED-----------------GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVS 687 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~-----------------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 687 (973)
++|...+.||+|+||.||+|.+++ +..||+|.++.. .......+|.+|++++.+++||||++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD-ANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCC-CCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 578888999999999999997532 336999998754 23445678999999999999999999
Q ss_pred eeeEEEeCCeEEEEEEecCCCCHHHHHHhhhhc--------------cCCCCCHHHHHHHHHHHHHHHHHHHhhccCCee
Q 041143 688 LLGYSIEGNERLLVYEYMPHGALSRHLFRWEKL--------------QLKPLSWTRRLSIALDVARGMEYLHCLARQTFI 753 (973)
Q Consensus 688 l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~--------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~iv 753 (973)
+++++.+.+..++||||+++|+|.+++...... ....++|.++.+++.||+.||+||| +.+|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCcc
Confidence 999999999999999999999999998653211 1135788999999999999999999 78999
Q ss_pred eccCCCCcEEECCCCCEEEeeccccccCCCCCc-ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh--CCC
Q 041143 754 HRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEK-SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT--GLA 830 (973)
Q Consensus 754 H~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt--g~~ 830 (973)
||||||+|||+++++.+||+|||+++....... .......++..|+|||++..+.++.++|||||||++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999985543322 12233456889999999988899999999999999999987 556
Q ss_pred CCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHH
Q 041143 831 ALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLS 904 (973)
Q Consensus 831 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~ 904 (973)
||......+ ...++......... . +.. .........+.+++.+|++.||++||++.||++.|+
T Consensus 241 p~~~~~~~~---~~~~~~~~~~~~~~--~-~~~-----~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 241 PYGELTDEQ---VIENAGEFFRDQGR--Q-VYL-----FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCcCCHHH---HHHHHHHHhhhccc--c-ccc-----cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 776544322 11111111100000 0 000 001112345789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=360.64 Aligned_cols=262 Identities=26% Similarity=0.419 Sum_probs=205.4
Q ss_pred hcCccccCcccccCccEEEEEEE------CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCC
Q 041143 624 TQNFAQENELGRGGFGTVYKGEL------EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGN 696 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 696 (973)
.++|+..+.||+|+||.||+|+. .++..||||+++... .....+.+.+|++++..+ +|||||+++++|.+.+
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 45788899999999999999963 245689999987543 233456788999999999 8999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhhhh---------------------------------------------------------
Q 041143 697 ERLLVYEYMPHGALSRHLFRWEK--------------------------------------------------------- 719 (973)
Q Consensus 697 ~~~lV~e~~~~g~L~~~l~~~~~--------------------------------------------------------- 719 (973)
..++||||+++|+|.++++....
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 99999999999999999975321
Q ss_pred -------------ccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCc
Q 041143 720 -------------LQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEK 786 (973)
Q Consensus 720 -------------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~ 786 (973)
.....++|..+.+++.||++||+||| +++|+||||||+|||++.++.+||+|||+++.......
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 01125789999999999999999999 78999999999999999999999999999985543322
Q ss_pred c-eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCcc
Q 041143 787 S-VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPA 864 (973)
Q Consensus 787 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 864 (973)
. ......++..|+|||++.+..++.++|||||||++|||++ |..||........ ...++. .. .. ...+.
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~--~~~~~~---~~---~~-~~~~~ 340 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK--FYKMIK---EG---YR-MLSPE 340 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH--HHHHHH---hC---cc-CCCCC
Confidence 1 1222345678999999999999999999999999999998 8889876542211 111111 00 00 00011
Q ss_pred ccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHh
Q 041143 865 LEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPL 906 (973)
Q Consensus 865 l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~ 906 (973)
....++.+++.+|++.||++||++.||++.|++.
T Consensus 341 --------~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 341 --------CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred --------CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 1124578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=341.67 Aligned_cols=256 Identities=23% Similarity=0.398 Sum_probs=205.3
Q ss_pred cCccccCcccccCccEEEEEEEC----CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE----DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLL 700 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 700 (973)
++|...+.||+|+||.||+|.+. .+..||+|.++... .....+.|.+|+.++++++||||+++++++..++..++
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 56888899999999999999753 35689999987652 34445679999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecccccc
Q 041143 701 VYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKL 780 (973)
Q Consensus 701 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~ 780 (973)
||||+++|+|.+++... ...++|.+++.++.|++.||+||| +++++||||||+||+++.++.+|++|||.+..
T Consensus 84 v~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~ 156 (266)
T cd05064 84 VTEYMSNGALDSFLRKH----EGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQE 156 (266)
T ss_pred EEEeCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCccccc
Confidence 99999999999998652 246899999999999999999999 88999999999999999999999999998765
Q ss_pred CCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHh
Q 041143 781 APDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKA 859 (973)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (973)
.............++..|+|||++.+..++.++|||||||++||+++ |+.||......+. .. .+..
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~---~~---~~~~------- 223 (266)
T cd05064 157 DKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV---IK---AVED------- 223 (266)
T ss_pred ccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---HH---HHHC-------
Confidence 43222111122345678999999999999999999999999999775 9999976653221 11 1111
Q ss_pred hcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHh
Q 041143 860 AIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPL 906 (973)
Q Consensus 860 ~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~ 906 (973)
..... ........+.+++.+|++.+|++||++.+|.+.|+++
T Consensus 224 ~~~~~-----~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 224 GFRLP-----APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCCC-----CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 00000 0112234578999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=359.41 Aligned_cols=263 Identities=26% Similarity=0.409 Sum_probs=206.1
Q ss_pred hcCccccCcccccCccEEEEEEEC------CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCC
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE------DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGN 696 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 696 (973)
.++|...+.||+|+||.||+|... ++..||||+++... .....+.+.+|+++++.+ +|+|||+++++|...+
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 357888999999999999998742 34579999997543 334456788999999999 8999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhhhh---------------------------------------------------------
Q 041143 697 ERLLVYEYMPHGALSRHLFRWEK--------------------------------------------------------- 719 (973)
Q Consensus 697 ~~~lV~e~~~~g~L~~~l~~~~~--------------------------------------------------------- 719 (973)
..++||||+++|+|.++++....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 99999999999999999865321
Q ss_pred --------ccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCcc-eec
Q 041143 720 --------LQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKS-VVT 790 (973)
Q Consensus 720 --------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~ 790 (973)
....++++.++++++.||++||+||| +++|+||||||+||++++++.+||+|||+++........ ...
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 01135788999999999999999999 889999999999999999999999999999854432221 122
Q ss_pred ccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccCCc
Q 041143 791 RLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNE 869 (973)
Q Consensus 791 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 869 (973)
...++..|+|||++....++.++|||||||++|||++ |+.||........ . .. ... ....+... .
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--~---~~-~~~------~~~~~~~~-~- 338 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--F---YK-MVK------RGYQMSRP-D- 338 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--H---HH-HHH------cccCccCC-C-
Confidence 2345678999999998899999999999999999997 9999976542211 0 00 000 00111100 0
Q ss_pred ccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhh
Q 041143 870 ETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLV 907 (973)
Q Consensus 870 ~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~ 907 (973)
.....+.+++.+|++.||++||++.+|++.|++++
T Consensus 339 ---~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 339 ---FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred ---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 01245789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=346.41 Aligned_cols=269 Identities=19% Similarity=0.276 Sum_probs=205.5
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
++|+..+.||+|+||.||+|+.+ +++.||||+++.........+.+.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36888999999999999999876 57899999997654444456678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|++++.+..+... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 81 YVEKNMLELLEEM-----PNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred cCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 9998777644322 245889999999999999999999 88999999999999999999999999999986544
Q ss_pred CCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHH--------Hhhchh
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWR--------IKSSKE 855 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~--------~~~~~~ 855 (973)
..........||+.|+|||++.+..++.++|||||||++|||++|+.||......+.......... ......
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07848 153 GSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP 232 (287)
T ss_pred cccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence 333333456799999999999988999999999999999999999999987654332111111000 000000
Q ss_pred HHHhhcCccccCCcc-----cHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 856 KFKAAIDPALEVNEE-----TFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 856 ~~~~~~~~~l~~~~~-----~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
.......+....... .......+.+++.+|++.||++||+++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000011100000 0012235889999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=321.53 Aligned_cols=272 Identities=23% Similarity=0.320 Sum_probs=208.6
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeC--CeEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEG--NERLLV 701 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV 701 (973)
+.|+.++.|++|+||.||+|+++ +++.||+|+++-......-.-...+||.+|.+++|||||.+..+.... +..|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 45677899999999999999875 688999999976533322223467899999999999999999987753 578999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccC
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA 781 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~ 781 (973)
||||+. +|...++.. .+++...++..++.|+++|++||| .+.|+|||+|++|+|+...|.+||+|||+|+.+
T Consensus 156 Me~~Eh-DLksl~d~m----~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETM----KQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred HHHHHh-hHHHHHHhc----cCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhh
Confidence 999966 899888762 267899999999999999999999 889999999999999999999999999999987
Q ss_pred CCCCcceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhh
Q 041143 782 PDGEKSVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAA 860 (973)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (973)
+... ...+..+-|..|+|||.+.+ ..|++..|+||+|||+.||+++++-|.+....+..+ ..+.-.-...+.+..-
T Consensus 228 gsp~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~--~If~llGtPte~iwpg 304 (419)
T KOG0663|consen 228 GSPL-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLD--KIFKLLGTPSEAIWPG 304 (419)
T ss_pred cCCc-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHH--HHHHHhCCCccccCCC
Confidence 7653 34677889999999999886 469999999999999999999999998876544322 2222111111111000
Q ss_pred cC--c---cccCCcccH-------H---HHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 861 ID--P---ALEVNEETF-------E---SISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 861 ~~--~---~l~~~~~~~-------~---~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
++ + .+.+...+. . ....-++|+..++..||.+|.|+.|.++ ++++..
T Consensus 305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~--h~~F~e 366 (419)
T KOG0663|consen 305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK--HEYFRE 366 (419)
T ss_pred ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc--cccccc
Confidence 00 0 011111110 0 1144678999999999999999999998 666543
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=317.09 Aligned_cols=257 Identities=23% Similarity=0.372 Sum_probs=209.0
Q ss_pred hcCccccCcccccCccEEEEEE-ECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
.+.|+.-+.||+|.|+.||++. ..+|+.+|+|.+..........+++.+|++|-+.++|||||++.+.+.+....|||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 3567777889999999999995 457999999988665555567788999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECC---CCCEEEeeccccc
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDD---DYRAKVSDFGLVK 779 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~---~~~~kl~DfGla~ 779 (973)
|+|.||+|..-+-.. ..+++..+-+.++||+++|.|+| .++|||||+||+|+++.. .--+|++|||+|.
T Consensus 90 e~m~G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR-----EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred ecccchHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEE
Confidence 999999998776552 34677888899999999999999 899999999999999953 3459999999999
Q ss_pred cCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHh
Q 041143 780 LAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKA 859 (973)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (973)
...+ ......++|||+|||||++...+|+..+|||+.||+||-|+.|+.||.+..... .+.++..
T Consensus 162 ~l~~--g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r------lye~I~~------- 226 (355)
T KOG0033|consen 162 EVND--GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR------LYEQIKA------- 226 (355)
T ss_pred EeCC--ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH------HHHHHhc-------
Confidence 7763 334556789999999999999999999999999999999999999998754221 1122222
Q ss_pred hcCccccCCcccH-HHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 860 AIDPALEVNEETF-ESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 860 ~~~~~l~~~~~~~-~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
..+++....+ .......+|+.+|+..||.+|.|+.|.+. ++|+.
T Consensus 227 ---g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~--HpWi~ 271 (355)
T KOG0033|consen 227 ---GAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK--HPWIC 271 (355)
T ss_pred ---cccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC--Cchhc
Confidence 2222222111 22244679999999999999999999987 55544
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=328.31 Aligned_cols=272 Identities=24% Similarity=0.395 Sum_probs=210.4
Q ss_pred HHHHHHhcCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHh--cCCCceeeeeeEEEeC
Q 041143 618 QVLRKVTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSK--VRHRHLVSLLGYSIEG 695 (973)
Q Consensus 618 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~ 695 (973)
-..+.+..+....+.||+|.||.||+|+++ |+.||||++... +.+.+.+|.++.+. ++|+||+.+++....+
T Consensus 204 LVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr-----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~ 277 (513)
T KOG2052|consen 204 LVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR-----DERSWFRETEIYQTVMLRHENILGFIAADNKD 277 (513)
T ss_pred HhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEeccc-----chhhhhhHHHHHHHHHhccchhhhhhhccccC
Confidence 344667788889999999999999999998 899999998543 23467788888876 5999999999987654
Q ss_pred C----eEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhh-----ccCCeeeccCCCCcEEECC
Q 041143 696 N----ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCL-----ARQTFIHRDLKSSNILLDD 766 (973)
Q Consensus 696 ~----~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~-----~~~~ivH~Dikp~Nill~~ 766 (973)
+ +.+||.+|.+.|+|++||.+ ..++....++++..+|.||+|||.. .++.|.|||||+.|||+.+
T Consensus 278 ~gs~TQLwLvTdYHe~GSL~DyL~r------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKk 351 (513)
T KOG2052|consen 278 NGSWTQLWLVTDYHEHGSLYDYLNR------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 351 (513)
T ss_pred CCceEEEEEeeecccCCcHHHHHhh------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEcc
Confidence 3 67999999999999999976 6789999999999999999999953 3678999999999999999
Q ss_pred CCCEEEeeccccccCCCCCc---ceecccccccCcccccccccCc----C--CCchhHHhHHHHHHHHHhC---------
Q 041143 767 DYRAKVSDFGLVKLAPDGEK---SVVTRLAGTFGYLAPEYAVMGK----I--TTKADVFSYGVVLMELLTG--------- 828 (973)
Q Consensus 767 ~~~~kl~DfGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~----~--~~~~Dv~S~Gvvl~elltg--------- 828 (973)
++...|+|+|+|........ ......+||.+|||||++...- + -..+||||||.|+||+.-+
T Consensus 352 n~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~ee 431 (513)
T KOG2052|consen 352 NGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEE 431 (513)
T ss_pred CCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehh
Confidence 99999999999986544322 2234568999999999986431 1 2368999999999999864
Q ss_pred -CCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhh
Q 041143 829 -LAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLV 907 (973)
Q Consensus 829 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~ 907 (973)
+.||.+..+.+... .+. +. -...+-+.|.+.......+.+..+.++++.||..+|..|-|+-.|-..|.++.
T Consensus 432 y~~Pyyd~Vp~DPs~-eeM-rk-----VVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 432 YQLPYYDVVPSDPSF-EEM-RK-----VVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred hcCCcccCCCCCCCH-HHH-hc-----ceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 55666554433211 000 00 00111122333323344577888999999999999999999999999998886
Q ss_pred h
Q 041143 908 E 908 (973)
Q Consensus 908 ~ 908 (973)
+
T Consensus 505 ~ 505 (513)
T KOG2052|consen 505 N 505 (513)
T ss_pred c
Confidence 5
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=340.77 Aligned_cols=260 Identities=32% Similarity=0.513 Sum_probs=208.4
Q ss_pred cCccccCcccccCccEEEEEEECC------CCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeE
Q 041143 625 QNFAQENELGRGGFGTVYKGELED------GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNER 698 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 698 (973)
++|+..+.||+|+||.||+|.... ...||+|.++... ......+|.+|++++++++||||+++++++...+..
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 467888999999999999997643 2579999987542 344566799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhhhccC-----------CCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCC
Q 041143 699 LLVYEYMPHGALSRHLFRWEKLQL-----------KPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDD 767 (973)
Q Consensus 699 ~lV~e~~~~g~L~~~l~~~~~~~~-----------~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~ 767 (973)
+++|||+++|+|.+++........ ..+++.+++.++.|++.||+||| ..+|+||||||+||+++++
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCC
Confidence 999999999999999976322111 45889999999999999999999 8899999999999999999
Q ss_pred CCEEEeeccccccCCCCCc-ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHH
Q 041143 768 YRAKVSDFGLVKLAPDGEK-SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAE 845 (973)
Q Consensus 768 ~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~ 845 (973)
+.+||+|||+++....... .......+++.|+|||++....++.++|||||||++|||++ |..||......+. ..
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~---~~ 237 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV---IE 237 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---HH
Confidence 9999999999985433221 22334467889999999998899999999999999999998 9999986554321 11
Q ss_pred HHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHh
Q 041143 846 WFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPL 906 (973)
Q Consensus 846 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~ 906 (973)
+ +.. .... .........+.+|+.+|++.||.+||+++||++.|+.+
T Consensus 238 ~---i~~----------~~~~--~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 238 M---IRS----------RQLL--PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred H---HHc----------CCcC--CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 1 111 0000 01112335688999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=341.81 Aligned_cols=253 Identities=28% Similarity=0.367 Sum_probs=201.0
Q ss_pred CccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 626 NFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
.|...+.||+|+||.||+|.. .+|+.||||.+..... .......+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367788999999999999976 4789999999864321 22334567899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+++|+|..++... ....+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++....
T Consensus 81 ~~~~g~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 81 IMNGGDLKFHIYNM---GNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE 154 (285)
T ss_pred ecCCCcHHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence 99999999888542 2246899999999999999999999 88999999999999999999999999999986543
Q ss_pred CCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCc
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDP 863 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (973)
.. ......||..|+|||++.+..++.++|||||||++|||++|+.||........... ..... ...
T Consensus 155 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~--~~~~~----------~~~ 220 (285)
T cd05631 155 GE--TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREE--VDRRV----------KED 220 (285)
T ss_pred CC--eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHH--HHHHh----------hcc
Confidence 22 22345799999999999999999999999999999999999999986543221110 00000 000
Q ss_pred cccCCcccHHHHHHHHHHHHHhhccCCCCCCC-----HhHHHH
Q 041143 864 ALEVNEETFESISIVAELAGHCTAREPYHRPD-----MGHVVN 901 (973)
Q Consensus 864 ~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~~v~~ 901 (973)
... ........+.+|+.+|++.||++||+ ++++++
T Consensus 221 ~~~---~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 221 QEE---YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred ccc---CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 001 01112245779999999999999997 677776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=353.45 Aligned_cols=264 Identities=26% Similarity=0.386 Sum_probs=208.0
Q ss_pred hcCccccCcccccCccEEEEEEEC------CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeeEEEeCC
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE------DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR-HRHLVSLLGYSIEGN 696 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 696 (973)
.++|.+.+.||+|+||.||+|+.. .+..||||+++.. ......+.+.+|++++++++ |||||+++++|.+..
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT-ARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 467888999999999999999753 2347999998654 23444567999999999996 999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhhhhc--------------------------------------------------------
Q 041143 697 ERLLVYEYMPHGALSRHLFRWEKL-------------------------------------------------------- 720 (973)
Q Consensus 697 ~~~lV~e~~~~g~L~~~l~~~~~~-------------------------------------------------------- 720 (973)
..++||||+++|+|.++++.....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 999999999999999999763210
Q ss_pred -----------------------------------cCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEEC
Q 041143 721 -----------------------------------QLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLD 765 (973)
Q Consensus 721 -----------------------------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~ 765 (973)
....+++.++..++.||++||+||| ..+|+||||||+||+++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEe
Confidence 1134788999999999999999999 78999999999999999
Q ss_pred CCCCEEEeeccccccCCCCCc-ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHH
Q 041143 766 DDYRAKVSDFGLVKLAPDGEK-SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYL 843 (973)
Q Consensus 766 ~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~ 843 (973)
+++.+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||........ .
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~--~ 349 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST--F 349 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH--H
Confidence 999999999999985433222 11223457788999999998899999999999999999997 9999876432211 0
Q ss_pred HHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 844 AEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 844 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
. ..+. ...... ........+.+++.+|++.||++||++.+|+++|+++.+
T Consensus 350 ~---~~~~-------~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 350 Y---NKIK-------SGYRMA-----KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred H---HHHh-------cCCCCC-----CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 0 0111 000110 011223457899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=345.11 Aligned_cols=246 Identities=26% Similarity=0.340 Sum_probs=200.9
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCC-CChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGV-TTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
++|...+.||+|+||.||+|... +|+.||+|++.... ......+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888899999999999999875 68999999986431 12234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++|+|.+++.. ...+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++...
T Consensus 81 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~ 152 (291)
T cd05612 81 EYVPGGELFSYLRN-----SGRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR 152 (291)
T ss_pred eCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhcc
Confidence 99999999999865 245889999999999999999999 8899999999999999999999999999998654
Q ss_pred CCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcC
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (973)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ...+...
T Consensus 153 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~------~~~i~~~--------- 213 (291)
T cd05612 153 DR----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI------YEKILAG--------- 213 (291)
T ss_pred CC----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhC---------
Confidence 32 2235799999999999988899999999999999999999999986553221 1111111
Q ss_pred ccccCCcccHHHHHHHHHHHHHhhccCCCCCCC-----HhHHHH
Q 041143 863 PALEVNEETFESISIVAELAGHCTAREPYHRPD-----MGHVVN 901 (973)
Q Consensus 863 ~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~~v~~ 901 (973)
...... .....+.+++.+|++.||.+||+ +.|+++
T Consensus 214 -~~~~~~---~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 214 -KLEFPR---HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred -CcCCCc---cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 111000 11234779999999999999995 676665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=336.26 Aligned_cols=255 Identities=25% Similarity=0.436 Sum_probs=207.9
Q ss_pred hcCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
.++|+..++||+|+||.||+|...++..||+|.+... ....+.+.+|+.++++++|+||+++++++...+..++|||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG---TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC---chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 3578889999999999999999888889999987643 2235678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+++|+|.++++.. ....+++.+++.++.|+++||+||| +.+++||||||+||+++.++.+||+|||+++...+
T Consensus 82 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 82 YMAKGSLLDFLKSD---EGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred cCCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCC
Confidence 99999999999752 2346889999999999999999999 78999999999999999999999999999986654
Q ss_pred CCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcC
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (973)
..........++..|+|||++....++.++|||||||++|||++ |+.||......+. ..++. . ...
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~~~~---~-------~~~ 222 (261)
T cd05072 156 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV---MSALQ---R-------GYR 222 (261)
T ss_pred CceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH---HHHHH---c-------CCC
Confidence 33222233456778999999988889999999999999999998 9999976543221 11111 0 000
Q ss_pred ccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHH
Q 041143 863 PALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSP 905 (973)
Q Consensus 863 ~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~ 905 (973)
... .......+.+++.+|++.+|++||+++++.+.|+.
T Consensus 223 ~~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 223 MPR-----MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCC-----CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 000 00122457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=326.95 Aligned_cols=272 Identities=25% Similarity=0.376 Sum_probs=204.7
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCe---E--
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNE---R-- 698 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---~-- 698 (973)
-.|...+++|.|+||.||+|... +++.||||++..+.. .-.+|+++|+.++|||||++..+|....+ .
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 35667799999999999999764 578999999865421 22479999999999999999998875332 2
Q ss_pred EEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCC-CCEEEeeccc
Q 041143 699 LLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDD-YRAKVSDFGL 777 (973)
Q Consensus 699 ~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~-~~~kl~DfGl 777 (973)
.+|||||+. +|.++++.+...+ ..++...+.-+..||.+||+||| ..+|+||||||.|+|+|.+ |.+||||||.
T Consensus 98 nlVleymP~-tL~~~~r~~~~~~-~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGS 172 (364)
T KOG0658|consen 98 NLVLEYMPE-TLYRVIRHYTRAN-QRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGS 172 (364)
T ss_pred HHHHHhchH-HHHHHHHHHhhcC-CCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCc
Confidence 489999955 9999998654333 55777778889999999999999 7899999999999999976 9999999999
Q ss_pred cccCCCCCcceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhc-hh
Q 041143 778 VKLAPDGEKSVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSS-KE 855 (973)
Q Consensus 778 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~ 855 (973)
|+....+... ..+.-|+.|+|||.+.+ .+|+.+.||||.|||+.||+-|++-|.+....+. +...+.-.-.. ++
T Consensus 173 AK~L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ--L~eIik~lG~Pt~e 248 (364)
T KOG0658|consen 173 AKVLVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ--LVEIIKVLGTPTRE 248 (364)
T ss_pred ceeeccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH--HHHHHHHhCCCCHH
Confidence 9976655433 33456899999999986 5799999999999999999999999998665443 22222111111 11
Q ss_pred HHH-------hhcCccccCCc----ccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCCC
Q 041143 856 KFK-------AAIDPALEVNE----ETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPI 913 (973)
Q Consensus 856 ~~~-------~~~~~~l~~~~----~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~~ 913 (973)
.+. +.-.|.+.... .......+.++++.++++.+|.+|.++.|++. ++..+.....
T Consensus 249 ~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~--h~fFdelr~~ 315 (364)
T KOG0658|consen 249 DIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA--HPFFDELRDP 315 (364)
T ss_pred HHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc--chhhHHhhCc
Confidence 111 11112222111 11223356889999999999999999999998 6776665544
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=348.05 Aligned_cols=243 Identities=26% Similarity=0.323 Sum_probs=197.1
Q ss_pred CcccccCccEEEEEEEC-CCCEEEEEEeecCC-CChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEecCCC
Q 041143 631 NELGRGGFGTVYKGELE-DGTKIAVKRMEAGV-TTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHG 708 (973)
Q Consensus 631 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 708 (973)
+.||+|+||.||+|+.. +|+.||+|+++... ........+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999764 68999999987532 12334567889999999999999999999999999999999999999
Q ss_pred CHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCcce
Q 041143 709 ALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSV 788 (973)
Q Consensus 709 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 788 (973)
+|.+++.. ...+++.++..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~ 151 (323)
T cd05571 81 ELFFHLSR-----ERVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-AT 151 (323)
T ss_pred cHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Cc
Confidence 99998865 246899999999999999999999 8899999999999999999999999999987532221 12
Q ss_pred ecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccCC
Q 041143 789 VTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVN 868 (973)
Q Consensus 789 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 868 (973)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ . ..+.... ..+.
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~---~---~~~~~~~--------~~~p-- 215 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---F---ELILMEE--------IRFP-- 215 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHH---H---HHHHcCC--------CCCC--
Confidence 3346799999999999999999999999999999999999999976543221 1 1111100 1111
Q ss_pred cccHHHHHHHHHHHHHhhccCCCCCC-----CHhHHHH
Q 041143 869 EETFESISIVAELAGHCTAREPYHRP-----DMGHVVN 901 (973)
Q Consensus 869 ~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~~v~~ 901 (973)
......+.+++.+|++.||++|| ++.++++
T Consensus 216 ---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 216 ---RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred ---CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 11223477999999999999999 7888876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=344.00 Aligned_cols=269 Identities=23% Similarity=0.350 Sum_probs=208.8
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
.++|+..+.||+|+||.||+++.. +|..||+|.+.... .....+.+.+|++++++++||||+++++++..++..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 368899999999999999999875 58889999987542 3445678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+ ..+|+||||||+||+++.++.+||+|||+++...
T Consensus 83 e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 155 (331)
T cd06649 83 EHMDGGSLDQVLKE-----AKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (331)
T ss_pred ecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence 99999999999865 2457899999999999999999993 2469999999999999999999999999987553
Q ss_pred CCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHh-hc--------
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIK-SS-------- 853 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~-~~-------- 853 (973)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... +.... ..
T Consensus 156 ~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 229 (331)
T cd06649 156 DS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAI---FGRPVVDGEEGEPHSI 229 (331)
T ss_pred cc---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---hcccccccccCCcccc
Confidence 32 12345799999999999998999999999999999999999999976554322111 10000 00
Q ss_pred ------------------------hhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 854 ------------------------KEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 854 ------------------------~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
......++..... ..........+.+++.+|++.||++||++.|+++ +.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~--h~~~~~ 306 (331)
T cd06649 230 SPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPP-KLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMN--HTFIKR 306 (331)
T ss_pred CcccccccccccccccccccchhHHHHHHHHHhCCCc-CCCCccccHHHHHHHHHHccCCcccCCCHHHHhc--ChHHhh
Confidence 0000000000000 0000112345889999999999999999999998 566554
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=357.86 Aligned_cols=266 Identities=27% Similarity=0.346 Sum_probs=215.8
Q ss_pred hcCccccCcccccCccEEEEEEECCC-CEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCceeeeee-EEEe------
Q 041143 624 TQNFAQENELGRGGFGTVYKGELEDG-TKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR-HRHLVSLLG-YSIE------ 694 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~~g-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~-~~~~------ 694 (973)
..++++.+.|.+|||+.||+|.+..+ .+||+|++-.. ++...+...+||++|++|+ |+|||.+++ ....
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 35667889999999999999988766 99999999765 7888899999999999997 999999999 3322
Q ss_pred CCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEee
Q 041143 695 GNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSD 774 (973)
Q Consensus 695 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D 774 (973)
.-+++|.||||++|.|-+++..+.. ..|++.++++|+.|+++|+++||.. ..+|||||||-+||||+.++..||||
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq---~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQ---TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHh---ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCc
Confidence 1367899999999999999986332 3499999999999999999999965 78899999999999999999999999
Q ss_pred ccccccCCCCC-c-cee------cccccccCcccccccc---cCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHH
Q 041143 775 FGLVKLAPDGE-K-SVV------TRLAGTFGYLAPEYAV---MGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYL 843 (973)
Q Consensus 775 fGla~~~~~~~-~-~~~------~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~ 843 (973)
||.|.-..... . ... -...-|+.|+|||++. +..+++|+||||+||+||-|+....||+....
T Consensus 190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~------ 263 (738)
T KOG1989|consen 190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK------ 263 (738)
T ss_pred ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc------
Confidence 99987221111 1 000 0124689999999874 67799999999999999999999999986532
Q ss_pred HHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCCCCCC
Q 041143 844 AEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPITDE 916 (973)
Q Consensus 844 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~~~~~ 916 (973)
-.+++..+.+... ......+.+||+.||+.||.+||++.||+..+-++...--+..+.
T Consensus 264 --------------laIlng~Y~~P~~-p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~ 321 (738)
T KOG1989|consen 264 --------------LAILNGNYSFPPF-PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDI 321 (738)
T ss_pred --------------eeEEeccccCCCC-ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCcccc
Confidence 1234444443222 456677999999999999999999999999999887765444443
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=349.94 Aligned_cols=246 Identities=26% Similarity=0.371 Sum_probs=201.2
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCC-CChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGV-TTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
++|...+.||+|+||.||+|+.. +|+.||||+++... ......+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 57888999999999999999875 58899999986431 12234567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++|+|.+++.. ...+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 98 e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 98 EFVVGGELFTHLRK-----AGRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred cCCCCChHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 99999999999865 245788889999999999999999 8899999999999999999999999999998654
Q ss_pred CCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcC
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (973)
... ....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+..
T Consensus 170 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~------~~~i~~---------- 229 (329)
T PTZ00263 170 DRT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI------YEKILA---------- 229 (329)
T ss_pred CCc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH------HHHHhc----------
Confidence 322 235799999999999999999999999999999999999999976543221 111111
Q ss_pred ccccCCcccHHHHHHHHHHHHHhhccCCCCCCC-----HhHHHH
Q 041143 863 PALEVNEETFESISIVAELAGHCTAREPYHRPD-----MGHVVN 901 (973)
Q Consensus 863 ~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~~v~~ 901 (973)
..+.... .....+.+++.+|++.||.+||+ +++++.
T Consensus 230 ~~~~~p~---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 230 GRLKFPN---WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred CCcCCCC---CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1111000 01134679999999999999997 566665
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=333.48 Aligned_cols=251 Identities=31% Similarity=0.472 Sum_probs=203.0
Q ss_pred cCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEe
Q 041143 625 QNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEY 704 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 704 (973)
++|+..+.||+|+||.||+|+++++..+|+|.++... ...+.+.+|++++++++||||+++++++...+..++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA---MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC---ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 4577889999999999999999888899999886432 2235788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCC
Q 041143 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG 784 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~ 784 (973)
+++|+|.++++.. ...++|..+..++.|++.||+||| +++|+||||||+||++++++.+||+|||.++.....
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05114 81 MENGCLLNYLRQR----QGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD 153 (256)
T ss_pred CCCCcHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCC
Confidence 9999999988652 135889999999999999999999 889999999999999999999999999998855433
Q ss_pred CcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCc
Q 041143 785 EKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDP 863 (973)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (973)
.........++..|+|||++.+..++.++||||||+++|||++ |+.||......+. .. .+.... ....+
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~---~~---~i~~~~----~~~~~ 223 (256)
T cd05114 154 EYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV---VE---MISRGF----RLYRP 223 (256)
T ss_pred ceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---HH---HHHCCC----CCCCC
Confidence 2222223345678999999988889999999999999999999 8999976543221 11 111100 00111
Q ss_pred cccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHH
Q 041143 864 ALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVL 903 (973)
Q Consensus 864 ~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L 903 (973)
.. ....+.+++.+|++.+|++||+++++++.|
T Consensus 224 ~~--------~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 224 KL--------ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CC--------CCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 11 123578999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=345.22 Aligned_cols=243 Identities=26% Similarity=0.336 Sum_probs=196.2
Q ss_pred CcccccCccEEEEEEEC-CCCEEEEEEeecCC-CChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEecCCC
Q 041143 631 NELGRGGFGTVYKGELE-DGTKIAVKRMEAGV-TTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHG 708 (973)
Q Consensus 631 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 708 (973)
+.||+|+||.||+++.. +|+.||+|+++... ........+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46899999999999764 68999999987542 12334567788999999999999999999999999999999999999
Q ss_pred CHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCcce
Q 041143 709 ALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSV 788 (973)
Q Consensus 709 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 788 (973)
+|..++.. ...+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~ 151 (323)
T cd05595 81 ELFFHLSR-----ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-AT 151 (323)
T ss_pred cHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Cc
Confidence 99988854 246899999999999999999999 8899999999999999999999999999987532221 12
Q ss_pred ecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccCC
Q 041143 789 VTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVN 868 (973)
Q Consensus 789 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 868 (973)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..+.. ......
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~------~~~~~----------~~~~~p 215 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF------ELILM----------EEIRFP 215 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHH------HHHhc----------CCCCCC
Confidence 23467999999999999999999999999999999999999999765432211 01111 111100
Q ss_pred cccHHHHHHHHHHHHHhhccCCCCCC-----CHhHHHH
Q 041143 869 EETFESISIVAELAGHCTAREPYHRP-----DMGHVVN 901 (973)
Q Consensus 869 ~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~~v~~ 901 (973)
. .....+.+++.+|++.||++|| ++.++++
T Consensus 216 ~---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 216 R---TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred C---CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 0 1123467999999999999998 7888876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=343.87 Aligned_cols=254 Identities=24% Similarity=0.370 Sum_probs=204.7
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
++|...+.||+|+||.||+|+.. +++.||||+++.... .....+.+.+|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999876 588999999875421 2234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++|+|.+++.. ...+++.++..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++...
T Consensus 81 e~~~g~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~ 152 (333)
T cd05600 81 EYVPGGDFRTLLNN-----LGVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV 152 (333)
T ss_pred eCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCcccc
Confidence 99999999999964 245789999999999999999999 8899999999999999999999999999998554
Q ss_pred CCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcC
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (973)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .+.... ..+.
T Consensus 153 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~------~i~~~~----~~~~ 218 (333)
T cd05600 153 T----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWE------NLKYWK----ETLQ 218 (333)
T ss_pred c----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHH------HHHhcc----cccc
Confidence 3 2234579999999999999999999999999999999999999998765433211 111000 0011
Q ss_pred ccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 863 PALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 863 ~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
.... ..........+.+++.+|+..+|.+||++.++++
T Consensus 219 ~~~~-~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~ 256 (333)
T cd05600 219 RPVY-DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKN 256 (333)
T ss_pred CCCC-CccccccCHHHHHHHHHHhhChhhhcCCHHHHHh
Confidence 0000 0000122345779999999999999999999997
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=344.02 Aligned_cols=243 Identities=27% Similarity=0.348 Sum_probs=196.8
Q ss_pred CcccccCccEEEEEEEC-CCCEEEEEEeecCC-CChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEecCCC
Q 041143 631 NELGRGGFGTVYKGELE-DGTKIAVKRMEAGV-TTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHG 708 (973)
Q Consensus 631 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 708 (973)
+.||+|+||.||+++.. +|+.||||+++... ........+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999764 68999999997542 22344567889999999999999999999999999999999999999
Q ss_pred CHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCcce
Q 041143 709 ALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSV 788 (973)
Q Consensus 709 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 788 (973)
+|..++.. ...+++.++..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~ 151 (328)
T cd05593 81 ELFFHLSR-----ERVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-AT 151 (328)
T ss_pred CHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-cc
Confidence 99988854 246899999999999999999999 8899999999999999999999999999987533221 12
Q ss_pred ecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccCC
Q 041143 789 VTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVN 868 (973)
Q Consensus 789 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 868 (973)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ...+.... ..+.
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~------~~~~~~~~--------~~~p-- 215 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL------FELILMED--------IKFP-- 215 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH------HHHhccCC--------ccCC--
Confidence 3346799999999999988999999999999999999999999976543221 11111100 0111
Q ss_pred cccHHHHHHHHHHHHHhhccCCCCCC-----CHhHHHH
Q 041143 869 EETFESISIVAELAGHCTAREPYHRP-----DMGHVVN 901 (973)
Q Consensus 869 ~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~~v~~ 901 (973)
......+.+++.+|++.||++|| ++.|+++
T Consensus 216 ---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 216 ---RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred ---CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 01123477999999999999997 7888876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=344.69 Aligned_cols=242 Identities=27% Similarity=0.357 Sum_probs=194.2
Q ss_pred ccccCccEEEEEEEC-CCCEEEEEEeecCC-CChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEecCCCCH
Q 041143 633 LGRGGFGTVYKGELE-DGTKIAVKRMEAGV-TTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGAL 710 (973)
Q Consensus 633 lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 710 (973)
||+|+||.||+|+.. +++.||+|+++... ........+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999875 57899999986431 2334456788999999999999999999999999999999999999999
Q ss_pred HHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCcceec
Q 041143 711 SRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVT 790 (973)
Q Consensus 711 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 790 (973)
.+++.. ...+++..+..++.||++||+||| +++|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 ~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~ 151 (312)
T cd05585 81 FHHLQR-----EGRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTN 151 (312)
T ss_pred HHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Cccc
Confidence 999865 245889999999999999999999 8899999999999999999999999999998543222 2234
Q ss_pred ccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccCCcc
Q 041143 791 RLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEE 870 (973)
Q Consensus 791 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 870 (973)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .+..+.. .......
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~------~~~~~~~----------~~~~~~~- 214 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE------MYRKILQ----------EPLRFPD- 214 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH------HHHHHHc----------CCCCCCC-
Confidence 4679999999999999999999999999999999999999997654321 1111111 1111111
Q ss_pred cHHHHHHHHHHHHHhhccCCCCCCCHhHHHHH
Q 041143 871 TFESISIVAELAGHCTAREPYHRPDMGHVVNV 902 (973)
Q Consensus 871 ~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~ 902 (973)
.....+.+++.+|++.||++||++..+.+.
T Consensus 215 --~~~~~~~~li~~~L~~dp~~R~~~~~~~e~ 244 (312)
T cd05585 215 --GFDRDAKDLLIGLLSRDPTRRLGYNGAQEI 244 (312)
T ss_pred --cCCHHHHHHHHHHcCCCHHHcCCCCCHHHH
Confidence 112346799999999999999865444333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=333.20 Aligned_cols=256 Identities=26% Similarity=0.410 Sum_probs=206.4
Q ss_pred hcCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
.++|...+.||+|+||.||+|...+++.||+|.++... ...+++.+|++++++++|+||+++++++...+..++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT---MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc---ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 45788899999999999999998878899999987542 234578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+++++|.+++.... ...+++.++..++.|++.|+.||| +.+|+||||||+||++++++.+||+|||+++....
T Consensus 82 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 82 LMKYGSLLEYLQGGA---GRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred cccCCcHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 999999999986522 346899999999999999999999 88999999999999999999999999999986653
Q ss_pred CCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcC
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (973)
..........++..|+|||++.+..++.++|||||||++|||++ |+.||........ .. .+.. ...
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~---~~~~-------~~~ 222 (261)
T cd05068 156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEV---LQ---QVDQ-------GYR 222 (261)
T ss_pred CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---HH---HHHc-------CCC
Confidence 22211111223457999999998899999999999999999999 9999976543221 11 1110 000
Q ss_pred ccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHh
Q 041143 863 PALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPL 906 (973)
Q Consensus 863 ~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~ 906 (973)
.. ........+.+++.+|++.+|++||++.++++.|+.+
T Consensus 223 ~~-----~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 223 MP-----CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CC-----CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 00 0112234588999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=333.07 Aligned_cols=255 Identities=27% Similarity=0.437 Sum_probs=206.0
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
.+|...+.||+|+||.||+|... .++.||+|+++.. ....+++.+|++++++++|+||+++++++..++..++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 45778899999999999999765 5889999998643 3345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+++|+|.+++... ....+++..++.++.|+++||+||| +.+++||||||+||++++++.+||+|||+++....
T Consensus 83 ~~~~~~L~~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 83 FMTYGNLLDYLREC---NRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred eCCCCcHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 99999999998652 2246899999999999999999999 78999999999999999999999999999986554
Q ss_pred CCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcC
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (973)
..........++..|+|||++.+..++.++|||||||++|||++ |..||......+. ..... ....
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~------~~~~~-------~~~~ 223 (263)
T cd05052 157 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV------YELLE-------KGYR 223 (263)
T ss_pred ceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH------HHHHH-------CCCC
Confidence 33222222334678999999998999999999999999999998 9999876543211 11111 1111
Q ss_pred ccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHh
Q 041143 863 PALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPL 906 (973)
Q Consensus 863 ~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~ 906 (973)
+.. .......+.+++.+|++.+|++||++.+++++|+.+
T Consensus 224 ~~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 224 MER-----PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCC-----CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 111 111234588999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=345.91 Aligned_cols=276 Identities=22% Similarity=0.348 Sum_probs=204.0
Q ss_pred CccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC-----eEE
Q 041143 626 NFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGN-----ERL 699 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 699 (973)
+|+..+.||+|+||.||+|... +|+.||||+++...........+.+|++++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4778899999999999999764 6899999998754334444567889999999999999999999886432 479
Q ss_pred EEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccc
Q 041143 700 LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK 779 (973)
Q Consensus 700 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~ 779 (973)
+||||+ +++|.+++.. ...+++..+..++.||++||+||| +++|+||||||+|||++.++.+||+|||+++
T Consensus 81 lv~e~~-~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~ 151 (338)
T cd07859 81 VVFELM-ESDLHQVIKA-----NDDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLAR 151 (338)
T ss_pred EEEecC-CCCHHHHHHh-----cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccc
Confidence 999999 5789888854 245899999999999999999999 8899999999999999999999999999998
Q ss_pred cCCCCC--cceecccccccCccccccccc--CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHH---------H
Q 041143 780 LAPDGE--KSVVTRLAGTFGYLAPEYAVM--GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAE---------W 846 (973)
Q Consensus 780 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~---------~ 846 (973)
...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||............. +
T Consensus 152 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 231 (338)
T cd07859 152 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET 231 (338)
T ss_pred ccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 543221 112244679999999999865 678999999999999999999999997655322111100 0
Q ss_pred HHHHhhc-hhHHHhhcCcccc--CCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCC
Q 041143 847 FWRIKSS-KEKFKAAIDPALE--VNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRP 912 (973)
Q Consensus 847 ~~~~~~~-~~~~~~~~~~~l~--~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~ 912 (973)
...+... .......+.+... ...........+.+++.+|++.||++||+++|+++ +++.+....
T Consensus 232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~--hp~f~~~~~ 298 (338)
T cd07859 232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA--DPYFKGLAK 298 (338)
T ss_pred HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc--CchhhhcCc
Confidence 0000000 0000000110000 00000011234679999999999999999999998 677665444
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=338.31 Aligned_cols=266 Identities=22% Similarity=0.316 Sum_probs=197.2
Q ss_pred cCccccCcccccCccEEEEEEEC--CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc---CCCceeeeeeEEEe-----
Q 041143 625 QNFAQENELGRGGFGTVYKGELE--DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV---RHRHLVSLLGYSIE----- 694 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----- 694 (973)
++|+..+.||+|+||.||+|+.. +|+.||||+++...........+.+|+.+++.+ +||||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999763 468899999875533333344566787777766 69999999999863
Q ss_pred CCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEee
Q 041143 695 GNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSD 774 (973)
Q Consensus 695 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D 774 (973)
....++||||+. ++|.+++... ....+++.++..++.||+.||+||| +++|+||||||+|||++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~D 153 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLAD 153 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEcc
Confidence 345799999995 6999988652 2245899999999999999999999 88999999999999999999999999
Q ss_pred ccccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhh-c
Q 041143 775 FGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKS-S 853 (973)
Q Consensus 775 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~ 853 (973)
||+++..... .......||+.|+|||++....++.++|||||||++|||++|+.||......+.. ...+..... .
T Consensus 154 fg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~--~~i~~~~~~~~ 229 (290)
T cd07862 154 FGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL--GKILDVIGLPG 229 (290)
T ss_pred ccceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHH--HHHHHHhCCCC
Confidence 9999865432 2233457899999999998889999999999999999999999999876543221 111100000 0
Q ss_pred hhHHHh-------hcCcccc--CCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 854 KEKFKA-------AIDPALE--VNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 854 ~~~~~~-------~~~~~l~--~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
...... .+.+... ...........+.+++.+|++.||++||++.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000000 0000000 00000011234679999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=305.77 Aligned_cols=264 Identities=23% Similarity=0.345 Sum_probs=209.4
Q ss_pred hcCccccCcccccCccEEEEEE-ECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC-----e
Q 041143 624 TQNFAQENELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGN-----E 697 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~ 697 (973)
.++|++.+.||+|||+.||.++ ..++..+|+|++... ..+..+..++|++..++++|||++++++++..+. +
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~--~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH--SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeecc--chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 4689999999999999999996 567889999999765 4567788999999999999999999999876543 4
Q ss_pred EEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccc
Q 041143 698 RLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL 777 (973)
Q Consensus 698 ~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGl 777 (973)
.|++++|...|+|.+.+..... +...+++.+.++|+.+|++||++||+. .++++||||||.|||+.+.+.+++.|||.
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~-kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKI-KGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred EEEEeehhccccHHHHHHHHhh-cCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccC
Confidence 8999999999999999987443 446799999999999999999999954 45699999999999999999999999999
Q ss_pred cccCCCC---Ccc-----eecccccccCcccccccc---cCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHH
Q 041143 778 VKLAPDG---EKS-----VVTRLAGTFGYLAPEYAV---MGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEW 846 (973)
Q Consensus 778 a~~~~~~---~~~-----~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 846 (973)
+....-. ... ....-.-|..|+|||.+. +...++++|||||||+||+|+.|..||+.... .
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-~------- 247 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-Q------- 247 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-c-------
Confidence 8743311 110 011223588999999886 34578999999999999999999999975432 1
Q ss_pred HHHHhhchhHHHh-hcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhh
Q 041143 847 FWRIKSSKEKFKA-AIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLV 907 (973)
Q Consensus 847 ~~~~~~~~~~~~~-~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~ 907 (973)
.+.+.- +..+.+...... ...+.+.++++.|++.||.+||+..+++..++.+.
T Consensus 248 -------GgSlaLAv~n~q~s~P~~~-~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 248 -------GGSLALAVQNAQISIPNSS-RYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred -------CCeEEEeeeccccccCCCC-CccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 111111 122233322222 25567899999999999999999999999887653
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=359.11 Aligned_cols=252 Identities=24% Similarity=0.310 Sum_probs=203.3
Q ss_pred CccccCcccccCccEEEEEEEC-C-CCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 626 NFAQENELGRGGFGTVYKGELE-D-GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~-~-g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
.|...+.||+|+||.||+|... + ++.||+|.+... .......+.+|+++++.++|||||++++++...+..++|||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E 145 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence 4888899999999999999654 3 678888876543 44455678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+++|+|.++++.... ...++++.++..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++....
T Consensus 146 ~~~gg~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLK-EHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred CCCCCCHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence 9999999999875322 2356889999999999999999999 88999999999999999999999999999986543
Q ss_pred CCc-ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcC
Q 041143 784 GEK-SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862 (973)
Q Consensus 784 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (973)
... ......+||++|+|||++.+..++.++|||||||++|||++|+.||......+. +..+... ..+
T Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~------~~~~~~~------~~~ 289 (478)
T PTZ00267 222 SVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREI------MQQVLYG------KYD 289 (478)
T ss_pred ccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhC------CCC
Confidence 322 223456799999999999999999999999999999999999999976543211 1111110 011
Q ss_pred ccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 863 PALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 863 ~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
+. .......+.+++.+|++.||++||++.+++.
T Consensus 290 ~~------~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 PF------PCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CC------CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 10 0112235789999999999999999999875
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=339.51 Aligned_cols=258 Identities=29% Similarity=0.427 Sum_probs=204.7
Q ss_pred cCccccCcccccCccEEEEEEEC-CCC----EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGT----KIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERL 699 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 699 (973)
.+|+..+.||+|+||.||+|.+. +|+ .||+|+++.. ......+++.+|+.+++.++||||++++|+|... ..+
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 56889999999999999999764 333 4899998643 3345567899999999999999999999999865 567
Q ss_pred EEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccc
Q 041143 700 LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK 779 (973)
Q Consensus 700 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~ 779 (973)
+|+||+++|+|.+++... ...+++..++.++.||+.||+||| +++|+||||||+||++++++.+||+|||+++
T Consensus 85 ~v~e~~~~g~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 85 LITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred eeeecCCCCCHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccc
Confidence 999999999999998752 245789999999999999999999 8899999999999999999999999999998
Q ss_pred cCCCCCcce-ecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHH
Q 041143 780 LAPDGEKSV-VTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKF 857 (973)
Q Consensus 780 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (973)
......... .....++..|+|||++....++.++|||||||++|||++ |+.||+.....+.. . +.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~---~----~~~~~~-- 228 (316)
T cd05108 158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---S----ILEKGE-- 228 (316)
T ss_pred cccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH---H----HHhCCC--
Confidence 654433221 122335678999999999999999999999999999998 99999765432211 1 111000
Q ss_pred HhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 858 KAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 858 ~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
... ........+.+++.+|++.+|.+||++.+++..+..+.+.
T Consensus 229 ------~~~---~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 229 ------RLP---QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred ------CCC---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 000 0011223577999999999999999999999999888664
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=331.24 Aligned_cols=256 Identities=25% Similarity=0.447 Sum_probs=206.2
Q ss_pred cCccccCcccccCccEEEEEEECC----CCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELED----GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLL 700 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 700 (973)
++|+..+.||+|+||.||+|.+.. ...||||.++.. ........|.+|+.++++++||||+++++++...+..++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG-SSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCC-CChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 578889999999999999998742 457999988654 244456679999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecccccc
Q 041143 701 VYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKL 780 (973)
Q Consensus 701 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~ 780 (973)
||||+++|+|.+++... ...+++.+++.++.|++.||+||| +++|+||||||+||++++++.+||+|||+++.
T Consensus 83 v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~ 155 (266)
T cd05033 83 ITEYMENGSLDKFLREN----DGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRR 155 (266)
T ss_pred EEEcCCCCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhc
Confidence 99999999999998652 136899999999999999999999 78999999999999999999999999999986
Q ss_pred CCCCCcc-eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHH
Q 041143 781 APDGEKS-VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFK 858 (973)
Q Consensus 781 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (973)
....... ......++..|+|||.+.+..++.++||||||+++|||++ |..||......+. ...+ .. .
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~---~~~~---~~-~---- 224 (266)
T cd05033 156 LEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV---IKAV---ED-G---- 224 (266)
T ss_pred ccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHH---HHHH---Hc-C----
Confidence 6422221 1222345678999999998899999999999999999998 9999865543211 1111 00 0
Q ss_pred hhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHh
Q 041143 859 AAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPL 906 (973)
Q Consensus 859 ~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~ 906 (973)
...+ ........+.+++.+|++.+|++||++.||++.|+++
T Consensus 225 -~~~~------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 225 -YRLP------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -CCCC------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0000 0112234578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=347.14 Aligned_cols=246 Identities=26% Similarity=0.323 Sum_probs=200.3
Q ss_pred cCccccCcccccCccEEEEEEECC--CCEEEEEEeecCC-CChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELED--GTKIAVKRMEAGV-TTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLV 701 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~--g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 701 (973)
++|...+.||+|+||.||+|..+. +..||+|++.... ......+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 578889999999999999997543 3689999986431 2233456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccC
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA 781 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~ 781 (973)
|||+++|+|.+++.. ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 110 ~Ey~~~g~L~~~i~~-----~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 110 LEFVIGGEFFTFLRR-----NKRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 999999999999865 245889999999999999999999 889999999999999999999999999999865
Q ss_pred CCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhc
Q 041143 782 PDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861 (973)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (973)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+..
T Consensus 182 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~------~~~i~~--------- 242 (340)
T PTZ00426 182 DTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI------YQKILE--------- 242 (340)
T ss_pred CCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH------HHHHhc---------
Confidence 332 2345799999999999988899999999999999999999999986553211 111111
Q ss_pred CccccCCcccHHHHHHHHHHHHHhhccCCCCCC-----CHhHHHH
Q 041143 862 DPALEVNEETFESISIVAELAGHCTAREPYHRP-----DMGHVVN 901 (973)
Q Consensus 862 ~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~~v~~ 901 (973)
....... .....+.+++.+|++.||++|+ +++++.+
T Consensus 243 -~~~~~p~---~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 243 -GIIYFPK---FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred -CCCCCCC---CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 1111001 1113467999999999999995 7888876
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=348.60 Aligned_cols=267 Identities=20% Similarity=0.245 Sum_probs=201.8
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
..+|...+.||+|+||.||+|... +++.||+|+... ..+.+|++++++++|||||++++++......++||
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 367999999999999999999764 688999996532 34678999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+ +++|..++.. ...+++.+++.++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+...
T Consensus 163 e~~-~~~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 163 PRY-KTDLYCYLAA-----KRNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPV 233 (391)
T ss_pred ecC-CCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence 999 5788888754 245789999999999999999999 7899999999999999999999999999997543
Q ss_pred CCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhh-----HHHHHHHHHHHhh-----
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEE-----SRYLAEWFWRIKS----- 852 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~-----~~~~~~~~~~~~~----- 852 (973)
...........||+.|+|||++.+..++.++|||||||++|||++|+.|+......+ ...+...+.....
T Consensus 234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~ 313 (391)
T PHA03212 234 DINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF 313 (391)
T ss_pred cccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence 332223345679999999999999899999999999999999999998875432111 1111111100000
Q ss_pred ---chhHHHhhc---------CccccCCc-ccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 853 ---SKEKFKAAI---------DPALEVNE-ETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 853 ---~~~~~~~~~---------~~~l~~~~-~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
....+.... .+...... ........+.+++.+|++.||++|||++|+++ +++++.
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~--hp~f~~ 381 (391)
T PHA03212 314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD--FAAFQD 381 (391)
T ss_pred CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc--Chhhcc
Confidence 000000000 00000000 01122346789999999999999999999998 666654
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=334.63 Aligned_cols=250 Identities=34% Similarity=0.563 Sum_probs=194.3
Q ss_pred ccCcccccCccEEEEEEEC-----CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 629 QENELGRGGFGTVYKGELE-----DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 629 ~~~~lG~G~fg~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
..+.||.|.||.||+|.+. .+..|+||.++.. ......+.|.+|++.+++++||||++++|++...+..++|||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeeccccccccccccccccccccccccccccccc
Confidence 3467999999999999876 3568999999653 345567899999999999999999999999998888999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+++|+|.++++.. ....+++.++..|+.|||+||+||| +.+|+|+||+++||++++++.+||+|||+++....
T Consensus 82 ~~~~g~L~~~L~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 82 YCPGGSLDDYLKSK---NKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp --TTEBHHHHHHHT---CTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred cccccccccccccc---ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 99999999999873 2356899999999999999999999 78999999999999999999999999999986532
Q ss_pred CC-cceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhc
Q 041143 784 GE-KSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861 (973)
Q Consensus 784 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (973)
.. ........+...|+|||.+....++.++||||||+++|||++ |+.|+......+ +. ..+.. ...
T Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~---~~---~~~~~-~~~----- 223 (259)
T PF07714_consen 156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE---II---EKLKQ-GQR----- 223 (259)
T ss_dssp SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH---HH---HHHHT-TEE-----
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cc---ccccc-ccc-----
Confidence 21 122233457789999999999999999999999999999999 789987664322 11 11111 000
Q ss_pred CccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHH
Q 041143 862 DPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVL 903 (973)
Q Consensus 862 ~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L 903 (973)
.. ........+.+++.+||+.||++||++.+|++.|
T Consensus 224 ---~~---~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 ---LP---IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ---TT---SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ---ce---eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 00 0111234577999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=360.05 Aligned_cols=258 Identities=27% Similarity=0.333 Sum_probs=207.8
Q ss_pred HHhcCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC----
Q 041143 622 KVTQNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGN---- 696 (973)
Q Consensus 622 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 696 (973)
...++|...+.||+|+||.||+|+. .+|+.||||++............+.+|+.++..++|+||+++++.+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3446899999999999999999975 46899999999766555666778899999999999999999988775432
Q ss_pred ----eEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEE
Q 041143 697 ----ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKV 772 (973)
Q Consensus 697 ----~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl 772 (973)
..++||||+++|+|.++++.... ....+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~-~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAK-TNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEE
Confidence 36799999999999999976332 2357899999999999999999999 889999999999999999999999
Q ss_pred eeccccccCCCCC-cceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHh
Q 041143 773 SDFGLVKLAPDGE-KSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIK 851 (973)
Q Consensus 773 ~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 851 (973)
+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .+....
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~------~~~~~~ 258 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE------VMHKTL 258 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHh
Confidence 9999998654321 122344679999999999999999999999999999999999999997654321 111111
Q ss_pred hchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 852 SSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 852 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
.. ..++ + +......+.+++.+|++.||.+||++.++++
T Consensus 259 ~~------~~~~-~-----~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 259 AG------RYDP-L-----PPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred cC------CCCC-C-----CCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 10 0111 1 1112245789999999999999999999987
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=305.40 Aligned_cols=259 Identities=27% Similarity=0.409 Sum_probs=211.3
Q ss_pred HHHhcCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCC------ChHHHHHHHHHHHHHHhc-CCCceeeeeeEE
Q 041143 621 RKVTQNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVT------TTKALDEFQSEIAVLSKV-RHRHLVSLLGYS 692 (973)
Q Consensus 621 ~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 692 (973)
....+.|...++||.|..++|-++.. ++|..+|+|++..... .....+.-.+|+.||+++ .||+|+.+.+++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 34556788889999999999999855 4688999999854322 122345677899999998 699999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEE
Q 041143 693 IEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKV 772 (973)
Q Consensus 693 ~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl 772 (973)
+.....++|+|.|+.|.|+++|.. ...+++.+..+|+.|+.+|++||| .+.|||||+||+|||+|++.++||
T Consensus 93 es~sF~FlVFdl~prGELFDyLts-----~VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~i 164 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTS-----KVTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKI 164 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhh-----heeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEE
Confidence 999999999999999999999965 356899999999999999999999 889999999999999999999999
Q ss_pred eeccccccCCCCCcceecccccccCccccccccc------CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHH
Q 041143 773 SDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVM------GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEW 846 (973)
Q Consensus 773 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 846 (973)
+|||+|+....+. .....+|||+|+|||.+.. ..|+..+|+||+||++|-|+.|.+||-....
T Consensus 165 sDFGFa~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ--------- 233 (411)
T KOG0599|consen 165 SDFGFACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ--------- 233 (411)
T ss_pred eccceeeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH---------
Confidence 9999999776654 3567899999999998853 3578899999999999999999999953321
Q ss_pred HHHHhhchhHHHhhcCccccCCcccHH-HHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhh
Q 041143 847 FWRIKSSKEKFKAAIDPALEVNEETFE-SISIVAELAGHCTAREPYHRPDMGHVVNVLSPLV 907 (973)
Q Consensus 847 ~~~~~~~~~~~~~~~~~~l~~~~~~~~-~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~ 907 (973)
--.++-+....+.+....+. ......+||.+|++.||.+|.|++|+++ +++.
T Consensus 234 -------mlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La--Hpff 286 (411)
T KOG0599|consen 234 -------MLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA--HPFF 286 (411)
T ss_pred -------HHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc--ChHH
Confidence 11223333444444444333 3345789999999999999999999998 5554
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=320.42 Aligned_cols=270 Identities=22% Similarity=0.315 Sum_probs=204.3
Q ss_pred hcCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCc-eeeeeeEEEeCC-----
Q 041143 624 TQNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRH-LVSLLGYSIEGN----- 696 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~----- 696 (973)
...|...++||+|+||+||+|+. .+|+.||+|+++.....+.......+|+.++++++|+| ||++++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 34566677899999999999975 46899999999765333333345689999999999999 999999999877
Q ss_pred -eEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeec
Q 041143 697 -ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDF 775 (973)
Q Consensus 697 -~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 775 (973)
..++||||+ .-+|..++....... ..++-..+..++.||++||+||| +++|+||||||+|||++++|.+||+||
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDF 164 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADF 164 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeecc
Confidence 788999999 569999997744322 34666889999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCCcceecccccccCcccccccccC-cCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhch
Q 041143 776 GLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMG-KITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSK 854 (973)
Q Consensus 776 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 854 (973)
|+|+...-.. ...+..++|..|+|||++.+. .|+...||||+||+++||++++.-|.+....+. +...+.-.-...
T Consensus 165 GlAra~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~q--l~~If~~lGtP~ 241 (323)
T KOG0594|consen 165 GLARAFSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQ--LFRIFRLLGTPN 241 (323)
T ss_pred chHHHhcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHH--HHHHHHHcCCCC
Confidence 9999544222 224556789999999999876 799999999999999999999999987765332 221111111110
Q ss_pred h-HHHhhc-Ccccc--CCc-c-c----HH---HHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 855 E-KFKAAI-DPALE--VNE-E-T----FE---SISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 855 ~-~~~~~~-~~~l~--~~~-~-~----~~---~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
+ ...... -+..+ +.. . . .. ......+++.+|++.+|.+|.|++.++.
T Consensus 242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~ 301 (323)
T KOG0594|consen 242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALT 301 (323)
T ss_pred ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhc
Confidence 0 011100 01111 000 0 0 00 1125789999999999999999999998
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=343.03 Aligned_cols=263 Identities=27% Similarity=0.439 Sum_probs=206.0
Q ss_pred cCccccCcccccCccEEEEEEEC------CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeC-C
Q 041143 625 QNFAQENELGRGGFGTVYKGELE------DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEG-N 696 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 696 (973)
++|++.+.||+|+||.||+|... +++.||+|+++... .....+.+.+|+.++.++ +|+||++++++|... .
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 57888999999999999999642 35789999987542 334456788999999999 899999999988754 5
Q ss_pred eEEEEEEecCCCCHHHHHHhhhhc--------------------------------------------------------
Q 041143 697 ERLLVYEYMPHGALSRHLFRWEKL-------------------------------------------------------- 720 (973)
Q Consensus 697 ~~~lV~e~~~~g~L~~~l~~~~~~-------------------------------------------------------- 720 (973)
..++||||+++|+|.+++......
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 678999999999999998642210
Q ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCcc-eecccccccCcc
Q 041143 721 QLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKS-VVTRLAGTFGYL 799 (973)
Q Consensus 721 ~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~ 799 (973)
....++|..+..++.||+.||+||| +.+|+||||||+||++++++.+||+|||+++........ ......++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 0136899999999999999999999 889999999999999999999999999999865332221 122345678899
Q ss_pred cccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHH
Q 041143 800 APEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIV 878 (973)
Q Consensus 800 aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 878 (973)
|||++.+..++.++|||||||++|||++ |+.||......+. +.. .+. ....+.. +......+
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~~---~~~-------~~~~~~~-----~~~~~~~~ 305 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FCR---RLK-------EGTRMRA-----PEYATPEI 305 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HHH---HHh-------ccCCCCC-----CccCCHHH
Confidence 9999999999999999999999999998 9999976443221 111 000 0000000 01122457
Q ss_pred HHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 879 AELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 879 ~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
.+++.+|++.+|++||++.||++.|+.+++
T Consensus 306 ~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 306 YSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 899999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=334.38 Aligned_cols=261 Identities=27% Similarity=0.399 Sum_probs=206.6
Q ss_pred CccccCcccccCccEEEEEEEC------CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEE
Q 041143 626 NFAQENELGRGGFGTVYKGELE------DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERL 699 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 699 (973)
+|...+.||+|+||.||+|... ....+|+|.+.... .....+++.+|+.+++.++||||+++++++...+..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 4677899999999999999753 23578888886542 3444578999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhhh-------------------ccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCC
Q 041143 700 LVYEYMPHGALSRHLFRWEK-------------------LQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSS 760 (973)
Q Consensus 700 lV~e~~~~g~L~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~ 760 (973)
+||||+.+|+|.+++..... .....+++.+++.++.|++.||+||| +.+|+||||||+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~ 156 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAAR 156 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhh
Confidence 99999999999999875321 11245889999999999999999999 889999999999
Q ss_pred cEEECCCCCEEEeeccccccCCCCCcc-eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChh
Q 041143 761 NILLDDDYRAKVSDFGLVKLAPDGEKS-VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPE 838 (973)
Q Consensus 761 Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~ 838 (973)
||++++++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |+.||....+.
T Consensus 157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 236 (290)
T cd05045 157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236 (290)
T ss_pred eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 999999999999999999854332221 1222346778999999988889999999999999999999 99999765433
Q ss_pred hHHHHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 839 ESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
+. ..+.. ....... .......+.+++.+|++.+|++||+++++++.|++++.
T Consensus 237 ~~---~~~~~----------~~~~~~~-----~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 237 RL---FNLLK----------TGYRMER-----PENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HH---HHHHh----------CCCCCCC-----CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 21 11110 0001100 11122457899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=335.80 Aligned_cols=265 Identities=22% Similarity=0.333 Sum_probs=200.9
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
++|...+.||+|+||.||+|..+ +++.||+|+++... .......+.+|++++++++||||+++++++..++..++|||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH-EEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccc-cCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 56888999999999999999765 68899999986542 22233467889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|++ |+|.+++... ...+++..+..++.||+.||+||| +++|+||||||+|||+++++.+||+|||+++....
T Consensus 84 ~~~-~~l~~~l~~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~ 155 (288)
T cd07871 84 YLD-SDLKQYLDNC----GNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSV 155 (288)
T ss_pred CCC-cCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence 996 5998888642 235788999999999999999999 88999999999999999999999999999975433
Q ss_pred CCcceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhh----------
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKS---------- 852 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---------- 852 (973)
... ......|++.|+|||++.+ ..++.++||||+||++|||++|+.||......+..... ......
T Consensus 156 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 232 (288)
T cd07871 156 PTK-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI--FRLLGTPTEETWPGIT 232 (288)
T ss_pred CCc-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHHhCCCChHHhhccc
Confidence 221 2234568999999998875 56899999999999999999999999876543322111 110000
Q ss_pred chhHHHhhcCccccCCc---ccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 853 SKEKFKAAIDPALEVNE---ETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 853 ~~~~~~~~~~~~l~~~~---~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
....+.....+...... ..........+++.+|++.||.+|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00111111111111000 00011235779999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=333.88 Aligned_cols=258 Identities=30% Similarity=0.487 Sum_probs=206.5
Q ss_pred cCccccCcccccCccEEEEEEECC------CCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeE
Q 041143 625 QNFAQENELGRGGFGTVYKGELED------GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNER 698 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 698 (973)
++|...+.||+|+||.||+|...+ ++.||||.++.. ...+..+.+.+|++++++++|+||+++++++......
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET-ASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeeccc-CCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 467788999999999999997643 478999998754 2333567899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhh---------hccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCC
Q 041143 699 LLVYEYMPHGALSRHLFRWE---------KLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYR 769 (973)
Q Consensus 699 ~lV~e~~~~g~L~~~l~~~~---------~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~ 769 (973)
++||||+++|+|.+++.... ......+++.++..++.|++.|++||| +++++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCe
Confidence 99999999999999997632 112345889999999999999999999 889999999999999999999
Q ss_pred EEEeeccccccCCCCCc-ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHH
Q 041143 770 AKVSDFGLVKLAPDGEK-SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWF 847 (973)
Q Consensus 770 ~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 847 (973)
+||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||......+. ...+
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~---~~~~ 237 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV---IECI 237 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---HHHH
Confidence 99999999975432221 11233456789999999999999999999999999999999 9999876543221 1111
Q ss_pred HHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHH
Q 041143 848 WRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLS 904 (973)
Q Consensus 848 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~ 904 (973)
.. .... .........+.+++.+|++.||++||++.||++.|+
T Consensus 238 ---~~----------~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 238 ---TQ----------GRLL--QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred ---Hc----------CCcC--CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 10 0000 001122345789999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=333.72 Aligned_cols=260 Identities=27% Similarity=0.468 Sum_probs=205.0
Q ss_pred cCccccCcccccCccEEEEEEE-----CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEE
Q 041143 625 QNFAQENELGRGGFGTVYKGEL-----EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERL 699 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 699 (973)
.+|+..+.||+|+||.||+|.. .++..||+|.++.. ........+.+|++++++++||||+++++++..++..+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI-NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 4677889999999999999974 24678999998754 23445578999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhhh------------ccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCC
Q 041143 700 LVYEYMPHGALSRHLFRWEK------------LQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDD 767 (973)
Q Consensus 700 lV~e~~~~g~L~~~l~~~~~------------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~ 767 (973)
+||||+++|+|.+++..... .....+++.+.+.++.|++.||+||| +++|+||||||+||+++++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCC
Confidence 99999999999999864211 01235789999999999999999999 7899999999999999999
Q ss_pred CCEEEeeccccccCCCCCc-ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHH
Q 041143 768 YRAKVSDFGLVKLAPDGEK-SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAE 845 (973)
Q Consensus 768 ~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~ 845 (973)
+.+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||......+. .+
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~---~~ 237 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV---IE 237 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---HH
Confidence 9999999999985433221 12233456778999999988889999999999999999998 9999876543211 11
Q ss_pred HHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHh
Q 041143 846 WFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPL 906 (973)
Q Consensus 846 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~ 906 (973)
.+. . . +.+. ........+.+++.+|++.||++||++.+|.+.|+.+
T Consensus 238 ~~~---~-~--------~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05090 238 MVR---K-R--------QLLP---CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRSW 283 (283)
T ss_pred HHH---c-C--------CcCC---CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhcC
Confidence 110 0 0 0000 0011224578899999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=337.39 Aligned_cols=253 Identities=26% Similarity=0.359 Sum_probs=215.4
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCe-EEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNE-RLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lV~ 702 (973)
++|..++.+|+|+||.++.++.+ ++..+++|.+..........+....|+.++++++|||||.+++.+.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888899999999999999654 57899999998776677777788999999999999999999999999888 89999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
+|++||++.+.+.+.+ ...++..+..+++.|++.|+.||| ++.|+|||||+.||+++.++.|||+|||+|+...
T Consensus 84 ~Y~eGg~l~~~i~~~k---~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK---GVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred eecCCCCHHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcC
Confidence 9999999999997743 366899999999999999999999 8899999999999999999999999999999776
Q ss_pred CCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcC
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (973)
... .....++||+.||.||.+.+.+|..|+||||+||++|||++-+++|...+... ++ .++. +..++
T Consensus 158 ~~~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~---Li---~ki~------~~~~~ 224 (426)
T KOG0589|consen 158 PED-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE---LI---LKIN------RGLYS 224 (426)
T ss_pred Cch-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH---HH---HHHh------hccCC
Confidence 543 23456789999999999999999999999999999999999999998765322 11 1111 11122
Q ss_pred ccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHH
Q 041143 863 PALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNV 902 (973)
Q Consensus 863 ~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~ 902 (973)
| .+......+..++..|++.+|+.||++.+++..
T Consensus 225 P------lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 225 P------LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred C------CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 2 222344568899999999999999999999986
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=332.09 Aligned_cols=256 Identities=30% Similarity=0.460 Sum_probs=209.0
Q ss_pred HhcCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 623 VTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
...+|...+.||+|+||.||+|...++..+|+|.+... .......+.+|+.+++.++|+||+++++++...+..++||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD--DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT 81 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEecccc--chhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence 34678889999999999999999988999999998754 3334567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++|+|.+++.... ...+++.++..++.|++.||+||| +++|+||||||+||++++++.+||+|||.+....
T Consensus 82 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~ 155 (261)
T cd05148 82 ELMEKGSLLAFLRSPE---GQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIK 155 (261)
T ss_pred eecccCCHHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcC
Confidence 9999999999997522 356899999999999999999999 8899999999999999999999999999998654
Q ss_pred CCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhc
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (973)
+.... .....++..|+|||++....++.++|||||||++|+|++ |+.||......+. ...+. . ..
T Consensus 156 ~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~---~~~~~---~-------~~ 221 (261)
T cd05148 156 EDVYL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV---YDQIT---A-------GY 221 (261)
T ss_pred Ccccc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH---HHHHH---h-------CC
Confidence 43221 223446778999999988899999999999999999998 8999976543221 11111 0 00
Q ss_pred CccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHH
Q 041143 862 DPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSP 905 (973)
Q Consensus 862 ~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~ 905 (973)
... ........+.+++.+|++.||++||+++++++.|+.
T Consensus 222 ~~~-----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 222 RMP-----CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred cCC-----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 000 011223457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=327.83 Aligned_cols=255 Identities=30% Similarity=0.475 Sum_probs=204.6
Q ss_pred cCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEe
Q 041143 625 QNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEY 704 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 704 (973)
++|...+.||+|+||.||+|++.+...||+|+++.... ..+.+.+|++++++++|+||+++++++. .+..++||||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 81 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence 56889999999999999999887777899999875322 2357899999999999999999999875 4567999999
Q ss_pred cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCC
Q 041143 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG 784 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~ 784 (973)
+++|+|.+++... ....+++..+..++.|+++||+||| +.+|+||||||+||++++++.+||+|||.++.....
T Consensus 82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 82 MSKGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred CCCCcHHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 9999999999652 1245799999999999999999999 889999999999999999999999999999865443
Q ss_pred CcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCc
Q 041143 785 EKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDP 863 (973)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (973)
.........++..|+|||+..+..++.++|||||||++|||++ |+.||......+.. ..+.. ....
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~------~~~~~-------~~~~ 222 (262)
T cd05071 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL------DQVER-------GYRM 222 (262)
T ss_pred ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHH------HHHhc-------CCCC
Confidence 3222223456778999999988899999999999999999999 88888765432110 01100 0000
Q ss_pred cccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhh
Q 041143 864 ALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLV 907 (973)
Q Consensus 864 ~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~ 907 (973)
. ...+....+.+++.+|++.+|++||+++++++.|+.+.
T Consensus 223 ~-----~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 223 P-----CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred C-----CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 0 11223455789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=345.35 Aligned_cols=254 Identities=24% Similarity=0.359 Sum_probs=196.0
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
.+|+..+.||+|+||.||+|+.. +|+.||||++... ......+.+.+|+++++.++|+||+++++++...+..++|||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGN-HEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecC-CcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 34556788999999999999865 6899999998654 234455679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+++|+|... ....+..+..++.||+.||+||| +++|+||||||+|||+++++.+||+|||+++....
T Consensus 153 ~~~~~~L~~~---------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 153 FMDGGSLEGT---------HIADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220 (353)
T ss_pred cCCCCccccc---------ccCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence 9999998542 23456778889999999999999 88999999999999999999999999999986543
Q ss_pred CCcceecccccccCccccccccc-----CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHH
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVM-----GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFK 858 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (973)
... ......||..|+|||++.. ...+.++|||||||++|||++|+.||......+...+.. .+..
T Consensus 221 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~---~~~~------ 290 (353)
T PLN00034 221 TMD-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC---AICM------ 290 (353)
T ss_pred ccc-cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH---HHhc------
Confidence 221 1234579999999998743 234568999999999999999999997433222111110 0000
Q ss_pred hhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 859 AAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 859 ~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
...+.. .......+.+++.+||+.||++||++.||++ +.++.+
T Consensus 291 -~~~~~~-----~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~--hp~~~~ 333 (353)
T PLN00034 291 -SQPPEA-----PATASREFRHFISCCLQREPAKRWSAMQLLQ--HPFILR 333 (353)
T ss_pred -cCCCCC-----CCccCHHHHHHHHHHccCChhhCcCHHHHhc--Cccccc
Confidence 000111 1112345789999999999999999999998 555543
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=327.53 Aligned_cols=262 Identities=25% Similarity=0.387 Sum_probs=210.6
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecC-CCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAG-VTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
++|+..+.||+|+||.||+|+.. +++.||||.++.. .........+.+|++++++++||||+++++++.+.+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57888999999999999999764 6899999987642 234455667899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++|+|.+++..... ....+++..+..++.|+++||+||| +++++|+||||+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 82 ELADAGDLSQMIKYFKK-QKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCcHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 99999999998865332 2355788999999999999999999 8899999999999999999999999999988654
Q ss_pred CCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcC
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (973)
.... ......|+..|+|||++.+..++.++|||||||++|||++|+.||....... ..+...+ .....
T Consensus 158 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~----~~~~~~~-------~~~~~ 225 (267)
T cd08228 158 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----FSLCQKI-------EQCDY 225 (267)
T ss_pred chhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH----HHHHHHH-------hcCCC
Confidence 3221 1223468899999999988889999999999999999999999986543211 1111111 11111
Q ss_pred ccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHh
Q 041143 863 PALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPL 906 (973)
Q Consensus 863 ~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~ 906 (973)
+.. ........+.+++.+|++.+|++||++.+|++.++++
T Consensus 226 ~~~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 226 PPL----PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CCC----ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 111 1112335688999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=339.17 Aligned_cols=269 Identities=20% Similarity=0.330 Sum_probs=207.1
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
.++|+..+.||+|+||.||+|... ++..+|+|.++... .....+.+.+|++++++++|+||+++++++.+.+..++||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 368899999999999999999876 58889999887642 3445567999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++|+|.+++.. ...+++.....++.|++.||+|||+ ..+|+||||||+||+++.++.+||+|||++....
T Consensus 83 e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 83 EHMDGGSLDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred ecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 99999999999865 2457888999999999999999993 3479999999999999999999999999987543
Q ss_pred CCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhch--------
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSK-------- 854 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------- 854 (973)
.. ......|+..|+|||++.+..++.++|||||||++|||++|+.||......+...... ......
T Consensus 156 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 229 (333)
T cd06650 156 DS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFG---CPVEGDPAESETSP 229 (333)
T ss_pred hh---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhc---CcccCCccccccCc
Confidence 32 1233578999999999998889999999999999999999999997654322111100 000000
Q ss_pred ----------------------hHH-HhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 855 ----------------------EKF-KAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 855 ----------------------~~~-~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
..+ ...+..... ..........+.+++.+||+.||++||++.|+++ +.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~--h~~~~~ 304 (333)
T cd06650 230 RPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPP-KLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV--HAFIKR 304 (333)
T ss_pred ccCCccchhhhhcccccccccHHHHHHHHhcCCCc-cCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh--CHHHhc
Confidence 000 000000000 0000011234789999999999999999999987 666653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=328.69 Aligned_cols=252 Identities=29% Similarity=0.445 Sum_probs=202.7
Q ss_pred cCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEe
Q 041143 625 QNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEY 704 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 704 (973)
++|...+.||+|+||.||+|+..++..+|||.++... ...+.|.+|+.++++++||||+++++++.+.+..++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS---MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc---ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 4577889999999999999988877789999886542 2235789999999999999999999999998889999999
Q ss_pred cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCC
Q 041143 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG 784 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~ 784 (973)
+++|+|.+++... ...+++.+++.++.||+.||+||| +.+++|+||||+||+++.++.+||+|||.++...+.
T Consensus 81 ~~~~~l~~~i~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 81 MSNGCLLNYLREH----GKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred CCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 9999999998652 135899999999999999999999 889999999999999999999999999998865443
Q ss_pred CcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCc
Q 041143 785 EKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDP 863 (973)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (973)
.........++..|+|||+..+..++.++|||||||++|||++ |+.||......+. .. .+... ..+
T Consensus 154 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~---~~---~~~~~-------~~~ 220 (256)
T cd05113 154 EYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET---VE---KVSQG-------LRL 220 (256)
T ss_pred ceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---HH---HHhcC-------CCC
Confidence 3222222345678999999988889999999999999999999 9999976543221 11 11110 000
Q ss_pred cccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHH
Q 041143 864 ALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLS 904 (973)
Q Consensus 864 ~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~ 904 (973)
... . .....+.+++.+|++.+|.+||++.+|++.|+
T Consensus 221 ~~~-~----~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 YRP-H----LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCC-C----CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 000 0 11346789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=333.05 Aligned_cols=262 Identities=31% Similarity=0.482 Sum_probs=208.8
Q ss_pred cCccccCcccccCccEEEEEEEC------CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE------DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNER 698 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 698 (973)
.+|...+.||+|+||.||++... ++..+|+|.+... .....+.+.+|++++++++||||+++++++...+..
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 57888899999999999999742 3456899988653 445567899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhhh--------ccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCE
Q 041143 699 LLVYEYMPHGALSRHLFRWEK--------LQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRA 770 (973)
Q Consensus 699 ~lV~e~~~~g~L~~~l~~~~~--------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~ 770 (973)
++||||+++|+|.+++..... .....+++.+++.++.|++.||+||| +++++||||||+||++++++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcE
Confidence 999999999999999975321 12235899999999999999999999 8899999999999999999999
Q ss_pred EEeeccccccCCCCCc-ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHH
Q 041143 771 KVSDFGLVKLAPDGEK-SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFW 848 (973)
Q Consensus 771 kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 848 (973)
||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |+.||......+. ..
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~---~~--- 233 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV---IE--- 233 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH---
Confidence 9999999985433221 11223446788999999998899999999999999999998 9999876553221 11
Q ss_pred HHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 849 RIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 849 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
.+... . ..... . .....+.+++.+|++.+|.+||++.+|++.|+.+.+.
T Consensus 234 ~i~~~--~-----~~~~~-~----~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 234 CITQG--R-----VLQRP-R----TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHHcC--C-----cCCCC-C----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 11110 0 00000 0 1123588999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=332.37 Aligned_cols=260 Identities=27% Similarity=0.448 Sum_probs=204.6
Q ss_pred HhcCccccCcccccCccEEEEEEEC------CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC
Q 041143 623 VTQNFAQENELGRGGFGTVYKGELE------DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGN 696 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 696 (973)
..++|+..+.||+|+||.||+|... .+..||||++.... ......++.+|+.+++.++|+||+++++++.++.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 4577999999999999999999753 35679999886432 3344567899999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhhhhc-----cCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEE
Q 041143 697 ERLLVYEYMPHGALSRHLFRWEKL-----QLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAK 771 (973)
Q Consensus 697 ~~~lV~e~~~~g~L~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~k 771 (973)
..++||||+++|+|.+++...... ....+++.++..++.|+++||+||| +.+++||||||+||++++++.+|
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEE
Confidence 999999999999999999753221 1234688999999999999999999 78999999999999999999999
Q ss_pred EeeccccccCCCCCcc-eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHH
Q 041143 772 VSDFGLVKLAPDGEKS-VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWR 849 (973)
Q Consensus 772 l~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 849 (973)
|+|||+++........ ......+++.|+|||++.+..++.++|||||||++|||++ |..||......+. ..+
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~---~~~--- 233 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV---LRF--- 233 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHH---
Confidence 9999998754332221 1122346788999999998899999999999999999999 7889876543221 110
Q ss_pred HhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHH
Q 041143 850 IKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLS 904 (973)
Q Consensus 850 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~ 904 (973)
.. ..... .........+.+++.+|++.+|++||++.|+++.|+
T Consensus 234 ~~----------~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 234 VM----------EGGLL--DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HH----------cCCcC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 00 00000 001112345789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=333.31 Aligned_cols=261 Identities=30% Similarity=0.473 Sum_probs=208.7
Q ss_pred cCccccCcccccCccEEEEEEEC------CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE------DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNER 698 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 698 (973)
.+|...+.||+|+||.||+|+.. ++..+++|.++.. .....+.+.+|++++++++|+||+++++++...+..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc--cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence 45778899999999999999743 3456899988653 444556799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhhh-----------ccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCC
Q 041143 699 LLVYEYMPHGALSRHLFRWEK-----------LQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDD 767 (973)
Q Consensus 699 ~lV~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~ 767 (973)
++||||+++++|.+++..... .....++|..++.++.||+.||+||| +++|+||||||+||+++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccC
Confidence 999999999999999975321 11235899999999999999999999 8899999999999999999
Q ss_pred CCEEEeeccccccCCCCCc-ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHH
Q 041143 768 YRAKVSDFGLVKLAPDGEK-SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAE 845 (973)
Q Consensus 768 ~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~ 845 (973)
+.+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |+.||......+. ..
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---~~ 236 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV---IE 236 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH
Confidence 9999999999975443221 12233457889999999999999999999999999999999 9999876554321 11
Q ss_pred HHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 846 WFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 846 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
. +. ..... .........+.+++.+|++.+|++||++.+|+++|+.+.+
T Consensus 237 ~---~~----------~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 237 C---IT----------QGRVL--ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred H---Hh----------CCCCC--CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 1 10 00000 0011123457899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=344.92 Aligned_cols=253 Identities=26% Similarity=0.350 Sum_probs=198.6
Q ss_pred CccccCcccccCccEEEEEEE----CCCCEEEEEEeecCC--CChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeE
Q 041143 626 NFAQENELGRGGFGTVYKGEL----EDGTKIAVKRMEAGV--TTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGNER 698 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~----~~g~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 698 (973)
+|+..+.||+|+||.||+++. .+++.||+|+++... ......+.+..|++++.++ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999975 357899999986431 1223456788999999999 599999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecccc
Q 041143 699 LLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLV 778 (973)
Q Consensus 699 ~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla 778 (973)
++||||+++|+|.+++.. ...+++.++..++.||+.||+||| +++|+||||||+|||++.++.+||+|||++
T Consensus 81 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~ 152 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ-----RDNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLS 152 (332)
T ss_pred EEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCC
Confidence 999999999999999865 245889999999999999999999 889999999999999999999999999999
Q ss_pred ccCCCCCcceecccccccCcccccccccC-cCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHH
Q 041143 779 KLAPDGEKSVVTRLAGTFGYLAPEYAVMG-KITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKF 857 (973)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (973)
+..............||+.|+|||++.+. .++.++|||||||++|||++|+.||.......... .....+..
T Consensus 153 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~--~~~~~~~~----- 225 (332)
T cd05614 153 KEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS--EVSRRILK----- 225 (332)
T ss_pred ccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH--HHHHHHhc-----
Confidence 86544333333456799999999998765 47889999999999999999999997543221111 00111111
Q ss_pred HhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCC-----CHhHHHH
Q 041143 858 KAAIDPALEVNEETFESISIVAELAGHCTAREPYHRP-----DMGHVVN 901 (973)
Q Consensus 858 ~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~~v~~ 901 (973)
.++.+. ......+.+++.+|++.||++|| ++.++++
T Consensus 226 ---~~~~~~-----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 226 ---CDPPFP-----SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred ---CCCCCC-----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 111111 01123467999999999999999 6667776
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=345.40 Aligned_cols=263 Identities=27% Similarity=0.399 Sum_probs=206.2
Q ss_pred hcCccccCcccccCccEEEEEEEC------CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeeEEEeCC
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE------DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR-HRHLVSLLGYSIEGN 696 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 696 (973)
.++|...+.||+|+||.||+|++. .++.||||+++... .....+.+.+|++++.++. |||||+++++|...+
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 346777899999999999999864 34689999997642 3334457899999999997 999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhhhh---------------------------------------------------------
Q 041143 697 ERLLVYEYMPHGALSRHLFRWEK--------------------------------------------------------- 719 (973)
Q Consensus 697 ~~~lV~e~~~~g~L~~~l~~~~~--------------------------------------------------------- 719 (973)
..++||||+++|+|.+++++...
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 99999999999999999976321
Q ss_pred ------------------------------------ccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEE
Q 041143 720 ------------------------------------LQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNIL 763 (973)
Q Consensus 720 ------------------------------------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nil 763 (973)
.....++|.+++.++.||++||+||| +++|+||||||+|||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEE
Confidence 01134788899999999999999999 889999999999999
Q ss_pred ECCCCCEEEeeccccccCCCCCc-ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHH
Q 041143 764 LDDDYRAKVSDFGLVKLAPDGEK-SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESR 841 (973)
Q Consensus 764 l~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~ 841 (973)
+++++.+||+|||+++....... .......++..|+|||++....++.++|||||||++|||++ |+.||......+.
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~- 350 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ- 350 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH-
Confidence 99999999999999985432221 11223457889999999998889999999999999999998 8899875432221
Q ss_pred HHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhh
Q 041143 842 YLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLV 907 (973)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~ 907 (973)
.. ..+.. . ..+.. +......+.+++.+|+..+|++||+++||++.|+.++
T Consensus 351 -~~---~~~~~-~------~~~~~-----p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 351 -FY---NAIKR-G------YRMAK-----PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred -HH---HHHHc-C------CCCCC-----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 00 00000 0 00000 0112245789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=342.70 Aligned_cols=259 Identities=23% Similarity=0.306 Sum_probs=205.6
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
++|...+.||+|+||.||+|+.. +|+.||+|+++.... .....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36888999999999999999765 688999999975422 2334567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++|+|.+++... ...+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 81 e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 153 (330)
T cd05601 81 EYQPGGDLLSLLNRY----EDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLT 153 (330)
T ss_pred CCCCCCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECC
Confidence 999999999998653 246899999999999999999999 8899999999999999999999999999998665
Q ss_pred CCCcceecccccccCcccccccc------cCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhH
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAV------MGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEK 856 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (973)
...........||+.|+|||++. ...++.++|||||||++|||++|+.||........ +..+....
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~------~~~i~~~~-- 225 (330)
T cd05601 154 ANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT------YNNIMNFQ-- 225 (330)
T ss_pred CCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH------HHHHHcCC--
Confidence 44333334457999999999986 45678999999999999999999999976543221 11111100
Q ss_pred HHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 857 FKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 857 ~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
..+... ........+.+++..|++ +|.+||++.++++ +++.+
T Consensus 226 ------~~~~~~-~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~--h~~~~ 267 (330)
T cd05601 226 ------RFLKFP-EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC--HPFFS 267 (330)
T ss_pred ------CccCCC-CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC--CCCcC
Confidence 001100 011122447789999998 9999999999986 54443
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=327.31 Aligned_cols=254 Identities=31% Similarity=0.498 Sum_probs=203.7
Q ss_pred hcCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
.++|+..+.||+|+||.||+|..+++..+|+|.++..... .+.+.+|+.++++++|+||+++++++. ....++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTE 80 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEE
Confidence 3578888999999999999999888889999998754332 356899999999999999999999875 456899999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+++++|.++++.. ....+++.++..++.|++.||+||| +.+|+||||||+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 81 YMSKGSLLDFLKDG---EGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred ecCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 99999999998652 2245899999999999999999999 78999999999999999999999999999986544
Q ss_pred CCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcC
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (973)
..........++..|+|||++.+..++.++|||||||++|||++ |+.||......+. ..+ +. ....
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~---~~~---~~-------~~~~ 221 (260)
T cd05070 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREV---LEQ---VE-------RGYR 221 (260)
T ss_pred cccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH---HHH---HH-------cCCC
Confidence 33222223345678999999988899999999999999999999 8999976543211 111 11 0001
Q ss_pred ccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHH
Q 041143 863 PALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSP 905 (973)
Q Consensus 863 ~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~ 905 (973)
... .......+.+++.+|++.+|++||++.++.+.|+.
T Consensus 222 ~~~-----~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 MPC-----PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCC-----CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 111 11223458899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=341.10 Aligned_cols=243 Identities=28% Similarity=0.401 Sum_probs=195.0
Q ss_pred CcccccCccEEEEEEE----CCCCEEEEEEeecCC--CChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEe
Q 041143 631 NELGRGGFGTVYKGEL----EDGTKIAVKRMEAGV--TTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEY 704 (973)
Q Consensus 631 ~~lG~G~fg~Vy~~~~----~~g~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 704 (973)
+.||+|+||.||+++. .+++.||||+++... ........+.+|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999975 357899999987531 1223345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCC
Q 041143 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG 784 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~ 784 (973)
+++|+|.+++.. ...+.+..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (323)
T cd05584 82 LSGGELFMHLER-----EGIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE 153 (323)
T ss_pred CCCchHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence 999999998865 245788888999999999999999 889999999999999999999999999998744322
Q ss_pred CcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCcc
Q 041143 785 EKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPA 864 (973)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 864 (973)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ +..+.. ..
T Consensus 154 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~------~~~~~~----------~~ 216 (323)
T cd05584 154 GT-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT------IDKILK----------GK 216 (323)
T ss_pred CC-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH------HHHHHc----------CC
Confidence 21 23345799999999999988899999999999999999999999986553211 111111 11
Q ss_pred ccCCcccHHHHHHHHHHHHHhhccCCCCCC-----CHhHHHH
Q 041143 865 LEVNEETFESISIVAELAGHCTAREPYHRP-----DMGHVVN 901 (973)
Q Consensus 865 l~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~~v~~ 901 (973)
..... .....+.+++.+|++.||++|| ++.++++
T Consensus 217 ~~~~~---~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 217 LNLPP---YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCC---CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 11111 1123467999999999999999 7787776
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=328.86 Aligned_cols=259 Identities=28% Similarity=0.448 Sum_probs=205.2
Q ss_pred ccccCcccccCccEEEEEEECC----CCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCe-----
Q 041143 627 FAQENELGRGGFGTVYKGELED----GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNE----- 697 (973)
Q Consensus 627 ~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 697 (973)
|...+.||+|+||.||+|.... +..||+|+++.........+.+.+|++.++.++|+||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567899999999999997642 3679999998665555667789999999999999999999999876554
Q ss_pred -EEEEEEecCCCCHHHHHHhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeec
Q 041143 698 -RLLVYEYMPHGALSRHLFRWEKL-QLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDF 775 (973)
Q Consensus 698 -~~lV~e~~~~g~L~~~l~~~~~~-~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 775 (973)
.++||||+++|+|..++...... ....+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence 68999999999999998653321 2246899999999999999999999 789999999999999999999999999
Q ss_pred cccccCCCCCcce-ecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhc
Q 041143 776 GLVKLAPDGEKSV-VTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSS 853 (973)
Q Consensus 776 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 853 (973)
|+++......... .....++..|+|||++....++.++|||||||++|||++ |..||......+ +..+. ...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~~~~---~~~ 231 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IYDYL---RHG 231 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH---HcC
Confidence 9998654332211 122345678999999988889999999999999999999 889987654321 11111 110
Q ss_pred hhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHh
Q 041143 854 KEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPL 906 (973)
Q Consensus 854 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~ 906 (973)
.... ........+.+++.+|++.||.+||++.||++.|+.+
T Consensus 232 -------~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 -------NRLK-----QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred -------CCCC-----CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0011 1112334688999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=327.90 Aligned_cols=251 Identities=28% Similarity=0.420 Sum_probs=201.6
Q ss_pred cCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEe
Q 041143 625 QNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEY 704 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 704 (973)
.+|+..+.||+|+||.||+|.++++..+|+|.+..... ..+.+.+|++++++++|+||+++++++...+..++||||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence 35778899999999999999988778899999864322 234688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCC
Q 041143 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG 784 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~ 784 (973)
+++++|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++...+.
T Consensus 81 ~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~ 153 (256)
T cd05059 81 MANGCLLNYLRERK----GKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD 153 (256)
T ss_pred CCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceecccc
Confidence 99999999986521 36899999999999999999999 889999999999999999999999999999865433
Q ss_pred CcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCc
Q 041143 785 EKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDP 863 (973)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (973)
.........++..|+|||++.+..++.++|||||||++|||++ |+.||......+. . ... ......
T Consensus 154 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~---~~~-------~~~~~~ 220 (256)
T cd05059 154 QYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV---V---ESV-------SAGYRL 220 (256)
T ss_pred cccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH---H---HHH-------HcCCcC
Confidence 2221122234567999999998999999999999999999999 8999976543221 1 111 111111
Q ss_pred cccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHH
Q 041143 864 ALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVL 903 (973)
Q Consensus 864 ~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L 903 (973)
... ......+.+++.+|+..+|++||++.||++.|
T Consensus 221 ~~~-----~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 221 YRP-----KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCC-----CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 111 11234588999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=328.52 Aligned_cols=258 Identities=27% Similarity=0.421 Sum_probs=201.8
Q ss_pred cccCcccccCccEEEEEEECCC-C--EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeC------CeE
Q 041143 628 AQENELGRGGFGTVYKGELEDG-T--KIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEG------NER 698 (973)
Q Consensus 628 ~~~~~lG~G~fg~Vy~~~~~~g-~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~ 698 (973)
.+.+.||+|+||.||+|.+.+. . .+|+|.++.........+.+.+|+++++.++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 4568899999999999987643 2 689999876655566678899999999999999999999988542 246
Q ss_pred EEEEEecCCCCHHHHHHhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccc
Q 041143 699 LLVYEYMPHGALSRHLFRWEK-LQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL 777 (973)
Q Consensus 699 ~lV~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGl 777 (973)
++||||+++|+|.+++..... .....+++.....++.|++.||+||| +++|+||||||+||++++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCCc
Confidence 899999999999998854221 12245899999999999999999999 78999999999999999999999999999
Q ss_pred cccCCCCCcce-ecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchh
Q 041143 778 VKLAPDGEKSV-VTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKE 855 (973)
Q Consensus 778 a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 855 (973)
++......... .....+++.|+|||+.....++.++|||||||++|||++ |+.||......+. . ..+.. ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~---~~~~~-~~ 231 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEI---Y---DYLRQ-GN 231 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH---H---HHHHc-CC
Confidence 98654432211 122346778999999998899999999999999999999 8899876443211 1 11111 00
Q ss_pred HHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHh
Q 041143 856 KFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPL 906 (973)
Q Consensus 856 ~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~ 906 (973)
. .. ........+.+++.+|++.||++||++.+|++.|+.+
T Consensus 232 ~--------~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 R--------LK---QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred C--------CC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 00 0111234478999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=334.63 Aligned_cols=258 Identities=26% Similarity=0.433 Sum_probs=213.9
Q ss_pred cCccccCcccccCccEEEEEEECC-CCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELED-GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
.+....++||-|.||.||.|.|+. .-.||||.++.+ ....++|..|..+|+.++|||+|+++|+|..+...|||.|
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED---tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE 343 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE 343 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhc---chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence 455677899999999999999874 567999999764 4557899999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
||..|+|.+||+.+.+ ..++....+.+|.||+.||+||. .+++|||||.++|+|+.++..+||+|||+++++..
T Consensus 344 fM~yGNLLdYLRecnr---~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg 417 (1157)
T KOG4278|consen 344 FMCYGNLLDYLRECNR---SEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG 417 (1157)
T ss_pred cccCccHHHHHHHhch---hhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhhcC
Confidence 9999999999988655 45677788899999999999999 89999999999999999999999999999998765
Q ss_pred CCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcC
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (973)
+.........-...|.|||-+....++.|+|||+|||+|||+.| |..|+.+.+-..... ++.
T Consensus 418 DTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~-----------------LLE 480 (1157)
T KOG4278|consen 418 DTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYG-----------------LLE 480 (1157)
T ss_pred CceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHH-----------------HHh
Confidence 44332222334678999999999999999999999999999988 677776654322211 122
Q ss_pred ccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 863 PALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 863 ~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
..++ -+.+..+..++.+|++.||+..|.+||+++|+-+.++.++..
T Consensus 481 kgyR-M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 481 KGYR-MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred cccc-ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 2222 122334556788999999999999999999999999988764
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=348.83 Aligned_cols=253 Identities=25% Similarity=0.357 Sum_probs=204.1
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
++|...+.||+|+||.||+|+.. +|+.||||+++.... .......+.+|++++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888999999999999999875 689999999875422 2234567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++|+|.+++... ..+++..+..++.||+.||+||| .++|+||||||+||+++.++.+||+|||+++...
T Consensus 81 e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 152 (350)
T cd05573 81 EYMPGGDLMNLLIRK-----DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMN 152 (350)
T ss_pred cCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCc
Confidence 999999999999752 46889999999999999999999 7899999999999999999999999999998554
Q ss_pred CCC----------------------------cceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCC
Q 041143 783 DGE----------------------------KSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDE 834 (973)
Q Consensus 783 ~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~ 834 (973)
... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~ 232 (350)
T cd05573 153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS 232 (350)
T ss_pred ccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCC
Confidence 332 1122345799999999999999999999999999999999999999987
Q ss_pred CChhhHHHHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCC-HhHHHH
Q 041143 835 ERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPD-MGHVVN 901 (973)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-~~~v~~ 901 (973)
....... ..+.... ..+..... ......+.+++.+|++ ||.+||+ +.++++
T Consensus 233 ~~~~~~~------~~i~~~~--------~~~~~p~~-~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 233 DTLQETY------NKIINWK--------ESLRFPPD-PPVSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred CCHHHHH------HHHhccC--------CcccCCCC-CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 6532211 1111100 01110000 0023457789999997 9999999 999987
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=325.48 Aligned_cols=248 Identities=29% Similarity=0.381 Sum_probs=198.5
Q ss_pred cccccCccEEEEEEE---CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEecCCC
Q 041143 632 ELGRGGFGTVYKGEL---EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHG 708 (973)
Q Consensus 632 ~lG~G~fg~Vy~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 708 (973)
.||+|+||.||+|.+ .++..+|+|+++.........+++.+|+.+++.++|+||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999965 35788999998765545556778999999999999999999999885 45678999999999
Q ss_pred CHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCcce
Q 041143 709 ALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSV 788 (973)
Q Consensus 709 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 788 (973)
+|.+++.. ...+++..+..++.|++.||+||| +++|+||||||+||++++++.+||+|||+++.........
T Consensus 81 ~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~ 152 (257)
T cd05116 81 PLNKFLQK-----NKHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY 152 (257)
T ss_pred cHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence 99999864 245889999999999999999999 8899999999999999999999999999998654432211
Q ss_pred --ecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccc
Q 041143 789 --VTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPAL 865 (973)
Q Consensus 789 --~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 865 (973)
.....++..|+|||.+....++.++|||||||++|||++ |+.||......+. ...+... . .+..
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~------~~~i~~~-~------~~~~ 219 (257)
T cd05116 153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV------TQMIESG-E------RMEC 219 (257)
T ss_pred eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH------HHHHHCC-C------CCCC
Confidence 122334678999999988889999999999999999998 9999986543221 1111110 0 0111
Q ss_pred cCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHh
Q 041143 866 EVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPL 906 (973)
Q Consensus 866 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~ 906 (973)
. ......+.+++.+|++.||++||++.+|++.|+.+
T Consensus 220 ~-----~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 220 P-----QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred C-----CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 1 11234578999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=336.47 Aligned_cols=272 Identities=20% Similarity=0.340 Sum_probs=201.9
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
.++|...+.||+|+||.||+|+.. +++.||||+++.... ......+.+|++++++++||||+++++++.+.+..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 367899999999999999999875 688999999865422 222345778999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+. ++|.+++... ...+++..+..++.||+.||+||| +++|+||||||+||++++++.+||+|||+++...
T Consensus 83 e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 83 EYVH-TDLCQYMDKH----PGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred ECCC-cCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 9994 6888887542 245788899999999999999999 8899999999999999999999999999987543
Q ss_pred CCCcceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhc--hhHHHh
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSS--KEKFKA 859 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 859 (973)
... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||........ . ...+...... ......
T Consensus 155 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~-~~~~~~~~~~~~~~~~~~ 231 (303)
T cd07869 155 VPS-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD-Q-LERIFLVLGTPNEDTWPG 231 (303)
T ss_pred CCC-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH-H-HHHHHHHhCCCChhhccc
Confidence 222 12234568999999998865 4588999999999999999999999986543211 1 1111110000 000000
Q ss_pred -----hcCc-cccC-Cccc-H------HHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 860 -----AIDP-ALEV-NEET-F------ESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 860 -----~~~~-~l~~-~~~~-~------~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
..++ .+.. .... . .....+.+++.+|++.||++|||+.|+++ +++.+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~--h~~f~~ 293 (303)
T cd07869 232 VHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS--HEYFSD 293 (303)
T ss_pred hhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc--Cccccc
Confidence 0000 0000 0000 0 01134679999999999999999999997 555543
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=344.23 Aligned_cols=240 Identities=27% Similarity=0.352 Sum_probs=194.6
Q ss_pred CcccccCccEEEEEEE----CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEecC
Q 041143 631 NELGRGGFGTVYKGEL----EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMP 706 (973)
Q Consensus 631 ~~lG~G~fg~Vy~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 706 (973)
+.||+|+||.||+++. .+|+.||+|+++...........+..|++++++++||||+++++++.+.+..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999965 358899999997543333344567889999999999999999999999999999999999
Q ss_pred CCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCc
Q 041143 707 HGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEK 786 (973)
Q Consensus 707 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~ 786 (973)
+|+|.+++.+ ...+++..+..++.||++||+||| +++|+||||||+||++++++.+||+|||+++.......
T Consensus 82 ~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 153 (318)
T cd05582 82 GGDLFTRLSK-----EVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 153 (318)
T ss_pred CCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC
Confidence 9999998864 245899999999999999999999 88999999999999999999999999999985543322
Q ss_pred ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCcccc
Q 041143 787 SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALE 866 (973)
Q Consensus 787 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 866 (973)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ...+.. ....
T Consensus 154 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~------~~~i~~----------~~~~ 216 (318)
T cd05582 154 -KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET------MTMILK----------AKLG 216 (318)
T ss_pred -ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH------HHHHHc----------CCCC
Confidence 23346799999999999988899999999999999999999999986543221 111111 1111
Q ss_pred CCcccHHHHHHHHHHHHHhhccCCCCCCCHhH
Q 041143 867 VNEETFESISIVAELAGHCTAREPYHRPDMGH 898 (973)
Q Consensus 867 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~ 898 (973)
... .....+.+++.+|++.||++||++.+
T Consensus 217 ~p~---~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 217 MPQ---FLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCC---CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 000 11234679999999999999999766
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=329.12 Aligned_cols=257 Identities=26% Similarity=0.432 Sum_probs=202.7
Q ss_pred cCccccCcccccCccEEEEEEEC-CCC----EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGT----KIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERL 699 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 699 (973)
++|+..+.||+|+||.||+|.+. +|+ ++++|.+... .......++..|+.++++++||||+++++++.. ...+
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~ 84 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQ 84 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccE
Confidence 46778899999999999999864 344 4777877532 233445678889999999999999999998764 4578
Q ss_pred EEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccc
Q 041143 700 LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK 779 (973)
Q Consensus 700 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~ 779 (973)
+|+||+++|+|.+++... ...++|..+..++.||+.||+||| +++++||||||+||++++++.+||+|||+++
T Consensus 85 ~i~e~~~~gsL~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~ 157 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQH----RDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVAD 157 (279)
T ss_pred EEEEeCCCCcHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccce
Confidence 899999999999999652 246899999999999999999999 7899999999999999999999999999998
Q ss_pred cCCCCCc-ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHH
Q 041143 780 LAPDGEK-SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKF 857 (973)
Q Consensus 780 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (973)
....... .......++..|+|||++.++.++.++|||||||++|||++ |+.||.+........+ +. . ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~---~~---~-~~-- 228 (279)
T cd05111 158 LLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL---LE---K-GE-- 228 (279)
T ss_pred eccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---HH---C-CC--
Confidence 6543322 22234567789999999998899999999999999999998 9999987654322111 10 0 00
Q ss_pred HhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 858 KAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 858 ~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
....+.. ....+.+++.+|+..+|++||++.|+++.|..+.+
T Consensus 229 -~~~~~~~--------~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 229 -RLAQPQI--------CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred -cCCCCCC--------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 0001111 12346789999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=332.83 Aligned_cols=264 Identities=28% Similarity=0.419 Sum_probs=207.1
Q ss_pred cCccccCcccccCccEEEEEEECC-CC--EEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELED-GT--KIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGNERLL 700 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~-g~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 700 (973)
++|++.+.||+|+||.||+|..++ +. .+++|.++.. ......+.+.+|++++.++ +||||+++++++......++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 578889999999999999998753 33 4788887643 2344566789999999999 79999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhc-----------cCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCC
Q 041143 701 VYEYMPHGALSRHLFRWEKL-----------QLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYR 769 (973)
Q Consensus 701 V~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~ 769 (973)
||||+++|+|.++++..... ....+++..+..++.|++.||+||| +++|+||||||+||++++++.
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCe
Confidence 99999999999999753211 1135889999999999999999999 889999999999999999999
Q ss_pred EEEeeccccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHH
Q 041143 770 AKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFW 848 (973)
Q Consensus 770 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 848 (973)
+||+|||++....... .......+..|+|||++....++.++|||||||++|||++ |+.||......+. ..
T Consensus 158 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~------~~ 229 (297)
T cd05089 158 SKIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL------YE 229 (297)
T ss_pred EEECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH------HH
Confidence 9999999986432111 1111223567999999988889999999999999999998 9999976653221 11
Q ss_pred HHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCC
Q 041143 849 RIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRP 912 (973)
Q Consensus 849 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~ 912 (973)
... ....+... ......+.+++.+|++.+|.+||++.+|++.|+.+.+.++.
T Consensus 230 ~~~-------~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 230 KLP-------QGYRMEKP-----RNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred HHh-------cCCCCCCC-----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 111 10111111 11224577999999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=345.74 Aligned_cols=261 Identities=21% Similarity=0.276 Sum_probs=202.7
Q ss_pred HHhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecC-CCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEE
Q 041143 622 KVTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAG-VTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERL 699 (973)
Q Consensus 622 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 699 (973)
...++|+..+.||+|+||.||+|+.. +++.||+|++... .......+.+.+|+.+++.++||||+++++++.+++..+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34578999999999999999999875 5789999998642 122334456889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccc
Q 041143 700 LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK 779 (973)
Q Consensus 700 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~ 779 (973)
+||||+++|+|.+++.. ..+++..+..++.||+.||+||| +++|+||||||+|||+++++.+||+|||+++
T Consensus 120 lv~Ey~~gg~L~~~l~~------~~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~ 190 (370)
T cd05621 120 MVMEYMPGGDLVNLMSN------YDVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCM 190 (370)
T ss_pred EEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccce
Confidence 99999999999998854 34788889999999999999999 8899999999999999999999999999998
Q ss_pred cCCCCCcceecccccccCcccccccccC----cCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchh
Q 041143 780 LAPDGEKSVVTRLAGTFGYLAPEYAVMG----KITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKE 855 (973)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 855 (973)
..............||+.|+|||++... .++.++||||+||++|||++|+.||........ +..+....
T Consensus 191 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~------~~~i~~~~- 263 (370)
T cd05621 191 KMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT------YSKIMDHK- 263 (370)
T ss_pred ecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH------HHHHHhCC-
Confidence 6543332223456799999999998754 378899999999999999999999986543211 11111100
Q ss_pred HHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCC--CCCHhHHHHHHHHhhh
Q 041143 856 KFKAAIDPALEVNEETFESISIVAELAGHCTAREPYH--RPDMGHVVNVLSPLVE 908 (973)
Q Consensus 856 ~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~--RPs~~~v~~~L~~~~~ 908 (973)
..+... ........+.+++..|+..++.+ |+++.|+++ +++.+
T Consensus 264 -------~~~~~p-~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~--hp~~~ 308 (370)
T cd05621 264 -------NSLNFP-EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ--HPFFK 308 (370)
T ss_pred -------cccCCC-CcccCCHHHHHHHHHHccCchhccCCCCHHHHhc--CcccC
Confidence 011100 11112234668888898755544 889999988 55554
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=334.30 Aligned_cols=259 Identities=25% Similarity=0.397 Sum_probs=216.5
Q ss_pred HHhcCccccCcccccCccEEEEEEECC-CCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcC-CCceeeeeeEEEeCCeE
Q 041143 622 KVTQNFAQENELGRGGFGTVYKGELED-GTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKVR-HRHLVSLLGYSIEGNER 698 (973)
Q Consensus 622 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 698 (973)
.....|...+.||+|.||.||+++.+. |+.+|+|.+..... .....+.+.+|+++|+++. |||||.+++++.+....
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 345678888999999999999998765 99999999965432 2334568899999999998 99999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCC----CCEEEee
Q 041143 699 LLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDD----YRAKVSD 774 (973)
Q Consensus 699 ~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~----~~~kl~D 774 (973)
++|||++.||.|.+.+... .+++..+..++.||+.++.||| ..+|+|||+||+|+|+... +.+|++|
T Consensus 112 ~lvmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~D 182 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLID 182 (382)
T ss_pred EEEEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEee
Confidence 9999999999999999763 2899999999999999999999 8999999999999999643 5799999
Q ss_pred ccccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhch
Q 041143 775 FGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSK 854 (973)
Q Consensus 775 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 854 (973)
||++..... .......+||+.|+|||++....|+..+||||+||++|.|++|.+||........
T Consensus 183 FGla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~-------------- 246 (382)
T KOG0032|consen 183 FGLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI-------------- 246 (382)
T ss_pred CCCceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH--------------
Confidence 999997766 3456678999999999999999999999999999999999999999987764322
Q ss_pred hHHHhhcCccccCCcccHHH-HHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 855 EKFKAAIDPALEVNEETFES-ISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 855 ~~~~~~~~~~l~~~~~~~~~-~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
+..+....+.+....++. ...+.+++..|+..||.+|+++.++++ ++|+..
T Consensus 247 --~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~--HpWi~~ 298 (382)
T KOG0032|consen 247 --FLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ--HPWIKS 298 (382)
T ss_pred --HHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc--CccccC
Confidence 112233333333333333 345779999999999999999999999 566554
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=342.30 Aligned_cols=272 Identities=23% Similarity=0.345 Sum_probs=204.4
Q ss_pred CccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC-----eEE
Q 041143 626 NFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGN-----ERL 699 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 699 (973)
+|+..+.||+|+||.||+|.. .+|+.||||++..........+.+.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999986 46899999998654444455678899999999999999999999998776 789
Q ss_pred EEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccc
Q 041143 700 LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK 779 (973)
Q Consensus 700 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~ 779 (973)
+||||+. ++|.+++.. ...+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 81 lv~e~~~-~~l~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~ 151 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS-----PQPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLAR 151 (372)
T ss_pred EEeeccc-cCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEecccccee
Confidence 9999995 678777743 246899999999999999999999 8899999999999999999999999999998
Q ss_pred cCCCCCcceecccccccCcccccccccC-cCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHH------Hhh
Q 041143 780 LAPDGEKSVVTRLAGTFGYLAPEYAVMG-KITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWR------IKS 852 (973)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~------~~~ 852 (973)
..............+|+.|+|||++.+. .++.++||||+||++|||++|+.||....+.+.......... ...
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 231 (372)
T cd07853 152 VEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS 231 (372)
T ss_pred ecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 6543333333445689999999998764 578999999999999999999999987664432111110000 000
Q ss_pred chhHHHhhcCccc-cCC------cccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 853 SKEKFKAAIDPAL-EVN------EETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 853 ~~~~~~~~~~~~l-~~~------~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
........+.... ... .........+.+++.+|++.||++||++.|+++ +++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~--hp~~~ 292 (372)
T cd07853 232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA--HPYLD 292 (372)
T ss_pred hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc--CHhhC
Confidence 0000011110000 000 000011345779999999999999999999987 45444
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=345.90 Aligned_cols=260 Identities=22% Similarity=0.283 Sum_probs=203.8
Q ss_pred HhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCC-CChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEE
Q 041143 623 VTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGV-TTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLL 700 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 700 (973)
..++|+..+.||+|+||.||+|+.. +++.||+|++.... ......+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3468899999999999999999775 58899999986431 122334567889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecccccc
Q 041143 701 VYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKL 780 (973)
Q Consensus 701 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~ 780 (973)
||||+++|+|.+++.. ..++...+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++.
T Consensus 121 v~Ey~~gg~L~~~l~~------~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 121 VMEYMPGGDLVNLMSN------YDIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 9999999999998864 34677888899999999999999 88999999999999999999999999999986
Q ss_pred CCCCCcceecccccccCcccccccccC----cCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhH
Q 041143 781 APDGEKSVVTRLAGTFGYLAPEYAVMG----KITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEK 856 (973)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (973)
.............||+.|+|||++... .++.++|||||||++|||++|+.||........ +..+....
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~i~~~~-- 263 (370)
T cd05596 192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT------YSKIMDHK-- 263 (370)
T ss_pred ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH------HHHHHcCC--
Confidence 543322223446799999999998643 478999999999999999999999986553211 11111100
Q ss_pred HHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCC--CCCHhHHHHHHHHhhh
Q 041143 857 FKAAIDPALEVNEETFESISIVAELAGHCTAREPYH--RPDMGHVVNVLSPLVE 908 (973)
Q Consensus 857 ~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~--RPs~~~v~~~L~~~~~ 908 (973)
..+.... .......+.+++.+|++.+|.+ ||++.|+++ +++++
T Consensus 264 ------~~~~~~~-~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~--h~~~~ 308 (370)
T cd05596 264 ------NSLTFPD-DIEISKQAKDLICAFLTDREVRLGRNGVDEIKS--HPFFK 308 (370)
T ss_pred ------CcCCCCC-cCCCCHHHHHHHHHHccChhhccCCCCHHHHhc--CcccC
Confidence 0111000 1112345779999999999988 999999988 45543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=323.52 Aligned_cols=248 Identities=26% Similarity=0.412 Sum_probs=197.4
Q ss_pred CcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEecCCCC
Q 041143 631 NELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGA 709 (973)
Q Consensus 631 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 709 (973)
+.||+|+||.||+|++. +++.||+|.+... ........+.+|++++++++||||+++++++......++||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 46999999999999874 6889999987654 234456779999999999999999999999999999999999999999
Q ss_pred HHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCccee
Q 041143 710 LSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVV 789 (973)
Q Consensus 710 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 789 (973)
|.+++... ...+++.+++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++..........
T Consensus 80 L~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 152 (252)
T cd05084 80 FLTFLRTE----GPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST 152 (252)
T ss_pred HHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCccccccccccc
Confidence 99998641 245889999999999999999999 88999999999999999999999999999875433211111
Q ss_pred -cccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccC
Q 041143 790 -TRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEV 867 (973)
Q Consensus 790 -~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 867 (973)
....++..|+|||.+.++.++.++|||||||++|||++ |..||.......... .+........
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~-------------~~~~~~~~~~-- 217 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTRE-------------AIEQGVRLPC-- 217 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHH-------------HHHcCCCCCC--
Confidence 11123467999999998899999999999999999998 888887554322111 0001011111
Q ss_pred CcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHH
Q 041143 868 NEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLS 904 (973)
Q Consensus 868 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~ 904 (973)
.......+.+++.+|++.+|++||++.+|.++|.
T Consensus 218 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 ---PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred ---cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 1112346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=341.68 Aligned_cols=243 Identities=26% Similarity=0.334 Sum_probs=195.7
Q ss_pred CcccccCccEEEEEEEC-CCCEEEEEEeecCC-CChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEecCCC
Q 041143 631 NELGRGGFGTVYKGELE-DGTKIAVKRMEAGV-TTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHG 708 (973)
Q Consensus 631 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 708 (973)
+.||+|+||.||++... +|+.||+|+++... ........+..|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999764 68999999997542 22334567788999999999999999999999999999999999999
Q ss_pred CHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhcc-CCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCcc
Q 041143 709 ALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLAR-QTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKS 787 (973)
Q Consensus 709 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~-~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~~ 787 (973)
+|..++.. ...+++.++..++.||+.||+||| + .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~- 151 (325)
T cd05594 81 ELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA- 151 (325)
T ss_pred cHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-
Confidence 99988854 246899999999999999999999 5 7999999999999999999999999999875332221
Q ss_pred eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccC
Q 041143 788 VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEV 867 (973)
Q Consensus 788 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 867 (973)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..+.... ..+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~------~~i~~~~--------~~~p- 216 (325)
T cd05594 152 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF------ELILMEE--------IRFP- 216 (325)
T ss_pred ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHH------HHHhcCC--------CCCC-
Confidence 223457999999999999999999999999999999999999999765432211 1111100 0111
Q ss_pred CcccHHHHHHHHHHHHHhhccCCCCCC-----CHhHHHH
Q 041143 868 NEETFESISIVAELAGHCTAREPYHRP-----DMGHVVN 901 (973)
Q Consensus 868 ~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~~v~~ 901 (973)
. .....+.+++.+|++.||++|+ ++.++++
T Consensus 217 -~---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 217 -R---TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred -C---CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 0 1123467999999999999997 8888886
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=338.32 Aligned_cols=275 Identities=20% Similarity=0.290 Sum_probs=207.0
Q ss_pred HhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeC------
Q 041143 623 VTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEG------ 695 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 695 (973)
..++|...+.||+|+||.||+|... .++.||||++............+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999764 588999999976544455567788999999999999999999987643
Q ss_pred CeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeec
Q 041143 696 NERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDF 775 (973)
Q Consensus 696 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 775 (973)
...++||||++ ++|.+++. ..+++.++..++.|+++||+||| +++|+||||||+||+++.++.+||+||
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Df 170 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQ-------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDF 170 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHH-------hcCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeC
Confidence 35799999995 47776663 24788899999999999999999 889999999999999999999999999
Q ss_pred cccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhc--
Q 041143 776 GLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSS-- 853 (973)
Q Consensus 776 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-- 853 (973)
|+++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||......+... ..+......
T Consensus 171 G~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~--~~~~~~~~~~~ 246 (364)
T cd07875 171 GLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWN--KVIEQLGTPCP 246 (364)
T ss_pred CCccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHhcCCCCH
Confidence 9998553321 2234578999999999999999999999999999999999999998765432111 000000000
Q ss_pred ------hhHHHhhcCccccC-----------------CcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhc
Q 041143 854 ------KEKFKAAIDPALEV-----------------NEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKW 910 (973)
Q Consensus 854 ------~~~~~~~~~~~l~~-----------------~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~ 910 (973)
.......+...... ..........+.+++.+|++.||++|||+.|+++ ++++..|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~--hp~~~~~ 324 (364)
T cd07875 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ--HPYINVW 324 (364)
T ss_pred HHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc--Ccccccc
Confidence 00000000000000 0000111245789999999999999999999998 6777665
Q ss_pred CCCC
Q 041143 911 RPIT 914 (973)
Q Consensus 911 ~~~~ 914 (973)
....
T Consensus 325 ~~~~ 328 (364)
T cd07875 325 YDPS 328 (364)
T ss_pred cCcc
Confidence 5443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=322.14 Aligned_cols=248 Identities=29% Similarity=0.464 Sum_probs=199.9
Q ss_pred CcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEecCCCCH
Q 041143 631 NELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGAL 710 (973)
Q Consensus 631 ~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 710 (973)
++||+|+||.||+|...++..+|+|+++... .......+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 3689999999999998889999999987543 344455789999999999999999999999999999999999999999
Q ss_pred HHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCcceec
Q 041143 711 SRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVT 790 (973)
Q Consensus 711 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 790 (973)
.+++... ...+++.+++.++.|++.||.||| .++++||||||+||++++++.+||+|||++............
T Consensus 80 ~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (250)
T cd05085 80 LSFLRKK----KDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSG 152 (250)
T ss_pred HHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccccccCC
Confidence 9988642 235789999999999999999999 889999999999999999999999999998754332222222
Q ss_pred ccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccCCc
Q 041143 791 RLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNE 869 (973)
Q Consensus 791 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 869 (973)
...++..|+|||++.+..++.++|||||||++|||++ |..||......... . .. ........
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~---~---~~-------~~~~~~~~---- 215 (250)
T cd05085 153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAR---E---QV-------EKGYRMSC---- 215 (250)
T ss_pred CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHH---H---HH-------HcCCCCCC----
Confidence 2345678999999998899999999999999999998 99999765432211 0 00 00011111
Q ss_pred ccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHH
Q 041143 870 ETFESISIVAELAGHCTAREPYHRPDMGHVVNVLS 904 (973)
Q Consensus 870 ~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~ 904 (973)
.......+.+++.+|++.+|++||++.|+++.|.
T Consensus 216 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 216 -PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred -CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 1112356889999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=326.60 Aligned_cols=255 Identities=27% Similarity=0.448 Sum_probs=205.4
Q ss_pred HhcCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 623 VTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
..++|...++||+|+||.||+|..++++.||+|.+..... ..+++.+|+.++++++|+||+++++++. .+..++||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM---SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT 79 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC---cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence 3467888999999999999999998899999999875432 2457889999999999999999999864 45789999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++|+|.+++... ....+++.++..++.|++.||+||| +.+++||||||+||++++++.++|+|||++....
T Consensus 80 e~~~~~~L~~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 80 EYMENGSLVDFLKTP---EGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIE 153 (260)
T ss_pred EcCCCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecC
Confidence 999999999998652 2346899999999999999999999 8899999999999999999999999999998655
Q ss_pred CCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhc
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (973)
...........++..|+|||++....++.++|||||||++|||++ |+.||......+. .. .+. ...
T Consensus 154 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~---~~~-------~~~ 220 (260)
T cd05067 154 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV---IQ---NLE-------RGY 220 (260)
T ss_pred CCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH---HH---HHH-------cCC
Confidence 332222233456788999999988889999999999999999999 9999976543221 11 111 000
Q ss_pred CccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHH
Q 041143 862 DPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSP 905 (973)
Q Consensus 862 ~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~ 905 (973)
..... ......+.+++.+|++.+|++||+++++...|+.
T Consensus 221 ~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 221 RMPRP-----DNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCC-----CCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 00110 1122458899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=331.42 Aligned_cols=258 Identities=26% Similarity=0.408 Sum_probs=203.6
Q ss_pred CccccCcccccCccEEEEEEEC------CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEE
Q 041143 626 NFAQENELGRGGFGTVYKGELE------DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERL 699 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 699 (973)
+|...+.||+|+||.||+|... ++..||+|+++... .....+.+.+|+.++..++||||+++++++...+..+
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 4666788999999999999763 25789999987542 3344567899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhh-----------hccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCC
Q 041143 700 LVYEYMPHGALSRHLFRWE-----------KLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDY 768 (973)
Q Consensus 700 lV~e~~~~g~L~~~l~~~~-----------~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~ 768 (973)
+++||+++++|.+++.... ......+++..+..++.|+++||+||| +++|+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCC
Confidence 9999999999999986321 011235889999999999999999999 88999999999999999999
Q ss_pred CEEEeeccccccCCCCCc-ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHH
Q 041143 769 RAKVSDFGLVKLAPDGEK-SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEW 846 (973)
Q Consensus 769 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~ 846 (973)
.+||+|||+++....... .......+++.|+|||++....++.++|||||||++|||++ |..||......+ +
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~ 235 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD------V 235 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH------H
Confidence 999999999885543222 12233456789999999988889999999999999999998 888887654321 1
Q ss_pred HHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHH
Q 041143 847 FWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSP 905 (973)
Q Consensus 847 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~ 905 (973)
...+. +.... .........+.+++..|++.+|++||++++|++.|+.
T Consensus 236 ~~~i~----------~~~~~--~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 IEMIR----------NRQVL--PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHH----------cCCcC--CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11111 11110 0111233457899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=339.21 Aligned_cols=242 Identities=28% Similarity=0.386 Sum_probs=191.9
Q ss_pred ccccCcccccCccEEEEEEEC-CCCEEEEEEeecCC-CChHHHHHHHHHHHHH---HhcCCCceeeeeeEEEeCCeEEEE
Q 041143 627 FAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGV-TTTKALDEFQSEIAVL---SKVRHRHLVSLLGYSIEGNERLLV 701 (973)
Q Consensus 627 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lV 701 (973)
|...+.||+|+||.||+|... +|+.||||+++... ......+.+.+|++++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567789999999999999765 68999999997532 1223345667776665 466899999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccC
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA 781 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~ 781 (973)
|||+++|+|..+++. ..+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 81 ~E~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 81 MEYAAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEG 151 (324)
T ss_pred EcCCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence 999999999887753 46899999999999999999999 889999999999999999999999999998743
Q ss_pred CCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhc
Q 041143 782 PDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861 (973)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (973)
.... .......|++.|+|||++.+..++.++|||||||++|||++|+.||......+. ...+....
T Consensus 152 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~------~~~i~~~~------- 217 (324)
T cd05589 152 MGFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV------FDSIVNDE------- 217 (324)
T ss_pred CCCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhCC-------
Confidence 2221 223446799999999999999999999999999999999999999986653221 11111100
Q ss_pred CccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHh
Q 041143 862 DPALEVNEETFESISIVAELAGHCTAREPYHRPDMG 897 (973)
Q Consensus 862 ~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ 897 (973)
..+. ......+.+++.+|++.||.+||++.
T Consensus 218 -~~~p-----~~~~~~~~~li~~~L~~dP~~R~~~~ 247 (324)
T cd05589 218 -VRYP-----RFLSREAISIMRRLLRRNPERRLGSG 247 (324)
T ss_pred -CCCC-----CCCCHHHHHHHHHHhhcCHhHcCCCC
Confidence 0010 01123467999999999999999543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=336.69 Aligned_cols=240 Identities=28% Similarity=0.408 Sum_probs=190.4
Q ss_pred CcccccCccEEEEEEEC-CCCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeEEEEEEecCC
Q 041143 631 NELGRGGFGTVYKGELE-DGTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGNERLLVYEYMPH 707 (973)
Q Consensus 631 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 707 (973)
+.||+|+||.||+|+.. +++.||||+++.... .....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 578899999875421 223344566677777654 899999999999999999999999999
Q ss_pred CCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCcc
Q 041143 708 GALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKS 787 (973)
Q Consensus 708 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~~ 787 (973)
|+|..++.. ...+++.++..++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 g~L~~~~~~-----~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~ 151 (316)
T cd05592 81 GDLMFHIQS-----SGRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-G 151 (316)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-C
Confidence 999988864 245888999999999999999999 7899999999999999999999999999998543322 2
Q ss_pred eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccC
Q 041143 788 VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEV 867 (973)
Q Consensus 788 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 867 (973)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. +..+... .+.+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~------~~~i~~~--------~~~~~- 216 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL------FDSILND--------RPHFP- 216 (316)
T ss_pred ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHH------HHHHHcC--------CCCCC-
Confidence 23446799999999999998999999999999999999999999986653221 1111110 01111
Q ss_pred CcccHHHHHHHHHHHHHhhccCCCCCCCHhH
Q 041143 868 NEETFESISIVAELAGHCTAREPYHRPDMGH 898 (973)
Q Consensus 868 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~ 898 (973)
......+.+++.+|++.||++||++.+
T Consensus 217 ----~~~~~~~~~ll~~~l~~~P~~R~~~~~ 243 (316)
T cd05592 217 ----RWISKEAKDCLSKLFERDPTKRLGVDG 243 (316)
T ss_pred ----CCCCHHHHHHHHHHccCCHHHcCCChH
Confidence 111234678999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=315.74 Aligned_cols=259 Identities=29% Similarity=0.396 Sum_probs=214.7
Q ss_pred cCccccCcccccCccEEEEEEECC-CCEEEEEEeecC-CCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELED-GTKIAVKRMEAG-VTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
+.|+..+.||+|.-|+||++++++ +..+|+|++... ....+...+.+.|-+||+.++||.++.||+.++.++..++||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 355667889999999999998875 588999999654 233455678889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
|||+||+|...+++ +..+.++...+.-+|..|+.||+||| ..|||.|||||+||||.++|++-|+||.++....
T Consensus 157 eyCpGGdL~~Lrqk---Qp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQK---QPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred ecCCCccHHHHHhh---CCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 99999999998876 34577999999999999999999999 8899999999999999999999999999864211
Q ss_pred C---------------------------------CCc----------------------ceecccccccCcccccccccC
Q 041143 783 D---------------------------------GEK----------------------SVVTRLAGTFGYLAPEYAVMG 807 (973)
Q Consensus 783 ~---------------------------------~~~----------------------~~~~~~~gt~~y~aPE~~~~~ 807 (973)
. ... .....++||-.|+|||++.+.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 0 000 011236899999999999999
Q ss_pred cCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhc
Q 041143 808 KITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTA 887 (973)
Q Consensus 808 ~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~ 887 (973)
..+.++|+|+|||++|||+.|..||.+... ++.+..++-+.+.+...+ .....+.+||++.|.
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~----------------~~Tl~NIv~~~l~Fp~~~-~vs~~akDLIr~LLv 373 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNN----------------KETLRNIVGQPLKFPEEP-EVSSAAKDLIRKLLV 373 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCc----------------hhhHHHHhcCCCcCCCCC-cchhHHHHHHHHHhc
Confidence 999999999999999999999999987653 345566666666654443 445668899999999
Q ss_pred cCCCCCCC----HhHHHHHHHHhhh
Q 041143 888 REPYHRPD----MGHVVNVLSPLVE 908 (973)
Q Consensus 888 ~dP~~RPs----~~~v~~~L~~~~~ 908 (973)
+||.+|.. +.||-+ ++..+
T Consensus 374 KdP~kRlg~~rGA~eIK~--HpFF~ 396 (459)
T KOG0610|consen 374 KDPSKRLGSKRGAAEIKR--HPFFE 396 (459)
T ss_pred cChhhhhccccchHHhhc--Ccccc
Confidence 99999998 777766 55544
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=345.54 Aligned_cols=258 Identities=24% Similarity=0.379 Sum_probs=199.6
Q ss_pred CccccCcccccCccEEEEEEEC-CCCEEEEEEeecCC-CChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 626 NFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGV-TTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
.|...+.||+|+||+||+|+.. +++.||||++.... ......+.+.+|++++++++|+|||++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788899999999999999764 68899999996532 233455678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+++|+|.+++.. ...+++..+..++.||+.||+||| ..+|+||||||+|||++.++++||+|||+++....
T Consensus 82 ~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~ 153 (381)
T cd05626 82 YIPGGDMMSLLIR-----MEVFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRW 153 (381)
T ss_pred cCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccccc
Confidence 9999999999865 245788889999999999999999 88999999999999999999999999999753211
Q ss_pred CC----------------------------------------------cceecccccccCcccccccccCcCCCchhHHh
Q 041143 784 GE----------------------------------------------KSVVTRLAGTFGYLAPEYAVMGKITTKADVFS 817 (973)
Q Consensus 784 ~~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S 817 (973)
.. .......+||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (381)
T cd05626 154 THNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS 233 (381)
T ss_pred ccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceee
Confidence 00 00112357999999999999889999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHH--hhccCCCCCCC
Q 041143 818 YGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGH--CTAREPYHRPD 895 (973)
Q Consensus 818 ~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~--cl~~dP~~RPs 895 (973)
|||++|||++|+.||......+... .+....... .+.+.. .....+.+++.+ |+..+|.+||+
T Consensus 234 lG~il~elltG~~Pf~~~~~~~~~~------~i~~~~~~~--~~~~~~-------~~s~~~~dli~~ll~~~~~~~~R~~ 298 (381)
T cd05626 234 VGVILFEMLVGQPPFLAPTPTETQL------KVINWENTL--HIPPQV-------KLSPEAVDLITKLCCSAEERLGRNG 298 (381)
T ss_pred hhhHHHHHHhCCCCCcCCCHHHHHH------HHHcccccc--CCCCCC-------CCCHHHHHHHHHHccCcccccCCCC
Confidence 9999999999999998765432111 010000000 000100 111335577766 55667777999
Q ss_pred HhHHHHHHHHhhh
Q 041143 896 MGHVVNVLSPLVE 908 (973)
Q Consensus 896 ~~~v~~~L~~~~~ 908 (973)
+.|+++ +++..
T Consensus 299 ~~~~l~--hp~f~ 309 (381)
T cd05626 299 ADDIKA--HPFFS 309 (381)
T ss_pred HHHHhc--CcccC
Confidence 999998 55544
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=330.68 Aligned_cols=253 Identities=27% Similarity=0.395 Sum_probs=200.3
Q ss_pred CccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 626 NFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
.|+..+.||+|+||.||++... +++.||||++..... .......+.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999764 689999999865322 22334567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+++|+|.+++... ....+++..+..++.|++.||+||| +.+|+||||||+||++++++.++|+|||+++....
T Consensus 81 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05605 81 LMNGGDLKFHIYNM---GNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE 154 (285)
T ss_pred ccCCCcHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 99999999888642 2246899999999999999999999 78999999999999999999999999999986543
Q ss_pred CCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCc
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDP 863 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (973)
... .....|+..|+|||++.+..++.++||||+||++|||++|+.||.......... . + ...+..
T Consensus 155 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~--~-~----------~~~~~~ 219 (285)
T cd05605 155 GET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKRE--E-V----------ERRVKE 219 (285)
T ss_pred CCc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHH--H-H----------HHHhhh
Confidence 322 233478999999999998899999999999999999999999998654321110 0 0 000100
Q ss_pred cccCCcccHHHHHHHHHHHHHhhccCCCCCC-----CHhHHHH
Q 041143 864 ALEVNEETFESISIVAELAGHCTAREPYHRP-----DMGHVVN 901 (973)
Q Consensus 864 ~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~~v~~ 901 (973)
.. ..........+.+++.+|++.||++|| +++++++
T Consensus 220 ~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 220 DQ--EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred cc--cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 00 001111234577999999999999999 6777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=328.43 Aligned_cols=264 Identities=24% Similarity=0.394 Sum_probs=210.9
Q ss_pred hcCccccCcccccCccEEEEEEECC-----CCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEe-CCe
Q 041143 624 TQNFAQENELGRGGFGTVYKGELED-----GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIE-GNE 697 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 697 (973)
.++|...+.||+|+||.||+|...+ +..||+|+++.. ......+.+.+|+.++++++|+||+++++++.. ...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 4678889999999999999998765 688999988653 345556788999999999999999999999876 467
Q ss_pred EEEEEEecCCCCHHHHHHhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEee
Q 041143 698 RLLVYEYMPHGALSRHLFRWEKL---QLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSD 774 (973)
Q Consensus 698 ~~lV~e~~~~g~L~~~l~~~~~~---~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D 774 (973)
.++++||+++|+|.+++...... ....+++.+++.++.|++.||+||| +++++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999999763221 1246899999999999999999999 88999999999999999999999999
Q ss_pred ccccccCCCCCcc-eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhh
Q 041143 775 FGLVKLAPDGEKS-VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKS 852 (973)
Q Consensus 775 fGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 852 (973)
||+++........ ......++..|+|||++....++.++|||||||++||+++ |+.||....+.+ +..++. .
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~---~ 234 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAYLK---D 234 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHHHH---c
Confidence 9999854332221 1223456778999999988889999999999999999999 999997654322 111111 1
Q ss_pred chhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 853 SKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 853 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
. ..... .......+.+++.+|++.||++||++.+|++.|+.+.++
T Consensus 235 -~------~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 235 -G------YRLAQ-----PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred -C------CCCCC-----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 0 00000 111224578999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=323.89 Aligned_cols=253 Identities=30% Similarity=0.483 Sum_probs=202.7
Q ss_pred cCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEe
Q 041143 625 QNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEY 704 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 704 (973)
++|...+.||+|+||.||+|....+..+|+|++.... ...+.+.+|++++++++|+|++++++++. .+..++||||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 5678889999999999999998877789999876532 22456889999999999999999999875 4567899999
Q ss_pred cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCC
Q 041143 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG 784 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~ 784 (973)
+++|+|.++++.. ....++|..+..++.|++.||+||| +.+|+||||||+||++++++.++|+|||+++.....
T Consensus 82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 82 MGKGSLLDFLKEG---DGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred CCCCCHHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 9999999999752 2245899999999999999999999 889999999999999999999999999999865443
Q ss_pred CcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCc
Q 041143 785 EKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDP 863 (973)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (973)
.........++..|+|||+..+..++.++|||||||++|||++ |+.||......+. ..++ . ....+
T Consensus 156 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~~---~-------~~~~~ 222 (260)
T cd05069 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV---LEQV---E-------RGYRM 222 (260)
T ss_pred cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH---H-------cCCCC
Confidence 3222223346778999999988899999999999999999999 8999976543221 1111 1 00011
Q ss_pred cccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHH
Q 041143 864 ALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSP 905 (973)
Q Consensus 864 ~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~ 905 (973)
.. .......+.+++.+|++.||++||++++|++.|+.
T Consensus 223 ~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 PC-----PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CC-----CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 10 11223457899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=328.56 Aligned_cols=249 Identities=25% Similarity=0.359 Sum_probs=196.0
Q ss_pred ccccCccEEEEEEEC-CCCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEecCCCCH
Q 041143 633 LGRGGFGTVYKGELE-DGTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGAL 710 (973)
Q Consensus 633 lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 710 (973)
||+|+||+||++... +|+.||||++..... .....+.+..|+++++.++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999765 688999999864321 223346778899999999999999999999999999999999999999
Q ss_pred HHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCcceec
Q 041143 711 SRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVT 790 (973)
Q Consensus 711 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 790 (973)
..++..... ....+++..+..++.||+.||+||| +++|+||||||+||++++++.+||+|||+++....... ...
T Consensus 81 ~~~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~ 155 (280)
T cd05608 81 RYHIYNVDE-ENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTK 155 (280)
T ss_pred HHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-ccc
Confidence 988865322 2356899999999999999999999 88999999999999999999999999999975543322 223
Q ss_pred ccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccCCcc
Q 041143 791 RLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEE 870 (973)
Q Consensus 791 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 870 (973)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.......... . ........... .
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~--~----------~~~~~~~~~~~---~ 220 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK--E----------LKQRILNDSVT---Y 220 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH--H----------HHHhhcccCCC---C
Confidence 4579999999999999999999999999999999999999997643221100 0 00111111111 1
Q ss_pred cHHHHHHHHHHHHHhhccCCCCCC-----CHhHHHH
Q 041143 871 TFESISIVAELAGHCTAREPYHRP-----DMGHVVN 901 (973)
Q Consensus 871 ~~~~~~~~~~l~~~cl~~dP~~RP-----s~~~v~~ 901 (973)
.......+.+++.+|++.||++|| +++++++
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 221 PDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred cccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 112234577999999999999999 5666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=388.89 Aligned_cols=374 Identities=25% Similarity=0.342 Sum_probs=219.7
Q ss_pred CeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCC-CCCCCCccceeeccCCCCCCCCccccCCCCCccEEEc
Q 041143 67 NRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLAL 145 (973)
Q Consensus 67 ~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~L 145 (973)
.+++.|+|++|.+++.+|..|+++++|++|+|++|++++.+| .|.++++|++|+|++|++....+..|.++++|++|+|
T Consensus 212 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 291 (968)
T PLN00113 212 KSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDL 291 (968)
T ss_pred CCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEEC
Confidence 578888888888888888888888888888888888888776 6888888888888888888766677788888888888
Q ss_pred ccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCC
Q 041143 146 DYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDA 225 (973)
Q Consensus 146 s~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~ 225 (973)
++|++.+. +|..+.++++|+.|+|++|.+++.+|..+.++++|+.|+|++|++++.+|..+.. ..++..|+...+
T Consensus 292 s~n~l~~~----~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~-~~~L~~L~Ls~n 366 (968)
T PLN00113 292 SDNSLSGE----IPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGK-HNNLTVLDLSTN 366 (968)
T ss_pred cCCeeccC----CChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhC-CCCCcEEECCCC
Confidence 88888764 7777777888888888888888777777888888888888888887777766643 122223333333
Q ss_pred CCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcccccCccccccc-ccCeEEccCCcCcCCCCC
Q 041143 226 GGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGPIPK 304 (973)
Q Consensus 226 ~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~g~~p~ 304 (973)
......+..+..+++|+.|++++|++.+.+|..+..+++|+.|+|++|++++.+|..+..+ .|+.|++++|.+++.+|.
T Consensus 367 ~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~ 446 (968)
T PLN00113 367 NLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINS 446 (968)
T ss_pred eeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccCh
Confidence 3222233444455555555555555555555555555555555555555555555555554 455555555555555443
Q ss_pred CCCCC-----cccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCC--------------CCCcccccc
Q 041143 305 FKAGN-----VTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPC--------------QGPWLGLSC 365 (973)
Q Consensus 305 ~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~--------------~~~~~~~~~ 365 (973)
.+... +.+..+.+.+..+... ....+..++++.|.+......... ........+
T Consensus 447 ~~~~l~~L~~L~L~~n~~~~~~p~~~-------~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 519 (968)
T PLN00113 447 RKWDMPSLQMLSLARNKFFGGLPDSF-------GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDEL 519 (968)
T ss_pred hhccCCCCcEEECcCceeeeecCccc-------ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHH
Confidence 21111 1111111111111100 012233344444433321100000 000001123
Q ss_pred CCCCcccEEecCCCcCCCccchhhhCccccceEEccCCccccccCccccCcCCCCeeeCCCCcCCCCCCCCCc---ccce
Q 041143 366 TSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLPEFHD---TVKL 442 (973)
Q Consensus 366 ~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~---~~~~ 442 (973)
..+++|++|+|++|.++|.+|..|+++++|+.|+|++|+++|.+|..+..+++|+.|++++|+++|.+|.... +...
T Consensus 520 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~ 599 (968)
T PLN00113 520 SSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINAS 599 (968)
T ss_pred cCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChh
Confidence 3445555555555555555555555555555555555555555555555555555555555555555554222 2223
Q ss_pred eecCCccccC
Q 041143 443 VIDGNPLLVG 452 (973)
Q Consensus 443 ~~~~N~~~c~ 452 (973)
.+.||+.+|+
T Consensus 600 ~~~~n~~lc~ 609 (968)
T PLN00113 600 AVAGNIDLCG 609 (968)
T ss_pred hhcCCccccC
Confidence 4555555554
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=344.19 Aligned_cols=275 Identities=23% Similarity=0.287 Sum_probs=202.4
Q ss_pred HHHHHHhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC------Cceeeeee
Q 041143 618 QVLRKVTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRH------RHLVSLLG 690 (973)
Q Consensus 618 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~ 690 (973)
+++....++|.+.+.||+|+||+||+|... .++.||||+++.. ....+.+..|+++++.++| .+++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~ 198 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV---PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQR 198 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc---hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEE
Confidence 334455688999999999999999999764 5788999998642 2334456678888777754 45899999
Q ss_pred EEEeC-CeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhcc-CCeeeccCCCCcEEECCCC
Q 041143 691 YSIEG-NERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLAR-QTFIHRDLKSSNILLDDDY 768 (973)
Q Consensus 691 ~~~~~-~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~-~~ivH~Dikp~Nill~~~~ 768 (973)
++... ...++|||++ +++|.+++.+ ...+++..+..|+.||+.||+||| . .+||||||||+|||++.++
T Consensus 199 ~~~~~~~~~~iv~~~~-g~~l~~~l~~-----~~~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~ 269 (467)
T PTZ00284 199 YFQNETGHMCIVMPKY-GPCLLDWIMK-----HGPFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSD 269 (467)
T ss_pred EEEcCCceEEEEEecc-CCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCC
Confidence 88764 4688999988 7889888864 246899999999999999999999 5 5999999999999998765
Q ss_pred ----------------CEEEeeccccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCC
Q 041143 769 ----------------RAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAAL 832 (973)
Q Consensus 769 ----------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~ 832 (973)
.+||+|||.+..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 270 ~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf 345 (467)
T PTZ00284 270 TVVDPVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLY 345 (467)
T ss_pred cccccccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 499999998764322 234568999999999999999999999999999999999999999
Q ss_pred CCCChhhHHHHHH---------HHHHHhhchhHHHhhcC------ccccC----------CcccHHHHHHHHHHHHHhhc
Q 041143 833 DEERPEESRYLAE---------WFWRIKSSKEKFKAAID------PALEV----------NEETFESISIVAELAGHCTA 887 (973)
Q Consensus 833 ~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~------~~l~~----------~~~~~~~~~~~~~l~~~cl~ 887 (973)
+.....+...... |..... .....++++ +.... ..........+.+|+.+||+
T Consensus 346 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~ 423 (467)
T PTZ00284 346 DTHDNLEHLHLMEKTLGRLPSEWAGRCG--TEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLH 423 (467)
T ss_pred CCCChHHHHHHHHHHcCCCCHHHHhhcc--chhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCC
Confidence 8765433222211 110000 000000110 00000 00000112357799999999
Q ss_pred cCCCCCCCHhHHHHHHHHhhhhcCC
Q 041143 888 REPYHRPDMGHVVNVLSPLVEKWRP 912 (973)
Q Consensus 888 ~dP~~RPs~~~v~~~L~~~~~~~~~ 912 (973)
.||++|||++|+++ ++++.++.+
T Consensus 424 ~dP~~R~ta~e~L~--Hp~~~~~~~ 446 (467)
T PTZ00284 424 YDRQKRLNARQMTT--HPYVLKYYP 446 (467)
T ss_pred cChhhCCCHHHHhc--CccccccCC
Confidence 99999999999998 777766543
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=335.90 Aligned_cols=262 Identities=21% Similarity=0.263 Sum_probs=195.2
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
..+|.+.+.||+|+||.||+|... .++.||||.... ..+.+|++++++++|+|||++++++..++..++||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 347999999999999999999875 478899996432 24568999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+ .++|..++... ...++|.+++.|+.||++||+||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 240 e~~-~~~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~ 311 (461)
T PHA03211 240 PKY-RSDLYTYLGAR----LRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFAR 311 (461)
T ss_pred Ecc-CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceecc
Confidence 999 57898888541 246899999999999999999999 8899999999999999999999999999998553
Q ss_pred CCCc-ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChh-h----HHHHHHHHHHHhhchhH
Q 041143 783 DGEK-SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPE-E----SRYLAEWFWRIKSSKEK 856 (973)
Q Consensus 783 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~-~----~~~~~~~~~~~~~~~~~ 856 (973)
.... .......||+.|+|||++.+..++.++|||||||++|||++|..++...... . ...+...+.........
T Consensus 312 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~ 391 (461)
T PHA03211 312 GSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDE 391 (461)
T ss_pred cccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccccc
Confidence 3221 1223467999999999999999999999999999999999988765322111 0 11111111110000000
Q ss_pred ------------HHhhcCc--cccCCcccH----HHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 857 ------------FKAAIDP--ALEVNEETF----ESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 857 ------------~~~~~~~--~l~~~~~~~----~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
+...... ........+ .....+.+|+.+||+.||++|||+.|+++
T Consensus 392 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 392 FPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred CCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 0000000 000000000 11124778999999999999999999998
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=344.30 Aligned_cols=253 Identities=23% Similarity=0.375 Sum_probs=199.8
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCC-CChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGV-TTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
++|+..+.||+|+||.||+|+.. +|+.||||+++... ........+.+|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46888999999999999999875 58999999997531 12334567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++|+|.+++.. ...+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 81 EYLPGGDMMTLLMK-----KDTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred CCCCCcHHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecc
Confidence 99999999999865 245899999999999999999999 8899999999999999999999999999987432
Q ss_pred CCCcc-------------------------------------eecccccccCcccccccccCcCCCchhHHhHHHHHHHH
Q 041143 783 DGEKS-------------------------------------VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMEL 825 (973)
Q Consensus 783 ~~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el 825 (973)
..... .....+||+.|+|||++....++.++|||||||++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 232 (364)
T cd05599 153 KSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232 (364)
T ss_pred ccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHh
Confidence 21100 01124699999999999999999999999999999999
Q ss_pred HhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCC---HhHHHH
Q 041143 826 LTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPD---MGHVVN 901 (973)
Q Consensus 826 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs---~~~v~~ 901 (973)
++|+.||......+.. ..+.... ..+.... .......+.+++.+|+. +|.+|++ +.|+++
T Consensus 233 ~~G~~Pf~~~~~~~~~------~~i~~~~--------~~~~~~~-~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 233 LVGYPPFCSDNPQETY------RKIINWK--------ETLQFPD-EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred hcCCCCCCCCCHHHHH------HHHHcCC--------CccCCCC-CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 9999999876543211 1111100 0011000 00112346688888986 9999998 888877
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=324.39 Aligned_cols=256 Identities=27% Similarity=0.380 Sum_probs=195.0
Q ss_pred CcccccCccEEEEEEECC---CCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEecCC
Q 041143 631 NELGRGGFGTVYKGELED---GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPH 707 (973)
Q Consensus 631 ~~lG~G~fg~Vy~~~~~~---g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 707 (973)
+.||+|+||.||+|...+ +..+|+|.++... .......+.+|+.++++++||||+++++++.+....++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA-SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 368999999999997653 4578999887543 234445789999999999999999999999999999999999999
Q ss_pred CCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCcc
Q 041143 708 GALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKS 787 (973)
Q Consensus 708 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~~ 787 (973)
|+|.++++..........++..+..++.|+++||+||| +.+++||||||+||+++.++++||+|||+++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 99999997644333345678888899999999999999 889999999999999999999999999999754332221
Q ss_pred -eecccccccCcccccccccC-------cCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHH
Q 041143 788 -VVTRLAGTFGYLAPEYAVMG-------KITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFK 858 (973)
Q Consensus 788 -~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (973)
......|+..|+|||++... .++.++|||||||++|||++ |+.||......+... .. . .....
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~---~~--~---~~~~~ 228 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT---YT--V---REQQL 228 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH---HH--h---hcccC
Confidence 12234678899999988642 35789999999999999996 999997654332211 00 0 00111
Q ss_pred hhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHH
Q 041143 859 AAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLS 904 (973)
Q Consensus 859 ~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~ 904 (973)
...++.+.. .....+.+++..|+ .+|++||+++||++.|+
T Consensus 229 ~~~~~~~~~-----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 229 KLPKPRLKL-----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCccCC-----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 111222211 11234667888998 68999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=332.24 Aligned_cols=264 Identities=27% Similarity=0.422 Sum_probs=209.0
Q ss_pred hcCccccCcccccCccEEEEEEEC--------CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEe
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE--------DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIE 694 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 694 (973)
.++|...+.||+|+||.||+|+.. ++..||+|.++.. ......+.+.+|+.+++.+ +||||+++++++..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc-cchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 467888899999999999999641 2457999988654 2345567899999999999 89999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHHhhhhc-----------cCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEE
Q 041143 695 GNERLLVYEYMPHGALSRHLFRWEKL-----------QLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNIL 763 (973)
Q Consensus 695 ~~~~~lV~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nil 763 (973)
....++||||+++|+|.+++...... ....++|.+++.++.||++||+||| +++|+||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEE
Confidence 99999999999999999999763221 1245889999999999999999999 889999999999999
Q ss_pred ECCCCCEEEeeccccccCCCCCcce-ecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHH
Q 041143 764 LDDDYRAKVSDFGLVKLAPDGEKSV-VTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESR 841 (973)
Q Consensus 764 l~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~ 841 (973)
+++++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||......+
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-- 247 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-- 247 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH--
Confidence 9999999999999998654332221 222346778999999988889999999999999999998 788886554322
Q ss_pred HHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 842 YLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
+...+... . ... ........+.+++.+|++.+|.+||++.||++.|+++..-
T Consensus 248 ----~~~~~~~~-------~--~~~---~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 248 ----LFKLLKEG-------H--RMD---KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred ----HHHHHHcC-------C--cCC---CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 11111110 0 000 0112234578999999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=331.20 Aligned_cols=259 Identities=26% Similarity=0.403 Sum_probs=205.9
Q ss_pred hcCccccCcccccCccEEEEEEEC------CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCC
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE------DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGN 696 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 696 (973)
.++|...+.||+|+||.||+|... .+..||||+++... .....+.+.+|+++++++ +|+||+++++++...+
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 357889999999999999999642 34579999887542 344456799999999999 7999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecc
Q 041143 697 ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFG 776 (973)
Q Consensus 697 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG 776 (973)
..++||||+++|+|.++++... ...+++.++..++.|++.||+||| +++|+|+||||+||+++.++.+|++|||
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~---~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKR---ESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCc
Confidence 9999999999999999986522 234899999999999999999999 7899999999999999999999999999
Q ss_pred ccccCCCCCcc-eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhch
Q 041143 777 LVKLAPDGEKS-VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSK 854 (973)
Q Consensus 777 la~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 854 (973)
+++........ ......++..|+|||++.+..++.++|||||||++|||++ |+.||......+. .....
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~~~~~------- 257 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--FYKLI------- 257 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--HHHHH-------
Confidence 99855433221 1223346788999999998899999999999999999998 9999876543211 10100
Q ss_pred hHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHh
Q 041143 855 EKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPL 906 (973)
Q Consensus 855 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~ 906 (973)
.....+.. .......+.+++.+|++.+|++||++.||++.|+++
T Consensus 258 ---~~~~~~~~-----~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 258 ---KEGYRMAQ-----PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ---HcCCcCCC-----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 00000000 011124588999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=358.01 Aligned_cols=266 Identities=22% Similarity=0.322 Sum_probs=208.1
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
++|+..++||+|+||.||+|... +|+.||+|+++.... .....++|.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57889999999999999999875 589999999875432 2344567999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhc------cCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecc
Q 041143 703 EYMPHGALSRHLFRWEKL------QLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFG 776 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG 776 (973)
||+++|+|.+++...... .....++..++.++.||++||+||| +++|+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence 999999999998753211 1234678889999999999999999 7899999999999999999999999999
Q ss_pred ccccCCCCCc-----------------ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhh
Q 041143 777 LVKLAPDGEK-----------------SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEE 839 (973)
Q Consensus 777 la~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~ 839 (973)
+++....... ......+||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9985421100 01123579999999999999999999999999999999999999997643221
Q ss_pred HHHHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCC-CHhHHHHHHHHhhhh
Q 041143 840 SRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRP-DMGHVVNVLSPLVEK 909 (973)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-s~~~v~~~L~~~~~~ 909 (973)
... . ....++. .. ....+....+.+++.+|++.||++|| +++++.+.|+.+.+.
T Consensus 239 i~~-----~---------~~i~~P~-~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 239 ISY-----R---------DVILSPI-EV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hhh-----h---------hhccChh-hc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 100 0 0001110 00 00012224477899999999999996 677788888887653
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=341.38 Aligned_cols=205 Identities=25% Similarity=0.405 Sum_probs=176.6
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCC-CChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGV-TTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
++|+..+.||+|+||+||+|+.. +++.||||+++... ........+.+|+.++.+++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999765 58899999986531 12334467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++|+|.+++.. ...+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 81 EFLPGGDMMTLLMK-----KDTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred cCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 99999999999865 246899999999999999999999 8899999999999999999999999999987432
Q ss_pred CCCc----------------------------------ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhC
Q 041143 783 DGEK----------------------------------SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTG 828 (973)
Q Consensus 783 ~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg 828 (973)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G 232 (363)
T cd05628 153 KAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (363)
T ss_pred ccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhC
Confidence 2110 001235799999999999999999999999999999999999
Q ss_pred CCCCCCCCh
Q 041143 829 LAALDEERP 837 (973)
Q Consensus 829 ~~p~~~~~~ 837 (973)
+.||.....
T Consensus 233 ~~Pf~~~~~ 241 (363)
T cd05628 233 YPPFCSETP 241 (363)
T ss_pred CCCCCCCCH
Confidence 999987654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=337.09 Aligned_cols=275 Identities=23% Similarity=0.326 Sum_probs=206.3
Q ss_pred HHhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC----
Q 041143 622 KVTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGN---- 696 (973)
Q Consensus 622 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 696 (973)
...++|...+.||+|+||.||+|... +|+.||||++............+.+|+.+++.++||||+++++++...+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 34578999999999999999999764 5899999999765445555677889999999999999999999987543
Q ss_pred --eEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEee
Q 041143 697 --ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSD 774 (973)
Q Consensus 697 --~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D 774 (973)
..++||||+++ +|.+.++ ..+++.++..++.||+.||+||| +++|+||||||+||+++.++.+||+|
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~D 166 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIH-------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILD 166 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHh-------ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEec
Confidence 46999999965 5666553 23788889999999999999999 88999999999999999999999999
Q ss_pred ccccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhc-
Q 041143 775 FGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSS- 853 (973)
Q Consensus 775 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~- 853 (973)
||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ...........
T Consensus 167 fg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~--~~~~~~~~~~~~ 242 (359)
T cd07876 167 FGLARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ--WNKVIEQLGTPS 242 (359)
T ss_pred CCCccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCc
Confidence 99997543321 22345789999999999999999999999999999999999999986653221 00000000000
Q ss_pred -------hhHHHhhcC--cccc------------CC---cccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 854 -------KEKFKAAID--PALE------------VN---EETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 854 -------~~~~~~~~~--~~l~------------~~---~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
.......+. +... .. .........+.+++.+|++.||++|||+.|+++ ++++..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~--hp~~~~ 320 (359)
T cd07876 243 AEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR--HPYITV 320 (359)
T ss_pred HHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc--Cchhhh
Confidence 000000000 0000 00 000011245789999999999999999999998 777766
Q ss_pred cCCC
Q 041143 910 WRPI 913 (973)
Q Consensus 910 ~~~~ 913 (973)
|..+
T Consensus 321 ~~~~ 324 (359)
T cd07876 321 WYDP 324 (359)
T ss_pred hcCc
Confidence 5544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=321.72 Aligned_cols=251 Identities=26% Similarity=0.415 Sum_probs=206.6
Q ss_pred CccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEe
Q 041143 626 NFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEY 704 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 704 (973)
+|...+.||+|+||.||+|... +++.|++|.+..........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677889999999999999775 689999999875544566677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCC
Q 041143 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG 784 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~ 784 (973)
+++++|.++++... ...+++.++..++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~l~~~~---~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 81 AENGDLHKLLKMQR---GRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred CCCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 99999999997632 256899999999999999999999 789999999999999999999999999998865443
Q ss_pred CcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCcc
Q 041143 785 EKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPA 864 (973)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 864 (973)
.. ......|++.|+|||+..+..++.++|||||||++|||++|+.||........ . ..... ... +.
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~---~~~~~------~~~-~~ 220 (256)
T cd08529 155 TN-FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL---I---LKIIR------GVF-PP 220 (256)
T ss_pred cc-hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH---H---HHHHc------CCC-CC
Confidence 22 22345688999999999998999999999999999999999999976552211 1 11110 000 11
Q ss_pred ccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 865 LEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 865 l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
+ .......+.+++.+|++.+|++||++.++++
T Consensus 221 ~-----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 221 V-----SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred C-----ccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 1 1122345889999999999999999999987
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=332.30 Aligned_cols=263 Identities=29% Similarity=0.427 Sum_probs=208.4
Q ss_pred HhcCccccCcccccCccEEEEEEEC------CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeC
Q 041143 623 VTQNFAQENELGRGGFGTVYKGELE------DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEG 695 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 695 (973)
..++|+..+.||+|+||.||+|... ....+|+|.++... ..+...++.+|++++.++ +|+||+++++++..+
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 3467888899999999999999764 23679999987542 344556789999999999 799999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhhhh-----------ccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEE
Q 041143 696 NERLLVYEYMPHGALSRHLFRWEK-----------LQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILL 764 (973)
Q Consensus 696 ~~~~lV~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill 764 (973)
+..++||||+++|+|..+++.... .....+++..++.++.|++.||+||| +++|+||||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEE
Confidence 999999999999999999975321 22356899999999999999999999 8899999999999999
Q ss_pred CCCCCEEEeeccccccCCCCCcce-ecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHH
Q 041143 765 DDDYRAKVSDFGLVKLAPDGEKSV-VTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRY 842 (973)
Q Consensus 765 ~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~ 842 (973)
++++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||......+...
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 245 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 245 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence 999999999999998654432211 122345678999999988899999999999999999998 999987654322110
Q ss_pred HHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhh
Q 041143 843 LAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLV 907 (973)
Q Consensus 843 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~ 907 (973)
.... .. ... ........+.+++.+|++.+|++|||+.|+++.|+.++
T Consensus 246 ------~~~~-------~~--~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 246 ------LLKE-------GY--RME---KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ------HHHc-------CC--cCC---CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 0100 00 000 11122345789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=332.42 Aligned_cols=263 Identities=29% Similarity=0.421 Sum_probs=207.7
Q ss_pred cCccccCcccccCccEEEEEEEC--------CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeC
Q 041143 625 QNFAQENELGRGGFGTVYKGELE--------DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEG 695 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 695 (973)
++|.+.+.||+|+||.||+|... ++..+|+|.++... ......++.+|+++++++ +|+||+++++++...
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 57889999999999999999753 23569999987542 344556788999999999 799999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhhhhc-----------cCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEE
Q 041143 696 NERLLVYEYMPHGALSRHLFRWEKL-----------QLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILL 764 (973)
Q Consensus 696 ~~~~lV~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill 764 (973)
+..++||||+++|+|.+++...... ....++|.+++.++.|++.||+||| +++++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEE
Confidence 9999999999999999999763221 1235899999999999999999999 8899999999999999
Q ss_pred CCCCCEEEeeccccccCCCCCcce-ecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHH
Q 041143 765 DDDYRAKVSDFGLVKLAPDGEKSV-VTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRY 842 (973)
Q Consensus 765 ~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~ 842 (973)
+.++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |+.||......+.
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~-- 251 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL-- 251 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH--
Confidence 999999999999987554322111 112234578999999998889999999999999999998 8888865543211
Q ss_pred HHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 843 LAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 843 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
...... .. ... ........+.+++.+|++.+|++||+|.+|++.|+++.+.
T Consensus 252 ----~~~~~~-------~~--~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 252 ----FKLLKE-------GH--RMD---KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred ----HHHHHc-------CC--CCC---CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 111111 00 000 1112234677999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=321.81 Aligned_cols=256 Identities=23% Similarity=0.345 Sum_probs=216.8
Q ss_pred HhcCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEE
Q 041143 623 VTQNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLV 701 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 701 (973)
+..-|...+.||+|.|+.|-+|+. -+|++||||++.....+.-....+.+|++.|+.++|||||++|++.......|||
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 445677888999999999999964 3799999999987766666677889999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEEC-CCCCEEEeecccccc
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLD-DDYRAKVSDFGLVKL 780 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~-~~~~~kl~DfGla~~ 780 (973)
+|.-.+|+|++|+-+++ ..+.+.-..+++.||+.|+.|+| +..+||||+||+||.+- +-|-+||+|||++..
T Consensus 96 LELGD~GDl~DyImKHe----~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNk 168 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHE----EGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNK 168 (864)
T ss_pred EEecCCchHHHHHHhhh----ccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeecccccc
Confidence 99999999999997643 45788889999999999999999 66899999999999875 558899999999987
Q ss_pred CCCCCcceecccccccCcccccccccCcCC-CchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHh
Q 041143 781 APDGEKSVVTRLAGTFGYLAPEYAVMGKIT-TKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKA 859 (973)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (973)
+..+. ..+..+|+..|-|||++.+..|+ +++||||+||+||-|++|+.||+..... +.+..
T Consensus 169 f~PG~--kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS----------------ETLTm 230 (864)
T KOG4717|consen 169 FQPGK--KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS----------------ETLTM 230 (864)
T ss_pred CCCcc--hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch----------------hhhhh
Confidence 66544 35678999999999999999997 5789999999999999999999876542 33445
Q ss_pred hcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 860 AIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 860 ~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
++|-.+.. +...-.++.+||..|+..||.+|.+..+|+. ..|++
T Consensus 231 ImDCKYtv---PshvS~eCrdLI~sMLvRdPkkRAslEeI~s--~~Wlq 274 (864)
T KOG4717|consen 231 IMDCKYTV---PSHVSKECRDLIQSMLVRDPKKRASLEEIVS--TSWLQ 274 (864)
T ss_pred hhcccccC---chhhhHHHHHHHHHHHhcCchhhccHHHHhc--ccccc
Confidence 55655442 2234456789999999999999999999998 45544
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=337.62 Aligned_cols=250 Identities=22% Similarity=0.359 Sum_probs=194.3
Q ss_pred CcccccCccEEEEEEEC-CCCEEEEEEeecCC-CChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeEEEEEEecCC
Q 041143 631 NELGRGGFGTVYKGELE-DGTKIAVKRMEAGV-TTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGNERLLVYEYMPH 707 (973)
Q Consensus 631 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 707 (973)
+.||+|+||.||+|+.. +++.||+|+++... ......+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999865 57899999997542 2334456688899998877 799999999999999999999999999
Q ss_pred CCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCcc
Q 041143 708 GALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKS 787 (973)
Q Consensus 708 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~~ 787 (973)
|+|..++.. ...+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~~~~-----~~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~ 151 (329)
T cd05618 81 GDLMFHMQR-----QRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-D 151 (329)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-C
Confidence 999888754 246899999999999999999999 8899999999999999999999999999987532221 1
Q ss_pred eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhh--HHHHHHHHHHHhhchhHHHhhcCccc
Q 041143 788 VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEE--SRYLAEWFWRIKSSKEKFKAAIDPAL 865 (973)
Q Consensus 788 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l 865 (973)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......+..... .....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i---------~~~~~ 222 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI---------LEKQI 222 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH---------hcCCC
Confidence 2334679999999999999999999999999999999999999996322111 011111111111 11111
Q ss_pred cCCcccHHHHHHHHHHHHHhhccCCCCCCCH------hHHHH
Q 041143 866 EVNEETFESISIVAELAGHCTAREPYHRPDM------GHVVN 901 (973)
Q Consensus 866 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~------~~v~~ 901 (973)
... ......+.+++.+|++.||++||++ .++++
T Consensus 223 ~~p---~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05618 223 RIP---RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 261 (329)
T ss_pred CCC---CCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence 111 1122447799999999999999984 56655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=336.84 Aligned_cols=238 Identities=26% Similarity=0.369 Sum_probs=191.6
Q ss_pred CcccccCccEEEEEEEC-CCCEEEEEEeecCC-CChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeEEEEEEecCC
Q 041143 631 NELGRGGFGTVYKGELE-DGTKIAVKRMEAGV-TTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGNERLLVYEYMPH 707 (973)
Q Consensus 631 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 707 (973)
+.||+|+||.||+|+.+ +++.||||+++... ......+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 58899999986532 1233456678899998876 699999999999999999999999999
Q ss_pred CCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCcc
Q 041143 708 GALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKS 787 (973)
Q Consensus 708 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~~ 787 (973)
|+|..++.. ...+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~L~~~i~~-----~~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~ 151 (320)
T cd05590 81 GDLMFHIQK-----SRRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-K 151 (320)
T ss_pred chHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-C
Confidence 999988865 245889999999999999999999 8899999999999999999999999999987533221 1
Q ss_pred eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccC
Q 041143 788 VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEV 867 (973)
Q Consensus 788 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 867 (973)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ...+..... ..+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~------~~~i~~~~~-----~~~~--- 217 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL------FEAILNDEV-----VYPT--- 217 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH------HHHHhcCCC-----CCCC---
Confidence 23446799999999999988999999999999999999999999986653221 111111100 0010
Q ss_pred CcccHHHHHHHHHHHHHhhccCCCCCCCH
Q 041143 868 NEETFESISIVAELAGHCTAREPYHRPDM 896 (973)
Q Consensus 868 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~ 896 (973)
.....+.+++.+|++.||++||++
T Consensus 218 -----~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 218 -----WLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred -----CCCHHHHHHHHHHcccCHHHCCCC
Confidence 112346799999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=337.08 Aligned_cols=243 Identities=25% Similarity=0.364 Sum_probs=194.6
Q ss_pred CcccccCccEEEEEEEC-CCCEEEEEEeecCC-CChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeEEEEEEecCC
Q 041143 631 NELGRGGFGTVYKGELE-DGTKIAVKRMEAGV-TTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGNERLLVYEYMPH 707 (973)
Q Consensus 631 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 707 (973)
+.||+|+||.||+|+.. +++.||||+++... ......+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999875 57899999987532 1233455678899999876 799999999999999999999999999
Q ss_pred CCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCcc
Q 041143 708 GALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKS 787 (973)
Q Consensus 708 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~~ 787 (973)
|+|..++.. ...+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~- 151 (321)
T cd05591 81 GDLMFQIQR-----SRKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV- 151 (321)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc-
Confidence 999988864 245889999999999999999999 88999999999999999999999999999875432221
Q ss_pred eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccC
Q 041143 788 VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEV 867 (973)
Q Consensus 788 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 867 (973)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ...+.... ...+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~------~~~i~~~~-----~~~p~--- 217 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL------FESILHDD-----VLYPV--- 217 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH------HHHHHcCC-----CCCCC---
Confidence 23346799999999999988999999999999999999999999987653221 11111110 00010
Q ss_pred CcccHHHHHHHHHHHHHhhccCCCCCC-------CHhHHHH
Q 041143 868 NEETFESISIVAELAGHCTAREPYHRP-------DMGHVVN 901 (973)
Q Consensus 868 ~~~~~~~~~~~~~l~~~cl~~dP~~RP-------s~~~v~~ 901 (973)
.....+.+++.+|++.||++|| ++.++++
T Consensus 218 -----~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 218 -----WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred -----CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 1123477999999999999999 6677765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=328.94 Aligned_cols=265 Identities=29% Similarity=0.432 Sum_probs=202.8
Q ss_pred cCccccCcccccCccEEEEEEECC---------------CCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeee
Q 041143 625 QNFAQENELGRGGFGTVYKGELED---------------GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLL 689 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~---------------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 689 (973)
++|+..+.||+|+||.||+|+... ...||+|.++... .....+.|.+|++++++++|+||++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 578899999999999999987542 2358999987542 344566799999999999999999999
Q ss_pred eEEEeCCeEEEEEEecCCCCHHHHHHhhhhc-------cCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcE
Q 041143 690 GYSIEGNERLLVYEYMPHGALSRHLFRWEKL-------QLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNI 762 (973)
Q Consensus 690 ~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~-------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Ni 762 (973)
+++...+..++||||+++++|.+++...... ....++|.+++.++.|+++||+||| +.+++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhE
Confidence 9999999999999999999999999653211 1124789999999999999999999 88999999999999
Q ss_pred EECCCCCEEEeeccccccCCCCCcc-eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh--CCCCCCCCChhh
Q 041143 763 LLDDDYRAKVSDFGLVKLAPDGEKS-VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT--GLAALDEERPEE 839 (973)
Q Consensus 763 ll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt--g~~p~~~~~~~~ 839 (973)
++++++.+||+|||+++........ ......++..|+|||+...+.++.++|||||||++|||++ |..||......+
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 9999999999999999854433221 1223345778999999998899999999999999999998 566776544322
Q ss_pred HHHHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHH
Q 041143 840 SRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLS 904 (973)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~ 904 (973)
. ........ ......... .........+.+++.+|++.||++||+|.+|++.|+
T Consensus 241 ~---~~~~~~~~------~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 V---IENTGEFF------RNQGRQIYL--SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred H---HHHHHHhh------hhccccccC--CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1 11110000 000000000 000011246889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=331.86 Aligned_cols=261 Identities=31% Similarity=0.487 Sum_probs=204.7
Q ss_pred cCccccCcccccCccEEEEEEEC-CCC--EEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGT--KIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGNERLL 700 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 700 (973)
++|+..+.||+|+||.||+|.++ ++. .+|+|.++.. ......+.+.+|++++.++ +|+||+++++++..++..++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 57888899999999999999864 454 4577776543 2345567889999999999 89999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhc-----------cCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCC
Q 041143 701 VYEYMPHGALSRHLFRWEKL-----------QLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYR 769 (973)
Q Consensus 701 V~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~ 769 (973)
||||+++|+|.++++..... ....+++.+++.++.|++.||+||| +++|+||||||+|||+++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCc
Confidence 99999999999999764321 1235789999999999999999999 889999999999999999999
Q ss_pred EEEeeccccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHH
Q 041143 770 AKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFW 848 (973)
Q Consensus 770 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 848 (973)
+||+|||+++...... ......++..|+|||++.+..++.++|||||||++|||+| |+.||......+. ..
T Consensus 163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~------~~ 234 (303)
T cd05088 163 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL------YE 234 (303)
T ss_pred EEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH------HH
Confidence 9999999986332111 1111234678999999988889999999999999999998 9999975543211 11
Q ss_pred HHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 849 RIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 849 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
... ....... .......+.+++.+|++.+|++||++.++++.|+.+.+.
T Consensus 235 ~~~-------~~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 235 KLP-------QGYRLEK-----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred HHh-------cCCcCCC-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 111 0000000 011223578999999999999999999999999887664
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=326.57 Aligned_cols=260 Identities=27% Similarity=0.384 Sum_probs=205.4
Q ss_pred cCccccCcccccCccEEEEEEEC-CCC----EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGT----KIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERL 699 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 699 (973)
++|+..+.||+|+||.||+|++. +|+ +||+|+++.. ......+.+.+|+.+++.++|+||+++++++... ..+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN-TSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC-CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 57888899999999999999753 444 4899998754 2444567889999999999999999999999754 568
Q ss_pred EEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccc
Q 041143 700 LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK 779 (973)
Q Consensus 700 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~ 779 (973)
++|||+++|+|.++++.. ...+++..++.++.||+.||+||| +++|+||||||+||++++++.+||+|||+++
T Consensus 85 l~~~~~~~g~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN----KDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred EEEEcCCCCCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCcee
Confidence 999999999999998652 245899999999999999999999 8899999999999999999999999999998
Q ss_pred cCCCCCcce-ecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHH
Q 041143 780 LAPDGEKSV-VTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKF 857 (973)
Q Consensus 780 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (973)
......... .....++..|+|||...+..++.++|||||||++|||++ |+.||+...... +..++..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~-------- 226 (279)
T cd05109 158 LLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPDLLEK-------- 226 (279)
T ss_pred ecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHHC--------
Confidence 654332211 122345678999999998899999999999999999998 899987654322 1111111
Q ss_pred HhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcC
Q 041143 858 KAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWR 911 (973)
Q Consensus 858 ~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~ 911 (973)
...+.. .......+.+++.+|++.||++||++.++++.|+.+.+.+.
T Consensus 227 --~~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~ 273 (279)
T cd05109 227 --GERLPQ-----PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPS 273 (279)
T ss_pred --CCcCCC-----CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCc
Confidence 000000 11122457799999999999999999999999988866543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=324.03 Aligned_cols=263 Identities=25% Similarity=0.375 Sum_probs=210.8
Q ss_pred cCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCC-CChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGV-TTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
++|...+.||+|+||.||+|.. .+|+.+|||.+.... .......++.+|+++++.++|+||+++++++.+++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4678889999999999999985 478999999876432 23344568899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++++|.+++..... ....+++.+++.++.||+.||+||| +++++|+||||+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 82 ELADAGDLSRMIKHFKK-QKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 99999999999875332 2356899999999999999999999 8899999999999999999999999999987654
Q ss_pred CCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcC
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (973)
.... ......|+..|+|||++.+..++.++||||||+++|||++|+.||........ .+.. .+.....
T Consensus 158 ~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----~~~~-------~~~~~~~ 225 (267)
T cd08229 158 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY----SLCK-------KIEQCDY 225 (267)
T ss_pred cCCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH----HHhh-------hhhcCCC
Confidence 3322 12335689999999999888899999999999999999999999965432111 1111 1111111
Q ss_pred ccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhh
Q 041143 863 PALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLV 907 (973)
Q Consensus 863 ~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~ 907 (973)
+... .......+.+++.+|++.+|++||||.+|+++++++.
T Consensus 226 ~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 226 PPLP----SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CCCC----cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 2111 1123345889999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=337.61 Aligned_cols=250 Identities=21% Similarity=0.355 Sum_probs=195.2
Q ss_pred CcccccCccEEEEEEEC-CCCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeEEEEEEecCC
Q 041143 631 NELGRGGFGTVYKGELE-DGTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGNERLLVYEYMPH 707 (973)
Q Consensus 631 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 707 (973)
++||+|+||.||+|+.. +++.||||+++.... .....+.+.+|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999765 688999999975422 233456788999999998 799999999999999999999999999
Q ss_pred CCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCcc
Q 041143 708 GALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKS 787 (973)
Q Consensus 708 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~~ 787 (973)
|+|..++.. ...+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 g~L~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~ 151 (329)
T cd05588 81 GDLMFHMQR-----QRKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-D 151 (329)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCC-C
Confidence 999988854 246899999999999999999999 8899999999999999999999999999987432211 1
Q ss_pred eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhh--HHHHHHHHHHHhhchhHHHhhcCccc
Q 041143 788 VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEE--SRYLAEWFWRIKSSKEKFKAAIDPAL 865 (973)
Q Consensus 788 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l 865 (973)
......||+.|+|||++.+..++.++|||||||++|||++|+.||+.....+ ......+..... .....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~---------~~~~~ 222 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI---------LEKQI 222 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH---------HcCCC
Confidence 2334679999999999999999999999999999999999999997432111 111111111111 11111
Q ss_pred cCCcccHHHHHHHHHHHHHhhccCCCCCCC------HhHHHH
Q 041143 866 EVNEETFESISIVAELAGHCTAREPYHRPD------MGHVVN 901 (973)
Q Consensus 866 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs------~~~v~~ 901 (973)
.... .....+.+++.+|++.||.+||+ +.++++
T Consensus 223 ~~p~---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 223 RIPR---SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCCC---CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 1011 11234779999999999999998 556654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=326.95 Aligned_cols=259 Identities=27% Similarity=0.426 Sum_probs=202.8
Q ss_pred hcCccccCcccccCccEEEEEEECC------CCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCe
Q 041143 624 TQNFAQENELGRGGFGTVYKGELED------GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNE 697 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 697 (973)
.++|...+.||+|+||.||+|.+.+ +..||+|.+... ........|.+|+.++++++|+||+++++++.+.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES-CSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 4678889999999999999998753 567899987643 234445678999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCC---CEEE
Q 041143 698 RLLVYEYMPHGALSRHLFRWEKL--QLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDY---RAKV 772 (973)
Q Consensus 698 ~~lV~e~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~---~~kl 772 (973)
.++||||+++|+|.+++...... ....++|.+++.++.||++||+||| +++++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEe
Confidence 99999999999999999764321 1235899999999999999999999 78999999999999998754 5999
Q ss_pred eeccccccCCCCCcc-eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHH
Q 041143 773 SDFGLVKLAPDGEKS-VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRI 850 (973)
Q Consensus 773 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 850 (973)
+|||+++........ .......+..|+|||++.+..++.++|||||||++|||++ |+.||......+.. . .+
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~---~---~~ 234 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM---E---FV 234 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH---H---HH
Confidence 999999865322111 1112234568999999999999999999999999999997 99999865543211 1 11
Q ss_pred hhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHH
Q 041143 851 KSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLS 904 (973)
Q Consensus 851 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~ 904 (973)
.. .. ... .+......+.+++.+|++.+|++||++.+|++.|.
T Consensus 235 ~~-~~--------~~~---~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 TG-GG--------RLD---PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred Hc-CC--------cCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 10 00 000 01112345789999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=336.18 Aligned_cols=243 Identities=25% Similarity=0.341 Sum_probs=194.4
Q ss_pred CccccCcccccCccEEEEEEEC-CCCEEEEEEeecCC-CChHHHHHHHHHHHHHHhcCC-CceeeeeeEEEeCCeEEEEE
Q 041143 626 NFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGV-TTTKALDEFQSEIAVLSKVRH-RHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~ 702 (973)
+|+..+.||+|+||.||+|+.. +++.||||+++... ......+.+..|++++..++| ++|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999999999775 57889999987532 123445678889999999975 56888999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++|+|.+++.. ...+++.++..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05587 81 EYVNGGDLMYHIQQ-----VGKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENI 152 (324)
T ss_pred cCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecC
Confidence 99999999988864 245789999999999999999999 8899999999999999999999999999987432
Q ss_pred CCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcC
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (973)
.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+. . ..+..
T Consensus 153 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~---~---~~i~~---------- 215 (324)
T cd05587 153 FGGK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL---F---QSIME---------- 215 (324)
T ss_pred CCCC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH---H---HHHHc----------
Confidence 2211 23345799999999999999999999999999999999999999986653221 1 11111
Q ss_pred ccccCCcccHHHHHHHHHHHHHhhccCCCCCCCH
Q 041143 863 PALEVNEETFESISIVAELAGHCTAREPYHRPDM 896 (973)
Q Consensus 863 ~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~ 896 (973)
...... ......+.+++.+|++.||.+|++.
T Consensus 216 ~~~~~~---~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 216 HNVSYP---KSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCCC---CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 111100 0112347799999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=328.28 Aligned_cols=268 Identities=27% Similarity=0.387 Sum_probs=203.1
Q ss_pred ccccCcccccCccEEEEEEE-----CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeC--CeEE
Q 041143 627 FAQENELGRGGFGTVYKGEL-----EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEG--NERL 699 (973)
Q Consensus 627 ~~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 699 (973)
|...+.||+|+||+||++.. .++..||+|.++... .....+.+.+|++++++++||||+++++++... ...+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ 84 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence 37789999999999988653 357889999987542 334456788999999999999999999998764 3578
Q ss_pred EEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccc
Q 041143 700 LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK 779 (973)
Q Consensus 700 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~ 779 (973)
+||||+++|+|.+++.. ..+++.++..++.|++.||+||| +++|+||||||+||++++++.+||+|||+++
T Consensus 85 lv~e~~~~~~l~~~~~~------~~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 85 LIMEYVPLGSLRDYLPK------HKLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred EEecCCCCCCHHHHHHH------cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeeccccc
Confidence 99999999999999864 35899999999999999999999 8899999999999999999999999999998
Q ss_pred cCCCCCcc--eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHH
Q 041143 780 LAPDGEKS--VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKF 857 (973)
Q Consensus 780 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (973)
........ ......++..|+|||.+....++.++|||||||++|||++|+.|+....... .....+.... .....+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~-~~~~~~ 233 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQ-MTVVRL 233 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccc-cchhhh
Confidence 65443221 1122345677999999988899999999999999999999999986543211 0111100000 001111
Q ss_pred HhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhh
Q 041143 858 KAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLV 907 (973)
Q Consensus 858 ~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~ 907 (973)
.+.++..... .........+.+++.+|++.+|++||++++|++.|+.+.
T Consensus 234 ~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 234 IELLERGMRL-PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhcCCCC-CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 1122211110 011123356889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=327.96 Aligned_cols=264 Identities=28% Similarity=0.433 Sum_probs=206.4
Q ss_pred HhcCccccCcccccCccEEEEEEEC------CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC
Q 041143 623 VTQNFAQENELGRGGFGTVYKGELE------DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGN 696 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 696 (973)
..++|++.+.||+|+||.||+|..+ .+..||+|.++... .......+.+|+.+++.++|+||+++++++.+.+
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 4578999999999999999999653 24579999886542 2334456889999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhhhhc-----cCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEE
Q 041143 697 ERLLVYEYMPHGALSRHLFRWEKL-----QLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAK 771 (973)
Q Consensus 697 ~~~lV~e~~~~g~L~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~k 771 (973)
..++||||+++|+|.+++...... .....++..+..++.|++.||.||| +++|+||||||+||++++++.+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEE
Confidence 999999999999999999763221 1234678888999999999999999 88999999999999999999999
Q ss_pred EeeccccccCCCCCc-ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHH
Q 041143 772 VSDFGLVKLAPDGEK-SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWR 849 (973)
Q Consensus 772 l~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 849 (973)
|+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |+.||......+. . ..
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~---~---~~ 233 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV---L---KF 233 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---H---HH
Confidence 999999885433221 11222345778999999998899999999999999999998 7888876543221 1 11
Q ss_pred HhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 850 IKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 850 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
+ .+.... .........+.+++.+|++.||++||++.++++.|+....
T Consensus 234 ~----------~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 280 (288)
T cd05061 234 V----------MDGGYL--DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 280 (288)
T ss_pred H----------HcCCCC--CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence 1 111100 0001112468899999999999999999999998887644
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=323.62 Aligned_cols=256 Identities=28% Similarity=0.482 Sum_probs=204.5
Q ss_pred cCccccCcccccCccEEEEEEEC-CC---CEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DG---TKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLL 700 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 700 (973)
++|+..+.||+|+||.||+|... ++ ..+|+|.++... .....+.+..|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 56788899999999999999875 33 368999886542 34445678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecccccc
Q 041143 701 VYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKL 780 (973)
Q Consensus 701 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~ 780 (973)
||||+++++|.+++... ...+++.++..++.|++.|++||| +.+++||||||+||++++++.+||+|||++..
T Consensus 84 v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 156 (268)
T cd05063 84 ITEYMENGALDKYLRDH----DGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRV 156 (268)
T ss_pred EEEcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCcccee
Confidence 99999999999998651 245899999999999999999999 78999999999999999999999999999885
Q ss_pred CCCCCcceec--ccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHH
Q 041143 781 APDGEKSVVT--RLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKF 857 (973)
Q Consensus 781 ~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (973)
.......... ....+..|+|||++....++.++|||||||++|||++ |+.||......+ +...+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~------~~~~i~~~---- 226 (268)
T cd05063 157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE------VMKAINDG---- 226 (268)
T ss_pred cccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH------HHHHHhcC----
Confidence 5433222111 1223467999999988889999999999999999998 999997654321 11111110
Q ss_pred HhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHh
Q 041143 858 KAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPL 906 (973)
Q Consensus 858 ~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~ 906 (973)
.. .....+....+.+++.+|++.+|++||++.+|++.|+++
T Consensus 227 -------~~-~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 -------FR-LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -------CC-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 001112335578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=321.74 Aligned_cols=263 Identities=25% Similarity=0.398 Sum_probs=211.0
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecC-CCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAG-VTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
++|+..+.||+|+||.||+|... +|+.||+|.++.. .......+.+.+|++++++++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999876 7899999988643 223344678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++|+|.+++..... ....+++.++..++.+++.||+||| +.+|+||||||+||+++.++.++|+|||+++...
T Consensus 82 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 82 ELADAGDLSRMIKHFKK-QKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred ecCCCCCHHHHHHHhcc-cCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 99999999999865332 2356899999999999999999999 8899999999999999999999999999987554
Q ss_pred CCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcC
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (973)
.... ......|+..|+|||++.+..++.++|||||||++|||++|+.||...... ......... ....
T Consensus 158 ~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~-------~~~~ 225 (267)
T cd08224 158 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIE-------KCDY 225 (267)
T ss_pred CCCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHHHhhhh-------cCCC
Confidence 3221 123346889999999998888999999999999999999999999654321 111111111 1011
Q ss_pred ccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhh
Q 041143 863 PALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLV 907 (973)
Q Consensus 863 ~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~ 907 (973)
+... .......+.+++.+|+..+|++||++.+|+++|+.+.
T Consensus 226 ~~~~----~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 226 PPLP----ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CCCC----hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 1111 1123345789999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=345.26 Aligned_cols=253 Identities=24% Similarity=0.325 Sum_probs=197.2
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCC-CChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGV-TTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
++|...+.||+|+||.||+|+.. +|+.||||++.... ......+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46888999999999999999764 68999999986431 12334567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++|+|.+++.. ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~ 152 (377)
T cd05629 81 EFLPGGDLMTMLIK-----YDTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFH 152 (377)
T ss_pred eCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccccc
Confidence 99999999999865 245788889999999999999999 8899999999999999999999999999986322
Q ss_pred CCCcc----------------------------------------------eecccccccCcccccccccCcCCCchhHH
Q 041143 783 DGEKS----------------------------------------------VVTRLAGTFGYLAPEYAVMGKITTKADVF 816 (973)
Q Consensus 783 ~~~~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~ 816 (973)
..... .....+||+.|+|||++.+..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 232 (377)
T cd05629 153 KQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWW 232 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeE
Confidence 10000 00124699999999999999999999999
Q ss_pred hHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCC---
Q 041143 817 SYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHR--- 893 (973)
Q Consensus 817 S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~R--- 893 (973)
||||++|||++|+.||......+.. ..+.... ..+.... .......+.+++.+|+. +|.+|
T Consensus 233 SlGvil~elltG~~Pf~~~~~~~~~------~~i~~~~--------~~~~~p~-~~~~s~~~~dli~~lL~-~~~~r~~r 296 (377)
T cd05629 233 SLGAIMFECLIGWPPFCSENSHETY------RKIINWR--------ETLYFPD-DIHLSVEAEDLIRRLIT-NAENRLGR 296 (377)
T ss_pred ecchhhhhhhcCCCCCCCCCHHHHH------HHHHccC--------CccCCCC-CCCCCHHHHHHHHHHhc-CHhhcCCC
Confidence 9999999999999999866543211 1111100 0011000 00112346789999997 66665
Q ss_pred CCHhHHHH
Q 041143 894 PDMGHVVN 901 (973)
Q Consensus 894 Ps~~~v~~ 901 (973)
+++.|+++
T Consensus 297 ~~~~~~l~ 304 (377)
T cd05629 297 GGAHEIKS 304 (377)
T ss_pred CCHHHHhc
Confidence 59998887
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=333.73 Aligned_cols=240 Identities=28% Similarity=0.370 Sum_probs=189.8
Q ss_pred CcccccCccEEEEEEEC-CCCEEEEEEeecCC-CChHHHHHHHHHHH-HHHhcCCCceeeeeeEEEeCCeEEEEEEecCC
Q 041143 631 NELGRGGFGTVYKGELE-DGTKIAVKRMEAGV-TTTKALDEFQSEIA-VLSKVRHRHLVSLLGYSIEGNERLLVYEYMPH 707 (973)
Q Consensus 631 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 707 (973)
+.||+|+||+||+|+.. +|+.||+|++.... ........+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999875 68999999986431 12223344555555 46789999999999999999999999999999
Q ss_pred CCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCcc
Q 041143 708 GALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKS 787 (973)
Q Consensus 708 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~~ 787 (973)
|+|..++.. ...+++..+..++.||++||+||| +++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~ 151 (323)
T cd05575 81 GELFFHLQR-----ERSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-K 151 (323)
T ss_pred CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-C
Confidence 999998864 246889999999999999999999 8899999999999999999999999999987533222 2
Q ss_pred eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccC
Q 041143 788 VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEV 867 (973)
Q Consensus 788 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 867 (973)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ...+.. .....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~------~~~i~~----------~~~~~ 215 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM------YDNILN----------KPLRL 215 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH------HHHHHc----------CCCCC
Confidence 23446799999999999999999999999999999999999999986543221 111111 11110
Q ss_pred CcccHHHHHHHHHHHHHhhccCCCCCCCHhH
Q 041143 868 NEETFESISIVAELAGHCTAREPYHRPDMGH 898 (973)
Q Consensus 868 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~ 898 (973)
.. .....+.+++.+|++.||.+||++.+
T Consensus 216 ~~---~~~~~~~~li~~~l~~~p~~R~~~~~ 243 (323)
T cd05575 216 KP---NISVSARHLLEGLLQKDRTKRLGAKD 243 (323)
T ss_pred CC---CCCHHHHHHHHHHhhcCHHhCCCCCC
Confidence 00 11245779999999999999999863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=338.93 Aligned_cols=273 Identities=20% Similarity=0.298 Sum_probs=205.9
Q ss_pred HHhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeC-----
Q 041143 622 KVTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEG----- 695 (973)
Q Consensus 622 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 695 (973)
...++|...+.||+|+||.||+|... .++.||||++..........+.+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 35578999999999999999999764 588999999976544555567788999999999999999999988643
Q ss_pred -CeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEee
Q 041143 696 -NERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSD 774 (973)
Q Consensus 696 -~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D 774 (973)
...++||||+++ ++.+++. ..+++.++..++.|+++||+||| +++|+||||||+||+++.++.+||+|
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~D 162 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILD 162 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHh-------hcCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEee
Confidence 346999999964 6666653 24788899999999999999999 88999999999999999999999999
Q ss_pred ccccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhc-
Q 041143 775 FGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSS- 853 (973)
Q Consensus 775 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~- 853 (973)
||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... ..+......
T Consensus 163 fg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~~~~~~~~~~ 238 (355)
T cd07874 163 FGLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN--KVIEQLGTPC 238 (355)
T ss_pred CcccccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHHhCCCC
Confidence 9999855332 12334578999999999999899999999999999999999999998765322110 000000000
Q ss_pred -------hhHHHhhcCc----------c------ccCCc-ccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 854 -------KEKFKAAIDP----------A------LEVNE-ETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 854 -------~~~~~~~~~~----------~------l~~~~-~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
.......++. . ..... ........+.+++.+|++.||++|||+.|+++ ++++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~--hp~~~~ 316 (355)
T cd07874 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ--HPYINV 316 (355)
T ss_pred HHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc--Ccchhc
Confidence 0000111100 0 00000 01112345789999999999999999999998 666655
Q ss_pred cC
Q 041143 910 WR 911 (973)
Q Consensus 910 ~~ 911 (973)
|.
T Consensus 317 ~~ 318 (355)
T cd07874 317 WY 318 (355)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=328.29 Aligned_cols=260 Identities=26% Similarity=0.451 Sum_probs=212.0
Q ss_pred HhcCccccCcccccCccEEEEEEECC---CC--EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCe
Q 041143 623 VTQNFAQENELGRGGFGTVYKGELED---GT--KIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNE 697 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~~~---g~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 697 (973)
..+.....++||+|-||.||+|.+.+ |+ .||||.-+.+. +....+.|..|..+|++++|||||+++|+|.+ ..
T Consensus 387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~-t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P 464 (974)
T KOG4257|consen 387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC-TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QP 464 (974)
T ss_pred ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC-ChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cc
Confidence 33455667889999999999997643 33 47888887653 44557889999999999999999999999986 46
Q ss_pred EEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccc
Q 041143 698 RLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL 777 (973)
Q Consensus 698 ~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGl 777 (973)
.++|||.++-|.|..||.. ....++......++.||+.||+||| +..+|||||.++|||+.....+|++|||+
T Consensus 465 ~WivmEL~~~GELr~yLq~----nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQ----NKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred eeEEEecccchhHHHHHHh----ccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccch
Confidence 8999999999999999976 2356888899999999999999999 88999999999999999999999999999
Q ss_pred cccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhH
Q 041143 778 VKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEK 856 (973)
Q Consensus 778 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (973)
++...+......+...-...|||||.+.-++++.++|||.|||.+||++. |..||.+....+... .+.. .
T Consensus 538 SR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~------~iEn-G-- 608 (974)
T KOG4257|consen 538 SRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG------HIEN-G-- 608 (974)
T ss_pred hhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE------EecC-C--
Confidence 99887766555555556778999999999999999999999999999976 899998765322100 0000 0
Q ss_pred HHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 857 FKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 857 ~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
.++ ..+..+...+..|+.+||+.||.+||.+.|+...|+.+.+.
T Consensus 609 ------eRl---P~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe 652 (974)
T KOG4257|consen 609 ------ERL---PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE 652 (974)
T ss_pred ------CCC---CCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence 011 12223445577999999999999999999999999998874
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=345.03 Aligned_cols=257 Identities=23% Similarity=0.332 Sum_probs=197.8
Q ss_pred CccccCcccccCccEEEEEEEC-CCCEEEEEEeecCC-CChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 626 NFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGV-TTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
+|+..+.||+|+||.||+|+.. +++.||||++.... ........+.+|++++++++|+||+++++++.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6888999999999999999764 58899999986431 122334668899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+++|+|.+++.. ...+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|.....
T Consensus 82 ~~~~g~L~~~i~~-----~~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 82 YIPGGDMMSLLIR-----LGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred CCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 9999999999865 245788888899999999999999 88999999999999999999999999999752210
Q ss_pred C------------------------------------------CcceecccccccCcccccccccCcCCCchhHHhHHHH
Q 041143 784 G------------------------------------------EKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVV 821 (973)
Q Consensus 784 ~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv 821 (973)
. ........+||+.|+|||++.+..++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 0 0001123579999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCC---CHhH
Q 041143 822 LMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRP---DMGH 898 (973)
Q Consensus 822 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RP---s~~~ 898 (973)
+|||++|+.||....+.+... .+....... .+... ......+.+++.+|+ .+|.+|+ ++.|
T Consensus 234 lyell~G~~Pf~~~~~~~~~~------~i~~~~~~~--~~~~~-------~~~s~~~~~li~~l~-~~p~~R~~~~t~~e 297 (376)
T cd05598 234 LYEMLVGQPPFLADTPAETQL------KVINWETTL--HIPSQ-------AKLSREASDLILRLC-CGAEDRLGKNGADE 297 (376)
T ss_pred eeehhhCCCCCCCCCHHHHHH------HHhccCccc--cCCCC-------CCCCHHHHHHHHHHh-cCHhhcCCCCCHHH
Confidence 999999999998765432211 111000000 00000 011233557777765 5999999 8888
Q ss_pred HHHHHHHhhh
Q 041143 899 VVNVLSPLVE 908 (973)
Q Consensus 899 v~~~L~~~~~ 908 (973)
+++ +++.+
T Consensus 298 ll~--h~~~~ 305 (376)
T cd05598 298 IKA--HPFFK 305 (376)
T ss_pred HhC--CCCcC
Confidence 887 44443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=323.09 Aligned_cols=256 Identities=27% Similarity=0.469 Sum_probs=204.7
Q ss_pred cCccccCcccccCccEEEEEEEC-C---CCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-D---GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLL 700 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~---g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 700 (973)
.+|...+.||+|+||.||+|... + +..+|+|.++... .....+.+.+|+.++++++||||+++++++..++..++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 56788899999999999999763 2 3379999887542 34456789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecccccc
Q 041143 701 VYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKL 780 (973)
Q Consensus 701 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~ 780 (973)
||||+++|+|.+++... ...+++.+++.++.|++.||+||| +.+++||||||+||+++.++.++++|||+++.
T Consensus 83 v~e~~~~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd05066 83 VTEYMENGSLDAFLRKH----DGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRV 155 (267)
T ss_pred EEEcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCcccc
Confidence 99999999999999652 245899999999999999999999 88999999999999999999999999999986
Q ss_pred CCCCCcceec--ccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHH
Q 041143 781 APDGEKSVVT--RLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKF 857 (973)
Q Consensus 781 ~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (973)
.......... ...++..|+|||++.+..++.++|||||||++||+++ |+.||......+. ... +..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~---~~~---~~~----- 224 (267)
T cd05066 156 LEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV---IKA---IEE----- 224 (267)
T ss_pred cccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH---HHH---HhC-----
Confidence 5443322221 1233568999999998899999999999999999887 9999976543221 111 111
Q ss_pred HhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHh
Q 041143 858 KAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPL 906 (973)
Q Consensus 858 ~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~ 906 (973)
..... ........+.+++.+|++.+|.+||+|.++++.|.++
T Consensus 225 --~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 225 --GYRLP-----APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred --CCcCC-----CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 00000 0111234578999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=328.39 Aligned_cols=266 Identities=27% Similarity=0.406 Sum_probs=206.1
Q ss_pred hcCccccCcccccCccEEEEEEECC-----------------CCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCcee
Q 041143 624 TQNFAQENELGRGGFGTVYKGELED-----------------GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLV 686 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~~-----------------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 686 (973)
.++|+..+.||+|+||.||+|...+ +..||+|++.... .....+.+.+|++++++++||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEe
Confidence 3578899999999999999997642 2458999987542 345567899999999999999999
Q ss_pred eeeeEEEeCCeEEEEEEecCCCCHHHHHHhhhhc------cCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCC
Q 041143 687 SLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKL------QLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSS 760 (973)
Q Consensus 687 ~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~ 760 (973)
++++++..++..++||||+++++|.+++...... ....+++..++.++.|++.||+||| +.+|+||||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~ 159 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATR 159 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchh
Confidence 9999999999999999999999999999764321 1236899999999999999999999 789999999999
Q ss_pred cEEECCCCCEEEeeccccccCCCCCc-ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh--CCCCCCCCCh
Q 041143 761 NILLDDDYRAKVSDFGLVKLAPDGEK-SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT--GLAALDEERP 837 (973)
Q Consensus 761 Nill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt--g~~p~~~~~~ 837 (973)
||+++.++.++|+|||+++....... .......++..|+|||++....++.++|||||||++|||++ |..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 99999999999999999885433221 22234457789999999988899999999999999999998 6777765432
Q ss_pred hhHHHHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHH
Q 041143 838 EESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLS 904 (973)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~ 904 (973)
.+ ............ ..... ..........+.+++.+|++.||++||++.||++.|+
T Consensus 240 ~~---~~~~~~~~~~~~-------~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 QQ---VIENAGHFFRDD-------GRQIY-LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HH---HHHHHHhccccc-------ccccc-CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 21 111111110000 00000 0001112246889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=322.12 Aligned_cols=255 Identities=26% Similarity=0.442 Sum_probs=205.7
Q ss_pred HhcCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 623 VTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
..++|...+.||+|+||.||+|.+.++..+|+|.++.. ....+.+.+|++++++++|+||+++++++.+ ...++||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 79 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence 34678899999999999999999888888999988643 3345678999999999999999999999887 7789999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++|+|.+++... ....+++.+++.++.|++.||+||| +.+++||||||+||+++.++.+||+|||.+....
T Consensus 80 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 153 (260)
T cd05073 80 EFMAKGSLLDFLKSD---EGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIE 153 (260)
T ss_pred EeCCCCcHHHHHHhC---CccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeecc
Confidence 999999999999652 2345789999999999999999999 7899999999999999999999999999998654
Q ss_pred CCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhc
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (973)
...........++..|+|||++....++.++|||||||++|||++ |+.||......+. ..++. . ..
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~~~~---~-------~~ 220 (260)
T cd05073 154 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV---IRALE---R-------GY 220 (260)
T ss_pred CCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH---HHHHh---C-------CC
Confidence 433222223346678999999998889999999999999999999 9999976543221 11110 0 00
Q ss_pred CccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHH
Q 041143 862 DPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSP 905 (973)
Q Consensus 862 ~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~ 905 (973)
... ........+.+++.+|++.+|++||++.++.+.|+.
T Consensus 221 --~~~---~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 221 --RMP---RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred --CCC---CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 000 011223458899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=332.92 Aligned_cols=243 Identities=28% Similarity=0.407 Sum_probs=192.5
Q ss_pred CcccccCccEEEEEEEC-CCCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeEEEEEEecCC
Q 041143 631 NELGRGGFGTVYKGELE-DGTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGNERLLVYEYMPH 707 (973)
Q Consensus 631 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 707 (973)
+.||+|+||.||+|+.. +++.||||+++.... .....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999875 578999999875421 122345567788888764 899999999999999999999999999
Q ss_pred CCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCcc
Q 041143 708 GALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKS 787 (973)
Q Consensus 708 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~~ 787 (973)
|+|.+++.. ...+++.++..++.|+++||+||| +++|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 151 (316)
T cd05619 81 GDLMFHIQS-----CHKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA- 151 (316)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-
Confidence 999998864 245789999999999999999999 88999999999999999999999999999875322221
Q ss_pred eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccC
Q 041143 788 VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEV 867 (973)
Q Consensus 788 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 867 (973)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. .. .+.. ..+.+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~---~~---~i~~--------~~~~~~- 216 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL---FQ---SIRM--------DNPCYP- 216 (316)
T ss_pred ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHH---HH---HHHh--------CCCCCC-
Confidence 23345799999999999988999999999999999999999999986543221 11 1110 011111
Q ss_pred CcccHHHHHHHHHHHHHhhccCCCCCCCHh-HHHH
Q 041143 868 NEETFESISIVAELAGHCTAREPYHRPDMG-HVVN 901 (973)
Q Consensus 868 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~-~v~~ 901 (973)
......+.+++.+|++.||++||++. ++.+
T Consensus 217 ----~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 217 ----RWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred ----ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 01123467999999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=322.71 Aligned_cols=253 Identities=32% Similarity=0.504 Sum_probs=197.4
Q ss_pred CcccccCccEEEEEEECC-CC--EEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeEEEEEEecC
Q 041143 631 NELGRGGFGTVYKGELED-GT--KIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGNERLLVYEYMP 706 (973)
Q Consensus 631 ~~lG~G~fg~Vy~~~~~~-g~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~ 706 (973)
+.||+|+||.||+|.+.+ +. .+|+|.++.. ......+.+.+|++++.++ +||||+++++++...+..++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 468999999999998754 43 4688887643 2344556789999999999 79999999999999999999999999
Q ss_pred CCCHHHHHHhhhhc-----------cCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeec
Q 041143 707 HGALSRHLFRWEKL-----------QLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDF 775 (973)
Q Consensus 707 ~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 775 (973)
+|+|.++++..... ....+++.++..++.|++.||+||| +++++||||||+||++++++.+||+||
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCC
Confidence 99999999763311 1235789999999999999999999 789999999999999999999999999
Q ss_pred cccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhch
Q 041143 776 GLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSK 854 (973)
Q Consensus 776 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 854 (973)
|+++...... .......+..|+|||++....++.++|||||||++|||++ |+.||......+. ...+..
T Consensus 157 gl~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~------~~~~~~-- 226 (270)
T cd05047 157 GLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL------YEKLPQ-- 226 (270)
T ss_pred CCccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHH------HHHHhC--
Confidence 9986322111 1111234667999999988889999999999999999997 9999976442211 111110
Q ss_pred hHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhh
Q 041143 855 EKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLV 907 (973)
Q Consensus 855 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~ 907 (973)
.. ... ........+.+++.+|++.+|.+||++.++++.|+++.
T Consensus 227 -----~~--~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 227 -----GY--RLE---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred -----CC--CCC---CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 00 000 01112245789999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=319.56 Aligned_cols=248 Identities=25% Similarity=0.401 Sum_probs=195.7
Q ss_pred cccccCccEEEEEEEC---CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEecCCC
Q 041143 632 ELGRGGFGTVYKGELE---DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHG 708 (973)
Q Consensus 632 ~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 708 (973)
.||+|+||.||+|.+. .+..||+|++... ......+.+.+|+.++++++|+||+++++++. .+..++||||+++|
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE-NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccc-cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCC
Confidence 3899999999999764 3557999998654 23445567999999999999999999999885 45789999999999
Q ss_pred CHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCcce
Q 041143 709 ALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSV 788 (973)
Q Consensus 709 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 788 (973)
+|.+++... ...+++.++++++.|+++||+||| +++++||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 152 (257)
T cd05115 80 PLNKFLSGK----KDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY 152 (257)
T ss_pred CHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence 999998641 246899999999999999999999 7899999999999999999999999999998554332221
Q ss_pred e--cccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccc
Q 041143 789 V--TRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPAL 865 (973)
Q Consensus 789 ~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 865 (973)
. ....++..|+|||++....++.++|||||||++|||++ |+.||......+. ... +... ..+..
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~---~~~~-------~~~~~ 219 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV---MSF---IEQG-------KRLDC 219 (257)
T ss_pred eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH---HHH---HHCC-------CCCCC
Confidence 1 11234578999999988889999999999999999996 9999976653221 111 1110 00011
Q ss_pred cCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHh
Q 041143 866 EVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPL 906 (973)
Q Consensus 866 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~ 906 (973)
+......+.+++.+|+..+|++||++.+|.+.|+.+
T Consensus 220 -----~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 220 -----PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred -----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 111234577899999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=334.88 Aligned_cols=243 Identities=24% Similarity=0.324 Sum_probs=194.9
Q ss_pred CccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeEEEEE
Q 041143 626 NFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 702 (973)
+|...+.||+|+||.||+|+.. +++.||||+++.... .....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999775 578999999875421 223345677788888877 5899999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++|+|..++.. ...+++.++..++.||+.||+||| +++|+||||||+|||+++++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~ 152 (323)
T cd05616 81 EYVNGGDLMYQIQQ-----VGRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENM 152 (323)
T ss_pred cCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence 99999999988864 245889999999999999999999 8899999999999999999999999999997543
Q ss_pred CCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcC
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (973)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. . ..+..
T Consensus 153 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~---~---~~i~~---------- 215 (323)
T cd05616 153 WDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL---F---QSIME---------- 215 (323)
T ss_pred CCC-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH---H---HHHHh----------
Confidence 221 123446799999999999999999999999999999999999999987653221 1 11111
Q ss_pred ccccCCcccHHHHHHHHHHHHHhhccCCCCCCCH
Q 041143 863 PALEVNEETFESISIVAELAGHCTAREPYHRPDM 896 (973)
Q Consensus 863 ~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~ 896 (973)
...... ......+.+++.+|++.||++|++.
T Consensus 216 ~~~~~p---~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 216 HNVAYP---KSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCCCC---CcCCHHHHHHHHHHcccCHHhcCCC
Confidence 111100 1122457799999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=322.24 Aligned_cols=255 Identities=27% Similarity=0.377 Sum_probs=191.0
Q ss_pred CcccccCccEEEEEEECC---CCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEecCC
Q 041143 631 NELGRGGFGTVYKGELED---GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPH 707 (973)
Q Consensus 631 ~~lG~G~fg~Vy~~~~~~---g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 707 (973)
+.||+|+||.||+|...+ ...+|+|.+... ........|.+|+++++.++|+||+++++++......++||||+++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCcc-CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 358999999999997543 356888877543 2344556789999999999999999999999999999999999999
Q ss_pred CCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCc-
Q 041143 708 GALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEK- 786 (973)
Q Consensus 708 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~- 786 (973)
|+|.+++...........++.....++.||+.||+||| +++|+||||||+||++++++.+||+|||+++.......
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence 99999997744333344578888999999999999999 88999999999999999999999999999875332211
Q ss_pred ceecccccccCccccccccc-------CcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHH
Q 041143 787 SVVTRLAGTFGYLAPEYAVM-------GKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFK 858 (973)
Q Consensus 787 ~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (973)
.......++..|+|||++.. ..++.++|||||||++|||++ |..||......+. +. .... . ...
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~~----~~~~-~-~~~ 228 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV--LK----QVVR-E-QDI 228 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH--HH----HHhh-c-cCc
Confidence 11223356778999998743 356789999999999999999 7888876543221 11 0000 0 000
Q ss_pred hhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHH
Q 041143 859 AAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVL 903 (973)
Q Consensus 859 ~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L 903 (973)
...++.+. ......+.+++..|+ .||++||++++|++.|
T Consensus 229 ~~~~~~~~-----~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 229 KLPKPQLD-----LKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred cCCCCccc-----ccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 11111111 112234567788888 5999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=324.19 Aligned_cols=247 Identities=24% Similarity=0.359 Sum_probs=194.4
Q ss_pred ccccCccEEEEEEEC-CCCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEecCCCCH
Q 041143 633 LGRGGFGTVYKGELE-DGTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGAL 710 (973)
Q Consensus 633 lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 710 (973)
||+|+||.||+++.+ +|+.||+|++..... .......+..|++++++++||||+++++++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999765 589999999864321 122234566799999999999999999999999999999999999999
Q ss_pred HHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCcceec
Q 041143 711 SRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVT 790 (973)
Q Consensus 711 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 790 (973)
.+++... ....+++..+..++.||+.||+||| +.+|+||||||+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~ 152 (277)
T cd05607 81 KYHIYNV---GERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TIT 152 (277)
T ss_pred HHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eee
Confidence 9888652 2245899999999999999999999 8899999999999999999999999999988654432 223
Q ss_pred ccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccCCcc
Q 041143 791 RLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEE 870 (973)
Q Consensus 791 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 870 (973)
...|+..|+|||++.+..++.++||||+||++|||++|+.||........ ....... .+.......
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~----------~~~~~~~~~-- 218 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRR----------TLEDEVKFE-- 218 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHH----------hhccccccc--
Confidence 45789999999999988899999999999999999999999975432111 0111111 111111100
Q ss_pred cHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 871 TFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 871 ~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
.......+.+++.+|++.||++||+++|+++
T Consensus 219 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 219 HQNFTEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred cccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence 0012234789999999999999999988764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=322.60 Aligned_cols=256 Identities=30% Similarity=0.486 Sum_probs=207.0
Q ss_pred HhcCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 623 VTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
..++|.+.+.||+|+||.||+|..+++..||||.+..... ..+++.+|+.++++++|+||+++++++......++||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM---SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc---CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 3468889999999999999999988888999999875422 2457889999999999999999999999988999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++++|.+++... ....+++.++..++.|++.|++||| +.+++|+||||+||++++++.+||+|||+++...
T Consensus 81 e~~~~~~L~~~i~~~---~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 154 (261)
T cd05034 81 EYMSKGSLLDFLKSG---EGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIE 154 (261)
T ss_pred eccCCCCHHHHHhcc---ccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceecc
Confidence 999999999999652 2246899999999999999999999 8899999999999999999999999999998654
Q ss_pred CCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhc
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (973)
...........++..|+|||.+.+..++.++|||||||++|||++ |+.||........ .. .+.. ..
T Consensus 155 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~~---~~~~-------~~ 221 (261)
T cd05034 155 DDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREV---LE---QVER-------GY 221 (261)
T ss_pred chhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH---HHHc-------CC
Confidence 322222222345678999999998899999999999999999999 9999976543211 11 1110 00
Q ss_pred CccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHH
Q 041143 862 DPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSP 905 (973)
Q Consensus 862 ~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~ 905 (973)
.... .......+.+++.+|++.+|++||+++++++.|+.
T Consensus 222 ~~~~-----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 222 RMPR-----PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCC-----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0000 01113457899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=339.37 Aligned_cols=259 Identities=21% Similarity=0.264 Sum_probs=200.8
Q ss_pred HHHHHhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecC-CCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC
Q 041143 619 VLRKVTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAG-VTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGN 696 (973)
Q Consensus 619 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 696 (973)
..+...++|+..+.||+|+||.||+|+.. +++.||+|++... .......+.+.+|+.+++.++||||+++++++.+++
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 34455689999999999999999999875 5789999998642 122333456889999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecc
Q 041143 697 ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFG 776 (973)
Q Consensus 697 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG 776 (973)
..++||||+++|+|.+++.. ..++...+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCC
Confidence 99999999999999998854 34778888899999999999999 8899999999999999999999999999
Q ss_pred ccccCCCCCcceecccccccCcccccccccC----cCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhh
Q 041143 777 LVKLAPDGEKSVVTRLAGTFGYLAPEYAVMG----KITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKS 852 (973)
Q Consensus 777 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 852 (973)
+++..............||+.|+|||++... .++.++|||||||++|||++|+.||........ +..+..
T Consensus 188 ~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------~~~i~~ 261 (371)
T cd05622 188 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT------YSKIMN 261 (371)
T ss_pred ceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH------HHHHHc
Confidence 9986544333233456799999999998653 378999999999999999999999986553211 111111
Q ss_pred chhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCC--CCCHhHHHH
Q 041143 853 SKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYH--RPDMGHVVN 901 (973)
Q Consensus 853 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~--RPs~~~v~~ 901 (973)
... .+... ........+.+++..|+..++.+ ||++.||++
T Consensus 262 ~~~--------~~~~~-~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~ 303 (371)
T cd05622 262 HKN--------SLTFP-DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 303 (371)
T ss_pred CCC--------cccCC-CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhc
Confidence 000 01100 01112344678999999844433 678888887
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=333.52 Aligned_cols=242 Identities=27% Similarity=0.393 Sum_probs=192.0
Q ss_pred CcccccCccEEEEEEEC-CCCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeEEEEEEecCC
Q 041143 631 NELGRGGFGTVYKGELE-DGTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGNERLLVYEYMPH 707 (973)
Q Consensus 631 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 707 (973)
+.||+|+||.||+|+.. +|+.||+|+++.... .....+.+..|.+++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999875 588999999875421 122345567788888764 899999999999999999999999999
Q ss_pred CCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCcc
Q 041143 708 GALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKS 787 (973)
Q Consensus 708 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~~ 787 (973)
|+|..++.. ...+++.++..++.|+++||+||| +++|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 g~L~~~i~~-----~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 151 (316)
T cd05620 81 GDLMFHIQD-----KGRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-N 151 (316)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-C
Confidence 999988864 245789999999999999999999 8899999999999999999999999999987432221 1
Q ss_pred eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccC
Q 041143 788 VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEV 867 (973)
Q Consensus 788 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 867 (973)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ...+... .+.+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~------~~~~~~~--------~~~~~- 216 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL------FESIRVD--------TPHYP- 216 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH------HHHHHhC--------CCCCC-
Confidence 23456799999999999999999999999999999999999999976543211 1111110 11111
Q ss_pred CcccHHHHHHHHHHHHHhhccCCCCCCCHh-HHH
Q 041143 868 NEETFESISIVAELAGHCTAREPYHRPDMG-HVV 900 (973)
Q Consensus 868 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~-~v~ 900 (973)
......+.+++.+|++.||++||++. ++.
T Consensus 217 ----~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 217 ----RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred ----CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 01123467899999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=334.10 Aligned_cols=275 Identities=22% Similarity=0.340 Sum_probs=206.0
Q ss_pred HHhcCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeC-----
Q 041143 622 KVTQNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEG----- 695 (973)
Q Consensus 622 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 695 (973)
.+.++|...+.||+|+||.||+|.. .+++.||||++..........+.+.+|++++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 4567899999999999999999976 4678999999875433344456788999999999999999999987643
Q ss_pred -CeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEee
Q 041143 696 -NERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSD 774 (973)
Q Consensus 696 -~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D 774 (973)
...+++||++ +++|.+++.. ..+++..+..++.||+.||+||| +++|+||||||+||++++++.+||+|
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~D 161 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC------QKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILD 161 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcC
Confidence 3568999988 8899877743 45899999999999999999999 88999999999999999999999999
Q ss_pred ccccccCCCCCcceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhc
Q 041143 775 FGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSS 853 (973)
Q Consensus 775 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 853 (973)
||+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+. +..+.......
T Consensus 162 fg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~ 235 (343)
T cd07878 162 FGLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ--LKRIMEVVGTP 235 (343)
T ss_pred CccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCC
Confidence 9999865432 234578999999999876 5689999999999999999999999976543221 11111000000
Q ss_pred h---------hHHHhhcCccccCCcccH-----HHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCCCC
Q 041143 854 K---------EKFKAAIDPALEVNEETF-----ESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPIT 914 (973)
Q Consensus 854 ~---------~~~~~~~~~~l~~~~~~~-----~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~~~ 914 (973)
. ......+...-....... .....+.+++.+|++.||.+|||+.|+++ ++++..+..+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~--hp~~~~~~~~~ 308 (343)
T cd07878 236 SPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA--HPYFSQYHDPE 308 (343)
T ss_pred CHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc--CcchhccCCCc
Confidence 0 000000000000000000 01124679999999999999999999998 77776655443
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=335.53 Aligned_cols=264 Identities=27% Similarity=0.413 Sum_probs=204.2
Q ss_pred hcCccccCcccccCccEEEEEEE------CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeC-
Q 041143 624 TQNFAQENELGRGGFGTVYKGEL------EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEG- 695 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~- 695 (973)
.++|...+.||+|+||.||+|.+ .+++.||||+++... .....+.+.+|+.++.++ +|+||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 35788999999999999999963 347889999997542 334456788999999999 689999999988764
Q ss_pred CeEEEEEEecCCCCHHHHHHhhhhc-------------------------------------------------------
Q 041143 696 NERLLVYEYMPHGALSRHLFRWEKL------------------------------------------------------- 720 (973)
Q Consensus 696 ~~~~lV~e~~~~g~L~~~l~~~~~~------------------------------------------------------- 720 (973)
...++||||+++|+|.++++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 4678999999999999998753210
Q ss_pred -------cCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCc-ceeccc
Q 041143 721 -------QLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEK-SVVTRL 792 (973)
Q Consensus 721 -------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~-~~~~~~ 792 (973)
....++|.++..++.||++||+||| +++|+||||||+||++++++++||+|||+++....... ......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 0134788999999999999999999 88999999999999999999999999999985433221 112223
Q ss_pred ccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccCCccc
Q 041143 793 AGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEET 871 (973)
Q Consensus 793 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 871 (973)
.++..|+|||++.+..++.++|||||||++|||++ |..||........ .. ..... . ...... .
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~---~~~~~-~------~~~~~~--~-- 305 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FC---RRLKE-G------TRMRAP--D-- 305 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--HH---HHHhc-c------CCCCCC--C--
Confidence 46678999999988899999999999999999997 9999875432211 00 00100 0 000000 0
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 872 FESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 872 ~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
.....+.+++..|++.+|++||++.||++.|+.+.+
T Consensus 306 -~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 306 -YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred -CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 012347899999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=325.78 Aligned_cols=271 Identities=26% Similarity=0.407 Sum_probs=201.6
Q ss_pred cCccccCcccccCccEEEEEEE-----CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEe--CCe
Q 041143 625 QNFAQENELGRGGFGTVYKGEL-----EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIE--GNE 697 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~ 697 (973)
++|...+.||+|+||.||+|.. .+++.||+|+++.. .....+.+.+|++++++++||||+++++++.. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 4678889999999999999974 25789999998754 45556789999999999999999999998764 346
Q ss_pred EEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccc
Q 041143 698 RLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL 777 (973)
Q Consensus 698 ~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGl 777 (973)
.++||||+++|+|.+++... ...++|..+..++.|++.||+||| +++|+||||||+||++++++.+||+|||+
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~ 154 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKH----RERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGL 154 (284)
T ss_pred eEEEEEecCCCCHHHHHHhc----CcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcc
Confidence 78999999999999998652 235899999999999999999999 88999999999999999999999999999
Q ss_pred cccCCCCCcce--ecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchh
Q 041143 778 VKLAPDGEKSV--VTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKE 855 (973)
Q Consensus 778 a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 855 (973)
++......... .....++..|+|||++.+..++.++|||||||++|||++|..++................. .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 233 (284)
T cd05081 155 TKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQG-QMIVY 233 (284)
T ss_pred cccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhccccccc-ccchH
Confidence 98654432211 1122344569999999888999999999999999999999877643321100000000000 00000
Q ss_pred HHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHh
Q 041143 856 KFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPL 906 (973)
Q Consensus 856 ~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~ 906 (973)
.+.+.+..... ..........+.+++.+|++.+|++||||.||++.|+.+
T Consensus 234 ~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 234 HLIELLKNNGR-LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHHhcCCc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 01111111100 001112234588999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=325.76 Aligned_cols=259 Identities=29% Similarity=0.436 Sum_probs=206.2
Q ss_pred hcCccccCcccccCccEEEEEEECC------CCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCe
Q 041143 624 TQNFAQENELGRGGFGTVYKGELED------GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNE 697 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 697 (973)
.++|...+.||+|+||.||+|...+ +..||+|.+.... .......+.+|+.+++.++|+||+++++++.....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 4678889999999999999997642 3689999986542 33445678899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhhhhc-----cCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEE
Q 041143 698 RLLVYEYMPHGALSRHLFRWEKL-----QLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKV 772 (973)
Q Consensus 698 ~~lV~e~~~~g~L~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl 772 (973)
.++||||+++|+|.+++...... ....++|..++.++.|++.||.||| +.+|+||||||+||++++++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEE
Confidence 99999999999999999763321 1235789999999999999999999 889999999999999999999999
Q ss_pred eeccccccCCCCCc-ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHH
Q 041143 773 SDFGLVKLAPDGEK-SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRI 850 (973)
Q Consensus 773 ~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 850 (973)
+|||+++....... .......++..|+|||.+....++.++|||||||++|||++ |+.||......+. ..+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---~~~~~-- 235 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV---LKFVI-- 235 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH---HHHHh--
Confidence 99999885433221 12233457889999999988889999999999999999998 9999976543321 11111
Q ss_pred hhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHH
Q 041143 851 KSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLS 904 (973)
Q Consensus 851 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~ 904 (973)
. . ..+... ......+.+++.+|++.+|++|||+.++++.|+
T Consensus 236 -~-~------~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 236 -D-G------GHLDLP-----ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -c-C------CCCCCC-----CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 0 0 000111 112356889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=322.04 Aligned_cols=254 Identities=31% Similarity=0.512 Sum_probs=203.3
Q ss_pred ccccCcccccCccEEEEEEECC-CCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEec
Q 041143 627 FAQENELGRGGFGTVYKGELED-GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYM 705 (973)
Q Consensus 627 ~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 705 (973)
|+..+.||+|+||+||+++... ++.+|+|++..............+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 5677899999999999998764 568999999876433344444567999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCC
Q 041143 706 PHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGE 785 (973)
Q Consensus 706 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~ 785 (973)
++++|.+++.. ...+++.++..++.|+++||+||| +.+|+|+||||+||++++++.++|+|||.+.... ..
T Consensus 81 ~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~ 151 (260)
T PF00069_consen 81 PGGSLQDYLQK-----NKPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS-EN 151 (260)
T ss_dssp TTEBHHHHHHH-----HSSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEEST-ST
T ss_pred ccccccccccc-----cccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc-cc
Confidence 99999999972 256899999999999999999999 7899999999999999999999999999997542 22
Q ss_pred cceecccccccCcccccccc-cCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCcc
Q 041143 786 KSVVTRLAGTFGYLAPEYAV-MGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPA 864 (973)
Q Consensus 786 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 864 (973)
........++..|+|||++. +..++.++||||+|+++|+|++|..||......+...... ..... ........
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~---~~~~~--~~~~~~~~- 225 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIE---KILKR--PLPSSSQQ- 225 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHH---HHHHT--HHHHHTTS-
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhh---hcccc--cccccccc-
Confidence 23445567899999999998 8889999999999999999999999998763322222111 11110 00000000
Q ss_pred ccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 865 LEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 865 l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
.......+.+++.+|++.||++||++.++++
T Consensus 226 ------~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 226 ------SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp ------HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ------cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0001156889999999999999999999986
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=326.37 Aligned_cols=259 Identities=29% Similarity=0.480 Sum_probs=204.5
Q ss_pred hcCccccCcccccCccEEEEEEEC------CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCe
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE------DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNE 697 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 697 (973)
.++|+..+.||+|+||.||+|... ++..||+|+++.. ......+++.+|+.++++++||||+++++++..++.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCC-cCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 367889999999999999999763 4678999998754 234455779999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhhhh-----------------ccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCC
Q 041143 698 RLLVYEYMPHGALSRHLFRWEK-----------------LQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSS 760 (973)
Q Consensus 698 ~~lV~e~~~~g~L~~~l~~~~~-----------------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~ 760 (973)
.++||||+++|+|.+++..... .....+++.+++.++.|++.||+||| .++++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHh
Confidence 9999999999999999975321 11134788999999999999999999 889999999999
Q ss_pred cEEECCCCCEEEeeccccccCCCCCc-ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChh
Q 041143 761 NILLDDDYRAKVSDFGLVKLAPDGEK-SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPE 838 (973)
Q Consensus 761 Nill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~ 838 (973)
||++++++.+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999875432211 11222345678999999998899999999999999999998 88888755432
Q ss_pred hHHHHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHH
Q 041143 839 ESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLS 904 (973)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~ 904 (973)
+. ...+.. .... .........+.+++.+|++.||++||++.|+++.|+
T Consensus 240 ~~------~~~~~~----------~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 240 EV------IYYVRD----------GNVL--SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred HH------HHHHhc----------CCCC--CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 21 111111 1100 000112345889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=332.84 Aligned_cols=239 Identities=28% Similarity=0.367 Sum_probs=188.4
Q ss_pred CcccccCccEEEEEEEC-CCCEEEEEEeecCCC-ChHHHHHHHHHHH-HHHhcCCCceeeeeeEEEeCCeEEEEEEecCC
Q 041143 631 NELGRGGFGTVYKGELE-DGTKIAVKRMEAGVT-TTKALDEFQSEIA-VLSKVRHRHLVSLLGYSIEGNERLLVYEYMPH 707 (973)
Q Consensus 631 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 707 (973)
++||+|+||.||+|+.. +|+.||+|++..... .......+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 588999999864311 2223344555654 57889999999999999999999999999999
Q ss_pred CCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCcc
Q 041143 708 GALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKS 787 (973)
Q Consensus 708 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~~ 787 (973)
|+|..++.. ...+++.++..++.||++||+||| +.+|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~ 151 (321)
T cd05603 81 GELFFHLQR-----ERCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-E 151 (321)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-C
Confidence 999888754 245788889999999999999999 7899999999999999999999999999987532222 2
Q ss_pred eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccC
Q 041143 788 VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEV 867 (973)
Q Consensus 788 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 867 (973)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+. ...+..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------~~~i~----------~~~~~~ 215 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM------YDNIL----------HKPLQL 215 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH------HHHHh----------cCCCCC
Confidence 23446799999999999988999999999999999999999999986543211 11111 111111
Q ss_pred CcccHHHHHHHHHHHHHhhccCCCCCCCHh
Q 041143 868 NEETFESISIVAELAGHCTAREPYHRPDMG 897 (973)
Q Consensus 868 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ 897 (973)
.. .....+.+++.+|++.||.+||++.
T Consensus 216 ~~---~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 PG---GKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CC---CCCHHHHHHHHHHccCCHhhcCCCC
Confidence 11 1123577999999999999999865
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=325.16 Aligned_cols=257 Identities=30% Similarity=0.466 Sum_probs=203.5
Q ss_pred cCccccCcccccCccEEEEEEEC------CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE------DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNER 698 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 698 (973)
.+|...+.||+|+||.||++... ++..+|+|.++.. .....+.+.+|+++++.++|+||+++++++...+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 46777899999999999999642 3567899987653 455567899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhhh----------ccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCC
Q 041143 699 LLVYEYMPHGALSRHLFRWEK----------LQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDY 768 (973)
Q Consensus 699 ~lV~e~~~~g~L~~~l~~~~~----------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~ 768 (973)
++||||+++|+|.++++.... .....+++.+++.++.|++.|++||| +++|+||||||+||++++++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCC
Confidence 999999999999999975321 01135899999999999999999999 88999999999999999999
Q ss_pred CEEEeeccccccCCCCCc-ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHH
Q 041143 769 RAKVSDFGLVKLAPDGEK-SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEW 846 (973)
Q Consensus 769 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~ 846 (973)
.+||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||......+..
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~----- 234 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI----- 234 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH-----
Confidence 999999999875433221 11222345788999999998999999999999999999998 89998755432211
Q ss_pred HHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHH
Q 041143 847 FWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLS 904 (973)
Q Consensus 847 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~ 904 (973)
..... ..... ........+.+++.+|++.||.+||++.||.+.|+
T Consensus 235 -~~~~~-------~~~~~-----~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 235 -ECITQ-------GRELE-----RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred -HHHHc-------CccCC-----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 11110 00000 00112245779999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=326.45 Aligned_cols=265 Identities=26% Similarity=0.422 Sum_probs=203.3
Q ss_pred cCccccCcccccCccEEEEEEEC-----------------CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceee
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-----------------DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVS 687 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-----------------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 687 (973)
++|+..+.||+|+||.||++... ++..||+|+++.. ......+++.+|++++++++|+||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED-ANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 57889999999999999998543 2346899998754 23445678999999999999999999
Q ss_pred eeeEEEeCCeEEEEEEecCCCCHHHHHHhhhhc------cCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCc
Q 041143 688 LLGYSIEGNERLLVYEYMPHGALSRHLFRWEKL------QLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSN 761 (973)
Q Consensus 688 l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~N 761 (973)
+++++...+..++||||+++|+|.+++...... ....+++.++..++.|++.||+||| +.+|+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhe
Confidence 999999999999999999999999999763221 1235788999999999999999999 8899999999999
Q ss_pred EEECCCCCEEEeeccccccCCCCCcc-eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh--CCCCCCCCChh
Q 041143 762 ILLDDDYRAKVSDFGLVKLAPDGEKS-VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT--GLAALDEERPE 838 (973)
Q Consensus 762 ill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt--g~~p~~~~~~~ 838 (973)
|++++++.++|+|||+++........ ......++..|+|||+...+.++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 99999999999999999854332211 1222345678999999888899999999999999999998 67888655432
Q ss_pred hHHHHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHH
Q 041143 839 ESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLS 904 (973)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~ 904 (973)
+... .......... .....+. .......+.+++.+|++.||.+||++.+|++.|+
T Consensus 241 ~~~~---~~~~~~~~~~--~~~~~~~------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 QVIE---NTGEFFRDQG--RQVYLPK------PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHH---HHHHHHhhcc--ccccCCC------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 2111 0000000000 0000010 1112256789999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=332.95 Aligned_cols=243 Identities=26% Similarity=0.374 Sum_probs=195.0
Q ss_pred CcccccCccEEEEEEEC-CCCEEEEEEeecCC-CChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeEEEEEEecCC
Q 041143 631 NELGRGGFGTVYKGELE-DGTKIAVKRMEAGV-TTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGNERLLVYEYMPH 707 (973)
Q Consensus 631 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 707 (973)
+.||+|+||.||+|+.. +++.||||+++... ......+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 57899999987542 1233456678899999888 699999999999999999999999999
Q ss_pred CCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCcc
Q 041143 708 GALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKS 787 (973)
Q Consensus 708 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~~ 787 (973)
|+|..++.. ...+++.++..++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 151 (318)
T cd05570 81 GDLMFHIQR-----SGRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV- 151 (318)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-
Confidence 999988865 246899999999999999999999 88999999999999999999999999999874322211
Q ss_pred eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccC
Q 041143 788 VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEV 867 (973)
Q Consensus 788 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 867 (973)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+.. .....
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~------~~~i~~----------~~~~~ 215 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL------FQSILE----------DEVRY 215 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH------HHHHHc----------CCCCC
Confidence 22345799999999999999999999999999999999999999976543211 111111 01110
Q ss_pred CcccHHHHHHHHHHHHHhhccCCCCCCCH-----hHHHH
Q 041143 868 NEETFESISIVAELAGHCTAREPYHRPDM-----GHVVN 901 (973)
Q Consensus 868 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~-----~~v~~ 901 (973)
+......+.+++.+|++.||.+||++ .++++
T Consensus 216 ---~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 216 ---PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred ---CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 01112357799999999999999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=330.75 Aligned_cols=260 Identities=22% Similarity=0.315 Sum_probs=198.9
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecC-CCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAG-VTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
++|+..+.||+|+||.||+++.. +++.||+|++... .......+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888999999999999999865 5889999998642 122334556889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++|+|.+++.+. ...+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||++....
T Consensus 81 e~~~g~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 153 (331)
T cd05597 81 DYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLL 153 (331)
T ss_pred ecCCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecC
Confidence 999999999998642 245788999999999999999999 8899999999999999999999999999987654
Q ss_pred CCCcceecccccccCccccccccc-----CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHH
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVM-----GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKF 857 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (973)
...........||+.|+|||++.. ..++.++|||||||++|||++|+.||......+. ...+.....
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~------~~~i~~~~~-- 225 (331)
T cd05597 154 ADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHKE-- 225 (331)
T ss_pred CCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH------HHHHHcCCC--
Confidence 433322333569999999999863 4578899999999999999999999976543221 111111000
Q ss_pred HhhcCccccCCcccHHHHHHHHHHHHHhhcc--CCCCCCCHhHHHHHHHHhh
Q 041143 858 KAAIDPALEVNEETFESISIVAELAGHCTAR--EPYHRPDMGHVVNVLSPLV 907 (973)
Q Consensus 858 ~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~--dP~~RPs~~~v~~~L~~~~ 907 (973)
.+............+.+++.+|+.. ++..||++.++++ +++.
T Consensus 226 ------~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~--hp~~ 269 (331)
T cd05597 226 ------HFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKD--HPFF 269 (331)
T ss_pred ------cccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhc--CCCC
Confidence 0110111111223466777777654 3344889999888 5554
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=343.93 Aligned_cols=271 Identities=20% Similarity=0.336 Sum_probs=198.7
Q ss_pred HhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeC------
Q 041143 623 VTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEG------ 695 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 695 (973)
...+|...+.||+|+||.||+|... +++.||||++.... ....+|+.+++.++|||||++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 3467999999999999999999764 68899999885431 2245799999999999999999987532
Q ss_pred --CeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCC-CEEE
Q 041143 696 --NERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDY-RAKV 772 (973)
Q Consensus 696 --~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~-~~kl 772 (973)
...++||||++ ++|.+++..... ....+++..+..++.||+.||+||| +++|+||||||+|||++.++ .+||
T Consensus 138 ~~~~l~lvmE~~~-~~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL 212 (440)
T PTZ00036 138 KNIFLNVVMEFIP-QTVHKYMKHYAR-NNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKL 212 (440)
T ss_pred CceEEEEEEecCC-ccHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceee
Confidence 13568999996 578777765332 2356899999999999999999999 88999999999999999664 7999
Q ss_pred eeccccccCCCCCcceecccccccCcccccccccC-cCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHh
Q 041143 773 SDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMG-KITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIK 851 (973)
Q Consensus 773 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 851 (973)
+|||+|+....... .....||+.|+|||++.+. .++.++|||||||++|||++|++||.+....+. +...+....
T Consensus 213 ~DFGla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~--~~~i~~~~~ 288 (440)
T PTZ00036 213 CDFGSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ--LVRIIQVLG 288 (440)
T ss_pred eccccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhC
Confidence 99999986543322 2345789999999998754 689999999999999999999999987654322 111111110
Q ss_pred hchhHHHhhcCcccc---CCc---c------cHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhc
Q 041143 852 SSKEKFKAAIDPALE---VNE---E------TFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKW 910 (973)
Q Consensus 852 ~~~~~~~~~~~~~l~---~~~---~------~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~ 910 (973)
...........+.+. ... . +......+.+++.+||+.||.+||++.|+++ +++.+..
T Consensus 289 ~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~--hp~f~~~ 357 (440)
T PTZ00036 289 TPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA--DPFFDDL 357 (440)
T ss_pred CCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC--ChhHHhh
Confidence 000000000111100 000 0 0012246889999999999999999999997 6666543
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=332.02 Aligned_cols=192 Identities=26% Similarity=0.392 Sum_probs=165.2
Q ss_pred HhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEE
Q 041143 623 VTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLV 701 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 701 (973)
...+|...+.||+|+||.||+|+.. +++.||+|+.... ....|+.++++++|+||+++++++......++|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 3457999999999999999999875 4678999975432 235699999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccC
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA 781 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~ 781 (973)
|||+ .|+|.+++.. ....+++..+..|+.||+.||+||| .++|+||||||+|||++.++.+||+|||+++..
T Consensus 136 ~e~~-~~~l~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 207 (357)
T PHA03209 136 LPHY-SSDLYTYLTK----RSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFP 207 (357)
T ss_pred EEcc-CCcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCcccccc
Confidence 9999 5688888854 2356899999999999999999999 789999999999999999999999999999753
Q ss_pred CCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCC
Q 041143 782 PDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAAL 832 (973)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~ 832 (973)
.... ......||+.|+|||++.+..++.++|||||||++|||+++..++
T Consensus 208 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 208 VVAP--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccCc--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 3221 223457999999999999999999999999999999999976655
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=342.19 Aligned_cols=204 Identities=26% Similarity=0.384 Sum_probs=174.2
Q ss_pred CccccCcccccCccEEEEEEEC-CCCEEEEEEeecCC-CChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 626 NFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGV-TTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
.|...+.||+|+||.||+|+.. +++.||+|++.... ......+.+.+|++++++++|+|||++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999764 58899999986431 223445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+++|+|.+++.+. ..+++.....++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~ 153 (382)
T cd05625 82 YIPGGDMMSLLIRM-----GIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (382)
T ss_pred CCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCccccc
Confidence 99999999998652 45788888999999999999999 78999999999999999999999999999753210
Q ss_pred CC----------------------------------------------cceecccccccCcccccccccCcCCCchhHHh
Q 041143 784 GE----------------------------------------------KSVVTRLAGTFGYLAPEYAVMGKITTKADVFS 817 (973)
Q Consensus 784 ~~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S 817 (973)
.. .......+||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (382)
T cd05625 154 THDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 233 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEe
Confidence 00 00012357999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCh
Q 041143 818 YGVVLMELLTGLAALDEERP 837 (973)
Q Consensus 818 ~Gvvl~elltg~~p~~~~~~ 837 (973)
+||++|||++|+.||....+
T Consensus 234 lGvil~elltG~~Pf~~~~~ 253 (382)
T cd05625 234 VGVILYEMLVGQPPFLAQTP 253 (382)
T ss_pred chHHHHHHHhCCCCCCCCCH
Confidence 99999999999999987654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=318.88 Aligned_cols=252 Identities=26% Similarity=0.386 Sum_probs=202.0
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCC---hHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTT---TKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLL 700 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 700 (973)
++|...+.||+|+||.||+|... ++++||+|.+...... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57888999999999999999764 6899999998644222 2234578899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecccccc
Q 041143 701 VYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKL 780 (973)
Q Consensus 701 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~ 780 (973)
||||+++++|.+++.. ...+++..+..++.|++.||+||| +.+|+||||||+||++++++.++|+|||+++.
T Consensus 82 v~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~ 153 (263)
T cd06625 82 FMEYMPGGSVKDQLKA-----YGALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKR 153 (263)
T ss_pred EEEECCCCcHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeccccee
Confidence 9999999999998865 245788999999999999999999 88999999999999999999999999999875
Q ss_pred CCCCCccee--cccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHH
Q 041143 781 APDGEKSVV--TRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFK 858 (973)
Q Consensus 781 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (973)
......... ....|+..|+|||++.+..++.++||||+|+++|||++|+.||......... .......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~~~~~---- 223 (263)
T cd06625 154 LQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI------FKIATQP---- 223 (263)
T ss_pred ccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH------HHHhccC----
Confidence 433221111 3356889999999999988999999999999999999999999765332110 0000000
Q ss_pred hhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 859 AAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 859 ~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
..+.+ +......+.+++.+|++.+|.+||++.|+++
T Consensus 224 --~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 224 --TNPQL-----PSHVSPDARNFLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred --CCCCC-----CccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence 00111 1112245779999999999999999999987
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=318.34 Aligned_cols=249 Identities=32% Similarity=0.504 Sum_probs=204.2
Q ss_pred cCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEe
Q 041143 625 QNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEY 704 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 704 (973)
++|+..+.||+|+||.||+|... |+.||+|.++.... ..+++.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 57788899999999999999876 78999999976522 567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCC
Q 041143 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG 784 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~ 784 (973)
+++++|.+++.... ...+++..+..++.|++.||.||| .++++||||||+||+++.++.+||+|||.++.....
T Consensus 82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~ 155 (256)
T cd05039 82 MAKGSLVDYLRSRG---RAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG 155 (256)
T ss_pred cCCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccccccccccc
Confidence 99999999986522 236899999999999999999999 889999999999999999999999999999865332
Q ss_pred CcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCc
Q 041143 785 EKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDP 863 (973)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (973)
.. ...++..|+|||++....++.++||||||+++|||++ |+.||......+. ...+. .....
T Consensus 156 ~~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~~~----------~~~~~ 218 (256)
T cd05039 156 QD----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPHVE----------KGYRM 218 (256)
T ss_pred cc----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHH---HHHHh----------cCCCC
Confidence 21 2335678999999988899999999999999999997 9999976543221 11110 00000
Q ss_pred cccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHH
Q 041143 864 ALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSP 905 (973)
Q Consensus 864 ~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~ 905 (973)
.. .......+.+++.+|++.+|++||++.+++++|+.
T Consensus 219 ~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 219 EA-----PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CC-----ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 00 11123457899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=333.63 Aligned_cols=246 Identities=22% Similarity=0.342 Sum_probs=192.8
Q ss_pred CcccccCccEEEEEEEC-CCCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeEEEEEEecCC
Q 041143 631 NELGRGGFGTVYKGELE-DGTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGNERLLVYEYMPH 707 (973)
Q Consensus 631 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 707 (973)
+.||+|+||.||+|... +++.||+|+++.... .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999765 578999999975422 234456788999999988 699999999999999999999999999
Q ss_pred CCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCcc
Q 041143 708 GALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKS 787 (973)
Q Consensus 708 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~~ 787 (973)
|+|..++.. ...+++..+..++.||++||+||| +++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~ 151 (327)
T cd05617 81 GDLMFHMQR-----QRKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-D 151 (327)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-C
Confidence 999988854 246899999999999999999999 7899999999999999999999999999987532221 1
Q ss_pred eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccC
Q 041143 788 VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEV 867 (973)
Q Consensus 788 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 867 (973)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.............+..... .......
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~---------~~~~~~~ 222 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI---------LEKPIRI 222 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHH---------HhCCCCC
Confidence 2334679999999999999999999999999999999999999996433221111111111111 1111110
Q ss_pred CcccHHHHHHHHHHHHHhhccCCCCCCCHh
Q 041143 868 NEETFESISIVAELAGHCTAREPYHRPDMG 897 (973)
Q Consensus 868 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ 897 (973)
. ......+.+++.+|++.||++|+++.
T Consensus 223 p---~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 223 P---RFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred C---CCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 0 01123467999999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=328.28 Aligned_cols=264 Identities=27% Similarity=0.427 Sum_probs=207.5
Q ss_pred hcCccccCcccccCccEEEEEEEC--------CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEe
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE--------DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIE 694 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 694 (973)
.++|...+.||+|+||.||+|+.. ....+|+|.++... .......+..|+++++++ +||||+++++++..
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 357888999999999999999642 24568999887542 344567789999999999 69999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHHhhhh-----------ccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEE
Q 041143 695 GNERLLVYEYMPHGALSRHLFRWEK-----------LQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNIL 763 (973)
Q Consensus 695 ~~~~~lV~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nil 763 (973)
.+..++||||+++|+|.+++..... .....++|.++.+++.|++.||+||| +++|+||||||+||+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEE
Confidence 9999999999999999999976321 11245899999999999999999999 889999999999999
Q ss_pred ECCCCCEEEeeccccccCCCCCcc-eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHH
Q 041143 764 LDDDYRAKVSDFGLVKLAPDGEKS-VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESR 841 (973)
Q Consensus 764 l~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~ 841 (973)
+++++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |+.||......+.
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~- 245 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL- 245 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH-
Confidence 999999999999999865432211 1122234568999999998899999999999999999999 8899876543221
Q ss_pred HHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 842 YLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
.. .+.. . . ... ........+.+++.+|++.+|++||++.|+++.|.++...
T Consensus 246 --~~---~~~~-~------~--~~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 246 --FK---LLRE-G------H--RMD---KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred --HH---HHHc-C------C--CCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 11 1110 0 0 000 0111223577999999999999999999999999988664
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=321.61 Aligned_cols=256 Identities=27% Similarity=0.473 Sum_probs=203.2
Q ss_pred cCccccCcccccCccEEEEEEECC-C---CEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELED-G---TKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLL 700 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~-g---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 700 (973)
..|...+.||+|+||.||+|.... + ..||||.++.. .......+|..|+.++++++||||+++++++.++...++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 357788999999999999998653 3 36999998754 245556789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecccccc
Q 041143 701 VYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKL 780 (973)
Q Consensus 701 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~ 780 (973)
||||+++|+|.+++... ...+++.+++.++.|++.||+||| +++++||||||+||+++.++.+||+|||+++.
T Consensus 83 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~ 155 (269)
T cd05065 83 ITEFMENGALDSFLRQN----DGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 155 (269)
T ss_pred EEecCCCCcHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccc
Confidence 99999999999998652 245899999999999999999999 88999999999999999999999999999875
Q ss_pred CCCCCcce-ec-ccc--cccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchh
Q 041143 781 APDGEKSV-VT-RLA--GTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKE 855 (973)
Q Consensus 781 ~~~~~~~~-~~-~~~--gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 855 (973)
........ .. ... ++..|+|||++....++.++|||||||++|||++ |+.||......+ ...++.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~~i~------- 225 (269)
T cd05065 156 LEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VINAIE------- 225 (269)
T ss_pred cccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHHHHH-------
Confidence 44322111 11 111 2457999999998999999999999999999886 999997654322 111111
Q ss_pred HHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHh
Q 041143 856 KFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPL 906 (973)
Q Consensus 856 ~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~ 906 (973)
... ... ...+....+.+++.+|++.+|.+||++.+|+..|+.+
T Consensus 226 ---~~~--~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 226 ---QDY--RLP---PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ---cCC--cCC---CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000 000 0112234577999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=317.77 Aligned_cols=249 Identities=30% Similarity=0.443 Sum_probs=197.4
Q ss_pred CcccccCccEEEEEEECC----CCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEecC
Q 041143 631 NELGRGGFGTVYKGELED----GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMP 706 (973)
Q Consensus 631 ~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 706 (973)
+.||+|+||.||+|.+.. +..+|+|.+...... ...+++.+|++++++++|+|||++++++. .+..++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 469999999999996532 268999998765332 45678999999999999999999999876 456899999999
Q ss_pred CCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCc
Q 041143 707 HGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEK 786 (973)
Q Consensus 707 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~ 786 (973)
+|+|.+++... ..+++..+..++.|++.||+||| ..+++||||||+||+++.++.+||+|||+++.......
T Consensus 79 ~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~ 150 (257)
T cd05060 79 LGPLLKYLKKR-----REIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150 (257)
T ss_pred CCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence 99999999652 35899999999999999999999 78999999999999999999999999999985543332
Q ss_pred ceec--ccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCc
Q 041143 787 SVVT--RLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDP 863 (973)
Q Consensus 787 ~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (973)
.... ...++..|+|||.+....++.++|||||||++|||++ |+.||......+ +..++... . +
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~~~~~~----~-------~ 216 (257)
T cd05060 151 YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIAMLESG----E-------R 216 (257)
T ss_pred ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHHcC----C-------c
Confidence 2111 1224568999999998899999999999999999998 999997654322 22221110 0 0
Q ss_pred cccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhh
Q 041143 864 ALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLV 907 (973)
Q Consensus 864 ~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~ 907 (973)
.. ........+.+++.+|+..+|++||++.+|++.|+.+.
T Consensus 217 -~~---~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 217 -LP---RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred -CC---CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 00 01112245789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=333.80 Aligned_cols=244 Identities=26% Similarity=0.338 Sum_probs=190.0
Q ss_pred CcccccCccEEEEEEEC-CCCEEEEEEeecCCC-ChHHHHHHHHHHH-HHHhcCCCceeeeeeEEEeCCeEEEEEEecCC
Q 041143 631 NELGRGGFGTVYKGELE-DGTKIAVKRMEAGVT-TTKALDEFQSEIA-VLSKVRHRHLVSLLGYSIEGNERLLVYEYMPH 707 (973)
Q Consensus 631 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 707 (973)
+.||+|+||.||+|+.. +++.||+|++..... .......+..|.. +++.++|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999875 578899999864311 1222334444544 56788999999999999999999999999999
Q ss_pred CCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCcc
Q 041143 708 GALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKS 787 (973)
Q Consensus 708 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~~ 787 (973)
|+|.+++.. ...+.+.....++.||++||+||| +.+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~ 151 (325)
T cd05602 81 GELFYHLQR-----ERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-G 151 (325)
T ss_pred CcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-C
Confidence 999998865 245678888889999999999999 8899999999999999999999999999997533222 1
Q ss_pred eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccC
Q 041143 788 VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEV 867 (973)
Q Consensus 788 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 867 (973)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ...+..... .+.+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------~~~i~~~~~----~~~~~--- 218 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM------YDNILNKPL----QLKPN--- 218 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH------HHHHHhCCc----CCCCC---
Confidence 23446799999999999999999999999999999999999999986553221 111111000 01111
Q ss_pred CcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHH
Q 041143 868 NEETFESISIVAELAGHCTAREPYHRPDMGHVVNV 902 (973)
Q Consensus 868 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~ 902 (973)
....+.+++.+|++.||.+||++.+.+..
T Consensus 219 ------~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 219 ------ITNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred ------CCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 12346799999999999999998865543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=322.83 Aligned_cols=258 Identities=24% Similarity=0.377 Sum_probs=208.7
Q ss_pred cCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR-HRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e 703 (973)
..|++.+.||+||.+.||++...+.+.+|+|++.....+.+..+-|..|+..|.+++ |.+||++++|-..++..|||||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 457778999999999999999988889999988777678888899999999999995 9999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|= ..+|..+|.+... ....| .+..+..|++.++.++| .+||||.||||.|+|+-+ |.+||+|||+|.....
T Consensus 441 ~G-d~DL~kiL~k~~~---~~~~~-~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 441 CG-DIDLNKILKKKKS---IDPDW-FLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQP 511 (677)
T ss_pred cc-cccHHHHHHhccC---CCchH-HHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence 86 6799999976322 33445 67789999999999999 889999999999999975 5899999999996554
Q ss_pred CCc-ceecccccccCcccccccccCc-----------CCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHh
Q 041143 784 GEK-SVVTRLAGTFGYLAPEYAVMGK-----------ITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIK 851 (973)
Q Consensus 784 ~~~-~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 851 (973)
+.. -.....+||+.||+||.+.... .+.++||||+||+||+|+.|+.||.....
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-------------- 577 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-------------- 577 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH--------------
Confidence 433 3345578999999999886433 55789999999999999999999964321
Q ss_pred hchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 852 SSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 852 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
.-.++..+.||.-+.+.........++++++.||+.||.+||+..++++ +.+.+
T Consensus 578 -~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq--hpFl~ 631 (677)
T KOG0596|consen 578 -QIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ--HPFLQ 631 (677)
T ss_pred -HHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc--Ccccc
Confidence 1234566777744322222222233889999999999999999999998 44433
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=332.21 Aligned_cols=256 Identities=21% Similarity=0.297 Sum_probs=197.3
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecC-CCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAG-VTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
++|...+.||+|+||.||+++.+ +++.+|+|++... .........+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888999999999999999876 4778999998542 112233456888999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++|+|.+++.+. ...+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 81 ey~~~g~L~~~l~~~----~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~ 153 (332)
T cd05623 81 DYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM 153 (332)
T ss_pred eccCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecc
Confidence 999999999999652 245889999999999999999999 8899999999999999999999999999997544
Q ss_pred CCCcceecccccccCcccccccc-----cCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHH
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAV-----MGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKF 857 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (973)
...........||+.|+|||++. ...++.++|||||||++|||++|+.||......+. +..+......
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~------~~~i~~~~~~- 226 (332)
T cd05623 154 EDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHKER- 226 (332)
T ss_pred cCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH------HHHHhCCCcc-
Confidence 33333334467999999999986 34688999999999999999999999986543221 1122111100
Q ss_pred HhhcCccccCCcccHHHHHHHHHHHHHhhccCCC--CCCCHhHHHH
Q 041143 858 KAAIDPALEVNEETFESISIVAELAGHCTAREPY--HRPDMGHVVN 901 (973)
Q Consensus 858 ~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~--~RPs~~~v~~ 901 (973)
.............+.+++.+|+..++. .|+++.|+++
T Consensus 227 -------~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~ 265 (332)
T cd05623 227 -------FQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQ 265 (332)
T ss_pred -------ccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhC
Confidence 000111111224466788887755444 4788998887
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=333.35 Aligned_cols=243 Identities=26% Similarity=0.341 Sum_probs=191.3
Q ss_pred CcccccCccEEEEEEEC-CCCEEEEEEeecCCC-ChHHHHHHHHHHH-HHHhcCCCceeeeeeEEEeCCeEEEEEEecCC
Q 041143 631 NELGRGGFGTVYKGELE-DGTKIAVKRMEAGVT-TTKALDEFQSEIA-VLSKVRHRHLVSLLGYSIEGNERLLVYEYMPH 707 (973)
Q Consensus 631 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 707 (973)
+.||+|+||.||+|+.. +|+.||+|++..... .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999764 689999999864321 2233345566655 46778999999999999999999999999999
Q ss_pred CCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCcc
Q 041143 708 GALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKS 787 (973)
Q Consensus 708 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~~ 787 (973)
|+|..++.. ...+++.++..++.||++||+||| +.+|+||||||+|||+++++.+||+|||+++...... .
T Consensus 81 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~ 151 (325)
T cd05604 81 GELFFHLQR-----ERSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-D 151 (325)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-C
Confidence 999888854 246889999999999999999999 8899999999999999999999999999987532221 1
Q ss_pred eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccC
Q 041143 788 VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEV 867 (973)
Q Consensus 788 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 867 (973)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. +..+.. ..+..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~------~~~~~~----------~~~~~ 215 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM------YDNILH----------KPLVL 215 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH------HHHHHc----------CCccC
Confidence 23446799999999999999999999999999999999999999986543221 111111 11110
Q ss_pred CcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 868 NEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 868 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
.. .....+.+++.+|++.+|.+||++++.++
T Consensus 216 ~~---~~~~~~~~ll~~ll~~~p~~R~~~~~~~~ 246 (325)
T cd05604 216 RP---GASLTAWSILEELLEKDRQRRLGAKEDFL 246 (325)
T ss_pred CC---CCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence 01 11234678999999999999999875444
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=318.64 Aligned_cols=249 Identities=29% Similarity=0.482 Sum_probs=199.8
Q ss_pred CcccccCccEEEEEEECC--C--CEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEecC
Q 041143 631 NELGRGGFGTVYKGELED--G--TKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMP 706 (973)
Q Consensus 631 ~~lG~G~fg~Vy~~~~~~--g--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 706 (973)
+.||+|+||.||+|.+.+ + ..||||.+...... ...+.+.+|++++++++||||+++++++.+ ...++||||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 468999999999998643 3 36899998765333 567789999999999999999999999988 88999999999
Q ss_pred CCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCc
Q 041143 707 HGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEK 786 (973)
Q Consensus 707 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~ 786 (973)
+|+|.+++..... ..++|..+..++.|++.||+||| +++++||||||+||+++.++.+||+|||+++.......
T Consensus 79 ~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 79 LGSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred CCcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEecccccccccccccc
Confidence 9999999976321 46899999999999999999999 88999999999999999999999999999986544222
Q ss_pred c--eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCc
Q 041143 787 S--VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDP 863 (973)
Q Consensus 787 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (973)
. ......++..|+|||++.+..++.++|||||||++|||++ |+.||......+. .. .+.. ...
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~---~~~~--------~~~ 218 (257)
T cd05040 153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI---LK---KIDK--------EGE 218 (257)
T ss_pred ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH---HH---HHHh--------cCC
Confidence 1 1123457889999999998899999999999999999999 9999976554321 11 1100 000
Q ss_pred cccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHH
Q 041143 864 ALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLS 904 (973)
Q Consensus 864 ~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~ 904 (973)
... ........+.+++.+|++.+|++||++.+|++.|.
T Consensus 219 ~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 219 RLE---RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred cCC---CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 010 01112345889999999999999999999999775
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=330.85 Aligned_cols=263 Identities=28% Similarity=0.414 Sum_probs=207.5
Q ss_pred cCccccCcccccCccEEEEEEEC--------CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeC
Q 041143 625 QNFAQENELGRGGFGTVYKGELE--------DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEG 695 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 695 (973)
.+|.+.+.||+|+||.||+|+.. .+..||+|.++.. ......+++.+|+++++++ +||||++++++|...
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 46888999999999999999642 1236899988753 2344567899999999999 799999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhhhh-----------ccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEE
Q 041143 696 NERLLVYEYMPHGALSRHLFRWEK-----------LQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILL 764 (973)
Q Consensus 696 ~~~~lV~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill 764 (973)
+..++||||+++|+|.+++..... .....++|.+++.++.|+++||+||| +++|+||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEE
Confidence 999999999999999999975321 12345899999999999999999999 8899999999999999
Q ss_pred CCCCCEEEeeccccccCCCCCcc-eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHH
Q 041143 765 DDDYRAKVSDFGLVKLAPDGEKS-VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRY 842 (973)
Q Consensus 765 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~ 842 (973)
++++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||......+.
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-- 245 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL-- 245 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH--
Confidence 99999999999999855432211 1122334578999999999999999999999999999998 8888876543221
Q ss_pred HHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 843 LAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 843 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
...+... .... ........+.+++.+|++.+|++||++.|+++.|+++...
T Consensus 246 ----~~~~~~~-------~~~~-----~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 246 ----FKLLKEG-------HRMD-----KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred ----HHHHHcC-------CCCC-----CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 1111110 0000 0111234578999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=328.15 Aligned_cols=274 Identities=22% Similarity=0.321 Sum_probs=203.8
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
++|...+.||+|+||.||+|+.+ +++.||+|+++.... ......+.+|++++++++||||+++++++..++..++|||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 56888999999999999999875 578899999875422 2233457789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|++ ++|.+++... ...+++..+..++.||++||+||| +++|+||||||+||+++.++.+||+|||+++....
T Consensus 85 ~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 156 (309)
T cd07872 85 YLD-KDLKQYMDDC----GNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSV 156 (309)
T ss_pred CCC-CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCC
Confidence 996 4888887542 245788999999999999999999 88999999999999999999999999999975433
Q ss_pred CCcceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHH--------HHHhhch
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWF--------WRIKSSK 854 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~ 854 (973)
... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||......+........ +......
T Consensus 157 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07872 157 PTK-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSN 235 (309)
T ss_pred Ccc-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcch
Confidence 221 2233468999999998865 46889999999999999999999999876543322211110 0000000
Q ss_pred hHHHhhcCccccCC---cccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhc
Q 041143 855 EKFKAAIDPALEVN---EETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKW 910 (973)
Q Consensus 855 ~~~~~~~~~~l~~~---~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~ 910 (973)
......-.+..... .........+.+++.+|++.||++|||+.|+++ +++.+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~--h~~~~~~ 292 (309)
T cd07872 236 DEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK--HAYFRSL 292 (309)
T ss_pred hhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc--Chhhhhc
Confidence 00000000110000 000011234679999999999999999999998 6665543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=324.18 Aligned_cols=254 Identities=22% Similarity=0.399 Sum_probs=204.5
Q ss_pred cCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
.+|+..+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.+++.++|+||+++++++..+...++|||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC--cchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 5788889999999999999976 468899999987542 2334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+++++|.+++.. ..+++.++..++.|++.||+||| ..+|+||||||+||+++.++.+||+|||++.....
T Consensus 98 ~~~~~~L~~~~~~------~~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~ 168 (296)
T cd06654 98 YLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (296)
T ss_pred ccCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence 9999999998854 35789999999999999999999 88999999999999999999999999999875433
Q ss_pred CCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCc
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDP 863 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (973)
... ......|++.|+|||++.+..++.++|||||||++|||++|+.||....+.... ...... ..+
T Consensus 169 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~-----~~~~~~--------~~~ 234 (296)
T cd06654 169 EQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL-----YLIATN--------GTP 234 (296)
T ss_pred ccc-ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH-----HHHhcC--------CCC
Confidence 221 123356899999999998888999999999999999999999999765532211 000000 001
Q ss_pred cccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 864 ALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 864 ~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
.+. ........+.+++.+|+..+|++||++.+|++ .+++.
T Consensus 235 ~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~--~~~~~ 274 (296)
T cd06654 235 ELQ---NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ--HQFLK 274 (296)
T ss_pred CCC---CccccCHHHHHHHHHHCcCCcccCcCHHHHhh--Chhhh
Confidence 111 11122345779999999999999999999998 44444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=317.22 Aligned_cols=251 Identities=31% Similarity=0.498 Sum_probs=202.1
Q ss_pred cCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEe
Q 041143 625 QNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEY 704 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 704 (973)
.+|+..+.||+|+||.||+|.+.++..+|+|.++..... ..+|.+|++++++++||||+++++++......++||||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 357778999999999999998877889999988654322 34688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCC
Q 041143 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG 784 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~ 784 (973)
+++|+|.+++... ...+++..+..++.|++.|++||| +.+++||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 153 (256)
T cd05112 81 MEHGCLSDYLRAQ----RGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD 153 (256)
T ss_pred CCCCcHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccC
Confidence 9999999998642 235789999999999999999999 789999999999999999999999999998855433
Q ss_pred CcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCc
Q 041143 785 EKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDP 863 (973)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (973)
.........++.+|+|||++.++.++.++|||||||++|||++ |+.||......+. ...+... .....+
T Consensus 154 ~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~------~~~~~~~----~~~~~~ 223 (256)
T cd05112 154 QYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV------VETINAG----FRLYKP 223 (256)
T ss_pred cccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH------HHHHhCC----CCCCCC
Confidence 2222222345678999999998899999999999999999998 9999976543221 1111110 001111
Q ss_pred cccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHH
Q 041143 864 ALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVL 903 (973)
Q Consensus 864 ~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L 903 (973)
.. ....+.+++.+|++.+|++||++.+|++.|
T Consensus 224 ~~--------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 224 RL--------ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CC--------CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 11 124588999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=320.64 Aligned_cols=254 Identities=23% Similarity=0.374 Sum_probs=200.5
Q ss_pred hcCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
..+|+..+.||+|+||.||+|+. .+++.||+|++... .....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~--~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLE--PGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecC--ccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 35788999999999999999986 46889999998654 2233456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++|+|.++++. ...+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 86 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06646 86 EYCGGGSLQDIYHV-----TGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKIT 157 (267)
T ss_pred eCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeec
Confidence 99999999998864 245789999999999999999999 7899999999999999999999999999998553
Q ss_pred CCCcceecccccccCcccccccc---cCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHh
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAV---MGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKA 859 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (973)
.... ......|+..|+|||.+. ...++.++|||||||++|||++|+.||....+.+... . +. .. .
T Consensus 158 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~--~----~~--~~---~ 225 (267)
T cd06646 158 ATIA-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF--L----MS--KS---N 225 (267)
T ss_pred cccc-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe--e----ee--cC---C
Confidence 3211 123356889999999874 3457889999999999999999999986544321110 0 00 00 0
Q ss_pred hcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHH
Q 041143 860 AIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNV 902 (973)
Q Consensus 860 ~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~ 902 (973)
...+... ........+.+++.+|++.+|++||++++|++.
T Consensus 226 ~~~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 226 FQPPKLK---DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred CCCCCCc---cccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 0011111 011123467899999999999999999999873
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=317.34 Aligned_cols=248 Identities=30% Similarity=0.467 Sum_probs=199.2
Q ss_pred cCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEe-CCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIE-GNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~e 703 (973)
.+|...+.||+|+||.||+|... |..||+|.++.. ...+.+.+|+.++++++|+|++++++++.. +...++|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 46888899999999999999876 788999988643 234578899999999999999999998654 557899999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+++|+|.+++... ....+++..++.++.|++.||+||| .++|+||||||+||++++++.+||+|||+++....
T Consensus 81 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 81 YMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred CCCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccc
Confidence 99999999998652 2245889999999999999999999 88999999999999999999999999999885433
Q ss_pred CCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcC
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (973)
.. ....++..|+|||++....++.++|||||||++|||++ |+.||......+ +.. .+.. ...
T Consensus 155 ~~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~~~---~~~~-------~~~ 217 (256)
T cd05082 155 TQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVP---RVEK-------GYK 217 (256)
T ss_pred cC----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHH---HHhc-------CCC
Confidence 22 22345678999999988889999999999999999998 999987543221 111 1111 001
Q ss_pred ccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHH
Q 041143 863 PALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSP 905 (973)
Q Consensus 863 ~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~ 905 (973)
+.. .......+.+++.+|++.+|++||++.++++.|+.
T Consensus 218 ~~~-----~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 218 MDA-----PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCC-----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 111 11123457799999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=314.13 Aligned_cols=248 Identities=30% Similarity=0.492 Sum_probs=199.6
Q ss_pred CcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEecCCCCH
Q 041143 631 NELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGAL 710 (973)
Q Consensus 631 ~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 710 (973)
++||+|+||.||+|.+.+++.||+|+++.... ....+.+.+|++++++++|+||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLP-PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 46999999999999887799999999876533 24567899999999999999999999999999999999999999999
Q ss_pred HHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCccee-
Q 041143 711 SRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVV- 789 (973)
Q Consensus 711 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~~~~- 789 (973)
.+++... ...+++..++.++.+++.||+||| +++++||||||+||+++.++.+||+|||+++..........
T Consensus 80 ~~~l~~~----~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (251)
T cd05041 80 LTFLRKK----KNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD 152 (251)
T ss_pred HHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence 9998652 235789999999999999999999 88999999999999999999999999999985543221111
Q ss_pred cccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccCC
Q 041143 790 TRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVN 868 (973)
Q Consensus 790 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 868 (973)
....++..|+|||++.+..++.++|||||||++|||++ |..||.......... ... ... ...
T Consensus 153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~------~~~-------~~~--~~~-- 215 (251)
T cd05041 153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRE------RIE-------SGY--RMP-- 215 (251)
T ss_pred ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHH------HHh-------cCC--CCC--
Confidence 12234667999999988899999999999999999999 888887654322111 000 000 000
Q ss_pred cccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHH
Q 041143 869 EETFESISIVAELAGHCTAREPYHRPDMGHVVNVLS 904 (973)
Q Consensus 869 ~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~ 904 (973)
........+.+++.+|++.+|++||++.||++.|+
T Consensus 216 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 216 -APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred -CCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 01112346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=322.04 Aligned_cols=252 Identities=28% Similarity=0.408 Sum_probs=199.6
Q ss_pred ccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEe
Q 041143 627 FAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEY 704 (973)
Q Consensus 627 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 704 (973)
|+..+.||+|+||.||+|... +++.||||.+..... .....+.+..|+.++++++|++|+++++++.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667788999999999999765 688999999865422 223345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCC
Q 041143 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG 784 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~ 784 (973)
+++|+|.+++.... ...+++.++..++.|++.||+||| +++|+||||||+||++++++.++|+|||++......
T Consensus 82 ~~g~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 82 MNGGDLKFHIYHMG---EAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred cCCCcHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 99999999886522 245899999999999999999999 889999999999999999999999999998765433
Q ss_pred CcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCcc
Q 041143 785 EKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPA 864 (973)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 864 (973)
.. .....|+..|+|||++.+..++.++|||||||++|||++|+.||............. .... ........
T Consensus 156 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~---~~~~---~~~~~~~~- 226 (285)
T cd05630 156 QT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE---RLVK---EVQEEYSE- 226 (285)
T ss_pred cc--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHH---hhhh---hhhhhcCc-
Confidence 22 223479999999999999899999999999999999999999998653221111000 0000 00000111
Q ss_pred ccCCcccHHHHHHHHHHHHHhhccCCCCCCC-----HhHHHH
Q 041143 865 LEVNEETFESISIVAELAGHCTAREPYHRPD-----MGHVVN 901 (973)
Q Consensus 865 l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~~v~~ 901 (973)
.....+.+++.+|++.||++||+ +.|+++
T Consensus 227 --------~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 227 --------KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred --------cCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 11234679999999999999999 778876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=321.81 Aligned_cols=248 Identities=28% Similarity=0.391 Sum_probs=196.5
Q ss_pred ccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEe
Q 041143 627 FAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEY 704 (973)
Q Consensus 627 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 704 (973)
|+..+.||+|+||+||+|... +++.||+|.+..... .......+.+|++++++++|+||+++++++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 666788999999999999764 688999999865422 223345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCC
Q 041143 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG 784 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~ 784 (973)
+++|+|.+++... ....+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||++......
T Consensus 82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 82 MNGGDLKFHIYNM---GNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred ccCccHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 9999999888652 2246899999999999999999999 889999999999999999999999999998754432
Q ss_pred CcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCcc
Q 041143 785 EKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPA 864 (973)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 864 (973)
.. .....|+..|+|||++.+..++.++|+|||||++|||++|+.||.......... .+....... ...+.+
T Consensus 156 ~~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~--~~~~~~~~~----~~~~~~- 226 (285)
T cd05632 156 ES--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKRE--EVDRRVLET----EEVYSA- 226 (285)
T ss_pred Cc--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHhhhcc----ccccCc-
Confidence 21 234578999999999998899999999999999999999999998654322111 111111100 001111
Q ss_pred ccCCcccHHHHHHHHHHHHHhhccCCCCCCCHh
Q 041143 865 LEVNEETFESISIVAELAGHCTAREPYHRPDMG 897 (973)
Q Consensus 865 l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ 897 (973)
.....+.+++..|++.||++||++.
T Consensus 227 --------~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 227 --------KFSEEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred --------cCCHHHHHHHHHHccCCHhHcCCCc
Confidence 1123467999999999999999944
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=331.66 Aligned_cols=256 Identities=21% Similarity=0.279 Sum_probs=198.0
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecC-CCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAG-VTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
++|...+.||+|+||.||+++.. +++.||+|++... .........+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999875 5788999998642 112333456888999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++|+|.+++... ...+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 81 Ey~~gg~L~~~l~~~----~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 153 (331)
T cd05624 81 DYYVGGDLLTLLSKF----EDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMN 153 (331)
T ss_pred eCCCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeecc
Confidence 999999999999652 245788999999999999999999 8899999999999999999999999999998654
Q ss_pred CCCcceecccccccCccccccccc-----CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHH
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVM-----GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKF 857 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (973)
...........||+.|+|||++.+ +.++.++|||||||++|||++|+.||......+. ...+.....
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~------~~~i~~~~~-- 225 (331)
T cd05624 154 QDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHEE-- 225 (331)
T ss_pred CCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH------HHHHHcCCC--
Confidence 433333334579999999999875 5678899999999999999999999976543221 111111000
Q ss_pred HhhcCccccCCcccHHHHHHHHHHHHHhhccCCCC--CCCHhHHHH
Q 041143 858 KAAIDPALEVNEETFESISIVAELAGHCTAREPYH--RPDMGHVVN 901 (973)
Q Consensus 858 ~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~--RPs~~~v~~ 901 (973)
.+............+.+++.+|+..++++ |++++++++
T Consensus 226 ------~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 226 ------RFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred ------cccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 01101111112345778888888865544 457777776
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=316.74 Aligned_cols=239 Identities=24% Similarity=0.393 Sum_probs=188.0
Q ss_pred CcccccCccEEEEEEECC-------------CCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCe
Q 041143 631 NELGRGGFGTVYKGELED-------------GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNE 697 (973)
Q Consensus 631 ~~lG~G~fg~Vy~~~~~~-------------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 697 (973)
+.||+|+||.||+|...+ ..+||+|.+... .......|.+|+.+++.++||||+++++++.....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 468999999999997532 235888887543 33445678899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCC-------E
Q 041143 698 RLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYR-------A 770 (973)
Q Consensus 698 ~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~-------~ 770 (973)
.++||||+++|+|..+++.. ...+++..++.++.||++||+||| +++|+||||||+|||++.++. +
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~ 151 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRK----SDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFI 151 (262)
T ss_pred CEEEEecccCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCcee
Confidence 99999999999999887641 245899999999999999999999 889999999999999987654 8
Q ss_pred EEeeccccccCCCCCcceecccccccCcccccccc-cCcCCCchhHHhHHHHHHHHH-hCCCCCCCCChhhHHHHHHHHH
Q 041143 771 KVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAV-MGKITTKADVFSYGVVLMELL-TGLAALDEERPEESRYLAEWFW 848 (973)
Q Consensus 771 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~S~Gvvl~ell-tg~~p~~~~~~~~~~~~~~~~~ 848 (973)
|++|||++...... ....|+..|+|||++. +..++.++|||||||++|||+ +|+.|+......+...
T Consensus 152 ~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~------ 220 (262)
T cd05077 152 KLSDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER------ 220 (262)
T ss_pred EeCCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH------
Confidence 99999998754322 2245788999999886 567899999999999999997 5888886544222110
Q ss_pred HHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHH
Q 041143 849 RIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVL 903 (973)
Q Consensus 849 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L 903 (973)
+.. ....... .....+.+++.+|++.||.+||++.+|++.|
T Consensus 221 --------~~~---~~~~~~~---~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 221 --------FYE---GQCMLVT---PSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred --------HHh---cCccCCC---CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 000 0000000 1124578999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=329.82 Aligned_cols=244 Identities=25% Similarity=0.350 Sum_probs=194.3
Q ss_pred CccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcC-CCceeeeeeEEEeCCeEEEEE
Q 041143 626 NFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKVR-HRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~ 702 (973)
+|...+.||+|+||.||+|... +|+.||+|+++.... .....+.+..|.+++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677889999999999999765 688999999875321 2334456788999998885 678888999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++|+|..++.. ...+++.++..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 81 Ey~~~g~L~~~i~~-----~~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~ 152 (323)
T cd05615 81 EYVNGGDLMYHIQQ-----VGKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHM 152 (323)
T ss_pred cCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccC
Confidence 99999999998854 245899999999999999999999 8899999999999999999999999999987533
Q ss_pred CCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcC
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (973)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ . ..+..
T Consensus 153 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~---~---~~i~~---------- 215 (323)
T cd05615 153 VDG-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL---F---QSIME---------- 215 (323)
T ss_pred CCC-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH---H---HHHHh----------
Confidence 221 123345799999999999988999999999999999999999999987653221 1 11111
Q ss_pred ccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHh
Q 041143 863 PALEVNEETFESISIVAELAGHCTAREPYHRPDMG 897 (973)
Q Consensus 863 ~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ 897 (973)
..... +......+.+++.+|++.+|.+|++..
T Consensus 216 ~~~~~---p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 216 HNVSY---PKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred CCCCC---CccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 11110 011123467899999999999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=328.94 Aligned_cols=248 Identities=27% Similarity=0.467 Sum_probs=200.7
Q ss_pred cccccCccEEEEEEECC-CCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEecCCCCH
Q 041143 632 ELGRGGFGTVYKGELED-GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGAL 710 (973)
Q Consensus 632 ~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 710 (973)
+||+|.||+||.|++.+ ...+|||.+... ..+..+-+.+||...++++|+|||+++|.|.+++..-+.||-++||+|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek--dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK--DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccc--cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 69999999999998764 567899988654 445566788999999999999999999999999999999999999999
Q ss_pred HHHHHhhhhccCCCC--CHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECC-CCCEEEeeccccccCCCCCcc
Q 041143 711 SRHLFRWEKLQLKPL--SWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDD-DYRAKVSDFGLVKLAPDGEKS 787 (973)
Q Consensus 711 ~~~l~~~~~~~~~~l--~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~-~~~~kl~DfGla~~~~~~~~~ 787 (973)
.+.|+. ...++ .+.+.-.+.+||++||.||| ++.|||||||-.|||++. .|.+||+|||-++....-. .
T Consensus 660 SsLLrs----kWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin-P 731 (1226)
T KOG4279|consen 660 SSLLRS----KWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN-P 731 (1226)
T ss_pred HHHHHh----ccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccCC-c
Confidence 999975 23455 67778889999999999999 889999999999999974 6899999999998654332 3
Q ss_pred eecccccccCcccccccccC--cCCCchhHHhHHHHHHHHHhCCCCCCCCChhh-HHHHHHHHHHHhhchhHHHhhcCcc
Q 041143 788 VVTRLAGTFGYLAPEYAVMG--KITTKADVFSYGVVLMELLTGLAALDEERPEE-SRYLAEWFWRIKSSKEKFKAAIDPA 864 (973)
Q Consensus 788 ~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 864 (973)
....+.||..|||||++..+ .|+.++|||||||++.||.||++||....... ..+-+.+++ +.|.
T Consensus 732 ~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyK------------vHP~ 799 (1226)
T KOG4279|consen 732 CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYK------------VHPP 799 (1226)
T ss_pred cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhccee------------cCCC
Confidence 35568899999999999855 48999999999999999999999997654322 111111100 1122
Q ss_pred ccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 865 LEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 865 l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
-+.+...+...+|.+|+.+||.+||+++++++ .++++
T Consensus 800 -----iPeelsaeak~FilrcFepd~~~R~sA~~LL~--DpFlq 836 (1226)
T KOG4279|consen 800 -----IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ--DPFLQ 836 (1226)
T ss_pred -----CcHHHHHHHHHHHHHHcCCCcccCccHHHhcc--Ccccc
Confidence 22344566789999999999999999999997 55544
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=322.56 Aligned_cols=261 Identities=25% Similarity=0.430 Sum_probs=201.9
Q ss_pred CccccCcccccCccEEEEEEE-----CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeC--CeE
Q 041143 626 NFAQENELGRGGFGTVYKGEL-----EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEG--NER 698 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 698 (973)
.|...+.||+|+||.||+++. .++..||+|.++.. ......+.+.+|++++++++||||+++++++... ...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE-SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 467789999999999999974 35788999998654 2344567899999999999999999999998875 567
Q ss_pred EEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecccc
Q 041143 699 LLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLV 778 (973)
Q Consensus 699 ~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla 778 (973)
++||||+++++|.+++... ...++|.++..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++
T Consensus 84 ~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN----KNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred EEEEEccCCCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCccc
Confidence 8999999999999998642 235899999999999999999999 889999999999999999999999999999
Q ss_pred ccCCCCCc--ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhh---------HHHHHHHH
Q 041143 779 KLAPDGEK--SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEE---------SRYLAEWF 847 (973)
Q Consensus 779 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~---------~~~~~~~~ 847 (973)
+....... .......|+..|+|||++.+..++.++|||||||++|||++++.|........ ......+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV 236 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence 85543222 11223457778999999988889999999999999999999877653321100 00000111
Q ss_pred HHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHh
Q 041143 848 WRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPL 906 (973)
Q Consensus 848 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~ 906 (973)
..... . .... ........+.+++.+|++.+|++||++.++++.|+.+
T Consensus 237 ~~~~~-------~--~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 237 RVLEE-------G--KRLP---RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHc-------C--ccCC---CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 10000 0 0000 0111235688999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=352.23 Aligned_cols=264 Identities=20% Similarity=0.324 Sum_probs=204.4
Q ss_pred HHhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeC--CeE
Q 041143 622 KVTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEG--NER 698 (973)
Q Consensus 622 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 698 (973)
...++|.+.+.||+|+||.||+|... .+..||+|++............|..|+.++++++|||||++++++... ...
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34578999999999999999999775 577899999876545556677899999999999999999999988653 568
Q ss_pred EEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhc----cCCeeeccCCCCcEEECC--------
Q 041143 699 LLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLA----RQTFIHRDLKSSNILLDD-------- 766 (973)
Q Consensus 699 ~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~----~~~ivH~Dikp~Nill~~-------- 766 (973)
|+||||+++|+|.+++..... ....+++..++.|+.||+.||+|||+.. .++||||||||+|||++.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~-~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYK-MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 999999999999999976332 2356899999999999999999999432 156999999999999964
Q ss_pred ---------CCCEEEeeccccccCCCCCcceecccccccCccccccccc--CcCCCchhHHhHHHHHHHHHhCCCCCCCC
Q 041143 767 ---------DYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVM--GKITTKADVFSYGVVLMELLTGLAALDEE 835 (973)
Q Consensus 767 ---------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~~ 835 (973)
.+.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 2458999999998654322 2234579999999999854 45889999999999999999999999754
Q ss_pred ChhhHHHHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 836 RPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
.... ..+..+.. . +.+... .....+.+|+..||+.+|.+||++.|++. .++++
T Consensus 247 ~~~~-----qli~~lk~-------~--p~lpi~----~~S~eL~dLI~~~L~~dPeeRPSa~QlL~--h~~ik 299 (1021)
T PTZ00266 247 NNFS-----QLISELKR-------G--PDLPIK----GKSKELNILIKNLLNLSAKERPSALQCLG--YQIIK 299 (1021)
T ss_pred CcHH-----HHHHHHhc-------C--CCCCcC----CCCHHHHHHHHHHhcCChhHCcCHHHHhc--cHHHh
Confidence 3221 11111111 0 111111 11245789999999999999999999986 34444
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=322.74 Aligned_cols=265 Identities=23% Similarity=0.311 Sum_probs=194.5
Q ss_pred CccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc---CCCceeeeeeEEEe-----CC
Q 041143 626 NFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV---RHRHLVSLLGYSIE-----GN 696 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~ 696 (973)
+|+..+.||+|+||.||+|+.. +|+.||+|.++...........+.+|+++++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999765 688999999875432222233456677777665 79999999998865 24
Q ss_pred eEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecc
Q 041143 697 ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFG 776 (973)
Q Consensus 697 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG 776 (973)
..++||||+. ++|.+++... ....+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg 153 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKV---PPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFG 153 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccC
Confidence 5789999996 5898888652 2245899999999999999999999 8899999999999999999999999999
Q ss_pred ccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhh-chh
Q 041143 777 LVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKS-SKE 855 (973)
Q Consensus 777 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~ 855 (973)
+++...... ......||..|+|||++.+..++.++||||+||++|||++|++||......+. +......... ...
T Consensus 154 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~--~~~~~~~~~~~~~~ 229 (288)
T cd07863 154 LARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ--LGKIFDLIGLPPED 229 (288)
T ss_pred ccccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH--HHHHHHHhCCCChh
Confidence 998654321 22345689999999999988999999999999999999999999976543321 1111110000 000
Q ss_pred HHHh-------hcCccccC--CcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 856 KFKA-------AIDPALEV--NEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 856 ~~~~-------~~~~~l~~--~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
.... .+.+.... ..........+.+++.+|++.||++||++.|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000 00000000 0000112345779999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=324.70 Aligned_cols=247 Identities=27% Similarity=0.441 Sum_probs=202.0
Q ss_pred cCccccCcccccCccEEEEEEE-CCCCEEEEEEeecC-CCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAG-VTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
..|..++.||.|+||.||-|++ .+.+.||||++.-. ....+...++..|+..|++++|||+|.+.|+|..+...+|||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 3466778899999999999976 46788999999654 223444678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||| -|+-.+.+.-. .+++...++..|+.+.+.||+||| +.+.||||||+.|||+++.|.|||+|||.|....
T Consensus 106 EYC-lGSAsDlleVh----kKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~ 177 (948)
T KOG0577|consen 106 EYC-LGSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA 177 (948)
T ss_pred HHH-hccHHHHHHHH----hccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcC
Confidence 999 66888877542 267889999999999999999999 7899999999999999999999999999988654
Q ss_pred CCCcceecccccccCcccccccc---cCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHh
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAV---MGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKA 859 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (973)
. ...++|||.|||||++. .+.|+-|+||||+|++..||.-+++|+..+..... ...+..
T Consensus 178 P-----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA------LYHIAQ------- 239 (948)
T KOG0577|consen 178 P-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQ------- 239 (948)
T ss_pred c-----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH------HHHHHh-------
Confidence 3 34589999999999985 57899999999999999999999999876553211 111111
Q ss_pred hcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 860 AIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 860 ~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
--.|.+. ..+....+..++..|++.-|.+|||..+++.
T Consensus 240 NesPtLq----s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 240 NESPTLQ----SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred cCCCCCC----CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 1123332 1233345779999999999999999998876
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=319.07 Aligned_cols=250 Identities=25% Similarity=0.359 Sum_probs=198.4
Q ss_pred cCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
++|+..++||+|+||.||+|.. .+++.||+|++.... .....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 3577889999999999999976 468899999986542 34455679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+++|+|..+. .+++..+..++.|++.||+||| +.+|+|+||||+||+++.++.+||+|||++.....
T Consensus 80 ~~~~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~ 147 (279)
T cd06619 80 FMDGGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN 147 (279)
T ss_pred cCCCCChHHhh---------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence 99999996542 3577888899999999999999 88999999999999999999999999999985543
Q ss_pred CCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHH-HHHHHHHHhhchhHHHhhcC
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRY-LAEWFWRIKSSKEKFKAAID 862 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 862 (973)
.. .....||..|+|||++.+..++.++|||||||++|||++|+.||.......... ...+...+. ....
T Consensus 148 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-------~~~~ 217 (279)
T cd06619 148 SI---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV-------DEDP 217 (279)
T ss_pred cc---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHh-------ccCC
Confidence 22 234578999999999998899999999999999999999999997543221110 001111000 0011
Q ss_pred ccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 863 PALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 863 ~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
+.+... .....+.+++.+|++.+|++||++.|+++
T Consensus 218 ~~~~~~----~~~~~~~~li~~~l~~~P~~Rp~~~eil~ 252 (279)
T cd06619 218 PVLPVG----QFSEKFVHFITQCMRKQPKERPAPENLMD 252 (279)
T ss_pred CCCCCC----cCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 111111 12235789999999999999999999998
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=328.15 Aligned_cols=267 Identities=24% Similarity=0.306 Sum_probs=208.3
Q ss_pred CccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-C-----CceeeeeeEEEeCCeE
Q 041143 626 NFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR-H-----RHLVSLLGYSIEGNER 698 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~ 698 (973)
+|++.+.||+|+||.|.+|.+ ++++.||||+++.. .....+...|+.+|..++ | -|+|++++|+...++.
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 899999999999999999965 46999999999864 445567788999999997 4 3899999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCC--CCEEEeecc
Q 041143 699 LLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDD--YRAKVSDFG 776 (973)
Q Consensus 699 ~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~--~~~kl~DfG 776 (973)
|||+|.+ .-+|+++++.. ....++...+..|+.||+.||.+|| +.+|||+||||+||||.+- ..+||+|||
T Consensus 264 ciVfELL-~~NLYellK~n---~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 264 CIVFELL-STNLYELLKNN---KFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred eeeehhh-hhhHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEecc
Confidence 9999988 67999999763 3466999999999999999999999 8899999999999999754 479999999
Q ss_pred ccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHh-----
Q 041143 777 LVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIK----- 851 (973)
Q Consensus 777 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~----- 851 (973)
.|......-. ...-++.|+|||++.+.+|+.+.||||||||+.||++|.+-|.+..+.+....+.-+..+.
T Consensus 337 SSc~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL 412 (586)
T KOG0667|consen 337 SSCFESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKML 412 (586)
T ss_pred cccccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9987654322 4566889999999999999999999999999999999999998887655432221110000
Q ss_pred hchhHHHhhcCc--------------------------------cccC-Cc------ccHHHHHHHHHHHHHhhccCCCC
Q 041143 852 SSKEKFKAAIDP--------------------------------ALEV-NE------ETFESISIVAELAGHCTAREPYH 892 (973)
Q Consensus 852 ~~~~~~~~~~~~--------------------------------~l~~-~~------~~~~~~~~~~~l~~~cl~~dP~~ 892 (973)
....+....++. .... +. ........+++++++|+..||.+
T Consensus 413 ~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~ 492 (586)
T KOG0667|consen 413 DTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAE 492 (586)
T ss_pred HhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchh
Confidence 000000001110 0000 00 01123345789999999999999
Q ss_pred CCCHhHHHHHHHHhhh
Q 041143 893 RPDMGHVVNVLSPLVE 908 (973)
Q Consensus 893 RPs~~~v~~~L~~~~~ 908 (973)
|+|+.|+++ ++++.
T Consensus 493 R~tp~qal~--Hpfl~ 506 (586)
T KOG0667|consen 493 RITPAQALN--HPFLT 506 (586)
T ss_pred cCCHHHHhc--Ccccc
Confidence 999999998 66655
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=313.35 Aligned_cols=252 Identities=24% Similarity=0.341 Sum_probs=206.6
Q ss_pred CccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEe
Q 041143 626 NFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEY 704 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 704 (973)
+|+..+.||+|+||.||.++. .+++.+++|.+..........+++.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 478889999999999999975 4588999999876544556677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCC
Q 041143 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG 784 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~ 784 (973)
+++|+|.+++.... ...+++.++..++.|+++||+||| +.+++|+||||+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 81 ANGGTLYDKIVRQK---GQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred cCCCcHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 99999999986522 246899999999999999999999 789999999999999999999999999999865443
Q ss_pred CcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCcc
Q 041143 785 EKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPA 864 (973)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 864 (973)
.. ......|++.|+|||+..+..++.++||||||+++|||++|+.||......+. ...+.. ..
T Consensus 155 ~~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~------~~~~~~----------~~ 217 (256)
T cd08221 155 YS-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL------VVKIVQ----------GN 217 (256)
T ss_pred cc-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHHc----------CC
Confidence 32 23345789999999999888899999999999999999999999976543221 111111 11
Q ss_pred ccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHH
Q 041143 865 LEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNV 902 (973)
Q Consensus 865 l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~ 902 (973)
.. .........+.+++.+|++.+|++||++.++++.
T Consensus 218 ~~--~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 218 YT--PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CC--CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 11 0111223457899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=313.86 Aligned_cols=250 Identities=22% Similarity=0.321 Sum_probs=202.8
Q ss_pred CccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEe
Q 041143 626 NFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEY 704 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 704 (973)
+|+..+.||+|+||.||++... +++.+|+|.++... .....+.+.+|+.+++.++|+||+++++++.+++..++||||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 4778899999999999999765 68899999986542 344567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCC
Q 041143 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG 784 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~ 784 (973)
+++|+|.+++... ....+++...+.++.|++.||.||| +++|+|+||||+||++++++.++++|||.++.....
T Consensus 80 ~~~~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 153 (255)
T cd08219 80 CDGGDLMQKIKLQ---RGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP 153 (255)
T ss_pred CCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence 9999999988642 2245789999999999999999999 889999999999999999999999999998755432
Q ss_pred CcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCcc
Q 041143 785 EKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPA 864 (973)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 864 (973)
.. ......|+..|+|||++.+..++.++||||||+++|+|++|+.||........ ....... ...+
T Consensus 154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~------~~~~~~~------~~~~- 219 (255)
T cd08219 154 GA-YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL------ILKVCQG------SYKP- 219 (255)
T ss_pred cc-ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH------HHHHhcC------CCCC-
Confidence 21 22345789999999999888899999999999999999999999986543211 1111110 0000
Q ss_pred ccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 865 LEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 865 l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
+ +......+.+++.+|++.||++||++.+|+.
T Consensus 220 ~-----~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 220 L-----PSHYSYELRSLIKQMFKRNPRSRPSATTILS 251 (255)
T ss_pred C-----CcccCHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence 1 1112235779999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=322.84 Aligned_cols=267 Identities=24% Similarity=0.358 Sum_probs=207.0
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
++|+..+.||+|+||.||++... ++..+|+|.++... ......++.+|++++++++||||+++++++.+++..++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 36888999999999999999765 57889999886542 34455678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+++|+|.+++... ..+++..+..++.|+++||+|||+ ..+++||||||+||+++.++.+||+|||++.....
T Consensus 80 y~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (308)
T cd06615 80 HMDGGSLDQVLKKA-----GRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 152 (308)
T ss_pred ccCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccc
Confidence 99999999999652 457899999999999999999993 35899999999999999999999999999875433
Q ss_pred CCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhc----------
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSS---------- 853 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------- 853 (973)
.. .....|+..|+|||.+.+..++.++|||||||++|||++|+.||......... .+.......
T Consensus 153 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 226 (308)
T cd06615 153 SM---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE---AMFGRPVSEGEAKESHRPV 226 (308)
T ss_pred cc---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHH---HhhcCccccccccCCcccc
Confidence 21 23457899999999998888999999999999999999999999754432211 111000000
Q ss_pred -------------hhHHHhhc---CccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcC
Q 041143 854 -------------KEKFKAAI---DPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWR 911 (973)
Q Consensus 854 -------------~~~~~~~~---~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~ 911 (973)
.+.....+ .+.+. .......+.+++.+|++.+|++||++.||++ ..++..+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~--~~~~~~~~ 294 (308)
T cd06615 227 SGHPPDSPRPMAIFELLDYIVNEPPPKLP----SGAFSDEFQDFVDKCLKKNPKERADLKELTK--HPFIKRAE 294 (308)
T ss_pred cCCCCCccchhhHHHHHHHHhcCCCccCc----CcccCHHHHHHHHHHccCChhhCcCHHHHhc--Chhhhhcc
Confidence 00000000 01110 0012234789999999999999999999998 66665543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=322.32 Aligned_cols=256 Identities=23% Similarity=0.419 Sum_probs=206.3
Q ss_pred hcCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
..+|...+.||+|+||.||+|.. .+++.||+|.+... .....+.+.+|+.+++.++|+||+++++++..++..++||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecC--ccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 36888999999999999999986 47899999998754 2233467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++++|.+++.. ..+++.++..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++....
T Consensus 96 e~~~~~~L~~~~~~------~~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~ 166 (297)
T cd06656 96 EYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166 (297)
T ss_pred cccCCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEcc
Confidence 99999999998854 45788999999999999999999 7899999999999999999999999999987544
Q ss_pred CCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcC
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (973)
.... ......|++.|+|||+..+..++.++|||||||++|+|++|+.||....+...... ... .-.
T Consensus 167 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~------~~~-------~~~ 232 (297)
T cd06656 167 PEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IAT-------NGT 232 (297)
T ss_pred CCcc-CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee------ecc-------CCC
Confidence 3221 22335688999999999988899999999999999999999999976543211000 000 000
Q ss_pred ccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 863 PALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 863 ~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
+... ........+.+++.+|++.+|++||++.+|++ .++++.
T Consensus 233 ~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~--~~~~~~ 274 (297)
T cd06656 233 PELQ---NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ--HPFLKL 274 (297)
T ss_pred CCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhc--Cchhcc
Confidence 1110 11112244678999999999999999999998 666554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=319.43 Aligned_cols=267 Identities=21% Similarity=0.307 Sum_probs=200.1
Q ss_pred CccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEe
Q 041143 626 NFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEY 704 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 704 (973)
+|...+.||+|+||.||+|+.. ++..||||+++.........+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999875 689999999865433333446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCC
Q 041143 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG 784 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~ 784 (973)
++ ++|.+++.... ....+++..+..++.|+++||+||| +++|+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 81 LS-MDLKKYLDSLP--KGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP 154 (285)
T ss_pred CC-CCHHHHHhcCC--CCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC
Confidence 96 68988886522 2356899999999999999999999 889999999999999999999999999998754322
Q ss_pred CcceecccccccCcccccccccC-cCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHh----------hc
Q 041143 785 EKSVVTRLAGTFGYLAPEYAVMG-KITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIK----------SS 853 (973)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~----------~~ 853 (973)
. .......+++.|+|||++.+. .++.++|||||||++|||+||+.||......+.. ........ ..
T Consensus 155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 155 V-RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQL--FRIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred c-ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHHHHhCCCChhhhhcchh
Confidence 1 122334678999999988654 4788999999999999999999999865432211 11100000 00
Q ss_pred hhHHHhhcCccccC--CcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 854 KEKFKAAIDPALEV--NEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 854 ~~~~~~~~~~~l~~--~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
.......++..... .........++.+++.+|++.||++||++.+|+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00011111100000 0000012245679999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=328.34 Aligned_cols=248 Identities=27% Similarity=0.444 Sum_probs=202.6
Q ss_pred ccCcccccCccEEEEEEEC--CCC--EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEe
Q 041143 629 QENELGRGGFGTVYKGELE--DGT--KIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEY 704 (973)
Q Consensus 629 ~~~~lG~G~fg~Vy~~~~~--~g~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 704 (973)
..++||+|.||.|++|.|. .|+ .||||.++...... ..++|.+|+.+|.+|+|+|+++|||+..+ ....||||.
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 3478999999999999875 344 57999998764433 67899999999999999999999999887 778899999
Q ss_pred cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCC
Q 041143 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG 784 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~ 784 (973)
++.|+|.+.|++ .....+-......++.|||.||.||. .+++||||+.++|+|+-....+||+|||+.+..+.+
T Consensus 192 aplGSLldrLrk---a~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 192 APLGSLLDRLRK---AKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred cccchHHHHHhh---ccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 999999999987 22356778888999999999999999 889999999999999999999999999999966654
Q ss_pred Ccce-e-cccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhc
Q 041143 785 EKSV-V-TRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861 (973)
Q Consensus 785 ~~~~-~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (973)
+... + ....-.+.|.|||.+..+.++.++|||+|||++|||+| |+.||-+...... -+.+
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qI-----------------L~~i 328 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQI-----------------LKNI 328 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHH-----------------HHhc
Confidence 4332 1 12345678999999999999999999999999999998 5778877654321 1222
Q ss_pred CccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHH
Q 041143 862 DPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNV 902 (973)
Q Consensus 862 ~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~ 902 (973)
|. -+....+..+.+.+.++++.||..+|++||++.+|.+.
T Consensus 329 D~-~erLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 329 DA-GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred cc-cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 31 11122333456778999999999999999999999853
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=315.70 Aligned_cols=252 Identities=26% Similarity=0.446 Sum_probs=201.5
Q ss_pred CccccCcccccCccEEEEEEECCCCEEEEEEeecCCC----ChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEE
Q 041143 626 NFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVT----TTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLV 701 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 701 (973)
+|...+.||+|+||.||+|...+|+.+|||.++.... .......+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4677899999999999999888899999999865422 123346789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccC
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA 781 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~ 781 (973)
|||+++++|.+++.+. ..+++..+..++.|++.||+||| +.+|+|+||||+||++++++.+||+|||+++..
T Consensus 81 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 81 MEFVPGGSISSILNRF-----GPLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 9999999999998652 35788999999999999999999 789999999999999999999999999998754
Q ss_pred CCCC-----cceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhH
Q 041143 782 PDGE-----KSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEK 856 (973)
Q Consensus 782 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (973)
.... ........|+..|+|||++.+..++.++|||||||++|||++|+.||.......... ....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~------~~~~---- 222 (265)
T cd06631 153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF------YIGA---- 222 (265)
T ss_pred hhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHH------Hhhh----
Confidence 2111 111233568999999999998889999999999999999999999997654322110 0000
Q ss_pred HHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 857 FKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 857 ~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
.....+.+. ......+.+++.+|++.+|++||++.++++
T Consensus 223 -~~~~~~~~~-----~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 223 -HRGLMPRLP-----DSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -ccCCCCCCC-----CCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000111111 112244789999999999999999999886
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=318.38 Aligned_cols=238 Identities=26% Similarity=0.429 Sum_probs=186.6
Q ss_pred cccccCccEEEEEEECC-------------------------CCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCcee
Q 041143 632 ELGRGGFGTVYKGELED-------------------------GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLV 686 (973)
Q Consensus 632 ~lG~G~fg~Vy~~~~~~-------------------------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 686 (973)
.||+|+||.||+|.... ...||+|++... .......|.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHHHHHHHHHHHHHHhcCCCCCee
Confidence 69999999999996421 135888888643 233456788899999999999999
Q ss_pred eeeeEEEeCCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECC
Q 041143 687 SLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDD 766 (973)
Q Consensus 687 ~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~ 766 (973)
+++++|.+....++||||+++|+|..++... ...+++..++.++.||++||+||| +++|+||||||+||++++
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~ 152 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKE----KGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLAR 152 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEec
Confidence 9999999999999999999999999888641 245789999999999999999999 889999999999999976
Q ss_pred CC-------CEEEeeccccccCCCCCcceecccccccCccccccccc-CcCCCchhHHhHHHHHHHH-HhCCCCCCCCCh
Q 041143 767 DY-------RAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMEL-LTGLAALDEERP 837 (973)
Q Consensus 767 ~~-------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el-ltg~~p~~~~~~ 837 (973)
.+ .+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++||| ++|+.||....+
T Consensus 153 ~~~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 227 (274)
T cd05076 153 LGLAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP 227 (274)
T ss_pred cCcccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence 43 4899999988643221 12357888999998865 5689999999999999999 579999976544
Q ss_pred hhHHHHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHH
Q 041143 838 EESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVL 903 (973)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L 903 (973)
.+.... ... ...+. .. ....+.+++.+|++.+|++||++.+|++.|
T Consensus 228 ~~~~~~---~~~------------~~~~~-~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 228 SEKERF---YEK------------KHRLP-EP----SCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHHH---HHh------------ccCCC-CC----CChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 322111 000 00010 00 113478999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=325.40 Aligned_cols=270 Identities=20% Similarity=0.280 Sum_probs=198.4
Q ss_pred ccCccccc--CccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEec
Q 041143 629 QENELGRG--GFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYM 705 (973)
Q Consensus 629 ~~~~lG~G--~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 705 (973)
..++||+| +||+||++.. .+|+.||+|+++.........+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35789999 7889999976 46899999999765445555677889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCC
Q 041143 706 PHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGE 785 (973)
Q Consensus 706 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~ 785 (973)
++|+|.+++.... ...+++..+..++.|++.||+||| +++|+||||||+||+++.++.++++||+.+.......
T Consensus 82 ~~~~l~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 82 AYGSAKDLICTHF---MDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred CCCcHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 9999999986522 245899999999999999999999 8899999999999999999999999998754322111
Q ss_pred cc------eecccccccCccccccccc--CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhh----c
Q 041143 786 KS------VVTRLAGTFGYLAPEYAVM--GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKS----S 853 (973)
Q Consensus 786 ~~------~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~----~ 853 (973)
.. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ .......... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~ 233 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPCLLDT 233 (327)
T ss_pred ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHHhcCCccccccc
Confidence 10 0122356788999999875 4589999999999999999999999975432211 1000000000 0
Q ss_pred ----hhHHH-----hhcCcccc----------------CCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 854 ----KEKFK-----AAIDPALE----------------VNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 854 ----~~~~~-----~~~~~~l~----------------~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
.+.+. ...+..+. ...........+.+++.+|++.||++|||++|+++ +++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~--~p~f~ 311 (327)
T cd08227 234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN--HSFFK 311 (327)
T ss_pred cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc--Chhhh
Confidence 00000 00000000 00011122346789999999999999999999997 44443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=321.28 Aligned_cols=255 Identities=23% Similarity=0.426 Sum_probs=206.4
Q ss_pred cCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
.+|+..+.||.|+||.||+|.. .+|+.||+|.+... .....+.+.+|+++++.++|+||+++++++...+..++|||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQ--KQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecc--cCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 4688899999999999999975 56899999998654 22335678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+++++|.+++.. ..+++.++..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++.....
T Consensus 97 ~~~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~ 167 (296)
T cd06655 97 YLAGGSLTDVVTE------TCMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP 167 (296)
T ss_pred ecCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence 9999999998854 45899999999999999999999 88999999999999999999999999999875433
Q ss_pred CCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCc
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDP 863 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (973)
... ......|+..|+|||.+.+..++.++|||||||++|||++|+.||........... . .. ...+
T Consensus 168 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~---~---~~-------~~~~ 233 (296)
T cd06655 168 EQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL---I---AT-------NGTP 233 (296)
T ss_pred ccc-cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---H---Hh-------cCCc
Confidence 222 22335689999999999888899999999999999999999999987654322110 0 00 0001
Q ss_pred cccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 864 ALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 864 ~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
.+. ........+.+++.+|++.||++||++.+|+. .++++.
T Consensus 234 ~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~--~~~~~~ 274 (296)
T cd06655 234 ELQ---NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ--HPFLKL 274 (296)
T ss_pred ccC---CcccCCHHHHHHHHHHhhcChhhCCCHHHHhh--ChHhhh
Confidence 111 01112234778999999999999999999998 666654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=316.71 Aligned_cols=257 Identities=23% Similarity=0.403 Sum_probs=203.9
Q ss_pred cCccccCcccccCccEEEEEEECC----CCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELED----GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLL 700 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 700 (973)
++|...+.||+|+||.||+|...+ ...||||..... ......+.+.+|+.++++++||||+++++++.+ ...++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC-TSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCc-CCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 457788999999999999997643 246899988654 234556789999999999999999999998875 45789
Q ss_pred EEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecccccc
Q 041143 701 VYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKL 780 (973)
Q Consensus 701 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~ 780 (973)
||||+++|+|.+++... ...+++.+++.++.|++.||+||| +.+++||||||+||+++.++.+||+|||+++.
T Consensus 84 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~ 156 (270)
T cd05056 84 VMELAPLGELRSYLQVN----KYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRY 156 (270)
T ss_pred EEEcCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeee
Confidence 99999999999999652 235899999999999999999999 88999999999999999999999999999986
Q ss_pred CCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHh
Q 041143 781 APDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKA 859 (973)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (973)
.............++..|+|||++....++.++|||||||++|||++ |+.||......+. ..++ ...
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---~~~~---~~~------ 224 (270)
T cd05056 157 LEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV---IGRI---ENG------ 224 (270)
T ss_pred cccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHH---HcC------
Confidence 54432222223345678999999988889999999999999999986 9999976653221 1111 110
Q ss_pred hcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 860 AIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 860 ~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
...... ......+.+++.+|+..+|++||++.++++.|+.+..
T Consensus 225 -~~~~~~-----~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 225 -ERLPMP-----PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred -CcCCCC-----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 000000 1122457899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=314.95 Aligned_cols=257 Identities=25% Similarity=0.408 Sum_probs=203.5
Q ss_pred CccccCcccccCccEEEEEEECC--CCEEEEEEeecCC--------CChHHHHHHHHHHHHHHh-cCCCceeeeeeEEEe
Q 041143 626 NFAQENELGRGGFGTVYKGELED--GTKIAVKRMEAGV--------TTTKALDEFQSEIAVLSK-VRHRHLVSLLGYSIE 694 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~~--g~~vavK~~~~~~--------~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 694 (973)
+|+..+.||+|+||.||+|.... ++.+|+|.+.... .......++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778899999999999998765 6889999875321 233445667889998875 799999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEee
Q 041143 695 GNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSD 774 (973)
Q Consensus 695 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D 774 (973)
.+..++||||+++++|.+++..... ....+++..++.++.|++.||.|||+ ..+++|+||||+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKE-KKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEec
Confidence 9999999999999999998865322 23568999999999999999999993 36899999999999999999999999
Q ss_pred ccccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhch
Q 041143 775 FGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSK 854 (973)
Q Consensus 775 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 854 (973)
||++....... ......|+..|+|||++.+..++.++|||||||++|||++|+.||........ ......
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~------~~~~~~-- 227 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL------ATKIVE-- 227 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH------HHHHhh--
Confidence 99998654432 33456789999999999988899999999999999999999999975542211 111110
Q ss_pred hHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHH
Q 041143 855 EKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLS 904 (973)
Q Consensus 855 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~ 904 (973)
....+ .. .......+.+++.+|++.||++||++.||.++++
T Consensus 228 ----~~~~~-~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 228 ----AVYEP-LP----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ----ccCCc-CC----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 00011 00 0012245779999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=317.80 Aligned_cols=249 Identities=26% Similarity=0.392 Sum_probs=198.6
Q ss_pred ccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEec
Q 041143 627 FAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYM 705 (973)
Q Consensus 627 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 705 (973)
|+..+.||+|+||.||+|... ++..+|+|.+... .....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 566788999999999999876 4778899988543 4555678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCC
Q 041143 706 PHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGE 785 (973)
Q Consensus 706 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~ 785 (973)
++|+|..++... ..++++..+..++.|+++||+||| +.+|+||||||+||+++.++++||+|||++.......
T Consensus 85 ~~~~l~~~~~~~----~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 85 AGGAVDAVMLEL----ERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 157 (282)
T ss_pred CCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEccccccccccccc
Confidence 999999887641 246899999999999999999999 7899999999999999999999999999987543322
Q ss_pred cceecccccccCcccccccc-----cCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhh
Q 041143 786 KSVVTRLAGTFGYLAPEYAV-----MGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAA 860 (973)
Q Consensus 786 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (973)
.......|+..|+|||++. ...++.++|||||||++|||++|+.||......+. ... ... .
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~----~~~-------~ 223 (282)
T cd06643 158 -QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV--LLK----IAK-------S 223 (282)
T ss_pred -cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH--HHH----Hhh-------c
Confidence 1223457899999999874 34577899999999999999999999976543211 111 000 0
Q ss_pred cCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 861 IDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 861 ~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
..+.+. .+......+.+++.+|++.+|.+||++.++++
T Consensus 224 ~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 224 EPPTLA---QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred CCCCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011111 01112245789999999999999999999987
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=319.10 Aligned_cols=253 Identities=25% Similarity=0.390 Sum_probs=199.1
Q ss_pred HHhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeC----
Q 041143 622 KVTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEG---- 695 (973)
Q Consensus 622 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~---- 695 (973)
.+.+.|+..+.||+|+||.||+|... +++.||+|++.... .....+.+|+.++.++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 45677888899999999999999765 58899999986542 2335688999999998 699999999998753
Q ss_pred --CeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEe
Q 041143 696 --NERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVS 773 (973)
Q Consensus 696 --~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~ 773 (973)
...++||||+++|+|.+++... ....+++..+..++.|++.||+||| +++|+||||||+||++++++.+||+
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~---~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~ 153 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNT---KGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLV 153 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEc
Confidence 4578999999999999998652 2246889999999999999999999 7899999999999999999999999
Q ss_pred eccccccCCCCCcceecccccccCcccccccc-----cCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHH
Q 041143 774 DFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAV-----MGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFW 848 (973)
Q Consensus 774 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 848 (973)
|||+++....... ......|+..|+|||++. ...++.++|||||||++|||++|+.||...........
T Consensus 154 Dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~----- 227 (272)
T cd06637 154 DFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL----- 227 (272)
T ss_pred cCCCceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH-----
Confidence 9999885433221 233457899999999986 34578899999999999999999999975543221110
Q ss_pred HHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 849 RIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 849 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
......+... .......+.+++.+|+..+|.+||++.+|++
T Consensus 228 --------~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 228 --------IPRNPAPRLK----SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred --------HhcCCCCCCC----CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0000111111 0112235789999999999999999999986
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=314.03 Aligned_cols=252 Identities=29% Similarity=0.431 Sum_probs=193.9
Q ss_pred CcccccCccEEEEEEEC----CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEe-CCeEEEEEEec
Q 041143 631 NELGRGGFGTVYKGELE----DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIE-GNERLLVYEYM 705 (973)
Q Consensus 631 ~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~e~~ 705 (973)
+.||+|+||.||+|.+. ++..||+|++... ......+.+.+|+.+++.++||||+++++++.. ++..++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 46899999999999753 2357999987542 234556788999999999999999999998764 55678999999
Q ss_pred CCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCC
Q 041143 706 PHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGE 785 (973)
Q Consensus 706 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~ 785 (973)
.+|+|.+++... ....++..++.++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++...+..
T Consensus 80 ~~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~ 152 (262)
T cd05058 80 KHGDLRNFIRSE----THNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE 152 (262)
T ss_pred CCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence 999999999652 134678888999999999999999 7899999999999999999999999999997543321
Q ss_pred cc---eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhC-CCCCCCCChhhHHHHHHHHHHHhhchhHHHhhc
Q 041143 786 KS---VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTG-LAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861 (973)
Q Consensus 786 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (973)
.. ......++..|+|||++....++.++|||||||++|||++| ..||......+ +...+ ... .
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~~~~---~~~-------~ 219 (262)
T cd05058 153 YYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---ITVYL---LQG-------R 219 (262)
T ss_pred ceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH---hcC-------C
Confidence 11 11233567789999999888999999999999999999995 55665443221 11111 100 0
Q ss_pred CccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 862 DPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 862 ~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
.+.. .......+.+++.+|++.+|++||++.||++.|+.+..
T Consensus 220 ~~~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 220 RLLQ-----PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CCCC-----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 0000 00112357799999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=321.48 Aligned_cols=259 Identities=29% Similarity=0.427 Sum_probs=202.8
Q ss_pred cCccccCcccccCccEEEEEEEC-CCC----EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGT----KIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERL 699 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 699 (973)
++|+..+.||+|+||.||+|.+. +|+ .||+|.+... .......++.+|+.+++.++||||++++++|... ..+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNET-TGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 56778899999999999999763 444 5788887653 2334455789999999999999999999998754 467
Q ss_pred EEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccc
Q 041143 700 LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK 779 (973)
Q Consensus 700 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~ 779 (973)
+|+||+++|+|.+++... ...+++..+..++.|++.||+||| +++|+||||||+||++++++.+||+|||+++
T Consensus 85 ~v~e~~~~g~l~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~ 157 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEH----KDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (303)
T ss_pred eeehhcCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccc
Confidence 999999999999998652 235789999999999999999999 8899999999999999999999999999998
Q ss_pred cCCCCCcc-eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHH
Q 041143 780 LAPDGEKS-VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKF 857 (973)
Q Consensus 780 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (973)
........ ......++..|+|||++.+..++.++|||||||++|||++ |+.||......+. ..++.. ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~---~~~~~~----~~-- 228 (303)
T cd05110 158 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI---PDLLEK----GE-- 228 (303)
T ss_pred cccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHC----CC--
Confidence 65432221 1222345778999999998899999999999999999997 8999976543221 111110 00
Q ss_pred HhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhc
Q 041143 858 KAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKW 910 (973)
Q Consensus 858 ~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~ 910 (973)
.... .......+.+++..|+..+|++||+++++++.|+.+.+..
T Consensus 229 ------~~~~---~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 229 ------RLPQ---PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred ------CCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 0000 0012235779999999999999999999999999886643
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=333.94 Aligned_cols=267 Identities=22% Similarity=0.304 Sum_probs=200.7
Q ss_pred hcCccccCcccccCccEEEEEEEC---CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE---DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLL 700 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 700 (973)
..+|...+.||+|+||.||+|... .+.+||||.+... +.+.+|++++++++|||||++++++......++
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 457999999999999999999753 3578999987543 234689999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecccccc
Q 041143 701 VYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKL 780 (973)
Q Consensus 701 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~ 780 (973)
||||+. ++|.+++.. ...+++.+++.++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++.
T Consensus 164 v~e~~~-~~l~~~l~~-----~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~ 234 (392)
T PHA03207 164 VMPKYK-CDLFTYVDR-----SGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACK 234 (392)
T ss_pred EehhcC-CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccc
Confidence 999994 788888833 256899999999999999999999 88999999999999999999999999999975
Q ss_pred CCCCCc-ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhH-HHHHHHHHHHhhch----
Q 041143 781 APDGEK-SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEES-RYLAEWFWRIKSSK---- 854 (973)
Q Consensus 781 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~---- 854 (973)
...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+...... ..+...+.......
T Consensus 235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~ 314 (392)
T PHA03207 235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP 314 (392)
T ss_pred cCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC
Confidence 543322 122346799999999999999999999999999999999999999976543221 11111111000000
Q ss_pred --------hHHHhh---cCccccCCcc--cHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 855 --------EKFKAA---IDPALEVNEE--TFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 855 --------~~~~~~---~~~~l~~~~~--~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
..+... ..+....... .......+.+++.+|++.||++||++.|++. .++..
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~--~p~f~ 379 (392)
T PHA03207 315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS--LPLFT 379 (392)
T ss_pred CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh--Cchhh
Confidence 000000 0000000000 0011234678999999999999999999998 55554
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=312.53 Aligned_cols=251 Identities=22% Similarity=0.357 Sum_probs=202.9
Q ss_pred CccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEe-CCeEEEEEE
Q 041143 626 NFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIE-GNERLLVYE 703 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~e 703 (973)
+|+..+.||+|+||.||++..+ +++.||+|++..........+.+.+|++++++++|+|++++++.+.. ....++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788899999999999999765 57899999987654455566778999999999999999999998764 445789999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+++++|.+++... ....+++.++..++.+++.|++||| +.+|+||||||+||+++.++.++|+|||+++....
T Consensus 81 ~~~~~~l~~~l~~~---~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 81 FCEGGDLYHKLKEQ---KGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred ccCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 99999999999652 2246899999999999999999999 88999999999999999999999999999986543
Q ss_pred CCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCc
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDP 863 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (973)
... ......|++.|+|||+..+..++.++|||||||+++||++|+.||........ ...+... .. +
T Consensus 155 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~------~~~~~~~------~~-~ 220 (257)
T cd08223 155 QCD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL------VYRIIEG------KL-P 220 (257)
T ss_pred cCC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH------HHHHHhc------CC-C
Confidence 222 23345689999999999999999999999999999999999999976542211 1111110 00 1
Q ss_pred cccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 864 ALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 864 ~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
.+ .......+.+++.+|++.+|++||++.++++
T Consensus 221 ~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 221 PM-----PKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred CC-----ccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 11 1122345789999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=312.99 Aligned_cols=249 Identities=26% Similarity=0.432 Sum_probs=203.7
Q ss_pred cCccccCcccccCccEEEEEEECC-CCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELED-GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
++|+..+.||+|+||.||+|...+ ++.+|+|.+... ...+++.+|++++++++|+||+++++++......+++||
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE----EDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH----HHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 578888999999999999998765 789999998643 226789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+++++|.+++... ...+++..+..++.|+++||.||| ..+|+||||+|+||+++.++.+||+|||++.....
T Consensus 79 ~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~ 151 (256)
T cd06612 79 YCGAGSVSDIMKIT----NKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD 151 (256)
T ss_pred cCCCCcHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhccc
Confidence 99999999998642 256899999999999999999999 78999999999999999999999999999986544
Q ss_pred CCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCc
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDP 863 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (973)
... ......|+..|+|||++.+..++.++|||||||++|||++|+.||........... ......+
T Consensus 152 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~-------------~~~~~~~ 217 (256)
T cd06612 152 TMA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-------------IPNKPPP 217 (256)
T ss_pred Ccc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh-------------hccCCCC
Confidence 321 22335588999999999988999999999999999999999999986543221100 0000011
Q ss_pred cccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 864 ALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 864 ~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
.+. ........+.+++.+|++.+|++||++.||++
T Consensus 218 ~~~---~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 218 TLS---DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CCC---chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 111 11122245789999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=317.99 Aligned_cols=251 Identities=26% Similarity=0.401 Sum_probs=200.6
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
+.|++.+.||+|+||.||+|+.. +++.||+|.+... .....+.+.+|+++++.++|+||+++++++..+...++|||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 56888899999999999999875 4889999998654 45566789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+++++|..++.+. ...+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~~~~~~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 162 (292)
T cd06644 90 FCPGGAVDAIMLEL----DRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK 162 (292)
T ss_pred cCCCCcHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence 99999998887542 245899999999999999999999 88999999999999999999999999999875332
Q ss_pred CCcceecccccccCcccccccc-----cCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHH
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAV-----MGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFK 858 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (973)
.. .......+++.|+|||++. ...++.++|||||||++|||++|+.||........ . ....
T Consensus 163 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~----~~~~------- 228 (292)
T cd06644 163 TL-QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--L----LKIA------- 228 (292)
T ss_pred cc-cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH--H----HHHh-------
Confidence 21 1123456889999999885 34568899999999999999999999976543211 1 1111
Q ss_pred hhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 859 AAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 859 ~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
....+... ........+.+++.+|++.+|++||++.+|++
T Consensus 229 ~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 229 KSEPPTLS---QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred cCCCccCC---CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 01111111 01122245779999999999999999999987
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=316.79 Aligned_cols=258 Identities=29% Similarity=0.431 Sum_probs=205.1
Q ss_pred cCccccCcccccCccEEEEEEEC-CCC----EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGT----KIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERL 699 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 699 (973)
.+|...+.||+|+||.||+|..+ +|+ .+|+|.+.... .......+.+|+.++++++|+||+++++++.. ...+
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 56788899999999999999764 333 58999876542 34456788999999999999999999999987 7889
Q ss_pred EEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccc
Q 041143 700 LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK 779 (973)
Q Consensus 700 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~ 779 (973)
+||||+++|+|.+++... ...+++..+..++.||+.||+||| +++|+||||||+||++++++.+||+|||+++
T Consensus 85 ~v~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~ 157 (279)
T cd05057 85 LITQLMPLGCLLDYVRNH----KDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (279)
T ss_pred EEEecCCCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccc
Confidence 999999999999998652 235899999999999999999999 7899999999999999999999999999998
Q ss_pred cCCCCCccee-cccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHH
Q 041143 780 LAPDGEKSVV-TRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKF 857 (973)
Q Consensus 780 ~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (973)
.......... ....++..|+|||.+....++.++|+|||||++||+++ |+.||......+. ... +... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~---~~~~-~-- 228 (279)
T cd05057 158 LLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEI---PDL---LEKG-E-- 228 (279)
T ss_pred cccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHH---HHH---HhCC-C--
Confidence 6543322211 11234678999999988889999999999999999999 9999987653221 111 1110 0
Q ss_pred HhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 858 KAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 858 ~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
... .+......+.+++.+|+..+|.+||++.++++.|+.+.+.
T Consensus 229 ------~~~---~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 229 ------RLP---QPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred ------CCC---CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 000 0001123477999999999999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=313.83 Aligned_cols=252 Identities=33% Similarity=0.497 Sum_probs=202.9
Q ss_pred CcccccCccEEEEEEECC----CCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEecC
Q 041143 631 NELGRGGFGTVYKGELED----GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMP 706 (973)
Q Consensus 631 ~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 706 (973)
+.||+|+||.||+|.... +..||+|.++...... ..+.+.+|++++..++|+||+++++++......++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 469999999999998754 7889999987653332 46789999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhhhhc----cCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 707 HGALSRHLFRWEKL----QLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 707 ~g~L~~~l~~~~~~----~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
+|+|.+++...... ....+++.++..++.|++.||+||| +++|+||||||+||++++++.+||+|||.+....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEcccccccccc
Confidence 99999999763211 1356899999999999999999999 8999999999999999999999999999998655
Q ss_pred CCCc-ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhh
Q 041143 783 DGEK-SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAA 860 (973)
Q Consensus 783 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (973)
.... .......++..|+|||.+....++.++||||+||++|||++ |+.||......+. ...... .
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------~~~~~~-------~ 223 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV------LEYLRK-------G 223 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHH------HHHHHc-------C
Confidence 4321 12233467889999999988889999999999999999999 6999987643221 111110 0
Q ss_pred cCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHH
Q 041143 861 IDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLS 904 (973)
Q Consensus 861 ~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~ 904 (973)
.... ........+.+++.+|++.+|++||++.|+++.|+
T Consensus 224 ~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 224 YRLP-----KPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCCC-----CCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0000 11112356889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=316.94 Aligned_cols=252 Identities=31% Similarity=0.477 Sum_probs=197.8
Q ss_pred CcccccCccEEEEEEECC-------CCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 631 NELGRGGFGTVYKGELED-------GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 631 ~~lG~G~fg~Vy~~~~~~-------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
+.||+|+||.||+|+..+ ++.+|+|.+... ........+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG-ATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcc-cchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 468999999999997642 257899987643 223445678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCC-----CEEEeecc
Q 041143 704 YMPHGALSRHLFRWEKL--QLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDY-----RAKVSDFG 776 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~-----~~kl~DfG 776 (973)
|+++|+|.++++..... ....++|.+++.++.|++.||+||| +.+++|+||||+||+++.++ .++++|||
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence 99999999999763321 2245789999999999999999999 78999999999999999877 89999999
Q ss_pred ccccCCCCCc-ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhch
Q 041143 777 LVKLAPDGEK-SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSK 854 (973)
Q Consensus 777 la~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 854 (973)
+++....... .......++..|+|||++.++.++.++|||||||++|||++ |+.||......+. ... +.. .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~---~~~---~~~-~ 229 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV---LQH---VTA-G 229 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHH---HHH---Hhc-C
Confidence 9875433221 11122346788999999999999999999999999999998 9999975543221 111 100 0
Q ss_pred hHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHH
Q 041143 855 EKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLS 904 (973)
Q Consensus 855 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~ 904 (973)
..+. ........+.+++.+|++.+|.+||++.+|++.|.
T Consensus 230 --------~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 230 --------GRLQ---KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred --------CccC---CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 0111 01122345789999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=302.58 Aligned_cols=272 Identities=24% Similarity=0.336 Sum_probs=220.6
Q ss_pred cHHHHHHHhcCccccCcccccCccEEEEEEEC------CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeee
Q 041143 616 SVQVLRKVTQNFAQENELGRGGFGTVYKGELE------DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLL 689 (973)
Q Consensus 616 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 689 (973)
..+++..-..+++...++-+|.||.||+|.+. +.+.|-||.++.. .++.+...+..|--.+..+.|||+..+.
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~sH~nll~V~ 353 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLYGASHPNLLSVL 353 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcCcCCCcccee
Confidence 34555666677888889999999999999654 3455778887765 3556677899999999999999999999
Q ss_pred eEEEeCC-eEEEEEEecCCCCHHHHHHhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEEC
Q 041143 690 GYSIEGN-ERLLVYEYMPHGALSRHLFRWEKL---QLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLD 765 (973)
Q Consensus 690 ~~~~~~~-~~~lV~e~~~~g~L~~~l~~~~~~---~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~ 765 (973)
+++.++. ..+.+|.++.-|+|..||..++.. ..+.++-.+.+.+|.|++.|++||| +++|||.||.++|+++|
T Consensus 354 ~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvId 430 (563)
T KOG1024|consen 354 GVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVID 430 (563)
T ss_pred EEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceeh
Confidence 9998754 567889999999999999865432 2345788889999999999999999 89999999999999999
Q ss_pred CCCCEEEeeccccc-cCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHH
Q 041143 766 DDYRAKVSDFGLVK-LAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYL 843 (973)
Q Consensus 766 ~~~~~kl~DfGla~-~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~ 843 (973)
+..++||+|=.+++ .++.+.......-.....||+||.+....|+.++|||||||+||||+| |+.|+..-++.+...+
T Consensus 431 d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~y 510 (563)
T KOG1024|consen 431 DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHY 510 (563)
T ss_pred hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHH
Confidence 99999999999998 555555544444456789999999999999999999999999999988 8999998888776443
Q ss_pred HHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 844 AEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 844 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
.. . .. ++. .+..+..++..++..||+.+|++||+++|++.-|+++..+
T Consensus 511 lk------d-Gy--------Rla---QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 511 LK------D-GY--------RLA---QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred Hh------c-cc--------eec---CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 21 1 11 111 1223445688999999999999999999999999887654
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=334.18 Aligned_cols=253 Identities=23% Similarity=0.359 Sum_probs=196.6
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCC-CChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGV-TTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
++|+..+.||+|+||.||+|+.. +++.||+|+++... ........+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888899999999999999765 58999999986431 12334567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++|+|.+++.. ...+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 81 EFLPGGDMMTLLMK-----KDTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred eCCCCccHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence 99999999999865 245889999999999999999999 8899999999999999999999999999987432
Q ss_pred CCCc----------------------------------ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhC
Q 041143 783 DGEK----------------------------------SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTG 828 (973)
Q Consensus 783 ~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg 828 (973)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG 232 (360)
T cd05627 153 KAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (360)
T ss_pred cccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccC
Confidence 2110 011235799999999999999999999999999999999999
Q ss_pred CCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCC---HhHHHH
Q 041143 829 LAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPD---MGHVVN 901 (973)
Q Consensus 829 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs---~~~v~~ 901 (973)
+.||....+.+.. ..+...... ..+.+.. .....+.+++.+|+ .||.+|++ +.|+.+
T Consensus 233 ~~Pf~~~~~~~~~------~~i~~~~~~--~~~p~~~-------~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 233 YPPFCSETPQETY------RKVMNWKET--LVFPPEV-------PISEKAKDLILRFC-TDSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCCCCCHHHHH------HHHHcCCCc--eecCCCC-------CCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence 9999876543221 111110000 0011111 11234667777766 49999996 556655
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=318.52 Aligned_cols=256 Identities=25% Similarity=0.388 Sum_probs=204.5
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
++|+..+.||+|+||+||+|... +|+.||+|++.... .....+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 56778899999999999999765 58899999886542 34456789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+++|+|.+++.. ...+++..+..++.+++.||.|||+ .++++||||||+||+++++++++|+|||++.....
T Consensus 84 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 84 FMDCGSLDRIYKK-----GGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred cCCCCCHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 9999999988854 2468999999999999999999993 35899999999999999999999999999875432
Q ss_pred CCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhh-----HHHHHHHHHHHhhchhHHH
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEE-----SRYLAEWFWRIKSSKEKFK 858 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 858 (973)
.. .....|+..|+|||++.+..++.++|||||||++|||++|+.||......+ ...+..++..+..
T Consensus 157 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------ 227 (284)
T cd06620 157 SI---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ------ 227 (284)
T ss_pred hc---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh------
Confidence 21 223578999999999988899999999999999999999999998654321 1111122211111
Q ss_pred hhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHH
Q 041143 859 AAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNV 902 (973)
Q Consensus 859 ~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~ 902 (973)
...+.+. .......+.+++.+|++.||++||++.||++.
T Consensus 228 -~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 228 -EPPPRLP----SSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred -ccCCCCC----chhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0011111 11133457899999999999999999999984
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=319.29 Aligned_cols=255 Identities=26% Similarity=0.453 Sum_probs=204.9
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
+.|+..+.||+|+||.||+|... +++.||+|.+.... .....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc-chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 34666788999999999999764 57889999886542 23455689999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+++++|.+++.. ..+++..+..++.|+++|+.||| +++++|+||+|+||++++++.++++|||++.....
T Consensus 83 ~~~~~~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06642 83 YLGGGSALDLLKP------GPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred ccCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccC
Confidence 9999999988853 45889999999999999999999 88999999999999999999999999999975543
Q ss_pred CCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCc
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDP 863 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (973)
... ......|+..|+|||++.+..++.++|||||||++|||++|+.|+....+.... ..+ .....+
T Consensus 154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~------~~~-------~~~~~~ 219 (277)
T cd06642 154 TQI-KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL------FLI-------PKNSPP 219 (277)
T ss_pred cch-hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH------hhh-------hcCCCC
Confidence 221 223346889999999999888999999999999999999999998754432210 000 001111
Q ss_pred cccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhc
Q 041143 864 ALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKW 910 (973)
Q Consensus 864 ~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~ 910 (973)
.+. ......+.+++.+|++.+|++||+|.+|++ ..++..+
T Consensus 220 ~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~--~~~~~~~ 259 (277)
T cd06642 220 TLE-----GQYSKPFKEFVEACLNKDPRFRPTAKELLK--HKFITRY 259 (277)
T ss_pred CCC-----cccCHHHHHHHHHHccCCcccCcCHHHHHH--hHHHHHH
Confidence 111 122345789999999999999999999998 5555543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=314.28 Aligned_cols=252 Identities=25% Similarity=0.437 Sum_probs=205.6
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
..|+..+.||+|+||.||+|... +++.||+|.+.... .......+.+|++++++++|+||+++++++.++...++|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 45677788999999999999875 58899999987542 34456789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+++|+|.+++.. ..+++.+...++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 83 ~~~~~~L~~~i~~------~~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06640 83 YLGGGSALDLLRA------GPFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred cCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence 9999999998854 45788999999999999999999 88999999999999999999999999999975543
Q ss_pred CCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCc
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDP 863 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (973)
... ......++..|+|||++.+..++.++|||||||++|||++|+.||....+..... .+ .....+
T Consensus 154 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~------~~-------~~~~~~ 219 (277)
T cd06640 154 TQI-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF------LI-------PKNNPP 219 (277)
T ss_pred Ccc-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh------hh-------hcCCCC
Confidence 221 2233568899999999988889999999999999999999999997654322110 00 000011
Q ss_pred cccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhh
Q 041143 864 ALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLV 907 (973)
Q Consensus 864 ~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~ 907 (973)
.........+.+++.+|++.+|++||++.++++ ..++
T Consensus 220 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~--~~~~ 256 (277)
T cd06640 220 -----TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLK--HKFI 256 (277)
T ss_pred -----CCchhhhHHHHHHHHHHcccCcccCcCHHHHHh--ChHh
Confidence 112234456889999999999999999999988 4444
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=322.21 Aligned_cols=199 Identities=27% Similarity=0.404 Sum_probs=161.7
Q ss_pred cCcccccCccEEEEEEEC---CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEe--CCeEEEEEEe
Q 041143 630 ENELGRGGFGTVYKGELE---DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIE--GNERLLVYEY 704 (973)
Q Consensus 630 ~~~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~e~ 704 (973)
.++||+|+||.||+|+.. +++.||+|.++.... ...+.+|++++++++||||+++++++.. +...++||||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 468999999999999864 467899999865422 2356789999999999999999998865 4567899999
Q ss_pred cCCCCHHHHHHhhhhc----cCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEE----CCCCCEEEeecc
Q 041143 705 MPHGALSRHLFRWEKL----QLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILL----DDDYRAKVSDFG 776 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~----~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill----~~~~~~kl~DfG 776 (973)
+. ++|..++...... ....+++..+..++.||+.||+||| +++|+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 82 AE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred cC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 84 5888877542211 1235889999999999999999999 8899999999999999 456789999999
Q ss_pred ccccCCCCCc--ceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCC
Q 041143 777 LVKLAPDGEK--SVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEER 836 (973)
Q Consensus 777 la~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~ 836 (973)
+++....... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 9986543221 12234678999999999876 458999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=316.00 Aligned_cols=265 Identities=23% Similarity=0.326 Sum_probs=202.6
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
++|+..+.||+|+||.||+|+.. +|+.||+|++..........+.+.+|++++++++|+||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999876 58999999986543333344568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|++++.|..+... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++++||+|||++.....
T Consensus 81 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07847 81 YCDHTVLNELEKN-----PRGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTG 152 (286)
T ss_pred ccCccHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCC
Confidence 9999888877643 245899999999999999999999 78999999999999999999999999999986544
Q ss_pred CCcceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhc-
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI- 861 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 861 (973)
... ......++..|+|||++.+ ..++.++|||||||++|||++|+.||......+.... ................
T Consensus 153 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 229 (286)
T cd07847 153 PGD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYL--IRKTLGDLIPRHQQIFS 229 (286)
T ss_pred Ccc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHH--HHHHhCCCChHHhhhcc
Confidence 322 2233467889999999875 5578999999999999999999999986654332111 1110000000000000
Q ss_pred ---------CccccCCccc-----HHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 862 ---------DPALEVNEET-----FESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 862 ---------~~~l~~~~~~-----~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
.+... .... ......+.+++.+|++.+|++||++.|++.
T Consensus 230 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 230 TNQFFKGLSIPEPE-TREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccccccCCCcc-cccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 11100 0000 011245789999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=314.23 Aligned_cols=254 Identities=25% Similarity=0.361 Sum_probs=189.6
Q ss_pred CcccccCccEEEEEEECCCC---EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEecCC
Q 041143 631 NELGRGGFGTVYKGELEDGT---KIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPH 707 (973)
Q Consensus 631 ~~lG~G~fg~Vy~~~~~~g~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 707 (973)
+.||+|+||.||+|...++. .+++|.++.. ......+.|.+|+.+++.++||||++++++|......++||||+++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKAN-ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCC-CChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 35999999999999765433 4566665543 2344567899999999999999999999999999999999999999
Q ss_pred CCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCC-c
Q 041143 708 GALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGE-K 786 (973)
Q Consensus 708 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~-~ 786 (973)
|+|.++++.... .....++.....++.||++||+||| +.+|+||||||+|||++.++.+||+|||++....... .
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~ 155 (268)
T cd05086 80 GDLKSYLSQEQW-HRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI 155 (268)
T ss_pred CcHHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhh
Confidence 999999976322 2345677788899999999999999 7899999999999999999999999999986432211 1
Q ss_pred ceecccccccCccccccccc-------CcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHH
Q 041143 787 SVVTRLAGTFGYLAPEYAVM-------GKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFK 858 (973)
Q Consensus 787 ~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (973)
.......|+..|+|||++.. ..++.++|||||||++|||++ |..||......+. +.... .+...
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~------~~~~~--~~~~~ 227 (268)
T cd05086 156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREV------LNHVI--KDQQV 227 (268)
T ss_pred hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHH------HHHHH--hhccc
Confidence 12234568899999998753 245789999999999999997 5668765443211 11111 11111
Q ss_pred hhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHH
Q 041143 859 AAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVL 903 (973)
Q Consensus 859 ~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L 903 (973)
...++.+... ....+.+++..|+ .+|++||++++|++.|
T Consensus 228 ~~~~~~~~~~-----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 228 KLFKPQLELP-----YSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred ccCCCccCCC-----CcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 2233333211 1234667888899 6799999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=315.13 Aligned_cols=254 Identities=27% Similarity=0.427 Sum_probs=206.7
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
++|+..+.||.|+||.||+|... +++.||+|.+.... .......+.+|+++++.++|+||+++++++.++...++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 36778899999999999999865 68899999987542 33445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+++++|.+++.. ..+++..+..++.|++.||.||| +++++||||+|+||++++++.++|+|||+++....
T Consensus 80 ~~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 150 (274)
T cd06609 80 YCGGGSCLDLLKP------GKLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTS 150 (274)
T ss_pred eeCCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecc
Confidence 9999999999865 26899999999999999999999 88999999999999999999999999999986544
Q ss_pred CCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCc
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDP 863 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (973)
.. .......|+..|+|||++.+..++.++|||||||++|||++|+.||....+... ...+ .....+
T Consensus 151 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~------~~~~-------~~~~~~ 216 (274)
T cd06609 151 TM-SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV------LFLI-------PKNNPP 216 (274)
T ss_pred cc-cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH------HHHh-------hhcCCC
Confidence 32 122345788999999999988899999999999999999999999976543211 1111 111111
Q ss_pred cccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 864 ALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 864 ~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
.+... .....+.+++.+|+..+|++||+++++++ .+++.
T Consensus 217 ~~~~~----~~~~~~~~~l~~~l~~~p~~Rpt~~~il~--~~~~~ 255 (274)
T cd06609 217 SLEGN----KFSKPFKDFVSLCLNKDPKERPSAKELLK--HKFIK 255 (274)
T ss_pred CCccc----ccCHHHHHHHHHHhhCChhhCcCHHHHhh--Chhhc
Confidence 11101 02335779999999999999999999988 55554
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=289.81 Aligned_cols=262 Identities=25% Similarity=0.393 Sum_probs=205.3
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR-HRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~ 702 (973)
++.+.+..||.|..|.|++++.+ .|..+|||.+.... ..+..+++...++++..-+ +|+||+-+|||......++.|
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 34455678999999999999876 47889999998763 4555677888888887765 999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
|.| ...++..+.+ -.+++++...-++...+++||.||.+ +++|||||+||+|||+|+.|.+|+||||++-+..
T Consensus 171 elM-s~C~ekLlkr----ik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlv 243 (391)
T KOG0983|consen 171 ELM-STCAEKLLKR----IKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV 243 (391)
T ss_pred HHH-HHHHHHHHHH----hcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceee
Confidence 998 4456666644 23568888888999999999999985 7799999999999999999999999999998766
Q ss_pred CCCcceecccccccCccccccccc---CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHh
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVM---GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKA 859 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (973)
+.. ..++.+|.+.|||||.+.- .+|+.++||||||++++||.||+.||.....+ ... ...+. .
T Consensus 244 dSk--AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-Fe~----ltkvl-------n 309 (391)
T KOG0983|consen 244 DSK--AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-FEV----LTKVL-------N 309 (391)
T ss_pred ccc--ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-HHH----HHHHH-------h
Confidence 543 3456689999999999863 46899999999999999999999999875421 111 11111 1
Q ss_pred hcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCCC
Q 041143 860 AIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPI 913 (973)
Q Consensus 860 ~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~~ 913 (973)
-..|.+.... .-...+.+++..|++.|+.+||...++++ +.++..+++.
T Consensus 310 ~ePP~L~~~~---gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~--h~Fi~~ye~a 358 (391)
T KOG0983|consen 310 EEPPLLPGHM---GFSPDFQSFVKDCLTKDHRKRPKYNKLLE--HPFIKRYETA 358 (391)
T ss_pred cCCCCCCccc---CcCHHHHHHHHHHhhcCcccCcchHHHhc--Ccceeecchh
Confidence 1223333221 12345789999999999999999999998 6666655543
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=304.07 Aligned_cols=249 Identities=27% Similarity=0.422 Sum_probs=205.6
Q ss_pred cCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
+-|.++++||+|+||.||+|.. ..|..+|+|++.. +...+++..|+.+|++++.|++|++||.|......++|||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc----cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 3466778999999999999965 4699999998753 3456788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
||--|+..+.++. ..+++++.++..|....++||+||| ...-||||||+.|||++.+|.+||+|||.|-...+
T Consensus 109 YCGAGSiSDI~R~----R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD 181 (502)
T KOG0574|consen 109 YCGAGSISDIMRA----RRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD 181 (502)
T ss_pred hcCCCcHHHHHHH----hcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhh
Confidence 9999999999865 3478999999999999999999999 45679999999999999999999999999975544
Q ss_pred CCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCc
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDP 863 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (973)
. ......+.||+.|||||++..-.|+.++||||+|++..||.-|++|+.+..+....+. +. ..|
T Consensus 182 T-MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM-------------IP--T~P 245 (502)
T KOG0574|consen 182 T-MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM-------------IP--TKP 245 (502)
T ss_pred h-HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe-------------cc--CCC
Confidence 2 2234557899999999999999999999999999999999999999987665322110 00 011
Q ss_pred cccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 864 ALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 864 ~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
... -..+..-..++-++++.|+-..|++|-|+.++.+
T Consensus 246 PPT-F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 246 PPT-FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred CCC-CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 111 1122334456889999999999999999988776
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=314.93 Aligned_cols=252 Identities=23% Similarity=0.396 Sum_probs=199.9
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
++|...+.||+|+||.||+|... +++.||+|.++.. .......+.+|+.+++.++||||+++++++...+..++|||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE--PGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecC--chhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 57778889999999999999764 6889999998754 33344568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+++++|.+++.. ...+++.++..++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||++.....
T Consensus 87 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06645 87 FCGGGSLQDIYHV-----TGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA 158 (267)
T ss_pred ccCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence 9999999998864 245889999999999999999999 78999999999999999999999999999875433
Q ss_pred CCcceecccccccCcccccccc---cCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhh
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAV---MGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAA 860 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (973)
.. .......|+..|+|||++. ...++.++|||||||++|||++|+.||....+...... ... ...
T Consensus 159 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~------~~~-----~~~ 226 (267)
T cd06645 159 TI-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL------MTK-----SNF 226 (267)
T ss_pred cc-cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHh------hhc-----cCC
Confidence 21 1223457899999999874 45688999999999999999999999865543221110 000 000
Q ss_pred cCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 861 IDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 861 ~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
..+... ........+.+++.+|++.+|++||++++|++
T Consensus 227 ~~~~~~---~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 227 QPPKLK---DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred CCCccc---ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 111111 00011234779999999999999999999886
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=342.73 Aligned_cols=281 Identities=17% Similarity=0.217 Sum_probs=196.3
Q ss_pred HHhcCccccCcccccCccEEEEEEECC--CCEEEEEEe---------------ecCCCChHHHHHHHHHHHHHHhcCCCc
Q 041143 622 KVTQNFAQENELGRGGFGTVYKGELED--GTKIAVKRM---------------EAGVTTTKALDEFQSEIAVLSKVRHRH 684 (973)
Q Consensus 622 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~--g~~vavK~~---------------~~~~~~~~~~~~~~~E~~~l~~l~h~n 684 (973)
...++|.+.+.||+|+||+||+|..+. +..+++|.+ +...........+.+|++++++++|+|
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 345789999999999999999986542 222222211 111112334567889999999999999
Q ss_pred eeeeeeEEEeCCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEE
Q 041143 685 LVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILL 764 (973)
Q Consensus 685 iv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill 764 (973)
||++++++...+..|+|+|++ .++|.+++..............+...|+.||+.||+||| +++||||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEE
Confidence 999999999999999999998 567888775422211223345667789999999999999 8899999999999999
Q ss_pred CCCCCEEEeeccccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCC-CCCCChhhHHHH
Q 041143 765 DDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAA-LDEERPEESRYL 843 (973)
Q Consensus 765 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p-~~~~~~~~~~~~ 843 (973)
+.++.+||+|||+++..............||..|+|||++.+..++.++|||||||++|||++|..+ +..........+
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 9999999999999986654433333456799999999999999999999999999999999998754 433322222222
Q ss_pred HHHHHHHhhchh-------HHHhhcCcc-ccCC-cccHH------HHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 844 AEWFWRIKSSKE-------KFKAAIDPA-LEVN-EETFE------SISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 844 ~~~~~~~~~~~~-------~~~~~~~~~-l~~~-~~~~~------~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
...+.......+ .+.+.++.. +... ..... ....+.+++.+|++.||.+||++.|+++ .+++.
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~--hp~f~ 458 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA--LPLFS 458 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh--Chhhh
Confidence 222111110000 011111100 0000 00000 1124667899999999999999999997 55543
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=319.81 Aligned_cols=267 Identities=22% Similarity=0.307 Sum_probs=204.9
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
++|+..+.||+|+||.||+|... +++.||||+++.........+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888899999999999999876 58899999987654444556788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|++++.+..+... ...+++.++..++.||+.||+||| ..+++||||+|+||++++++.+||+|||++.....
T Consensus 81 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~ 152 (288)
T cd07833 81 YVERTLLELLEAS-----PGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRA 152 (288)
T ss_pred cCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence 9998777655432 245899999999999999999999 78999999999999999999999999999986554
Q ss_pred CCcceecccccccCcccccccccC-cCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhc-
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVMG-KITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI- 861 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 861 (973)
..........++..|+|||++.+. .++.++||||||+++|||++|+.||......+.......... ..........
T Consensus 153 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 230 (288)
T cd07833 153 RPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLG--PLPPSHQELFS 230 (288)
T ss_pred CccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC--CCCHHHhhhcc
Confidence 433233456788999999999888 889999999999999999999999976543322111111000 0000000000
Q ss_pred -CccccC------C-------cccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 862 -DPALEV------N-------EETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 862 -~~~l~~------~-------~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
++.... . .........+.+++.+|+..+|++||++++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000000 0 000112456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=320.22 Aligned_cols=257 Identities=25% Similarity=0.422 Sum_probs=204.7
Q ss_pred CccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEe
Q 041143 626 NFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEY 704 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 704 (973)
.|.....||+|+||.||++... ++..||||++... .....+.+.+|+.+++.++|+||+++++++..++..++||||
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~ 100 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR--KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF 100 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc--hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence 3444567999999999999764 6889999998653 344566789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCC
Q 041143 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG 784 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~ 784 (973)
+++++|.+++.. ..+++.++..++.||+.||+||| +++|+||||||+||++++++.+||+|||++......
T Consensus 101 ~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~ 171 (292)
T cd06658 101 LEGGALTDIVTH------TRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE 171 (292)
T ss_pred CCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc
Confidence 999999998743 35789999999999999999999 789999999999999999999999999998754332
Q ss_pred CcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCcc
Q 041143 785 EKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPA 864 (973)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 864 (973)
.. ......|+..|+|||+..+..++.++|||||||++|||++|+.||......... . .+...+.+.
T Consensus 172 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~------~-------~~~~~~~~~ 237 (292)
T cd06658 172 VP-KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM------R-------RIRDNLPPR 237 (292)
T ss_pred cc-cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------H-------HHHhcCCCc
Confidence 21 223356899999999998888999999999999999999999999765432211 0 111112222
Q ss_pred ccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCC
Q 041143 865 LEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRP 912 (973)
Q Consensus 865 l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~ 912 (973)
+.. .......+.+++.+|++.||.+||++.|+++ +++.+...+
T Consensus 238 ~~~---~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~--~~~~~~~~~ 280 (292)
T cd06658 238 VKD---SHKVSSVLRGFLDLMLVREPSQRATAQELLQ--HPFLKLAGP 280 (292)
T ss_pred ccc---ccccCHHHHHHHHHHccCChhHCcCHHHHhh--ChhhhccCC
Confidence 211 0112234778999999999999999999998 666654443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=314.97 Aligned_cols=259 Identities=28% Similarity=0.465 Sum_probs=202.7
Q ss_pred ccccCcccccCccEEEEEEEC----CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC------
Q 041143 627 FAQENELGRGGFGTVYKGELE----DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGN------ 696 (973)
Q Consensus 627 ~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 696 (973)
|...+.||+|+||.||+|.+. +++.||||+++.........+++.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 556788999999999999753 3688999999876556666788999999999999999999999887543
Q ss_pred eEEEEEEecCCCCHHHHHHhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeec
Q 041143 697 ERLLVYEYMPHGALSRHLFRWEK-LQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDF 775 (973)
Q Consensus 697 ~~~lV~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 775 (973)
..++++||+++|+|..++..... .....+++.....++.||+.||+||| +.+|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence 23789999999999988864221 11235789999999999999999999 789999999999999999999999999
Q ss_pred cccccCCCCCcc-eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhc
Q 041143 776 GLVKLAPDGEKS-VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSS 853 (973)
Q Consensus 776 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 853 (973)
|+++........ ......+++.|++||.+....++.++|||||||++|||++ |+.||......+ +..++. .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~~~~~~---~- 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---IYNYLI---K- 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---HHHHHH---c-
Confidence 999865432211 1223345678999999988889999999999999999999 889987654321 111111 0
Q ss_pred hhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHh
Q 041143 854 KEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPL 906 (973)
Q Consensus 854 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~ 906 (973)
.. .+. ........+.+++.+|++.+|++||++.++++.|+.+
T Consensus 231 ~~--------~~~---~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GN--------RLK---QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CC--------cCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 000 0011234688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=319.39 Aligned_cols=271 Identities=27% Similarity=0.431 Sum_probs=205.2
Q ss_pred cCccccCcccccCccEEEEEEEC-----CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEe--CCe
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-----DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIE--GNE 697 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~ 697 (973)
+.|...+.||+|+||.||+|++. ++..||||+++..... ...+.|.+|+++++.++|+||+++++++.. ...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 45677789999999999999754 3678999999765332 456789999999999999999999999887 557
Q ss_pred EEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccc
Q 041143 698 RLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL 777 (973)
Q Consensus 698 ~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGl 777 (973)
.++||||+++++|.+++.... ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.++|+|||+
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~ 155 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHR----DQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGL 155 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCc----cccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEccccc
Confidence 899999999999999997522 25899999999999999999999 78999999999999999999999999999
Q ss_pred cccCCCCCcce--ecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchh
Q 041143 778 VKLAPDGEKSV--VTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKE 855 (973)
Q Consensus 778 a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 855 (973)
+.......... .....++..|+|||+.....++.++||||||+++|||++|+.|+............. . .......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~-~~~~~~~ 233 (284)
T cd05038 156 AKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI-A-QGQMIVT 233 (284)
T ss_pred ccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc-c-cccccHH
Confidence 98665322211 112345667999999988899999999999999999999999986543211000000 0 0000001
Q ss_pred HHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHh
Q 041143 856 KFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPL 906 (973)
Q Consensus 856 ~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~ 906 (973)
.+.+.+...... .........+.+++.+|++.+|++||+|.||+++|+.+
T Consensus 234 ~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 234 RLLELLKEGERL-PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHHcCCcC-CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 111111111110 01112235688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=316.52 Aligned_cols=262 Identities=22% Similarity=0.373 Sum_probs=205.6
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
++|+..+.||+|+||.||+|... +|..||+|.++... .....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 35778899999999999999876 68999999887542 34445788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+++++|..++.... ....+++..+..++.|++.||.|||+ +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 80 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 155 (286)
T cd06622 80 YMDAGSLDKLYAGGV--ATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA 155 (286)
T ss_pred ecCCCCHHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC
Confidence 999999999886521 12468999999999999999999993 35899999999999999999999999999875533
Q ss_pred CCcceecccccccCcccccccccC------cCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHH
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVMG------KITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKF 857 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (973)
.. .....|++.|+|||++.+. .++.++|||||||++|||++|+.||......... . .+
T Consensus 156 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~----------~~ 219 (286)
T cd06622 156 SL---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF---A----------QL 219 (286)
T ss_pred Cc---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH---H----------HH
Confidence 21 2234688899999988544 3578999999999999999999999754321110 0 01
Q ss_pred HhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcC
Q 041143 858 KAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWR 911 (973)
Q Consensus 858 ~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~ 911 (973)
..+.+.... .........+.+++.+|++.+|++||++.++++ .+++..+.
T Consensus 220 ~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~--~~~~~~~~ 269 (286)
T cd06622 220 SAIVDGDPP--TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE--HPWLVKYK 269 (286)
T ss_pred HHHhhcCCC--CCCcccCHHHHHHHHHHcccCcccCCCHHHHhc--Chhhhhcc
Confidence 111111100 011123355779999999999999999999998 66666554
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=315.91 Aligned_cols=259 Identities=29% Similarity=0.442 Sum_probs=203.5
Q ss_pred cCccccCcccccCccEEEEEEEC------CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE------DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNER 698 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 698 (973)
++|...+.||+|+||.||+|+.+ +.+.||+|.+... ......+.+.+|++++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT-KDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc-cchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 57888899999999999999864 2467899987643 2233567899999999999999999999999998999
Q ss_pred EEEEEecCCCCHHHHHHhhhhcc----CCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEee
Q 041143 699 LLVYEYMPHGALSRHLFRWEKLQ----LKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSD 774 (973)
Q Consensus 699 ~lV~e~~~~g~L~~~l~~~~~~~----~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D 774 (973)
++||||+++|+|.+++....... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++++|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEcc
Confidence 99999999999999997633111 126899999999999999999999 88999999999999999999999999
Q ss_pred ccccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhc
Q 041143 775 FGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSS 853 (973)
Q Consensus 775 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 853 (973)
||+++..............++..|+|||.+.+..++.++|||||||++|||++ |..||....... +. ......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~---~~~~~~ 234 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VL---NRLQAG 234 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HH---HHHHcC
Confidence 99987443322222334456788999999988889999999999999999999 788886543221 11 111100
Q ss_pred hhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHH
Q 041143 854 KEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLS 904 (973)
Q Consensus 854 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~ 904 (973)
... .. ........+.+++.+|++.+|++||++.|+++.|+
T Consensus 235 --~~~------~~---~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 --KLE------LP---VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred --CcC------CC---CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 000 00 00012245789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=311.54 Aligned_cols=251 Identities=22% Similarity=0.356 Sum_probs=204.1
Q ss_pred CccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEe
Q 041143 626 NFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEY 704 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 704 (973)
+|+..+.||+|+||.||++... +|+.||+|++..........+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4788899999999999999764 688999999875433455567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCC
Q 041143 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG 784 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~ 784 (973)
+++++|.+++... ....+++.+++.++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~ 154 (256)
T cd08218 81 CEGGDLYKKINAQ---RGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154 (256)
T ss_pred CCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence 9999999988652 1235789999999999999999999 789999999999999999999999999999865432
Q ss_pred CcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCcc
Q 041143 785 EKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPA 864 (973)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 864 (973)
.. ......|++.|+|||+..+..++.++|||||||+++||++|+.||......+. +..+.. ..
T Consensus 155 ~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~------~~~~~~----------~~ 217 (256)
T cd08218 155 VE-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL------VLKIIR----------GS 217 (256)
T ss_pred hh-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH------HHHHhc----------CC
Confidence 21 12334688999999999888899999999999999999999999976543211 111111 00
Q ss_pred ccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 865 LEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 865 l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
.. .........+.+++.+|++.+|.+||+|.+|++
T Consensus 218 ~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 218 YP--PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CC--CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 00 011122345789999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=316.23 Aligned_cols=257 Identities=27% Similarity=0.424 Sum_probs=204.9
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
.++|++.+.||+|+||.||+|... ++..||+|+++.. .....+.+.+|++++++++|+||+++++++......++||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 356888899999999999999874 6889999998754 4555678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++++|.+++... ...+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~ 154 (280)
T cd06611 82 EFCDGGALDSIMLEL----ERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNK 154 (280)
T ss_pred eccCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhc
Confidence 999999999998652 246899999999999999999999 8899999999999999999999999999987543
Q ss_pred CCCcceecccccccCcccccccc-----cCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHH
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAV-----MGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKF 857 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (973)
.... ......|++.|+|||++. ...++.++|||||||++|||++|+.||........ .. ...
T Consensus 155 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~--~~----~~~------ 221 (280)
T cd06611 155 STLQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV--LL----KIL------ 221 (280)
T ss_pred cccc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH--HH----HHh------
Confidence 3221 223456899999999875 34467899999999999999999999976543221 11 111
Q ss_pred HhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 858 KAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 858 ~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
....+.+.. .......+.+++.+|++.+|++||++.+|++ ++++.
T Consensus 222 -~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~il~--~~~~~ 266 (280)
T cd06611 222 -KSEPPTLDQ---PSKWSSSFNDFLKSCLVKDPDDRPTAAELLK--HPFVS 266 (280)
T ss_pred -cCCCCCcCC---cccCCHHHHHHHHHHhccChhhCcCHHHHhc--Chhhc
Confidence 111111110 1112235779999999999999999999988 55544
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=314.51 Aligned_cols=255 Identities=25% Similarity=0.378 Sum_probs=199.3
Q ss_pred HHHhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEE
Q 041143 621 RKVTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERL 699 (973)
Q Consensus 621 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 699 (973)
+..++++.....||+|+||.||+|.+. ++..||+|.+... .....+.+.+|++++++++|+||+++++++..++..+
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC--CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 344566666778999999999999764 5788999988654 3445678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhhhccCCCC--CHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECC-CCCEEEeecc
Q 041143 700 LVYEYMPHGALSRHLFRWEKLQLKPL--SWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDD-DYRAKVSDFG 776 (973)
Q Consensus 700 lV~e~~~~g~L~~~l~~~~~~~~~~l--~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~-~~~~kl~DfG 776 (973)
+||||+++++|.+++.... ..+ ++..+..++.||+.||+||| +++|+||||||+||+++. ++.+||+|||
T Consensus 82 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg 154 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKW----GPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFG 154 (268)
T ss_pred EEEecCCCCCHHHHHHHhc----ccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecch
Confidence 9999999999999997521 234 78888999999999999999 889999999999999986 6799999999
Q ss_pred ccccCCCCCcceecccccccCcccccccccCc--CCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhch
Q 041143 777 LVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGK--ITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSK 854 (973)
Q Consensus 777 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 854 (973)
++........ ......|+..|+|||++.... ++.++|||||||++|||++|+.||......... .+......
T Consensus 155 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~---~~~~~~~~-- 228 (268)
T cd06624 155 TSKRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA---MFKVGMFK-- 228 (268)
T ss_pred hheecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh---Hhhhhhhc--
Confidence 9875533222 223346899999999986543 788999999999999999999999754321111 01000000
Q ss_pred hHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 855 EKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 855 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
..+.+. ......+.+++.+|++.+|.+||++.|+++
T Consensus 229 ------~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 229 ------IHPEIP-----ESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred ------cCCCCC-----cccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 011111 112244779999999999999999999986
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=315.80 Aligned_cols=240 Identities=23% Similarity=0.391 Sum_probs=188.5
Q ss_pred CcccccCccEEEEEEECC--------CCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 631 NELGRGGFGTVYKGELED--------GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 631 ~~lG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
+.||+|+||.||+|.... ..+||+|.+... .....+.+.+|+.+++.++||||+++++++..++..++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 469999999999997642 234888877543 3344567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCC--------EEEee
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYR--------AKVSD 774 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~--------~kl~D 774 (973)
||+++|+|.++++.. ...+++..++.++.||+.||+||| +++|+||||||+||+++.++. ++++|
T Consensus 79 e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d 151 (258)
T cd05078 79 EYVKFGSLDTYLKKN----KNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD 151 (258)
T ss_pred ecCCCCcHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecc
Confidence 999999999999752 135789999999999999999999 889999999999999987765 69999
Q ss_pred ccccccCCCCCcceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCC-CCCCCCChhhHHHHHHHHHHHhh
Q 041143 775 FGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGL-AALDEERPEESRYLAEWFWRIKS 852 (973)
Q Consensus 775 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~ 852 (973)
||++..... .....++..|+|||++.+ ..++.++|||||||++|||++|. .|+........... ..
T Consensus 152 ~g~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~-------~~ 219 (258)
T cd05078 152 PGISITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF-------YE 219 (258)
T ss_pred cccccccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH-------HH
Confidence 998875432 123468899999999876 45789999999999999999995 55554332211100 00
Q ss_pred chhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHH
Q 041143 853 SKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLS 904 (973)
Q Consensus 853 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~ 904 (973)
. ...+. ......+.+++.+|++.||++||+++++++.|+
T Consensus 220 ~--------~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 220 D--------RHQLP-----APKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred c--------cccCC-----CCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 00111 011245789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=311.13 Aligned_cols=256 Identities=25% Similarity=0.376 Sum_probs=206.7
Q ss_pred CccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEe--CCeEEEEE
Q 041143 626 NFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIE--GNERLLVY 702 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~ 702 (973)
+|+..+.||.|+||.||+|.. .+|+.||+|++..........+++..|++++++++|+||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477889999999999999975 468899999987655556667789999999999999999999998764 34678999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhc--cCCeeeccCCCCcEEECCCCCEEEeecccccc
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLA--RQTFIHRDLKSSNILLDDDYRAKVSDFGLVKL 780 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~--~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~ 780 (973)
||+++++|.+++..... ....+++..++.++.|++.||+|||..+ ..+|+|+||||+||+++.++.+||+|||++..
T Consensus 81 e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 81 EYCEGGDLAQLIQKCKK-ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred hhccCCCHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 99999999999976432 2357899999999999999999999554 67899999999999999999999999999986
Q ss_pred CCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhh
Q 041143 781 APDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAA 860 (973)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (973)
...... ......|+..|+|||++....++.++||||||+++|+|++|+.||....... +.. .+. ..
T Consensus 160 ~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~---~~~-------~~ 225 (265)
T cd08217 160 LGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---LAS---KIK-------EG 225 (265)
T ss_pred ccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH---HHH---HHh-------cC
Confidence 554332 1233568999999999998889999999999999999999999998654221 111 111 11
Q ss_pred cCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 861 IDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 861 ~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
..+.+ .......+.+++.+|++.+|++||++.+|++
T Consensus 226 ~~~~~-----~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 226 KFRRI-----PYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred CCCCC-----ccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 11111 1122356789999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=328.98 Aligned_cols=254 Identities=30% Similarity=0.427 Sum_probs=206.5
Q ss_pred ccCcccccCccEEEEEEE-CCCC----EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 629 QENELGRGGFGTVYKGEL-EDGT----KIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 629 ~~~~lG~G~fg~Vy~~~~-~~g~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
..++||+|+||+||+|.+ ..|+ +||+|++... ...+..+++.+|+-+|.+++|||+++++|+|.... ..||.+
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~-t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF-TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeecc-CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 457899999999999965 3443 6899988654 45666788999999999999999999999999876 789999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
||+.|+|.+|++.. ...+.-...+.+..|||+||.||| .+++|||||.++||||.+-..+||.|||+++....
T Consensus 778 ~mP~G~LlDyvr~h----r~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREH----RDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred hcccchHHHHHHHh----hccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 99999999999763 356778889999999999999999 89999999999999999999999999999996554
Q ss_pred CCcce-ecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhc
Q 041143 784 GEKSV-VTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861 (973)
Q Consensus 784 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (973)
..... .....-.+.|||-|.+....|+.++|||||||++||++| |..|+++...++..++.+ ..++
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle-------~geR----- 918 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE-------KGER----- 918 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh-------cccc-----
Confidence 43322 222334568999999999999999999999999999998 888988776444322221 0111
Q ss_pred CccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 862 DPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 862 ~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
+ ..+......+..++.+||..|+..||+++++...+.++.+.
T Consensus 919 ---L---sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 919 ---L---SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred ---C---CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 1 12223345577889999999999999999999999887654
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=319.47 Aligned_cols=268 Identities=24% Similarity=0.362 Sum_probs=202.3
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
++|+..+.||+|+||.||+|..+ +++.||+|++..........+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888899999999999999876 58999999986543333445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+++++|..+... ...++|.++..++.||++||+||| +.+|+|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 81 FVDHTVLDDLEKY-----PNGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred cCCccHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 9999998877643 234899999999999999999999 78999999999999999999999999999886543
Q ss_pred CCcceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhH-HHHHHHHHHHhhc-------h
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEES-RYLAEWFWRIKSS-------K 854 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~-------~ 854 (973)
.. .......++..|+|||++.+ ..++.++|||||||++|||++|+.||......+. ..+..+....... .
T Consensus 153 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 153 PG-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred Cc-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 32 22334568899999998875 4478899999999999999999999975543221 1111111000000 0
Q ss_pred hHHHhhcCccccCCcc----cHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 855 EKFKAAIDPALEVNEE----TFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 855 ~~~~~~~~~~l~~~~~----~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
........+....... .......+.+++.+|++.+|++||++.+|++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000000111000000 0112345889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=317.33 Aligned_cols=262 Identities=23% Similarity=0.341 Sum_probs=202.3
Q ss_pred cHHHHHHHhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEE
Q 041143 616 SVQVLRKVTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSI 693 (973)
Q Consensus 616 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 693 (973)
.++.+..+.++|+..+.||+|+||.||+|... +++.+|+|+++.. ......+.+|+.+++++ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~---~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 85 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI---HDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc---cchHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence 33555667889999999999999999999764 5789999987542 22235678899999999 6999999999885
Q ss_pred -----eCCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCC
Q 041143 694 -----EGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDY 768 (973)
Q Consensus 694 -----~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~ 768 (973)
.++..++||||+++|+|.++++.... ....+++..+..++.|+++||.||| +.+|+||||||+||++++++
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~ 161 (286)
T cd06638 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLK-RGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEG 161 (286)
T ss_pred ecccCCCCeEEEEEeecCCCCHHHHHHHhhc-cCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCC
Confidence 34568999999999999998865322 2356889999999999999999999 78999999999999999999
Q ss_pred CEEEeeccccccCCCCCcceecccccccCccccccccc-----CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHH
Q 041143 769 RAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVM-----GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYL 843 (973)
Q Consensus 769 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~ 843 (973)
.+||+|||+++....... ......|++.|+|||++.. ..++.++|||||||++|||++|+.||........ +
T Consensus 162 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~--~ 238 (286)
T cd06638 162 GVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA--L 238 (286)
T ss_pred CEEEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH--H
Confidence 999999999885543221 2233468999999998753 4578899999999999999999999976543211 0
Q ss_pred HHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 844 AEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 844 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
.. . .....+..... ......+.+++.+|++.||++||++.||++
T Consensus 239 ~~----~-------~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 282 (286)
T cd06638 239 FK----I-------PRNPPPTLHQP---ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282 (286)
T ss_pred hh----c-------cccCCCcccCC---CCcCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 00 0 00001111000 011235789999999999999999999987
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=311.12 Aligned_cols=258 Identities=27% Similarity=0.422 Sum_probs=205.6
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
++|+..+.||+|+||.||+|... ++..+|+|++....... ..+.+.+|+++++.++|+||+++++.+..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 46888999999999999999764 67899999986543333 56789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+++++|.++++.... ...+++.....++.|++.||+||| +.+|+||||||+||++++++.+||+|||++.....
T Consensus 80 ~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~ 154 (267)
T cd06610 80 YLSGGSLLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLAD 154 (267)
T ss_pred ccCCCcHHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence 9999999999975221 246899999999999999999999 88999999999999999999999999999875543
Q ss_pred CCcc---eecccccccCcccccccccC-cCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHh
Q 041143 784 GEKS---VVTRLAGTFGYLAPEYAVMG-KITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKA 859 (973)
Q Consensus 784 ~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (973)
.... ......|+..|+|||++... .++.++|||||||++|||++|+.||........ +.. ...
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~----~~~------- 221 (267)
T cd06610 155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LML----TLQ------- 221 (267)
T ss_pred CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HHH----Hhc-------
Confidence 3222 22345689999999998876 789999999999999999999999976543211 111 110
Q ss_pred hcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 860 AIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 860 ~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
.-.+.+............+.+++.+|++.||++||++.+|++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 222 NDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 011111111111123355789999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=311.47 Aligned_cols=246 Identities=34% Similarity=0.503 Sum_probs=197.6
Q ss_pred cCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEe
Q 041143 625 QNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEY 704 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 704 (973)
++|...+.||+|+||.||+|.. .++.||+|.++... ..+.+.+|+.++++++||||+++++++... ..++||||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~ 79 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL 79 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence 4688889999999999999975 47889999986432 235788999999999999999999998754 47999999
Q ss_pred cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCC
Q 041143 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG 784 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~ 784 (973)
+++|+|.+++... ....+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||+++.....
T Consensus 80 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 80 MSKGNLVNFLRTR---GRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG 153 (254)
T ss_pred CCCCCHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceecccc
Confidence 9999999999652 2245789999999999999999999 889999999999999999999999999998754332
Q ss_pred CcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCc
Q 041143 785 EKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDP 863 (973)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (973)
. .....+..|+|||++.+..++.++|||||||++|||++ |+.||......+.. ..+.. ...+
T Consensus 154 ~----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~------~~~~~-------~~~~ 216 (254)
T cd05083 154 V----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVK------ECVEK-------GYRM 216 (254)
T ss_pred C----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHH------HHHhC-------CCCC
Confidence 1 12334678999999988899999999999999999998 99999765532211 11110 0000
Q ss_pred cccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHH
Q 041143 864 ALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLS 904 (973)
Q Consensus 864 ~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~ 904 (973)
. ........+.+++.+|++.+|++||+++++++.|+
T Consensus 217 --~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 217 --E---PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred --C---CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 0 01112345779999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=319.26 Aligned_cols=269 Identities=23% Similarity=0.361 Sum_probs=201.4
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
++|...+.||+|+||.||+|+.. +++.||+|.++.... ......+.+|++++++++|+||+++++++...+..++|||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 57888999999999999999765 578999999865422 2223457789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|++ ++|.+++... ...+++..+..++.||++||+||| +.+|+||||||+||++++++.+||+|||+++....
T Consensus 85 ~~~-~~l~~~l~~~----~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 156 (301)
T cd07873 85 YLD-KDLKQYLDDC----GNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSI 156 (301)
T ss_pred ccc-cCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence 996 6898888652 245789999999999999999999 88999999999999999999999999999875433
Q ss_pred CCcceecccccccCcccccccccC-cCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhc--hhHHHhh
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVMG-KITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSS--KEKFKAA 860 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 860 (973)
... ......+++.|+|||++.+. .++.++|||||||++|||++|+.||......+... .+...... ......+
T Consensus 157 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 232 (301)
T cd07873 157 PTK-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLH---FIFRILGTPTEETWPGI 232 (301)
T ss_pred CCC-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHcCCCChhhchhh
Confidence 221 12234578999999988654 57889999999999999999999998765432211 11111000 0000111
Q ss_pred cC---------ccccCC---cccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 861 ID---------PALEVN---EETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 861 ~~---------~~l~~~---~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
++ +..... .........+.+++.+|++.||.+|||++||++ +++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~--h~~f~ 290 (301)
T cd07873 233 LSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK--HPYFH 290 (301)
T ss_pred hccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc--Ccccc
Confidence 00 100000 000011235779999999999999999999998 44443
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=311.28 Aligned_cols=250 Identities=27% Similarity=0.459 Sum_probs=200.5
Q ss_pred CccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCC-------hHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCe
Q 041143 626 NFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTT-------TKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNE 697 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 697 (973)
+|...+.||+|+||.||+|... +++.||+|.+...... ....+.+.+|++++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4677789999999999999764 5789999988654222 1234578899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccc
Q 041143 698 RLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL 777 (973)
Q Consensus 698 ~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGl 777 (973)
.++||||+++++|.+++.. ...+++..+..++.|++.||+||| +.+++||||||+||++++++.+||+|||+
T Consensus 81 ~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~ 152 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN-----YGAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGI 152 (267)
T ss_pred cEEEEEecCCCCHHHHHHh-----ccCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCC
Confidence 9999999999999999965 245788999999999999999999 78999999999999999999999999999
Q ss_pred cccCCCCCc-----ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhh
Q 041143 778 VKLAPDGEK-----SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKS 852 (973)
Q Consensus 778 a~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 852 (973)
++....... .......|+..|+|||++.+..++.++|||||||++|||++|+.||......... ..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~------~~--- 223 (267)
T cd06628 153 SKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI------FK--- 223 (267)
T ss_pred CcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHH------HH---
Confidence 885542111 1112346889999999999888999999999999999999999999765422110 00
Q ss_pred chhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 853 SKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 853 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
......+.+. ......+.+++.+|++.||.+||++.||++
T Consensus 224 ----~~~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 224 ----IGENASPEIP-----SNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ----HhccCCCcCC-----cccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 1111111111 122355789999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=317.28 Aligned_cols=261 Identities=24% Similarity=0.345 Sum_probs=202.8
Q ss_pred HHHHHHHhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEe
Q 041143 617 VQVLRKVTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIE 694 (973)
Q Consensus 617 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 694 (973)
.+.+..+.++|...+.||+|+||.||+|... +++.+|+|++... ......+.+|+.+++++ +|||++++++++..
T Consensus 14 ~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~---~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI---SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred cccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc---ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 3444556788999999999999999999774 6889999998643 22345678899999999 79999999999875
Q ss_pred C-----CeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCC
Q 041143 695 G-----NERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYR 769 (973)
Q Consensus 695 ~-----~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~ 769 (973)
. +..++||||+++|+|.++++.... ....+++..++.++.|++.||+||| +.+|+||||||+||++++++.
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLI-CGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGG 166 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCC
Confidence 4 357999999999999998865322 2356899999999999999999999 789999999999999999999
Q ss_pred EEEeeccccccCCCCCcceecccccccCcccccccccC-----cCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 041143 770 AKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMG-----KITTKADVFSYGVVLMELLTGLAALDEERPEESRYLA 844 (973)
Q Consensus 770 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~ 844 (973)
+||+|||+++........ .....|+..|+|||++... .++.++|||||||++|||++|+.||........ +.
T Consensus 167 ~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~--~~ 243 (291)
T cd06639 167 VKLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT--LF 243 (291)
T ss_pred EEEeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH--HH
Confidence 999999998855432211 2234688999999987543 368899999999999999999999976543211 11
Q ss_pred HHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 845 EWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 845 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
. +. ....+.+. ........+.+++.+|++.+|++||++.|+++
T Consensus 244 ~----~~-------~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 244 K----IP-------RNPPPTLL---HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred H----Hh-------cCCCCCCC---cccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1 11 00111111 01112245889999999999999999999987
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=313.28 Aligned_cols=247 Identities=28% Similarity=0.385 Sum_probs=198.3
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecC-CCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAG-VTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
+.|+.-++||+||||.||-++.+ +|+.+|.|++... ....+.......|-.|+.+++.+.||.+-..|+..+..++||
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 56788899999999999999765 6899999987432 222334456778999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
..|.||+|.-|+... +...+++.+++-+|.+|+.||++|| +.+||.||+||+|||+|+.|+++|+|.|+|...+
T Consensus 265 tlMNGGDLkfHiyn~---g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNH---GNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EeecCCceeEEeecc---CCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 999999999888663 2357899999999999999999999 8999999999999999999999999999999887
Q ss_pred CCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHH-HHHHHHHHHhhchhHHHhhc
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESR-YLAEWFWRIKSSKEKFKAAI 861 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 861 (973)
++... ...+||.+|||||++....|+...|.||+||++|||+.|+.||......... .+. +++....+
T Consensus 339 ~g~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvd---rr~~~~~~------ 407 (591)
T KOG0986|consen 339 EGKPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVD---RRTLEDPE------ 407 (591)
T ss_pred CCCcc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHH---HHHhcchh------
Confidence 75543 3348999999999999999999999999999999999999999754322111 000 11111111
Q ss_pred CccccCCcccHHHHHHHHHHHHHhhccCCCCCCC
Q 041143 862 DPALEVNEETFESISIVAELAGHCTAREPYHRPD 895 (973)
Q Consensus 862 ~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs 895 (973)
+++..-..+...|....++.||++|.-
T Consensus 408 -------ey~~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 408 -------EYSDKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred -------hcccccCHHHHHHHHHHHccCHHHhcc
Confidence 111122234567888899999999973
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=316.43 Aligned_cols=265 Identities=25% Similarity=0.357 Sum_probs=204.2
Q ss_pred CccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEe
Q 041143 626 NFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEY 704 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 704 (973)
+|...+.||+|+||.||+|... +|+.||||++..........+.+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778899999999999999874 689999999976544445567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCC
Q 041143 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG 784 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~ 784 (973)
+ +++|.+++.... ..+++.++..++.||++||+||| +.+|+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~-~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 81 M-PSDLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred c-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 9 999999986522 56899999999999999999999 789999999999999999999999999999865543
Q ss_pred CcceecccccccCcccccccccC-cCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhc--h-------
Q 041143 785 EKSVVTRLAGTFGYLAPEYAVMG-KITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSS--K------- 854 (973)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~------- 854 (973)
.........|+..|+|||++.+. .++.++||||+||++|||++|+++|........ ..++...... .
T Consensus 153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07832 153 EPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ---LAIVFRTLGTPNEETWPGLT 229 (286)
T ss_pred CCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH---HHHHHHHcCCCChHHHhhcc
Confidence 32223445789999999988654 468999999999999999999888866543221 1111111000 0
Q ss_pred --hHHHhhcCcccc---CCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 855 --EKFKAAIDPALE---VNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 855 --~~~~~~~~~~l~---~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
........+.-. ......+....+.+++.+|++.+|++||+++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred CcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 000000000000 00000112366889999999999999999999987
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=328.36 Aligned_cols=238 Identities=26% Similarity=0.343 Sum_probs=185.1
Q ss_pred ccccCccEEEEEEEC-CCCEEEEEEeecCC-CChHHHHHHHHHHHHHHhc---CCCceeeeeeEEEeCCeEEEEEEecCC
Q 041143 633 LGRGGFGTVYKGELE-DGTKIAVKRMEAGV-TTTKALDEFQSEIAVLSKV---RHRHLVSLLGYSIEGNERLLVYEYMPH 707 (973)
Q Consensus 633 lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lV~e~~~~ 707 (973)
||+|+||+||+|+.. +|+.||||++.... ........+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999765 58999999985421 1222334556677777665 699999999999999999999999999
Q ss_pred CCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCcc
Q 041143 708 GALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKS 787 (973)
Q Consensus 708 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~~ 787 (973)
|+|..++.. ...+++..+..++.||++||+||| +++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~-----~~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~- 151 (330)
T cd05586 81 GELFWHLQK-----EGRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK- 151 (330)
T ss_pred ChHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-
Confidence 999988864 245889999999999999999999 88999999999999999999999999999875332221
Q ss_pred eecccccccCcccccccccC-cCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCcccc
Q 041143 788 VVTRLAGTFGYLAPEYAVMG-KITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALE 866 (973)
Q Consensus 788 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 866 (973)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+. ...+.... ..+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~------~~~i~~~~--------~~~~ 217 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM------YRNIAFGK--------VRFP 217 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH------HHHHHcCC--------CCCC
Confidence 23346799999999998754 489999999999999999999999976543221 11111110 0111
Q ss_pred CCcccHHHHHHHHHHHHHhhccCCCCCCCHh
Q 041143 867 VNEETFESISIVAELAGHCTAREPYHRPDMG 897 (973)
Q Consensus 867 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ 897 (973)
.. .....+.+++.+|++.||.+||++.
T Consensus 218 ~~----~~~~~~~~li~~~L~~~P~~R~~~~ 244 (330)
T cd05586 218 KN----VLSDEGRQFVKGLLNRNPQHRLGAH 244 (330)
T ss_pred Cc----cCCHHHHHHHHHHcCCCHHHCCCCC
Confidence 00 1123467899999999999999543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=309.48 Aligned_cols=251 Identities=26% Similarity=0.408 Sum_probs=195.6
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCC---ChHHHHHHHHHHHHHHhcCCCceeeeeeEEEe--CCeE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVT---TTKALDEFQSEIAVLSKVRHRHLVSLLGYSIE--GNER 698 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 698 (973)
.+|...+.||+|+||.||+|... ++..||+|++..... ..+..+.+.+|+.++++++||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36888999999999999999764 588999998864321 23345678999999999999999999998876 3567
Q ss_pred EEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecccc
Q 041143 699 LLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLV 778 (973)
Q Consensus 699 ~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla 778 (973)
++||||+++++|.+++.. ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 82 ~l~~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~ 153 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA-----YGALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGAS 153 (266)
T ss_pred EEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCc
Confidence 899999999999999865 235789999999999999999999 889999999999999999999999999998
Q ss_pred ccCCCCC--cceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhH
Q 041143 779 KLAPDGE--KSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEK 856 (973)
Q Consensus 779 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (973)
+...... ........++..|+|||++.+..++.++|||||||++|||++|+.||......... ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~------~~~~----- 222 (266)
T cd06651 154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI------FKIA----- 222 (266)
T ss_pred cccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHH------HHHh-----
Confidence 7543211 11123356889999999999888999999999999999999999999765322110 0000
Q ss_pred HHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 857 FKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 857 ~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
.....+.+. ......+.+++ .|+..+|++||+++||++
T Consensus 223 -~~~~~~~~~-----~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 223 -TQPTNPQLP-----SHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred -cCCCCCCCc-----hhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 000111111 11223345566 688899999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=312.07 Aligned_cols=237 Identities=26% Similarity=0.440 Sum_probs=188.6
Q ss_pred CcccccCccEEEEEEECCCC-----------EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEE
Q 041143 631 NELGRGGFGTVYKGELEDGT-----------KIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERL 699 (973)
Q Consensus 631 ~~lG~G~fg~Vy~~~~~~g~-----------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 699 (973)
+.||+|+||.||+|.+.+.. .|++|.+.... .....|.+|+.++++++||||+++++++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 46899999999999876433 57788765432 125788999999999999999999999988 7789
Q ss_pred EEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCC-------CEEE
Q 041143 700 LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDY-------RAKV 772 (973)
Q Consensus 700 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~-------~~kl 772 (973)
+||||+++|+|.+++.... ..+++..++.++.||+.||+||| +++|+||||||+||+++.++ .+||
T Consensus 77 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl 149 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREK----NNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKL 149 (259)
T ss_pred EEEEcCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEe
Confidence 9999999999999997521 26889999999999999999999 88999999999999999887 7999
Q ss_pred eeccccccCCCCCcceecccccccCcccccccccC--cCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHH
Q 041143 773 SDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMG--KITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWR 849 (973)
Q Consensus 773 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 849 (973)
+|||+++.... .....++..|+|||++... .++.++|||||||++|||++ |..|+......+... +..
T Consensus 150 ~Dfg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~---~~~- 220 (259)
T cd05037 150 SDPGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER---FYQ- 220 (259)
T ss_pred CCCCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH---HHh-
Confidence 99999985443 1224567889999998876 78999999999999999999 577776554221110 000
Q ss_pred HhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHH
Q 041143 850 IKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVL 903 (973)
Q Consensus 850 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L 903 (973)
. ..... .. ....+.+++.+|+..+|.+||++.+|++.|
T Consensus 221 --~---------~~~~~-~~----~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 221 --D---------QHRLP-MP----DCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred --c---------CCCCC-CC----CchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0 00011 00 115688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=318.64 Aligned_cols=254 Identities=25% Similarity=0.334 Sum_probs=202.6
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTT-TKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
++|...+.||+|+||.||+|... +++.||+|.+...... ....+.+.+|+++++.++|+||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888899999999999999876 4899999998764322 235667899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+.+++|.+++... ....+++..+..++.|+++||+||| ..+++|+||||+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 81 DYCPGGELFRLLQRQ---PGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EecCCCCHHHHHHhC---CCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence 999999999998642 2356899999999999999999999 8899999999999999999999999999987433
Q ss_pred CCCcc----------------------------eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCC
Q 041143 783 DGEKS----------------------------VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDE 834 (973)
Q Consensus 783 ~~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~ 834 (973)
..... ......||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 234 (316)
T cd05574 155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKG 234 (316)
T ss_pred ccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCC
Confidence 21110 11234689999999999988899999999999999999999999976
Q ss_pred CChhhHHHHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCC----HhHHHH
Q 041143 835 ERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPD----MGHVVN 901 (973)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs----~~~v~~ 901 (973)
...... +....+....... .......+.+++.+|++.||++||+ +.|+++
T Consensus 235 ~~~~~~----------------~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 235 SNRDET----------------FSNILKKEVTFPG-SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred CchHHH----------------HHHHhcCCccCCC-ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 553221 1111111111111 1113456889999999999999999 555555
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=309.02 Aligned_cols=253 Identities=27% Similarity=0.458 Sum_probs=203.3
Q ss_pred CccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEe
Q 041143 626 NFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEY 704 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 704 (973)
+|...+.||+|+||.||+|... +++.||+|.++.........+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4778899999999999999764 688999999986644445678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCC
Q 041143 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG 784 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~ 784 (973)
+++++|.+++.. ...+++..+..++.++++||+||| +.+|+|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~ 152 (264)
T cd06626 81 CSGGTLEELLEH-----GRILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN 152 (264)
T ss_pred CCCCcHHHHHhh-----cCCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence 999999999865 234788999999999999999999 889999999999999999999999999998865443
Q ss_pred Cccee---cccccccCcccccccccCc---CCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHH
Q 041143 785 EKSVV---TRLAGTFGYLAPEYAVMGK---ITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFK 858 (973)
Q Consensus 785 ~~~~~---~~~~gt~~y~aPE~~~~~~---~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (973)
..... ....++..|+|||++.+.. ++.++||||||+++|||++|+.||........ . ......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~--~---~~~~~~------ 221 (264)
T cd06626 153 TTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ--I---MFHVGA------ 221 (264)
T ss_pred CCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH--H---HHHHhc------
Confidence 32211 1356889999999998766 88999999999999999999999975532111 0 001110
Q ss_pred hhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 859 AAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 859 ~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
...+.+. ........+.+++.+|++.+|++||++.|++.
T Consensus 222 -~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 222 -GHKPPIP---DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -CCCCCCC---cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0111111 00111344679999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=317.64 Aligned_cols=265 Identities=20% Similarity=0.283 Sum_probs=197.0
Q ss_pred CccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEe
Q 041143 626 NFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEY 704 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 704 (973)
+|+..+.||+|+||.||+|+.. +|+.||+|+++...........+.+|++++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778899999999999999875 689999999875433333345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCC
Q 041143 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG 784 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~ 784 (973)
++ ++|.+++... ...+++..+..++.||++||.||| .++|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 152 (284)
T cd07839 81 CD-QDLKKYFDSC----NGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 152 (284)
T ss_pred CC-CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence 96 5888877542 245899999999999999999999 789999999999999999999999999999855432
Q ss_pred CcceecccccccCcccccccccC-cCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhh-c-hh---HHH
Q 041143 785 EKSVVTRLAGTFGYLAPEYAVMG-KITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKS-S-KE---KFK 858 (973)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~-~~---~~~ 858 (973)
.. ......++..|+|||++.+. .++.++|||||||++|||++|+.|+........ .+ ....+... . .. ...
T Consensus 153 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07839 153 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QL-KRIFRLLGTPTEESWPGVS 229 (284)
T ss_pred CC-CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH-HH-HHHHHHhCCCChHHhHHhh
Confidence 22 12334678999999988764 478999999999999999999998654332211 11 10000000 0 00 000
Q ss_pred hhcCc----cccC----CcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 859 AAIDP----ALEV----NEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 859 ~~~~~----~l~~----~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
...+. .... ..........+.+++.+|++.||.+|||++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 230 KLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00000 0000 0000112345779999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=311.92 Aligned_cols=261 Identities=26% Similarity=0.401 Sum_probs=207.4
Q ss_pred CccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEe
Q 041143 626 NFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEY 704 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 704 (973)
+|+..+.||+|+||.||+|... +++.+|+|++.... .....+++.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI-NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc-ChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 5777889999999999999876 68899999987653 235567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhcc-CCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLAR-QTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~-~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
+++++|.+++.... ..+++.....++.|++.||+||| + .+++|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~ 153 (265)
T cd06605 81 MDGGSLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN 153 (265)
T ss_pred cCCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHH
Confidence 99999999986521 56888999999999999999999 6 8999999999999999999999999999875432
Q ss_pred CCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCc
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDP 863 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (973)
... ....|+..|+|||++.+..++.++||||||+++|+|++|+.||....... ............ ...+
T Consensus 154 ~~~---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~-------~~~~ 222 (265)
T cd06605 154 SLA---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIVN-------EPPP 222 (265)
T ss_pred HHh---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHhc-------CCCC
Confidence 221 12678899999999998899999999999999999999999997553111 111111111111 0111
Q ss_pred cccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcC
Q 041143 864 ALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWR 911 (973)
Q Consensus 864 ~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~ 911 (973)
.+... .....+.+++.+|+..+|++||++.+++. .++.++|+
T Consensus 223 ~~~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~ll~--~~~~~~~~ 264 (265)
T cd06605 223 RLPSG----KFSPDFQDFVNLCLIKDPRERPSYKELLE--HPFIKKYE 264 (265)
T ss_pred CCChh----hcCHHHHHHHHHHcCCCchhCcCHHHHhh--Cchhhccc
Confidence 11100 12345789999999999999999999997 66665543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=317.28 Aligned_cols=257 Identities=22% Similarity=0.317 Sum_probs=201.1
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
++|...+.||+|+||.||++... .++.||+|.+..... .....+.+.+|+++++.++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888899999999999999765 578999999865421 2234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++|+|.+++.. ...+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 81 e~~~g~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~ 152 (305)
T cd05609 81 EYVEGGDCATLLKN-----IGALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGL 152 (305)
T ss_pred ecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccC
Confidence 99999999999965 245889999999999999999999 7899999999999999999999999999987321
Q ss_pred CCC--------------cceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHH
Q 041143 783 DGE--------------KSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFW 848 (973)
Q Consensus 783 ~~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 848 (973)
... ........|+..|+|||++....++.++|+|||||++|||++|+.||.+....+ +..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~------~~~ 226 (305)
T cd05609 153 MSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE------LFG 226 (305)
T ss_pred cCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHH
Confidence 100 001122467889999999988889999999999999999999999997654322 111
Q ss_pred HHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHH
Q 041143 849 RIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSP 905 (973)
Q Consensus 849 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~ 905 (973)
..... ....+... ......+.+++.+|++.||++||++.++.+.|+.
T Consensus 227 ~~~~~-----~~~~~~~~-----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 227 QVISD-----DIEWPEGD-----EALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHHhc-----ccCCCCcc-----ccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 11110 00111110 0122347899999999999999997766665543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=317.76 Aligned_cols=252 Identities=24% Similarity=0.413 Sum_probs=200.2
Q ss_pred ccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEec
Q 041143 627 FAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYM 705 (973)
Q Consensus 627 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 705 (973)
|.....||+|+||.||+|... +++.||+|++... .....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~ 100 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLR--KQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL 100 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEec--ccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence 334457999999999999764 6899999998654 2233466889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCC
Q 041143 706 PHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGE 785 (973)
Q Consensus 706 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~ 785 (973)
++++|..++.. ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~ 171 (297)
T cd06659 101 QGGALTDIVSQ------TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV 171 (297)
T ss_pred CCCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc
Confidence 99999987743 45789999999999999999999 8899999999999999999999999999987543322
Q ss_pred cceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccc
Q 041143 786 KSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPAL 865 (973)
Q Consensus 786 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 865 (973)
. ......|+..|+|||++.+..++.++|||||||++|||++|+.||......+.. ..+.. ...+..
T Consensus 172 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~------~~~~~-------~~~~~~ 237 (297)
T cd06659 172 P-KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM------KRLRD-------SPPPKL 237 (297)
T ss_pred c-cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHhc-------cCCCCc
Confidence 1 123356899999999999889999999999999999999999999765432211 11100 001111
Q ss_pred cCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 866 EVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 866 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
. ........+.+++.+|++.+|++||++.++++ .+++.
T Consensus 238 ~---~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~--~~~~~ 275 (297)
T cd06659 238 K---NAHKISPVLRDFLERMLTREPQERATAQELLD--HPFLL 275 (297)
T ss_pred c---ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh--Chhhc
Confidence 1 00011234779999999999999999999998 44444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=318.95 Aligned_cols=199 Identities=27% Similarity=0.407 Sum_probs=161.0
Q ss_pred cCcccccCccEEEEEEEC---CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEe--CCeEEEEEEe
Q 041143 630 ENELGRGGFGTVYKGELE---DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIE--GNERLLVYEY 704 (973)
Q Consensus 630 ~~~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~e~ 704 (973)
..+||+|+||.||+|+.. ++..||+|.++.... ...+.+|++++++++||||+++++++.. +...++||||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 357999999999999865 357899998865321 2357789999999999999999999864 4567899999
Q ss_pred cCCCCHHHHHHhhhhc----cCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEE----CCCCCEEEeecc
Q 041143 705 MPHGALSRHLFRWEKL----QLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILL----DDDYRAKVSDFG 776 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~----~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill----~~~~~~kl~DfG 776 (973)
++ ++|.+++...... ....+++..+..++.||+.||+||| +.+|+||||||+||++ +.++++||+|||
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 85 5787777542211 1235889999999999999999999 8899999999999999 566799999999
Q ss_pred ccccCCCCCc--ceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCC
Q 041143 777 LVKLAPDGEK--SVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEER 836 (973)
Q Consensus 777 la~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~ 836 (973)
+++....... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||....
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 9986543321 12234578999999999876 458999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=307.87 Aligned_cols=252 Identities=35% Similarity=0.551 Sum_probs=200.6
Q ss_pred ccccCcccccCccEEEEEEECC-----CCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEE
Q 041143 627 FAQENELGRGGFGTVYKGELED-----GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLV 701 (973)
Q Consensus 627 ~~~~~~lG~G~fg~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 701 (973)
|...+.||.|+||.||+|...+ +..||+|+++... .....+.+..|++++..++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA-DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC-ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 3456889999999999998754 4789999986542 233567899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccC
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA 781 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~ 781 (973)
|||+++++|.+++..... ..+++.++..++.|++.||+||| +.+++||||||+||+++.++.++|+|||+++..
T Consensus 80 ~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~ 153 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDL 153 (258)
T ss_pred EeccCCCCHHHHHHhhhh---ccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceec
Confidence 999999999999875221 22899999999999999999999 889999999999999999999999999999865
Q ss_pred CCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhh
Q 041143 782 PDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAA 860 (973)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (973)
............+++.|+|||.+.+..++.++||||+|++++||++ |+.||......+. ... .....
T Consensus 154 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~---~~~---~~~~~------ 221 (258)
T smart00219 154 YDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEV---LEY---LKKGY------ 221 (258)
T ss_pred ccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH---HhcCC------
Confidence 5432222212347889999999988889999999999999999998 7888876432211 111 11100
Q ss_pred cCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHH
Q 041143 861 IDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVL 903 (973)
Q Consensus 861 ~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L 903 (973)
... ........+.+++.+|+..+|++||++.|+++.|
T Consensus 222 ---~~~---~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 222 ---RLP---KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---CCC---CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 000 0111234578899999999999999999998754
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=308.08 Aligned_cols=249 Identities=27% Similarity=0.450 Sum_probs=200.8
Q ss_pred CccccCcccccCccEEEEEEEC-CCCEEEEEEeecCC---CChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEE
Q 041143 626 NFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGV---TTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLV 701 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 701 (973)
+|+..+.||+|+||.||+|... +++.|++|.+.... ...+..+.+.+|+++++.++|+||+++++++..+...++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677789999999999999876 78999999986432 1234567899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccC
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA 781 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~ 781 (973)
|||+++++|.+++.. ...+++..+..++.|+++||+||| ..+|+|+||+|+||+++.++.+||+|||++...
T Consensus 81 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~ 152 (258)
T cd06632 81 LELVPGGSLAKLLKK-----YGSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQV 152 (258)
T ss_pred EEecCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceec
Confidence 999999999999865 245789999999999999999999 789999999999999999999999999998755
Q ss_pred CCCCcceecccccccCcccccccccCc-CCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhh
Q 041143 782 PDGEKSVVTRLAGTFGYLAPEYAVMGK-ITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAA 860 (973)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (973)
.... ......|+..|+|||.+.... ++.++|+|||||++|||++|+.||........ . ...... .. ...
T Consensus 153 ~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~--~----~~~~~~-~~-~~~ 222 (258)
T cd06632 153 VEFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA--V----FKIGRS-KE-LPP 222 (258)
T ss_pred cccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH--H----HHHHhc-cc-CCC
Confidence 4332 223456899999999987766 89999999999999999999999976542111 1 111100 00 000
Q ss_pred cCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 861 IDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 861 ~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
+.+ .....+.+++.+|++.+|.+||++.+++.
T Consensus 223 ~~~---------~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 223 IPD---------HLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred cCC---------CcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 111 11244678999999999999999999986
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=306.91 Aligned_cols=251 Identities=24% Similarity=0.356 Sum_probs=196.6
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCC---CChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeC--CeE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGV---TTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEG--NER 698 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 698 (973)
++|...+.||+|+||.||+|... +|+.||+|.+.... ......+.+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47888999999999999999764 58999999885432 1234456889999999999999999999988764 457
Q ss_pred EEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecccc
Q 041143 699 LLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLV 778 (973)
Q Consensus 699 ~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla 778 (973)
++||||+++|+|.+++... ..+++.....++.|++.||+||| +.+|+|+||||+||+++.++.+||+|||++
T Consensus 82 ~~v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~ 153 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY-----GALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGAS 153 (265)
T ss_pred EEEEEecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccc
Confidence 8999999999999988642 34788889999999999999999 889999999999999999999999999998
Q ss_pred ccCCCCCc--ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhH
Q 041143 779 KLAPDGEK--SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEK 856 (973)
Q Consensus 779 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (973)
+....... .......|+..|+|||++.+..++.++|||||||++|||++|+.||........ . ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~----~~~~----- 222 (265)
T cd06652 154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA--I----FKIA----- 222 (265)
T ss_pred cccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH--H----HHHh-----
Confidence 75432111 112335689999999999888899999999999999999999999975432211 0 0000
Q ss_pred HHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 857 FKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 857 ~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
..+.. ...+......+.+++.+|+. +|++||+++||++
T Consensus 223 ----~~~~~--~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 223 ----TQPTN--PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred ----cCCCC--CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 00000 11112233457788888984 9999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=306.74 Aligned_cols=253 Identities=25% Similarity=0.423 Sum_probs=204.3
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
++|...+.||+|+||.||+|... +++.+|+|.+... .....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE--PGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcC--chhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 57888999999999999999764 5788999998754 23356788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+++++|.+++... ...+++.++..++.|++.||+||| +.+|+|+||||+||++++++.+||+|||++.....
T Consensus 81 ~~~~~~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 153 (262)
T cd06613 81 YCGGGSLQDIYQVT----RGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTA 153 (262)
T ss_pred CCCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhh
Confidence 99999999988652 245889999999999999999999 88999999999999999999999999999875443
Q ss_pred CCcceecccccccCcccccccccC---cCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhh
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVMG---KITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAA 860 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (973)
.. .......++..|+|||.+... .++.++|||||||++|||++|+.||............ . . ...
T Consensus 154 ~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~------~--~---~~~ 221 (262)
T cd06613 154 TI-AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLI------S--K---SNF 221 (262)
T ss_pred hh-hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------H--h---ccC
Confidence 21 122345688999999998776 8899999999999999999999999866543221100 0 0 000
Q ss_pred cCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 861 IDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 861 ~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
-.+.+. ........+.+++.+|+..+|.+||++.+|+.
T Consensus 222 ~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 222 PPPKLK---DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred CCcccc---chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 011111 11223456889999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=313.87 Aligned_cols=264 Identities=23% Similarity=0.345 Sum_probs=199.7
Q ss_pred CccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEe
Q 041143 626 NFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEY 704 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 704 (973)
+|+..+.||+|+||.||+|+.. +|+.||||+++.........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999775 689999999875543444446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCC
Q 041143 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG 784 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~ 784 (973)
+. ++|.+++... ....+++..+..++.|+++||+||| +.+++||||+|+||+++.++.+||+|||+++.....
T Consensus 81 ~~-~~l~~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~ 153 (284)
T cd07860 81 LH-QDLKKFMDAS---PLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 153 (284)
T ss_pred cc-cCHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 95 6898888652 2356899999999999999999999 889999999999999999999999999998754332
Q ss_pred CcceecccccccCcccccccccCc-CCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchh--------
Q 041143 785 EKSVVTRLAGTFGYLAPEYAVMGK-ITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKE-------- 855 (973)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------- 855 (973)
.. ......++..|+|||++.+.. ++.++|||||||++|||+||+.||......+ .....+........
T Consensus 154 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07860 154 VR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTS 230 (284)
T ss_pred cc-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhhhhH
Confidence 21 123345788999999887644 6889999999999999999999997654322 11111111100000
Q ss_pred ------HHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 856 ------KFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 856 ------~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
.+.......+. .........+.+++.+|++.||++||++++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 231 LPDYKPSFPKWARQDFS--KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHhhcccccccCHH--HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000000000 000011234678999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=319.94 Aligned_cols=251 Identities=26% Similarity=0.406 Sum_probs=202.9
Q ss_pred cCccccCcccccCccEEEEEEECC-CCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELED-GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
+-|.++..||.|+||.||+|..++ +-..|.|++... .....++|.-||+||..++||+||++++.|..++..++..|
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 345667789999999999997764 344567777543 66778899999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
||.||-.+..+-.. ...++..++.-+++|++.||.||| ++.|||||||+.|||++-+|.++|+|||.+-....
T Consensus 110 FC~GGAVDaimlEL----~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~ 182 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLEL----GRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS 182 (1187)
T ss_pred ecCCchHhHHHHHh----ccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchh
Confidence 99999999888652 367999999999999999999999 89999999999999999999999999998753322
Q ss_pred CCcceecccccccCcccccccc-----cCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHH
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAV-----MGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFK 858 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (973)
. ......+.|||.|||||+++ ..+|+.++||||||++|.||..+.+|.....+... +. .+.
T Consensus 183 t-~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV--ll----Kia------- 248 (1187)
T KOG0579|consen 183 T-RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LL----KIA------- 248 (1187)
T ss_pred H-HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH--HH----HHh-------
Confidence 1 22345689999999999875 45799999999999999999999999877664321 11 111
Q ss_pred hhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 859 AAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 859 ~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
.--.|.+- .+......+.+++..|+..+|..||+++++++
T Consensus 249 KSePPTLl---qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 249 KSEPPTLL---QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred hcCCCccc---CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 11122221 12233456889999999999999999999886
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=311.76 Aligned_cols=256 Identities=25% Similarity=0.421 Sum_probs=204.8
Q ss_pred CccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEe
Q 041143 626 NFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEY 704 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 704 (973)
.|...+.||+|++|.||+|.. .+++.+|+|++... .....+.+.+|+.+++.++|+||+++++++...+..++|+||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 344557899999999999976 46889999988643 334456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCC
Q 041143 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG 784 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~ 784 (973)
+++++|.+++.. ..+++.++..++.|++.||+||| +++|+||||||+||+++.++.++|+|||.+......
T Consensus 98 ~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~ 168 (285)
T cd06648 98 LEGGALTDIVTH------TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE 168 (285)
T ss_pred cCCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccC
Confidence 999999998864 35789999999999999999999 889999999999999999999999999988754332
Q ss_pred CcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCcc
Q 041143 785 EKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPA 864 (973)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 864 (973)
.. ......|++.|+|||+..+..++.++|||||||++|||++|+.||....+... .... .....+.
T Consensus 169 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~------~~~~-------~~~~~~~ 234 (285)
T cd06648 169 VP-RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA------MKRI-------RDNLPPK 234 (285)
T ss_pred Cc-ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH------HHHH-------HhcCCCC
Confidence 21 12335689999999999888899999999999999999999999976543221 1111 1111111
Q ss_pred ccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcC
Q 041143 865 LEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWR 911 (973)
Q Consensus 865 l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~ 911 (973)
.. ........+.+++.+|++.+|++||++.++++ .+++++..
T Consensus 235 ~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~--~~~~~~~~ 276 (285)
T cd06648 235 LK---NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN--HPFLAKAG 276 (285)
T ss_pred Cc---ccccCCHHHHHHHHHHcccChhhCcCHHHHcc--CcccccCC
Confidence 11 01112345889999999999999999999998 56665544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=321.42 Aligned_cols=279 Identities=22% Similarity=0.328 Sum_probs=209.4
Q ss_pred HHhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeC-----
Q 041143 622 KVTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEG----- 695 (973)
Q Consensus 622 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 695 (973)
.+.++|+..+.||+|+||.||+|... +|+.||+|++..........+.+.+|+.++++++|+||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 35688999999999999999999764 689999999865444455556788899999999999999999988643
Q ss_pred -CeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEee
Q 041143 696 -NERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSD 774 (973)
Q Consensus 696 -~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D 774 (973)
...++||||+. ++|.+.+.. .+++.++..++.|+++||+||| ..+|+||||||+||+++.++.+||+|
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~D 161 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILD 161 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEcc
Confidence 34699999995 588877743 2788899999999999999999 78999999999999999999999999
Q ss_pred ccccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHH-HHH--------H
Q 041143 775 FGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESR-YLA--------E 845 (973)
Q Consensus 775 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~-~~~--------~ 845 (973)
||+++...... ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||...+..... .+. +
T Consensus 162 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 239 (353)
T cd07850 162 FGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDE 239 (353)
T ss_pred CccceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 99998654322 123346889999999999999999999999999999999999999765432110 000 0
Q ss_pred HHHHHh-------hc-----hhHHHhhcCccccC---CcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhc
Q 041143 846 WFWRIK-------SS-----KEKFKAAIDPALEV---NEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKW 910 (973)
Q Consensus 846 ~~~~~~-------~~-----~~~~~~~~~~~l~~---~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~ 910 (973)
+..... .. ...+.+.+...... ..........+.+++.+|++.||++||++.|+++ .++++.|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~--~~~~~~~ 317 (353)
T cd07850 240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ--HPYINVW 317 (353)
T ss_pred HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc--ChhHhhc
Confidence 000000 00 00000111110000 0001123445789999999999999999999998 8888777
Q ss_pred CCCCC
Q 041143 911 RPITD 915 (973)
Q Consensus 911 ~~~~~ 915 (973)
....+
T Consensus 318 ~~~~~ 322 (353)
T cd07850 318 YDPSE 322 (353)
T ss_pred cCCcc
Confidence 65443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=310.35 Aligned_cols=254 Identities=25% Similarity=0.447 Sum_probs=203.5
Q ss_pred CccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcC---CCceeeeeeEEEeCCeEEEE
Q 041143 626 NFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR---HRHLVSLLGYSIEGNERLLV 701 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV 701 (973)
.|+..+.||+|+||.||+|.. .+++.||+|.++... .....+++.+|++++++++ |||++++++++..+...++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 467788999999999999986 468999999986542 3344567889999999996 99999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccC
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA 781 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~ 781 (973)
|||+++++|.+++.. ..+++.....++.|++.||.||| +.+|+|+||+|+||+++.++.++|+|||++...
T Consensus 81 ~e~~~~~~L~~~~~~------~~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06917 81 MEYAEGGSVRTLMKA------GPIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALL 151 (277)
T ss_pred EecCCCCcHHHHHHc------cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeec
Confidence 999999999998854 36899999999999999999999 889999999999999999999999999999865
Q ss_pred CCCCcceecccccccCcccccccccC-cCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhh
Q 041143 782 PDGEKSVVTRLAGTFGYLAPEYAVMG-KITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAA 860 (973)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (973)
..... ......|+..|+|||++.++ .++.++|||||||++|||++|+.||........ ... ....
T Consensus 152 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~------~~~-------~~~~ 217 (277)
T cd06917 152 NQNSS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA------MML-------IPKS 217 (277)
T ss_pred CCCcc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh------hhc-------cccC
Confidence 54332 23345789999999988654 468899999999999999999999976543211 000 0011
Q ss_pred cCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 861 IDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 861 ~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
..+.+... .....+.+++.+|++.||++||++.+++. .+++++
T Consensus 218 ~~~~~~~~----~~~~~~~~~i~~~l~~~p~~R~~~~~il~--~~~~~~ 260 (277)
T cd06917 218 KPPRLEDN----GYSKLLREFVAACLDEEPKERLSAEELLK--SKWIKA 260 (277)
T ss_pred CCCCCCcc----cCCHHHHHHHHHHcCCCcccCcCHHHHhh--ChHhhc
Confidence 11222111 12345789999999999999999999988 555543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=307.05 Aligned_cols=250 Identities=24% Similarity=0.361 Sum_probs=202.8
Q ss_pred CccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEe
Q 041143 626 NFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEY 704 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 704 (973)
+|+..+.||+|+||.||+|... +++.+|||++..........+.+.+|++++++++||||+++++++..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4778899999999999999764 688999999876544555677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCC-CCEEEeeccccccCCC
Q 041143 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDD-YRAKVSDFGLVKLAPD 783 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~-~~~kl~DfGla~~~~~ 783 (973)
+++++|.+++.... ...+++..+..++.++++||+||| +++|+|+||||+||+++++ +.+||+|||+++....
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 81 APGGTLAEYIQKRC---NSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred CCCCCHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 99999999997522 245899999999999999999999 8899999999999999865 4689999999986544
Q ss_pred CCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCc
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDP 863 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (973)
... .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||........ . ..... ... .
T Consensus 155 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~---~~~~~------~~~-~ 219 (256)
T cd08220 155 KSK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL---V---LKIMS------GTF-A 219 (256)
T ss_pred Ccc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH---H---HHHHh------cCC-C
Confidence 321 2235689999999999888899999999999999999999999976543211 1 11110 000 0
Q ss_pred cccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 864 ALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 864 ~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
.+. ......+.+++.+|++.+|++||++.|+++
T Consensus 220 ~~~-----~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 220 PIS-----DRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCC-----CCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 000 012235779999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=316.01 Aligned_cols=271 Identities=23% Similarity=0.331 Sum_probs=203.4
Q ss_pred CccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCC---hHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEE
Q 041143 626 NFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTT---TKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLV 701 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 701 (973)
+|...+.||+|+||.||+|... +|+.||||+++..... ......+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777889999999999999865 6899999999765332 23345677899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccC
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA 781 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~ 781 (973)
|||+ +|+|.+++.... ..+++..+..++.||++||+||| ..+|+|+||||+||+++.++.+||+|||+++..
T Consensus 81 ~e~~-~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~ 152 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSF 152 (298)
T ss_pred Eccc-CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeec
Confidence 9999 999999986521 36899999999999999999999 889999999999999999999999999999865
Q ss_pred CCCCcceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhc-hhHHH-
Q 041143 782 PDGEKSVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSS-KEKFK- 858 (973)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~- 858 (973)
..... ......+++.|+|||.+.+ ..++.++|||||||++|||++|..+|......+. +.......... .....
T Consensus 153 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 229 (298)
T cd07841 153 GSPNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ--LGKIFEALGTPTEENWPG 229 (298)
T ss_pred cCCCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH--HHHHHHHcCCCchhhhhh
Confidence 44322 1233456889999998864 4678999999999999999999888876543221 11111100000 00000
Q ss_pred -----hhcCc----cccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 859 -----AAIDP----ALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 859 -----~~~~~----~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
..... ..............+.+++.+|++.||++||+++||++ ..+.+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~--~~~~~~ 287 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE--HPYFSN 287 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh--CccccC
Confidence 00000 00000000112346789999999999999999999998 655554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=312.44 Aligned_cols=259 Identities=25% Similarity=0.385 Sum_probs=198.0
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHH-HHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAV-LSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
++|+..+.||+|+||.||+|+.. +|+.||+|+++....... ...+..|+.+ ++..+||||+++++++..++..++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 36888899999999999999875 689999999876533333 3455566665 56678999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccC-CeeeccCCCCcEEECCCCCEEEeeccccccC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQ-TFIHRDLKSSNILLDDDYRAKVSDFGLVKLA 781 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~-~ivH~Dikp~Nill~~~~~~kl~DfGla~~~ 781 (973)
||++ |+|.+++...... ...+++..+..++.||+.||+||| ++ +++||||||+||+++.++.+||+|||+++..
T Consensus 80 e~~~-~~l~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDK-GLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL 154 (283)
T ss_pred hhhc-ccHHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 9995 7898888653322 256899999999999999999999 55 8999999999999999999999999998865
Q ss_pred CCCCcceecccccccCccccccccc----CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHH
Q 041143 782 PDGEKSVVTRLAGTFGYLAPEYAVM----GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKF 857 (973)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (973)
.... ......|+..|+|||++.+ ..++.++|+|||||++|||++|+.||...... ...+.. .
T Consensus 155 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~----~------- 220 (283)
T cd06617 155 VDSV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-FQQLKQ----V------- 220 (283)
T ss_pred cccc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-HHHHHH----H-------
Confidence 4321 1233568899999998764 45688999999999999999999999643211 111110 0
Q ss_pred HhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 858 KAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 858 ~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
.....+.+... .....+.+++.+|++.+|++||++.+|++ .++++.
T Consensus 221 ~~~~~~~~~~~----~~~~~l~~li~~~l~~~p~~Rp~~~~il~--~~~~~~ 266 (283)
T cd06617 221 VEEPSPQLPAE----KFSPEFQDFVNKCLKKNYKERPNYPELLQ--HPFFEL 266 (283)
T ss_pred HhcCCCCCCcc----ccCHHHHHHHHHHccCChhhCcCHHHHhc--Cchhhh
Confidence 01111111101 12245789999999999999999999988 555443
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=318.39 Aligned_cols=280 Identities=24% Similarity=0.326 Sum_probs=206.7
Q ss_pred HHhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeC--Ce
Q 041143 622 KVTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEG--NE 697 (973)
Q Consensus 622 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~ 697 (973)
.+.++|+..+.||+|+||.||+|.+. +|+.+|||++............+.+|+.+++++ +||||+++++++... ..
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 35578899999999999999999875 588999998865433444456678899999999 999999999998754 36
Q ss_pred EEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccc
Q 041143 698 RLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL 777 (973)
Q Consensus 698 ~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGl 777 (973)
.++||||++ ++|..++.. ..++|..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 84 ~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~ 153 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRA------NILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGL 153 (337)
T ss_pred EEEEecccc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccc
Confidence 799999996 699888754 26789999999999999999999 78999999999999999999999999999
Q ss_pred cccCCCCCc----ceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhh
Q 041143 778 VKLAPDGEK----SVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKS 852 (973)
Q Consensus 778 a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 852 (973)
++....... .......|+..|+|||++.+ ..++.++|||||||++|||++|+.||......+...-.........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07852 154 ARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPS 233 (337)
T ss_pred hhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 985543322 12334578999999998765 4578899999999999999999999976543322111000000000
Q ss_pred -------chhHHHhhcC----cccc-CCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCCC
Q 041143 853 -------SKEKFKAAID----PALE-VNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPI 913 (973)
Q Consensus 853 -------~~~~~~~~~~----~~l~-~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~~ 913 (973)
........++ .... ...........+.+++.+|++.||++||++.++++ .++++++...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~--~~~~~~~~~~ 304 (337)
T cd07852 234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE--HPYVAQFHNP 304 (337)
T ss_pred HHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh--ChhhhhhccC
Confidence 0000001111 0000 00000112345789999999999999999999998 6666665443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=309.53 Aligned_cols=264 Identities=22% Similarity=0.324 Sum_probs=204.7
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeC--CeEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEG--NERLLV 701 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV 701 (973)
++|...+.||.|++|.||+|... +++.+|+|.+.... ......++.+|++++++++||||+++++++.+. ...++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP-NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC-chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 36788899999999999999875 57899999987542 234567789999999999999999999998754 367999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccC
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA 781 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~ 781 (973)
|||+++++|.+++..... ....+++.....++.|++.||+||| ..+++|+||+|+||++++++.++|+|||++...
T Consensus 80 ~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~ 155 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL 155 (287)
T ss_pred EEecCCCCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccc
Confidence 999999999998865332 2356889999999999999999999 889999999999999999999999999998754
Q ss_pred CCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCCh--hhHHHHHHHHHHHhhchhHHHh
Q 041143 782 PDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERP--EESRYLAEWFWRIKSSKEKFKA 859 (973)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 859 (973)
.... .....++..|+|||.+.+..++.++||||+||++|||++|+.||..... ........+..... ...+
T Consensus 156 ~~~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~-- 228 (287)
T cd06621 156 VNSL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP--NPEL-- 228 (287)
T ss_pred cccc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC--chhh--
Confidence 3322 1234678899999999988999999999999999999999999986532 11111122211100 0000
Q ss_pred hcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhh
Q 041143 860 AIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLV 907 (973)
Q Consensus 860 ~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~ 907 (973)
.... .........+.+++.+|++.+|++||++.||++ .+++
T Consensus 229 --~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~--~~~~ 269 (287)
T cd06621 229 --KDEP---GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE--HPWI 269 (287)
T ss_pred --ccCC---CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh--Cccc
Confidence 0000 001122356789999999999999999999998 4444
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=296.17 Aligned_cols=251 Identities=28% Similarity=0.356 Sum_probs=203.3
Q ss_pred HhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEE
Q 041143 623 VTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLL 700 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 700 (973)
..++|..+++||+|.||+|.+++-+ .|+.+|+|+++..+. .......-..|-++|+..+||.+..+...++..+..++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 3478889999999999999999754 689999999987643 33445667889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecccccc
Q 041143 701 VYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKL 780 (973)
Q Consensus 701 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~ 780 (973)
||||..||.|.-+|.+ .+.+++....-+...|+.||.||| +++||.||+|.+|.|+|.+|++||+|||+++.
T Consensus 246 VMeyanGGeLf~HLsr-----er~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE 317 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSR-----ERVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKE 317 (516)
T ss_pred EEEEccCceEeeehhh-----hhcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchh
Confidence 9999999999998865 355788888889999999999999 88999999999999999999999999999984
Q ss_pred CCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhh
Q 041143 781 APDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAA 860 (973)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (973)
.... ......++|||.|+|||++....|+.++|.|.+|||+|||++|+.||...+.... .+. +...+-++..
T Consensus 318 ~I~~-g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kL---FeL---Il~ed~kFPr- 389 (516)
T KOG0690|consen 318 EIKY-GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKL---FEL---ILMEDLKFPR- 389 (516)
T ss_pred cccc-cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHH---HHH---HHhhhccCCc-
Confidence 3322 2345678999999999999999999999999999999999999999987654321 111 1111111111
Q ss_pred cCccccCCcccHHHHHHHHHHHHHhhccCCCCCC-----CHhHHHH
Q 041143 861 IDPALEVNEETFESISIVAELAGHCTAREPYHRP-----DMGHVVN 901 (973)
Q Consensus 861 ~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~~v~~ 901 (973)
.+ ..+...|+.-.+..||.+|. .++||.+
T Consensus 390 ---~l---------s~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 390 ---TL---------SPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred ---cC---------CHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 11 12345778889999999996 4555554
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=309.29 Aligned_cols=255 Identities=25% Similarity=0.455 Sum_probs=198.6
Q ss_pred CccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCC--------hHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC
Q 041143 626 NFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTT--------TKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGN 696 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 696 (973)
+|...+.||+|+||.||+|... +|+.||+|.++..... ....+.+.+|+.++++++|+||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677889999999999999754 6899999987532111 112356888999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecc
Q 041143 697 ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFG 776 (973)
Q Consensus 697 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG 776 (973)
..++||||+++|+|.++++.. ..+++..+..++.||+.||.||| +++++||||+|+||+++.++.++|+|||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~ 153 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-----GRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFG 153 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecc
Confidence 999999999999999998652 46889999999999999999999 7899999999999999999999999999
Q ss_pred ccccCCCCCcc-eecccccccCcccccccccCc--CCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhc
Q 041143 777 LVKLAPDGEKS-VVTRLAGTFGYLAPEYAVMGK--ITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSS 853 (973)
Q Consensus 777 la~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 853 (973)
+++........ ......|+..|+|||++.... ++.++||||||+++|||++|+.||........ + .....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~----~~~~~- 226 (272)
T cd06629 154 ISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA--M----FKLGN- 226 (272)
T ss_pred ccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH--H----HHhhc-
Confidence 99855432211 123356899999999987654 78999999999999999999999965432211 0 00000
Q ss_pred hhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 854 KEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 854 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
......++... .......+.+++.+|++.+|++||++.+|++
T Consensus 227 -~~~~~~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 227 -KRSAPPIPPDV-----SMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred -cccCCcCCccc-----cccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 00000111111 1122356789999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=310.33 Aligned_cols=255 Identities=27% Similarity=0.391 Sum_probs=201.2
Q ss_pred HhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCC----
Q 041143 623 VTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGN---- 696 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~---- 696 (973)
.+++|+..+.||+|+||.||+|... +++.+++|++... ....+++.+|+++++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII---EDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecC---chhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 4678999999999999999999875 5789999998754 22346789999999999 6999999999997644
Q ss_pred --eEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEee
Q 041143 697 --ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSD 774 (973)
Q Consensus 697 --~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D 774 (973)
..++||||+++++|.+++..... ....+++..+..++.|+++||+||| +.+++|+||+|+||++++++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d 156 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRK-KGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVD 156 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECC
Confidence 48999999999999999865332 2356899999999999999999999 88999999999999999999999999
Q ss_pred ccccccCCCCCcceecccccccCccccccccc-----CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHH
Q 041143 775 FGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVM-----GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWR 849 (973)
Q Consensus 775 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 849 (973)
||++........ ......|+..|+|||++.. ..++.++|||||||++|||++|+.||........ +..
T Consensus 157 ~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~---- 229 (275)
T cd06608 157 FGVSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA--LFK---- 229 (275)
T ss_pred Cccceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH--HHH----
Confidence 999875443221 2233568999999998753 3467899999999999999999999975432211 110
Q ss_pred HhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 850 IKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 850 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
+. ....+.+. ........+.+++.+|+..||++||++.|+++
T Consensus 230 ~~-------~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 230 IP-------RNPPPTLK---SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hh-------ccCCCCCC---chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 10 01111111 11123346789999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=306.73 Aligned_cols=258 Identities=24% Similarity=0.391 Sum_probs=209.4
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
++|+..+.||+|++|.||+|... +++.||||++...... ...+.+.+|++++.+++|+||+++++++...+..++|||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 36788899999999999999876 4899999998765322 456789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhcc-CCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLAR-QTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~-~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
|+++++|.+++... ..+++..+..++.|+++|++||| . .+++||||+|+||+++.++.++|+|||++....
T Consensus 80 ~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~ 151 (264)
T cd06623 80 YMDGGSLADLLKKV-----GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLE 151 (264)
T ss_pred ecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 99999999999652 56899999999999999999999 7 999999999999999999999999999988654
Q ss_pred CCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcC
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (973)
..... .....++..|+|||.+....++.++||||||+++|||++|+.||.............++. ....
T Consensus 152 ~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~----------~~~~ 220 (264)
T cd06623 152 NTLDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC----------DGPP 220 (264)
T ss_pred cCCCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh----------cCCC
Confidence 33222 224568899999999998889999999999999999999999997664211111111111 1111
Q ss_pred ccccCCcccHH-HHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 863 PALEVNEETFE-SISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 863 ~~l~~~~~~~~-~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
+.+. .. ....+.+++.+|++.+|++||++.++++ .++++.
T Consensus 221 ~~~~-----~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~--~~~~~~ 261 (264)
T cd06623 221 PSLP-----AEEFSPEFRDFISACLQKDPKKRPSAAELLQ--HPFIKK 261 (264)
T ss_pred CCCC-----cccCCHHHHHHHHHHccCChhhCCCHHHHHh--CHHHHh
Confidence 1111 11 3356889999999999999999999998 555553
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=317.84 Aligned_cols=302 Identities=23% Similarity=0.352 Sum_probs=221.0
Q ss_pred CccccCcccccCccEEEEEEEC-C--CCEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeC----Ce
Q 041143 626 NFAQENELGRGGFGTVYKGELE-D--GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEG----NE 697 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~-~--g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~ 697 (973)
+|...+.||+|+||.||+++.. . +..||+|++..........+.+.+|+++++++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4777889999999999999865 3 67899999875433444456788999999999 599999999976532 45
Q ss_pred EEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccc
Q 041143 698 RLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL 777 (973)
Q Consensus 698 ~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGl 777 (973)
.++++||+. ++|.+++.. ...+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 81 ~~~~~e~~~-~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~ 151 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS-----GQPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGL 151 (332)
T ss_pred EEEEEeccc-CCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCC
Confidence 688899985 689888854 256899999999999999999999 88999999999999999999999999999
Q ss_pred cccCCCCCc---ceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHH-H--------
Q 041143 778 VKLAPDGEK---SVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYL-A-------- 844 (973)
Q Consensus 778 a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~-~-------- 844 (973)
++....... .......||..|+|||++.+ ..++.++||||+||++|+|++|+.||........... .
T Consensus 152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 231 (332)
T cd07857 152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDE 231 (332)
T ss_pred ceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCH
Confidence 985443221 11234578999999998765 4689999999999999999999999976543211000 0
Q ss_pred HHHHHHhhchh-HHHhhcC--ccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCCCCCCCcccC
Q 041143 845 EWFWRIKSSKE-KFKAAID--PALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPITDESECCS 921 (973)
Q Consensus 845 ~~~~~~~~~~~-~~~~~~~--~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~~~~~~~~~~ 921 (973)
.+......... ....... +..............+.+++.+|++.||++||++.+++. .+++.+|+.+.....|+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~--~~~~~~~~~~~~~~~~~~ 309 (332)
T cd07857 232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE--HPYLAIWHDPDDEPVCQK 309 (332)
T ss_pred HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc--ChhhhhhcCccccccccc
Confidence 00000000000 0000000 000000000011245789999999999999999999998 899999998877777888
Q ss_pred CCCCCCCchhHHHHHHH
Q 041143 922 GIDYSLPLPQMLKVWQE 938 (973)
Q Consensus 922 ~~~~~~~~p~~~~~~~~ 938 (973)
..+++...-+.++.-+.
T Consensus 310 ~~~~~~~~~~~~~~~~~ 326 (332)
T cd07857 310 PFDFSFESEDSMEELRD 326 (332)
T ss_pred cccCCccccccHHHHHH
Confidence 77777766666655443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=312.82 Aligned_cols=255 Identities=24% Similarity=0.426 Sum_probs=204.8
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
.+|...+.||+|+||.||+|... ++..||+|.+... .....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc--cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence 67888899999999999999754 6789999998643 33345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+++++|.+++.. ..+++.++..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++.....
T Consensus 97 ~~~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~ 167 (293)
T cd06647 97 YLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (293)
T ss_pred cCCCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence 9999999999864 35789999999999999999999 88999999999999999999999999999875443
Q ss_pred CCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCc
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDP 863 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (973)
... ......|++.|+|||++....++.++|||||||++||+++|+.||.......... ...... .+
T Consensus 168 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~------~~~~~~-------~~ 233 (293)
T cd06647 168 EQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNG-------TP 233 (293)
T ss_pred ccc-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee------ehhcCC-------CC
Confidence 322 2233468899999999988889999999999999999999999997654322100 000000 00
Q ss_pred cccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 864 ALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 864 ~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
... ........+.+++.+|++.+|++||++.+++. +++.+.
T Consensus 234 ~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~--h~~~~~ 274 (293)
T cd06647 234 ELQ---NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ--HPFLKI 274 (293)
T ss_pred CCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhc--CHHHhc
Confidence 110 11112345779999999999999999999998 555543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=307.83 Aligned_cols=253 Identities=26% Similarity=0.454 Sum_probs=203.4
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
+-|...+.||+|+||.||+|... +++.||+|.+.... .....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 34667789999999999999764 68899999876442 23445678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+++|+|.+++.. ..+++..+..++.|++.|+.||| +.+++|+||||+||+++.++.++|+|||++.....
T Consensus 83 ~~~~~~l~~~i~~------~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06641 83 YLGGGSALDLLEP------GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 153 (277)
T ss_pred eCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence 9999999998854 45789999999999999999999 88999999999999999999999999999875543
Q ss_pred CCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCc
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDP 863 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (973)
... ......|+..|+|||++.+..++.++|||||||++|||++|..||........ ...+.. .-.+
T Consensus 154 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~-------~~~~ 219 (277)
T cd06641 154 TQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV------LFLIPK-------NNPP 219 (277)
T ss_pred chh-hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH------HHHHhc-------CCCC
Confidence 221 12335688999999999888899999999999999999999999975443211 111110 0011
Q ss_pred cccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 864 ALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 864 ~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
.+. ......+.+++.+|++.+|.+||++.++++ .++..
T Consensus 220 ~~~-----~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~--~~~~~ 257 (277)
T cd06641 220 TLE-----GNYSKPLKEFVEACLNKEPSFRPTAKELLK--HKFIV 257 (277)
T ss_pred CCC-----cccCHHHHHHHHHHccCChhhCcCHHHHHh--CHHHh
Confidence 111 112344778999999999999999999998 44443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=309.26 Aligned_cols=254 Identities=25% Similarity=0.447 Sum_probs=200.9
Q ss_pred CccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCC----hHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEE
Q 041143 626 NFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTT----TKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLL 700 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 700 (973)
+|+..+.||+|+||.||+|.. .+++.||+|++...... ....+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999975 56899999998643211 2245688999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCC-CEEEeeccccc
Q 041143 701 VYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDY-RAKVSDFGLVK 779 (973)
Q Consensus 701 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~-~~kl~DfGla~ 779 (973)
||||+++++|.+++.. ..++++..+..++.|++.||+||| +++++|+||||+||+++.++ .+||+|||++.
T Consensus 81 v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~ 152 (268)
T cd06630 81 FVEWMAGGSVSHLLSK-----YGAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAA 152 (268)
T ss_pred EEeccCCCcHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccc
Confidence 9999999999999864 246889999999999999999999 88999999999999998776 59999999987
Q ss_pred cCCCCCc---ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhH
Q 041143 780 LAPDGEK---SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEK 856 (973)
Q Consensus 780 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (973)
....... .......|+..|+|||++.+..++.++||||+||++|||++|+.||........... ......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~~~~~---- 225 (268)
T cd06630 153 RLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL---IFKIAS---- 225 (268)
T ss_pred ccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH---HHHHhc----
Confidence 5543211 112235688999999999888899999999999999999999999975432211111 111000
Q ss_pred HHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 857 FKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 857 ~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
....+ ..+......+.+++.+|++.+|++||++.+++.
T Consensus 226 --~~~~~-----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 226 --ATTAP-----SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred --cCCCC-----CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 00011 111123345779999999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=317.43 Aligned_cols=302 Identities=22% Similarity=0.349 Sum_probs=219.7
Q ss_pred HHHhcCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC---
Q 041143 621 RKVTQNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGN--- 696 (973)
Q Consensus 621 ~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--- 696 (973)
....++|...+.||+|+||.||+|.. .+|..||||++..........+.+.+|++++++++||||+++++++....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 34567899999999999999999975 46899999998654444445567889999999999999999999987643
Q ss_pred ---eEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEe
Q 041143 697 ---ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVS 773 (973)
Q Consensus 697 ---~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~ 773 (973)
..++||||+ +++|.+++.. ..+++..+..++.||++||+||| +.+|+||||||+||+++.++.+||+
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~ 160 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKIL 160 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEe
Confidence 458999999 7899887743 46899999999999999999999 8899999999999999999999999
Q ss_pred eccccccCCCCCcceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHH-HH-------
Q 041143 774 DFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRY-LA------- 844 (973)
Q Consensus 774 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~-~~------- 844 (973)
|||++...... .....+++.|+|||++.+ ..++.++|+||+||++|+|++|+.||.......... ..
T Consensus 161 dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 236 (343)
T cd07880 161 DFGLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPS 236 (343)
T ss_pred ecccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 99999855332 223467899999998875 458899999999999999999999998654321100 00
Q ss_pred -HHHHHHhhchhHHHhhcC--ccccCCc---ccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCCCCCCCc
Q 041143 845 -EWFWRIKSSKEKFKAAID--PALEVNE---ETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPITDESE 918 (973)
Q Consensus 845 -~~~~~~~~~~~~~~~~~~--~~l~~~~---~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~~~~~~~ 918 (973)
.+...+.. ......+. +...... ........+.+++.+|++.||++||++.++++ +++++.+.....+..
T Consensus 237 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~--~~~~~~~~~~~~~~~ 312 (343)
T cd07880 237 KEFVQKLQS--EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA--HPYFEEFHDPEDETE 312 (343)
T ss_pred HHHHHhhcc--hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc--CccHhhhcCcccccC
Confidence 00000000 00000000 0000000 00011234779999999999999999999997 778777665544332
Q ss_pred ccCCCCCCCCchhHHHHHHHhc
Q 041143 919 CCSGIDYSLPLPQMLKVWQEAE 940 (973)
Q Consensus 919 ~~~~~~~~~~~p~~~~~~~~~~ 940 (973)
...-.+......+.+++|+...
T Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~ 334 (343)
T cd07880 313 APPYDDSFDEVDQSLEEWKRLT 334 (343)
T ss_pred CCCccccHHhhccchHHHHHHH
Confidence 2222222234556778888654
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=312.26 Aligned_cols=246 Identities=27% Similarity=0.378 Sum_probs=200.2
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCC-CChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGV-TTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
++|...+.||+|+||.||++... +++.||+|+++... ......+.+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36888899999999999999765 58999999986432 22344567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++++|.+++... ..+++..+..++.|++.||+||| +.+|+||||+|+||+++.++.+||+|||+++...
T Consensus 81 e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 152 (290)
T cd05580 81 EYVPGGELFSHLRKS-----GRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK 152 (290)
T ss_pred ecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccC
Confidence 999999999998652 46889999999999999999999 7899999999999999999999999999998654
Q ss_pred CCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcC
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (973)
.. .....|++.|+|||.+.+...+.++||||||+++|||++|+.||........ . ..+. .
T Consensus 153 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~---~~~~----------~ 212 (290)
T cd05580 153 GR----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI---Y---EKIL----------E 212 (290)
T ss_pred CC----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH---H---HHHh----------c
Confidence 43 2345689999999999888889999999999999999999999976552211 0 0111 1
Q ss_pred ccccCCcccHHHHHHHHHHHHHhhccCCCCCC-----CHhHHHH
Q 041143 863 PALEVNEETFESISIVAELAGHCTAREPYHRP-----DMGHVVN 901 (973)
Q Consensus 863 ~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~~v~~ 901 (973)
....... .....+.+++.+|++.||.+|+ +++|+++
T Consensus 213 ~~~~~~~---~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 213 GKVRFPS---FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred CCccCCc---cCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 1111000 1124577999999999999999 5566654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=312.33 Aligned_cols=266 Identities=21% Similarity=0.318 Sum_probs=196.4
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
+++|...+.||+|+||.||+|... +|+.||+|++..... ......+.+|+++++.++|+||+++++++..++..++||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 467889999999999999999764 688999999865422 222345778999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+. +++.+++... ...+.+.++..++.|++.||+||| +.+|+|+||||+||+++.++++||+|||+++...
T Consensus 83 e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 154 (291)
T cd07870 83 EYMH-TDLAQYMIQH----PGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKS 154 (291)
T ss_pred eccc-CCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccC
Confidence 9995 7887776441 235778889999999999999999 7899999999999999999999999999987543
Q ss_pred CCCcceecccccccCcccccccccC-cCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhh-c-hh----
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMG-KITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKS-S-KE---- 855 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~-~~---- 855 (973)
.... ......++..|+|||++.+. .++.++|||||||++|||++|+.||+....... .+.. .+.... . ..
T Consensus 155 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~-~~~~-~~~~~~~~~~~~~~~ 231 (291)
T cd07870 155 IPSQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE-QLEK-IWTVLGVPTEDTWPG 231 (291)
T ss_pred CCCC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH-HHHH-HHHHcCCCChhhhhh
Confidence 2211 12234578999999998754 578899999999999999999999986543211 1111 000000 0 00
Q ss_pred -----HH-HhhcC----ccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 856 -----KF-KAAID----PALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 856 -----~~-~~~~~----~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
.. ..... +.+............+.+++.+|++.||.+|||+.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 232 VSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00 00000 000000000011245779999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=317.83 Aligned_cols=287 Identities=20% Similarity=0.335 Sum_probs=214.1
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEe----CCeE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIE----GNER 698 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 698 (973)
.++|+..+.||+|+||.||+|... +|+.||+|++..........+.+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 368899999999999999999765 68999999987653334455678889999999999999999998763 3467
Q ss_pred EEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecccc
Q 041143 699 LLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLV 778 (973)
Q Consensus 699 ~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla 778 (973)
++||||+. |+|.+++.. ...+++..+..++.||++||+||| .++|+||||||+||++++++.+||+|||++
T Consensus 84 ~lv~e~~~-~~l~~~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~ 154 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS-----DQPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMA 154 (334)
T ss_pred EEEEehhh-hhHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccc
Confidence 99999995 689888754 245899999999999999999999 789999999999999999999999999999
Q ss_pred ccCCCCCc---ceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhh--
Q 041143 779 KLAPDGEK---SVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKS-- 852 (973)
Q Consensus 779 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-- 852 (973)
+....... .......|+..|+|||++.. ..++.++|||||||++|||++|+.||........... +.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~---~~~~~g~~ 231 (334)
T cd07855 155 RGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKL---ILSVLGSP 231 (334)
T ss_pred eeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHH---HHHHhCCC
Confidence 75433221 11234578999999998765 5688999999999999999999999976653322111 000000
Q ss_pred --------chhHHHhhcCccccCCcc-----cHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCCCCCCCcc
Q 041143 853 --------SKEKFKAAIDPALEVNEE-----TFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPITDESEC 919 (973)
Q Consensus 853 --------~~~~~~~~~~~~l~~~~~-----~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~~~~~~~~ 919 (973)
....+.+.++..-..... .......+.+++.+|++.+|++||++.++++ .++++++.....+..+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~--~~~~~~~~~~~~~~~~ 309 (334)
T cd07855 232 SEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ--HPFLAQYHDPDDEPTC 309 (334)
T ss_pred hhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh--ChhhhhccCCcccccC
Confidence 001111111100000001 1122456889999999999999999999998 7888877766665554
Q ss_pred cCCCC
Q 041143 920 CSGID 924 (973)
Q Consensus 920 ~~~~~ 924 (973)
...++
T Consensus 310 ~~~~~ 314 (334)
T cd07855 310 PPPFD 314 (334)
T ss_pred CCCCC
Confidence 44333
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=310.88 Aligned_cols=257 Identities=25% Similarity=0.396 Sum_probs=200.8
Q ss_pred HHHHHHhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEe-
Q 041143 618 QVLRKVTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIE- 694 (973)
Q Consensus 618 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~- 694 (973)
.++....+.|+..+.||+|+||.||+|... +++.+|+|++... .....++..|+.++.++ +|+||+++++++..
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 9 SALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 344456678899999999999999999874 6889999988543 33446788999999998 69999999999863
Q ss_pred -----CCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCC
Q 041143 695 -----GNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYR 769 (973)
Q Consensus 695 -----~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~ 769 (973)
....++||||+++|+|.+++.... ...+++..+..++.||++||+||| +.+|+||||||+||++++++.
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~ 159 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK---GNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAE 159 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCC
Confidence 457799999999999999886522 245788889999999999999999 789999999999999999999
Q ss_pred EEEeeccccccCCCCCcceecccccccCcccccccc-----cCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 041143 770 AKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAV-----MGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLA 844 (973)
Q Consensus 770 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~ 844 (973)
++|+|||++........ ......|++.|+|||.+. ...++.++|||||||++|||++|+.||....+......
T Consensus 160 ~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~- 237 (282)
T cd06636 160 VKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL- 237 (282)
T ss_pred EEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh-
Confidence 99999999875432211 123456899999999875 34678899999999999999999999976543221110
Q ss_pred HHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 845 EWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 845 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
......+.+. .......+.+++.+|++.||.+||++.|+++
T Consensus 238 ------------~~~~~~~~~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 238 ------------IPRNPPPKLK----SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ------------HhhCCCCCCc----ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0111111111 1112345889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=320.44 Aligned_cols=274 Identities=22% Similarity=0.350 Sum_probs=203.1
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC-----e
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGN-----E 697 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~ 697 (973)
.++|...+.||+|+||.||+|... +|+.||+|++... ........+.+|+.++++++|+||+++++++.... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF-EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc-ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 468999999999999999999764 6899999998643 22344567889999999999999999999876543 5
Q ss_pred EEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccc
Q 041143 698 RLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL 777 (973)
Q Consensus 698 ~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGl 777 (973)
.++||||+. ++|.+++.. ..+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 83 ~~lv~e~~~-~~l~~~~~~------~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~ 152 (336)
T cd07849 83 VYIVQELME-TDLYKLIKT------QHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGL 152 (336)
T ss_pred EEEEehhcc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccc
Confidence 799999995 588777643 46899999999999999999999 88999999999999999999999999999
Q ss_pred cccCCCCCc--ceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhh--
Q 041143 778 VKLAPDGEK--SVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKS-- 852 (973)
Q Consensus 778 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-- 852 (973)
++....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ..++.....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~---~~~~~~~~~~~ 229 (336)
T cd07849 153 ARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ---LNLILGVLGTP 229 (336)
T ss_pred eeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCC
Confidence 875433221 11233578999999998754 5688999999999999999999999976543221 111111000
Q ss_pred chhHHHhhcCcc-------ccC-Ccc-----cHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCCC
Q 041143 853 SKEKFKAAIDPA-------LEV-NEE-----TFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPI 913 (973)
Q Consensus 853 ~~~~~~~~~~~~-------l~~-~~~-----~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~~ 913 (973)
..+....+.+.. ... ... .......+.+++.+|++.||++||++.|+++ .++.+.+...
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~--hp~~~~~~~~ 301 (336)
T cd07849 230 SQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALA--HPYLEQYHDP 301 (336)
T ss_pred CHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhc--CccccccCCC
Confidence 001111111100 000 000 0112345789999999999999999999999 6666655443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=313.56 Aligned_cols=286 Identities=23% Similarity=0.357 Sum_probs=214.6
Q ss_pred HHhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEe-CCeEE
Q 041143 622 KVTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIE-GNERL 699 (973)
Q Consensus 622 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~ 699 (973)
.++++|+..+.||+|+||.||+|... +++.||||++..........+.+.+|++++++++||||+++++++.. ....+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 46788999999999999999999765 78999999886543344445678899999999999999999999876 56789
Q ss_pred EEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccc
Q 041143 700 LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK 779 (973)
Q Consensus 700 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~ 779 (973)
+||||+ +++|.+++.. ..+++.....++.|+++||+||| +.+|+||||||+||++++++.+||+|||++.
T Consensus 87 lv~e~~-~~~L~~~~~~------~~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 87 FVTELL-GTDLHRLLTS------RPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEeehh-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 999998 6789887753 45788888899999999999999 8899999999999999999999999999987
Q ss_pred cCCCCCcceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHH-HH--------HHHH
Q 041143 780 LAPDGEKSVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYL-AE--------WFWR 849 (973)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~-~~--------~~~~ 849 (973)
..... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||........... .. |...
T Consensus 157 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 157 IQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred ccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 54321 123467889999998765 5689999999999999999999999976654221111 00 0110
Q ss_pred HhhchhHHHhhcCccccCCccc-----HHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCCCCCCCcccCCCC
Q 041143 850 IKSSKEKFKAAIDPALEVNEET-----FESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPITDESECCSGID 924 (973)
Q Consensus 850 ~~~~~~~~~~~~~~~l~~~~~~-----~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~~~~~~~~~~~~~ 924 (973)
... .....-....... .... ......+.+++.+|++.+|++||++.+++. .++.+++.....++..+..++
T Consensus 233 ~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~--~~~~~~~~~~~~~~~~~~~~~ 308 (328)
T cd07856 233 ICS-ENTLRFVQSLPKR-EPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA--HPYLAPYHDPTDEPVAEEKFD 308 (328)
T ss_pred ccc-hhhHHHHhhcccc-CCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc--CCccccccCCccccCchhhcC
Confidence 000 0000000000000 0000 012256889999999999999999999998 888888877766665555554
Q ss_pred C
Q 041143 925 Y 925 (973)
Q Consensus 925 ~ 925 (973)
.
T Consensus 309 ~ 309 (328)
T cd07856 309 W 309 (328)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=308.41 Aligned_cols=257 Identities=26% Similarity=0.445 Sum_probs=206.9
Q ss_pred HhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEE
Q 041143 623 VTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLV 701 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 701 (973)
.++.|+..+.||+|+||.||+|... ++..||+|++..... ..+.+.+|++++++++|+||+++++++...+..++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 4466788889999999999999876 688999999975422 456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccC
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA 781 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~ 781 (973)
|||+++++|.+++.... ..+++..+..++.|++.||+||| ..+|+|+||+|+||+++.++.++|+|||++...
T Consensus 94 ~e~~~~~~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 166 (286)
T cd06614 94 MEYMDGGSLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQL 166 (286)
T ss_pred EeccCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhh
Confidence 99999999999997622 37899999999999999999999 789999999999999999999999999998754
Q ss_pred CCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhc
Q 041143 782 PDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861 (973)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (973)
..... ......++..|+|||++.+..++.++|||||||++|||++|+.||....+..... . +.. ...
T Consensus 167 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~--~----~~~------~~~ 233 (286)
T cd06614 167 TKEKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF--L----ITT------KGI 233 (286)
T ss_pred ccchh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH--H----HHh------cCC
Confidence 33221 2233457899999999988889999999999999999999999997654332111 0 000 000
Q ss_pred CccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 862 DPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 862 ~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
+... ........+.+++.+|++.+|.+||++.+|++ .++++
T Consensus 234 -~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~--~~~~~ 274 (286)
T cd06614 234 -PPLK---NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ--HPFLK 274 (286)
T ss_pred -CCCc---chhhCCHHHHHHHHHHhccChhhCcCHHHHhh--ChHhh
Confidence 0111 11112345789999999999999999999987 55544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=306.55 Aligned_cols=251 Identities=24% Similarity=0.390 Sum_probs=201.6
Q ss_pred CccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEe
Q 041143 626 NFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEY 704 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 704 (973)
+|...+.||+|+||.||+|..+ +|..+|+|.+..........+.+.+|++++++++|+||+++++++......++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999875 588999999865433334556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCC-CEEEeeccccccCCC
Q 041143 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDY-RAKVSDFGLVKLAPD 783 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~-~~kl~DfGla~~~~~ 783 (973)
+++++|.+++... ....+++..+..++.|+++||+||| +.+++|+||||+||++++++ .+||+|||.+.....
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 81 CDGGDLMKRINRQ---RGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred CCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 9999999998652 2235799999999999999999999 78999999999999999885 469999999876543
Q ss_pred CCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCc
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDP 863 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (973)
... ......|++.|+|||+.....++.++|||||||++|||++|+.||......+ ++..... ..+.+
T Consensus 155 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~------~~~~~ 221 (257)
T cd08225 155 SME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ------LVLKICQ------GYFAP 221 (257)
T ss_pred Ccc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHhc------ccCCC
Confidence 322 2233468999999999988889999999999999999999999997554221 1111111 11111
Q ss_pred cccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 864 ALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 864 ~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
. .......+.+++.+|++.+|++||++.||++
T Consensus 222 ~------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 222 I------SPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred C------CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 0 0111245789999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=311.71 Aligned_cols=263 Identities=26% Similarity=0.360 Sum_probs=199.4
Q ss_pred CccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeeEEEeCCeEEEEEE
Q 041143 626 NFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR-HRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e 703 (973)
+|...+.||+|+||.||++... +++.||+|++..... ......+.+|+.++.++. |+||+++++++..++..++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD-EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC-hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 4556678999999999999765 589999999865422 245567899999999996 9999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+. +++.++...........+++..+..++.|+++||+|||+ ..+|+||||||+||+++.++.+||+|||+++....
T Consensus 84 ~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred ccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 985 466554432111223568999999999999999999993 35899999999999999999999999999975433
Q ss_pred CCcceecccccccCcccccccccC---cCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhh
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVMG---KITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAA 860 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (973)
... .....|+..|+|||++... .++.++|||||||++|||++|+.||..... ....+..... .
T Consensus 161 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~-------~ 226 (288)
T cd06616 161 SIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVK-------G 226 (288)
T ss_pred CCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcC-------C
Confidence 221 2334689999999998766 689999999999999999999999975431 1111111110 0
Q ss_pred cCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 861 IDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 861 ~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
..+.+. ..........+.+++.+|++.+|++||++.+|++ .++++.
T Consensus 227 ~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~--~~~~~~ 272 (288)
T cd06616 227 DPPILS-NSEEREFSPSFVNFINLCLIKDESKRPKYKELLE--HPFIKD 272 (288)
T ss_pred CCCcCC-CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc--Chhhhc
Confidence 111221 1111223456889999999999999999999998 666554
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=311.35 Aligned_cols=265 Identities=23% Similarity=0.356 Sum_probs=196.8
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
++|+..+.||+|+||.||+|..+ +++.||+|.+...... .....+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 57888999999999999999875 6899999998654222 223456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+. ++|.+++... ...+++.....++.|+++||.||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 84 ~~~-~~L~~~~~~~----~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 155 (291)
T cd07844 84 YLD-TDLKQYMDDC----GGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSV 155 (291)
T ss_pred cCC-CCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCC
Confidence 997 5999988652 136789999999999999999999 88999999999999999999999999999874332
Q ss_pred CCcceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhh-c-hhHHHhh
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKS-S-KEKFKAA 860 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~ 860 (973)
... ......++..|+|||++.+ ..++.++||||+||++|||++|+.||......... + ..+..... . .......
T Consensus 156 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07844 156 PSK-TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ-L-HKIFRVLGTPTEETWPGV 232 (291)
T ss_pred CCc-cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH-H-HHHHHhcCCCChhhhhhh
Confidence 111 1222356889999998875 45889999999999999999999999765421111 1 00111000 0 0000000
Q ss_pred cC--------------ccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 861 ID--------------PALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 861 ~~--------------~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
.. ..+............+.+++.+|++.+|++||++.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00 000000000111245679999999999999999999886
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=310.54 Aligned_cols=247 Identities=27% Similarity=0.433 Sum_probs=198.0
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecC-CCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAG-VTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
+.|...+.||+|+||.||+|... +|+.||+|++... .......+++.+|+++++.++||||++++++|.+.+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 56888899999999999999765 6899999998643 233445567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||++ |++.+++... ...+++..+..++.|++.||.||| ..+|+||||+|+||++++++.+||+|||++....
T Consensus 95 e~~~-g~l~~~~~~~----~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 95 EYCL-GSASDILEVH----KKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred HhhC-CCHHHHHHHc----ccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 9996 6777766431 245899999999999999999999 7899999999999999999999999999987543
Q ss_pred CCCcceecccccccCcccccccc---cCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHh
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAV---MGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKA 859 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (973)
.. ....|++.|+|||++. ...++.++|||||||++|||++|+.||.......... ....
T Consensus 167 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~------~~~~------- 228 (307)
T cd06607 167 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIAQ------- 228 (307)
T ss_pred CC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHH------HHhc-------
Confidence 32 2346888999999874 4568899999999999999999999997654322110 0000
Q ss_pred hcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 860 AIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 860 ~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
...+.+. .......+.+++.+|++.+|++||++.+|+.
T Consensus 229 ~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 229 NDSPTLS----SNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred CCCCCCC----chhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0011111 1122345889999999999999999999987
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=314.36 Aligned_cols=271 Identities=23% Similarity=0.328 Sum_probs=199.1
Q ss_pred CccccCcccccCccEEEEEEEC---CCCEEEEEEeecCC-CChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeC--CeEE
Q 041143 626 NFAQENELGRGGFGTVYKGELE---DGTKIAVKRMEAGV-TTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEG--NERL 699 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 699 (973)
+|...+.||+|+||.||+|... +++.||+|.+.... ......+.+.+|++++++++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4777889999999999999875 47899999987632 1222345678899999999999999999999988 7899
Q ss_pred EEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECC----CCCEEEeec
Q 041143 700 LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDD----DYRAKVSDF 775 (973)
Q Consensus 700 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~----~~~~kl~Df 775 (973)
+||||++ +++.+++..........+++..+..++.||+.||+||| +.+|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 9999996 47777775533333347889999999999999999999 889999999999999999 899999999
Q ss_pred cccccCCCCCc--ceecccccccCcccccccccC-cCCCchhHHhHHHHHHHHHhCCCCCCCCChhh-------HHHHHH
Q 041143 776 GLVKLAPDGEK--SVVTRLAGTFGYLAPEYAVMG-KITTKADVFSYGVVLMELLTGLAALDEERPEE-------SRYLAE 845 (973)
Q Consensus 776 Gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~-------~~~~~~ 845 (973)
|+++....... .......+++.|+|||++.+. .++.++|||||||++|||++|+.||....... ...+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99986543322 112335688999999988764 57899999999999999999999997654322 111111
Q ss_pred HHHHHhhchh----------HHHh----hcCccccCCcccH-------HHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 846 WFWRIKSSKE----------KFKA----AIDPALEVNEETF-------ESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 846 ~~~~~~~~~~----------~~~~----~~~~~l~~~~~~~-------~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
.+........ .... ....... ..... .....+.+++.+|++.||++||++.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYP-SNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCC-CccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 1111000000 0000 0000000 00000 12245789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=303.62 Aligned_cols=251 Identities=26% Similarity=0.404 Sum_probs=206.8
Q ss_pred CccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEe
Q 041143 626 NFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEY 704 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 704 (973)
+|+..+.||+|+||.||++... +++.+|+|++............+.+|++++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778899999999999999654 688999999876544555567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCC
Q 041143 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG 784 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~ 784 (973)
+++++|.+++.... .....+++..++.++.|+++||+||| +.+++|+||+|+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 81 APFGDLSKAISKRK-KKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred cCCCCHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 99999999987633 23356899999999999999999999 889999999999999999999999999999866543
Q ss_pred CcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCcc
Q 041143 785 EKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPA 864 (973)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 864 (973)
......|+..|+|||+..+..++.++|+||+|+++|||++|+.||......+.. . ... . ..
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~---~---~~~-------~---~~ 217 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR---Y---KVQ-------R---GK 217 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---H---HHh-------c---CC
Confidence 122346889999999999989999999999999999999999999866532211 0 000 0 01
Q ss_pred ccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 865 LEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 865 l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
. ..........+.+++.+|++.+|++||++.++++
T Consensus 218 ~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 218 Y--PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred C--CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 0111133456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=291.64 Aligned_cols=266 Identities=22% Similarity=0.366 Sum_probs=210.9
Q ss_pred CcccccCccEEEEEE-ECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeeEEEeCCeEEEEEEecCCC
Q 041143 631 NELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR-HRHLVSLLGYSIEGNERLLVYEYMPHG 708 (973)
Q Consensus 631 ~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~g 708 (973)
++||+|+|+.|--+. +.+|.++|||++.+. ......+..+|++++.+.+ |+||++++++|++++..|||||-|.||
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GG 161 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGG 161 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCc
Confidence 679999999999884 678999999999765 4556678899999999995 999999999999999999999999999
Q ss_pred CHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCC---CEEEeeccccccCCCCC
Q 041143 709 ALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDY---RAKVSDFGLVKLAPDGE 785 (973)
Q Consensus 709 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~---~~kl~DfGla~~~~~~~ 785 (973)
.|..++++ .+.+++.++.++..+||.||.+|| .+||.|||+||+|||-.... -+||+||.+........
T Consensus 162 plLshI~~-----~~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~ 233 (463)
T KOG0607|consen 162 PLLSHIQK-----RKHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNN 233 (463)
T ss_pred hHHHHHHH-----hhhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeeccccccccccCC
Confidence 99999976 356889999999999999999999 89999999999999997554 48999998865322111
Q ss_pred ------cceecccccccCcccccccc-----cCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhch
Q 041143 786 ------KSVVTRLAGTFGYLAPEYAV-----MGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSK 854 (973)
Q Consensus 786 ------~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 854 (973)
.......+|+..|||||+.. ...|+.+.|.||+|||+|-|++|++||.+.-..+-..--.-+-+... .
T Consensus 234 ~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ-~ 312 (463)
T KOG0607|consen 234 DCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQ-N 312 (463)
T ss_pred CCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHH-H
Confidence 12234568999999999864 34688999999999999999999999987654332110000001111 2
Q ss_pred hHHHhhcCccccCCcccHHHHHH-HHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 855 EKFKAAIDPALEVNEETFESISI-VAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 855 ~~~~~~~~~~l~~~~~~~~~~~~-~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
.-++.+-+..+++.+.++..+.. ..+++...+..|+.+|.++.++++ .++++.
T Consensus 313 ~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln--hPw~~~ 366 (463)
T KOG0607|consen 313 KLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN--HPWVQR 366 (463)
T ss_pred HHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC--Cccccc
Confidence 33455666777777777766654 558999999999999999999988 555554
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=310.82 Aligned_cols=267 Identities=23% Similarity=0.311 Sum_probs=199.6
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeC--CeEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEG--NERLLV 701 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV 701 (973)
++|+..+.||+|+||.||+|... +++.+|+|.++...........+.+|+.++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999876 588999999976533333344677899999999999999999999887 889999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccC
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA 781 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~ 781 (973)
|||++ ++|.+++.... ..+++..+..++.||+.||+||| +.+|+|+||||+||+++.++.+||+|||+++..
T Consensus 85 ~e~~~-~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~ 156 (293)
T cd07843 85 MEYVE-HDLKSLMETMK----QPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREY 156 (293)
T ss_pred ehhcC-cCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeec
Confidence 99996 59988886521 36899999999999999999999 789999999999999999999999999999865
Q ss_pred CCCCcceecccccccCcccccccccC-cCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHH-HHHH-------HHHhh
Q 041143 782 PDGEKSVVTRLAGTFGYLAPEYAVMG-KITTKADVFSYGVVLMELLTGLAALDEERPEESRYL-AEWF-------WRIKS 852 (973)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~-~~~~-------~~~~~ 852 (973)
..... ......+++.|+|||++.+. .++.++|+|||||++|||++|+.||......+.... ...+ +....
T Consensus 157 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 157 GSPLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred cCCcc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence 54321 12334578899999988754 468999999999999999999999986654322110 0000 00000
Q ss_pred c----h-hHHHhhcCccccCCcccHH-HHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 853 S----K-EKFKAAIDPALEVNEETFE-SISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 853 ~----~-~~~~~~~~~~l~~~~~~~~-~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
. . ..........+. ...... ....+.+++.+|++.+|++||++.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLR-KKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred ccchhcccccccccchhhh-ccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0 0 000000000000 000000 1345779999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=307.82 Aligned_cols=265 Identities=22% Similarity=0.328 Sum_probs=198.8
Q ss_pred ccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEec
Q 041143 627 FAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYM 705 (973)
Q Consensus 627 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 705 (973)
|+..+.||+|++|.||+|... +|..||+|++..........+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567788999999999999764 7999999998755333344467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCC
Q 041143 706 PHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGE 785 (973)
Q Consensus 706 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~ 785 (973)
+++|.+++.... ...+++..++.++.|+++||+||| +++++||||+|+||+++.++.++|+|||+++......
T Consensus 81 -~~~l~~~~~~~~---~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~ 153 (283)
T cd07835 81 -DLDLKKYMDSSP---LTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV 153 (283)
T ss_pred -CcCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence 578999886522 146899999999999999999999 7899999999999999999999999999997543322
Q ss_pred cceecccccccCcccccccccC-cCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhch----------
Q 041143 786 KSVVTRLAGTFGYLAPEYAVMG-KITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSK---------- 854 (973)
Q Consensus 786 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 854 (973)
. ......++..|+|||++.+. .++.++|||||||++|||++|+.||......+. +...........
T Consensus 154 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 154 R-TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFRIFRTLGTPDEDVWPGVTSL 230 (283)
T ss_pred c-ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHHhhhhhhc
Confidence 1 12233568899999987654 578899999999999999999999976553221 111111000000
Q ss_pred hHHHhhcCccc--cCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 855 EKFKAAIDPAL--EVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 855 ~~~~~~~~~~l--~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
..+...+.... ............+.+++.+|++.||++||+++||++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000000000 000001111245779999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=335.04 Aligned_cols=255 Identities=26% Similarity=0.385 Sum_probs=193.0
Q ss_pred HHHhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeC----
Q 041143 621 RKVTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEG---- 695 (973)
Q Consensus 621 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---- 695 (973)
.+...+|++.+.||+||||.|||++.+ ||+.||||++.... ..+....+.+|+..+++++|||||+++..+.+.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 345678899999999999999999876 89999999998765 566677889999999999999999987432211
Q ss_pred --------------------------------------------------------------------------------
Q 041143 696 -------------------------------------------------------------------------------- 695 (973)
Q Consensus 696 -------------------------------------------------------------------------------- 695 (973)
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence
Q ss_pred -----------------------------------CeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHH
Q 041143 696 -----------------------------------NERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARG 740 (973)
Q Consensus 696 -----------------------------------~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~g 740 (973)
...||-||||+...+..++++..... .-...++++.+|++|
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~----~~d~~wrLFreIlEG 709 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS----QRDEAWRLFREILEG 709 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch----hhHHHHHHHHHHHHH
Confidence 01367899998888877776522111 345678999999999
Q ss_pred HHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC------C-----------CCcceecccccccCcccccc
Q 041143 741 MEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP------D-----------GEKSVVTRLAGTFGYLAPEY 803 (973)
Q Consensus 741 l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~------~-----------~~~~~~~~~~gt~~y~aPE~ 803 (973)
|+|+| +.+||||||||.||++|++..|||+|||+|+... + ......+..+||.-|+|||+
T Consensus 710 LaYIH---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl 786 (1351)
T KOG1035|consen 710 LAYIH---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL 786 (1351)
T ss_pred HHHHH---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence 99999 8899999999999999999999999999998511 0 01123456789999999999
Q ss_pred cccC---cCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccCC-cccHHHHHHHH
Q 041143 804 AVMG---KITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVN-EETFESISIVA 879 (973)
Q Consensus 804 ~~~~---~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~~~~ 879 (973)
+.+. .|+.|+|+||+|||++||+. ||.... +.... +...-++.+... ....+....-.
T Consensus 787 l~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM--ERa~i-------------L~~LR~g~iP~~~~f~~~~~~~e~ 848 (1351)
T KOG1035|consen 787 LSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM--ERASI-------------LTNLRKGSIPEPADFFDPEHPEEA 848 (1351)
T ss_pred hcccccccccchhhhHHHHHHHHHHhc---cCCchH--HHHHH-------------HHhcccCCCCCCcccccccchHHH
Confidence 8754 49999999999999999996 565332 22111 111112222211 11223344456
Q ss_pred HHHHHhhccCCCCCCCHhHHHH
Q 041143 880 ELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 880 ~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
++|.++++.||.+|||+.|++.
T Consensus 849 slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 849 SLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHHHhcCCCccCCCHHHHhh
Confidence 8999999999999999999886
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=288.34 Aligned_cols=264 Identities=22% Similarity=0.299 Sum_probs=210.7
Q ss_pred HhcCcccc-CcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEe----C
Q 041143 623 VTQNFAQE-NELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIE----G 695 (973)
Q Consensus 623 ~~~~~~~~-~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~ 695 (973)
++++|.+. ++||-|-.|.|-.+.. .+|+++|+|++... ...++|++..-.. .|||||.++++|.. .
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 45566553 6799999999999965 47899999998643 3457888887766 59999999999875 3
Q ss_pred CeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCC---CCEEE
Q 041143 696 NERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDD---YRAKV 772 (973)
Q Consensus 696 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~---~~~kl 772 (973)
...++|||+|+||.|+..+.. .+...+++.++..|+.||+.|+.||| ..+|.||||||+|+|...+ -.+||
T Consensus 132 kcLLiVmE~meGGeLfsriq~---~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKL 205 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQD---RGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKL 205 (400)
T ss_pred eeeEeeeecccchHHHHHHHH---cccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEe
Confidence 456789999999999998866 33467999999999999999999999 8899999999999999754 57999
Q ss_pred eeccccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhh
Q 041143 773 SDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKS 852 (973)
Q Consensus 773 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 852 (973)
+|||+|+..... ......+-|+.|.|||++-..+|+...|+||+||++|-|++|.+||........
T Consensus 206 tDfGFAK~t~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai------------ 271 (400)
T KOG0604|consen 206 TDFGFAKETQEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI------------ 271 (400)
T ss_pred cccccccccCCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC------------
Confidence 999999976542 234556889999999999988999999999999999999999999987654211
Q ss_pred chhHHHhhcCccccCCcccHHHHHH-HHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCCCCC
Q 041143 853 SKEKFKAAIDPALEVNEETFESISI-VAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPITD 915 (973)
Q Consensus 853 ~~~~~~~~~~~~l~~~~~~~~~~~~-~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~~~~ 915 (973)
..+.-..+....+.+....+.++++ ..++|+.+++.+|.+|.|..++++ ++++.+......
T Consensus 272 spgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~--hpwi~~~~~vp~ 333 (400)
T KOG0604|consen 272 SPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD--HPWINQYEAVPQ 333 (400)
T ss_pred ChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc--CchhcccccCCC
Confidence 1122223334455666666777765 458999999999999999999998 777776554433
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=310.65 Aligned_cols=270 Identities=21% Similarity=0.276 Sum_probs=199.0
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeeEEEeCCe-----
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR-HRHLVSLLGYSIEGNE----- 697 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~----- 697 (973)
++|+..+.||+|+||.||+|... +|+.||+|+++...........+.+|+++++.++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36888899999999999999875 6899999988654333333457888999999995 6999999999987665
Q ss_pred EEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECC-CCCEEEeecc
Q 041143 698 RLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDD-DYRAKVSDFG 776 (973)
Q Consensus 698 ~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~-~~~~kl~DfG 776 (973)
.++||||+++ +|.+++..........+++..+..++.||++||+||| .++|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999975 8999887643332356899999999999999999999 889999999999999998 8999999999
Q ss_pred ccccCCCCCcceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchh
Q 041143 777 LVKLAPDGEKSVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKE 855 (973)
Q Consensus 777 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 855 (973)
+++....... ......+++.|+|||++.+ ..++.++|||||||++|||++|..||......+. +...+........
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~ 233 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ--LLHIFKLLGTPTE 233 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHHHHhCCCCh
Confidence 9875432211 1223357889999998865 4578999999999999999999999976543221 1111110000000
Q ss_pred -HHHhhc-------CccccC---CcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 856 -KFKAAI-------DPALEV---NEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 856 -~~~~~~-------~~~l~~---~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
...... .+.... ..........+.+++.+|++.||.+||++.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000000 000000 0000112345789999999999999999999986
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=308.35 Aligned_cols=273 Identities=20% Similarity=0.285 Sum_probs=200.5
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
++|+..+.||+|+||.||+|... +|+.||+|++..........+.+.+|++++++++|+||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57888999999999999999875 68899999986543333445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECC-CCCEEEeeccccccCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDD-DYRAKVSDFGLVKLAP 782 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~-~~~~kl~DfGla~~~~ 782 (973)
|++ ++|.+++... ....+++.....++.||+.||+||| +++|+||||||+||+++. ++.+||+|||++....
T Consensus 82 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 82 YLD-LDLKKHMDSS---PDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred ccc-ccHHHHHHhC---CCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 995 6888877542 1234578888899999999999999 789999999999999985 5679999999997543
Q ss_pred CCCcceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHH----
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKF---- 857 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---- 857 (973)
... .......+++.|+|||++.+ ..++.++|||||||++|||+||+.||......+... ..+..........
T Consensus 155 ~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 231 (294)
T PLN00009 155 IPV-RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELF--KIFRILGTPNEETWPGV 231 (294)
T ss_pred CCc-cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHHhCCCChhhcccc
Confidence 321 11233467899999998865 457899999999999999999999997655432211 1000000000000
Q ss_pred ---Hhhc--CccccCC---cccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 858 ---KAAI--DPALEVN---EETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 858 ---~~~~--~~~l~~~---~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
.... -+..... .........+.+++.+|++.+|++||++.++++ .++.+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~--~~~~~~ 289 (294)
T PLN00009 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE--HEYFKD 289 (294)
T ss_pred ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc--CchHhH
Confidence 0000 0000000 000111234779999999999999999999998 555543
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=319.77 Aligned_cols=271 Identities=26% Similarity=0.384 Sum_probs=207.2
Q ss_pred cccCcccccCccEEEEEE-ECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeC------CeEEE
Q 041143 628 AQENELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEG------NERLL 700 (973)
Q Consensus 628 ~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l 700 (973)
...+.||+|+||.||+|+ ...|+.||||.++... .....+...+|+++|++++|+|||+++++-.+. ....+
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 345679999999999998 5579999999987643 445567889999999999999999999876544 35689
Q ss_pred EEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEEC--CCC--CEEEeecc
Q 041143 701 VYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLD--DDY--RAKVSDFG 776 (973)
Q Consensus 701 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~--~~~--~~kl~DfG 776 (973)
|||||.+|||...|.+.+ +...++..+.+.+..+++.||.||| +++|+||||||.||++- ++| ..||+|||
T Consensus 95 vmEyC~gGsL~~~L~~PE--N~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPE--NAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred EEeecCCCcHHHHhcCcc--cccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 999999999999997633 3467999999999999999999999 89999999999999993 333 48999999
Q ss_pred ccccCCCCCcceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchh
Q 041143 777 LVKLAPDGEKSVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKE 855 (973)
Q Consensus 777 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 855 (973)
.|+...++. ..+.++||..|++||+... +.|+..+|.|||||++||.+||..||..........-.. +.+.....
T Consensus 170 ~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~--~~~~tkkp 245 (732)
T KOG4250|consen 170 AARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIM--WHIITKKP 245 (732)
T ss_pred ccccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhh--hhhhccCC
Confidence 999887654 5778899999999999984 889999999999999999999999997654332111112 22221111
Q ss_pred H-HHhhcCcc----------ccC-CcccHHHHHHHHHHHHHhhccCCCCCC--CHhHHHHHHHHhhh
Q 041143 856 K-FKAAIDPA----------LEV-NEETFESISIVAELAGHCTAREPYHRP--DMGHVVNVLSPLVE 908 (973)
Q Consensus 856 ~-~~~~~~~~----------l~~-~~~~~~~~~~~~~l~~~cl~~dP~~RP--s~~~v~~~L~~~~~ 908 (973)
. ..-..++. +.. ..........+-+.+..++..+|++|- ...+....+..+..
T Consensus 246 ~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 246 SGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred CceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 0 00000100 110 112234455677888888999999998 77777776666654
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=347.80 Aligned_cols=257 Identities=26% Similarity=0.371 Sum_probs=206.2
Q ss_pred HHHHhcCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeE
Q 041143 620 LRKVTQNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNER 698 (973)
Q Consensus 620 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 698 (973)
++.++-++.....||.|.||.||-|.. .+|+-.|||-++......+..+.+.+|+.++..++|||+|+.||+-...+..
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 455666788889999999999999964 5689999999877655666777899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecccc
Q 041143 699 LLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLV 778 (973)
Q Consensus 699 ~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla 778 (973)
+|.||||++|+|.+.+... +..++.-...+..|++.|++||| ++|||||||||.||+++.+|.+|++|||.|
T Consensus 1310 ~IFMEyC~~GsLa~ll~~g-----ri~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa 1381 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHG-----RIEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSA 1381 (1509)
T ss_pred HHHHHHhccCcHHHHHHhc-----chhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccce
Confidence 9999999999999998652 23455555668899999999999 899999999999999999999999999999
Q ss_pred ccCCCCCc---ceecccccccCcccccccccCc---CCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhh
Q 041143 779 KLAPDGEK---SVVTRLAGTFGYLAPEYAVMGK---ITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKS 852 (973)
Q Consensus 779 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 852 (973)
........ ......+||+.|||||++.+.. -.-++||||+|||+.||+||++||...+. .|.-..+.
T Consensus 1382 ~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------e~aIMy~V 1454 (1509)
T KOG4645|consen 1382 VKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------EWAIMYHV 1454 (1509)
T ss_pred eEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------hhHHHhHH
Confidence 86544321 2234578999999999998644 45689999999999999999999986553 23333332
Q ss_pred chhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 853 SKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 853 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
..+... ..+......-.+++..|++.||++|.++.|+++
T Consensus 1455 ~~gh~P----------q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1455 AAGHKP----------QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred hccCCC----------CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 222111 111113344569999999999999998887776
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=307.51 Aligned_cols=252 Identities=24% Similarity=0.410 Sum_probs=202.5
Q ss_pred CcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEecCCCC
Q 041143 631 NELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGA 709 (973)
Q Consensus 631 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 709 (973)
..||+|+||.||+|... +|+.||||++... .....+.+.+|+.+++.++|+||+++++++...+..++||||+++++
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence 56999999999999774 6899999988543 33455679999999999999999999999999999999999999999
Q ss_pred HHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCccee
Q 041143 710 LSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVV 789 (973)
Q Consensus 710 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 789 (973)
|.+++.. ..+++.....++.|++.||+||| +.+++||||||+||++++++.++|+|||++........ ..
T Consensus 104 L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~ 173 (292)
T cd06657 104 LTDIVTH------TRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RR 173 (292)
T ss_pred HHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceecccccc-cc
Confidence 9987743 35789999999999999999999 78999999999999999999999999999875433221 12
Q ss_pred cccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccCCc
Q 041143 790 TRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNE 869 (973)
Q Consensus 790 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 869 (973)
....|++.|+|||++.+..++.++|||||||++|||++|+.||......+... . ......+.+...
T Consensus 174 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~---~----------~~~~~~~~~~~~- 239 (292)
T cd06657 174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK---M----------IRDNLPPKLKNL- 239 (292)
T ss_pred cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---H----------HHhhCCcccCCc-
Confidence 33568999999999988889999999999999999999999997654322111 0 111111111100
Q ss_pred ccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCC
Q 041143 870 ETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRP 912 (973)
Q Consensus 870 ~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~ 912 (973)
......+.+++.+|++.+|.+||++.++++ +++..++.+
T Consensus 240 --~~~~~~l~~li~~~l~~~P~~R~~~~~ll~--~~~~~~~~~ 278 (292)
T cd06657 240 --HKVSPSLKGFLDRLLVRDPAQRATAAELLK--HPFLAKAGP 278 (292)
T ss_pred --ccCCHHHHHHHHHHHhCCcccCcCHHHHhc--ChHHhccCC
Confidence 011234678999999999999999999998 777776554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=298.78 Aligned_cols=249 Identities=28% Similarity=0.470 Sum_probs=203.6
Q ss_pred CccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEe
Q 041143 626 NFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEY 704 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 704 (973)
+|+..+.||+|++|.||++... +++.+++|++..... ...+.+.+|++++++++|+||+++++++......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 4677889999999999999875 688999999876422 4567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCC
Q 041143 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG 784 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~ 784 (973)
+++++|.+++.... ..+++..+..++.|+++||+||| ..+++||||+|+||++++++.++|+|||.+......
T Consensus 79 ~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 79 CSGGSLKDLLKSTN----QTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT 151 (253)
T ss_pred CCCCcHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence 99999999886521 46899999999999999999999 789999999999999999999999999998865543
Q ss_pred CcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCcc
Q 041143 785 EKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPA 864 (973)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 864 (973)
.. .....|+..|+|||++....++.++||||||+++|+|++|+.||........... . .....+.
T Consensus 152 ~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~------~-------~~~~~~~ 216 (253)
T cd05122 152 KA--RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK------I-------ATNGPPG 216 (253)
T ss_pred cc--ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH------H-------HhcCCCC
Confidence 32 3345789999999999888899999999999999999999999976543221110 0 0000111
Q ss_pred ccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 865 LEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 865 l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
+. ........+.+++.+|++.||++||++.|+++
T Consensus 217 ~~---~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 217 LR---NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred cC---cccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11 01111345889999999999999999999986
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=313.77 Aligned_cols=249 Identities=22% Similarity=0.353 Sum_probs=207.6
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
...|.+...||+|.|+.|.+|+.. +|..||+|.+....-.....+.+.+|+++|..++|||||+++.+.......|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 367888899999999999999754 6899999999877666666677999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+.+|.+++|+.+..+ .....+..++.|+.++++||| .+.|||||||++||||+.++.+||+|||++..+.
T Consensus 135 eya~~ge~~~yl~~~gr-----~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGR-----MKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EeccCchhHHHHHhccc-----chhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeec
Confidence 99999999999987433 334677889999999999999 8899999999999999999999999999999776
Q ss_pred CCCcceecccccccCcccccccccCcC-CCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhc
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMGKI-TTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (973)
. .......+|++.|.|||++.+.+| ++++|+||+||++|-|+.|..||++..-.+.+ +..+
T Consensus 207 ~--~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr----------------~rvl 268 (596)
T KOG0586|consen 207 Y--GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR----------------PRVL 268 (596)
T ss_pred c--cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc----------------chhe
Confidence 4 345677899999999999998887 47999999999999999999999976532110 1111
Q ss_pred CccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 862 DPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 862 ~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
...+..... ....+.+++++++..+|.+|+++++|..
T Consensus 269 ~gk~rIp~~---ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 269 RGKYRIPFY---MSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred eeeecccce---eechhHHHHHHhhccCccccCCHHHhhh
Confidence 111111111 1123558999999999999999999987
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=316.69 Aligned_cols=281 Identities=23% Similarity=0.323 Sum_probs=206.0
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeC-----Ce
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEG-----NE 697 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 697 (973)
.++|...+.||+|+||+||+|+.. +++.||||+++...........+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457889999999999999999764 689999999875433444456778899999999999999999988654 34
Q ss_pred EEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccc
Q 041143 698 RLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL 777 (973)
Q Consensus 698 ~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGl 777 (973)
.++||||+. ++|.+++.. ...+++..+..++.|++.||.||| +++++||||||+||+++.++.+||+|||+
T Consensus 84 ~~lv~e~~~-~~L~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~ 154 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS-----SQTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGL 154 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCcc
Confidence 799999995 788888754 246899999999999999999999 88999999999999999999999999999
Q ss_pred cccCCCCCcceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHH-HHHHHH-----
Q 041143 778 VKLAPDGEKSVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLA-EWFWRI----- 850 (973)
Q Consensus 778 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~-~~~~~~----- 850 (973)
++...... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||............ ......
T Consensus 155 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07858 155 ARTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL 233 (337)
T ss_pred ccccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence 98654332 22234568899999998764 46889999999999999999999999765432211110 000000
Q ss_pred -hhchhHHHhhcC---c--cccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCCCCCC
Q 041143 851 -KSSKEKFKAAID---P--ALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPITDE 916 (973)
Q Consensus 851 -~~~~~~~~~~~~---~--~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~~~~~ 916 (973)
..........+. . ..............+.+++.+|++.+|++||+++++++ .++.+........
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~--h~~~~~~~~~~~~ 303 (337)
T cd07858 234 GFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALA--HPYLASLHDPSDE 303 (337)
T ss_pred hhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHc--CcchhhhcCcccC
Confidence 000000000000 0 00000001122345789999999999999999999998 6666554444333
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=310.75 Aligned_cols=275 Identities=25% Similarity=0.317 Sum_probs=203.2
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeC--CeEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEG--NERLL 700 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 700 (973)
.++|+..+.||+|+||.||+|... +|+.||+|+++...........+.+|++++++++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 367889999999999999999875 589999999875433333334567899999999999999999998765 46899
Q ss_pred EEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecccccc
Q 041143 701 VYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKL 780 (973)
Q Consensus 701 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~ 780 (973)
||||+. ++|.+++... ...+++.++..++.||++||+||| +.+++||||||+||++++++.+||+|||+++.
T Consensus 86 v~e~~~-~~l~~~l~~~----~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~ 157 (309)
T cd07845 86 VMEYCE-QDLASLLDNM----PTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLART 157 (309)
T ss_pred EEecCC-CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeee
Confidence 999996 5888888652 256899999999999999999999 88999999999999999999999999999986
Q ss_pred CCCCCcceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHh
Q 041143 781 APDGEKSVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKA 859 (973)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (973)
...... ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||....+.+...... ............
T Consensus 158 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~--~~~~~~~~~~~~ 234 (309)
T cd07845 158 YGLPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLII--QLLGTPNESIWP 234 (309)
T ss_pred cCCccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--HhcCCCChhhch
Confidence 543321 1223346788999998865 457899999999999999999999998765433211110 000000000000
Q ss_pred hc---C--ccccCCc----c----cHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcC
Q 041143 860 AI---D--PALEVNE----E----TFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWR 911 (973)
Q Consensus 860 ~~---~--~~l~~~~----~----~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~ 911 (973)
.+ . ....... . .......+.+++.+|++.||++||++.|+++ +++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~--h~~f~~~~ 297 (309)
T cd07845 235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE--SSYFKEKP 297 (309)
T ss_pred hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc--ChhhccCC
Confidence 00 0 0000000 0 0011345678999999999999999999998 66666543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=308.38 Aligned_cols=252 Identities=27% Similarity=0.428 Sum_probs=199.1
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecC-CCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAG-VTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
+.|...+.||+|+||.||+|+.. ++..||+|++... ....+....+.+|++++++++|+|++++++++.+++..++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 34777889999999999999864 6889999998643 223445567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+. |+|.+++... ..+++|.++..++.|++.||.||| +++|+||||+|+||+++.++.+||+|||++....
T Consensus 105 e~~~-g~l~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (317)
T cd06635 105 EYCL-GSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS 176 (317)
T ss_pred eCCC-CCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccC
Confidence 9996 5787776531 245899999999999999999999 8899999999999999999999999999987543
Q ss_pred CCCcceecccccccCcccccccc---cCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHh
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAV---MGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKA 859 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (973)
.. ....|++.|+|||++. .+.++.++|||||||++|||++|+.||......... .. +...
T Consensus 177 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~--~~----~~~~------ 239 (317)
T cd06635 177 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL--YH----IAQN------ 239 (317)
T ss_pred Cc-----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH--HH----HHhc------
Confidence 32 2346889999999874 456889999999999999999999998765422111 11 1000
Q ss_pred hcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHh
Q 041143 860 AIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPL 906 (973)
Q Consensus 860 ~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~ 906 (973)
..+... .......+.+++.+|++.+|.+||++.+|++.....
T Consensus 240 -~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 240 -ESPTLQ----SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred -cCCCCC----CccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 001111 112234578999999999999999999999855433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=310.49 Aligned_cols=262 Identities=26% Similarity=0.412 Sum_probs=199.8
Q ss_pred hcCccccCcccccCccEEEEEEECC-CCEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeeEEEeCCeEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELED-GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR-HRHLVSLLGYSIEGNERLLV 701 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV 701 (973)
.++|+..+.||+|+||.||+|..++ ++.||||+++.... ......+.+|+.++.+.. |+||+++++++.++...++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC-hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 3678889999999999999998875 88999999975432 233456677888777775 99999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccC
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA 781 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~ 781 (973)
|||+ ++++..++... ...+++..+..++.||++||+|||+ .++|+||||+|+||++++++.+||+|||++...
T Consensus 93 ~e~~-~~~l~~l~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 93 MELM-STCLDKLLKRI----QGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred eecc-CcCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 9998 45777766441 2468999999999999999999993 258999999999999999999999999998765
Q ss_pred CCCCcceecccccccCcccccccccCc----CCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHH
Q 041143 782 PDGEKSVVTRLAGTFGYLAPEYAVMGK----ITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKF 857 (973)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (973)
..... .....++..|+|||++.+.. ++.++|||||||++|||++|+.||...... ...+ .......
T Consensus 166 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~----~~~~~~~--- 235 (296)
T cd06618 166 VDSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-FEVL----TKILQEE--- 235 (296)
T ss_pred cCCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-HHHH----HHHhcCC---
Confidence 43222 22345788999999987554 788999999999999999999999653221 1111 1111100
Q ss_pred HhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCC
Q 041143 858 KAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRP 912 (973)
Q Consensus 858 ~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~ 912 (973)
.+... ........+.+++.+|++.||++||++.++++ .++++.+..
T Consensus 236 ----~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~--~~~~~~~~~ 281 (296)
T cd06618 236 ----PPSLP---PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ--HPFIRRYET 281 (296)
T ss_pred ----CCCCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHhc--Chhhhccch
Confidence 01111 00012345789999999999999999999998 566665543
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=306.23 Aligned_cols=249 Identities=22% Similarity=0.291 Sum_probs=201.9
Q ss_pred CccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 626 NFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
+|...+.||.|+||.||+|... +++.||+|.+..... .....+.+.+|++++++++||||+++++++.++...++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999876 589999999865422 23456789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+++++|.+++... ..+++.++..++.|+++||.||| .++++|+||||+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 152 (258)
T cd05578 81 LLLGGDLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP 152 (258)
T ss_pred CCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCC
Confidence 99999999998651 46889999999999999999999 78999999999999999999999999999886544
Q ss_pred CCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCc
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDP 863 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (973)
.. ......|+..|+|||++....++.++|+||||+++|+|++|+.||..........+ ..... .....+
T Consensus 153 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~---~~~~~~-- 221 (258)
T cd05578 153 DT--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI----RAKQE---TADVLY-- 221 (258)
T ss_pred Cc--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHH----HHHhc---cccccC--
Confidence 32 22345688999999999888899999999999999999999999986653211111 11100 000001
Q ss_pred cccCCcccHHHHHHHHHHHHHhhccCCCCCCCH--hHHH
Q 041143 864 ALEVNEETFESISIVAELAGHCTAREPYHRPDM--GHVV 900 (973)
Q Consensus 864 ~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~--~~v~ 900 (973)
+......+.+++.+|++.||.+||++ +|+.
T Consensus 222 -------~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 222 -------PATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -------cccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 11122567899999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=306.36 Aligned_cols=264 Identities=23% Similarity=0.327 Sum_probs=199.9
Q ss_pred ccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeC--CeEEEEEE
Q 041143 627 FAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEG--NERLLVYE 703 (973)
Q Consensus 627 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~e 703 (973)
|+..+.||+|+||.||+|+.. +|+.+|+|++..........+.+.+|++++++++|+|++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 566788999999999999876 488999999976543344456788999999999999999999999988 78999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|++ ++|.+++... ...+++.++..++.||++||+||| +.+++|+||||+||++++++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~~~~~----~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~ 152 (287)
T cd07840 81 YMD-HDLTGLLDSP----EVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTK 152 (287)
T ss_pred ccc-ccHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence 996 5888887542 146899999999999999999999 78999999999999999999999999999986554
Q ss_pred CCcceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhc--hhHHH--
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSS--KEKFK-- 858 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~-- 858 (973)
..........++..|+|||.+.+ ..++.++||||||+++|||++|+.||........... +...... .....
T Consensus 153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 229 (287)
T cd07840 153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEK---IFELCGSPTDENWPGV 229 (287)
T ss_pred CCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHhCCCchhhcccc
Confidence 43222334467889999998765 4578999999999999999999999987654322111 1110000 00000
Q ss_pred ------hhcCccccCCc-----ccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 859 ------AAIDPALEVNE-----ETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 859 ------~~~~~~l~~~~-----~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
....+...... ........+.+++.+|++.+|++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred ccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000000000 00001346789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=313.61 Aligned_cols=277 Identities=23% Similarity=0.343 Sum_probs=210.7
Q ss_pred CccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC-----eEE
Q 041143 626 NFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGN-----ERL 699 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 699 (973)
+|...+.||+|+||.||+|... +++.||+|++..........+.+.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999875 4899999998765433455678999999999999999999999998775 789
Q ss_pred EEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccc
Q 041143 700 LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK 779 (973)
Q Consensus 700 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~ 779 (973)
+||||++ ++|.+++.. ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++|+|||++.
T Consensus 81 lv~e~~~-~~l~~~l~~-----~~~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~ 151 (330)
T cd07834 81 IVTELME-TDLHKVIKS-----PQPLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLAR 151 (330)
T ss_pred EEecchh-hhHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceE
Confidence 9999997 588888754 237899999999999999999999 8899999999999999999999999999998
Q ss_pred cCCCCCc--ceecccccccCcccccccccC-cCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhh----
Q 041143 780 LAPDGEK--SVVTRLAGTFGYLAPEYAVMG-KITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKS---- 852 (973)
Q Consensus 780 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---- 852 (973)
....... .......++..|+|||++.+. .++.++||||||+++|+|++|+.||......+..... .....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i---~~~~~~~~~ 228 (330)
T cd07834 152 GVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLI---VEVLGTPSE 228 (330)
T ss_pred eecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHH---HHhcCCCCh
Confidence 6544321 123345688999999999887 7899999999999999999999999876643221110 00000
Q ss_pred ------chhHHHhhcC---cc--ccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCCCCCC
Q 041143 853 ------SKEKFKAAID---PA--LEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPITDE 916 (973)
Q Consensus 853 ------~~~~~~~~~~---~~--l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~~~~~ 916 (973)
........+. .. .............+.+++.+|++.+|++||++.++++ .++++.+....++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~--~~~~~~~~~~~~~ 301 (330)
T cd07834 229 EDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA--HPYLAQLHDPEDE 301 (330)
T ss_pred hHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh--CccHHhhcccccC
Confidence 0000000000 00 0000000112345789999999999999999999998 6677766655444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=303.73 Aligned_cols=266 Identities=22% Similarity=0.346 Sum_probs=199.0
Q ss_pred CccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEe
Q 041143 626 NFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEY 704 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 704 (973)
+|+..+.||+|++|.||+|+.. +|+.||||+++.... ....+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 4788899999999999999875 588999999875432 22345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCC
Q 041143 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG 784 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~ 784 (973)
++ |+|.+++.... ....+++..+..++.|+++||+||| +.+++||||||+||++++++.++|+|||+++.....
T Consensus 80 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~ 153 (284)
T cd07836 80 MD-KDLKKYMDTHG--VRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP 153 (284)
T ss_pred CC-ccHHHHHHhcC--CCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC
Confidence 97 58888886522 1346899999999999999999999 789999999999999999999999999999754332
Q ss_pred CcceecccccccCcccccccccC-cCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhc-hhHHHhhcC
Q 041143 785 EKSVVTRLAGTFGYLAPEYAVMG-KITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSS-KEKFKAAID 862 (973)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 862 (973)
.. ......++..|+|||++.+. .++.++|||||||++|||++|+.||......+... ......... ........+
T Consensus 154 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 154 VN-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLL--KIFRIMGTPTESTWPGISQ 230 (284)
T ss_pred cc-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHH--HHHHHhCCCChhhHHHHhc
Confidence 21 12234578899999988654 57889999999999999999999998665432111 000000000 000000000
Q ss_pred -----ccccC-Ccc-----cHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 863 -----PALEV-NEE-----TFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 863 -----~~l~~-~~~-----~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
..... ... .......+.+++.+|++.||.+||++.||++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred CchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000 000 0112345779999999999999999999986
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=307.75 Aligned_cols=269 Identities=27% Similarity=0.365 Sum_probs=200.5
Q ss_pred HHhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC----
Q 041143 622 KVTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGN---- 696 (973)
Q Consensus 622 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 696 (973)
...++|+..+.||+|+||.||+|... +|+.||+|+++...........+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999875 5889999999765333334456788999999999999999999987655
Q ss_pred ------eEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCE
Q 041143 697 ------ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRA 770 (973)
Q Consensus 697 ------~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~ 770 (973)
..++||||+++ ++..++... ...+++..+..++.||+.||+||| +.+|+||||||+||++++++.+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~ 155 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG----LVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQI 155 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcE
Confidence 78999999975 777766541 246899999999999999999999 8899999999999999999999
Q ss_pred EEeeccccccCCCCCcceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHH
Q 041143 771 KVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWR 849 (973)
Q Consensus 771 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 849 (973)
||+|||++...............++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+.. .. +..
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~--~~-~~~ 232 (302)
T cd07864 156 KLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQL--EL-ISR 232 (302)
T ss_pred EeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH--HH-HHH
Confidence 999999998654433222233456888999998764 35788999999999999999999999865432211 11 111
Q ss_pred Hhhc--hhHHHhhc--------CccccC----CcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 850 IKSS--KEKFKAAI--------DPALEV----NEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 850 ~~~~--~~~~~~~~--------~~~l~~----~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
.... ......+. ++.-.. ..........+.+++..|++.||.+||++.+|++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1100 00000000 000000 0000011345789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=303.66 Aligned_cols=259 Identities=16% Similarity=0.190 Sum_probs=183.8
Q ss_pred hcCccccCcccccCccEEEEEEECC----CCEEEEEEeecCCCChHH---------HHHHHHHHHHHHhcCCCceeeeee
Q 041143 624 TQNFAQENELGRGGFGTVYKGELED----GTKIAVKRMEAGVTTTKA---------LDEFQSEIAVLSKVRHRHLVSLLG 690 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~~~---------~~~~~~E~~~l~~l~h~niv~l~~ 690 (973)
.++|.+.+.||+|+||.||+|...+ +..+|+|+.......... ......+...+..++|++|+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3678999999999999999998754 345666654322111100 011223344556678999999999
Q ss_pred EEEeCC----eEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECC
Q 041143 691 YSIEGN----ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDD 766 (973)
Q Consensus 691 ~~~~~~----~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~ 766 (973)
++.... ..+++||++. .++.+.+.. ....++..+..|+.|+++||+||| +++|+||||||+|||++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~ 161 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKR-----IKCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDG 161 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHh-----hccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcC
Confidence 876543 3467888773 466655543 123567888999999999999999 889999999999999999
Q ss_pred CCCEEEeeccccccCCCCCc------ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhh-
Q 041143 767 DYRAKVSDFGLVKLAPDGEK------SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEE- 839 (973)
Q Consensus 767 ~~~~kl~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~- 839 (973)
++.++|+|||+|+....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~ 241 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence 99999999999985532221 11123469999999999999999999999999999999999999998663211
Q ss_pred HHHHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHH
Q 041143 840 SRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVL 903 (973)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L 903 (973)
...... .+....+..+.+.... ....+.+++..|++.+|++||++.++.+.|
T Consensus 242 ~~~~~~--------~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 242 LIHAAK--------CDFIKRLHEGKIKIKN----ANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHhH--------HHHHHHhhhhhhccCC----CCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 111000 0011111111111111 124578999999999999999999999865
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=304.70 Aligned_cols=260 Identities=21% Similarity=0.280 Sum_probs=194.4
Q ss_pred ccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeeEEEeC--CeEEEEE
Q 041143 627 FAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR-HRHLVSLLGYSIEG--NERLLVY 702 (973)
Q Consensus 627 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lV~ 702 (973)
|+..+.||+|+||.||+|... +++.||+|+++........ ....+|+.++.++. |+||+++++++.+. +..++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 566788999999999999764 6889999998764333322 34457899999885 99999999999987 8899999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||++ |+|.+++... ...++|.++..++.|++.||+||| ..+++||||||+||+++. +.+||+|||+++...
T Consensus 80 e~~~-~~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~ 150 (282)
T cd07831 80 ELMD-MNLYELIKGR----KRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIY 150 (282)
T ss_pred ecCC-ccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccc
Confidence 9996 6888877541 246899999999999999999999 789999999999999999 999999999998654
Q ss_pred CCCcceecccccccCcccccccc-cCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhc-hhHHHhh
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAV-MGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSS-KEKFKAA 860 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 860 (973)
.... .....++..|+|||++. +..++.++|||||||++|||++|+.||......+. ..+....... .......
T Consensus 151 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 225 (282)
T cd07831 151 SKPP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ---IAKIHDVLGTPDAEVLKK 225 (282)
T ss_pred cCCC--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH---HHHHHHHcCCCCHHHHHh
Confidence 3222 23356889999999765 45578899999999999999999999987654322 1111111100 0000001
Q ss_pred cCcc----ccCCc--------ccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 861 IDPA----LEVNE--------ETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 861 ~~~~----l~~~~--------~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
+... ..... ........+.+++.+|++.+|++||++.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 226 FRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred hcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 1000 00000 00122456889999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=310.45 Aligned_cols=268 Identities=20% Similarity=0.295 Sum_probs=196.8
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC------
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGN------ 696 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 696 (973)
.++|...+.||+|+||.||+|... +++.||||++............+.+|++++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357899999999999999999775 6899999998654333333345678999999999999999999987654
Q ss_pred --eEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEee
Q 041143 697 --ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSD 774 (973)
Q Consensus 697 --~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D 774 (973)
..++||||+. ++|.+++.. ....+++.++..++.||+.||+||| +++++|+||||+||+++.++.+||+|
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~d 162 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSN----KNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLAD 162 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECc
Confidence 3499999995 588877754 1235899999999999999999999 78999999999999999999999999
Q ss_pred ccccccCCCCCcc---eecccccccCcccccccccC-cCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHH
Q 041143 775 FGLVKLAPDGEKS---VVTRLAGTFGYLAPEYAVMG-KITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRI 850 (973)
Q Consensus 775 fGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 850 (973)
||++......... ......++..|+|||++.+. .++.++|||||||++|||++|+.||..............+...
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~ 242 (310)
T cd07865 163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGS 242 (310)
T ss_pred CCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999855332211 12234678899999988654 4788999999999999999999999876543322222111100
Q ss_pred hhchhHHHhh-----cCccccCCccc----H------HHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 851 KSSKEKFKAA-----IDPALEVNEET----F------ESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 851 ~~~~~~~~~~-----~~~~l~~~~~~----~------~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
.. .+..... .+ .+...... . .....+.+++.+|++.||++||+++|+++
T Consensus 243 ~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 243 IT-PEVWPGVDKLELFK-KMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred CC-hhhcccccchhhhh-hccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00 0000000 00 00000000 0 01134678999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=303.24 Aligned_cols=243 Identities=24% Similarity=0.313 Sum_probs=186.3
Q ss_pred cccccCccEEEEEEEC-CCCEEEEEEeecCCCC-hHHHHHHHHHHHHHHh---cCCCceeeeeeEEEeCCeEEEEEEecC
Q 041143 632 ELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTT-TKALDEFQSEIAVLSK---VRHRHLVSLLGYSIEGNERLLVYEYMP 706 (973)
Q Consensus 632 ~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~---l~h~niv~l~~~~~~~~~~~lV~e~~~ 706 (973)
.||+|+||.||++... +++.+|+|.+...... ......+.+|..+++. .+||||+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999874 5889999988654222 2222334455444433 479999999999999999999999999
Q ss_pred CCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCc
Q 041143 707 HGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEK 786 (973)
Q Consensus 707 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~ 786 (973)
+|+|.+++.. ...+++..+..++.|++.||+||| +.+|+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~-----~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~- 151 (279)
T cd05633 81 GGDLHYHLSQ-----HGVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 151 (279)
T ss_pred CCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-
Confidence 9999988864 246899999999999999999999 8899999999999999999999999999987543322
Q ss_pred ceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccc
Q 041143 787 SVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPAL 865 (973)
Q Consensus 787 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 865 (973)
.....|+..|+|||.+.. ..++.++|||||||++|||++|+.||..........+.. .. ...+..+
T Consensus 152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~----~~-------~~~~~~~ 218 (279)
T cd05633 152 --PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR----MT-------LTVNVEL 218 (279)
T ss_pred --ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHH----Hh-------hcCCcCC
Confidence 223468999999998864 568899999999999999999999997544322111111 00 0011111
Q ss_pred cCCcccHHHHHHHHHHHHHhhccCCCCCC-----CHhHHHH
Q 041143 866 EVNEETFESISIVAELAGHCTAREPYHRP-----DMGHVVN 901 (973)
Q Consensus 866 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~~v~~ 901 (973)
. ......+.+++.+|++.||++|| +++|+++
T Consensus 219 ~-----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 219 P-----DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred c-----cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 1 11224577999999999999999 5888877
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=312.25 Aligned_cols=282 Identities=21% Similarity=0.329 Sum_probs=210.4
Q ss_pred HHHHHHhcCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeC-
Q 041143 618 QVLRKVTQNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEG- 695 (973)
Q Consensus 618 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~- 695 (973)
..+..+.++|...+.||+|+||.||+|.. .+|+.||+|+++.........+.+.+|++++++++||||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 44566779999999999999999999975 4689999999875433444456788999999999999999999988643
Q ss_pred -----CeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCE
Q 041143 696 -----NERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRA 770 (973)
Q Consensus 696 -----~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~ 770 (973)
...++|+|++ +++|.+++.. ..+++..+..++.|+++||+||| +.+|+||||||+||++++++.+
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCE
Confidence 3467888887 8899887743 45899999999999999999999 8899999999999999999999
Q ss_pred EEeeccccccCCCCCcceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHH
Q 041143 771 KVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWR 849 (973)
Q Consensus 771 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 849 (973)
||+|||+++..... .....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.......... .....
T Consensus 160 kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~--~~~~~ 233 (345)
T cd07877 160 KILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK--LILRL 233 (345)
T ss_pred EEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHH
Confidence 99999998854322 233568899999998866 568889999999999999999999997654322111 00000
Q ss_pred Hhhc-hhHH-----------HhhcCcccc--CCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCCCCC
Q 041143 850 IKSS-KEKF-----------KAAIDPALE--VNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPITD 915 (973)
Q Consensus 850 ~~~~-~~~~-----------~~~~~~~l~--~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~~~~ 915 (973)
.... .... ...++.... ...........+.+++.+|++.||.+||++.++++ +++.+++..+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~--h~~f~~~~~~~~ 311 (345)
T cd07877 234 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA--HAYFAQYHDPDD 311 (345)
T ss_pred hCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc--ChhhhhcCCCCc
Confidence 0000 0000 000000000 00000011235789999999999999999999998 788877766555
Q ss_pred CC
Q 041143 916 ES 917 (973)
Q Consensus 916 ~~ 917 (973)
+.
T Consensus 312 ~~ 313 (345)
T cd07877 312 EP 313 (345)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=298.35 Aligned_cols=253 Identities=25% Similarity=0.419 Sum_probs=207.3
Q ss_pred CccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEe
Q 041143 626 NFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEY 704 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 704 (973)
+|...+.||+|+||.||++... ++..+|+|++..........+.+.+|+++++.++|+|++++++.+..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999875 688999999976654556677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCC
Q 041143 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG 784 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~ 784 (973)
+++++|.+++..... ....+++.++..++.+++.||+||| +.+++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 999999999976322 2367899999999999999999999 789999999999999999999999999999865443
Q ss_pred CcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCcc
Q 041143 785 EKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPA 864 (973)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 864 (973)
. .......|++.|+|||......++.++||||+|+++++|++|+.||........ ...... ... +.
T Consensus 157 ~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~------~~~~~~------~~~-~~ 222 (258)
T cd08215 157 V-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLEL------ALKILK------GQY-PP 222 (258)
T ss_pred c-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHH------HHHHhc------CCC-CC
Confidence 2 223345789999999999888899999999999999999999999976542211 111110 001 11
Q ss_pred ccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 865 LEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 865 l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
+. ......+.+++.+|+..+|++||++.++++
T Consensus 223 ~~-----~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 223 IP-----SQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CC-----CCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 11 122345789999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=299.24 Aligned_cols=244 Identities=27% Similarity=0.325 Sum_probs=195.6
Q ss_pred ccccCccEEEEEEEC-CCCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEecCCCCH
Q 041143 633 LGRGGFGTVYKGELE-DGTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGAL 710 (973)
Q Consensus 633 lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 710 (973)
||+|+||.||+|+.. +++.+|+|++..... .....+.+.+|++++++++||||+++++++.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999875 488999999865422 234457799999999999999999999999999999999999999999
Q ss_pred HHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCcceec
Q 041143 711 SRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVT 790 (973)
Q Consensus 711 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 790 (973)
.+++.+. ..+++..+..++.|++.||+||| +++++|+||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~ 150 (262)
T cd05572 81 WTILRDR-----GLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTW 150 (262)
T ss_pred HHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccc
Confidence 9999652 34789999999999999999999 7899999999999999999999999999998665432 123
Q ss_pred ccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccCCcc
Q 041143 791 RLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEE 870 (973)
Q Consensus 791 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 870 (973)
...|+..|+|||++....++.++|+||+|+++|||++|+.||........ .....+... ..... .
T Consensus 151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~~--------~~~~~---~ 215 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM----EIYNDILKG--------NGKLE---F 215 (262)
T ss_pred cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH----HHHHHHhcc--------CCCCC---C
Confidence 34688999999999888899999999999999999999999976652111 111111100 00111 1
Q ss_pred cHHHHHHHHHHHHHhhccCCCCCCC-----HhHHHH
Q 041143 871 TFESISIVAELAGHCTAREPYHRPD-----MGHVVN 901 (973)
Q Consensus 871 ~~~~~~~~~~l~~~cl~~dP~~RPs-----~~~v~~ 901 (973)
+......+.+++.+|++.+|++||+ ++|+++
T Consensus 216 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 216 PNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 1111346889999999999999999 566665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=297.82 Aligned_cols=252 Identities=27% Similarity=0.420 Sum_probs=205.3
Q ss_pred CccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeC--CeEEEEE
Q 041143 626 NFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEG--NERLLVY 702 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~ 702 (973)
+|...+.||+|++|.||+|... +++.|++|++..........+.+.+|++++++++|+||+++++++... ...++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677889999999999999876 689999999876544456678899999999999999999999999988 8899999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++++|.+++... ..+++..+..++.|+++||+||| +.+++|+||+|+||+++.++.++|+|||.+....
T Consensus 81 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 152 (260)
T cd06606 81 EYVSGGSLSSLLKKF-----GKLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLG 152 (260)
T ss_pred EecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence 999999999998652 27899999999999999999999 7899999999999999999999999999988655
Q ss_pred CCCcc-eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhc
Q 041143 783 DGEKS-VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861 (973)
Q Consensus 783 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (973)
..... ......++..|+|||.......+.++||||||+++|+|++|+.||....... .......
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~---------- 217 (260)
T cd06606 153 DIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM-----AALYKIG---------- 217 (260)
T ss_pred cccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-----HHHHhcc----------
Confidence 43321 1234568899999999988889999999999999999999999998665111 0011110
Q ss_pred CccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 862 DPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 862 ~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
..... ..........+.+++.+|++.+|++||++.|+++
T Consensus 218 ~~~~~-~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 218 SSGEP-PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred ccCCC-cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 00000 0111112356889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=296.24 Aligned_cols=249 Identities=29% Similarity=0.488 Sum_probs=204.3
Q ss_pred CccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEe
Q 041143 626 NFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEY 704 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 704 (973)
+|+..+.||+|++|.||+|... +++.||+|.+..........+.+.+|++++++++|+|++++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4777899999999999999765 578999999977644445677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCC
Q 041143 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG 784 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~ 784 (973)
+++++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 81 AENGSLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152 (254)
T ss_pred CCCCcHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence 9999999998652 56899999999999999999999 889999999999999999999999999999866543
Q ss_pred CcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCcc
Q 041143 785 EKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPA 864 (973)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 864 (973)
... .....|+..|+|||+..+..++.++||||+|+++|+|++|+.||........ . +.... ...+.
T Consensus 153 ~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~--~----~~~~~-------~~~~~ 218 (254)
T cd06627 153 SKD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA--L----FRIVQ-------DDHPP 218 (254)
T ss_pred ccc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH--H----HHHhc-------cCCCC
Confidence 322 2345689999999999888889999999999999999999999976542211 0 00000 00111
Q ss_pred ccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 865 LEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 865 l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
+. ......+.+++.+|+..+|++||++.+++.
T Consensus 219 ~~-----~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 219 LP-----EGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CC-----CCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 11 111245779999999999999999999985
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=313.06 Aligned_cols=248 Identities=24% Similarity=0.429 Sum_probs=196.8
Q ss_pred cCcccccCccEEEEEEEC-CCCEEEEEEe--ecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCe--EEEEEEe
Q 041143 630 ENELGRGGFGTVYKGELE-DGTKIAVKRM--EAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNE--RLLVYEY 704 (973)
Q Consensus 630 ~~~lG~G~fg~Vy~~~~~-~g~~vavK~~--~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lV~e~ 704 (973)
..+||+|+|-+||||.+. +|..||--.+ ..-.......++|..|+.+|+.|+|||||++|.++.+... ..+|.|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 367999999999999664 5777764322 2222355667899999999999999999999999988665 6789999
Q ss_pred cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCC-CCEEEeeccccccCCC
Q 041143 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDD-YRAKVSDFGLVKLAPD 783 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~-~~~kl~DfGla~~~~~ 783 (973)
+..|+|..|+.++ +.++......++.||++||.|||+. .++|||||||-.||+|+.+ |.|||+|+|+|.....
T Consensus 125 ~TSGtLr~Y~kk~-----~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 125 FTSGTLREYRKKH-----RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred ccCCcHHHHHHHh-----ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 9999999999874 3466778899999999999999976 7899999999999999865 8999999999986644
Q ss_pred CCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhc--hhHHHhhc
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSS--KEKFKAAI 861 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 861 (973)
.. ...+.|||.|||||+.. ..|++.+||||||..++||+|+..||..=. .-++.++++..+ ...+..+-
T Consensus 199 s~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~-----n~AQIYKKV~SGiKP~sl~kV~ 269 (632)
T KOG0584|consen 199 SH---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT-----NPAQIYKKVTSGIKPAALSKVK 269 (632)
T ss_pred cc---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC-----CHHHHHHHHHcCCCHHHhhccC
Confidence 32 23478999999999775 789999999999999999999999986433 233333443332 11222222
Q ss_pred CccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 862 DPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 862 ~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
|| ++.++|.+|+.. .++||++.|++. ..+..
T Consensus 270 dP-------------evr~fIekCl~~-~~~R~sa~eLL~--d~Ff~ 300 (632)
T KOG0584|consen 270 DP-------------EVREFIEKCLAT-KSERLSAKELLK--DPFFD 300 (632)
T ss_pred CH-------------HHHHHHHHHhcC-chhccCHHHHhh--Chhhc
Confidence 33 366999999999 999999999997 55544
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=312.94 Aligned_cols=271 Identities=21% Similarity=0.338 Sum_probs=200.9
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeC------C
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEG------N 696 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 696 (973)
..+|...+.||+|+||.||+|... +|+.||||+++...........+.+|++++++++|+||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999999999999864 689999999875433344455688999999999999999999998754 3
Q ss_pred eEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecc
Q 041143 697 ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFG 776 (973)
Q Consensus 697 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG 776 (973)
..++||||+. .+|..+. ...+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||
T Consensus 94 ~~~lv~e~~~-~~l~~~~-------~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg 162 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIM-------GHPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFG 162 (342)
T ss_pred eEEEEecccc-cCHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCC
Confidence 4689999995 4666544 135789999999999999999999 7899999999999999999999999999
Q ss_pred ccccCCCCCcceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchh
Q 041143 777 LVKLAPDGEKSVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKE 855 (973)
Q Consensus 777 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 855 (973)
+++..... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||............... ......
T Consensus 163 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~--~~~~~~ 236 (342)
T cd07879 163 LARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV--TGVPGP 236 (342)
T ss_pred CCcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh--cCCCCH
Confidence 98754322 223467889999999876 46889999999999999999999999875532211110000 000000
Q ss_pred HHHh---------hcC--ccccCCc---ccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCCC
Q 041143 856 KFKA---------AID--PALEVNE---ETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPI 913 (973)
Q Consensus 856 ~~~~---------~~~--~~l~~~~---~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~~ 913 (973)
.+.+ .+. +...... ........+.+++.+|++.||++||++++++. +++++...+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~--h~~f~~~~~~ 306 (342)
T cd07879 237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE--HPYFDSFRDA 306 (342)
T ss_pred HHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc--Ccchhhcccc
Confidence 0000 000 0000000 00012235789999999999999999999997 6676665543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=300.83 Aligned_cols=246 Identities=27% Similarity=0.406 Sum_probs=196.3
Q ss_pred ccccCccEEEEEEECC-CCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEecCCCCH
Q 041143 633 LGRGGFGTVYKGELED-GTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGAL 710 (973)
Q Consensus 633 lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 710 (973)
||+|+||.||+++... |+.+|+|++..... .....+.+.+|++++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999998864 89999999865422 234566789999999999999999999999999999999999999999
Q ss_pred HHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCc----
Q 041143 711 SRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEK---- 786 (973)
Q Consensus 711 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~---- 786 (973)
.+++.+. ..+++..+..++.||++||+||| +.+++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 152 (265)
T cd05579 81 ASLLENV-----GSLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN 152 (265)
T ss_pred HHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc
Confidence 9998652 36899999999999999999999 88999999999999999999999999999875433211
Q ss_pred ---ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCc
Q 041143 787 ---SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDP 863 (973)
Q Consensus 787 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (973)
.......++..|+|||......++.++||||||+++|||++|+.||......+. +..... .
T Consensus 153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~------~~~~~~----------~ 216 (265)
T cd05579 153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI------FQNILN----------G 216 (265)
T ss_pred cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHhc----------C
Confidence 122345688899999999888899999999999999999999999976653221 111111 0
Q ss_pred cccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHH
Q 041143 864 ALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVL 903 (973)
Q Consensus 864 ~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L 903 (973)
....... ......+.+++.+|++.+|++||++.+|.+.|
T Consensus 217 ~~~~~~~-~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 217 KIEWPED-VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred CcCCCcc-ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 1110000 00134578999999999999999996666544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=305.71 Aligned_cols=257 Identities=25% Similarity=0.353 Sum_probs=198.9
Q ss_pred CccccCcccccCccEEEEEEE----CCCCEEEEEEeecCCC--ChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeE
Q 041143 626 NFAQENELGRGGFGTVYKGEL----EDGTKIAVKRMEAGVT--TTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGNER 698 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~----~~g~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 698 (973)
+|...+.||+|+||.||+++. .+++.||||.++.... .....+.+..|++++.++ +|+||+++++++..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 367788999999999999974 3578899999864311 223456788999999999 599999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecccc
Q 041143 699 LLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLV 778 (973)
Q Consensus 699 ~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla 778 (973)
++||||+++|+|.+++.. ...+++..+..++.|+++||+||| ..+++||||||+||+++.++.++|+|||++
T Consensus 81 ~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~ 152 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ-----REHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLS 152 (288)
T ss_pred EEEEecCCCCcHHHHHhh-----cCCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccc
Confidence 999999999999999864 245789999999999999999999 789999999999999999999999999998
Q ss_pred ccCCCCCcceecccccccCcccccccccCc--CCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhH
Q 041143 779 KLAPDGEKSVVTRLAGTFGYLAPEYAVMGK--ITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEK 856 (973)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (973)
+..............|+..|+|||...+.. .+.++||||||+++|||++|+.||........ ..........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~---- 226 (288)
T cd05583 153 KEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISRRILK---- 226 (288)
T ss_pred cccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHHHHHc----
Confidence 854433222223356899999999987655 78899999999999999999999964322110 0111111110
Q ss_pred HHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHH
Q 041143 857 FKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSP 905 (973)
Q Consensus 857 ~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~ 905 (973)
. .+... ......+.+++.+|++.||++|||+++|.+.|+.
T Consensus 227 --~--~~~~~-----~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 227 --S--KPPFP-----KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred --c--CCCCC-----cccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 0 01111 0112346789999999999999999988876643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=284.45 Aligned_cols=210 Identities=28% Similarity=0.400 Sum_probs=176.3
Q ss_pred HhcCccccCcccccCccEEEEEEECC-----CCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEe-CC
Q 041143 623 VTQNFAQENELGRGGFGTVYKGELED-----GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIE-GN 696 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~ 696 (973)
....|+....||+|.||.||+|...+ ...+|+|+++.............+|+..++.++|||+|.+..++.. +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 34678899999999999999995432 2368999998764443444567899999999999999999999988 77
Q ss_pred eEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCC----CCEEE
Q 041143 697 ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDD----YRAKV 772 (973)
Q Consensus 697 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~----~~~kl 772 (973)
..++++||.+. +|...++-.+....+.++-..+..|..||+.|+.||| ++=|+|||+||.|||+..+ |.|||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEe
Confidence 88999999976 8888887766666678899999999999999999999 7889999999999999877 89999
Q ss_pred eeccccccCCCCCcc--eecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCC
Q 041143 773 SDFGLVKLAPDGEKS--VVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEER 836 (973)
Q Consensus 773 ~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~ 836 (973)
+|||+++.+.+.-.. ....++-|..|+|||.+.+ +.|+.+.||||.||++.||+|-++-|....
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 999999976554322 2345678999999999986 469999999999999999999988886543
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=304.46 Aligned_cols=253 Identities=26% Similarity=0.379 Sum_probs=195.4
Q ss_pred CccccCcccccCccEEEEEEE----CCCCEEEEEEeecCCC--ChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeE
Q 041143 626 NFAQENELGRGGFGTVYKGEL----EDGTKIAVKRMEAGVT--TTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGNER 698 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~----~~g~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 698 (973)
+|+..+.||+|+||.||+|+. .+|+.||+|+++.... .....+.+.+|++++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 467788999999999999976 3689999999865321 123346788999999999 599999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecccc
Q 041143 699 LLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLV 778 (973)
Q Consensus 699 ~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla 778 (973)
++||||+++++|.+++.. ...+++.+...++.|+++||+||| +.+++||||||+||++++++.+||+|||++
T Consensus 81 ~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 152 (290)
T cd05613 81 HLILDYINGGELFTHLSQ-----RERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLS 152 (290)
T ss_pred EEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccc
Confidence 999999999999999865 245788899999999999999999 889999999999999999999999999999
Q ss_pred ccCCCCCcceecccccccCcccccccccC--cCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhH
Q 041143 779 KLAPDGEKSVVTRLAGTFGYLAPEYAVMG--KITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEK 856 (973)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (973)
+..............|+..|+|||++... .++.++||||||+++|||++|+.||........ ...+.......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~--- 227 (290)
T cd05613 153 KEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEISRRILKS--- 227 (290)
T ss_pred eecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHHHHhhcc---
Confidence 86544332223345689999999998753 467899999999999999999999964322111 11111111110
Q ss_pred HHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCC-----CHhHHHH
Q 041143 857 FKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRP-----DMGHVVN 901 (973)
Q Consensus 857 ~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~~v~~ 901 (973)
.+.. +......+.+++.+|++.||++|| ++.+++.
T Consensus 228 -----~~~~-----~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 228 -----EPPY-----PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred -----CCCC-----CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 0111 111224577999999999999997 5555554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=286.72 Aligned_cols=256 Identities=25% Similarity=0.318 Sum_probs=200.7
Q ss_pred cccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeEEEEEEec
Q 041143 628 AQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGNERLLVYEYM 705 (973)
Q Consensus 628 ~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~ 705 (973)
+.+..||.|+||+|+|-..+ .|+..|||+++... ..+..+++..|.+...+- +.||||++||.+..++..++.||.|
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n-~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM 145 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN-IEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM 145 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeecc-chHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence 34567999999999999654 69999999998764 356677889998876665 7999999999999999999999999
Q ss_pred CCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCC
Q 041143 706 PHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGE 785 (973)
Q Consensus 706 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~ 785 (973)
.-+|+.+-......+...+++...-+|+.-++.||.||-. ...|||||+||+|||+|..|.+||||||++-...+.
T Consensus 146 -d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S- 221 (361)
T KOG1006|consen 146 -DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS- 221 (361)
T ss_pred -hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHH-
Confidence 5677665543333344678888888999999999999984 668999999999999999999999999998754332
Q ss_pred cceecccccccCccccccccc--CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCc
Q 041143 786 KSVVTRLAGTFGYLAPEYAVM--GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDP 863 (973)
Q Consensus 786 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (973)
...+.-+|...|||||.+.. ..|+.++||||+|++|||+.||+.|+..... +.+.+..+..+ =.|
T Consensus 222 -iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv~g-------dpp 288 (361)
T KOG1006|consen 222 -IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVVIG-------DPP 288 (361)
T ss_pred -HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHHcC-------CCC
Confidence 22344579999999999863 3489999999999999999999999875432 11111111111 123
Q ss_pred cccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 864 ALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 864 ~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
.+.......+....+..++--|+..|-.+||...++..
T Consensus 289 ~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 289 ILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred eecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 34434444556667889999999999999999999887
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=307.15 Aligned_cols=267 Identities=21% Similarity=0.317 Sum_probs=197.4
Q ss_pred Cccccc--CccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEecCC
Q 041143 631 NELGRG--GFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPH 707 (973)
Q Consensus 631 ~~lG~G--~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 707 (973)
..||+| +||+||+|... +|+.||+|++..........+.+.+|+.+++.++||||+++++++..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456776 99999999864 799999999876544555667899999999999999999999999999999999999999
Q ss_pred CCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCcc
Q 041143 708 GALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKS 787 (973)
Q Consensus 708 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~~ 787 (973)
|+|.+++.... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++++||+.+.........
T Consensus 84 ~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 84 GSANSLLKTYF---PEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred CCHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence 99999987632 235889999999999999999999 889999999999999999999999999865422111100
Q ss_pred ------eecccccccCcccccccccC--cCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHH----------
Q 041143 788 ------VVTRLAGTFGYLAPEYAVMG--KITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWR---------- 849 (973)
Q Consensus 788 ------~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~---------- 849 (973)
......++..|+|||++.+. .++.++|||||||++|||++|+.||........ +......
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~ 235 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDITT 235 (328)
T ss_pred ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCccccc
Confidence 01112356779999998763 478999999999999999999999976543211 1110000
Q ss_pred -------HhhchhHHH--------------hhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 850 -------IKSSKEKFK--------------AAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 850 -------~~~~~~~~~--------------~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
......... ...+..+. ..........+.+++.+|++.||++|||+.|+++ +.+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~--~~~~~ 312 (328)
T cd08226 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLR-TPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS--HAFFK 312 (328)
T ss_pred cchhhhhhccchhhhhcccccchhcccccccccccccc-chhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh--CHHHH
Confidence 000000000 00000111 1111234456889999999999999999999997 55544
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=315.15 Aligned_cols=276 Identities=23% Similarity=0.355 Sum_probs=208.9
Q ss_pred HhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCe----
Q 041143 623 VTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNE---- 697 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 697 (973)
..++|...+.||+|+||.||+|+.. +++.||||++..........+.+.+|+.++++++|+||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4578999999999999999999875 57899999986543344455678889999999999999999998876554
Q ss_pred --EEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeec
Q 041143 698 --RLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDF 775 (973)
Q Consensus 698 --~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 775 (973)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||+||| +.+|+||||||+||++++++.+||+||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~df 162 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDF 162 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEccc
Confidence 89999998 7799888854 46899999999999999999999 789999999999999999999999999
Q ss_pred cccccCCCCCcceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHH-HHH--------
Q 041143 776 GLVKLAPDGEKSVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRY-LAE-------- 845 (973)
Q Consensus 776 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~-~~~-------- 845 (973)
|++...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+... +..
T Consensus 163 g~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 238 (343)
T cd07851 163 GLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE 238 (343)
T ss_pred ccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Confidence 999855432 233467889999998865 367899999999999999999999997654322110 000
Q ss_pred HHHHHhhchhHHHhhcCccccCC-----cccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCCCCCC
Q 041143 846 WFWRIKSSKEKFKAAIDPALEVN-----EETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPITDE 916 (973)
Q Consensus 846 ~~~~~~~~~~~~~~~~~~~l~~~-----~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~~~~~ 916 (973)
+..+.. .......+....... .........+.+++.+|++.+|++||++.+|++ ++++++|...+++
T Consensus 239 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~--h~~~~~~~~~~~~ 310 (343)
T cd07851 239 LLQKIS--SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA--HPYLAEYHDPEDE 310 (343)
T ss_pred HHhhcc--chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc--CCCccccCCCccc
Confidence 000000 000000100000000 000112346889999999999999999999988 7888877666544
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=301.13 Aligned_cols=242 Identities=27% Similarity=0.379 Sum_probs=189.8
Q ss_pred ccccCccEEEEEEEC-CCCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEecCCCCH
Q 041143 633 LGRGGFGTVYKGELE-DGTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGAL 710 (973)
Q Consensus 633 lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 710 (973)
||+|+||+||+|... +|+.||+|.+..... .......+..|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999754 689999999864321 223345677899999999999999999999999999999999999999
Q ss_pred HHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCcceec
Q 041143 711 SRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVT 790 (973)
Q Consensus 711 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 790 (973)
.+++.... ...+++.++..++.|++.||.||| ..+++||||+|+||++++++.+||+|||.+....... ...
T Consensus 81 ~~~l~~~~---~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~ 152 (277)
T cd05577 81 KYHIYNVG---EPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIK 152 (277)
T ss_pred HHHHHHcC---cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--ccc
Confidence 99986522 246899999999999999999999 8899999999999999999999999999987554321 123
Q ss_pred ccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhh-cCccccCCc
Q 041143 791 RLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAA-IDPALEVNE 869 (973)
Q Consensus 791 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~~~ 869 (973)
...++..|+|||++.+..++.++|||||||++|+|++|+.||.......... .+... ......
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------------~~~~~~~~~~~~--- 216 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE-------------ELKRRTLEMAVE--- 216 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH-------------HHHhcccccccc---
Confidence 3467889999999988889999999999999999999999997654311100 00000 000000
Q ss_pred ccHHHHHHHHHHHHHhhccCCCCCCCHhH
Q 041143 870 ETFESISIVAELAGHCTAREPYHRPDMGH 898 (973)
Q Consensus 870 ~~~~~~~~~~~l~~~cl~~dP~~RPs~~~ 898 (973)
........+.+++.+|++.+|++||+..+
T Consensus 217 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 217 YPDKFSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred CCccCCHHHHHHHHHHccCChhHccCCCc
Confidence 00111234779999999999999994444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=301.78 Aligned_cols=264 Identities=24% Similarity=0.329 Sum_probs=198.1
Q ss_pred ccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc---CCCceeeeeeEEEeCCe-----
Q 041143 627 FAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV---RHRHLVSLLGYSIEGNE----- 697 (973)
Q Consensus 627 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----- 697 (973)
|+..+.||+|+||.||+|+.+ +++.||+|+++...........+.+|+.+++++ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567789999999999999886 489999999975533333345677788877766 59999999999998776
Q ss_pred EEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccc
Q 041143 698 RLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL 777 (973)
Q Consensus 698 ~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGl 777 (973)
.+++|||+. ++|.+++.... ...+++..++.++.|+++||+||| +.+++|+||+|+||+++.++.+||+|||+
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~---~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~ 153 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCP---KPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGL 153 (287)
T ss_pred eEEEehhcc-cCHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCc
Confidence 899999996 58988886522 235899999999999999999999 78999999999999999999999999999
Q ss_pred cccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhch-hH
Q 041143 778 VKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSK-EK 856 (973)
Q Consensus 778 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~ 856 (973)
+........ .....++..|+|||++.+..++.++|||||||++|||++|+.||......+. +..+........ ..
T Consensus 154 ~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 229 (287)
T cd07838 154 ARIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ--LDKIFDVIGLPSEEE 229 (287)
T ss_pred ceeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH--HHHHHHHcCCCChHh
Confidence 886543321 2234578899999999988999999999999999999999999986554321 111111110000 00
Q ss_pred H-------HhhcCcccc--CCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 857 F-------KAAIDPALE--VNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 857 ~-------~~~~~~~l~--~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
. ......... ...........+.+++.+|++.||.+||++.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0 000000000 00011122356779999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=329.65 Aligned_cols=263 Identities=28% Similarity=0.441 Sum_probs=208.4
Q ss_pred cCccccCcccccCccEEEEEEEC----C----CCEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeC
Q 041143 625 QNFAQENELGRGGFGTVYKGELE----D----GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEG 695 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~----~----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 695 (973)
++....+.||+|.||.|++|... . ...||||.++..... ...+.+..|+++|..+ +|+||+.++|+|..+
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 44455568999999999999743 1 357999999876544 6778999999999998 699999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhhh---------hccCC--CCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEE
Q 041143 696 NERLLVYEYMPHGALSRHLFRWE---------KLQLK--PLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILL 764 (973)
Q Consensus 696 ~~~~lV~e~~~~g~L~~~l~~~~---------~~~~~--~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill 764 (973)
+..++|+||++.|+|.++|+..+ ..... .++....+.++.|||.||+||+ +.++||||+.++|||+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVLI 451 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEEe
Confidence 99999999999999999998865 11112 3889999999999999999999 8899999999999999
Q ss_pred CCCCCEEEeeccccccCCCCCcceeccccc--ccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHH
Q 041143 765 DDDYRAKVSDFGLVKLAPDGEKSVVTRLAG--TFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESR 841 (973)
Q Consensus 765 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~ 841 (973)
.++..+||+|||+|+............-.| ...|||||.+....|+.|+|||||||+||||+| |..|+.+.....
T Consensus 452 ~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~-- 529 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE-- 529 (609)
T ss_pred cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH--
Confidence 999999999999999655544433232233 456999999999999999999999999999998 667776532111
Q ss_pred HHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 842 YLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
.+.++... ..+ .+.+..+..++.++++.||+.+|++||++.++++.++...+
T Consensus 530 ~l~~~l~~--------------G~r-~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 530 ELLEFLKE--------------GNR-MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred HHHHHHhc--------------CCC-CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 11221111 111 11222334567799999999999999999999999998654
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=301.76 Aligned_cols=264 Identities=21% Similarity=0.331 Sum_probs=202.0
Q ss_pred ccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEec
Q 041143 627 FAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYM 705 (973)
Q Consensus 627 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 705 (973)
|...+.||+|++|.||+|... +|+.+|+|+++...........+.+|++++++++|+||+++++++..++..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 556788999999999999775 6889999998765444445678889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCC
Q 041143 706 PHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGE 785 (973)
Q Consensus 706 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~ 785 (973)
++ +|.+++... ...+++.++..++.|++.||+||| ..+|+|+||||+||++++++.+||+|||.+.......
T Consensus 81 ~~-~l~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~ 152 (283)
T cd05118 81 DT-DLYKLIKDR----QRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV 152 (283)
T ss_pred CC-CHHHHHHhh----cccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence 64 888887652 146899999999999999999999 8899999999999999999999999999998654433
Q ss_pred cceecccccccCcccccccccC-cCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhch-hHHHhhcC-
Q 041143 786 KSVVTRLAGTFGYLAPEYAVMG-KITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSK-EKFKAAID- 862 (973)
Q Consensus 786 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~- 862 (973)
.......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||......+..... ........ .......+
T Consensus 153 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05118 153 -RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKI--FRTLGTPDPEVWPKFTSL 229 (283)
T ss_pred -ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHHcCCCchHhcccchhh
Confidence 122334688899999998776 7899999999999999999999999766543221110 00000000 00000000
Q ss_pred --------cc---ccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 863 --------PA---LEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 863 --------~~---l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
+. .............+.+++.+|++.||.+||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00 0000011123456889999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=295.16 Aligned_cols=251 Identities=26% Similarity=0.383 Sum_probs=196.9
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCC---CChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeC--CeE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGV---TTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEG--NER 698 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 698 (973)
.+|...+.||+|+||.||+|... ++..||+|.+.... ........+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47888999999999999999764 58999999875321 1234556899999999999999999999998764 457
Q ss_pred EEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecccc
Q 041143 699 LLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLV 778 (973)
Q Consensus 699 ~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla 778 (973)
++||||+++++|.+++.. ...+++.....++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++
T Consensus 82 ~~v~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~ 153 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA-----YGALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGAS 153 (264)
T ss_pred EEEEEeCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccc
Confidence 899999999999998864 234788899999999999999999 889999999999999999999999999999
Q ss_pred ccCCCCC--cceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhH
Q 041143 779 KLAPDGE--KSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEK 856 (973)
Q Consensus 779 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (973)
+...... ........|+..|+|||++.+..++.++|||||||++|||++|+.||........ .. ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~----~~~~---- 223 (264)
T cd06653 154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA--IF----KIAT---- 223 (264)
T ss_pred cccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH--HH----HHHc----
Confidence 8543211 1112345689999999999888899999999999999999999999975432211 00 0000
Q ss_pred HHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 857 FKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 857 ~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
....+.+ +......+.+++.+|++ +|.+||+..+++.
T Consensus 224 --~~~~~~~-----p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 224 --QPTKPML-----PDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred --CCCCCCC-----CcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 0001111 11223457899999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=296.02 Aligned_cols=245 Identities=24% Similarity=0.339 Sum_probs=189.1
Q ss_pred CcccccCccEEEEEEEC-CCCEEEEEEeecCCC-ChHHHHHHHHHHHHHH-hcCCCceeeeeeEEEeCCeEEEEEEecCC
Q 041143 631 NELGRGGFGTVYKGELE-DGTKIAVKRMEAGVT-TTKALDEFQSEIAVLS-KVRHRHLVSLLGYSIEGNERLLVYEYMPH 707 (973)
Q Consensus 631 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 707 (973)
+.||+|+||.||+|... +|+.||||.++.... .......+..|..++. ..+|+||+++++++..++..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56899999999999764 588999999864321 1222334455655544 45899999999999999999999999999
Q ss_pred CCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCcc
Q 041143 708 GALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKS 787 (973)
Q Consensus 708 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~~ 787 (973)
++|.+++... ..+++..+..++.|++.||.||| +.+++||||+|+||++++++.+||+|||+++....
T Consensus 82 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---- 149 (260)
T cd05611 82 GDCASLIKTL-----GGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---- 149 (260)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc----
Confidence 9999998652 45788999999999999999999 78999999999999999999999999999875433
Q ss_pred eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccC
Q 041143 788 VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEV 867 (973)
Q Consensus 788 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 867 (973)
.....|+..|+|||...+..++.++||||||+++|||++|..||........ +..+.... .+ ..
T Consensus 150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~------~~--~~- 213 (260)
T cd05611 150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV------FDNILSRR------IN--WP- 213 (260)
T ss_pred -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHHhcc------cC--CC-
Confidence 2234688999999999888899999999999999999999999976553221 11111100 00 00
Q ss_pred CcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHH
Q 041143 868 NEETFESISIVAELAGHCTAREPYHRPDMGHVVNVL 903 (973)
Q Consensus 868 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L 903 (973)
..........+.+++.+|++.+|++||++.++.+.|
T Consensus 214 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 214 EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 000011234578999999999999999886665544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=305.67 Aligned_cols=270 Identities=20% Similarity=0.248 Sum_probs=197.4
Q ss_pred CcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEecCCCCH
Q 041143 631 NELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGAL 710 (973)
Q Consensus 631 ~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 710 (973)
+.+|.|+++.||++.. +++.||||+++.........+.+.+|++++++++|+||+++++++.+.+..+++|||+++|+|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 3445555555555544 589999999976544556678899999999999999999999999999999999999999999
Q ss_pred HHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCc----
Q 041143 711 SRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEK---- 786 (973)
Q Consensus 711 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~---- 786 (973)
.+++.... ...+++.....++.|+++||+||| +.+|+||||||+||+++.++.+||+|||.+........
T Consensus 87 ~~~l~~~~---~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 87 EDLLKTHF---PEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred HHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 99997532 235788899999999999999999 88999999999999999999999999998874332111
Q ss_pred --ceecccccccCccccccccc--CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhh---chhH---
Q 041143 787 --SVVTRLAGTFGYLAPEYAVM--GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKS---SKEK--- 856 (973)
Q Consensus 787 --~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~--- 856 (973)
.......++..|+|||++.. ..++.++|||||||++|||++|+.||........ +.+....... ....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 238 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYPL 238 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchhh
Confidence 11223457889999999875 3588999999999999999999999986543221 1110000000 0000
Q ss_pred ----HHh----hcCcccc---CCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcC
Q 041143 857 ----FKA----AIDPALE---VNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWR 911 (973)
Q Consensus 857 ----~~~----~~~~~l~---~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~ 911 (973)
... ..++... ...........+.+++.+||+.||++||++.++++ .++.+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~--~p~~~~~~ 302 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN--HSFFKQCK 302 (314)
T ss_pred hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc--CchHhhhc
Confidence 000 0000000 00011122346789999999999999999999998 66666443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=295.84 Aligned_cols=246 Identities=22% Similarity=0.246 Sum_probs=190.1
Q ss_pred HHHhcCccccCcc--cccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCC
Q 041143 621 RKVTQNFAQENEL--GRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGN 696 (973)
Q Consensus 621 ~~~~~~~~~~~~l--G~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 696 (973)
....++|.+.+.+ |+|+||.||++..+ +++.+|+|.+....... .|+.....+ +|+||+++++++...+
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEecCC
Confidence 3445677777776 99999999999764 68889999886432111 122222222 6999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCC-CEEEeec
Q 041143 697 ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDY-RAKVSDF 775 (973)
Q Consensus 697 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~-~~kl~Df 775 (973)
..++||||+++|+|.+++... ..++|.++..++.||++||+||| +.+++||||||+||+++.++ .++|+||
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~df 154 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKE-----GKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDY 154 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecC
Confidence 999999999999999998651 37899999999999999999999 78999999999999999998 9999999
Q ss_pred cccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchh
Q 041143 776 GLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKE 855 (973)
Q Consensus 776 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 855 (973)
|+++..... ....|+..|+|||++.+..++.++|||||||++|||++|+.||....... .....+....
T Consensus 155 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~----- 223 (267)
T PHA03390 155 GLCKIIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ----- 223 (267)
T ss_pred ccceecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh-----
Confidence 998755432 22468999999999998899999999999999999999999998544322 1112221111
Q ss_pred HHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCC-HhHHHH
Q 041143 856 KFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPD-MGHVVN 901 (973)
Q Consensus 856 ~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-~~~v~~ 901 (973)
..... ........+.+++.+|++.+|.+||+ ++|+++
T Consensus 224 ------~~~~~---~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 224 ------QKKLP---FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ------cccCC---cccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 11110 00122345789999999999999995 688885
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=330.14 Aligned_cols=147 Identities=29% Similarity=0.466 Sum_probs=132.0
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecC-CCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAG-VTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
++|.+.+.||+|+||.||+|.+. +++.||||+++.. .........+.+|+.++..++|+||+++++++...+..|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 67889999999999999999876 6899999998753 233445577899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccc
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK 779 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~ 779 (973)
||+++|+|.++++.. ..+++..++.|+.||+.||+||| .++||||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~-----~~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIY-----GYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999998652 35788899999999999999999 7899999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=301.47 Aligned_cols=247 Identities=27% Similarity=0.434 Sum_probs=195.5
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecC-CCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAG-VTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
+.|...+.||+|+||.||+|+.. +++.+|+|.+... .......+++.+|+++++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34667788999999999999865 5788999988643 223445567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+. |++.+++... ...+++.++..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++....
T Consensus 95 e~~~-~~l~~~~~~~----~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 95 EYCL-GSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred EccC-CCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 9996 6887777531 245889999999999999999999 7899999999999999999999999999987543
Q ss_pred CCCcceecccccccCcccccccc---cCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHh
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAV---MGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKA 859 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (973)
.. ....|+..|+|||++. ...++.++|||||||++|||++|+.||......+... ....
T Consensus 167 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~------~~~~------- 228 (308)
T cd06634 167 PA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIAQ------- 228 (308)
T ss_pred Cc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH------HHhh-------
Confidence 32 2346889999999874 3567889999999999999999999986543221111 0000
Q ss_pred hcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 860 AIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 860 ~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
...+... .......+.+++.+|++.+|++||++.+|+.
T Consensus 229 ~~~~~~~----~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~ 266 (308)
T cd06634 229 NESPALQ----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (308)
T ss_pred cCCCCcC----cccccHHHHHHHHHHhhCCcccCCCHHHHhh
Confidence 0011111 1122244779999999999999999999997
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=306.80 Aligned_cols=270 Identities=24% Similarity=0.304 Sum_probs=196.2
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC------
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGN------ 696 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 696 (973)
.++|...+.||+|+||.||+|... +++.+|||++............+.+|++++++++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999865 6899999998654333333346778999999999999999999876543
Q ss_pred --eEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEee
Q 041143 697 --ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSD 774 (973)
Q Consensus 697 --~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D 774 (973)
..++||||+. +++...+.. ....+++.++..++.|+++||+||| +.+|+||||||+||++++++.+||+|
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~----~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~d 158 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLEN----PSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIAD 158 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhc----cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECc
Confidence 4699999995 467776654 1246899999999999999999999 88999999999999999999999999
Q ss_pred ccccccCCCCCc----------ceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHH
Q 041143 775 FGLVKLAPDGEK----------SVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYL 843 (973)
Q Consensus 775 fGla~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~ 843 (973)
||+++....... ...+...|++.|+|||++.+ ..++.++|||||||++|||++|++||...........
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~ 238 (311)
T cd07866 159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL 238 (311)
T ss_pred CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 999875432211 11123467889999998765 4588999999999999999999999986654332111
Q ss_pred HHHHHHHhhc-----hhHHHhhc----CccccCC--cccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 844 AEWFWRIKSS-----KEKFKAAI----DPALEVN--EETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 844 ~~~~~~~~~~-----~~~~~~~~----~~~l~~~--~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
.......... ...+.... ....... .........+.+++.+|++.||++||++.|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 1100000000 00000000 0000000 000011245789999999999999999999886
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=296.01 Aligned_cols=243 Identities=24% Similarity=0.310 Sum_probs=186.6
Q ss_pred cccccCccEEEEEEEC-CCCEEEEEEeecCCCC-hHHHHHHHHHHH---HHHhcCCCceeeeeeEEEeCCeEEEEEEecC
Q 041143 632 ELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTT-TKALDEFQSEIA---VLSKVRHRHLVSLLGYSIEGNERLLVYEYMP 706 (973)
Q Consensus 632 ~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 706 (973)
.||+|+||.||+|... +++.||+|.+...... ......+..|.. .++..+||+|+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999764 5889999998654222 122223344443 4445579999999999999999999999999
Q ss_pred CCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCc
Q 041143 707 HGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEK 786 (973)
Q Consensus 707 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~ 786 (973)
+|+|..++.. ...+++.++..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 81 g~~L~~~l~~-----~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~- 151 (278)
T cd05606 81 GGDLHYHLSQ-----HGVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 151 (278)
T ss_pred CCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC-
Confidence 9999988854 246899999999999999999999 7899999999999999999999999999987543322
Q ss_pred ceecccccccCcccccccccC-cCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccc
Q 041143 787 SVVTRLAGTFGYLAPEYAVMG-KITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPAL 865 (973)
Q Consensus 787 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 865 (973)
.....|+..|+|||++.++ .++.++||||+||++|||++|+.||............ .. ....++.+
T Consensus 152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~---~~--------~~~~~~~~ 218 (278)
T cd05606 152 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---RM--------TLTMAVEL 218 (278)
T ss_pred --CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH---HH--------hhccCCCC
Confidence 1234689999999998754 6899999999999999999999999765332211110 00 00011111
Q ss_pred cCCcccHHHHHHHHHHHHHhhccCCCCCC-----CHhHHHH
Q 041143 866 EVNEETFESISIVAELAGHCTAREPYHRP-----DMGHVVN 901 (973)
Q Consensus 866 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~~v~~ 901 (973)
. ......+.+++.+|+..+|.+|| ++.++++
T Consensus 219 ~-----~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 219 P-----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred C-----CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 1 01124578999999999999999 8888886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-32 Score=298.74 Aligned_cols=245 Identities=27% Similarity=0.434 Sum_probs=194.5
Q ss_pred ccccCcccccCccEEEEEEEC-CCCEEEEEEeecCC-CChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEe
Q 041143 627 FAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGV-TTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEY 704 (973)
Q Consensus 627 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 704 (973)
|...+.||+|+||.||+|+.. +|+.||+|++.... ......+.+.+|+++++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 666788999999999999764 68899999986432 2334456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCC
Q 041143 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG 784 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~ 784 (973)
+. |++.+++... ..++++.++..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~----~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~- 173 (313)
T cd06633 103 CL-GSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP- 173 (313)
T ss_pred CC-CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCC-
Confidence 95 6787777541 246899999999999999999999 78999999999999999999999999999864322
Q ss_pred CcceecccccccCcccccccc---cCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhc
Q 041143 785 EKSVVTRLAGTFGYLAPEYAV---MGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861 (973)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (973)
.....|+..|+|||++. ...++.++|||||||++|||++|+.||......... ..... ..
T Consensus 174 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~------~~~~~-------~~ 236 (313)
T cd06633 174 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQ-------ND 236 (313)
T ss_pred ----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHHh-------cC
Confidence 22356889999999974 456888999999999999999999999765432211 11110 00
Q ss_pred CccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 862 DPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 862 ~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
.+... .......+.+++.+|++.+|.+||++.++++
T Consensus 237 ~~~~~----~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 237 SPTLQ----SNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred CCCCC----ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01111 0111234778999999999999999999997
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=327.04 Aligned_cols=267 Identities=24% Similarity=0.318 Sum_probs=208.3
Q ss_pred cHHHHHHHhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecC-CCChHHHHHHHHHHHHHHhcCCCceeeeeeEEE
Q 041143 616 SVQVLRKVTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAG-VTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSI 693 (973)
Q Consensus 616 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 693 (973)
....++.-.++|.++++||+|+||.|..++.+ +++.||+|++..- .........|..|-.+|..-+.+-||.++-.|+
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 34556666789999999999999999999875 5788999998642 112234467999999999999999999999999
Q ss_pred eCCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEe
Q 041143 694 EGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVS 773 (973)
Q Consensus 694 ~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~ 773 (973)
+....|+|||||+||+|-..+.++. .++...+..++..|+-||.-+| +.|+|||||||.|||+|..|++||+
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk~~-----~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLA 217 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSKFD-----RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLA 217 (1317)
T ss_pred CccceEEEEecccCchHHHHHhhcC-----CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeec
Confidence 9999999999999999999997632 4677777889999999999999 8899999999999999999999999
Q ss_pred eccccccCCCCCcceecccccccCcccccccc----c-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHH
Q 041143 774 DFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAV----M-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFW 848 (973)
Q Consensus 774 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 848 (973)
|||.+-.+..++.......+|||.|.+||++. + +.|+..+|.||+||++|||+.|..||.... +++-+.
T Consensus 218 DFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads------lveTY~ 291 (1317)
T KOG0612|consen 218 DFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS------LVETYG 291 (1317)
T ss_pred cchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH------HHHHHH
Confidence 99998877666666667789999999999985 3 679999999999999999999999997533 333333
Q ss_pred HHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCC---HhHHHHHHHHhhh
Q 041143 849 RIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPD---MGHVVNVLSPLVE 908 (973)
Q Consensus 849 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs---~~~v~~~L~~~~~ 908 (973)
++..-++ .+.+. ...+......+||...+ -+|+.|.. ..++-. ++++.
T Consensus 292 KIm~hk~--------~l~FP-~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~--HpFF~ 342 (1317)
T KOG0612|consen 292 KIMNHKE--------SLSFP-DETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKN--HPFFE 342 (1317)
T ss_pred HHhchhh--------hcCCC-cccccCHHHHHHHHHHh-cChhhhcccccHHHHHh--Ccccc
Confidence 3332111 12222 11123334556666544 35777776 777766 55543
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=300.04 Aligned_cols=250 Identities=23% Similarity=0.361 Sum_probs=201.4
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecC-CCChHHHHHHHHHHHHHHhcC-CCceeeeeeEEEeCCeEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAG-VTTTKALDEFQSEIAVLSKVR-HRHLVSLLGYSIEGNERLLV 701 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV 701 (973)
++|...+.||+|+||.||+|... +|+.||+|++... .......+.+.+|++++++++ |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36888899999999999999775 6899999998653 223344567889999999998 99999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccC
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA 781 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~ 781 (973)
|||+++++|.+++.+. ..+++..+..++.|++.||+||| +.+++|+||||+||+++.++.++++|||++...
T Consensus 81 ~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~ 152 (280)
T cd05581 81 LEYAPNGELLQYIRKY-----GSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVL 152 (280)
T ss_pred EcCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCcccccc
Confidence 9999999999998652 36899999999999999999999 889999999999999999999999999998754
Q ss_pred CCCCc-------------------ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHH
Q 041143 782 PDGEK-------------------SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRY 842 (973)
Q Consensus 782 ~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~ 842 (973)
..... .......|+..|+|||......++.++||||||++++|+++|+.||........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-- 230 (280)
T cd05581 153 DPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT-- 230 (280)
T ss_pred CCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH--
Confidence 33221 122335688999999999888899999999999999999999999986542111
Q ss_pred HHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCH----hHHHH
Q 041143 843 LAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDM----GHVVN 901 (973)
Q Consensus 843 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~----~~v~~ 901 (973)
+.... ..... ........+.+++.+|++.+|.+||++ .++++
T Consensus 231 ----~~~~~----------~~~~~---~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 231 ----FQKIL----------KLEYS---FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred ----HHHHH----------hcCCC---CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 11111 10100 001113457899999999999999999 66654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-32 Score=295.19 Aligned_cols=265 Identities=23% Similarity=0.327 Sum_probs=197.6
Q ss_pred ccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeeEEEeCCeEEEEEEe
Q 041143 627 FAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR-HRHLVSLLGYSIEGNERLLVYEY 704 (973)
Q Consensus 627 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~ 704 (973)
|...+.||+|+||.||+|... +++.||||++...... .......+|+..+++++ |+||+++++++..++..++||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 566788999999999999876 4788999998654322 22334567999999999 99999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCC
Q 041143 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG 784 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~ 784 (973)
+ +|+|.+++.... ...+++.++..++.|++.+|+||| +++++|+||+|+||++++++.++|+|||+++.....
T Consensus 80 ~-~~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (283)
T cd07830 80 M-EGNLYQLMKDRK---GKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR 152 (283)
T ss_pred C-CCCHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCC
Confidence 9 889998886522 246899999999999999999999 789999999999999999999999999999855432
Q ss_pred CcceecccccccCcccccccc-cCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHH-HHHHH----HhhchhHHH
Q 041143 785 EKSVVTRLAGTFGYLAPEYAV-MGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLA-EWFWR----IKSSKEKFK 858 (973)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~-~~~~~----~~~~~~~~~ 858 (973)
.. .....|+..|+|||++. ...++.++|+||||++++||++|+.||......+..... .+... .........
T Consensus 153 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07830 153 PP--YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLA 230 (283)
T ss_pred CC--cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhh
Confidence 21 23356889999999875 455789999999999999999999999766543221100 00000 000000000
Q ss_pred hhcCccccC------CcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 859 AAIDPALEV------NEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 859 ~~~~~~l~~------~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
..++..+.. ..........+.+++.+|++.+|++||+++|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 011111000 0000011356889999999999999999999986
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=303.49 Aligned_cols=271 Identities=22% Similarity=0.314 Sum_probs=199.7
Q ss_pred cCccc-cCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChH------------HHHHHHHHHHHHHhcCCCceeeeee
Q 041143 625 QNFAQ-ENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTK------------ALDEFQSEIAVLSKVRHRHLVSLLG 690 (973)
Q Consensus 625 ~~~~~-~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~------------~~~~~~~E~~~l~~l~h~niv~l~~ 690 (973)
++|.. .+.||+|+||.||+|... +++.||||+++....... ....+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45654 467999999999999865 689999999865422210 0124778999999999999999999
Q ss_pred EEEeCCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCE
Q 041143 691 YSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRA 770 (973)
Q Consensus 691 ~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~ 770 (973)
++..++..++||||+. |+|.+++.. ...+++.....++.|++.||+||| +.+|+||||||+||+++.++.+
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~-----~~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR-----KIRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGIC 158 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCE
Confidence 9999999999999996 689888854 245889999999999999999999 8899999999999999999999
Q ss_pred EEeeccccccCCCCC-------------cceecccccccCcccccccccC-cCCCchhHHhHHHHHHHHHhCCCCCCCCC
Q 041143 771 KVSDFGLVKLAPDGE-------------KSVVTRLAGTFGYLAPEYAVMG-KITTKADVFSYGVVLMELLTGLAALDEER 836 (973)
Q Consensus 771 kl~DfGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~~ 836 (973)
||+|||+++...... ........++..|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999987544110 1111223568899999998764 46899999999999999999999998765
Q ss_pred hhhHHHHHHHHHHHhhc--hhHHHhhc------------CccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHH
Q 041143 837 PEESRYLAEWFWRIKSS--KEKFKAAI------------DPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNV 902 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~~~--~~~~~~~~------------~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~ 902 (973)
..+.. ..+...... ...+.... .+... .........+.+++.+|++.+|++||++.|++.
T Consensus 239 ~~~~~---~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~- 312 (335)
T PTZ00024 239 EIDQL---GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK--TIFPNASDDAIDLLQSLLKLNPLERISAKEALK- 312 (335)
T ss_pred HHHHH---HHHHHHhCCCchhhCcchhhcccccccCcCCcccHH--HhCcCCChHHHHHHHHHcCCCchhccCHHHHhc-
Confidence 43221 111110000 00000000 00000 000011245779999999999999999999998
Q ss_pred HHHhhhhcC
Q 041143 903 LSPLVEKWR 911 (973)
Q Consensus 903 L~~~~~~~~ 911 (973)
.++.+.+.
T Consensus 313 -~~~~~~~~ 320 (335)
T PTZ00024 313 -HEYFKSDP 320 (335)
T ss_pred -CcccCCCC
Confidence 66665443
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=306.75 Aligned_cols=273 Identities=19% Similarity=0.295 Sum_probs=199.4
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeC--------
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEG-------- 695 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------- 695 (973)
.+|...+.||.|+||.||+|... +|+.||+|++... .....+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~--~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecC--CCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 67889999999999999999764 6889999998654 234456788999999999999999999876643
Q ss_pred ------CeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEEC-CCC
Q 041143 696 ------NERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLD-DDY 768 (973)
Q Consensus 696 ------~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~-~~~ 768 (973)
...++||||++ ++|.+++.. ..+++..+..++.||+.||+||| +.+|+||||||+||+++ +++
T Consensus 83 ~~~~~~~~~~lv~e~~~-~~L~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~ 152 (342)
T cd07854 83 GSLTELNSVYIVQEYME-TDLANVLEQ------GPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDL 152 (342)
T ss_pred ccccccceEEEEeeccc-ccHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCc
Confidence 35789999996 588877743 35889999999999999999999 78999999999999997 456
Q ss_pred CEEEeeccccccCCCCCc--ceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHH
Q 041143 769 RAKVSDFGLVKLAPDGEK--SVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAE 845 (973)
Q Consensus 769 ~~kl~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~ 845 (973)
.+|++|||+++....... .......|+..|+|||++.. ..++.++|||||||++|||++|+.||....+.+.....
T Consensus 153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~- 231 (342)
T cd07854 153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI- 231 (342)
T ss_pred eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-
Confidence 789999999875432211 11123467889999998654 56788999999999999999999999866543221110
Q ss_pred HHHHHhhc----hhH----HHhhcCccccCCccc-----HHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCC
Q 041143 846 WFWRIKSS----KEK----FKAAIDPALEVNEET-----FESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRP 912 (973)
Q Consensus 846 ~~~~~~~~----~~~----~~~~~~~~l~~~~~~-----~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~ 912 (973)
....... ... ............... ......+.+++.+|++.||++||++.|++. .++.+.+..
T Consensus 232 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~--h~~~~~~~~ 308 (342)
T cd07854 232 -LESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM--HPYMSCYSC 308 (342)
T ss_pred -HHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC--CCccccccC
Confidence 0000000 000 000000000000000 012245779999999999999999999998 777776554
Q ss_pred C
Q 041143 913 I 913 (973)
Q Consensus 913 ~ 913 (973)
+
T Consensus 309 ~ 309 (342)
T cd07854 309 P 309 (342)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=289.74 Aligned_cols=242 Identities=25% Similarity=0.348 Sum_probs=194.0
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCC-hHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTT-TKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGNERLLV 701 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 701 (973)
.+|..+.+||+|+||.|.+|..+ +.+.+|||+++..+.- ....+--..|-++|+.- +-|.+++++.+++.-+..|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 57888899999999999999765 4577999999876432 22334445677777765 578999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccC
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA 781 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~ 781 (973)
|||+.||+|--++++. ..+.+..++-+|..||-||-+|| +++||.||||..||++|.+|++||+|||+++..
T Consensus 429 MEyvnGGDLMyhiQQ~-----GkFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQV-----GKFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred EEEecCchhhhHHHHh-----cccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeeccccccc
Confidence 9999999999888764 34566778889999999999999 999999999999999999999999999999854
Q ss_pred CCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhc
Q 041143 782 PDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861 (973)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (973)
..+. .....++||+.|+|||++...+|+..+|.|||||+||||+.|++||++.++++ -+..+.
T Consensus 501 i~~~-~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e----------------lF~aI~ 563 (683)
T KOG0696|consen 501 IFDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE----------------LFQAIM 563 (683)
T ss_pred ccCC-cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH----------------HHHHHH
Confidence 3322 33556899999999999999999999999999999999999999999876432 122222
Q ss_pred CccccCCcccHHHHHHHHHHHHHhhccCCCCCC
Q 041143 862 DPALEVNEETFESISIVAELAGHCTAREPYHRP 894 (973)
Q Consensus 862 ~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RP 894 (973)
+.... ++.....+...+.+..+...|.+|.
T Consensus 564 ehnvs---yPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 564 EHNVS---YPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred HccCc---CcccccHHHHHHHHHHhhcCCcccc
Confidence 22221 1112223456788888999999996
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=297.10 Aligned_cols=253 Identities=24% Similarity=0.374 Sum_probs=205.0
Q ss_pred cCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEecCCC
Q 041143 630 ENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHG 708 (973)
Q Consensus 630 ~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 708 (973)
.++||.|.||+||-|.. ++|+.||||++.+.....+...++++|+.||++++||.||.+.-.|+..+..+.|||-+. |
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence 47899999999999965 579999999997766666677889999999999999999999999999999999999995 5
Q ss_pred CHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCC---CCEEEeeccccccCCCCC
Q 041143 709 ALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDD---YRAKVSDFGLVKLAPDGE 785 (973)
Q Consensus 709 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~---~~~kl~DfGla~~~~~~~ 785 (973)
+..+.+-..+ ...++......+..||+.||.||| .++|+|+|+||+|||+... .++||||||+|++.++
T Consensus 648 DMLEMILSsE---kgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE-- 719 (888)
T KOG4236|consen 648 DMLEMILSSE---KGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE-- 719 (888)
T ss_pred hHHHHHHHhh---cccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecch--
Confidence 5555444323 356888888889999999999999 8899999999999999654 4799999999998765
Q ss_pred cceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccc
Q 041143 786 KSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPAL 865 (973)
Q Consensus 786 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 865 (973)
......++||+.|+|||++..+.|...-|+||.||++|--++|..||.....- -+++-+..+
T Consensus 720 ksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI------------------ndQIQNAaF 781 (888)
T KOG4236|consen 720 KSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI------------------NDQIQNAAF 781 (888)
T ss_pred hhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch------------------hHHhhcccc
Confidence 34456689999999999999999999999999999999999999999754311 111122223
Q ss_pred cCCcccHHHH-HHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcC
Q 041143 866 EVNEETFESI-SIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWR 911 (973)
Q Consensus 866 ~~~~~~~~~~-~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~ 911 (973)
-+...++.++ ...+++|...++..-++|-+....+. +.|.+.+.
T Consensus 782 MyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls--h~Wlq~yq 826 (888)
T KOG4236|consen 782 MYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS--HPWLQDYQ 826 (888)
T ss_pred ccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc--chhhhcch
Confidence 2334444444 34679999999999999999988777 55655433
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=291.66 Aligned_cols=252 Identities=23% Similarity=0.343 Sum_probs=196.7
Q ss_pred CccccCcccccCccEEEEEEECC-CCEEEEEEeecCC---CChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEE
Q 041143 626 NFAQENELGRGGFGTVYKGELED-GTKIAVKRMEAGV---TTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLV 701 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 701 (973)
+|...+.||+|+||.||++.... +..+++|.++... .......++..|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47788999999999999997653 4456666654321 1223344677899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccC
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA 781 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~ 781 (973)
|||+++++|..++..... ....+++.+++.++.|+++||.||| +.+++|+||||+||++++ +.+||+|||+++..
T Consensus 81 ~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~ 155 (260)
T cd08222 81 TEYCEGRDLDCKLEELKH-TGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLL 155 (260)
T ss_pred EEeCCCCCHHHHHHHHhh-cccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeec
Confidence 999999999999876433 2357899999999999999999999 889999999999999975 56999999998865
Q ss_pred CCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhc
Q 041143 782 PDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861 (973)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (973)
..... ......|++.|+|||+..+..++.++|+||||+++|+|++|+.||....... ...... ...
T Consensus 156 ~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~------~~~~~~-------~~~ 221 (260)
T cd08222 156 MGSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS------VVLRIV-------EGP 221 (260)
T ss_pred CCCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHH-------cCC
Confidence 43222 2234568899999999988888999999999999999999999996543211 111111 011
Q ss_pred CccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 862 DPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 862 ~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
.+.. .......+.+++.+|++.+|++||++.|+++
T Consensus 222 ~~~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 222 TPSL-----PETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CCCC-----cchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1111 1123346789999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.5e-32 Score=293.91 Aligned_cols=263 Identities=25% Similarity=0.354 Sum_probs=200.0
Q ss_pred ccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEec
Q 041143 627 FAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYM 705 (973)
Q Consensus 627 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 705 (973)
|+..+.||+|+||.||+|+.. +++.||+|++..........+.+..|++++++++|+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456688999999999999876 4899999998765433444567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCC
Q 041143 706 PHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGE 785 (973)
Q Consensus 706 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~ 785 (973)
+ ++|.+++.... ..+++..+..++.|+++||+||| +.+|+||||+|+||++++++.+||+|||.++......
T Consensus 81 ~-~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 152 (282)
T cd07829 81 D-MDLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL 152 (282)
T ss_pred C-cCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCc
Confidence 7 59999997521 46899999999999999999999 7899999999999999999999999999988654332
Q ss_pred cceecccccccCcccccccccC-cCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHh-hchh-HHHhh--
Q 041143 786 KSVVTRLAGTFGYLAPEYAVMG-KITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIK-SSKE-KFKAA-- 860 (973)
Q Consensus 786 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~-- 860 (973)
. ......++..|+|||++.+. .++.++|||||||++|||++|+.||......+.. ..+.... ...+ .....
T Consensus 153 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07829 153 R-TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQL---FKIFQILGTPTEESWPGVTK 228 (282)
T ss_pred c-ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH---HHHHHHhCCCcHHHHHhhcc
Confidence 2 22234567889999998766 7899999999999999999999999765532211 0010000 0000 00000
Q ss_pred ---cC---ccccCC---cccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 861 ---ID---PALEVN---EETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 861 ---~~---~~l~~~---~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
.+ +..... .........+.+++.+|++.+|++||++.+|+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00 000000 000011346889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=286.75 Aligned_cols=238 Identities=32% Similarity=0.401 Sum_probs=193.1
Q ss_pred ccccCccEEEEEEEC-CCCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEecCCCCH
Q 041143 633 LGRGGFGTVYKGELE-DGTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGAL 710 (973)
Q Consensus 633 lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 710 (973)
||+|+||.||++... +++.+|+|++..... .....+.+..|++++++++|+||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999875 589999999865422 233566889999999999999999999999999999999999999999
Q ss_pred HHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCcceec
Q 041143 711 SRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVT 790 (973)
Q Consensus 711 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 790 (973)
.+++... ..+++.....++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~ 151 (250)
T cd05123 81 FSHLSKE-----GRFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTN 151 (250)
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-Cccc
Confidence 9998652 35899999999999999999999 7899999999999999999999999999988654332 1233
Q ss_pred ccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccCCcc
Q 041143 791 RLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEE 870 (973)
Q Consensus 791 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 870 (973)
...++..|+|||...+...+.++|+||||+++|||++|+.||....... ....+.. ..+.....
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~------~~~~~~~----------~~~~~~~~ 215 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE------IYEKILK----------DPLRFPEF 215 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHhc----------CCCCCCCC
Confidence 4568899999999988888999999999999999999999997654311 1111111 11111111
Q ss_pred cHHHHHHHHHHHHHhhccCCCCCCCHhH
Q 041143 871 TFESISIVAELAGHCTAREPYHRPDMGH 898 (973)
Q Consensus 871 ~~~~~~~~~~l~~~cl~~dP~~RPs~~~ 898 (973)
....+.+++.+|+..||++||++++
T Consensus 216 ---~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 216 ---LSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred ---CCHHHHHHHHHHhcCCHhhCCCccc
Confidence 1244679999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-33 Score=288.26 Aligned_cols=260 Identities=27% Similarity=0.380 Sum_probs=198.7
Q ss_pred HhcCccccCcccccCccEEEEEE-ECCCCEEEEEEeecCCC-----ChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeC-
Q 041143 623 VTQNFAQENELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVT-----TTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEG- 695 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~- 695 (973)
..++|..+++||+|||+.||+|- +...+.||||+-..... .....+...+|.+|.+.++||.||++|+|+.-+
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 44678888999999999999994 55688999997543211 122345678999999999999999999999754
Q ss_pred CeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECC---CCCEEE
Q 041143 696 NERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDD---DYRAKV 772 (973)
Q Consensus 696 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~---~~~~kl 772 (973)
+..+-|+||++|.+|+-||.. .+.+++.++..|+.||+.||.||.+. +.+|||-||||.|||+.. -|.+||
T Consensus 541 dsFCTVLEYceGNDLDFYLKQ-----hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQ-----HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred ccceeeeeecCCCchhHHHHh-----hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEe
Confidence 567889999999999999976 35678999999999999999999865 889999999999999954 478999
Q ss_pred eeccccccCCCCCcc------eecccccccCcccccccccC----cCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHH
Q 041143 773 SDFGLVKLAPDGEKS------VVTRLAGTFGYLAPEYAVMG----KITTKADVFSYGVVLMELLTGLAALDEERPEESRY 842 (973)
Q Consensus 773 ~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~ 842 (973)
+|||+++.+.++... .....+||++|++||.+.-+ +++.|+||||.||++|+.+.|+.||...... +.
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ--Qd 692 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ--QD 692 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH--HH
Confidence 999999977654322 23457899999999987633 5788999999999999999999999865432 22
Q ss_pred HHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 843 LAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 843 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
+.+...-+...+ --+.+. +....+...+|++|++.--++|....++..
T Consensus 693 ILqeNTIlkAtE----VqFP~K-------PvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 693 ILQENTILKATE----VQFPPK-------PVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred HHhhhchhccee----ccCCCC-------CccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 222111111100 001111 112244678999999999999988777654
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-32 Score=280.99 Aligned_cols=277 Identities=22% Similarity=0.275 Sum_probs=209.9
Q ss_pred CceeecHHHHHHHhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-C-C----
Q 041143 611 GTLVISVQVLRKVTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR-H-R---- 683 (973)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h-~---- 683 (973)
|...+...+ ..+++|.+...+|+|.||.|-.+.+. .+..||||+++. ..+..+...-|+++++++. + |
T Consensus 77 GH~v~~~gD--~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~---V~kYreAa~iEi~vLqki~~~DP~g~~ 151 (415)
T KOG0671|consen 77 GHYVYQVGD--ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN---VDKYREAALIEIEVLQKINESDPNGKF 151 (415)
T ss_pred ceEEEEecc--ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHH---HHHHhhHHHHHHHHHHHHHhcCCCCce
Confidence 434444333 34789999999999999999999654 478999999975 3556667788999999994 2 2
Q ss_pred ceeeeeeEEEeCCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEE
Q 041143 684 HLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNIL 763 (973)
Q Consensus 684 niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nil 763 (973)
-+|.+.+++.-.++.++|+|.+ |-++.++|.. ....+++..++..|+.|++++++||| +.+++|-|+||+|||
T Consensus 152 rcv~m~~wFdyrghiCivfell-G~S~~dFlk~---N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENIL 224 (415)
T KOG0671|consen 152 RCVQMRDWFDYRGHICIVFELL-GLSTFDFLKE---NNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENIL 224 (415)
T ss_pred EEEeeehhhhccCceEEEEecc-ChhHHHHhcc---CCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEE
Confidence 3788899999999999999988 7799999965 34577899999999999999999999 889999999999999
Q ss_pred ECC--------------------CCCEEEeeccccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHH
Q 041143 764 LDD--------------------DYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLM 823 (973)
Q Consensus 764 l~~--------------------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ 823 (973)
+.+ +..+||+|||.|....... ..++.|..|.|||++.+-.++.++||||+||||+
T Consensus 225 fvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ 300 (415)
T KOG0671|consen 225 FVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILV 300 (415)
T ss_pred EeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEE
Confidence 932 2358999999998655433 4567899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChhhHHHHHHHHHHHhhc-------hhHHHh-----hcC---------------ccc---cCCcccHH
Q 041143 824 ELLTGLAALDEERPEESRYLAEWFWRIKSS-------KEKFKA-----AID---------------PAL---EVNEETFE 873 (973)
Q Consensus 824 elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~-----~~~---------------~~l---~~~~~~~~ 873 (973)
|++||...|+..+..+ .+ ..+.++... +....+ -+| +.. ..-.....
T Consensus 301 ElytG~~LFqtHen~E--HL-aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~ 377 (415)
T KOG0671|consen 301 ELYTGETLFQTHENLE--HL-AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDL 377 (415)
T ss_pred EeeccceecccCCcHH--HH-HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcH
Confidence 9999999998766333 11 111111100 000000 011 000 00011224
Q ss_pred HHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 874 SISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 874 ~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
+...+++|++.|+..||.+|+|++|++. +++..
T Consensus 378 e~~~LfDLl~~mL~fDP~~RiTl~EAL~--HpFF~ 410 (415)
T KOG0671|consen 378 EHVQLFDLLRRMLEFDPARRITLREALS--HPFFA 410 (415)
T ss_pred HHhHHHHHHHHHHccCccccccHHHHhc--CHHhh
Confidence 5567999999999999999999999997 55544
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-32 Score=249.58 Aligned_cols=267 Identities=20% Similarity=0.276 Sum_probs=196.7
Q ss_pred CccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEe
Q 041143 626 NFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEY 704 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 704 (973)
+|...++||+|.||+||+|+.. .++.||+|+++....++.......+||-+++.++|+|||+++++...+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4556678999999999999754 588999999987655555556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCC
Q 041143 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG 784 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~ 784 (973)
+ .-+|..|.... ...++......++.|+++||.++| ++++.|||+||.|.|++.+|+.|++|||+++.++-.
T Consensus 83 c-dqdlkkyfdsl----ng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgip 154 (292)
T KOG0662|consen 83 C-DQDLKKYFDSL----NGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP 154 (292)
T ss_pred h-hHHHHHHHHhc----CCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence 9 55787777542 256788889999999999999999 889999999999999999999999999999976544
Q ss_pred CcceecccccccCcccccccccCc-CCCchhHHhHHHHHHHHHhC-CCCCCCCChhhHHHHHHHHHHHhhchhH--HHhh
Q 041143 785 EKSVVTRLAGTFGYLAPEYAVMGK-ITTKADVFSYGVVLMELLTG-LAALDEERPEESRYLAEWFWRIKSSKEK--FKAA 860 (973)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~S~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 860 (973)
-... ..-+-|..|.+|.++.+.+ |++..|+||.||++.|+... ++.|.+.+-.+...-+-|.-....++.+ +.+.
T Consensus 155 vrcy-saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~l 233 (292)
T KOG0662|consen 155 VRCY-SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKL 233 (292)
T ss_pred eEee-eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccC
Confidence 3332 2345689999999998765 78889999999999999875 4445555443322211111111111110 0011
Q ss_pred cC----ccccCCcc----cHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 861 ID----PALEVNEE----TFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 861 ~~----~~l~~~~~----~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
-| |.+..... .+..-.+-.+++.+.+.-+|.+|.++++.++
T Consensus 234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 11 00000000 0111123457888888889999999998876
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=294.14 Aligned_cols=244 Identities=28% Similarity=0.349 Sum_probs=194.7
Q ss_pred HhcCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeEEE
Q 041143 623 VTQNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGNERLL 700 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 700 (973)
.++.|.....+|.|+|+.|-.+.. .+++..+||++... ..+-.+|+.++... +||||+++.+.+.++.+.|+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~------~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~ 393 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR------ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL 393 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc------ccccccccchhhhhcCCCcceeecceecCCceeee
Confidence 456788888899999999999865 45788999998654 12345688777776 69999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEE-CCCCCEEEeeccccc
Q 041143 701 VYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILL-DDDYRAKVSDFGLVK 779 (973)
Q Consensus 701 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill-~~~~~~kl~DfGla~ 779 (973)
|||++.+|-+.+.+.. .+..-..+..|+.+|+.++.||| .+||||||+||+|||+ ++.++++|+|||.++
T Consensus 394 v~e~l~g~ell~ri~~------~~~~~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~ 464 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRS------KPEFCSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWS 464 (612)
T ss_pred eehhccccHHHHHHHh------cchhHHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhh
Confidence 9999999988776654 12222677789999999999999 7999999999999999 588999999999998
Q ss_pred cCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHh
Q 041143 780 LAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKA 859 (973)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (973)
..... ....+-|..|.|||+.....|++++|+|||||+||+|++|+.||.....+. +...++.
T Consensus 465 ~~~~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~-----ei~~~i~-------- 527 (612)
T KOG0603|consen 465 ELERS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI-----EIHTRIQ-------- 527 (612)
T ss_pred hCchh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH-----HHHHhhc--------
Confidence 66543 223456889999999999999999999999999999999999998665331 1111111
Q ss_pred hcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhh
Q 041143 860 AIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLV 907 (973)
Q Consensus 860 ~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~ 907 (973)
.+. .....-....+|+.+|++.||.+||+|.++.. ++++
T Consensus 528 --~~~-----~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~--h~w~ 566 (612)
T KOG0603|consen 528 --MPK-----FSECVSDEAKDLLQQLLQVDPALRLGADEIGA--HPWF 566 (612)
T ss_pred --CCc-----cccccCHHHHHHHHHhccCChhhCcChhhhcc--Ccch
Confidence 111 11112234669999999999999999999998 6665
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-33 Score=269.59 Aligned_cols=268 Identities=21% Similarity=0.335 Sum_probs=196.5
Q ss_pred CccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeC--------C
Q 041143 626 NFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEG--------N 696 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~ 696 (973)
.|+...+||+|.||.||+|+.+ .|++||+|++--+......-....+|++++..++|+|++.+++.|... .
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 4555678999999999999765 578899987632211222233567899999999999999999988642 2
Q ss_pred eEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecc
Q 041143 697 ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFG 776 (973)
Q Consensus 697 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG 776 (973)
..|+||++++. +|.-.|.. ....++..++.+++.++..||.|+| +..|+|||+||.|+|++.++.+||+|||
T Consensus 98 t~ylVf~~ceh-DLaGlLsn----~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSN----RKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcC----ccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccc
Confidence 47999999965 77777743 2256889999999999999999999 8899999999999999999999999999
Q ss_pred ccccCCCCC---cceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhh
Q 041143 777 LVKLAPDGE---KSVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKS 852 (973)
Q Consensus 777 la~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 852 (973)
+++.+.... ....+..+-|..|++||.+.+ ++|+++.|||..||++.||+||.+-+.+........+++-.-....
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t 249 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT 249 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence 997443222 223455677999999999886 5799999999999999999999999988876555444432211111
Q ss_pred c-------hhHHHhhcCcc-ccCCcc--cHHHH------HHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 853 S-------KEKFKAAIDPA-LEVNEE--TFESI------SIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 853 ~-------~~~~~~~~~~~-l~~~~~--~~~~~------~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
. .-.+.+.+.-. +..... ..+.. ...++|+..++..||.+|+++++++.
T Consensus 250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 0 00111111000 100000 00111 14679999999999999999999997
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=297.30 Aligned_cols=261 Identities=24% Similarity=0.394 Sum_probs=209.6
Q ss_pred ecHHHHHHHhcCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEE
Q 041143 615 ISVQVLRKVTQNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYS 692 (973)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 692 (973)
+.++.+...++.|++.+.||+|.+|.||+++. ++|+.+|||++... ....++...|.++++.. +|||++.++|++
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~---~d~deEiE~eynil~~~~~hpnv~~fyg~~ 85 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT---EDEEEEIELEYNMLKKYSHHPNVATFYGAF 85 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC---ccccHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 34444555667889999999999999999964 57889999987643 33445678899999987 699999999998
Q ss_pred Ee-----CCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCC
Q 041143 693 IE-----GNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDD 767 (973)
Q Consensus 693 ~~-----~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~ 767 (973)
.. +++.+||||||.+|+.-+.+.... ...+.|....-|+..+++|+.||| ...++|||||-.|||++.+
T Consensus 86 ~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e 159 (953)
T KOG0587|consen 86 IKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTEN 159 (953)
T ss_pred EEecCCCCCeEEEEeeccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEecc
Confidence 74 568899999999999999997643 567999999999999999999999 8999999999999999999
Q ss_pred CCEEEeeccccccCCCCCcceecccccccCcccccccccC-----cCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHH
Q 041143 768 YRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMG-----KITTKADVFSYGVVLMELLTGLAALDEERPEESRY 842 (973)
Q Consensus 768 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~ 842 (973)
+.||++|||.+....... .......||+.|||||++... .|+.++|+||+|++..||.-|.+|+.+..+....+
T Consensus 160 ~~VKLvDFGvSaQldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF 238 (953)
T KOG0587|consen 160 AEVKLVDFGVSAQLDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALF 238 (953)
T ss_pred CcEEEeeeeeeeeeeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhc
Confidence 999999999987544322 234457899999999998643 47778999999999999999999998876543211
Q ss_pred HHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 843 LAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 843 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
. +...-.|.+. .+..-..++.++|..|+..|.++||++.++++
T Consensus 239 ~-------------IpRNPPPkLk---rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 239 L-------------IPRNPPPKLK---RPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred c-------------CCCCCCcccc---chhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 0 0111112221 23344567889999999999999999999886
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=275.55 Aligned_cols=222 Identities=21% Similarity=0.221 Sum_probs=175.9
Q ss_pred cCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEecCCCCHHHHH
Q 041143 636 GGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHL 714 (973)
Q Consensus 636 G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l 714 (973)
|.||.||++++. +++.||+|+++... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 899999999764 68899999986531 2344555556667999999999999999999999999999999998
Q ss_pred HhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCcceeccccc
Q 041143 715 FRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAG 794 (973)
Q Consensus 715 ~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~g 794 (973)
... ..+++..+..++.|+++||+||| +++|+||||||+||+++.++.++++|||.+...... .....+
T Consensus 77 ~~~-----~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~ 144 (237)
T cd05576 77 SKF-----LNIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAV 144 (237)
T ss_pred HHh-----cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCc
Confidence 652 34899999999999999999999 889999999999999999999999999987654332 122356
Q ss_pred ccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccCCcccHHH
Q 041143 795 TFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFES 874 (973)
Q Consensus 795 t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 874 (973)
+..|+|||++....++.++||||+||++|||++|+.|+....... . ......+. ...
T Consensus 145 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------~-------~~~~~~~~-----~~~ 201 (237)
T cd05576 145 ENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------N-------THTTLNIP-----EWV 201 (237)
T ss_pred CccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------c-------cccccCCc-----ccC
Confidence 778999999988889999999999999999999998875322100 0 00000010 011
Q ss_pred HHHHHHHHHHhhccCCCCCCCHhHH
Q 041143 875 ISIVAELAGHCTAREPYHRPDMGHV 899 (973)
Q Consensus 875 ~~~~~~l~~~cl~~dP~~RPs~~~v 899 (973)
...+.+++.+|++.||++||++.+.
T Consensus 202 ~~~~~~li~~~l~~dp~~R~~~~~~ 226 (237)
T cd05576 202 SEEARSLLQQLLQFNPTERLGAGVA 226 (237)
T ss_pred CHHHHHHHHHHccCCHHHhcCCCcc
Confidence 2457799999999999999997543
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=305.62 Aligned_cols=273 Identities=18% Similarity=0.202 Sum_probs=175.3
Q ss_pred HhcCccccCcccccCccEEEEEEEC-C----CCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeE------
Q 041143 623 VTQNFAQENELGRGGFGTVYKGELE-D----GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGY------ 691 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------ 691 (973)
..++|...+.||+|+||.||+|++. + +..||||++..... .+.+..| .+.+..+.+++.++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 4578999999999999999999875 4 68999998764311 1111111 1122222222222211
Q ss_pred EEeCCeEEEEEEecCCCCHHHHHHhhhhc---------------cCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeecc
Q 041143 692 SIEGNERLLVYEYMPHGALSRHLFRWEKL---------------QLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRD 756 (973)
Q Consensus 692 ~~~~~~~~lV~e~~~~g~L~~~l~~~~~~---------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~D 756 (973)
+..+...++||||+.+++|.+++...... .........+..++.||++||+||| +++|+|||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRD 280 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRD 280 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCc
Confidence 24566889999999999999998652110 0001123345679999999999999 78999999
Q ss_pred CCCCcEEECC-CCCEEEeeccccccCCCCCcceecccccccCcccccccccC----------------------cCCCch
Q 041143 757 LKSSNILLDD-DYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMG----------------------KITTKA 813 (973)
Q Consensus 757 ikp~Nill~~-~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~ 813 (973)
|||+|||++. ++.+||+|||+|+..............||+.|+|||.+... .++.++
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 9999999986 58999999999986544444444567899999999965322 244567
Q ss_pred hHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccCC----cc-cHHHHHHHHHHHHHhhcc
Q 041143 814 DVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVN----EE-TFESISIVAELAGHCTAR 888 (973)
Q Consensus 814 Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~----~~-~~~~~~~~~~l~~~cl~~ 888 (973)
|||||||++|||+++..+++.... .+...+.........+...+.+..... .. .........+|+.+|++.
T Consensus 361 DVwSlGviL~el~~~~~~~~~~~~----~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDSNLI----QFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCchHHH----HHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence 999999999999998666442210 110000000000111111222211000 00 000112345899999999
Q ss_pred CCCCCCCHhHHHHHHHHhhhhc
Q 041143 889 EPYHRPDMGHVVNVLSPLVEKW 910 (973)
Q Consensus 889 dP~~RPs~~~v~~~L~~~~~~~ 910 (973)
||++|||++|+++ ++++...
T Consensus 437 dP~kR~ta~e~L~--Hpff~~~ 456 (566)
T PLN03225 437 KGRQRISAKAALA--HPYFDRE 456 (566)
T ss_pred CcccCCCHHHHhC--CcCcCCC
Confidence 9999999999998 6776543
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=295.38 Aligned_cols=268 Identities=19% Similarity=0.253 Sum_probs=182.5
Q ss_pred HhcCccccCcccccCccEEEEEEE-----------------CCCCEEEEEEeecCCCChHHH--------------HHHH
Q 041143 623 VTQNFAQENELGRGGFGTVYKGEL-----------------EDGTKIAVKRMEAGVTTTKAL--------------DEFQ 671 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~-----------------~~g~~vavK~~~~~~~~~~~~--------------~~~~ 671 (973)
..++|.+.++||+|+||.||+|.+ .+++.||||+++... .... +.+.
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~--~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDR--QGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccc--hhhHHHHHhhhhhhhcccchhH
Confidence 357899999999999999999964 235689999986431 1112 2334
Q ss_pred HHHHHHHhcCCCce-----eeeeeEEEe--------CCeEEEEEEecCCCCHHHHHHhhhh-------------------
Q 041143 672 SEIAVLSKVRHRHL-----VSLLGYSIE--------GNERLLVYEYMPHGALSRHLFRWEK------------------- 719 (973)
Q Consensus 672 ~E~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lV~e~~~~g~L~~~l~~~~~------------------- 719 (973)
.|+.++.+++|.++ +++++||.. .+..++||||+++|+|.++++....
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 57777888876654 678888763 3567999999999999999975211
Q ss_pred ccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCcceecccccccCcc
Q 041143 720 LQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYL 799 (973)
Q Consensus 720 ~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~ 799 (973)
.....++|..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++..............+|+.|+
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~ 377 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYS 377 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCccee
Confidence 01124578889999999999999999 789999999999999999999999999999754433222222234588999
Q ss_pred cccccccCc--------------------C--CCchhHHhHHHHHHHHHhCCC-CCCCCChhhHHHHHHHHHHHhhchhH
Q 041143 800 APEYAVMGK--------------------I--TTKADVFSYGVVLMELLTGLA-ALDEERPEESRYLAEWFWRIKSSKEK 856 (973)
Q Consensus 800 aPE~~~~~~--------------------~--~~~~Dv~S~Gvvl~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (973)
|||.+.... | ..+.||||+||++|||++|.. |+......... + .........
T Consensus 378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~-~----~~~~~~~~~ 452 (507)
T PLN03224 378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE-L----RQYDNDLNR 452 (507)
T ss_pred ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH-H----hhccchHHH
Confidence 999875432 1 134799999999999999875 66533211110 0 000000000
Q ss_pred HHhhcCccccCCcccHHHHHHHHHHHHHhhccCC---CCCCCHhHHHH
Q 041143 857 FKAAIDPALEVNEETFESISIVAELAGHCTAREP---YHRPDMGHVVN 901 (973)
Q Consensus 857 ~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP---~~RPs~~~v~~ 901 (973)
.+........+.. ....-....+++.+|+..+| .+|+|++|+++
T Consensus 453 ~r~~~~~~~~~~~-~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 453 WRMYKGQKYDFSL-LDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred HHhhcccCCCccc-ccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 1111111111110 01112446789999999765 68999999997
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=293.30 Aligned_cols=346 Identities=21% Similarity=0.232 Sum_probs=237.2
Q ss_pred EEEEEecccCCcccCCcCcccccccceeeccCcccCCCCCCCCC-CCccceeeccCCCCCCCCccccCCCC---------
Q 041143 69 VTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSG-LSELEFAYLDFNEFDTIPSDFFDGLS--------- 138 (973)
Q Consensus 69 v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-l~~L~~L~L~~N~l~~i~~~~f~~l~--------- 138 (973)
+..|+|++|.|..+-+..|.+|++|+.++|.+|.++.+ |.|++ ..+|+.|+|.+|.|+++..+.++.++
T Consensus 80 t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt~I-P~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSr 158 (873)
T KOG4194|consen 80 TQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELTRI-PRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSR 158 (873)
T ss_pred eeeeeccccccccCcHHHHhcCCcceeeeeccchhhhc-ccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhh
Confidence 45678888888877777777777777777777777654 33333 22355555555555554444444444
Q ss_pred ---------------CccEEEcccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCc
Q 041143 139 ---------------SVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLS 203 (973)
Q Consensus 139 ---------------~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 203 (973)
++++|+|++|.|+.+ --..|.++.+|..|.|+.|+|+...+..|.+|++|+.|+|..|+|.
T Consensus 159 N~is~i~~~sfp~~~ni~~L~La~N~It~l----~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~ir 234 (873)
T KOG4194|consen 159 NLISEIPKPSFPAKVNIKKLNLASNRITTL----ETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIR 234 (873)
T ss_pred chhhcccCCCCCCCCCceEEeecccccccc----ccccccccchheeeecccCcccccCHHHhhhcchhhhhhcccccee
Confidence 455555555555443 2334455555555555555555444445555555555555555554
Q ss_pred ccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcccccCcccc
Q 041143 204 GVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSL 283 (973)
Q Consensus 204 ~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 283 (973)
.+...-++.+..+..+.+..+++......+|..+.++++|+|..|+++..--.++.+|++|+.||||+|.|...-++.+
T Consensus 235 -ive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~W 313 (873)
T KOG4194|consen 235 -IVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSW 313 (873)
T ss_pred -eehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchh
Confidence 2222222334444444455555555556778888888888888888887777788888888888888888888777777
Q ss_pred ccc-ccCeEEccCCcCcCCCCCCCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCccc
Q 041143 284 ANM-ELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLG 362 (973)
Q Consensus 284 ~~l-~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~ 362 (973)
... +|+.|+|++|+|+...+ .....+..+.+++++.|-+..+-.+
T Consensus 314 sftqkL~~LdLs~N~i~~l~~-------------------------~sf~~L~~Le~LnLs~Nsi~~l~e~--------- 359 (873)
T KOG4194|consen 314 SFTQKLKELDLSSNRITRLDE-------------------------GSFRVLSQLEELNLSHNSIDHLAEG--------- 359 (873)
T ss_pred hhcccceeEeccccccccCCh-------------------------hHHHHHHHhhhhcccccchHHHHhh---------
Confidence 766 78888888888874333 2334577888899999988877554
Q ss_pred cccCCCCcccEEecCCCcCCCccch---hhhCccccceEEccCCccccccCccccCcCCCCeeeCCCCcCCCCCCC-CC-
Q 041143 363 LSCTSNSKVSIINLPRHNLTGTLSP---SIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLPE-FH- 437 (973)
Q Consensus 363 ~~~~~~~~L~~L~Ls~N~l~~~~p~---~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~-~~- 437 (973)
.+..+++|+.|||++|.+++.|-. .|..|++|+.|+|.+|+|...--.+|..+++|+.|||.+|.|...=|. |.
T Consensus 360 -af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~ 438 (873)
T KOG4194|consen 360 -AFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEP 438 (873)
T ss_pred -HHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeeccccccc
Confidence 456678999999999999998764 588899999999999999955557899999999999999999877554 32
Q ss_pred -cccceeecCCccccCCCC
Q 041143 438 -DTVKLVIDGNPLLVGGIN 455 (973)
Q Consensus 438 -~~~~~~~~~N~~~c~~~~ 455 (973)
++.+|.+..-.++|.+-.
T Consensus 439 m~Lk~Lv~nSssflCDCql 457 (873)
T KOG4194|consen 439 MELKELVMNSSSFLCDCQL 457 (873)
T ss_pred chhhhhhhcccceEEeccH
Confidence 445577777778887543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=294.35 Aligned_cols=246 Identities=30% Similarity=0.419 Sum_probs=188.2
Q ss_pred ccccCcccccCccE-EEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeEEEEEEe
Q 041143 627 FAQENELGRGGFGT-VYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGNERLLVYEY 704 (973)
Q Consensus 627 ~~~~~~lG~G~fg~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~ 704 (973)
|...+++|.|+-|+ ||+|..+ |+.||||++-. ...+..++|+..++.- +|||||++++.-.+....|++.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL 584 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL 584 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence 34456789999885 7999997 88999999843 3345678999999988 599999999988888999999999
Q ss_pred cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECC---C--CCEEEeeccccc
Q 041143 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDD---D--YRAKVSDFGLVK 779 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~---~--~~~kl~DfGla~ 779 (973)
| ..+|.+++... ........-...+.+..|++.||+||| ..+||||||||.||||+. + .+++|+|||+++
T Consensus 585 C-~~sL~dlie~~-~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK 659 (903)
T KOG1027|consen 585 C-ACSLQDLIESS-GLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSK 659 (903)
T ss_pred h-hhhHHHHHhcc-ccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence 9 67999999763 111111111345678999999999999 789999999999999975 2 579999999999
Q ss_pred cCCCCCcce--ecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhC-CCCCCCCChhhHHHHHHHHHHHhhchhH
Q 041143 780 LAPDGEKSV--VTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTG-LAALDEERPEESRYLAEWFWRIKSSKEK 856 (973)
Q Consensus 780 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (973)
....+.... .....||-||+|||++....-+.++||||+|||+|+.++| .+||.+.-..+.. +..+...
T Consensus 660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N--------Il~~~~~ 731 (903)
T KOG1027|consen 660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN--------ILTGNYT 731 (903)
T ss_pred ccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh--------hhcCccc
Confidence 776554332 3346799999999999988888899999999999999997 9999865432210 1111111
Q ss_pred HHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 857 FKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 857 ~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
+. .+. .. .++ ...+||.+|++.+|..||++.+|+.
T Consensus 732 L~-----~L~--~~-~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 732 LV-----HLE--PL-PDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ee-----eec--cC-chH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 00 111 11 111 5779999999999999999999986
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=249.34 Aligned_cols=207 Identities=27% Similarity=0.376 Sum_probs=171.6
Q ss_pred HhcCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeEEE
Q 041143 623 VTQNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGNERLL 700 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 700 (973)
..+.......||+|++|.|-+-++ .+|...|||+++.... .+..++..+|+.+..+. .+|.+|.+||........++
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwI 122 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWI 122 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEE
Confidence 334445567899999999988865 4799999999987654 45566788898887765 79999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecccccc
Q 041143 701 VYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKL 780 (973)
Q Consensus 701 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~ 780 (973)
.||.| .-+|+.+-.+.- .....+++.-.-+||..|.+||.|||+ +..|||||+||+|||++.+|++|+||||++-.
T Consensus 123 cME~M-~tSldkfy~~v~-~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~ 198 (282)
T KOG0984|consen 123 CMELM-DTSLDKFYRKVL-KKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGY 198 (282)
T ss_pred eHHHh-hhhHHHHHHHHH-hcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEccccccee
Confidence 99999 568887765533 334678899999999999999999995 67899999999999999999999999999876
Q ss_pred CCCCCcceecccccccCccccccccc----CcCCCchhHHhHHHHHHHHHhCCCCCCCCC
Q 041143 781 APDGEKSVVTRLAGTFGYLAPEYAVM----GKITTKADVFSYGVVLMELLTGLAALDEER 836 (973)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~ 836 (973)
..+.- ..+.-.|...|||||.+.. ..|+.|+||||+|++++||.+++.|++...
T Consensus 199 L~dSi--Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 199 LVDSI--AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred ehhhh--HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 55432 2233468899999998853 368999999999999999999999997543
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=266.16 Aligned_cols=250 Identities=21% Similarity=0.342 Sum_probs=195.6
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGNERLL 700 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 700 (973)
.++|...++||+|+|++|..++++ +.+.+|+|+++.... ..+..+-.+.|-.+..+. +||.+|.++.+++.+...++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 468899999999999999999875 567899999976633 344456677788888776 79999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecccccc
Q 041143 701 VYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKL 780 (973)
Q Consensus 701 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~ 780 (973)
|.||++||+|--++++. +.+++..+..+...|..||.||| ++|||.||+|..|||+|..|++|++|+|+++.
T Consensus 329 vieyv~ggdlmfhmqrq-----rklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred EEEEecCcceeeehhhh-----hcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhc
Confidence 99999999998888652 45788888889999999999999 89999999999999999999999999999985
Q ss_pred CCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhH-HHHHHHHHHHhhchhHHHh
Q 041143 781 APDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEES-RYLAEWFWRIKSSKEKFKA 859 (973)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 859 (973)
..... .....++||+.|.|||++.+.+|...+|.|++||+++||+.|+.||+....... ....++... -
T Consensus 401 ~l~~g-d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfq---------v 470 (593)
T KOG0695|consen 401 GLGPG-DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQ---------V 470 (593)
T ss_pred CCCCC-cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHH---------H
Confidence 43322 345678999999999999999999999999999999999999999984331110 111111111 1
Q ss_pred hcCccccCCcccHHHHHHHHHHHHHhhccCCCCCC
Q 041143 860 AIDPALEVNEETFESISIVAELAGHCTAREPYHRP 894 (973)
Q Consensus 860 ~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RP 894 (973)
++...++. ++....+...+++.-+..||.+|.
T Consensus 471 ilekqiri---prslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 471 ILEKQIRI---PRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred Hhhhcccc---cceeehhhHHHHHHhhcCCcHHhc
Confidence 11111111 011112355788889999999985
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-32 Score=286.49 Aligned_cols=250 Identities=24% Similarity=0.310 Sum_probs=205.0
Q ss_pred cCccccCcccccCccEEEEEEECCCC-EEEEEEeecC-CCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELEDGT-KIAVKRMEAG-VTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~g~-~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
.++..+..||-||||.|-++..+... .+|+|.++.. ....+..+....|-.+|...+.|.||++|..|.+....|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45556678999999999999877443 3788888543 445666778899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
|-|-||.|...|++ ...++..+...++..+++|++||| +++||.||+||+|.++|.+|-+||.|||+|+...
T Consensus 500 EaClGGElWTiLrd-----Rg~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 500 EACLGGELWTILRD-----RGSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred HhhcCchhhhhhhh-----cCCcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 99999999999976 255777888889999999999999 8999999999999999999999999999999877
Q ss_pred CCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcC
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (973)
.+.. ...++||+.|.|||++..+..+.++|.||+|+++|||++|.+||.+.++.....++ ..+- +.+
T Consensus 572 ~g~K--TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I------LkGi---d~i-- 638 (732)
T KOG0614|consen 572 SGRK--TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI------LKGI---DKI-- 638 (732)
T ss_pred cCCc--eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH------Hhhh---hhh--
Confidence 6543 45689999999999999999999999999999999999999999988875443221 1111 111
Q ss_pred ccccCCcccHHHHHHHHHHHHHhhccCCCCCCC-----HhHHHH
Q 041143 863 PALEVNEETFESISIVAELAGHCTAREPYHRPD-----MGHVVN 901 (973)
Q Consensus 863 ~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~~v~~ 901 (973)
..+........+|+++..+.+|.+|.- ..+|-+
T Consensus 639 ------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk 676 (732)
T KOG0614|consen 639 ------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKK 676 (732)
T ss_pred ------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHh
Confidence 111222344668999999999999985 455554
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=282.77 Aligned_cols=208 Identities=27% Similarity=0.423 Sum_probs=175.2
Q ss_pred cCccccCcccccCccEEEEEEE-CCCCEEEEEEeecC-CCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAG-VTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
.-|..++.||-|+||.|.+++. ++...+|+|.+++. +...........|-+||+..+.+-||+||-.|++.+..|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 3577788999999999999954 44667899988654 334445667889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||++||++-.+|.+. ..+.+.-+..++..+++|+++.| +.|+|||||||.|||||.+|++||+|||++.-+.
T Consensus 709 dYIPGGDmMSLLIrm-----gIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRM-----GIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred eccCCccHHHHHHHh-----ccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccce
Confidence 999999999999762 45667777788899999999999 8999999999999999999999999999975221
Q ss_pred ---------CCCcc--------------------------------eecccccccCcccccccccCcCCCchhHHhHHHH
Q 041143 783 ---------DGEKS--------------------------------VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVV 821 (973)
Q Consensus 783 ---------~~~~~--------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvv 821 (973)
.++.. .....+||+.|+|||++....|+.-+|.||.|||
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI 860 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence 11100 0012579999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChhhH
Q 041143 822 LMELLTGLAALDEERPEES 840 (973)
Q Consensus 822 l~elltg~~p~~~~~~~~~ 840 (973)
||||+.|+.||....+.+.
T Consensus 861 l~em~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLADTPGET 879 (1034)
T ss_pred HHHHhhCCCCccCCCCCcc
Confidence 9999999999988777654
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-32 Score=288.60 Aligned_cols=341 Identities=24% Similarity=0.266 Sum_probs=263.9
Q ss_pred eEEeeCCeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCC-CCCCCCccceeeccCCCCCCCCccccCCCCC
Q 041143 61 HVFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFDTIPSDFFDGLSS 139 (973)
Q Consensus 61 gv~C~~~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~ 139 (973)
-..|+...+..++- ..|.|.+|. .-+.|||++|+|+.+-+ .|.++++|++++|.+|.++.||.. .....+
T Consensus 56 lldcs~~~lea~~~--~~l~g~lp~------~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt~IP~f-~~~sgh 126 (873)
T KOG4194|consen 56 LLDCSDRELEAIDK--SRLKGFLPS------QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELTRIPRF-GHESGH 126 (873)
T ss_pred eeecCccccccccc--cccCCcCcc------ceeeeeccccccccCcHHHHhcCCcceeeeeccchhhhcccc-cccccc
Confidence 34455544444332 234555553 45679999999998766 589999999999999999999863 344556
Q ss_pred ccEEEcccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHh
Q 041143 140 VRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILW 219 (973)
Q Consensus 140 L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~ 219 (973)
|+.|+|.+|.|+.+ -...++.++.|+.|||+.|.|+.+.-..|..-.+|++|+|++|+|+..-.+.|. ++..++.
T Consensus 127 l~~L~L~~N~I~sv----~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~-~lnsL~t 201 (873)
T KOG4194|consen 127 LEKLDLRHNLISSV----TSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFD-SLNSLLT 201 (873)
T ss_pred eeEEeeeccccccc----cHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeecccccccccccccc-ccchhee
Confidence 99999999999975 446788899999999999999966666787888999999999999966556664 4458888
Q ss_pred hcccCCCCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcccccCccccccc-ccCeEEccCCcC
Q 041143 220 LNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLL 298 (973)
Q Consensus 220 l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l 298 (973)
|.+..+...+.+...|.++++|+.|+|..|+|.-.---.|.+|++|+.|.|..|.+...-...|-.+ ++++|+|+.|++
T Consensus 202 lkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l 281 (873)
T KOG4194|consen 202 LKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRL 281 (873)
T ss_pred eecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchh
Confidence 8888888889999999999999999999999984335678999999999999999997777777777 899999999999
Q ss_pred cCCCCCCCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCC
Q 041143 299 MGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPR 378 (973)
Q Consensus 299 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~ 378 (973)
+..--.++.+ +-.+..++++.|.|..+-.. .| +-..+|+.|+||+
T Consensus 282 ~~vn~g~lfg-------------------------Lt~L~~L~lS~NaI~rih~d-----~W-----sftqkL~~LdLs~ 326 (873)
T KOG4194|consen 282 QAVNEGWLFG-------------------------LTSLEQLDLSYNAIQRIHID-----SW-----SFTQKLKELDLSS 326 (873)
T ss_pred hhhhcccccc-------------------------cchhhhhccchhhhheeecc-----hh-----hhcccceeEeccc
Confidence 7432222111 23466777888877665321 11 2235888888888
Q ss_pred CcCCCccchhhhCccccceEEccCCccccccCccccCcCCCCeeeCCCCcCCCCCCC-------CCcccceeecCCccc
Q 041143 379 HNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLPE-------FHDTVKLVIDGNPLL 450 (973)
Q Consensus 379 N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~-------~~~~~~~~~~~N~~~ 450 (973)
|+|+..-+..|..|..|++|+|++|.|+-.-...|..+++|+.|||++|.|++.|.. +..+.+|.+.||...
T Consensus 327 N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk 405 (873)
T KOG4194|consen 327 NRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLK 405 (873)
T ss_pred cccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceee
Confidence 888888888888888888888888888866667788888888888888888876652 345566777787653
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=268.61 Aligned_cols=239 Identities=29% Similarity=0.411 Sum_probs=192.0
Q ss_pred CccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEecCCCCHHHHHH
Q 041143 637 GFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLF 715 (973)
Q Consensus 637 ~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~ 715 (973)
+||.||+|... +|+.+|+|++........ .+.+.+|++.+++++|+||+++++++......++||||+++++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 58999999886 489999999875432221 5789999999999999999999999999999999999999999999986
Q ss_pred hhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCcceecccccc
Q 041143 716 RWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGT 795 (973)
Q Consensus 716 ~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt 795 (973)
.. ..+++..+..++.++++++.||| +.+++|+||+|+||++++++.++|+|||.+....... ......++
T Consensus 80 ~~-----~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~ 149 (244)
T smart00220 80 KR-----GRLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGT 149 (244)
T ss_pred hc-----cCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCC
Confidence 52 22889999999999999999999 7899999999999999999999999999998655432 23345688
Q ss_pred cCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccCCcccHHHH
Q 041143 796 FGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESI 875 (973)
Q Consensus 796 ~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 875 (973)
..|++||.+....++.++||||||+++++|++|..||...... .....+.. ..............
T Consensus 150 ~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~~~~~-------------~~~~~~~~~~~~~~ 214 (244)
T smart00220 150 PEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELFKKIG-------------KPKPPFPPPEWKIS 214 (244)
T ss_pred cCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHh-------------ccCCCCccccccCC
Confidence 9999999998888999999999999999999999999763211 11111111 11111000000023
Q ss_pred HHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 876 SIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 876 ~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
..+.+++.+|+..+|++||++.++++
T Consensus 215 ~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 215 PEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHHHccCCchhccCHHHHhh
Confidence 56889999999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-30 Score=260.89 Aligned_cols=267 Identities=23% Similarity=0.346 Sum_probs=204.6
Q ss_pred cCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeC------Ce
Q 041143 625 QNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEG------NE 697 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 697 (973)
.+|...+.+|.|.- .|-.|-+ -.++.||+|++..........++..+|...+..++|+||++++.++.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 46777788999987 5655533 3588999999876655556677889999999999999999999998744 35
Q ss_pred EEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccc
Q 041143 698 RLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL 777 (973)
Q Consensus 698 ~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGl 777 (973)
.|+||||| .++|...++. .++-.+...|..|+++|+.||| +.+|+||||||+||++..+..+||.|||+
T Consensus 96 ~y~v~e~m-~~nl~~vi~~-------elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVILM-------ELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGL 164 (369)
T ss_pred HHHHHHhh-hhHHHHHHHH-------hcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchh
Confidence 69999999 6799888763 2455677889999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhch---
Q 041143 778 VKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSK--- 854 (973)
Q Consensus 778 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 854 (973)
|+..... -..+.++.|..|.|||++.+..|.+.+||||.||++.||++|+.-|.+.+ .+.+|.+.+....
T Consensus 165 ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d-----~idQ~~ki~~~lgtpd 237 (369)
T KOG0665|consen 165 ARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD-----HIDQWNKIIEQLGTPD 237 (369)
T ss_pred hcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch-----HHHHHHHHHHHhcCCC
Confidence 9855432 35677889999999999999889999999999999999999999887554 2334433222110
Q ss_pred ------------------hH-----HHhhc-CccccCC-cccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 855 ------------------EK-----FKAAI-DPALEVN-EETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 855 ------------------~~-----~~~~~-~~~l~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
++ +.+.+ |..+... +...-......+++.+|+..+|++|.+++++++ +++++-
T Consensus 238 ~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~--HPY~~v 315 (369)
T KOG0665|consen 238 PSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR--HPYIKV 315 (369)
T ss_pred HHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc--CCeeee
Confidence 00 01111 1111000 001112234668999999999999999999999 888887
Q ss_pred cCC
Q 041143 910 WRP 912 (973)
Q Consensus 910 ~~~ 912 (973)
|..
T Consensus 316 w~~ 318 (369)
T KOG0665|consen 316 WYD 318 (369)
T ss_pred ecc
Confidence 743
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-31 Score=257.45 Aligned_cols=267 Identities=22% Similarity=0.336 Sum_probs=199.6
Q ss_pred cccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC-----eEEEE
Q 041143 628 AQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGN-----ERLLV 701 (973)
Q Consensus 628 ~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lV 701 (973)
+..+.||-|+||.||.+++ ++|+.||.|++..-...-...+.+.+|++++..++|.|++..++...-.. +.|.|
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 4557899999999999976 47999999998765445556778999999999999999999988766543 45778
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccC
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA 781 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~ 781 (973)
.|.| ..+|.+.+-. -+.++-..+.-+.+||++||.||| +.+|.||||||.|.|++.+...||||||+|+..
T Consensus 136 TELm-QSDLHKIIVS-----PQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 136 TELM-QSDLHKIIVS-----PQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHH-Hhhhhheecc-----CCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEeccccccccc
Confidence 8877 4466665533 356788888889999999999999 889999999999999999999999999999966
Q ss_pred CCCCcceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHH------Hh-hc
Q 041143 782 PDGEKSVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWR------IK-SS 853 (973)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~------~~-~~ 853 (973)
........+.-+-|-.|+|||++++ +.|+.+.||||.||++.|++.++..|....+-+...++...-. +. .-
T Consensus 207 e~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC 286 (449)
T KOG0664|consen 207 DQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC 286 (449)
T ss_pred chhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh
Confidence 5544445555677899999999986 5699999999999999999999999987776554333321110 00 00
Q ss_pred hhHHHhhcCccccCCc--------ccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHH
Q 041143 854 KEKFKAAIDPALEVNE--------ETFESISIVAELAGHCTAREPYHRPDMGHVVNVL 903 (973)
Q Consensus 854 ~~~~~~~~~~~l~~~~--------~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L 903 (973)
++.-..++....+... .+.+.-.+...+...++..||++|.+..+.+..+
T Consensus 287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 1111122221111100 0112223456788889999999999999888744
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-28 Score=232.28 Aligned_cols=258 Identities=17% Similarity=0.313 Sum_probs=193.8
Q ss_pred cCccccCcccccCccEEEEEE-ECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeeEEEeCC--eEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR-HRHLVSLLGYSIEGN--ERLL 700 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~~l 700 (973)
++|++.+++|+|.++.||.|. ..+.++++||+++.- ..+.+.+|+.+|+.++ ||||+++++...+.. ...|
T Consensus 38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred chHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 578888999999999999995 567889999998642 3457899999999997 999999999988754 5679
Q ss_pred EEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCC-CCEEEeeccccc
Q 041143 701 VYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDD-YRAKVSDFGLVK 779 (973)
Q Consensus 701 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~-~~~kl~DfGla~ 779 (973)
|+||+.+.+..... ..++...+...+.++++||.|+| +.||+|||+||.|+++|.. ...+|+|+|+|.
T Consensus 113 iFE~v~n~Dfk~ly--------~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAE 181 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY--------PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
T ss_pred HhhhhccccHHHHh--------hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHh
Confidence 99999998876544 44677788889999999999999 8899999999999999965 579999999999
Q ss_pred cCCCCCcceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhc-----
Q 041143 780 LAPDGEKSVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSS----- 853 (973)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----- 853 (973)
+...+... .-.+.+..|.-||.+.. ..|+..-|+|||||++..|+..+.||-.... ....++..+.-.-..
T Consensus 182 FYHp~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d-N~DQLVkIakVLGt~el~~Y 258 (338)
T KOG0668|consen 182 FYHPGKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD-NYDQLVKIAKVLGTDELYAY 258 (338)
T ss_pred hcCCCcee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC-CHHHHHHHHHHhChHHHHHH
Confidence 87665432 33456788999998875 4578889999999999999999999965432 222222221111000
Q ss_pred hhHHHhhcCccccC--------------CcccHHH-HHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 854 KEKFKAAIDPALEV--------------NEETFES-ISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 854 ~~~~~~~~~~~l~~--------------~~~~~~~-~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
-.+..-.+||.+.. ..+.... ..+.++++.+.++.|-++|+|++|.++
T Consensus 259 l~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 259 LNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 00111112332210 0001111 145789999999999999999999887
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-28 Score=259.77 Aligned_cols=278 Identities=20% Similarity=0.253 Sum_probs=213.9
Q ss_pred CCceeecHHHHHHHhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcC------C
Q 041143 610 SGTLVISVQVLRKVTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR------H 682 (973)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------h 682 (973)
.|...+.+. +..-.+|.+....|+|-|++|.+|.+. .|..||||++... +...+.=+.|+++|++|+ -
T Consensus 419 EGYYrv~ig--E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN---E~M~KtGl~EleiLkKL~~AD~Edk 493 (752)
T KOG0670|consen 419 EGYYRVRIG--ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN---EVMHKTGLKELEILKKLNDADPEDK 493 (752)
T ss_pred cceEEEehh--hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc---hHHhhhhhHHHHHHHHhhccCchhh
Confidence 344444443 456689999999999999999999765 4789999999764 334455578999999995 2
Q ss_pred CceeeeeeEEEeCCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcE
Q 041143 683 RHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNI 762 (973)
Q Consensus 683 ~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Ni 762 (973)
-|+++++..|...++.|||+|-+ ..+|.+.|.++... ..|....+..+++|+.-||..|- ..+|+|.||||.||
T Consensus 494 ~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~n--vGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNi 567 (752)
T KOG0670|consen 494 FHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRN--VGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNI 567 (752)
T ss_pred hHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcc--cceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccce
Confidence 48999999999999999999987 77999999886543 45777888999999999999999 88999999999999
Q ss_pred EECCC-CCEEEeeccccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHH
Q 041143 763 LLDDD-YRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESR 841 (973)
Q Consensus 763 ll~~~-~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~ 841 (973)
|+++. ..+||||||.|....++. .+.+..+..|.|||++.+-.|+...|+||.||+||||+||+..|.+.....+.
T Consensus 568 LVNE~k~iLKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~ML 644 (752)
T KOG0670|consen 568 LVNESKNILKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQML 644 (752)
T ss_pred EeccCcceeeeccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHH
Confidence 99976 468999999998776543 34455678899999999999999999999999999999999999887755443
Q ss_pred HHHHHHH-----HHhhchhHHHhhcC--------------------------c----------cccCCcccHHHHHHHHH
Q 041143 842 YLAEWFW-----RIKSSKEKFKAAID--------------------------P----------ALEVNEETFESISIVAE 880 (973)
Q Consensus 842 ~~~~~~~-----~~~~~~~~~~~~~~--------------------------~----------~l~~~~~~~~~~~~~~~ 880 (973)
.+.--+. ++.....-..+-+| | .-....+++..+..+.+
T Consensus 645 rl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rd 724 (752)
T KOG0670|consen 645 RLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRD 724 (752)
T ss_pred HHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHH
Confidence 3221110 00000000001111 1 00122344556677889
Q ss_pred HHHHhhccCCCCCCCHhHHHH
Q 041143 881 LAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 881 l~~~cl~~dP~~RPs~~~v~~ 901 (973)
|+..|+..||++|.+..+++.
T Consensus 725 LLdkml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 725 LLDKMLILDPEKRITVNQALK 745 (752)
T ss_pred HHHHHhccChhhcCCHHHHhc
Confidence 999999999999999999886
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-26 Score=240.16 Aligned_cols=211 Identities=37% Similarity=0.595 Sum_probs=182.3
Q ss_pred ccccCccEEEEEEECC-CCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEecCCCCHH
Q 041143 633 LGRGGFGTVYKGELED-GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALS 711 (973)
Q Consensus 633 lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 711 (973)
||+|.+|.||++...+ ++.+++|++....... ..+.+.+|++.++.++|++|+++++++......++||||+.+++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 6899999999998864 8999999987642221 3567999999999999999999999999999999999999999999
Q ss_pred HHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECC-CCCEEEeeccccccCCCCCcceec
Q 041143 712 RHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDD-DYRAKVSDFGLVKLAPDGEKSVVT 790 (973)
Q Consensus 712 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~-~~~~kl~DfGla~~~~~~~~~~~~ 790 (973)
+++.... ..+++..+..++.+++++++||| +.+++|+||+|.||+++. ++.++|+|||.+........ ...
T Consensus 80 ~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~ 151 (215)
T cd00180 80 DLLKENE----GKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLK 151 (215)
T ss_pred HHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhh
Confidence 9986521 35889999999999999999999 789999999999999999 89999999999986544321 123
Q ss_pred ccccccCcccccccccC-cCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccCCc
Q 041143 791 RLAGTFGYLAPEYAVMG-KITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNE 869 (973)
Q Consensus 791 ~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 869 (973)
...+...|++||..... .++.++|+|++|+++++|
T Consensus 152 ~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------- 187 (215)
T cd00180 152 TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------- 187 (215)
T ss_pred cccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------------
Confidence 35678899999998877 788999999999999999
Q ss_pred ccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHH
Q 041143 870 ETFESISIVAELAGHCTAREPYHRPDMGHVVNV 902 (973)
Q Consensus 870 ~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~ 902 (973)
..+.+++..|++.+|++||++.++++.
T Consensus 188 ------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 236689999999999999999999863
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.2e-30 Score=274.48 Aligned_cols=338 Identities=24% Similarity=0.336 Sum_probs=278.4
Q ss_pred CCeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCCCCCCCCccceeeccCCCCC--CCCccccCCCCCccEE
Q 041143 66 GNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFD--TIPSDFFDGLSSVRVL 143 (973)
Q Consensus 66 ~~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~--~i~~~~f~~l~~L~~L 143 (973)
..+++.|.|...+|. .+|++++.|.+|++|.+++|++..+--.++.|+.|+.+++.+|++. +||++.| .|..|..|
T Consensus 31 Mt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF-~l~dLt~l 108 (1255)
T KOG0444|consen 31 MTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLISVHGELSDLPRLRSVIVRDNNLKNSGIPTDIF-RLKDLTIL 108 (1255)
T ss_pred hhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhHhhhhhhccchhhHHHhhhccccccCCCCchhc-ccccceee
Confidence 468999999999998 8999999999999999999999988888999999999999999997 7888866 69999999
Q ss_pred EcccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhh-hHHHHHhhcc
Q 041143 144 ALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQ-SLMQILWLND 222 (973)
Q Consensus 144 ~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~~~~~~l~~ 222 (973)
|||+|++.. .|..+..-+++-.|+|++|+|..+....|.+|+.|-+||||+|++. .+|..+.. ..++.+.|+.
T Consensus 109 DLShNqL~E-----vP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~ 182 (1255)
T KOG0444|consen 109 DLSHNQLRE-----VPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSN 182 (1255)
T ss_pred ecchhhhhh-----cchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCC
Confidence 999999995 8999999999999999999999555557889999999999999998 66666643 3455555554
Q ss_pred cCCCCCCCcchhhcCCccccEEEccCCccc-cCCCccccCCCCCCEEeCcCCcccccCccccccc-ccCeEEccCCcCcC
Q 041143 223 QDAGGMTGPIDVVAKMVSLTQLWLHGNQFT-GSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMG 300 (973)
Q Consensus 223 ~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~-g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~g 300 (973)
+-.+.+ ....+-.+++|+.|.+++.+=+ ..+|.++..+.+|..+|||.|+|. .+|+.+-++ +|+.|+|++|.|+.
T Consensus 183 NPL~hf--QLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~ite 259 (1255)
T KOG0444|consen 183 NPLNHF--QLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITE 259 (1255)
T ss_pred ChhhHH--HHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceee
Confidence 443322 1223345777888888877643 358899999999999999999998 778888887 89999999999873
Q ss_pred CCCCCCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCc
Q 041143 301 PIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHN 380 (973)
Q Consensus 301 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~ 380 (973)
.-. ....-..+..+|++.|++..+|.. +..+++|+.|.+.+|+
T Consensus 260 L~~--------------------------~~~~W~~lEtLNlSrNQLt~LP~a-----------vcKL~kL~kLy~n~Nk 302 (1255)
T KOG0444|consen 260 LNM--------------------------TEGEWENLETLNLSRNQLTVLPDA-----------VCKLTKLTKLYANNNK 302 (1255)
T ss_pred eec--------------------------cHHHHhhhhhhccccchhccchHH-----------HhhhHHHHHHHhccCc
Confidence 211 122345677788999998888753 4578899999999999
Q ss_pred CCC-ccchhhhCccccceEEccCCccccccCccccCcCCCCeeeCCCCcCCCCCCC---CCcccceeecCCccccC
Q 041143 381 LTG-TLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLPE---FHDTVKLVIDGNPLLVG 452 (973)
Q Consensus 381 l~~-~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~---~~~~~~~~~~~N~~~c~ 452 (973)
++- -||..+++|.+|+.+..++|+|. .+|+.++.|..|+.|.|+.|+|...+.. +..+..|++..||.+.-
T Consensus 303 L~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLiTLPeaIHlL~~l~vLDlreNpnLVM 377 (1255)
T KOG0444|consen 303 LTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLITLPEAIHLLPDLKVLDLRENPNLVM 377 (1255)
T ss_pred ccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhcccccceeechhhhhhcCCcceeeccCCcCccC
Confidence 976 57999999999999999999998 9999999999999999999999876655 45566789999997753
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-30 Score=264.13 Aligned_cols=370 Identities=26% Similarity=0.385 Sum_probs=256.7
Q ss_pred eEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEccc
Q 041143 68 RVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDY 147 (973)
Q Consensus 68 ~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~ 147 (973)
-++.|++.+|.++ .+|++++.+..++.|+.++|+++..++.+..+.+|..|+++.|.+..++++ +..+..|+.|+..+
T Consensus 69 ~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls~lp~~i~s~~~l~~l~~s~n~~~el~~~-i~~~~~l~dl~~~~ 146 (565)
T KOG0472|consen 69 CLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLSELPEQIGSLISLVKLDCSSNELKELPDS-IGRLLDLEDLDATN 146 (565)
T ss_pred ceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHhhccHHHhhhhhhhhhhccccceeecCch-HHHHhhhhhhhccc
Confidence 4788899999888 788888888888888888888888877888888888888888888887766 44566677777777
Q ss_pred CCCCCccCCCCCcccccccccCeeecccccccC----------------------CcchhccCCCCCCeEEccCCcCccc
Q 041143 148 NPFNKTFGWSIPDSLANSVQLTNLSLINCNLVG----------------------PLPDFLGTLPSLAALKLSYNRLSGV 205 (973)
Q Consensus 148 N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~----------------------~~p~~l~~l~~L~~L~Ls~N~l~~~ 205 (973)
|+++. +|..+.++.+|..|++.+|++.. .+|..++.|.+|..|||..|+|. .
T Consensus 147 N~i~s-----lp~~~~~~~~l~~l~~~~n~l~~l~~~~i~m~~L~~ld~~~N~L~tlP~~lg~l~~L~~LyL~~Nki~-~ 220 (565)
T KOG0472|consen 147 NQISS-----LPEDMVNLSKLSKLDLEGNKLKALPENHIAMKRLKHLDCNSNLLETLPPELGGLESLELLYLRRNKIR-F 220 (565)
T ss_pred ccccc-----CchHHHHHHHHHHhhccccchhhCCHHHHHHHHHHhcccchhhhhcCChhhcchhhhHHHHhhhcccc-c
Confidence 77764 45555555555444444444442 45555666666666666666665 5
Q ss_pred CChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcccccCcccccc
Q 041143 206 IPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLAN 285 (973)
Q Consensus 206 ~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 285 (973)
+|..-+++.+..++...+... ..+.....++++|..|||..|+++ ..|..++-+++|.+||+|+|.+++ .|.++++
T Consensus 221 lPef~gcs~L~Elh~g~N~i~--~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~-Lp~sLgn 296 (565)
T KOG0472|consen 221 LPEFPGCSLLKELHVGENQIE--MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISS-LPYSLGN 296 (565)
T ss_pred CCCCCccHHHHHHHhcccHHH--hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCcccc-CCccccc
Confidence 553334445555555444333 234566778999999999999999 899999999999999999999995 6788999
Q ss_pred cccCeEEccCCcCcCC----CC-------CCCCCCcccccCcc--cC----------CCCC----------------ccc
Q 041143 286 MELDNLVLNNNLLMGP----IP-------KFKAGNVTYDSNSF--CQ----------SEPG----------------IEC 326 (973)
Q Consensus 286 l~L~~L~l~~N~l~g~----~p-------~~~~~~~~~~~~~~--~~----------~~~~----------------~~~ 326 (973)
+.|+.|.+.+|.+... +. +++...++-+..+- .+ +.+. +..
T Consensus 297 lhL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~ 376 (565)
T KOG0472|consen 297 LHLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTL 376 (565)
T ss_pred ceeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhccccccccc
Confidence 9999999999988421 00 00000000000000 00 0000 000
Q ss_pred CCc---chhhhhhccCCCCCCcccCCCCCC-------------CCCCCCccccccCCCCcccEEecCCCcCCCccchhhh
Q 041143 327 APD---VNVLLDFLGGVNYPVNLVSQWPGN-------------DPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIA 390 (973)
Q Consensus 327 ~~~---~~~~~~~l~~l~~~~n~~~~~~~~-------------~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~ 390 (973)
.++ ..+.-+....++++.|++-.+|.. ......|.+..++.+++|..|+|++|-+. .+|..++
T Consensus 377 VPdEVfea~~~~~Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~ 455 (565)
T KOG0472|consen 377 VPDEVFEAAKSEIVTSVNFSKNQLCELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMG 455 (565)
T ss_pred CCHHHHHHhhhcceEEEecccchHhhhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcchhhh
Confidence 000 001122355677888888877752 23345688888999999999999988876 7888999
Q ss_pred CccccceEEccCCccc----------------------cccCcc-ccCcCCCCeeeCCCCcCCCCCCCCCcc---cceee
Q 041143 391 NLDSLIEIRLGKNSIS----------------------GTVPNN-FTELKSLRLLDVSDNNIKPPLPEFHDT---VKLVI 444 (973)
Q Consensus 391 ~l~~L~~L~L~~N~l~----------------------g~~p~~-~~~l~~L~~L~Ls~N~l~g~~p~~~~~---~~~~~ 444 (973)
.+..|+.|||+.|++. |.++.+ +.+|.+|..|||.+|.|...+|.+.+. ..+.+
T Consensus 456 ~lv~Lq~LnlS~NrFr~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL 535 (565)
T KOG0472|consen 456 SLVRLQTLNLSFNRFRMLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLEL 535 (565)
T ss_pred hhhhhheecccccccccchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEe
Confidence 9999999999988775 123333 888999999999999999999987655 45789
Q ss_pred cCCccc
Q 041143 445 DGNPLL 450 (973)
Q Consensus 445 ~~N~~~ 450 (973)
+|||+.
T Consensus 536 ~gNpfr 541 (565)
T KOG0472|consen 536 DGNPFR 541 (565)
T ss_pred cCCccC
Confidence 999985
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-27 Score=247.32 Aligned_cols=131 Identities=27% Similarity=0.392 Sum_probs=113.3
Q ss_pred cCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-----C---CceeeeeeEEEe-
Q 041143 625 QNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR-----H---RHLVSLLGYSIE- 694 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~- 694 (973)
.+|.+.++||=|.|++||+|.+ ...+.||+|+.+.. ....+....||++|++++ | .+||+|+++|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 6899999999999999999965 45788999999753 556677889999999984 2 379999999874
Q ss_pred ---CCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEE
Q 041143 695 ---GNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILL 764 (973)
Q Consensus 695 ---~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill 764 (973)
+.+.+||+|++ |.+|..++..+. .+.++...+.+|++||+.||.|||. +.+|||-||||+|||+
T Consensus 155 GpNG~HVCMVfEvL-GdnLLklI~~s~---YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVL-GDNLLKLIKYSN---YRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLL 221 (590)
T ss_pred CCCCcEEEEEehhh-hhHHHHHHHHhC---CCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeee
Confidence 56889999999 889999997643 4668899999999999999999996 5699999999999999
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-27 Score=257.53 Aligned_cols=199 Identities=22% Similarity=0.322 Sum_probs=167.4
Q ss_pred hcCccccCcccccCccEEEEEEECC-CCEEEEEEeecCCCChH------HHHHHHHHHHHHHhcC---CCceeeeeeEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELED-GTKIAVKRMEAGVTTTK------ALDEFQSEIAVLSKVR---HRHLVSLLGYSI 693 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~---h~niv~l~~~~~ 693 (973)
..+|...+.+|+|+||.|+.|.++. ...|+||.+.+...-.. ..-..-.||+||..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 3468899999999999999998764 55688888754321111 1112456999999997 999999999999
Q ss_pred eCCeEEEEEEec-CCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEE
Q 041143 694 EGNERLLVYEYM-PHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKV 772 (973)
Q Consensus 694 ~~~~~~lV~e~~-~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl 772 (973)
+.+.+||+||-. ++-+|++++.. ...+++.++..|+.||+.|+++|| +.+|||||||-+||.++.+|-+||
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~-----kp~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~kl 711 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEF-----KPRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKL 711 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhc-----cCccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEE
Confidence 999999999964 56688888865 356889999999999999999999 899999999999999999999999
Q ss_pred eeccccccCCCCCcceecccccccCcccccccccCcC-CCchhHHhHHHHHHHHHhCCCCCC
Q 041143 773 SDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKI-TTKADVFSYGVVLMELLTGLAALD 833 (973)
Q Consensus 773 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvvl~elltg~~p~~ 833 (973)
+|||.|.....+. ...++||.+|.|||++.+.+| +..-|||++|++||-++....||.
T Consensus 712 idfgsaa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 712 IDFGSAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eeccchhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9999988765543 456789999999999998877 466799999999999998888874
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-26 Score=239.52 Aligned_cols=200 Identities=34% Similarity=0.463 Sum_probs=172.0
Q ss_pred ccccCcccccCccEEEEEEECC-CCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEec
Q 041143 627 FAQENELGRGGFGTVYKGELED-GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYM 705 (973)
Q Consensus 627 ~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 705 (973)
|...+.||+|++|.||+|...+ ++.+|+|.+...... ...+.+.+|++.+++++|+|++++++++......++++||+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 4567889999999999998875 889999998754222 25678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCC
Q 041143 706 PHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGE 785 (973)
Q Consensus 706 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~ 785 (973)
++++|.+++.... ..+++.....++.+++.++.||| ..+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 80 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~ 152 (225)
T smart00221 80 EGGDLFDYLRKKG----GKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL 152 (225)
T ss_pred CCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc
Confidence 9999999987522 11789999999999999999999 7799999999999999999999999999998665432
Q ss_pred cceecccccccCccccccc-ccCcCCCchhHHhHHHHHHHHHhCCCCCCC
Q 041143 786 KSVVTRLAGTFGYLAPEYA-VMGKITTKADVFSYGVVLMELLTGLAALDE 834 (973)
Q Consensus 786 ~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~ 834 (973)
........++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 153 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 153 AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 1122345678899999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.1e-28 Score=263.50 Aligned_cols=253 Identities=25% Similarity=0.414 Sum_probs=203.8
Q ss_pred HhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEE
Q 041143 623 VTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLV 701 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 701 (973)
..++|+....+|.|.||.|||+++. .++..|||+++.. ......-.+.|+-+++..+|+|||.++|.+...+..+++
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe--p~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE--PGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeecc--CCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 3468888999999999999999764 6899999999876 334456678999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccC
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA 781 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~ 781 (973)
|||+.+|+|.+.-+. -.++++.+...+++...+|++||| +.+=+|||||-.||++++.|.+|++|||.+-..
T Consensus 91 MEycgggslQdiy~~-----TgplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqi 162 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHV-----TGPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQI 162 (829)
T ss_pred EEecCCCcccceeee-----cccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhh
Confidence 999999999886654 367899999999999999999999 888999999999999999999999999987644
Q ss_pred CCCCcceecccccccCcccccccc---cCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHH
Q 041143 782 PDGEKSVVTRLAGTFGYLAPEYAV---MGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFK 858 (973)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (973)
...- .....+.||+.|||||+.. .+.|..++|||+.|++..|+---++|..+..+.....+.. .
T Consensus 163 tati-~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmT------------k 229 (829)
T KOG0576|consen 163 TATI-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMT------------K 229 (829)
T ss_pred hhhh-hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhh------------c
Confidence 3221 2245578999999999874 4568999999999999999998888876665543322211 1
Q ss_pred hhcC-ccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 859 AAID-PALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 859 ~~~~-~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
..++ |.++ +...-...+.++++.|+-.+|++||++...++
T Consensus 230 S~~qpp~lk---Dk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 230 SGFQPPTLK---DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred cCCCCCccc---CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1122 2222 11223345779999999999999999987654
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=227.62 Aligned_cols=254 Identities=21% Similarity=0.340 Sum_probs=186.0
Q ss_pred HhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeE-EEeCCeEE
Q 041143 623 VTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGY-SIEGNERL 699 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~~ 699 (973)
..+.|.+.+.||+|.||.+-+++.+ ..+.+++|.+... ....++|.+|..---.+ .|.||+.-|+. |+..+.++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p---~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv 98 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP---QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV 98 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc---hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence 3467889999999999999999876 4678899988654 33467899998876666 49999988875 45667788
Q ss_pred EEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEE-C-CCCCEEEeeccc
Q 041143 700 LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILL-D-DDYRAKVSDFGL 777 (973)
Q Consensus 700 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill-~-~~~~~kl~DfGl 777 (973)
+++||++.|+|.+-+.. ..+.+....+++.|++.|+.||| ++++||||||.+|||+ + +..++||||||+
T Consensus 99 F~qE~aP~gdL~snv~~------~GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~ 169 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEA------AGIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGL 169 (378)
T ss_pred EeeccCccchhhhhcCc------ccccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeeccc
Confidence 99999999999876643 44677888899999999999999 8899999999999999 3 335899999999
Q ss_pred cccCCCCCcceecccccccCcccccccccC-----cCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhh
Q 041143 778 VKLAPDGEKSVVTRLAGTFGYLAPEYAVMG-----KITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKS 852 (973)
Q Consensus 778 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 852 (973)
.+..+.. .....-+..|.|||..... ...+.+|||.||+++|.++||+.||+..... ...+..|.+-...
T Consensus 170 t~k~g~t----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~-d~~Y~~~~~w~~r 244 (378)
T KOG1345|consen 170 TRKVGTT----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM-DKPYWEWEQWLKR 244 (378)
T ss_pred ccccCce----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc-CchHHHHHHHhcc
Confidence 8754331 2223345679999977532 3456789999999999999999999844332 2333444332221
Q ss_pred chhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHH
Q 041143 853 SKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVL 903 (973)
Q Consensus 853 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L 903 (973)
... .+...+. .-.+++.++.++-+.++|++|=-..++..+.
T Consensus 245 k~~----~~P~~F~------~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 245 KNP----ALPKKFN------PFSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred cCc----cCchhhc------ccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 111 1111111 1224567888888999999995555554443
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-26 Score=239.95 Aligned_cols=202 Identities=25% Similarity=0.386 Sum_probs=167.3
Q ss_pred HHHHhcCccccCcccccCccEEEEEEEC----CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeeEEEe
Q 041143 620 LRKVTQNFAQENELGRGGFGTVYKGELE----DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR-HRHLVSLLGYSIE 694 (973)
Q Consensus 620 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 694 (973)
.....+.|..+++||+|.|++||++.+. ..+.||+|.+..... ..++..|+++|..+. +.||+++.+++..
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----p~ri~~El~~L~~~gG~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----PSRILNELEMLYRLGGSDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC----chHHHHHHHHHHHhccchhhhcchhhhcc
Confidence 4456678999999999999999999653 467899999865422 245789999999995 9999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECC-CCCEEEe
Q 041143 695 GNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDD-DYRAKVS 773 (973)
Q Consensus 695 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~-~~~~kl~ 773 (973)
.+...+|+||++.....++... ++..++..+...+.+||+|+| .+|||||||||+|+|.+. .++-.|.
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~~--------l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~Lv 175 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYRS--------LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLV 175 (418)
T ss_pred CCeeEEEecccCccCHHHHHhc--------CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEE
Confidence 9999999999999998888743 667888899999999999999 899999999999999985 4788999
Q ss_pred eccccccCC-----------------C--CC------------------------cceecccccccCccccccccc-CcC
Q 041143 774 DFGLVKLAP-----------------D--GE------------------------KSVVTRLAGTFGYLAPEYAVM-GKI 809 (973)
Q Consensus 774 DfGla~~~~-----------------~--~~------------------------~~~~~~~~gt~~y~aPE~~~~-~~~ 809 (973)
|||+|.... . +. .......+||+||.|||++.. ...
T Consensus 176 DFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Q 255 (418)
T KOG1167|consen 176 DFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQ 255 (418)
T ss_pred echhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCc
Confidence 999986100 0 00 001112579999999999874 567
Q ss_pred CCchhHHhHHHHHHHHHhCCCCCCCCC
Q 041143 810 TTKADVFSYGVVLMELLTGLAALDEER 836 (973)
Q Consensus 810 ~~~~Dv~S~Gvvl~elltg~~p~~~~~ 836 (973)
++++||||.||+++-+++++.||-...
T Consensus 256 ttaiDiws~GVI~Lslls~~~PFf~a~ 282 (418)
T KOG1167|consen 256 TTAIDIWSAGVILLSLLSRRYPFFKAK 282 (418)
T ss_pred CCccceeeccceeehhhccccccccCc
Confidence 889999999999999999999996543
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-27 Score=256.74 Aligned_cols=321 Identities=21% Similarity=0.306 Sum_probs=246.9
Q ss_pred CeEEEEEecccCCcccCCcCcccccccceeeccCcccC--CCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEE
Q 041143 67 NRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFN--GKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLA 144 (973)
Q Consensus 67 ~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~ 144 (973)
..+..|.+.+|+|. .+-.++..|+.|+.+++..|++. |+++.+..|..|+.|||++|++.++|.+ +..-+++.+|+
T Consensus 55 qkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~EvP~~-LE~AKn~iVLN 132 (1255)
T KOG0444|consen 55 QKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLREVPTN-LEYAKNSIVLN 132 (1255)
T ss_pred hhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhhhcchh-hhhhcCcEEEE
Confidence 46888999999998 67788999999999999999985 5677899999999999999999999876 78889999999
Q ss_pred cccCCCCCccCCCCCccc-ccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhh-hHHHHHhhcc
Q 041143 145 LDYNPFNKTFGWSIPDSL-ANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQ-SLMQILWLND 222 (973)
Q Consensus 145 Ls~N~l~~~~~~~ip~~~-~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~~~~~~l~~ 222 (973)
||+|+|.. ||..+ -+|+.|-.|||++|++. .+|..+..|..|++|+|++|.+.-..-..+.. ..++.++++.
T Consensus 133 LS~N~Iet-----IPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~ 206 (1255)
T KOG0444|consen 133 LSYNNIET-----IPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSN 206 (1255)
T ss_pred cccCcccc-----CCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhccc
Confidence 99999995 78654 68999999999999999 78888999999999999999886221111111 1133333333
Q ss_pred cCCCCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcccccCccccccc-ccCeEEccCCcCcCC
Q 041143 223 QDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGP 301 (973)
Q Consensus 223 ~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~g~ 301 (973)
..-. ....+..+..+.+|..+|||.|.+. .+|+.+.++++|+.|+||+|+|+.. ....... +|++|+|++|+|+ .
T Consensus 207 TqRT-l~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL-~~~~~~W~~lEtLNlSrNQLt-~ 282 (1255)
T KOG0444|consen 207 TQRT-LDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITEL-NMTEGEWENLETLNLSRNQLT-V 282 (1255)
T ss_pred ccch-hhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeee-eccHHHHhhhhhhccccchhc-c
Confidence 2221 1223455677889999999999999 8999999999999999999999843 2233333 7999999999997 4
Q ss_pred CCCCCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcC
Q 041143 302 IPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNL 381 (973)
Q Consensus 302 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l 381 (973)
+|..+. .+..+..+-..+|++.- .=.+..++.+..|+++.+++|++
T Consensus 283 LP~avc-------------------------KL~kL~kLy~n~NkL~F---------eGiPSGIGKL~~Levf~aanN~L 328 (1255)
T KOG0444|consen 283 LPDAVC-------------------------KLTKLTKLYANNNKLTF---------EGIPSGIGKLIQLEVFHAANNKL 328 (1255)
T ss_pred chHHHh-------------------------hhHHHHHHHhccCcccc---------cCCccchhhhhhhHHHHhhcccc
Confidence 554322 12222222222332211 01112356677899999999988
Q ss_pred CCccchhhhCccccceEEccCCccccccCccccCcCCCCeeeCCCCcCCCCCCC
Q 041143 382 TGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLPE 435 (973)
Q Consensus 382 ~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~ 435 (973)
. ..|..++.+.+|+.|.|++|+|- ++|+.+--|+.|+.|||.+|.=--.+|.
T Consensus 329 E-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPPK 380 (1255)
T KOG0444|consen 329 E-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPPK 380 (1255)
T ss_pred c-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCCC
Confidence 6 78999999999999999999998 8999999999999999999965555553
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.1e-28 Score=249.15 Aligned_cols=313 Identities=25% Similarity=0.332 Sum_probs=232.5
Q ss_pred eEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEccc
Q 041143 68 RVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDY 147 (973)
Q Consensus 68 ~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~ 147 (973)
++..||+..|.+. ++|+.++.|.+|+.|+|.+|+|...+ .|.++..|++|++..|+|+.+|++...++.+|.+|||..
T Consensus 184 ~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRd 261 (565)
T KOG0472|consen 184 RLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIRFLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRD 261 (565)
T ss_pred HHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccccCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccc
Confidence 5666666666664 89999999999999999999999754 999999999999999999999999999999999999999
Q ss_pred CCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhh-hH---HHHHh----
Q 041143 148 NPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQ-SL---MQILW---- 219 (973)
Q Consensus 148 N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~---~~~~~---- 219 (973)
|+++. .|+.+..+.+|.+||+++|.|+ .+|..++++ .|+.|-|.+|.+. .+-.++.+ ++ ++++.
T Consensus 262 Nklke-----~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlr-TiRr~ii~~gT~~vLKyLrs~~~ 333 (565)
T KOG0472|consen 262 NKLKE-----VPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLR-TIRREIISKGTQEVLKYLRSKIK 333 (565)
T ss_pred ccccc-----CchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchH-HHHHHHHcccHHHHHHHHHHhhc
Confidence 99995 8999999999999999999999 678899999 9999999999987 33333211 11 12111
Q ss_pred ---------------------------------hcccCCCCCCCcchhhcCCc--cccEEEccCCccccCCCccccCCCC
Q 041143 220 ---------------------------------LNDQDAGGMTGPIDVVAKMV--SLTQLWLHGNQFTGSIPEDIGALSS 264 (973)
Q Consensus 220 ---------------------------------l~~~~~~~~~~~~~~~~~l~--~L~~L~L~~N~l~g~~p~~~~~l~~ 264 (973)
|.....+....|...|.... -....+++.|++. .+|..+..++.
T Consensus 334 ~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lke 412 (565)
T KOG0472|consen 334 DDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKE 412 (565)
T ss_pred cCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHH
Confidence 11111111222333333222 2678888888888 77777776666
Q ss_pred CCE-EeCcCCcccccCccccccc-ccCeEEccCCcCcCCCCCCCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCC
Q 041143 265 LKD-LNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNY 342 (973)
Q Consensus 265 L~~-L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 342 (973)
+.+ +.+++|.++ .+|..+..+ +|..|+|++|.+. .+|.- ...+..++.+++
T Consensus 413 lvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e-------------------------~~~lv~Lq~Lnl 465 (565)
T KOG0472|consen 413 LVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEE-------------------------MGSLVRLQTLNL 465 (565)
T ss_pred HHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchh-------------------------hhhhhhhheecc
Confidence 544 344444443 666666666 6777777777665 23321 111233566666
Q ss_pred CCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCCCccchhhhCccccceEEccCCccccccCccccCcCCCCee
Q 041143 343 PVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLL 422 (973)
Q Consensus 343 ~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L 422 (973)
+.|-.+..|.. |..+..|+.+-.++|++....|..+.+|.+|..|||.+|.|. .||..+++|.+|++|
T Consensus 466 S~NrFr~lP~~-----------~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hL 533 (565)
T KOG0472|consen 466 SFNRFRMLPEC-----------LYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHL 533 (565)
T ss_pred cccccccchHH-----------HhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEE
Confidence 66655555422 122334566666778888887878999999999999999998 999999999999999
Q ss_pred eCCCCcCC
Q 041143 423 DVSDNNIK 430 (973)
Q Consensus 423 ~Ls~N~l~ 430 (973)
+|++|+|.
T Consensus 534 eL~gNpfr 541 (565)
T KOG0472|consen 534 ELDGNPFR 541 (565)
T ss_pred EecCCccC
Confidence 99999998
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.6e-26 Score=221.96 Aligned_cols=249 Identities=24% Similarity=0.408 Sum_probs=197.5
Q ss_pred ccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEecCCC
Q 041143 629 QENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHG 708 (973)
Q Consensus 629 ~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 708 (973)
...+|.+...|..|+|+++ |..+++|++.....+....++|..|+-.++-+.||||++++|.|.......++..||+.|
T Consensus 194 l~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g 272 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG 272 (448)
T ss_pred hhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence 3456888999999999998 667888888766666667789999999999999999999999999999999999999999
Q ss_pred CHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEe--eccccccCCCCCc
Q 041143 709 ALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVS--DFGLVKLAPDGEK 786 (973)
Q Consensus 709 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~--DfGla~~~~~~~~ 786 (973)
+|+..||... ...++-.+++++|.+||+|++|||++ ++-|.---+.+..|++|++.+++|+ |--++. ...
T Consensus 273 slynvlhe~t---~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsf--qe~-- 344 (448)
T KOG0195|consen 273 SLYNVLHEQT---SVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSF--QEV-- 344 (448)
T ss_pred HHHHHHhcCc---cEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeee--ecc--
Confidence 9999998732 24567889999999999999999986 4445556799999999999998875 322111 110
Q ss_pred ceecccccccCcccccccccCcCC---CchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCc
Q 041143 787 SVVTRLAGTFGYLAPEYAVMGKIT---TKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDP 863 (973)
Q Consensus 787 ~~~~~~~gt~~y~aPE~~~~~~~~---~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (973)
...-.+.||+||.++.++.+ .++|+|||++++||+.|+..||.+..+.+... +..-+.++--+.|
T Consensus 345 ----gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm--------kialeglrv~ipp 412 (448)
T KOG0195|consen 345 ----GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM--------KIALEGLRVHIPP 412 (448)
T ss_pred ----ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh--------hhhhccccccCCC
Confidence 11236889999999876654 47899999999999999999999887765422 2223334444444
Q ss_pred cccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhh
Q 041143 864 ALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLV 907 (973)
Q Consensus 864 ~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~ 907 (973)
.+. ..+.+|+.-|+..||.+||.+..|+-.|++++
T Consensus 413 gis---------~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 413 GIS---------RHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred Ccc---------HHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 443 34778899999999999999999999998764
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-25 Score=275.60 Aligned_cols=195 Identities=16% Similarity=0.215 Sum_probs=138.7
Q ss_pred hcCC-CceeeeeeEEE-------eCCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccC
Q 041143 679 KVRH-RHLVSLLGYSI-------EGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQ 750 (973)
Q Consensus 679 ~l~h-~niv~l~~~~~-------~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~ 750 (973)
.++| .||+++++++. ..+..+.+|||+ +++|.+++.. ....+++.+++.++.||++||+||| ++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH---~~ 99 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN----PDRSVDAFECFHVFRQIVEIVNAAH---SQ 99 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc----ccccccHHHHHHHHHHHHHHHHHHH---hC
Confidence 3445 57788888772 234567789987 7799999964 1256899999999999999999999 88
Q ss_pred CeeeccCCCCcEEECC-------------------CCCEEEeeccccccCCCCCc---------------ceeccccccc
Q 041143 751 TFIHRDLKSSNILLDD-------------------DYRAKVSDFGLVKLAPDGEK---------------SVVTRLAGTF 796 (973)
Q Consensus 751 ~ivH~Dikp~Nill~~-------------------~~~~kl~DfGla~~~~~~~~---------------~~~~~~~gt~ 796 (973)
+|+||||||+|||++. ++.+|++|||+++....... .......||+
T Consensus 100 gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 179 (793)
T PLN00181 100 GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMS 179 (793)
T ss_pred CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCc
Confidence 9999999999999954 44566666666653211000 0011246899
Q ss_pred CcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccCCcccHHHHH
Q 041143 797 GYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESIS 876 (973)
Q Consensus 797 ~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 876 (973)
.|||||++.+..|+.++|||||||+||||++|..|+..... .... .. ...+++.. .....
T Consensus 180 ~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~----~~------~~~~~~~~------~~~~~ 239 (793)
T PLN00181 180 WYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSS----LR------HRVLPPQI------LLNWP 239 (793)
T ss_pred ceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHH----HH------HhhcChhh------hhcCH
Confidence 99999999999999999999999999999999887642210 0000 00 01111111 11123
Q ss_pred HHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 877 IVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 877 ~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
....++.+|++.+|.+||+|.||++
T Consensus 240 ~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 240 KEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHHHHhCCCChhhCcChHHHhh
Confidence 3567888999999999999999987
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-23 Score=211.09 Aligned_cols=169 Identities=27% Similarity=0.266 Sum_probs=126.4
Q ss_pred CCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCcc
Q 041143 708 GALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKS 787 (973)
Q Consensus 708 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~~ 787 (973)
|+|.++++.. ...++|.++..|+.||++||+||| +++ ||+||+++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-- 63 (176)
T smart00750 1 VSLADILEVR----GRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ-- 63 (176)
T ss_pred CcHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecccc--
Confidence 7899998652 246999999999999999999999 444 999999999999999 99998654322
Q ss_pred eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccC
Q 041143 788 VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEV 867 (973)
Q Consensus 788 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 867 (973)
..||+.|||||++.+..++.++|||||||++|||++|+.||....... ..+..+..... . .++.-.
T Consensus 64 ----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~~~~~~~~-------~-~~~~~~- 129 (176)
T smart00750 64 ----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-AILEILLNGMP-------A-DDPRDR- 129 (176)
T ss_pred ----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-HHHHHHHHHhc-------c-CCcccc-
Confidence 258999999999999999999999999999999999999996543211 11111111100 0 001000
Q ss_pred CcccHHHH--HHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 868 NEETFESI--SIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 868 ~~~~~~~~--~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
....... ..+.+++.+|++.+|++||++.|+++.+.....
T Consensus 130 -~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 130 -SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred -ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 0111111 258899999999999999999999998876644
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-25 Score=229.83 Aligned_cols=259 Identities=25% Similarity=0.300 Sum_probs=209.2
Q ss_pred CCCCCCCCCCc--CeEEeeCC-----------eEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCC-CCCCCC
Q 041143 49 NGDDPCGPPPW--PHVFCSGN-----------RVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLS 114 (973)
Q Consensus 49 ~~~d~C~~~~w--~gv~C~~~-----------~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~ 114 (973)
..+.||.++.- ..|.|++. ..+.|+|+.|+|+.+.+.+|+.+.+|+.|||++|+|+.+-| +|.+|.
T Consensus 36 ~CP~pC~Cs~~~g~~VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~ 115 (498)
T KOG4237|consen 36 ACPAPCTCSDVEGGIVDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLA 115 (498)
T ss_pred cCCCCcccCCCCCceEEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhH
Confidence 35778875433 34889862 57889999999998888999999999999999999999888 899999
Q ss_pred ccceeeccC-CCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCC
Q 041143 115 ELEFAYLDF-NEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLA 193 (973)
Q Consensus 115 ~L~~L~L~~-N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~ 193 (973)
+|..|-+.+ |+|+.++.++|.+|.+|+.|.+.-|++.-+ ....|..|++|..|.|.+|.+..+--..|..+.+++
T Consensus 116 ~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Ci----r~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~ 191 (498)
T KOG4237|consen 116 SLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCI----RQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIK 191 (498)
T ss_pred hhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcch----hHHHHHHhhhcchhcccchhhhhhccccccchhccc
Confidence 998887766 999999999999999999999999999975 567889999999999999999944444899999999
Q ss_pred eEEccCCcCcc------------cCChh------------------------hhhhHHHH-HhhcccCCCCCCCcchhhc
Q 041143 194 ALKLSYNRLSG------------VIPAS------------------------FGQSLMQI-LWLNDQDAGGMTGPIDVVA 236 (973)
Q Consensus 194 ~L~Ls~N~l~~------------~~p~~------------------------~~~~~~~~-~~l~~~~~~~~~~~~~~~~ 236 (973)
.+.+..|.+-. ..|.. |...+-.+ -.+....+-....+...|.
T Consensus 192 tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~ 271 (498)
T KOG4237|consen 192 TLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFK 271 (498)
T ss_pred hHhhhcCccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHh
Confidence 99999998321 11111 11110000 0122233334455678899
Q ss_pred CCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcccccCccccccc-ccCeEEccCCcCcCCCCCCCCCCcc
Q 041143 237 KMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGPIPKFKAGNVT 311 (973)
Q Consensus 237 ~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~g~~p~~~~~~~~ 311 (973)
++++|+.|+|++|+|++.-+.+|..+..|+.|.|..|+|...-...|.++ .|+.|+|.+|+|+...|..+.....
T Consensus 272 ~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~ 347 (498)
T KOG4237|consen 272 KLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFS 347 (498)
T ss_pred hcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccce
Confidence 99999999999999999999999999999999999999997777788888 7999999999999877766544333
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=228.20 Aligned_cols=169 Identities=26% Similarity=0.236 Sum_probs=131.7
Q ss_pred HHHhcCccccCcccccCccEEEEEEEC--CCCEEEEEEeecCCC---ChHHHHHHHHHHHHHHhcCCCceee-eeeEEEe
Q 041143 621 RKVTQNFAQENELGRGGFGTVYKGELE--DGTKIAVKRMEAGVT---TTKALDEFQSEIAVLSKVRHRHLVS-LLGYSIE 694 (973)
Q Consensus 621 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~--~g~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~ 694 (973)
+....+|...+.||+|+||+||+|... +++.||||++..... .....+.|.+|++++++++|+|+++ +++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---- 89 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---- 89 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----
Confidence 455678999999999999999999764 577889998753211 2334567999999999999999985 443
Q ss_pred CCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccC-CCCcEEECCCCCEEEe
Q 041143 695 GNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDL-KSSNILLDDDYRAKVS 773 (973)
Q Consensus 695 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Di-kp~Nill~~~~~~kl~ 773 (973)
.+..++||||+++++|.. +.. .. ...++.++++||+||| +++|+|||| ||+|||++.++.+||+
T Consensus 90 ~~~~~LVmE~~~G~~L~~-~~~-----~~------~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLi 154 (365)
T PRK09188 90 TGKDGLVRGWTEGVPLHL-ARP-----HG------DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVI 154 (365)
T ss_pred cCCcEEEEEccCCCCHHH-hCc-----cc------hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEE
Confidence 245799999999999962 210 01 1457889999999999 889999999 9999999999999999
Q ss_pred eccccccCCCCCcc-------eecccccccCcccccccccCc
Q 041143 774 DFGLVKLAPDGEKS-------VVTRLAGTFGYLAPEYAVMGK 808 (973)
Q Consensus 774 DfGla~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~ 808 (973)
|||+|+........ ..+...+++.|+|||++...+
T Consensus 155 DFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~ 196 (365)
T PRK09188 155 DFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRE 196 (365)
T ss_pred ECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhh
Confidence 99999855433211 124567899999999987443
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.6e-23 Score=243.18 Aligned_cols=266 Identities=24% Similarity=0.341 Sum_probs=186.0
Q ss_pred eeCCeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEE
Q 041143 64 CSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVL 143 (973)
Q Consensus 64 C~~~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L 143 (973)
|-...-..|+|++++|+ .+|+.+. ++|+.|+|++|+|+.++. .+++|++|+|++|+|+.+|.. .++|+.|
T Consensus 198 Cl~~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~LP~---lp~~Lk~LdLs~N~LtsLP~l----p~sL~~L 267 (788)
T PRK15387 198 CLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSLPA---LPPELRTLEVSGNQLTSLPVL----PPGLLEL 267 (788)
T ss_pred HhcCCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCCCCC---CCCCCcEEEecCCccCcccCc----cccccee
Confidence 54445567899999998 7888876 489999999999998543 258899999999999999852 5789999
Q ss_pred EcccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhccc
Q 041143 144 ALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQ 223 (973)
Q Consensus 144 ~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~ 223 (973)
+|++|+|+. +|..+ .+|+.|+|++|+|+ .+|. .+++|+.|+|++|+|++ +|..
T Consensus 268 ~Ls~N~L~~-----Lp~lp---~~L~~L~Ls~N~Lt-~LP~---~p~~L~~LdLS~N~L~~-Lp~l-------------- 320 (788)
T PRK15387 268 SIFSNPLTH-----LPALP---SGLCKLWIFGNQLT-SLPV---LPPGLQELSVSDNQLAS-LPAL-------------- 320 (788)
T ss_pred eccCCchhh-----hhhch---hhcCEEECcCCccc-cccc---cccccceeECCCCcccc-CCCC--------------
Confidence 999999985 56533 56889999999999 4554 35789999999999984 5542
Q ss_pred CCCCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcccccCcccccccccCeEEccCCcCcCCCC
Q 041143 224 DAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMGPIP 303 (973)
Q Consensus 224 ~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~L~~L~l~~N~l~g~~p 303 (973)
..+|+.|++++|+|+ .+|.. ..+|++|+|++|+|++ +|.... +|..|++++|+|++ +|
T Consensus 321 --------------p~~L~~L~Ls~N~L~-~LP~l---p~~Lq~LdLS~N~Ls~-LP~lp~--~L~~L~Ls~N~L~~-LP 378 (788)
T PRK15387 321 --------------PSELCKLWAYNNQLT-SLPTL---PSGLQELSVSDNQLAS-LPTLPS--ELYKLWAYNNRLTS-LP 378 (788)
T ss_pred --------------cccccccccccCccc-ccccc---ccccceEecCCCccCC-CCCCCc--ccceehhhcccccc-Cc
Confidence 123445555555555 34421 1345555555555553 232211 34455555555542 33
Q ss_pred CCCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCCC
Q 041143 304 KFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTG 383 (973)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~ 383 (973)
... ..+..++++.|.+..+|. ..++|+.|+|++|+|++
T Consensus 379 ~l~----------------------------~~L~~LdLs~N~Lt~LP~--------------l~s~L~~LdLS~N~Lss 416 (788)
T PRK15387 379 ALP----------------------------SGLKELIVSGNRLTSLPV--------------LPSELKELMVSGNRLTS 416 (788)
T ss_pred ccc----------------------------cccceEEecCCcccCCCC--------------cccCCCEEEccCCcCCC
Confidence 210 112233444444443331 12468899999999986
Q ss_pred ccchhhhCccccceEEccCCccccccCccccCcCCCCeeeCCCCcCCCCCCC
Q 041143 384 TLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLPE 435 (973)
Q Consensus 384 ~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~ 435 (973)
+|..+ .+|+.|+|++|+|+ .+|..|.++++|+.|+|++|+|+|.+|.
T Consensus 417 -IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~ 463 (788)
T PRK15387 417 -LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 463 (788)
T ss_pred -CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence 66543 46788999999998 8999999999999999999999998775
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.3e-22 Score=219.18 Aligned_cols=262 Identities=21% Similarity=0.264 Sum_probs=194.6
Q ss_pred CccccCcccccCccEEEEEEECCC--CEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC----CceeeeeeEE-EeCCeE
Q 041143 626 NFAQENELGRGGFGTVYKGELEDG--TKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRH----RHLVSLLGYS-IEGNER 698 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~~g--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~ 698 (973)
+|.+.+.||+|+||.||+|..... ..+|+|.......... ..+..|+.++..+.. +++..+++.. ..+...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 799999999999999999987653 4788887754321111 157788888888863 6899999998 477788
Q ss_pred EEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCC-----CCEEEe
Q 041143 699 LLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDD-----YRAKVS 773 (973)
Q Consensus 699 ~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~-----~~~kl~ 773 (973)
++||+.+ |.+|.+...... .+.++..+.++|+.|++.+|++|| +.|++||||||.|+++... ..++|.
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~ll 169 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLL 169 (322)
T ss_pred EEEEecc-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEE
Confidence 9999987 889999775532 467899999999999999999999 8999999999999999865 469999
Q ss_pred eccccc--cCCCCCc----ce---ecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 041143 774 DFGLVK--LAPDGEK----SV---VTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLA 844 (973)
Q Consensus 774 DfGla~--~~~~~~~----~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~ 844 (973)
|||+++ ....... .. ...+.||..|+++....+.+.+.+.|+||++.++.|++.|..||...........
T Consensus 170 DfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~- 248 (322)
T KOG1164|consen 170 DFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSK- 248 (322)
T ss_pred ecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHH-
Confidence 999998 3222211 11 1235699999999999999999999999999999999999999965543221110
Q ss_pred HHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhc
Q 041143 845 EWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKW 910 (973)
Q Consensus 845 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~ 910 (973)
+.. ......... . ..... ..+.++...+-..+...+|....+...++......
T Consensus 249 --~~~-----~~~~~~~~~-~--~~~~~---~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 249 --FEK-----DPRKLLTDR-F--GDLKP---EEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred --HHH-----Hhhhhcccc-c--cCCCh---HHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 000 001111111 0 11122 23445555555689999999999999988887654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.3e-22 Score=201.72 Aligned_cols=275 Identities=18% Similarity=0.267 Sum_probs=210.3
Q ss_pred cCccccCcccccCccEEEEEE-ECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 702 (973)
-.|.+.++||+|.||.++.|+ +-+++.||||.-.... ..-++..|.+..+.+ ..+.|..+|-|..++.+-.|||
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 478899999999999999995 4579999999743321 223567788888887 4789999999989999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCC-----CCEEEeeccc
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDD-----YRAKVSDFGL 777 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~-----~~~kl~DfGl 777 (973)
|.+ |-+|++...-+ .+.++..+++.||.|++.-++|+| .+.+|.|||||+|+||..- ..+.++|||+
T Consensus 104 dLL-GPSLEDLFD~C----gR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm 175 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLC----GRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGM 175 (449)
T ss_pred hhh-CcCHHHHHHHh----cCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccc
Confidence 988 88999887543 256899999999999999999999 8899999999999999653 3589999999
Q ss_pred cccCCCCCcc------eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHh
Q 041143 778 VKLAPDGEKS------VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIK 851 (973)
Q Consensus 778 a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 851 (973)
|+.+.+.... ......||.+||+-....+++.+.+.|+-|+|-|+.+.+-|..||.+......
T Consensus 176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tn----------- 244 (449)
T KOG1165|consen 176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTN----------- 244 (449)
T ss_pred hhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcch-----------
Confidence 9976655432 22446799999999999999999999999999999999999999987654322
Q ss_pred hchhHHHhhcCccc--cCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCCCCCCCcccCCCC
Q 041143 852 SSKEKFKAAIDPAL--EVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPITDESECCSGID 924 (973)
Q Consensus 852 ~~~~~~~~~~~~~l--~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~~~~~~~~~~~~~ 924 (973)
+++.+.+=+..- .....+.....++..-+.-.-+.+-.+-|..+-+...+..+.+......|..+++-+..
T Consensus 245 --K~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~~ln 317 (449)
T KOG1165|consen 245 --KEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWMGLN 317 (449)
T ss_pred --HHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcccccccccccC
Confidence 122222222111 00111122233444555555566788889999888888888887777777766665554
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.9e-22 Score=236.44 Aligned_cols=320 Identities=19% Similarity=0.319 Sum_probs=203.3
Q ss_pred hhccCCCCChhHHHHHHHHHhhCCCCc-cCC----CCCCCCCCCCCCC-------------cCeEEeeCCeEEEEEeccc
Q 041143 16 VGVANSATDPNDLKILNDFKNGLENPE-LLK----WPANGDDPCGPPP-------------WPHVFCSGNRVTQIQVQNL 77 (973)
Q Consensus 16 ~~~~~~~~~~~~~~~l~~~k~~~~~~~-l~~----w~~~~~d~C~~~~-------------w~gv~C~~~~v~~L~L~~~ 77 (973)
.+.....+.+++.+.++++.+.+..|. +.+ |.. ++|+|.... =..|.|.++.||.+..-+.
T Consensus 53 ~~~~~~~~~~~~~~~~~~~~~~l~~p~~~~~~~~~~~~-~~~fc~~~~~~~~~l~~~~~~~~~tv~~~~~~vt~l~~~g~ 131 (754)
T PRK15370 53 LCHPPETASPEEIKSKFECLRMLAFPAYADNIQYSRGG-ADQYCILSENSQEILSIVFNTEGYTVEGGGKSVTYTRVTES 131 (754)
T ss_pred HhCCCCCCCHHHHHHHHHHHHHhcCCchhhccccccCC-CCcccccCCcchhhheeeecCCceEEecCCCcccccccccc
Confidence 455567888999999999999998885 334 754 578996422 3358999999998877653
Q ss_pred CCcccCC--c--------------------------Cc-----ccccccceeeccCcccCCCCCCCCCCCccceeeccCC
Q 041143 78 GLKGPLP--Q--------------------------NF-----NQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFN 124 (973)
Q Consensus 78 ~l~g~~~--~--------------------------~~-----~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N 124 (973)
....... . ++ +-..+...|+|+++.++.++..+. +.|+.|+|++|
T Consensus 132 ~~~~~~~~~~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~LtsLP~~Ip--~~L~~L~Ls~N 209 (754)
T PRK15370 132 EQASSASGSKDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLTTIPACIP--EQITTLILDNN 209 (754)
T ss_pred cccccCCCCCChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcCcCCcccc--cCCcEEEecCC
Confidence 2221110 0 00 111345667777777776544332 35777777777
Q ss_pred CCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcc
Q 041143 125 EFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSG 204 (973)
Q Consensus 125 ~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 204 (973)
+|+.+|...+ .+|++|+|++|+|+. +|..+. .+|+.|+|++|++. .+|..+. ++|+.|+|++|+|+
T Consensus 210 ~LtsLP~~l~---~nL~~L~Ls~N~Lts-----LP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~- 275 (754)
T PRK15370 210 ELKSLPENLQ---GNIKTLYANSNQLTS-----IPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS- 275 (754)
T ss_pred CCCcCChhhc---cCCCEEECCCCcccc-----CChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-
Confidence 7777766544 367777777777764 554443 35677777777776 4555443 46777777777776
Q ss_pred cCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcccccCccccc
Q 041143 205 VIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLA 284 (973)
Q Consensus 205 ~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 284 (973)
.+|..+ .++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+. +|..+.
T Consensus 276 ~LP~~l---------------------------~~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l~ 324 (754)
T PRK15370 276 CLPENL---------------------------PEELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLTA-LPETLP 324 (754)
T ss_pred cccccc---------------------------CCCCcEEECCCCccc-cCcccch--hhHHHHHhcCCcccc-CCcccc
Confidence 455433 235777777777776 4554443 356777777777764 343322
Q ss_pred ccccCeEEccCCcCcCCCCCCCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCccccc
Q 041143 285 NMELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLS 364 (973)
Q Consensus 285 ~l~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~ 364 (973)
.+|+.|++++|.|++ +|..
T Consensus 325 -~sL~~L~Ls~N~Lt~-LP~~----------------------------------------------------------- 343 (754)
T PRK15370 325 -PGLKTLEAGENALTS-LPAS----------------------------------------------------------- 343 (754)
T ss_pred -ccceeccccCCcccc-CChh-----------------------------------------------------------
Confidence 256667777776653 3321
Q ss_pred cCCCCcccEEecCCCcCCCccchhhhCccccceEEccCCccccccCccccCcCCCCeeeCCCCcCCCCCCCC-------C
Q 041143 365 CTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLPEF-------H 437 (973)
Q Consensus 365 ~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~-------~ 437 (973)
-.++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. .+|+.|++++|+|++.+..+ .
T Consensus 344 --l~~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~~LP~sl~~~~~~~~ 415 (754)
T PRK15370 344 --LPPELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLVRLPESLPHFRGEGP 415 (754)
T ss_pred --hcCcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcccCchhHHHHhhcCC
Confidence 0146888888888887 4666553 67888999999888 5676654 36888889999888543322 3
Q ss_pred cccceeecCCccccC
Q 041143 438 DTVKLVIDGNPLLVG 452 (973)
Q Consensus 438 ~~~~~~~~~N~~~c~ 452 (973)
.+..+.+.+||+...
T Consensus 416 ~l~~L~L~~Npls~~ 430 (754)
T PRK15370 416 QPTRIIVEYNPFSER 430 (754)
T ss_pred CccEEEeeCCCccHH
Confidence 345678888887644
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.8e-22 Score=191.54 Aligned_cols=266 Identities=21% Similarity=0.250 Sum_probs=204.0
Q ss_pred HhcCccccCcccccCccEEEEEE-ECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC-CceeeeeeEEEeCCeEEE
Q 041143 623 VTQNFAQENELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRH-RHLVSLLGYSIEGNERLL 700 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~l 700 (973)
....|..++.||.|+||.+|.|. ..+|++||+|+-+..+.- .++..|.++.+.++| ..|..+..|..+...-.+
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl 88 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL 88 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence 34789999999999999999995 678999999986544322 356788999998874 577778888888889999
Q ss_pred EEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCC---CCEEEeeccc
Q 041143 701 VYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDD---YRAKVSDFGL 777 (973)
Q Consensus 701 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~---~~~kl~DfGl 777 (973)
|||.+ |-+|.+...-+. +.++..+++-.|-|++.-++|+| .+++|||||||+|+|..-+ ..+.++|||+
T Consensus 89 VMdLL-GPsLEdLfnfC~----R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGL 160 (341)
T KOG1163|consen 89 VMDLL-GPSLEDLFNFCS----RRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGL 160 (341)
T ss_pred eeecc-CccHHHHHHHHh----hhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccc
Confidence 99988 889999886543 56888999999999999999999 8899999999999999644 4689999999
Q ss_pred cccCCCCCcc------eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHh
Q 041143 778 VKLAPDGEKS------VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIK 851 (973)
Q Consensus 778 a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 851 (973)
|+.+.+.... ......||.+|.+-....+.+.+.+.|+-|+|.+|..+--|..||++........-.+.+...+
T Consensus 161 aKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK 240 (341)
T KOG1163|consen 161 AKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKK 240 (341)
T ss_pred hhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhh
Confidence 9966543321 1244689999999988888888999999999999999999999999877544322222111111
Q ss_pred hchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcC
Q 041143 852 SSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWR 911 (973)
Q Consensus 852 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~ 911 (973)
. ...+ ...+...+.++.-.+..|-..--++-|...-+-+.++-+.....
T Consensus 241 ~-----s~~i------e~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln 289 (341)
T KOG1163|consen 241 M-----STPI------EVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLN 289 (341)
T ss_pred c-----CCCH------HHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhcc
Confidence 1 0000 01112223456677778888888899998888888777766544
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-20 Score=209.49 Aligned_cols=262 Identities=29% Similarity=0.465 Sum_probs=198.6
Q ss_pred ccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChH-HHHHHHHHHHHHHhcCCC-ceeeeeeEEEeCCeEEEEEEe
Q 041143 627 FAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTK-ALDEFQSEIAVLSKVRHR-HLVSLLGYSIEGNERLLVYEY 704 (973)
Q Consensus 627 ~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lV~e~ 704 (973)
|...+.||.|+||.||++... ..+++|.+........ ....+.+|+.+++.+.|+ +|+++++++......++++||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566788999999999999887 7899999876644433 577899999999999988 799999999777778999999
Q ss_pred cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCC-CEEEeeccccccCCC
Q 041143 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDY-RAKVSDFGLVKLAPD 783 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~-~~kl~DfGla~~~~~ 783 (973)
+.++++.+++...... ..+.......++.|++.+++|+| ..+++|||+||+||+++..+ .++++|||.++....
T Consensus 80 ~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 80 VDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred CCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence 9999999666441110 26788899999999999999999 78899999999999999988 799999999985443
Q ss_pred CCcc-----eecccccccCccccccccc---CcCCCchhHHhHHHHHHHHHhCCCCCCCCChh-hHHHHHHHHHHHhhch
Q 041143 784 GEKS-----VVTRLAGTFGYLAPEYAVM---GKITTKADVFSYGVVLMELLTGLAALDEERPE-ESRYLAEWFWRIKSSK 854 (973)
Q Consensus 784 ~~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~ 854 (973)
.... ......||..|+|||.+.+ ..+....|+||+|++++++++|..||...... ........+.....
T Consensus 155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~-- 232 (384)
T COG0515 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT-- 232 (384)
T ss_pred CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCC--
Confidence 3221 2356789999999999987 57888999999999999999999997665431 01111111111000
Q ss_pred hHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHH
Q 041143 855 EKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNV 902 (973)
Q Consensus 855 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~ 902 (973)
. ....... ..........+.+++..|+..+|..|.++.+....
T Consensus 233 -~---~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 233 -P---SLASPLS-PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred -c---ccccccC-ccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0 0000111 00001223457799999999999999999987764
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.6e-23 Score=236.24 Aligned_cols=364 Identities=24% Similarity=0.346 Sum_probs=220.6
Q ss_pred eEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEccc
Q 041143 68 RVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDY 147 (973)
Q Consensus 68 ~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~ 147 (973)
.+.+|+|++|.+. ..|..+..+.+|+.|+++.|.|...+....++.+|++|.|.+|++..+|.. +..+++|++|++++
T Consensus 46 ~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~~vp~s~~~~~~l~~lnL~~n~l~~lP~~-~~~lknl~~LdlS~ 123 (1081)
T KOG0618|consen 46 KLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIRSVPSSCSNMRNLQYLNLKNNRLQSLPAS-ISELKNLQYLDLSF 123 (1081)
T ss_pred eeEEeeccccccc-cCCchhhhHHHHhhcccchhhHhhCchhhhhhhcchhheeccchhhcCchh-HHhhhcccccccch
Confidence 3899999999887 789999999999999999999998887899999999999999999999876 88999999999999
Q ss_pred CCCCCccCCCCCcccccccccCeeecccc-------------------cccCCcchhccCCCCCCeEEccCCcCcccCCh
Q 041143 148 NPFNKTFGWSIPDSLANSVQLTNLSLINC-------------------NLVGPLPDFLGTLPSLAALKLSYNRLSGVIPA 208 (973)
Q Consensus 148 N~l~~~~~~~ip~~~~~l~~L~~L~L~~N-------------------~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 208 (973)
|++.. +|..+..++.+..+.+++| .+.+.++..+.+++. .|+|.+|.+.-..-.
T Consensus 124 N~f~~-----~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~~~dls 196 (1081)
T KOG0618|consen 124 NHFGP-----IPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEMEVLDLS 196 (1081)
T ss_pred hccCC-----CchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchhhhhe--eeecccchhhhhhhh
Confidence 99985 7877777776666666665 344445555555554 577888877611111
Q ss_pred hhhhhHHHHHhhcccCCCCCCC----------------cchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcC
Q 041143 209 SFGQSLMQILWLNDQDAGGMTG----------------PIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNR 272 (973)
Q Consensus 209 ~~~~~~~~~~~l~~~~~~~~~~----------------~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~ 272 (973)
.+ ..++.+....+....+.. ..+.-..-.+|++++++.|+++ .+|+|++.+.+|+.|+..+
T Consensus 197 ~~--~~l~~l~c~rn~ls~l~~~g~~l~~L~a~~n~l~~~~~~p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~ 273 (1081)
T KOG0618|consen 197 NL--ANLEVLHCERNQLSELEISGPSLTALYADHNPLTTLDVHPVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANH 273 (1081)
T ss_pred hc--cchhhhhhhhcccceEEecCcchheeeeccCcceeeccccccccceeeecchhhhh-cchHHHHhcccceEecccc
Confidence 11 112222222221111100 0011112346888888888888 6778888888888888888
Q ss_pred CcccccCccccccc-ccCeEEccCCcCcCCCCCCCCCCcccccCcccCCCCCcccCCcchhhh-hhccCCCCCCcccCCC
Q 041143 273 NQLVGLIPKSLANM-ELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLL-DFLGGVNYPVNLVSQW 350 (973)
Q Consensus 273 N~l~~~~p~~~~~l-~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~l~~l~~~~n~~~~~ 350 (973)
|+|+ .+|..+... +|+.|++..|.+....| +..+--.+..+.+..+....-- ......+ ..+..++.+.|.+...
T Consensus 274 N~l~-~lp~ri~~~~~L~~l~~~~nel~yip~-~le~~~sL~tLdL~~N~L~~lp-~~~l~v~~~~l~~ln~s~n~l~~l 350 (1081)
T KOG0618|consen 274 NRLV-ALPLRISRITSLVSLSAAYNELEYIPP-FLEGLKSLRTLDLQSNNLPSLP-DNFLAVLNASLNTLNVSSNKLSTL 350 (1081)
T ss_pred hhHH-hhHHHHhhhhhHHHHHhhhhhhhhCCC-cccccceeeeeeehhccccccc-hHHHhhhhHHHHHHhhhhcccccc
Confidence 8886 333333222 34444444444432111 1110000001111000000000 0000011 1122222222222222
Q ss_pred CC-------------------CCCCCCCccccccCCCCcccEEecCCCcCCCccchhhhCccccceEEccCCccccccCc
Q 041143 351 PG-------------------NDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPN 411 (973)
Q Consensus 351 ~~-------------------~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~ 411 (973)
+. ++.|.. -+.++.+|++|+|++|++..-....+.++..|++|+||+|+|+ .+|.
T Consensus 351 p~~~e~~~~~Lq~LylanN~Ltd~c~p-----~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~ 424 (1081)
T KOG0618|consen 351 PSYEENNHAALQELYLANNHLTDSCFP-----VLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPD 424 (1081)
T ss_pred ccccchhhHHHHHHHHhcCcccccchh-----hhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhH
Confidence 20 111111 1245667777777777777555556777777777777777776 3332
Q ss_pred ----------------------cccCcCCCCeeeCCCCcCCCC-CCC---CCcccceeecCCccccC
Q 041143 412 ----------------------NFTELKSLRLLDVSDNNIKPP-LPE---FHDTVKLVIDGNPLLVG 452 (973)
Q Consensus 412 ----------------------~~~~l~~L~~L~Ls~N~l~g~-~p~---~~~~~~~~~~~N~~~c~ 452 (973)
++.+++.|+++|||.|+|+.. +|. ..++..|++.||.|+--
T Consensus 425 tva~~~~L~tL~ahsN~l~~fPe~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l~~ 491 (1081)
T KOG0618|consen 425 TVANLGRLHTLRAHSNQLLSFPELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRLVF 491 (1081)
T ss_pred HHHhhhhhHHHhhcCCceeechhhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCccccc
Confidence 677888999999999999853 443 25677899999998543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.4e-22 Score=236.80 Aligned_cols=261 Identities=20% Similarity=0.251 Sum_probs=191.8
Q ss_pred cccCcccccCccEEEEEEEC-CCCEEEEEEee----cCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 628 AQENELGRGGFGTVYKGELE-DGTKIAVKRME----AGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 628 ~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~----~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
...+++|.|++|.|+.+... ..+..+.|..+ ......+....+..|+.+-..++|+|++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45678999999988877543 33444444332 22122222223667888888999999999888888877777779
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++ +|...+... ..+...++-.++.|+..|+.|+| ..||.|||+|++|++++.+|.+||+|||.+..+.
T Consensus 401 E~~~~-Dlf~~~~~~-----~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN-----GKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred hcccH-HHHHHHhcc-----cccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeec
Confidence 99999 999988651 35777888899999999999999 8899999999999999999999999999987443
Q ss_pred CC-Cc--ceecccccccCcccccccccCcCCC-chhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHH
Q 041143 783 DG-EK--SVVTRLAGTFGYLAPEYAVMGKITT-KADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFK 858 (973)
Q Consensus 783 ~~-~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (973)
.. +. .....++|+..|+|||++.+.+|++ ..||||.|+++..|++|+.||......+..+.. .. ..
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~-----~~-----~~ 541 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT-----NN-----YS 541 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh-----hc-----cc
Confidence 22 22 4556688999999999999999986 579999999999999999999765544332100 00 00
Q ss_pred hhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 859 AAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 859 ~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
..................+...++.++++.||.+|.++.+|++ .+|++.
T Consensus 542 ~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~--d~W~~~ 590 (601)
T KOG0590|consen 542 DQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN--DEWIRS 590 (601)
T ss_pred cccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh--ChHhhh
Confidence 0000000001112233455778999999999999999999999 666654
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.7e-21 Score=231.73 Aligned_cols=253 Identities=23% Similarity=0.398 Sum_probs=195.2
Q ss_pred EEeeCCeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCcc
Q 041143 62 VFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVR 141 (973)
Q Consensus 62 v~C~~~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~ 141 (973)
..|...+.+.|+|++++++ .+|..+. ++|+.|+|++|+|+.++..+. .+|++|+|++|+|+.+|.... .+|+
T Consensus 173 ~~Cl~~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~LtsLP~~l~--~nL~~L~Ls~N~LtsLP~~l~---~~L~ 244 (754)
T PRK15370 173 RDCLKNNKTELRLKILGLT-TIPACIP--EQITTLILDNNELKSLPENLQ--GNIKTLYANSNQLTSIPATLP---DTIQ 244 (754)
T ss_pred HhhcccCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCCcCChhhc--cCCCEEECCCCccccCChhhh---cccc
Confidence 4577778899999999999 5777664 589999999999998765543 589999999999999987543 4799
Q ss_pred EEEcccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhc
Q 041143 142 VLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLN 221 (973)
Q Consensus 142 ~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~ 221 (973)
.|+|++|++.. +|..+. .+|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+
T Consensus 245 ~L~Ls~N~L~~-----LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~l----------- 302 (754)
T PRK15370 245 EMELSINRITE-----LPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHL----------- 302 (754)
T ss_pred EEECcCCccCc-----CChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc-cCcccc-----------
Confidence 99999999984 777664 48999999999999 5676554 58999999999998 466544
Q ss_pred ccCCCCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcccccCcccccccccCeEEccCCcCcCC
Q 041143 222 DQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMGP 301 (973)
Q Consensus 222 ~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~L~~L~l~~N~l~g~ 301 (973)
.++|+.|+|++|+++ .+|..+. ++|++|++++|.|++ +|..+. -+|+.|++++|+|+ .
T Consensus 303 ----------------p~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~-~sL~~L~Ls~N~L~-~ 360 (754)
T PRK15370 303 ----------------PSGITHLNVQSNSLT-ALPETLP--PGLKTLEAGENALTS-LPASLP-PELQVLDVSKNQIT-V 360 (754)
T ss_pred ----------------hhhHHHHHhcCCccc-cCCcccc--ccceeccccCCcccc-CChhhc-CcccEEECCCCCCC-c
Confidence 236778888888888 5665543 588888899888885 565543 27888888888886 2
Q ss_pred CCCCCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcC
Q 041143 302 IPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNL 381 (973)
Q Consensus 302 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l 381 (973)
+|..+ .++|+.|+|++|+|
T Consensus 361 LP~~l-------------------------------------------------------------p~~L~~LdLs~N~L 379 (754)
T PRK15370 361 LPETL-------------------------------------------------------------PPTITTLDVSRNAL 379 (754)
T ss_pred CChhh-------------------------------------------------------------cCCcCEEECCCCcC
Confidence 44310 13688888888888
Q ss_pred CCccchhhhCccccceEEccCCccccccCccc----cCcCCCCeeeCCCCcCCC
Q 041143 382 TGTLSPSIANLDSLIEIRLGKNSISGTVPNNF----TELKSLRLLDVSDNNIKP 431 (973)
Q Consensus 382 ~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~----~~l~~L~~L~Ls~N~l~g 431 (973)
+. +|..+. ..|+.|++++|+|+ .+|..+ ..++.+..|+|.+|.|+.
T Consensus 380 t~-LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls~ 429 (754)
T PRK15370 380 TN-LPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFSE 429 (754)
T ss_pred CC-CCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCccH
Confidence 84 565554 36888899999987 566544 345788899999998873
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.7e-23 Score=212.61 Aligned_cols=90 Identities=20% Similarity=0.239 Sum_probs=80.7
Q ss_pred cCCCCcccEEecCCCcCCCccchhhhCccccceEEccCCccccccCccccCcCCCCeeeCCCCcCCCCCCCC----Cccc
Q 041143 365 CTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLPEF----HDTV 440 (973)
Q Consensus 365 ~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~----~~~~ 440 (973)
|..+++|++|+|++|+++++-+.+|..+..|++|+|..|+|.-.--..|.++..|+.|+|.+|+|+...|.. ..+.
T Consensus 270 f~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~ 349 (498)
T KOG4237|consen 270 FKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLS 349 (498)
T ss_pred HhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceee
Confidence 567899999999999999999999999999999999999998777778999999999999999999877753 4456
Q ss_pred ceeecCCccccCCC
Q 041143 441 KLVIDGNPLLVGGI 454 (973)
Q Consensus 441 ~~~~~~N~~~c~~~ 454 (973)
++.+-+|||.|..-
T Consensus 350 ~l~l~~Np~~CnC~ 363 (498)
T KOG4237|consen 350 TLNLLSNPFNCNCR 363 (498)
T ss_pred eeehccCcccCccc
Confidence 78999999999764
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.4e-21 Score=191.23 Aligned_cols=141 Identities=18% Similarity=0.229 Sum_probs=109.3
Q ss_pred cCcccccCccEEEEEEECCCCEEEEEEeecCCCChHH------------------------HHHHHHHHHHHHhcCCCce
Q 041143 630 ENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKA------------------------LDEFQSEIAVLSKVRHRHL 685 (973)
Q Consensus 630 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~------------------------~~~~~~E~~~l~~l~h~ni 685 (973)
...||+|+||.||+|...+|+.||||+++........ ......|++++.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999998888999999999764221111 1123459999999988776
Q ss_pred eeeeeEEEeCCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHH-HhhccCCeeeccCCCCcEEE
Q 041143 686 VSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYL-HCLARQTFIHRDLKSSNILL 764 (973)
Q Consensus 686 v~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~L-H~~~~~~ivH~Dikp~Nill 764 (973)
.....+.. ...++||||++++++...... ...+++.+...++.|++.+|.|+ | ..+|+||||||+||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli 151 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK-----DAPLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLY 151 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh-----cCCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEE
Confidence 44333322 234899999998877644321 24678899999999999999999 6 6799999999999999
Q ss_pred CCCCCEEEeeccccccC
Q 041143 765 DDDYRAKVSDFGLVKLA 781 (973)
Q Consensus 765 ~~~~~~kl~DfGla~~~ 781 (973)
+ ++.++|+|||+|...
T Consensus 152 ~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 152 H-DGKLYIIDVSQSVEH 167 (190)
T ss_pred E-CCcEEEEEccccccC
Confidence 8 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.6e-21 Score=193.58 Aligned_cols=174 Identities=16% Similarity=0.178 Sum_probs=136.0
Q ss_pred HHhcCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChH-HHHH------HHHHHHHHHhcCCCceeeeeeEEEe
Q 041143 622 KVTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTK-ALDE------FQSEIAVLSKVRHRHLVSLLGYSIE 694 (973)
Q Consensus 622 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~-~~~~------~~~E~~~l~~l~h~niv~l~~~~~~ 694 (973)
...++|...+++|.|+||.||++.. ++..+|||.++......+ .... +.+|+..+.+++|++|..+.+++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 4568999999999999999999766 577899999975533322 2222 6899999999999999999998664
Q ss_pred C--------CeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECC
Q 041143 695 G--------NERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDD 766 (973)
Q Consensus 695 ~--------~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~ 766 (973)
. ...++||||++|.+|.++.. ++. ....+++.++..+| ..+++|||+||+||+++.
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~ 170 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSK 170 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeC
Confidence 3 35789999999999977631 121 24569999999999 889999999999999999
Q ss_pred CCCEEEeeccccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHH
Q 041143 767 DYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELL 826 (973)
Q Consensus 767 ~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ell 826 (973)
++ ++|+|||..+........ ..+.....|..++|+|+|||++....
T Consensus 171 ~g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CC-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 88 999999988754322111 11445566778999999999987664
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.3e-20 Score=219.08 Aligned_cols=256 Identities=21% Similarity=0.251 Sum_probs=195.6
Q ss_pred cccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCe
Q 041143 91 TKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTN 170 (973)
Q Consensus 91 ~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~ 170 (973)
..-..|+|++|.|+.+++.+. ++|+.|+|.+|+|+.+|. .+++|++|+|++|+|+. +|.. .++|+.
T Consensus 201 ~~~~~LdLs~~~LtsLP~~l~--~~L~~L~L~~N~Lt~LP~----lp~~Lk~LdLs~N~Lts-----LP~l---p~sL~~ 266 (788)
T PRK15387 201 NGNAVLNVGESGLTTLPDCLP--AHITTLVIPDNNLTSLPA----LPPELRTLEVSGNQLTS-----LPVL---PPGLLE 266 (788)
T ss_pred CCCcEEEcCCCCCCcCCcchh--cCCCEEEccCCcCCCCCC----CCCCCcEEEecCCccCc-----ccCc---ccccce
Confidence 345679999999997766665 479999999999999885 36899999999999995 5643 358899
Q ss_pred eecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCc
Q 041143 171 LSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQ 250 (973)
Q Consensus 171 L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~ 250 (973)
|+|++|.|+ .+|.. .++|+.|+|++|+|+ .+|.. +++|+.|+|++|+
T Consensus 267 L~Ls~N~L~-~Lp~l---p~~L~~L~Ls~N~Lt-~LP~~----------------------------p~~L~~LdLS~N~ 313 (788)
T PRK15387 267 LSIFSNPLT-HLPAL---PSGLCKLWIFGNQLT-SLPVL----------------------------PPGLQELSVSDNQ 313 (788)
T ss_pred eeccCCchh-hhhhc---hhhcCEEECcCCccc-ccccc----------------------------ccccceeECCCCc
Confidence 999999998 45543 367889999999998 45531 5689999999999
Q ss_pred cccCCCccccCCCCCCEEeCcCCcccccCcccccccccCeEEccCCcCcCCCCCCCCCCcccccCcccCCCCCcccCCcc
Q 041143 251 FTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDV 330 (973)
Q Consensus 251 l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (973)
|+ .+|... .+|+.|++++|+|++ +|... .+|+.|+|++|+|++ +|...
T Consensus 314 L~-~Lp~lp---~~L~~L~Ls~N~L~~-LP~lp--~~Lq~LdLS~N~Ls~-LP~lp------------------------ 361 (788)
T PRK15387 314 LA-SLPALP---SELCKLWAYNNQLTS-LPTLP--SGLQELSVSDNQLAS-LPTLP------------------------ 361 (788)
T ss_pred cc-cCCCCc---ccccccccccCcccc-ccccc--cccceEecCCCccCC-CCCCC------------------------
Confidence 99 466532 468899999999985 55422 279999999999984 45421
Q ss_pred hhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCCCccchhhhCccccceEEccCCccccccC
Q 041143 331 NVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVP 410 (973)
Q Consensus 331 ~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p 410 (973)
..+..+++.+|.+..+|.. ..+|+.|+|++|+|++ +|.. .++|+.|+|++|+|+ .+|
T Consensus 362 ----~~L~~L~Ls~N~L~~LP~l--------------~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Ls-sIP 418 (788)
T PRK15387 362 ----SELYKLWAYNNRLTSLPAL--------------PSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLT-SLP 418 (788)
T ss_pred ----cccceehhhccccccCccc--------------ccccceEEecCCcccC-CCCc---ccCCCEEEccCCcCC-CCC
Confidence 1234456677777766531 2468999999999996 5543 367999999999998 577
Q ss_pred ccccCcCCCCeeeCCCCcCCCCCCC---CCcccceeecCCcccc
Q 041143 411 NNFTELKSLRLLDVSDNNIKPPLPE---FHDTVKLVIDGNPLLV 451 (973)
Q Consensus 411 ~~~~~l~~L~~L~Ls~N~l~g~~p~---~~~~~~~~~~~N~~~c 451 (973)
..+ .+|+.|+|++|+|+..+.. +.++..+++.+|++..
T Consensus 419 ~l~---~~L~~L~Ls~NqLt~LP~sl~~L~~L~~LdLs~N~Ls~ 459 (788)
T PRK15387 419 MLP---SGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPLSE 459 (788)
T ss_pred cch---hhhhhhhhccCcccccChHHhhccCCCeEECCCCCCCc
Confidence 643 4688999999999954333 4566679999999764
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.8e-20 Score=181.21 Aligned_cols=189 Identities=20% Similarity=0.157 Sum_probs=141.4
Q ss_pred cccCcccccCccEEEEEEECCCCEEEEEEeecCCCC--hHHHHHHHHHHHHHHhcC-CCceeeeeeEEEeCCeEEEEEEe
Q 041143 628 AQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTT--TKALDEFQSEIAVLSKVR-HRHLVSLLGYSIEGNERLLVYEY 704 (973)
Q Consensus 628 ~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~ 704 (973)
.+...|++|+||+||.+.. ++.+++.+.+.....- ......|.+|+++|++++ |+++++++++ +..++||||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3567899999999998866 5788888877654221 112235889999999995 5889999886 456999999
Q ss_pred cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccC-CCCcEEECCCCCEEEeeccccccCCC
Q 041143 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDL-KSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Di-kp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
++|.+|...... . ...++.|++++|+++| ..||+|||| ||+|||++.++.++|+|||+|.....
T Consensus 80 I~G~~L~~~~~~------~------~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 80 LAGAAMYQRPPR------G------DLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred ecCccHHhhhhh------h------hHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 999998654311 1 1347789999999999 889999999 79999999999999999999985543
Q ss_pred CCcc----e--------ecccccccCcccccccccC-cCC-CchhHHhHHHHHHHHHhCCCCCCCCC
Q 041143 784 GEKS----V--------VTRLAGTFGYLAPEYAVMG-KIT-TKADVFSYGVVLMELLTGLAALDEER 836 (973)
Q Consensus 784 ~~~~----~--------~~~~~gt~~y~aPE~~~~~-~~~-~~~Dv~S~Gvvl~elltg~~p~~~~~ 836 (973)
.... . ......++.|++|+....- ..+ .+.+.++-|..+|.++||+.+.-...
T Consensus 145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 3210 0 0112367888888854322 223 46799999999999999998875443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-19 Score=184.06 Aligned_cols=142 Identities=20% Similarity=0.224 Sum_probs=111.8
Q ss_pred cCcccccCccEEEEEEECCCCEEEEEEeecCCCChH------------------------HHHHHHHHHHHHHhcCCCce
Q 041143 630 ENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTK------------------------ALDEFQSEIAVLSKVRHRHL 685 (973)
Q Consensus 630 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~------------------------~~~~~~~E~~~l~~l~h~ni 685 (973)
...||+|+||.||+|...+|+.||||+++....... ....+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 467999999999999887899999999876421100 02234689999999999987
Q ss_pred eeeeeEEEeCCeEEEEEEecCCCCHHHH-HHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhcc-CCeeeccCCCCcEE
Q 041143 686 VSLLGYSIEGNERLLVYEYMPHGALSRH-LFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLAR-QTFIHRDLKSSNIL 763 (973)
Q Consensus 686 v~l~~~~~~~~~~~lV~e~~~~g~L~~~-l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~-~~ivH~Dikp~Nil 763 (973)
.....+... ..++||||++++++... +.. ..++..+...++.|++.++.|+| . .+|+||||||+||+
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~------~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIl 150 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD------VPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNIL 150 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh------ccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEE
Confidence 555444333 34899999988865433 322 34677888999999999999999 6 89999999999999
Q ss_pred ECCCCCEEEeeccccccCCC
Q 041143 764 LDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 764 l~~~~~~kl~DfGla~~~~~ 783 (973)
++ +++++|+|||+++....
T Consensus 151 l~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 151 YH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred EE-CCCEEEEEcccceecCC
Confidence 99 88999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.4e-21 Score=219.17 Aligned_cols=266 Identities=24% Similarity=0.325 Sum_probs=202.3
Q ss_pred cccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCe
Q 041143 91 TKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTN 170 (973)
Q Consensus 91 ~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~ 170 (973)
++|+.|+.++|.++...+. ..-.+|+++++++|+++.+| +++..+.+|+.|+..+|+|.. +|..+..+++|+.
T Consensus 219 ~~l~~L~a~~n~l~~~~~~-p~p~nl~~~dis~n~l~~lp-~wi~~~~nle~l~~n~N~l~~-----lp~ri~~~~~L~~ 291 (1081)
T KOG0618|consen 219 PSLTALYADHNPLTTLDVH-PVPLNLQYLDISHNNLSNLP-EWIGACANLEALNANHNRLVA-----LPLRISRITSLVS 291 (1081)
T ss_pred cchheeeeccCcceeeccc-cccccceeeecchhhhhcch-HHHHhcccceEecccchhHHh-----hHHHHhhhhhHHH
Confidence 4566666667766643332 22468999999999999999 999999999999999999974 8999999999999
Q ss_pred eecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCC-CCcchhhcCCccccEEEccCC
Q 041143 171 LSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGM-TGPIDVVAKMVSLTQLWLHGN 249 (973)
Q Consensus 171 L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~-~~~~~~~~~l~~L~~L~L~~N 249 (973)
|++.+|.+. .+|..+..+++|++|+|..|+|. ..|..+.......+.......+.. +.+--.=..++.|+.|+|.+|
T Consensus 292 l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN 369 (1081)
T KOG0618|consen 292 LSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANN 369 (1081)
T ss_pred HHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcC
Confidence 999999999 78888999999999999999998 777766443332222222222222 212111124678999999999
Q ss_pred ccccCCCccccCCCCCCEEeCcCCcccccCccccccc-ccCeEEccCCcCcCCCCCCCCCCcccccCcccCCCCCcccCC
Q 041143 250 QFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAP 328 (973)
Q Consensus 250 ~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (973)
.|+...-..+.+.++|+.|+|++|+|.......+.++ .|+.|+||+|+|+. +|.
T Consensus 370 ~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~~-Lp~------------------------ 424 (1081)
T KOG0618|consen 370 HLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLTT-LPD------------------------ 424 (1081)
T ss_pred cccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhhh-hhH------------------------
Confidence 9998887789999999999999999996555566777 79999999999982 332
Q ss_pred cchhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCCCccchhhhCccccceEEccCCcccc-
Q 041143 329 DVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISG- 407 (973)
Q Consensus 329 ~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g- 407 (973)
++..++.|++|..-+|++. ..| .+.+++.|+.+||+.|+|+-
T Consensus 425 -----------------------------------tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~ 467 (1081)
T KOG0618|consen 425 -----------------------------------TVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEV 467 (1081)
T ss_pred -----------------------------------HHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhh
Confidence 2234556777777777776 344 78888888899999888864
Q ss_pred ccCccccCcCCCCeeeCCCCc
Q 041143 408 TVPNNFTELKSLRLLDVSDNN 428 (973)
Q Consensus 408 ~~p~~~~~l~~L~~L~Ls~N~ 428 (973)
.+|...- .++|++|||++|.
T Consensus 468 ~l~~~~p-~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 468 TLPEALP-SPNLKYLDLSGNT 487 (1081)
T ss_pred hhhhhCC-CcccceeeccCCc
Confidence 3333333 3889999999987
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.4e-19 Score=223.95 Aligned_cols=314 Identities=18% Similarity=0.237 Sum_probs=178.9
Q ss_pred CeEEEEEeccc------CCcccCCcCccccc-ccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCC
Q 041143 67 NRVTQIQVQNL------GLKGPLPQNFNQLT-KLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSS 139 (973)
Q Consensus 67 ~~v~~L~L~~~------~l~g~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~ 139 (973)
.++..|.+.++ ++...+|..|..++ +|+.|++.+|.++..+..| .+.+|+.|+|.+|+|..++.. +..+++
T Consensus 558 ~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~~lP~~f-~~~~L~~L~L~~s~l~~L~~~-~~~l~~ 635 (1153)
T PLN03210 558 RNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLRCMPSNF-RPENLVKLQMQGSKLEKLWDG-VHSLTG 635 (1153)
T ss_pred ccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCCCCCCcC-CccCCcEEECcCccccccccc-cccCCC
Confidence 45556666443 23344566666553 4777777777776655554 456777777777777766544 466777
Q ss_pred ccEEEcccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHh
Q 041143 140 VRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILW 219 (973)
Q Consensus 140 L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~ 219 (973)
|++|+|++|.... .+| .++.+++|+.|+|++|.....+|..+.++++|+.|+|++|...+.+|..+. +..+..
T Consensus 636 Lk~L~Ls~~~~l~----~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i~--l~sL~~ 708 (1153)
T PLN03210 636 LRNIDLRGSKNLK----EIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGIN--LKSLYR 708 (1153)
T ss_pred CCEEECCCCCCcC----cCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcCC--CCCCCE
Confidence 7777777654333 244 366677777777777665556777777777777777777654445665442 122223
Q ss_pred hcccCCCCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCccc-------ccCccccccc-ccCeE
Q 041143 220 LNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLV-------GLIPKSLANM-ELDNL 291 (973)
Q Consensus 220 l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~-------~~~p~~~~~l-~L~~L 291 (973)
|....+..+...+. ...+|+.|+|++|.++ .+|..+ .+++|++|++.++... ...+..+... +|+.|
T Consensus 709 L~Lsgc~~L~~~p~---~~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L 783 (1153)
T PLN03210 709 LNLSGCSRLKSFPD---ISTNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRL 783 (1153)
T ss_pred EeCCCCCCcccccc---ccCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhccccchhe
Confidence 33333322222111 2456778888888876 566554 4566666666653221 1111111111 46666
Q ss_pred EccCCcCcCCCCCCCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCc-ccCCCCCCCCCCCCccccccCCCCc
Q 041143 292 VLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVN-LVSQWPGNDPCQGPWLGLSCTSNSK 370 (973)
Q Consensus 292 ~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n-~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (973)
+|++|...+.+|..+.. +..|..+++.++ .+..+|.. ..+++
T Consensus 784 ~Ls~n~~l~~lP~si~~-------------------------L~~L~~L~Ls~C~~L~~LP~~------------~~L~s 826 (1153)
T PLN03210 784 FLSDIPSLVELPSSIQN-------------------------LHKLEHLEIENCINLETLPTG------------INLES 826 (1153)
T ss_pred eCCCCCCccccChhhhC-------------------------CCCCCEEECCCCCCcCeeCCC------------CCccc
Confidence 66666665555542211 111222222221 12222211 13567
Q ss_pred ccEEecCCCcCCCccchhhhCccccceEEccCCccccccCccccCcCCCCeeeCCC-CcCCCCCCC
Q 041143 371 VSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSD-NNIKPPLPE 435 (973)
Q Consensus 371 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~-N~l~g~~p~ 435 (973)
|+.|+|++|.....+|.. ..+|+.|+|++|.|+ .+|..+..+++|++|+|++ |+|++.++.
T Consensus 827 L~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~ 888 (1153)
T PLN03210 827 LESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLN 888 (1153)
T ss_pred cCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcc
Confidence 788888887666666543 356778888888887 6787888888888888887 666664443
|
syringae 6; Provisional |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.3e-20 Score=208.36 Aligned_cols=227 Identities=26% Similarity=0.303 Sum_probs=177.3
Q ss_pred cccccCccEEEEEEE----CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeeEEEeCCeEEEEEEecC
Q 041143 632 ELGRGGFGTVYKGEL----EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR-HRHLVSLLGYSIEGNERLLVYEYMP 706 (973)
Q Consensus 632 ~lG~G~fg~Vy~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~ 706 (973)
.+|+|.||.|++++. +.|.-+|+|+.+..............|..++..++ ||.+|++...++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999998742 34677888887654222222225667888999997 9999999999999999999999999
Q ss_pred CCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCc
Q 041143 707 HGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEK 786 (973)
Q Consensus 707 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~ 786 (973)
+|+|...+.. ...++..........+|-+++++| +.+|+|||+|++||+++.+|++++.|||+++...+...
T Consensus 81 gg~lft~l~~-----~~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~ 152 (612)
T KOG0603|consen 81 GGDLFTRLSK-----EVMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI 152 (612)
T ss_pred cchhhhcccc-----CCchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhh
Confidence 9999888754 244566667778888999999999 88999999999999999999999999999996655433
Q ss_pred ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCcccc
Q 041143 787 SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALE 866 (973)
Q Consensus 787 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 866 (973)
. +||.-|||||++. .....+|.||||++++||+||-.||.. +. ..++.. .+
T Consensus 153 ~-----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~---~~-------~~~Il~----------~~-- 203 (612)
T KOG0603|consen 153 A-----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG---DT-------MKRILK----------AE-- 203 (612)
T ss_pred c-----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch---HH-------HHHHhh----------hc--
Confidence 2 8999999999887 567789999999999999999999976 11 111111 01
Q ss_pred CCcccHHHHHHHHHHHHHhhccCCCCCCCH
Q 041143 867 VNEETFESISIVAELAGHCTAREPYHRPDM 896 (973)
Q Consensus 867 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~ 896 (973)
...+.+......+++..++..+|..|--.
T Consensus 204 -~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 204 -LEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred -cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 12233344556688889999999999855
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.3e-18 Score=222.16 Aligned_cols=305 Identities=21% Similarity=0.249 Sum_probs=192.2
Q ss_pred CeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCCCCCCCCccceeeccCCC-CCCCCccccCCCCCccEEEc
Q 041143 67 NRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNE-FDTIPSDFFDGLSSVRVLAL 145 (973)
Q Consensus 67 ~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~-l~~i~~~~f~~l~~L~~L~L 145 (973)
..++.|.+.++.++ .+|..| .+.+|+.|+|.+|++......+..+++|+.|+|++|. +..+|. +..+++|+.|+|
T Consensus 589 ~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~--ls~l~~Le~L~L 664 (1153)
T PLN03210 589 PKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLEKLWDGVHSLTGLRNIDLRGSKNLKEIPD--LSMATNLETLKL 664 (1153)
T ss_pred cccEEEEecCCCCC-CCCCcC-CccCCcEEECcCccccccccccccCCCCCEEECCCCCCcCcCCc--cccCCcccEEEe
Confidence 35777888887775 667666 4678888888888887765567778888888887754 566653 677888888888
Q ss_pred ccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCC
Q 041143 146 DYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDA 225 (973)
Q Consensus 146 s~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~ 225 (973)
++|.... .+|..+.++++|+.|+|++|...+.+|..+ ++++|++|+|++|...+.+|.... .++.+.+..+..
T Consensus 665 ~~c~~L~----~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~~~--nL~~L~L~~n~i 737 (1153)
T PLN03210 665 SDCSSLV----ELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDIST--NISWLDLDETAI 737 (1153)
T ss_pred cCCCCcc----ccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccccC--CcCeeecCCCcc
Confidence 8876544 378888888888888888865445666655 678888888888765555554321 122223322221
Q ss_pred CCCCCcchhhcCCccccEEEccCCccc-------cCCCccccCCCCCCEEeCcCCcccccCccccccc-ccCeEEccCCc
Q 041143 226 GGMTGPIDVVAKMVSLTQLWLHGNQFT-------GSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNL 297 (973)
Q Consensus 226 ~~~~~~~~~~~~l~~L~~L~L~~N~l~-------g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~ 297 (973)
...+. . ..+++|+.|++.++... ...|..+...++|+.|+|++|...+.+|..+.++ +|+.|++++|.
T Consensus 738 --~~lP~-~-~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~ 813 (1153)
T PLN03210 738 --EEFPS-N-LRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCI 813 (1153)
T ss_pred --ccccc-c-ccccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCC
Confidence 11111 1 13555565555543211 1111122223456666666665555566666655 56666666654
Q ss_pred CcCCCCCCCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCc-ccCCCCCCCCCCCCccccccCCCCcccEEec
Q 041143 298 LMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVN-LVSQWPGNDPCQGPWLGLSCTSNSKVSIINL 376 (973)
Q Consensus 298 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n-~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~L 376 (973)
..+.+|... .+..+..++++.+ .+..++ ....+|+.|+|
T Consensus 814 ~L~~LP~~~--------------------------~L~sL~~L~Ls~c~~L~~~p--------------~~~~nL~~L~L 853 (1153)
T PLN03210 814 NLETLPTGI--------------------------NLESLESLDLSGCSRLRTFP--------------DISTNISDLNL 853 (1153)
T ss_pred CcCeeCCCC--------------------------CccccCEEECCCCCcccccc--------------ccccccCEeEC
Confidence 444444321 0111222222211 111111 11257899999
Q ss_pred CCCcCCCccchhhhCccccceEEccCC-ccccccCccccCcCCCCeeeCCCCc
Q 041143 377 PRHNLTGTLSPSIANLDSLIEIRLGKN-SISGTVPNNFTELKSLRLLDVSDNN 428 (973)
Q Consensus 377 s~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~g~~p~~~~~l~~L~~L~Ls~N~ 428 (973)
++|.+. .+|..+..+++|+.|+|++| +|. .+|..+..+++|+.|+++++.
T Consensus 854 s~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 854 SRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred CCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence 999998 57889999999999999994 566 688899999999999999863
|
syringae 6; Provisional |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.4e-19 Score=183.62 Aligned_cols=235 Identities=23% Similarity=0.305 Sum_probs=152.4
Q ss_pred ccccCcccccCccEEEEEEEC-CCCEEEEEEeecCC-CChHHHHHHHHHHHHHHhcCC-----------CceeeeeeEEE
Q 041143 627 FAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGV-TTTKALDEFQSEIAVLSKVRH-----------RHLVSLLGYSI 693 (973)
Q Consensus 627 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h-----------~niv~l~~~~~ 693 (973)
+...+.||.|+|+.||.+++. +|+++|||++.... ......+++.+|.-....+.+ .-++++ +...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~-d~~~ 92 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPL-DLLR 92 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---S-EEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeee-EEEE
Confidence 445678999999999999886 48999999975432 233456777777765555332 222222 2211
Q ss_pred ---------eCC--------eEEEEEEecCCCCHHHHHHhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhhccCCeee
Q 041143 694 ---------EGN--------ERLLVYEYMPHGALSRHLFRWEKLQ--LKPLSWTRRLSIALDVARGMEYLHCLARQTFIH 754 (973)
Q Consensus 694 ---------~~~--------~~~lV~e~~~~g~L~~~l~~~~~~~--~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH 754 (973)
... ..+++|+-+ -+||.+.+....... ...+....++.+..|+++.+++|| ..|++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEe
Confidence 111 236778877 678888764322211 123455667788899999999999 889999
Q ss_pred ccCCCCcEEECCCCCEEEeeccccccCCCCCcceecccccccCcccccccccC--------cCCCchhHHhHHHHHHHHH
Q 041143 755 RDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMG--------KITTKADVFSYGVVLMELL 826 (973)
Q Consensus 755 ~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~Dv~S~Gvvl~ell 826 (973)
+||||+|++++.+|.++|+||+.....+... .. ...+..|.+||..... .++.+.|.|++|+++|.|+
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~---~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRY---RC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEE---EG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCcee---ec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 9999999999999999999999877554321 11 3456789999977442 4788999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCC
Q 041143 827 TGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHR 893 (973)
Q Consensus 827 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~R 893 (973)
+|..||+...+..... . .+ ..-. +..+.+..||..+++.+|++|
T Consensus 245 C~~lPf~~~~~~~~~~-------------~-------~f--~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPE-------------W-------DF--SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTSG-------------G-------GG--TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCcccccc-------------c-------cc--hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999998764322100 0 11 1122 556778899999999999988
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.2e-19 Score=209.62 Aligned_cols=247 Identities=20% Similarity=0.249 Sum_probs=175.7
Q ss_pred CccccCcccccCccEEEEEEECCCCEEEEEEeecCC--CChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 626 NFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGV--TTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
+|...+.||.+.|=+|.+|+++.|. |+||++-... ..-....+-.+|++ ...++|||.+++.-+-......|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5677789999999999999999887 8999874432 12222333344444 555689999998877666777789989
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccc--cC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK--LA 781 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~--~~ 781 (973)
|+. -+|++.+.. +.-+...+..-||.|+++||..+| +.+|+|||||.+|||++.-.=+.|+||..-| ..
T Consensus 102 yvk-hnLyDRlST-----RPFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYL 172 (1431)
T KOG1240|consen 102 YVK-HNLYDRLST-----RPFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYL 172 (1431)
T ss_pred HHh-hhhhhhhcc-----chHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccC
Confidence 884 478777643 234566778889999999999999 8999999999999999988889999998766 33
Q ss_pred CCCCcceecccccc----cCcccccccccC-----------cCCCchhHHhHHHHHHHHHhC-CCCCCCCChhhHHHHHH
Q 041143 782 PDGEKSVVTRLAGT----FGYLAPEYAVMG-----------KITTKADVFSYGVVLMELLTG-LAALDEERPEESRYLAE 845 (973)
Q Consensus 782 ~~~~~~~~~~~~gt----~~y~aPE~~~~~-----------~~~~~~Dv~S~Gvvl~elltg-~~p~~~~~~~~~~~~~~ 845 (973)
+.++....+.+..| ..|.|||.+... ..+++.||||+||+++||++- +++|.-.. +..
T Consensus 173 PeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ------L~a 246 (1431)
T KOG1240|consen 173 PEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ------LLA 246 (1431)
T ss_pred CCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH------HHh
Confidence 33333333222222 369999987541 156788999999999999885 77775321 111
Q ss_pred HHHH-HhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHH
Q 041143 846 WFWR-IKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNV 902 (973)
Q Consensus 846 ~~~~-~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~ 902 (973)
+-.. ....+.-++++-|+. +..++..|++.||++|.++.+.++.
T Consensus 247 Yr~~~~~~~e~~Le~Ied~~-------------~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 247 YRSGNADDPEQLLEKIEDVS-------------LRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HhccCccCHHHHHHhCcCcc-------------HHHHHHHHHccCchhccCHHHHHHh
Confidence 1110 000011122232332 5589999999999999999999987
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=6.4e-19 Score=182.55 Aligned_cols=197 Identities=26% Similarity=0.319 Sum_probs=138.3
Q ss_pred CCCceeeeeeEEEeC---------------------------CeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHH
Q 041143 681 RHRHLVSLLGYSIEG---------------------------NERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSI 733 (973)
Q Consensus 681 ~h~niv~l~~~~~~~---------------------------~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i 733 (973)
+|||||++.++|.++ ...|+||.-. ..+|.+++.. ...+...+.-|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~------~~~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWT------RHRSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhc------CCCchHHHHHH
Confidence 599999999887653 2458999877 4589888865 33455666778
Q ss_pred HHHHHHHHHHHHhhccCCeeeccCCCCcEEE--CCCC--CEEEeeccccccCCCC-----CcceecccccccCccccccc
Q 041143 734 ALDVARGMEYLHCLARQTFIHRDLKSSNILL--DDDY--RAKVSDFGLVKLAPDG-----EKSVVTRLAGTFGYLAPEYA 804 (973)
Q Consensus 734 ~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill--~~~~--~~kl~DfGla~~~~~~-----~~~~~~~~~gt~~y~aPE~~ 804 (973)
..|+++|+.||| +++|.|||+|++|||+ |+|+ ...|+|||.+--.... .........|...-||||+.
T Consensus 347 laQlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ 423 (598)
T KOG4158|consen 347 LAQLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIA 423 (598)
T ss_pred HHHHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhh
Confidence 999999999999 8999999999999999 3443 5789999987522211 11112234578889999988
Q ss_pred ccCc------CCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHH
Q 041143 805 VMGK------ITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIV 878 (973)
Q Consensus 805 ~~~~------~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 878 (973)
.... --.|+|.|+.|.+.||+++...||....... +. ...+++.--|.+. ......+
T Consensus 424 ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~---L~---------~r~Yqe~qLPalp-----~~vpp~~ 486 (598)
T KOG4158|consen 424 TAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML---LD---------TRTYQESQLPALP-----SRVPPVA 486 (598)
T ss_pred hcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe---ec---------hhhhhhhhCCCCc-----ccCChHH
Confidence 6432 1348999999999999999999998743211 10 0111111112221 1122236
Q ss_pred HHHHHHhhccCCCCCCCHhHHHHHHH
Q 041143 879 AELAGHCTAREPYHRPDMGHVVNVLS 904 (973)
Q Consensus 879 ~~l~~~cl~~dP~~RPs~~~v~~~L~ 904 (973)
.+++...+++||.+|++..=....|.
T Consensus 487 rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 487 RQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHHHHhcCCccccCCccHHHhHHH
Confidence 68999999999999999876666553
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=8.1e-19 Score=195.15 Aligned_cols=217 Identities=26% Similarity=0.424 Sum_probs=162.9
Q ss_pred HHhcCCCceeeeeeEEEeCCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCe-eec
Q 041143 677 LSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTF-IHR 755 (973)
Q Consensus 677 l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~i-vH~ 755 (973)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+.. ....++|.-...+..+|++||+|+| ..+| .|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~----~~~~~d~~F~~s~~rdi~~Gl~ylh---~s~i~~hg 73 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN----EDIKLDYFFILSFIRDISKGLAYLH---NSPIGYHG 73 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc----cccCccHHHHHHHHHHHHHHHHHHh---cCcceeee
Confidence 3568899999999999999999999999999999999965 3356899999999999999999999 4444 999
Q ss_pred cCCCCcEEECCCCCEEEeeccccccCCCC-CcceecccccccCcccccccccCc-------CCCchhHHhHHHHHHHHHh
Q 041143 756 DLKSSNILLDDDYRAKVSDFGLVKLAPDG-EKSVVTRLAGTFGYLAPEYAVMGK-------ITTKADVFSYGVVLMELLT 827 (973)
Q Consensus 756 Dikp~Nill~~~~~~kl~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~Dv~S~Gvvl~ellt 827 (973)
.++++|+++|....+|++|||+.....+. .........-..-|.|||.+.... .+.+.||||||++++|+++
T Consensus 74 ~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~ 153 (484)
T KOG1023|consen 74 ALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILF 153 (484)
T ss_pred eeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHh
Confidence 99999999999999999999998765321 111111122345799999887531 4667999999999999999
Q ss_pred CCCCCCCCChhhH-HHHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHh
Q 041143 828 GLAALDEERPEES-RYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPL 906 (973)
Q Consensus 828 g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~ 906 (973)
.+.||+....... ..++.+ +.. .....+.|.+.... +....+..++..||..+|++||++++|-..++.+
T Consensus 154 r~~~~~~~~~~~~~~eii~~---~~~---~~~~~~rP~i~~~~---e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 154 RSGPFDLRNLVEDPDEIILR---VKK---GGSNPFRPSIELLN---ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred ccCccccccccCChHHHHHH---HHh---cCCCCcCcchhhhh---hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 9999986443222 122222 221 11112223322111 2333688999999999999999999999888777
Q ss_pred hhh
Q 041143 907 VEK 909 (973)
Q Consensus 907 ~~~ 909 (973)
...
T Consensus 225 ~~~ 227 (484)
T KOG1023|consen 225 NKG 227 (484)
T ss_pred ccc
Confidence 553
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.2e-17 Score=169.97 Aligned_cols=137 Identities=15% Similarity=0.193 Sum_probs=105.5
Q ss_pred ccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc-----CCCceeeeeeEEEeCC---eE
Q 041143 627 FAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-----RHRHLVSLLGYSIEGN---ER 698 (973)
Q Consensus 627 ~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~~ 698 (973)
+...+.||+|+||.||. .-.++.. +||++... .....+.+.+|+++++.+ .||||++++|++.++. ..
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~--~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHR--GDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEecc--ccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 34567899999999996 3334444 69988653 223456799999999999 5799999999998864 33
Q ss_pred E-EEEEe--cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHH-HHHHhhccCCeeeccCCCCcEEECC----CCCE
Q 041143 699 L-LVYEY--MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGM-EYLHCLARQTFIHRDLKSSNILLDD----DYRA 770 (973)
Q Consensus 699 ~-lV~e~--~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl-~~LH~~~~~~ivH~Dikp~Nill~~----~~~~ 770 (973)
+ +|||| +.+|+|.+++.+ ..+++. ..++.+++.++ +||| +++|+||||||+|||++. +..+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~------~~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~ 148 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQ------CRYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIP 148 (210)
T ss_pred EEEEecCCCCcchhHHHHHHc------ccccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcE
Confidence 3 78999 557999999954 124444 35678888887 9999 889999999999999974 3479
Q ss_pred EEeecccc
Q 041143 771 KVSDFGLV 778 (973)
Q Consensus 771 kl~DfGla 778 (973)
+|+||+.+
T Consensus 149 ~LiDg~G~ 156 (210)
T PRK10345 149 VVCDNIGE 156 (210)
T ss_pred EEEECCCC
Confidence 99995433
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.4e-20 Score=168.33 Aligned_cols=165 Identities=30% Similarity=0.512 Sum_probs=95.7
Q ss_pred ccccccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccc
Q 041143 88 NQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQ 167 (973)
Q Consensus 88 ~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~ 167 (973)
-++.+++.|.|++|+++..+|.+..|.+|+.|++.+|+|+.+|.. ++.+++|+.|++.-|++.. +|..|+.++.
T Consensus 30 f~~s~ITrLtLSHNKl~~vppnia~l~nlevln~~nnqie~lp~~-issl~klr~lnvgmnrl~~-----lprgfgs~p~ 103 (264)
T KOG0617|consen 30 FNMSNITRLTLSHNKLTVVPPNIAELKNLEVLNLSNNQIEELPTS-ISSLPKLRILNVGMNRLNI-----LPRGFGSFPA 103 (264)
T ss_pred cchhhhhhhhcccCceeecCCcHHHhhhhhhhhcccchhhhcChh-hhhchhhhheecchhhhhc-----CccccCCCch
Confidence 344455555555555555555555555555555555555555543 4555555555555555553 5556666666
Q ss_pred cCeeeccccccc-CCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEc
Q 041143 168 LTNLSLINCNLV-GPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWL 246 (973)
Q Consensus 168 L~~L~L~~N~l~-~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L 246 (973)
|+.|||.+|++. ..+|..|..|..|+.|+|++|.+. .+|..++ ++++|+.|.+
T Consensus 104 levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg-------------------------~lt~lqil~l 157 (264)
T KOG0617|consen 104 LEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVG-------------------------KLTNLQILSL 157 (264)
T ss_pred hhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhh-------------------------hhcceeEEee
Confidence 666666666554 245555555666666666666665 5555543 3666666666
Q ss_pred cCCccccCCCccccCCCCCCEEeCcCCcccccCccccccc
Q 041143 247 HGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM 286 (973)
Q Consensus 247 ~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 286 (973)
..|.+- .+|..++.+..|+.|++.+|+++ .+|..++++
T Consensus 158 rdndll-~lpkeig~lt~lrelhiqgnrl~-vlppel~~l 195 (264)
T KOG0617|consen 158 RDNDLL-SLPKEIGDLTRLRELHIQGNRLT-VLPPELANL 195 (264)
T ss_pred ccCchh-hCcHHHHHHHHHHHHhcccceee-ecChhhhhh
Confidence 666665 56666666666666666666666 445555543
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.6e-20 Score=171.25 Aligned_cols=180 Identities=26% Similarity=0.447 Sum_probs=158.2
Q ss_pred CCeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEc
Q 041143 66 GNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLAL 145 (973)
Q Consensus 66 ~~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~L 145 (973)
...+|.|.|++|.++ .+|+.+..|.+|+.|++++|+|+..+++++.+++|++|++.-|++..+|.+ |+.++.|+.|||
T Consensus 32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~~lprg-fgs~p~levldl 109 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLNILPRG-FGSFPALEVLDL 109 (264)
T ss_pred hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhhcCccc-cCCCchhhhhhc
Confidence 357999999999998 789999999999999999999999999999999999999999999988866 999999999999
Q ss_pred ccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCC
Q 041143 146 DYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDA 225 (973)
Q Consensus 146 s~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~ 225 (973)
++|+++.. .+|..|..++.|+.|+|++|.+. .+|...+++++|+.|.+..|.+- .+|..++.
T Consensus 110 tynnl~e~---~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~------------- 171 (264)
T KOG0617|consen 110 TYNNLNEN---SLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGD------------- 171 (264)
T ss_pred cccccccc---cCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHH-------------
Confidence 99999987 69999999999999999999998 88999999999999999999997 88888764
Q ss_pred CCCCCcchhhcCCccccEEEccCCccccCCCccccCCCC---CCEEeCcCCccccc
Q 041143 226 GGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSS---LKDLNLNRNQLVGL 278 (973)
Q Consensus 226 ~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~---L~~L~Ls~N~l~~~ 278 (973)
++.|++|.+.+|+++ .+|..++++.- =+.+.+.+|.....
T Consensus 172 ------------lt~lrelhiqgnrl~-vlppel~~l~l~~~k~v~r~E~NPwv~p 214 (264)
T KOG0617|consen 172 ------------LTRLRELHIQGNRLT-VLPPELANLDLVGNKQVMRMEENPWVNP 214 (264)
T ss_pred ------------HHHHHHHhcccceee-ecChhhhhhhhhhhHHHHhhhhCCCCCh
Confidence 889999999999999 88888877532 23444455544433
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.2e-19 Score=199.41 Aligned_cols=130 Identities=27% Similarity=0.269 Sum_probs=68.1
Q ss_pred EEEecccCCc-ccCCcCcccccccceeeccCcccCCC----CC-CCCCCCccceeeccCCCCCCCC------ccccCCCC
Q 041143 71 QIQVQNLGLK-GPLPQNFNQLTKLYNLGLQRNKFNGK----LP-TFSGLSELEFAYLDFNEFDTIP------SDFFDGLS 138 (973)
Q Consensus 71 ~L~L~~~~l~-g~~~~~~~~l~~L~~L~L~~N~l~~~----~~-~~~~l~~L~~L~L~~N~l~~i~------~~~f~~l~ 138 (973)
.|+|.++.++ +.....|..+.+|+.|+|+++.++.. ++ .+...++|++|+++++.+..++ ...|..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 3566666666 34445556666777777777777542 12 3455566667777666665321 12344455
Q ss_pred CccEEEcccCCCCCccCCCCCcccccccc---cCeeecccccccC----CcchhccCC-CCCCeEEccCCcCcc
Q 041143 139 SVRVLALDYNPFNKTFGWSIPDSLANSVQ---LTNLSLINCNLVG----PLPDFLGTL-PSLAALKLSYNRLSG 204 (973)
Q Consensus 139 ~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~---L~~L~L~~N~l~~----~~p~~l~~l-~~L~~L~Ls~N~l~~ 204 (973)
+|+.|+|++|.+... .+..+..+.+ |++|++++|++++ .+...+..+ ++|+.|+|++|.+++
T Consensus 82 ~L~~L~l~~~~~~~~----~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~ 151 (319)
T cd00116 82 GLQELDLSDNALGPD----GCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEG 151 (319)
T ss_pred ceeEEEccCCCCChh----HHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCc
Confidence 555555555555432 2333333333 5555555555542 222233444 555555555555553
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.9e-17 Score=171.62 Aligned_cols=144 Identities=18% Similarity=0.170 Sum_probs=111.2
Q ss_pred CccccCcccccCccEEEEEE--ECCCCEEEEEEeecCCCCh----------------------HHHHHHHHHHHHHHhcC
Q 041143 626 NFAQENELGRGGFGTVYKGE--LEDGTKIAVKRMEAGVTTT----------------------KALDEFQSEIAVLSKVR 681 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~--~~~g~~vavK~~~~~~~~~----------------------~~~~~~~~E~~~l~~l~ 681 (973)
.|.+.+.||+|+||.||+|. ..+|+.||||+++...... .....+..|++++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47888999999999999998 5689999999987542110 01234678999999997
Q ss_pred CCc--eeeeeeEEEeCCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCC-eeeccCC
Q 041143 682 HRH--LVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQT-FIHRDLK 758 (973)
Q Consensus 682 h~n--iv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~-ivH~Dik 758 (973)
+.. +.+++++ ...++||||+++++|..+... .......+...++.||+.+++||| ..+ |+|||||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dik 176 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-----DVEPEEEEEFELYDDILEEMRKLY---KEGELVHGDLS 176 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccc-----cCCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCC
Confidence 533 3444443 235899999999888665422 133455667889999999999999 788 9999999
Q ss_pred CCcEEECCCCCEEEeeccccccCC
Q 041143 759 SSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 759 p~Nill~~~~~~kl~DfGla~~~~ 782 (973)
|+||+++ +++++|+|||.+....
T Consensus 177 p~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 177 EYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hhhEEEE-CCCEEEEEChhhhccC
Confidence 9999999 8899999999987543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=9.1e-17 Score=166.73 Aligned_cols=136 Identities=22% Similarity=0.340 Sum_probs=114.5
Q ss_pred CcccccCccEEEEEEECCCCEEEEEEeecCCCChH------HHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEe
Q 041143 631 NELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTK------ALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEY 704 (973)
Q Consensus 631 ~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 704 (973)
+.||+|++|.||+|.. +|..++||+......... ....+.+|++++..++|++|.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 578899998654322111 234678899999999999998888888788888999999
Q ss_pred cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecccccc
Q 041143 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKL 780 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~ 780 (973)
++|++|.+++... .+ ++..++.+++.+|.++| ..+++|||++|.||+++ ++.++|+|||.++.
T Consensus 81 ~~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN--------GM-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988541 12 78899999999999999 88999999999999999 78999999998864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.7e-17 Score=165.57 Aligned_cols=146 Identities=23% Similarity=0.212 Sum_probs=112.3
Q ss_pred HHHHHhcCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCCh--------------------HHHHHHHHHHHHHH
Q 041143 619 VLRKVTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTT--------------------KALDEFQSEIAVLS 678 (973)
Q Consensus 619 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~--------------------~~~~~~~~E~~~l~ 678 (973)
++......|...+.||+|+||.||+|..++|+.||||++....... .....+..|+.++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 3334334478889999999999999998889999999876432110 01123678999999
Q ss_pred hcCCCc--eeeeeeEEEeCCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeecc
Q 041143 679 KVRHRH--LVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRD 756 (973)
Q Consensus 679 ~l~h~n--iv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~D 756 (973)
.+.|++ +.+.++ ....++||||+++++|...... .....++.+++.++.++| ..+|+|||
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh---~~gi~H~D 150 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAY---KHGIIHGD 150 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHH---HCCCCcCC
Confidence 998774 444443 2455899999999998764320 234578899999999999 78999999
Q ss_pred CCCCcEEECCCCCEEEeeccccccCC
Q 041143 757 LKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 757 ikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
|||+||+++++++++|+|||++....
T Consensus 151 l~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 151 LSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCcccEEEcCCCcEEEEECCccccCC
Confidence 99999999999999999999986443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.5e-17 Score=192.15 Aligned_cols=195 Identities=24% Similarity=0.293 Sum_probs=156.9
Q ss_pred HHHhcCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcC---CCceeeeeeEEEeCCe
Q 041143 621 RKVTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR---HRHLVSLLGYSIEGNE 697 (973)
Q Consensus 621 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~ 697 (973)
+...+.|.+.+.||+|+||+||+|...+|+.||+|+-+....- +|.-=.+++.+|+ -+-|..+...+.-.+.
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W-----EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW-----EFYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce-----eeeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 3345678888999999999999999888999999987654221 2222234445554 2345556666666788
Q ss_pred EEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECC-------CCCE
Q 041143 698 RLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDD-------DYRA 770 (973)
Q Consensus 698 ~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~-------~~~~ 770 (973)
.++|+||.+.|+|.+++. ..+..+|.-++.++.|+++.+++|| ..+|||+||||+|+||.. ...+
T Consensus 769 S~lv~ey~~~Gtlld~~N-----~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l 840 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLIN-----TNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGL 840 (974)
T ss_pred ceeeeeccccccHHHhhc-----cCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccce
Confidence 899999999999999986 3467899999999999999999999 889999999999999942 3469
Q ss_pred EEeeccccc---cCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCC
Q 041143 771 KVSDFGLVK---LAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLA 830 (973)
Q Consensus 771 kl~DfGla~---~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~ 830 (973)
+|+|||-+- .++++ ......++|-.+--+|+..++.++..+|.|.++-+++-|+.|+.
T Consensus 841 ~lIDfG~siDm~lfp~~--~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 841 YLIDFGRSIDMKLFPDG--TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EEEecccceeeeEcCCC--cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 999999875 34443 34556678899999999999999999999999999999999854
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.4e-16 Score=163.67 Aligned_cols=133 Identities=23% Similarity=0.370 Sum_probs=108.4
Q ss_pred cccccCccEEEEEEECCCCEEEEEEeecCCCC------hHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEec
Q 041143 632 ELGRGGFGTVYKGELEDGTKIAVKRMEAGVTT------TKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYM 705 (973)
Q Consensus 632 ~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 705 (973)
.||+|+||.||+|.. +|..+++|+....... .....++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 4788999986543211 112356788999999999887766666666777789999999
Q ss_pred CCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccC
Q 041143 706 PHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA 781 (973)
Q Consensus 706 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~ 781 (973)
+|++|.+++.... . .++.+++++|.+|| ..+++|+|++|.||+++ ++.++++|||+++..
T Consensus 80 ~g~~l~~~~~~~~-----~-------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGN-----D-------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcH-----H-------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999998875411 0 78999999999999 88999999999999999 889999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.6e-17 Score=192.59 Aligned_cols=209 Identities=26% Similarity=0.379 Sum_probs=145.0
Q ss_pred cCccccCcccccCccEEEEEEECC-CCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELED-GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
.+|..++.|..|+||.||.++++. .+.+|+|.=+.. .+.+- ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq~--------lilRn--ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN--------LILRN--ILTFAGNPFVV----------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcccccc--------hhhhc--cccccCCccee-----------------
Confidence 578889999999999999998763 567888432221 01110 33333344444
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+-...+.. .+++.. +++.+++|+| +.+|+|||+||+|.+++.-|++|++|||+++....
T Consensus 136 ----gDc~tllk~-----~g~lPv--------dmvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLm 195 (1205)
T KOG0606|consen 136 ----GDCATLLKN-----IGPLPV--------DMVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLM 195 (1205)
T ss_pred ----chhhhhccc-----CCCCcc--------hhhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhh
Confidence 333333322 122222 2277899999 89999999999999999999999999999874221
Q ss_pred CCc--------------ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHH
Q 041143 784 GEK--------------SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWR 849 (973)
Q Consensus 784 ~~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 849 (973)
... -....++||+.|.|||++....|+..+|+|++|+++||.+.|+.||.+..+++.
T Consensus 196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel--------- 266 (1205)
T KOG0606|consen 196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL--------- 266 (1205)
T ss_pred hccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH---------
Confidence 110 112346899999999999999999999999999999999999999998876542
Q ss_pred HhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCH
Q 041143 850 IKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDM 896 (973)
Q Consensus 850 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~ 896 (973)
+..++.-.+...+.+.....+..+++.+.++.+|..|--.
T Consensus 267 -------fg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt 306 (1205)
T KOG0606|consen 267 -------FGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGT 306 (1205)
T ss_pred -------HhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhccc
Confidence 1111111122222233444567899999999999999733
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.7e-16 Score=187.50 Aligned_cols=141 Identities=24% Similarity=0.357 Sum_probs=113.9
Q ss_pred HhcCccccCcccccCccEEEEEEECCCCEEEEEEe-ecCCCC-----hHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC
Q 041143 623 VTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRM-EAGVTT-----TKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGN 696 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~-~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 696 (973)
....|...+.||+|+||.||+|.+... .+++|+. ...... ....+.+.+|++++++++|++++..+.++....
T Consensus 331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 331 VKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred cccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 344556778999999999999987644 4444443 211111 122356889999999999999998888888878
Q ss_pred eEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecc
Q 041143 697 ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFG 776 (973)
Q Consensus 697 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG 776 (973)
..++||||+++++|.+++. .+..++.+++++|.||| +.+|+||||||+||++ +++.++|+|||
T Consensus 410 ~~~lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFG 472 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFG 472 (535)
T ss_pred CCEEEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCc
Confidence 8899999999999998874 24578999999999999 8899999999999999 67899999999
Q ss_pred ccccC
Q 041143 777 LVKLA 781 (973)
Q Consensus 777 la~~~ 781 (973)
+++..
T Consensus 473 la~~~ 477 (535)
T PRK09605 473 LGKYS 477 (535)
T ss_pred ccccC
Confidence 98753
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.4e-17 Score=178.11 Aligned_cols=173 Identities=28% Similarity=0.377 Sum_probs=129.0
Q ss_pred eEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecc
Q 041143 697 ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFG 776 (973)
Q Consensus 697 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG 776 (973)
..|+.|+++...+|.+|+.+.+ .....+|.....++.|++.|++| ++.+|||+||.||+...+..+||.|||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~--~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRR--TGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCC--cccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhh
Confidence 4679999999999999997532 33567889999999999999999 589999999999999999999999999
Q ss_pred ccccCCCCC-----cceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHh
Q 041143 777 LVKLAPDGE-----KSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIK 851 (973)
Q Consensus 777 la~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 851 (973)
+........ ....+.-.||..||+||.+.+..|+.|+||||+|++|+|++. +|.... + ++.
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~---~f~T~~--e---------r~~ 467 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI---QFSTQF--E---------RIA 467 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH---HhccHH--H---------HHH
Confidence 987554443 233456689999999999999999999999999999999997 222111 1 111
Q ss_pred hchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHh
Q 041143 852 SSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMG 897 (973)
Q Consensus 852 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ 897 (973)
...+.-...++|....+ ++ .-..++.+++...|.+||++.
T Consensus 468 t~~d~r~g~ip~~~~~d-~p-----~e~~ll~~lls~~p~~RP~~~ 507 (516)
T KOG1033|consen 468 TLTDIRDGIIPPEFLQD-YP-----EEYTLLQQLLSPSPEERPSAI 507 (516)
T ss_pred hhhhhhcCCCChHHhhc-Cc-----HHHHHHHHhcCCCcccCchHH
Confidence 11111112233333211 11 124788899999999999433
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.66 E-value=5.7e-18 Score=188.06 Aligned_cols=190 Identities=21% Similarity=0.185 Sum_probs=143.0
Q ss_pred CeEEEEEecccCCccc----CCcCcccccccceeeccCcccCCCC-------CCCCCCCccceeeccCCCCCCCCccccC
Q 041143 67 NRVTQIQVQNLGLKGP----LPQNFNQLTKLYNLGLQRNKFNGKL-------PTFSGLSELEFAYLDFNEFDTIPSDFFD 135 (973)
Q Consensus 67 ~~v~~L~L~~~~l~g~----~~~~~~~l~~L~~L~L~~N~l~~~~-------~~~~~l~~L~~L~L~~N~l~~i~~~~f~ 135 (973)
..++.|+|.++.+++. ++..+...+.|++|+++++.+.+.. ..+..+++|+.|+|++|.+....+..|.
T Consensus 23 ~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~ 102 (319)
T cd00116 23 LCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLE 102 (319)
T ss_pred hhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHH
Confidence 3499999999998643 5666778889999999999987411 1467789999999999999876666665
Q ss_pred CCCC---ccEEEcccCCCCCccCCCCCcccccc-cccCeeecccccccC----CcchhccCCCCCCeEEccCCcCcccCC
Q 041143 136 GLSS---VRVLALDYNPFNKTFGWSIPDSLANS-VQLTNLSLINCNLVG----PLPDFLGTLPSLAALKLSYNRLSGVIP 207 (973)
Q Consensus 136 ~l~~---L~~L~Ls~N~l~~~~~~~ip~~~~~l-~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~~p 207 (973)
.+.+ |++|++++|++++.....+...+..+ ++|+.|+|++|.+++ .++..+..+++|++|+|++|.+++...
T Consensus 103 ~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~ 182 (319)
T cd00116 103 SLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGI 182 (319)
T ss_pred HHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHH
Confidence 5555 99999999999853222244566677 899999999999984 344567778899999999999985322
Q ss_pred hhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCccccC----CCccccCCCCCCEEeCcCCcccc
Q 041143 208 ASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGS----IPEDIGALSSLKDLNLNRNQLVG 277 (973)
Q Consensus 208 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~~ 277 (973)
..+. ..+..+++|++|+|++|.+++. ++..+..+++|++|++++|.+++
T Consensus 183 ~~l~---------------------~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~ 235 (319)
T cd00116 183 RALA---------------------EGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTD 235 (319)
T ss_pred HHHH---------------------HHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCch
Confidence 2221 1233467999999999998743 34456677888899998888875
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.4e-15 Score=181.39 Aligned_cols=153 Identities=31% Similarity=0.544 Sum_probs=112.9
Q ss_pred CCCCChhHHHHHHHHHhhCCCCccCCCCCCCCCCCCC--CCcCeEEeeC------CeEEEEEecccCCcccCCcCccccc
Q 041143 20 NSATDPNDLKILNDFKNGLENPELLKWPANGDDPCGP--PPWPHVFCSG------NRVTQIQVQNLGLKGPLPQNFNQLT 91 (973)
Q Consensus 20 ~~~~~~~~~~~l~~~k~~~~~~~l~~w~~~~~d~C~~--~~w~gv~C~~------~~v~~L~L~~~~l~g~~~~~~~~l~ 91 (973)
..++.+.|..||++||.++.++...+|. .|||.+ ++|.||.|+. ..|+.|+|++++++|.+|..|++|+
T Consensus 366 ~~~t~~~~~~aL~~~k~~~~~~~~~~W~---g~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~ 442 (623)
T PLN03150 366 ESKTLLEEVSALQTLKSSLGLPLRFGWN---GDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLR 442 (623)
T ss_pred ccccCchHHHHHHHHHHhcCCcccCCCC---CCCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCC
Confidence 4567889999999999999776545773 367753 3699999953 1488899999999999998888888
Q ss_pred ccceeeccCcccCCCCC-CCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCe
Q 041143 92 KLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTN 170 (973)
Q Consensus 92 ~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~ 170 (973)
+|+.|+|++|.|+|.+| .+.. +++|+.|+|++|++++. +|..++++++|+.
T Consensus 443 ~L~~L~Ls~N~l~g~iP~~~~~------------------------l~~L~~LdLs~N~lsg~----iP~~l~~L~~L~~ 494 (623)
T PLN03150 443 HLQSINLSGNSIRGNIPPSLGS------------------------ITSLEVLDLSYNSFNGS----IPESLGQLTSLRI 494 (623)
T ss_pred CCCEEECCCCcccCcCChHHhC------------------------CCCCCEEECCCCCCCCC----CchHHhcCCCCCE
Confidence 88888888888887666 3444 44455555555555543 6677777777777
Q ss_pred eecccccccCCcchhccCC-CCCCeEEccCCcCc
Q 041143 171 LSLINCNLVGPLPDFLGTL-PSLAALKLSYNRLS 203 (973)
Q Consensus 171 L~L~~N~l~~~~p~~l~~l-~~L~~L~Ls~N~l~ 203 (973)
|+|++|+++|.+|..++.+ .++..+++.+|...
T Consensus 495 L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~l 528 (623)
T PLN03150 495 LNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGL 528 (623)
T ss_pred EECcCCcccccCChHHhhccccCceEEecCCccc
Confidence 7777777777777776653 46677888888654
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.8e-15 Score=152.31 Aligned_cols=138 Identities=23% Similarity=0.276 Sum_probs=99.8
Q ss_pred cCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHH----------------------HHHHHHHHhcCCCc--e
Q 041143 630 ENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEF----------------------QSEIAVLSKVRHRH--L 685 (973)
Q Consensus 630 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~----------------------~~E~~~l~~l~h~n--i 685 (973)
.+.||+|+||.||+|...+|+.||||+++...........+ ..|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998889999999987543222221111 35666676665433 4
Q ss_pred eeeeeEEEeCCeEEEEEEecCCCCHHHH-HHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhcc-CCeeeccCCCCcEE
Q 041143 686 VSLLGYSIEGNERLLVYEYMPHGALSRH-LFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLAR-QTFIHRDLKSSNIL 763 (973)
Q Consensus 686 v~l~~~~~~~~~~~lV~e~~~~g~L~~~-l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~-~~ivH~Dikp~Nil 763 (973)
.+.+++ ...++||||++++.+... +.... .. .+...++.+++.++.++| . ++|+||||||+||+
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~------~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nil 147 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR------LL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNIL 147 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh------hc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEE
Confidence 444433 245899999999654321 11100 01 556789999999999999 6 89999999999999
Q ss_pred ECCCCCEEEeeccccccCC
Q 041143 764 LDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 764 l~~~~~~kl~DfGla~~~~ 782 (973)
++ ++.++++|||.+....
T Consensus 148 i~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 148 VD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred EE-CCcEEEEECccccccc
Confidence 99 8999999999987443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.61 E-value=3e-15 Score=146.32 Aligned_cols=135 Identities=21% Similarity=0.200 Sum_probs=113.7
Q ss_pred ccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC--CceeeeeeEEEeCCeEEEEEEecC
Q 041143 629 QENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRH--RHLVSLLGYSIEGNERLLVYEYMP 706 (973)
Q Consensus 629 ~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV~e~~~ 706 (973)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+.+++.++| .+++++++++...+..+++|||++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~ 76 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE 76 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence 35679999999999999864 7899998865422 4578899999999976 589999998888888999999998
Q ss_pred CCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecccccc
Q 041143 707 HGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKL 780 (973)
Q Consensus 707 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~ 780 (973)
++.+..+ ++.....++.+++++++++|.....+++|+|++|+||++++.+.+++.|||.++.
T Consensus 77 g~~~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 77 GETLDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CeecccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 8777432 4556678899999999999955446899999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.8e-14 Score=149.51 Aligned_cols=138 Identities=21% Similarity=0.220 Sum_probs=106.3
Q ss_pred cCccc-ccCccEEEEEEECCCCEEEEEEeecCCC-----------ChHHHHHHHHHHHHHHhcCCCce--eeeeeEEEeC
Q 041143 630 ENELG-RGGFGTVYKGELEDGTKIAVKRMEAGVT-----------TTKALDEFQSEIAVLSKVRHRHL--VSLLGYSIEG 695 (973)
Q Consensus 630 ~~~lG-~G~fg~Vy~~~~~~g~~vavK~~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~ 695 (973)
...|| .||.|+||++... +..++||++..... .......+.+|++++.+++|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 45688 8999999999886 77899998753210 11233568889999999998875 6777765443
Q ss_pred C----eEEEEEEecCC-CCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCE
Q 041143 696 N----ERLLVYEYMPH-GALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRA 770 (973)
Q Consensus 696 ~----~~~lV~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~ 770 (973)
. ..++||||+++ .+|.+++.. ..++. ..+.+|+.++.+|| ..||+||||||.|||++.++.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~------~~l~~----~~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v 181 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE------APLSE----EQWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKF 181 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc------CCCCH----HHHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCE
Confidence 2 23599999997 689888753 22333 24678999999999 8999999999999999999999
Q ss_pred EEeeccccccC
Q 041143 771 KVSDFGLVKLA 781 (973)
Q Consensus 771 kl~DfGla~~~ 781 (973)
+|+|||.++..
T Consensus 182 ~LIDfg~~~~~ 192 (239)
T PRK01723 182 WLIDFDRGELR 192 (239)
T ss_pred EEEECCCcccC
Confidence 99999988753
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.50 E-value=1e-12 Score=149.72 Aligned_cols=146 Identities=28% Similarity=0.345 Sum_probs=103.4
Q ss_pred CccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHH--------------------------------------H
Q 041143 626 NFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKA--------------------------------------L 667 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~--------------------------------------~ 667 (973)
.|+ .+.||.|++|.||+|++++|+.||||+.+......-. .
T Consensus 119 ~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E 197 (437)
T TIGR01982 119 EFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE 197 (437)
T ss_pred hCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence 344 3689999999999999999999999998654211100 0
Q ss_pred HHHHHHHHHHHhcC----CCceeeeeeEEE-eCCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHH-H
Q 041143 668 DEFQSEIAVLSKVR----HRHLVSLLGYSI-EGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARG-M 741 (973)
Q Consensus 668 ~~~~~E~~~l~~l~----h~niv~l~~~~~-~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~g-l 741 (973)
-+|.+|.+.+.+++ |.+-+.+-.++. ..+..+|||||++|++|.++..... ... .+.+++..+++. +
T Consensus 198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~----~~~---~~~~ia~~~~~~~l 270 (437)
T TIGR01982 198 LDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE----AGL---DRKALAENLARSFL 270 (437)
T ss_pred HCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh----cCC---CHHHHHHHHHHHHH
Confidence 13556666666652 333333333333 2456799999999999988764311 111 244577777663 6
Q ss_pred HHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 742 EYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 742 ~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
..+| ..|++|+|+||.||+++.+++++++|||++....
T Consensus 271 ~ql~---~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 271 NQVL---RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHH---hCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 7777 7899999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.48 E-value=2e-15 Score=176.93 Aligned_cols=256 Identities=22% Similarity=0.298 Sum_probs=189.6
Q ss_pred CccccCcccccCccEEEEEEEC--CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeeEEEeCCeEEEEE
Q 041143 626 NFAQENELGRGGFGTVYKGELE--DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR-HRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~ 702 (973)
.|...+.||+|.|+.|-..... ....+|+|.+..........+....|..+-..+. |+|++.+++.....+..+++.
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 4556677999999999888653 3455677766544333444556667888888886 999999999999999999999
Q ss_pred EecCCCCHHHHH-HhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCC-CEEEeecccccc
Q 041143 703 EYMPHGALSRHL-FRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDY-RAKVSDFGLVKL 780 (973)
Q Consensus 703 e~~~~g~L~~~l-~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~-~~kl~DfGla~~ 780 (973)
||..+|++.+-+ +. .....+-...-.+..|+..++.|+|. ..++.||||||+|.+++..+ ..+++|||+|..
T Consensus 101 ~~s~g~~~f~~i~~~----~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHP----DSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred CcccccccccccccC----CccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 999999998776 32 11134555667789999999999994 67899999999999999999 999999999985
Q ss_pred CCC--CCcceeccccc-ccCcccccccccCc-CCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhH
Q 041143 781 APD--GEKSVVTRLAG-TFGYLAPEYAVMGK-ITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEK 856 (973)
Q Consensus 781 ~~~--~~~~~~~~~~g-t~~y~aPE~~~~~~-~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (973)
+.. +........+| ++.|+|||...+.. .....|+||.|+++.-+++|..|++.....+. ....|... ...
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~~~~~~----~~~ 249 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYSSWKSN----KGR 249 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-cceeeccc----ccc
Confidence 544 44444556678 99999999988854 46778999999999999999999986654332 11122111 000
Q ss_pred HHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 857 FKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 857 ~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
.....-. .......++..+++..+|..|.+.+++..
T Consensus 250 ~~~~~~~---------~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 250 FTQLPWN---------SISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cccCccc---------cCChhhhhcccccccCCchhccccccccc
Confidence 0000001 11123567888888899999999998776
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.46 E-value=2.1e-13 Score=162.71 Aligned_cols=89 Identities=26% Similarity=0.480 Sum_probs=81.5
Q ss_pred ccCCCCcccEEecCCCcCCCccchhhhCccccceEEccCCccccccCccccCcCCCCeeeCCCCcCCCCCCCC-----Cc
Q 041143 364 SCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLPEF-----HD 438 (973)
Q Consensus 364 ~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~-----~~ 438 (973)
.+..+++|+.|+|++|++.|.+|..++.+++|+.|+|++|+|+|.+|..+++|++|+.|+|++|+|+|.+|.. .+
T Consensus 437 ~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~ 516 (623)
T PLN03150 437 DISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLH 516 (623)
T ss_pred HHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhcccc
Confidence 4567789999999999999999999999999999999999999999999999999999999999999999962 23
Q ss_pred ccceeecCCccccC
Q 041143 439 TVKLVIDGNPLLVG 452 (973)
Q Consensus 439 ~~~~~~~~N~~~c~ 452 (973)
+..+.+.+|+.+|+
T Consensus 517 ~~~l~~~~N~~lc~ 530 (623)
T PLN03150 517 RASFNFTDNAGLCG 530 (623)
T ss_pred CceEEecCCccccC
Confidence 45688999999997
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.42 E-value=8.5e-15 Score=159.13 Aligned_cols=151 Identities=34% Similarity=0.506 Sum_probs=92.5
Q ss_pred CCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCC
Q 041143 113 LSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSL 192 (973)
Q Consensus 113 l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L 192 (973)
|.--...||+.|++..+|.+ +..+..|+.|.|+.|.+.. ||..+.++..|++|||+.|+++ .+|..++.|+ |
T Consensus 74 ltdt~~aDlsrNR~~elp~~-~~~f~~Le~liLy~n~~r~-----ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-L 145 (722)
T KOG0532|consen 74 LTDTVFADLSRNRFSELPEE-ACAFVSLESLILYHNCIRT-----IPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-L 145 (722)
T ss_pred ccchhhhhccccccccCchH-HHHHHHHHHHHHHhcccee-----cchhhhhhhHHHHhhhccchhh-cCChhhhcCc-c
Confidence 44455566666666666654 3445566666666666663 6666666666666666666666 5566666655 6
Q ss_pred CeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcC
Q 041143 193 AALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNR 272 (973)
Q Consensus 193 ~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~ 272 (973)
+.|-+++|+++ .+|..++ .+..|..||.+.|.+. .+|..++.+.+|+.|++..
T Consensus 146 kvli~sNNkl~-~lp~~ig-------------------------~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrR 198 (722)
T KOG0532|consen 146 KVLIVSNNKLT-SLPEEIG-------------------------LLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRR 198 (722)
T ss_pred eeEEEecCccc-cCCcccc-------------------------cchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhh
Confidence 66666666665 5555443 2556666666666666 5666666666666666666
Q ss_pred CcccccCcccccccccCeEEccCCcCc
Q 041143 273 NQLVGLIPKSLANMELDNLVLNNNLLM 299 (973)
Q Consensus 273 N~l~~~~p~~~~~l~L~~L~l~~N~l~ 299 (973)
|++. .+|..+..+.|..||++.|++.
T Consensus 199 n~l~-~lp~El~~LpLi~lDfScNkis 224 (722)
T KOG0532|consen 199 NHLE-DLPEELCSLPLIRLDFSCNKIS 224 (722)
T ss_pred hhhh-hCCHHHhCCceeeeecccCcee
Confidence 6666 3444444555555555555554
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.40 E-value=7.9e-13 Score=151.90 Aligned_cols=152 Identities=20% Similarity=0.228 Sum_probs=99.2
Q ss_pred HHhcCccccCcccccCccEEEEEEECC-CCEEEEEEeecCCCCh--------------------------------HHHH
Q 041143 622 KVTQNFAQENELGRGGFGTVYKGELED-GTKIAVKRMEAGVTTT--------------------------------KALD 668 (973)
Q Consensus 622 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~--------------------------------~~~~ 668 (973)
.....|+. +.||.|++|.||+|++++ |+.||||+++...... +..+
T Consensus 117 ~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~ 195 (537)
T PRK04750 117 EWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEK 195 (537)
T ss_pred HHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHH
Confidence 34456776 789999999999999987 9999999997542110 0011
Q ss_pred ------HHHHHHHHHHhcC----CCceeeeeeEEEe-CCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHH
Q 041143 669 ------EFQSEIAVLSKVR----HRHLVSLLGYSIE-GNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDV 737 (973)
Q Consensus 669 ------~~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i 737 (973)
+|.+|+..+.+++ +...+.+-.++.+ ....+|||||++|+.+.++-.- .. ...+ +..++...
T Consensus 196 ~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l-~~---~g~d---~~~la~~~ 268 (537)
T PRK04750 196 TLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAAL-RA---AGTD---MKLLAERG 268 (537)
T ss_pred HHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHH-Hh---cCCC---HHHHHHHH
Confidence 2455555555552 4444444444443 5567899999999999774321 11 1111 11233222
Q ss_pred HHHHHHHHhhccCCeeeccCCCCcEEECCCC----CEEEeeccccccCCC
Q 041143 738 ARGMEYLHCLARQTFIHRDLKSSNILLDDDY----RAKVSDFGLVKLAPD 783 (973)
Q Consensus 738 a~gl~~LH~~~~~~ivH~Dikp~Nill~~~~----~~kl~DfGla~~~~~ 783 (973)
++. |+++....|++|+|+||.||+++.++ ++++.|||++.....
T Consensus 269 v~~--~~~Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 269 VEV--FFTQVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHH--HHHHHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 221 22222367999999999999999888 999999999876543
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.39 E-value=3.4e-14 Score=154.50 Aligned_cols=146 Identities=27% Similarity=0.443 Sum_probs=120.3
Q ss_pred eeccCCCCCCCCccccC-CCCCccEEEcccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEc
Q 041143 119 AYLDFNEFDTIPSDFFD-GLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKL 197 (973)
Q Consensus 119 L~L~~N~l~~i~~~~f~-~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 197 (973)
|.|++-+++..|-.++. .+.--...||+.|++.. +|..+..+..|+.|.|++|.|. .+|..++++..|.+|||
T Consensus 55 l~Ls~rrlk~fpr~a~~~~ltdt~~aDlsrNR~~e-----lp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~l 128 (722)
T KOG0532|consen 55 LLLSGRRLKEFPRGAASYDLTDTVFADLSRNRFSE-----LPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDL 128 (722)
T ss_pred cccccchhhcCCCccccccccchhhhhcccccccc-----CchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhh
Confidence 45566666666655544 45566788999999995 8999999999999999999998 88999999999999999
Q ss_pred cCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcccc
Q 041143 198 SYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVG 277 (973)
Q Consensus 198 s~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~ 277 (973)
+.|+++ .+|..++ .--|+.|-+++|+++ .+|+.++.+..|..||.+.|.+.
T Consensus 129 s~NqlS-~lp~~lC--------------------------~lpLkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~- 179 (722)
T KOG0532|consen 129 SSNQLS-HLPDGLC--------------------------DLPLKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ- 179 (722)
T ss_pred ccchhh-cCChhhh--------------------------cCcceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-
Confidence 999998 7777664 346889999999999 89999998899999999999998
Q ss_pred cCccccccc-ccCeEEccCCcCc
Q 041143 278 LIPKSLANM-ELDNLVLNNNLLM 299 (973)
Q Consensus 278 ~~p~~~~~l-~L~~L~l~~N~l~ 299 (973)
.+|..++.+ +|+.|.+..|++.
T Consensus 180 slpsql~~l~slr~l~vrRn~l~ 202 (722)
T KOG0532|consen 180 SLPSQLGYLTSLRDLNVRRNHLE 202 (722)
T ss_pred hchHHhhhHHHHHHHHHhhhhhh
Confidence 456666666 7888888888775
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.2e-12 Score=146.19 Aligned_cols=250 Identities=23% Similarity=0.234 Sum_probs=180.6
Q ss_pred cCccccCcccc--cCccEEEEEEE---CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeeEEEeCCeE
Q 041143 625 QNFAQENELGR--GGFGTVYKGEL---EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR-HRHLVSLLGYSIEGNER 698 (973)
Q Consensus 625 ~~~~~~~~lG~--G~fg~Vy~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 698 (973)
..|.....+|. |.+|.||.+.. .++..+|+|+-+...........=.+|+...+.++ |+|.|+.+..+.+++..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34566678999 99999999976 46889999986554443344344456777777775 99999988889999999
Q ss_pred EEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHH----HHHHHHhhccCCeeeccCCCCcEEECCC-CCEEEe
Q 041143 699 LLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVAR----GMEYLHCLARQTFIHRDLKSSNILLDDD-YRAKVS 773 (973)
Q Consensus 699 ~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~----gl~~LH~~~~~~ivH~Dikp~Nill~~~-~~~kl~ 773 (973)
++-.|++ +.+|.++.+.... .+.....+.+..+..+ |+.++| ..+++|-|+||.||+...+ ...+++
T Consensus 194 fiqtE~~-~~sl~~~~~~~~~----~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~ 265 (524)
T KOG0601|consen 194 FIQTELC-GESLQSYCHTPCN----FLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLT 265 (524)
T ss_pred eeeeccc-cchhHHhhhcccc----cCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecC
Confidence 9999988 5788887765332 2444555566666677 999999 8999999999999999999 889999
Q ss_pred eccccccCCCCCcc----eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHH
Q 041143 774 DFGLVKLAPDGEKS----VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWR 849 (973)
Q Consensus 774 DfGla~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 849 (973)
|||+.....++... ...+..|...|++||.. .+-++.++|+|++|.++.|..++.+....... ..|..
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~------~~W~~- 337 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKN------SSWSQ- 337 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCC------CCccc-
Confidence 99998866655421 12333678889999965 56778899999999999999999776643310 11211
Q ss_pred HhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 850 IKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 850 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
+++.+...++....-..+...+..+++.+|..|++.+.+.+
T Consensus 338 -----------~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 338 -----------LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -----------cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 01111111122122233445888899999999998887665
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.29 E-value=4.6e-12 Score=144.90 Aligned_cols=198 Identities=32% Similarity=0.484 Sum_probs=113.3
Q ss_pred eeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCccccccc-ccCeeecccccccCCcchhccCCCCCCeEE
Q 041143 118 FAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSV-QLTNLSLINCNLVGPLPDFLGTLPSLAALK 196 (973)
Q Consensus 118 ~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~-~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 196 (973)
.|++..|.+..-... ...++.++.|++.+|+++. ++.....+. +|+.|++++|++. .+|..+.++++|+.|+
T Consensus 97 ~l~~~~~~~~~~~~~-~~~~~~l~~L~l~~n~i~~-----i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~ 169 (394)
T COG4886 97 SLDLNLNRLRSNISE-LLELTNLTSLDLDNNNITD-----IPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLD 169 (394)
T ss_pred eeeccccccccCchh-hhcccceeEEecCCccccc-----Cccccccchhhcccccccccchh-hhhhhhhccccccccc
Confidence 455555555222111 2334556666666666664 555555553 6666666666666 4445566666666666
Q ss_pred ccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCccc
Q 041143 197 LSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLV 276 (973)
Q Consensus 197 Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~ 276 (973)
+++|+++ .+|.... .+++|+.|++++|+++ .+|..+..+..|++|.+++|.+.
T Consensus 170 l~~N~l~-~l~~~~~-------------------------~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~ 222 (394)
T COG4886 170 LSFNDLS-DLPKLLS-------------------------NLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII 222 (394)
T ss_pred cCCchhh-hhhhhhh-------------------------hhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce
Confidence 6666666 3333221 2556666666666666 55555544445666666666422
Q ss_pred ccCcccccccccCeEEccCCcCcCCCCCCCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCC
Q 041143 277 GLIPKSLANMELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPC 356 (973)
Q Consensus 277 ~~~p~~~~~l~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~ 356 (973)
.++..+.+
T Consensus 223 -~~~~~~~~----------------------------------------------------------------------- 230 (394)
T COG4886 223 -ELLSSLSN----------------------------------------------------------------------- 230 (394)
T ss_pred -ecchhhhh-----------------------------------------------------------------------
Confidence 12222222
Q ss_pred CCCccccccCCCCcccEEecCCCcCCCccchhhhCccccceEEccCCccccccCccccCcCCCCeeeCCCCcCCCCCCC
Q 041143 357 QGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLPE 435 (973)
Q Consensus 357 ~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~ 435 (973)
+.++..+.+.+|++... +..++.+..|+.|++++|+++ .++. ++.+.+|+.||+++|.+...+|.
T Consensus 231 -----------~~~l~~l~l~~n~~~~~-~~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 231 -----------LKNLSGLELSNNKLEDL-PESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred -----------cccccccccCCceeeec-cchhccccccceecccccccc-cccc-ccccCccCEEeccCccccccchh
Confidence 22333334444444322 445677777888888888887 4555 78888888888888888877664
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.28 E-value=3.1e-12 Score=146.33 Aligned_cols=209 Identities=26% Similarity=0.369 Sum_probs=144.0
Q ss_pred cCeEEeeCCeEE---EEEecccCCcccCCcCcccccccceeeccCcccCCCCCCCCCCC-ccceeeccCCCCCCCCcccc
Q 041143 59 WPHVFCSGNRVT---QIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLS-ELEFAYLDFNEFDTIPSDFF 134 (973)
Q Consensus 59 w~gv~C~~~~v~---~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~-~L~~L~L~~N~l~~i~~~~f 134 (973)
+.+..+....+. .+++..+.+.. ....+..++.++.|++.+|.++.+.+....+. +|+.|++++|++..++ ..+
T Consensus 82 ~l~~~~~~~~~~~~~~l~~~~~~~~~-~~~~~~~~~~l~~L~l~~n~i~~i~~~~~~~~~nL~~L~l~~N~i~~l~-~~~ 159 (394)
T COG4886 82 SLDGSENLLNLLPLPSLDLNLNRLRS-NISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIESLP-SPL 159 (394)
T ss_pred cccccccccCCCCCceeecccccccc-CchhhhcccceeEEecCCcccccCccccccchhhcccccccccchhhhh-hhh
Confidence 445555544444 35666665542 22334455667777777777777666555553 7777777777777765 235
Q ss_pred CCCCCccEEEcccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhH
Q 041143 135 DGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSL 214 (973)
Q Consensus 135 ~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~ 214 (973)
..+++|+.|++++|+++. +|...+.++.|+.|++++|+++ .+|.....+..|++|++++|++. .++.
T Consensus 160 ~~l~~L~~L~l~~N~l~~-----l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~------ 226 (394)
T COG4886 160 RNLPNLKNLDLSFNDLSD-----LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLS------ 226 (394)
T ss_pred hccccccccccCCchhhh-----hhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecch------
Confidence 667777777777777774 5655556677777777777777 55655555566777777777533 2222
Q ss_pred HHHHhhcccCCCCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcccccCccccccc-ccCeEEc
Q 041143 215 MQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVL 293 (973)
Q Consensus 215 ~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l 293 (973)
.+.++.++..|.+.+|++. .++..+..+++|++|++++|+++... . +..+ +++.|++
T Consensus 227 -------------------~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~~i~-~-~~~~~~l~~L~~ 284 (394)
T COG4886 227 -------------------SLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISSIS-S-LGSLTNLRELDL 284 (394)
T ss_pred -------------------hhhhcccccccccCCceee-eccchhccccccceeccccccccccc-c-ccccCccCEEec
Confidence 2456888888999999998 55788999999999999999999543 3 6665 8999999
Q ss_pred cCCcCcCCCCC
Q 041143 294 NNNLLMGPIPK 304 (973)
Q Consensus 294 ~~N~l~g~~p~ 304 (973)
++|.+....|.
T Consensus 285 s~n~~~~~~~~ 295 (394)
T COG4886 285 SGNSLSNALPL 295 (394)
T ss_pred cCccccccchh
Confidence 99999987776
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.26 E-value=8.7e-12 Score=127.38 Aligned_cols=205 Identities=21% Similarity=0.293 Sum_probs=140.3
Q ss_pred HHHHHhcCCCceeeeeeEEEeCC-----eEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhc
Q 041143 674 IAVLSKVRHRHLVSLLGYSIEGN-----ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLA 748 (973)
Q Consensus 674 ~~~l~~l~h~niv~l~~~~~~~~-----~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~ 748 (973)
+..+-++-|-|||+++.|+.+.. +..++.|||.-|++..+|++..+.+ ..+....-.+++.||..||.|||+.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~-~a~~~~~wkkw~tqIlsal~yLhs~- 195 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQ-KALFQKAWKKWCTQILSALSYLHSC- 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhh-hhhhHHHHHHHHHHHHhhhhhhhcc-
Confidence 44455667999999999887543 4678999999999999998855543 5566667778999999999999975
Q ss_pred cCCeeeccCCCCcEEECCCCCEEEeecccccc---CCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHH
Q 041143 749 RQTFIHRDLKSSNILLDDDYRAKVSDFGLVKL---APDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMEL 825 (973)
Q Consensus 749 ~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~---~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el 825 (973)
.++|+|+++.-+-|++..++-+|+.----... ...........-.|-++|.|||+-.....+.++|||+||.-.+||
T Consensus 196 ~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 196 DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 89999999999999999998888742111000 000011111223467899999988888888899999999999999
Q ss_pred HhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 826 LTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 826 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
..+..--.... ..... ++.....+- .+. ... =.+++.+|++..|..||+|.+++.
T Consensus 276 ailEiq~tnse---S~~~~---------ee~ia~~i~-~le-n~l-------qr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 276 AILEIQSTNSE---SKVEV---------EENIANVII-GLE-NGL-------QRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HHheeccCCCc---ceeeh---------hhhhhhhee-ecc-Ccc-------ccCcCcccccCCCCCCcchhhhhc
Confidence 88744311111 00000 111111110 000 000 126778899999999999998765
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.24 E-value=2.4e-11 Score=121.27 Aligned_cols=130 Identities=20% Similarity=0.175 Sum_probs=95.1
Q ss_pred cCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCcee-eeeeEEEeCCeEEEEEEecCCC
Q 041143 630 ENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLV-SLLGYSIEGNERLLVYEYMPHG 708 (973)
Q Consensus 630 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lV~e~~~~g 708 (973)
.+.|+.|.++.||+++.. +..|++|....... ....+..|+++++.+.+.+++ +++.+. ....++||||+++.
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~ 76 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGS 76 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCC
Confidence 356899999999999876 77899998754321 123467899999998765554 444433 33458999999998
Q ss_pred CHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhc--cCCeeeccCCCCcEEECCCCCEEEeeccccc
Q 041143 709 ALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLA--RQTFIHRDLKSSNILLDDDYRAKVSDFGLVK 779 (973)
Q Consensus 709 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~--~~~ivH~Dikp~Nill~~~~~~kl~DfGla~ 779 (973)
++.... .....++.+++++|+.||... ...++|+|++|.||+++ ++.++++|||.+.
T Consensus 77 ~l~~~~-------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 77 ELLTED-------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccccc-------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 875320 011245788999999999431 12369999999999999 6689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.3e-10 Score=114.17 Aligned_cols=137 Identities=15% Similarity=0.161 Sum_probs=97.5
Q ss_pred CcccccCccEEEEEEECC-------CCEEEEEEeecCCCC--------------------hHHHHHH----HHHHHHHHh
Q 041143 631 NELGRGGFGTVYKGELED-------GTKIAVKRMEAGVTT--------------------TKALDEF----QSEIAVLSK 679 (973)
Q Consensus 631 ~~lG~G~fg~Vy~~~~~~-------g~~vavK~~~~~~~~--------------------~~~~~~~----~~E~~~l~~ 679 (973)
..||.|--+.||.|...+ +..+|||+.+..... ....+.+ .+|++.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997653 479999987432110 0011223 389999999
Q ss_pred cCC--CceeeeeeEEEeCCeEEEEEEecCCCCHHH-HHHhhhhccCCCCCHHHHHHHHHHHHHHHHHH-HhhccCCeeec
Q 041143 680 VRH--RHLVSLLGYSIEGNERLLVYEYMPHGALSR-HLFRWEKLQLKPLSWTRRLSIALDVARGMEYL-HCLARQTFIHR 755 (973)
Q Consensus 680 l~h--~niv~l~~~~~~~~~~~lV~e~~~~g~L~~-~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~L-H~~~~~~ivH~ 755 (973)
+.. -++.+++++ ...++||||+.++.+.. .+.. ..++..+...+..+++.+|.+| | +.+|||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHG 149 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHA 149 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHHHHHHH---hCCeecC
Confidence 853 455566654 56789999997654422 1211 2234455667889999999999 7 7899999
Q ss_pred cCCCCcEEECCCCCEEEeeccccccC
Q 041143 756 DLKSSNILLDDDYRAKVSDFGLVKLA 781 (973)
Q Consensus 756 Dikp~Nill~~~~~~kl~DfGla~~~ 781 (973)
|+++.||+++ ++.+.|+|||.+...
T Consensus 150 DLs~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 150 DLSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred CCCHHHEEEE-CCcEEEEECCCceeC
Confidence 9999999997 467999999987644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.8e-09 Score=121.77 Aligned_cols=167 Identities=17% Similarity=0.206 Sum_probs=124.7
Q ss_pred EECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEecCCCCHHHHHHhhhhccCCC
Q 041143 645 ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKP 724 (973)
Q Consensus 645 ~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~ 724 (973)
+..++.+|.|++.+.. .........+-++.|+.++||||+++++....++..|+|.|-+.. |..++..
T Consensus 33 ~k~~~~~vsVF~~~~~--~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~-------- 100 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRS--NGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKE-------- 100 (690)
T ss_pred eeccCCceEEEEEeCC--CchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHHH--------
Confidence 4457889999888765 224445567788999999999999999999999999999998744 5556644
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCcceecccccccCccccccc
Q 041143 725 LSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYA 804 (973)
Q Consensus 725 l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~ 804 (973)
+......-.+.||++||.+||+ +.+++|++|....|++++.|+.||++|-++........ ......---.|..|+.+
T Consensus 101 l~~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~ 177 (690)
T KOG1243|consen 101 LGKEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEI 177 (690)
T ss_pred hHHHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhc
Confidence 2234455678999999999985 67999999999999999999999999998764433221 01111112245666654
Q ss_pred ccCcCCCchhHHhHHHHHHHHHhC
Q 041143 805 VMGKITTKADVFSYGVVLMELLTG 828 (973)
Q Consensus 805 ~~~~~~~~~Dv~S~Gvvl~elltg 828 (973)
.... -..|.|-||++++|++.|
T Consensus 178 ~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 178 DPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred Cccc--cchhhhhHHHHHHHHhCc
Confidence 3222 346999999999999999
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.11 E-value=5.9e-11 Score=132.68 Aligned_cols=252 Identities=19% Similarity=0.175 Sum_probs=179.3
Q ss_pred HHHHhcCccccCcccccCccEEEEEEE--CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCC
Q 041143 620 LRKVTQNFAQENELGRGGFGTVYKGEL--EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGN 696 (973)
Q Consensus 620 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 696 (973)
....+.+|..+..||.|.|+.||+... .++..|++|.+............-..|+.+...+ .|.++++.+..+..-+
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 445567899999999999999999854 4678899998876654444444445677776666 4899999888888888
Q ss_pred eEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCC-CCEEEeec
Q 041143 697 ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDD-YRAKVSDF 775 (973)
Q Consensus 697 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~-~~~kl~Df 775 (973)
..|+--||++++++.....- ...++...++++..|++.++.++| ++.++|+|+||+||++..+ +..++.||
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~-----~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~ 411 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVT-----SQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDF 411 (524)
T ss_pred cccCchhhhcCcchhhhhHH-----HHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhcccc
Confidence 88899999999998776622 234677788899999999999999 8899999999999999886 78899999
Q ss_pred cccccCCCCCcceecccccccCc-ccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhch
Q 041143 776 GLVKLAPDGEKSVVTRLAGTFGY-LAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSK 854 (973)
Q Consensus 776 Gla~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 854 (973)
|.+....-.. ....-++..| .+++......+-.+.|+||||..+.|.+++..--.... +|...
T Consensus 412 ~~~t~~~~~~---~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--------~~~~i----- 475 (524)
T KOG0601|consen 412 GCWTRLAFSS---GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--------QSLTI----- 475 (524)
T ss_pred ccccccceec---ccccccccccccchhhccccccccccccccccccccccccCcccCcccc--------cceee-----
Confidence 9986422110 1111223334 35555556778889999999999999999865332211 11110
Q ss_pred hHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHH
Q 041143 855 EKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLS 904 (973)
Q Consensus 855 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~ 904 (973)
..-.-+.+. .....+..+.+.+...++..||.+.+.....+
T Consensus 476 ---~~~~~p~~~------~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 476 ---RSGDTPNLP------GLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred ---ecccccCCC------chHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 001111111 11144567777889999999999888766443
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.09 E-value=7.3e-11 Score=115.41 Aligned_cols=58 Identities=26% Similarity=0.364 Sum_probs=8.3
Q ss_pred cccceeeccCcccCCCCCCCC-CCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCC
Q 041143 91 TKLYNLGLQRNKFNGKLPTFS-GLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFN 151 (973)
Q Consensus 91 ~~L~~L~L~~N~l~~~~~~~~-~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~ 151 (973)
.++++|+|++|.|+.+ ..+. .+.+|+.|+|++|+|+.+. .|..+++|++|+|++|+|+
T Consensus 19 ~~~~~L~L~~n~I~~I-e~L~~~l~~L~~L~Ls~N~I~~l~--~l~~L~~L~~L~L~~N~I~ 77 (175)
T PF14580_consen 19 VKLRELNLRGNQISTI-ENLGATLDKLEVLDLSNNQITKLE--GLPGLPRLKTLDLSNNRIS 77 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S--T--T----TT--EEE--SS---
T ss_pred cccccccccccccccc-cchhhhhcCCCEEECCCCCCcccc--CccChhhhhhcccCCCCCC
Confidence 3444555555554432 1222 2344444444444444433 1333444444444444444
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.09 E-value=5.7e-11 Score=116.12 Aligned_cols=125 Identities=22% Similarity=0.259 Sum_probs=57.2
Q ss_pred eEEEEEecccCCcccCCcCcc-cccccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcc
Q 041143 68 RVTQIQVQNLGLKGPLPQNFN-QLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALD 146 (973)
Q Consensus 68 ~v~~L~L~~~~l~g~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls 146 (973)
++++|+|.+|+|+. + +.++ .+++|+.|||++|.|+.+ ..+..+++|++|+|++|+|+.+.......+++|++|+|+
T Consensus 20 ~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~~l-~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~L~ 96 (175)
T PF14580_consen 20 KLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQITKL-EGLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELYLS 96 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S---TT----TT--EEE--SS---S-CHHHHHH-TT--EEE-T
T ss_pred cccccccccccccc-c-cchhhhhcCCCEEECCCCCCccc-cCccChhhhhhcccCCCCCCccccchHHhCCcCCEEECc
Confidence 57899999999984 3 3566 589999999999999975 468889999999999999999976545679999999999
Q ss_pred cCCCCCccCCCCCcccccccccCeeecccccccCCc---chhccCCCCCCeEEcc
Q 041143 147 YNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPL---PDFLGTLPSLAALKLS 198 (973)
Q Consensus 147 ~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~---p~~l~~l~~L~~L~Ls 198 (973)
+|+|... ..-..+..+++|+.|+|.+|.++... ...+..+|+|+.||-.
T Consensus 97 ~N~I~~l---~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~~ 148 (175)
T PF14580_consen 97 NNKISDL---NELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDGQ 148 (175)
T ss_dssp TS---SC---CCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETTE
T ss_pred CCcCCCh---HHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCCE
Confidence 9999874 22356788999999999999998432 1256779999999853
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.8e-09 Score=103.42 Aligned_cols=134 Identities=24% Similarity=0.352 Sum_probs=101.5
Q ss_pred CcccccCccEEEEEEECCCCEEEEEEeec-CCCChH-----HHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEe
Q 041143 631 NELGRGGFGTVYKGELEDGTKIAVKRMEA-GVTTTK-----ALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEY 704 (973)
Q Consensus 631 ~~lG~G~fg~Vy~~~~~~g~~vavK~~~~-~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 704 (973)
..+++|+-+.+|.+.+. |.++.+|.-.. ....+. ..++..+|++++.+++--.|...+=|..+.+...|||||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999776 55566665322 211111 234567899999998765555555566777888999999
Q ss_pred cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccC
Q 041143 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA 781 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~ 781 (973)
++|-.|.+.+... +..++..|-+-+.-|| ..+|+|+|+.++||++..+. +.++|||++...
T Consensus 81 I~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 81 IEGELLKDALEEA------------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred eCChhHHHHHHhc------------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 9999988888652 2456777778888999 89999999999999998775 999999998743
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.08 E-value=5.7e-10 Score=116.72 Aligned_cols=143 Identities=22% Similarity=0.304 Sum_probs=108.3
Q ss_pred CcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCC--ceeeeeeEEEeCC---eEEEEEEec
Q 041143 631 NELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHR--HLVSLLGYSIEGN---ERLLVYEYM 705 (973)
Q Consensus 631 ~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~---~~~lV~e~~ 705 (973)
+.|+.|.++.||+++..+|+.+++|........ .....+..|+++++.+++. .+.+++.+..... ..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 568999999999998877789999987543211 1345688999999999753 4566777766542 568999999
Q ss_pred CCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhc-------------------------------------
Q 041143 706 PHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLA------------------------------------- 748 (973)
Q Consensus 706 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~------------------------------------- 748 (973)
+|+++...+.. ..++..++..++.+++++|.+||+..
T Consensus 83 ~G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (223)
T cd05154 83 DGRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA 156 (223)
T ss_pred CCEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence 99888654321 24566777788888888888888420
Q ss_pred ----------------cCCeeeccCCCCcEEECC--CCCEEEeecccccc
Q 041143 749 ----------------RQTFIHRDLKSSNILLDD--DYRAKVSDFGLVKL 780 (973)
Q Consensus 749 ----------------~~~ivH~Dikp~Nill~~--~~~~kl~DfGla~~ 780 (973)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 66789999997763
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.1e-11 Score=128.19 Aligned_cols=61 Identities=20% Similarity=0.228 Sum_probs=33.5
Q ss_pred cccEEecCCCcCCCccchhhh-----CccccceEEccCCcccc----ccCccccCcCCCCeeeCCCCcCC
Q 041143 370 KVSIINLPRHNLTGTLSPSIA-----NLDSLIEIRLGKNSISG----TVPNNFTELKSLRLLDVSDNNIK 430 (973)
Q Consensus 370 ~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~L~~N~l~g----~~p~~~~~l~~L~~L~Ls~N~l~ 430 (973)
.|+.|+++.+.+.......|. ..++|+.|.|.+|.|+- .+-..+...+.|..|+|++|++.
T Consensus 242 ~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 242 HLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred hheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 444555555444443332221 24566666666766642 23334555677777777777773
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.04 E-value=5.9e-11 Score=138.84 Aligned_cols=250 Identities=24% Similarity=0.269 Sum_probs=168.8
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLV 701 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 701 (973)
.+.|.+.+.+-.|.|+.++.+.-. .|...+.|+...... .....+...++-.+.-..+||-+++....+......+||
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 356666778889999999887533 233334443322100 011122233333333344567777666555667788999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccC
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA 781 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~ 781 (973)
++|+.+++|...||... ..+..-.......+..+++||| ...+.|||++|.|++...++..+++|||.....
T Consensus 883 ~~~~~~~~~~Skl~~~~-----~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNSG-----CLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hHHhccCCchhhhhcCC-----CcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCcccccccc
Confidence 99999999999987632 3344444455667788999999 666999999999999999999999999843211
Q ss_pred CC------C------------------------CcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCC
Q 041143 782 PD------G------------------------EKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAA 831 (973)
Q Consensus 782 ~~------~------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p 831 (973)
.. . +........||+.|.|||...+......+|.|++|++++|.++|..|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 00 0 00012235789999999999999999999999999999999999999
Q ss_pred CCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHh
Q 041143 832 LDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMG 897 (973)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ 897 (973)
|....+... ++.++................+.+++...+..+|.+|-.|.
T Consensus 1035 ~na~tpq~~----------------f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETPQQI----------------FENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCcchhhh----------------hhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 988765322 22222222222222333344567888888999999998877
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.03 E-value=5.4e-11 Score=119.84 Aligned_cols=59 Identities=22% Similarity=0.297 Sum_probs=31.9
Q ss_pred CccccEEEccCCccccCCCccccCCCCCCEEeCcCCcccccCccccccc-ccCeEEccCCcCc
Q 041143 238 MVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLM 299 (973)
Q Consensus 238 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~ 299 (973)
+|.++.|++++|.|+ .+- .+..+++|+.||||+|.++.. -..-..+ +++.|.|++|.|.
T Consensus 306 ~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls~~-~Gwh~KLGNIKtL~La~N~iE 365 (490)
T KOG1259|consen 306 APKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLAEC-VGWHLKLGNIKTLKLAQNKIE 365 (490)
T ss_pred ccceeEEecccccee-eeh-hhhhcccceEeecccchhHhh-hhhHhhhcCEeeeehhhhhHh
Confidence 566666666666666 332 255666666666666666532 1121222 5566666666554
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.99 E-value=4.3e-09 Score=99.99 Aligned_cols=145 Identities=19% Similarity=0.210 Sum_probs=105.5
Q ss_pred ccCcccccCccEEEEEEECCCCEEEEEEeecCCC------ChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 629 QENELGRGGFGTVYKGELEDGTKIAVKRMEAGVT------TTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 629 ~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
....+-+|+-+.|+++.+. |+...||.--.... ..-...+..+|++.+.+++--.|.-..=++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4577889999999999887 77777775321111 1123456788999999987555544444566666678999
Q ss_pred EecCC-CCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCC---CEEEeecccc
Q 041143 703 EYMPH-GALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDY---RAKVSDFGLV 778 (973)
Q Consensus 703 e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~---~~kl~DfGla 778 (973)
||+++ -++.+++..... ...........+..|-+.+.-|| ..+|||+||..+||++..++ .+.++|||++
T Consensus 90 E~~~g~~~vk~~i~~~~~---~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTME---DESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred EeccchhHHHHHHHHHcc---CcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecch
Confidence 99966 488888866322 22222333678899999999999 89999999999999997654 4689999997
Q ss_pred cc
Q 041143 779 KL 780 (973)
Q Consensus 779 ~~ 780 (973)
..
T Consensus 164 ~~ 165 (229)
T KOG3087|consen 164 SV 165 (229)
T ss_pred hc
Confidence 63
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=9.3e-11 Score=134.22 Aligned_cols=176 Identities=30% Similarity=0.344 Sum_probs=109.3
Q ss_pred ccccccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccc
Q 041143 88 NQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQ 167 (973)
Q Consensus 88 ~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~ 167 (973)
..+..++.+++..|.|......+..+++|+.|+|.+|+|..+... +..+++|++|+|++|+|+.+ ..+..++.
T Consensus 69 ~~l~~l~~l~l~~n~i~~~~~~l~~~~~l~~l~l~~n~i~~i~~~-l~~~~~L~~L~ls~N~I~~i------~~l~~l~~ 141 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIAKILNHLSKLKSLEALDLYDNKIEKIENL-LSSLVNLQVLDLSFNKITKL------EGLSTLTL 141 (414)
T ss_pred HHhHhHHhhccchhhhhhhhcccccccceeeeeccccchhhcccc-hhhhhcchheeccccccccc------cchhhccc
Confidence 356667777777777776555577777788888888887776643 56677778888888877764 35666666
Q ss_pred cCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEcc
Q 041143 168 LTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLH 247 (973)
Q Consensus 168 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~ 247 (973)
|+.|++++|.|+. ...+..+++|+.+++++|++...-+.. ...+.+|+.+++.
T Consensus 142 L~~L~l~~N~i~~--~~~~~~l~~L~~l~l~~n~i~~ie~~~-------------------------~~~~~~l~~l~l~ 194 (414)
T KOG0531|consen 142 LKELNLSGNLISD--ISGLESLKSLKLLDLSYNRIVDIENDE-------------------------LSELISLEELDLG 194 (414)
T ss_pred hhhheeccCcchh--ccCCccchhhhcccCCcchhhhhhhhh-------------------------hhhccchHHHhcc
Confidence 7777777777773 224555777777777777777332210 1235667777777
Q ss_pred CCccccCCCccccCCCCCCEEeCcCCcccccCccccccc-ccCeEEccCCcCc
Q 041143 248 GNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLM 299 (973)
Q Consensus 248 ~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~ 299 (973)
+|.+. . ...+..+..+..+++..|.++..-+-..... .|+.+++++|++.
T Consensus 195 ~n~i~-~-i~~~~~~~~l~~~~l~~n~i~~~~~l~~~~~~~L~~l~l~~n~i~ 245 (414)
T KOG0531|consen 195 GNSIR-E-IEGLDLLKKLVLLSLLDNKISKLEGLNELVMLHLRELYLSGNRIS 245 (414)
T ss_pred CCchh-c-ccchHHHHHHHHhhcccccceeccCcccchhHHHHHHhcccCccc
Confidence 77766 2 2334444455555666666663321111100 2566666666654
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=8.4e-11 Score=134.60 Aligned_cols=192 Identities=23% Similarity=0.290 Sum_probs=137.0
Q ss_pred eEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEccc
Q 041143 68 RVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDY 147 (973)
Q Consensus 68 ~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~ 147 (973)
.+..+++..|.++. +-..+..+++|+.|+|.+|+|..+...+..+++|++|+|++|+|+.+.. +..+..|+.|++++
T Consensus 73 ~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i~~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L~l~~ 149 (414)
T KOG0531|consen 73 SLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKIENLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKELNLSG 149 (414)
T ss_pred hHHhhccchhhhhh-hhcccccccceeeeeccccchhhcccchhhhhcchheeccccccccccc--hhhccchhhheecc
Confidence 45555677777763 4455888999999999999999877768889999999999999998864 56788899999999
Q ss_pred CCCCCccCCCCCcccccccccCeeecccccccCCcc-hhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCC
Q 041143 148 NPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLP-DFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAG 226 (973)
Q Consensus 148 N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~ 226 (973)
|.|+.. ..+..+..|+.+++++|++...-+ . +..+.+|+.+++.+|.+........
T Consensus 150 N~i~~~------~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i~~~~~---------------- 206 (414)
T KOG0531|consen 150 NLISDI------SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREIEGLDL---------------- 206 (414)
T ss_pred Ccchhc------cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcccchHH----------------
Confidence 999963 467779999999999999995444 2 6889999999999999973322221
Q ss_pred CCCCcchhhcCCccccEEEccCCccccCCCccccCCCC--CCEEeCcCCcccccCccccccc-ccCeEEccCCcCc
Q 041143 227 GMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSS--LKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLM 299 (973)
Q Consensus 227 ~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~--L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~ 299 (973)
+..+..+++..|.++-.- .+..+.. |+.+++++|.+.. ++..+..+ .+..|++.+|++.
T Consensus 207 -----------~~~l~~~~l~~n~i~~~~--~l~~~~~~~L~~l~l~~n~i~~-~~~~~~~~~~l~~l~~~~n~~~ 268 (414)
T KOG0531|consen 207 -----------LKKLVLLSLLDNKISKLE--GLNELVMLHLRELYLSGNRISR-SPEGLENLKNLPVLDLSSNRIS 268 (414)
T ss_pred -----------HHHHHHhhcccccceecc--CcccchhHHHHHHhcccCcccc-ccccccccccccccchhhcccc
Confidence 333444466666665211 1222222 6667777776663 22333333 4556666666554
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.94 E-value=8.5e-11 Score=118.42 Aligned_cols=131 Identities=28% Similarity=0.269 Sum_probs=102.7
Q ss_pred CCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCC
Q 041143 113 LSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSL 192 (973)
Q Consensus 113 l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L 192 (973)
-+.|++|||++|.|+.|... ..-+++++.|++|+|.|..+ ..+..|.+|+.|||++|.++ .+..+-..|-++
T Consensus 283 Wq~LtelDLS~N~I~~iDES-vKL~Pkir~L~lS~N~i~~v------~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNI 354 (490)
T KOG1259|consen 283 WQELTELDLSGNLITQIDES-VKLAPKLRRLILSQNRIRTV------QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNI 354 (490)
T ss_pred Hhhhhhccccccchhhhhhh-hhhccceeEEeccccceeee------hhhhhcccceEeecccchhH-hhhhhHhhhcCE
Confidence 35688889999999888754 56678899999999988853 45888899999999999888 555566678889
Q ss_pred CeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCccccCC-CccccCCCCCCEEeCc
Q 041143 193 AALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSI-PEDIGALSSLKDLNLN 271 (973)
Q Consensus 193 ~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~-p~~~~~l~~L~~L~Ls 271 (973)
+.|.|++|.|.. +. -+.++-+|..||+++|+|...- -..++++|-|+.|.|.
T Consensus 355 KtL~La~N~iE~-LS--------------------------GL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~ 407 (490)
T KOG1259|consen 355 KTLKLAQNKIET-LS--------------------------GLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLT 407 (490)
T ss_pred eeeehhhhhHhh-hh--------------------------hhHhhhhheeccccccchhhHHHhcccccccHHHHHhhc
Confidence 999999998862 11 1345778899999999887321 3689999999999999
Q ss_pred CCccccc
Q 041143 272 RNQLVGL 278 (973)
Q Consensus 272 ~N~l~~~ 278 (973)
+|.+.+.
T Consensus 408 ~NPl~~~ 414 (490)
T KOG1259|consen 408 GNPLAGS 414 (490)
T ss_pred CCCcccc
Confidence 9999864
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.2e-10 Score=123.71 Aligned_cols=203 Identities=23% Similarity=0.224 Sum_probs=110.6
Q ss_pred eEEEEEecccCCcccCC--cCcccccccceeeccCcccCCCCC--C-CCCCCccceeeccCCCCCCCCc-cccCCCCCcc
Q 041143 68 RVTQIQVQNLGLKGPLP--QNFNQLTKLYNLGLQRNKFNGKLP--T-FSGLSELEFAYLDFNEFDTIPS-DFFDGLSSVR 141 (973)
Q Consensus 68 ~v~~L~L~~~~l~g~~~--~~~~~l~~L~~L~L~~N~l~~~~~--~-~~~l~~L~~L~L~~N~l~~i~~-~~f~~l~~L~ 141 (973)
.+..+.|.++.+. ..+ .....+++++.|||++|-|...-+ . ...|++|+.|+|+.|++..... ..-..+++|+
T Consensus 122 kL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK 200 (505)
T KOG3207|consen 122 KLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLK 200 (505)
T ss_pred hhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhh
Confidence 3445555555443 122 244556666666666666655433 2 3446666666666666553221 1112455566
Q ss_pred EEEcccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhc
Q 041143 142 VLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLN 221 (973)
Q Consensus 142 ~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~ 221 (973)
.|.|+.|.|+-. .+-..+..+++|+.|+|..|...+.-......+..|+.|||++|++- ..+.
T Consensus 201 ~L~l~~CGls~k---~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~------------- 263 (505)
T KOG3207|consen 201 QLVLNSCGLSWK---DVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQ------------- 263 (505)
T ss_pred eEEeccCCCCHH---HHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc-cccc-------------
Confidence 666666655532 22233344555666666666432233334444555666666666554 1111
Q ss_pred ccCCCCCCCcchhhcCCccccEEEccCCccccC-CCcc-----ccCCCCCCEEeCcCCcccccCccccccc----ccCeE
Q 041143 222 DQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGS-IPED-----IGALSSLKDLNLNRNQLVGLIPKSLANM----ELDNL 291 (973)
Q Consensus 222 ~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~-~p~~-----~~~l~~L~~L~Ls~N~l~~~~p~~~~~l----~L~~L 291 (973)
......++.|..|+++.+.+... +|+. ...+++|++|++..|++... .++.++ +|..|
T Consensus 264 ----------~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w--~sl~~l~~l~nlk~l 331 (505)
T KOG3207|consen 264 ----------GYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDW--RSLNHLRTLENLKHL 331 (505)
T ss_pred ----------ccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccc--cccchhhccchhhhh
Confidence 02234678888888888887632 2333 34567888888888888632 233332 57777
Q ss_pred EccCCcCcC
Q 041143 292 VLNNNLLMG 300 (973)
Q Consensus 292 ~l~~N~l~g 300 (973)
.+..|.|..
T Consensus 332 ~~~~n~ln~ 340 (505)
T KOG3207|consen 332 RITLNYLNK 340 (505)
T ss_pred hcccccccc
Confidence 777887764
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.85 E-value=4.4e-08 Score=103.79 Aligned_cols=142 Identities=14% Similarity=0.143 Sum_probs=100.6
Q ss_pred CcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHH----------HHHHHHHHHHhcCCCce--eeeeeEEEe----
Q 041143 631 NELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALD----------EFQSEIAVLSKVRHRHL--VSLLGYSIE---- 694 (973)
Q Consensus 631 ~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~----------~~~~E~~~l~~l~h~ni--v~l~~~~~~---- 694 (973)
+.+-+-....|+++... |+.|.||+....... +..+ .+.+|.+.+.++...+| .+++++...
T Consensus 28 e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~-~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 28 EVFRELEGRRTLRFELA-GKSYFLKWHRGTGWG-EIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred cEEecCCCceEEEEEEC-CEEEEEEEecCCcHH-HHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 33443444557777664 788999977433211 1111 47899999988853333 344556543
Q ss_pred -CCeEEEEEEecCCC-CHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECC------
Q 041143 695 -GNERLLVYEYMPHG-ALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDD------ 766 (973)
Q Consensus 695 -~~~~~lV~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~------ 766 (973)
....++|||++++. +|.+++..+.. .+.+...+..++.+++..+.-|| ..||+|+|++++|||++.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~~---~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~ 179 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWAT---NPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGRE 179 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCC
Confidence 23578999999886 89888854221 33455677789999999999999 899999999999999985
Q ss_pred -CCCEEEeecccccc
Q 041143 767 -DYRAKVSDFGLVKL 780 (973)
Q Consensus 767 -~~~~kl~DfGla~~ 780 (973)
++.+.++||+.++.
T Consensus 180 ~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 180 EDLKLSVIDLHRAQI 194 (268)
T ss_pred CCceEEEEECCcccc
Confidence 46899999998753
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.83 E-value=2.2e-09 Score=86.24 Aligned_cols=60 Identities=37% Similarity=0.532 Sum_probs=38.7
Q ss_pred cccceeeccCcccCCCCC-CCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCC
Q 041143 91 TKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPF 150 (973)
Q Consensus 91 ~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l 150 (973)
++|++|+|++|+|+.+++ .|.++++|++|++++|+|+.+++++|.++++|++|+|++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 356666666666666555 566666666666666666666666666666666666666653
|
... |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.81 E-value=4.6e-08 Score=97.51 Aligned_cols=127 Identities=25% Similarity=0.337 Sum_probs=83.1
Q ss_pred EEEEEEECCCCEEEEEEeecCCCC------------------------hHHHHHHHHHHHHHHhcCCC--ceeeeeeEEE
Q 041143 640 TVYKGELEDGTKIAVKRMEAGVTT------------------------TKALDEFQSEIAVLSKVRHR--HLVSLLGYSI 693 (973)
Q Consensus 640 ~Vy~~~~~~g~~vavK~~~~~~~~------------------------~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~ 693 (973)
.||.|...+|..+|||..+..... ........+|.+.|.++... ++.+++++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 489999999999999986432110 11233577899999999765 45556544
Q ss_pred eCCeEEEEEEecC--CCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHH-HhhccCCeeeccCCCCcEEECCCCCE
Q 041143 694 EGNERLLVYEYMP--HGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYL-HCLARQTFIHRDLKSSNILLDDDYRA 770 (973)
Q Consensus 694 ~~~~~~lV~e~~~--~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~L-H~~~~~~ivH~Dikp~Nill~~~~~~ 770 (973)
. ..++||||++ |..+.. +.. ..++......++.+++..+..+ | ..+|+|+|+.+.||+++++ .+
T Consensus 79 ~--~~~ivME~I~~~G~~~~~-l~~------~~~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 79 N--RNVIVMEYIGEDGVPLPR-LKD------VDLSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp E--TTEEEEE--EETTEEGGC-HHH------CGGGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CE
T ss_pred e--CCEEEEEecCCCccchhh-HHh------ccccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eE
Confidence 2 3479999998 544433 322 1111334566788888866664 6 8899999999999999988 99
Q ss_pred EEeeccccccC
Q 041143 771 KVSDFGLVKLA 781 (973)
Q Consensus 771 kl~DfGla~~~ 781 (973)
.|+|||.+...
T Consensus 146 ~iIDf~qav~~ 156 (188)
T PF01163_consen 146 YIIDFGQAVDS 156 (188)
T ss_dssp EE--GTTEEET
T ss_pred EEEecCcceec
Confidence 99999987644
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.5e-09 Score=115.60 Aligned_cols=164 Identities=23% Similarity=0.222 Sum_probs=99.6
Q ss_pred CCCCCccceeeccCCCCCCCCc-cccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeeecccccccCCcchh-cc
Q 041143 110 FSGLSELEFAYLDFNEFDTIPS-DFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDF-LG 187 (973)
Q Consensus 110 ~~~l~~L~~L~L~~N~l~~i~~-~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~-l~ 187 (973)
-+++.+|+.+.|++..+..++. +....+++++.|||++|-|.... .+-.-...|++|+.|+|+.|.+.-..... -.
T Consensus 117 Qsn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~--~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~ 194 (505)
T KOG3207|consen 117 QSNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWF--PVLKIAEQLPSLENLNLSSNRLSNFISSNTTL 194 (505)
T ss_pred hhhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHH--HHHHHHHhcccchhcccccccccCCccccchh
Confidence 4557778888888877776554 45667888888888888777531 12234456778888888888876332222 12
Q ss_pred CCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCE
Q 041143 188 TLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKD 267 (973)
Q Consensus 188 ~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~ 267 (973)
.+++|+.|.|+.|.|+-.--..+ ...+|+|+.|+|..|..-+.-.....-+..|+.
T Consensus 195 ~l~~lK~L~l~~CGls~k~V~~~------------------------~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~ 250 (505)
T KOG3207|consen 195 LLSHLKQLVLNSCGLSWKDVQWI------------------------LLTFPSLEVLYLEANEIILIKATSTKILQTLQE 250 (505)
T ss_pred hhhhhheEEeccCCCCHHHHHHH------------------------HHhCCcHHHhhhhcccccceecchhhhhhHHhh
Confidence 56778888888888872211111 224777777787777432233334445567777
Q ss_pred EeCcCCcccccCc-cccccc-ccCeEEccCCcCc
Q 041143 268 LNLNRNQLVGLIP-KSLANM-ELDNLVLNNNLLM 299 (973)
Q Consensus 268 L~Ls~N~l~~~~p-~~~~~l-~L~~L~l~~N~l~ 299 (973)
|||++|++-...- ...+.+ .|..|.++.+.+.
T Consensus 251 LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~ 284 (505)
T KOG3207|consen 251 LDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIA 284 (505)
T ss_pred ccccCCcccccccccccccccchhhhhccccCcc
Confidence 8888777764310 112222 4566666666554
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.75 E-value=7.7e-10 Score=114.78 Aligned_cols=191 Identities=20% Similarity=0.202 Sum_probs=130.7
Q ss_pred cccccccceeeccCcccCCCCC-C----CCCCCccceeeccCCCCCCCCccc-------------cCCCCCccEEEcccC
Q 041143 87 FNQLTKLYNLGLQRNKFNGKLP-T----FSGLSELEFAYLDFNEFDTIPSDF-------------FDGLSSVRVLALDYN 148 (973)
Q Consensus 87 ~~~l~~L~~L~L~~N~l~~~~~-~----~~~l~~L~~L~L~~N~l~~i~~~~-------------f~~l~~L~~L~Ls~N 148 (973)
+...++|++||||.|.|.-.-+ . +.++..|++|+|.+|.+...--.. ...-++|+++...+|
T Consensus 88 L~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rN 167 (382)
T KOG1909|consen 88 LLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRN 167 (382)
T ss_pred HhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeecc
Confidence 3445688888888888865322 2 566888888888888887433222 345578888888888
Q ss_pred CCCCccCCCCCcccccccccCeeecccccccC----CcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccC
Q 041143 149 PFNKTFGWSIPDSLANSVQLTNLSLINCNLVG----PLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQD 224 (973)
Q Consensus 149 ~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~ 224 (973)
++..-....+...|...+.|+.+.++.|.|.. .+...|..+++|+.|||.+|-|+-.-...++
T Consensus 168 rlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~La------------- 234 (382)
T KOG1909|consen 168 RLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALA------------- 234 (382)
T ss_pred ccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHH-------------
Confidence 88764333344566777888888888888762 2344677888999999999988744333333
Q ss_pred CCCCCCcchhhcCCccccEEEccCCccccCCCcccc-----CCCCCCEEeCcCCcccccCccc----cccc-ccCeEEcc
Q 041143 225 AGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIG-----ALSSLKDLNLNRNQLVGLIPKS----LANM-ELDNLVLN 294 (973)
Q Consensus 225 ~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~-----~l~~L~~L~Ls~N~l~~~~p~~----~~~l-~L~~L~l~ 294 (973)
.++..+++|+.|++++|.+...-..+|. ..++|+.|.|.+|.++..--.. +... .|..|+|+
T Consensus 235 --------kaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLn 306 (382)
T KOG1909|consen 235 --------KALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLN 306 (382)
T ss_pred --------HHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCC
Confidence 3445677888888888888744333332 2578888888888887432222 2222 58888888
Q ss_pred CCcC
Q 041143 295 NNLL 298 (973)
Q Consensus 295 ~N~l 298 (973)
+|.+
T Consensus 307 gN~l 310 (382)
T KOG1909|consen 307 GNRL 310 (382)
T ss_pred cccc
Confidence 8888
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.74 E-value=9.1e-09 Score=82.68 Aligned_cols=61 Identities=31% Similarity=0.553 Sum_probs=57.6
Q ss_pred CcccEEecCCCcCCCccchhhhCccccceEEccCCccccccCccccCcCCCCeeeCCCCcC
Q 041143 369 SKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNI 429 (973)
Q Consensus 369 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l 429 (973)
++|++|+|++|++....+..|.++++|++|+|++|+|+...|..|..+++|++|+|++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4789999999999988888999999999999999999988889999999999999999986
|
... |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.69 E-value=5.9e-07 Score=95.76 Aligned_cols=260 Identities=18% Similarity=0.185 Sum_probs=158.5
Q ss_pred ccCcccccCccEEEEE-EECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeE------EEeCCe-EE
Q 041143 629 QENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGY------SIEGNE-RL 699 (973)
Q Consensus 629 ~~~~lG~G~fg~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~------~~~~~~-~~ 699 (973)
..+.||+|+-+.+|-. ...+ .+-|+.... ..... ...++.|... .||-+-.-+.+ .-++.. .-
T Consensus 15 ~gr~LgqGgea~ly~l~e~~d---~VAKIYh~P--ppa~~---aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iG 86 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVRD---QVAKIYHAP--PPAAQ---AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIG 86 (637)
T ss_pred CCccccCCccceeeecchhhc---hhheeecCC--CchHH---HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeE
Confidence 4577999999999965 2221 234555433 11111 1233444444 46643331111 112222 56
Q ss_pred EEEEecCCCCH-HHHHH-hhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccc
Q 041143 700 LVYEYMPHGAL-SRHLF-RWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL 777 (973)
Q Consensus 700 lV~e~~~~g~L-~~~l~-~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGl 777 (973)
+.|..+++..= ..++. ..++......+|...++++..+|.+.+.|| ..|.+-+|+.++|+|+.+++.+.+.|-..
T Consensus 87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccc
Confidence 77887766422 11111 112334456899999999999999999999 88999999999999999999999988554
Q ss_pred cccCCCCCcceecccccccCcccccccc-----cCcCCCchhHHhHHHHHHHHHhC-CCCCCCCChh-----hHH-HHHH
Q 041143 778 VKLAPDGEKSVVTRLAGTFGYLAPEYAV-----MGKITTKADVFSYGVVLMELLTG-LAALDEERPE-----ESR-YLAE 845 (973)
Q Consensus 778 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~elltg-~~p~~~~~~~-----~~~-~~~~ 845 (973)
-..... .......+|...|.+||... +-.-+...|.|.+||++++++.| ++||.+..-. ..+ .+..
T Consensus 164 fqi~~n--g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~ 241 (637)
T COG4248 164 FQINAN--GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH 241 (637)
T ss_pred eeeccC--CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence 333322 22334457899999999765 33456678999999999999888 9999754311 011 1110
Q ss_pred HHHHHhhchhHHHhhcC--ccccC--CcccH-HHHHHHHHHHHHhhccC--CCCCCCHhHHHHHHHHhhhhc
Q 041143 846 WFWRIKSSKEKFKAAID--PALEV--NEETF-ESISIVAELAGHCTARE--PYHRPDMGHVVNVLSPLVEKW 910 (973)
Q Consensus 846 ~~~~~~~~~~~~~~~~~--~~l~~--~~~~~-~~~~~~~~l~~~cl~~d--P~~RPs~~~v~~~L~~~~~~~ 910 (973)
+.+...-+ +.+.. ..-+. -....+..+..+|+... +.-||+++..+..|..+.++.
T Consensus 242 ---------g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 242 ---------GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred ---------ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 00000000 00100 00111 12234667777888653 678999999999998877653
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.5e-07 Score=95.77 Aligned_cols=136 Identities=24% Similarity=0.239 Sum_probs=96.8
Q ss_pred ccccCcccccCccEEEEEEECCCCEEEEEEeecCCCC--------------------hHHHHHHHHHHHHHHhcCCC--c
Q 041143 627 FAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTT--------------------TKALDEFQSEIAVLSKVRHR--H 684 (973)
Q Consensus 627 ~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--------------------~~~~~~~~~E~~~l~~l~h~--n 684 (973)
..+.+.||.|--+.||.|....|.++|||.=+...++ .-.....++|.++|.++... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 4566899999999999999999999999954322110 11234577899999999644 5
Q ss_pred eeeeeeEEEeCCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEE
Q 041143 685 LVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILL 764 (973)
Q Consensus 685 iv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill 764 (973)
+.+.+++ +...+||||++|--|...- ++-...-.|+..|++-+..+- ..||||+|+.+-||++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV 235 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILV 235 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEE
Confidence 5555543 5678999999886553221 122233345555555555544 5789999999999999
Q ss_pred CCCCCEEEeeccccc
Q 041143 765 DDDYRAKVSDFGLVK 779 (973)
Q Consensus 765 ~~~~~~kl~DfGla~ 779 (973)
+++|.+.++||--+.
T Consensus 236 ~~dg~~~vIDwPQ~v 250 (304)
T COG0478 236 TEDGDIVVIDWPQAV 250 (304)
T ss_pred ecCCCEEEEeCcccc
Confidence 999999999996443
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.3e-07 Score=115.67 Aligned_cols=117 Identities=26% Similarity=0.331 Sum_probs=87.5
Q ss_pred ccccccceeeccCcccCCCCCCCCCCCccceeeccCCC--CCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccc
Q 041143 88 NQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNE--FDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANS 165 (973)
Q Consensus 88 ~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~--l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l 165 (973)
.+....+...+.+|.+....-.. ..++|++|-+..|. +..++.++|..++.|++|||++|.=-+ .+|..++.|
T Consensus 520 ~~~~~~rr~s~~~~~~~~~~~~~-~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~----~LP~~I~~L 594 (889)
T KOG4658|consen 520 KSWNSVRRMSLMNNKIEHIAGSS-ENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLS----KLPSSIGEL 594 (889)
T ss_pred cchhheeEEEEeccchhhccCCC-CCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccC----cCChHHhhh
Confidence 34466777777777776543322 23478888888886 788888888888888888888865444 488888888
Q ss_pred cccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhh
Q 041143 166 VQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASF 210 (973)
Q Consensus 166 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~ 210 (973)
-+|++|+|++..+. .+|..+++|+.|.+|++..+.-...+|...
T Consensus 595 i~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~ 638 (889)
T KOG4658|consen 595 VHLRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGIL 638 (889)
T ss_pred hhhhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchh
Confidence 88888888888888 788888888888888888877654554433
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.3e-06 Score=95.93 Aligned_cols=171 Identities=20% Similarity=0.260 Sum_probs=123.6
Q ss_pred ccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEe----CCeEEEEEEecCC-CCHH
Q 041143 638 FGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIE----GNERLLVYEYMPH-GALS 711 (973)
Q Consensus 638 fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~e~~~~-g~L~ 711 (973)
-.+.||+.. .||..|..|+++... ......-..-+++.+++.|+|+|++.+++.. +...++||+|.++ ++|.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r--~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDR--DQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred cceeEeeeeccCCceeeeeeecccc--ccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 357899954 589999999994321 1111112345788899999999999998873 3467899999986 5666
Q ss_pred HHHHhhhh----------ccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccC
Q 041143 712 RHLFRWEK----------LQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA 781 (973)
Q Consensus 712 ~~l~~~~~----------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~ 781 (973)
+.-..... ......++...+.++.|++.||.++| +.|..-+-+.+.+|+++.+.+++|+..|.....
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeee
Confidence 64432111 11234677889999999999999999 889999999999999999999999888776544
Q ss_pred CCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCC
Q 041143 782 PDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAA 831 (973)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p 831 (973)
..+.. |-+. --.+-|.-.||.+++.|.||..-
T Consensus 444 ~~d~~---------------~~le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 444 QEDPT---------------EPLE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred cCCCC---------------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 33220 1111 12356888999999999999554
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.53 E-value=5.9e-07 Score=103.05 Aligned_cols=143 Identities=23% Similarity=0.315 Sum_probs=95.5
Q ss_pred CcccccCccEEEEEEECCCCEEEEEEeecCCCChH----------------------------HHH----------HHHH
Q 041143 631 NELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTK----------------------------ALD----------EFQS 672 (973)
Q Consensus 631 ~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~----------------------------~~~----------~~~~ 672 (973)
+.|+.++-|.||+|++++|+.||||+.+.+....- ..+ ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 67999999999999999999999998755432110 011 2445
Q ss_pred HHHHHHhcC-----CCceeeeeeEEE-eCCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHh
Q 041143 673 EIAVLSKVR-----HRHLVSLLGYSI-EGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHC 746 (973)
Q Consensus 673 E~~~l~~l~-----h~niv~l~~~~~-~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~ 746 (973)
|...+.+++ .+++ ++=.+|. -.+...|+|||++|-.+.+...... ...+ +..++..++++. +-+
T Consensus 211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~----~g~d---~k~ia~~~~~~f--~~q 280 (517)
T COG0661 211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS----AGID---RKELAELLVRAF--LRQ 280 (517)
T ss_pred HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh----cCCC---HHHHHHHHHHHH--HHH
Confidence 555555542 2332 3333333 3567899999999988887743211 2233 334444444432 222
Q ss_pred hccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 747 LARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 747 ~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
.-..|++|.|.+|.||+++.++++.+.|||+......
T Consensus 281 ~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 281 LLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHhcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 2256999999999999999999999999999875543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.48 E-value=2.8e-06 Score=85.06 Aligned_cols=139 Identities=20% Similarity=0.198 Sum_probs=102.3
Q ss_pred ccccCccEEEEEEECCCCEEEEEEeecCCC-C---hHHHHHHHHHHHHHHhcCCC--ceeeeeeEEE-eC----CeEEEE
Q 041143 633 LGRGGFGTVYKGELEDGTKIAVKRMEAGVT-T---TKALDEFQSEIAVLSKVRHR--HLVSLLGYSI-EG----NERLLV 701 (973)
Q Consensus 633 lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~-~---~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~-~~----~~~~lV 701 (973)
-|+||.+.|++.... |..+-+|+-..... + +.....|.+|+..+.++... .+.++. ++. .. ...+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 367999999998776 45788998642211 1 22456799999999998532 244444 332 21 235899
Q ss_pred EEecCC-CCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCC--EEEeecccc
Q 041143 702 YEYMPH-GALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYR--AKVSDFGLV 778 (973)
Q Consensus 702 ~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~--~kl~DfGla 778 (973)
+|-+.+ -+|.+++... ...+.+...+..+..+|++.+.-|| ..++.|+|+.+.||+++.++. ++++||.-+
T Consensus 104 Te~L~g~~~L~~~l~~~---~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~ 177 (216)
T PRK09902 104 TEDMAGFISIADWYAQH---AVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKS 177 (216)
T ss_pred EEeCCCCccHHHHHhcC---CcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence 998754 5888887542 2234577778899999999999999 899999999999999986666 999999866
Q ss_pred c
Q 041143 779 K 779 (973)
Q Consensus 779 ~ 779 (973)
+
T Consensus 178 r 178 (216)
T PRK09902 178 R 178 (216)
T ss_pred c
Confidence 5
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.3e-06 Score=89.62 Aligned_cols=106 Identities=26% Similarity=0.375 Sum_probs=83.0
Q ss_pred HHHHHHHHHHHhcCCC--ceeeeeeEEEeCC----eEEEEEEecCCC-CHHHHHHhhhhccCCCCCHHHHHHHHHHHHHH
Q 041143 668 DEFQSEIAVLSKVRHR--HLVSLLGYSIEGN----ERLLVYEYMPHG-ALSRHLFRWEKLQLKPLSWTRRLSIALDVARG 740 (973)
Q Consensus 668 ~~~~~E~~~l~~l~h~--niv~l~~~~~~~~----~~~lV~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~g 740 (973)
..+.+|...+.++... ...+.+++..... ..++|+|++++. +|.+++..... .+...+..++.++++.
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-----~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-----LDPSQRRELLRALARL 130 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-----cchhhHHHHHHHHHHH
Confidence 4678898888887533 3456666666532 458999999884 79888865221 4555677899999999
Q ss_pred HHHHHhhccCCeeeccCCCCcEEECCCC---CEEEeeccccccC
Q 041143 741 MEYLHCLARQTFIHRDLKSSNILLDDDY---RAKVSDFGLVKLA 781 (973)
Q Consensus 741 l~~LH~~~~~~ivH~Dikp~Nill~~~~---~~kl~DfGla~~~ 781 (973)
++-|| ..||+|+|+++.|||++.+. .+.++||+-++..
T Consensus 131 i~~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 131 IAKLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999 89999999999999999887 8999999977643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.46 E-value=9.6e-09 Score=92.29 Aligned_cols=108 Identities=24% Similarity=0.218 Sum_probs=60.7
Q ss_pred eeeccCcccCCCCC---CCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCee
Q 041143 95 NLGLQRNKFNGKLP---TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNL 171 (973)
Q Consensus 95 ~L~L~~N~l~~~~~---~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L 171 (973)
.|||+.+.|..+.. .+.....|+..+|++|.+..+|+.+-...+.++.|+|++|.|+. +|..+..++.|+.|
T Consensus 31 ~ldLssc~lm~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neisd-----vPeE~Aam~aLr~l 105 (177)
T KOG4579|consen 31 FLDLSSCQLMYIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEISD-----VPEELAAMPALRSL 105 (177)
T ss_pred hcccccchhhHHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhhh-----chHHHhhhHHhhhc
Confidence 34445444443322 23444455555666666666665554555556666666666654 56666666666666
Q ss_pred ecccccccCCcchhccCCCCCCeEEccCCcCcccCChh
Q 041143 172 SLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPAS 209 (973)
Q Consensus 172 ~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~ 209 (973)
+++.|.|. ..|..+..|.+|.+|+..+|.+. .+|-.
T Consensus 106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~d 141 (177)
T KOG4579|consen 106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVD 141 (177)
T ss_pred ccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHH
Confidence 66666665 45555555666666666666655 44443
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.39 E-value=5.2e-09 Score=117.52 Aligned_cols=127 Identities=24% Similarity=0.244 Sum_probs=99.0
Q ss_pred eEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEccc
Q 041143 68 RVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDY 147 (973)
Q Consensus 68 ~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~ 147 (973)
.+...+.+.|.|+ .+..++.-++.|+.|||++|+++..- .+..|++|++|||++|.+..+|--.-.+.. |+.|.|++
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~-~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrn 241 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD-NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRN 241 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH-HHHhcccccccccccchhccccccchhhhh-heeeeecc
Confidence 3445555566665 55677888899999999999998754 677889999999999999988865555565 99999999
Q ss_pred CCCCCccCCCCCcccccccccCeeecccccccCC-cchhccCCCCCCeEEccCCcCc
Q 041143 148 NPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGP-LPDFLGTLPSLAALKLSYNRLS 203 (973)
Q Consensus 148 N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~-~p~~l~~l~~L~~L~Ls~N~l~ 203 (973)
|-++.. ..+.+|.+|+.|||++|-|.+- --..+..|..|+.|+|.+|.+.
T Consensus 242 N~l~tL------~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 242 NALTTL------RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred cHHHhh------hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 988854 4678889999999999988752 2234667788899999999886
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.37 E-value=1e-07 Score=108.27 Aligned_cols=151 Identities=20% Similarity=0.243 Sum_probs=102.1
Q ss_pred HHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCccee--------cccccccCcccccccc
Q 041143 734 ALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVV--------TRLAGTFGYLAPEYAV 805 (973)
Q Consensus 734 ~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~~~~--------~~~~gt~~y~aPE~~~ 805 (973)
+.+++.|+.|+|. +.++||++|.|++|.++.++..||+.|+.+........... .-..-...|.|||++.
T Consensus 105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 3445589999994 77999999999999999999999999998764333111110 0112345799999999
Q ss_pred cCcCCCchhHHhHHHHHHHHH-hCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHH
Q 041143 806 MGKITTKADVFSYGVVLMELL-TGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGH 884 (973)
Q Consensus 806 ~~~~~~~~Dv~S~Gvvl~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~ 884 (973)
....+.++|+||+||++|.+. .|+.-+........... ....+..-. ..+......++.+-+.+
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~--------------~~~~~~~~~-~~~s~~~p~el~~~l~k 247 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSF--------------SRNLLNAGA-FGYSNNLPSELRESLKK 247 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhh--------------hhccccccc-ccccccCcHHHHHHHHH
Confidence 988899999999999999999 55554443322111110 000010000 11112334567788888
Q ss_pred hhccCCCCCCCHhHHHH
Q 041143 885 CTAREPYHRPDMGHVVN 901 (973)
Q Consensus 885 cl~~dP~~RPs~~~v~~ 901 (973)
++..++..||++.++..
T Consensus 248 ~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 248 LLNGDSAVRPTLDLLLS 264 (700)
T ss_pred HhcCCcccCcchhhhhc
Confidence 99999999998877765
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.36 E-value=4e-07 Score=111.43 Aligned_cols=290 Identities=21% Similarity=0.252 Sum_probs=154.1
Q ss_pred eEEEEEecccCCcccCCcCcccccccceeeccCcc--cCCCCC-CCCCCCccceeeccCCCC-CCCCccccCCCCCccEE
Q 041143 68 RVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNK--FNGKLP-TFSGLSELEFAYLDFNEF-DTIPSDFFDGLSSVRVL 143 (973)
Q Consensus 68 ~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~--l~~~~~-~~~~l~~L~~L~L~~N~l-~~i~~~~f~~l~~L~~L 143 (973)
.+..+.+-++.+. .++....+ +.|++|-+..|. +..+.. .|..++.|+.|||++|.= ..+| ..++.|-+|++|
T Consensus 524 ~~rr~s~~~~~~~-~~~~~~~~-~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP-~~I~~Li~LryL 600 (889)
T KOG4658|consen 524 SVRRMSLMNNKIE-HIAGSSEN-PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLP-SSIGELVHLRYL 600 (889)
T ss_pred heeEEEEeccchh-hccCCCCC-CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCC-hHHhhhhhhhcc
Confidence 4455555555554 22322222 267777777775 333333 367778888888876543 3444 447777788888
Q ss_pred EcccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhccc
Q 041143 144 ALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQ 223 (973)
Q Consensus 144 ~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~ 223 (973)
+|++..+.. +|.++.+|..|.+|++..+.-...+|..+..|.+|++|.|..-..... ...+.. +-.+.+|...
T Consensus 601 ~L~~t~I~~-----LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~-~~~l~e-l~~Le~L~~l 673 (889)
T KOG4658|consen 601 DLSDTGISH-----LPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSND-KLLLKE-LENLEHLENL 673 (889)
T ss_pred cccCCCccc-----cchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccc-hhhHHh-hhcccchhhh
Confidence 888887774 778888888888888887766556677777788888887765542210 000000 0111111111
Q ss_pred CCCCCCC-cchhhcCCcccc----EEEccCCccccCCCccccCCCCCCEEeCcCCcccccCcccccccccCeEE----cc
Q 041143 224 DAGGMTG-PIDVVAKMVSLT----QLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLV----LN 294 (973)
Q Consensus 224 ~~~~~~~-~~~~~~~l~~L~----~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~L~~L~----l~ 294 (973)
....... ....+..+..|. .+.+.++... ..+..+..+.+|+.|.+.++.+........... ..++ +.
T Consensus 674 s~~~~s~~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~--~~~~~f~~l~ 750 (889)
T KOG4658|consen 674 SITISSVLLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESL--IVLLCFPNLS 750 (889)
T ss_pred eeecchhHhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCchhhccccccc--chhhhHHHHH
Confidence 1111110 001112222222 3333333433 455677788888888888887764332222211 1110 00
Q ss_pred CCcCcC-CCCCCCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccE
Q 041143 295 NNLLMG-PIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSI 373 (973)
Q Consensus 295 ~N~l~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~ 373 (973)
...+.. ..|. ...|. .-.++|+.
T Consensus 751 ~~~~~~~~~~r----------------------------------------------------~l~~~----~f~~~L~~ 774 (889)
T KOG4658|consen 751 KVSILNCHMLR----------------------------------------------------DLTWL----LFAPHLTS 774 (889)
T ss_pred HHHhhcccccc----------------------------------------------------ccchh----hccCcccE
Confidence 000000 0000 00000 12357888
Q ss_pred EecCCCcCCCccchhhhCccccceEEccCCccccc-cCccccCcCCCCeeeCCC
Q 041143 374 INLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGT-VPNNFTELKSLRLLDVSD 426 (973)
Q Consensus 374 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~-~p~~~~~l~~L~~L~Ls~ 426 (973)
|.+........+.+....+..+..+-+..+.+.+. .-...+.++++..+.+++
T Consensus 775 l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l~~~~~l~~l~~i~~~~l~~ 828 (889)
T KOG4658|consen 775 LSLVSCRLLEDIIPKLKALLELKELILPFNKLEGLRMLCSLGGLPQLYWLPLSF 828 (889)
T ss_pred EEEecccccccCCCHHHHhhhcccEEecccccccceeeecCCCCceeEecccCc
Confidence 88887777777777777777777777777777765 345555566555555554
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.35 E-value=3.8e-08 Score=88.55 Aligned_cols=134 Identities=24% Similarity=0.272 Sum_probs=85.9
Q ss_pred ccceeeccCCCCCCCCccc--cCCCCCccEEEcccCCCCCccCCCCCccccc-ccccCeeecccccccCCcchhccCCCC
Q 041143 115 ELEFAYLDFNEFDTIPSDF--FDGLSSVRVLALDYNPFNKTFGWSIPDSLAN-SVQLTNLSLINCNLVGPLPDFLGTLPS 191 (973)
Q Consensus 115 ~L~~L~L~~N~l~~i~~~~--f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~-l~~L~~L~L~~N~l~~~~p~~l~~l~~ 191 (973)
.+..++|+.++|-.++... +.....|+..+|++|.|.. .|+.|.. .+.++.|+|++|.|+ .+|..+..++.
T Consensus 28 E~h~ldLssc~lm~i~davy~l~~~~el~~i~ls~N~fk~-----fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~a 101 (177)
T KOG4579|consen 28 ELHFLDLSSCQLMYIADAVYMLSKGYELTKISLSDNGFKK-----FPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPA 101 (177)
T ss_pred HhhhcccccchhhHHHHHHHHHhCCceEEEEecccchhhh-----CCHHHhhccchhhhhhcchhhhh-hchHHHhhhHH
Confidence 4566778888777665432 4455667777888888875 6766654 457788888888888 67777888888
Q ss_pred CCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCc
Q 041143 192 LAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLN 271 (973)
Q Consensus 192 L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls 271 (973)
|+.|+++.|.|. ..|..+.. +.+|..|+..+|.+. .+|..+..-+.....++.
T Consensus 102 Lr~lNl~~N~l~-~~p~vi~~-------------------------L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lg 154 (177)
T KOG4579|consen 102 LRSLNLRFNPLN-AEPRVIAP-------------------------LIKLDMLDSPENARA-EIDVDLFYSSLPALIKLG 154 (177)
T ss_pred hhhcccccCccc-cchHHHHH-------------------------HHhHHHhcCCCCccc-cCcHHHhccccHHHHHhc
Confidence 888888888887 55655543 555555666666655 555443333333444455
Q ss_pred CCcccccCcc
Q 041143 272 RNQLVGLIPK 281 (973)
Q Consensus 272 ~N~l~~~~p~ 281 (973)
++.+.+.-+.
T Consensus 155 nepl~~~~~~ 164 (177)
T KOG4579|consen 155 NEPLGDETKK 164 (177)
T ss_pred CCcccccCcc
Confidence 5555544433
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.26 E-value=4.8e-06 Score=95.10 Aligned_cols=144 Identities=20% Similarity=0.280 Sum_probs=93.4
Q ss_pred CcccccCccEEEEEEECCCCEEEEEEeecCCCChHH-----------------------------------HHHHHHHHH
Q 041143 631 NELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKA-----------------------------------LDEFQSEIA 675 (973)
Q Consensus 631 ~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~-----------------------------------~~~~~~E~~ 675 (973)
+.||.-+.|.||+|++++|+.||||+-+........ .-+|..|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 679999999999999999999999987654322100 013555655
Q ss_pred HHHhc----CCCc---eeeeeeEEEe-CCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhh
Q 041143 676 VLSKV----RHRH---LVSLLGYSIE-GNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCL 747 (973)
Q Consensus 676 ~l~~l----~h~n---iv~l~~~~~~-~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~ 747 (973)
...++ .|-+ =|.+=.++.+ ...+.|+||||+|..+.+.-.- ++ ..++-. .|+..+.++ |++..
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i-~~---~gi~~~---~i~~~l~~~--~~~qI 317 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI-DK---RGISPH---DILNKLVEA--YLEQI 317 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH-HH---cCCCHH---HHHHHHHHH--HHHHH
Confidence 55544 3545 1112223332 4578999999999877665322 11 223333 344444433 23323
Q ss_pred ccCCeeeccCCCCcEEECC----CCCEEEeeccccccCCC
Q 041143 748 ARQTFIHRDLKSSNILLDD----DYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 748 ~~~~ivH~Dikp~Nill~~----~~~~kl~DfGla~~~~~ 783 (973)
-..|++|+|-+|.||+++. ++++.+-|||+......
T Consensus 318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 3568999999999999984 67899999999875543
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 973 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-52 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-51 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-47 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-46 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-46 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-46 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-46 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-43 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-27 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-27 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-25 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-25 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-25 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-24 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-24 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-24 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-24 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-24 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-24 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-24 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-24 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-24 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-24 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-24 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-24 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-24 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-24 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-24 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-24 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-24 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-24 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-24 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-24 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-24 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-24 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-24 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-24 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-24 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 7e-24 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-24 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 9e-24 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-23 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-23 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-23 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-23 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-23 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-23 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-23 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-23 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-23 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-23 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-23 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-23 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-23 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-23 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-23 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-23 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 9e-23 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-22 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-22 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-22 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-22 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-22 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-22 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-22 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-22 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-22 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-22 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-22 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 7e-22 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-22 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-22 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-22 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 7e-22 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-22 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-22 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 8e-22 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 8e-22 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 9e-22 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 9e-22 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 9e-22 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 9e-22 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-21 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-21 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-21 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-21 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-21 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-21 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-21 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-21 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-21 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-21 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-21 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-21 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-21 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-21 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-21 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-21 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-21 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-21 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-21 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-21 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-21 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-21 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-21 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-21 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-21 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 5e-21 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-21 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-20 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-20 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-20 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-20 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-20 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-20 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-20 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-20 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-20 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-20 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-20 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-20 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-20 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-20 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-20 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-20 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-20 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-20 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-20 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-20 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-20 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-20 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-20 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-20 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-20 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 7e-20 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 7e-20 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-20 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 8e-20 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 8e-20 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-20 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 8e-20 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-20 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 9e-20 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 9e-20 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 9e-20 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-19 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-19 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-19 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-19 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-19 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-19 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-19 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-19 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-19 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-19 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-19 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-19 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-19 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-19 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-19 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-19 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 6e-19 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-19 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-19 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-19 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-19 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 7e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 7e-19 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-19 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 7e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-19 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 8e-19 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-19 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 8e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 8e-19 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 8e-19 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 9e-19 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-18 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-18 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-18 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-18 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-18 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-18 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-18 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-18 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-18 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-18 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-18 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 8e-18 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-17 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-17 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-17 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-17 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-17 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-17 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-17 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-17 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-17 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-17 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-17 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-17 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-17 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 7e-17 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-17 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 9e-17 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 9e-17 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-16 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-16 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-16 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-16 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-16 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-16 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-16 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-16 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-16 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-16 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-16 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-16 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-16 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-16 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-16 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-16 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-16 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-16 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 6e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 7e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 8e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 9e-16 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-15 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-15 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-15 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-15 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-15 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-15 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 1e-15 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-15 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-15 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-15 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-15 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-15 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-15 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-15 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-15 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-15 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-15 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-15 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-15 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-15 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-15 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-15 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-15 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-15 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-15 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-15 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-15 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-15 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-15 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-15 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-15 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-15 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-15 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-15 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-15 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 6e-15 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-15 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 8e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 8e-15 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 9e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 9e-15 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 9e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 9e-15 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 9e-15 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-14 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-14 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-14 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-14 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-14 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-14 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-14 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-14 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-14 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-14 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-14 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-14 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-14 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-14 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-14 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-14 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-14 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-14 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 8e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 9e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-13 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-13 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-13 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-13 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-13 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-13 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-13 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 8e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-13 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 9e-13 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-12 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-12 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-12 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-12 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-12 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-12 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-12 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-12 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-12 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-12 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-12 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-12 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-12 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-12 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-12 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-12 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-12 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-12 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-12 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-12 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-12 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-12 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-12 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-12 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-12 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-12 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-12 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 7e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 8e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 8e-12 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 8e-12 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 8e-12 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 8e-12 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 9e-12 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-12 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 9e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-11 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-11 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-11 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-11 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-11 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-11 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-11 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-11 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-11 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-11 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-11 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-11 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-11 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-11 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-11 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-11 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-11 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 7e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-11 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 8e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 8e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-11 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 9e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 9e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 9e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-10 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-10 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-10 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-10 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-10 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-10 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-10 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-10 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-10 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-10 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-10 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-10 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-10 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 7e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-10 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 7e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 8e-10 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 8e-10 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 9e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-10 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 9e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 9e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 9e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-09 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 5e-09 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 9e-09 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 6e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-09 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 8e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 9e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 9e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 9e-09 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 9e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 9e-09 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-08 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-08 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-08 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-08 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-08 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-08 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-08 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 5e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 6e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 7e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 7e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-08 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 8e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 9e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-08 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 9e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 9e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-07 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-07 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 6e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 8e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 9e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 9e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 9e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-06 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-06 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-06 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-06 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 7e-06 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 7e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-06 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 7e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 7e-06 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 8e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 8e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-05 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 2e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-05 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 400 bits (1029), Expect = e-132
Identities = 113/314 (35%), Positives = 179/314 (57%), Gaps = 20/314 (6%)
Query: 603 ENSHVIESGTLVISVQVLRKVTQNFAQE------NELGRGGFGTVYKGELEDGTKIAVKR 656
++ V ++ S L+ VT NF + N++G GGFG VYKG + + T +AVK+
Sbjct: 3 KSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKK 61
Query: 657 MEAGVTTT--KALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHL 714
+ A V T + +F EI V++K +H +LV LLG+S +G++ LVY YMP+G+L L
Sbjct: 62 LAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL 121
Query: 715 FRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSD 774
+ PLSW R IA A G+ +LH IHRD+KS+NILLD+ + AK+SD
Sbjct: 122 SCLDG--TPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISD 176
Query: 775 FGLVKLAPDGEKSVV-TRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALD 833
FGL + + ++V+ +R+ GT Y+APE + G+IT K+D++S+GVVL+E++TGL A+D
Sbjct: 177 FGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVD 235
Query: 834 EERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHR 893
E R + L + I+ ++ + ID + + S+ + +A C + R
Sbjct: 236 EHREPQ--LLLDIKEEIEDEEKTIEDYIDKKMN--DADSTSVEAMYSVASQCLHEKKNKR 291
Query: 894 PDMGHVVNVLSPLV 907
PD+ V +L +
Sbjct: 292 PDIKKVQQLLQEMT 305
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 389 bits (1002), Expect = e-128
Identities = 119/324 (36%), Positives = 188/324 (58%), Gaps = 10/324 (3%)
Query: 586 LSSQTVASSGSTNSGATENSHVIESGTLVISVQVLRKVTQNFAQENELGRGGFGTVYKGE 645
+ S+ ++ S N A +S+++ + + + L + T NF + +G G FG VYKG
Sbjct: 1 MGSKYSKATNSIND-ALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGV 59
Query: 646 LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYM 705
L DG K+A+KR +++ ++EF++EI LS RH HLVSL+G+ E NE +L+Y+YM
Sbjct: 60 LRDGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYM 117
Query: 706 PHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLD 765
+G L RHL+ L +SW +RL I + ARG+ YLH + IHRD+KS NILLD
Sbjct: 118 ENGNLKRHLYG-SDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLD 173
Query: 766 DDYRAKVSDFGLVKLAPDGEKS-VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLME 824
+++ K++DFG+ K + +++ + T + GT GY+ PEY + G++T K+DV+S+GVVL E
Sbjct: 174 ENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFE 233
Query: 825 LLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGH 884
+L +A+ + P E LAEW + + + +DP L ++ ES+ + A
Sbjct: 234 VLCARSAIVQSLPREMVNLAEWAVESH-NNGQLEQIVDPNLA-DKIRPESLRKFGDTAVK 291
Query: 885 CTAREPYHRPDMGHVVNVLSPLVE 908
C A RP MG V+ L +
Sbjct: 292 CLALSSEDRPSMGDVLWKLEYALR 315
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 378 bits (972), Expect = e-123
Identities = 122/295 (41%), Positives = 172/295 (58%), Gaps = 8/295 (2%)
Query: 620 LRKVTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSK 679
L+ + NF+ +N LGRGGFG VYKG L DGT +AVKR++ T +FQ+E+ ++S
Sbjct: 25 LQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEE-RTQGGELQFQTEVEMISM 83
Query: 680 VRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVAR 739
HR+L+ L G+ + ERLLVY YM +G+++ L + Q PL W +R IAL AR
Sbjct: 84 AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP-PLDWPKRQRIALGSAR 142
Query: 740 GMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYL 799
G+ YLH IHRD+K++NILLD+++ A V DFGL KL + V T + GT G++
Sbjct: 143 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 202
Query: 800 APEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERP--EESRYLAEWFWRIKSSKEKF 857
APEY GK + K DVF YGV+L+EL+TG A D R ++ L +W + K K
Sbjct: 203 APEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK-KL 261
Query: 858 KAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLS--PLVEKW 910
+A +D L+ E + + ++A CT P RP M VV +L L E+W
Sbjct: 262 EALVDVDLQ-GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERW 315
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 258 bits (661), Expect = 1e-78
Identities = 72/328 (21%), Positives = 123/328 (37%), Gaps = 34/328 (10%)
Query: 600 GATENSHVIESGTLVISVQVLRKVTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEA 659
G + H + + L + RG FG V+K +L +AVK
Sbjct: 2 GHHHHHHSSGVD---LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFP- 56
Query: 660 GVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGN----ERLLVYEYMPHGALSRHLF 715
K + + E+ L ++H +++ +G G + L+ + G+LS L
Sbjct: 57 --IQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK 114
Query: 716 RWEKLQLKPLSWTRRLSIALDVARGMEYLH-------CLARQTFIHRDLKSSNILLDDDY 768
+SW IA +ARG+ YLH + HRD+KS N+LL ++
Sbjct: 115 A------NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL 168
Query: 769 RAKVSDFGL-VKLAPDGEKSVVTRLAGTFGYLAPEYA-----VMGKITTKADVFSYGVVL 822
A ++DFGL +K GT Y+APE + D+++ G+VL
Sbjct: 169 TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVL 228
Query: 823 MELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAA----IDPALEVNEETFESISIV 878
EL + A D E E + S ++ + P L + ++++
Sbjct: 229 WELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAML 288
Query: 879 AELAGHCTAREPYHRPDMGHVVNVLSPL 906
E C + R G V ++ +
Sbjct: 289 CETIEECWDHDAEARLSAGCVGERITQM 316
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 1e-68
Identities = 88/288 (30%), Positives = 144/288 (50%), Gaps = 22/288 (7%)
Query: 630 ENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLL 689
+ ++G G FGTV++ E G+ +AVK + + ++EF E+A++ ++RH ++V +
Sbjct: 42 KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 690 GYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLAR 749
G + +V EY+ G+L R L + + L RRLS+A DVA+GM YLH
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHK--SGAREQLDERRRLSMAYDVAKGMNYLHNRNP 158
Query: 750 QTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKI 809
+HR+LKS N+L+D Y KV DFGL +L S AGT ++APE
Sbjct: 159 -PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS-SKSAAGTPEWMAPEVLRDEPS 216
Query: 810 TTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNE 869
K+DV+S+GV+L EL T ++P + A+ + ++ LE+
Sbjct: 217 NEKSDVYSFGVILWELATL------QQPWGNLNPAQVVAAVGFKCKR--------LEIPR 262
Query: 870 ETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPITDES 917
+ A + C EP+ RP ++++L PL++ P + S
Sbjct: 263 NLNPQV---AAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRS 307
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 2e-64
Identities = 78/290 (26%), Positives = 127/290 (43%), Gaps = 35/290 (12%)
Query: 630 ENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLL 689
E +GRG FG V K + +A+K++E + F E+ LS+V H ++V L
Sbjct: 13 EEVVGRGAFGVVCKAKW-RAKDVAIKQIE----SESERKAFIVELRQLSRVNHPNIVKLY 67
Query: 690 GYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLAR 749
G + N LV EY G+L L L + +S L ++G+ YLH +
Sbjct: 68 GACL--NPVCLVMEYAEGGSLYNVLHG--AEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 123
Query: 750 QTFIHRDLKSSNILLDDDYR-AKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGK 808
+ IHRDLK N+LL K+ DFG ++ +T G+ ++APE
Sbjct: 124 KALIHRDLKPPNLLLVAGGTVLKICDFGTACD----IQTHMTNNKGSAAWMAPEVFEGSN 179
Query: 809 ITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI--DPALE 866
+ K DVFS+G++L E++T +P F I + A+
Sbjct: 180 YSEKCDVFSWGIILWEVITR------RKP---------FDEIGGPAFRIMWAVHNGTRPP 224
Query: 867 VNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPITDE 916
+ + + I L C +++P RP M +V +++ L+ + P DE
Sbjct: 225 LIKNLPKPI---ESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF-PGADE 270
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 6e-63
Identities = 78/284 (27%), Positives = 128/284 (45%), Gaps = 37/284 (13%)
Query: 630 ENELGRGGFGTVYKGELEDGTKIAVKRMEAGVT--TTKALDEFQSEIAVLSKVRHRHLVS 687
E +G GGFG VY+ G ++AVK ++ ++ + E + + ++H ++++
Sbjct: 12 EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 688 LLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCL 747
L G ++ LV E+ G L+R L K + ++ A+ +ARGM YLH
Sbjct: 71 LRGVCLKEPNLCLVMEFARGGPLNRVL------SGKRIPPDILVNWAVQIARGMNYLHDE 124
Query: 748 ARQTFIHRDLKSSNILLDDDYR--------AKVSDFGLVKLAPDGEKSVVTRLAGTFGYL 799
A IHRDLKSSNIL+ K++DFGL + ++ AG + ++
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW---HRTTKMSAAGAYAWM 181
Query: 800 APEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKA 859
APE + +DV+SYGV+L ELLTG E P + + +K
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTG------EVPFRGIDGLAVAYGVAMNKLA--- 232
Query: 860 AIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVL 903
L + E A+L C +P+ RP ++++ L
Sbjct: 233 -----LPIPSTCPEPF---AKLMEDCWNPDPHSRPSFTNILDQL 268
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 4e-62
Identities = 64/300 (21%), Positives = 111/300 (37%), Gaps = 63/300 (21%)
Query: 630 ENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLL 689
+L G ++KG G I VK ++ +T+ +F E L H +++ +L
Sbjct: 15 LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 690 GYSIEGNERLL--VYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCL 747
G + +MP+G+L L + ++ + ALD+ARGM +LH L
Sbjct: 74 GACQSPPAPHPTLITHWMPYGSLYNVLHEGTN---FVVDQSQAVKFALDMARGMAFLHTL 130
Query: 748 ARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMG 807
L S ++++D+D A++S + ++APE A+
Sbjct: 131 EPL-IPRHALNSRSVMIDEDMTARISMADVKFSFQS------PGRMYAPAWVAPE-ALQK 182
Query: 808 K----ITTKADVFSYGVVLMELLTG--------------LAALDEERPEESRYLAEWFWR 849
K AD++S+ V+L EL+T AL+ RP
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT----------- 231
Query: 850 IKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909
I I P + ++L C +P RP +V +L + +K
Sbjct: 232 IPPG-------ISPHV-------------SKLMKICMNEDPAKRPKFDMIVPILEKMQDK 271
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 8e-62
Identities = 82/294 (27%), Positives = 136/294 (46%), Gaps = 47/294 (15%)
Query: 630 ENELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKA-----LDEFQSEIAVLSKVRHR 683
E ++G+GGFG V+KG ++D + +A+K + G + + EFQ E+ ++S + H
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 684 HLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEY 743
++V L G +V E++P G L L + P+ W+ +L + LD+A G+EY
Sbjct: 84 NIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLD----KAHPIKWSVKLRLMLDIALGIEY 137
Query: 744 LHCLARQTFIHRDLKSSNILLD-----DDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGY 798
+ +HRDL+S NI L AKV+DFGL + V+ L G F +
Sbjct: 138 MQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGNFQW 192
Query: 799 LAPEYAVM----GKITTKADVFSYGVVLMELLTGLAALDEERP--EESRYLAEWFWRIKS 852
+APE + T KAD +S+ ++L +LTG E P E S ++ I+
Sbjct: 193 MAPE--TIGAEEESYTEKADTYSFAMILYTILTG------EGPFDEYSYGKIKFINMIRE 244
Query: 853 SKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPL 906
+ + E+ + + C + +P RP ++V LS L
Sbjct: 245 EGLR--------PTIPEDCPPRL---RNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 9e-62
Identities = 73/284 (25%), Positives = 122/284 (42%), Gaps = 27/284 (9%)
Query: 630 ENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLL 689
+G G FGTVYKG+ +AVK + T + L F++E+ VL K RH +++ +
Sbjct: 29 GQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 690 GYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLAR 749
GYS +V ++ +L HL + + IA ARGM+YLH
Sbjct: 87 GYSTAPQ-LAIVTQWCEGSSLYHHL----HASETKFEMKKLIDIARQTARGMDYLH---A 138
Query: 750 QTFIHRDLKSSNILLDDDYRAKVSDFGLVKL-APDGEKSVVTRLAGTFGYLAPE---YAV 805
++ IHRDLKS+NI L +D K+ DFGL + +L+G+ ++APE
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 806 MGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPAL 865
+ ++DV+++G+VL EL+TG + + K ++ +
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRM 258
Query: 866 EVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909
L C ++ RP ++ + L +
Sbjct: 259 -------------KRLMAECLKKKRDERPSFPRILAEIEELARE 289
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 1e-60
Identities = 71/329 (21%), Positives = 118/329 (35%), Gaps = 48/329 (14%)
Query: 624 TQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAV--LSKVR 681
N +GRG +G VYKG L D +AVK + F +E + + +
Sbjct: 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF-----SFANRQNFINEKNIYRVPLME 65
Query: 682 HRHLVSLLGYSIEGN-----ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALD 736
H ++ + E LLV EY P+G+L ++L W +A
Sbjct: 66 HDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL------HTSDWVSSCRLAHS 119
Query: 737 VARGMEYLH------CLARQTFIHRDLKSSNILLDDDYRAKVSDFGL-------VKLAPD 783
V RG+ YLH + HRDL S N+L+ +D +SDFGL + P
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPG 179
Query: 784 GEKSVVTRLAGTFGYLAPEYA-------VMGKITTKADVFSYGVVLMELLTGLAALDEER 836
E + GT Y+APE + D+++ G++ E+ L
Sbjct: 180 EEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239
Query: 837 PEESRYLAEWFWRIKS--SKEKFKAAID-----PAL-EVNEETFESISIVAELAGHCTAR 888
Y + + + + E + + P E +E ++ + E C +
Sbjct: 240 SVPE-YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQ 298
Query: 889 EPYHRPDMGHVVNVLSPLVEKWRPITDES 917
+ R ++ L+ W S
Sbjct: 299 DAEARLTAQXAEERMAELMMIWERNKSVS 327
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 6e-60
Identities = 67/296 (22%), Positives = 110/296 (37%), Gaps = 43/296 (14%)
Query: 630 ENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSL 688
LG+G FG K E G + +K + + F E+ V+ + H +++
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKF 72
Query: 689 LGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLA 748
+G + + EY+ G L + + W++R+S A D+A GM YLH
Sbjct: 73 IGVLYKDKRLNFITEYIKGGTLRGIIKSMDS----QYPWSQRVSFAKDIASGMAYLH--- 125
Query: 749 RQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGE-------------KSVVTRLAGT 795
IHRDL S N L+ ++ V+DFGL +L D + + + G
Sbjct: 126 SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185
Query: 796 FGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYL--AEWFWRIKSS 853
++APE K DVFS+G+VL E++ + A + P + F
Sbjct: 186 PYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCP 245
Query: 854 KEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909
P+ + C +P RP + + L L
Sbjct: 246 PN-----CPPSF-------------FPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 9e-59
Identities = 56/295 (18%), Positives = 111/295 (37%), Gaps = 40/295 (13%)
Query: 630 ENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLL 689
+G+G FG VY G ++A++ ++ L F+ E+ + RH ++V +
Sbjct: 38 GELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 690 GYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLAR 749
G + ++ L + + L + IA ++ +GM YLH
Sbjct: 96 GACMSPPHLAIITSLCKGRTLYSVV----RDAKIVLDVNKTRQIAQEIVKGMGYLHA--- 148
Query: 750 QTFIHRDLKSSNILLDDDYRAKVSDFGLVKL----APDGEKSVVTRLAGTFGYLAPEYAV 805
+ +H+DLKS N+ D+ + ++DFGL + + + G +LAPE
Sbjct: 149 KGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIR 207
Query: 806 MGKI---------TTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEK 856
+ +DVF+ G + EL + E + +
Sbjct: 208 QLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMK------- 260
Query: 857 FKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWR 911
+ + +E ++++ C A E RP ++++L L ++ R
Sbjct: 261 ---PNLSQIGMGKE-------ISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR 305
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 6e-58
Identities = 99/430 (23%), Positives = 164/430 (38%), Gaps = 63/430 (14%)
Query: 19 ANSATDPNDLKILNDFKNGLENPELLK-WPANGDDPCGPPPWPHVFCSGNRVTQIQVQNL 77
+ S + ++ L FK+ L + LL W ++ +PC + V C ++VT I + +
Sbjct: 5 SPSQSLYREIHQLISFKDVLPDKNLLPDW-SSNKNPCT---FDGVTCRDDKVTSIDLSSK 60
Query: 78 GLK---GPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEF-DTIPSDF 133
L + + LT L +L L + NG + F + L L N + +
Sbjct: 61 PLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLT 120
Query: 134 FDG-LSSVRVLALDYNPFNKTFGWSIPDS-LANSVQLTNLSLINCNLVGPLPD---FLGT 188
G S ++ L + N + + S L L L ++ G
Sbjct: 121 SLGSCSGLKFLNVSSNTLD----FPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDG 176
Query: 189 LPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHG 248
L L +S N++SG + S +L + L ++ + + I + +L L + G
Sbjct: 177 CGELKHLAISGNKISGDVDVSRCVNL-EFLDVSSNN---FSTGIPFLGDCSALQHLDISG 232
Query: 249 NQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKS-LANMELDNLVLNNNLLMGPIPKFKA 307
N+ +G I + LK LN++ NQ VG IP L +++ L L N G IP F +
Sbjct: 233 NKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQ--YLSLAENKFTGEIPDFLS 290
Query: 308 GNVTYDSNSFCQSEPGIECAPDVNVLLDFLG-GVNYPVNLVSQWPGNDPCQGPWLGLSCT 366
G L L N + P P+ G
Sbjct: 291 GACDT---------------------LTGLDLSGN---HFYGAVP-------PFFG---- 315
Query: 367 SNSKVSIINLPRHNLTGTLSP-SIANLDSLIEIRLGKNSISGTVPNNFTELK-SLRLLDV 424
S S + + L +N +G L ++ + L + L N SG +P + T L SL LD+
Sbjct: 316 SCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDL 375
Query: 425 SDNNIKPPLP 434
S NN P+
Sbjct: 376 SSNNFSGPIL 385
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 1e-53
Identities = 101/364 (27%), Positives = 155/364 (42%), Gaps = 47/364 (12%)
Query: 78 GLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFD-TIPSDFFDG 136
L G + + T+L L + N+F G +P L L++ L N+F IP
Sbjct: 234 KLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP-LKSLQYLSLAENKFTGEIPDFLSGA 292
Query: 137 LSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLP-DFLGTLPSLAAL 195
++ L L N F G ++P + L +L+L + N G LP D L + L L
Sbjct: 293 CDTLTGLDLSGNHFY---G-AVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVL 348
Query: 196 KLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPI---DVVAKMVSLTQLWLHGNQFT 252
LS+N SG +P S +L L D + +GPI +L +L+L N FT
Sbjct: 349 DLSFNEFSGELPESLTNLSASLLTL-DLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFT 407
Query: 253 GSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGPIPKFKAGNVT 311
G IP + S L L+L+ N L G IP SL ++ +L +L L N+L G IP
Sbjct: 408 GKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIP-------- 459
Query: 312 YDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKV 371
+E L L N ++ G P L + + +
Sbjct: 460 ---QELMYV-KTLE-------TLI-LDF-----NDLT---GEIP---SGLS----NCTNL 492
Query: 372 SIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKP 431
+ I+L + LTG + I L++L ++L NS SG +P + +SL LD++ N
Sbjct: 493 NWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNG 552
Query: 432 PLPE 435
+P
Sbjct: 553 TIPA 556
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 3e-52
Identities = 88/370 (23%), Positives = 138/370 (37%), Gaps = 54/370 (14%)
Query: 76 NLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP----TFSGLSELEFAYLDFNEFD-TIP 130
L G + L L L L N +G G EL+ + N+ +
Sbjct: 137 TLDFPGKVSGGLK-LNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD 195
Query: 131 SDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLP 190
++ L + N F+ IP L + L +L + L G + T
Sbjct: 196 ---VSRCVNLEFLDVSSNNFS---T-GIP-FLGDCSALQHLDISGNKLSGDFSRAISTCT 247
Query: 191 SLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPI--DVVAKMVSLTQLWLHG 248
L L +S N+ G IP +SL Q L L + TG I + +LT L L G
Sbjct: 248 ELKLLNISSNQFVGPIPPLPLKSL-QYLSLAEN---KFTGEIPDFLSGACDTLTGLDLSG 303
Query: 249 NQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPK-SLANM-ELDNLVLNNNLLMGPIPKFK 306
N F G++P G+ S L+ L L+ N G +P +L M L L L+ N G +P
Sbjct: 304 NHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELP--- 360
Query: 307 AGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCT 366
S + LD N N P L +
Sbjct: 361 --------ESLTNLSASLL-------TLDL--SSN---NFSGPIL-------PNLCQNPK 393
Query: 367 SNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSD 426
+ + + L + TG + P+++N L+ + L N +SGT+P++ L LR L +
Sbjct: 394 NT--LQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWL 451
Query: 427 NNIKPPLPEF 436
N ++ +P+
Sbjct: 452 NMLEGEIPQE 461
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 7e-51
Identities = 89/391 (22%), Positives = 159/391 (40%), Gaps = 58/391 (14%)
Query: 55 GPPPWPHVFCSGNRVTQIQVQNLGLKGPLPQNF---NQLTKLYNLGLQRNKFNGKLPTFS 111
G N + + + + G + + +L +L + NK +G + S
Sbjct: 142 GKVSG---GLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD-VS 197
Query: 112 GLSELEFAYLDFNEFD-TIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTN 170
LEF + N F IP S+++ L + N + G +++ +L
Sbjct: 198 RCVNLEFLDVSSNNFSTGIPF--LGDCSALQHLDISGNKLS---G-DFSRAISTCTELKL 251
Query: 171 LSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSL--MQILWLNDQDAGGM 228
L++ + VGP+P L SL L L+ N+ +G IP + + L L+
Sbjct: 252 LNISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSG---NHF 306
Query: 229 TGPI-DVVAKMVSLTQLWLHGNQFTGSIPED-IGALSSLKDLNLNRNQLVGLIPKSLANM 286
G + L L L N F+G +P D + + LK L+L+ N+ G +P+SL N+
Sbjct: 307 YGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNL 366
Query: 287 --ELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPV 344
L L L++N GPI + CQ+ + L +L
Sbjct: 367 SASLLTLDLSSNNFSGPIL-----------PNLCQNPK-----NTLQEL--YLQN----- 403
Query: 345 NLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNS 404
N + G P P L + S++ ++L + L+GT+ S+ +L L +++L N
Sbjct: 404 NGFT---GKIP---PTLS----NCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNM 453
Query: 405 ISGTVPNNFTELKSLRLLDVSDNNIKPPLPE 435
+ G +P +K+L L + N++ +P
Sbjct: 454 LEGEIPQELMYVKTLETLILDFNDLTGEIPS 484
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 6e-50
Identities = 86/394 (21%), Positives = 144/394 (36%), Gaps = 66/394 (16%)
Query: 57 PPWPHVFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSEL 116
+ + + + + G + ++ L L + N F+ +P S L
Sbjct: 168 VVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFLGDCSAL 225
Query: 117 EFAYLDFNEFD-TIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLIN 175
+ + N+ + +++L + N F IP L LSL
Sbjct: 226 QHLDISGNKLSGDFSRAIS-TCTELKLLNISSNQFV----GPIPPL--PLKSLQYLSLAE 278
Query: 176 CNLVGPLPDFL-GTLPSLAALKLSYNRLSGVIPASFGQ-SLMQILWLNDQDAGGMTGPI- 232
G +PDFL G +L L LS N G +P FG SL++ L L+ +G +
Sbjct: 279 NKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSN---NFSGELP 335
Query: 233 -DVVAKMVSLTQLWLHGNQFTGSIPEDIGALS-SLKDLNLNRNQLVGLIPKSLANMELDN 290
D + KM L L L N+F+G +PE + LS SL L+L+ N G I +L +
Sbjct: 336 MDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNT 395
Query: 291 LV---LNNNLLMGPIPKF--KAGNVTY---DSNSFCQSEPGIECAPDVNVLLDFLGGVNY 342
L L NN G IP + N
Sbjct: 396 LQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLS------------------------ 431
Query: 343 PVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGK 402
G P LG S SK+ + L + L G + + + +L + L
Sbjct: 432 ---------GTIP---SSLG----SLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDF 475
Query: 403 NSISGTVPNNFTELKSLRLLDVSDNNIKPPLPEF 436
N ++G +P+ + +L + +S+N + +P++
Sbjct: 476 NDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKW 509
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 2e-49
Identities = 87/359 (24%), Positives = 135/359 (37%), Gaps = 53/359 (14%)
Query: 79 LKGPLPQNFNQLT-KLYNLGLQRNKFNGKLPTFSG---LSELEFAYLDFNEFD-TIPSDF 133
G LP++ L+ L L L N F+G + + L+ YL N F IP
Sbjct: 355 FSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTL 414
Query: 134 FDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLA 193
+ S + L L +N + G +IP SL + +L +L L L G +P L + +L
Sbjct: 415 SN-CSELVSLHLSFNYLS---G-TIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLE 469
Query: 194 ALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTG 253
L L +N L+G IP+ +L + L N+ TG
Sbjct: 470 TLILDFNDLTGEIPSGLS-------------------------NCTNLNWISLSNNRLTG 504
Query: 254 SIPEDIGALSSLKDLNLNRNQLVGLIPKSLANME-LDNLVLNNNLLMGPIPKFKAGNVTY 312
IP+ IG L +L L L+ N G IP L + L L LN NL G IP +
Sbjct: 505 EIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPA-AMFKQSG 563
Query: 313 D--SNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSK 370
+N + G + ++ G L S
Sbjct: 564 KIAANFIAGKRYVYIKNDGMKKECHGAGNLL-------EFQGIRS---EQLN----RLST 609
Query: 371 VSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNI 429
+ N+ G SP+ N S++ + + N +SG +P + L +L++ N+I
Sbjct: 610 RNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDI 668
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 1e-47
Identities = 94/383 (24%), Positives = 141/383 (36%), Gaps = 71/383 (18%)
Query: 79 LKGPLPQN-FNQLTKLYNLGLQRNKFNGKLPT-FSGLSELEFAYLDFNEF-DTIPSDFFD 135
G +P L L L N F G +P F S LE L N F +P D
Sbjct: 281 FTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLL 340
Query: 136 GLSSVRVLALDYNPFNKTFGWSIPDSLAN-SVQLTNLSLINCNLVGPLPDFLG--TLPSL 192
+ ++VL L +N F+ G +P+SL N S L L L + N GP+ L +L
Sbjct: 341 KMRGLKVLDLSFNEFS---G-ELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTL 396
Query: 193 AALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFT 252
L L N +G IP + L L L N +
Sbjct: 397 QELYLQNNGFTGKIPPTLS-------------------------NCSELVSLHLSFNYLS 431
Query: 253 GSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGPIPKFKAGNVT 311
G+IP +G+LS L+DL L N L G IP+ L + L+ L+L+ N L G IP
Sbjct: 432 GTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPS------- 484
Query: 312 YDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKV 371
++N + L N ++ G P W+G +
Sbjct: 485 ----GLSNC-------TNLNWI--SLSN-----NRLT---GEIP---KWIG----RLENL 516
Query: 372 SIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKP 431
+I+ L ++ +G + + + SLI + L N +GT+P + +
Sbjct: 517 AILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYV 576
Query: 432 PLPEFHDTVKLVIDGNPLLVGGI 454
+ + GN L GI
Sbjct: 577 YIKNDGMKKECHGAGNLLEFQGI 599
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 9e-44
Identities = 107/429 (24%), Positives = 155/429 (36%), Gaps = 71/429 (16%)
Query: 79 LKGPLPQNF--NQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFD-TIPSDFF 134
GP+ N N L L LQ N F GK+P T S SEL +L FN TIPS
Sbjct: 380 FSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLG 439
Query: 135 DGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAA 194
LS +R L L N IP L L L L +L G +P L +L
Sbjct: 440 S-LSKLRDLKLWLNMLE----GEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNW 494
Query: 195 LKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGS 254
+ LS NRL+G IP G ++ +L L L N F+G+
Sbjct: 495 ISLSNNRLTGEIPKWIG-------------------------RLENLAILKLSNNSFSGN 529
Query: 255 IPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMGPIPKFKAGN---VT 311
IP ++G SL L+LN N G IP ++ + N + G + +
Sbjct: 530 IPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK---IAANFIAGKRYVYIKNDGMKKE 586
Query: 312 YDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLG------LSC 365
GI + L N + G+ G +S
Sbjct: 587 CHGAGNLLEFQGIR--SEQLNRLSTRNPCNITSRVYG---GHTSPTFDNNGSMMFLDMSY 641
Query: 366 -----------TSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFT 414
S + I+NL ++++G++ + +L L + L N + G +P +
Sbjct: 642 NMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMS 701
Query: 415 ELKSLRLLDVSDNNIKPPLPE---FHDTVKLVIDGNPLLVGGINHTQAPTSPGPVSSPTP 471
L L +D+S+NN+ P+PE F NP L G P S+
Sbjct: 702 ALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG------YPLPRCDPSNADG 755
Query: 472 PGSQSPSNH 480
S+H
Sbjct: 756 YAHHQRSHH 764
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 8e-37
Identities = 62/251 (24%), Positives = 101/251 (40%), Gaps = 17/251 (6%)
Query: 60 PHVFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEF 118
P + + + + + L G +P + L+KL +L L N G++P + LE
Sbjct: 411 PPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLET 470
Query: 119 AYLDFNEFD-TIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCN 177
LDFN+ IPS + +++ ++L N G IP + L L L N +
Sbjct: 471 LILDFNDLTGEIPSGLSN-CTNLNWISLSNNRLT---G-EIPKWIGRLENLAILKLSNNS 525
Query: 178 LVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPI-DVVA 236
G +P LG SL L L+ N +G IPA+ + + N + G +
Sbjct: 526 FSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFK-QSGKIAANF-----IAGKRYVYIK 579
Query: 237 KMVSLTQLWLHGN--QFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANME-LDNLVL 293
+ GN +F G E + LS+ N+ G + N + L +
Sbjct: 580 NDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDM 639
Query: 294 NNNLLMGPIPK 304
+ N+L G IPK
Sbjct: 640 SYNMLSGYIPK 650
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-29
Identities = 48/250 (19%), Positives = 83/250 (33%), Gaps = 39/250 (15%)
Query: 60 PHVFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEF 118
P + + + L G +P + T L + L N+ G++P L L
Sbjct: 459 PQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAI 518
Query: 119 AYLDFNEFD-TIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCN 177
L N F IP++ D S+ L L+ N FN G +IP ++ + N
Sbjct: 519 LKLSNNSFSGNIPAELGD-CRSLIWLDLNTNLFN---G-TIPAAMFK---QSGKIAAN-F 569
Query: 178 LVGPLPDFLGTLPSLAALKLSYN--RLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVV 235
+ G ++ + N G+
Sbjct: 570 IAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLN------------------------ 605
Query: 236 AKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLN 294
++ + + + G S+ L+++ N L G IPK + +M L L L
Sbjct: 606 -RLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLG 664
Query: 295 NNLLMGPIPK 304
+N + G IP
Sbjct: 665 HNDISGSIPD 674
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 8e-24
Identities = 47/288 (16%), Positives = 91/288 (31%), Gaps = 84/288 (29%)
Query: 164 NSVQLTNLSLINCNL---VGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWL 220
++T++ L + L + L +L L +L LS + ++G + F
Sbjct: 48 RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKC-------- 98
Query: 221 NDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPED--IGALSSLKDLNLNRNQLVGL 278
SLT L L N +G + +G+ S LK LN++ N L
Sbjct: 99 -----------------SASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFP 141
Query: 279 IPKS-LANM-ELDNLVLNNNLLMG--PIPKFKAGNVTY------DSNSFCQSEPGIECAP 328
S + L+ L L+ N + G + + N
Sbjct: 142 GKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKI----------- 190
Query: 329 DVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPS 388
G + + + +++ +N + + P
Sbjct: 191 ----------------------------SGD---VDVSRCVNLEFLDVSSNNFSTGI-PF 218
Query: 389 IANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLPEF 436
+ + +L + + N +SG + L+LL++S N P+P
Sbjct: 219 LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL 266
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 5e-17
Identities = 47/264 (17%), Positives = 78/264 (29%), Gaps = 78/264 (29%)
Query: 55 GPPPWPHVFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLS 114
G + L +G + N+L+ + + G
Sbjct: 572 GKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTS------ 625
Query: 115 ELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLI 174
FD S+ L + YN
Sbjct: 626 -----------------PTFDNNGSMMFLDMSYN-------------------------- 642
Query: 175 NCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDV 234
L G +P +G++P L L L +N +SG IP G L + L+
Sbjct: 643 --MLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGD-LRGLNILD------------- 686
Query: 235 VAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKS--LANMELDNLV 292
L N+ G IP+ + AL+ L +++L+ N L G IP+ +
Sbjct: 687 -----------LSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFL 735
Query: 293 LNNNLLMGPIPKFKAGNVTYDSNS 316
N L P+P+ N ++
Sbjct: 736 NNPGLCGYPLPRCDPSNADGYAHH 759
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 3e-14
Identities = 40/218 (18%), Positives = 74/218 (33%), Gaps = 54/218 (24%)
Query: 240 SLTQLWLHGNQFT---GSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNN 296
+T + L ++ + +L+ L+ L L+ + + G + + L +L L+ N
Sbjct: 51 KVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRN 110
Query: 297 LLMGPIPKFKA-GNVTY------DSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQ 349
L GP+ + G+ + SN+
Sbjct: 111 SLSGPVTTLTSLGSCSGLKFLNVSSNTL-------------------------------D 139
Query: 350 WPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIA---NLDSLIEIRLGKNSIS 406
+PG GL S + +++L ++++G L + + N IS
Sbjct: 140 FPGKVS-----GGLKLNS---LEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKIS 191
Query: 407 GTVPNNFTELKSLRLLDVSDNNIKPPLPEFHDTVKLVI 444
G V + +L LDVS NN +P D L
Sbjct: 192 GDVD--VSRCVNLEFLDVSSNNFSTGIPFLGDCSALQH 227
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 3e-12
Identities = 29/113 (25%), Positives = 52/113 (46%), Gaps = 9/113 (7%)
Query: 329 DVNVLLDFLGGVNYPVNLVSQW-PGNDPCQGPWLGLSCTSNSKVSIINLPRHNLT---GT 384
+++ L+ F + L W +PC + G++C + KV+ I+L L
Sbjct: 13 EIHQLISFKDVLPDKNLLPD-WSSNKNPCT--FDGVTC-RDDKVTSIDLSSKPLNVGFSA 68
Query: 385 LSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLPEFH 437
+S S+ +L L + L + I+G+V F SL LD+S N++ P+
Sbjct: 69 VSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRNSLSGPVTTLT 120
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 8e-57
Identities = 77/351 (21%), Positives = 131/351 (37%), Gaps = 51/351 (14%)
Query: 581 DTARSLSSQTVASSGSTNSGATENSHVIESGTLVISVQVLRKVTQNFAQENELGRGGFGT 640
++ R L Q+ SSGS SG + + + ++G+G +G
Sbjct: 9 ESLRDLIEQS-QSSGS-GSGLPLLVQRTIAKQIQM--------------VKQIGKGRYGE 52
Query: 641 VYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNER-- 698
V+ G+ G K+AVK TT +A ++EI +RH +++ + I+G
Sbjct: 53 VWMGKW-RGEKVAVKVFF---TTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108
Query: 699 --LLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTF---- 752
L+ +Y +G+L +L + L L +A G+ +LH T
Sbjct: 109 QLYLITDYHENGSLYDYL------KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA 162
Query: 753 -IHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSV---VTRLAGTFGYLAPE------ 802
HRDLKS NIL+ + ++D GL V GT Y+ PE
Sbjct: 163 IAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL 222
Query: 803 YAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862
+ AD++S+G++L E+ + + Y S E + +
Sbjct: 223 NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD--PSYEDMREIVC 280
Query: 863 -----PALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908
P+ + E + + +L C A P R V L+ + E
Sbjct: 281 IKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 6e-56
Identities = 64/313 (20%), Positives = 124/313 (39%), Gaps = 35/313 (11%)
Query: 616 SVQVLRKVTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIA 675
S+Q R V ++ +G+G +G V++G G +AVK + + ++E+
Sbjct: 1 SMQ--RTVARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFS---SRDEKSWFRETELY 54
Query: 676 VLSKVRHRHLVSLLGYSIEGN----ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRL 731
+RH +++ + + + L+ Y G+L +L QL L L
Sbjct: 55 NTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL------QLTTLDTVSCL 108
Query: 732 SIALDVARGMEYLHCLARQTF-----IHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEK 786
I L +A G+ +LH T HRDLKS NIL+ + + ++D GL +
Sbjct: 109 RIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTN 168
Query: 787 SVV---TRLAGTFGYLAPE------YAVMGKITTKADVFSYGVVLMELLTGLAALDEERP 837
+ GT Y+APE + D++++G+VL E+ + +
Sbjct: 169 QLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 228
Query: 838 EESRYLAEWFWRIKSSKEKFKAAID----PALEVNEETFESISIVAELAGHCTAREPYHR 893
+ + + S ++ K P + + +++ +A+L C + P R
Sbjct: 229 YKPPF-YDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSAR 287
Query: 894 PDMGHVVNVLSPL 906
+ L+ +
Sbjct: 288 LTALRIKKTLTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 2e-53
Identities = 81/367 (22%), Positives = 143/367 (38%), Gaps = 56/367 (15%)
Query: 566 DPSDPENMVKIAVSNDTARSLSSQTVASSGSTNSGATENSHVIESGTLVISVQVLRKVTQ 625
DPS + S T + +SGS SG + T+V+
Sbjct: 2 DPSLDRPFI----SEGTTLKDLIYDMTTSGS-GSGLPLLVQRTIARTIVL---------- 46
Query: 626 NFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHL 685
+ +G+G FG V++G+ G ++AVK + + ++EI +RH ++
Sbjct: 47 ----QESIGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENI 98
Query: 686 VSLLGYSIEGN----ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGM 741
+ + + N + LV +Y HG+L +L R ++ + +AL A G+
Sbjct: 99 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGL 152
Query: 742 EYLHCLARQT-----FIHRDLKSSNILLDDDYRAKVSDFGLVKL---APDGEKSVVTRLA 793
+LH T HRDLKS NIL+ + ++D GL A D
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 212
Query: 794 GTFGYLAPEYAVM-GKI-------TTKADVFSYGVVLMELLTGLAALDEERPEESRYLAE 845
GT Y+APE V+ I +AD+++ G+V E+ + + Y +
Sbjct: 213 GTKRYMAPE--VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY-YD 269
Query: 846 WFWRIKSSKEKFKAAID----PALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901
S +E K + P + ++ E++ ++A++ C R +
Sbjct: 270 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329
Query: 902 VLSPLVE 908
LS L +
Sbjct: 330 TLSQLSQ 336
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 2e-50
Identities = 71/297 (23%), Positives = 125/297 (42%), Gaps = 28/297 (9%)
Query: 23 TDPNDLKILNDFKNGLENPELLK-WPANGDDPCGPPPWPHVFCSG----NRVTQIQVQNL 77
+P D + L K L NP L W C W V C RV + + L
Sbjct: 3 CNPQDKQALLQIKKDLGNPTTLSSW--LPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGL 60
Query: 78 GLKG--PLPQNFNQLTKLYNLGLQ-RNKFNGKLP-TFSGLSELEFAYLDFNEFD-TIPSD 132
L P+P + L L L + N G +P + L++L + Y+ IP
Sbjct: 61 NLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPD- 119
Query: 133 FFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSL 192
F + ++ L YN + G ++P S+++ L ++ + G +PD G+ L
Sbjct: 120 FLSQIKTLVTLDFSYNALS---G-TLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL 175
Query: 193 A-ALKLSYNRLSGVIPASFGQSLMQILWL--NDQDAGGMTGPI-DVVAKMVSLTQLWLHG 248
++ +S NRL+G IP +F + + L N + G + + ++ L
Sbjct: 176 FTSMTISRNRLTGKIPPTFANLNLAFVDLSRN-----MLEGDASVLFGSDKNTQKIHLAK 230
Query: 249 NQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANME-LDNLVLNNNLLMGPIPK 304
N + + +G +L L+L N++ G +P+ L ++ L +L ++ N L G IP+
Sbjct: 231 NSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-44
Identities = 74/324 (22%), Positives = 115/324 (35%), Gaps = 70/324 (21%)
Query: 136 GLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCN-LVGPLPDFLGTLPSLAA 194
V L L K + IP SLAN L L + N LVGP+P + L L
Sbjct: 48 QTYRVNNLDLSGLNLPKPY--PIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHY 105
Query: 195 LKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGS 254
L +++ +SG IP Q + +L L N +G+
Sbjct: 106 LYITHTNVSGAIPDFLSQ-------------------------IKTLVTLDFSYNALSGT 140
Query: 255 IPEDIGALSSLKDLNLNRNQLVGLIPKSLANME--LDNLVLNNNLLMGPIPKFKAGNVTY 312
+P I +L +L + + N++ G IP S + ++ ++ N L G IP
Sbjct: 141 LPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPP-------- 192
Query: 313 DSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVS 372
+F +D N++ G+ G S+
Sbjct: 193 ---TFANLNL---------AFVDLSR------NMLE---GDAS---VLFG----SDKNTQ 224
Query: 373 IINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIK-- 430
I+L +++L L + +L + L N I GT+P T+LK L L+VS NN+
Sbjct: 225 KIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE 283
Query: 431 -PPLPEFHDTVKLVIDGNPLLVGG 453
P N L G
Sbjct: 284 IPQGGNLQRFDVSAYANNKCLCGS 307
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 2e-30
Identities = 59/289 (20%), Positives = 93/289 (32%), Gaps = 70/289 (24%)
Query: 157 SIPDSLANSVQL----TNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGV--IPASF 210
I L N L N +G L D + L LS L IP+S
Sbjct: 13 QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72
Query: 211 GQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHG-NQFTGSIPEDIGALSSLKDLN 269
+ L L++ G N G IP I L+ L L
Sbjct: 73 A-------------------------NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLY 107
Query: 270 LNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAP 328
+ + G IP L+ + L L + N L G +P S S +
Sbjct: 108 ITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLP---------PSISSLPN-------- 150
Query: 329 DVNVLLDFLG-GVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSP 387
L + N + P G S + + + R+ LTG + P
Sbjct: 151 -----LVGITFDGN---RISGAIP-------DSYG-SFSKLFT--SMTISRNRLTGKIPP 192
Query: 388 SIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLPEF 436
+ ANL +L + L +N + G F K+ + + ++ N++ L +
Sbjct: 193 TFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKV 240
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 3e-16
Identities = 33/114 (28%), Positives = 52/114 (45%), Gaps = 6/114 (5%)
Query: 329 DVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSC---TSNSKVSIINLPRHNLTGT- 384
D LL + P L S P D C WLG+ C T +V+ ++L NL
Sbjct: 7 DKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPY 66
Query: 385 -LSPSIANLDSLIEIRL-GKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLPEF 436
+ S+ANL L + + G N++ G +P +L L L ++ N+ +P+F
Sbjct: 67 PIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDF 120
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 8e-48
Identities = 72/300 (24%), Positives = 114/300 (38%), Gaps = 59/300 (19%)
Query: 630 ENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSL 688
++GRG FG V+ G L D T +AVK +F E +L + H ++V L
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 689 LGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLA 748
+G + +V E + G L + + L L + D A GMEYL
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFL----RTEGARLRVKTLLQMVGDAAAGMEYLE--- 230
Query: 749 RQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGY----LAPEYA 804
+ IHRDL + N L+ + K+SDFG+ + DG G APE
Sbjct: 231 SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV---YAASGGLRQVPVKWTAPEAL 287
Query: 805 VMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPA 864
G+ ++++DV+S+G++L E + P + +
Sbjct: 288 NYGRYSSESDVWSFGILLWETFS-----LGASP---------YPNLS------------- 320
Query: 865 LEVNEETFESIS-------------IVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWR 911
N++T E + V L C A EP RP + L + ++ R
Sbjct: 321 ---NQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRHR 377
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 3e-47
Identities = 65/208 (31%), Positives = 109/208 (52%), Gaps = 20/208 (9%)
Query: 630 ENELGRGGFGTVYKGELE-----DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRH 684
+LG+G FG+V + G +AVK+++ T + L +F+ EI +L ++H +
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDN 72
Query: 685 LVSLLGYSIEGNER--LLVYEYMPHGALSRHLFRWE-KLQLKPLSWTRRLSIALDVARGM 741
+V G R L+ EY+P+G+L +L + + ++ L L + +GM
Sbjct: 73 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGM 127
Query: 742 EYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTF--GYL 799
EYL + +IHRDL + NIL++++ R K+ DFGL K+ P ++ + G +
Sbjct: 128 EYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY 184
Query: 800 APEYAVMGKITTKADVFSYGVVLMELLT 827
APE K + +DV+S+GVVL EL T
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFT 212
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 5e-47
Identities = 65/208 (31%), Positives = 109/208 (52%), Gaps = 20/208 (9%)
Query: 630 ENELGRGGFGTVYKGELE-----DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRH 684
+LG+G FG+V + G +AVK+++ T + L +F+ EI +L ++H +
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDN 103
Query: 685 LVSLLGYSIEGNER--LLVYEYMPHGALSRHLFRWE-KLQLKPLSWTRRLSIALDVARGM 741
+V G R L+ EY+P+G+L +L + + ++ L L + +GM
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGM 158
Query: 742 EYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTF--GYL 799
EYL + +IHRDL + NIL++++ R K+ DFGL K+ P ++ + G +
Sbjct: 159 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY 215
Query: 800 APEYAVMGKITTKADVFSYGVVLMELLT 827
APE K + +DV+S+GVVL EL T
Sbjct: 216 APESLTESKFSVASDVWSFGVVLYELFT 243
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 7e-47
Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 19/208 (9%)
Query: 630 ENELGRGGFGTVYKGELE-----DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRH 684
+LG G FG V + G ++AVK ++ + + + + EI +L + H +
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE-SGGNHIADLKKEIEILRNLYHEN 84
Query: 685 LVSLLG--YSIEGNERLLVYEYMPHGALSRHLFRWE-KLQLKPLSWTRRLSIALDVARGM 741
+V G GN L+ E++P G+L +L + + K+ LK L A+ + +GM
Sbjct: 85 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQ-----LKYAVQICKGM 139
Query: 742 EYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTF--GYL 799
+YL + ++HRDL + N+L++ +++ K+ DFGL K ++ + +
Sbjct: 140 DYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY 196
Query: 800 APEYAVMGKITTKADVFSYGVVLMELLT 827
APE + K +DV+S+GV L ELLT
Sbjct: 197 APECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 1e-46
Identities = 61/204 (29%), Positives = 104/204 (50%), Gaps = 14/204 (6%)
Query: 629 QENELGRGGFGTVYKGELEDG---TKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHL 685
++ ELG G FGTV KG + +AVK ++ DE +E V+ ++ + ++
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 686 VSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLH 745
V ++G E +LV E G L+++L + ++ K + + + V+ GM+YL
Sbjct: 81 VRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVSMGMKYL- 133
Query: 746 CLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTF--GYLAPEY 803
F+HRDL + N+LL + AK+SDFGL K E + G + + APE
Sbjct: 134 --EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 191
Query: 804 AVMGKITTKADVFSYGVVLMELLT 827
K ++K+DV+S+GV++ E +
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFS 215
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 3e-46
Identities = 69/207 (33%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 630 ENELGRGGFGTVYKGELED-----GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRH 684
+LG G FG V + G +AVK ++A + ++ EI +L + H H
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEH 94
Query: 685 LVSLLGYSIEGNER--LLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGME 742
++ G + LV EY+P G+L +L + L L L A + GM
Sbjct: 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQL-----LLFAQQICEGMA 148
Query: 743 YLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTF--GYLA 800
YLH Q +IHRDL + N+LLD+D K+ DFGL K P+G + R G + A
Sbjct: 149 YLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 205
Query: 801 PEYAVMGKITTKADVFSYGVVLMELLT 827
PE K +DV+S+GV L ELLT
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 4e-46
Identities = 63/201 (31%), Positives = 99/201 (49%), Gaps = 16/201 (7%)
Query: 630 ENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLL 689
E+G G FG V+ G + K+A+K + G + ++F E V+ K+ H LV L
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLY 69
Query: 690 GYSIEGNERLLVYEYMPHGALSRHL-FRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLA 748
G +E LV E+M HG LS +L + + L L + LDV GM YL
Sbjct: 70 GVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDVCEGMAYL---E 121
Query: 749 RQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGY--LAPEYAVM 806
IHRDL + N L+ ++ KVSDFG+ + D + + F +PE
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWASPEVFSF 179
Query: 807 GKITTKADVFSYGVVLMELLT 827
+ ++K+DV+S+GV++ E+ +
Sbjct: 180 SRYSSKSDVWSFGVLMWEVFS 200
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 7e-46
Identities = 64/200 (32%), Positives = 100/200 (50%), Gaps = 14/200 (7%)
Query: 630 ENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLL 689
ELG G FG V G+ + +AVK ++ G + DEF E + K+ H LV
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFY 69
Query: 690 GYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLAR 749
G + +V EY+ +G L +L R L+P ++ L + DV GM +L
Sbjct: 70 GVCSKEYPIYIVTEYISNGCLLNYL-RSHGKGLEP---SQLLEMCYDVCEGMAFL---ES 122
Query: 750 QTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGY--LAPEYAVMG 807
FIHRDL + N L+D D KVSDFG+ + D + V+ + F APE
Sbjct: 123 HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ--YVSSVGTKFPVKWSAPEVFHYF 180
Query: 808 KITTKADVFSYGVVLMELLT 827
K ++K+DV+++G+++ E+ +
Sbjct: 181 KYSSKSDVWAFGILMWEVFS 200
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 2e-45
Identities = 64/205 (31%), Positives = 109/205 (53%), Gaps = 15/205 (7%)
Query: 630 ENELGRGGFGTVYKGEL-----EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRH 684
+ +G G FG VYKG L + +A+K ++AG T K +F E ++ + H +
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHN 107
Query: 685 LVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYL 744
++ L G + +++ EYM +GAL + L R + + L + + + +A GM+YL
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFL-REKDGEFSVL---QLVGMLRGIAAGMKYL 163
Query: 745 HCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGY--LAPE 802
A ++HRDL + NIL++ + KVSDFGL ++ D ++ T G APE
Sbjct: 164 ---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 220
Query: 803 YAVMGKITTKADVFSYGVVLMELLT 827
K T+ +DV+S+G+V+ E++T
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMT 245
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 2e-45
Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 24/214 (11%)
Query: 630 ENELGRGGFGTVYKGELEDG----TKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHL 685
LG G FG+V +G L+ K+AVK M+ ++ + ++EF SE A + H ++
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 686 VSLLGYSIEGN-----ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRR--LSIALDVA 738
+ LLG IE + + +++ +M +G L +L + +L+ P + L +D+A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL-LYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 739 RGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGY 798
GMEY L+ + F+HRDL + N +L DD V+DFG L+ R G
Sbjct: 158 LGMEY---LSNRNFLHRDLAARNCMLRDDMTVCVADFG---LSKKIYSGDYYR-QGRIAK 210
Query: 799 L-----APEYAVMGKITTKADVFSYGVVLMELLT 827
+ A E T+K+DV+++GV + E+ T
Sbjct: 211 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 2e-45
Identities = 62/203 (30%), Positives = 98/203 (48%), Gaps = 20/203 (9%)
Query: 630 ENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLL 689
ELG G FG V G+ +A+K ++ G + DEF E V+ + H LV L
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLY 85
Query: 690 GYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLAR 749
G + ++ EYM +G L +L R + + + + L + DV MEYL
Sbjct: 86 GVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQT---QQLLEMCKDVCEAMEYL---ES 138
Query: 750 QTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYL-----APEYA 804
+ F+HRDL + N L++D KVSDFGL + D E T G PE
Sbjct: 139 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVG--SKFPVRWSPPEVL 193
Query: 805 VMGKITTKADVFSYGVVLMELLT 827
+ K ++K+D++++GV++ E+ +
Sbjct: 194 MYSKFSSKSDIWAFGVLMWEIYS 216
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 3e-45
Identities = 70/220 (31%), Positives = 108/220 (49%), Gaps = 31/220 (14%)
Query: 630 ENELGRGGFGTVYKGEL------EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHR 683
+ ELG G FG V+ E +D +AVK ++ T A +FQ E +L+ ++H
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAELLTNLQHE 77
Query: 684 HLVSLLGYSIEGNERLLVYEYMPHGALSRHL-----------FRWEKLQLKPLSWTRRLS 732
H+V G +G+ ++V+EYM HG L++ L + L ++ L
Sbjct: 78 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 733 IALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRL 792
IA +A GM Y LA Q F+HRDL + N L+ + K+ DFG ++ D + R
Sbjct: 138 IASQIASGMVY---LASQHFVHRDLATRNCLVGANLLVKIGDFG---MSRDVYSTDYYR- 190
Query: 793 AGTFGYL-----APEYAVMGKITTKADVFSYGVVLMELLT 827
G L PE + K TT++DV+S+GV+L E+ T
Sbjct: 191 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 3e-45
Identities = 66/208 (31%), Positives = 99/208 (47%), Gaps = 20/208 (9%)
Query: 630 ENELGRGGFGTVYKGEL-----EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRH 684
++LG+G FG+V G +AVK+++ +FQ EI +L +
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDF 85
Query: 685 LVSLLGYSIEGNER--LLVYEYMPHGALSRHLFRWE-KLQLKPLSWTRRLSIALDVARGM 741
+V G S + LV EY+P G L L R +L L L + + +GM
Sbjct: 86 IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRL-----LLYSSQICKGM 140
Query: 742 EYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTF--GYL 799
EYL + +HRDL + NIL++ + K++DFGL KL P + V R G +
Sbjct: 141 EYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 197
Query: 800 APEYAVMGKITTKADVFSYGVVLMELLT 827
APE + ++DV+S+GVVL EL T
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 4e-45
Identities = 61/204 (29%), Positives = 100/204 (49%), Gaps = 14/204 (6%)
Query: 630 ENELGRGGFGTVYKGEL----EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHL 685
E +G G G V G L + +A+K ++AG T + +F SE +++ + H ++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG-YTERQRRDFLSEASIMGQFDHPNI 112
Query: 686 VSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLH 745
+ L G G ++V EYM +G+L L R Q + + + V GM YL
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFL-RTHDGQFTI---MQLVGMLRGVGAGMRYL- 167
Query: 746 CLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYL--APEY 803
+ ++HRDL + N+L+D + KVSDFGL ++ D + T G APE
Sbjct: 168 --SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEA 225
Query: 804 AVMGKITTKADVFSYGVVLMELLT 827
++ +DV+S+GVV+ E+L
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLA 249
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 5e-45
Identities = 60/205 (29%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 630 ENELGRGGFGTVYKGEL----EDGTKIAVKRMEAGVTTT-KALDEFQSEIAVLSKVRHRH 684
+LG G FG V +GE +AVK ++ V + +A+D+F E+ + + HR+
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 685 LVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYL 744
L+ L G + +V E P G+L L R + A+ VA GM YL
Sbjct: 83 LIRLYGV-VLTPPMKMVTELAPLGSLLDRL-RKHQGHFLL---GTLSRYAVQVAEGMGYL 137
Query: 745 HCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGY--LAPE 802
+ FIHRDL + N+LL K+ DFGL++ P + V + + APE
Sbjct: 138 ---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 194
Query: 803 YAVMGKITTKADVFSYGVVLMELLT 827
+ +D + +GV L E+ T
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 9e-45
Identities = 61/215 (28%), Positives = 102/215 (47%), Gaps = 25/215 (11%)
Query: 630 ENELGRGGFGTVYKGELEDG----TKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHL 685
LG+G FG+V + +L+ K+AVK ++A + + ++EF E A + + H H+
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 686 VSLLGYSIEGNER------LLVYEYMPHGALSRHLFRWEKLQLKP--LSWTRRLSIALDV 737
L+G S+ + +++ +M HG L L ++ P L + +D+
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL-LASRIGENPFNLPLQTLVRFMVDI 146
Query: 738 ARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFG 797
A GMEYL + + FIHRDL + N +L +D V+DFG L+ R G
Sbjct: 147 ACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFG---LSRKIYSGDYYR-QGCAS 199
Query: 798 YL-----APEYAVMGKITTKADVFSYGVVLMELLT 827
L A E T +DV+++GV + E++T
Sbjct: 200 KLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 9e-45
Identities = 58/220 (26%), Positives = 97/220 (44%), Gaps = 30/220 (13%)
Query: 630 ENELGRGGFGTVYKGEL------EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHR 683
ELG FG VYKG L E +A+K ++ +EF+ E + ++++H
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK-AEGPLREEFRHEAMLRARLQHP 72
Query: 684 HLVSLLGYSIEGNERLLVYEYMPHGALSRHL-----------FRWEKLQLKPLSWTRRLS 732
++V LLG + +++ Y HG L L ++ L +
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 733 IALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRL 792
+ +A GMEY L+ +H+DL + N+L+ D K+SD G L + + +
Sbjct: 133 LVAQIAAGMEY---LSSHHVVHKDLATRNVLVYDKLNVKISDLG---LFREVYAADYYK- 185
Query: 793 AGTFGYL-----APEYAVMGKITTKADVFSYGVVLMELLT 827
L APE + GK + +D++SYGVVL E+ +
Sbjct: 186 LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 1e-44
Identities = 59/203 (29%), Positives = 103/203 (50%), Gaps = 14/203 (6%)
Query: 630 ENELGRGGFGTVYKGELEDG---TKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLV 686
+ ELG G FG+V +G +A+K ++ G T +E E ++ ++ + ++V
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIV 73
Query: 687 SLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHC 746
L+G + +LV E G L + L ++ ++ + + V+ GM+YL
Sbjct: 74 RLIGV-CQAEALMLVMEMAGGGPLHKFL-VGKREEI---PVSNVAELLHQVSMGMKYL-- 126
Query: 747 LARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTF--GYLAPEYA 804
+ F+HRDL + N+LL + + AK+SDFGL K + R AG + + APE
Sbjct: 127 -EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 185
Query: 805 VMGKITTKADVFSYGVVLMELLT 827
K ++++DV+SYGV + E L+
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALS 208
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-44
Identities = 69/210 (32%), Positives = 106/210 (50%), Gaps = 24/210 (11%)
Query: 630 ENELGRGGFGTVYKGELEDG----TKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHL 685
+ +G+G FG VY GE D + A+K + T + ++ F E ++ + H ++
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNV 84
Query: 686 VSLLGYSIEGNERLL-VYEYMPHGALSRHLFRWEK--LQLKPLSWTRRLSIALDVARGME 742
++L+G + + YM HG L + + R + +K L +S L VARGME
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFI-RSPQRNPTVKDL-----ISFGLQVARGME 138
Query: 743 YLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYL--- 799
YL A Q F+HRDL + N +LD+ + KV+DFGL + D E + L
Sbjct: 139 YL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE--YYSVQQHRHARLPVK 193
Query: 800 --APEYAVMGKITTKADVFSYGVVLMELLT 827
A E + TTK+DV+S+GV+L ELLT
Sbjct: 194 WTALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 2e-44
Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 19/206 (9%)
Query: 630 ENELGRGGFGTVYKGELEDG-----TKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRH 684
LG G FGTVYKG +A+K + T+ KA E E V++ V + H
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPH 78
Query: 685 LVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYL 744
+ LLG + L+ + MP G L ++ R K + L+ + +A+GM YL
Sbjct: 79 VCRLLGI-CLTSTVQLITQLMPFGCLLDYV-REHKDNIGS---QYLLNWCVQIAKGMNYL 133
Query: 745 HCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGE---KSVVTRLAGTFGYLAP 801
+ +HRDL + N+L+ K++DFGL KL E + ++ ++A
Sbjct: 134 ---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--IKWMAL 188
Query: 802 EYAVMGKITTKADVFSYGVVLMELLT 827
E + T ++DV+SYGV + EL+T
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-44
Identities = 68/213 (31%), Positives = 106/213 (49%), Gaps = 24/213 (11%)
Query: 631 NELGRGGFGTVYKGEL------EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRH 684
ELG+G FG VY+G E T++A+K + + + EF +E +V+ + H
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHH 89
Query: 685 LVSLLGYSIEGNERLLVYEYMPHGALSRHL-----FRWEKLQLKPLSWTRRLSIALDVAR 739
+V LLG +G L++ E M G L +L L P S ++ + +A ++A
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 740 GMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYL 799
GM Y L F+HRDL + N ++ +D+ K+ DFG + D ++ R G G L
Sbjct: 150 GMAY---LNANKFVHRDLAARNCMVAEDFTVKIGDFG---MTRDIYETDYYR-KGGKGLL 202
Query: 800 -----APEYAVMGKITTKADVFSYGVVLMELLT 827
+PE G TT +DV+S+GVVL E+ T
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 3e-44
Identities = 59/201 (29%), Positives = 103/201 (51%), Gaps = 14/201 (6%)
Query: 630 ENELGRGGFGTVYKGELEDG-TKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSL 688
+++LG G +G VY+G + +AVK ++ +EF E AV+ +++H +LV L
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPNLVQL 74
Query: 689 LGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLA 748
LG ++ E+M +G L +L + ++ L +A ++ MEYL
Sbjct: 75 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA---VVLLYMATQISSAMEYL---E 128
Query: 749 RQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGE--KSVVTRLAGTFGYLAPEYAVM 806
++ FIHRDL + N L+ +++ KV+DFGL +L + + APE
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPESLAY 186
Query: 807 GKITTKADVFSYGVVLMELLT 827
K + K+DV+++GV+L E+ T
Sbjct: 187 NKFSIKSDVWAFGVLLWEIAT 207
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 3e-44
Identities = 64/214 (29%), Positives = 100/214 (46%), Gaps = 24/214 (11%)
Query: 630 ENELGRGGFGTVYKGEL------EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHR 683
LG G FG VY+G++ ++AVK + + + +F E ++SK H+
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQ 93
Query: 684 HLVSLLGYSIEGNERLLVYEYMPHGALSRHL--FRWEKLQLKPLSWTRRLSIALDVARGM 741
++V +G S++ R ++ E M G L L R Q L+ L +A D+A G
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 742 EYLHCLARQTFIHRDLKSSNILLD---DDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGY 798
+Y L FIHRD+ + N LL AK+ DFG +A D ++ R G
Sbjct: 154 QY---LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG---MARDIYRASYYR-KGGCAM 206
Query: 799 L-----APEYAVMGKITTKADVFSYGVVLMELLT 827
L PE + G T+K D +S+GV+L E+ +
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 3e-44
Identities = 73/219 (33%), Positives = 108/219 (49%), Gaps = 30/219 (13%)
Query: 630 ENELGRGGFGTVYKGEL------EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHR 683
+ ELG G FG V+ E +D +AVK ++ + A +FQ E +L+ ++H+
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQ 103
Query: 684 HLVSLLGYSIEGNERLLVYEYMPHGAL----------SRHLFRWEKLQLKPLSWTRRLSI 733
H+V G EG L+V+EYM HG L ++ L E + PL + L++
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 734 ALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLA 793
A VA GM Y LA F+HRDL + N L+ K+ DFG ++ D + R
Sbjct: 164 ASQVAAGMVY---LAGLHFVHRDLATRNCLVGQGLVVKIGDFG---MSRDIYSTDYYR-V 216
Query: 794 GTFGYL-----APEYAVMGKITTKADVFSYGVVLMELLT 827
G L PE + K TT++DV+S+GVVL E+ T
Sbjct: 217 GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 4e-44
Identities = 72/218 (33%), Positives = 106/218 (48%), Gaps = 31/218 (14%)
Query: 630 ENELGRGGFGTVYKGELEDG---TKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHL 685
++ +G G FG V K ++ A+KRM+ + +F E+ VL K+ H ++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 686 VSLLGYSIEGNERLLVYEYMPHGALSRHL-----------FRWEKLQLKPLSWTRRLSIA 734
++LLG L EY PHG L L F LS + L A
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 735 LDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAG 794
DVARGM+YL +++ FIHRDL + NIL+ ++Y AK++DFG L+ E +
Sbjct: 149 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFG---LSRGQE----VYVKK 198
Query: 795 TFGYL-----APEYAVMGKITTKADVFSYGVVLMELLT 827
T G L A E TT +DV+SYGV+L E+++
Sbjct: 199 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 5e-44
Identities = 62/200 (31%), Positives = 104/200 (52%), Gaps = 14/200 (7%)
Query: 630 ENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLL 689
LG G FG V+ G TK+AVK ++ G + D F +E ++ +++H+ LV L
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLY 74
Query: 690 GYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLAR 749
+ ++ EYM +G+L L ++L + L +A +A GM ++
Sbjct: 75 A-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTI---NKLLDMAAQIAEGMAFI---EE 127
Query: 750 QTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGE--KSVVTRLAGTFGYLAPEYAVMG 807
+ +IHRDL+++NIL+ D K++DFGL +L D E + + APE G
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP--IKWTAPEAINYG 185
Query: 808 KITTKADVFSYGVVLMELLT 827
T K+DV+S+G++L E++T
Sbjct: 186 TFTIKSDVWSFGILLTEIVT 205
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 6e-44
Identities = 60/204 (29%), Positives = 105/204 (51%), Gaps = 14/204 (6%)
Query: 630 ENELGRGGFGTVYKGEL----EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHL 685
+ +G G FG V G L + +A+K ++ G T K +F E +++ + H ++
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGEASIMGQFDHPNI 108
Query: 686 VSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLH 745
+ L G + ++V EYM +G+L L R Q + + + + +A GM+YL
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVI---QLVGMLRGIASGMKYL- 163
Query: 746 CLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYL--APEY 803
+ ++HRDL + NIL++ + KVSDFGL ++ D ++ T G +PE
Sbjct: 164 --SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 804 AVMGKITTKADVFSYGVVLMELLT 827
K T+ +DV+SYG+VL E+++
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMS 245
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 9e-44
Identities = 63/228 (27%), Positives = 100/228 (43%), Gaps = 38/228 (16%)
Query: 630 ENELGRGGFGTVYKGEL------EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHR 683
LG G FG V K T +AVK ++ + L + SE VL +V H
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHP 86
Query: 684 HLVSLLGYSIEGNERLLVYEYMPHGALSRHL-------------------FRWEKLQLKP 724
H++ L G + LL+ EY +G+L L + +
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 725 LSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG 784
L+ +S A +++GM+YL A +HRDL + NIL+ + + K+SDFGL + D
Sbjct: 147 LTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGL---SRDV 200
Query: 785 EKSVVTRLAGTFGYL-----APEYAVMGKITTKADVFSYGVVLMELLT 827
+ + G + A E TT++DV+S+GV+L E++T
Sbjct: 201 YEEDSYV-KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-43
Identities = 62/223 (27%), Positives = 106/223 (47%), Gaps = 33/223 (14%)
Query: 630 ENELGRGGFGTVYKGEL--------EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV- 680
LG G FG V E ++ +AVK ++ T K L + SE+ ++ +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIG 98
Query: 681 RHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHL-----------FRWEKLQLKPLSWTR 729
+H+++++LLG + ++ EY G L +L + ++ + +++
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 730 RLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVV 789
+S +ARGMEYL A Q IHRDL + N+L+ ++ K++DFG LA D
Sbjct: 159 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFG---LARDINNIDY 212
Query: 790 TRLAGTFGYL-----APEYAVMGKITTKADVFSYGVVLMELLT 827
+ T G L APE T ++DV+S+GV++ E+ T
Sbjct: 213 YK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 1e-43
Identities = 59/201 (29%), Positives = 105/201 (52%), Gaps = 14/201 (6%)
Query: 630 ENELGRGGFGTVYKGELED-GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSL 688
+++LG G +G VY+G + +AVK ++ ++EF E AV+ +++H +LV L
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQL 281
Query: 689 LGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLA 748
LG ++ E+M +G L +L + + +S L +A ++ MEYL
Sbjct: 282 LGVCTREPPFYIITEFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYL---E 335
Query: 749 RQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGE--KSVVTRLAGTFGYLAPEYAVM 806
++ FIHR+L + N L+ +++ KV+DFGL +L + + APE
Sbjct: 336 KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPESLAY 393
Query: 807 GKITTKADVFSYGVVLMELLT 827
K + K+DV+++GV+L E+ T
Sbjct: 394 NKFSIKSDVWAFGVLLWEIAT 414
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 2e-43
Identities = 70/209 (33%), Positives = 99/209 (47%), Gaps = 22/209 (10%)
Query: 630 ENELGRGGFGTVYKGELEDG----TKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHL 685
+GRG FG VY G L D AVK + T + +F +E ++ H ++
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNV 88
Query: 686 VSLLGYSIEGNE-RLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYL 744
+SLLG + L+V YM HG L + R E + L VA+GM+YL
Sbjct: 89 LSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTV---KDLIGFGLQVAKGMKYL 144
Query: 745 HCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYL----- 799
A + F+HRDL + N +LD+ + KV+DFG LA D + G
Sbjct: 145 ---ASKKFVHRDLAARNCMLDEKFTVKVADFG---LARDMYDKEYYSVHNKTGAKLPVKW 198
Query: 800 -APEYAVMGKITTKADVFSYGVVLMELLT 827
A E K TTK+DV+S+GV+L EL+T
Sbjct: 199 MALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 3e-43
Identities = 64/214 (29%), Positives = 100/214 (46%), Gaps = 24/214 (11%)
Query: 630 ENELGRGGFGTVYKGEL------EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHR 683
LG G FG VY+G++ ++AVK + + + +F E ++SK H+
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQ 134
Query: 684 HLVSLLGYSIEGNERLLVYEYMPHGALSRHL--FRWEKLQLKPLSWTRRLSIALDVARGM 741
++V +G S++ R ++ E M G L L R Q L+ L +A D+A G
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194
Query: 742 EYLHCLARQTFIHRDLKSSNILLD---DDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGY 798
+Y L FIHRD+ + N LL AK+ DFG +A D ++ R G
Sbjct: 195 QY---LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG---MARDIYRAGYYR-KGGCAM 247
Query: 799 L-----APEYAVMGKITTKADVFSYGVVLMELLT 827
L PE + G T+K D +S+GV+L E+ +
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 4e-43
Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 17/204 (8%)
Query: 630 ENELGRGGFGTVYKGEL----EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHL 685
LG G FG VY+G + +AVK + T ++F SE ++ + H H+
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD-CTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 686 VSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLH 745
V L+G IE ++ E P+G L +L K LK L + +L + + M YL
Sbjct: 76 VKLIGI-IEEEPTWIIMELYPYGELGHYL-ERNKNSLKVL---TLVLYSLQICKAMAYL- 129
Query: 746 CLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGE--KSVVTRLAGTFGYLAPEY 803
+HRD+ NIL+ K+ DFGL + D + K+ VTRL +++PE
Sbjct: 130 --ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP--IKWMSPES 185
Query: 804 AVMGKITTKADVFSYGVVLMELLT 827
+ TT +DV+ + V + E+L+
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILS 209
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 4e-43
Identities = 50/204 (24%), Positives = 88/204 (43%), Gaps = 17/204 (8%)
Query: 630 ENELGRGGFGTVYKGELEDG----TKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHL 685
+G G FG V++G +A+K + T+ ++F E + + H H+
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHI 78
Query: 686 VSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLH 745
V L+G I N ++ E G L L + K L + A ++ + YL
Sbjct: 79 VKLIGV-ITENPVWIIMELCTLGELRSFL-QVRKYSLDL---ASLILYAYQLSTALAYL- 132
Query: 746 CLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTF--GYLAPEY 803
+ F+HRD+ + N+L+ + K+ DFGL + D G ++APE
Sbjct: 133 --ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST--YYKASKGKLPIKWMAPES 188
Query: 804 AVMGKITTKADVFSYGVVLMELLT 827
+ T+ +DV+ +GV + E+L
Sbjct: 189 INFRRFTSASDVWMFGVCMWEILM 212
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 6e-43
Identities = 62/223 (27%), Positives = 106/223 (47%), Gaps = 33/223 (14%)
Query: 630 ENELGRGGFGTVYKGEL--------EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV- 680
LG G FG V E ++ +AVK ++ T K L + SE+ ++ +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIG 144
Query: 681 RHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHL-----------FRWEKLQLKPLSWTR 729
+H+++++LLG + ++ EY G L +L + ++ + +++
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 730 RLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVV 789
+S +ARGMEYL A Q IHRDL + N+L+ ++ K++DFG LA D
Sbjct: 205 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFG---LARDINNIDY 258
Query: 790 TRLAGTFGYL-----APEYAVMGKITTKADVFSYGVVLMELLT 827
+ T G L APE T ++DV+S+GV++ E+ T
Sbjct: 259 YK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 6e-43
Identities = 63/204 (30%), Positives = 102/204 (50%), Gaps = 15/204 (7%)
Query: 630 ENELGRGGFGTVYKGELEDG-----TKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRH 684
LG G FGTV+KG + +K +E + ++ + + + H H
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK-SGRQSFQAVTDHMLAIGSLDHAH 76
Query: 685 LVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYL 744
+V LLG G+ LV +Y+P G+L H+ R + L P L+ + +A+GM YL
Sbjct: 77 IVRLLGL-CPGSSLQLVTQYLPLGSLLDHV-RQHRGALGP---QLLLNWGVQIAKGMYYL 131
Query: 745 HCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGT-FGYLAPEY 803
+HR+L + N+LL + +V+DFG+ L P +K ++ A T ++A E
Sbjct: 132 ---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALES 188
Query: 804 AVMGKITTKADVFSYGVVLMELLT 827
GK T ++DV+SYGV + EL+T
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELMT 212
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 6e-43
Identities = 65/221 (29%), Positives = 98/221 (44%), Gaps = 32/221 (14%)
Query: 631 NELGRGGFGTVYKGEL------EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHR 683
LGRG FG V + + +AVK ++ G T SE+ +L + H
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHL 91
Query: 684 HLVSLLGY-SIEGNERLLVYEYMPHGALSRHL-----------FRWEKLQLKPLSWTRRL 731
++V+LLG + G +++ E+ G LS +L E L L+ +
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 732 SIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTR 791
+ VA+GME+L A + IHRDL + NILL + K+ DFG LA D K
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFG---LARDIYKDPDYV 205
Query: 792 LAGTFGYL-----APEYAVMGKITTKADVFSYGVVLMELLT 827
L APE T ++DV+S+GV+L E+ +
Sbjct: 206 -RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 8e-43
Identities = 61/200 (30%), Positives = 101/200 (50%), Gaps = 14/200 (7%)
Query: 630 ENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLL 689
E +LG G FG V+ TK+AVK M+ G + ++ F +E V+ ++H LV L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLH 249
Query: 690 GYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLAR 749
+ ++ E+M G+L L E + + + +A GM ++ +
Sbjct: 250 A-VVTKEPIYIITEFMAKGSLLDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFI---EQ 302
Query: 750 QTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGY--LAPEYAVMG 807
+ +IHRDL+++NIL+ K++DFGL ++ D E R F APE G
Sbjct: 303 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE--YTAREGAKFPIKWTAPEAINFG 360
Query: 808 KITTKADVFSYGVVLMELLT 827
T K+DV+S+G++LME++T
Sbjct: 361 SFTIKSDVWSFGILLMEIVT 380
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 8e-43
Identities = 59/227 (25%), Positives = 96/227 (42%), Gaps = 45/227 (19%)
Query: 630 ENELGRGGFGTVYKGEL------EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RH 682
LG G FG V + + K+AVK +++ + SE+ ++S + +H
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST-AHADEKEALMSELKIMSHLGQH 109
Query: 683 RHLVSLLGYSIEGNERLLVYEYMPHGALSRHL---------FRWEKLQLKPLSWTRRLSI 733
++V+LLG G L++ EY +G L L + S L
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 734 ALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTR-- 791
+ VA+GM +L A + IHRD+ + N+LL + + AK+ DFGL R
Sbjct: 170 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGL------------ARDI 214
Query: 792 ------LAGTFGYL-----APEYAVMGKITTKADVFSYGVVLMELLT 827
+ L APE T ++DV+SYG++L E+ +
Sbjct: 215 MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 8e-43
Identities = 67/223 (30%), Positives = 104/223 (46%), Gaps = 33/223 (14%)
Query: 630 ENELGRGGFGTVYKGEL--------EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV- 680
LG G FG V E TK+AVK +++ T K L + SE+ ++ +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIG 132
Query: 681 RHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHL-----------FRWEKLQLKPLSWTR 729
+H+++++LLG + ++ EY G L +L + + LS
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 730 RLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVV 789
+S A VARGMEYL A + IHRDL + N+L+ +D K++DFGL + +
Sbjct: 193 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID---- 245
Query: 790 TRLAGTFGYL-----APEYAVMGKITTKADVFSYGVVLMELLT 827
T G L APE T ++DV+S+GV+L E+ T
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 1e-42
Identities = 69/201 (34%), Positives = 104/201 (51%), Gaps = 20/201 (9%)
Query: 630 ENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLL 689
+G+G FG V G+ G K+AVK ++ T F +E +V++++RH +LV LL
Sbjct: 26 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA----QAFLAEASVMTQLRHSNLVQLL 80
Query: 690 GYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLA 748
G +E L +V EYM G+L +L + L L +LDV MEYL
Sbjct: 81 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYL---E 134
Query: 749 RQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGY--LAPEYAVM 806
F+HRDL + N+L+ +D AKVSDFGL + + + G APE
Sbjct: 135 GNNFVHRDLAARNVLVSEDNVAKVSDFGL---TKEASST---QDTGKLPVKWTAPEALRE 188
Query: 807 GKITTKADVFSYGVVLMELLT 827
K +TK+DV+S+G++L E+ +
Sbjct: 189 KKFSTKSDVWSFGILLWEIYS 209
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-42
Identities = 81/288 (28%), Positives = 122/288 (42%), Gaps = 33/288 (11%)
Query: 563 HPRDPSDPENMVKIAVSNDTARSLSSQTVASSGSTNSGATENSHVIESGTLVISVQVLRK 622
H R + + + + + S S+ +EN + + T+ I + L
Sbjct: 14 HGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNP 73
Query: 623 VTQNFAQE-------------NELGRGGFGTVYKGELEDG----TKIAVKRMEAGVTTTK 665
Q +GRG FG VY G L D AVK + T
Sbjct: 74 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIG 132
Query: 666 ALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNE-RLLVYEYMPHGALSRHLFRWEKLQLKP 724
+ +F +E ++ H +++SLLG + L+V YM HG L + R E
Sbjct: 133 EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTV 191
Query: 725 LSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG 784
+ L VA+GM++L A + F+HRDL + N +LD+ + KV+DFGL + D
Sbjct: 192 ---KDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245
Query: 785 EKSVVTRLAGTFGYL-----APEYAVMGKITTKADVFSYGVVLMELLT 827
E V T L A E K TTK+DV+S+GV+L EL+T
Sbjct: 246 EFDSVH--NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-42
Identities = 64/223 (28%), Positives = 92/223 (41%), Gaps = 33/223 (14%)
Query: 630 ENELGRGGFGTVYKGEL------EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RH 682
LG G FG V + + +AVK ++ + SE+ VLS + H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNH 86
Query: 683 RHLVSLLGYSIEGNERLLVYEYMPHGAL-------------SRHLFRWEKLQLKPLSWTR 729
++V+LLG G L++ EY +G L S+ + L
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 730 RLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVV 789
LS + VA+GM +L A + IHRDL + NILL K+ DFG LA D +
Sbjct: 147 LLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFG---LARDIKNDSN 200
Query: 790 TRLAGTFGYL-----APEYAVMGKITTKADVFSYGVVLMELLT 827
L APE T ++DV+SYG+ L EL +
Sbjct: 201 YV-VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-42
Identities = 63/228 (27%), Positives = 105/228 (46%), Gaps = 38/228 (16%)
Query: 630 ENELGRGGFGTVYKGELEDG------TKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHR 683
++G G FG V++ T +AVK ++ + +FQ E A++++ +
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNP 110
Query: 684 HLVSLLGYSIEGNERLLVYEYMPHGALSRHL-------------------FRWEKLQLKP 724
++V LLG G L++EYM +G L+ L R P
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 725 LSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG 784
LS +L IA VA GM Y L+ + F+HRDL + N L+ ++ K++DFG L+ +
Sbjct: 171 LSCAEQLCIARQVAAGMAY---LSERKFVHRDLATRNCLVGENMVVKIADFG---LSRNI 224
Query: 785 EKSVVTRLAGTFGYL-----APEYAVMGKITTKADVFSYGVVLMELLT 827
+ + A + PE + TT++DV++YGVVL E+ +
Sbjct: 225 YSADYYK-ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 3e-42
Identities = 67/198 (33%), Positives = 107/198 (54%), Gaps = 10/198 (5%)
Query: 630 ENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLL 689
E +LG+G FG V+ G T++A+K ++ G + + F E V+ K+RH LV L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLY 245
Query: 690 GYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLAR 749
+ +V EYM G+L L + K L + + +A +A GM Y+ R
Sbjct: 246 AV-VSEEPIYIVTEYMSKGSLLDFL---KGETGKYLRLPQLVDMAAQIASGMAYV---ER 298
Query: 750 QTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKI 809
++HRDL+++NIL+ ++ KV+DFGL +L D E + + APE A+ G+
Sbjct: 299 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 358
Query: 810 TTKADVFSYGVVLMELLT 827
T K+DV+S+G++L EL T
Sbjct: 359 TIKSDVWSFGILLTELTT 376
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-42
Identities = 60/228 (26%), Positives = 99/228 (43%), Gaps = 38/228 (16%)
Query: 630 ENELGRGGFGTVYKGEL------EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RH 682
LG G FG V ++AVK ++ + + SE+ +++++ H
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK-ADSSEREALMSELKMMTQLGSH 108
Query: 683 RHLVSLLGYSIEGNERLLVYEYMPHGAL------SRHLFRWEKLQ------------LKP 724
++V+LLG L++EY +G L R F ++++ L
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 725 LSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG 784
L++ L A VA+GME+L ++ +HRDL + N+L+ K+ DFGL A D
Sbjct: 169 LTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGL---ARDI 222
Query: 785 EKSVVTRLAGTFGYL-----APEYAVMGKITTKADVFSYGVVLMELLT 827
L APE G T K+DV+SYG++L E+ +
Sbjct: 223 MSDSNYV-VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 5e-42
Identities = 69/200 (34%), Positives = 104/200 (52%), Gaps = 18/200 (9%)
Query: 630 ENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLL 689
+G+G FG V G+ G K+AVK ++ T F +E +V++++RH +LV LL
Sbjct: 198 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA----QAFLAEASVMTQLRHSNLVQLL 252
Query: 690 GYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLA 748
G +E L +V EYM G+L +L + L L +LDV MEYL
Sbjct: 253 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYL---E 306
Query: 749 RQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG-EKSVVTRLAGTFGYLAPEYAVMG 807
F+HRDL + N+L+ +D AKVSDFG L + +L + APE
Sbjct: 307 GNNFVHRDLAARNVLVSEDNVAKVSDFG---LTKEASSTQDTGKLP--VKWTAPEALREK 361
Query: 808 KITTKADVFSYGVVLMELLT 827
K +TK+DV+S+G++L E+ +
Sbjct: 362 KFSTKSDVWSFGILLWEIYS 381
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 7e-42
Identities = 58/203 (28%), Positives = 102/203 (50%), Gaps = 14/203 (6%)
Query: 630 ENELGRGGFGTVYKGELEDG---TKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLV 686
+ ELG G FG+V +G +A+K ++ G T +E E ++ ++ + ++V
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIV 399
Query: 687 SLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHC 746
L+G + +LV E G L + L ++ ++ + + V+ GM+YL
Sbjct: 400 RLIGV-CQAEALMLVMEMAGGGPLHKFL-VGKREEI---PVSNVAELLHQVSMGMKYL-- 452
Query: 747 LARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGY--LAPEYA 804
+ F+HR+L + N+LL + + AK+SDFGL K + R AG + APE
Sbjct: 453 -EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 511
Query: 805 VMGKITTKADVFSYGVVLMELLT 827
K ++++DV+SYGV + E L+
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALS 534
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 7e-42
Identities = 64/206 (31%), Positives = 97/206 (47%), Gaps = 19/206 (9%)
Query: 630 ENELGRGGFGTVYKGELEDG-----TKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRH 684
LG G FGTVYKG +A+K + T+ KA E E V++ V + H
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPH 78
Query: 685 LVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYL 744
+ LLG + L+ + MP G L ++ R K + L+ + +A+GM YL
Sbjct: 79 VCRLLGI-CLTSTVQLITQLMPFGCLLDYV-REHKDNIGS---QYLLNWCVQIAKGMNYL 133
Query: 745 HCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGT---FGYLAP 801
+ +HRDL + N+L+ K++DFGL KL EK G ++A
Sbjct: 134 ---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE--GGKVPIKWMAL 188
Query: 802 EYAVMGKITTKADVFSYGVVLMELLT 827
E + T ++DV+SYGV + EL+T
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 7e-41
Identities = 67/198 (33%), Positives = 107/198 (54%), Gaps = 10/198 (5%)
Query: 630 ENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLL 689
E +LG+G FG V+ G T++A+K ++ G + + F E V+ K+RH LV L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLY 328
Query: 690 GYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLAR 749
+ +V EYM G+L L + K L + + +A +A GM Y+ R
Sbjct: 329 AV-VSEEPIYIVTEYMSKGSLLDFL---KGETGKYLRLPQLVDMAAQIASGMAYV---ER 381
Query: 750 QTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKI 809
++HRDL+++NIL+ ++ KV+DFGL +L D E + + APE A+ G+
Sbjct: 382 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 441
Query: 810 TTKADVFSYGVVLMELLT 827
T K+DV+S+G++L EL T
Sbjct: 442 TIKSDVWSFGILLTELTT 459
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 1e-40
Identities = 67/353 (18%), Positives = 137/353 (38%), Gaps = 34/353 (9%)
Query: 490 SSGNSPPSPITHPNSNHSSIHVQPQRKSTKRLKLLVVVG---------ISVVVTVVLVVI 540
+ + P+ + N + I ++ L + + + +
Sbjct: 254 TDKGANPTHLADFNQVQT-IQYSNSEDKDRKGMLQLKIAGAPEPLTVTAPSLTIAENMAD 312
Query: 541 LLCIYCCKKRKGTLEAPGSIVVHPRDPSDPENMVKIAVSNDTARSLSSQTVASSGSTNSG 600
L+ YC + A S ++ P+ + ++N+ + + S TV+ S + +
Sbjct: 313 LIDGYC----RLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYA 368
Query: 601 ATENSHVIESGTLVISVQVLRKVTQNFAQENELGRGGFGTVYKGELEDG----TKIAVKR 656
+ + ++ R+ +G G FG V++G +A+K
Sbjct: 369 EIIDEEDTYTMPSTRDYEIQRE---RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKT 425
Query: 657 MEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFR 716
+ T+ ++F E + + H H+V L+G I N ++ E G L L +
Sbjct: 426 CKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFL-Q 482
Query: 717 WEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFG 776
K L + A ++ + YL + F+HRD+ + N+L+ + K+ DFG
Sbjct: 483 VRKFSLDLA---SLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFG 536
Query: 777 LVKLAPDGE--KSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT 827
L + D K+ +L ++APE + T+ +DV+ +GV + E+L
Sbjct: 537 LSRYMEDSTYYKASKGKLP--IKWMAPESINFRRFTSASDVWMFGVCMWEILM 587
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 9e-40
Identities = 50/225 (22%), Positives = 90/225 (40%), Gaps = 43/225 (19%)
Query: 626 NFAQENELGRGGFGTVYKGEL--------EDGTKIAVKRMEAGVTTTKALDEFQSEIAVL 677
+ LG+G F ++KG T++ +K ++ + F +++
Sbjct: 9 DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFFEAASMM 66
Query: 678 SKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDV 737
SK+ H+HLV G + G+E +LV E++ G+L +L + K + L +L +A +
Sbjct: 67 SKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL-KKNKNCINIL---WKLEVAKQL 122
Query: 738 ARGMEYLHCLARQTFIHRDLKSSNILLDDDYR--------AKVSDFGLVKLAPDGEKSVV 789
A M + L T IH ++ + NILL + K+SD G+ +
Sbjct: 123 AAAMHF---LEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD---- 175
Query: 790 TRLAGTFGY------LAPEYAVMGKI-TTKADVFSYGVVLMELLT 827
+ PE K D +S+G L E+ +
Sbjct: 176 -------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-39
Identities = 67/385 (17%), Positives = 123/385 (31%), Gaps = 92/385 (23%)
Query: 62 VFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAY 120
CS ++TQ+ P + T + L L N+ F+ S+L
Sbjct: 9 ADCSHLKLTQV-----------PDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLD 55
Query: 121 LDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVG 180
+ FN + + L ++VL L +N ++ + A LT L L++ ++
Sbjct: 56 VGFNTISKLEPELCQKLPMLKVLNLQHNELSQ----LSDKTFAFCTNLTELHLMSNSIQK 111
Query: 181 PLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVS 240
+ +L L LS+N LS + Q + +
Sbjct: 112 IKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQ-------------------------LEN 146
Query: 241 LTQLWLHGNQFTGSIPEDIGAL--SSLKDLNLNRNQLVGLIPKSLANME-LDNLVLNNNL 297
L +L L N+ E++ SSLK L L+ NQ+ P + L L LNN
Sbjct: 147 LQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQ 206
Query: 298 LMGPIPK--FKAGNVTY------DSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQ 349
L + + T ++ +
Sbjct: 207 LGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT------------------------- 241
Query: 350 WPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTV 409
+ +++++L +NL + S A L L L N+I
Sbjct: 242 -------------FLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLF 288
Query: 410 PNNFTELKSLRLLDVSDNNIKPPLP 434
++ L ++R L++ + K +
Sbjct: 289 SHSLHGLFNVRYLNLKRSFTKQSIS 313
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 3e-37
Identities = 63/375 (16%), Positives = 118/375 (31%), Gaps = 39/375 (10%)
Query: 79 LKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFDTIPSDFFDGL 137
L + F T L L L N F L L N + L
Sbjct: 85 LSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQL 144
Query: 138 SSVRVLALDYNPFNKTFGWSIPDSLA--NSVQLTNLSLINCNLVGPLPDFLGTLPSLAAL 195
+++ L L N + L + L L L + + P + L L
Sbjct: 145 ENLQELLLSNNKIQA----LKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGL 200
Query: 196 KLSYNRLSGVIPASFGQSL----MQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQF 251
L+ +L + L ++ L L++ + + K +LT L L N
Sbjct: 201 FLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNL 260
Query: 252 TGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGP-----IPKF 305
+ L L+ L N + L SL + + L L + +PK
Sbjct: 261 NVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKI 320
Query: 306 KAG------NVTY---DSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPC 356
+ + + N + + L L ++ + S
Sbjct: 321 DDFSFQWLKCLEHLNMEDNDIPGIKSNMFTG------LINLKYLSLSNSFTS---LRTLT 371
Query: 357 QGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNN-FTE 415
++ L ++S + I+NL ++ ++ S + + L L + LG N I + +
Sbjct: 372 NETFVSL---AHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRG 428
Query: 416 LKSLRLLDVSDNNIK 430
L+++ + +S N
Sbjct: 429 LENIFEIYLSYNKYL 443
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 9e-35
Identities = 78/415 (18%), Positives = 137/415 (33%), Gaps = 83/415 (20%)
Query: 60 PHVFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP----------T 109
F ++ ++ ++ + + L + L L+R+ + +
Sbjct: 265 NDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFS 324
Query: 110 FSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFN-KTFGWSIPDSLANSVQL 168
F L LE ++ N+ I S+ F GL +++ L+L + + +T SLA+S L
Sbjct: 325 FQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHS-PL 383
Query: 169 TNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGM 228
L+L + D L L L L N + + + L I + +
Sbjct: 384 HILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIY------L 437
Query: 229 TG------PIDVVAKMVSLTQLWLHGNQFTG--SIPEDIGALSSLKDLNLNRNQLVGLIP 280
+ + A + SL +L L S P L +L L+L+ N + +
Sbjct: 438 SYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANIND 497
Query: 281 KSLANME-LDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGG 339
L +E L+ L L +N
Sbjct: 498 DMLEGLEKLEILDLQHN------------------------------------------- 514
Query: 340 VNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIR 399
NL W +P GP L S+ + I+NL + +L L I
Sbjct: 515 -----NLARLWKHANP-GGPIYFLKGLSH--LHILNLESNGFDEIPVEVFKDLFELKIID 566
Query: 400 LGKNSISGTVPNNFTELKSLRLLDVSDNNIK-PPLPEFHDTVK----LVIDGNPL 449
LG N+++ + F SL+ L++ N I F + L + NP
Sbjct: 567 LGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPF 621
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-31
Identities = 70/398 (17%), Positives = 134/398 (33%), Gaps = 41/398 (10%)
Query: 60 PHVFCSGNRVTQIQVQNLGLKGPLPQNF---NQLTKLYNLGLQRNKFNGKLP-TFSGL-- 113
P F + R+ + + N+ L L + T + NL L ++ + TF GL
Sbjct: 188 PGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKW 247
Query: 114 SELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSL 173
+ L L +N + + +D F L + L+YN SL + L+L
Sbjct: 248 TNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQH----LFSHSLHGLFNVRYLNL 303
Query: 174 IN---------CNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASF-GQSLMQILWLNDQ 223
+L L L L + N + G+ F G ++ L L++
Sbjct: 304 KRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNS 363
Query: 224 DAGGMTGPIDVVAKMV--SLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPK 281
T + + L L L N+ + + L L+ L+L N++ +
Sbjct: 364 FTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTG 423
Query: 282 S-LANME-LDNLVLNNNLLMGPIPKF--KAGNVTY---DSNSFCQSEPGIECAPDVNVLL 334
+E + + L+ N + ++ + ++ +P L
Sbjct: 424 QEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALK----NVDSSPSPFQPL 479
Query: 335 DFLGGVNYPVNLVSQWPGNDPCQGP---WLGLSCTSNSKVSIINLPRHNLTGTLSPSIAN 391
L ++ N ++ + L L N ++ L +H G +
Sbjct: 480 RNLTILDLSNNNIANINDDMLEGLEKLEILDLQ--HN---NLARLWKHANPGGPIYFLKG 534
Query: 392 LDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNI 429
L L + L N F +L L+++D+ NN+
Sbjct: 535 LSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNL 572
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-31
Identities = 61/323 (18%), Positives = 111/323 (34%), Gaps = 49/323 (15%)
Query: 115 ELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLI 174
E A + +P D +++ VL L +N + + QLT+L +
Sbjct: 5 SHEVADCSHLKLTQVPDDLP---TNITVLNLTHNQLRR----LPAANFTRYSQLTSLDVG 57
Query: 175 NCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQ-SLMQILWLNDQDAGGMTGPI- 232
+ P+ LP L L L +N LS + +F + + L L +
Sbjct: 58 FNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSN---SIQKIKN 114
Query: 233 DVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPK---SLANMELD 289
+ K +L L L N + + L +L++L L+ N++ L + AN L
Sbjct: 115 NPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLK 174
Query: 290 NLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQ 349
L L++N + P F + L FL L
Sbjct: 175 KLELSSNQIKEFSP-----------GCFHAI-------GRLFGL--FLNN-V---QLGPS 210
Query: 350 WPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLD--SLIEIRLGKNSISG 407
+N+ + ++L L+ T + + L +L + L N+++
Sbjct: 211 LTEKL--------CLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNV 262
Query: 408 TVPNNFTELKSLRLLDVSDNNIK 430
++F L L + NNI+
Sbjct: 263 VGNDSFAWLPQLEYFFLEYNNIQ 285
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-29
Identities = 64/377 (16%), Positives = 126/377 (33%), Gaps = 67/377 (17%)
Query: 79 LKGPLPQNFNQLTKLYNLGLQRNKFNGKLP----TFSGLSELEFAYLDFNEFDTIPSDFF 134
+K P F+ + +L+ L L + L + + L ++ T + F
Sbjct: 183 IKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTF 242
Query: 135 DGL--SSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSL 192
GL +++ +L L YN N DS A QL L N+ L L ++
Sbjct: 243 LGLKWTNLTMLDLSYNNLNVV----GNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNV 298
Query: 193 AALKLSYN---------RLSGVIPASFGQ-SLMQILWLNDQDAGGMTGPI-DVVAKMVSL 241
L L + L + SF ++ L + D + G ++ +++L
Sbjct: 299 RYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMED---NDIPGIKSNMFTGLINL 355
Query: 242 TQLWLHGNQFT-GSIPEDIGA---LSSLKDLNLNRNQLVGLIPKSLANME-LDNLVLNNN 296
L L + + ++ + S L LNL +N++ + + + + L+ L L N
Sbjct: 356 KYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLN 415
Query: 297 LLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPC 356
+ + + ++ + +L N +
Sbjct: 416 EIGQELT----------GQEWRGL-------ENIFEI--YLSY-N---KYLQLTRN---- 448
Query: 357 QGPWLGLSCTSNSKVSIINLPRHN-LTG--TLSPSIANLDSLIEIRLGKNSISGTVPNNF 413
S + + L R L + L +L + L N+I+ +
Sbjct: 449 -------SFALVPSLQRLML-RRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDML 500
Query: 414 TELKSLRLLDVSDNNIK 430
L+ L +LD+ NN+
Sbjct: 501 EGLEKLEILDLQHNNLA 517
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 7e-20
Identities = 54/274 (19%), Positives = 87/274 (31%), Gaps = 66/274 (24%)
Query: 165 SVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQD 224
+V + L +PD L ++ L L++N+L + A+F +
Sbjct: 3 TVSHEVADCSHLKLTQ-VPDDL--PTNITVLNLTHNQLRRLPAANFTR------------ 47
Query: 225 AGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLA 284
LT L + N + PE L LK LNL N+L L K+ A
Sbjct: 48 -------------YSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFA 94
Query: 285 NME-LDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYP 343
L L L +N + N F + ++ L L N
Sbjct: 95 FCTNLTELHLMSNSIQKIKN-----------NPFVKQ-------KNLITL--DLSH-N-- 131
Query: 344 VNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLD--SLIEIRLG 401
L S G + + + L + + S + SL ++ L
Sbjct: 132 -GLSSTKLG-----------TQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELS 179
Query: 402 KNSISGTVPNNFTELKSLRLLDVSDNNIKPPLPE 435
N I P F + L L +++ + P L E
Sbjct: 180 SNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTE 213
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-19
Identities = 41/224 (18%), Positives = 67/224 (29%), Gaps = 50/224 (22%)
Query: 65 SGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELE------ 117
+ + P F L L L L N GL +LE
Sbjct: 462 RRVALKNV--------DSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQH 513
Query: 118 --FAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLIN 175
A L + P F GLS + +L L+ N F++ + + +L + L
Sbjct: 514 NNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDE----IPVEVFKDLFELKIIDLGL 569
Query: 176 CNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVV 235
NL SL +L L N ++ V FG +
Sbjct: 570 NNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAF--------------------- 608
Query: 236 AKMVSLTQLWLHGNQFTGSIPEDIGALSSLKD-LNLNRNQLVGL 278
+LT+L + N F +++ + +N + L
Sbjct: 609 ---RNLTELDMRFNPFDC----TCESIAWFVNWINETHTNIPEL 645
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-14
Identities = 44/222 (19%), Positives = 71/222 (31%), Gaps = 52/222 (23%)
Query: 240 SLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLL 298
++T L L NQ + S L L++ N + L P+ + L L L +N L
Sbjct: 26 NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNEL 85
Query: 299 MGPIPKFKAG--NVTY---DSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGN 353
K A N+T SNS + +
Sbjct: 86 SQLSDKTFAFCTNLTELHLMSNSIQKIKNN------------------------------ 115
Query: 354 DPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNF 413
+ ++L + L+ T + L++L E+ L N I
Sbjct: 116 ----------PFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEEL 165
Query: 414 TELK--SLRLLDVSDNNIKPPLPE-FHDTVKL---VIDGNPL 449
SL+ L++S N IK P FH +L ++ L
Sbjct: 166 DIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQL 207
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 1e-05
Identities = 16/93 (17%), Positives = 31/93 (33%), Gaps = 11/93 (11%)
Query: 363 LSCTSNSKVSI-INLPRH---------NLTGTLSPSIANLDSLIEIRLGKNSISGTVPNN 412
C+ + +LP + L + + L + +G N+IS P
Sbjct: 9 ADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPEL 68
Query: 413 FTELKSLRLLDVSDNNIK-PPLPEFHDTVKLVI 444
+L L++L++ N + F L
Sbjct: 69 CQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTE 101
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 6e-38
Identities = 65/271 (23%), Positives = 119/271 (43%), Gaps = 36/271 (13%)
Query: 632 ELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLG 690
E+GRG F TVYKG + E ++A ++ T F+ E +L ++H ++V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 691 Y---SIEGNERLLVY-EYMPHGALSRHLFRWEKLQLKPL-SWTRRLSIALDVARGMEYLH 745
+++G + +++ E M G L +L R++ +++K L SW R + +G+++LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCR------QILKGLQFLH 146
Query: 746 CLARQTFIHRDLKSSNILLDDDY-RAKVSDFGLVKLAP-DGEKSVVTRLAGTFGYLAPEY 803
IHRDLK NI + K+ D GL L K+V+ GT ++APE
Sbjct: 147 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI----GTPEFMAPEM 201
Query: 804 AVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDP 863
K DV+++G+ ++E+ T E P + +++ + ++
Sbjct: 202 -YEEKYDESVDVYAFGMCMLEMATS------EYP---------YSECQNAAQIYRRVTSG 245
Query: 864 ALEVNEETFESISIVAELAGHCTAREPYHRP 894
+ + V E+ C + R
Sbjct: 246 VKPASFDKVAI-PEVKEIIEGCIRQNKDERY 275
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 9e-37
Identities = 59/223 (26%), Positives = 97/223 (43%), Gaps = 28/223 (12%)
Query: 625 QNFAQENELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHR 683
+++ +LG GGF V E L DG A+KR+ + +E Q E + H
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRIL--CHEQQDREEAQREADMHRLFNHP 86
Query: 684 HLVSLLGYSIE----GNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVAR 739
+++ L+ Y + +E L+ + G L + K + L+ + L + L + R
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI-ERLKDKGNFLTEDQILWLLLGICR 145
Query: 740 GMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLA------ 793
G+E +H + + HRDLK +NILL D+ + + D G + A + L
Sbjct: 146 GLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202
Query: 794 --GTFGYLAPE------YAVMGKITTKADVFSYGVVLMELLTG 828
T Y APE + V I + DV+S G VL ++ G
Sbjct: 203 QRCTISYRAPELFSVQSHCV---IDERTDVWSLGCVLYAMMFG 242
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-36
Identities = 59/376 (15%), Positives = 106/376 (28%), Gaps = 79/376 (21%)
Query: 62 VFCSGNRVTQIQVQNLGLKGPLPQN-FNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFA 119
C +I P N L L N +F EL+
Sbjct: 12 YQCMELNFYKI-----------PDNLPFSTKNLD---LSFNPLRHLGSYSFFSFPELQVL 57
Query: 120 YLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLV 179
L E TI + LS + L L NP + + L L + NL
Sbjct: 58 DLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS----LALGAFSGLSSLQKLVAVETNLA 113
Query: 180 GPLPDFLGTLPSLAALKLSYNRLSGV-IPASFGQSLMQILWLNDQDAGGMTGPIDVVAKM 238
+G L +L L +++N + +P F +
Sbjct: 114 SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN-------------------------L 148
Query: 239 VSLTQLWLHGNQFTGSIPEDIGALSSLK----DLNLNRNQLVGLIPKSLANMELDNLVLN 294
+L L L N+ D+ L + L+L+ N + + P + + L L L
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLR 208
Query: 295 NNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGND 354
NN + K + Q G+E + + G + ++ +
Sbjct: 209 NNFDSLNVMK-----------TCIQGLAGLE-------VHRLVLGEFRNEGNLEKFDKS- 249
Query: 355 PCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSI-ANLDSLIEIRLGKNSISGTVPNNF 413
L N + L + + L ++ L +I +F
Sbjct: 250 -------ALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDF 300
Query: 414 TELKSLRLLDVSDNNI 429
+ + L++ +
Sbjct: 301 SYNFGWQHLELVNCKF 316
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-31
Identities = 71/428 (16%), Positives = 132/428 (30%), Gaps = 86/428 (20%)
Query: 65 SGNRVTQIQVQNLG--------------LKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-T 109
S N + + + ++ + L+ L L L N
Sbjct: 36 SFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGA 95
Query: 110 FSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLT 169
FSGLS L+ ++ + L +++ L + +N +P+ +N L
Sbjct: 96 FSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF---KLPEYFSNLTNLE 152
Query: 170 NLSLINCNLVGPLPDFLGTLPSL----AALKLSYNRLSGVIPASFGQSLMQILWLNDQDA 225
+L L + + L L + +L LS N ++ + P +F
Sbjct: 153 HLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF--------------- 197
Query: 226 GGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPED-IGALSSLKDLNLNRNQLVGLIP---- 280
K + L +L L N + ++ + I L+ L+ L +
Sbjct: 198 -----------KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKF 246
Query: 281 -----KSLANMELDNLVLN-NNLLMGPIPKFKAG--NVTY---DSNSFCQSEPGIECAPD 329
+ L N+ ++ L + + I NV+ S + + +
Sbjct: 247 DKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY---- 302
Query: 330 VNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLS-CTSNSKVSIINLP----------R 378
N L Q+P L + + S ++LP
Sbjct: 303 -NFGWQHL---ELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNG 358
Query: 379 HNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIK--PPLPEF 436
+ G S S SL + L N + T+ +NF L+ L LD +N+K F
Sbjct: 359 LSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVF 417
Query: 437 HDTVKLVI 444
L+
Sbjct: 418 LSLRNLIY 425
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 7e-31
Identities = 44/232 (18%), Positives = 68/232 (29%), Gaps = 33/232 (14%)
Query: 76 NLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDT-IPSDFF 134
L KG Q+ T L L L N F GL +LE + F
Sbjct: 358 GLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVF 417
Query: 135 DGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPL-PDFLGTLPSLA 193
L ++ L + + + L L + + PD L +L
Sbjct: 418 LSLRNLIYLDISHTHTR----VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT 473
Query: 194 ALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTG 253
L LS +L + P +F + SL L + N F
Sbjct: 474 FLDLSQCQLEQLSPTAFN-------------------------SLSSLQVLNMSHNNFFS 508
Query: 254 SIPEDIGALSSLKDLNLNRNQLVGLIPKSLANME--LDNLVLNNNLLMGPIP 303
L+SL+ L+ + N ++ + L + L L L N
Sbjct: 509 LDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 560
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-30
Identities = 47/241 (19%), Positives = 80/241 (33%), Gaps = 15/241 (6%)
Query: 70 TQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFN--EFD 127
+++ N L +L + + L LEF L N F
Sbjct: 307 QHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGN----AFSEVDLPSLEFLDLSRNGLSFK 362
Query: 128 TIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLP-DFL 186
S G +S++ L L +N ++ + QL +L + NL
Sbjct: 363 GCCSQSDFGTTSLKYLDLSFNGVI-----TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVF 417
Query: 187 GTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQD-AGGMTGPIDVVAKMVSLTQLW 245
+L +L L +S+ F L + L + D+ ++ +LT L
Sbjct: 418 LSLRNLIYLDISHTHTRVAFNGIFN-GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 476
Query: 246 LHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGPIPK 304
L Q P +LSSL+ LN++ N L + L L + N +M +
Sbjct: 477 LSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQ 536
Query: 305 F 305
Sbjct: 537 E 537
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 9e-30
Identities = 64/394 (16%), Positives = 126/394 (31%), Gaps = 50/394 (12%)
Query: 79 LKGPLPQNFNQLTKLYNLGLQRNKFNGKLP--TFSGLSELEFAYLDFNEF------DTIP 130
+ P F ++ +L+ L L+ N + + GL+ LE L EF +
Sbjct: 189 MNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFD 247
Query: 131 SDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLP 190
+GL ++ + + + I D +++ SL++ +
Sbjct: 248 KSALEGLCNLTIEEFRLA-YLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNF 304
Query: 191 SLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQ 250
L+L + ++ L G +D + SL L L N
Sbjct: 305 GWQHLELVNCKFGQFPTLKLKS--LKRLTFTSNKGGNAFSEVD----LPSLEFLDLSRNG 358
Query: 251 --FTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMGPIPKFKAG 308
F G + +SLK L+L+ N ++ + L +L++L ++ L
Sbjct: 359 LSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 418
Query: 309 NVTY------DSNSFCQSEPG-IECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWL 361
++ + G + VL + G N + + + + L
Sbjct: 419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL--KMAG-N---SFQENFLPDIFTELRNL 472
Query: 362 GLSCTSNSKVSIINLPRHN-LTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLR 420
+ ++L L + +L SL + + N+ + L SL+
Sbjct: 473 ----------TFLDL-SQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQ 521
Query: 421 LLDVSDNNIK-PPLPEFHDTVK----LVIDGNPL 449
+LD S N+I E L + N
Sbjct: 522 VLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 555
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-26
Identities = 62/412 (15%), Positives = 117/412 (28%), Gaps = 67/412 (16%)
Query: 60 PHVFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNG-KLP-TFSGLSELE 117
F + + ++ L L L L + N KLP FS L+ LE
Sbjct: 93 LGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLE 152
Query: 118 FAYLDFNEFDTIPSDFFDGLSSVRV----LALDYNPFNKTFGWSIPDSLANSVQLTNLSL 173
L N+ +I L + + L L NP N I ++L L+L
Sbjct: 153 HLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-----FIQPGAFKEIRLHKLTL 207
Query: 174 INCNLVGPLP-DFLGTLPSLAALKLSYNRLSG------VIPASFG---QSLMQILWLNDQ 223
N + + L L +L ++ ++ L
Sbjct: 208 RNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 267
Query: 224 DAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSL 283
D ID+ + +++ L +D + L L + L
Sbjct: 268 DYYL-DDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQFPTLKL 324
Query: 284 ANMELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYP 343
+++ L +N + ++ + LD
Sbjct: 325 KSLK--RLTFTSNKGGNAFSEVDLPSLEF---------------------LDLSRNGLSF 361
Query: 344 VNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKN 403
SQ + + ++L N T+S + L+ L + +
Sbjct: 362 KGCCSQSDFG--------------TTSLKYLDL-SFNGVITMSSNFLGLEQLEHLDFQHS 406
Query: 404 SISGTVPNN-FTELKSLRLLDVSDNNIKPPLPE-FHDTVKLV---IDGNPLL 450
++ + F L++L LD+S + + F+ L + GN
Sbjct: 407 NLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ 458
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-24
Identities = 39/234 (16%), Positives = 65/234 (27%), Gaps = 49/234 (20%)
Query: 83 LPQNFNQLTKLYNLGLQRNKFNGKLP--TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSV 140
+ NF L +L +L Q + F L L + + + F+GLSS+
Sbjct: 388 MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL 447
Query: 141 RVLALDYNPFNKTFGWS---------------------IPDSLANSVQLTNLSLINCNLV 179
VL + N F + F P + + L L++ + N
Sbjct: 448 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF 507
Query: 180 GPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMV 239
L SL L S N +
Sbjct: 508 SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPS------------------------ 543
Query: 240 SLTQLWLHGNQFTGSIPED--IGALSSLKDLNLNRNQLVGLIPKSLANMELDNL 291
SL L L N F + + + + L + ++ P M + +L
Sbjct: 544 SLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMPVLSL 597
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 5e-20
Identities = 51/327 (15%), Positives = 85/327 (25%), Gaps = 79/327 (24%)
Query: 157 SIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQ 216
IPD+L S NL L L + P L L LS + + ++
Sbjct: 21 KIPDNLPFS--TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQS---- 74
Query: 217 ILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLV 276
+ L+ L L GN LSSL+ L L
Sbjct: 75 ---------------------LSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA 113
Query: 277 GLIPKSLANME-LDNLVL-NNNLLMGPIPKFKAG--NVTY---DSNSFCQSEPGIECAPD 329
L + +++ L L + +N + +P++ + N+ + SN
Sbjct: 114 SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT------ 167
Query: 330 VNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSI 389
D P+ +S L LS N + P
Sbjct: 168 -----DLRVLHQMPLLNLS------------LDLS--------------LNPMNFIQPGA 196
Query: 390 ANLDSLIEIRLGKNSISGTVPNN-FTELKSLRLLDVSDNNIK-------PPLPEFHDTVK 441
L ++ L N S V L L + + +
Sbjct: 197 FKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN 256
Query: 442 LVIDGNPLLVGGINHTQAPTSPGPVSS 468
L I+ L +++
Sbjct: 257 LTIEEFRLAYLDYYLDDIIDLFNCLTN 283
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 5e-17
Identities = 40/276 (14%), Positives = 73/276 (26%), Gaps = 73/276 (26%)
Query: 165 SVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQD 224
+ Q L+ +PD L S L LS+N L + SF
Sbjct: 11 TYQCMELNFYK------IPDNL--PFSTKNLDLSFNPLRHLGSYSFFS------------ 50
Query: 225 AGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLA 284
L L L + +LS L L L N + L + +
Sbjct: 51 -------------FPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFS 97
Query: 285 NM-ELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYP 343
+ L LV L + L + N
Sbjct: 98 GLSSLQKLVAVETNLASLEN-----------FPIGHL-------KTLKEL--NVAH-NLI 136
Query: 344 VNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSL----IEIR 399
+ L ++ + + ++L + + + L + + +
Sbjct: 137 QSFK-------------LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLD 183
Query: 400 LGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLPE 435
L N ++ P F E+ L L + +N + +
Sbjct: 184 LSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMK 218
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-36
Identities = 61/398 (15%), Positives = 122/398 (30%), Gaps = 74/398 (18%)
Query: 70 TQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNG---------KLPTFSGLSELEFAY 120
T ++V N LP L ++ + + N+ L +++ Y
Sbjct: 252 TDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIY 311
Query: 121 LDFNEFDTIP-SDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLV 179
+ +N T P + + +L YN + + ++L +L+L +
Sbjct: 312 IGYNNLKTFPVETSLQKMKKLGMLECLYNQLE-----GKLPAFGSEIKLASLNLAYNQIT 366
Query: 180 GPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSL--MQILWLND-----QDAGGMTGPI 232
+F G + L ++N+L + +S+ M + + D
Sbjct: 367 EIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLD 426
Query: 233 DVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGL-------IPKSLAN 285
K ++++ + L NQ + E S L +NL N L + ++ N
Sbjct: 427 PTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKN 486
Query: 286 ME-LDNLVLNNNLLMGPIPKFKAGNVTY------DSNSFCQSEPGIECAPDVNVLLDFLG 338
L ++ L N L F+A + Y NSF +
Sbjct: 487 TYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSF-------------SKFPTQPL 533
Query: 339 GVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEI 398
+ L G+ + + + I SL ++
Sbjct: 534 NSS---TLKG------------FGIR-------NQRDAQGNRTLREWPEGITLCPSLTQL 571
Query: 399 RLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLPEF 436
++G N I V ++ +LD+ DN +
Sbjct: 572 QIGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDLSY 606
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 5e-35
Identities = 68/370 (18%), Positives = 117/370 (31%), Gaps = 59/370 (15%)
Query: 79 LKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLS 138
+ + ++ K +G N L++L Y+ + F
Sbjct: 171 QQKSIKKSSRITLKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFVAEN-----ICE 225
Query: 139 SVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLS 198
+ +Y KT N LT++ + NC + LP FL LP + + ++
Sbjct: 226 AWENENSEYAQQYKT----EDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVA 281
Query: 199 YNRL--------SGVIPASFGQ-SLMQILWLNDQDAGGMTGPI-DVVAKMVSLTQLWLHG 248
NR A +QI+++ + T P+ + KM L L
Sbjct: 282 CNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNN--LKTFPVETSLQKMKKLGMLECLY 339
Query: 249 NQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGPIPKFKA 307
NQ G +P G+ L LNL NQ+ + +++NL +N L F A
Sbjct: 340 NQLEGKLPA-FGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDA 398
Query: 308 GNVTYDSNSFCQSEPGIECAPDVN-VLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCT 366
+V+ +DF N + G +
Sbjct: 399 KSVS-------------------VMSAIDFSY------NEIGSVDGKNFDPLDPTPFKGI 433
Query: 367 SNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISG-------TVPNNFTELKSL 419
+ VS INL + ++ + L I L N ++ NF L
Sbjct: 434 N---VSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLL 490
Query: 420 RLLDVSDNNI 429
+D+ N +
Sbjct: 491 TSIDLRFNKL 500
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-34
Identities = 69/416 (16%), Positives = 133/416 (31%), Gaps = 76/416 (18%)
Query: 75 QNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFDTIPSDF 133
+ ++ L L ++ + KLP L E++ + N +
Sbjct: 233 EYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLK 292
Query: 134 FDG--------LSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDF 185
D ++++ + YN KTF + SL +L L + L G LP F
Sbjct: 293 DDWQALADAPVGEKIQIIYIGYNNL-KTF--PVETSLQKMKKLGMLECLYNQLEGKLPAF 349
Query: 186 LGTLPSLAALKLSYNRLSGVIPASFGQ-SLMQILWLND---------QDAGGMTGPIDVV 235
G+ LA+L L+YN+++ + G ++ L DA ++
Sbjct: 350 -GSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVS------ 402
Query: 236 AKMVSLTQLWLHGNQFTG-------SIPEDIGALSSLKDLNLNRNQLVGLIPKSLANME- 287
++ + N+ + ++ +NL+ NQ+ + +
Sbjct: 403 ----VMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSP 458
Query: 288 LDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLV 347
L ++ L N+L IPK NS + + + L N +
Sbjct: 459 LSSINLMGNMLTE-IPK----------NSLKDENENFKNTYLLTSI--DLRF-----NKL 500
Query: 348 SQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLG------ 401
++ + T+ + I+L +N N +L +
Sbjct: 501 TKLSDD---------FRATTLPYLVGIDL-SYNSFSKFPTQPLNSSTLKGFGIRNQRDAQ 550
Query: 402 KNSISGTVPNNFTELKSLRLLDVSDNNI-KPPLPEFHDTVKLVIDGNPLLVGGINH 456
N P T SL L + N+I K + L I NP + +++
Sbjct: 551 GNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKITPNISVLDIKDNPNISIDLSY 606
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-32
Identities = 48/305 (15%), Positives = 90/305 (29%), Gaps = 38/305 (12%)
Query: 26 NDLKILNDFKNGLENPELLKWPANGD------------DPCGPPPWPHVFCSGN-RVTQI 72
D L + + L W G + P V + N RVT +
Sbjct: 30 KDYLALKEIWDALNGKN---WSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGL 86
Query: 73 QVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTF--SGLSELEFAYLDFNEFDTIP 130
++ G G +P QLT+L L L + F G+S
Sbjct: 87 SLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQ 146
Query: 131 SDFFDGLSSVRVLALDYNPFNKTFG-WSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTL 189
F D L + N SI S +++ T + ++ N+ + + L
Sbjct: 147 KTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRL 205
Query: 190 PSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDV-VAKMVSLTQLWLHG 248
L + + ++ Q D+ + LT + ++
Sbjct: 206 TKLRQFYMGNSPFVAENICEAWENEN--SEYAQQ-----YKTEDLKWDNLKDLTDVEVYN 258
Query: 249 NQFTGSIPEDIGALSSLKDLNLNRNQLVGL--------IPKSLANME-LDNLVL-NNNLL 298
+P + AL ++ +N+ N+ + E + + + NNL
Sbjct: 259 CPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK 318
Query: 299 MGPIP 303
P+
Sbjct: 319 TFPVE 323
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 6e-28
Identities = 46/255 (18%), Positives = 79/255 (30%), Gaps = 47/255 (18%)
Query: 65 SGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKL--------PTFSGLSEL 116
+ N++ I P + ++ + + N+ PT +
Sbjct: 385 AHNKLKYI---------PNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINV 435
Query: 117 EFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFN---KTFGWSIPDSLANSVQLTNLSL 173
L N+ P + F S + + L N K ++ N+ LT++ L
Sbjct: 436 SSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDL 495
Query: 174 INCNLVGPLPD--FLGTLPSLAALKLSYNRLSGVIPASFGQ-SLMQILWLNDQDAGGMTG 230
L L D TLP L + LSYN S P S ++ + +Q
Sbjct: 496 RFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQ------- 546
Query: 231 PIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDN 290
GN+ PE I SL L + N + + K N +
Sbjct: 547 -------------RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKITPN--ISV 591
Query: 291 LVLNNNLLMGPIPKF 305
L + +N + +
Sbjct: 592 LDIKDNPNISIDLSY 606
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-24
Identities = 45/329 (13%), Positives = 102/329 (31%), Gaps = 40/329 (12%)
Query: 134 FDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLA 193
G + ++N +G SL ++ ++T LSL G +PD +G L L
Sbjct: 49 QQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELE 108
Query: 194 ALKLSYNRLSGVIPASFGQSLMQILWLNDQDAG-----GMTGPIDVVAKMVSLTQLWLHG 248
L L + + + + + D L + ++
Sbjct: 109 VLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINS 168
Query: 249 NQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANME-LDNLVLNNNLLMGPIPKFKA 307
+ SI + + N + + K++ + L + N+ +
Sbjct: 169 DPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAW 227
Query: 308 GNVTYDSNSFCQSEPGIECAPDVNVL-----LDFLGGVNYPVNLVSQWPGNDPCQGPWLG 362
N + ++E + L ++ +++ P +L
Sbjct: 228 ENENSEYAQQYKTED-----LKWDNLKDLTDVEVYNC-----PNLTKLP-------TFLK 270
Query: 363 -------LSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSI-SGTVPNNFT 414
++ N I+ + + + I +G N++ + V +
Sbjct: 271 ALPEMQLINVACNR---GISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQ 327
Query: 415 ELKSLRLLDVSDNNIKPPLPEFHDTVKLV 443
++K L +L+ N ++ LP F +KL
Sbjct: 328 KMKKLGMLECLYNQLEGKLPAFGSEIKLA 356
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 8e-20
Identities = 38/286 (13%), Positives = 71/286 (24%), Gaps = 59/286 (20%)
Query: 156 WSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLM 215
WS N + L + + L L SG +P + GQ
Sbjct: 47 WSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQ--- 103
Query: 216 QILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTG----SIPEDIGALSSLKDLNLN 271
+ L L L + P+ I A S +
Sbjct: 104 ----------------------LTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKM 141
Query: 272 RNQLVGLIPKSLANMELDNLV---LNNNLLMGPIPKFKAGNVTY-----DSNSFCQSEPG 323
R + +L+ +N++ I K + SN+
Sbjct: 142 RMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFVSKA 201
Query: 324 IECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTG 383
+ + ++G S + + C+ N
Sbjct: 202 VMRLTKLRQF--YMGN--------SPFVAENICEAWEN------------ENSEYAQQYK 239
Query: 384 TLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNI 429
T NL L ++ + +P L ++L++V+ N
Sbjct: 240 TEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRG 285
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-10
Identities = 27/166 (16%), Positives = 54/166 (32%), Gaps = 33/166 (19%)
Query: 65 SGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP---TFSGLSELEFAYL 121
GN +T+I +L +NF L ++ L+ NK L + L L L
Sbjct: 465 MGNMLTEIPKNSLK---DENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDL 520
Query: 122 DFNEFDTIPSDFFDGLSSVRVLALDYNP---FNKTFGWSIPDSLANSVQLTNLSLINCNL 178
+N F P+ + S+++ + N+T P+ + LT L + + ++
Sbjct: 521 SYNSFSKFPTQPLN-SSTLKGFGIRNQRDAQGNRTLR-EWPEGITLCPSLTQLQIGSNDI 578
Query: 179 ---------------------VGPLPDFLGTLPSLAALKLSYNRLS 203
+ ++ L Y++
Sbjct: 579 RKVNEKITPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-10
Identities = 23/124 (18%), Positives = 41/124 (33%), Gaps = 14/124 (11%)
Query: 339 GVNYPVNLVSQWPGNDPC--QGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLI 396
G + W N G G+S SN +V+ ++L +G + +I L L
Sbjct: 51 GFGTQ--PGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELE 108
Query: 397 EIRLGKNSISG----TVPNNFTELKSLRLLDVSDNNIKPPLP------EFHDTVKLVIDG 446
+ LG + P + S + + +F D +K I+
Sbjct: 109 VLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINS 168
Query: 447 NPLL 450
+P
Sbjct: 169 DPQQ 172
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 8e-36
Identities = 60/209 (28%), Positives = 87/209 (41%), Gaps = 17/209 (8%)
Query: 625 QNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RH 682
Q+F + + LG G +G V+K EDG AVKR + K +E+ KV +H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 683 RHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGME 742
V L EG L E +L +H W L + D +
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGA----SLPEAQVWGYLRDTLLALA 171
Query: 743 YLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKL--APDGEKSVVTRLAGTFGYLA 800
+LH Q +H D+K +NI L R K+ DFGL+ + G Y+A
Sbjct: 172 HLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE----GDPRYMA 224
Query: 801 PEYAVMGKITTKADVFSYGVVLMELLTGL 829
PE + G T ADVFS G+ ++E+ +
Sbjct: 225 PE-LLQGSYGTAADVFSLGLTILEVACNM 252
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 72/336 (21%), Positives = 130/336 (38%), Gaps = 46/336 (13%)
Query: 601 ATENSHVIESGTLVISVQVLRKVTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAG 660
+S ++ GT + Q + + ++ ++G GG V++ E A+K +
Sbjct: 4 HHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLE 63
Query: 661 VTTTKALDEFQSEIAVLSKVRH--RHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWE 718
+ LD +++EIA L+K++ ++ L Y I +V E + L+ L + +
Sbjct: 64 EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKK 122
Query: 719 KLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLV 778
+ + ++ + +H + +H DLK +N L+ D K+ DFG+
Sbjct: 123 SI---DPWERKS--YWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDG-MLKLIDFGIA 173
Query: 779 KLAPDGEKSVVTR-LAGTFGYLAPE-----------YAVMGKITTKADVFSYGVVLMELL 826
SVV GT Y+ PE KI+ K+DV+S G +L +
Sbjct: 174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 233
Query: 827 TGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCT 886
G P F +I + K A IDP E+ + ++ C
Sbjct: 234 YGKT------P---------FQQIINQISKLHAIIDPNHEIEFPDIPEKDLQ-DVLKCCL 277
Query: 887 AREPYHRPD----MGH--VVNVLSPLVEKWRPITDE 916
R+P R + H V P+ + + T+E
Sbjct: 278 KRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEE 313
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 4e-35
Identities = 62/374 (16%), Positives = 96/374 (25%), Gaps = 79/374 (21%)
Query: 61 HVFCSGNRVTQIQVQNLGLKGPLPQN-FNQLTKLYNLGLQRNKFNGKLPT-FSGLSELEF 118
C + +I P N L N T FS L L F
Sbjct: 16 TYNCENLGLNEI-----------PGTLPNSTECLE---FSFNVLPTIQNTTFSRLINLTF 61
Query: 119 AYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNL 178
L + I D F + L L NP +L+ L +L I +
Sbjct: 62 LDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIF----MAETALSGPKALKHLFFIQTGI 117
Query: 179 VGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKM 238
L +L +L L N +S +
Sbjct: 118 SSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFP-------------------------T 152
Query: 239 VSLTQLWLHGNQFTGSIPEDIGALSSLK--DLNLNRNQLVGLIPKSLANMELDNLVLNNN 296
L L N ED+ +L LNLN N + G+ P + + +L
Sbjct: 153 EKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGT 212
Query: 297 LLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPC 356
+ I K + L +
Sbjct: 213 QNLLVIFK---------GLKNST--------------IQSLWLGTFEDMDDEDISPAVFE 249
Query: 357 QGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTEL 416
+ + INL +H S + L E+ L +S +P+ L
Sbjct: 250 GLCEMSV--------ESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGL 300
Query: 417 KSLRLLDVSDNNIK 430
+L+ L +S N +
Sbjct: 301 STLKKLVLSANKFE 314
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-33
Identities = 68/401 (16%), Positives = 124/401 (30%), Gaps = 67/401 (16%)
Query: 65 SGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDF 123
G + + + L + + L+ + P F GL E+ ++
Sbjct: 210 GGTQNLLVIFKGLK--------NSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINL 261
Query: 124 --NEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGP 181
+ F I S+ F S ++ L L + +P L L L L
Sbjct: 262 QKHYFFNISSNTFHCFSGLQELDLTATHLS-----ELPSGLVGLSTLKKLVLSANKFENL 316
Query: 182 LPDFLGTLPSLAALKLSYNRLSGVIPASFGQSL--MQILWLNDQDAGGMTGPIDVVAKMV 239
PSL L + N + ++L ++ L L+ D + +
Sbjct: 317 CQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLS 376
Query: 240 SLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKS-LANME-LDNLVLNNNL 297
L L L N+ E L+ L+L +L +S N+ L L L+++L
Sbjct: 377 HLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSL 436
Query: 298 LMGPIPKFKAG--NVTY---DSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPG 352
L + G + + N F G + L L
Sbjct: 437 LDISSEQLFDGLPALQHLNLQGNHF---PKGNIQKTNSLQTLGRLE-------------- 479
Query: 353 NDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNN 412
L LS +L+ + +L + + L N ++ +
Sbjct: 480 -------ILVLS--FC-----------DLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEA 519
Query: 413 FTELKSLRLLDVSDNNIKPPLPEFHDTVK----LVIDGNPL 449
+ LK + L+++ N+I LP + + + NPL
Sbjct: 520 LSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPL 559
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-33
Identities = 64/380 (16%), Positives = 120/380 (31%), Gaps = 44/380 (11%)
Query: 65 SGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNG-KLPTFSGLSELEFAYLDF 123
++ I + L +L L N + KLP +L+
Sbjct: 113 IQTGISSID----------FIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQN 162
Query: 124 NEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLP 183
N + + L L+L+ N N I +S +L+ + +
Sbjct: 163 NAIHYLSKEDMSSLQQATNLSLNLN-GNDI--AGIEPGAFDSAVFQSLNFGGTQNLLVIF 219
Query: 184 DFLG--TLPSLAALKLSYNRLSGVIPASF-GQSLMQILWLNDQDAGGMTGPIDVVAKMVS 240
L T+ SL + PA F G M + +N Q +
Sbjct: 220 KGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSG 279
Query: 241 LTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLM 299
L +L L + +P + LS+LK L L+ N+ L S +N L +L + N
Sbjct: 280 LQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKR 338
Query: 300 GPIPKFKAGNVTY------DSNSFCQSEPGIECAPDVNVL--LDFLGGVNYPVNLVSQWP 351
+ N+ + S+ +++ L L+ N +S
Sbjct: 339 LELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSY--N---EPLSLKT 393
Query: 352 GNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSI-ANLDSLIEIRLGKNSISGTVP 410
+ ++ +++L L + S NL L + L + + +
Sbjct: 394 E-----------AFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSE 442
Query: 411 NNFTELKSLRLLDVSDNNIK 430
F L +L+ L++ N+
Sbjct: 443 QLFDGLPALQHLNLQGNHFP 462
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-27
Identities = 60/404 (14%), Positives = 113/404 (27%), Gaps = 78/404 (19%)
Query: 60 PHVFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEF 118
+ + + + + + KL L Q N + S L +
Sbjct: 122 FIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATN 181
Query: 119 AYLD--FNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANS--VQLTNLSLI 174
L+ N+ I FD + + L I L NS L +
Sbjct: 182 LSLNLNGNDIAGIEPGAFD-SAVFQSLNFGGTQNLLV----IFKGLKNSTIQSLWLGTFE 236
Query: 175 NCNLVGPLPDFLGTLP--SLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPI 232
+ + P L S+ ++ L + + +F
Sbjct: 237 DMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHC-------------------- 276
Query: 233 DVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNL 291
L +L L + +P + LS+LK L L+ N+ L S +N L +L
Sbjct: 277 -----FSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHL 330
Query: 292 VLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWP 351
+ N + + ++ L L + +
Sbjct: 331 SIKGNTKRLELG----------TGCLENL-------ENLREL--DLSH-----DDIETSD 366
Query: 352 GNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSP-SIANLDSLIEIRLGKNSISGTVP 410
C L S + +NL +N +L + L + L +
Sbjct: 367 ---CCNLQLRNL-----SHLQSLNL-SYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDA 417
Query: 411 NN-FTELKSLRLLDVSDNNIKPPLPE-FHDTVKLV---IDGNPL 449
+ F L L++L++S + + + F L + GN
Sbjct: 418 QSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHF 461
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-27
Identities = 52/258 (20%), Positives = 79/258 (30%), Gaps = 13/258 (5%)
Query: 56 PPPWPHVFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSE 115
P V I +Q F+ + L L L + GLS
Sbjct: 243 ISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLST 302
Query: 116 LEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLIN 175
L+ L N+F+ + S+ L++ N L N L L L +
Sbjct: 303 LKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLEL---GTGCLENLENLRELDLSH 359
Query: 176 CNL--VGPLPDFLGTLPSLAALKLSYNRLSGVIPASFG--QSLMQILWLNDQDAGGMTGP 231
++ L L L +L LSYN + +F L ++L L
Sbjct: 360 DDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQL-ELLDLAFTRLKVKD-A 417
Query: 232 IDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLI---PKSLANME- 287
+ L L L + S + L +L+ LNL N SL +
Sbjct: 418 QSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGR 477
Query: 288 LDNLVLNNNLLMGPIPKF 305
L+ LVL+ L
Sbjct: 478 LEILVLSFCDLSSIDQHA 495
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 7e-14
Identities = 32/144 (22%), Positives = 52/144 (36%), Gaps = 19/144 (13%)
Query: 65 SGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNG----KLPTFSGLSELEFAY 120
S + + Q F+ L L +L LQ N F K + L LE
Sbjct: 433 SHSLLDISS----------EQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILV 482
Query: 121 LDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVG 180
L F + +I F L + + L +N S ++L++ + L+L + ++
Sbjct: 483 LSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTS----SSIEALSHLKGIY-LNLASNHISI 537
Query: 181 PLPDFLGTLPSLAALKLSYNRLSG 204
LP L L + L N L
Sbjct: 538 ILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 5e-06
Identities = 27/142 (19%), Positives = 42/142 (29%), Gaps = 24/142 (16%)
Query: 65 SGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDF 123
S ++ I F L + ++ L N+ S L + L
Sbjct: 484 SFCDLSSID----------QHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYL-NLAS 532
Query: 124 NEFDTIPSDFFDGLSSVRVLALDYNPFNKTFG--WSIPDSLANSVQLTNLSLINCNLVGP 181
N I LS R + L NP + T + + N +L + C
Sbjct: 533 NHISIILPSLLPILSQQRTINLRQNPLDCTCSNIYFLEWYKENMQKLEDTEDTLCE---- 588
Query: 182 LPDFLGTLPSLAALKLSYNRLS 203
P L ++LS LS
Sbjct: 589 ------NPPLLRGVRLSDVTLS 604
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-34
Identities = 59/287 (20%), Positives = 113/287 (39%), Gaps = 30/287 (10%)
Query: 625 QNFAQENELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHR 683
+ + + ++G G FG + EDG + +K + ++K +E + E+AVL+ ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 684 HLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEY 743
++V E +V +Y G L + + + + L + + +++
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRI---NAQKGVLFQEDQILDWFVQICLALKH 140
Query: 744 LHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEY 803
+H + +HRD+KS NI L D ++ DFG+ ++ + + GT YL+PE
Sbjct: 141 VH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL-NSTVELARACIGTPYYLSPEI 196
Query: 804 AVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSK-EKFKAAID 862
K+D+++ G VL EL T + E+ + +I S
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTL------KHAFEAGSMKNLVLKIISGSFPPVSLHYS 250
Query: 863 PALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909
L L R P RP + ++ + K
Sbjct: 251 YDL-------------RSLVSQLFKRNPRDRPSVNSILE--KGFIAK 282
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-34
Identities = 71/348 (20%), Positives = 125/348 (35%), Gaps = 49/348 (14%)
Query: 563 HPRDPSDPENMVKIAVSNDTARSLSSQTVASSGSTNSGATENSHVIESGTLVISVQVLRK 622
H S A+ + T+ +S S ISV+
Sbjct: 3 HHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASS----SANECISVKG--- 55
Query: 623 VTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRH 682
+ ++ ++G GG V++ E A+K + + LD +++EIA L+K++
Sbjct: 56 --RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 113
Query: 683 --RHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARG 740
++ L Y I +V E + L+ L + + + + ++
Sbjct: 114 HSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSI---DPWERKS--YWKNMLEA 167
Query: 741 MEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTR-LAGTFGYL 799
+ +H + +H DLK +N L+ D K+ DFG+ SVV G Y+
Sbjct: 168 VHTIH---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYM 223
Query: 800 APE-----------YAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFW 848
PE KI+ K+DV+S G +L + G P F
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT------P---------FQ 268
Query: 849 RIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDM 896
+I + K A IDP E+ + ++ C R+P R +
Sbjct: 269 QIINQISKLHAIIDPNHEIEFPDIPE-KDLQDVLKCCLKRDPKQRISI 315
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 3e-34
Identities = 63/280 (22%), Positives = 109/280 (38%), Gaps = 40/280 (14%)
Query: 631 NELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRH--RHLVSL 688
++G GG V++ E A+K + + LD +++EIA L+K++ ++ L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 689 LGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLA 748
Y I +V E + L+ L + + + + ++ + +H
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSI---DPWERKS--YWKNMLEAVHTIH--- 125
Query: 749 RQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTR-LAGTFGYLAPE----- 802
+ +H DLK +N L+ D K+ DFG+ SVV GT Y+ PE
Sbjct: 126 QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 803 ------YAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEK 856
KI+ K+DV+S G +L + G P F +I + K
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT------P---------FQQIINQISK 229
Query: 857 FKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDM 896
A IDP E+ + ++ C R+P R +
Sbjct: 230 LHAIIDPNHEIEFPDIPEKDLQ-DVLKCCLKRDPKQRISI 268
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 63/270 (23%), Positives = 101/270 (37%), Gaps = 50/270 (18%)
Query: 624 TQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRH 682
+F + LG+G FG V K D A+K++ T + L SE+ +L+ + H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR---HTEEKLSTILSEVMLLASLNH 61
Query: 683 RHLVSLLGYSIEGNERL-------------LVYEYMPHGALSRHLFRWEKLQLKPLSWTR 729
+++V +E + + EY +G L + Q + W
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW-- 119
Query: 730 RLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKL--------- 780
+ + + Y+H Q IHRDLK NI +D+ K+ DFGL K
Sbjct: 120 --RLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 781 ----APDGEKSVVTRLAGTFGYLAPEYAVM---GKITTKADVFSYGVVLMELLTGLAALD 833
G +T GT Y+A E V+ G K D++S G++ E++ +
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATE--VLDGTGHYNEKIDMYSLGIIFFEMIYPFST-G 231
Query: 834 EERPEESR-------YLAEWFWRIKSSKEK 856
ER + F K EK
Sbjct: 232 MERVNILKKLRSVSIEFPPDFDDNKMKVEK 261
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 60/222 (27%), Positives = 103/222 (46%), Gaps = 33/222 (14%)
Query: 625 QNFAQENELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHR 683
+F + +G GGFG V+K + DG +KR++ ++ + E+ L+K+ H
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK------YNNEKAEREVKALAKLDHV 64
Query: 684 HLVSLLGYSIEGNERL----------------LVYEYMPHGALSRHLFRWEKLQLKPLSW 727
++V G + + E+ G L + + EK + + L
Sbjct: 65 NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI---EKRRGEKLDK 121
Query: 728 TRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK-LAPDGEK 786
L + + +G++Y+H + I+RDLK SNI L D + K+ DFGLV L DG++
Sbjct: 122 VLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR 178
Query: 787 SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTG 828
TR GT Y++PE + D+++ G++L ELL
Sbjct: 179 ---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV 217
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-33
Identities = 47/218 (21%), Positives = 94/218 (43%), Gaps = 30/218 (13%)
Query: 633 LGRGGFGTVYKGELEDGTKIAVK---------------RMEAGVTTTKALDEFQSEIAVL 677
L +G F + E +D A+K ++ D+F++E+ ++
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 678 SKVRHRHLVSLLGYSIEGNERL-LVYEYMPHGALSRHL---FRWEKLQLKPLSWTRRLSI 733
+ +++ + ++ G I + + ++YEYM + ++ + F +K + I
Sbjct: 98 TDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 734 ALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLA 793
V Y+H + HRD+K SNIL+D + R K+SDFG + D + +
Sbjct: 157 IKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK---IKGSR 211
Query: 794 GTFGYLAPEYAVMGKITT---KADVFSYGVVLMELLTG 828
GT+ ++ PE + + K D++S G+ L +
Sbjct: 212 GTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYN 248
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 67/229 (29%), Positives = 104/229 (45%), Gaps = 23/229 (10%)
Query: 633 LGRGGFGTVYKG-ELEDGTKIAVKRME-AGVTTTKALDEFQSEIAVLSKVRHRHLVSLLG 690
LG+G FG VY E + +A+K + A + + + E+ + S +RH +++ L G
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 691 YSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLAR 749
Y R+ L+ EY P G + R L + K T ++A + Y H
Sbjct: 77 Y-FHDATRVYLILEYAPLGTVYRELQKLSKF---DEQRTAT--YITELANALSYCH---S 127
Query: 750 QTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKI 809
+ IHRD+K N+LL K++DFG AP ++ L GT YL PE + G++
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--D-LCGTLDYLPPE-MIEGRM 183
Query: 810 -TTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKF 857
K D++S GV+ E L G P E+ E + RI + F
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKP------PFEANTYQETYKRISRVEFTF 226
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-33
Identities = 61/377 (16%), Positives = 104/377 (27%), Gaps = 58/377 (15%)
Query: 65 SGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFN 124
SGN ++QI + TKL L L N LS L L+ N
Sbjct: 42 SGNPLSQIS----------AADLAPFTKLELLNLSSNVLYE-TLDLESLSTLRTLDLNNN 90
Query: 125 EFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPD 184
+ S+ L N + + S N+ L N +
Sbjct: 91 YVQELL-----VGPSIETLHAANNNIS-----RVSCSRGQG--KKNIYLANNKITMLRDL 138
Query: 185 FLGTLPSLAALKLSYNRLSGVIPASFGQSL--MQILWLND---QDAGGMTGPIDVVAKMV 239
G + L L N + V A S ++ L L D +
Sbjct: 139 DEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-------VKGQVVFA 191
Query: 240 SLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLL 298
L L L N+ + + + + + ++L N+LV I K+L L++ L N
Sbjct: 192 KLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGF 249
Query: 299 M-GPIPKFKAG-----NVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPG 352
G + F + V + + EC + P
Sbjct: 250 HCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFAD---- 305
Query: 353 NDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNN 412
L + ++++ + T L N EI K +
Sbjct: 306 ---------RLIALKRKEHALLSGQ-GSETERLECERENQARQREIDALKEQYRTVIDQV 355
Query: 413 FTELKSLRLLDVSDNNI 429
++ L+ +
Sbjct: 356 TLRKQAKITLEQKKKAL 372
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 2e-20
Identities = 59/379 (15%), Positives = 110/379 (29%), Gaps = 60/379 (15%)
Query: 83 LPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVR 141
+ QN N+ + + L ++ L N I + + +
Sbjct: 5 IKQNGNRYKIEK---VTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 142 VLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNR 201
+L L N D L + L L L N + L PS+ L + N
Sbjct: 62 LLNLSSNVLY-----ETLD-LESLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNN 110
Query: 202 LSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTG-SIPEDIG 260
+S + S GQ + ++L + + + L L N+ + E
Sbjct: 111 IS-RVSCSRGQGK-KNIYLANNKITML--RDLDEGCRSRVQYLDLKLNEIDTVNFAELAA 166
Query: 261 ALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQS 320
+ +L+ LNL N + + + +L L L++N L +
Sbjct: 167 SSDTLEHLNLQYNFIYD-VKGQVVFAKLKTLDLSSNKLAF-MG----------------- 207
Query: 321 EPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHN 380
P + A V + L N + + + + +L R N
Sbjct: 208 -PEFQSAAGVTWI--SLRN-----NKLVLIEK-----------ALRFSQNLEHFDL-RGN 247
Query: 381 LTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKP-PLPEFHDT 439
+ + + K ++ N E L + P P
Sbjct: 248 GFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRL 307
Query: 440 VKLVIDGNPLLVGGINHTQ 458
+ L + LL G + T+
Sbjct: 308 IALKRKEHALLSGQGSETE 326
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 7e-15
Identities = 30/213 (14%), Positives = 62/213 (29%), Gaps = 12/213 (5%)
Query: 89 QLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYN 148
KL L L NK P F + + + L N+ I ++ L N
Sbjct: 189 VFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVLIEKAL-RFSQNLEHFDLRGN 247
Query: 149 PFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPA 208
F+ ++ D + + ++ ++ + + T+P+L +PA
Sbjct: 248 GFHCG---TLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTL--GHYGAYCCE-DLPA 301
Query: 209 SFGQSLMQILWLNDQDAGGMTGPIDVVAK----MVSLTQLWLHGNQFTGSIPEDIGALSS 264
F L+ + G + + ++ Q+ I + +
Sbjct: 302 PFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQA 361
Query: 265 LKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNN 296
L + L + ELD +
Sbjct: 362 KITLEQKKKALDEQVSNGRRAHAELDGTLQQAV 394
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 2e-13
Identities = 26/144 (18%), Positives = 54/144 (37%), Gaps = 14/144 (9%)
Query: 157 SIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQ--SL 214
+I + N + + + +L L + ++ L LS N LS + A L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 215 MQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQ 274
++L L+ + +D + + +L L L+ N ++ S++ L+ N
Sbjct: 61 -ELLNLSSNV---LYETLD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNN 110
Query: 275 LVGLIPKSLANMELDNLVLNNNLL 298
+ + N+ L NN +
Sbjct: 111 ISRVSCSRGQG--KKNIYLANNKI 132
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 21/242 (8%), Positives = 70/242 (28%), Gaps = 20/242 (8%)
Query: 65 SGNRVTQI--------QVQNLGLKG------PLPQNFNQLTKLYNLGLQRNKFNGKLPTF 110
N++ I +++ L+G L F++ ++ + Q K
Sbjct: 222 RNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK-KLTGQNE 280
Query: 111 SGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTN 170
+ + + +P+ F D L +++ + + N +
Sbjct: 281 EECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQRE 340
Query: 171 LSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQ--SLMQILWLNDQDAGGM 228
+ + + + L+ L + L L +
Sbjct: 341 IDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQ-IEL 399
Query: 229 TGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMEL 288
+ + + L + + + + ++++D ++ +++ L ++ +L
Sbjct: 400 QHATEEQSPLQLLRAIVKRYEE--MYVEQQSVQNNAIRDWDMYQHKETQLAEENARLKKL 457
Query: 289 DN 290
+
Sbjct: 458 NG 459
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-33
Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 7/206 (3%)
Query: 625 QNFAQENELGRGGFGTVYKGE-LEDGTKIAVKRME-AGVTTTKALDEFQSEIAVLSKVRH 682
NF E ++GRG F VY+ L DG +A+K+++ + KA + EI +L ++ H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 683 RHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGME 742
+++ IE NE +V E G LSR + + K Q + + + + +E
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMI-KHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 743 YLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPE 802
++H + +HRD+K +N+ + K+ D GL + + + L GT Y++PE
Sbjct: 151 HMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPYYMSPE 206
Query: 803 YAVMGKITTKADVFSYGVVLMELLTG 828
K+D++S G +L E+
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAAL 232
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 5e-33
Identities = 62/277 (22%), Positives = 111/277 (40%), Gaps = 50/277 (18%)
Query: 633 LGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTT-TKALDEFQSEIAVLSKVRHRHLVSLLG 690
LG GG TVY E K+A+K + + L F+ E+ S++ H+++VS++
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 691 YSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQ 750
E + LV EY+ LS ++ PLS ++ + G+++ H
Sbjct: 79 VDEEDDCYYLVMEYIEGPTLSEYI-----ESHGPLSVDTAINFTNQILDGIKHAH---DM 130
Query: 751 TFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKIT 810
+HRD+K NIL+D + K+ DFG+ K + + + GT Y +PE A
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATD 190
Query: 811 TKADVFSYGVVLMELLTG-------------LAALDEERPEESRYLAEWFWRIKSSKEKF 857
D++S G+VL E+L G + + + P +
Sbjct: 191 ECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTT--------------DV 236
Query: 858 KAAIDPALEVNEETFESISIVAELAGHCTAREPYHRP 894
+ I +L +++ T ++ +R
Sbjct: 237 RKDIPQSLS---------NVIL----RATEKDKANRY 260
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 5e-33
Identities = 64/228 (28%), Positives = 99/228 (43%), Gaps = 32/228 (14%)
Query: 625 QNFAQENELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHR 683
+F LGRGGFG V++ + D A+KR+ A ++ E+ L+K+ H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP-NRELAREKVMREVKALAKLEHP 63
Query: 684 HLVSLLGYSIEGNE---------RLLVY---EYMPHGALSRHLFRWEKLQLKPLSWTRRL 731
+V +E N ++ +Y + L + + ++ + L
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNG--RCTIEERERSVCL 121
Query: 732 SIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK-----------L 780
I L +A +E+LH + +HRDLK SNI D KV DFGLV L
Sbjct: 122 HIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 781 APDGEKSVVTRLAGTFGYLAPEYAVMGK-ITTKADVFSYGVVLMELLT 827
P + T GT Y++PE + G + K D+FS G++L ELL
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPE-QIHGNSYSHKVDIFSLGLILFELLY 225
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 7e-33
Identities = 56/236 (23%), Positives = 99/236 (41%), Gaps = 15/236 (6%)
Query: 625 QNFAQENELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHR 683
+++ +G G +G K DG + K ++ G T SE+ +L +++H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 684 HLVSLLG-YSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGM 741
++V N L +V EY G L+ + + K + + L L + + +
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER-QYLDEEFVLRVMTQLTLAL 124
Query: 742 EYLH--CLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYL 799
+ H T +HRDLK +N+ LD K+ DFGL ++ + + S GT Y+
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKTFVGTPYYM 183
Query: 800 APEYAVMGKI-TTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSK 854
+PE + K+D++S G +L EL P + E +I+ K
Sbjct: 184 SPE-QMNRMSYNEKSDIWSLGCLLYELCAL------MPPFTAFSQKELAGKIREGK 232
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-32
Identities = 66/258 (25%), Positives = 108/258 (41%), Gaps = 25/258 (9%)
Query: 579 SNDTARSLSSQTVASSGSTNSGATENSHVIESGTLVISVQVLRKVTQNFAQENELGRGGF 638
S + S A +N V+ + L R+ + +GRG F
Sbjct: 12 SLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSF 71
Query: 639 GTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEF-QSEIAVLSKVRHRHLVSLLGYSIEGN 696
G V++ + + G + AVK++ L+ F E+ + + +V L G EG
Sbjct: 72 GEVHRMKDKQTGFQCAVKKVR--------LEVFRVEELVACAGLSSPRIVPLYGAVREGP 123
Query: 697 ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRD 756
+ E + G+L + + + L R L G+EYLH + +H D
Sbjct: 124 WVNIFMELLEGGSLGQLIKQM-----GCLPEDRALYYLGQALEGLEYLH---TRRILHGD 175
Query: 757 LKSSNILLDDD-YRAKVSDFGLVK-LAPDGEKSVVTR---LAGTFGYLAPEYAVMGK-IT 810
+K+ N+LL D RA + DFG L PDG + + GT ++APE VMGK
Sbjct: 176 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE-VVMGKPCD 234
Query: 811 TKADVFSYGVVLMELLTG 828
K D++S +++ +L G
Sbjct: 235 AKVDIWSSCCMMLHMLNG 252
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-32
Identities = 60/392 (15%), Positives = 116/392 (29%), Gaps = 79/392 (20%)
Query: 61 HVFCSGNRVTQIQVQNLGLKGPLPQN-FNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEF 118
C +++++ P + + + L N +FS SEL++
Sbjct: 15 TYQCMDQKLSKV-----------PDDIPSSTKNID---LSFNPLKILKSYSFSNFSELQW 60
Query: 119 AYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNL 178
L E +TI + GL + L L NP P S + L NL + L
Sbjct: 61 LDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQS----FSPGSFSGLTSLENLVAVETKL 116
Query: 179 VGPLPDFLGTLPSLAALKLSYNRLSGV-IPASFGQSLMQILWLNDQDAGGMTGPIDVVAK 237
+G L +L L +++N + +PA F
Sbjct: 117 ASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSN------------------------- 151
Query: 238 MVSLTQLWLHGNQFTGSIPEDIGALSSLKD----LNLNRNQLVGLIPKSLANMELDNLVL 293
+ +L + L N D+ L L+++ N + + ++ ++L L L
Sbjct: 152 LTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTL 211
Query: 294 NNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGN 353
N I K + Q+ G+ V+ L+ + +
Sbjct: 212 RGNFNSSNIMK-----------TCLQNLAGLH----VHRLILGEFKDERNLEIFEPSIME 256
Query: 354 DPCQGPWLGLSCTSNSKVSIINLPRHNLTG----TLS-------PSIANLDSLIEIRLGK 402
C T + S + H L +L+ + + + +
Sbjct: 257 GLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIR 316
Query: 403 NSISGTVPNNFTELKSLRLLDVSDNNIKPPLP 434
+ +L L+ L ++ N
Sbjct: 317 CQLKQ---FPTLDLPFLKSLTLTMNKGSISFK 345
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 9e-26
Identities = 44/224 (19%), Positives = 69/224 (30%), Gaps = 12/224 (5%)
Query: 87 FNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFD--GLSSVRVLA 144
L L +L L NK + L L + L N + G +S+R L
Sbjct: 324 TLDLPFLKSLTLTMNKGSI-SFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLD 382
Query: 145 LDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVG-PLPDFLGTLPSLAALKLSYNRLS 203
L +N + + +L +L + L +L L L +SY
Sbjct: 383 LSFNGAI-----IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTK 437
Query: 204 GVIPASFGQSLMQILWLNDQDAGGMTGPI-DVVAKMVSLTQLWLHGNQFTGSIPEDIGAL 262
F L + L + +V A +LT L L Q L
Sbjct: 438 IDFDGIF-LGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTL 496
Query: 263 SSLKDLNLNRNQLVGLIPKSLANME-LDNLVLNNNLLMGPIPKF 305
L+ LN++ N L+ L + L L + N +
Sbjct: 497 HRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGIL 540
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 6e-25
Identities = 70/377 (18%), Positives = 122/377 (32%), Gaps = 44/377 (11%)
Query: 78 GLKGPLPQNFNQLTKLYNLGLQRNKFNG-KLP-TFSGLSELEFAYLDFNEFDTIPSDFFD 135
L QL L L + N + KLP FS L+ L L +N TI +
Sbjct: 115 KLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQ 174
Query: 136 GLSSVR----VLALDYNPFNKTFGWSIPDSLANSVQLTNLSL-INCNLVGPLPDFLGTLP 190
L L + NP + I D ++L L+L N N + L L
Sbjct: 175 FLRENPQVNLSLDMSLNPID-----FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLA 229
Query: 191 SLAALKLSYNRLSG-----VIPASFGQSL--MQILWLNDQDAGGMTGPIDVVAKMVSLTQ 243
L +L + S + L + I + I + +++
Sbjct: 230 GLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSA 289
Query: 244 LWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMGPIP 303
+ L G ED+ + L++ R QL L L +L L N
Sbjct: 290 MSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQFPTLDLPF--LKSLTLTMNKGSISFK 345
Query: 304 KFKAGNVTY---DSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPW 360
K +++Y N+ C ++ + L ++ N N +
Sbjct: 346 KVALPSLSYLDLSRNAL----SFSGCCSYSDLGTNSLRHLDLSFNGAIIMSAN------F 395
Query: 361 LGLSCTSNSKVSIINLPRHN-LTGTLSPS-IANLDSLIEIRLGKNSISGTVPNNFTELKS 418
+GL ++ ++ +H+ L S +L+ L+ + + + F L S
Sbjct: 396 MGLE-----ELQHLDF-QHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTS 449
Query: 419 LRLLDVSDNNIKPPLPE 435
L L ++ N+ K
Sbjct: 450 LNTLKMAGNSFKDNTLS 466
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-24
Identities = 45/252 (17%), Positives = 76/252 (30%), Gaps = 27/252 (10%)
Query: 65 SGNRVTQIQVQNL---------GLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPT---FSG 112
++ Q +L KG + L L L L RN + G
Sbjct: 315 IRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLG 374
Query: 113 LSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLS 172
+ L L FN I S F GL ++ L ++ + + + + +L L
Sbjct: 375 TNSLRHLDLSFNGA-IIMSANFMGLEELQHLDFQHSTLKRV---TEFSAFLSLEKLLYLD 430
Query: 173 LINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSL--MQILWL--NDQDAGGM 228
+ N L SL LK++ N ++ + + L L +
Sbjct: 431 ISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKC-----QL 485
Query: 229 TG-PIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANME 287
V + L L + N L SL L+ + N++ +
Sbjct: 486 EQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPK 545
Query: 288 -LDNLVLNNNLL 298
L L NN +
Sbjct: 546 SLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-24
Identities = 62/390 (15%), Positives = 114/390 (29%), Gaps = 62/390 (15%)
Query: 76 NLGLKGPLPQNFNQLTKLYNLGLQRNKFNG-------KLPTFSGLSELEFAYLDF--NEF 126
N + L L+ L +F + GL ++
Sbjct: 214 NFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTND 273
Query: 127 DTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFL 186
+ F L++V ++L + + + +LS+I C L P
Sbjct: 274 FSDDIVKFHCLANVSAMSLAGVSIKY------LEDVPKHFKWQSLSIIRCQL-KQFPTL- 325
Query: 187 GTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWL 246
LP L +L L+ N+ S SL L L+ SL L L
Sbjct: 326 -DLPFLKSLTLTMNKGSISFKKVALPSL-SYLDLSRNALSFSGCCSYSDLGTNSLRHLDL 383
Query: 247 HGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKS-LANM-ELDNLVLNNNLLMGPIPK 304
N + + L L+ L+ + L + S ++ +L L ++
Sbjct: 384 SFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFD- 441
Query: 305 FKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLS 364
F +N L + G ++ N +S N
Sbjct: 442 ----------GIFLGL-------TSLNTL--KMAGNSFKDNTLSNVFAN----------- 471
Query: 365 CTSNSKVSIINLPRHN-LTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLD 423
+ ++ ++L L L L + + N++ +++ +L SL LD
Sbjct: 472 ---TTNLTFLDL-SKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLD 527
Query: 424 VSDNNIKPPLPEFHDTVK----LVIDGNPL 449
S N I+ K + N +
Sbjct: 528 CSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-23
Identities = 66/408 (16%), Positives = 127/408 (31%), Gaps = 58/408 (14%)
Query: 65 SGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDF 123
S + I+ + ++ L L NL L N P +FSGL+ LE
Sbjct: 64 SRCEIETIE----------DKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVE 113
Query: 124 NEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLP 183
+ ++ S L +++ L + +N + +P +N L ++ L +
Sbjct: 114 TKLASLESFPIGQLITLKKLNVAHNFIHSC---KLPAYFSNLTNLVHVDLSYNYIQTITV 170
Query: 184 DFLGTLPSLAA----LKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPI-DVVAKM 238
+ L L L +S N + + +F +++ L + + + + +
Sbjct: 171 NDLQFLRENPQVNLSLDMSLNPIDFIQDQAF--QGIKLHELTLRGNFNSSNIMKTCLQNL 228
Query: 239 VSLTQLWLHGNQFTGSIPEDIGALSSLK--------DLNLNRNQLVGLIPKSLANM-ELD 289
L L +F +I S ++ + L + +
Sbjct: 229 AGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVS 288
Query: 290 NLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQ 349
+ L + K S CQ ++ P ++ L FL + +N S
Sbjct: 289 AMSLAGVSIKYLEDVPKHFKWQSLSIIRCQ----LKQFPTLD--LPFLKSLTLTMNKGSI 342
Query: 350 WPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSP---SIANLDSLIEIRLGKNSIS 406
+ +S ++L N S +SL + L N
Sbjct: 343 SFKK------------VALPSLSYLDL-SRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI 389
Query: 407 GTVPNNFTELKSLRLLDVSDNNIK--PPLPEFHDTVKLV---IDGNPL 449
+ NF L+ L+ LD + +K F KL+ I
Sbjct: 390 -IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNT 436
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-21
Identities = 64/381 (16%), Positives = 117/381 (30%), Gaps = 46/381 (12%)
Query: 65 SGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNG-KLPTFSGLSELEFAYLDF 123
S N + I V +L L +N L + N + + F G+ L L
Sbjct: 161 SYNYIQTITVNDLQ---FLRENPQVNLSLD---MSLNPIDFIQDQAFQGIK-LHELTLRG 213
Query: 124 NEFDT-IPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLAN----SVQLTNLSLINCNL 178
N + I L+ + V L F I + V + L N
Sbjct: 214 NFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTND 273
Query: 179 VGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKM 238
L +++A+ L+ + + Q L + +
Sbjct: 274 FSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKW-QSLSIIRCQLKQFPT-----LDL 327
Query: 239 VSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLV---LNN 295
L L L N+ GSI AL SL L+L+RN L S +++ ++L L+
Sbjct: 328 PFLKSLTLTMNK--GSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSF 385
Query: 296 NLLMGPIPKFKA-GNVTY---DSNSFCQSEPGIECAPDVN-VLLDFLGGVNYPVNLVSQW 350
N + F + + ++ + + LD
Sbjct: 386 NGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISY------TNTKID 439
Query: 351 PGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSI-ANLDSLIEIRLGKNSISGTV 409
+ ++ + + ++ ++ AN +L + L K +
Sbjct: 440 FDG----------IFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQIS 489
Query: 410 PNNFTELKSLRLLDVSDNNIK 430
F L L+LL++S NN+
Sbjct: 490 WGVFDTLHRLQLLNMSHNNLL 510
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-20
Identities = 44/217 (20%), Positives = 74/217 (34%), Gaps = 16/217 (7%)
Query: 83 LPQNFNQLTKLYNLGLQRNKFNGKLP--TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSV 140
+ NF L +L +L Q + F L +L + + + F GL+S+
Sbjct: 391 MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSL 450
Query: 141 RVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYN 200
L + N F ++ + AN+ LT L L C L TL L L +S+N
Sbjct: 451 NTLKMAGNSFKDN---TLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHN 507
Query: 201 RLSGVIPASFGQ--SLMQILWLNDQDAGGMTG-PIDVVAKMVSLTQLWLHGNQFTGSIPE 257
L + + + Q SL L + + + SL L N I E
Sbjct: 508 NLLFLDSSHYNQLYSL-STLDCSFNR---IETSKGILQHFPKSLAFFNLTNNSVA-CICE 562
Query: 258 DIGALSSLKDLNLNRNQLVGLI---PKSLANMELDNL 291
L +K+ + + P + + +
Sbjct: 563 HQKFLQWVKEQKQFLVNVEQMTCATPVEMNTSLVLDF 599
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 6e-12
Identities = 42/286 (14%), Positives = 77/286 (26%), Gaps = 73/286 (25%)
Query: 159 PDSLANSVQLTNLSLINC---NLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLM 215
P SL +++ C L +PD + S + LS+N L + SF
Sbjct: 1 PGSLNPCIEVVPNITYQCMDQKLSK-VPDDIP--SSTKNIDLSFNPLKILKSYSFSN--- 54
Query: 216 QILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQL 275
L L L + + L L +L L N +
Sbjct: 55 ----------------------FSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPI 92
Query: 276 VGLIPKSLANM-ELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLL 334
P S + + L+NLV L Q + L
Sbjct: 93 QSFSPGSFSGLTSLENLVAVETKLASLES-----------FPIGQL-------ITLKKL- 133
Query: 335 DFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHN-LTGTLSPSIANL- 392
+ N+ + L ++ + + ++L +N + + L
Sbjct: 134 -NVAH-NFIHSC-------------KLPAYFSNLTNLVHVDL-SYNYIQTITVNDLQFLR 177
Query: 393 ---DSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLPE 435
+ + + N I F + L L + N + +
Sbjct: 178 ENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMK 222
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 9e-08
Identities = 21/128 (16%), Positives = 37/128 (28%), Gaps = 13/128 (10%)
Query: 58 PWPHVFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSEL 116
+VF + +T + + L+ F+ L +L L + N ++ L L
Sbjct: 464 TLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSL 523
Query: 117 EFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLA-------NSVQLT 169
FN +T S+ L N I + L
Sbjct: 524 STLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA-----CICEHQKFLQWVKEQKQFLV 578
Query: 170 NLSLINCN 177
N+ + C
Sbjct: 579 NVEQMTCA 586
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 16/201 (7%)
Query: 633 LGRGGFGTVYKG-ELEDGTKIAVKRME-AGVTTTKALDEFQSEIAVLSKVRHRHLVSLLG 690
LG+G F VY+ + G ++A+K ++ + + Q+E+ + +++H ++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 691 YSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLAR 749
Y E + + LV E +G ++R+L K ++KP S + GM YLH
Sbjct: 79 Y-FEDSNYVYLVLEMCHNGEMNRYL----KNRVKPFSENEARHFMHQIITGMLYLH---S 130
Query: 750 QTFIHRDLKSSNILLDDDYRAKVSDFGL-VKLAPDGEKSVVTRLAGTFGYLAPEYAVMGK 808
+HRDL SN+LL + K++DFGL +L EK L GT Y++PE
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK--HYTLCGTPNYISPE-IATRS 187
Query: 809 I-TTKADVFSYGVVLMELLTG 828
++DV+S G + LL G
Sbjct: 188 AHGLESDVWSLGCMFYTLLIG 208
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-32
Identities = 50/214 (23%), Positives = 86/214 (40%), Gaps = 24/214 (11%)
Query: 626 NFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRH 684
+F ++ LG G GT+ + D +AVKR+ + E+ +L + H +
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRIL-----PECFSFADREVQLLRESDEHPN 79
Query: 685 LVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYL 744
++ + + + E A L + + + +++ G+ +L
Sbjct: 80 VIRYFCTEKDRQFQYIAIELC--AAT---LQEYVEQKDFAHLGLEPITLLQQTTSGLAHL 134
Query: 745 HCLARQTFIHRDLKSSNILL-----DDDYRAKVSDFGLVKLAPDGEKSVVTR--LAGTFG 797
H +HRDLK NIL+ +A +SDFGL K G S R + GT G
Sbjct: 135 H---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191
Query: 798 YLAPEY---AVMGKITTKADVFSYGVVLMELLTG 828
++APE T D+FS G V +++
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-32
Identities = 63/258 (24%), Positives = 98/258 (37%), Gaps = 25/258 (9%)
Query: 632 ELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLG 690
LG+G V++G + G A+K ++ + +D E VL K+ H+++V L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNN-ISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 691 YSIEGNERL--LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLA 748
E R L+ E+ P G+L L E L + L + DV GM +L
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLE--EPSNAYGLPESEFLIVLRDVVGGMNHLR--- 129
Query: 749 RQTFIHRDLKSSNILL----DDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPE-- 802
+HR++K NI+ D K++DFG + D E+ L GT YL P+
Sbjct: 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ--FVSLYGTEEYLHPDMY 187
Query: 803 ------YAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEK 856
K D++S GV TG E R E ++I + K
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF--EGPRRNKEVMYKIITGKPS 245
Query: 857 FKAAIDPALEVNEETFES 874
+ E +
Sbjct: 246 GAISGVQKAENGPIDWSG 263
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 8e-32
Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 16/202 (7%)
Query: 633 LGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGY 691
LG+G +G VY G +L + +IA+K + ++ EIA+ ++H+++V LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIP--ERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 692 SIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRL--SIALDVARGMEYLHCLAR 749
E + E +P G+LS L + + PL + + G++YLH
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALL----RSKWGPLKDNEQTIGFYTKQILEGLKYLH---D 140
Query: 750 QTFIHRDLKSSNILLD-DDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGK 808
+HRD+K N+L++ K+SDFG K T GT Y+APE G
Sbjct: 141 NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGP 199
Query: 809 I--TTKADVFSYGVVLMELLTG 828
AD++S G ++E+ TG
Sbjct: 200 RGYGKAADIWSLGCTIIEMATG 221
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-31
Identities = 51/269 (18%), Positives = 91/269 (33%), Gaps = 50/269 (18%)
Query: 633 LGRGGFGTVYKGE--LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLG 690
+ GG G +Y +G + +K + +A +E L++V H +V +
Sbjct: 88 IAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 691 YSIEGNERL-----LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLH 745
+ + +V EY+ +L R + L ++ L++ + YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLH 199
Query: 746 CLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAV 805
++ DLK NI+L ++ + K+ D G V + + GT G+ APE
Sbjct: 200 ---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS-RINSFGYLY----GTPGFQAPEIV- 249
Query: 806 MGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPAL 865
T D+++ G L L RY+ DP L
Sbjct: 250 RTGPTVATDIYTVGRTLAALTLD------LPTRNGRYVDG------------LPEDDPVL 291
Query: 866 EVNEETFESISIVAELAGHCTAREPYHRP 894
+ + L +P R
Sbjct: 292 KTYDS-------YGRLLRRAIDPDPRQRF 313
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 62/229 (27%), Positives = 104/229 (45%), Gaps = 23/229 (10%)
Query: 633 LGRGGFGTVYKG-ELEDGTKIAVKRME-AGVTTTKALDEFQSEIAVLSKVRHRHLVSLLG 690
LG+G FG VY E ++ +A+K + + + + + EI + S +RH +++ +
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 691 YSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLAR 749
Y +R+ L+ E+ P G L + L + + + ++A + Y H
Sbjct: 82 Y-FHDRKRIYLMLEFAPRGELYKELQKHGRF---DEQRSAT--FMEELADALHYCH---E 132
Query: 750 QTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKI 809
+ IHRD+K N+L+ K++DFG AP + T + GT YL PE + GK
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR--T-MCGTLDYLPPE-MIEGKT 188
Query: 810 -TTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKF 857
K D++ GV+ E L G+ P +S E RI + KF
Sbjct: 189 HDEKVDLWCAGVLCYEFLVGMP------PFDSPSHTETHRRIVNVDLKF 231
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 47/230 (20%), Positives = 86/230 (37%), Gaps = 33/230 (14%)
Query: 622 KVTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV 680
+ T F + ++G G FG+V+K + DG A+KR + + + E+ + +
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 681 -RHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVAR 739
+H H+V E + L+ EY G+L+ + + + + L V R
Sbjct: 68 GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYR-IMSYFKEAELKDLLLQVGR 126
Query: 740 GMEYLHCLARQTFIHRDLKSSNILLDDD-------------------YRAKVSDFGLVKL 780
G+ Y+H + +H D+K SNI + K+ D G V
Sbjct: 127 GLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183
Query: 781 APDGEKSVVTRLAGTFGYLAPEYAVMGKI--TTKADVFSYGVVLMELLTG 828
+ G +LA E + KAD+F+ + ++
Sbjct: 184 I-SSPQVEE----GDSRFLANE-VLQENYTHLPKADIFALALTVVCAAGA 227
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 5e-31
Identities = 73/300 (24%), Positives = 118/300 (39%), Gaps = 44/300 (14%)
Query: 622 KVTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV 680
+ + + LG GGFG V + + G ++A+K+ ++ K + + EI ++ K+
Sbjct: 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSP-KNRERWCLEIQIMKKL 69
Query: 681 RHRHLVSLL------GYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIA 734
H ++VS + LL EY G L ++L ++E L ++
Sbjct: 70 NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCC--GLKEGPIRTLL 127
Query: 735 LDVARGMEYLHCLARQTFIHRDLKSSNILLD---DDYRAKVSDFGLVKLAPDGEKSVVTR 791
D++ + YLH IHRDLK NI+L K+ D G K GE T
Sbjct: 128 SDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL--CTE 182
Query: 792 LAGTFGYLAPEYAVMGKI-TTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRI 850
GT YLAPE + K T D +S+G + E +TG RP + +
Sbjct: 183 FVGTLQYLAPE-LLEQKKYTVTVDYWSFGTLAFECITG------FRPFLPNWQPVQWHGK 235
Query: 851 KSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKW 910
K E I + +L G + P H+ +L+ +E+W
Sbjct: 236 VREKS----------------NEHIVVYDDLTGA--VKFSSVLPTPNHLSGILAGKLERW 277
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-31
Identities = 67/401 (16%), Positives = 124/401 (30%), Gaps = 72/401 (17%)
Query: 65 SGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDF 123
S R +I++ + Q N L + + + + L + +
Sbjct: 376 SEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIG-NLT 434
Query: 124 NEFDTIPSDFFDGLSSVRVLALDYNPFNK---------------TFGWSIPDSLANSVQL 168
N I L+ ++++ +PF + S +N L
Sbjct: 435 NRITFISKAIQ-RLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDL 493
Query: 169 TNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGV---------IPASFGQ-SLMQIL 218
T++ L NC + LPDFL LP L +L ++ NR + +QI
Sbjct: 494 TDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIF 553
Query: 219 WLNDQDAGGMTG-PIDVV-AKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLV 276
++ + + P KMV L L N+ + G L DL L+ NQ+
Sbjct: 554 YMGYNN---LEEFPASASLQKMVKLGLLDCVHNKVR-HLEA-FGTNVKLTDLKLDYNQIE 608
Query: 277 GLIPKSLANM-ELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLD 335
+ A +++ L ++N L F A + +
Sbjct: 609 EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKS------------------------VY 644
Query: 336 FLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSL 395
+G V++ N + N C S + L + + + A +
Sbjct: 645 VMGSVDFSYNKIGSEGRNISCSMDDYKG-----INASTVTLSYNEIQKFPTELFATGSPI 699
Query: 396 IEIRLGKNSIS-------GTVPNNFTELKSLRLLDVSDNNI 429
I L N ++ N+ L +D+ N +
Sbjct: 700 STIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKL 740
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-30
Identities = 68/420 (16%), Positives = 128/420 (30%), Gaps = 80/420 (19%)
Query: 70 TQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFDT 128
+++ L L ++ L +LP L EL+ + N +
Sbjct: 470 EDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGIS 529
Query: 129 IPS---------DFFDGLSSVRVLALDYNPFNKTFGWSIPDS--LANSVQLTNLSLINCN 177
D D +++ + YN P S L V+L L ++
Sbjct: 530 AAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-----EFPASASLQKMVKLGLLDCVHNK 584
Query: 178 LVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSL--MQILWLND------QDAGGMT 229
+ L F GT L LKL YN++ IP F ++ L + +
Sbjct: 585 VRH-LEAF-GTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAK 641
Query: 230 GPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGA------LSSLKDLNLNRNQLVGLIPKSL 283
+ + + N+ S +I + + L+ N++ +
Sbjct: 642 -------SVYVMGSVDFSYNKIG-SEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELF 693
Query: 284 ANME-LDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNY 342
A + ++L+NNL+ IP NS + + + + L
Sbjct: 694 ATGSPISTIILSNNLM-TSIP----------ENSLKPKDGNYKNTYLLTTI--DLRF--- 737
Query: 343 PVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRL-- 400
N ++ + T+ +S +++ +N + N L +
Sbjct: 738 --NKLTSLSDD---------FRATTLPYLSNMDV-SYNCFSSFPTQPLNSSQLKAFGIRH 785
Query: 401 ----GKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLPE--FHDTVKLVIDGNPLLVGGI 454
N I P T SL L + N+I+ + E L I NP + +
Sbjct: 786 QRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKLTPQLYILDIADNPNISIDV 844
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 7e-30
Identities = 43/262 (16%), Positives = 83/262 (31%), Gaps = 39/262 (14%)
Query: 64 CSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDF 123
N + + P + ++ KL L NK L F +L LD+
Sbjct: 555 MGYNNLEEF---------PASASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKLTDLKLDY 604
Query: 124 NEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPD--SLANSVQLTNLSLINCNLVGP 181
N+ + IP DF V L +N IP+ + + + ++ +
Sbjct: 605 NQIEEIPEDFCAFTDQVEGLGFSHNKLK-----YIPNIFNAKSVYVMGSVDFSYNKIGSE 659
Query: 182 LPDFLGTLP-----SLAALKLSYNRLSGVIPASFGQ-SLMQILWLND-----QDAGGMTG 230
+ ++ + + + LSYN + F S + + L++ +
Sbjct: 660 GRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKP 719
Query: 231 PIDVVAKMVSLTQLWLHGNQFTGSIPEDI--GALSSLKDLNLNRNQLVGLIPKSLANM-- 286
LT + L N+ T S+ +D L L +++++ N P N
Sbjct: 720 KDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQ 777
Query: 287 --ELD---NLVLNNNLLMGPIP 303
N ++ P
Sbjct: 778 LKAFGIRHQRDAEGNRILRQWP 799
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 4e-27
Identities = 63/425 (14%), Positives = 119/425 (28%), Gaps = 81/425 (19%)
Query: 32 NDFKNGLENPELLK--WPANGDDPCGPPPWPHVFCSGN-RVTQIQVQNLGLKGPLPQNFN 88
+ +G N + W N + P V N RVT + + G KG +P
Sbjct: 286 WRYYSGTINNTIHSLNWNFN-KELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIG 344
Query: 89 QLTKLYNLGLQRNKFNGKLPTFS--GLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALD 146
QLT+L L + F L+ F D + + L
Sbjct: 345 QLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLL 404
Query: 147 YNPFNK-TFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGV 205
+ N+ I S++ T + + N + + + L L + + + +
Sbjct: 405 QDAINRNPEMKPIKKDSRISLKDTQIGNLT-NRITFISKAIQRLTKLQIIYFANSPFTYD 463
Query: 206 IPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSL 265
A + + + + LT + L+ +P+ + L L
Sbjct: 464 NIAVDWEDA---NSDYAKQYENEELSW---SNLKDLTDVELYNCPNMTQLPDFLYDLPEL 517
Query: 266 KDLNLNRNQLVGL---------IPKSLANM-ELDNLVLNNNLLMGPIPKFKAGNVTYDSN 315
+ LN+ N+ + + ++ + N L P
Sbjct: 518 QSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEE-FP------------ 564
Query: 316 SFCQSEPGIECAPDVNVL---------LDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCT 366
+ ++ + +L L+ G V L L L
Sbjct: 565 ----ASASLQKMVKLGLLDCVHNKVRHLEAFGT---NVKLT------------DLKLD-- 603
Query: 367 SNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPN--NFTELKSLRLLDV 424
N I +P + + L N + +PN N + + +D
Sbjct: 604 YN---QIEEIPED--FCAFTDQVEGLG------FSHNKLK-YIPNIFNAKSVYVMGSVDF 651
Query: 425 SDNNI 429
S N I
Sbjct: 652 SYNKI 656
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-24
Identities = 44/254 (17%), Positives = 77/254 (30%), Gaps = 46/254 (18%)
Query: 65 SGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNG-------KLPTFSGLSELE 117
S N++ I P N + + ++ NK + + G++
Sbjct: 627 SHNKLKYI---------PNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGIN-AS 676
Query: 118 FAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPF---NKTFGWSIPDSLANSVQLTNLSLI 174
L +NE P++ F S + + L N + + N+ LT + L
Sbjct: 677 TVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLR 736
Query: 175 NCNLVG-PLPDFLGTLPSLAALKLSYNRLSGVIPASFGQ-SLMQILWLNDQDAGGMTGPI 232
L TLP L+ + +SYN S P S ++ + Q
Sbjct: 737 FNKLTSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQ--------- 786
Query: 233 DVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLV 292
GN+ P I SL L + N + + K L L
Sbjct: 787 -----------RDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRKVDEKLTPQ--LYILD 833
Query: 293 L-NNNLLMGPIPKF 305
+ +N + +
Sbjct: 834 IADNPNISIDVTSV 847
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 2e-19
Identities = 49/361 (13%), Positives = 107/361 (29%), Gaps = 66/361 (18%)
Query: 88 NQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDY 147
N+LTK N+ +Q + + + L + + D ++ G + + +L++
Sbjct: 249 NKLTKDANVPIQLKETAEYIKDYKALKAI------WEALDGKNWRYYSGTINNTIHSLNW 302
Query: 148 NPFNKTFGWS--IPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGV 205
N + W L N+ ++T LSL G +PD +G L L L + +
Sbjct: 303 NFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVS 362
Query: 206 IPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSL 265
+ L + + M + L L + PE + +
Sbjct: 363 GRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAIN-RNPE-MKPIKKD 420
Query: 266 KDLNLNRNQLVGL------IPKSLANM-ELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFC 318
++L Q+ L I K++ + +L + N+ + D
Sbjct: 421 SRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQY 480
Query: 319 QSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPR 378
++E NL ++ + L
Sbjct: 481 ENEE------------LSWS------NL----------------------KDLTDVELYN 500
Query: 379 HNLTGTLSPSIANLDSLIEIRLGKNSISG---------TVPNNFTELKSLRLLDVSDNNI 429
L + +L L + + N + ++ +++ + NN+
Sbjct: 501 CPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNL 560
Query: 430 K 430
+
Sbjct: 561 E 561
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 3e-16
Identities = 37/286 (12%), Positives = 78/286 (27%), Gaps = 34/286 (11%)
Query: 180 GPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDV-VAKM 238
+ D+ AL R + ++ + W +++ V +
Sbjct: 266 EYIKDYKALKAIWEALDGKNWRYYSGTINN---TIHSLNWNFNKELDMWGDQPGVDLDNN 322
Query: 239 VSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIP-KSLANMELDNLVLNNNL 297
+T L L G G +P+ IG L+ LK L+ + + D +
Sbjct: 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHR 382
Query: 298 LMGPIPKFKAGNVTY------DSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWP 351
+ K ++ ++ D + L N N ++
Sbjct: 383 IRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLT-NRITFIS 441
Query: 352 GNDPCQGPWLG-------LSCTSNSKVSII--------NLPRHNLTGTLSPSIANLDSLI 396
+ + ++ N S +NL L
Sbjct: 442 -------KAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLT 494
Query: 397 EIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLPEFHDTVKL 442
++ L +P+ +L L+ L+++ N D +L
Sbjct: 495 DVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRL 540
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 2e-14
Identities = 29/166 (17%), Positives = 59/166 (35%), Gaps = 18/166 (10%)
Query: 65 SGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP---TFSGLSELEFAYL 121
S N +T I +L P N+ L + L+ NK L + L L +
Sbjct: 705 SNNLMTSIPENSLK---PKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDV 760
Query: 122 DFNEFDTIPSDFFDGLSSVRVLALDYNPF---NKTFGWSIPDSLANSVQLTNLSLINCNL 178
+N F + P+ + S ++ + + N+ P + L L + + ++
Sbjct: 761 SYNCFSSFPTQPLN-SSQLKAFGIRHQRDAEGNRILR-QWPTGITTCPSLIQLQIGSNDI 818
Query: 179 VGPLPDFLGTLPSLAALKLSYNRLSGVIPASFG---QSLMQILWLN 221
+ + P L L ++ N + S ++ M +L +
Sbjct: 819 RK-VDE--KLTPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYD 861
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 6e-31
Identities = 60/263 (22%), Positives = 95/263 (36%), Gaps = 41/263 (15%)
Query: 592 ASSGSTNSGATENSHVIESGTLVI---SVQVLRKVTQNFAQENELGRGGFGTVYKGE-LE 647
A GS + + T+ + ++V R L GGF VY+ + +
Sbjct: 2 AGPGSLGGASGRDQSDFVGQTVELGELRLRVRRV----------LAEGGFAFVYEAQDVG 51
Query: 648 DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR-HRHLVSLLGYSIEGNER-------L 699
G + A+KR+ + E+ + K+ H ++V + G E
Sbjct: 52 SGREYALKRLL--SNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEF 109
Query: 700 LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKS 759
L+ + G L L + PLS L I R ++++H + IHRDLK
Sbjct: 110 LLLTELCKGQLVEFLKK--MESRGPLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKV 166
Query: 760 SNILLDDDYRAKVSDFGLV---KLAPDGEKSVVTRLA--------GTFGYLAPE-YAVMG 807
N+LL + K+ DFG PD S R T Y PE +
Sbjct: 167 ENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYS 226
Query: 808 K--ITTKADVFSYGVVLMELLTG 828
I K D+++ G +L L
Sbjct: 227 NFPIGEKQDIWALGCILYLLCFR 249
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-30
Identities = 66/230 (28%), Positives = 106/230 (46%), Gaps = 23/230 (10%)
Query: 633 LGRGGFGTVYKG-ELEDGTKIAVKRME-AGVTTTKALDEFQSEIAVLSKVRHRHLVSLLG 690
LG+GGF ++ + + A K + + + ++ EI++ + H+H+V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 691 YSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLAR 749
+ E N+ + +V E +L R + L R + G +YLH R
Sbjct: 83 F-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPE---ARYYLRQI--VLGCQYLH---R 133
Query: 750 QTFIHRDLKSSNILLDDDYRAKVSDFGL-VKLAPDGEKSVVTRLAGTFGYLAPEYAVMGK 808
IHRDLK N+ L++D K+ DFGL K+ DGE+ L GT Y+APE + K
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPE-VLSKK 190
Query: 809 I-TTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKF 857
+ + DV+S G ++ LL G P E+ L E + RIK ++
Sbjct: 191 GHSFEVDVWSIGCIMYTLLVGKP------PFETSCLKETYLRIKKNEYSI 234
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-30
Identities = 72/278 (25%), Positives = 115/278 (41%), Gaps = 27/278 (9%)
Query: 621 RKVT-QNFAQENELGRGGFGTVYKGELEDGTKI-AVKRME-AGVTTTKALDEFQSEIAVL 677
+ + F LGRGGFG V+ +++ K+ A K++ + K E +L
Sbjct: 180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKIL 239
Query: 678 SKVRHRHLVSLLGYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALD 736
+KV R +VSL Y+ E L LV M G + H++ ++ R +
Sbjct: 240 AKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN-PGFQEPRAIFYTAQ 297
Query: 737 VARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTF 796
+ G+E+LH ++ I+RDLK N+LLDDD ++SD GL G+ AGT
Sbjct: 298 IVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY-AGTP 353
Query: 797 GYLAPEYAVMGKITTKA-DVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKE 855
G++APE ++G+ + D F+ GV L E++ E E R+
Sbjct: 354 GFMAPE-LLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR--GEKVENKELKQRVLEQAV 410
Query: 856 KFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHR 893
+ P S L ++P R
Sbjct: 411 TYPDKFSP---------ASKDFCEAL----LQKDPEKR 435
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 3e-30
Identities = 61/237 (25%), Positives = 91/237 (38%), Gaps = 41/237 (17%)
Query: 621 RKVTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV 680
+ + E LG G GTV G +AVKRM D EI +L++
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI-----DFCDIALMEIKLLTES 65
Query: 681 -RHRHLVSLLGYSIEGNERLLVYEYMPHGAL-----SRHLFRWEKLQLKPLSWTRRLSIA 734
H +++ + E L S+++ LK +S+
Sbjct: 66 DDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDEN---LKLQKEYNPISLL 121
Query: 735 LDVARGMEYLHCLARQTFIHRDLKSSNILLD-------------DDYRAKVSDFGLVKLA 781
+A G+ +LH IHRDLK NIL+ ++ R +SDFGL K
Sbjct: 122 RQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 178
Query: 782 PDGEKSVVTRL---AGTFGYLAPE-------YAVMGKITTKADVFSYGVVLMELLTG 828
G+ S T L +GT G+ APE ++T D+FS G V +L+
Sbjct: 179 DSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-30
Identities = 61/257 (23%), Positives = 96/257 (37%), Gaps = 25/257 (9%)
Query: 633 LGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGY 691
LG+G V++G + G A+K ++ + +D E VL K+ H+++V L
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNN-ISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 692 SIEGNERL--LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLAR 749
E R L+ E+ P G+L L E L + L + DV GM +L
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLE--EPSNAYGLPESEFLIVLRDVVGGMNHLR---E 130
Query: 750 QTFIHRDLKSSNILL----DDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPE--- 802
+HR++K NI+ D K++DFG + D E+ L GT YL P+
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ--FVSLYGTEEYLHPDMYE 188
Query: 803 -----YAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKF 857
K D++S GV TG E ++I + K
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--NKEVMYKIITGKPSG 246
Query: 858 KAAIDPALEVNEETFES 874
+ E +
Sbjct: 247 AISGVQKAENGPIDWSG 263
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-30
Identities = 61/278 (21%), Positives = 105/278 (37%), Gaps = 54/278 (19%)
Query: 633 LGRGGFGTVYKGELED---GTKIAVKRMEAGVTTTKALDE-FQSEIAVLSKVRHRHLVSL 688
+GRGG G VY+ E D +A+K M +++ Q E +++ H+V +
Sbjct: 42 VGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 689 LGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLA 748
+ + + + L+ L R PL+ R ++I + ++ H
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAMLRRQG-----PLAPPRAVAIVRQIGSALDAAH--- 151
Query: 749 RQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGK 808
HRD+K NIL+ D A + DFG+ D + + + GT Y+APE
Sbjct: 152 AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESH 211
Query: 809 ITTKADVFSYGVVLMELLTG------------LAALDEERPEESRYLAEWFWRIKSSKEK 856
T +AD+++ VL E LTG A +++ P S
Sbjct: 212 ATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPST--------------- 256
Query: 857 FKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRP 894
+ I A + +++A A+ P R
Sbjct: 257 VRPGIPVAFD---------AVIA----RGMAKNPEDRY 281
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-30
Identities = 66/230 (28%), Positives = 106/230 (46%), Gaps = 23/230 (10%)
Query: 633 LGRGGFGTVYKG-ELEDGTKIAVKRME-AGVTTTKALDEFQSEIAVLSKVRHRHLVSLLG 690
LG+GGF ++ + + A K + + + ++ EI++ + H+H+V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 691 YSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLAR 749
+ E N+ + +V E +L R + L R + G +YLH R
Sbjct: 109 F-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPE---ARY--YLRQIVLGCQYLH---R 159
Query: 750 QTFIHRDLKSSNILLDDDYRAKVSDFGL-VKLAPDGEKSVVTRLAGTFGYLAPEYAVMGK 808
IHRDLK N+ L++D K+ DFGL K+ DGE+ L GT Y+APE + K
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPE-VLSKK 216
Query: 809 I-TTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKF 857
+ + DV+S G ++ LL G P E+ L E + RIK ++
Sbjct: 217 GHSFEVDVWSIGCIMYTLLVGKP------PFETSCLKETYLRIKKNEYSI 260
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 7e-30
Identities = 64/370 (17%), Positives = 121/370 (32%), Gaps = 47/370 (12%)
Query: 86 NFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLAL 145
L + LQ+ + T L + + + +I + L+++ L L
Sbjct: 17 PDADLAEGIRAVLQKASVTD-VVTQEELESITKLVVAGEKVASIQG--IEYLTNLEYLNL 73
Query: 146 DYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGV 205
+ N L+N V+LTNL + + L L +L L L+ + +S +
Sbjct: 74 NGNQITD------ISPLSNLVKLTNLYIGTNKITDI--SALQNLTNLRELYLNEDNISDI 125
Query: 206 IPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSL 265
P + + L L + ++ M L L + ++ P I L+ L
Sbjct: 126 SPLANLTKM-YSLNLGANH---NLSDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDL 179
Query: 266 KDLNLNRNQLVGLIPKSLANME-LDNLVLNNNLLMGPIPKFKAGNVTY---DSNSFCQSE 321
L+LN NQ+ + P LA++ L N + P + +N
Sbjct: 180 YSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITPVANMTRLNSLKIGNNKI-TDL 236
Query: 322 PGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNL 381
+ + L +G N +S +K+ ++N+ + +
Sbjct: 237 SPLANLSQLTWL--EIGT-----NQISDINA------------VKDLTKLKMLNVGSNQI 277
Query: 382 TGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIK--PPLPEFHDT 439
+ + NL L + L N + L +L L +S N+I PL
Sbjct: 278 SD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKM 335
Query: 440 VKLVIDGNPL 449
+
Sbjct: 336 DSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-28
Identities = 72/371 (19%), Positives = 131/371 (35%), Gaps = 79/371 (21%)
Query: 64 CSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDF 123
+G +V IQ LT L L L N+ + S L +L Y+
Sbjct: 51 VAGEKVASIQ------------GIEYLTNLEYLNLNGNQITD-ISPLSNLVKLTNLYIGT 97
Query: 124 NEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLP 183
N+ I + L+++R L L+ + + LAN ++ +L+L + +
Sbjct: 98 NKITDISA--LQNLTNLRELYLNEDNISD------ISPLANLTKMYSLNLGANHNLS-DL 148
Query: 184 DFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLND---QDAGGMTGPIDVVAKMVS 240
L + L L ++ +++ V P + L L LN +D I +A + S
Sbjct: 149 SPLSNMTGLNYLTVTESKVKDVTPIANLTDL-YSLSLNYNQIED-------ISPLASLTS 200
Query: 241 LTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANME-LDNLVLNNNLLM 299
L + NQ T P + ++ L L + N++ L P LAN+ L L + N +
Sbjct: 201 LHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQIS 256
Query: 300 GPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGP 359
++ + +L +G N +S
Sbjct: 257 DI--------------------NAVKDLTKLKML--NVGS-----NQISDIS-------- 281
Query: 360 WLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSL 419
+ S+++ + L + L I L +L + L +N I+ P L +
Sbjct: 282 ----VLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKM 335
Query: 420 RLLDVSDNNIK 430
D ++ IK
Sbjct: 336 DSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 96.8 bits (242), Expect = 1e-21
Identities = 54/258 (20%), Positives = 100/258 (38%), Gaps = 36/258 (13%)
Query: 61 HVFCSGNRVTQI-------QVQNLGLKG---PLPQNFNQLTKLYNLGLQRNKFNGKLPTF 110
++ +GN++T I ++ NL + LT L L L + + +
Sbjct: 70 YLNLNGNQITDISPLSNLVKLTNLYIGTNKITDISALQNLTNLRELYLNEDNISD-ISPL 128
Query: 111 SGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTN 170
+ L+++ L N + S ++ + L + + +AN L +
Sbjct: 129 ANLTKMYSLNLGANHNLSDLSPLS-NMTGLNYLTVTESKVKD------VTPIANLTDLYS 181
Query: 171 LSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLND---QDAGG 227
LSL + P L +L SL N+++ + P + L L + + D
Sbjct: 182 LSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITPVANMTRL-NSLKIGNNKITD--- 235
Query: 228 MTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANME 287
+ +A + LT L + NQ + + L+ LK LN+ NQ+ + L N+
Sbjct: 236 ----LSPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISDI--SVLNNLS 287
Query: 288 -LDNLVLNNNLLMGPIPK 304
L++L LNNN L +
Sbjct: 288 QLNSLFLNNNQLGNEDME 305
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 2e-20
Identities = 63/373 (16%), Positives = 115/373 (30%), Gaps = 91/373 (24%)
Query: 93 LYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNK 152
L N ++ + L+E A L + + + L S+ L +
Sbjct: 2 AATLATLPAPIN-QIFPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA- 57
Query: 153 TFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQ 212
SI + L L+L + P L L L L + N+++
Sbjct: 58 ----SIQG-IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD-------- 102
Query: 213 SLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNR 272
I + + +L +L+L+ + + P + L+ + LNL
Sbjct: 103 -------------------ISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGA 141
Query: 273 NQLVGLIPKSLANM-ELDNLVLNNNLLMGPIPKFKAGNVTY---DSNSFCQSEPGIECAP 328
N + L+NM L+ L + + + P ++ + N P
Sbjct: 142 NHNLS-DLSPLSNMTGLNYLTVTESKVKDVTPIANLTDLYSLSLNYNQIEDISP------ 194
Query: 329 DVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSII-NLPRHNLTGTLS- 386
L L +L + ++ + N+ L +L
Sbjct: 195 -----LASL------TSLHY------------FTAYVNQITDITPVANMT--RLN-SLKI 228
Query: 387 --------PSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIK--PPLPEF 436
+ANL L + +G N IS N +L L++L+V N I L
Sbjct: 229 GNNKITDLSPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISDISVLNNL 286
Query: 437 HDTVKLVIDGNPL 449
L ++ N L
Sbjct: 287 SQLNSLFLNNNQL 299
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 7e-17
Identities = 59/321 (18%), Positives = 107/321 (33%), Gaps = 73/321 (22%)
Query: 136 GLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAAL 195
G ++ LA P N+ F A+ + L ++ + L S+ L
Sbjct: 1 GAAT---LATLPAPINQIF------PDADLAEGIRAVLQKASVTDVVT--QEELESITKL 49
Query: 196 KLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSI 255
++ +++ + + +L + L LN I ++ +V LT L++ N+ T
Sbjct: 50 VVAGEKVASIQGIEYLTNL-EYLNLNGNQITD----ISPLSNLVKLTNLYIGTNKIT--D 102
Query: 256 PEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGPIPKFKA-GNVTY- 312
+ L++L++L LN + + + P LAN+ ++ +L L N + + + Y
Sbjct: 103 ISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYL 160
Query: 313 --DSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSK 370
+ P + L +L S LS N
Sbjct: 161 TVTESKVKDVTP-----------IANL------TDLYS--------------LSLNYNQI 189
Query: 371 VSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIK 430
I L A+L SL N I+ + L L + +N I
Sbjct: 190 EDISPL-------------ASLTSLHYFTAYVNQITD--ITPVANMTRLNSLKIGNNKIT 234
Query: 431 --PPLPEFHDTVKLVIDGNPL 449
PL L I N +
Sbjct: 235 DLSPLANLSQLTWLEIGTNQI 255
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 5e-15
Identities = 34/190 (17%), Positives = 62/190 (32%), Gaps = 48/190 (25%)
Query: 63 FCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLD 122
N++T I +T+L +L + NK L + LS+L + +
Sbjct: 205 TAYVNQITDIT------------PVANMTRLNSLKIGNNKIT-DLSPLANLSQLTWLEIG 251
Query: 123 FNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPL 182
N+ I + L+ +++L + N + L N QL +L L N L
Sbjct: 252 TNQISDINA--VKDLTKLKMLNVGSNQISD------ISVLNNLSQLNSLFLNNNQLGNED 303
Query: 183 PDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLT 242
+ +G L +L L LS N ++ + P +A + +
Sbjct: 304 MEVIGGLTNLTTLFLSQNHITDIRP---------------------------LASLSKMD 336
Query: 243 QLWLHGNQFT 252
Sbjct: 337 SADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 42.1 bits (100), Expect = 7e-04
Identities = 21/80 (26%), Positives = 35/80 (43%), Gaps = 6/80 (7%)
Query: 373 IINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIK-- 430
+NL + +T ++NL L + +G N I T + L +LR L ++++NI
Sbjct: 70 YLNLNGNQITD--ISPLSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISDI 125
Query: 431 PPLPEFHDTVKLVIDGNPLL 450
PL L + N L
Sbjct: 126 SPLANLTKMYSLNLGANHNL 145
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 56/209 (26%), Positives = 104/209 (49%), Gaps = 19/209 (9%)
Query: 624 TQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRH 682
++G G G V E G ++AVK M+ + + + +E+ ++ +H
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD--LRKQQRRELLFNEVVIMRDYQH 101
Query: 683 RHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGME 742
++V + + G E ++ E++ GAL+ + + L+ + ++ V + +
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGALT------DIVSQVRLNEEQIATVCEAVLQALA 155
Query: 743 YLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL-VKLAPDGEK--SVVTRLAGTFGYL 799
YLH Q IHRD+KS +ILL D R K+SDFG +++ D K S+V GT ++
Sbjct: 156 YLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV----GTPYWM 208
Query: 800 APEYAVMGKITTKADVFSYGVVLMELLTG 828
APE T+ D++S G++++E++ G
Sbjct: 209 APEVISRSLYATEVDIWSLGIMVIEMVDG 237
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 62/223 (27%), Positives = 105/223 (47%), Gaps = 17/223 (7%)
Query: 626 NFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRH 684
++ + +G G V K+A+KR+ T +DE EI +S+ H +
Sbjct: 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS-MDELLKEIQAMSQCHHPN 74
Query: 685 LVSLLGYSIEGNERLLVYEYMPHGALS---RHLFRWEKLQLKPLSWTRRLSIALDVARGM 741
+VS + +E LV + + G++ +H+ + + L + +I +V G+
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 742 EYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFG----LVKLAPDGEKSVVTRLAGTFG 797
EYLH + IHRD+K+ NILL +D +++DFG L V GT
Sbjct: 135 EYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 798 YLAPEYAVMGKIT---TKADVFSYGVVLMELLTGLAALDEERP 837
++APE VM ++ KAD++S+G+ +EL TG A + P
Sbjct: 192 WMAPE--VMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP 232
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 65/287 (22%), Positives = 107/287 (37%), Gaps = 65/287 (22%)
Query: 633 LGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTT-TKALDEFQSE---IAVLSKVRHRHLVS 687
LG GG V+ L D +AVK + A + F+ E A L+ H +V+
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN---HPAIVA 76
Query: 688 LLGYSIE-GNERLLVY---EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEY 743
+ L Y EY+ L + P++ R + + D + + +
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIV-----HTEGPMTPKRAIEVIADACQALNF 131
Query: 744 LHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTR---LAGTFGYLA 800
H + IHRD+K +NI++ KV DFG+ + A + VT+ + GT YL+
Sbjct: 132 SH---QNGIIHRDVKPANIMISATNAVKVMDFGIAR-AIADSGNSVTQTAAVIGTAQYLS 187
Query: 801 PEYAVMGKITTKADVFSYGVVLMELLTG-------------LAALDEERPEESRYLAEWF 847
PE A + ++DV+S G VL E+LTG + E+ S
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS------- 240
Query: 848 WRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRP 894
+ L+ ++V A+ P +R
Sbjct: 241 --------ARHEGLSADLD---------AVVL----KALAKNPENRY 266
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 53/209 (25%), Positives = 109/209 (52%), Gaps = 19/209 (9%)
Query: 624 TQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRH 682
+ + + ++G+G GTVY ++ G ++A+++M + + +EI V+ + ++
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKN 76
Query: 683 RHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGME 742
++V+ L + G+E +V EY+ G+L+ + + + + ++ + + +E
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLT------DVVTETCMDEGQIAAVCRECLQALE 130
Query: 743 YLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL-VKLAPDGEK--SVVTRLAGTFGYL 799
+LH IHRD+KS NILL D K++DFG ++ P+ K ++V GT ++
Sbjct: 131 FLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV----GTPYWM 183
Query: 800 APEYAVMGKITTKADVFSYGVVLMELLTG 828
APE K D++S G++ +E++ G
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-29
Identities = 71/281 (25%), Positives = 110/281 (39%), Gaps = 36/281 (12%)
Query: 621 RKVTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSK 679
+ + LG+G FG V K + + AVK + K E+ +L K
Sbjct: 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKK 77
Query: 680 VRHRHLVSLLGYSIEGNERL-LVYEYMPHGALSRHLFRWEK-LQLKPLSWTRRLSIALDV 737
+ H +++ L +E + +V E G L +++ ++ K S I V
Sbjct: 78 LDHPNIMKLFEI-LEDSSSFYIVGELYTGGEL------FDEIIKRKRFSEHDAARIIKQV 130
Query: 738 ARGMEYLHCLARQTFIHRDLKSSNILL---DDDYRAKVSDFGLVKLAPDGEKSVVTRLAG 794
G+ Y+H + +HRDLK NILL + D K+ DFGL K + G
Sbjct: 131 FSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK--MKDRIG 185
Query: 795 TFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSK 854
T Y+APE + G K DV+S GV+L LL+G P F+ K+
Sbjct: 186 TAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG------TPP---------FYG-KNEY 228
Query: 855 EKFKAAIDPALEVNEETFESISIVA-ELAGHCTAREPYHRP 894
+ K + + +IS A +L P R
Sbjct: 229 DILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRI 269
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-29
Identities = 78/278 (28%), Positives = 128/278 (46%), Gaps = 30/278 (10%)
Query: 621 RKVT-QNFAQENELGRGGFGTVYKGELEDGTKI-AVKRME-AGVTTTKALDEFQSEIAVL 677
+ VT F Q LG+GGFG V ++ K+ A K++E + K +E +L
Sbjct: 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQIL 238
Query: 678 SKVRHRHLVSLLGYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALD 736
KV R +VSL Y+ E + L LV M G L H++ + R + A +
Sbjct: 239 EKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPE---ARAVFYAAE 294
Query: 737 VARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTF 796
+ G+E LH R+ ++RDLK NILLDD ++SD GL P+G+ + GT
Sbjct: 295 ICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTV 349
Query: 797 GYLAPEYAVMGKITTKA-DVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKE 855
GY+APE V + T + D ++ G +L E++ G + + ++ E +K E
Sbjct: 350 GYMAPE-VVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR--KKKIKREEVERLVKEVPE 406
Query: 856 KFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHR 893
++ P ++ S+ ++L ++P R
Sbjct: 407 EYSERFSP---------QARSLCSQL----LCKDPAER 431
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 4e-29
Identities = 24/254 (9%), Positives = 55/254 (21%), Gaps = 40/254 (15%)
Query: 607 VIESGTLVISVQVLRKVTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRME-AGVTTT 664
V +L + + L G V+ ++E A+K +
Sbjct: 44 VWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSR 103
Query: 665 KALDEFQSEIAVLSKVRHRHLVSLLGY--------------------------SIEGNER 698
L+ +++
Sbjct: 104 SELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANY 163
Query: 699 LLVYEYMPHGALSR--HLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRD 756
LL+ L + + + + R L + +H
Sbjct: 164 LLLMPAA-SVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGH 219
Query: 757 LKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKI--TTKAD 814
N+ + D R + D + G + + Y E+ T +
Sbjct: 220 FTPDNLFIMPDGRLMLGDVSALW--KVGTRG--PASSVPVTYAPREFLNASTATFTHALN 275
Query: 815 VFSYGVVLMELLTG 828
+ G+ + +
Sbjct: 276 AWQLGLSIYRVWCL 289
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-29
Identities = 68/288 (23%), Positives = 110/288 (38%), Gaps = 41/288 (14%)
Query: 619 VLRKVTQNFAQ----ENELGRGGFGTVYKG-ELEDGTKIAVKRME-AGVTTTKALDEFQS 672
++ T F+ + LG+G FG V + G + AVK + V +
Sbjct: 16 FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR 75
Query: 673 EIAVLSKVRHRHLVSLLGYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLK-PLSWTRR 730
E+ +L ++ H +++ L + E LV E G L ++++ + S
Sbjct: 76 EVQLLKQLDHPNIMKLYEF-FEDKGYFYLVGEVYTGGEL------FDEIISRKRFSEVDA 128
Query: 731 LSIALDVARGMEYLHCLARQTFIHRDLKSSNILL---DDDYRAKVSDFGLVKLAPDGEKS 787
I V G+ Y+H + +HRDLK N+LL D ++ DFGL +K
Sbjct: 129 ARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK- 184
Query: 788 VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWF 847
+ GT Y+APE + G K DV+S GV+L LL+G P F
Sbjct: 185 -MKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG------CPP---------F 227
Query: 848 WRIKSSKEKFKAAIDPALEVNEETFESISIVA-ELAGHCTAREPYHRP 894
+ + K ++ +S A +L P R
Sbjct: 228 NG-ANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRI 274
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-29
Identities = 64/279 (22%), Positives = 116/279 (41%), Gaps = 34/279 (12%)
Query: 622 KVTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV 680
+++ + + +LG G +G V + + A+K + +T + + E+AVL +
Sbjct: 34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL 93
Query: 681 RHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLK-PLSWTRRLSIALDVAR 739
H +++ L + + LV E G L ++++ + + I V
Sbjct: 94 DHPNIMKLYDFFEDKRNYYLVMECYKGGEL------FDEIIHRMKFNEVDAAVIIKQVLS 147
Query: 740 GMEYLHCLARQTFIHRDLKSSNILL---DDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTF 796
G+ YLH + +HRDLK N+LL + D K+ DFGL + + +K + GT
Sbjct: 148 GVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK--MKERLGTA 202
Query: 797 GYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEK 856
Y+APE + K K DV+S GV+L LL G P F ++ +E
Sbjct: 203 YYIAPE-VLRKKYDEKCDVWSIGVILFILLAG------YPP---------FGG-QTDQEI 245
Query: 857 FKAAIDPALEVNEETFESISIVA-ELAGHCTAREPYHRP 894
+ + ++++S A +L + R
Sbjct: 246 LRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRI 284
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 8e-29
Identities = 47/284 (16%), Positives = 86/284 (30%), Gaps = 43/284 (15%)
Query: 624 TQNFAQENELGRGGFGTVYKGE------LEDGTKIAVKRMEAGVTTTKALDEFQ---SEI 674
++ + LG G F VY+ ++ K +K + EF +
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP-----ANPWEFYIGTQLM 118
Query: 675 AVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIA 734
L + + N +LV E +G L + ++ K + +S A
Sbjct: 119 ERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178
Query: 735 LDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRA-----------KVSDFGL---VKL 780
+ + +E +H IH D+K N +L + + + D G +KL
Sbjct: 179 MRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235
Query: 781 APDGEKSVVTRLAGTFGYLAPEYAVMGKI-TTKADVFSYGVVLMELLTGLAALDEERPEE 839
P G + T T G+ E + K + D F + +L G +
Sbjct: 236 FPKGT--IFTAKCETSGFQCVE-MLSNKPWNYQIDYFGVAATVYCMLFG------TYMKV 286
Query: 840 SRYLAEWFWRIKSSKEKFKAAIDPALEV--NEETFESISIVAEL 881
E + + V N + + L
Sbjct: 287 KNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLL 330
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-28
Identities = 80/437 (18%), Positives = 134/437 (30%), Gaps = 62/437 (14%)
Query: 61 HVFCSGNRVTQI------QVQNL-----GLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP- 108
C +I +NL L+ +F +L L L R + +
Sbjct: 11 TYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIED 69
Query: 109 -TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQ 167
+ LS L L N ++ F GLSS++ L + +
Sbjct: 70 GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASL----ENFPIGHLKT 125
Query: 168 LTNLSLINCNL-VGPLPDFLGTLPSLAALKLSYNRLSGVIPASFG-----QSLMQILWLN 221
L L++ + + LP++ L +L L LS N++ + L L L+
Sbjct: 126 LKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLS 185
Query: 222 DQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPED-IGALSSLKDLNLNRNQLVGL-- 278
M K + L +L L N + ++ + I L+ L+ L +
Sbjct: 186 LNP---MNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGN 242
Query: 279 -------IPKSLANMELDNLVLN-NNLLMGPIPKFKAG--NVTYDSNSFCQSEPGIECAP 328
+ L N+ ++ L + + I NV+ S IE
Sbjct: 243 LEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVT----IERVK 298
Query: 329 DVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKV-SIINLPR-------HN 380
D + Q+P L + S ++LP N
Sbjct: 299 DF-SYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRN 357
Query: 381 ---LTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIK--PPLPE 435
G S S SL + L N + T+ +NF L+ L LD +N+K
Sbjct: 358 GLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSV 416
Query: 436 FHDTVKLV---IDGNPL 449
F L+ I
Sbjct: 417 FLSLRNLIYLDISHTHT 433
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 6e-21
Identities = 49/220 (22%), Positives = 80/220 (36%), Gaps = 22/220 (10%)
Query: 87 FNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTI--PSDFFDGLSSVRVLA 144
+L L L NK + L LEF L N S G +S++ L
Sbjct: 321 TLKLKSLKRLTFTSNKGG-NAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLD 379
Query: 145 LDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVG-PLPDFLGTLPSLAALKLSYNRLS 203
L +N ++ + QL +L + NL +L +L L +S+
Sbjct: 380 LSFNGVI-----TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR 434
Query: 204 GVIPASFGQ--SLMQILWLND---QDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPED 258
F SL ++L + Q+ D+ ++ +LT L L Q +
Sbjct: 435 VAFNGIFNGLSSL-EVLKMAGNSFQE----NFLPDIFTELRNLTFLDLSQCQLE-QLSPT 488
Query: 259 I-GALSSLKDLNLNRNQLVGLIPKSLANME-LDNLVLNNN 296
+LSSL+ LN+ NQL + + L + L+ N
Sbjct: 489 AFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTN 528
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 2e-19
Identities = 61/381 (16%), Positives = 112/381 (29%), Gaps = 49/381 (12%)
Query: 87 FNQLTKLYNLGLQRNKFN--GKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRV-- 142
L L L + N FS L+ LE L N+ +I L + +
Sbjct: 120 IGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLN 179
Query: 143 --LALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPD-FLGTLPSLAALKLSY 199
L L NP N I ++L L+L N + + L L +L
Sbjct: 180 LSLDLSLNPMN-----FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVL 234
Query: 200 NRLSG-----VIPASFGQSL----MQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQ 250
S + L ++ L D ID+ + +++ L
Sbjct: 235 GEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYL-DDIIDLFNCLTNVSSFSLVSVT 293
Query: 251 FTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMGPIPKFKAGNV 310
+ + + L L + L + L L +N + ++
Sbjct: 294 IE-RVKDFSY-NFGWQHLELVNCKFGQFPTLKLKS--LKRLTFTSNKGGNAFSEVDLPSL 349
Query: 311 TY---DSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTS 367
+ N C + L ++ N V N +LGL
Sbjct: 350 EFLDLSRNGLSF----KGCCSQSDFGTTSLKYLDLSFNGVITMSSN------FLGLE--- 396
Query: 368 NSKVSIINLPRHNLTGTLSPSIA--NLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVS 425
++ ++ +H+ +S +L +LI + + F L SL +L ++
Sbjct: 397 --QLEHLDF-QHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMA 453
Query: 426 DNNIKPPLPE--FHDTVKLVI 444
N+ + F + L
Sbjct: 454 GNSFQENFLPDIFTELRNLTF 474
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 8e-19
Identities = 43/278 (15%), Positives = 77/278 (27%), Gaps = 38/278 (13%)
Query: 24 DPNDLKILNDFKNGLENPELLKWPANGDDPCGPPPWPHVFCSGNRVTQIQVQNLGLKGPL 83
+ N K GL N + ++ D +F V+ + ++ ++
Sbjct: 240 EGNLEKFDKSALEGLCNLTIEEFRLAYLD-YYLDDIIDLFNCLTNVSSFSLVSVTIERVK 298
Query: 84 PQNFN-QLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRV 142
++N L + + +F L L+ N+ S L S+
Sbjct: 299 DFSYNFGWQHLELVNCKFGQF-----PTLKLKSLKRLTFTSNKGGNAFS--EVDLPSLEF 351
Query: 143 LALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRL 202
L L N + S + L L L ++ + L L L ++ L
Sbjct: 352 LDLSRNGLSFKG--CCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNL 408
Query: 203 SGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGAL 262
+ S SL +L L + + L
Sbjct: 409 KQMSEFSVFLSL------------------------RNLIYLDISHTHTRVAFNGIFNGL 444
Query: 263 SSLKDLNLNRNQLVGLIPK-SLANME-LDNLVLNNNLL 298
SSL+ L + N + L L L+ L
Sbjct: 445 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 482
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 3e-18
Identities = 54/219 (24%), Positives = 77/219 (35%), Gaps = 44/219 (20%)
Query: 61 HVFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP--TFSGLSELEF 118
++ S N V + NF L +L +L Q + F L L +
Sbjct: 377 YLDLSFNGVITM-----------SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY 425
Query: 119 AYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNL 178
+ + F+GLSS+ VL + N F + F I L N LT L L C L
Sbjct: 426 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRN---LTFLDLSQCQL 482
Query: 179 VGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKM 238
P +L SL L ++ N+L V F ++
Sbjct: 483 EQLSPTAFNSLSSLQVLNMASNQLKSVPDGIF-------------------------DRL 517
Query: 239 VSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVG 277
SL ++WLH N + S I LS LN N + G
Sbjct: 518 TSLQKIWLHTNPWDCS-CPRIDYLSRW--LNKNSQKEQG 553
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 3e-17
Identities = 74/406 (18%), Positives = 125/406 (30%), Gaps = 53/406 (13%)
Query: 82 PLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFA----YLDFNEFDTIPSDFFDG 136
LP+ F+ LT L +L L NK L ++ L N + I F
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE 199
Query: 137 LSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDF-LGTLPSLAAL 195
+ + L L N + + LA ++ L L G L F L L L
Sbjct: 200 IR-LHKLTLRNNFDSLNVMKTCIQGLAGL-EVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257
Query: 196 KLSYNRLSGV------IPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGN 249
+ RL+ + I F + + + + + + + L L
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLF--NCLTNVSSFSLVSVTIER-VKDFSYNFGWQHLELVNC 314
Query: 250 QFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLL----MGPIPKF 305
+F P L SLK L N+ + L+ L L+ N L F
Sbjct: 315 KFG-QFPT--LKLKSLKRLTFTSNKGGN-AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDF 370
Query: 306 KAGNVTY---DSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGP--- 359
++ Y N + L + NL +
Sbjct: 371 GTTSLKYLDLSFNGVITMSSNFLGLEQLEHL--DFQH-S---NLKQMSEFSVFLSLRNLI 424
Query: 360 WLGLS-----------CTSNSKVSIINLPRHNLTGTLSPSI-ANLDSLIEIRLGKNSISG 407
+L +S S + ++ + ++ P I L +L + L + +
Sbjct: 425 YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ 484
Query: 408 TVPNNFTELKSLRLLDVSDNNIK-PPLPEFHDTVKLV---IDGNPL 449
P F L SL++L+++ N +K P F L + NP
Sbjct: 485 LSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 59/218 (27%), Positives = 111/218 (50%), Gaps = 18/218 (8%)
Query: 624 TQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRH 682
+ F + ++G+G FG V+KG + +A+K ++ + +++ Q EI VLS+
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDS 79
Query: 683 RHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGME 742
++ G ++ + ++ EY+ G+ + L+ PL T+ +I ++ +G++
Sbjct: 80 PYVTKYYGSYLKDTKLWIIMEYLGGGSAL------DLLEPGPLDETQIATILREILKGLD 133
Query: 743 YLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLV-KLAPDGEK--SVVTRLAGTFGYL 799
YLH + IHRD+K++N+LL + K++DFG+ +L K + V GT ++
Sbjct: 134 YLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV----GTPFWM 186
Query: 800 APEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERP 837
APE +KAD++S G+ +EL G E P
Sbjct: 187 APEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP 224
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 19/209 (9%)
Query: 624 TQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRH 682
+ F +LG G +G+VYK E G +A+K++ L E EI+++ +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP----VESDLQEIIKEISIMQQCDS 83
Query: 683 RHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGME 742
H+V G + + +V EY G++S + +L+ K L+ +I +G+E
Sbjct: 84 PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII----RLRNKTLTEDEIATILQSTLKGLE 139
Query: 743 YLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLV-KLAPDGEK--SVVTRLAGTFGYL 799
YLH IHRD+K+ NILL+ + AK++DFG+ +L K +V+ GT ++
Sbjct: 140 YLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI----GTPFWM 192
Query: 800 APEYAVMGKITTKADVFSYGVVLMELLTG 828
APE AD++S G+ +E+ G
Sbjct: 193 APEVIQEIGYNCVADIWSLGITAIEMAEG 221
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 8e-28
Identities = 76/370 (20%), Positives = 130/370 (35%), Gaps = 51/370 (13%)
Query: 86 NFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLAL 145
+ L ++ L R + L+ L N+ I L+ + + +
Sbjct: 41 SQTDLDQVTTLQADRLGIK-SIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILM 97
Query: 146 DYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGV 205
+ N LAN LT L+L N + D L L +L L+LS N +S +
Sbjct: 98 NNNQIAD------ITPLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISDI 149
Query: 206 IPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSL 265
S SL Q L +Q + +A + +L +L + N+ + + L++L
Sbjct: 150 SALSGLTSL-QQLSFGNQVTD-----LKPLANLTTLERLDISSNKVSD--ISVLAKLTNL 201
Query: 266 KDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGPIPKFKAGNVTY---DSNSFCQSE 321
+ L NQ+ + P L + LD L LN N L N+T +N +
Sbjct: 202 ESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQI-SNL 258
Query: 322 PGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNL 381
+ + L LG N +S + ++ + L + L
Sbjct: 259 APLSGLTKLTEL--KLGA-----NQISNISP------------LAGLTALTNLELNENQL 299
Query: 382 TGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIK--PPLPEFHDT 439
I+NL +L + L N+IS P + L L+ L +N + L +
Sbjct: 300 ED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDVSSLANLTNI 355
Query: 440 VKLVIDGNPL 449
L N +
Sbjct: 356 NWLSAGHNQI 365
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-27
Identities = 57/259 (22%), Positives = 92/259 (35%), Gaps = 37/259 (14%)
Query: 63 FCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLD 122
+ N+++ I LT L L L N+ + T + L+ L L
Sbjct: 205 IATNNQISDIT------------PLGILTNLDELSLNGNQLK-DIGTLASLTNLTDLDLA 251
Query: 123 FNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPL 182
N+ + GL+ + L L N + LA LTNL L L
Sbjct: 252 NNQISNLAP--LSGLTKLTELKLGANQISNI------SPLAGLTALTNLELNENQLEDIS 303
Query: 183 PDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLND---QDAGGMTGPIDVVAKMV 239
P + L +L L L +N +S + P S L Q L+ + D + +A +
Sbjct: 304 P--ISNLKNLTYLTLYFNNISDISPVSSLTKL-QRLFFYNNKVSD-------VSSLANLT 353
Query: 240 SLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLN-NNLL 298
++ L NQ + P + L+ + L LN AN+ + N V N L
Sbjct: 354 NINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL 411
Query: 299 MGPIPKFKAGNVTYDSNSF 317
+ P G+ T ++
Sbjct: 412 IAPATISDGGSYTEPDITW 430
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 7e-27
Identities = 86/398 (21%), Positives = 138/398 (34%), Gaps = 86/398 (21%)
Query: 61 HVFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAY 120
+ + N++ I LT L L L N+ + L+ L
Sbjct: 94 DILMNNNQIADIT------------PLANLTNLTGLTLFNNQITD-IDPLKNLTNLNRLE 140
Query: 121 LDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVG 180
L N I + GL+S++ L+ + LAN L L + + +
Sbjct: 141 LSSNTISDISA--LSGLTSLQQLSFGNQV-------TDLKPLANLTTLERLDISSNKVSD 191
Query: 181 PLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLND---QDAGGMTGPIDVVAK 237
L L +L +L + N++S + P +L L LN +D I +A
Sbjct: 192 I--SVLAKLTNLESLIATNNQISDITPLGILTNL-DELSLNGNQLKD-------IGTLAS 241
Query: 238 MVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNN 296
+ +LT L L NQ + P + L+ L +L L NQ+ + P LA + L NL LN N
Sbjct: 242 LTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNEN 297
Query: 297 LLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPC 356
L P N+TY + F + + V+ L
Sbjct: 298 QLEDISPISNLKNLTYLTLYFNN--------------ISDISPVSSLTKLQR-------- 335
Query: 357 QGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTEL 416
L +N KVS + S+ANL ++ + G N IS P L
Sbjct: 336 ------LFFYNN-KVSDV------------SSLANLTNINWLSAGHNQISDLTP--LANL 374
Query: 417 KSLRLLDVSDNNIKPPLPEFHDTVKL---VIDGNPLLV 451
+ L ++D + V + V + L+
Sbjct: 375 TRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI 412
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-26
Identities = 75/389 (19%), Positives = 143/389 (36%), Gaps = 53/389 (13%)
Query: 67 NRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEF 126
++VT +Q LG+K L L + N+ + L++L ++ N+
Sbjct: 46 DQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTD-ITPLKNLTKLVDILMNNNQI 102
Query: 127 DTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFL 186
I L+++ L L N D L N L L L + + L
Sbjct: 103 ADITP--LANLTNLTGLTLFNNQITD------IDPLKNLTNLNRLELSSNTISDI--SAL 152
Query: 187 GTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWL 246
L SL L N+++ + P + + ++ L ++ I V+AK+ +L L
Sbjct: 153 SGLTSLQQLSFG-NQVTDLKPLA-NLTTLERLDISSNKVSD----ISVLAKLTNLESLIA 206
Query: 247 HGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANME-LDNLVLNNNLLMGPIPKF 305
NQ + P +G L++L +L+LN NQL + +LA++ L +L L NN + P
Sbjct: 207 TNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAPLS 262
Query: 306 KAGNVTY---DSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLG 362
+T +N + + + L L N +
Sbjct: 263 GLTKLTELKLGANQI-SNISPLAGLTALTNL--ELNE-----NQLEDISP---------- 304
Query: 363 LSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLL 422
++ ++ + L +N++ +++L L + N +S ++ L ++ L
Sbjct: 305 --ISNLKNLTYLTLYFNNISD--ISPVSSLTKLQRLFFYNNKVSD--VSSLANLTNINWL 358
Query: 423 DVSDNNIK--PPLPEFHDTVKLVIDGNPL 449
N I PL +L ++
Sbjct: 359 SAGHNQISDLTPLANLTRITQLGLNDQAW 387
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-24
Identities = 71/370 (19%), Positives = 133/370 (35%), Gaps = 60/370 (16%)
Query: 61 HVFCSGNRVTQI-------QVQNLGLKGPL--PQNFNQLTKLYNLGLQRNKFNGKLPTFS 111
+ S N ++ I +Q L + + LT L L + NK + + +
Sbjct: 138 RLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSD-ISVLA 196
Query: 112 GLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNL 171
L+ LE N+ I L+++ L+L+ N +LA+ LT+L
Sbjct: 197 KLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD------IGTLASLTNLTDL 248
Query: 172 SLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLND---QDAGGM 228
L N + P L L L LKL N++S + P + +L L LN+ +D
Sbjct: 249 DLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTAL-TNLELNENQLED---- 301
Query: 229 TGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANME- 287
I ++ + +LT L L+ N + P + +L+ L+ L N++ + LAN+
Sbjct: 302 ---ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDVSS--LANLTN 354
Query: 288 LDNLVLNNNLLMGPIPKFKAGNVTY---DSNSFCQSEPGI-ECAPDVNVLLDFLGGVNYP 343
++ L +N + P +T + ++ + N + + G + P
Sbjct: 355 INWLSAGHNQISDLTPLANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAP 414
Query: 344 VNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKN 403
+ + + ++ NL + + I G
Sbjct: 415 ATI-------------------SDGGSYTEPDI-TWNLPSYTNEVSYTFSQPVTIGKGTT 454
Query: 404 SISGTVPNNF 413
+ SGTV
Sbjct: 455 TFSGTVTQPL 464
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-19
Identities = 74/361 (20%), Positives = 122/361 (33%), Gaps = 79/361 (21%)
Query: 98 LQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWS 157
Q N ++ T + L+E L S L V L D
Sbjct: 9 TQDTPIN-QIFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI------K 59
Query: 158 IPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQI 217
D + LT ++ N L P L L L + ++ N+++ + P + +L
Sbjct: 60 SIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNL-TG 116
Query: 218 LWLND---QDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQ 274
L L + D ID + + +L +L L N + + L+SL+ L+ NQ
Sbjct: 117 LTLFNNQITD-------IDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG-NQ 166
Query: 275 LVGLIPKSLANME-LDNLVLNNNLLMGPIPKFKAGNVTY---DSNSFCQSEPGIECAPDV 330
+ L P LAN+ L+ L +++N + K N+ +N P
Sbjct: 167 VTDLKP--LANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITP-------- 216
Query: 331 NVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIA 390
L L NL LS N + ++ ++A
Sbjct: 217 ---LGIL------TNLDE--------------LSLNGNQ---LKDIG----------TLA 240
Query: 391 NLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIK--PPLPEFHDTVKLVIDGNP 448
+L +L ++ L N IS + L L L + N I PL L ++ N
Sbjct: 241 SLTNLTDLDLANNQISN--LAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQ 298
Query: 449 L 449
L
Sbjct: 299 L 299
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 8e-15
Identities = 55/285 (19%), Positives = 97/285 (34%), Gaps = 57/285 (20%)
Query: 168 LTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGG 227
L + ++ + + L L ++ + + L Q+ L G
Sbjct: 3 LGSATITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVSQT---DLDQVTTLQADRLGI 58
Query: 228 MTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIP-KSLANM 286
+ ID V + +LTQ+ NQ T P + L+ L D+ +N NQ+ + P +L N
Sbjct: 59 KS--IDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTN- 113
Query: 287 ELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNL 346
L L L NN + P N+ S + + ++ +L
Sbjct: 114 -LTGLTLFNNQITDIDPLKNLTNLNRLELSSNT--------------ISDISALSGLTSL 158
Query: 347 VSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSIS 406
L N + L ANL +L + + N +S
Sbjct: 159 QQ------------LSFG---NQVTDLKPL-------------ANLTTLERLDISSNKVS 190
Query: 407 GTVPNNFTELKSLRLLDVSDNNIK--PPLPEFHDTVKLVIDGNPL 449
+ +L +L L ++N I PL + +L ++GN L
Sbjct: 191 D--ISVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQL 233
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 56/214 (26%), Positives = 101/214 (47%), Gaps = 22/214 (10%)
Query: 624 TQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRH 682
+ + ELG G FG VYK E G A K +E + + L+++ EI +L+ H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE--TKSEEELEDYIVEIEILATCDH 75
Query: 683 RHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGME 742
++V LLG + ++ E+ P GA+ + + L+ + + + +
Sbjct: 76 PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIM----LELDRGLTEPQIQVVCRQMLEALN 131
Query: 743 YLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL-VKLAPDGEK--SVVTRLAGTFGYL 799
+LH + IHRDLK+ N+L+ + +++DFG+ K +K S + GT ++
Sbjct: 132 FLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI----GTPYWM 184
Query: 800 APEYAVMGKIT-----TKADVFSYGVVLMELLTG 828
APE + + KAD++S G+ L+E+
Sbjct: 185 APEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-27
Identities = 53/235 (22%), Positives = 87/235 (37%), Gaps = 52/235 (22%)
Query: 621 RKVTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRME------AGVTTTKALDEFQSE 673
+ + + LG G G V E + K+A+K + ++E
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 674 IAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGAL--------------SRHLFRWEK 719
I +L K+ H ++ + + + + +V E M G L + F
Sbjct: 66 IEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY--- 121
Query: 720 LQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILL---DDDYRAKVSDFG 776
+ ++YLH IHRDLK N+LL ++D K++DFG
Sbjct: 122 ----------------QMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFG 162
Query: 777 LVKLAPDGEKSVVTRLAGTFGYLAPE---YAVMGKITTKADVFSYGVVLMELLTG 828
K+ + ++ L GT YLAPE D +S GV+L L+G
Sbjct: 163 HSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-27
Identities = 36/281 (12%), Positives = 79/281 (28%), Gaps = 40/281 (14%)
Query: 584 RSLSSQTVASSGSTNSGATENSHVIESGTLVISVQVLRKVTQNFAQENELGRGGFGTVYK 643
+ +T + + + + ++ + +G L + + + LG+ +
Sbjct: 37 PQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLE 96
Query: 644 GE-LEDGTKIAVKRMEAG-VTTTKALDEFQSEIAVLSKVRH-----------RHLVSLLG 690
E G V + A+ + + E+ L +R R +
Sbjct: 97 ATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156
Query: 691 YSIEGNERLL-------------VYEYMPH-----GALSRHLFRWEKLQLKPLSWTRRLS 732
++++ + P L K L RL
Sbjct: 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH-KSLVHHARLQ 215
Query: 733 IALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRL 792
+ L V R + LH +H L+ +I+LD ++ F + S + R
Sbjct: 216 LTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRG 272
Query: 793 AGTFGYLAPEYAVM-----GKITTKADVFSYGVVLMELLTG 828
A +T D ++ G+ + +
Sbjct: 273 FAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 2e-27
Identities = 43/215 (20%), Positives = 87/215 (40%), Gaps = 21/215 (9%)
Query: 627 FAQENELGRG--GFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHR 683
+ +G+G TV G + V+R+ + + + Q E+ V H
Sbjct: 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86
Query: 684 HLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEY 743
++V I NE +V +M +G+ + L + ++ I V + ++Y
Sbjct: 87 NIVPYRATFIADNELWVVTSFMAYGSA-KDLICTHFM--DGMNELAIAYILQGVLKALDY 143
Query: 744 LHCLARQTFIHRDLKSSNILLDDDYRAKVSDFG-LVKLAPDGEK-----SVVTRLAGTFG 797
+H ++HR +K+S+IL+ D + +S + + G++
Sbjct: 144 IH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP 200
Query: 798 YLAPEYAVMGKI----TTKADVFSYGVVLMELLTG 828
+L+PE V+ + K+D++S G+ EL G
Sbjct: 201 WLSPE--VLQQNLQGYDAKSDIYSVGITACELANG 233
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-27
Identities = 52/235 (22%), Positives = 87/235 (37%), Gaps = 52/235 (22%)
Query: 621 RKVTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRME------AGVTTTKALDEFQSE 673
+ + + LG G G V E + K+A++ + ++E
Sbjct: 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 190
Query: 674 IAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGAL--------------SRHLFRWEK 719
I +L K+ H ++ + + + + +V E M G L + F
Sbjct: 191 IEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY--- 246
Query: 720 LQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILL---DDDYRAKVSDFG 776
+ ++YLH IHRDLK N+LL ++D K++DFG
Sbjct: 247 ----------------QMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFG 287
Query: 777 LVKLAPDGEKSVVTRLAGTFGYLAPE---YAVMGKITTKADVFSYGVVLMELLTG 828
K+ + ++ L GT YLAPE D +S GV+L L+G
Sbjct: 288 HSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-27
Identities = 69/385 (17%), Positives = 122/385 (31%), Gaps = 82/385 (21%)
Query: 62 VFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP--TFSGLSELEFA 119
F +TQ+ PQ N +L L N + +F L +L+
Sbjct: 9 AFYRFCNLTQV-----------PQVLNTTERLL---LSFNYIR-TVTASSFPFLEQLQLL 53
Query: 120 YLDFNEF-DTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIP-DSLANSVQLTNLSLINCN 177
L TI + F L ++R+L L + + + D+ L L L C
Sbjct: 54 ELGSQYTPLTIDKEAFRNLPNLRILDLGSSKI-----YFLHPDAFQGLFHLFELRLYFCG 108
Query: 178 L--VGPLPDFLGTLPSLAALKLSYNRLSGV-IPASFGQSLMQILWLNDQDAGGMTGPIDV 234
L + L +L L LS N++ + + SFG+
Sbjct: 109 LSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGK---------------------- 146
Query: 235 VAKMVSLTQLWLHGNQFTGSIPEDIGALS--SLKDLNLNRNQLVGLIP-------KSLAN 285
+ SL + NQ ++ L +L +L N L + N
Sbjct: 147 ---LNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRN 203
Query: 286 MELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVN 345
M L+ L ++ N I +F + + +L + G + +
Sbjct: 204 MVLEILDVSGNGWTVDIT-----------GNFSNAISKSQ--AFSLILAHHIMGAGFGFH 250
Query: 346 LVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSI 405
+ N + + S V ++L + S L L + L N I
Sbjct: 251 NIKDPDQNT--------FAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKI 302
Query: 406 SGTVPNNFTELKSLRLLDVSDNNIK 430
+ F L +L++L++S N +
Sbjct: 303 NKIADEAFYGLDNLQVLNLSYNLLG 327
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-22
Identities = 90/496 (18%), Positives = 163/496 (32%), Gaps = 78/496 (15%)
Query: 64 CSGNRVTQIQVQNL--GLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGL--SELEF 118
SGN T N + + + G + TF+GL S +
Sbjct: 211 VSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRH 270
Query: 119 AYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNL 178
L ++ S F+ L ++VL L YN NK ++ L L+L L
Sbjct: 271 LDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIA----DEAFYGLDNLQVLNLSYNLL 326
Query: 179 VGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKM 238
LP +A + L N ++ + +F +
Sbjct: 327 GELYSSNFYGLPKVAYIDLQKNHIAIIQDQTF-------------------------KFL 361
Query: 239 VSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLL 298
L L L N T I + S+ D+ L+ N+LV L +L + + N L
Sbjct: 362 EKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVTLPKINLTANLIH--LSENRLE 414
Query: 299 MGPIPKFKAG--NVTY---DSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGN 353
I F ++ + N F + + ++ FLG N++
Sbjct: 415 NLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGE-----NMLQLAWET 469
Query: 354 DPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNF 413
+ C + GLS + ++ L + L ++L +L + L N ++ N+
Sbjct: 470 ELCWDVFEGLS-----HLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDL 524
Query: 414 TELKSLRLLDVSDNNIK-PPLPEFHDTVKLVIDGNPLLVGGINHTQAPTSPGPVSSPTPP 472
+L +LD+S N + P F L I N I + T ++
Sbjct: 525 --PANLEILDISRNQLLAPNPDVFVSLSVLDITHNKF----ICECELSTFINWLNHTNVT 578
Query: 473 GSQSPSNHTSSGRGQSPSSGNSPPSPITHPNSNHSSIHVQP--QRKSTKRLKLLVVVGIS 530
+ P++ P + + S+ + + + K LK + + +
Sbjct: 579 IAGPPADIYCV-------------YPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCT 625
Query: 531 VVVTVVLVVILLCIYC 546
V +T+ L+ IL
Sbjct: 626 VTLTLFLMTILTVTKF 641
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 1e-08
Identities = 34/155 (21%), Positives = 58/155 (37%), Gaps = 24/155 (15%)
Query: 61 HVFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPT------FSGLS 114
+ + NR + Q ++ L L L N T F GLS
Sbjct: 430 ILILNQNRFSSC---------SGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLS 480
Query: 115 ELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLI 174
L+ YL+ N +++P F L+++R L+L+ N + + L L +
Sbjct: 481 HLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-----VLSHN-DLPANLEILDIS 534
Query: 175 NCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPAS 209
L+ P PD SL+ L +++N+ S
Sbjct: 535 RNQLLAPNPD---VFVSLSVLDITHNKFICECELS 566
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 4e-07
Identities = 42/257 (16%), Positives = 78/257 (30%), Gaps = 69/257 (26%)
Query: 189 LPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHG 248
L + L LS+N + V +SF + L L L
Sbjct: 23 LNTTERLLLSFNYIRTVTASSF-------------------------PFLEQLQLLELGS 57
Query: 249 NQFTGSIPEDI-GALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGPIPKFK 306
+I ++ L +L+ L+L +++ L P + + L L L L +
Sbjct: 58 QYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVL--- 114
Query: 307 AGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCT 366
+ + ++ + LD L N +L + L+
Sbjct: 115 -------KDGYFRNLKALT-------RLD-LSK-NQIRSL--------YLHPSFGKLN-- 148
Query: 367 SNSKVSIINLPRHNLTGTLSP-SIANLD--SLIEIRLGKNSISGTVPNNFTEL------K 417
+ I+ N + + L +L L NS+ V ++ +
Sbjct: 149 ---SLKSIDF-SSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNM 204
Query: 418 SLRLLDVSDNNIKPPLP 434
L +LDVS N +
Sbjct: 205 VLEILDVSGNGWTVDIT 221
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 54/224 (24%), Positives = 99/224 (44%), Gaps = 20/224 (8%)
Query: 610 SGTLVISVQVLRKVTQNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALD 668
L +V +F + +ELG G G V+K G +A K + + +
Sbjct: 18 EAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI-RN 76
Query: 669 EFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWT 728
+ E+ VL + ++V G E + E+M G+L + L + ++ + L
Sbjct: 77 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-- 134
Query: 729 RRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFG----LVKLAPDG 784
+++ V +G+ YL + +HRD+K SNIL++ K+ DFG L+
Sbjct: 135 ---KVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI------ 183
Query: 785 EKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTG 828
S+ GT Y++PE + ++D++S G+ L+E+ G
Sbjct: 184 -DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 226
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-27
Identities = 69/319 (21%), Positives = 119/319 (37%), Gaps = 51/319 (15%)
Query: 598 NSGATENSHVIESGTLVISVQVLRKVTQNFAQ----ENELGRGGFGTVYKG-ELEDGTKI 652
+ ++ ++ G + +RK + +LG G +G V E ++
Sbjct: 5 HHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEK 64
Query: 653 AVK-----------RMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERL-L 700
A+K + K +E +EI++L + H +++ L E + L
Sbjct: 65 AIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV-FEDKKYFYL 123
Query: 701 VYEYMPHGALSRHLFRWEKL-QLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKS 759
V E+ G L +E++ +I + G+ YLH + +HRD+K
Sbjct: 124 VTEFYEGGEL------FEQIINRHKFDECDAANIMKQILSGICYLH---KHNIVHRDIKP 174
Query: 760 SNILL---DDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVF 816
NILL + K+ DFGL K + GT Y+APE + K K DV+
Sbjct: 175 ENILLENKNSLLNIKIVDFGLSSFFSKDYK--LRDRLGTAYYIAPE-VLKKKYNEKCDVW 231
Query: 817 SYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESIS 876
S GV++ LL G P F ++ ++ K + +++IS
Sbjct: 232 SCGVIMYILLCG------YPP---------FGG-QNDQDIIKKVEKGKYYFDFNDWKNIS 275
Query: 877 IVA-ELAGHCTAREPYHRP 894
A EL + R
Sbjct: 276 DEAKELIKLMLTYDYNKRC 294
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-27
Identities = 53/239 (22%), Positives = 93/239 (38%), Gaps = 23/239 (9%)
Query: 65 SGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP--TFSGLSELEFAYLD 122
+ N V+ ++ P FN L L LGL+ N+ +P F+GLS L +
Sbjct: 64 NENIVSAVE----------PGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDIS 112
Query: 123 FNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPD-SLANSVQLTNLSLINCNLVGP 181
N+ + F L +++ L + N I + + L L+L CNL
Sbjct: 113 ENKIVILLDYMFQDLYNLKSLEVGDNDLV-----YISHRAFSGLNSLEQLTLEKCNLTSI 167
Query: 182 LPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSL 241
+ L L L L+L + ++ + SF + L ++ L + ++L
Sbjct: 168 PTEALSHLHGLIVLRLRHLNINAIRDYSF-KRLYRLKVLEISHWPYLDTMTPNCLYGLNL 226
Query: 242 TQLWLHGNQFTGSIPED-IGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLL 298
T L + T ++P + L L+ LNL+ N + + L + L + L L
Sbjct: 227 TSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQL 284
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 9e-26
Identities = 80/405 (19%), Positives = 125/405 (30%), Gaps = 103/405 (25%)
Query: 61 HVFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP--TFSGLSELEF 118
V C R + P+ T+L L L +N+ L F+ LE
Sbjct: 15 AVLCHRKRFVAV-----------PEGIPTETRL--LDLGKNRI-KTLNQDEFASFPHLEE 60
Query: 119 AYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIP-DSLANSVQLTNLSLINCN 177
L+ N + F+ L ++R L L N IP LT L +
Sbjct: 61 LELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK-----LIPLGVFTGLSNLTKLDISENK 115
Query: 178 LVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAK 237
+V L L +L +L++ N L + +F +
Sbjct: 116 IVILLDYMFQDLYNLKSLEVGDNDLVYISHRAF-------------------------SG 150
Query: 238 MVSLTQLWLHGNQFTGSIPEDI-GALSSLKDLNLNRNQLVGLIPKSLANME-LDNLVLNN 295
+ SL QL L T SIP + L L L L + + S + L L +++
Sbjct: 151 LNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISH 209
Query: 296 NLLMGPIPK--FKAGNVTY---DSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQW 350
+ + N+T +
Sbjct: 210 WPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYL--------------------------- 242
Query: 351 PGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSI-ANLDSLIEIRLGKNSISGTV 409
+ + +NL +N T+ S+ L L EI+L ++
Sbjct: 243 -------------AVRHLVYLRFLNL-SYNPISTIEGSMLHELLRLQEIQLVGGQLAVVE 288
Query: 410 PNNFTELKSLRLLDVSDNNIKPPLPE--FHDTVKLV---IDGNPL 449
P F L LR+L+VS N + L E FH L +D NPL
Sbjct: 289 PYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 8e-25
Identities = 52/272 (19%), Positives = 102/272 (37%), Gaps = 40/272 (14%)
Query: 65 SGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP--TFSGLSELEFAYLD 122
S N++ + F L L +L + N + FSGL+ LE L+
Sbjct: 112 SENKIVILL----------DYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLE 160
Query: 123 FNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPD-SLANSVQLTNLSLINCNLVGP 181
+IP++ L + VL L + N +I D S +L L + + +
Sbjct: 161 KCNLTSIPTEALSHLHGLIVLRLRHLNIN-----AIRDYSFKRLYRLKVLEISHWPYLDT 215
Query: 182 LPDFLGTLPSLAALKLSYNRLSGVIPASF-GQSLMQILWLNDQDAGGMTGPIDVVAK--- 237
+ +L +L +++ L+ V + ++ L L+ PI +
Sbjct: 216 MTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYN-------PISTIEGSML 268
Query: 238 --MVSLTQLWLHGNQFTGSIPEDI-GALSSLKDLNLNRNQLVGLIPKSLANME-LDNLVL 293
++ L ++ L G Q + L+ L+ LN++ NQL L ++ L+ L+L
Sbjct: 269 HELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLIL 327
Query: 294 NNNLL-----MGPIPKFKAGNVTYDSNSFCQS 320
++N L + + + + C +
Sbjct: 328 DSNPLACDCRLLWVFRRRWRLNFNRQQPTCAT 359
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-27
Identities = 43/297 (14%), Positives = 92/297 (30%), Gaps = 51/297 (17%)
Query: 574 VKIAVSNDTARSLSSQTVASSGSTNSGATENSHVIESGTLVISVQVLRKVTQNFAQENEL 633
V I + + +T + + + + ++ + +G L + + + L
Sbjct: 22 VVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVL 81
Query: 634 GRGGFGTVYKG-ELEDGTKIAVK--------------RMEAGVTTTKALDEFQSEIAVLS 678
G+ + + E G V +M+ V + L +++
Sbjct: 82 GQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKV 141
Query: 679 KVR------------HRHLVSLLGY--SIEGNERLLVYEYM--PHGALSRHLFRWEKLQL 722
+R + ++ + + R +Y M L
Sbjct: 142 HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH- 200
Query: 723 KPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782
K L RL + L V R + LH +H L+ +I+LD ++ F +
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV--R 255
Query: 783 DGEKSVVTRLAGTFGYLAPEYAVM-----------GKITTKADVFSYGVVLMELLTG 828
DG + V + + G+ PE +T D ++ G+V+ +
Sbjct: 256 DGARVVSS---VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 7e-27
Identities = 70/288 (24%), Positives = 114/288 (39%), Gaps = 50/288 (17%)
Query: 621 RKVT-QNFAQENELGRGGFGTVYKGELEDGTKI-AVKRME-------AGVTTTKALDEFQ 671
+T +F+ +GRGGFG VY D K+ A+K ++ G T
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALN----- 238
Query: 672 SEIAVLSKV---RHRHLVSLLGYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSW 727
E +LS V +V + Y+ ++L + + M G L HL +
Sbjct: 239 -ERIMLSLVSTGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA---- 292
Query: 728 TRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKS 787
R A ++ G+E++H + ++RDLK +NILLD+ ++SD GL +
Sbjct: 293 DMRFYAA-EIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 346
Query: 788 VVTR-LAGTFGYLAPEYAVMGKITTKA-DVFSYGVVLMELLTGLAALDEERPEESRYLAE 845
GT GY+APE G + D FS G +L +LL G + R +++ E
Sbjct: 347 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF---RQHKTKDKHE 401
Query: 846 WFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHR 893
+ + + P E S++ L R+ R
Sbjct: 402 IDRMTLTMAVELPDSFSP---------ELRSLLEGL----LQRDVNRR 436
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 8e-27
Identities = 58/275 (21%), Positives = 99/275 (36%), Gaps = 53/275 (19%)
Query: 603 ENSHVIESGTLVISVQV--LRKVTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVK---R 656
+ H SG + Q L ++ + + + +G+G +G V E + A+K +
Sbjct: 2 HHHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNK 61
Query: 657 MEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERL-LVYEYMPHGALSRHLF 715
+ K ++ ++E+ ++ K+ H ++ L E + + LV E G L L
Sbjct: 62 NKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEV-YEDEQYICLVMELCHGGHLLDKLN 120
Query: 716 RWEKLQLKPLSWTRRL-----------------------------------SIALDVARG 740
+ + +I +
Sbjct: 121 VFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180
Query: 741 MEYLHCLARQTFIHRDLKSSNILL--DDDYRAKVSDFGL---VKLAPDGEKSVVTRLAGT 795
+ YLH Q HRD+K N L + + K+ DFGL +GE +T AGT
Sbjct: 181 LHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGT 237
Query: 796 FGYLAPE--YAVMGKITTKADVFSYGVVLMELLTG 828
++APE K D +S GV+L LL G
Sbjct: 238 PYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMG 272
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-26
Identities = 66/297 (22%), Positives = 112/297 (37%), Gaps = 57/297 (19%)
Query: 564 PRDPSDPENMVKIAVSNDTARSLSSQTVASSGSTNSGATENSHVIESGTLVISVQVLRKV 623
P + ++ +D ++S + A + + +S +
Sbjct: 30 PNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAA- 88
Query: 624 TQNFAQE----NELGRGGFGTVYKG-ELEDGTKIAVKRME------AGVTTTKALDEFQS 672
+ F Q+ + +GRG V + G + AVK ME + + + +
Sbjct: 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRR 148
Query: 673 EIAVLSKVR-HRHLVSLLGYSIEGNERLLVYEYMPHGAL--------------SRHLFRW 717
E +L +V H H+++L+ + LV++ M G L +R + R
Sbjct: 149 ETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMR- 207
Query: 718 EKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL 777
+ + +LH +HRDLK NILLDD+ + ++SDFG
Sbjct: 208 ------------------SLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGF 246
Query: 778 VKLAPDGEKSVVTRLAGTFGYLAPE------YAVMGKITTKADVFSYGVVLMELLTG 828
GEK + L GT GYLAPE + D+++ GV+L LL G
Sbjct: 247 SCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-26
Identities = 56/260 (21%), Positives = 101/260 (38%), Gaps = 34/260 (13%)
Query: 622 KVTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV 680
V + ELG G FG V++ E G K + ++EI++++++
Sbjct: 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFIN--TPYPLDKYTVKNEISIMNQL 105
Query: 681 RHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIAL--DVA 738
H L++L + E +L+ E++ G LF +++ + + I
Sbjct: 106 HHPKLINLHDAFEDKYEMVLILEFLSGG----ELF--DRIAAEDYKMSEAEVINYMRQAC 159
Query: 739 RGMEYLHCLARQTFIHRDLKSSNILL--DDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTF 796
G++++H + +H D+K NI+ K+ DFGL E V T
Sbjct: 160 EGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI--VKVTTATA 214
Query: 797 GYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEK 856
+ APE + D+++ GV+ LL+GL P F + E
Sbjct: 215 EFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL------SP---------FAG-EDDLET 258
Query: 857 FKAAIDPALEVNEETFESIS 876
+ E +E+ F S+S
Sbjct: 259 LQNVKRCDWEFDEDAFSSVS 278
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 32/223 (14%)
Query: 621 RKVT-QNFAQENELGRGGFGTVYKGELEDGTKI-AVKRME-AGVTTTKALDEFQSEIAVL 677
RK ++F LG G F TV ++ A+K +E + + E V+
Sbjct: 25 RKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM 84
Query: 678 SKVRHRHLVSLLGYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALD 736
S++ H V L ++ + +E+L Y +G L +++ +
Sbjct: 85 SRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRK-----------IGSFDE--T 130
Query: 737 VAR--------GMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSV 788
R +EYLH + IHRDLK NILL++D +++DFG K+ K
Sbjct: 131 CTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 187
Query: 789 VTR-LAGTFGYLAPEYAVMGKITTKA-DVFSYGVVLMELLTGL 829
GT Y++PE + K K+ D+++ G ++ +L+ GL
Sbjct: 188 RANSFVGTAQYVSPE-LLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 53/264 (20%), Positives = 109/264 (41%), Gaps = 35/264 (13%)
Query: 621 RKVTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSK 679
+++ + + +LGRG FG V++ E K ++ + EI++L+
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK---VKGTDQVLVKKEISILNI 57
Query: 680 VRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIAL--DV 737
RHR+++ L E ++++E++ +F E++ R ++ V
Sbjct: 58 ARHRNILHLHESFESMEELVMIFEFISGL----DIF--ERINTSAFELNEREIVSYVHQV 111
Query: 738 ARGMEYLHCLARQTFIHRDLKSSNILL--DDDYRAKVSDFGLVKLAPDGEKSVVTRLAGT 795
+++LH H D++ NI+ K+ +FG + G+ L
Sbjct: 112 CEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--FRLLFTA 166
Query: 796 FGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKE 855
Y APE ++T D++S G ++ LL+G+ P F +++++
Sbjct: 167 PEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGI------NP---------FLA-ETNQQ 210
Query: 856 KFKAAIDPALEVNEETFESISIVA 879
+ ++ +EE F+ ISI A
Sbjct: 211 IIENIMNAEYTFDEEAFKEISIEA 234
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 55/250 (22%), Positives = 88/250 (35%), Gaps = 47/250 (18%)
Query: 54 CGPPPWPHVFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP--TFS 111
C P C + + P ++ + L N+ + +P +F
Sbjct: 8 CYNEPKVTTSCPQQGLQAV-----------PVGIPAASQ--RIFLHGNRIS-HVPAASFR 53
Query: 112 GLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNL 171
L +L N I + F GL+ + L L N ++ P + +L L
Sbjct: 54 ACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVD---PATFHGLGRLHTL 110
Query: 172 SLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGP 231
L C L P L +L L L N L + P
Sbjct: 111 HLDRCGLQELGPGLFRGLAALQYLYLQDNALQAL-------------------------P 145
Query: 232 IDVVAKMVSLTQLWLHGNQFTGSIPEDI-GALSSLKDLNLNRNQLVGLIPKSLANM-ELD 289
D + +LT L+LHGN+ + S+PE L SL L L++N++ + P + ++ L
Sbjct: 146 DDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLM 204
Query: 290 NLVLNNNLLM 299
L L N L
Sbjct: 205 TLYLFANNLS 214
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 53/236 (22%), Positives = 73/236 (30%), Gaps = 68/236 (28%)
Query: 65 SGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP--TFSGLSELEFAYLD 122
N + +I F L L L L N + TF GL L +LD
Sbjct: 64 HSNVLARID----------AAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLD 113
Query: 123 FNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPL 182
+ F GL++++ L L N L L
Sbjct: 114 RCGLQELGPGLFRGLAALQYLYLQDN------------------ALQALP---------- 145
Query: 183 PDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLT 242
D L +L L L NR+S V +F + SL
Sbjct: 146 DDTFRDLGNLTHLFLHGNRISSVPERAF-------------------------RGLHSLD 180
Query: 243 QLWLHGNQFTGSIPEDI-GALSSLKDLNLNRNQLVGLIPKSLANME-LDNLVLNNN 296
+L LH N+ + L L L L N L L ++LA + L L LN+N
Sbjct: 181 RLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 4e-09
Identities = 21/89 (23%), Positives = 36/89 (40%), Gaps = 13/89 (14%)
Query: 65 SGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP--TFSGLSELEFAYLD 122
GNR++ + + F L L L L +N+ + F L L YL
Sbjct: 161 HGNRISSVP----------ERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLF 209
Query: 123 FNEFDTIPSDFFDGLSSVRVLALDYNPFN 151
N +P++ L +++ L L+ NP+
Sbjct: 210 ANNLSALPTEALAPLRALQYLRLNDNPWV 238
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 65/267 (24%), Positives = 109/267 (40%), Gaps = 39/267 (14%)
Query: 621 RKVTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVK----RMEAGVTTTKALDEFQSEIA 675
+KV + ELG G F V K E G + A K R + +E + E++
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 676 VLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIAL 735
+L +V H ++++L + +L+ E + G L ++ L K S + + +
Sbjct: 68 ILRQVLHHNVITLHDVYENRTDVVLILELVSGGEL------FDFLAQKE-SLSEEEATSF 120
Query: 736 --DVARGMEYLHCLARQTFIHRDLKSSNILL----DDDYRAKVSDFGLVKLAPDGEKSVV 789
+ G+ YLH + H DLK NI+L K+ DFGL DG +
Sbjct: 121 IKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--F 175
Query: 790 TRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWR 849
+ GT ++APE + +AD++S GV+ LL+G + P F
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS------P---------FLG 220
Query: 850 IKSSKEKFKAAIDPALEVNEETFESIS 876
+ +E + + +EE F S
Sbjct: 221 -DTKQETLANITSVSYDFDEEFFSHTS 246
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 57/226 (25%), Positives = 87/226 (38%), Gaps = 45/226 (19%)
Query: 622 KVTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV 680
+ + LG+G FG V K + + AVK + K E+ +L K+
Sbjct: 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 681 RHRHLVSLLGYSIEGNERLLVYEYMPHGAL--------------SRHLFRWEKLQLKPLS 726
H +++ L + + +V E G L + + +
Sbjct: 79 DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK---------- 128
Query: 727 WTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILL---DDDYRAKVSDFGLVKLAPD 783
V G+ Y+H + +HRDLK NILL + D K+ DFGL
Sbjct: 129 ---------QVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176
Query: 784 GEKSVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTG 828
+ GT Y+APE V+ G K DV+S GV+L LL+G
Sbjct: 177 NT--KMKDRIGTAYYIAPE--VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-26
Identities = 58/214 (27%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 624 TQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTK-ALDEFQSEIAVLSKVR 681
+ F+ E+G G FG VY ++ + +A+K+M + + E+ L K+R
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 682 HRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGM 741
H + + G + + LV EY G+ S L ++ KPL ++ +G+
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLL----EVHKKPLQEVEIAAVTHGALQGL 167
Query: 742 EYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFG----LVKLAPDGEKSVVTRLAGTFG 797
YLH IHRD+K+ NILL + K+ DFG + S V GT
Sbjct: 168 AYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFV----GTPY 215
Query: 798 YLAPEYAVMGKITT---KADVFSYGVVLMELLTG 828
++APE + K DV+S G+ +EL
Sbjct: 216 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 249
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 56/236 (23%), Positives = 86/236 (36%), Gaps = 53/236 (22%)
Query: 622 KVTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVK-------RMEAGVTTTKALDEFQSE 673
+N+ + LGRG V + + AVK + + + E
Sbjct: 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKE 73
Query: 674 IAVLSKV-RHRHLVSLLGYSIEGNERLLVYEYMPHGAL--------------SRHLFRWE 718
+ +L KV H +++ L LV++ M G L +R + R
Sbjct: 74 VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMR-- 131
Query: 719 KLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLV 778
+ + LH + +HRDLK NILLDDD K++DFG
Sbjct: 132 -----------------ALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS 171
Query: 779 KLAPDGEKSVVTRLAGTFGYLAPE------YAVMGKITTKADVFSYGVVLMELLTG 828
GE + + GT YLAPE + D++S GV++ LL G
Sbjct: 172 CQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-26
Identities = 68/275 (24%), Positives = 113/275 (41%), Gaps = 21/275 (7%)
Query: 563 HPRDPSDPENMVKIAVSNDTARSLSSQTVASSGSTNSGATENSHVIESGTLVISVQVLRK 622
P +P+ P + + Q G + +++V + V K
Sbjct: 92 KPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIK 151
Query: 623 ---VTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLS 678
V ++ ELG G FG V++ E G A K + + K + + EI +S
Sbjct: 152 HDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK--ETVRKEIQTMS 209
Query: 679 KVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIAL--D 736
+RH LV+L + NE +++YE+M G LF EK+ + + ++
Sbjct: 210 VLRHPTLVNLHDAFEDDNEMVMIYEFMSGG----ELF--EKVADEHNKMSEDEAVEYMRQ 263
Query: 737 VARGMEYLHCLARQTFIHRDLKSSNILL--DDDYRAKVSDFGLVKLAPDGEKSVVTRLAG 794
V +G+ ++H ++H DLK NI+ K+ DFGL + V G
Sbjct: 264 VCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS--VKVTTG 318
Query: 795 TFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGL 829
T + APE A + D++S GV+ LL+GL
Sbjct: 319 TAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGL 353
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-26
Identities = 62/282 (21%), Positives = 97/282 (34%), Gaps = 44/282 (15%)
Query: 43 LLKWPANGDDPCGP-----PPWPHVFCSGNRVTQI------QVQNLGLKG----PLPQN- 86
C + V C + ++ + L L + N
Sbjct: 24 GCVAETGSAQTCPSVCSCSNQFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNS 83
Query: 87 FNQLTKLYNLGLQRNKFNGKLP--TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLA 144
F L L L L RN + F+GL+ L L N TIP+ F LS ++ L
Sbjct: 84 FKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELW 142
Query: 145 LDYNPFNKTFGWSIP-DSLANSVQLTNLSLINCNLVGPLPD--FLGTLPSLAALKLSYNR 201
L NP SIP + L L L + + + F G L +L L L+
Sbjct: 143 LRNNPIE-----SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEG-LSNLRYLNLAMCN 196
Query: 202 LSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVV-----AKMVSLTQLWLHGNQFTGSIP 256
L IP + L L+ + + ++ L +LW+ +Q I
Sbjct: 197 LR-EIPNLTPLIKLDELDLSGN-------HLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIE 247
Query: 257 ED-IGALSSLKDLNLNRNQLVGLIPKSLANME-LDNLVLNNN 296
+ L SL ++NL N L L + L+ + L++N
Sbjct: 248 RNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 7e-08
Identities = 22/89 (24%), Positives = 36/89 (40%), Gaps = 13/89 (14%)
Query: 65 SGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP--TFSGLSELEFAYLD 122
SGN ++ I+ P +F L L L + +++ + F L L L
Sbjct: 215 SGNHLSAIR----------PGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLA 263
Query: 123 FNEFDTIPSDFFDGLSSVRVLALDYNPFN 151
N +P D F L + + L +NP+N
Sbjct: 264 HNNLTLLPHDLFTPLHHLERIHLHHNPWN 292
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 62/277 (22%), Positives = 93/277 (33%), Gaps = 71/277 (25%)
Query: 625 QNFAQENELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHR 683
+F +GRGGFG V++ + D A+KR+ A ++ E+ L+K+ H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLP-NRELAREKVMREVKALAKLEHP 64
Query: 684 HLVSLLGYSIEGNERLLVYEYMPHGAL------------SRHLFRWEKLQLKPLSWTRR- 730
+V +E E + ++ P S
Sbjct: 65 GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124
Query: 731 ------------------------------------------LSIALDVARGMEYLHCLA 748
L I + +A +E+LH
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH--- 181
Query: 749 RQTFIHRDLKSSNILLDDDYRAKVSDFGLVK-----------LAPDGEKSVVTRLAGTFG 797
+ +HRDLK SNI D KV DFGLV L P + T GT
Sbjct: 182 SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241
Query: 798 YLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDE 834
Y++PE + K D+FS G++L ELL + E
Sbjct: 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME 278
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 55/227 (24%), Positives = 91/227 (40%), Gaps = 46/227 (20%)
Query: 622 KVTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV 680
K + N+ + ELG+G F V + G + A K + + + + + E + K+
Sbjct: 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 62
Query: 681 RHRHLVSLLGYSIEGNERLLVYEYMPHGAL--------------SRHLFRWEKLQLKPLS 726
+H ++V L E + LV++ + G L + H +
Sbjct: 63 QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ---------- 112
Query: 727 WTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILL---DDDYRAKVSDFGLVKLAPD 783
+ + Y H +HR+LK N+LL K++DFGL D
Sbjct: 113 ---------QILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160
Query: 784 GEKSVVTRLAGTFGYLAPEYAVMGKI--TTKADVFSYGVVLMELLTG 828
E AGT GYL+PE V+ K + D+++ GV+L LL G
Sbjct: 161 SE--AWHGFAGTPGYLSPE--VLKKDPYSKPVDIWACGVILYILLVG 203
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 65/266 (24%), Positives = 107/266 (40%), Gaps = 39/266 (14%)
Query: 622 KVTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVK----RMEAGVTTTKALDEFQSEIAV 676
KV + ELG G F V K E G + A K R +E + E+++
Sbjct: 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSI 68
Query: 677 LSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIAL- 735
L +V H ++++L + +L+ E + G L ++ L K S + + +
Sbjct: 69 LRQVLHPNIITLHDVYENRTDVVLILELVSGGEL------FDFLAQK-ESLSEEEATSFI 121
Query: 736 -DVARGMEYLHCLARQTFIHRDLKSSNILL----DDDYRAKVSDFGLVKLAPDGEKSVVT 790
+ G+ YLH + H DLK NI+L K+ DFGL DG +
Sbjct: 122 KQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--FK 176
Query: 791 RLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRI 850
+ GT ++APE + +AD++S GV+ LL+G + P F
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS------P---------FLG- 220
Query: 851 KSSKEKFKAAIDPALEVNEETFESIS 876
+ +E + + +EE F S
Sbjct: 221 DTKQETLANITAVSYDFDEEFFSQTS 246
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-25
Identities = 60/389 (15%), Positives = 118/389 (30%), Gaps = 94/389 (24%)
Query: 65 SGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP--TFSGLSELEFAYLD 122
+ + ++ + ++ L L + ++ F+ ++ Y+
Sbjct: 53 KNSTMRKLP----------AALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMG 101
Query: 123 FNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIP-DSLANSVQLTNLSLINCNLVGP 181
FN +P F + + VL L+ N + S+P N+ +LT LS+ N NL
Sbjct: 102 FNAIRYLPPHVFQNVPLLTVLVLERNDLS-----SLPRGIFHNTPKLTTLSMSNNNLERI 156
Query: 182 LPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSL 241
D SL L+LS NRL+ V + SL
Sbjct: 157 EDDTFQATTSLQNLQLSSNRLTHVDLSLIP----------------------------SL 188
Query: 242 TQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMGP 301
+ N + + ++++L+ + N + + L L L +N L
Sbjct: 189 FHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVE--LTILKLQHNNL--- 238
Query: 302 IPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWL 361
+ P + + L N + + +
Sbjct: 239 -----------------TDTAWLLNYPGLVEV--DLSY-----NELEKIMYH-------- 266
Query: 362 GLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRL 421
++ + + +N L+ + +L + L N + V N + L
Sbjct: 267 --PFVKMQRLERLYI-SNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLEN 322
Query: 422 LDVSDNNIKP-PLPEFHDTVKLVIDGNPL 449
L + N+I L H L + N
Sbjct: 323 LYLDHNSIVTLKLSTHHTLKNLTLSHNDW 351
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 8e-23
Identities = 59/382 (15%), Positives = 117/382 (30%), Gaps = 79/382 (20%)
Query: 83 LPQNFNQLTKLYNLGLQRNKFNGKL-PTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVR 141
+ N Y++ + + L+ + + +P+ D V
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 142 VLALDYNPFNKTFGWSIP-DSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYN 200
+L L+ I + A + + L + + P +P L L L N
Sbjct: 73 LLNLNDLQIE-----EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERN 127
Query: 201 RLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDI- 259
LS + F LT L + N I +D
Sbjct: 128 DLSSLPRGIF-------------------------HNTPKLTTLSMSNNNLE-RIEDDTF 161
Query: 260 GALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQ 319
A +SL++L L+ N+L + + + L + ++ NLL T +
Sbjct: 162 QATTSLQNLQLSSNRLTHVDLSLIPS--LFHANVSYNLL-----------STLAIPIAVE 208
Query: 320 SEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVS-IINLPR 378
LD N ++ G + L L + + + ++N P
Sbjct: 209 E-------------LDASH------NSINVVRGPVNVELTILKLQHNNLTDTAWLLNYPG 249
Query: 379 -------HNLTGTLSPSI-ANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIK 430
+N + + L + + N + + + +L++LD+S N++
Sbjct: 250 LVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL 308
Query: 431 ---PPLPEFHDTVKLVIDGNPL 449
P+F L +D N +
Sbjct: 309 HVERNQPQFDRLENLYLDHNSI 330
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 23/218 (10%)
Query: 623 VTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVK----RMEAGVTTTKALDEFQSEIAVL 677
V ++ ELG G F V K + G + A K R + + +E + E+ +L
Sbjct: 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62
Query: 678 SKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIAL-- 735
++RH ++++L + +L+ E + G LF + L K S T +
Sbjct: 63 REIRHPNIITLHDIFENKTDVVLILELVSGG----ELF--DFLAEKE-SLTEDEATQFLK 115
Query: 736 DVARGMEYLHCLARQTFIHRDLKSSNILL----DDDYRAKVSDFGLVKLAPDGEKSVVTR 791
+ G+ YLH + H DLK NI+L + R K+ DFG+ G +
Sbjct: 116 QILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE--FKN 170
Query: 792 LAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGL 829
+ GT ++APE + +AD++S GV+ LL+G
Sbjct: 171 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 208
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 62/239 (25%), Positives = 96/239 (40%), Gaps = 27/239 (11%)
Query: 602 TENSHVIESGTLVISVQVLRKVTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAG 660
+ S ++G L I Q + + E+G G G V+K + G IAVK+M
Sbjct: 2 SSGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS 61
Query: 661 VTTTKALDEFQSEIAVLSK-VRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEK 719
+ ++ V+ K ++V G I + + E M A
Sbjct: 62 GNKEE-NKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGP 120
Query: 720 LQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFG--- 776
+ + L + + + + + YL + IHRD+K SNILLD+ + K+ DFG
Sbjct: 121 IPERILG-----KMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGISG 173
Query: 777 -LVKLAPDGEKSVV-TRLAGTFGYLAPE-----YAVMGKITTKADVFSYGVVLMELLTG 828
LV R AG Y+APE +ADV+S G+ L+EL TG
Sbjct: 174 RLV-------DDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATG 225
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-25
Identities = 63/282 (22%), Positives = 103/282 (36%), Gaps = 44/282 (15%)
Query: 43 LLKWPANGDDPCGP-----PPWPHVFCSGNRVTQI------QVQNLGLKG----PLPQN- 86
+ + G C + V C+ ++++ + L L + +
Sbjct: 35 IAAAASAGPQNCPSVCSCSNQFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADT 94
Query: 87 FNQLTKLYNLGLQRNKFNGKLP--TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLA 144
F L L L L RN ++ F+GL+ L L N IPS F+ LS +R L
Sbjct: 95 FRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELW 153
Query: 145 LDYNPFNKTFGWSIP-DSLANSVQLTNLSLINCNLVGPLPD--FLGTLPSLAALKLSYNR 201
L NP SIP + L L L + + + F G L +L L L
Sbjct: 154 LRNNPIE-----SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEG-LFNLKYLNLGMCN 207
Query: 202 LSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVV-----AKMVSLTQLWLHGNQFTGSIP 256
+ +P ++ L ++ + + SL +LW+ +Q + I
Sbjct: 208 IK-DMPNLTPLVGLEELEMSG-------NHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIE 258
Query: 257 ED-IGALSSLKDLNLNRNQLVGLIPKSLANME-LDNLVLNNN 296
+ L+SL +LNL N L L + L L L++N
Sbjct: 259 RNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 3e-16
Identities = 42/190 (22%), Positives = 72/190 (37%), Gaps = 21/190 (11%)
Query: 65 SGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP--TFSGLSELEFAYL- 121
N +T I F L+KL L L+ N +P F+ + L L
Sbjct: 131 FDNWLTVIP----------SGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLG 179
Query: 122 DFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGP 181
+ + + I F+GL +++ L L +P+ L V L L + +
Sbjct: 180 ELKKLEYISEGAFEGLFNLKYLNLGMCNIK-----DMPN-LTPLVGLEELEMSGNHFPEI 233
Query: 182 LPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSL 241
P L SL L + +++S + +F L ++ LN + P D+ + L
Sbjct: 234 RPGSFHGLSSLKKLWVMNSQVSLIERNAF-DGLASLVELNLAHNNLSSLPHDLFTPLRYL 292
Query: 242 TQLWLHGNQF 251
+L LH N +
Sbjct: 293 VELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 8e-08
Identities = 24/89 (26%), Positives = 40/89 (44%), Gaps = 13/89 (14%)
Query: 65 SGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP--TFSGLSELEFAYLD 122
SGN +I+ P +F+ L+ L L + ++ + + F GL+ L L
Sbjct: 226 SGNHFPEIR----------PGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLA 274
Query: 123 FNEFDTIPSDFFDGLSSVRVLALDYNPFN 151
N ++P D F L + L L +NP+N
Sbjct: 275 HNNLSSLPHDLFTPLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 8e-04
Identities = 25/109 (22%), Positives = 40/109 (36%), Gaps = 16/109 (14%)
Query: 356 CQGPWLGLSCTSNSKVSI-INLP--------RHNLTGTLSPSI-ANLDSLIEIRLGKNSI 405
C + + CT + +P N + +L L ++LG+NSI
Sbjct: 52 CSNQFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 406 SGTVPNNFTELKSLRLLDVSDNNIKPPLPE--FHDTVKLV---IDGNPL 449
F L SL L++ DN + +P F KL + NP+
Sbjct: 112 RQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPI 159
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 55/229 (24%), Positives = 97/229 (42%), Gaps = 53/229 (23%)
Query: 622 KVTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDE--FQSEIAVLS 678
+ + F LG G F V+ + G A+K ++ + A + ++EIAVL
Sbjct: 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIK----KSPAFRDSSLENEIAVLK 61
Query: 679 KVRHRHLVSLLGYSIEGNERLLVYEYMPHGAL--------------SRHLFRWEKLQLKP 724
K++H ++V+L LV + + G L + + +
Sbjct: 62 KIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQ-------- 113
Query: 725 LSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILL---DDDYRAKVSDFGLVKLA 781
V ++YLH +HRDLK N+L +++ + ++DFGL K+
Sbjct: 114 -----------QVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159
Query: 782 PDGEKSVVTRLAGTFGYLAPEYAVMGKI--TTKADVFSYGVVLMELLTG 828
+G +++ GT GY+APE V+ + + D +S GV+ LL G
Sbjct: 160 QNG---IMSTACGTPGYVAPE--VLAQKPYSKAVDCWSIGVITYILLCG 203
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 62/270 (22%), Positives = 97/270 (35%), Gaps = 53/270 (19%)
Query: 585 SLSSQTVASSGSTNSGATENSHVIESGTLVISVQVLRKVTQNFAQENELGRGGFGTVYKG 644
S SSG G+ T + + + + LG GGFG+VY G
Sbjct: 3 SSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSG 62
Query: 645 E-LEDGTKIAVKRMEAGVTTTKALDEFQS----EIAVLSKVRHR--HLVSLLGYSIEGNE 697
+ D +A+K +E + + E+ +L KV ++ LL + E +
Sbjct: 63 IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW-FERPD 121
Query: 698 RL-LVYEY-----------MPHGALS----RHLFRWEKLQLKPLSWTRRLSIALDVARGM 741
L+ E GAL R F Q+ +
Sbjct: 122 SFVLILERPEPVQDLFDFITERGALQEELARSFFW----QV---------------LEAV 162
Query: 742 EYLHCLARQTFIHRDLKSSNILLD-DDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLA 800
+ H +HRD+K NIL+D + K+ DFG L D V T GT Y
Sbjct: 163 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSP 216
Query: 801 PEYAVMGK--ITTKADVFSYGVVLMELLTG 828
PE+ + A V+S G++L +++ G
Sbjct: 217 PEW-IRYHRYHGRSAAVWSLGILLYDMVCG 245
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-25
Identities = 69/281 (24%), Positives = 111/281 (39%), Gaps = 40/281 (14%)
Query: 609 ESGTLVISVQVLRKVTQNFAQ-----ENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVT 662
SG + + + + +NF ELGRG F V + G + A K ++
Sbjct: 8 SSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR 67
Query: 663 TTKALDEFQSEIAVLSKVRHR-HLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQ 721
E EIAVL + +++L +E +L+ EY G +F
Sbjct: 68 GQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGG----EIF--SLCL 121
Query: 722 LKPL-SWTRRLSIAL--DVARGMEYLHCLARQTFIHRDLKSSNILL---DDDYRAKVSDF 775
+ + I L + G+ YLH + +H DLK NILL K+ DF
Sbjct: 122 PELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDF 178
Query: 776 GLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEE 835
G+ + + + + GT YLAPE ITT D+++ G++ LLT
Sbjct: 179 GMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHT------ 230
Query: 836 RPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESIS 876
P F + ++E + ++ +EETF S+S
Sbjct: 231 SP---------FVG-EDNQETYLNISQVNVDYSEETFSSVS 261
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-25
Identities = 44/234 (18%), Positives = 72/234 (30%), Gaps = 24/234 (10%)
Query: 82 PLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDG-LSSV 140
P +Q + YN R + + + D
Sbjct: 27 PYHDVLSQWQRHYNADRNRWHSAWRQA---NSNNPQIETRTGRALKATADLLEDATQPGR 83
Query: 141 RVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYN 200
L L P PD L ++++ L+ LPD + L L L+ N
Sbjct: 84 VALELRSVPLP-----QFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARN 137
Query: 201 RLSGVIPASFGQ--SLMQILWLNDQ-------DAGGMTGPIDVVAKMVSLTQLWLHGNQF 251
L +PAS L + L + + T +V+L L L
Sbjct: 138 PLR-ALPASIASLNRL-RELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGI 195
Query: 252 TGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANME-LDNLVLNNNLLMGPIPK 304
S+P I L +LK L + + L L ++ ++ L+ L L + P
Sbjct: 196 R-SLPASIANLQNLKSLKIRNSPLSAL-GPAIHHLPKLEELDLRGCTALRNYPP 247
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 49/228 (21%), Positives = 79/228 (34%), Gaps = 45/228 (19%)
Query: 83 LPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYL-DFNEFDTIPSDF------- 133
LP Q L L L RN LP + + L+ L + E +P
Sbjct: 119 LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASG 177
Query: 134 -FDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSL 192
GL +++ L L++ S+P S+AN L +L + N L L + LP L
Sbjct: 178 EHQGLVNLQSLRLEWTGIR-----SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKL 231
Query: 193 AALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHG-NQF 251
L L P FG L +L L +
Sbjct: 232 EELDLRGCTALRNYPPIFGG-------------------------RAPLKRLILKDCSNL 266
Query: 252 TGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANME-LDNLVLNNNLL 298
++P DI L+ L+ L+L + +P +A + +++ +L
Sbjct: 267 L-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ 313
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 53/286 (18%), Positives = 81/286 (28%), Gaps = 78/286 (27%)
Query: 155 GWSIPDSLANSVQLTNLSLINCNLVGPLPDFLG--TLPSLAALKLSYNRLSGVIPASFGQ 212
W ANS + + D L T P AL+L L P +
Sbjct: 45 RWHSAWRQANSNNPQ-IETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFR 102
Query: 213 SLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNR 272
+ L + + +P+ + + L+ L L R
Sbjct: 103 -------------------------LSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLAR 136
Query: 273 NQLVGLIPKSLANME-LDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVN 331
N L L P S+A++ L L + + +P
Sbjct: 137 NPLRAL-PASIASLNRLRELSIRACPELTELP-----------EPLAS------------ 172
Query: 332 VLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKV--SIINLP-------RHNLT 382
D G VNL L L T + SI NL R++
Sbjct: 173 --TDASGEHQGLVNLQ------------SLRLEWTGIRSLPASIANLQNLKSLKIRNSPL 218
Query: 383 GTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNN 428
L P+I +L L E+ L + P F L+ L + D +
Sbjct: 219 SALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCS 264
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 5e-06
Identities = 22/197 (11%), Positives = 46/197 (23%), Gaps = 42/197 (21%)
Query: 240 SLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNN-LL 298
L+ G+ + + + + NR N +++
Sbjct: 13 GRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQAN-SNNPQIETRTGRALKAT 71
Query: 299 MGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQG 358
+ + PD L +L
Sbjct: 72 ADLLEDATQPGRVALELRSVP----LPQFPDQAFRL---------SHLQ----------- 107
Query: 359 PWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKS 418
+ + ++ LP ++ L + L +N + +P + L
Sbjct: 108 -HMTIDAAG-----LMELP---------DTMQQFAGLETLTLARNPLR-ALPASIASLNR 151
Query: 419 LRLLDVSDNNIKPPLPE 435
LR L + LPE
Sbjct: 152 LRELSIRACPELTELPE 168
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 21/112 (18%), Positives = 34/112 (30%), Gaps = 7/112 (6%)
Query: 83 LPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYL-DFNEFDTIPSDFFDGLSSV 140
L + L KL L L+ P F G + L+ L D + T+P D L+ +
Sbjct: 221 LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHR-LTQL 279
Query: 141 RVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSL 192
L L +P +A + + P+
Sbjct: 280 EKLDLRGCVNLS----RLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 5e-05
Identities = 20/178 (11%), Positives = 45/178 (25%), Gaps = 39/178 (21%)
Query: 253 GSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMGPIPKFKAGNVTY 312
GS S ++L + + L+ + + N + + N
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYN-ADRNRWHSAWRQANSNNPQI 60
Query: 313 DSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVS 372
++ + + D L P V+ L L
Sbjct: 61 ETRTGRALK----------ATADLLEDATQP-GRVA------------LELRSV-----P 92
Query: 373 IINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIK 430
+ P L L + + + +P+ + L L ++ N ++
Sbjct: 93 LPQFP---------DQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR 140
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 63/231 (27%), Positives = 95/231 (41%), Gaps = 23/231 (9%)
Query: 610 SGTLVISV-QVLRKVTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKAL 667
SG L IS Q ++ E+GRG +G+V K G +AVKR+ + V +
Sbjct: 6 SGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKE-Q 64
Query: 668 DEFQSEIAV-LSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLS 726
+ ++ V + ++V G + + E M + + + +
Sbjct: 65 KQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIP 123
Query: 727 WTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFG----LVKLAP 782
I L + + +L IHRD+K SNILLD K+ DFG LV
Sbjct: 124 EEILGKITLATVKALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV---- 177
Query: 783 DGEKSVV-TRLAGTFGYLAPE----YAVMGKITTKADVFSYGVVLMELLTG 828
S+ TR AG Y+APE A ++DV+S G+ L EL TG
Sbjct: 178 ---DSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATG 225
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 57/230 (24%), Positives = 95/230 (41%), Gaps = 46/230 (20%)
Query: 632 ELGRGGFGTVYKGE-LEDGTKIAVK------------------------RMEAGVTTTKA 666
E+G+G +G V D T A+K +
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 667 LDEFQSEIAVLSKVRHRHLVSLLGYS-IEGNERL---LVYEYMPHGALSRHLFRWEKLQL 722
+++ EIA+L K+ H ++V L ++ +V+E + G + E L
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPV------MEVPTL 131
Query: 723 KPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782
KPLS + D+ +G+EYLH Q IHRD+K SN+L+ +D K++DFG+
Sbjct: 132 KPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188
Query: 783 DGEKSVVTRLAGTFGYLAPEYAVMGKIT----TKADVFSYGVVLMELLTG 828
+ + GT ++APE ++ DV++ GV L + G
Sbjct: 189 GSDALLSNT-VGTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYCFVFG 236
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-25
Identities = 60/389 (15%), Positives = 118/389 (30%), Gaps = 94/389 (24%)
Query: 65 SGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP--TFSGLSELEFAYLD 122
+ + ++ + ++ L L + ++ F+ ++ Y+
Sbjct: 59 KNSTMRKLP----------AALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMG 107
Query: 123 FNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIP-DSLANSVQLTNLSLINCNLVGP 181
FN +P F + + VL L+ N + S+P N+ +LT LS+ N NL
Sbjct: 108 FNAIRYLPPHVFQNVPLLTVLVLERNDLS-----SLPRGIFHNTPKLTTLSMSNNNLERI 162
Query: 182 LPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSL 241
D SL L+LS NRL+ V + SL
Sbjct: 163 EDDTFQATTSLQNLQLSSNRLTHVDLSLIP----------------------------SL 194
Query: 242 TQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMGP 301
+ N + + ++++L+ + N + + L L L +N L
Sbjct: 195 FHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVE--LTILKLQHNNL--- 244
Query: 302 IPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWL 361
+ P + + L N + + +
Sbjct: 245 -----------------TDTAWLLNYPGLVEV--DLSY-----NELEKIMYH-------- 272
Query: 362 GLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRL 421
++ + + +N L+ + +L + L N + V N + L
Sbjct: 273 --PFVKMQRLERLYI-SNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLEN 328
Query: 422 LDVSDNNIKP-PLPEFHDTVKLVIDGNPL 449
L + N+I L H L + N
Sbjct: 329 LYLDHNSIVTLKLSTHHTLKNLTLSHNDW 357
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 90.0 bits (223), Expect = 1e-18
Identities = 59/386 (15%), Positives = 118/386 (30%), Gaps = 87/386 (22%)
Query: 83 LPQNFNQLTKLYNLGLQRNKFNGKL-PTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVR 141
+ N Y++ + + L+ + + +P+ D V
Sbjct: 19 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 78
Query: 142 VLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNR 201
+L L+ Q+ + ++ L + +N
Sbjct: 79 LLNLNDL------------------QIEEID----------TYAFAYAHTIQKLYMGFNA 110
Query: 202 LSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDI-G 260
+ + P F + LT L L N + S+P I
Sbjct: 111 IRYLPPHVF-------------------------QNVPLLTVLVLERNDLS-SLPRGIFH 144
Query: 261 ALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLL----MGPIPKFKAGNVTYDSN 315
L L+++ N L + + L NL L++N L + IP NV+Y+
Sbjct: 145 NTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLL 204
Query: 316 SFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVS-II 374
S +E LD N ++ G + L L + + + ++
Sbjct: 205 STLAIPIAVE-------ELDASH------NSINVVRGPVNVELTILKLQHNNLTDTAWLL 251
Query: 375 NLPR-------HNLTGTLSPSI-ANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSD 426
N P +N + + L + + N + + + +L++LD+S
Sbjct: 252 NYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSH 310
Query: 427 NNIK---PPLPEFHDTVKLVIDGNPL 449
N++ P+F L +D N +
Sbjct: 311 NHLLHVERNQPQFDRLENLYLDHNSI 336
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 80.0 bits (197), Expect = 2e-15
Identities = 55/369 (14%), Positives = 98/369 (26%), Gaps = 104/369 (28%)
Query: 65 SGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFN 124
S N + ++ +LT L LQ N L L +N
Sbjct: 219 SHNSINVVR----------GPVNVELTILK---LQHNNLT-DTAWLLNYPGLVEVDLSYN 264
Query: 125 EFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPD 184
E + I F + + L + N +L L
Sbjct: 265 ELEKIMYHPFVKMQRLERLYISNN------------------RLVA-----------LNL 295
Query: 185 FLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQL 244
+ +P+L L LS+N L V L L
Sbjct: 296 YGQPIPTLKVLDLSHNHLLHVERNQPQ--------------------------FDRLENL 329
Query: 245 WLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMGPIPK 304
+L N ++ + +LK+L L+ N + N L
Sbjct: 330 YLDHNSIV-TLK--LSTHHTLKNLTLSHND------------------WDCNSLRALFRN 368
Query: 305 FKAGNVTYDSNSFC----QSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPW 360
V D++ C Q E G+ C LD L ++V +
Sbjct: 369 VARPAV-DDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVV--------EKVQR 419
Query: 361 LGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSL-IEIRLGKNSISGTVPNNFTELKSL 419
C++ ++ + H +T + + L E+ + + + + L
Sbjct: 420 AQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQLL 479
Query: 420 RLLDVSDNN 428
+ L +
Sbjct: 480 QGLHAEIDT 488
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 8e-25
Identities = 63/411 (15%), Positives = 112/411 (27%), Gaps = 48/411 (11%)
Query: 65 SGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP--TFSGLSELEFAYLD 122
S N++T I + L L L+ ++ N + F L LE L
Sbjct: 34 SFNKITYIG----------HGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLS 82
Query: 123 FNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPL 182
N ++ S +F LSS++ L L NP+ + N L L + N +
Sbjct: 83 DNHLSSLSSSWFGPLSSLKYLNLMGNPYQTL---GVTSLFPNLTNLQTLRIGNVETFSEI 139
Query: 183 P-DFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSL 241
L SL L++ L S +S+ I L + + S+
Sbjct: 140 RRIDFAGLTSLNELEIKALSLRNYQSQSL-KSIRDIHHLTLHLSESAFLLEIFADILSSV 198
Query: 242 TQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMGP 301
L L + + + L +S + L L L
Sbjct: 199 RYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNEL-LKLLRYILELSEVE 257
Query: 302 IPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGP-- 359
+ + S + V + + ++ P +
Sbjct: 258 FDDCTLNGLGDFNPSESDV---VSELGKVETV--TIRRLHIPQFYLFYDLSTVYSLLEKV 312
Query: 360 -WLGLS-----------CTSNSKVSIINLPRHN----LTGTLSPSIANLDSLIEIRLGKN 403
+ + + ++L N S SL + L +N
Sbjct: 313 KRITVENSKVFLVPCSFSQHLKSLEFLDL-SENLMVEEYLKNSACKGAWPSLQTLVLSQN 371
Query: 404 SIS--GTVPNNFTELKSLRLLDVSDNNIKPPLPEFHDTVKLV---IDGNPL 449
+ LK+L LD+S N P K+ + +
Sbjct: 372 HLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGI 422
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 8e-25
Identities = 59/386 (15%), Positives = 117/386 (30%), Gaps = 69/386 (17%)
Query: 64 CSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP--TFSGLSELEFAYL 121
T I P + +L L NK + + L+ L
Sbjct: 12 GRSRSFTSI-----------PSGL--TAAMKSLDLSFNKIT-YIGHGDLRACANLQVLIL 57
Query: 122 DFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDS-LANSVQLTNLSLINCNLVG 180
+ +TI D F L S+ L L N + S+ S L L+L+
Sbjct: 58 KSSRINTIEGDAFYSLGSLEHLDLSDNHLS-----SLSSSWFGPLSSLKYLNLMGNPYQT 112
Query: 181 -PLPDFLGTLPSLAALKLS-YNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKM 238
+ L +L L++ S + F A +
Sbjct: 113 LGVTSLFPNLTNLQTLRIGNVETFSEIRRIDF-------------------------AGL 147
Query: 239 VSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANME-LDNLVLNNNL 297
SL +L + + + ++ + L L+ ++ L+ + + L L +
Sbjct: 148 TSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTN 207
Query: 298 LMG-------------PIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPV 344
L P+ K SF + + + L + + +
Sbjct: 208 LARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNE----LLKLLRYILELSEVEFDDCTL 263
Query: 345 NLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNS 404
N + + ++ L + +++P+ L LS + L+ + I + +
Sbjct: 264 NGLGDFNPSES--DVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSK 321
Query: 405 ISGTVPNNFTELKSLRLLDVSDNNIK 430
+ + LKSL LD+S+N +
Sbjct: 322 VFLVPCSFSQHLKSLEFLDLSENLMV 347
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 9e-21
Identities = 54/282 (19%), Positives = 101/282 (35%), Gaps = 26/282 (9%)
Query: 26 NDLKILNDFKNGLENPELLKWPANGDDPCGPPPWPHVFCSGNRVTQIQVQNLGL-----K 80
N+L L + L E NG P V +V + ++ L +
Sbjct: 241 NELLKLLRYILELSEVEFDDCTLNGLG-DFNPSESDVVSELGKVETVTIRRLHIPQFYLF 299
Query: 81 GPLPQNFNQLTKLYNLGLQRNKFNGKLP--TFSGLSELEFAYLDFNEFDTIP---SDFFD 135
L ++ L K+ + ++ +K +P L LEF L N S
Sbjct: 300 YDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKG 358
Query: 136 GLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAAL 195
S++ L L N + L LT+L + + N P+PD + L
Sbjct: 359 AWPSLQTLVLSQNHLRSM--QKTGEILLTLKNLTSLDI-SRNTFHPMPDSCQWPEKMRFL 415
Query: 196 KLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSI 255
LS + V+ Q+L ++L +++ + + L +L++ N+ ++
Sbjct: 416 NLSSTGIR-VVKTCIPQTL-EVLDVSNNNLD------SFSLFLPRLQELYISRNKLK-TL 466
Query: 256 PEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNN 296
P+ L + ++RNQL + + L + L+ N
Sbjct: 467 PDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTN 507
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 2e-20
Identities = 63/391 (16%), Positives = 130/391 (33%), Gaps = 63/391 (16%)
Query: 84 PQNFNQLTKLYNLGLQRNKFN--GKLPTFSGLSELEFAYL-DFNEFDTIPSDFFDGLSSV 140
F L+ L L L N + G F L+ L+ + + F I F GL+S+
Sbjct: 91 SSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSL 150
Query: 141 RVLALDYNPFNKTFGWSIPD-SLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSY 199
L + + SL + + +L+L L F L S+ L+L
Sbjct: 151 NELEIKALSLR-----NYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRD 205
Query: 200 NRLSGVIPASFGQSLM---------QILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQ 250
L+ + + + L D+ + + + ++ + N
Sbjct: 206 TNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNG 265
Query: 251 FTGSIPEDIGALS--------SLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGP 301
P + +S +++ L++ + L + + + ++ + + N+
Sbjct: 266 LGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENS----- 320
Query: 302 IPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWL 361
V SF Q +E LD N +V ++ N C+G W
Sbjct: 321 -------KVFLVPCSFSQHLKSLE-------FLDLSE--N---LMVEEYLKNSACKGAWP 361
Query: 362 GLSCTSNSKVSIINLPRHNLT--GTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSL 419
L + L +++L + L +L + + +N+ +P++ + +
Sbjct: 362 SLQ--------TLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKM 412
Query: 420 RLLDVSDNNIKP-PLPEFHDTVKLVIDGNPL 449
R L++S I+ L + N L
Sbjct: 413 RFLNLSSTGIRVVKTCIPQTLEVLDVSNNNL 443
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 2e-19
Identities = 54/391 (13%), Positives = 124/391 (31%), Gaps = 64/391 (16%)
Query: 82 PLPQNFNQLTKLYNLGLQRNKFNGKLP--TFSGLSELEFAYLDFNEFDTIPSDFFDGLSS 139
+ F LT L L + + ++ F+GL+ L + S +
Sbjct: 114 GVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRD 173
Query: 140 VRVLALDYNPFNKTFGWSIPDSLANS-VQLTNLSLINCNLVGPLPDFLGTLPSLAALKLS 198
+ L L + + + A+ + L L + NL L + +K
Sbjct: 174 IHHLTLHLSESA-----FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKL 228
Query: 199 YNRLSGVIPASFGQ-------------------SLMQILWLNDQDAGGMTGPIDVVAKMV 239
R S + SF + +L + N ++ ++ V + V
Sbjct: 229 AFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKV--ETV 286
Query: 240 SLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANME-LDNLVLNNNLL 298
++ +L + + L +K + + +++ + +++ L+ L L+ NL+
Sbjct: 287 TIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLM 346
Query: 299 MGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQG 358
+ +++ + P ++ L N+ ++
Sbjct: 347 V---------EEYLKNSACKGAWPSLQ-------TLVLSQ--NHLRSM------------ 376
Query: 359 PWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKS 418
G + ++ +++ N + S + + + L I L+
Sbjct: 377 QKTGEILLTLKNLTSLDI-SRNTFHPMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLE- 434
Query: 419 LRLLDVSDNNIKPPLPEFHDTVKLVIDGNPL 449
+LDVS+NN+ +L I N L
Sbjct: 435 --VLDVSNNNLDSFSLFLPRLQELYISRNKL 463
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 4e-19
Identities = 39/281 (13%), Positives = 78/281 (27%), Gaps = 53/281 (18%)
Query: 20 NSATDPNDLKILNDFKNGLENPELLKWPANGDDPCGPPPWPHVFCSGNRVTQIQVQNLGL 79
+ + + V + + N
Sbjct: 214 SPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSE 273
Query: 80 KGPLPQN-FNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFDTIPSDFFDGL 137
+ + + + L + + L +S L +++ ++ ++ +P F L
Sbjct: 274 SDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHL 333
Query: 138 SSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKL 197
S+ L L N + L N G PSL L L
Sbjct: 334 KSLEFLDLSEN------------------LMVEEYLKNSA-------CKGAWPSLQTLVL 368
Query: 198 SYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPE 257
S N L M +++ + +LT L + N F +P+
Sbjct: 369 SQNHLR-----------------------SMQKTGEILLTLKNLTSLDISRNTFH-PMPD 404
Query: 258 DIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLL 298
++ LNL+ + + +E+ L ++NN L
Sbjct: 405 SCQWPEKMRFLNLSSTGIRVVKTCIPQTLEV--LDVSNNNL 443
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 8e-19
Identities = 66/390 (16%), Positives = 125/390 (32%), Gaps = 49/390 (12%)
Query: 76 NLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP--TFSGLSELEFAYLDFNEFDTIPSDF 133
+F LT L L ++ + + ++ L +E + F
Sbjct: 133 VETFSEIRRIDFAGLTSLNELEIKALSLR-NYQSQSLKSIRDIHHLTLHLSESAFLLEIF 191
Query: 134 FDGLSSVRVLALDYNPFNKTFGWSIPDSLANSV------QLTNLSLINCNLVGPLPDFLG 187
D LSSVR L L + +P +S + + L+ + N + L ++
Sbjct: 192 ADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYIL 251
Query: 188 TLPSLAALKLSYNRLSGVIPASFGQ-------SLMQILWLNDQDAGGMTGPIDVVAKMVS 240
L + + N L P+ + I L+ V + +
Sbjct: 252 ELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEK 311
Query: 241 LTQLWLHGNQFTGSIPEDIGA-LSSLKDLNLNRNQLVGLIPKSLANME----LDNLVLNN 295
+ ++ + ++ +P L SL+ L+L+ N +V K+ A L LVL+
Sbjct: 312 VKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQ 370
Query: 296 NLL--MGPIPKFKAG--NVTY---DSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVS 348
N L M + N+T N+F + + L L +
Sbjct: 371 NHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFL--NLSS-----TGIR 423
Query: 349 QWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLS---------PSIANLDSLIEIR 399
P L +S N+ + +L L L P + L+ ++
Sbjct: 424 VVKTCIPQTLEVLDVS---NNNLDSFSLFLPRLQ-ELYISRNKLKTLPDASLFPVLLVMK 479
Query: 400 LGKNSISGTVPNNFTELKSLRLLDVSDNNI 429
+ +N + F L SL+ + + N
Sbjct: 480 ISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 3e-06
Identities = 22/98 (22%), Positives = 40/98 (40%), Gaps = 8/98 (8%)
Query: 61 HVFCSGNRVTQI------QVQNLGLKG-PLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGL 113
+ S + + ++ L + L L +L L + RNK LP S
Sbjct: 414 FLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLK-TLPDASLF 472
Query: 114 SELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFN 151
L + N+ ++P FD L+S++ + L NP++
Sbjct: 473 PVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-25
Identities = 52/214 (24%), Positives = 95/214 (44%), Gaps = 21/214 (9%)
Query: 625 QNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAV-LSKVRH 682
+ ELGRG +G V K + G +AVKR+ A V + + ++ + + V
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE-QKRLLMDLDISMRTVDC 65
Query: 683 RHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGME 742
V+ G + + E M +L + ++ + + + IA+ + + +E
Sbjct: 66 PFTVTFYGALFREGDVWICMELMD-TSLDK-FYKQVIDKGQTIPEDILGKIAVSIVKALE 123
Query: 743 YLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFG----LVKLAPDGEKSVVTRLAGTFGY 798
+LH ++ + IHRD+K SN+L++ + K+ DFG LV AG Y
Sbjct: 124 HLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD------DVAKDIDAGCKPY 175
Query: 799 LAPE----YAVMGKITTKADVFSYGVVLMELLTG 828
+APE + K+D++S G+ ++EL
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAIL 209
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 64/266 (24%), Positives = 104/266 (39%), Gaps = 39/266 (14%)
Query: 622 KVTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVK----RMEAGVTTTKALDEFQSEIAV 676
V + ELG G F V K E G + A K R + ++ + E+++
Sbjct: 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 677 LSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIAL- 735
L +++H ++++L + +L+ E + G LF + L K S T +
Sbjct: 68 LKEIQHPNVITLHEVYENKTDVILILELVAGG----ELF--DFLAEKE-SLTEEEATEFL 120
Query: 736 -DVARGMEYLHCLARQTFIHRDLKSSNILL----DDDYRAKVSDFGLVKLAPDGEKSVVT 790
+ G+ YLH H DLK NI+L R K+ DFGL G +
Sbjct: 121 KQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FK 175
Query: 791 RLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRI 850
+ GT ++APE + +AD++S GV+ LL+G P F
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA------SP---------FLG- 219
Query: 851 KSSKEKFKAAIDPALEVNEETFESIS 876
+ +E E +E F + S
Sbjct: 220 DTKQETLANVSAVNYEFEDEYFSNTS 245
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 55/227 (24%), Positives = 91/227 (40%), Gaps = 46/227 (20%)
Query: 622 KVTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV 680
K + N+ + ELG+G F V + G + A K + + + + + E + K+
Sbjct: 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 85
Query: 681 RHRHLVSLLGYSIEGNERLLVYEYMPHGAL--------------SRHLFRWEKLQLKPLS 726
+H ++V L E + LV++ + G L + H +
Sbjct: 86 QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ---------- 135
Query: 727 WTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILL---DDDYRAKVSDFGLVKLAPD 783
+ + Y H +HR+LK N+LL K++DFGL D
Sbjct: 136 ---------QILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183
Query: 784 GEKSVVTRLAGTFGYLAPEYAVMGKI--TTKADVFSYGVVLMELLTG 828
E AGT GYL+PE V+ K + D+++ GV+L LL G
Sbjct: 184 SE--AWHGFAGTPGYLSPE--VLKKDPYSKPVDIWACGVILYILLVG 226
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 18/209 (8%)
Query: 626 NFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRH 684
++ LG G FG V+K E G K+A K ++ K +E ++EI+V++++ H +
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIK--TRGMKDKEEVKNEISVMNQLDHAN 147
Query: 685 LVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIAL--DVARGME 742
L+ L N+ +LV EY+ G LF +++ + + T +I + G+
Sbjct: 148 LIQLYDAFESKNDIVLVMEYVDGG----ELF--DRIIDESYNLTELDTILFMKQICEGIR 201
Query: 743 YLHCLARQTFIHRDLKSSNILL--DDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLA 800
++H + +H DLK NIL D + K+ DFGL + EK + GT +LA
Sbjct: 202 HMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LKVNFGTPEFLA 256
Query: 801 PEYAVMGKITTKADVFSYGVVLMELLTGL 829
PE ++ D++S GV+ LL+GL
Sbjct: 257 PEVVNYDFVSFPTDMWSVGVIAYMLLSGL 285
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 63/234 (26%), Positives = 99/234 (42%), Gaps = 22/234 (9%)
Query: 603 ENSHVIESGTLVISVQVLRKVTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGV 661
+ H SG + Q + F + +LG G FG V+ E G + +K +
Sbjct: 2 HHHHHHSSGRENLYFQ--GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKD- 58
Query: 662 TTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERL-LVYEYMPHGALSRHLF-RWEK 719
+ +++ ++EI VL + H +++ + E + +V E G L R
Sbjct: 59 RSQVPMEQIEAEIEVLKSLDHPNIIKIFEV-FEDYHNMYIVMETCEGG----ELLERIVS 113
Query: 720 LQLKPLSWTRRLSIAL--DVARGMEYLHCLARQTFIHRDLKSSNILL---DDDYRAKVSD 774
Q + + + L + + Y H Q +H+DLK NIL K+ D
Sbjct: 114 AQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIID 170
Query: 775 FGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTG 828
FGL +L E T AGT Y+APE +T K D++S GVV+ LLTG
Sbjct: 171 FGLAELFKSDEH--STNAAGTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTG 221
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 54/208 (25%), Positives = 83/208 (39%), Gaps = 30/208 (14%)
Query: 633 LGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGY 691
LG G +G V +AVK ++ + + EI + + H ++V G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 692 SIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVAR--------GMEY 743
EGN + L EY G L + + A+ G+ Y
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPE-------------PDAQRFFHQLMAGVVY 120
Query: 744 LHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLA-GTFGYLAPE 802
LH HRD+K N+LLD+ K+SDFGL + + + GT Y+APE
Sbjct: 121 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 803 YAVMGK--ITTKADVFSYGVVLMELLTG 828
+ + DV+S G+VL +L G
Sbjct: 178 -LLKRREFHAEPVDVWSCGIVLTAMLAG 204
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 59/230 (25%), Positives = 106/230 (46%), Gaps = 29/230 (12%)
Query: 615 ISVQVLRKVTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSE 673
I + LR F +G G +G VYKG ++ G A+K M+ T +E + E
Sbjct: 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQE 70
Query: 674 IAVLSKV-RHRHLVSLLG-----YSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLS 726
I +L K HR++ + G +++L LV E+ G+++ + + + L
Sbjct: 71 INMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI---KNTKGNTLK 127
Query: 727 WTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL-VKLAPDGE 785
I ++ RG+ +LH + IHRD+K N+LL ++ K+ DFG+ +L
Sbjct: 128 EEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG 184
Query: 786 K--SVVTRLAGTFGYLAPEYAVMGKIT-----TKADVFSYGVVLMELLTG 828
+ + + GT ++APE + K+D++S G+ +E+ G
Sbjct: 185 RRNTFI----GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-24
Identities = 65/240 (27%), Positives = 106/240 (44%), Gaps = 26/240 (10%)
Query: 633 LGRGGFGTVYKGELEDGTKI-AVKRME-AGVTTTKALDEFQSEIAVLSKVRHRHLVSLLG 690
+G+G FG V + D K+ A+K M + E+ ++ + H LV+L
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW- 81
Query: 691 YSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLAR 749
YS + E + +V + + G L HL + + + T +L I ++ ++YL
Sbjct: 82 YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE----TVKLFIC-ELVMALDYLQ---N 133
Query: 750 QTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPE--YAVMG 807
Q IHRD+K NILLD+ ++DF + + P + T +AGT Y+APE + G
Sbjct: 134 QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI--TTMAGTKPYMAPEMFSSRKG 191
Query: 808 KITTKA-DVFSYGVVLMELLTGLAALDEERP---EESRYLAEWFWRIKSSKEKFKAAIDP 863
+ A D +S GV ELL G RP S E +++ + +A
Sbjct: 192 AGYSFAVDWWSLGVTAYELLRGR------RPYHIRSSTSSKEIVHTFETTVVTYPSAWSQ 245
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 57/215 (26%), Positives = 93/215 (43%), Gaps = 46/215 (21%)
Query: 633 LGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGY 691
+G+G F V + G ++A+K ++ +L + E+ ++ + H ++V L +
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL--F 80
Query: 692 S-IEGNERL-LVYEYMP----------HGALS----RHLFRWEKLQLKPLSWTRRLSIAL 735
IE + L L+ EY HG + R FR Q+
Sbjct: 81 EVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR----QI------------- 123
Query: 736 DVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGT 795
++Y H ++ +HRDLK+ N+LLD D K++DFG G K + G
Sbjct: 124 --VSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK--LDAFCGA 176
Query: 796 FGYLAPEYAVMGK--ITTKADVFSYGVVLMELLTG 828
Y APE GK + DV+S GV+L L++G
Sbjct: 177 PPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSG 210
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 58/232 (25%), Positives = 91/232 (39%), Gaps = 51/232 (21%)
Query: 622 KVTQNFAQENELGRGGFGTVYKGE-LEDGTKIAVKRM------EAGVTTTKALDEFQSEI 674
+ +Q ++ + LG G FG V+ E ++ VK + E L + EI
Sbjct: 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEI 80
Query: 675 AVLSKVRHRHLVSLLGYSIEGNERL-LVYEY-----------MPHGALS----RHLFRWE 718
A+LS+V H +++ +L E LV E H L ++FR
Sbjct: 81 AILSRVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFR-- 137
Query: 719 KLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLV 778
QL + YL + IHRD+K NI++ +D+ K+ DFG
Sbjct: 138 --QL---------------VSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSA 177
Query: 779 KLAPDGEKSVVTRLAGTFGYLAPEYAVMGK--ITTKADVFSYGVVLMELLTG 828
G+ GT Y APE +MG + +++S GV L L+
Sbjct: 178 AYLERGKL--FYTFCGTIEYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFE 226
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 53/226 (23%), Positives = 88/226 (38%), Gaps = 47/226 (20%)
Query: 622 KVTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV 680
+ Q + EN +GRG +G V + + A K++ + +D F+ EI ++ +
Sbjct: 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPK--YFVEDVDRFKQEIEIMKSL 63
Query: 681 RHRHLVSLLGYSIEGNERL-LVYEYMPHGAL--------------SRHLFRWEKLQLKPL 725
H +++ L E N + LV E G L + + +
Sbjct: 64 DHPNIIRLYET-FEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMK--------- 113
Query: 726 SWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILL---DDDYRAKVSDFGLVKLAP 782
DV + Y H + HRDLK N L D K+ DFGL
Sbjct: 114 ----------DVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160
Query: 783 DGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTG 828
G+ ++ GT Y++P+ + G + D +S GV++ LL G
Sbjct: 161 PGK--MMRTKVGTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 203
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-23
Identities = 48/228 (21%), Positives = 92/228 (40%), Gaps = 47/228 (20%)
Query: 622 KVTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV 680
+ T+ + ELG+G F V + ++ G + A + + + + + E + +
Sbjct: 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL 67
Query: 681 RHRHLVSLLGYSIEGNERLLVYEYMPHGAL--------------SRHLFRWEKLQLKPLS 726
+H ++V L E L+++ + G L + H +
Sbjct: 68 KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQ---------- 117
Query: 727 WTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILL---DDDYRAKVSDFGL-VKLAP 782
+ + + H + +HR+LK N+LL K++DFGL +++
Sbjct: 118 ---------QILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165
Query: 783 DGEKSVVTRLAGTFGYLAPEYAVMGKI--TTKADVFSYGVVLMELLTG 828
+ + AGT GYL+PE V+ K D+++ GV+L LL G
Sbjct: 166 EQQ--AWFGFAGTPGYLSPE--VLRKDPYGKPVDLWACGVILYILLVG 209
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 65/213 (30%), Positives = 96/213 (45%), Gaps = 41/213 (19%)
Query: 633 LGRGGFGTVYKGE-LEDGTKIAVKRME-AGVTTTKALDEFQSEIAVLSKVRHRHLVSLLG 690
LG G FG V GE G K+AVK + + + + + + EI L RH H++ L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL-- 76
Query: 691 YS-IEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVAR--------G 740
Y I +V EY+ G L ++ + +++ AR
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEE-------------MEARRLFQQILSA 123
Query: 741 MEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLA---GTFG 797
++Y H R +HRDLK N+LLD AK++DFGL + DGE L G+
Sbjct: 124 VDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-----LRTSCGSPN 175
Query: 798 YLAPEYAVMGK--ITTKADVFSYGVVLMELLTG 828
Y APE + G+ + D++S GV+L LL G
Sbjct: 176 YAAPE-VISGRLYAGPEVDIWSCGVILYALLCG 207
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-23
Identities = 71/386 (18%), Positives = 121/386 (31%), Gaps = 81/386 (20%)
Query: 62 VFCSGNRVTQI-----QVQNLGLKG------PLPQNFNQLTKLYNLGLQRNKFNGKLP-- 108
C + Q+ V + L +F++L L L +++ +
Sbjct: 15 AICINRGLHQVPELPAHVNYVDLSLNSIAELN-ETSFSRLQDLQFLKVEQQTPGLVIRNN 73
Query: 109 TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQL 168
TF GLS L LD+N+F + + F+GL+++ VL L L
Sbjct: 74 TFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQC------------------NL 115
Query: 169 TNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGM 228
L +F L SL L L N + + PASF ++
Sbjct: 116 DGAVL--------SGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNM-------------- 153
Query: 229 TGPIDVVAKMVSLTQLWLHGNQFTGSIPEDI---GALSSLKDLNLNRNQLVGLIPKSLAN 285
L L N+ SI E+ L L+ L + L
Sbjct: 154 ----------RRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGW 202
Query: 286 MELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVN 345
+ N N ++ + N F +S + L ++ N
Sbjct: 203 EKCGNPFKNTSITTLDL----------SGNGFKESMAKRFFDAIAGTKIQSL-ILSNSYN 251
Query: 346 LVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSI-ANLDSLIEIRLGKNS 404
+ S + + S V +L + L S+ ++ L ++ L +N
Sbjct: 252 MGSSFGHTNFKDPDNFTFKGLEASGVKTCDL-SKSKIFALLKSVFSHFTDLEQLTLAQNE 310
Query: 405 ISGTVPNNFTELKSLRLLDVSDNNIK 430
I+ N F L L L++S N +
Sbjct: 311 INKIDDNAFWGLTHLLKLNLSQNFLG 336
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 3e-13
Identities = 44/230 (19%), Positives = 70/230 (30%), Gaps = 60/230 (26%)
Query: 51 DDPCGPPPWPHVFCSGNRVTQIQVQNLGLKGPLPQNFNQL--TKLYNLGLQRNKFNGKLP 108
D + S + + K P F L + + L ++K L
Sbjct: 233 FDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALL 291
Query: 109 --TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSV 166
FS ++LE L NE + I + F GL+ + L L N
Sbjct: 292 KSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQN------------------ 333
Query: 167 QLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAG 226
L ++ L L L LSYN + +
Sbjct: 334 FLGSID----------SRMFENLDKLEVLDLSYNHIRAL--------------------- 362
Query: 227 GMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDI-GALSSLKDLNLNRNQL 275
+ +L +L L NQ S+P+ I L+SL+ + L+ N
Sbjct: 363 ----GDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 23/67 (34%), Positives = 34/67 (50%), Gaps = 3/67 (4%)
Query: 87 FNQLTKLYNLGLQRNKFNGKLP--TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLA 144
F L KL L L N L +F GL L+ LD N+ ++P FD L+S++ +
Sbjct: 343 FENLDKLEVLDLSYNHIRA-LGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIW 401
Query: 145 LDYNPFN 151
L NP++
Sbjct: 402 LHTNPWD 408
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 54/208 (25%), Positives = 83/208 (39%), Gaps = 30/208 (14%)
Query: 633 LGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGY 691
LG G +G V +AVK ++ + + EI + + H ++V G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 692 SIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVAR--------GMEY 743
EGN + L EY G L + + A+ G+ Y
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPE-------------PDAQRFFHQLMAGVVY 120
Query: 744 LHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLA-GTFGYLAPE 802
LH HRD+K N+LLD+ K+SDFGL + + + GT Y+APE
Sbjct: 121 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 803 YAVMGK--ITTKADVFSYGVVLMELLTG 828
+ + DV+S G+VL +L G
Sbjct: 178 -LLKRREFHAEPVDVWSCGIVLTAMLAG 204
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 46/240 (19%), Positives = 84/240 (35%), Gaps = 21/240 (8%)
Query: 62 VFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAY 120
+ +GNR +V + LK L + L L N + + ++LE
Sbjct: 5 IKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLN 64
Query: 121 LDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVG 180
L N + LS++R L L+ N L + L N N +
Sbjct: 65 LSSNVLYETLD--LESLSTLRTLDLNNNYVQ---------ELLVGPSIETLHAAN-NNIS 112
Query: 181 PLPDFLGTLPSLAALKLSYNRLSGVIPASFGQ-SLMQILWLNDQDAGGMTGPIDVVAKMV 239
+ + L+ N+++ + G S +Q L L + + ++ A
Sbjct: 113 RVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFA-ELAASSD 169
Query: 240 SLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANME-LDNLVLNNNLL 298
+L L L N + + + LK L+L+ N+L + + + + L NN L
Sbjct: 170 TLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKL 226
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 7e-23
Identities = 35/264 (13%), Positives = 72/264 (27%), Gaps = 36/264 (13%)
Query: 65 SGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFN 124
S N + + + L+ L L L N + +E + N
Sbjct: 66 SSNVLYETL------------DLESLSTLRTLDLNNNY----VQELLVGPSIETLHAANN 109
Query: 125 EFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPD-SLANSVQLTNLSLINCNLVG-PL 182
+ G + + L N + D ++ L L +
Sbjct: 110 NISRVSCSRGQGK---KNIYLANNKIT-----MLRDLDEGCRSRVQYLDLKLNEIDTVNF 161
Query: 183 PDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLND-QDAGGMTGPIDVVAKMVSL 241
+ + +L L L YN + V L + L L+ + + +
Sbjct: 162 AELAASSDTLEHLNLQYNFIYDVKGQVVFAKL-KTLDLSSNK----LAFMGPEFQSAAGV 216
Query: 242 TQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSL--ANMELDNLVLNNN-LL 298
T + L N+ I + + +L+ +L N + N + + L
Sbjct: 217 TWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKL 275
Query: 299 MGPIPKFKAGNVTYDSNSFCQSEP 322
G + ++C +
Sbjct: 276 TGQNEEECTVPTLGHYGAYCCEDL 299
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 5e-20
Identities = 36/219 (16%), Positives = 68/219 (31%), Gaps = 42/219 (19%)
Query: 83 LPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVR 141
+ + + + + L ++ L N I + + +
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 142 VLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNR 201
+L L N D L + L L L N + L PS+ L + N
Sbjct: 62 LLNLSSNVLY-----ETLD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNN 110
Query: 202 LSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGA 261
+S + S GQ ++L N+ T D G
Sbjct: 111 IS-RVSCSRGQGK---------------------------KNIYLANNKITMLRDLDEGC 142
Query: 262 LSSLKDLNLNRNQLVGL-IPKSLANME-LDNLVLNNNLL 298
S ++ L+L N++ + + A+ + L++L L N +
Sbjct: 143 RSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 8e-15
Identities = 30/214 (14%), Positives = 67/214 (31%), Gaps = 29/214 (13%)
Query: 65 SGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP---TFSGLSELEFAYL 121
+ N++T ++ + +++ L L+ N+ + + + LE L
Sbjct: 128 ANNKITMLR----------DLDEGCRSRVQYLDLKLNEID-TVNFAELAASSDTLEHLNL 176
Query: 122 DFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGP 181
+N + + ++ L L N + ++ +T +SL N LV
Sbjct: 177 QYNFIYDVKGQVV--FAKLKTLDLSSNKLA-----FMGPEFQSAAGVTWISLRNNKLVL- 228
Query: 182 LPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSL 241
+ L +L L N F ++ + Q +TG + +
Sbjct: 229 IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECT---V 285
Query: 242 TQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQL 275
L +G +P + + L +
Sbjct: 286 PTLGHYGAYCCEDLPAPFA----DRLIALGHHHH 315
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 26/144 (18%), Positives = 54/144 (37%), Gaps = 14/144 (9%)
Query: 157 SIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQ--SL 214
+I + N + + + +L L + ++ L LS N LS + A L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 215 MQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQ 274
++L L+ + +D + + +L L L+ N ++ S++ L+ N
Sbjct: 61 -ELLNLSSNV---LYETLD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNN 110
Query: 275 LVGLIPKSLANMELDNLVLNNNLL 298
+ + N+ L NN +
Sbjct: 111 ISRVSCSRGQG--KKNIYLANNKI 132
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 5e-05
Identities = 8/52 (15%), Positives = 16/52 (30%), Gaps = 1/52 (1%)
Query: 379 HNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIK 430
N + P + + I L N + + ++L D+ N
Sbjct: 200 SNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH 250
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 28/190 (14%), Positives = 49/190 (25%), Gaps = 46/190 (24%)
Query: 254 SIPEDIGALSSLKDLNLNRNQLVGLIPKSLANME-LDNLVL-NNNLLMGPIPKFKA-GNV 310
+I E + K + + L + + + L L N L +
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 311 TY---DSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTS 367
SN + D+ L L L L+ +
Sbjct: 61 ELLNLSSNV-------LYETLDLESL----------STLR------------TLDLN--N 89
Query: 368 NSKVSIINLPR-------HNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLR 420
N ++ P +N +S S I L N I+ + ++
Sbjct: 90 NYVQELLVGPSIETLHAANNNISRVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQ 147
Query: 421 LLDVSDNNIK 430
LD+ N I
Sbjct: 148 YLDLKLNEID 157
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 13/74 (17%), Positives = 28/74 (37%), Gaps = 1/74 (1%)
Query: 369 SKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNN 428
++ I + +L L+ + ++ E+ L N +S + L LL++S N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 429 IKPPLPEFHDTVKL 442
+ + L
Sbjct: 70 LY-ETLDLESLSTL 82
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 55/256 (21%), Positives = 85/256 (33%), Gaps = 53/256 (20%)
Query: 52 DPCG-PPPWPHVFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-- 108
+PC P C +I P N TK NL L N L
Sbjct: 1 EPCVEVVPNITYQCMELNFYKI-----------PDNLPFSTK--NLDLSFNPL-RHLGSY 46
Query: 109 TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQL 168
+F EL+ L E TI + LS + L L NP ++ L++ L
Sbjct: 47 SFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI-QSLALGAFSGLSS---L 102
Query: 169 TNLSLINCNLVGPLPDFL-GTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGG 227
L + NL L +F G L +L L +++N +
Sbjct: 103 QKLVAVETNLAS-LENFPIGHLKTLKELNVAHNLIQSFKLP------------------- 142
Query: 228 MTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDI-GALSSLK----DLNLNRNQLVGLIPKS 282
+ + + +L L L N+ SI L + L+L+ N + + P +
Sbjct: 143 -----EYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGA 196
Query: 283 LANMELDNLVLNNNLL 298
+ L L L+ N L
Sbjct: 197 FKEIRLKELALDTNQL 212
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 28/121 (23%), Positives = 38/121 (31%), Gaps = 13/121 (10%)
Query: 87 FNQLTKLYNLGLQRNKFNGKLP---TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRV- 142
L L L + N FS L+ LE L N+ +I L + +
Sbjct: 120 IGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLL 178
Query: 143 ---LALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSY 199
L L NP N I ++L L+L L L SL + L
Sbjct: 179 NLSLDLSLNPMN-----FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHT 233
Query: 200 N 200
N
Sbjct: 234 N 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 9e-05
Identities = 22/99 (22%), Positives = 37/99 (37%), Gaps = 30/99 (30%)
Query: 82 PLPQNFNQLTKLYNLGLQRNKFNGKLP--TFSGLSELEFA-------------------- 119
LP+ F+ LT L +L L NK + L ++
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK 198
Query: 120 -------YLDFNEFDTIPSDFFDGLSSVRVLALDYNPFN 151
LD N+ ++P FD L+S++ + L NP++
Sbjct: 199 EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 237
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-23
Identities = 82/332 (24%), Positives = 135/332 (40%), Gaps = 36/332 (10%)
Query: 567 PSDPENMVKIAVSNDTARSLSSQTVASSGSTNSGATENSHVIESGTLVISVQVLRKVT-Q 625
+ E A L Q A + ++NS E + + +VT
Sbjct: 91 ETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPK--HRVTMN 148
Query: 626 NFAQENELGRGGFGTVYKGELEDGTKI-AVKRME-AGVTTTKALDEFQSEIAVLSKVRHR 683
F LG+G FG V + + + A+K ++ + + +E VL RH
Sbjct: 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 208
Query: 684 HLVSLLGYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGME 742
L +L YS + ++RL V EY G L HL R R A ++ ++
Sbjct: 209 FLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED----RARFYGA-EIVSALD 262
Query: 743 YLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPE 802
YLH + + ++RDLK N++LD D K++DFGL K ++ T GT YLAPE
Sbjct: 263 YLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPE 319
Query: 803 YAVMGKITTKA-DVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861
+ +A D + GVV+ E++ G P ++ + F I + +F +
Sbjct: 320 -VLEDNDYGRAVDWWGLGVVMYEMMCGRL------PFYNQDHEKLFELILMEEIRFPRTL 372
Query: 862 DPALEVNEETFESISIVAELAGHCTAREPYHR 893
P E+ S+++ L ++P R
Sbjct: 373 GP---------EAKSLLSGL----LKKDPKQR 391
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 53/215 (24%), Positives = 85/215 (39%), Gaps = 37/215 (17%)
Query: 633 LGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQ--SEIAVLSKVRHRHLVSLL 689
LG G +G V + E + AVK ++ E EI +L ++RH++++ L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL- 71
Query: 690 GYSIEGNER----LLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVAR------ 739
+ NE +V EY G + + + K + A
Sbjct: 72 -VDVLYNEEKQKMYMVMEYCVCGMQE--ML--DSVPEKRFP--------VCQAHGYFCQL 118
Query: 740 --GMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLA-GTF 796
G+EYLH Q +H+D+K N+LL K+S G+ + R + G+
Sbjct: 119 IDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSP 175
Query: 797 GYLAPEYAVMGKIT---TKADVFSYGVVLMELLTG 828
+ PE G T K D++S GV L + TG
Sbjct: 176 AFQPPE-IANGLDTFSGFKVDIWSAGVTLYNITTG 209
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-23
Identities = 60/270 (22%), Positives = 103/270 (38%), Gaps = 52/270 (19%)
Query: 579 SNDTARSLSSQTVASSGSTNSGATENSHVIESGTLVISVQVLRKVTQNFAQENELGRGGF 638
S + + + S T S A + ++ + S + ++ F E+ELGRG
Sbjct: 9 SGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNR--DALSDFFEVESELGRGAT 66
Query: 639 GTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNE 697
VY+ + A+K ++ T ++EI VL ++ H +++ L E
Sbjct: 67 SIVYRCKQKGTQKPYALKVLK----KTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTE 122
Query: 698 RLLVYEYMPHGAL--------------SRHLFRWEKLQLKPLSWTRRLSIALDVARGMEY 743
LV E + G L + + + + Y
Sbjct: 123 ISLVLELVTGGELFDRIVEKGYYSERDAADAVK-------------------QILEAVAY 163
Query: 744 LHCLARQTFIHRDLKSSNILL---DDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLA 800
LH +HRDLK N+L D K++DFGL K+ ++ + GT GY A
Sbjct: 164 LH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--LMKTVCGTPGYCA 218
Query: 801 PEYAVMGKI--TTKADVFSYGVVLMELLTG 828
PE ++ + D++S G++ LL G
Sbjct: 219 PE--ILRGCAYGPEVDMWSVGIITYILLCG 246
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 56/260 (21%), Positives = 98/260 (37%), Gaps = 36/260 (13%)
Query: 61 HVFCSGNRVTQI------QVQNLGLKG----PLPQN-FNQLTKLYNLGLQRNKFNGK--- 106
+ C+ +T + L L+ LP F++LT+L L L N + K
Sbjct: 11 EIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCC 70
Query: 107 LPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSV 166
+ G + L++ L FN T+ S+ F GL + L ++ + +S+ SL N
Sbjct: 71 SQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN-- 127
Query: 167 QLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSL--MQILWLNDQD 224
L L + + + L SL LK++ N L + L L+
Sbjct: 128 -LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC- 185
Query: 225 AGGMTGPIDVV-----AKMVSLTQLWLHGNQFTGSIPEDI-GALSSLKDLNLNRNQLVGL 278
++ + + SL L + N F S+ L+SL+ L+ + N ++
Sbjct: 186 ------QLEQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIMTS 238
Query: 279 IPKSLANME--LDNLVLNNN 296
+ L + L L L N
Sbjct: 239 KKQELQHFPSSLAFLNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 4e-22
Identities = 46/197 (23%), Positives = 66/197 (33%), Gaps = 33/197 (16%)
Query: 83 LPQNFNQLTKLYNLGLQRNKFNGKLP--TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSV 140
+ NF L +L +L Q + F L L + + + F+GLSS+
Sbjct: 93 MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL 152
Query: 141 RVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYN 200
VL + N F + F I L N LT L L C L P +L SL L +S+N
Sbjct: 153 EVLKMAGNSFQENFLPDIFTELRN---LTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHN 209
Query: 201 RLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDI- 259
+ + + SL L N + +
Sbjct: 210 NFFSLDTFPY-------------------------KCLNSLQVLDYSLNHIM-TSKKQEL 243
Query: 260 -GALSSLKDLNLNRNQL 275
SSL LNL +N
Sbjct: 244 QHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 44/183 (24%), Positives = 76/183 (41%), Gaps = 9/183 (4%)
Query: 120 YLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLV 179
L+ N+ ++P FD L+ + L+L N +F S + L L L ++
Sbjct: 34 ELESNKLQSLPHGVFDKLTQLTKLSLSSNGL--SFKGCCSQSDFGTTSLKYLDLSFNGVI 91
Query: 180 GPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSL--MQILWLNDQDAGGMTGPIDVVAK 237
+FLG L L L ++ L + S SL + L ++ +
Sbjct: 92 TMSSNFLG-LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVA--FNGIFNG 148
Query: 238 MVSLTQLWLHGNQFTGSIPEDI-GALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNN 295
+ SL L + GN F + DI L +L L+L++ QL L P + ++ L L +++
Sbjct: 149 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSH 208
Query: 296 NLL 298
N
Sbjct: 209 NNF 211
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 30/143 (20%), Positives = 48/143 (33%), Gaps = 19/143 (13%)
Query: 65 SGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP--TFSGLSELEFAYLD 122
S FN L+ L L + N F F+ L L F L
Sbjct: 134 SHTHTRVAF----------NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 183
Query: 123 FNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDS-LANSVQLTNLSLINCNLVG- 180
+ + + F+ LSS++VL + +N F S+ L L +++
Sbjct: 184 QCQLEQLSPTAFNSLSSLQVLNMSHNNFF-----SLDTFPYKCLNSLQVLDYSLNHIMTS 238
Query: 181 PLPDFLGTLPSLAALKLSYNRLS 203
+ SLA L L+ N +
Sbjct: 239 KKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 28/154 (18%), Positives = 46/154 (29%), Gaps = 14/154 (9%)
Query: 157 SIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASF---GQS 213
S+P + T L L + L L L L LS N LS S G +
Sbjct: 21 SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78
Query: 214 LMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGA---LSSLKDLNL 270
++ L L+ M+ + L L + + E L +L L++
Sbjct: 79 SLKYLDLSFNGVITMSSNFL---GLEQLEHLDFQHSNLK-QMSEF-SVFLSLRNLIYLDI 133
Query: 271 NRNQLVGLIPKSLANME-LDNLVLNNNLLMGPIP 303
+ + L+ L + N
Sbjct: 134 SHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 167
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 8e-06
Identities = 40/223 (17%), Positives = 73/223 (32%), Gaps = 53/223 (23%)
Query: 240 SLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLV---LNNN 296
S T+L L N+ L+ L L+L+ N L S ++ +L L+ N
Sbjct: 29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFN 88
Query: 297 LLMGPIPKFKA-GNVTY---DSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPG 352
++ F + + ++ ++ + +V L NL+
Sbjct: 89 GVITMSSNFLGLEQLEHLDFQHSN-------LKQMSEFSVFLSL-------RNLI----- 129
Query: 353 NDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNN 412
+L +S G L SL +++ NS +
Sbjct: 130 -------YLDIS--HT---HTRVAFNGIFNG--------LSSLEVLKMAGNSFQENFLPD 169
Query: 413 -FTELKSLRLLDVSDNNIKPPLPE--FHDTVKLV---IDGNPL 449
FTEL++L LD+S ++ L F+ L + N
Sbjct: 170 IFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNF 211
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 8e-04
Identities = 38/218 (17%), Positives = 60/218 (27%), Gaps = 40/218 (18%)
Query: 240 SLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVL-NNNL 297
S T++ + T S+P I SS L L N+L L + +L L L +N L
Sbjct: 8 SGTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64
Query: 298 LMGPIPKFKAGNVTY------DSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWP 351
T N + L + + Q
Sbjct: 65 SFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHL--DFQH-----SNLKQMS 117
Query: 352 GNDPCQG----PWLGLSCTSNSKVSI-----INLPR-------HN--LTGTLSPSIANLD 393
+L +S L N L L
Sbjct: 118 EFSVFLSLRNLIYLDIS--HTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELR 175
Query: 394 SLIEIRLGKNSISGTVPNN-FTELKSLRLLDVSDNNIK 430
+L + L + + + F L SL++L++S NN
Sbjct: 176 NLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFF 212
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-23
Identities = 54/210 (25%), Positives = 90/210 (42%), Gaps = 24/210 (11%)
Query: 632 ELGRGGFGTVYKG-ELEDGTKIAVKRME-AGVTTTKALDE--FQSEIAVLSKVRHRHLVS 687
+G+G F V + E G + AVK ++ A T++ L + E ++ ++H H+V
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 688 LLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIAL--DVARGMEYLH 745
LL +V+E+M L F K ++ ++ + + Y H
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQILEALRYCH 147
Query: 746 CLARQTFIHRDLKSSNILL---DDDYRAKVSDFGL-VKLAPDGEKSVVTRLAGTFGYLAP 801
IHRD+K +LL ++ K+ FG+ ++L G V GT ++AP
Sbjct: 148 ---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--VAGGRVGTPHFMAP 202
Query: 802 E---YAVMGKITTKADVFSYGVVLMELLTG 828
E GK DV+ GV+L LL+G
Sbjct: 203 EVVKREPYGK---PVDVWGCGVILFILLSG 229
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 59/225 (26%), Positives = 88/225 (39%), Gaps = 55/225 (24%)
Query: 632 ELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQS----EIAVLSKVR----H 682
LG+GGFGTV+ G L D ++A+K + + E+A+L KV H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 683 RHLVSLLGYSIEGNERL-LVYEY-----------MPHGALS----RHLFRWEKLQLKPLS 726
++ LL + E E LV E G L R F Q+
Sbjct: 98 PGVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFG----QV---- 148
Query: 727 WTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDY-RAKVSDFGLVKLAPDGE 785
+++ H + +HRD+K NIL+D AK+ DFG L D
Sbjct: 149 -----------VAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE- 193
Query: 786 KSVVTRLAGTFGYLAPEYAVMGK--ITTKADVFSYGVVLMELLTG 828
T GT Y PE+ + A V+S G++L +++ G
Sbjct: 194 --PYTDFDGTRVYSPPEW-ISRHQYHALPATVWSLGILLYDMVCG 235
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-22
Identities = 63/264 (23%), Positives = 113/264 (42%), Gaps = 47/264 (17%)
Query: 585 SLSSQTVASSGSTNSGATENSHVIESGTLVISVQVLRKVTQNFAQENELGRGGFGTVYKG 644
S + +G + + + VI+ L + + + +G G FG V++
Sbjct: 2 SFTMSNAPLNGVKLNPLDDPNKVIKV--LASDGKTGEQREIAYTNCKVIGNGSFGVVFQA 59
Query: 645 ELEDGTKIAVKRMEAGVTTTKALD-EFQS-EIAVLSKVRHRHLVSLLGYSIEGNERL--- 699
+L + ++A+K++ D F++ E+ ++ V+H ++V L + ++
Sbjct: 60 KLVESDEVAIKKVL--------QDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111
Query: 700 ---LVYEYMPHGALSRHLFRWEKL-QLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHR 755
LV EY+P + R + KL Q P+ + + R + Y+H + HR
Sbjct: 112 FLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIK--LYMYQLLRSLAYIHSIG---ICHR 165
Query: 756 DLKSSNILLD-DDYRAKVSDFGLVKLAPDGEKS---VVTRLAGTFGYLAPE-------YA 804
D+K N+LLD K+ DFG K+ GE + + +R Y APE Y
Sbjct: 166 DIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY-----YRAPELIFGATNY- 219
Query: 805 VMGKITTKADVFSYGVVLMELLTG 828
TT D++S G V+ EL+ G
Sbjct: 220 -----TTNIDIWSTGCVMAELMQG 238
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-22
Identities = 60/242 (24%), Positives = 107/242 (44%), Gaps = 38/242 (15%)
Query: 633 LGRGGFGTVYKGELEDGTKI-AVKRME-AGVTTTKALDEFQSEIAVLSKVRHRHLVSLLG 690
+GRG FG V +L++ K+ A+K + + F+ E VL + + +L
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH- 140
Query: 691 YSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVAR--------GM 741
Y+ + + L LV +Y G L L ++E RL ++AR +
Sbjct: 141 YAFQDDNNLYLVMDYYVGGDLLTLLSKFE----------DRLP--EEMARFYLAEMVIAI 188
Query: 742 EYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAP 801
+ +H + ++HRD+K NIL+D + +++DFG + + GT Y++P
Sbjct: 189 DSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISP 245
Query: 802 E-----YAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEK 856
E G+ + D +S GV + E+L G P + L E + +I + KE+
Sbjct: 246 EILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET------PFYAESLVETYGKIMNHKER 299
Query: 857 FK 858
F+
Sbjct: 300 FQ 301
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-22
Identities = 60/227 (26%), Positives = 89/227 (39%), Gaps = 36/227 (15%)
Query: 621 RKVTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSK 679
RK F E G+G FGTV G E G +A+K++ E Q + L+
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF--RNRELQ-IMQDLAV 75
Query: 680 VRHRHLVSLLGYSIEGNER-------LLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLS 732
+ H ++V L Y ER +V EY+P L R R +
Sbjct: 76 LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCC-RNYYRRQVAPPPILIKV 133
Query: 733 IALDVARGMEYLHCLARQTFIHRDLKSSNILLD-DDYRAKVSDFGLVKLAPDGEKS---V 788
+ R + LH + HRD+K N+L++ D K+ DFG K E + +
Sbjct: 134 FLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYI 192
Query: 789 VTRLAGTFGYLAPE-------YAVMGKITTKADVFSYGVVLMELLTG 828
+R Y APE Y TT D++S G + E++ G
Sbjct: 193 CSRY-----YRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLG 228
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-22
Identities = 55/230 (23%), Positives = 97/230 (42%), Gaps = 41/230 (17%)
Query: 617 VQVLRKVTQNFAQE----NELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQ 671
VQ L + + F ++G G + + + AVK ++ K+ +
Sbjct: 10 VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID------KSKRDPT 63
Query: 672 SEIAVLSK-VRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRR 730
EI +L + +H ++++L +G +V E M G L +K+ + +
Sbjct: 64 EEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGG----ELL--DKILRQ-----KF 112
Query: 731 LS------IALDVARGMEYLHCLARQTFIHRDLKSSNILL----DDDYRAKVSDFGLVKL 780
S + + + +EYLH Q +HRDLK SNIL + ++ DFG K
Sbjct: 113 FSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169
Query: 781 APDGEKSVVTRLAGTFGYLAPEYAVMGKI--TTKADVFSYGVVLMELLTG 828
++T T ++APE V+ + D++S GV+L +LTG
Sbjct: 170 LRAENGLLMT-PCYTANFVAPE--VLERQGYDAACDIWSLGVLLYTMLTG 216
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 2e-22
Identities = 60/250 (24%), Positives = 98/250 (39%), Gaps = 42/250 (16%)
Query: 633 LGRGGFGTVYKGELEDGTKI-AVKRME-AGVTTTKALDEFQSEIAVLSKVRHRHLVSLLG 690
+GRG F V +++ ++ A+K M + + F+ E VL R + L
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH- 127
Query: 691 YSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVAR--------GM 741
++ + L LV EY G L L ++ R+ ++AR +
Sbjct: 128 FAFQDENYLYLVMEYYVGGDLLTLLSKFG----------ERIP--AEMARFYLAEIVMAI 175
Query: 742 EYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK-LAPDGEKSVVTRLAGTFGYLA 800
+ +H R ++HRD+K NILLD +++DFG L DG + GT YL+
Sbjct: 176 DSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV-AVGTPDYLS 231
Query: 801 PE-------YAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSS 853
PE G + D ++ GV E+ G P + AE + +I
Sbjct: 232 PEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT------PFYADSTAETYGKIVHY 285
Query: 854 KEKFKAAIDP 863
KE +
Sbjct: 286 KEHLSLPLVD 295
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-22
Identities = 65/213 (30%), Positives = 97/213 (45%), Gaps = 41/213 (19%)
Query: 633 LGRGGFGTVYKGE-LEDGTKIAVKRME-AGVTTTKALDEFQSEIAVLSKVRHRHLVSLLG 690
LG G FG V G+ G K+AVK + + + + + + EI L RH H++ L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL-- 81
Query: 691 YS-IEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVAR--------G 740
Y I + +V EY+ G L ++ + +L +R G
Sbjct: 82 YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDE-------------KESRRLFQQILSG 128
Query: 741 MEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLA---GTFG 797
++Y H R +HRDLK N+LLD AK++DFGL + DGE L G+
Sbjct: 129 VDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-----LRTSCGSPN 180
Query: 798 YLAPEYAVMGK--ITTKADVFSYGVVLMELLTG 828
Y APE + G+ + D++S GV+L LL G
Sbjct: 181 YAAPE-VISGRLYAGPEVDIWSSGVILYALLCG 212
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 3e-22
Identities = 62/228 (27%), Positives = 97/228 (42%), Gaps = 44/228 (19%)
Query: 621 RKVTQNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALD-EFQS-EIAVL 677
R ++ +G G FG VY+ +L + G +A+K++ D F++ E+ ++
Sbjct: 50 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL--------QDKRFKNRELQIM 101
Query: 678 SKVRHRHLVSLLGYSIEGNERL------LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRL 731
K+ H ++V L + E+ LV +Y+P + R R + L
Sbjct: 102 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVA-RHYSRAKQTLPVIYVK 159
Query: 732 SIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDD-YRAKVSDFGLVKLAPDGEKS--- 787
+ R + Y+H HRD+K N+LLD D K+ DFG K GE +
Sbjct: 160 LYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 216
Query: 788 VVTRLAGTFGYLAPE-------YAVMGKITTKADVFSYGVVLMELLTG 828
+ +R Y APE Y T+ DV+S G VL ELL G
Sbjct: 217 ICSRY-----YRAPELIFGATDY------TSSIDVWSAGCVLAELLLG 253
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 3e-22
Identities = 59/381 (15%), Positives = 104/381 (27%), Gaps = 100/381 (26%)
Query: 53 PCGPPPWPHVFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP--TF 110
S + I P + K +L L N+ +
Sbjct: 27 SLSCDRNGICKGSSGSLNSI-----------PSGLTEAVK--SLDLSNNRIT-YISNSDL 72
Query: 111 SGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTN 170
L+ L N +TI D F L S+ L L YN L+N
Sbjct: 73 QRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYN------------------YLSN 114
Query: 171 LSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTG 230
LS + L SL L L N + S L ++ L + T
Sbjct: 115 LS----------SSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTK 164
Query: 231 -PIDVVAKMVSLTQLWLHGNQFTGSIPEDI-GALSSLKDLNLNRNQLVGLIPKSLANM-E 287
A + L +L + + S ++ ++ L L+ Q + L+ +
Sbjct: 165 IQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSS 223
Query: 288 LDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLV 347
++ L L + L D+ F + G + +
Sbjct: 224 VECLELRDTDL--------------DTFHFSELSTG-----------ETNSLIKKFTFRN 258
Query: 348 SQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISG 407
+ T S ++ L + + L+E+ +N +
Sbjct: 259 ---------------VKITDESLFQVMKL------------LNQISGLLELEFSRNQLKS 291
Query: 408 TVPNNFTELKSLRLLDVSDNN 428
F L SL+ + + N
Sbjct: 292 VPDGIFDRLTSLQKIWLHTNP 312
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 9e-10
Identities = 56/344 (16%), Positives = 98/344 (28%), Gaps = 102/344 (29%)
Query: 120 YLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLV 179
L N I + +++ L L N + +
Sbjct: 58 DLSNNRITYISNSDLQRCVNLQALVLTSN------------------GINTIE------- 92
Query: 180 GPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMV 239
D +L SL L LSYN LS + + F +
Sbjct: 93 ---EDSFSSLGSLEHLDLSYNYLSNLSSSWF-------------------------KPLS 124
Query: 240 SLTQLWLHGNQFTGSIPEDI--GALSSLKDLNLNRN-QLVGLIPKSLANM-ELDNLVL-N 294
SLT L L GN + ++ E L+ L+ L + + K A + L+ L +
Sbjct: 125 SLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDA 183
Query: 295 NNLLMGPIPKFKA-GNVTY---DSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQW 350
++L K+ NV++ +D V
Sbjct: 184 SDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIF---------VDVTSSVE--------- 225
Query: 351 PGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVP 410
L L T + L+ + S+ + +++ S+ V
Sbjct: 226 ---------CLELRDTD-----LDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVM 270
Query: 411 NNFTELKSLRLLDVSDNNIKPPLPE--FHDTVKLV---IDGNPL 449
++ L L+ S N +K +P+ F L + NP
Sbjct: 271 KLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 13/87 (14%), Positives = 30/87 (34%), Gaps = 2/87 (2%)
Query: 65 SGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFN 124
+ L + + N+ + + + +S L N
Sbjct: 230 RDTDLDTFHFSEL--STGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRN 287
Query: 125 EFDTIPSDFFDGLSSVRVLALDYNPFN 151
+ ++P FD L+S++ + L NP++
Sbjct: 288 QLKSVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-22
Identities = 62/218 (28%), Positives = 93/218 (42%), Gaps = 52/218 (23%)
Query: 633 LGRGGFGTVYKGE-LEDGTKIAVKRME-AGVTTTKALDEFQSEIAVLSKVRHRHLVSLLG 690
LG G FG V + K+A+K + + + + EI+ L +RH H++ L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-- 74
Query: 691 YS-IEGNERL-LVYEY---------MPHGALS----RHLFRWEKLQLKPLSWTRRLSIAL 735
Y I + +V EY + ++ R F+ Q+ I
Sbjct: 75 YDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQ----QI----------IC- 119
Query: 736 DVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLA-- 793
+EY H R +HRDLK N+LLDD+ K++DFGL + DG L
Sbjct: 120 ----AIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF-----LKTS 167
Query: 794 -GTFGYLAPEYAVMGK--ITTKADVFSYGVVLMELLTG 828
G+ Y APE + GK + DV+S G+VL +L G
Sbjct: 168 CGSPNYAAPE-VINGKLYAGPEVDVWSCGIVLYVMLVG 204
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 3e-22
Identities = 78/244 (31%), Positives = 95/244 (38%), Gaps = 55/244 (22%)
Query: 633 LGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDE-FQSEIAVLSKVRHRHLVSLLG 690
+G G FG +AVK +E G A+DE Q EI +RH ++V
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERG----AAIDENVQREIINHRSLRHPNIVRF-- 81
Query: 691 YS-IEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVAR--------G 740
I L ++ EY G L + R S D AR G
Sbjct: 82 KEVILTPTHLAIIMEYASGGELYERICN-----------AGRFSE--DEARFFFQQLLSG 128
Query: 741 MEYLHCLARQTFIHRDLKSSNILLDDDY--RAKVSDFGLVKLAPDGE--KSVVTRLAGTF 796
+ Y H HRDLK N LLD R K+ DFG K + KS V GT
Sbjct: 129 VSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV----GTP 181
Query: 797 GYLAPE------YAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRI 850
Y+APE Y GK ADV+S GV L +L G A E PEE R + RI
Sbjct: 182 AYIAPEVLLRQEYD--GK---IADVWSCGVTLYVMLVG--AYPFEDPEEPRDYRKTIQRI 234
Query: 851 KSSK 854
S K
Sbjct: 235 LSVK 238
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 96.8 bits (242), Expect = 8e-22
Identities = 73/271 (26%), Positives = 122/271 (45%), Gaps = 44/271 (16%)
Query: 633 LGRGGFGTVY---KGELEDGTKI-AVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSL 688
LG+G FG V+ K D ++ A+K ++ + + E +L +V H +V L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 689 LGYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTR----RLSIALDVARGMEY 743
Y+ + +L L+ +++ G L L + + L++AL ++
Sbjct: 92 H-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMF---TEEDVKFYLAELALAL------DH 141
Query: 744 LHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEY 803
LH I+RDLK NILLD++ K++DFGL K + D EK + GT Y+APE
Sbjct: 142 LH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAPE- 196
Query: 804 AVMGKITTKA-DVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862
V + T++ D +S+GV++ E+LTG P + + E I +K +
Sbjct: 197 VVNRRGHTQSADWWSFGVLMFEMLTGTL------PFQGKDRKETMTMILKAKLGMPQFLS 250
Query: 863 PALEVNEETFESISIVAELAGHCTAREPYHR 893
P E+ S++ L R P +R
Sbjct: 251 P---------EAQSLLRML----FKRNPANR 268
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 9e-22
Identities = 69/253 (27%), Positives = 105/253 (41%), Gaps = 40/253 (15%)
Query: 625 QNFAQENELGRGGFGTVYKGELEDGTKI-AVKRME-AGVTTTKALDEFQSEIAVLSKVRH 682
F + LG G FG V + ++ A+K ++ V K ++ +E +L V
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 683 RHLVSLLGYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVAR-- 739
LV L +S + N L +V EY+ G + HL R R S AR
Sbjct: 101 PFLVKLE-FSFKDNSNLYMVMEYVAGGEMFSHLRR-----------IGRFSE--PHARFY 146
Query: 740 ------GMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLA 793
EYLH I+RDLK N+L+D +V+DFG K + L
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT----LC 199
Query: 794 GTFGYLAPEYAVMGKITTKA-DVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKS 852
GT LAPE ++ K KA D ++ GV++ E+ G ++P + + +I S
Sbjct: 200 GTPEALAPE-IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI------YEKIVS 252
Query: 853 SKEKFKAAIDPAL 865
K +F + L
Sbjct: 253 GKVRFPSHFSSDL 265
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 9e-22
Identities = 52/208 (25%), Positives = 84/208 (40%), Gaps = 23/208 (11%)
Query: 628 AQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR-HRHL 685
++ LG G F K + AVK + + + Q EI L H ++
Sbjct: 14 LKDKPLGEGSFSICRKCVHKKSNQAFAVK-----IISKRMEANTQKEITALKLCEGHPNI 68
Query: 686 VSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLH 745
V L + LV E + G L + + K S T I + + ++H
Sbjct: 69 VKLHEVFHDQLHTFLVMELLNGGELFERI-----KKKKHFSETEASYIMRKLVSAVSHMH 123
Query: 746 CLARQTFIHRDLKSSNILL---DDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPE 802
+HRDLK N+L +D+ K+ DFG +L P + + T T Y APE
Sbjct: 124 ---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP-CFTLHYAAPE 179
Query: 803 YAVMGKIT--TKADVFSYGVVLMELLTG 828
++ + D++S GV+L +L+G
Sbjct: 180 --LLNQNGYDESCDLWSLGVILYTMLSG 205
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-21
Identities = 45/249 (18%), Positives = 92/249 (36%), Gaps = 43/249 (17%)
Query: 65 SGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP--TFSGLSELEFAYLD 122
N++++I + F+ L KL L + +N ++P S L EL +
Sbjct: 86 VNNKISKIH----------EKAFSPLRKLQKLYISKNHLV-EIPPNLPSSLVEL---RIH 131
Query: 123 FNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPL 182
N +P F GL ++ + + NP + + ++L L + L G +
Sbjct: 132 DNRIRKVPKGVFSGLRNMNCIEMGGNPLENS---GFEPGAFDGLKLNYLRISEAKLTG-I 187
Query: 183 PDFLGTLPSLAALKLSYNRLSGVIPASF-GQSLMQILWLNDQDAGGMTGPIDVV-----A 236
P +L L L +N++ + S + L L I ++ +
Sbjct: 188 PK--DLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHN-------QIRMIENGSLS 238
Query: 237 KMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANME-------LD 289
+ +L +L L N+ + +P + L L+ + L+ N + + + +
Sbjct: 239 FLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYN 297
Query: 290 NLVLNNNLL 298
+ L NN +
Sbjct: 298 GISLFNNPV 306
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 56/246 (22%), Positives = 94/246 (38%), Gaps = 37/246 (15%)
Query: 61 HVFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP--TFSGLSELEF 118
V CS + + P+ + T L L LQ N + +L F GL L
Sbjct: 37 VVQCSDLGLKAV-----------PKEISPDTTL--LDLQNNDIS-ELRKDDFKGLQHLYA 82
Query: 119 AYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNL 178
L N+ I F L ++ L + N IP +L +S L L + + +
Sbjct: 83 LVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-----EIPPNLPSS--LVELRIHDNRI 135
Query: 179 VGPLPDFLGTLPSLAALKLSYNRL--SGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVA 236
L ++ +++ N L SG P +F + L +++ + +
Sbjct: 136 RKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISE-------AKLTGIP 188
Query: 237 KMV--SLTQLWLHGNQFTGSIPEDI-GALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLV 292
K + +L +L L N+ +I + S L L L NQ+ + SL+ + L L
Sbjct: 189 KDLPETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELH 247
Query: 293 LNNNLL 298
L+NN L
Sbjct: 248 LDNNKL 253
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 7e-13
Identities = 56/326 (17%), Positives = 104/326 (31%), Gaps = 89/326 (27%)
Query: 157 SIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQ 216
++P + S T L L N ++ D L L AL L N++S + +F
Sbjct: 47 AVPKEI--SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAF------ 98
Query: 217 ILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLV 276
+ + L +L++ N IP SSL +L ++ N++
Sbjct: 99 -------------------SPLRKLQKLYISKNHLV-EIPP--NLPSSLVELRIHDNRIR 136
Query: 277 GLIPKSLANME-LDNLVL-NNNLLMGPIPK--FKAGNVTYDSNSFCQSEPGIECAPDVNV 332
+ + + ++ + + N L F + Y S + + P
Sbjct: 137 KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAK----LTGIPK--- 189
Query: 333 LLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSII------NLPR-------H 379
+ P L L L ++K+ I + H
Sbjct: 190 --------DLPETLN------------ELHLD---HNKIQAIELEDLLRYSKLYRLGLGH 226
Query: 380 NLTGTLSPSI-ANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIK-------P 431
N + + L +L E+ L N +S VP +LK L+++ + NNI
Sbjct: 227 NQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFC 285
Query: 432 PLPEFHDTVKL---VIDGNPLLVGGI 454
P+ + NP+ +
Sbjct: 286 PVGFGVKRAYYNGISLFNNPVPYWEV 311
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 32/214 (14%), Positives = 55/214 (25%), Gaps = 66/214 (30%)
Query: 65 SGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP--TFSGLSELEFAYLD 122
S ++T I L +L+ L NK + S+L L
Sbjct: 180 SEAKLTGIP----------KDLPETLNELH---LDHNKIQ-AIELEDLLRYSKLYRLGLG 225
Query: 123 FNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPL 182
N+ I + L ++R L LD N +L+ +
Sbjct: 226 HNQIRMIENGSLSFLPTLRELHLDNN------------------KLSR-----------V 256
Query: 183 PDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLT 242
P L L L + L N ++ V F P+ K
Sbjct: 257 PAGLPDLKLLQVVYLHTNNITKVGVNDF-------------------CPVGFGVKRAYYN 297
Query: 243 QLWLHGNQFT-GSIPEDI-GALSSLKDLNLNRNQ 274
+ L N + ++ + +
Sbjct: 298 GISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-21
Identities = 50/244 (20%), Positives = 93/244 (38%), Gaps = 32/244 (13%)
Query: 65 SGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP--TFSGLSELEFAYLD 122
N++++I P F L KL L L +N+ +LP L EL +
Sbjct: 84 INNKISKIS----------PGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQEL---RVH 129
Query: 123 FNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPL 182
NE + F+GL+ + V+ L NP + +L+ + + + N+ +
Sbjct: 130 ENEITKVRKSVFNGLNQMIVVELGTNPL--KSSGIENGAFQGMKKLSYIRIADTNITT-I 186
Query: 183 PDFLGTLPSLAALKLSYNRLSGVIPASF-GQSLMQILWLNDQDAGGMTGPIDVVAKMVSL 241
P G PSL L L N+++ V AS G + + L L+ + +A L
Sbjct: 187 PQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAV--DNGSLANTPHL 242
Query: 242 TQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-------ELDNLVLN 294
+L L+ N+ +P + ++ + L+ N + + + L
Sbjct: 243 RELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLF 301
Query: 295 NNLL 298
+N +
Sbjct: 302 SNPV 305
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-20
Identities = 59/247 (23%), Positives = 93/247 (37%), Gaps = 38/247 (15%)
Query: 61 HVFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP--TFSGLSELEF 118
V CS + ++ P++ T L L LQ NK ++ F L L
Sbjct: 35 VVQCSDLGLEKV-----------PKDLPPDTAL--LDLQNNKIT-EIKDGDFKNLKNLHT 80
Query: 119 AYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNL 178
L N+ I F L + L L N +P+ + + L L + +
Sbjct: 81 LILINNKISKISPGAFAPLVKLERLYLSKNQLK-----ELPEKMPKT--LQELRVHENEI 133
Query: 179 VGPLPDFLGTLPSLAALKLSYNRL--SGVIPASF-GQSLMQILWLNDQDAGGMTGPIDVV 235
L + ++L N L SG+ +F G + + + D I +
Sbjct: 134 TKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADT-------NITTI 186
Query: 236 AKMV--SLTQLWLHGNQFTGSIPEDI-GALSSLKDLNLNRNQLVGLIPKSLANME-LDNL 291
+ + SLT+L L GN+ T + L++L L L+ N + + SLAN L L
Sbjct: 187 PQGLPPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLREL 245
Query: 292 VLNNNLL 298
LNNN L
Sbjct: 246 HLNNNKL 252
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 33/213 (15%), Positives = 54/213 (25%), Gaps = 66/213 (30%)
Query: 65 SGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP--TFSGLSELEFAYLD 122
+ +T I LT+L+ L NK K+ + GL+ L L
Sbjct: 179 ADTNITTIP----------QGLPPSLTELH---LDGNKIT-KVDAASLKGLNNLAKLGLS 224
Query: 123 FNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPL 182
FN + + +R L L+ N +L +
Sbjct: 225 FNSISAVDNGSLANTPHLRELHLNNN------------------KLVK-----------V 255
Query: 183 PDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLT 242
P L + + L N +S + F P K S +
Sbjct: 256 PGGLADHKYIQVVYLHNNNISAIGSNDF-------------------CPPGYNTKKASYS 296
Query: 243 QLWLHGNQFT-GSIPEDI-GALSSLKDLNLNRN 273
+ L N I + + L
Sbjct: 297 GVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 6e-10
Identities = 24/146 (16%), Positives = 50/146 (34%), Gaps = 24/146 (16%)
Query: 65 SGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP--TFSGLSELEFAYLD 122
GN++T++ + L L LGL N + + + + L +L+
Sbjct: 200 DGNKITKVD----------AASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLN 248
Query: 123 FNEFDTIPSDFFDGLSSVRVLALDYNPF----NKTFGWSIPDSLANSVQLTNLSLINCNL 178
N+ +P ++V+ L N + F P + +SL + +
Sbjct: 249 NNKLVKVPGGLA-DHKYIQVVYLHNNNISAIGSNDF--CPPGYNTKKASYSGVSLFSNPV 305
Query: 179 -VGPLPD--FLGTLPSLAALKLSYNR 201
+ F + AA++L +
Sbjct: 306 QYWEIQPSTFRC-VYVRAAVQLGNYK 330
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 96.9 bits (241), Expect = 1e-21
Identities = 56/270 (20%), Positives = 92/270 (34%), Gaps = 78/270 (28%)
Query: 630 ENELGRGGFGTVYKGEL------EDGTKIAVKRMEAGVTTTKALDEFQSEIA-------- 675
LGRG FG V + + +AVK ++ G T SE+
Sbjct: 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHH 85
Query: 676 -------------------VLSKVRHRHLVSLL-------------------GYSIEGNE 697
++ + +L + L G G
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAI 145
Query: 698 RLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRR-----------------LSIALDVARG 740
+ + + S+ ++ K LS + + VA+G
Sbjct: 146 PVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKG 205
Query: 741 MEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGE---KSVVTRLAGTFG 797
ME+L A + IHRDL + NILL + K+ DFGL + + RL
Sbjct: 206 MEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP--LK 260
Query: 798 YLAPEYAVMGKITTKADVFSYGVVLMELLT 827
++APE T ++DV+S+GV+L E+ +
Sbjct: 261 WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 1e-21
Identities = 71/265 (26%), Positives = 114/265 (43%), Gaps = 34/265 (12%)
Query: 633 LGRGGFGTVYKGELEDGTKI-AVKRME-AGVTTTKALDEFQSEIAVLSKVRHRHLVSLLG 690
LG+G FG V + + A+K + + + +E VL RH L +L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK- 71
Query: 691 YSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLAR 749
Y+ + ++RL V EY G L HL R + R A ++ +EYLH
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE----RARFYGA-EIVSALEYLH---S 123
Query: 750 QTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKI 809
+ ++RD+K N++LD D K++DFGL K ++ T GT YLAPE +
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPE-VLEDND 181
Query: 810 TTKA-DVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVN 868
+A D + GVV+ E++ G P ++ F I + +F + P
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRL------PFYNQDHERLFELILMEEIRFPRTLSP----- 230
Query: 869 EETFESISIVAELAGHCTAREPYHR 893
E+ S++A L ++P R
Sbjct: 231 ----EAKSLLAGL----LKKDPKQR 247
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 2e-21
Identities = 58/248 (23%), Positives = 91/248 (36%), Gaps = 39/248 (15%)
Query: 633 LGRGGFGTVYKGELEDGTKI-AVKRME-AGVTTTKALDEFQSEIAVLSKVRHRHLVSLLG 690
+GRG FG V + K+ A+K + + F E +++ +V L
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF- 135
Query: 691 YSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVAR--------GM 741
Y+ + + L +V EYMP G L + + AR +
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDLVNLM--------------SNYDVPEKWARFYTAEVVLAL 181
Query: 742 EYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAP 801
+ +H FIHRD+K N+LLD K++DFG GT Y++P
Sbjct: 182 DAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISP 238
Query: 802 E----YAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKF 857
E G + D +S GV L E+L G P + L + +I + K
Sbjct: 239 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT------PFYADSLVGTYSKIMNHKNSL 292
Query: 858 KAAIDPAL 865
D +
Sbjct: 293 TFPDDNDI 300
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 4e-21
Identities = 61/244 (25%), Positives = 110/244 (45%), Gaps = 40/244 (16%)
Query: 633 LGRGGFGTVYKGELEDGTKI-AVKRME-AGVTTTKALDEFQSEIAVLSKVRHRHLVSLLG 690
LG G FG V+ + A+K ++ V K ++ E +LS V H ++ +
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW- 72
Query: 691 YSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVAR--------GM 741
+ + +++ ++ +Y+ G L L + ++R VA+ +
Sbjct: 73 GTFQDAQQIFMIMDYIEGGELFSLLRK-----------SQRFPN--PVAKFYAAEVCLAL 119
Query: 742 EYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAP 801
EYLH + I+RDLK NILLD + K++DFG K PD + L GT Y+AP
Sbjct: 120 EYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT----LCGTPDYIAP 172
Query: 802 EYAVMGKITTKA-DVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAA 860
E V K K+ D +S+G+++ E+L G + ++ + +I +++ +F
Sbjct: 173 E-VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT------YEKILNAELRFPPF 225
Query: 861 IDPA 864
+
Sbjct: 226 FNED 229
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 6e-21
Identities = 59/223 (26%), Positives = 104/223 (46%), Gaps = 46/223 (20%)
Query: 625 QNFAQENELGRGGFGTVYKGELEDGTKIAVK--RMEA---GVTTTKALDEFQSEIAVLSK 679
+ + + ++G G +G VYK + G +A+K R++A G+ +T A+ EI++L +
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPST-AI----REISLLKE 75
Query: 680 VRHRHLVSLLGYSIEGNERLLVYEYMPH---GALSRHLFRWEKLQLKPLSWTRRLSIALD 736
+ H ++VSL+ LV+E+M L + + Q+K
Sbjct: 76 LHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIK--------IYLYQ 127
Query: 737 VARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKS----VVTRL 792
+ RG+ + H + +HRDLK N+L++ D K++DFGL + +S VVT
Sbjct: 128 LLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLW 184
Query: 793 AGTFGYLAPE-------YAVMGKITTKADVFSYGVVLMELLTG 828
Y AP+ Y +T D++S G + E++TG
Sbjct: 185 -----YRAPDVLMGSKKY------STSVDIWSIGCIFAEMITG 216
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 7e-21
Identities = 41/267 (15%), Positives = 73/267 (27%), Gaps = 56/267 (20%)
Query: 632 ELGRGGFGTVYKGELED---GTKIAVKRMEA-GVTTTKALDEFQSEIAVLSKVRHRHLVS 687
G ++ D ++A+ ++ GV L E S LS++ +
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 688 LLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCL 747
+L L+V E++ G+L S + +A + H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADT-------SPSPVGAIRAMQSLAAAADAAH-- 146
Query: 748 ARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMG 807
R S + + D G V LA +
Sbjct: 147 -RAGVALSIDHPSRVRVSID--------GDVVLA-------------YPATMPDA----- 179
Query: 808 KITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEV 867
+ D+ G L LL L E AE ++ I+PA
Sbjct: 180 --NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE--------RDTAGQPIEPADID 229
Query: 868 NEETFESISIVAELAGHCTAREPYHRP 894
+ F+ ++ +A + R
Sbjct: 230 RDIPFQ----ISAVAARSVQGDGGIRS 252
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 8e-21
Identities = 40/234 (17%), Positives = 75/234 (32%), Gaps = 11/234 (4%)
Query: 67 NRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNE 125
++ +++Q + L L + + F + S + +
Sbjct: 252 FSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSG 311
Query: 126 FDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNL--VGPLP 183
+ +S L N T + L +L L L L + +
Sbjct: 312 TRMVHMLCPSKISPFLHLDFSNNLLTDTV-FENCGHL---TELETLILQMNQLKELSKIA 367
Query: 184 DFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQ 243
+ + SL L +S N +S +L LN + +
Sbjct: 368 EMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKV 425
Query: 244 LWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANME-LDNLVLNNN 296
L LH N+ SIP+ + L +L++LN+ NQL + + L + L+ N
Sbjct: 426 LDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 91.5 bits (227), Expect = 3e-19
Identities = 36/230 (15%), Positives = 72/230 (31%), Gaps = 19/230 (8%)
Query: 55 GPPPWPHVFCSGNRVTQIQVQNLG---LKGPLPQNFNQLTKLYNLGLQRNKFNG-KLPTF 110
G + SG + + + + P + + + + +
Sbjct: 261 GQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCP 320
Query: 111 SGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDS---LANSVQ 167
S +S N + L+ + L L N +
Sbjct: 321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-----ELSKIAEMTTQMKS 375
Query: 168 LTNLSLINCNLVGPLPD-FLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAG 226
L L + ++ SL +L +S N L+ I + ++L L+
Sbjct: 376 LQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRI-KVLDLHSNK-- 432
Query: 227 GMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDI-GALSSLKDLNLNRNQL 275
+ V K+ +L +L + NQ S+P+ I L+SL+ + L+ N
Sbjct: 433 -IKSIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 5e-17
Identities = 57/387 (14%), Positives = 101/387 (26%), Gaps = 48/387 (12%)
Query: 62 VFCSGNRVTQI------QVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSE 115
V S N + + + L + + N +++L+ LS+
Sbjct: 5 VDRSKNGLIHVPKDLSQKTTILNI------SQNYISELWT------------SDILSLSK 46
Query: 116 LEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIP-DSLANSVQLTNLSLI 174
L + N + F + L L +N I N L +L L
Sbjct: 47 LRILIISHNRIQYLDISVFKFNQELEYLDLSHNKL-----VKISCHPTVN---LKHLDLS 98
Query: 175 NCNL-VGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPID 233
P+ G + L L LS L + + L + G +
Sbjct: 99 FNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPE 158
Query: 234 VVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLVL 293
+ LH T I +S NL + + ++ + + L L
Sbjct: 159 ---GLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAK 215
Query: 294 NNNLLMGPIPKFKAGNVTYDSNSFC---QSEPGIECAPDVNVLLDFLGGVNYPV------ 344
T++S + NV L
Sbjct: 216 LQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSL 275
Query: 345 -NLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKN 403
L +D P + S ++I N + + + + N
Sbjct: 276 KALSIHQVVSDVFGFPQSYI-YEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNN 334
Query: 404 SISGTVPNNFTELKSLRLLDVSDNNIK 430
++ TV N L L L + N +K
Sbjct: 335 LLTDTVFENCGHLTELETLILQMNQLK 361
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 1e-12
Identities = 57/368 (15%), Positives = 118/368 (32%), Gaps = 44/368 (11%)
Query: 87 FNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSD-FFDGLSSVRVLAL 145
F +L L L NK K+ L+ L FN FD +P F +S ++ L L
Sbjct: 65 FKFNQELEYLDLSHNKLV-KIS-CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGL 122
Query: 146 DYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSG- 204
K S +A+ L ++ L L +
Sbjct: 123 STTHLEK----SSVLPIAHLNISKVLLVLGETYGEKED--PEGLQDFNTESLHIVFPTNK 176
Query: 205 ---VIPASFGQSLMQILWLN------DQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSI 255
I +++ + N D + + L+ L L+ + T +
Sbjct: 177 EFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNS 236
Query: 256 PEDIGAL---SSLKDLNLNRNQLVGLIPKSLANMELDNL-------VLNNNLLMGPIPKF 305
I L +++ +++ +L G + + +L V+++ +
Sbjct: 237 FIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIY 296
Query: 306 KA-GNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWL-GL 363
+ N+ + + + P L ++ NL++ + L L
Sbjct: 297 EIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHL---DFSNNLLTDTVFENCGHLTELETL 353
Query: 364 SCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVP-NNFTELKSLRLL 422
N + L + ++ + SL ++ + +NS+S + + KSL L
Sbjct: 354 ILQMNQ---LKELSK------IAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSL 404
Query: 423 DVSDNNIK 430
++S N +
Sbjct: 405 NMSSNILT 412
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 8e-12
Identities = 63/376 (16%), Positives = 122/376 (32%), Gaps = 63/376 (16%)
Query: 75 QNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPT------FSGLSELEFAYLDFNEFDT 128
LG ++ L L K ++ LE + + D
Sbjct: 145 LVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDN 204
Query: 129 IPSDFFDGLSSV------RVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPL 182
S F L+ + L L+ I + ++ + S+ N L G L
Sbjct: 205 KCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHT-TVWYFSISNVKLQGQL 263
Query: 183 ----PDFLGT-LPSLAALKLSYNRLSGVIPASFGQ-SLMQILWLNDQDAGGMTGPIDVVA 236
D+ GT L +L+ ++ + + S M I + +
Sbjct: 264 DFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTR--MVHMLCPS 321
Query: 237 KMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDN---LVL 293
K+ L N T ++ E+ G L+ L+ L L NQL L + ++ + L +
Sbjct: 322 KISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDI 381
Query: 294 NNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGN 353
+ N + E +C L L N+ S N
Sbjct: 382 SQNSVS-------------------YDEKKGDC--SWTKSLLSL-------NMSS----N 409
Query: 354 DPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNN- 412
+ L ++ +++L + + ++ + L++L E+ + N + +VP+
Sbjct: 410 ILTDTIFRCLP----PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGI 463
Query: 413 FTELKSLRLLDVSDNN 428
F L SL+ + + N
Sbjct: 464 FDRLTSLQKIWLHTNP 479
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 18/99 (18%), Positives = 33/99 (33%), Gaps = 22/99 (22%)
Query: 75 QNLGLKGPLPQNFNQLTKLYNLGLQRNKFN----GKLPT------------------FSG 112
QN + + L +L + N LP
Sbjct: 383 QNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIKSIPKQVVK 442
Query: 113 LSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFN 151
L L+ + N+ ++P FD L+S++ + L NP++
Sbjct: 443 LEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 481
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 9e-21
Identities = 50/226 (22%), Positives = 84/226 (37%), Gaps = 35/226 (15%)
Query: 623 VTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQS---------E 673
+ + + + G +G V G +G +A+KR+ V+ + ++ E
Sbjct: 20 MQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLRE 79
Query: 674 IAVLSKVRHRHLVSLLG----YSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWT 728
I +L+ H +++ L + +L LV E M L + Q +S
Sbjct: 80 IRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-----TDLAQVIHDQRIVISPQ 134
Query: 729 RRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKS- 787
+ G+ LH A +HRDL NILL D+ + DF L +
Sbjct: 135 HIQYFMYHILLGLHVLHE-AG--VVHRDLHPGNILLADNNDITICDFNLAREDTADANKT 191
Query: 788 --VVTRLAGTFGYLAPEYAVM---GKITTKADVFSYGVVLMELLTG 828
V R Y APE ++ T D++S G V+ E+
Sbjct: 192 HYVTHRW-----YRAPE--LVMQFKGFTKLVDMWSAGCVMAEMFNR 230
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 1e-20
Identities = 58/220 (26%), Positives = 103/220 (46%), Gaps = 37/220 (16%)
Query: 626 NFAQENELGRGGFGTVYKG-ELEDGTKIAVK--RMEA--GVTTTKALDEFQSEIAVLSKV 680
F Q +LG G + TVYKG G +A+K ++++ G +T A+ EI+++ ++
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPST-AI----REISLMKEL 60
Query: 681 RHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHL-FRWEKLQLKPLSWTRRLSIALDVAR 739
+H ++V L N+ LV+E+M + L +++ R + L + +
Sbjct: 61 KHENIVRLYDVIHTENKLTLVFEFMDND-LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 740 GMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKS----VVTRLAGT 795
G+ + H +HRDLK N+L++ + K+ DFGL + + VVT
Sbjct: 120 GLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLW--- 173
Query: 796 FGYLAPE-------YAVMGKITTKADVFSYGVVLMELLTG 828
Y AP+ Y +T D++S G +L E++TG
Sbjct: 174 --YRAPDVLMGSRTY------STSIDIWSCGCILAEMITG 205
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 1e-20
Identities = 69/273 (25%), Positives = 113/273 (41%), Gaps = 46/273 (16%)
Query: 633 LGRGGFGTVY---KGELEDGTKI-AVK--RMEAGVTTTKALDEFQSEIAVLSKVRHRHLV 686
LG+GG+G V+ K + KI A+K + V K ++E +L +V+H +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 687 SLLGYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTR----RLSIALDVARGM 741
L+ Y+ + +L L+ EY+ G L L R +S+AL
Sbjct: 85 DLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIF---MEDTACFYLAEISMAL------ 134
Query: 742 EYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAP 801
+LH ++ I+RDLK NI+L+ K++DFGL K + T GT Y+AP
Sbjct: 135 GHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT-FCGTIEYMAP 190
Query: 802 EYAVMGKITTKA-DVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAA 860
E +M +A D +S G ++ ++LTG P + +I K
Sbjct: 191 E-ILMRSGHNRAVDWWSLGALMYDMLTGAP------PFTGENRKKTIDKILKCKLNLPPY 243
Query: 861 IDPALEVNEETFESISIVAELAGHCTAREPYHR 893
+ E+ ++ +L R R
Sbjct: 244 LTQ---------EARDLLKKL----LKRNAASR 263
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 1e-20
Identities = 60/237 (25%), Positives = 105/237 (44%), Gaps = 51/237 (21%)
Query: 615 ISVQVLRKVTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVK--RMEA------GVTTTK 665
+++ V + + + + + LG G F TVYK + +A+K ++ G+ T
Sbjct: 1 MALDVKSRA-KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRT- 58
Query: 666 ALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPH---GALSRHLFRWEKLQL 722
AL EI +L ++ H +++ LL + LV+++M + + +
Sbjct: 59 AL----REIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHI 114
Query: 723 KPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782
K ++ +G+EYLH + +HRDLK +N+LLD++ K++DFGL K
Sbjct: 115 K--AYMLMT------LQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163
Query: 783 DGEKS----VVTRLAGTFGYLAPE-------YAVMGKITTKADVFSYGVVLMELLTG 828
++ VVTR Y APE Y D+++ G +L ELL
Sbjct: 164 SPNRAYTHQVVTRW-----YRAPELLFGARMY------GVGVDMWAVGCILAELLLR 209
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-20
Identities = 80/301 (26%), Positives = 126/301 (41%), Gaps = 32/301 (10%)
Query: 579 SNDTARSLSSQTVASSGSTNSGATENSHVIESGTLVISVQVLRKVT-QNFAQENELGRGG 637
++ S +S G + V KV +NF LG G
Sbjct: 7 HHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGA 66
Query: 638 FGTVY---KGELEDGTKI-AVK--RMEAGVTTTKALDEFQSEIAVLSKVRHRH-LVSLLG 690
+G V+ K D K+ A+K + V K + ++E VL +R LV+L
Sbjct: 67 YGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH- 125
Query: 691 YSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTR----RLSIALDVARGMEYLH 745
Y+ + +L L+ +Y+ G L HL + E+ + + +AL E+LH
Sbjct: 126 YAFQTETKLHLILDYINGGELFTHLSQRERF---TEHEVQIYVGEIVLAL------EHLH 176
Query: 746 CLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAV 805
+ I+RD+K NILLD + ++DFGL K E GT Y+AP+ V
Sbjct: 177 ---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD-IV 232
Query: 806 MGKIT--TKA-DVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862
G + KA D +S GV++ ELLTG + + + S+ AE RI S+ + +
Sbjct: 233 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKSEPPYPQEMS 290
Query: 863 P 863
Sbjct: 291 A 291
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 95.9 bits (238), Expect = 2e-20
Identities = 79/465 (16%), Positives = 149/465 (32%), Gaps = 35/465 (7%)
Query: 434 PEFHDTVKLVIDGNPLLVGGINHTQAPTSPGPVSSPTPPGSQSPSNHTSSGRGQSPSSGN 493
+ + + + P S +
Sbjct: 150 SLCGTDHTERRGRIYIQAHIDREVLIVVVRDAKNLVPMDPNGLSDPYVKLKLIPDPKSES 209
Query: 494 SPPSPITHPNSNHSSIHVQPQRKSTKRLKLLVVVGISVVVTVVLVVILLCIYCCKKRKGT 553
+ + N + + V I + +
Sbjct: 210 KQKTKTIKSSLNPEWNETFRFQLKESDKDRRLSVEIWDWDLTSRNDFMGSLSFGISELQK 269
Query: 554 LEAPGSIVVHPRDPSDPENMVKIAVSNDTARSLSSQTVASSGSTNSGATENSHVIESGTL 613
G + ++ + N+ ++ L + + + A E
Sbjct: 270 AGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKF 329
Query: 614 VISVQVLRKVTQNFAQENELGRGGFGTVYKGELEDGTKI-AVKRME-AGVTTTKALDEFQ 671
+ R +F LG+G FG V E + ++ AVK ++ V ++
Sbjct: 330 DNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTM 389
Query: 672 SEIAVLSKV-RHRHLVSLLGYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTR 729
E VL+ + L L + +RL V EY+ G L H+ + + +
Sbjct: 390 VEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP-----H 443
Query: 730 RLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVV 789
+ A ++A G+ +L + I+RDLK N++LD + K++DFG+ K +
Sbjct: 444 AVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK 500
Query: 790 TRLAGTFGYLAPEYAVMGKITTKA-DVFSYGVVLMELLTGLAALDEERPEESRYLAEWFW 848
T GT Y+APE + + K+ D +++GV+L E+L G A P E E F
Sbjct: 501 T-FCGTPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQA------PFEGEDEDELFQ 552
Query: 849 RIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHR 893
I + ++ E+++I L + P R
Sbjct: 553 SIMEHNVAYPKSMSK---------EAVAICKGL----MTKHPGKR 584
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 91.4 bits (228), Expect = 3e-20
Identities = 54/228 (23%), Positives = 97/228 (42%), Gaps = 47/228 (20%)
Query: 625 QNFAQENELGRGGFGTVYKG-ELEDGTKIAVK--RMEA---GVTTTKALDEFQSEIAVLS 678
Q + + ++G G +GTV+K E +A+K R++ GV ++ AL EI +L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSS-AL----REICLLK 56
Query: 679 KVRHRHLVSLLGYSIEGNERLLVYEYMPH---GALSRHLFRWEKLQLKPLSWTRRLSIAL 735
+++H+++V L + LV+E+ + +K S
Sbjct: 57 ELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVK--------SFLF 108
Query: 736 DVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKL--APDGEKS--VVTR 791
+ +G+ + H + +HRDLK N+L++ + K+++FGL + P S VVT
Sbjct: 109 QLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTL 165
Query: 792 LAGTFGYLAPE-------YAVMGKITTKADVFSYGVVLMELLTGLAAL 832
Y P+ Y +T D++S G + EL L
Sbjct: 166 W-----YRPPDVLFGAKLY------STSIDMWSAGCIFAELANAGRPL 202
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 91.4 bits (228), Expect = 3e-20
Identities = 55/223 (24%), Positives = 99/223 (44%), Gaps = 46/223 (20%)
Query: 625 QNFAQENELGRGGFGTVYKGELEDGTKIAVK--RMEA---GVTTTKALDEFQSEIAVLSK 679
+ + ++G G +G VYK + G A+K R+E G+ +T + EI++L +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPST-TI----REISILKE 56
Query: 680 VRHRHLVSLLGYSIEGNERLLVYEYMPH---GALSRHLFRWEKLQLKPLSWTRRLSIALD 736
++H ++V L +LV+E++ L E + K S L
Sbjct: 57 LKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAK--------SFLLQ 108
Query: 737 VARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKL--APDGEKS--VVTRL 792
+ G+ Y H + +HRDLK N+L++ + K++DFGL + P + + +VT
Sbjct: 109 LLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLW 165
Query: 793 AGTFGYLAPE-------YAVMGKITTKADVFSYGVVLMELLTG 828
Y AP+ Y +T D++S G + E++ G
Sbjct: 166 -----YRAPDVLMGSKKY------STTIDIWSVGCIFAEMVNG 197
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 3e-20
Identities = 57/222 (25%), Positives = 92/222 (41%), Gaps = 43/222 (19%)
Query: 625 QNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRM-----EAGVTTTKALDEFQSEIAVLS 678
+ + + ++G G +G V+K + G +A+K+ + + AL EI +L
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKI-AL----REIRMLK 57
Query: 679 KVRHRHLVSLLGYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDV 737
+++H +LV+LL RL LV+EY H + L + + SI
Sbjct: 58 QLKHPNLVNLLEV-FRRKRRLHLVFEYCDHT-VLHEL----DRYQRGVPEHLVKSITWQT 111
Query: 738 ARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKS----VVTRLA 793
+ + + H + IHRD+K NIL+ K+ DFG +L V TR
Sbjct: 112 LQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRW- 167
Query: 794 GTFGYLAPE-------YAVMGKITTKADVFSYGVVLMELLTG 828
Y +PE Y DV++ G V ELL+G
Sbjct: 168 ----YRSPELLVGDTQY------GPPVDVWAIGCVFAELLSG 199
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 4e-20
Identities = 47/259 (18%), Positives = 80/259 (30%), Gaps = 42/259 (16%)
Query: 52 DPCGPPPWPHVFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP--T 109
PC + + +I P L L +P
Sbjct: 6 PPCECHQEEDFRVTCKDIQRI-----------PSLPPSTQTLK---LIETHLR-TIPSHA 50
Query: 110 FSGLSELEFAYLDFN-EFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQL 168
FS L + Y+ + + S F LS V + + PD+L L
Sbjct: 51 FSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYID---PDALKELPLL 107
Query: 169 TNLSLINCNLVGPLPD--FLGTLPSLAALKLSYNRLSGVIPA-SFG--QSLMQILWLNDQ 223
L + N L PD + + L+++ N IP +F + L L +
Sbjct: 108 KFLGIFNTGLKM-FPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYN- 165
Query: 224 DAGGMTGPIDVVAKMV----SLTQLWLHGNQFTGSIPEDI--GALSSLKDLNLNRNQLVG 277
V L ++L+ N++ I +D G S L++++ +
Sbjct: 166 ------NGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA 219
Query: 278 LIPKSLANMELDNLVLNNN 296
L K L + L L+ N
Sbjct: 220 LPSKGLEH--LKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 3e-17
Identities = 37/195 (18%), Positives = 70/195 (35%), Gaps = 12/195 (6%)
Query: 111 SGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTN 170
S + L TIPS F L ++ + + + + S N ++T+
Sbjct: 28 SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLE---SHSFYNLSKVTH 84
Query: 171 LSLINCNLVGPLPD--FLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGM 228
+ + N + + LP L L + L + S L D M
Sbjct: 85 IEIRNTRNLTYIDPDALKE-LPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYM 143
Query: 229 TG-PIDVVAKMVSLTQ-LWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPK-SLAN 285
T P++ + + T L L+ N FT S+ + L + LN+N+ + +I K +
Sbjct: 144 TSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGG 202
Query: 286 ME--LDNLVLNNNLL 298
+ L ++ +
Sbjct: 203 VYSGPSLLDVSQTSV 217
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 5e-06
Identities = 43/273 (15%), Positives = 75/273 (27%), Gaps = 74/273 (27%)
Query: 189 LPSLAALKLSYNRLSGVIPASF-GQSLMQILWL--NDQDAGGMTG-PIDVVAKMVSLTQL 244
PS LKL L + +F + +++ + + + +T +
Sbjct: 30 PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVT----LQQLESHSFYNLSKVTHI 85
Query: 245 WLHGNQFTGSIPEDI-GALSSLKDLNLNRNQLVGLIPKSLAN--MELDNLVLNNNLLMGP 301
+ + I D L LK L + L + L + +N M
Sbjct: 86 EIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTS 145
Query: 302 IPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWL 361
IP N+F L ++ L
Sbjct: 146 IP----------VNAF--------------------------QGLCNETL--------TL 161
Query: 362 GLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNN-FTELKS-L 419
L +N ++ + GT L + L KN + + F + S
Sbjct: 162 KLY--NNG---FTSVQGYAFNGT---------KLDAVYLNKNKYLTVIDKDAFGGVYSGP 207
Query: 420 RLLDVSDNNIKPPLPE--FHDTVKLVIDGNPLL 450
LLDVS ++ LP +L+ L
Sbjct: 208 SLLDVSQTSVT-ALPSKGLEHLKELIARNTWTL 239
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 5e-20
Identities = 62/236 (26%), Positives = 102/236 (43%), Gaps = 47/236 (19%)
Query: 621 RKVTQNFAQENE-LGRGGFGTVYKG---ELEDGTKIAVKRMEA-GVTTTKALDEFQSEIA 675
+V F E +GRG +G VYK + +D A+K++E G++ + EIA
Sbjct: 16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA-----CREIA 70
Query: 676 VLSKVRHRHLVSLLGYSIEGNERL--LVYEYMPH---GALSRHLFRWEKLQLKPLSWTRR 730
+L +++H +++SL + +R L+++Y H + H + L
Sbjct: 71 LLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMV 130
Query: 731 LSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRA----KVSDFGL-------VK 779
S+ + G+ YLH +HRDLK +NIL+ + K++D G +K
Sbjct: 131 KSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 187
Query: 780 LAPDGEKSVVTRLAGTFGYLAPE-------YAVMGKITTKADVFSYGVVLMELLTG 828
D + VV TF Y APE Y T D+++ G + ELLT
Sbjct: 188 PLADLDPVVV-----TFWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTS 232
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 6e-20
Identities = 46/239 (19%), Positives = 66/239 (27%), Gaps = 50/239 (20%)
Query: 61 HVFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP--TFSGLSELEF 118
V C +T + P + L L N T + L
Sbjct: 14 EVNCDKRNLTAL-----------PPDL--PKDTTILHLSENLL-YTFSLATLMPYTRLTQ 59
Query: 119 AYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNL 178
LD E + L + L L +N S+P LT L + L
Sbjct: 60 LNLDRAELTKLQV--DGTLPVLGTLDLSHNQLQ-----SLPLLGQTLPALTVLDVSFNRL 112
Query: 179 VGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKM 238
L L L L L N L ++L P ++
Sbjct: 113 TSLPLGALRGLGELQELYLKGNEL---------KTL----------------PPGLLTPT 147
Query: 239 VSLTQLWLHGNQFTGSIPEDI-GALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNN 296
L +L L N T +P + L +L L L N L + + L L+ N
Sbjct: 148 PKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGN 205
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 7e-20
Identities = 57/235 (24%), Positives = 99/235 (42%), Gaps = 59/235 (25%)
Query: 626 NFAQENELGRGGFGTVYKG-ELEDGTKIAVK--RMEA---GVTTTKALDEFQSEIAVLSK 679
+ + ++G+G FG V+K + G K+A+K ME G T AL EI +L
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT-AL----REIKILQL 72
Query: 680 VRHRHLVSLLGYSIEGNERL--------LVYEYMPH---GALSRHLFRWEKLQLKPLSWT 728
++H ++V+L+ LV+++ H G LS L ++ ++K
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK----- 127
Query: 729 RRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKL--APDGEK 786
+ + G+ Y+H R +HRD+K++N+L+ D K++DFGL + +
Sbjct: 128 ---RVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 181
Query: 787 S------VVTRLAGTFGYLAPE-------YAVMGKITTKADVFSYGVVLMELLTG 828
VVT Y PE Y D++ G ++ E+ T
Sbjct: 182 PNRYTNRVVTLW-----YRPPELLLGERDY------GPPIDLWGAGCIMAEMWTR 225
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-19
Identities = 67/273 (24%), Positives = 114/273 (41%), Gaps = 40/273 (14%)
Query: 633 LGRGGFGTVYKGELEDGTKI-AVKRME-AGVTTTKALDEFQSEIAVLSKV-RHRHLVSLL 689
+GRG + V L+ +I A+K ++ V + +D Q+E V + H LV L
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 690 GYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTR----RLSIALDVARGMEYL 744
+ RL V EY+ G L H+ R KL P R +S+AL YL
Sbjct: 77 -SCFQTESRLFFVIEYVNGGDLMFHMQRQRKL---PEEHARFYSAEISLAL------NYL 126
Query: 745 HCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYA 804
H + I+RDLK N+LLD + K++D+G+ K + T GT Y+APE
Sbjct: 127 H---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIAPE-I 181
Query: 805 VMGKITTKA-DVFSYGVVLMELLTGL---AALDEERPEESRYLAEWFWRIKSSKEKFKAA 860
+ G+ + D ++ GV++ E++ G + + F I + + +
Sbjct: 182 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 241
Query: 861 IDPALEVNEETFESISIVAELAGHCTAREPYHR 893
+ ++ S++ ++P R
Sbjct: 242 LSV---------KAASVLKSF----LNKDPKER 261
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 70/243 (28%), Positives = 97/243 (39%), Gaps = 56/243 (23%)
Query: 62 VFCSGNRVTQIQVQNLGLKGPLPQN-FNQLTKLYNLGLQRNKFNGKLP--TFSGLSELEF 118
V CS ++T I P N KL LQ NK + LP F L++L
Sbjct: 21 VDCSSKKLTAI-----------PSNIPADTKKLD---LQSNKLS-SLPSKAFHRLTKLRL 65
Query: 119 AYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSL-ANSVQLTNLSLINCN 177
YL+ N+ T+P+ F L ++ L + N ++P + V L L L + N
Sbjct: 66 LYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQ-----ALPIGVFDQLVNLAELRL-DRN 119
Query: 178 LVGPLPD--FLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVV 235
+ LP F L L L L YN L QSL P V
Sbjct: 120 QLKSLPPRVFDS-LTKLTYLSLGYNEL---------QSL----------------PKGVF 153
Query: 236 AKMVSLTQLWLHGNQFTGSIPEDI-GALSSLKDLNLNRNQLVGLIPKSLANME-LDNLVL 293
K+ SL +L L+ NQ +PE L+ LK L L+ NQL + + ++E L L L
Sbjct: 154 DKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQL 212
Query: 294 NNN 296
N
Sbjct: 213 QEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 4e-12
Identities = 44/183 (24%), Positives = 68/183 (37%), Gaps = 60/183 (32%)
Query: 120 YLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLV 179
L N+ ++PS F L+ +R+L L+ N +L L
Sbjct: 43 DLQSNKLSSLPSKAFHRLTKLRLLYLNDN------------------KLQTLP------- 77
Query: 180 GPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMV 239
L +L L ++ N+L Q+L PI V ++V
Sbjct: 78 ---AGIFKELKNLETLWVTDNKL---------QAL----------------PIGVFDQLV 109
Query: 240 SLTQLWLHGNQFTGSIPEDI-GALSSLKDLNLNRNQLVGLIP---KSLANMELDNLVLNN 295
+L +L L NQ S+P + +L+ L L+L N+L L L + L L L N
Sbjct: 110 NLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTS--LKELRLYN 166
Query: 296 NLL 298
N L
Sbjct: 167 NQL 169
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 7e-08
Identities = 25/72 (34%), Positives = 40/72 (55%), Gaps = 4/72 (5%)
Query: 83 LPQN-FNQLTKLYNLGLQRNKFNGKLPT--FSGLSELEFAYLDFNEFDTIPSDFFDGLSS 139
LP+ F++LT L L L N+ ++P F L+EL+ LD N+ +P FD L
Sbjct: 148 LPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEK 206
Query: 140 VRVLALDYNPFN 151
+++L L NP++
Sbjct: 207 LKMLQLQENPWD 218
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-19
Identities = 63/357 (17%), Positives = 122/357 (34%), Gaps = 89/357 (24%)
Query: 83 LPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRV 142
LP+ L L + P LE+ + N+ + +P S +++
Sbjct: 106 LPELPQSLKSLLVDNNNLKALSDLPPL------LEYLGVSNNQLEKLPE--LQNSSFLKI 157
Query: 143 LALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRL 202
+ +D N +PD + L ++ N L LP+ LP L A+ N L
Sbjct: 158 IDVDNNSLK-----KLPDLPPS---LEFIAAGNNQLEE-LPEL-QNLPFLTAIYADNNSL 207
Query: 203 SGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGAL 262
+P ++ + + + + + LT ++ N ++P+
Sbjct: 208 K-KLPDLPLS--LESIVAGNNI----LEELPELQNLPFLTTIYADNNLLK-TLPDLPP-- 257
Query: 263 SSLKDLNLNRNQLVGL--IPKSLANMELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQS 320
SL+ LN+ N L L +P+SL +++ + + + + N+ Y + S +
Sbjct: 258 -SLEALNVRDNYLTDLPELPQSLTFLDVSENIFSG------LSEL-PPNLYYLNASSNE- 308
Query: 321 EPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHN 380
+ L D +L L+ ++N
Sbjct: 309 ---------IRSLCDLPP------SLEE--------------LNVSNN-----------K 328
Query: 381 LTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIK--PPLPE 435
L L L+ LI N ++ VP ++L+ L V N ++ P +PE
Sbjct: 329 LI-ELPALPPRLERLI---ASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPE 377
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-17
Identities = 39/217 (17%), Positives = 70/217 (32%), Gaps = 37/217 (17%)
Query: 83 LPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRV 142
LP+ LT L + L L + NE ++ D S+
Sbjct: 272 LPELPQSLTFLDVSENIFSG----LSEL--PPNLYYLNASSNEIRSLC----DLPPSLEE 321
Query: 143 LALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRL 202
L + N +P L L +L +P+ +L L + YN L
Sbjct: 322 LNVSNNKLI-----ELPALPPR---LERLIASFNHLAE-VPELPQ---NLKQLHVEYNPL 369
Query: 203 SGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGAL 262
P ++ L +N +V +L QL + N P+
Sbjct: 370 R-EFPDIPES--VEDLRMNSH-------LAEVPELPQNLKQLHVETNPLR-EFPDIPE-- 416
Query: 263 SSLKDLNLNRNQLVGLIPKSLANME-LDNLVLNNNLL 298
S++DL +N ++V + + L++ V ++
Sbjct: 417 -SVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHH 452
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 7e-17
Identities = 62/400 (15%), Positives = 124/400 (31%), Gaps = 89/400 (22%)
Query: 83 LPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRV 142
+P + +++ P +
Sbjct: 26 MPVEAENVKSKTEYYNAWSEWERNAP-------PGNGEQREMAVSRLRDCLDRQA---HE 75
Query: 143 LALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRL 202
L L+ + S+P+ + L +L +L LP+ +L SL + L
Sbjct: 76 LELNNLGLS-----SLPELPPH---LESLVASCNSLT-ELPELPQSLKSLLVDNNNLKAL 126
Query: 203 SGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGAL 262
S + P L++ L +++ + + L + + N +P+ +L
Sbjct: 127 SDLPP------LLEYLGVSNNQLEK----LPELQNSSFLKIIDVDNNSLK-KLPDLPPSL 175
Query: 263 -------------------SSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMGP-- 301
L + + N L L P + L+++V NN+L
Sbjct: 176 EFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKL-PDLPLS--LESIVAGNNILEELPE 232
Query: 302 IPKFKAGNVTY---DSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQG 358
+ +T D+N ++ PD+ L+ L + + + + P +
Sbjct: 233 LQNLP--FLTTIYADNNL-------LKTLPDLPPSLEALNVRDNYLTDLPELPQS----- 278
Query: 359 PWLGLSCTSNSKVSIINLP--------RHNLTGTLSPSIANLDSLIEIRLGKNSISGTVP 410
L + N + LP N +L +L+ L + N + +P
Sbjct: 279 -LTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELN---VSNNKLI-ELP 333
Query: 411 NNFTELKSLRLLDVSDNNIKPPLPEFHDTVK-LVIDGNPL 449
L L S N++ +PE +K L ++ NPL
Sbjct: 334 A---LPPRLERLIASFNHLA-EVPELPQNLKQLHVEYNPL 369
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-16
Identities = 47/251 (18%), Positives = 83/251 (33%), Gaps = 62/251 (24%)
Query: 87 FNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALD 146
+ L ++ N +LP L L Y D N T+P D S+ L +
Sbjct: 211 PDLPLSLESIVAGNNILE-ELPELQNLPFLTTIYADNNLLKTLP----DLPPSLEALNVR 265
Query: 147 YNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTL----------------- 189
N +P+ + LT L + G L + L
Sbjct: 266 DNYLT-----DLPELPQS---LTFLDVSENIFSG-LSELPPNLYYLNASSNEIRSLCDLP 316
Query: 190 PSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVV-AKMVSLTQLWLHG 248
PSL L +S N+L +PA + ++ L + + V +L QL +
Sbjct: 317 PSLEELNVSNNKLI-ELPALPPR--LERLIASFNH-------LAEVPELPQNLKQLHVEY 366
Query: 249 NQFTGSIPEDIGAL----------------SSLKDLNLNRNQLVGLIPKSLANMELDNLV 292
N P+ ++ +LK L++ N L P + +++L
Sbjct: 367 NPLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLREF-PDIPES--VEDLR 422
Query: 293 LNNNLLMGPIP 303
+N+ ++ P
Sbjct: 423 MNSERVVDPYE 433
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 7e-11
Identities = 52/299 (17%), Positives = 92/299 (30%), Gaps = 70/299 (23%)
Query: 165 SVQLTNL--SLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSL-MQILWLN 221
+V T L L + + + +P + S +++ P G+ M + L
Sbjct: 7 NVSNTFLQEPLRHSSNLTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLR 66
Query: 222 DQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPK 281
D +L L+ + S+PE L+ L + N L L P+
Sbjct: 67 D-------------CLDRQAHELELNNLGLS-SLPELPP---HLESLVASCNSLTEL-PE 108
Query: 282 SLANME-LDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGV 340
+++ L N L P + V+ N +E P++
Sbjct: 109 LPQSLKSLLVDNNNLKALSDLPPLLEYLGVSN--NQ-------LEKLPELQNS------- 152
Query: 341 NYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTG-TLS-------PSIANL 392
L + +NS + +LP +L P + NL
Sbjct: 153 ---SFLKI--------------IDVDNNSLKKLPDLP-PSLEFIAAGNNQLEELPELQNL 194
Query: 393 DSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIK--PPLPEFHDTVKLVIDGNPL 449
L I NS+ +P+ SL + +N ++ P L + D N L
Sbjct: 195 PFLTAIYADNNSLK-KLPD---LPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLL 249
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 52/318 (16%), Positives = 81/318 (25%), Gaps = 98/318 (30%)
Query: 157 SIPDSLANSVQLTNLSLINCNLVGPLPDFLGTL-------------PSLAALKLSYNRLS 203
+P N T P G L+L+ LS
Sbjct: 25 EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS 84
Query: 204 GVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALS 263
+P L L N T +PE +L
Sbjct: 85 -SLPELPPH----------------------------LESLVASCNSLT-ELPELPQSLK 114
Query: 264 SLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMGPIPKF-KAGNVTY---DSNSFCQ 319
SL N N L L P L+ L ++NN L +P+ + + D+NS
Sbjct: 115 SLLVDNNNLKALSDLPPL------LEYLGVSNNQLEK-LPELQNSSFLKIIDVDNNSL-- 165
Query: 320 SEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKV-SIINLP- 377
L D +L + ++ + NLP
Sbjct: 166 -----------KKLPDLPP------SLEF------------IAAGNNQLEELPELQNLPF 196
Query: 378 ------RHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKP 431
+N L +L+S++ G N + L L + +N +K
Sbjct: 197 LTAIYADNNSLKKLPDLPLSLESIV---AGNNIL--EELPELQNLPFLTTIYADNNLLKT 251
Query: 432 PLPEFHDTVKLVIDGNPL 449
L + N L
Sbjct: 252 LPDLPPSLEALNVRDNYL 269
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-19
Identities = 66/266 (24%), Positives = 114/266 (42%), Gaps = 35/266 (13%)
Query: 633 LGRGGFGTVYKGELEDGTKI-AVKRME-AGVTTTKALDEFQSEIAVLSKV-RHRHLVSLL 689
LG+G FG V E + ++ AVK ++ V ++ E VL+ + L L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 690 GYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLA 748
+ +RL V EY+ G L H+ + + + A ++A G+ +L
Sbjct: 88 -SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP----HAVFYAA-EIAIGLFFLQ--- 138
Query: 749 RQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGK 808
+ I+RDLK N++LD + K++DFG+ K + T GT Y+APE + +
Sbjct: 139 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPDYIAPE-IIAYQ 196
Query: 809 ITTKA-DVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEV 867
K+ D +++GV+L E+L G A + E +E F I + ++
Sbjct: 197 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL------FQSIMEHNVAYPKSMSK---- 246
Query: 868 NEETFESISIVAELAGHCTAREPYHR 893
E+++I L + P R
Sbjct: 247 -----EAVAICKGL----MTKHPGKR 263
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 3e-19
Identities = 57/223 (25%), Positives = 96/223 (43%), Gaps = 46/223 (20%)
Query: 625 QNFAQENELGRGGFGTVYKG-ELEDGTKIAVK--RMEA--GVTTTKALDEFQSEIAVLSK 679
+ + + ++LG G + TVYKG +A+K R+E G T A+ E+++L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCT-AI----REVSLLKD 56
Query: 680 VRHRHLVSLLGYSIEGNERLLVYEYMPH---GALSRHLFRWEKLQLKPLSWTRRLSIALD 736
++H ++V+L LV+EY+ L +K
Sbjct: 57 LKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVK--------LFLFQ 108
Query: 737 VARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKS----VVTRL 792
+ RG+ Y H RQ +HRDLK N+L+++ K++DFGL + K+ VVT
Sbjct: 109 LLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLW 165
Query: 793 AGTFGYLAPE-------YAVMGKITTKADVFSYGVVLMELLTG 828
Y P+ Y +T+ D++ G + E+ TG
Sbjct: 166 -----YRPPDILLGSTDY------STQIDMWGVGCIFYEMATG 197
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 3e-19
Identities = 74/270 (27%), Positives = 108/270 (40%), Gaps = 43/270 (15%)
Query: 633 LGRGGFGTVYKGELEDGTKI-AVKRME-AGVTTTKALDEFQSEIAVLSK-VRHRHLVSLL 689
+G+G FG V + AVK ++ + K SE VL K V+H LV L
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 690 GYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTR----RLSIALDVARGMEYL 744
+S + ++L V +Y+ G L HL R R ++ AL YL
Sbjct: 106 -FSFQTADKLYFVLDYINGGELFYHLQRERCF---LEPRARFYAAEIASAL------GYL 155
Query: 745 HCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYA 804
H ++RDLK NILLD ++DFGL K + + T GT YLAPE
Sbjct: 156 H---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST-FCGTPEYLAPE-V 210
Query: 805 VMGKITTKA-DVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDP 863
+ + + D + G VL E+L GL P SR AE + I + + K I
Sbjct: 211 LHKQPYDRTVDWWCLGAVLYEMLYGLP------PFYSRNTAEMYDNILNKPLQLKPNITN 264
Query: 864 ALEVNEETFESISIVAELAGHCTAREPYHR 893
+ ++ L ++ R
Sbjct: 265 ---------SARHLLEGL----LQKDRTKR 281
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 4e-19
Identities = 56/225 (24%), Positives = 90/225 (40%), Gaps = 41/225 (18%)
Query: 626 NFAQENELGRGGFGTVYKG-ELEDGTKIAVK--RMEAGVTTTKALDEFQS----EIAVL- 677
+ E+G G +GTVYK + G +A+K R+ E+A+L
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVP---NGGGGGGGLPISTVREVALLR 66
Query: 678 --SKVRHRHLVSLL----GYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRR 730
H ++V L+ + ++ LV+E++ L +L +K L
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYL---DKAPPPGLPAETI 122
Query: 731 LSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL-------VKLAPD 783
+ RG+++LH +HRDLK NIL+ K++DFGL + L P
Sbjct: 123 KDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPV 179
Query: 784 GEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTG 828
VVT Y APE + T D++S G + E+
Sbjct: 180 ----VVTLW-----YRAPEVLLQSTYATPVDMWSVGCIFAEMFRR 215
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 4e-19
Identities = 56/260 (21%), Positives = 105/260 (40%), Gaps = 48/260 (18%)
Query: 591 VASSGSTNSGATENSHVIESGTLVISVQVLRKVTQNFAQENELGRGGFGTVYKG-ELEDG 649
+A + G E V + + + + +LG G +G VYK +
Sbjct: 1 MAHHHHHHMGTLEAQTQGPGSMSVSAAPSATSI-DRYRRITKLGEGTYGEVYKAIDTVTN 59
Query: 650 TKIAVK--RMEA---GVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEY 704
+A+K R+E GV T A+ E+++L +++HR+++ L + L++EY
Sbjct: 60 ETVAIKRIRLEHEEEGVPGT-AI----REVSLLKELQHRNIIELKSVIHHNHRLHLIFEY 114
Query: 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILL 764
+ L +++ + +S S + G+ + H + +HRDLK N+LL
Sbjct: 115 AEND-LKKYMDK-----NPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLL 165
Query: 765 DDDYRA-----KVSDFGLVKL--APDGEKS--VVTRLAGTFGYLAPE-------YAVMGK 808
+ K+ DFGL + P + + ++T Y PE Y
Sbjct: 166 SVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLW-----YRPPEILLGSRHY----- 215
Query: 809 ITTKADVFSYGVVLMELLTG 828
+T D++S + E+L
Sbjct: 216 -STSVDIWSIACIWAEMLMK 234
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 5e-19
Identities = 53/237 (22%), Positives = 84/237 (35%), Gaps = 30/237 (12%)
Query: 606 HVIESGTLVISVQVLRKVTQNFAQ-----ENELGRGGFGTVYKG-ELEDGTKIAVKRMEA 659
H S L + Q + LG G G V + G K A+K +
Sbjct: 5 HHHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY- 63
Query: 660 GVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGY----SIEGNERLLVYEYMPHGALSRHL 714
+ Q E+ + H+V +L L++ E M G L
Sbjct: 64 -----DSPKARQ-EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGEL---F 114
Query: 715 FRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILL---DDDYRAK 771
R ++ + + I D+ +++LH HRD+K N+L + D K
Sbjct: 115 SRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLK 171
Query: 772 VSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTG 828
++DFG K + T Y+APE K D++S GV++ LL G
Sbjct: 172 LTDFGFAKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 5e-19
Identities = 62/266 (23%), Positives = 112/266 (42%), Gaps = 35/266 (13%)
Query: 633 LGRGGFGTVYKGELEDGTKI-AVKRME-AGVTTTKALDEFQSEIAVLSKV-RHRHLVSLL 689
LG+G FG V +++ + AVK ++ + ++ +E +LS H L L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90
Query: 690 GYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLA 748
+ +RL V E++ G L H+ + + + R A ++ + +LH
Sbjct: 91 -CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRF---DEARAR--FYAAEIISALMFLH--- 141
Query: 749 RQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGK 808
+ I+RDLK N+LLD + K++DFG+ K + T GT Y+APE +
Sbjct: 142 DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT-FCGTPDYIAPE-ILQEM 199
Query: 809 ITTKA-DVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEV 867
+ A D ++ GV+L E+L G A + E ++ F I + + + +
Sbjct: 200 LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL------FEAILNDEVVYPTWLHE---- 249
Query: 868 NEETFESISIVAELAGHCTAREPYHR 893
++ I+ + P R
Sbjct: 250 -----DATGILKSF----MTKNPTMR 266
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 5e-19
Identities = 66/273 (24%), Positives = 114/273 (41%), Gaps = 40/273 (14%)
Query: 633 LGRGGFGTVYKGELEDGTKI-AVKRME-AGVTTTKALDEFQSEIAVLSKV-RHRHLVSLL 689
+GRG + V L+ +I A++ ++ V + +D Q+E V + H LV L
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 690 GYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTR----RLSIALDVARGMEYL 744
+ RL V EY+ G L H+ R KL P R +S+AL YL
Sbjct: 120 -SCFQTESRLFFVIEYVNGGDLMFHMQRQRKL---PEEHARFYSAEISLAL------NYL 169
Query: 745 HCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYA 804
H + I+RDLK N+LLD + K++D+G+ K + T GT Y+APE
Sbjct: 170 H---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIAPE-I 224
Query: 805 VMGKITTKA-DVFSYGVVLMELLTGL---AALDEERPEESRYLAEWFWRIKSSKEKFKAA 860
+ G+ + D ++ GV++ E++ G + + F I + + +
Sbjct: 225 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 284
Query: 861 IDPALEVNEETFESISIVAELAGHCTAREPYHR 893
+ ++ S++ ++P R
Sbjct: 285 LSV---------KAASVLKSF----LNKDPKER 304
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 6e-19
Identities = 61/389 (15%), Positives = 120/389 (30%), Gaps = 87/389 (22%)
Query: 64 CSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDF 123
C+ N +T + + +Q T L L NK L + L++L + D
Sbjct: 71 CTSNNITTL-------------DLSQNTNLTYLACDSNKLT-NLD-VTPLTKLTYLNCDT 115
Query: 124 NEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLP 183
N+ + + L N I ++++ QLT L + L
Sbjct: 116 NKLTKLD---VSQNPLLTYLNCARNTLT-----EID--VSHNTQLTELDCHLNKKITKLD 165
Query: 184 DFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQ 243
+ L L S+N+++ + S + L L + +T +D+ + + LT
Sbjct: 166 --VTPQTQLTTLDCSFNKITE-LDVSQNKLL-NRLNCDT---NNITK-LDL-NQNIQLTF 216
Query: 244 LWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMGPIP 303
L N+ T I D+ L+ L + + N L L +L+ L L L+ I
Sbjct: 217 LDCSSNKLT-EI--DVTPLTQLTYFDCSVNPLTELDVSTLSK--LTTLHCIQTDLLE-ID 270
Query: 304 KFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGL 363
+ Y C+ ++ V + L L
Sbjct: 271 LTHNTQLIYFQAEGCRKIKELD--------------VTHNTQLYL--------------L 302
Query: 364 SCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLD 423
C + I L ++ L+ + L ++ + + L+ L
Sbjct: 303 DCQAAG---ITELD-----------LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLS 345
Query: 424 VSDNNIK--PPLPEFHDTVKLVIDGNPLL 450
+ +I+ + + +
Sbjct: 346 CVNAHIQDFSSVGKIPALNNNFEAEGQTI 374
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 4e-15
Identities = 46/247 (18%), Positives = 74/247 (29%), Gaps = 35/247 (14%)
Query: 61 HVFCSGNRVTQIQVQNL---------GLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFS 111
++ C+ N +T+I V + K + T+L L NK +L S
Sbjct: 131 YLNCARNTLTEIDVSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKIT-ELD-VS 188
Query: 112 GLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNL 171
L D N + + + L N I + QLT
Sbjct: 189 QNKLLNRLNCDTNNITKLD---LNQNIQLTFLDCSSNKLT-----EID--VTPLTQLTYF 238
Query: 172 SLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGP 231
+ N + L + TL L L L I + Q+++ + +
Sbjct: 239 DC-SVNPLTELD--VSTLSKLTTLHCIQTDLL-EIDLT---HNTQLIYFQAEGCRKIK-E 290
Query: 232 IDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNL 291
+D V L L T + D+ L L LN +L L L +L
Sbjct: 291 LD-VTHNTQLYLLDCQAAGIT-EL--DLSQNPKLVYLYLNNTELTELDVSHNTK--LKSL 344
Query: 292 VLNNNLL 298
N +
Sbjct: 345 SCVNAHI 351
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 2e-14
Identities = 35/256 (13%), Positives = 72/256 (28%), Gaps = 58/256 (22%)
Query: 61 HVFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAY 120
+ C N +T++ + NQ +L L NK ++ + L++L +
Sbjct: 195 RLNCDTNNITKL-------------DLNQNIQLTFLDCSSNKLT-EID-VTPLTQLTYFD 239
Query: 121 LDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVG 180
N + LS + L I L ++ QL C +
Sbjct: 240 CSVNPLTELD---VSTLSKLTTLHCIQTDLL-----EID--LTHNTQLIYFQAEGCRKIK 289
Query: 181 PLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVS 240
L + L L ++ +D+ ++
Sbjct: 290 ELD--VTHNTQLYLLDCQAAGIT---------------------------ELDL-SQNPK 319
Query: 241 LTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMG 300
L L+L+ + T + D+ + LK L+ + +N +
Sbjct: 320 LVYLYLNNTELT-EL--DVSHNTKLKSLSCVNAHIQDFSSVGKIPALNNNFEAEGQTITM 376
Query: 301 PIPKFKAGNVTYDSNS 316
P ++T +
Sbjct: 377 PKETLTNNSLTIAVSP 392
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 4e-14
Identities = 48/352 (13%), Positives = 107/352 (30%), Gaps = 64/352 (18%)
Query: 86 NFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLAL 145
+ QL L +L + + L+ L N T+ +++ LA
Sbjct: 37 SEEQLATLTSLDCHNSSIT-DMTGIEKLTGLTKLICTSNNITTLD---LSQNTNLTYLAC 92
Query: 146 DYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGV 205
D N ++ + +LT L+ L L + P L L + N L+ +
Sbjct: 93 DSNKLT-----NLD--VTPLTKLTYLNCDTNKL-TKLD--VSQNPLLTYLNCARNTLTEI 142
Query: 206 IPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSL 265
V+ LT+L H N+ + D+ + L
Sbjct: 143 ----------------------------DVSHNTQLTELDCHLNKKITKL--DVTPQTQL 172
Query: 266 KDLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMG-PIPKFKAGNVTYDSNSFCQSEPGI 324
L+ + N++ L L+ L + N + + + +T+ S + +
Sbjct: 173 TTLDCSFNKITELDVSQNKL--LNRLNCDTNNITKLDLNQNI--QLTFLDCSSNK----L 224
Query: 325 ECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPR------ 378
L L + VN +++ + + L T ++ + + +
Sbjct: 225 TEIDVTP--LTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQA 282
Query: 379 HNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIK 430
+ + L + I+ + ++ L L +++ +
Sbjct: 283 EGCRKIKELDVTHNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELT 331
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 1e-09
Identities = 44/288 (15%), Positives = 89/288 (30%), Gaps = 47/288 (16%)
Query: 144 ALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLS 203
A FN F PD + + L +L +L + ++
Sbjct: 5 AGQTQSFNDWF----PDD-----NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT 55
Query: 204 GVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALS 263
+ L L + +T +D+ ++ +LT L N+ T ++ + L+
Sbjct: 56 DMTGIEKLTGL-TKLICTSNN---ITT-LDL-SQNTNLTYLACDSNKLT-NLD--VTPLT 106
Query: 264 SLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMG-PIPKFKAGNVTYDSNSFCQSEP 322
L LN + N+L L L L N L + + ++
Sbjct: 107 KLTYLNCDTNKLTKLDVSQNPL--LTYLNCARNTLTEIDVSHNTQLTELDCHLNKKITKL 164
Query: 323 GIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLT 382
+ + L ++ N +++ L + N ++ +N +N+T
Sbjct: 165 DVTPQTQLTTL-----DCSF--NKITE-------------LDVSQNKLLNRLNCDTNNIT 204
Query: 383 GTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIK 430
+ L + N ++ + T L L D S N +
Sbjct: 205 ---KLDLNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT 246
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 8e-19
Identities = 54/222 (24%), Positives = 90/222 (40%), Gaps = 43/222 (19%)
Query: 625 QNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRM-----EAGVTTTKALDEFQSEIAVLS 678
+ + +G G +G V K + G +A+K+ + V A+ EI +L
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKI-AM----REIKLLK 79
Query: 679 KVRHRHLVSLLGYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDV 737
++RH +LV+LL + +R LV+E++ H + L +L L + +
Sbjct: 80 QLRHENLVNLLEV-CKKKKRWYLVFEFVDHT-ILDDL----ELFPNGLDYQVVQKYLFQI 133
Query: 738 ARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKS----VVTRLA 793
G+ + H IHRD+K NIL+ K+ DFG + + V TR
Sbjct: 134 INGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRW- 189
Query: 794 GTFGYLAPE-------YAVMGKITTKADVFSYGVVLMELLTG 828
Y APE Y DV++ G ++ E+ G
Sbjct: 190 ----YRAPELLVGDVKY------GKAVDVWAIGCLVTEMFMG 221
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 9e-19
Identities = 72/266 (27%), Positives = 117/266 (43%), Gaps = 35/266 (13%)
Query: 633 LGRGGFGTVYKGELEDGTKI-AVKRME-AGVTTTKALDEFQSEIAVLSKV-RHRHLVSLL 689
LG+G FG V+ E + + A+K ++ V ++ E VLS H L +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 690 GYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLA 748
+ + E L V EY+ G L H+ K L A ++ G+++LH
Sbjct: 85 -CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS----RATFYAA-EIILGLQFLH--- 135
Query: 749 RQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGK 808
+ ++RDLK NILLD D K++DFG+ K G+ T GT Y+APE ++G+
Sbjct: 136 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPE-ILLGQ 193
Query: 809 ITTKA-DVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEV 867
+ D +S+GV+L E+L G + + EE F I+ + ++
Sbjct: 194 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL------FHSIRMDNPFYPRWLEK---- 243
Query: 868 NEETFESISIVAELAGHCTAREPYHR 893
E+ ++ +L REP R
Sbjct: 244 -----EAKDLLVKL----FVREPEKR 260
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 90.0 bits (223), Expect = 1e-18
Identities = 52/244 (21%), Positives = 91/244 (37%), Gaps = 47/244 (19%)
Query: 64 CSGNRVTQI-----QVQNLGLKG----PLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLS 114
N +T + +++ L + G LP L +L LP+ GL
Sbjct: 68 IPDNNLTSLPALPPELRTLEVSGNQLTSLPVLPPGLLELSIFSNPLTHLP-ALPS--GLC 124
Query: 115 ELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLI 174
+L ++ N+ ++P ++ L++ N S+P + L L
Sbjct: 125 KL---WIFGNQLTSLPVL----PPGLQELSVSDNQLA-----SLPALPSE---LCKLWAY 169
Query: 175 NCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDV 234
N L LP L L +S N+L+ +P + + LW + +
Sbjct: 170 NNQLTS-LPMLPS---GLQELSVSDNQLA-SLPTLPSE--LYKLWAYNNRL------TSL 216
Query: 235 VAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLN 294
A L +L + GN+ T S+P LK+L ++ N+L L P + L +L +
Sbjct: 217 PALPSGLKELIVSGNRLT-SLPVLPS---ELKELMVSGNRLTSL-PMLPSG--LLSLSVY 269
Query: 295 NNLL 298
N L
Sbjct: 270 RNQL 273
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 6e-18
Identities = 44/221 (19%), Positives = 76/221 (34%), Gaps = 32/221 (14%)
Query: 83 LPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRV 142
LP L +L + N+ S L +L + N+ ++P S ++
Sbjct: 136 LPVLPPGLQELS---VSDNQLASLPALPSELCKL---WAYNNQLTSLP----MLPSGLQE 185
Query: 143 LALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRL 202
L++ N S+P + L L N L LP L L +S NRL
Sbjct: 186 LSVSDNQLA-----SLPTLPSE---LYKLWAYNNRLT-SLPALPS---GLKELIVSGNRL 233
Query: 203 SGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGAL 262
+ +P + ++ L ++ + L L ++ NQ T +PE + L
Sbjct: 234 TS-LPVLPSE--LKELMVSG------NRLTSLPMLPSGLLSLSVYRNQLT-RLPESLIHL 283
Query: 263 SSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMGPIP 303
SS +NL N L ++L + +
Sbjct: 284 SSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAG 324
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 84.2 bits (208), Expect = 8e-17
Identities = 63/367 (17%), Positives = 110/367 (29%), Gaps = 70/367 (19%)
Query: 90 LTKLYNLGLQRNKFNGKLPT--FSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDY 147
L + + LP + ++ L + N ++P +R L +
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLPAHITTL---VIPDNNLTSLP----ALPPELRTLEVSG 90
Query: 148 NPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIP 207
N S+P ++L+ S + LP L L + N+L+ +P
Sbjct: 91 NQLT-----SLPVLPPGLLELSIFSN-PLTHLPALPS------GLCKLWIFGNQLT-SLP 137
Query: 208 ASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKD 267
+Q L ++D + L +LW + NQ T S+P L++
Sbjct: 138 VLPPG--LQELSVSDNQLASLPALPS------ELCKLWAYNNQLT-SLPMLPS---GLQE 185
Query: 268 LNLNRNQLVGLIPKSLANMELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECA 327
L+++ NQL L P + + L NN L +P + S + +
Sbjct: 186 LSVSDNQLASL-PTLPSELY--KLWAYNNRLT-SLPAL-PSGLKELIVSGNR----LTSL 236
Query: 328 PDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLG----LSCTSNSKVSIINLPRHNLTG 383
P L L + N ++ P LS N LT
Sbjct: 237 PV---LPSELKELMVSGNRLTSLP-------MLPSGLLSLSVYRN-----------QLT- 274
Query: 384 TLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLPEFHDTVKLV 443
L S+ +L S + L N +S E+ S + +
Sbjct: 275 RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRAL 334
Query: 444 IDGNPLL 450
Sbjct: 335 HLAAADW 341
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 6e-15
Identities = 69/390 (17%), Positives = 109/390 (27%), Gaps = 114/390 (29%)
Query: 111 SGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTN 170
+G + L + + T+P + + L + N S+P L
Sbjct: 40 NGNAVL---NVGESGLTTLPDCLP---AHITTLVIPDNNLT-----SLPALPPE---LRT 85
Query: 171 LSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTG 230
L + L LP L L+ L +
Sbjct: 86 LEVSGNQLTS-LPVLPPGLLELSIFSNPLTHLPALPS----------------------- 121
Query: 231 PIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDN 290
L +LW+ GNQ T S+P L++L+++ NQL L P + L
Sbjct: 122 ---------GLCKLWIFGNQLT-SLPVLPP---GLQELSVSDNQLASL-PALPSE--LCK 165
Query: 291 LVLNNNLLMGPIPKFKAGNVTY---DSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLV 347
L NN L +P + N L
Sbjct: 166 LWAYNNQLTS-LPM-LPSGLQELSVSDNQLASLPTLPS-------------------ELY 204
Query: 348 SQWPGNDPCQGPWLGLSCTSNSKVSIINLPR--------HNLTGTLSPSIANLDSLIEIR 399
L +N S+ LP N +L + L L
Sbjct: 205 K--------------LWAYNNRLTSLPALPSGLKELIVSGNRLTSLPVLPSELKEL---M 247
Query: 400 LGKNSISGTVPNNFTELKSLRLLDVSDNNIK--PP-LPEFHDTVKLVIDGNPL----LVG 452
+ N ++ ++P L L V N + P L + ++GNPL L
Sbjct: 248 VSGNRLT-SLPM---LPSGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPLSERTLQA 303
Query: 453 GINHTQAPTSPGPVSSPTPPGSQSPSNHTS 482
T AP GP+ G+ +P +
Sbjct: 304 LREITSAPGYSGPIIRFDMAGASAPRETRA 333
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 1e-13
Identities = 40/244 (16%), Positives = 77/244 (31%), Gaps = 57/244 (23%)
Query: 64 CSGNRVTQI-----QVQNLGLKG----PLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLS 114
S N++ + ++ L LP + L +L + N+ LP + S
Sbjct: 148 VSDNQLASLPALPSELCKLWAYNNQLTSLPMLPSGLQELS---VSDNQLA-SLP--TLPS 201
Query: 115 ELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLI 174
EL + N ++P+ S ++ L + N S+P + L L +
Sbjct: 202 ELYKLWAYNNRLTSLPAL----PSGLKELIVSGNRLT-----SLPVLPSE---LKELMVS 249
Query: 175 NCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDV 234
L LP L SL + N+L+ +P S
Sbjct: 250 GNRLTS-LPMLPSGLLSL---SVYRNQLT-RLPESLIH---------------------- 282
Query: 235 VAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLN 294
+ S T + L GN + + + ++S + + + +L
Sbjct: 283 ---LSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAA 339
Query: 295 NNLL 298
+ L+
Sbjct: 340 DWLV 343
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 43/231 (18%), Positives = 67/231 (29%), Gaps = 60/231 (25%)
Query: 219 WLNDQDAGGMTGPIDVVAKMV-----SLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRN 273
W A G VV KM L + + T ++P+ + + + L + N
Sbjct: 15 WRRAAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDN 71
Query: 274 QLVGLIPKSLANMELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVL 333
L L P L L ++ N L +P
Sbjct: 72 NLTSL-PALPPE--LRTLEVSGNQLTS-LP---------VLPPGLLE------------- 105
Query: 334 LDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLP--------RHNLTGTL 385
L + P+ + P L N S+ LP N +L
Sbjct: 106 LSIF---SNPLTHLPALPSG------LCKLWIFGNQLTSLPVLPPGLQELSVSDNQLASL 156
Query: 386 SPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIK--PPLP 434
+ L L N ++ ++P L+ L VSDN + P LP
Sbjct: 157 PALPSELCKL---WAYNNQLT-SLPM---LPSGLQELSVSDNQLASLPTLP 200
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-18
Identities = 56/226 (24%), Positives = 96/226 (42%), Gaps = 43/226 (19%)
Query: 625 QNFAQENELGRGGFGTVYKG--ELEDGTKIAVK--RMEA---GVTTTKALDEFQSEIAVL 677
Q + E+G G +G V+K G +A+K R++ G+ + + E+AVL
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLS-TI----REVAVL 65
Query: 678 ---SKVRHRHLVSLL----GYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTR 729
H ++V L + +L LV+E++ L+ +L +K+ +
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYL---DKVPEPGVPTET 121
Query: 730 RLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL-------VKLAP 782
+ + RG+++LH +HRDLK NIL+ + K++DFGL + L
Sbjct: 122 IKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS 178
Query: 783 DGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTG 828
VVT Y APE + T D++S G + E+
Sbjct: 179 V----VVTLW-----YRAPEVLLQSSYATPVDLWSVGCIFAEMFRR 215
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 56/224 (25%), Positives = 96/224 (42%), Gaps = 42/224 (18%)
Query: 629 QENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR-HRHLV 686
QE+ LG G V L + AVK +E + E+ +L + + HR+++
Sbjct: 17 QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIR--SRVFREVEMLYQCQGHRNVL 74
Query: 687 SLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLS------IALDVARG 740
L+ + E + LV+E M G + + + R + + DVA
Sbjct: 75 ELIEFFEEEDRFYLVFEKMRGG----SIL--SHIHKR-----RHFNELEASVVVQDVASA 123
Query: 741 MEYLHCLARQTFIHRDLKSSNILL---DDDYRAKVSDFGL-VKLAPDGEKSVVTR----- 791
+++LH + HRDLK NIL + K+ DF L + +G+ S ++
Sbjct: 124 LDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT 180
Query: 792 LAGTFGYLAPEYAVMGKITT-------KADVFSYGVVLMELLTG 828
G+ Y+APE V+ + + D++S GV+L LL+G
Sbjct: 181 PCGSAEYMAPE--VVEAFSEEASIYDKRCDLWSLGVILYILLSG 222
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 3e-18
Identities = 51/256 (19%), Positives = 86/256 (33%), Gaps = 37/256 (14%)
Query: 64 CSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDF 123
G VT I+ L L L L+ N+ L L+++ L
Sbjct: 48 AFGTGVTTIE------------GVQYLNNLIGLELKDNQIT-DLAPLKNLTKITELELSG 94
Query: 124 NEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLP 183
N + + GL S++ L L LA L L L + P
Sbjct: 95 NPLKNVSA--IAGLQSIKTLDLTSTQITDV------TPLAGLSNLQVLYLDLNQITNISP 146
Query: 184 DFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLND---QDAGGMTGPIDVVAKMVS 240
L L +L L + ++S + P + L L +D D I +A + +
Sbjct: 147 --LAGLTNLQYLSIGNAQVSDLTPLANLSKL-TTLKADDNKISD-------ISPLASLPN 196
Query: 241 LTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMG 300
L ++ L NQ + + + S+L + L + N+ + N+V +
Sbjct: 197 LIEVHLKNNQIS-DVSP-LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPI 254
Query: 301 PIPKFKAGNVTYDSNS 316
P + N TY S +
Sbjct: 255 A-PATISDNGTYASPN 269
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 34/168 (20%), Positives = 67/168 (39%), Gaps = 24/168 (14%)
Query: 135 DGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAA 194
L++ +A + + A+ +T LS + + + L +L
Sbjct: 16 PALANAIKIAAGKSNVTD------TVTQADLDGITTLSAFGTGVTT--IEGVQYLNNLIG 67
Query: 195 LKLSYNRLSGVIPASFGQSLMQILWLND---QDAGGMTGPIDVVAKMVSLTQLWLHGNQF 251
L+L N+++ + P + L L+ ++ + +A + S+ L L Q
Sbjct: 68 LELKDNQITDLAPLKNLTKI-TELELSGNPLKN-------VSAIAGLQSIKTLDLTSTQI 119
Query: 252 TGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANME-LDNLVLNNNLL 298
T P + LS+L+ L L+ NQ+ + P LA + L L + N +
Sbjct: 120 TDVTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQV 163
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 47/287 (16%), Positives = 96/287 (33%), Gaps = 56/287 (19%)
Query: 186 LGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLW 245
L + + + ++ + + + L + G V + +L L
Sbjct: 15 DPALANAIKIAAGKSNVTDTVTQADLDGI-TTLSAFGTGVTTIEG----VQYLNNLIGLE 69
Query: 246 LHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIP-KSLANMELDNLVLNNNLL--MGPI 302
L NQ T + + L+ + +L L+ N L + L + + L L + + + P+
Sbjct: 70 LKDNQIT-DLAP-LKNLTKITELELSGNPLKNVSAIAGLQS--IKTLDLTSTQITDVTPL 125
Query: 303 PKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLG 362
N+ Q I + L NL L
Sbjct: 126 AGLS--NLQVLYLDLNQ----ITNISPLAGL----------TNLQY------------LS 157
Query: 363 LSCTSNSKVSII-NLPR-------HNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFT 414
+ S ++ + NL + N +SP +A+L +LIE+ L N IS P
Sbjct: 158 IGNAQVSDLTPLANLSKLTTLKADDNKISDISP-LASLPNLIEVHLKNNQISDVSP--LA 214
Query: 415 ELKSLRLLDVSDNNIKPPLPEFHDTVKLV-----IDGNPLLVGGINH 456
+L ++ +++ I +++ + + G P+ I+
Sbjct: 215 NTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIAPATISD 261
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 6e-18
Identities = 54/227 (23%), Positives = 89/227 (39%), Gaps = 48/227 (21%)
Query: 623 VTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQS--------- 672
V + + +G G G V + +A+K K FQ+
Sbjct: 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK---------KLSRPFQNQTHAKRAYR 110
Query: 673 EIAVLSKVRHRHLVSLL-----GYSIEG-NERLLVYEYMPH--GALSRHLFRWEKLQLKP 724
E+ ++ V H++++SLL ++E + LV E M + +
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ----------ME 160
Query: 725 LSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG 784
L R + + G+++LH IHRDLK SNI++ D K+ DFGL + A
Sbjct: 161 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 217
Query: 785 EK---SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTG 828
VVTR Y APE + D++S G ++ E++
Sbjct: 218 FMMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMVRH 259
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 7e-18
Identities = 54/266 (20%), Positives = 96/266 (36%), Gaps = 90/266 (33%)
Query: 622 KVTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQS---EIAVL 677
++ ++ LG G FG V + ++E G + A+K K L + + E+ ++
Sbjct: 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALK---------KVLQDPRYKNRELDIM 54
Query: 678 SKVRHRHLVSLLGYSIEGNERL-------------------------------------- 699
+ H +++ L+ Y +
Sbjct: 55 KVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLN 114
Query: 700 LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIAL------DVARGMEYLHCLARQTFI 753
++ EY+P L + L + + R + + L + R + ++H L
Sbjct: 115 VIMEYVPD-TLHKVLKSFIRSG-------RSIPMNLISIYIYQLFRAVGFIHSLG---IC 163
Query: 754 HRDLKSSNILLD-DDYRAKVSDFGLVKLAPDGEKS---VVTRLAGTFGYLAPE------- 802
HRD+K N+L++ D K+ DFG K E S + +R Y APE
Sbjct: 164 HRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPELMLGATE 218
Query: 803 YAVMGKITTKADVFSYGVVLMELLTG 828
Y T D++S G V EL+ G
Sbjct: 219 Y------TPSIDLWSIGCVFGELILG 238
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 7e-18
Identities = 49/245 (20%), Positives = 76/245 (31%), Gaps = 78/245 (31%)
Query: 62 VFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP---TFSGLSELEF 118
+ CS ++ + PQ+ T L L N +L T + L+ L
Sbjct: 23 LSCSKQQLPNV-----------PQSLPSYTA--LLDLSHNNL-SRLRAEWTPTRLTNLHS 68
Query: 119 AYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNL 178
L N + I S+ F + ++R L L N L L
Sbjct: 69 LLLSHNHLNFISSEAFVPVPNLRYLDLSSN------------------HLHTLD------ 104
Query: 179 VGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKM 238
L +L L L N + V +F M
Sbjct: 105 ----EFLFSDLQALEVLLLYNNHIVVVDRNAF-------------------------EDM 135
Query: 239 VSLTQLWLHGNQFTGSIPEDI----GALSSLKDLNLNRNQLVGLIPKSLANM---ELDNL 291
L +L+L NQ + P ++ L L L+L+ N+L L L + + L
Sbjct: 136 AQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGL 194
Query: 292 VLNNN 296
L+NN
Sbjct: 195 YLHNN 199
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-17
Identities = 54/228 (23%), Positives = 88/228 (38%), Gaps = 50/228 (21%)
Query: 623 VTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQS--------- 672
V + + +G G G V + +A+K K FQ+
Sbjct: 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIK---------KLSRPFQNQTHAKRAYR 73
Query: 673 EIAVLSKVRHRHLVSLL-----GYSIEG-NERLLVYEYMP---HGALSRHLFRWEKLQLK 723
E+ ++ V H++++ LL S+E + +V E M +
Sbjct: 74 ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ-----------M 122
Query: 724 PLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783
L R + + G+++LH IHRDLK SNI++ D K+ DFGL + A
Sbjct: 123 ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179
Query: 784 GEKS---VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTG 828
VVTR Y APE + D++S G ++ E++ G
Sbjct: 180 SFMMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 86.6 bits (214), Expect = 1e-17
Identities = 46/246 (18%), Positives = 78/246 (31%), Gaps = 57/246 (23%)
Query: 64 CSGNRVTQI------QVQNLGLKG----PLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSG 112
+ ++ + Q+ L + LP+ L L N+ + LP +
Sbjct: 66 LNRLNLSSLPDNLPPQITVLEITQNALISLPELPASLEYLD---ACDNRLS-TLPELPAS 121
Query: 113 LSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLS 172
L L +D N+ +P + + + + D N +P+ + L LS
Sbjct: 122 LKHL---DVDNNQLTMLP----ELPALLEYINADNNQLT-----MLPELPTS---LEVLS 166
Query: 173 LINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPI 232
+ N L LP+ SL AL +S N L +PA +
Sbjct: 167 VRNNQLTF-LPELPE---SLEALDVSTNLLES-LPAVPVR-NHHSEET------------ 208
Query: 233 DVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLV 292
N+ T IPE+I +L + L N L I +SL+
Sbjct: 209 --------EIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDY 259
Query: 293 LNNNLL 298
+
Sbjct: 260 HGPRIY 265
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 79.2 bits (195), Expect = 2e-15
Identities = 57/359 (15%), Positives = 99/359 (27%), Gaps = 114/359 (31%)
Query: 83 LPQNFNQLTKLYNLGLQRNKFNGKLP--TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSV 140
+++ K G RN+ L + SEL L+ ++P + +
Sbjct: 29 YFSAWDKWEKQALPGENRNEAVSLLKECLINQFSEL---QLNRLNLSSLPDNLPPQI--- 82
Query: 141 RVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYN 200
VL + N S+P+ A+ L L + L LP+ SL L + N
Sbjct: 83 TVLEITQNALI-----SLPELPAS---LEYLDACDNRLST-LPE---LPASLKHLDVDNN 130
Query: 201 RLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIG 260
+L+ ++P L + NQ T +PE
Sbjct: 131 QLT-MLPELPAL----------------------------LEYINADNNQLT-MLPELPT 160
Query: 261 ALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQS 320
SL+ L++ NQL L P+ ++E L ++
Sbjct: 161 ---SLEVLSVRNNQLTFL-PELPESLE--ALDVST------------------------- 189
Query: 321 EPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHN 380
NL+ P + S R N
Sbjct: 190 ------------------------NLLESLP-------AVPVRNHHSEETEIFFRC-REN 217
Query: 381 LTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLPEFHDT 439
+ +I +LD I L N +S + ++ + +T
Sbjct: 218 RITHIPENILSLDPTCTIILEDNPLS-SRIRESLSQQTAQPDYHGPRIYFSMSDGQQNT 275
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 78.1 bits (192), Expect = 6e-15
Identities = 34/247 (13%), Positives = 67/247 (27%), Gaps = 58/247 (23%)
Query: 64 CSGNRVTQI-----QVQNLGLKG----PLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLS 114
+ N + + ++ L LP+ L L + N+ LP +
Sbjct: 87 ITQNALISLPELPASLEYLDACDNRLSTLPELPASLKHLD---VDNNQLT-MLP--ELPA 140
Query: 115 ELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLI 174
LE+ D N+ +P +S+ VL++ N +P+ + L L +
Sbjct: 141 LLEYINADNNQLTMLPEL----PTSLEVLSVRNNQLT-----FLPELPES---LEALDVS 188
Query: 175 NCNLVGPLPDFLGTLPSL----AALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTG 230
L LP + NR++ IP +
Sbjct: 189 TNLLES-LPAVPVRNHHSEETEIFFRCRENRIT-HIPENILS------------------ 228
Query: 231 PIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDN 290
+ + L N + I E + ++ D + R +
Sbjct: 229 -------LDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLA 281
Query: 291 LVLNNNL 297
+
Sbjct: 282 DAVTAWF 288
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 4e-17
Identities = 49/310 (15%), Positives = 92/310 (29%), Gaps = 41/310 (13%)
Query: 23 TDPNDLK--ILNDFKNGLENPELLKWPANGDDPCGPPPWPHVFCSGNRVTQIQVQNLGLK 80
PN L +N N L + +L N ++ + G + + +Q++
Sbjct: 203 FHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETT 262
Query: 81 GPLP---QNFNQLTKLYNLGLQRNKFNGKLP------TFSGLSELEFAYLDFNEFDTIPS 131
F + L + ++ + + L L ++ F
Sbjct: 263 WKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKE 322
Query: 132 DFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPS 191
+ + + + L + P S ++ T L+ + TL
Sbjct: 323 ALYSVFAEMNIKMLSIS-DTPFIHMVCPPSPSS---FTFLNFTQNVFTDSVFQGCSTLKR 378
Query: 192 LAALKLSYNRLSGVIPASFGQSLMQILWLND-QDAGGMTGPIDVVAKM------------ 238
L L L N L + M L D + D
Sbjct: 379 LQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSN 438
Query: 239 -----------VSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANME 287
+ L LH N+ SIP+D+ L +L++LN+ NQL + +
Sbjct: 439 MLTGSVFRCLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLT 497
Query: 288 -LDNLVLNNN 296
L + L++N
Sbjct: 498 SLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 6e-16
Identities = 58/399 (14%), Positives = 113/399 (28%), Gaps = 74/399 (18%)
Query: 62 VFCSGNRVTQI------QVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPT-FSGLS 114
V S +T + + + L L + N +++L S LS
Sbjct: 36 VDYSNRNLTHVPKDLPPRTKALSL------SQNSISEL-------------RMPDISFLS 76
Query: 115 ELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLI 174
EL L N ++ F + L + +N +I L +L L
Sbjct: 77 ELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRL-----QNISCC--PMASLRHLDLS 129
Query: 175 NCNL-VGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPID 233
+ V P+ G L L L LS + + + + L+ G +
Sbjct: 130 FNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETE 189
Query: 234 VVAKM-VSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVG--------LIPKSLA 284
+ ++ L H N ++++L L L+ +L + +
Sbjct: 190 SLQIPNTTVLHLVFHPNSLFSVQVNM--SVNALGHLQLSNIKLNDENCQRLMTFLSELTR 247
Query: 285 NMELDNLVLNN-------------NLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVN 331
L N+ L + P+ N+T + E A
Sbjct: 248 GPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSL 307
Query: 332 VLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIAN 391
++ + L +++I L + +
Sbjct: 308 MIEHV------KNQVFLFSK-------EALYSVFA---EMNIKMLSISDTPFIHMVCPPS 351
Query: 392 LDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIK 430
S + +N + +V + LK L+ L + N +K
Sbjct: 352 PSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK 390
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 4e-12
Identities = 62/361 (17%), Positives = 114/361 (31%), Gaps = 49/361 (13%)
Query: 80 KGPLPQNFNQLTKLYNLGLQRNKFNGKLPT--FSGLSELEFAYLDFNEFD--TIPSDFFD 135
G T + +L N + L L+ + + N+ + + + +
Sbjct: 185 GGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSE 244
Query: 136 GLSSVRVLALDYNPFNKTFGWSIPD-SLANSVQLTNLSLINCNLVGP-----LPDFLGTL 189
+L + T+ S+ + L++ N + L
Sbjct: 245 LTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETAL 304
Query: 190 PSLAALKLSYNRLSGVIPASF-GQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHG 248
SL + A + + M I L+ D + S T L
Sbjct: 305 KSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTP--FIHMVCPPSPSSFTFLNFTQ 362
Query: 249 NQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMGPIPKFKAG 308
N FT S+ + L L+ L L RN L +L + +L + L
Sbjct: 363 NVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSL---------- 412
Query: 309 NVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSN 368
NS CA + + L NL S N + L
Sbjct: 413 ------NSLNSHAYDRTCAWAES--ILVL-------NLSS----NMLTGSVFRCLP---- 449
Query: 369 SKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNN-FTELKSLRLLDVSDN 427
KV +++L + + ++ + +L +L E+ + N + +VP+ F L SL+ + + DN
Sbjct: 450 PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDN 507
Query: 428 N 428
Sbjct: 508 P 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 4e-09
Identities = 31/206 (15%), Positives = 62/206 (30%), Gaps = 34/206 (16%)
Query: 73 QVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPT--FSGLSELEFAYLDFNEFDTIP 130
V+N ++ ++ L + + S F N F
Sbjct: 311 HVKNQVFLFSKEALYSVFAEMNIKMLSISD-TPFIHMVCPPSPSSFTFLNFTQNVFTDSV 369
Query: 131 SDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLV----GPLPDFL 186
L ++ L L N + + +++L ++ +L
Sbjct: 370 FQGCSTLKRLQTLILQRNGLK-----NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTC 424
Query: 187 GTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLND-------QDAGGMTG--------- 230
S+ L LS N L+G + + ++L L++ +D +
Sbjct: 425 AWAESILVLNLSSNMLTGSVFRCLPPKV-KVLDLHNNRIMSIPKDVTHLQALQELNVASN 483
Query: 231 -----PIDVVAKMVSLTQLWLHGNQF 251
P V ++ SL +WLH N +
Sbjct: 484 QLKSVPDGVFDRLTSLQYIWLHDNPW 509
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 6e-17
Identities = 53/277 (19%), Positives = 94/277 (33%), Gaps = 37/277 (13%)
Query: 563 HPRDPSDPENMVKIAVSNDTARSLSSQTVASSGSTNSGATENSHVIESGTLVISVQVLRK 622
P P + + ++ I+ ++ +V +
Sbjct: 9 SPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQ 68
Query: 623 VTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV- 680
V LG G G V + K A+K ++ + E+ + +
Sbjct: 69 V---------LGLGINGKVLQIFNKRTQEKFALKMLQ------DCPKARR-EVELHWRAS 112
Query: 681 RHRHLVSLLGY---SIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRR--LSIA 734
+ H+V ++ G + L +V E + G L + ++T R I
Sbjct: 113 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI-----QDRGDQAFTEREASEIM 167
Query: 735 LDVARGMEYLHCLARQTFIHRDLKSSNILL---DDDYRAKVSDFGLVKLAPDGEKSVVTR 791
+ ++YLH HRD+K N+L + K++DFG K +T
Sbjct: 168 KSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN--SLTT 222
Query: 792 LAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTG 828
T Y+APE K D++S GV++ LL G
Sbjct: 223 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 8e-17
Identities = 56/230 (24%), Positives = 96/230 (41%), Gaps = 55/230 (23%)
Query: 623 VTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQS--------- 672
+ + + +G G +G+V + G K+A+K K FQS
Sbjct: 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK---------KLSRPFQSEIFAKRAYR 72
Query: 673 EIAVLSKVRHRHLVSLL-----GYSIEGNERL-LVYEYMP---HGALSRHLFRWEKLQLK 723
E+ +L ++H +++ LL S+ LV +M +
Sbjct: 73 ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG-----------L 121
Query: 724 PLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783
S + + + +G++Y+H +HRDLK N+ +++D K+ DFGL + A D
Sbjct: 122 KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHA-D 177
Query: 784 GEKS--VVTRLAGTFGYLAPEYAVM---GKITTKADVFSYGVVLMELLTG 828
E + VVTR Y APE V+ D++S G ++ E+LTG
Sbjct: 178 AEMTGYVVTRW-----YRAPE--VILSWMHYNQTVDIWSVGCIMAEMLTG 220
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-16
Identities = 56/232 (24%), Positives = 99/232 (42%), Gaps = 54/232 (23%)
Query: 623 VTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQS--------- 672
V + + +G G +G V + + ++A+K++ F+
Sbjct: 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP----------FEHQTYCQRTLR 74
Query: 673 EIAVLSKVRHRHLVSLLG----YSIEGNERL-LVYEYMP---HGALSRHLFRWEKLQLKP 724
EI +L + RH +++ + +IE + + +V + M + L + +
Sbjct: 75 EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY-----KLLKT-----QH 124
Query: 725 LSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG 784
LS + RG++Y+H A +HRDLK SN+LL+ K+ DFGL ++A
Sbjct: 125 LSNDHICYFLYQILRGLKYIHS-AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181
Query: 785 EKS-------VVTRLAGTFGYLAPEYAVMGKITTKA-DVFSYGVVLMELLTG 828
V TR Y APE + K TK+ D++S G +L E+L+
Sbjct: 182 HDHTGFLTEYVATR-----WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 3e-16
Identities = 58/246 (23%), Positives = 96/246 (39%), Gaps = 65/246 (26%)
Query: 618 QVLRKVTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQS---- 672
+++ ++ +F ++ LG G +G V G +A+K++E F
Sbjct: 4 RIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP----------FDKPLFA 53
Query: 673 -----EIAVLSKVRHRHLVSLL----GYSIEGNERL-LVYEYMP---HGALSRHLFRWEK 719
EI +L +H +++++ S E + ++ E M H +S
Sbjct: 54 LRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIST------- 106
Query: 720 LQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK 779
+ LS R ++ LH + IHRDLK SN+L++ + KV DFGL +
Sbjct: 107 ---QMLSDDHIQYFIYQTLRAVKVLHG-SN--VIHRDLKPSNLLINSNCDLKVCDFGLAR 160
Query: 780 LAPDGEKS--------------VVTRLAGTFGYLAPEYAVMG---KITTKADVFSYGVVL 822
+ + V TR Y APE VM K + DV+S G +L
Sbjct: 161 IIDESAADNSEPTGQQSGMVEFVATR-----WYRAPE--VMLTSAKYSRAMDVWSCGCIL 213
Query: 823 MELLTG 828
EL
Sbjct: 214 AELFLR 219
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 6e-16
Identities = 61/243 (25%), Positives = 91/243 (37%), Gaps = 73/243 (30%)
Query: 63 FCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLD 122
N + QI N +K L + L L NK + + L+ L + L
Sbjct: 37 QNELNSIDQIIANNSDIKSVQG--IQYLPNVRYLALGGNKLH-DISALKELTNLTYLILT 93
Query: 123 FNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPL 182
N+ ++P+ FD L++++ L L N QL +L
Sbjct: 94 GNQLQSLPNGVFDKLTNLKELVLVEN------------------QLQSLP---------- 125
Query: 183 PDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLT 242
L +L L L++N+L QSL P V K+ +LT
Sbjct: 126 DGVFDKLTNLTYLNLAHNQL---------QSL----------------PKGVFDKLTNLT 160
Query: 243 QLWLHGNQFTGSIPEDIGA---LSSLKDLNLNRNQLVGLIPKSLANMELDNLV------L 293
+L L NQ S+PE G L+ LKDL L +NQL KS+ + D L L
Sbjct: 161 ELDLSYNQLQ-SLPE--GVFDKLTQLKDLRLYQNQL-----KSVPDGVFDRLTSLQYIWL 212
Query: 294 NNN 296
++N
Sbjct: 213 HDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 44/208 (21%), Positives = 73/208 (35%), Gaps = 65/208 (31%)
Query: 95 NLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTF 154
L++ T + L+ ++ + ++ ++ L +VR LAL N
Sbjct: 23 KANLKKKSVT-DAVTQNELNSIDQIIANNSDIKSVQG--IQYLPNVRYLALGGN------ 73
Query: 155 GWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSL 214
+L ++S + L +L L L+ N+L +
Sbjct: 74 ------------KLHDISALK------------ELTNLTYLILTGNQLQSL--------- 100
Query: 215 MQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDI-GALSSLKDLNLNRN 273
P V K+ +L +L L NQ S+P+ + L++L LNL N
Sbjct: 101 ----------------PNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHN 143
Query: 274 QLVGLIPK---SLANMELDNLVLNNNLL 298
QL L L N L L L+ N L
Sbjct: 144 QLQSLPKGVFDKLTN--LTELDLSYNQL 169
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 6e-04
Identities = 22/67 (32%), Positives = 37/67 (55%), Gaps = 3/67 (4%)
Query: 87 FNQLTKLYNLGLQRNKFNGKLPT--FSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLA 144
F++LT L L L N+ LP F L++L+ L N+ ++P FD L+S++ +
Sbjct: 153 FDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIW 211
Query: 145 LDYNPFN 151
L NP++
Sbjct: 212 LHDNPWD 218
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 6e-16
Identities = 57/229 (24%), Positives = 95/229 (41%), Gaps = 52/229 (22%)
Query: 623 VTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQS--------- 672
V + +G G +G V + G K+A+K K FQS
Sbjct: 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK---------KLYRPFQSELFAKRAYR 73
Query: 673 EIAVLSKVRHRHLVSLL-----GYSIEG-NERLLVYEYMP---HGALSRHLFRWEKLQLK 723
E+ +L +RH +++ LL +++ + LV +M + +
Sbjct: 74 ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH----------E 123
Query: 724 PLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783
L R + + +G+ Y+H IHRDLK N+ +++D K+ DFGL + A
Sbjct: 124 KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 180
Query: 784 GEKS-VVTRLAGTFGYLAPEYAVM---GKITTKADVFSYGVVLMELLTG 828
VVTR Y APE V+ + T D++S G ++ E++TG
Sbjct: 181 EMTGYVVTRW-----YRAPE--VILNWMRYTQTVDIWSVGCIMAEMITG 222
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 9e-16
Identities = 39/249 (15%), Positives = 67/249 (26%), Gaps = 38/249 (15%)
Query: 63 FCSGNRVTQIQVQNLGLKGPLPQN--FNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFA- 119
+ + ++ ++NL + G P L L L+ + + + L +
Sbjct: 91 VLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPG 150
Query: 120 ----YLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLIN 175
+ + ++ L L NP G L L+L N
Sbjct: 151 LKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRN 210
Query: 176 CN---LVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPI 232
G L L LS+N L A
Sbjct: 211 AGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWP------------------ 252
Query: 233 DVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLV 292
L L L +P+ + + L L+L+ N+L P ++ NL
Sbjct: 253 ------SQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLDR-NPSPDELPQVGNLS 302
Query: 293 LNNNLLMGP 301
L N +
Sbjct: 303 LKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 4e-15
Identities = 45/234 (19%), Positives = 72/234 (30%), Gaps = 18/234 (7%)
Query: 86 NFNQLTKLYNLGLQRNKFNGKLPT-------FSGLSELEFAYLDFNEFDTIPSDFFDGLS 138
+ + L L ++ + ++ SGL EL L+ P
Sbjct: 63 DIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTG-TAPPPLLEATGP 121
Query: 139 SVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLS 198
+ +L L + W L LS+ + + + + P+L+ L LS
Sbjct: 122 DLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLS 181
Query: 199 YNRLSGVIPAS-----FGQSLMQILWLNDQDAGGMTGPI-DVVAKMVSLTQLWLHGNQFT 252
N G +Q+L L + +G + A V L L L N
Sbjct: 182 DNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLR 241
Query: 253 GSIPEDIGA-LSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMGPIPKF 305
+ S L LNL+ L + A L L L+ N L P
Sbjct: 242 DAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAK--LSVLDLSYNRLDR-NPSP 292
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 57/339 (16%), Positives = 89/339 (26%), Gaps = 82/339 (24%)
Query: 110 FSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLA---NSV 166
+ G LE+ + + F D + S+ + L I
Sbjct: 39 YGGGRSLEYLLKRVDT-EADLGQFTDIIKSLSLKRLTVR--AARIPSRILFGALRVLGIS 95
Query: 167 QLTNLSLINCNLVG--PLPDFLGTLPSLAALKLSYNRLSGV---IPASFGQSLMQILWLN 221
L L+L N + G P P T P L L L + + + L+
Sbjct: 96 GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLS 155
Query: 222 DQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDI----GALSSLKDLNLNRNQ--- 274
A + + V +L+ L L N G +L+ L L
Sbjct: 156 IAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMET 215
Query: 275 LVGLIPKSLANME-LDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVL 333
G+ A L L L++N S + C
Sbjct: 216 PSGVCSALAAARVQLQGLDLSHN-------------------SLRDAAGAPSC------- 249
Query: 334 LDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLD 393
++P L S L LS T +V L ++ LD
Sbjct: 250 -------DWPSQLNS------------LNLSFTGLKQV----------PKGLPAKLSVLD 280
Query: 394 SLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPP 432
L N + P+ EL + L + N
Sbjct: 281 ------LSYNRLD-RNPS-PDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 52/279 (18%), Positives = 84/279 (30%), Gaps = 48/279 (17%)
Query: 176 CNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVV 235
CN P PD+ L A + G+SL +L D +A G +
Sbjct: 15 CNFSDPKPDWSSAFNCLGAADVELYGG--------GRSLEYLLKRVDTEAD--LGQFTDI 64
Query: 236 AKMVSLTQLWLHGNQFTGSIPED---IGALSSLKDLNLNRNQLVGLIPKSLANME---LD 289
K +SL +L + + I + +S L++L L ++ G P L L+
Sbjct: 65 IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLN 124
Query: 290 NLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQ 349
L L N A + + +PG++ L
Sbjct: 125 ILNLRNVSW--------ATRDAWLAELQQWLKPGLKV-------LSIAQ------AHSLN 163
Query: 350 WPGNDPCQGP---WLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSIS 406
+ P L LS N ++ L L L G + S
Sbjct: 164 FSCEQVRVFPALSTLDLS--DNPELGERGLISALCPLKFP----TLQVLALRNAGMETPS 217
Query: 407 GTVPNNFTELKSLRLLDVSDNNIK--PPLPEFHDTVKLV 443
G L+ LD+S N+++ P +L
Sbjct: 218 GVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLN 256
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 59/230 (25%), Positives = 100/230 (43%), Gaps = 54/230 (23%)
Query: 623 VTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQS--------- 672
V + + + +G G +G+V + + G ++AVK K FQS
Sbjct: 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK---------KLSRPFQSIIHAKRTYR 77
Query: 673 EIAVLSKVRHRHLVSLL-----GYSIEGNERL-LVYEYMP---HGALSRHLFRWEKLQLK 723
E+ +L ++H +++ LL S+E + LV M + + + +
Sbjct: 78 ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----------KCQ 127
Query: 724 PLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783
L+ + + RG++Y+H IHRDLK SN+ +++D K+ DFGL +
Sbjct: 128 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT-A 183
Query: 784 GEKS--VVTRLAGTFGYLAPEYAVM---GKITTKADVFSYGVVLMELLTG 828
E + V TR Y APE +M D++S G ++ ELLTG
Sbjct: 184 DEMTGYVATRW-----YRAPE--IMLNWMHYNQTVDIWSVGCIMAELLTG 226
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 3e-15
Identities = 25/209 (11%), Positives = 59/209 (28%), Gaps = 39/209 (18%)
Query: 89 QLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYN 148
N L ++ T + ++ L + L + + +++ L ++
Sbjct: 21 TFKAYLNGLLGQSS--TANITEAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINNI 76
Query: 149 PFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPA 208
+ ++ L L ++ ++ L L SL L +S++ I
Sbjct: 77 HATNY------NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILT 130
Query: 209 SFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDL 268
+ + + L N I + L LK L
Sbjct: 131 KI-------------------------NTLPKVNSIDLSYNGAITDI-MPLKTLPELKSL 164
Query: 269 NLNRNQLVGLIPKSLANME-LDNLVLNNN 296
N+ + + + + L+ L +
Sbjct: 165 NIQFDGVHDYRG--IEDFPKLNQLYAFSQ 191
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 4e-11
Identities = 26/170 (15%), Positives = 50/170 (29%), Gaps = 17/170 (10%)
Query: 87 FNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALD 146
Q+ L + L L ++ ++ + GLS++ L +
Sbjct: 40 EAQMNSLTYITLANINVT-DLTGIEYAHNIKDLTINNIHATNY--NPISGLSNLERLRIM 96
Query: 147 YNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVI 206
+L+ LT L + + + + TLP + ++ LSYN I
Sbjct: 97 GKDVTS----DKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI 152
Query: 207 PASFGQSLMQILWLND---QDAGGMTGPIDVVAKMVSLTQLWLHGNQFTG 253
++ L + D + L QL+ G
Sbjct: 153 MPLKTLPELKSLNIQFDGVHD-------YRGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 2e-09
Identities = 23/143 (16%), Positives = 42/143 (29%), Gaps = 20/143 (13%)
Query: 64 CSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKF-NGKLPTFSGLSELEFAYLD 122
+ T + L+ L L + + K+P SGL+ L +
Sbjct: 73 INNIHATNYN------------PISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDIS 120
Query: 123 FNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPL 182
+ D + L V + L YN + L +L +L++ +
Sbjct: 121 HSAHDDSILTKINTLPKVNSIDLSYN--GAI---TDIMPLKTLPELKSLNIQFDGVHDYR 175
Query: 183 PDFLGTLPSLAALKLSYNRLSGV 205
+ P L L + G
Sbjct: 176 G--IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 9/55 (16%), Positives = 25/55 (45%)
Query: 374 INLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNN 428
+ + ++T P+++ L SL + + ++ ++ L + +D+S N
Sbjct: 93 LRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNG 147
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 13/45 (28%), Positives = 23/45 (51%), Gaps = 1/45 (2%)
Query: 385 LSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNI 429
+P I+ L +L +R+ ++ N + L SL LLD+S +
Sbjct: 81 YNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAH 124
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 4e-15
Identities = 34/242 (14%), Positives = 67/242 (27%), Gaps = 46/242 (19%)
Query: 62 VFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYL 121
C ++VT+I P + EL
Sbjct: 14 FLCQESKVTEI-----------PSDL----------------------PRNAIEL---RF 37
Query: 122 DFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGP 181
+ I F G + + + N + D +N +L + + N +
Sbjct: 38 VLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIE---ADVFSNLPKLHEIRIEKANNLLY 94
Query: 182 LP-DFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTG-PIDVVAKMV 239
+ + LP+L L +S + +P +Q + L+ QD + + +
Sbjct: 95 INPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLS 153
Query: 240 SLTQ-LWLHGNQFTGSIPEDI-GALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNN 296
+ LWL+ N I + + N L L L ++
Sbjct: 154 FESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRT 212
Query: 297 LL 298
+
Sbjct: 213 RI 214
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 3e-12
Identities = 35/272 (12%), Positives = 79/272 (29%), Gaps = 41/272 (15%)
Query: 60 PHVFCSGNRVTQIQV-QNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP--TFSGLSEL 116
F + +I++ QN L+ F+ L KL+ + +++ + F L L
Sbjct: 47 KGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNL 106
Query: 117 EFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINC 176
++ + +P +L + N + +
Sbjct: 107 QYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNI-----------------NIHTI----- 144
Query: 177 NLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASF-GQSLMQILWLNDQDAGGMTGPIDVV 235
F+G L L+ N + + ++F G L ++ ++ + + P DV
Sbjct: 145 ----ERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEEL--PNDVF 198
Query: 236 AKMVSLTQLWLHGNQFTGSIPEDI-GALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLN 294
L + + S+P L L+ + + + + L L L
Sbjct: 199 HGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLKKLP-TLEKLVA--LMEASLT 254
Query: 295 NNL----LMGPIPKFKAGNVTYDSNSFCQSEP 322
+ + + + Q
Sbjct: 255 YPSHCCAFANWRRQISELHPICNKSILRQEVD 286
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 9e-06
Identities = 34/255 (13%), Positives = 76/255 (29%), Gaps = 41/255 (16%)
Query: 187 GTLPSLAALKLSYNRLSGVIPASF-GQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLW 245
+ L+ +L + +F G ++ + ++ D + DV + + L ++
Sbjct: 27 DLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEA-DVFSNLPKLHEIR 85
Query: 246 L-HGNQFTGSIPEDI-GALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGPI 302
+ N I + L +L+ L ++ + L + + L + +N+ + I
Sbjct: 86 IEKANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTI 144
Query: 303 PKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLG 362
NSF V W +
Sbjct: 145 E----------RNSFV----------------------GLSFESVILWLNK--NGIQEIH 170
Query: 363 LSCTSNSKVSIINLPRHNLTGTLSPSI-ANLDSLIEIRLGKNSISGTVPNNFTELKSLRL 421
S + +++ +NL +N L + + + + + I LK LR
Sbjct: 171 NSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRA 230
Query: 422 LDVSDNNIKPPLPEF 436
+ P L +
Sbjct: 231 RSTYNLKKLPTLEKL 245
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 7e-15
Identities = 47/221 (21%), Positives = 65/221 (29%), Gaps = 78/221 (35%)
Query: 62 VFCSGNRVTQI------QVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSE 115
V CS ++ +I L L N N+ T L G+ F L +
Sbjct: 16 VDCSNQKLNKIPEHIPQYTAELRL------NNNEFTVLEATGI-----------FKKLPQ 58
Query: 116 LEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLIN 175
L N+ I F+G S V + L N +L N+
Sbjct: 59 LRKINFSNNKITDIEEGAFEGASGVNEILLTSN------------------RLENV---- 96
Query: 176 CNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVV 235
F G L SL L L NR+ + D
Sbjct: 97 -----QHKMFKG-LESLKTLMLRSNRI---------TCV----------------GNDSF 125
Query: 236 AKMVSLTQLWLHGNQFTGSIPEDI-GALSSLKDLNLNRNQL 275
+ S+ L L+ NQ T ++ L SL LNL N
Sbjct: 126 IGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 9e-09
Identities = 19/106 (17%), Positives = 41/106 (38%), Gaps = 3/106 (2%)
Query: 195 LKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGS 254
L+L+ N + + + L Q+ +N + + ++ L N+ +
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE-N 95
Query: 255 IPEDI-GALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLL 298
+ + L SLK L L N++ + S + + L L +N +
Sbjct: 96 VQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQI 141
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 25/86 (29%), Positives = 35/86 (40%), Gaps = 8/86 (9%)
Query: 73 QVQNLGLKG----PLPQN-FNQLTKLYNLGLQRNKFNGKLP--TFSGLSELEFAYLDFNE 125
V + L + F L L L L+ N+ + +F GLS + L N+
Sbjct: 82 GVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQ 140
Query: 126 FDTIPSDFFDGLSSVRVLALDYNPFN 151
T+ FD L S+ L L NPFN
Sbjct: 141 ITTVAPGAFDTLHSLSTLNLLANPFN 166
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 9e-07
Identities = 24/108 (22%), Positives = 44/108 (40%), Gaps = 16/108 (14%)
Query: 198 SYNRLSGV---IPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGS 254
S +L+ + IP L LN+ + + + K+ L ++ N+ T
Sbjct: 19 SNQKLNKIPEHIPQY-----TAELRLNNNEFTVLE-ATGIFKKLPQLRKINFSNNKIT-D 71
Query: 255 IPEDIGA---LSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLL 298
I E GA S + ++ L N+L + K + L L+L +N +
Sbjct: 72 IEE--GAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRI 117
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 53/235 (22%), Positives = 95/235 (40%), Gaps = 51/235 (21%)
Query: 623 VTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRM--EAGVTTTKALDEFQSEIAVLSK 679
+ + LG GG G V+ + + ++A+K++ + AL EI ++ +
Sbjct: 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL----REIKIIRR 64
Query: 680 VRHRHLVSLL--------------GYSIEGNERLLVYEYMP---HGALSRHLFRWEKLQL 722
+ H ++V + G E N +V EYM L +
Sbjct: 65 LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ---------- 114
Query: 723 KPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLD-DDYRAKVSDFGLVKLA 781
PL + RG++Y+H +HRDLK +N+ ++ +D K+ DFGL ++
Sbjct: 115 GPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIM 171
Query: 782 PDGEKS-------VVTRLAGTFGYLAPEYAVMGKITTKA-DVFSYGVVLMELLTG 828
+VT+ Y +P + TKA D+++ G + E+LTG
Sbjct: 172 DPHYSHKGHLSEGLVTKW-----YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 221
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 2e-14
Identities = 41/193 (21%), Positives = 64/193 (33%), Gaps = 47/193 (24%)
Query: 62 VFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP--TFSGLSELEFA 119
V C G +T+I P N + + L++N +P FS +L
Sbjct: 16 VDCRGKGLTEI-----------PTNLPETIT--EIRLEQNTIK-VIPPGAFSPYKKLRRI 61
Query: 120 YLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLV 179
L N+ + D F GL S+ L L N S+ + L L L L N N +
Sbjct: 62 DLSNNQISELAPDAFQGLRSLNSLVLYGNKI-TELPKSLFEGL---FSLQLLLL-NANKI 116
Query: 180 GPLPDFL-GTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKM 238
L L +L L L N+L + +F + +
Sbjct: 117 NCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTF-------------------------SPL 151
Query: 239 VSLTQLWLHGNQF 251
++ + L N F
Sbjct: 152 RAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 26/106 (24%), Positives = 50/106 (47%), Gaps = 4/106 (3%)
Query: 195 LKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGS 254
++L N + + P +F ++ ++ + D + SL L L+GN+ T
Sbjct: 37 IRLEQNTIKVIPPGAF-SPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-E 94
Query: 255 IPEDI-GALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLL 298
+P+ + L SL+ L LN N++ L + ++ L+ L L +N L
Sbjct: 95 LPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKL 140
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 24/72 (33%), Positives = 31/72 (43%), Gaps = 4/72 (5%)
Query: 83 LPQN-FNQLTKLYNLGLQRNKFNGKLP--TFSGLSELEFAYLDFNEFDTIPSDFFDGLSS 139
LP++ F L L L L NK N L F L L L N+ TI F L +
Sbjct: 95 LPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRA 153
Query: 140 VRVLALDYNPFN 151
++ + L NPF
Sbjct: 154 IQTMHLAQNPFI 165
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 16/62 (25%), Positives = 30/62 (48%), Gaps = 3/62 (4%)
Query: 239 VSLTQLWLHGNQFTGSIPEDI-GALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNN 296
++T++ L N IP L+ ++L+ NQ+ L P + + L++LVL N
Sbjct: 32 ETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90
Query: 297 LL 298
+
Sbjct: 91 KI 92
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 6e-14
Identities = 65/312 (20%), Positives = 117/312 (37%), Gaps = 77/312 (24%)
Query: 577 AVSNDTARSLSSQTVASSGSTNSGATENSHVIESGTLVISVQVLRKVTQNFAQENELGRG 636
A + S + TV+ S ++ + ++ ++ + + +G G
Sbjct: 6 AAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRP-HSDWQIPDRYEIRHLIGTG 64
Query: 637 GFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQS---------EIAVLSKVRHRHLV 686
+G V + + + +A+K++ F+ EIA+L+++ H H+V
Sbjct: 65 SYGHVCEAYDKLEKRVVAIKKIL---------RVFEDLIDCKRILREIAILNRLNHDHVV 115
Query: 687 SLL----GYSIEGNERL-LVYEYMP---HGALSRHLFRWEKLQLKPLSWTRRLSIALDVA 738
+L +E + L +V E LFR L+ ++ ++
Sbjct: 116 KVLDIVIPKDVEKFDELYVVLEIADSDFK-----KLFR----TPVYLTELHIKTLLYNLL 166
Query: 739 RGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL---VKLAPDGEKS-------- 787
G++Y+H A +HRDLK +N L++ D KV DFGL V +G
Sbjct: 167 VGVKYVHS-AG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223
Query: 788 --------------------VVTRLAGTFGYLAPEYAVMGKITTKA-DVFSYGVVLMELL 826
VVTR Y APE ++ + T+A DV+S G + ELL
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRW-----YRAPELILLQENYTEAIDVWSIGCIFAELL 278
Query: 827 TGLAALDEERPE 838
+ +
Sbjct: 279 NMIKENVAYHAD 290
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 7e-14
Identities = 43/241 (17%), Positives = 83/241 (34%), Gaps = 35/241 (14%)
Query: 61 HVFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAY 120
+ + + + +Q L + L L NK + + L L + +
Sbjct: 50 QIIANNSDIKSVQ------------GIQYLPNVTKLFLNGNKLT-DIKPLANLKNLGWLF 96
Query: 121 LDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVG 180
LD N+ + L ++ L+L++N + + L + QL +L L N +
Sbjct: 97 LDENKVKDL--SSLKDLKKLKSLSLEHNGISDI------NGLVHLPQLESLYLGNNKITD 148
Query: 181 PLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLND---QDAGGMTGPIDVVAK 237
L L L L L N++S ++P + L Q L+L+ D + +A
Sbjct: 149 I--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKL-QNLYLSKNHISD-------LRALAG 198
Query: 238 MVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNL 297
+ +L L L + L + LV S + + + + +L
Sbjct: 199 LKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS-DDGDYEKPNVKWHL 257
Query: 298 L 298
Sbjct: 258 P 258
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 5e-05
Identities = 45/235 (19%), Positives = 87/235 (37%), Gaps = 39/235 (16%)
Query: 232 IDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIP-KSLANMELDN 290
++ S+ Q+ + + S+ + I L ++ L LN N+L + P +L N L
Sbjct: 39 AVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLTDIKPLANLKN--LGW 94
Query: 291 LVLNNNLL--MGPIPKFKAGNVTYDSNSFCQ--SEPGIECAPDVNVLLDFLGGVNYPVNL 346
L L+ N + + + K + S G+ P + L +LG N
Sbjct: 95 LFLDENKVKDLSSLKDLK--KLKSLSLEHNGISDINGLVHLPQLESL--YLGN-----NK 145
Query: 347 VSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSIS 406
++ LS +K+ ++L + ++ + P +A L L + L KN IS
Sbjct: 146 ITDIT----------VLS--RLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS 191
Query: 407 GTVPNNFTELKSLRLLDVSDNNIKPPLPEFHDTVKLV-----IDGNPLLVGGINH 456
LK+L +L++ + + DG+ + I+
Sbjct: 192 DL--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISD 244
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 8e-04
Identities = 43/226 (19%), Positives = 70/226 (30%), Gaps = 60/226 (26%)
Query: 232 IDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANME---- 287
I + L T ++ L+S+ + N + + KS+ ++
Sbjct: 17 IFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI-----KSVQGIQYLPN 69
Query: 288 LDNLVLNNNLL--MGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVN 345
+ L LN N L + P+ K N+ + + ++ D++ L D
Sbjct: 70 VTKLFLNGNKLTDIKPLANLK--NLGWLFLDENK----VK---DLSSLKDL-------KK 113
Query: 346 LVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSI 405
L S LS N I L +L L + LG N I
Sbjct: 114 LKS--------------LSLEHNGISDINGL-------------VHLPQLESLYLGNNKI 146
Query: 406 SGTVPNNFTELKSLRLLDVSDNNIK--PPLPEFHDTVKLVIDGNPL 449
T + L L L + DN I PL L + N +
Sbjct: 147 --TDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHI 190
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 50/207 (24%), Positives = 75/207 (36%), Gaps = 61/207 (29%)
Query: 95 NLGLQRNKFNGKLPT-FSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKT 153
L LQ F GL++L + LD+N+ T+ + FD L+ + L L N
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANN----- 93
Query: 154 FGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQS 213
QL +L L L L L N+L +S
Sbjct: 94 -------------QLASLP----------LGVFDHLTQLDKLYLGGNQL---------KS 121
Query: 214 LMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGA---LSSLKDLNL 270
L P V ++ L +L L+ NQ SIP GA L++L+ L+L
Sbjct: 122 L----------------PSGVFDRLTKLKELRLNTNQLQ-SIPA--GAFDKLTNLQTLSL 162
Query: 271 NRNQLVGLIPKSLANME-LDNLVLNNN 296
+ NQL + + + L + L N
Sbjct: 163 STNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 50/186 (26%), Positives = 64/186 (34%), Gaps = 66/186 (35%)
Query: 120 YLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLV 179
L T+ F GL+ + L LDYN QL LS
Sbjct: 41 DLQSTGLATLSDATFRGLTKLTWLNLDYN------------------QLQTLS------- 75
Query: 180 GPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMV 239
L L L L+ N+L SL P+ V +
Sbjct: 76 ---AGVFDDLTELGTLGLANNQL---------ASL----------------PLGVFDHLT 107
Query: 240 SLTQLWLHGNQFTGSIPEDIGA---LSSLKDLNLNRNQLVGLIPK----SLANMELDNLV 292
L +L+L GNQ S+P G L+ LK+L LN NQL + P L N L L
Sbjct: 108 QLDKLYLGGNQLK-SLPS--GVFDRLTKLKELRLNTNQLQSI-PAGAFDKLTN--LQTLS 161
Query: 293 LNNNLL 298
L+ N L
Sbjct: 162 LSTNQL 167
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 42/148 (28%), Positives = 61/148 (41%), Gaps = 17/148 (11%)
Query: 60 PHVFCSGNRVTQIQVQNLGLKGPLPQN-FNQLTKLYNLGLQRNKFNGKLPT--FSGLSEL 116
F ++T + + L+ L F+ LT+L LGL N+ LP F L++L
Sbjct: 52 DATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQL 109
Query: 117 EFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIP----DSLANSVQLTNLS 172
+ YL N+ ++PS FD L+ ++ L L+ N SIP D L L LS
Sbjct: 110 DKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-----SIPAGAFDKL---TNLQTLS 161
Query: 173 LINCNLVGPLPDFLGTLPSLAALKLSYN 200
L L L L + L N
Sbjct: 162 LSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 21/67 (31%), Positives = 34/67 (50%), Gaps = 3/67 (4%)
Query: 87 FNQLTKLYNLGLQRNKFNGKLPT--FSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLA 144
F++LTKL L L N+ +P F L+ L+ L N+ ++P FD L ++ +
Sbjct: 127 FDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTIT 185
Query: 145 LDYNPFN 151
L N F+
Sbjct: 186 LFGNQFD 192
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 3e-13
Identities = 57/254 (22%), Positives = 101/254 (39%), Gaps = 71/254 (27%)
Query: 623 VTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQS--------- 672
V N+ ++ +GRG +G VY + +A+K++ F+
Sbjct: 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN---------RMFEDLIDCKRILR 74
Query: 673 EIAVLSKVRHRHLVSLL-----GYSIEGNERLLVYEYMP---HGALSRHLFRWEKLQLKP 724
EI +L++++ +++ L ++ +E +V E LF+
Sbjct: 75 EITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLK-----KLFK----TPIF 125
Query: 725 LSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG 784
L+ +I ++ G ++H + IHRDLK +N LL+ D KV DFGL +
Sbjct: 126 LTEEHIKTILYNLLLGENFIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182
Query: 785 EKS--------------------------VVTRLAGTFGYLAPEYAVMGKITTKA-DVFS 817
+ + VVTR Y APE ++ + TK+ D++S
Sbjct: 183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTR-----WYRAPELILLQENYTKSIDIWS 237
Query: 818 YGVVLMELLTGLAA 831
G + ELL L +
Sbjct: 238 TGCIFAELLNMLQS 251
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 72.4 bits (177), Expect = 3e-13
Identities = 46/261 (17%), Positives = 85/261 (32%), Gaps = 35/261 (13%)
Query: 61 HVFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAY 120
+ + + + +Q L + L L NK + + L L + +
Sbjct: 47 QIIANNSDIKSVQ------------GIQYLPNVTKLFLNGNKLT-DIKPLTNLKNLGWLF 93
Query: 121 LDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVG 180
LD N+ + L ++ L+L++N + + L + QL +L L N +
Sbjct: 94 LDENKIKDL--SSLKDLKKLKSLSLEHNGISDI------NGLVHLPQLESLYLGNNKITD 145
Query: 181 PLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLND---QDAGGMTGPIDVVAK 237
L L L L L N++S ++P + L Q L+L+ D + +A
Sbjct: 146 I--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKL-QNLYLSKNHISD-------LRALAG 195
Query: 238 MVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKS-LANMELDNLVLNNN 296
+ +L L L + L + LV S + E N+ +
Sbjct: 196 LKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLP 255
Query: 297 LLMGPIPKFKAGNVTYDSNSF 317
+ VT
Sbjct: 256 EFTNEVSFIFYQPVTIGKAKA 276
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 57.8 bits (139), Expect = 1e-08
Identities = 50/284 (17%), Positives = 100/284 (35%), Gaps = 58/284 (20%)
Query: 186 LGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLW 245
L ++ + + S+ + N+ D + G + + ++T+L+
Sbjct: 17 DDAFAETIKDNLKKKSVTDAVTQNELNSI-DQIIANNSDIKSVQG----IQYLPNVTKLF 71
Query: 246 LHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIP-KSLANMELDNLVLNNNLLMGPIPK 304
L+GN+ T I + + L +L L L+ N++ L K L L +L L +N +
Sbjct: 72 LNGNKLT-DI-KPLTNLKNLGWLFLDENKIKDLSSLKDLKK--LKSLSLEHNGI------ 121
Query: 305 FKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLS 364
G+ P + L +LG N ++ LS
Sbjct: 122 --------------SDINGLVHLPQLESL--YLGN-----NKITDITV----------LS 150
Query: 365 CTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDV 424
+K+ ++L + ++ + P +A L L + L KN I + LK+L +L++
Sbjct: 151 --RLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHI--SDLRALAGLKNLDVLEL 204
Query: 425 SDNNIKPPLPEFHDTVKLV-----IDGNPLLVGGINHTQAPTSP 463
+ + DG+ + I+ P
Sbjct: 205 FSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKP 248
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 47.8 bits (113), Expect = 1e-05
Identities = 44/226 (19%), Positives = 70/226 (30%), Gaps = 60/226 (26%)
Query: 232 IDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANME---- 287
I + L T ++ L+S+ + N + + KS+ ++
Sbjct: 14 IFPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI-----KSVQGIQYLPN 66
Query: 288 LDNLVLNNNLL--MGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVN 345
+ L LN N L + P+ K N+ + + I+ D++ L D
Sbjct: 67 VTKLFLNGNKLTDIKPLTNLK--NLGWLFLDENK----IK---DLSSLKDL-------KK 110
Query: 346 LVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSI 405
L S LS N I L +L L + LG N I
Sbjct: 111 LKS--------------LSLEHNGISDINGL-------------VHLPQLESLYLGNNKI 143
Query: 406 SGTVPNNFTELKSLRLLDVSDNNIK--PPLPEFHDTVKLVIDGNPL 449
T + L L L + DN I PL L + N +
Sbjct: 144 --TDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHI 187
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 6e-13
Identities = 44/210 (20%), Positives = 74/210 (35%), Gaps = 53/210 (25%)
Query: 632 ELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLL 689
LG G G V + K A+K ++ + E+ + + + H+V ++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQ------DCPK-ARREVELHWRASQCPHIVRIV 77
Query: 690 GY----SIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSW-TRR--LSIALDVARGME 742
L+V E + G LF ++Q + T R I + ++
Sbjct: 78 DVYENLYAGRKCLLIVMECLDGG----ELF--SRIQDRGDQAFTEREASEIMKSIGEAIQ 131
Query: 743 YLHCLARQTFIHRDLKSSNILL---DDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYL 799
YLH HRD+K N+L + K++DFG
Sbjct: 132 YLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFG----------------------F 166
Query: 800 APEYAVMGKI-TTKADVFSYGVVLMELLTG 828
A E G+ D++S GV++ LL G
Sbjct: 167 AKE--TTGEKYDKSCDMWSLGVIMYILLCG 194
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 68.0 bits (165), Expect = 3e-12
Identities = 35/214 (16%), Positives = 65/214 (30%), Gaps = 54/214 (25%)
Query: 624 TQNFAQENELGRGGFGTVYKGELEDGTKIAVKRM------EAGVTTTKALDEFQSEIAVL 677
T+ + ++G G FG V++ D T +A+K + + K +E EI +
Sbjct: 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 678 SKV---------RHRHLVSLLGYSI------------------------------EGNER 698
++ R + L + ++
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 699 LLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLK 758
+V E+ G E+++ K S SI + + A F HRDL
Sbjct: 138 FIVLEFEFGGIDL------EQMRTKLSSLATAKSILHQLTASLAVAE--ASLRFEHRDLH 189
Query: 759 SSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRL 792
N+LL K+ K + + +
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSI 223
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 38/236 (16%), Positives = 80/236 (33%), Gaps = 30/236 (12%)
Query: 86 NFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLAL 145
L L + L + LS ++ D + ++ ++++ L L
Sbjct: 14 PDPGLANAVKQNLGKQSVT-DLVSQKELSGVQNFNGDNSNIQSL--AGMQFFTNLKELHL 70
Query: 146 DYNPFNKTFGWSIPDSLANSVQLTNLSLINCNL--VGPLPDFLGTLPSLAALKLSYNRLS 203
+N + L + +L LS+ L + + L+ L L N L
Sbjct: 71 SHNQISDL------SPLKDLTKLEELSVNRNRLKNLNGI-----PSACLSRLFLDNNELR 119
Query: 204 GVIPASFGQSLMQILWLND---QDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIG 260
++L +IL + + + I ++ + L L LHGN+ T + +
Sbjct: 120 DTDSLIHLKNL-EILSIRNNKLKS-------IVMLGFLSKLEVLDLHGNEIT-NT-GGLT 169
Query: 261 ALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMGPIPKFKAGNVTYDSNS 316
L + ++L + V K + + N V + + P + + +Y
Sbjct: 170 RLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWIS-PYYISNGGSYVDGC 224
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 5e-12
Identities = 53/226 (23%), Positives = 98/226 (43%), Gaps = 51/226 (22%)
Query: 633 LGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR---------- 681
LG G F TV+ + + + T +A+K + T+A + EI +L +V
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA---AEDEIKLLQRVNDADNTKEDSM 83
Query: 682 -HRHLVSLLGY-SIEGNERL---LVYEYMPHGALSRHLFRWEKLQLK---PLSWTRRLSI 733
H++ LL + + +G + +V+E L +L K PL + ++ I
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFE-----VLGENLLALIKKYEHRGIPLIYVKQ--I 136
Query: 734 ALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRA------KVSDFGLVKLAPDGEKS 787
+ + G++Y+H IH D+K N+L++ K++D G A ++
Sbjct: 137 SKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGN---ACWYDEH 191
Query: 788 ----VVTRLAGTFGYLAPEYAVMG-KITTKADVFSYGVVLMELLTG 828
+ TR Y +PE ++G AD++S ++ EL+TG
Sbjct: 192 YTNSIQTRE-----YRSPE-VLLGAPWGCGADIWSTACLIFELITG 231
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 6e-12
Identities = 40/215 (18%), Positives = 92/215 (42%), Gaps = 30/215 (13%)
Query: 623 VTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR 681
++ +LGRG + V++ + + K+ VK ++ V K EI +L +R
Sbjct: 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-VKKKKIK----REIKILENLR 88
Query: 682 -HRHLVSLLG--YSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVA 738
++++L LV+E++ + + ++ ++
Sbjct: 89 GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIR--------FYMYEIL 140
Query: 739 RGMEYLHCLARQTFIHRDLKSSNILLDDDYRA-KVSDFGLVKLAPDGEK---SVVTRLAG 794
+ ++Y H +HRD+K N+++D ++R ++ D+GL + G++ V +R
Sbjct: 141 KALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-- 195
Query: 795 TFGYLAPEYAVMGKITTKA-DVFSYGVVLMELLTG 828
+ PE V ++ + D++S G +L ++
Sbjct: 196 ---FKGPELLVDYQMYDYSLDMWSLGCMLASMIFR 227
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 1e-11
Identities = 62/248 (25%), Positives = 103/248 (41%), Gaps = 69/248 (27%)
Query: 623 VTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQS--------- 672
V + + +LG+G +G V+K + G +AVK K D FQ+
Sbjct: 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVK---------KIFDAFQNSTDAQRTFR 57
Query: 673 EIAVLSKVR-HRHLVSLLG--YSIEGNERLLVYEYMP---HGALSRHLFRWEKLQLKPLS 726
EI +L+++ H ++V+LL + + LV++YM H + + L
Sbjct: 58 EIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVI----------RANILE 107
Query: 727 WTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEK 786
+ + + + ++YLH +HRD+K SNILL+ + KV+DFGL + + +
Sbjct: 108 PVHKQYVVYQLIKVIKYLHS-GG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164
Query: 787 S-------------------------VVTRLAGTFGYLAPEYAVMGKITTKA-DVFSYGV 820
V TR Y APE + TK D++S G
Sbjct: 165 VTNNIPLSINENTENFDDDQPILTDYVATR-----WYRAPEILLGSTKYTKGIDMWSLGC 219
Query: 821 VLMELLTG 828
+L E+L G
Sbjct: 220 ILGEILCG 227
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 2e-10
Identities = 53/216 (24%), Positives = 90/216 (41%), Gaps = 39/216 (18%)
Query: 633 LGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEF----QSEIAVLSKVRHR---- 683
+G+G FG V K + +A+K K F Q E+ +L +
Sbjct: 62 IGKGSFGQVVKAYDRVEQEWVAIK-------IIKNKKAFLNQAQIEVRLLELMNKHDTEM 114
Query: 684 --HLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKL-QLKPLSWTRRLSIALDVARG 740
++V L + + N LV+E LS +L+ + + +S A +
Sbjct: 115 KYYIVHLKRHFMFRNHLCLVFEM-----LSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTA 169
Query: 741 MEYLHCLARQTFIHRDLKSSNILLDDDYRA--KVSDFGLVKLAPDGEKS---VVTRLAGT 795
+ +L + IH DLK NILL + R+ K+ DFG G++ + +R
Sbjct: 170 LLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFG--SSCQLGQRIYQYIQSR---- 222
Query: 796 FGYLAPEYAVMG-KITTKADVFSYGVVLMELLTGLA 830
F Y +PE ++G D++S G +L+E+ TG
Sbjct: 223 F-YRSPE-VLLGMPYDLAIDMWSLGCILVEMHTGEP 256
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 53/211 (25%), Positives = 90/211 (42%), Gaps = 31/211 (14%)
Query: 633 LGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHR------HL 685
+G+G FG V K + +A+K + + + EI +L +R + ++
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRN---EKRFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 686 VSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKL-QLKPLSWTRRLSIALDVARGMEYL 744
+ +L N + +E LS +L+ K + + S A + + ++ L
Sbjct: 162 IHMLENFTFRNHICMTFEL-----LSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDAL 216
Query: 745 HCLARQTFIHRDLKSSNILLDDDYRA--KVSDFGLVKLAPDGEKS---VVTRLAGTFGYL 799
H + IH DLK NILL R+ KV DFG + ++ + +R F Y
Sbjct: 217 H---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY--EHQRVYTYIQSR----F-YR 266
Query: 800 APEYAVMGKITTKADVFSYGVVLMELLTGLA 830
APE + + D++S G +L ELLTG
Sbjct: 267 APEVILGARYGMPIDMWSLGCILAELLTGYP 297
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 54/220 (24%), Positives = 90/220 (40%), Gaps = 25/220 (11%)
Query: 621 RKVTQNFAQENELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSK 679
+V + ++G G FG +Y G + G ++A+K +E T L E +
Sbjct: 5 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-LECVKTKHPQL---HIESKIYKM 60
Query: 680 VRH-RHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVA 738
++ + ++ EG+ ++V E + G LF + + S L +A +
Sbjct: 61 MQGGVGIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNF---CSRKFSLKTVLLLADQMI 115
Query: 739 RGMEYLHCLARQTFIHRDLKSSNILL---DDDYRAKVSDFGLVK--LAPDGEKSVVTR-- 791
+EY+H + FIHRD+K N L+ + DFGL K + + R
Sbjct: 116 SRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 172
Query: 792 --LAGTFGYLAPEYAVMGKITT-KADVFSYGVVLMELLTG 828
L GT Y A +G + + D+ S G VLM G
Sbjct: 173 KNLTGTARY-ASINTHLGIEQSRRDDLESLGYVLMYFNLG 211
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 45/222 (20%), Positives = 85/222 (38%), Gaps = 31/222 (13%)
Query: 623 VTQNFAQENELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR 681
V ++ +G G FG +++G L + ++A+K E + L + E +
Sbjct: 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK-FEPRRSDAPQLRD---EYRTYKLLA 63
Query: 682 H-RHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRW--EKLQLKPLSWTRRLSIALDVA 738
+ ++ + EG +LV + + G L K +K + A +
Sbjct: 64 GCTGIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTV-----AMAAKQML 116
Query: 739 RGMEYLHCLARQTFIHRDLKSSNILLDDDYRAK-----VSDFGLVKLAPDGEKSV----- 788
++ +H ++ ++RD+K N L+ V DFG+VK D
Sbjct: 117 ARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYR 173
Query: 789 -VTRLAGTFGYLAPEYAVMGKITT-KADVFSYGVVLMELLTG 828
L+GT Y +G+ + + D+ + G V M L G
Sbjct: 174 EKKNLSGTARY-MSINTHLGREQSRRDDLEALGHVFMYFLRG 214
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 56/229 (24%), Positives = 90/229 (39%), Gaps = 32/229 (13%)
Query: 616 SVQVLRKVTQNFAQENELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEI 674
S+ VL V NF ++G G FG + G+ L +A+K +E + L E
Sbjct: 1 SMGVLM-VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHL---EY 55
Query: 675 AVLSKVRH-RHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRW--EKLQLKPLSWTRRL 731
++ + + + G +V E + G LF LK + L
Sbjct: 56 RFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTV-----L 108
Query: 732 SIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVS-----DFGLVK--LAPDG 784
IA+ + MEY+H + I+RD+K N L+ DF L K + P+
Sbjct: 109 MIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPET 165
Query: 785 EKSVVTR----LAGTFGYLAPEYAVMGKITT-KADVFSYGVVLMELLTG 828
+K + R L GT Y +GK + + D+ + G + M L G
Sbjct: 166 KKHIPYREHKSLTGTARY-MSINTHLGKEQSRRDDLEALGHMFMYFLRG 213
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 29/218 (13%), Positives = 71/218 (32%), Gaps = 37/218 (16%)
Query: 582 TARSLSSQTVASSGSTNSGATENSHVIESGTLVISVQVLRKVTQNFAQENELGRGGFGTV 641
+ L ++ + T S + +GT++ + + ++ R G +
Sbjct: 9 SGVDLGTENLYFQSMTTS-----LEALPTGTVLTDK-----SGRQWKLKSFQTRDNQGIL 58
Query: 642 YKGE---------LEDGTKIAVK--------RMEAGVTTTKALDEFQSEIAVLSKVRHRH 684
Y+ K ++K E A ++ L
Sbjct: 59 YEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLA 118
Query: 685 LVSLLGY-SIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEY 743
+ + +G+ + R LV + G + + L +A + +E+
Sbjct: 119 IPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSV--LQVACRLLDALEF 174
Query: 744 LHCLARQTFIHRDLKSSNILLDDDYRAKV--SDFGLVK 779
LH ++H ++ + NI +D + +++V + +G
Sbjct: 175 LH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 30/106 (28%), Positives = 49/106 (46%), Gaps = 5/106 (4%)
Query: 195 LKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGS 254
L L N+++ + P F SL+ + L P+ V + LT L L NQ T
Sbjct: 45 LYLHDNQITKLEPGVF-DSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT-V 102
Query: 255 IPEDI-GALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLL 298
+P + L LK+L + N+L +P+ + + L +L L+ N L
Sbjct: 103 LPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQL 147
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 5e-09
Identities = 41/161 (25%), Positives = 57/161 (35%), Gaps = 39/161 (24%)
Query: 95 NLGLQRNKFNGKLPT-FSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKT 153
L L N+ P F L L+ YL N+ +P FD L+ + VL L N
Sbjct: 44 ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT-- 101
Query: 154 FGWSIP----DSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPAS 209
+P D L V L L + CN + LP + L L L L N+L + +
Sbjct: 102 ---VLPSAVFDRL---VHLKELFM-CCNKLTELPRGIERLTHLTHLALDQNQLKSIPHGA 154
Query: 210 FGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQ 250
F ++ SLT +L GN
Sbjct: 155 F-------------------------DRLSSLTHAYLFGNP 170
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 9e-05
Identities = 28/85 (32%), Positives = 39/85 (45%), Gaps = 7/85 (8%)
Query: 73 QVQNLGLKG----PLPQN-FNQLTKLYNLGLQRNKFNGKLPT-FSGLSELEFAYLDFNEF 126
Q+ L L LP F++L L L + NK +LP L+ L LD N+
Sbjct: 89 QLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQL 147
Query: 127 DTIPSDFFDGLSSVRVLALDYNPFN 151
+IP FD LSS+ L NP++
Sbjct: 148 KSIPHGAFDRLSSLTHAYLFGNPWD 172
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 8e-04
Identities = 23/63 (36%), Positives = 29/63 (46%), Gaps = 5/63 (7%)
Query: 239 VSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGL---IPKSLANMELDNLVLNN 295
+ L+LH NQ T P +L +LK+L L NQL L + SL L L L
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQ--LTVLDLGT 97
Query: 296 NLL 298
N L
Sbjct: 98 NQL 100
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 58.9 bits (142), Expect = 5e-09
Identities = 56/219 (25%), Positives = 95/219 (43%), Gaps = 25/219 (11%)
Query: 622 KVTQNFAQENELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV 680
+V F ++G G FG +Y G ++ ++A+K +E T L E + +
Sbjct: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQL---LYESKIYRIL 59
Query: 681 R-HRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVAR 739
+ + ++ + +EG+ +LV + + G LF + + LS L +A +
Sbjct: 60 QGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNF---CSRKLSLKTVLMLADQMIN 114
Query: 740 GMEYLHCLARQTFIHRDLKSSNILLDDDYRAK---VSDFGLVKLAPDGEKSV------VT 790
+E++H ++F+HRD+K N L+ RA + DFGL K D
Sbjct: 115 RVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENK 171
Query: 791 RLAGTFGYLAPEYAVMGKITT-KADVFSYGVVLMELLTG 828
L GT Y A +G + + D+ S G VLM L G
Sbjct: 172 NLTGTARY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRG 209
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 36/109 (33%), Positives = 45/109 (41%), Gaps = 10/109 (9%)
Query: 195 LKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGS 254
L L N L + F L + L + P V K+ SLT L L NQ S
Sbjct: 33 LDLETNSLKSLPNGVF-DELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ-S 90
Query: 255 IPEDI-GALSSLKDLNLNRNQLVGLIPK----SLANMELDNLVLNNNLL 298
+P + L+ LK+L LN NQL L P L L +L L N L
Sbjct: 91 LPNGVFDKLTQLKELALNTNQLQSL-PDGVFDKLTQ--LKDLRLYQNQL 136
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 52/219 (23%), Positives = 76/219 (34%), Gaps = 74/219 (33%)
Query: 64 CSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPT-FSGLSELEFAYLD 122
CSG V + + G +P T L L+ N F L+ L YL
Sbjct: 7 CSGTTV---ECYSQGRTS-VPTGIPAQTT--YLDLETNSLKSLPNGVFDELTSLTQLYLG 60
Query: 123 FNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIP----DSLANSVQLTNLSLINCNL 178
N+ ++P+ F+ L+S+ L L N S+P D L QL L+
Sbjct: 61 GNKLQSLPNGVFNKLTSLTYLNLSTNQLQ-----SLPNGVFDKL---TQLKELA------ 106
Query: 179 VGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKM 238
L+ N+L QSL P V K+
Sbjct: 107 ------------------LNTNQL---------QSL----------------PDGVFDKL 123
Query: 239 VSLTQLWLHGNQFTGSIPEDIGA---LSSLKDLNLNRNQ 274
L L L+ NQ S+P+ G L+SL+ + L+ N
Sbjct: 124 TQLKDLRLYQNQLK-SVPD--GVFDRLTSLQYIWLHDNP 159
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 22/67 (32%), Positives = 38/67 (56%), Gaps = 3/67 (4%)
Query: 87 FNQLTKLYNLGLQRNKFNGKLPT--FSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLA 144
F++LT+L L L N+ LP F L++L+ L N+ ++P FD L+S++ +
Sbjct: 96 FDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIW 154
Query: 145 LDYNPFN 151
L NP++
Sbjct: 155 LHDNPWD 161
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 57.1 bits (137), Expect = 2e-08
Identities = 43/249 (17%), Positives = 86/249 (34%), Gaps = 35/249 (14%)
Query: 51 DDPCGPPPWPHVFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNK---FNGKL 107
+D + ++ + + + + ++ +L+ L K +L
Sbjct: 310 NDQLPQHTFRVIWTGSDSQKECVLLKDRPEC-WCRDSATDEQLFRCELSVEKSTVLQSEL 368
Query: 108 PTFSGLSELEFAY-------------LDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTF 154
+ L ELE LD ++ +F L +V + Y ++
Sbjct: 369 ESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSK 428
Query: 155 G-WSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFG-- 211
+ L L + +L + L L + L LS+NRL +P +
Sbjct: 429 FLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLR-ALPPALAAL 485
Query: 212 QSLMQILWLND---QDAGGMTGPIDVVAKMVSLTQLWLHGNQFTG-SIPEDIGALSSLKD 267
+ L ++L +D ++ +D VA + L +L L N+ + + + + L
Sbjct: 486 RCL-EVLQASDNALEN-------VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVL 537
Query: 268 LNLNRNQLV 276
LNL N L
Sbjct: 538 LNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 48.2 bits (114), Expect = 1e-05
Identities = 44/285 (15%), Positives = 87/285 (30%), Gaps = 16/285 (5%)
Query: 23 TDPND------LKILNDFKNGLENPELLKWPANGD--DPCGPPPWPHVFCSGNRVTQIQV 74
TDPND + L + + C P G + +
Sbjct: 221 TDPNDQSAWFYHRWLLGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDE 280
Query: 75 QNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFF 134
L ++ P N+ + ++ L N +LP + +
Sbjct: 281 APLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPEC 340
Query: 135 DGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAA 194
S L + + L + +L L N + + + L L
Sbjct: 341 WCRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400
Query: 195 LKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGS 254
K + S + M+ +L+D + + + + + L L T
Sbjct: 401 EKETLQYFSTLKAVDP----MRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-V 455
Query: 255 IPEDIGALSSLKDLNLNRNQLVGLIPKSLANME-LDNLVLNNNLL 298
+ + L + L+L+ N+L +P +LA + L+ L ++N L
Sbjct: 456 LCH-LEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNAL 498
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 45.5 bits (107), Expect = 8e-05
Identities = 48/314 (15%), Positives = 90/314 (28%), Gaps = 39/314 (12%)
Query: 164 NSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIP--ASFGQSLMQILWLN 221
+ + ++S L L + L L + + G++ +WL
Sbjct: 243 DVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLC 302
Query: 222 DQDAGGMTGPIDVVAKMVSLTQL-----WLHGNQFTGSIPEDIGALSSLKDLNLNRNQLV 276
D A + + V T + D L L+ +
Sbjct: 303 DLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST 362
Query: 277 GLIPKSLANMELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVL--L 334
L + + EL L N + + + E + L +
Sbjct: 363 VLQSELESCKELQELEPENKWCLL--------TIILLMRALDPLLYEKETLQYFSTLKAV 414
Query: 335 DFLGGVNYPVNLVSQWPGNDPCQGPWLG----LSCTSNSKVSIINLPR----------HN 380
D + Y +L S++ + L + +L + HN
Sbjct: 415 DPMR-AAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVLCHLEQLLLVTHLDLSHN 473
Query: 381 LTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIK-----PPLPE 435
L P++A L L ++ N++ V L L+ L + +N ++ PL
Sbjct: 474 RLRALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQSAAIQPLVS 531
Query: 436 FHDTVKLVIDGNPL 449
V L + GN L
Sbjct: 532 CPRLVLLNLQGNSL 545
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 3e-08
Identities = 32/130 (24%), Positives = 56/130 (43%), Gaps = 25/130 (19%)
Query: 62 VFCSGNRVTQI------QVQNLGLKG----PLPQNFNQLTKLYNLGLQRNKFNGKLP--T 109
V CS + + V L L G +P+ + L + L N+ + L +
Sbjct: 15 VRCSNKGLKVLPKGIPRDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRIS-TLSNQS 73
Query: 110 FSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIP----DSLANS 165
FS +++L L +N IP FDGL S+R+L+L N + +P + L+
Sbjct: 74 FSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDIS-----VVPEGAFNDLSA- 127
Query: 166 VQLTNLSLIN 175
L++L++
Sbjct: 128 --LSHLAIGA 135
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 27/137 (19%), Positives = 42/137 (30%), Gaps = 43/137 (31%)
Query: 169 TNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGM 228
T L L + N +P L L + LS NR+ +L
Sbjct: 34 TELYL-DGNQFTLVPKELSNYKHLTLIDLSNNRI---------STL-------------- 69
Query: 229 TGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGA---LSSLKDLNLNRNQLVGLIPKSLAN 285
+ M L L L N+ IP L SL+ L+L+ N + +
Sbjct: 70 --SNQSFSNMTQLLTLILSYNRLR-CIPP--RTFDGLKSLRLLSLHGNDI-----SVVPE 119
Query: 286 MELDNLV------LNNN 296
++L + N
Sbjct: 120 GAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 5e-06
Identities = 26/95 (27%), Positives = 41/95 (43%), Gaps = 5/95 (5%)
Query: 60 PHVFCSGNRVTQIQVQNLGLKGPLPQN-FNQLTKLYNLGLQRNKFNGKLPT--FSGLSEL 116
P + +T I + N + L F+ +T+L L L N+ +P F GL L
Sbjct: 47 PKELSNYKHLTLIDLSNNRIST-LSNQSFSNMTQLLTLILSYNRLRC-IPPRTFDGLKSL 104
Query: 117 EFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFN 151
L N+ +P F+ LS++ LA+ NP
Sbjct: 105 RLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 4e-08
Identities = 40/231 (17%), Positives = 78/231 (33%), Gaps = 51/231 (22%)
Query: 633 LGRGGFGTVYKGELEDGTKIAVK---------------RMEAGVTTTKALDEFQSEIAVL 677
+G+GGFG +Y ++ + E A E +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 678 SKVRHRHLVSLLGYSIEGNE----RLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSI 733
K+++ + G + R ++ + G+ + ++ K S L +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEA---NAKRFSRKTVLQL 157
Query: 734 ALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKV--SDFGLVKLAPDGEKSVV-- 789
+L + +EY+H ++H D+K+SN+LL+ +V D+GL
Sbjct: 158 SLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYA 214
Query: 790 ----TRLAGTFGYLAPEYAVMGKITT--------KADVFSYGVVLMELLTG 828
GT E+ I + D+ G +++ LTG
Sbjct: 215 ADPKRCHDGT-----IEFTS---IDAHNGVAPSRRGDLEILGYCMIQWLTG 257
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 4e-08
Identities = 57/256 (22%), Positives = 91/256 (35%), Gaps = 71/256 (27%)
Query: 633 LGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR--------HR 683
LG G F TV+ ++ +A+K +++ T+ + EI +L VR
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD---EIRLLKSVRNSDPNDPNRE 101
Query: 684 HLVSLLGY----SIEGNERLLVYEYM-PHGALSRHLFRWEKLQLKPLSWTRRLSIALDVA 738
+V LL + G +V+E + H ++ L PL ++ I V
Sbjct: 102 MVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGL---PLPCVKK--IIQQVL 156
Query: 739 RGMEYLHCLARQTFIHRDLKSSNILLDDD------------------------------- 767
+G++YLH R IH D+K NILL +
Sbjct: 157 QGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAP 214
Query: 768 ----------YRAKVSDFGLVKLAPDGE----KSVVTRLAGTFGYLAPEYAVMG-KITTK 812
K ++ VK+A G T T Y + E ++G T
Sbjct: 215 ATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLE-VLIGSGYNTP 273
Query: 813 ADVFSYGVVLMELLTG 828
AD++S + EL TG
Sbjct: 274 ADIWSTACMAFELATG 289
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.0 bits (134), Expect = 5e-08
Identities = 46/321 (14%), Positives = 104/321 (32%), Gaps = 69/321 (21%)
Query: 650 TKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRH---------LVS--LLGYSIEGNER 698
K V R++ + +AL E + VL + + L Y ++
Sbjct: 127 AKYNVSRLQPYLKLRQALLELRPAKNVL--I---DGVLGSGKTWVALDVCLSYKVQCKMD 181
Query: 699 LLVYEYMPHGALSRHLFRWEKLQ-----LKPLSWTRRLSIALDVARGMEYLHCLARQTFI 753
++ ++ + E LQ + P +WT R + ++ + + R+
Sbjct: 182 FKIF-WLNLKNCNSPETVLEMLQKLLYQIDP-NWTSRSDHSSNIKLRIHSIQAELRRLLK 239
Query: 754 HRDLKSSNILLDDDYRAKVSD-FGLVKLAPDGEKSVV-TRLAGTFGYLAPEYAVMGKITT 811
+ ++ ++L + AK + F L K ++ TR +L+ TT
Sbjct: 240 SKPYENCLLVLLNVQNAKAWNAFNL------SCKILLTTRFKQVTDFLS------AATTT 287
Query: 812 KADVFSYGVVLMELLTGLAALDEERPEESR-YLAEWFWRIKSSKEKFKA-AIDPALEVNE 869
+ L L P+E + L ++ + + +P
Sbjct: 288 H-------ISLDHHSMTLT------PDEVKSLLLKYLD-CRPQDLPREVLTTNPRR---- 329
Query: 870 ETFESISIVAELAGHCTAR-EPYHRPDMGHVVNVLSPLVEKWRPITDESEC---CSGIDY 925
+SI+AE A + + + + ++ + P + + S
Sbjct: 330 -----LSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEP-AEYRKMFDRLSVFPP 383
Query: 926 SLPLP-QMLKV-WQEAESKEI 944
S +P +L + W + ++
Sbjct: 384 SAHIPTILLSLIWFDVIKSDV 404
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.8 bits (123), Expect = 1e-06
Identities = 47/275 (17%), Positives = 83/275 (30%), Gaps = 73/275 (26%)
Query: 59 WPHV-FCSGNRVTQIQVQNLGLKGPLPQNFNQLTK-LYNLGLQRNKFNGKLPTFSGLSEL 116
W ++ C+ +Q L + + N+ + N+ L+ + +L
Sbjct: 186 WLNLKNCNSPETVLEMLQKLLYQ--IDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY 243
Query: 117 EFAY--LD-------FNEFD--------TIPSDFFDGLSSVRVLALDYNPFNKTFG---- 155
E L +N F+ T D LS+ + + + T
Sbjct: 244 ENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEV 303
Query: 156 --------WSIPDSLANSVQLTNLSLINCNLVGP-LPDFLGTL----------------P 190
P L V TN ++ ++ + D L T
Sbjct: 304 KSLLLKYLDCRPQDLPREVLTTNPRRLS--IIAESIRDGLATWDNWKHVNCDKLTTIIES 361
Query: 191 SLAAL-----KLSYNRLS----GV-IPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVS 240
SL L + ++RLS IP L+ ++W + + + VV K+
Sbjct: 362 SLNVLEPAEYRKMFDRLSVFPPSAHIPTI----LLSLIWFDVIK----SDVMVVVNKLHK 413
Query: 241 LTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQL 275
+ + + T SIP I LK N L
Sbjct: 414 YSLVEKQPKESTISIP-SI--YLELKVKLENEYAL 445
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 3e-04
Identities = 57/410 (13%), Positives = 95/410 (23%), Gaps = 134/410 (32%)
Query: 94 YNLGLQRNKFNGKLPTFSG--LSELEFAY-LDF-------NEFDTI---PSDFFDGLSSV 140
+ G + ++ L F + + D E D I +S
Sbjct: 9 FETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDA----VSGT 64
Query: 141 RVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYN 200
L F W++ VQ F+ L+++Y
Sbjct: 65 LRL----------F-WTLLSKQEEMVQ----------------KFVEE-----VLRINYK 92
Query: 201 RLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVS-LTQLWLHGNQFTG---SIP 256
+L P + + +L+ F S
Sbjct: 93 ------------------FLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRL 134
Query: 257 EDIGAL-SSLKDLNLNRNQLVGL-----IPKS-LANMELDNLVLNNNLLMGPIPKF--KA 307
+ L +L L L + V + K+ +A + + + F
Sbjct: 135 QPYLKLRQAL--LELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKM---DFKIFWLNL 189
Query: 308 GNVTYDS------NSFC-QSEPGIECAPD--VNVLLDFLGGVNYPVNLVSQWPGN----- 353
N Q +P D N+ L L+ P
Sbjct: 190 KNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLV 249
Query: 354 -DPCQGPW----LGLSC----TSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNS 404
Q LSC T+ K +T LS + SL +
Sbjct: 250 LLNVQNAKAWNAFNLSCKILLTTRFK---------QVTDFLSAATTTHISLDHHSMT--- 297
Query: 405 ISGTVPNNFTELKSLRLLDVSDNNIKPPLPEFHDTVKLVIDGNPLLVGGI 454
T + LL + LP V+ NP + I
Sbjct: 298 --------LTPDEVKSLLLKYLDCRPQDLPR------EVLTTNPRRLSII 333
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 9e-08
Identities = 28/128 (21%), Positives = 46/128 (35%), Gaps = 22/128 (17%)
Query: 62 VFCSGNRVTQI------QVQNLGLKG------PLPQNFNQLTKLYNLGLQRNKFNGKLP- 108
V C+G + +I L L F +L L L L+RN+ +
Sbjct: 13 VDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEP 71
Query: 109 -TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQ 167
F G S ++ L N+ I + F GL ++ L L N + +
Sbjct: 72 NAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQIS-----CVMPGSFEH-- 124
Query: 168 LTNLSLIN 175
L +L+ +N
Sbjct: 125 LNSLTSLN 132
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 9e-07
Identities = 21/109 (19%), Positives = 36/109 (33%), Gaps = 13/109 (11%)
Query: 195 LKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGS 254
L L+ N L + L ++ L + + + +L L N+
Sbjct: 34 LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK-E 92
Query: 255 IPEDI-GALSSLKDLNLNRNQLVGLIPKSLANMELDNLV------LNNN 296
I + L LK LNL NQ+ + ++L L +N
Sbjct: 93 ISNKMFLGLHQLKTLNLYDNQI-----SCVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 6e-06
Identities = 20/67 (29%), Positives = 31/67 (46%), Gaps = 3/67 (4%)
Query: 87 FNQLTKLYNLGLQRNKFNGKLPT--FSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLA 144
F + + L L NK ++ F GL +L+ L N+ + F+ L+S+ L
Sbjct: 74 FEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLN 132
Query: 145 LDYNPFN 151
L NPFN
Sbjct: 133 LASNPFN 139
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 43/231 (18%), Positives = 74/231 (32%), Gaps = 54/231 (23%)
Query: 633 LGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVL---------SKVRH 682
+G GGFG +Y K A ++ L SE+ K
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLF---SELKFYQRVAKKDCIKKWIE 101
Query: 683 RHLVSLLG----------YSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLS 732
R + LG + R +V E L L +K+
Sbjct: 102 RKQLDYLGIPLFYGSGLTEFKGRSYRFMVMER-----LGIDL---QKI----SGQNGTFK 149
Query: 733 ------IALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKV--SDFGLVKLAPDG 784
+ + + +EY+H ++H D+K++N+LL +V +D+GL
Sbjct: 150 KSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPN 206
Query: 785 EKSV------VTRLAGTFGYLAPEYAVMGK-ITTKADVFSYGVVLMELLTG 828
GT + A G ++ ++DV G ++ L G
Sbjct: 207 GNHKQYQENPRKGHNGTIEF-TSLDAHKGVALSRRSDVEILGYCMLRWLCG 256
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 54.0 bits (129), Expect = 1e-07
Identities = 21/132 (15%), Positives = 38/132 (28%), Gaps = 22/132 (16%)
Query: 52 DPCGPPPWPHVFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP--T 109
D C P + C+ + + L L ++ + L
Sbjct: 3 DACCPHGSSGLRCTRDGALDS-----------LHHLPGAENLTELYIENQQHLQHLELRD 51
Query: 110 FSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLT 169
GL EL + + + D F + L L +N S+ + L
Sbjct: 52 LRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-----SLSWKTVQGLSLQ 106
Query: 170 NLSL----INCN 177
L L ++C+
Sbjct: 107 ELVLSGNPLHCS 118
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 51.7 bits (123), Expect = 6e-07
Identities = 25/121 (20%), Positives = 37/121 (30%), Gaps = 27/121 (22%)
Query: 157 SIPDSLANSVQLTNLSLINCNLVGPLPDF-LGTLPSLAALKLSYNRLSGVIPASFGQSLM 215
L + LT L + N + L L L L L + + L V P +F
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF----- 76
Query: 216 QILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQL 275
L++L L N S+ SL++L L+ N L
Sbjct: 77 --------------------HFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
Query: 276 V 276
Sbjct: 116 H 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 51.3 bits (122), Expect = 8e-07
Identities = 21/131 (16%), Positives = 37/131 (28%), Gaps = 27/131 (20%)
Query: 167 QLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAG 226
+ L + L G +L L + + +
Sbjct: 9 GSSGLRCTRDGALDSLHHLPG-AENLTELYIENQQHLQHLEL------------------ 49
Query: 227 GMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDI-GALSSLKDLNLNRNQLVGLIPKSLAN 285
+ + L L + + + D L LNL+ N L L K++
Sbjct: 50 ------RDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNLSFNALESLSWKTVQG 102
Query: 286 MELDNLVLNNN 296
+ L LVL+ N
Sbjct: 103 LSLQELVLSGN 113
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.5 bits (120), Expect = 2e-06
Identities = 19/90 (21%), Positives = 34/90 (37%), Gaps = 3/90 (3%)
Query: 134 FDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLA 193
G ++ L ++ + L +L NL+++ L PD P L+
Sbjct: 27 LPGAENLTELYIENQQHLQHLEL---RDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS 83
Query: 194 ALKLSYNRLSGVIPASFGQSLMQILWLNDQ 223
L LS+N L + + +Q L L+
Sbjct: 84 RLNLSFNALESLSWKTVQGLSLQELVLSGN 113
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 48/231 (20%), Positives = 84/231 (36%), Gaps = 49/231 (21%)
Query: 633 LGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEF----QSEIAVLSKVRHR---- 683
+G G FG V + +++ AVK + + ++ + E +L K+++
Sbjct: 43 MGDGTFGRVLLCQHIDNKKYYAVK-------VVRNIKKYTRSAKIEADILKKIQNDDINN 95
Query: 684 -HLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKL-QLKPLSWTRRLSIALDVARGM 741
++V G + + L++E L L+ +++ + +
Sbjct: 96 NNIVKYHGKFMYYDHMCLIFE-----PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKAL 150
Query: 742 EYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGT----FG 797
YL + + H DLK NILLDD Y K + T+ G FG
Sbjct: 151 NYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG 207
Query: 798 -----------------YLAPEYAVMG-KITTKADVFSYGVVLMELLTGLA 830
Y APE ++ +D++S+G VL EL TG
Sbjct: 208 CATFKSDYHGSIINTRQYRAPE-VILNLGWDVSSDMWSFGCVLAELYTGSL 257
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 3e-07
Identities = 42/232 (18%), Positives = 77/232 (33%), Gaps = 55/232 (23%)
Query: 633 LGRGGFGTVYKG--ELEDGTKIAVKRMEAGVTTTKALDEF----QSEIAVLSKVRHR--- 683
LG G FG V + +++A+K + + + ++ + EI VL K++ +
Sbjct: 27 LGEGTFGKVVECLDHARGKSQVALKII-------RNVGKYREAARLEINVLKKIKEKDKE 79
Query: 684 ---HLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKL-QLKPLSWTRRLSIALDVAR 739
V + + + +E L ++ F + K +P +A +
Sbjct: 80 NKFLCVLMSDWFNFHGHMCIAFE-----LLGKNTFEFLKENNFQPYPLPHVRHMAYQLCH 134
Query: 740 GMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKS------------ 787
+ +LH H DLK NIL + + + + +
Sbjct: 135 ALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF 191
Query: 788 --------VVTRLAGTFGYLAPEYAVMG-KITTKADVFSYGVVLMELLTGLA 830
V TR Y PE ++ DV+S G +L E G
Sbjct: 192 DHEHHTTIVATR----H-YRPPE-VILELGWAQPCDVWSIGCILFEYYRGFT 237
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 8e-07
Identities = 34/111 (30%), Positives = 50/111 (45%), Gaps = 18/111 (16%)
Query: 195 LKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGS 254
L+L N+L + F L Q+ L+ + P V K+ LT L+LH N+ S
Sbjct: 33 LELESNKLQSLPHGVF-DKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQ-S 90
Query: 255 IPEDIGA---LSSLKDLNLNRNQLVGLIPKSLANMELDNLV------LNNN 296
+P G L+ LK+L L+ NQL KS+ + D L L+ N
Sbjct: 91 LPN--GVFDKLTQLKELALDTNQL-----KSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 5e-05
Identities = 25/67 (37%), Positives = 39/67 (58%), Gaps = 3/67 (4%)
Query: 87 FNQLTKLYNLGLQRNKFNGKLPT--FSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLA 144
F++LTKL L L NK LP F L++L+ LD N+ ++P FD L+S++ +
Sbjct: 72 FDKLTKLTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIW 130
Query: 145 LDYNPFN 151
L NP++
Sbjct: 131 LHTNPWD 137
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 35/137 (25%), Positives = 53/137 (38%), Gaps = 41/137 (29%)
Query: 120 YLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIP----DSLANSVQLTNLSLIN 175
L+ N+ ++P FD L+ + L+L N S+P D L +LT L L +
Sbjct: 34 ELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-----SLPDGVFDKL---TKLTILYL-H 84
Query: 176 CNLVGPLPD--FLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPID 233
N + LP+ F L L L L N+L V P
Sbjct: 85 ENKLQSLPNGVF-DKLTQLKELALDTNQLKSV-------------------------PDG 118
Query: 234 VVAKMVSLTQLWLHGNQ 250
+ ++ SL ++WLH N
Sbjct: 119 IFDRLTSLQKIWLHTNP 135
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 5e-04
Identities = 26/87 (29%), Positives = 37/87 (42%), Gaps = 15/87 (17%)
Query: 95 NLGLQRNKFNGKLPT--FSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNK 152
L L+ NK LP F L++L L N+ ++P FD L+ + +L L N
Sbjct: 32 RLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQ- 89
Query: 153 TFGWSIP----DSLANSVQLTNLSLIN 175
S+P D L QL L+L
Sbjct: 90 ----SLPNGVFDKL---TQLKELALDT 109
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 7e-06
Identities = 35/191 (18%), Positives = 62/191 (32%), Gaps = 32/191 (16%)
Query: 138 SSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNL-------------VGPLPD 184
+ + L N F T + D L+ L +L L N L +
Sbjct: 94 PKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNK 153
Query: 185 FLGTLPSLAALKLSYNRLSGVIPASFGQSLMQI-------LWLND-QDAGGMTGPIDVVA 236
P L ++ NRL + ++ + N + G ++ +A
Sbjct: 154 KAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLA 213
Query: 237 KMVSLTQLWLHGNQFTG----SIPEDIGALSSLKDLNLNRNQL----VGLIPKSLA---N 285
L L L N FT ++ + + +L++L LN L + + + N
Sbjct: 214 YCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLEN 273
Query: 286 MELDNLVLNNN 296
+ L L L N
Sbjct: 274 IGLQTLRLQYN 284
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 4e-04
Identities = 42/321 (13%), Positives = 92/321 (28%), Gaps = 65/321 (20%)
Query: 139 SVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGP-----LPDFLGTLPSLA 193
S+ +L + S+ L + + L + G L + + + L
Sbjct: 5 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTI-GTEAARWLSENIASKKDLE 63
Query: 194 ALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTG 253
+ S + D+ + + + K L + L N F
Sbjct: 64 IAEFSDIFTGR---------------VKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGP 108
Query: 254 SIPEDIGAL----SSLKDLNLNRNQL----VGLIPKSLANMELDNLVLNNNLLMGPIPKF 305
+ E + + L+ L L+ N L I ++L + ++ N L
Sbjct: 109 TAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLR----SI 164
Query: 306 KAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSC 365
G N + ++ V +V + + L
Sbjct: 165 ICGR-----NRL-----ENGSMKEWAKTFQSHRLLHT-VKMVQNGIRPEGIEH-LLLEGL 212
Query: 366 TSNSKVSIINLPRHNLTGT-----LSPSIANLDSLIEIRLGKNSISG----------TVP 410
++ +++L + N L+ ++ + +L E+ L +S +
Sbjct: 213 AYCQELKVLDL-QDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKL 271
Query: 411 NNFTELKSLRLLDVSDNNIKP 431
N L+ L + N I+
Sbjct: 272 EN----IGLQTLRLQYNEIEL 288
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 1e-05
Identities = 34/109 (31%), Positives = 47/109 (43%), Gaps = 23/109 (21%)
Query: 198 SYNRLSGV---IPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGS 254
RL+ V IP Q LWLN+ + V +V+L QL+ + N+ T +
Sbjct: 20 QNIRLASVPAGIPTD-----KQRLWLNNNQITKL--EPGVFDHLVNLQQLYFNSNKLT-A 71
Query: 255 IPEDI-GALSSLKDLNLNRNQLVGLIPKSLANMELDNLV------LNNN 296
IP + L+ L L+LN N L KS+ DNL L NN
Sbjct: 72 IPTGVFDKLTQLTQLDLNDNHL-----KSIPRGAFDNLKSLTHIYLYNN 115
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 48/232 (20%), Positives = 75/232 (32%), Gaps = 55/232 (23%)
Query: 633 LGRGGFGTVYKG--ELEDGTKIAVKRMEAGVTTTKALDEF----QSEIAVLSKVRHR--- 683
LG G FG V + G +AVK K +D + +SEI VL +
Sbjct: 22 LGEGAFGKVVECIDHKAGGRHVAVK-------IVKNVDRYCEAARSEIQVLEHLNTTDPN 74
Query: 684 ---HLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKL-QLKPLSWTRRLSIALDVAR 739
V +L + +V+E L + + K P +A + +
Sbjct: 75 STFRCVQMLEWFEHHGHICIVFE-----LLGLSTYDFIKENGFLPFRLDHIRKMAYQICK 129
Query: 740 GMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKS------------ 787
+ +LH H DLK NIL + + + +
Sbjct: 130 SVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY 186
Query: 788 --------VVTRLAGTFGYLAPEYAVMG-KITTKADVFSYGVVLMELLTGLA 830
V TR Y APE ++ + DV+S G +L+E G
Sbjct: 187 DDEHHSTLVSTR----H-YRAPE-VILALGWSQPCDVWSIGCILIEYYLGFT 232
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 2e-05
Identities = 34/109 (31%), Positives = 47/109 (43%), Gaps = 23/109 (21%)
Query: 198 SYNRLSGV---IPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGS 254
S L+ V IP + Q+L+L D + V ++ LT+L L NQ T
Sbjct: 17 SGKSLASVPTGIPTT-----TQVLYLYDNQITKL--EPGVFDRLTQLTRLDLDNNQLT-V 68
Query: 255 IPEDI-GALSSLKDLNLNRNQLVGLIPKSLANMELDNLV------LNNN 296
+P + L+ L L+LN NQL KS+ DNL L NN
Sbjct: 69 LPAGVFDKLTQLTQLSLNDNQL-----KSIPRGAFDNLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 7e-04
Identities = 31/101 (30%), Positives = 44/101 (43%), Gaps = 14/101 (13%)
Query: 62 VFCSGNRVTQI------QVQNLGLKG----PLPQN-FNQLTKLYNLGLQRNKFNGKLPT- 109
V CSG + + Q L L L F++LT+L L L N+ LP
Sbjct: 14 VDCSGKSLASVPTGIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAG 72
Query: 110 -FSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNP 149
F L++L L+ N+ +IP FD L S+ + L NP
Sbjct: 73 VFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNNP 113
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 28/136 (20%), Positives = 45/136 (33%), Gaps = 30/136 (22%)
Query: 164 NSVQLTNLSLINC-NLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLND 222
+ L L NC + G + +L L L L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS------------------ 63
Query: 223 QDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGL-IPK 281
+ + K+ L +L L N+ G + L +L LNL+ N+L + +
Sbjct: 64 ---------VSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLE 114
Query: 282 SLANME-LDNLVLNNN 296
L +E L +L L N
Sbjct: 115 PLKKLECLKSLDLFNC 130
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 30/139 (21%), Positives = 56/139 (40%), Gaps = 20/139 (14%)
Query: 143 LALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRL 202
L P K + +L+ +L+L + N + + L + +L L L N +
Sbjct: 30 LHGMIPPIEK-----MDATLSTLKACKHLAL-STNNIEKI-SSLSGMENLRILSLGRNLI 82
Query: 203 SGVIPASFGQSLMQILWLND---QDAGGMTGPIDVVAKMVSLTQLWLHGNQFT--GSIPE 257
+ ++ LW++ + + K+V+L L++ N+ T G I +
Sbjct: 83 KKIENLDAVADTLEELWISYNQIAS-------LSGIEKLVNLRVLYMSNNKITNWGEI-D 134
Query: 258 DIGALSSLKDLNLNRNQLV 276
+ AL L+DL L N L
Sbjct: 135 KLAALDKLEDLLLAGNPLY 153
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 35/163 (21%), Positives = 65/163 (39%), Gaps = 26/163 (15%)
Query: 120 YLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLV 179
+ + + + L + + LAL N K SL+ L LSL NL+
Sbjct: 31 HGMIPPIEKMDATL-STLKACKHLALSTNNIEKI------SSLSGMENLRILSL-GRNLI 82
Query: 180 GPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLND---QDAGGMTGPIDVVA 236
+ + +L L +SYN+++ + +L ++L++++ + G ID +A
Sbjct: 83 KKIENLDAVADTLEELWISYNQIASLSGIEKLVNL-RVLYMSNNKITNWGE----IDKLA 137
Query: 237 KMVSLTQLWLHGNQFTGSIPED----------IGALSSLKDLN 269
+ L L L GN E+ + L +LK L+
Sbjct: 138 ALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 7e-04
Identities = 14/69 (20%), Positives = 31/69 (44%), Gaps = 12/69 (17%)
Query: 235 VAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANME-----LD 289
++ + + L L N I + + +L+ L+L RN + K + N++ L+
Sbjct: 44 LSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLI-----KKIENLDAVADTLE 96
Query: 290 NLVLNNNLL 298
L ++ N +
Sbjct: 97 ELWISYNQI 105
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 4e-05
Identities = 27/133 (20%), Positives = 43/133 (32%), Gaps = 30/133 (22%)
Query: 167 QLTNLSLINC-NLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDA 225
+ L L N + G L L L L+
Sbjct: 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS--------------------- 56
Query: 226 GGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGL-IPKSLA 284
I + K+ L +L L N+ +G + +L LNL+ N++ L + L
Sbjct: 57 ------IANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLK 110
Query: 285 NME-LDNLVLNNN 296
+E L +L L N
Sbjct: 111 KLENLKSLDLFNC 123
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 7e-05
Identities = 35/181 (19%), Positives = 57/181 (31%), Gaps = 45/181 (24%)
Query: 138 SSVRVLALDYNPFNKTFGWSIPDSLA-NSVQLTNLSLINCNL----VGPLPDFLGTLPSL 192
+++ L L N + + L +L L L C+L PL L P
Sbjct: 113 PTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDF 172
Query: 193 AALKLSYNRLS--GVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQ 250
L +S N ++ GV + L Q L + L L L
Sbjct: 173 KELTVSNNDINEAGV------RVLCQGLKDS----------------PCQLEALKLESCG 210
Query: 251 FTGSIPEDIGALS-------SLKDLNLNRNQL----VGLIPKSL--ANMELDNLVLNNNL 297
T ++ L SL++L L N+L + + L + L L +
Sbjct: 211 VT---SDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECG 267
Query: 298 L 298
+
Sbjct: 268 I 268
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 3e-04
Identities = 33/177 (18%), Positives = 57/177 (32%), Gaps = 41/177 (23%)
Query: 138 SSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNL----VGPLPDFLGTLPSLA 193
++ L + + + L + L +C L + L P+LA
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQ---CQVVRLDDCGLTEARCKDISSALRVNPALA 59
Query: 194 ALKLSYNRL--SGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQF 251
L L N L GV ++Q L + +L L
Sbjct: 60 ELNLRSNELGDVGV------HCVLQGLQTPSC----------------KIQKLSLQNCCL 97
Query: 252 T----GSIPEDIGALSSLKDLNLNRNQL----VGLIPKSLA--NMELDNLVLNNNLL 298
T G + + L +L++L+L+ N L + L+ + L L+ L L L
Sbjct: 98 TGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSL 154
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 6e-04
Identities = 36/192 (18%), Positives = 65/192 (33%), Gaps = 33/192 (17%)
Query: 135 DGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNL----VGPLPDFLG-TL 189
S +R L + + L L LSL L L + L
Sbjct: 253 HPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPG 312
Query: 190 PSLAALKLSYNRLSGVIPASFGQSL-----MQILWLND---QDAGGMTGPIDVVAKMV-- 239
L +L + + + F L + L +++ +DAG + + +
Sbjct: 313 CQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRE-----LCQGLGQ 367
Query: 240 ---SLTQLWLHGNQFT----GSIPEDIGALSSLKDLNLNRNQL----VGLIPKSLANME- 287
L LWL + S+ + A SL++L+L+ N L + + +S+
Sbjct: 368 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 427
Query: 288 -LDNLVLNNNLL 298
L+ LVL +
Sbjct: 428 LLEQLVLYDIYW 439
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 27/139 (19%), Positives = 44/139 (31%), Gaps = 30/139 (21%)
Query: 160 DSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILW 219
N+V+ L L + + + TL A+ S N +
Sbjct: 13 AQYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIR---------------- 55
Query: 220 LNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGL- 278
+D + L L ++ N+ AL L +L L N LV L
Sbjct: 56 -----------KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELG 104
Query: 279 IPKSLANME-LDNLVLNNN 296
LA+++ L L + N
Sbjct: 105 DLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 17/102 (16%), Positives = 29/102 (28%), Gaps = 15/102 (14%)
Query: 363 LSCTSNSKVSIINLPRH-------NLTGTLSPSIANLDSLIEIR---LGKNSISGTVPNN 412
L I NL + + + L ++ + N I
Sbjct: 24 LDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLDGFPLLRRLKTLLVNNNRICRIGEGL 83
Query: 413 FTELKSLRLLDVSDNNIK-----PPLPEFHDTVKLVIDGNPL 449
L L L +++N++ PL L I NP+
Sbjct: 84 DQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPV 125
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 973 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.98 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.98 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.97 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.97 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.97 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.97 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.97 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.97 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.97 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.97 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.97 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.97 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.97 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.96 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.96 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.96 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.96 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.96 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.95 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.95 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.94 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.94 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.94 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.94 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.94 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.94 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.94 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.93 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.93 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.93 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.92 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.92 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.91 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.9 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.9 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.89 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.89 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.89 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.88 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.87 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.87 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.87 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.86 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.86 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.85 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.85 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.85 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.85 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.85 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.85 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.85 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.85 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.82 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.8 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.79 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.79 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.79 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.78 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.78 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.78 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.78 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.78 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.78 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.77 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.77 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.76 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.76 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.75 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.74 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.73 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.73 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.72 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.72 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.71 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.71 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.7 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.7 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.67 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.67 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.66 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.64 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.63 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.62 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.61 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.61 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.6 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.6 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.58 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.57 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.52 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.52 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.52 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.51 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.47 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.46 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.45 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.42 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.41 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.4 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.38 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.27 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.25 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.22 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.22 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.21 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.12 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.1 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 98.95 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.94 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.93 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.87 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.79 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.77 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.75 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.65 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.57 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.52 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.52 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.49 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.47 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.32 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.29 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.27 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.24 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.08 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.91 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.86 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.82 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.71 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.61 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.56 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.48 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.42 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.36 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.3 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.27 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.19 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.1 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.99 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.97 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.61 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.55 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.39 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.35 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.26 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.03 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.65 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.46 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.04 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 87.77 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 86.29 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-53 Score=458.91 Aligned_cols=262 Identities=31% Similarity=0.465 Sum_probs=214.4
Q ss_pred cCccccCcccccCccEEEEEEEC------CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE------DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNER 698 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 698 (973)
++|...+.||+|+||+||+|++. ++..||||+++.. .....++|.+|+++|++++|||||+++|+|.+++..
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 57788899999999999999864 4778999999754 566678899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhhh--------ccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCE
Q 041143 699 LLVYEYMPHGALSRHLFRWEK--------LQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRA 770 (973)
Q Consensus 699 ~lV~e~~~~g~L~~~l~~~~~--------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~ 770 (973)
+||||||++|+|.++|+.... .....++|.++++|+.|||+||+||| +++||||||||+|||+++++.+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcE
Confidence 999999999999999986431 22357999999999999999999999 7899999999999999999999
Q ss_pred EEeeccccccCCCCCcc-eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHH
Q 041143 771 KVSDFGLVKLAPDGEKS-VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFW 848 (973)
Q Consensus 771 kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 848 (973)
||+|||+|+........ ......||+.|||||++.+..|+.|+|||||||++|||+| |+.||......+. . .
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~---~---~ 241 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV---I---E 241 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH---H---H
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---H---H
Confidence 99999999865433222 2234579999999999999999999999999999999999 8999987654321 1 1
Q ss_pred HHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 849 RIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 849 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
.+.... .+.. +......+.+|+.+||+.||++||||+||++.|+.+.+.
T Consensus 242 ~i~~~~-------~~~~-----p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 242 CITQGR-------VLQR-----PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HHHHTC-------CCCC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHcCC-------CCCC-----CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 111110 0111 111234578999999999999999999999999988653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-53 Score=462.27 Aligned_cols=261 Identities=31% Similarity=0.487 Sum_probs=208.6
Q ss_pred cCccccCcccccCccEEEEEEEC------CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE------DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNER 698 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 698 (973)
++|...++||+|+||+||+|++. +++.||||+++.. .....++|.+|+++|++++|||||+++|+|.+.+..
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 46777889999999999999864 4788999999754 566678899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhhh----------ccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCC
Q 041143 699 LLVYEYMPHGALSRHLFRWEK----------LQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDY 768 (973)
Q Consensus 699 ~lV~e~~~~g~L~~~l~~~~~----------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~ 768 (973)
+||||||++|+|.++++.... ....+++|.+++.|+.|||+||+||| +++||||||||+|||+++++
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTT
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCC
Confidence 999999999999999976432 12346999999999999999999999 78999999999999999999
Q ss_pred CEEEeeccccccCCCCC-cceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHH
Q 041143 769 RAKVSDFGLVKLAPDGE-KSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEW 846 (973)
Q Consensus 769 ~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~ 846 (973)
.+||+|||+|+...... ....+...||+.|||||++.+..|+.++|||||||++|||+| |+.||......+. ..
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~---~~- 271 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA---ID- 271 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH---HH-
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH---HH-
Confidence 99999999998654332 223345789999999999999999999999999999999999 8999987654322 11
Q ss_pred HHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 847 FWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 847 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
.+... ..+... ......+.+|+.+||+.||++||||+||++.|+.+.+
T Consensus 272 --~i~~g-------~~~~~p-----~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 272 --CITQG-------RELERP-----RACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp --HHHHT-------CCCCCC-----TTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --HHHcC-------CCCCCc-----ccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 11111 111111 1123457899999999999999999999999999876
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=452.41 Aligned_cols=261 Identities=28% Similarity=0.484 Sum_probs=207.6
Q ss_pred cCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEe
Q 041143 625 QNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEY 704 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 704 (973)
+++...+.||+|+||+||+|++++ .||||+++.........+.|.+|++++++++|||||+++|+|.+ +..+|||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 567778899999999999998763 69999998766667778899999999999999999999998865 568999999
Q ss_pred cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCC
Q 041143 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG 784 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~ 784 (973)
|++|+|.++|+.. ...++|.+++.|+.|||+||+||| +++||||||||+|||+++++.+||+|||+|+.....
T Consensus 113 ~~gGsL~~~l~~~----~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 113 CEGSSLYKHLHVQ----ETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp CSSCBHHHHHHTS----CCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred CCCCCHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 9999999999752 256999999999999999999999 789999999999999999999999999999865432
Q ss_pred C-cceecccccccCccccccccc---CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhh
Q 041143 785 E-KSVVTRLAGTFGYLAPEYAVM---GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAA 860 (973)
Q Consensus 785 ~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (973)
. .......+||+.|||||++.+ +.|+.|+|||||||++|||+||+.||......... . .... ...
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~--~----~~~~-----~~~ 254 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQI--I----FMVG-----RGY 254 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH--H----HHHH-----TTC
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHH--H----HHHh-----cCC
Confidence 2 233455789999999999864 45899999999999999999999999876543211 1 1110 111
Q ss_pred cCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 861 IDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 861 ~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
..|.+. .........+.+|+.+||+.||++||||+||++.|+.+..
T Consensus 255 ~~p~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 255 ASPDLS--KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp CCCCST--TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred CCCCcc--cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 222221 1111233457899999999999999999999999987754
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-53 Score=458.49 Aligned_cols=260 Identities=26% Similarity=0.425 Sum_probs=210.6
Q ss_pred cCccccCcccccCccEEEEEEEC------CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE------DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNER 698 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 698 (973)
.++...+.||+|+||+||+|++. +++.||||+++... .....++|.+|+.++++++|||||+++|+|.+++..
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~ 104 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL 104 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence 34556788999999999999863 46789999997542 334457899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhhh-----------ccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCC
Q 041143 699 LLVYEYMPHGALSRHLFRWEK-----------LQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDD 767 (973)
Q Consensus 699 ~lV~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~ 767 (973)
+||||||++|+|.++|+.... .....++|.++++|+.|||+||+||| +++||||||||+|||++++
T Consensus 105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDK 181 (308)
T ss_dssp EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGG
T ss_pred EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCC
Confidence 999999999999999976321 11246999999999999999999999 7899999999999999999
Q ss_pred CCEEEeeccccccCCCC-CcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHH
Q 041143 768 YRAKVSDFGLVKLAPDG-EKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAE 845 (973)
Q Consensus 768 ~~~kl~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~ 845 (973)
+++||+|||+|+..... .....+...||++|||||++.++.|+.++|||||||++|||+| |+.||.+....+ +..
T Consensus 182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~---~~~ 258 (308)
T 4gt4_A 182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---VVE 258 (308)
T ss_dssp GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH---HHH
T ss_pred CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH---HHH
Confidence 99999999999854332 2223445689999999999999999999999999999999998 899998765432 111
Q ss_pred HHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHh
Q 041143 846 WFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPL 906 (973)
Q Consensus 846 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~ 906 (973)
.+... ..+. .+......+.+|+.+||+.||++||||+||++.|+.+
T Consensus 259 ---~i~~~---------~~~~---~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 259 ---MIRNR---------QVLP---CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp ---HHHTT---------CCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred ---HHHcC---------CCCC---CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11110 0011 1112234578999999999999999999999999764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=451.99 Aligned_cols=257 Identities=22% Similarity=0.361 Sum_probs=208.9
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
++|+..+.||+|+||+||+|+.. +|+.||||+++.........+.+.+|+++|++++|||||++++++.+++..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999864 69999999998766666777889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|++||+|.+++... ....+++.+++.|+.||+.||+||| +++||||||||+|||+++++.+||+|||+|+....
T Consensus 104 y~~gg~L~~~i~~~---~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ---KGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp CCTTCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred CCCCCcHHHHHHHc---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 99999999999752 2345789999999999999999999 88999999999999999999999999999986543
Q ss_pred CCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCc
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDP 863 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (973)
.. ...+..+||+.|||||++.+..|+.++|||||||++|||+||+.||......+. +..+... ...
T Consensus 178 ~~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~------~~~i~~~------~~~- 243 (350)
T 4b9d_A 178 TV-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL------VLKIISG------SFP- 243 (350)
T ss_dssp HH-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHT------CCC-
T ss_pred Cc-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH------HHHHHcC------CCC-
Confidence 21 223456899999999999999999999999999999999999999987653321 1222211 011
Q ss_pred cccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 864 ALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 864 ~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
.+. ......+.+|+.+||+.||++|||+.|+++ +++++
T Consensus 244 ~~~-----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~--hp~~~ 281 (350)
T 4b9d_A 244 PVS-----LHYSYDLRSLVSQLFKRNPRDRPSVNSILE--KGFIA 281 (350)
T ss_dssp CCC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT--SHHHH
T ss_pred CCC-----ccCCHHHHHHHHHHccCChhHCcCHHHHhc--CHHhh
Confidence 111 111235779999999999999999999987 44443
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-51 Score=447.71 Aligned_cols=256 Identities=24% Similarity=0.391 Sum_probs=212.8
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
+.|+..+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+++..|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE 151 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 151 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG--CSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 56889999999999999999875 69999999996542 2233568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
||++|+|.+++.. ..+++.++..++.||+.||+||| +++||||||||+|||++.++.+||+|||+|+....
T Consensus 152 y~~gg~L~~~l~~------~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 222 (346)
T 4fih_A 152 FLEGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 222 (346)
T ss_dssp CCTTEEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred CCCCCcHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCC
Confidence 9999999998864 45899999999999999999999 88999999999999999999999999999986654
Q ss_pred CCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCc
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDP 863 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (973)
.. ......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+....+.. ..+ .....+
T Consensus 223 ~~-~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~------~~i-------~~~~~~ 288 (346)
T 4fih_A 223 EV-PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM------KMI-------RDNLPP 288 (346)
T ss_dssp SS-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHH-------HHSSCC
T ss_pred CC-CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH------HHH-------HcCCCC
Confidence 32 2345678999999999999999999999999999999999999999876543221 111 111222
Q ss_pred cccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhc
Q 041143 864 ALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKW 910 (973)
Q Consensus 864 ~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~ 910 (973)
.+.. .......+.+|+.+||+.||++|||+.|+++ ++++++.
T Consensus 289 ~~~~---~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~--Hp~~~~~ 330 (346)
T 4fih_A 289 RLKN---LHKVSPSLKGFLDRLLVRDPAQRATAAELLK--HPFLAKA 330 (346)
T ss_dssp CCSC---GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT--CGGGGGC
T ss_pred CCCc---cccCCHHHHHHHHHHcCCChhHCcCHHHHhc--CHhhcCC
Confidence 2221 1112245779999999999999999999998 7777653
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=433.88 Aligned_cols=250 Identities=26% Similarity=0.419 Sum_probs=201.9
Q ss_pred cccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEe----CCeEEEEE
Q 041143 628 AQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIE----GNERLLVY 702 (973)
Q Consensus 628 ~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~ 702 (973)
...++||+|+||+||+|.+. +++.||||++..........+.|.+|++++++++|||||++++++.+ ++..||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45567999999999999875 58899999997665566677889999999999999999999999875 24579999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCC--eeeccCCCCcEEECC-CCCEEEeeccccc
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQT--FIHRDLKSSNILLDD-DYRAKVSDFGLVK 779 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~--ivH~Dikp~Nill~~-~~~~kl~DfGla~ 779 (973)
|||++|+|.+++.+ ...+++..+..++.||+.||+||| +++ ||||||||+|||++. ++.+||+|||+|+
T Consensus 109 Ey~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR-----FKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp ECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred eCCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence 99999999999975 256899999999999999999999 556 999999999999984 7999999999998
Q ss_pred cCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHh
Q 041143 780 LAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKA 859 (973)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (973)
..... .....+||+.|||||++. +.|+.++|||||||++|||+||+.||........ ....+...
T Consensus 181 ~~~~~---~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~-----~~~~i~~~------ 245 (290)
T 3fpq_A 181 LKRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-----IYRRVTSG------ 245 (290)
T ss_dssp GCCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-----HHHHHTTT------
T ss_pred eCCCC---ccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH-----HHHHHHcC------
Confidence 65432 234578999999999876 4699999999999999999999999976543211 11111111
Q ss_pred hcCc-cccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 860 AIDP-ALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 860 ~~~~-~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
..+ .+. ......+.+|+.+||+.||++|||++|+++ +++++
T Consensus 246 -~~~~~~~-----~~~~~~~~~li~~~L~~dP~~R~s~~e~l~--Hp~~~ 287 (290)
T 3fpq_A 246 -VKPASFD-----KVAIPEVKEIIEGCIRQNKDERYSIKDLLN--HAFFQ 287 (290)
T ss_dssp -CCCGGGG-----GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGC
T ss_pred -CCCCCCC-----ccCCHHHHHHHHHHccCChhHCcCHHHHhc--Ccccc
Confidence 111 111 011134779999999999999999999988 55554
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=440.67 Aligned_cols=255 Identities=23% Similarity=0.317 Sum_probs=207.6
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
+.|...++||+|+||.||+|+.. +|+.||||+++.... +.+|++++++++|||||++++++.+++..|||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE 130 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 46778889999999999999875 689999999976422 2469999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCC-CEEEeeccccccCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDY-RAKVSDFGLVKLAP 782 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~-~~kl~DfGla~~~~ 782 (973)
||+||+|.+++++. ..+++.++..++.||+.||+||| +++||||||||+|||++.++ ++||+|||+|+...
T Consensus 131 y~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~ 202 (336)
T 4g3f_A 131 LLEGGSLGQLIKQM-----GCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQ 202 (336)
T ss_dssp CCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred ccCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence 99999999999752 46899999999999999999999 88999999999999999987 69999999998654
Q ss_pred CCCcc----eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHH
Q 041143 783 DGEKS----VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFK 858 (973)
Q Consensus 783 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (973)
..... ....++||+.|||||++.+..|+.++|||||||++|||+||+.||......+.. ..+......+.
T Consensus 203 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~------~~i~~~~~~~~ 276 (336)
T 4g3f_A 203 PDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC------LKIASEPPPIR 276 (336)
T ss_dssp -----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH------HHHHHSCCGGG
T ss_pred CCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH------HHHHcCCCCch
Confidence 33211 123468999999999999999999999999999999999999999876543221 11111111111
Q ss_pred hhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhc
Q 041143 859 AAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKW 910 (973)
Q Consensus 859 ~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~ 910 (973)
.+.+ .....+.+++.+||+.||++|||+.|+++.|..+.+..
T Consensus 277 -~~~~---------~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~ 318 (336)
T 4g3f_A 277 -EIPP---------SCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318 (336)
T ss_dssp -GSCT---------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred -hcCc---------cCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence 0111 12245779999999999999999999999998887754
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=441.54 Aligned_cols=269 Identities=23% Similarity=0.337 Sum_probs=204.6
Q ss_pred cCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC----eEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGN----ERLL 700 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~l 700 (973)
++|...+.||+|+||+||+|++. |+.||||+++.. ......+.+|+..+.+++|||||+++|+|.+++ ..+|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 46778899999999999999985 899999998643 222233445666677899999999999998754 5799
Q ss_pred EEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhh-----ccCCeeeccCCCCcEEECCCCCEEEeec
Q 041143 701 VYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCL-----ARQTFIHRDLKSSNILLDDDYRAKVSDF 775 (973)
Q Consensus 701 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~-----~~~~ivH~Dikp~Nill~~~~~~kl~Df 775 (973)
|||||++|+|.++++. ..++|.++++++.|+|+||+|||+. +.++||||||||+|||++.++++||+||
T Consensus 79 V~Ey~~~gsL~~~l~~------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DF 152 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred EecCCCCCcHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeC
Confidence 9999999999999975 4689999999999999999999943 1349999999999999999999999999
Q ss_pred cccccCCCCCcc---eecccccccCcccccccccC------cCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHH-----
Q 041143 776 GLVKLAPDGEKS---VVTRLAGTFGYLAPEYAVMG------KITTKADVFSYGVVLMELLTGLAALDEERPEESR----- 841 (973)
Q Consensus 776 Gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~----- 841 (973)
|+|+........ .....+||+.|||||++.+. .++.|+|||||||++|||+||+.|+.........
T Consensus 153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~ 232 (303)
T 3hmm_A 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcc
Confidence 999865443322 22346899999999998754 4778999999999999999998877543221100
Q ss_pred ----HHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 842 ----YLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 842 ----~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
....+... .....++|.+.......+....+.+|+.+||+.||++||||.||++.|+++.++
T Consensus 233 ~~~~~~~~~~~~------~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 233 PSDPSVEEMRKV------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CSSCCHHHHHHH------HTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cccchHHHHHHH------HhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 00011000 111223333332223345667788999999999999999999999999998764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=444.92 Aligned_cols=272 Identities=25% Similarity=0.382 Sum_probs=218.6
Q ss_pred HHHHHHHhcCccccCcccccCccEEEEEEECC------CCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC-Cceeeee
Q 041143 617 VQVLRKVTQNFAQENELGRGGFGTVYKGELED------GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRH-RHLVSLL 689 (973)
Q Consensus 617 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~ 689 (973)
....+...++|+..+.||+|+||+||+|++.. ++.||||+++.. ......+.|.+|+++|.+++| ||||+++
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~-~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccc-cChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 33344556889999999999999999998642 357999999765 344556789999999999965 8999999
Q ss_pred eEEEeC-CeEEEEEEecCCCCHHHHHHhhhhc-----------cCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccC
Q 041143 690 GYSIEG-NERLLVYEYMPHGALSRHLFRWEKL-----------QLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDL 757 (973)
Q Consensus 690 ~~~~~~-~~~~lV~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Di 757 (973)
|+|.+. +..++|||||++|+|.++|+..... ....++|.+++.|+.|||+||+||| +++||||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCcc
Confidence 999775 5689999999999999999864321 1345899999999999999999999 889999999
Q ss_pred CCCcEEECCCCCEEEeeccccccCCCCC-cceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCC
Q 041143 758 KSSNILLDDDYRAKVSDFGLVKLAPDGE-KSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEE 835 (973)
Q Consensus 758 kp~Nill~~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~ 835 (973)
||+|||+++++.+||+|||+|+...... .......+||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~ 291 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 291 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999999654433 333455789999999999999999999999999999999998 99999875
Q ss_pred ChhhHHHHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 836 RPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
...+. +.. .+. +...+... . .....+.+++.+||+.||++|||++||++.|+.+++.
T Consensus 292 ~~~~~--~~~---~i~-------~g~~~~~p--~---~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 292 KIDEE--FCR---RLK-------EGTRMRAP--D---YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp CCSHH--HHH---HHH-------HTCCCCCC--T---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHH--HHH---HHH-------cCCCCCCC--c---cCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 43221 111 111 11111111 1 1224577999999999999999999999999998874
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-50 Score=448.83 Aligned_cols=256 Identities=24% Similarity=0.389 Sum_probs=213.3
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
+.|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+++..|||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE 228 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 228 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT--CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence 57999999999999999999875 69999999997542 2234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
||++|+|.+++.. ..+++.++..|+.||+.||+||| +++||||||||+|||++.++.+||+|||+|+....
T Consensus 229 y~~gG~L~~~i~~------~~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~ 299 (423)
T 4fie_A 229 FLEGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 299 (423)
T ss_dssp CCTTEEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCS
T ss_pred CCCCCcHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCC
Confidence 9999999998864 45899999999999999999999 88999999999999999999999999999986644
Q ss_pred CCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCc
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDP 863 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (973)
.. ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+....+.. ..+ .....+
T Consensus 300 ~~-~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~------~~i-------~~~~~~ 365 (423)
T 4fie_A 300 EV-PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM------KMI-------RDNLPP 365 (423)
T ss_dssp SC-CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHH-------HHSCCC
T ss_pred CC-ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH------HHH-------HcCCCC
Confidence 32 2345678999999999999999999999999999999999999999876543221 111 111222
Q ss_pred cccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhc
Q 041143 864 ALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKW 910 (973)
Q Consensus 864 ~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~ 910 (973)
.+.... .....+.+|+.+||+.||++|||+.|+++ ++++++.
T Consensus 366 ~~~~~~---~~s~~~~dli~~~L~~dP~~R~ta~ell~--Hp~~~~~ 407 (423)
T 4fie_A 366 RLKNLH---KVSPSLKGFLDRLLVRDPAQRATAAELLK--HPFLAKA 407 (423)
T ss_dssp CCSCTT---SSCHHHHHHHHHHSCSSTTTSCCHHHHTT--CGGGGGC
T ss_pred CCcccc---cCCHHHHHHHHHHcCCChhHCcCHHHHhc--CHHhcCC
Confidence 222111 11235779999999999999999999998 7777653
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=436.14 Aligned_cols=250 Identities=22% Similarity=0.344 Sum_probs=207.8
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCC-CChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGV-TTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
++|+..+.||+|+||+||+|+.. +|+.||||++.... ......+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999864 68999999996431 11223567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||++||+|.+++.+ ...+++.++..++.||+.||+||| +++||||||||+|||++.++.+||+|||+|+...
T Consensus 112 Ey~~gG~L~~~i~~-----~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~ 183 (311)
T 4aw0_A 112 SYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 183 (311)
T ss_dssp CCCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecC
Confidence 99999999999965 246899999999999999999999 8899999999999999999999999999999664
Q ss_pred CC-CcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhc
Q 041143 783 DG-EKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861 (973)
Q Consensus 783 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (973)
.. ........+||+.|||||++.+..|+.++||||+||++|||++|+.||......+. +..+....
T Consensus 184 ~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~------~~~i~~~~------- 250 (311)
T 4aw0_A 184 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLI------FAKIIKLE------- 250 (311)
T ss_dssp TTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHTC-------
T ss_pred CCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHcCC-------
Confidence 33 23344567999999999999999999999999999999999999999987653221 12222111
Q ss_pred CccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 862 DPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 862 ~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
+.+.. .....+.+|+.+||+.||++|||++|+..
T Consensus 251 ---~~~p~---~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 251 ---YDFPE---KFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp ---CCCCT---TCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred ---CCCCc---ccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 11111 11234779999999999999999999754
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=423.45 Aligned_cols=252 Identities=26% Similarity=0.388 Sum_probs=194.9
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
++|+..+.||+|+||+||+|+.. +|+.||||++..... .....+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999864 699999999975432 2333567999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+ +|+|.+++.+ ...+++.++..++.||+.||+||| +++|+||||||+|||+++++++||+|||+|+...
T Consensus 93 Ey~-~g~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ-----RDKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT 163 (275)
T ss_dssp ECC-CEEHHHHHHH-----SCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred eCC-CCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecC
Confidence 999 7899999865 256899999999999999999999 8899999999999999999999999999998654
Q ss_pred CCCcceecccccccCcccccccccCcC-CCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhc
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMGKI-TTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (973)
+.. .....+||+.|||||++.+..| +.++||||+||++|||+||+.||....... .+..+......+
T Consensus 164 ~~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~------~~~~i~~~~~~~---- 231 (275)
T 3hyh_A 164 DGN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV------LFKNISNGVYTL---- 231 (275)
T ss_dssp -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHTCCCC----
T ss_pred CCC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHcCCCCC----
Confidence 432 2345789999999999998876 579999999999999999999998754322 122222111111
Q ss_pred CccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 862 DPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 862 ~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
+.. ....+.+++.+||+.||++|||++|+++ +++++
T Consensus 232 p~~---------~s~~~~~li~~~L~~dP~~R~s~~eil~--hpw~k 267 (275)
T 3hyh_A 232 PKF---------LSPGAAGLIKRMLIVNPLNRISIHEIMQ--DDWFK 267 (275)
T ss_dssp CTT---------SCHHHHHHHHHHSCSSGGGSCCHHHHHH--CHHHH
T ss_pred CCC---------CCHHHHHHHHHHccCChhHCcCHHHHHc--Ccccc
Confidence 111 1234679999999999999999999998 67765
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-50 Score=432.49 Aligned_cols=244 Identities=27% Similarity=0.331 Sum_probs=194.7
Q ss_pred cCccccCcccccCccEEEEEEEC----CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE----DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLL 700 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 700 (973)
++|+..+.||+|+||+||+|+.. .++.||||+++...........+.+|+++|++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999762 47899999996543222333468899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecccccc
Q 041143 701 VYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKL 780 (973)
Q Consensus 701 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~ 780 (973)
||||++||+|.+++.+ ...+++.++..++.||+.||+||| +++||||||||+|||+++++.+||+|||+|+.
T Consensus 104 vmEy~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 175 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK-----EVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKE 175 (304)
T ss_dssp EECCCTTCEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred EEEcCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence 9999999999999975 246899999999999999999999 88999999999999999999999999999986
Q ss_pred CCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhh
Q 041143 781 APDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAA 860 (973)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (973)
..+... .....+||+.|||||++.+..|+.++||||+||++|||+||+.||.+....+. +..+....
T Consensus 176 ~~~~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~------~~~i~~~~------ 242 (304)
T 3ubd_A 176 SIDHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET------MTMILKAK------ 242 (304)
T ss_dssp -----C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHCC------
T ss_pred ccCCCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHH------HHHHHcCC------
Confidence 543322 23457899999999999999999999999999999999999999987654321 11222111
Q ss_pred cCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCH
Q 041143 861 IDPALEVNEETFESISIVAELAGHCTAREPYHRPDM 896 (973)
Q Consensus 861 ~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~ 896 (973)
+.... .....+.+|+.+||+.||++||++
T Consensus 243 ----~~~p~---~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 243 ----LGMPQ---FLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp ----CCCCT---TSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred ----CCCCC---cCCHHHHHHHHHHcccCHHHCCCC
Confidence 11111 112347799999999999999985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-48 Score=416.62 Aligned_cols=256 Identities=26% Similarity=0.387 Sum_probs=193.1
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC-------
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGN------- 696 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------- 696 (973)
++|+..+.||+|+||+||+|+.. +|+.||||+++.. ......+.+.+|+++|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~-~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP-NRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEEC-SSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEecc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 56899999999999999999875 6899999999754 24555678999999999999999999999987644
Q ss_pred -----eEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEE
Q 041143 697 -----ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAK 771 (973)
Q Consensus 697 -----~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~k 771 (973)
..|+||||+++|+|.+++..... ....++..++.|+.||+.||+||| +++||||||||+|||++.++.+|
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vK 158 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCT--IEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVK 158 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCS--GGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEE
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCC--CChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEE
Confidence 36899999999999999976322 234577788999999999999999 88999999999999999999999
Q ss_pred EeeccccccCCCCCc-----------ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhH
Q 041143 772 VSDFGLVKLAPDGEK-----------SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEES 840 (973)
Q Consensus 772 l~DfGla~~~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~ 840 (973)
|+|||+|+....... ...+..+||+.|||||++.+..|+.++|||||||++|||++ ||.... +.
T Consensus 159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~--~~ 233 (299)
T 4g31_A 159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM--ER 233 (299)
T ss_dssp ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH--HH
T ss_pred EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc--HH
Confidence 999999986543221 11234679999999999999999999999999999999996 775321 11
Q ss_pred HHHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 841 RYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
. ..+..+. .... ............+++.+||+.||++|||+.|+++ +++.+
T Consensus 234 ~---~~~~~~~----------~~~~--p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~--h~~~~ 284 (299)
T 4g31_A 234 V---RTLTDVR----------NLKF--PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE--NAVFE 284 (299)
T ss_dssp H---HHHHHHH----------TTCC--CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT--SGGGC
T ss_pred H---HHHHHHh----------cCCC--CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc--CHhhC
Confidence 0 1011111 0000 1111222334568999999999999999999987 55554
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=423.15 Aligned_cols=283 Identities=20% Similarity=0.365 Sum_probs=219.2
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEe------CCe
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIE------GNE 697 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 697 (973)
++|+..+.||+|+||+||+|+.. +|+.||||+++.........+.+.+|+++|++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999874 69999999998765666677889999999999999999999998764 357
Q ss_pred EEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccc
Q 041143 698 RLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL 777 (973)
Q Consensus 698 ~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGl 777 (973)
.|||||||+ |+|.+++.. ...+++.++..++.||+.||+||| +++||||||||+|||++.++.+||+|||+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~-----~~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHS-----SQPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp EEEEEECCS-EEHHHHHTS-----SSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEeCCC-CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecce
Confidence 899999995 789998854 357999999999999999999999 88999999999999999999999999999
Q ss_pred cccCCCCC---cceecccccccCcccccccccC-cCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhc
Q 041143 778 VKLAPDGE---KSVVTRLAGTFGYLAPEYAVMG-KITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSS 853 (973)
Q Consensus 778 a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 853 (973)
|+...... .......+||+.|||||++.+. .|+.++||||+||++|||++|+.||.+....+....+ ......
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I---~~~~g~ 281 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLI---MMVLGT 281 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHH---HHHHCC
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHH---HHhcCC
Confidence 98654321 2234567899999999998875 5699999999999999999999999877644322111 111000
Q ss_pred -hh------------HHHhhcCccccCCcccHH-----HHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCCCCC
Q 041143 854 -KE------------KFKAAIDPALEVNEETFE-----SISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPITD 915 (973)
Q Consensus 854 -~~------------~~~~~~~~~l~~~~~~~~-----~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~~~~ 915 (973)
.. .....+.+. ...... ....+.+|+.+||+.||++|||+.|+++ +++++++..+.+
T Consensus 282 p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~--Hp~f~~~~~p~~ 356 (398)
T 4b99_A 282 PSPAVIQAVGAERVRAYIQSLPPR---QPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR--HPFLAKYHDPDD 356 (398)
T ss_dssp CCGGGTC-----CHHHHHHSSCCC---CCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT--SGGGTTTCCGGG
T ss_pred CChHHhhhhhhhhhhhhhhcCCCc---CCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc--CHhhCcCCCCcc
Confidence 00 000001110 001111 1235779999999999999999999999 899888776665
Q ss_pred CCcccCCCC
Q 041143 916 ESECCSGID 924 (973)
Q Consensus 916 ~~~~~~~~~ 924 (973)
++.+...++
T Consensus 357 ~p~~~~~~~ 365 (398)
T 4b99_A 357 EPDCAPPFD 365 (398)
T ss_dssp SCCCSSCCC
T ss_pred ccCCCCCCC
Confidence 554444333
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=409.04 Aligned_cols=200 Identities=25% Similarity=0.386 Sum_probs=171.1
Q ss_pred HHhcCccccCcccccCccEEEEEEEC----CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCC
Q 041143 622 KVTQNFAQENELGRGGFGTVYKGELE----DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGN 696 (973)
Q Consensus 622 ~~~~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 696 (973)
...++|++.+.||+|+||+||+|+.+ .++.||||++.... ...++.+|+++|+.+ +|||||++++++.+.+
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~ 93 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKND 93 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence 45678999999999999999999753 46789999986532 234678999999998 6999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCC-CCEEEeec
Q 041143 697 ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDD-YRAKVSDF 775 (973)
Q Consensus 697 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~-~~~kl~Df 775 (973)
..|+||||+++|+|.+++. .+++.++..++.||+.||+||| +++||||||||+|||++.+ +.+||+||
T Consensus 94 ~~~lvmE~~~g~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DF 162 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDILN--------SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDF 162 (361)
T ss_dssp EEEEEEECCCCCCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred EEEEEEeCCCcccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcC
Confidence 9999999999999999883 3789999999999999999999 8899999999999999877 79999999
Q ss_pred cccccCCCCCc---------------------------ceecccccccCcccccccccC-cCCCchhHHhHHHHHHHHHh
Q 041143 776 GLVKLAPDGEK---------------------------SVVTRLAGTFGYLAPEYAVMG-KITTKADVFSYGVVLMELLT 827 (973)
Q Consensus 776 Gla~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~ellt 827 (973)
|+|+...+... ...+..+||+.|||||++.+. .|+.++||||+||++|||++
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~ 242 (361)
T 4f9c_A 163 GLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS 242 (361)
T ss_dssp TTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH
T ss_pred CCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHH
Confidence 99985443211 112345899999999999875 58999999999999999999
Q ss_pred CCCCCCCCC
Q 041143 828 GLAALDEER 836 (973)
Q Consensus 828 g~~p~~~~~ 836 (973)
|+.||....
T Consensus 243 G~~Pf~~~~ 251 (361)
T 4f9c_A 243 GRYPFYKAS 251 (361)
T ss_dssp TCSSSSCCS
T ss_pred CCCCCCCCC
Confidence 999996554
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=449.85 Aligned_cols=91 Identities=26% Similarity=0.446 Sum_probs=69.3
Q ss_pred ccCCCCcccEEecCCCcCCCccchhhhCccccceEEccCCccccccCccccCcCCCCeeeCCCCcCCCCCCCC---Cccc
Q 041143 364 SCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLPEF---HDTV 440 (973)
Q Consensus 364 ~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~---~~~~ 440 (973)
.+..++.|+.|+|++|+++|.+|..|+++++|+.|||++|+|+|.+|..|..+++|++||||+|+|+|.+|.. ..+.
T Consensus 651 ~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~ 730 (768)
T 3rgz_A 651 EIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFP 730 (768)
T ss_dssp GGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSC
T ss_pred HHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCC
Confidence 3556677777777777777788878888888888888888888888888888888888888888888888753 3344
Q ss_pred ceeecCCccccCCC
Q 041143 441 KLVIDGNPLLVGGI 454 (973)
Q Consensus 441 ~~~~~~N~~~c~~~ 454 (973)
...+.|||.+||.+
T Consensus 731 ~~~~~gN~~Lcg~~ 744 (768)
T 3rgz_A 731 PAKFLNNPGLCGYP 744 (768)
T ss_dssp GGGGCSCTEEESTT
T ss_pred HHHhcCCchhcCCC
Confidence 46688899999854
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=398.80 Aligned_cols=283 Identities=40% Similarity=0.706 Sum_probs=236.4
Q ss_pred HHHHHhcCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeE
Q 041143 619 VLRKVTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNER 698 (973)
Q Consensus 619 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 698 (973)
++...+++|...+.||+|+||.||+|++.+|+.||||++... .....+.+.+|++++++++||||+++++++.+.+..
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSC--CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEeccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 344567899999999999999999999888999999998754 334567899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecccc
Q 041143 699 LLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLV 778 (973)
Q Consensus 699 ~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla 778 (973)
++||||+++|+|.+++.... .....++|.+++.++.||++||+||| +++|+||||||+||+++.++.+||+|||++
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 186 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSD-LPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGIS 186 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSC-CCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred EEEEEcCCCCcHHHHHhccC-CCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeecccc
Confidence 99999999999999886522 22346899999999999999999999 789999999999999999999999999999
Q ss_pred ccCCCCC-cceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHH
Q 041143 779 KLAPDGE-KSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKF 857 (973)
Q Consensus 779 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (973)
+...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....+.+......|...... ...+
T Consensus 187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~ 265 (321)
T 2qkw_B 187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN-NGQL 265 (321)
T ss_dssp EECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT-TTCC
T ss_pred cccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc-cccH
Confidence 8544322 2223445699999999999999999999999999999999999999987766555555555543322 3334
Q ss_pred HhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 858 KAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 858 ~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
...+++.+. .....+....+.+++.+|++.||++||++.||++.|+.+.+.
T Consensus 266 ~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 266 EQIVDPNLA-DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp CSSSSSSCT-TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHhcChhhc-cccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 455555554 344567778899999999999999999999999999988764
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=417.22 Aligned_cols=255 Identities=24% Similarity=0.306 Sum_probs=201.4
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCC----CChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGV----TTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERL 699 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 699 (973)
++|+..++||+|+||.||+|+.. +|+.||||+++... ...........++.+++.++|||||++++++.+.+..|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 57999999999999999999875 69999999996431 11222223344566777789999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccc
Q 041143 700 LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK 779 (973)
Q Consensus 700 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~ 779 (973)
+||||++||+|.+++.+ ...+++..+..++.||+.||+||| +++||||||||+|||++.+|.+||+|||+|+
T Consensus 269 lVmEy~~GGdL~~~l~~-----~~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQ-----HGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEECCCCSCBHHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceee
Confidence 99999999999999975 246899999999999999999999 8999999999999999999999999999998
Q ss_pred cCCCCCcceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHH
Q 041143 780 LAPDGEKSVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFK 858 (973)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (973)
...... ....+||+.|||||++.. ..|+.++||||+||++|||++|+.||......+...+ ...+....
T Consensus 341 ~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i---~~~i~~~~---- 410 (689)
T 3v5w_A 341 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI---DRMTLTMA---- 410 (689)
T ss_dssp ECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHH---HHHHHHCC----
T ss_pred ecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHhhcCCC----
Confidence 665432 345689999999999975 5799999999999999999999999975433222111 11111111
Q ss_pred hhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCC-----HhHHHHHHHHhhh
Q 041143 859 AAIDPALEVNEETFESISIVAELAGHCTAREPYHRPD-----MGHVVNVLSPLVE 908 (973)
Q Consensus 859 ~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~~v~~~L~~~~~ 908 (973)
..+. . .....+.+|+.+||+.||.+|++ +.||.+ +++.+
T Consensus 411 ----~~~p--~---~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~--HpfF~ 454 (689)
T 3v5w_A 411 ----VELP--D---SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE--SPFFR 454 (689)
T ss_dssp ----CCCC--T---TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT--SGGGT
T ss_pred ----CCCC--c---cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc--Ccccc
Confidence 1111 0 11234779999999999999998 677776 55543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=419.01 Aligned_cols=258 Identities=24% Similarity=0.367 Sum_probs=212.7
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
.++|++.+.||+|+||.||+|+.+ +|+.||+|++... .....+.+.+|+++|+.++|||||++++++.+.+..||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~ 233 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 233 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc--chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 468999999999999999999875 6999999999764 4555678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCC--CCEEEeecccccc
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDD--YRAKVSDFGLVKL 780 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~--~~~kl~DfGla~~ 780 (973)
|||+||+|.+++.. ....+++.++..++.||+.||+||| +++|+||||||+|||++.+ +.+||+|||+|+.
T Consensus 234 E~~~gg~L~~~i~~----~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~ 306 (573)
T 3uto_A 234 EFMSGGELFEKVAD----EHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 306 (573)
T ss_dssp ECCCCCBHHHHHTC----TTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred eecCCCcHHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeE
Confidence 99999999999854 1246899999999999999999999 8899999999999999854 8999999999997
Q ss_pred CCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhh
Q 041143 781 APDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAA 860 (973)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (973)
..... .....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+....+. +..+......
T Consensus 307 ~~~~~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~------~~~i~~~~~~---- 374 (573)
T 3uto_A 307 LDPKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET------LRNVKSCDWN---- 374 (573)
T ss_dssp CCTTS--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHHHHTTCCC----
T ss_pred ccCCC--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH------HHHHHhCCCC----
Confidence 65433 34456899999999999999999999999999999999999999987654322 1111111100
Q ss_pred cCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 861 IDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 861 ~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
++.. ........+.+|+.+||+.||.+||++.|+++ +++++.
T Consensus 375 ~~~~-----~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~--Hpw~~~ 416 (573)
T 3uto_A 375 MDDS-----AFSGISEDGKDFIRKLLLADPNTRMTIHQALE--HPWLTP 416 (573)
T ss_dssp CCSG-----GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH--STTTSC
T ss_pred CCcc-----cccCCCHHHHHHHHHHccCChhHCcCHHHHhc--CcCcCC
Confidence 0000 00111234779999999999999999999998 666654
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=395.44 Aligned_cols=291 Identities=41% Similarity=0.674 Sum_probs=236.7
Q ss_pred ceeecHHHHHHHhcCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeE
Q 041143 612 TLVISVQVLRKVTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGY 691 (973)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 691 (973)
...++..+++...++|...+.||+|+||.||+|+..+|+.||||++..... ......+.+|++++++++||||++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccC-chHHHHHHHHHHHHHhccCCCccceEEE
Confidence 456788899999999999999999999999999988899999999875421 2222368999999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEE
Q 041143 692 SIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAK 771 (973)
Q Consensus 692 ~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~k 771 (973)
+...+..++||||+++|+|.+++..... ....++|..+..++.|++.||+|||+.+..+|+||||||+||+++.++.+|
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPE-SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCST-TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 9999999999999999999999976332 335699999999999999999999943333999999999999999999999
Q ss_pred EeeccccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCCh--hhHHHHHHHHHH
Q 041143 772 VSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERP--EESRYLAEWFWR 849 (973)
Q Consensus 772 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~--~~~~~~~~~~~~ 849 (973)
|+|||+++..............||+.|+|||++.+..++.++|||||||++|||++|+.||+.... ........|+..
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred eccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 999999987665555555667799999999999999999999999999999999999999962211 111223334333
Q ss_pred HhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHh
Q 041143 850 IKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPL 906 (973)
Q Consensus 850 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~ 906 (973)
... .......++..+. .....+....+.+++.+|++.||.+|||+.||++.|++.
T Consensus 255 ~~~-~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 255 LLK-EKKLEALVDVDLQ-GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TTS-SCCSTTSSCTTCT-TSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred Hhh-chhhhhhcChhhc-cccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 222 2233444455444 345567788899999999999999999999999999764
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=428.93 Aligned_cols=408 Identities=21% Similarity=0.287 Sum_probs=285.5
Q ss_pred CCCChhHHHHHHHHHhhCCCCccCCCCCCC----CCCCCCCCc------------CeEEeeC-CeEEEEEecccCCcccC
Q 041143 21 SATDPNDLKILNDFKNGLENPELLKWPANG----DDPCGPPPW------------PHVFCSG-NRVTQIQVQNLGLKGPL 83 (973)
Q Consensus 21 ~~~~~~~~~~l~~~k~~~~~~~l~~w~~~~----~d~C~~~~w------------~gv~C~~-~~v~~L~L~~~~l~g~~ 83 (973)
+++...|..||++||+++.+| +|...+ .+||. |.| .||.|+. ++|+.|+|++++|+|.+
T Consensus 264 ~~~~~~d~~ALl~~k~~l~~~---~W~~~~~~~~~~~~~-C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~i 339 (876)
T 4ecn_A 264 TAEYIKDYKALKAIWEALDGK---NWRYYSGTINNTIHS-LNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRV 339 (876)
T ss_dssp CCHHHHHHHHHHHHHHHTTGG---GCCCCCSSCSSCCCC-CSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEEE
T ss_pred cccchHHHHHHHHHHHHcCCC---CCCcCCCcccccCCc-cccccccccccccCcCceEecCCCCEEEEECccCCCCCcC
Confidence 455678999999999999876 785543 46621 239 9999984 89999999999999999
Q ss_pred CcCcccccccceeec-cCcccCCC--------------------------------------------------------
Q 041143 84 PQNFNQLTKLYNLGL-QRNKFNGK-------------------------------------------------------- 106 (973)
Q Consensus 84 ~~~~~~l~~L~~L~L-~~N~l~~~-------------------------------------------------------- 106 (973)
|++|++|++|++|+| ++|.++|.
T Consensus 340 p~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~ 419 (876)
T 4ecn_A 340 PDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKK 419 (876)
T ss_dssp CGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCC
T ss_pred chHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccccccc
Confidence 999999999999999 77765443
Q ss_pred --------------------CC-CCCCCCccceeeccCCCCCC------------------CCccc-cCCCCCccEEEcc
Q 041143 107 --------------------LP-TFSGLSELEFAYLDFNEFDT------------------IPSDF-FDGLSSVRVLALD 146 (973)
Q Consensus 107 --------------------~~-~~~~l~~L~~L~L~~N~l~~------------------i~~~~-f~~l~~L~~L~Ls 146 (973)
+| .|.++++|++|+|++|+|+. +|... |.++++|++|+|+
T Consensus 420 ~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls 499 (876)
T 4ecn_A 420 DSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELY 499 (876)
T ss_dssp CCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEE
T ss_pred ccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECc
Confidence 44 68889999999999999998 77664 5599999999999
Q ss_pred cCCCCCccCCCCCcccccccccCeeeccccc-ccC-CcchhccCCC-------CCCeEEccCCcCcccCCh--hhhhhHH
Q 041143 147 YNPFNKTFGWSIPDSLANSVQLTNLSLINCN-LVG-PLPDFLGTLP-------SLAALKLSYNRLSGVIPA--SFGQSLM 215 (973)
Q Consensus 147 ~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~-l~~-~~p~~l~~l~-------~L~~L~Ls~N~l~~~~p~--~~~~~~~ 215 (973)
+|++.+. +|..|+++++|+.|+|++|+ +++ .+|..+++++ +|++|+|++|+++ .+|. .+.. +.
T Consensus 500 ~N~l~~~----iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~-L~ 573 (876)
T 4ecn_A 500 NCPNMTQ----LPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQK-MV 573 (876)
T ss_dssp SCTTCCS----CCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTT-CT
T ss_pred CCCCCcc----ChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhc-CC
Confidence 9998875 89999999999999999998 888 7888776655 9999999999998 8887 6643 33
Q ss_pred HHHhhcccCCCCCCCcchhhcCCccccEEEccCCccccCCCccccCCCC-CCEEeCcCCcccccCccccccc---ccCeE
Q 041143 216 QILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSS-LKDLNLNRNQLVGLIPKSLANM---ELDNL 291 (973)
Q Consensus 216 ~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~-L~~L~Ls~N~l~~~~p~~~~~l---~L~~L 291 (973)
.+..|....+.....+ .|.++++|+.|+|++|+++ .+|..+..+++ |+.|+|++|+|+ .+|..+... +|+.|
T Consensus 574 ~L~~L~Ls~N~l~~lp--~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L 649 (876)
T 4ecn_A 574 KLGLLDCVHNKVRHLE--AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSV 649 (876)
T ss_dssp TCCEEECTTSCCCBCC--CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEE
T ss_pred CCCEEECCCCCcccch--hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEE
Confidence 3444444444444333 7888999999999999999 88989999998 999999999998 678877765 38999
Q ss_pred EccCCcCcCCCCCCCCCC-----cccccCcccCCCCCcccCC-cchhhhhhccCCCCCCcccCCCCCCCCCCCCcccccc
Q 041143 292 VLNNNLLMGPIPKFKAGN-----VTYDSNSFCQSEPGIECAP-DVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSC 365 (973)
Q Consensus 292 ~l~~N~l~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~ 365 (973)
+|++|.+.|.+|...... ..+....+..+... ..+ .....+..+..++++.|.+..++...... ....+
T Consensus 650 ~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~--~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~---~~~~l 724 (876)
T 4ecn_A 650 DFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ--KFPTELFATGSPISTIILSNNLMTSIPENSLKP---KDGNY 724 (876)
T ss_dssp ECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC--SCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSC---TTSCC
T ss_pred ECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC--ccCHHHHccCCCCCEEECCCCcCCccChHHhcc---ccccc
Confidence 999999998877543110 11222233222221 222 22223556778888888887766532110 00012
Q ss_pred CCCCcccEEecCCCcCCCccchhhh--CccccceEEccCCccccccCccccCcCCCCeeeCCC------CcCCCCCCC--
Q 041143 366 TSNSKVSIINLPRHNLTGTLSPSIA--NLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSD------NNIKPPLPE-- 435 (973)
Q Consensus 366 ~~~~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~------N~l~g~~p~-- 435 (973)
.++++|+.|+|++|+++ .+|..+. .+++|+.|+|++|+|++ +|..+..+++|+.|+|++ |++.+.+|.
T Consensus 725 ~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l 802 (876)
T 4ecn_A 725 KNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGI 802 (876)
T ss_dssp TTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTG
T ss_pred cccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHH
Confidence 23335555555555555 4455544 55555555555555554 455555555555555543 445555442
Q ss_pred --CCcccceeecCCcc
Q 041143 436 --FHDTVKLVIDGNPL 449 (973)
Q Consensus 436 --~~~~~~~~~~~N~~ 449 (973)
+.++..|++.+|.+
T Consensus 803 ~~L~~L~~L~Ls~N~L 818 (876)
T 4ecn_A 803 TTCPSLIQLQIGSNDI 818 (876)
T ss_dssp GGCSSCCEEECCSSCC
T ss_pred hcCCCCCEEECCCCCC
Confidence 23334455555544
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=420.05 Aligned_cols=414 Identities=19% Similarity=0.222 Sum_probs=303.3
Q ss_pred CCChhHHHHHHHHHhhCCCCcc----------CCCCCCCCCCCCCCCc---CeEEeeC-CeEEEEEecccCCcccCCcCc
Q 041143 22 ATDPNDLKILNDFKNGLENPEL----------LKWPANGDDPCGPPPW---PHVFCSG-NRVTQIQVQNLGLKGPLPQNF 87 (973)
Q Consensus 22 ~~~~~~~~~l~~~k~~~~~~~l----------~~w~~~~~d~C~~~~w---~gv~C~~-~~v~~L~L~~~~l~g~~~~~~ 87 (973)
+....|+.||.+|+.++..+.. .+|.. +.|||. | .||.|+. ++|+.|+|++++++|.+|++|
T Consensus 26 ~~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~-~~~~c~---w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~l 101 (636)
T 4eco_A 26 AEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNF-NKELDM---WGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAI 101 (636)
T ss_dssp CHHHHHHHHHHHHHHHTTGGGCCCCC------CCCCC-SSCGGG---TTCCTTEEECTTCCEEEEECTTSCCEEEECGGG
T ss_pred hhHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCC-CCCccc---ccCCCCeEEcCCCCEEEEEecCcccCCcCChHH
Confidence 4456799999999999876542 36864 578998 9 9999975 699999999999999999999
Q ss_pred ccccccceeeccCcc-----------------------------------------------------------------
Q 041143 88 NQLTKLYNLGLQRNK----------------------------------------------------------------- 102 (973)
Q Consensus 88 ~~l~~L~~L~L~~N~----------------------------------------------------------------- 102 (973)
++|++|++|+|++|.
T Consensus 102 ~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~ 181 (636)
T 4eco_A 102 GQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRI 181 (636)
T ss_dssp GGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCC
T ss_pred hcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCcccccccccccc
Confidence 999999999999984
Q ss_pred -------------cCCCCCCCCCCCccceeeccCCCCCC------------------CCccccC--CCCCccEEEcccCC
Q 041143 103 -------------FNGKLPTFSGLSELEFAYLDFNEFDT------------------IPSDFFD--GLSSVRVLALDYNP 149 (973)
Q Consensus 103 -------------l~~~~~~~~~l~~L~~L~L~~N~l~~------------------i~~~~f~--~l~~L~~L~Ls~N~ 149 (973)
++++++.|.++++|++|+|++|+|+. +|.. +. ++++|++|+|++|+
T Consensus 182 ~l~~l~l~~~~n~l~~ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~-l~~~~l~~L~~L~L~~n~ 260 (636)
T 4eco_A 182 TLKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTED-LKWDNLKDLTDVEVYNCP 260 (636)
T ss_dssp CCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSC-CCGGGCTTCCEEEEECCT
T ss_pred chhhhhhccccCCCccCCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchh-hhhcccCCCCEEEecCCc
Confidence 34533368889999999999999998 6654 66 89999999999999
Q ss_pred CCCccCCCCCcccccccccCeeeccccc-ccC-CcchhccCC------CCCCeEEccCCcCcccCCh--hhhhhHHHHHh
Q 041143 150 FNKTFGWSIPDSLANSVQLTNLSLINCN-LVG-PLPDFLGTL------PSLAALKLSYNRLSGVIPA--SFGQSLMQILW 219 (973)
Q Consensus 150 l~~~~~~~ip~~~~~l~~L~~L~L~~N~-l~~-~~p~~l~~l------~~L~~L~Ls~N~l~~~~p~--~~~~~~~~~~~ 219 (973)
+.+. +|..++++++|++|+|++|+ ++| .+|..++++ ++|++|+|++|+++ .+|. .+.. +..+..
T Consensus 261 l~~~----~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~-l~~L~~ 334 (636)
T 4eco_A 261 NLTK----LPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQK-MKKLGM 334 (636)
T ss_dssp TCSS----CCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTT-CTTCCE
T ss_pred CCcc----ChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhcc-CCCCCE
Confidence 8885 89999999999999999998 888 889888876 89999999999998 7887 6643 333444
Q ss_pred hcccCCCCCCCcchhhcCCccccEEEccCCccccCCCccccCCCC-CCEEeCcCCcccccCccccccc---ccCeEEccC
Q 041143 220 LNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSS-LKDLNLNRNQLVGLIPKSLANM---ELDNLVLNN 295 (973)
Q Consensus 220 l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~-L~~L~Ls~N~l~~~~p~~~~~l---~L~~L~l~~ 295 (973)
|+...+......+ .|.++++|++|+|++|+++ .+|..+..+++ |++|+|++|+++ .+|..+... +|+.|++++
T Consensus 335 L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~ 411 (636)
T 4eco_A 335 LECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSY 411 (636)
T ss_dssp EECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCS
T ss_pred EeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcC
Confidence 4444444431222 7888899999999999999 88888999998 999999999999 678777665 589999999
Q ss_pred CcCcCCCCCCCC-------CCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCC------------
Q 041143 296 NLLMGPIPKFKA-------GNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPC------------ 356 (973)
Q Consensus 296 N~l~g~~p~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~------------ 356 (973)
|.+++.+|..+. ....+....+.++... .........+..+..++++.|.+..++.....
T Consensus 412 N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L 490 (636)
T 4eco_A 412 NEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQIS-KFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLL 490 (636)
T ss_dssp SCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCC-SCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGC
T ss_pred CcCCCcchhhhcccccccccCCCCCEEECcCCccC-cCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCc
Confidence 999988887554 2222333333333222 11112222355677777877777766543211
Q ss_pred --------CCCccccccC--CCCcccEEecCCCcCCCccchhhhCccccceEEc------cCCccccccCccccCcCCCC
Q 041143 357 --------QGPWLGLSCT--SNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRL------GKNSISGTVPNNFTELKSLR 420 (973)
Q Consensus 357 --------~~~~~~~~~~--~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L------~~N~l~g~~p~~~~~l~~L~ 420 (973)
........+. .+++|+.|+|++|++++ +|..++++++|+.|+| ++|++.+.+|..|..+++|+
T Consensus 491 ~~L~Ls~N~l~~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~ 569 (636)
T 4eco_A 491 TSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLT 569 (636)
T ss_dssp CEEECCSSCCCBCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCC
T ss_pred cEEECcCCcCCccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCC
Confidence 0011111222 56677777777777776 6666777777777777 45666667777777777777
Q ss_pred eeeCCCCcCCCCCCC--CCcccceeecCCccccC
Q 041143 421 LLDVSDNNIKPPLPE--FHDTVKLVIDGNPLLVG 452 (973)
Q Consensus 421 ~L~Ls~N~l~g~~p~--~~~~~~~~~~~N~~~c~ 452 (973)
.|+|++|+| +.+|. ..++..+++.+|++.|-
T Consensus 570 ~L~Ls~N~l-~~ip~~~~~~L~~L~Ls~N~l~~~ 602 (636)
T 4eco_A 570 QLQIGSNDI-RKVNEKITPNISVLDIKDNPNISI 602 (636)
T ss_dssp EEECCSSCC-CBCCSCCCTTCCEEECCSCTTCEE
T ss_pred EEECCCCcC-CccCHhHhCcCCEEECcCCCCccc
Confidence 777777777 44443 24455567777777664
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=382.01 Aligned_cols=267 Identities=32% Similarity=0.510 Sum_probs=208.6
Q ss_pred HhcCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 623 VTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
..++|...+.||+|+||.||+|+.. |+.||||++..........+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 3568999999999999999999874 889999999876556677788999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCC--eeeccCCCCcEEECCCCCEEEeecccccc
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQT--FIHRDLKSSNILLDDDYRAKVSDFGLVKL 780 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~--ivH~Dikp~Nill~~~~~~kl~DfGla~~ 780 (973)
||+++|+|.+++..... ...+++..++.++.||++||+||| +.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 114 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGA--REQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp ECCTTCBHHHHHHSTTH--HHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred ecCCCCcHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 99999999999975321 234899999999999999999999 778 99999999999999999999999999985
Q ss_pred CCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhh
Q 041143 781 APDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAA 860 (973)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (973)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... ....
T Consensus 189 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~------~~~~-------- 253 (309)
T 3p86_A 189 KASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVA------AVGF-------- 253 (309)
T ss_dssp --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH------HHHH--------
T ss_pred ccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHh--------
Confidence 44322 22344679999999999999999999999999999999999999998765432211 1100
Q ss_pred cCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCCC
Q 041143 861 IDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPI 913 (973)
Q Consensus 861 ~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~~ 913 (973)
....... +......+.+++.+|++.||++||++.+|++.|+.+++...+.
T Consensus 254 ~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~ 303 (309)
T 3p86_A 254 KCKRLEI---PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303 (309)
T ss_dssp SCCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred cCCCCCC---CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence 0011110 1112235789999999999999999999999999998865443
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=385.70 Aligned_cols=265 Identities=25% Similarity=0.392 Sum_probs=215.7
Q ss_pred hcCccccCcccccCccEEEEEEEC--------CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEe
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE--------DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIE 694 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 694 (973)
.++|...+.||+|+||.||+|++. ++..||||+++.. ......+.+.+|+++++++ +||||+++++++.+
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 367889999999999999999752 3567999999765 3455677899999999999 89999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHHhhhh-----------ccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEE
Q 041143 695 GNERLLVYEYMPHGALSRHLFRWEK-----------LQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNIL 763 (973)
Q Consensus 695 ~~~~~lV~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nil 763 (973)
.+..++||||+++|+|.+++..... .....+++.+++.++.||++||+||| +++|+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEE
Confidence 9999999999999999999976431 12245899999999999999999999 789999999999999
Q ss_pred ECCCCCEEEeeccccccCCCCCc-ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHH
Q 041143 764 LDDDYRAKVSDFGLVKLAPDGEK-SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESR 841 (973)
Q Consensus 764 l~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~ 841 (973)
++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||......+..
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~ 315 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 315 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 99999999999999986543322 22234567889999999999999999999999999999999 99999876543221
Q ss_pred HHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhc
Q 041143 842 YLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKW 910 (973)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~ 910 (973)
. .+.. ...+.. +......+.+++.+|++.||++||++.|+++.|+.++...
T Consensus 316 ~------~~~~-------~~~~~~-----~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 316 K------LLKE-------GHRMDK-----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp H------HHHT-------TCCCCC-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred H------HHhc-------CCCCCC-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 1 1111 011111 1112245789999999999999999999999999987643
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=375.09 Aligned_cols=225 Identities=29% Similarity=0.483 Sum_probs=168.4
Q ss_pred CCChhHHHHHHHHHhhCCCCc-cCCCCCCCCCCCCCCCcCeEEeeC----CeEEEEEecccCCcc--cCCcCcccccccc
Q 041143 22 ATDPNDLKILNDFKNGLENPE-LLKWPANGDDPCGPPPWPHVFCSG----NRVTQIQVQNLGLKG--PLPQNFNQLTKLY 94 (973)
Q Consensus 22 ~~~~~~~~~l~~~k~~~~~~~-l~~w~~~~~d~C~~~~w~gv~C~~----~~v~~L~L~~~~l~g--~~~~~~~~l~~L~ 94 (973)
.|.++|.+||++||+++.+|. +.+|+. +.|||. +.|.||.|+. ++|+.|+|++++++| .+|+.|+++++|+
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~~l~~W~~-~~~~C~-~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~ 79 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPTTLSSWLP-TTDCCN-RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN 79 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCT-TSCTTT-TCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCS
T ss_pred CCCHHHHHHHHHHHHhcCCcccccCCCC-CCCCCc-CCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCC
Confidence 588999999999999998875 678864 578885 4599999985 689999999999999 8999999898888
Q ss_pred eeeccC-cccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeeec
Q 041143 95 NLGLQR-NKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSL 173 (973)
Q Consensus 95 ~L~L~~-N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L 173 (973)
+|+|++ |.+++.+| ..|.++++|++|+|++|++++. +|..|.++++|++|+|
T Consensus 80 ~L~L~~~n~l~~~~p-----------------------~~l~~l~~L~~L~Ls~n~l~~~----~p~~~~~l~~L~~L~L 132 (313)
T 1ogq_A 80 FLYIGGINNLVGPIP-----------------------PAIAKLTQLHYLYITHTNVSGA----IPDFLSQIKTLVTLDF 132 (313)
T ss_dssp EEEEEEETTEESCCC-----------------------GGGGGCTTCSEEEEEEECCEEE----CCGGGGGCTTCCEEEC
T ss_pred eeeCCCCCcccccCC-----------------------hhHhcCCCCCEEECcCCeeCCc----CCHHHhCCCCCCEEeC
Confidence 888884 77776555 2234455555555555555543 6777777788888888
Q ss_pred ccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCc-cccEEEccCCccc
Q 041143 174 INCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMV-SLTQLWLHGNQFT 252 (973)
Q Consensus 174 ~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~-~L~~L~L~~N~l~ 252 (973)
++|.|++.+|..|.++++|++|+|++|++++.+|..+. .++ +|++|+|++|+++
T Consensus 133 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~-------------------------~l~~~L~~L~L~~N~l~ 187 (313)
T 1ogq_A 133 SYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYG-------------------------SFSKLFTSMTISRNRLT 187 (313)
T ss_dssp CSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGG-------------------------CCCTTCCEEECCSSEEE
T ss_pred CCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHh-------------------------hhhhcCcEEECcCCeee
Confidence 88888877777777888888888888888777776653 355 7777777777777
Q ss_pred cCCCccccCCCCCCEEeCcCCcccccCccccccc-ccCeEEccCCcCcCC
Q 041143 253 GSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGP 301 (973)
Q Consensus 253 g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~g~ 301 (973)
+.+|..+..++ |++|+|++|++++.+|..+..+ +|+.|+|++|.+++.
T Consensus 188 ~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 236 (313)
T 1ogq_A 188 GKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFD 236 (313)
T ss_dssp EECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCB
T ss_pred ccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeee
Confidence 77777777776 7777777777777666666655 555555555555443
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=378.32 Aligned_cols=255 Identities=22% Similarity=0.345 Sum_probs=213.5
Q ss_pred hcCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
.++|...+.||+|+||.||+|+. .+|+.||||++..........+.+.+|+++++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 36899999999999999999987 57999999999776556667788999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++|+|.+++... ..+++.++..++.||++||+||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 94 e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH-----GRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp CCCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred ECCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 999999999999652 45899999999999999999999 7899999999999999999999999999998654
Q ss_pred CCCcceecccccccCcccccccccCcCC-CchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhc
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMGKIT-TKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (973)
... .....+||+.|+|||++.+..+. .++||||+||++|||++|+.||......+. ...+...
T Consensus 166 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~i~~~-------- 229 (328)
T 3fe3_A 166 VGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL------RERVLRG-------- 229 (328)
T ss_dssp SSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHC--------
T ss_pred CCC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHH------HHHHHhC--------
Confidence 432 24556899999999999888875 789999999999999999999987654321 1111111
Q ss_pred CccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 862 DPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 862 ~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
...... .....+.+++.+|++.||.+|||+.|+++ ++++..
T Consensus 230 --~~~~p~---~~s~~~~~li~~~L~~dP~~R~t~~eil~--h~~~~~ 270 (328)
T 3fe3_A 230 --KYRIPF---YMSTDCENLLKRFLVLNPIKRGTLEQIMK--DRWINA 270 (328)
T ss_dssp --CCCCCT---TSCHHHHHHHHHHCCSSTTTSCCHHHHTT--CTTTTT
T ss_pred --CCCCCC---CCCHHHHHHHHHHCCCChhHCcCHHHHhc--CHhhcC
Confidence 111000 11234779999999999999999999998 666654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=381.13 Aligned_cols=272 Identities=25% Similarity=0.353 Sum_probs=210.0
Q ss_pred cCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC----eEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGN----ERLL 700 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~l 700 (973)
++|+..+.||+|+||.||+|+.. ++.||||++... ......+.+|+.++++++|||||++++++.... ..++
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred hhchhhheecccCceEEEEEEEC-CCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 68899999999999999999887 789999998643 334456677999999999999999999998754 4699
Q ss_pred EEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccC----------CeeeccCCCCcEEECCCCCE
Q 041143 701 VYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQ----------TFIHRDLKSSNILLDDDYRA 770 (973)
Q Consensus 701 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~----------~ivH~Dikp~Nill~~~~~~ 770 (973)
||||+++|+|.+++.. ..++|..+..++.|+++||+||| +. +|+||||||+|||++.++.+
T Consensus 100 v~e~~~~g~L~~~l~~------~~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~ 170 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA------NVVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA 170 (322)
T ss_dssp EEECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCE
T ss_pred EEecCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeE
Confidence 9999999999999965 45899999999999999999999 66 99999999999999999999
Q ss_pred EEeeccccccCCCCCc-ceecccccccCccccccccc-----CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 041143 771 KVSDFGLVKLAPDGEK-SVVTRLAGTFGYLAPEYAVM-----GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLA 844 (973)
Q Consensus 771 kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~ 844 (973)
||+|||+++....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||............
T Consensus 171 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~ 250 (322)
T 3soc_A 171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250 (322)
T ss_dssp EECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH
T ss_pred EEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchh
Confidence 9999999985543322 22334679999999999876 35667899999999999999999999765432111100
Q ss_pred HHHHHHhhchhHH----HhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 845 EWFWRIKSSKEKF----KAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 845 ~~~~~~~~~~~~~----~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
............. .....+.+............+.+++.+||+.||++|||+.||++.|+.+.+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 0000000000000 1111122221112234556789999999999999999999999999998764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=369.84 Aligned_cols=285 Identities=39% Similarity=0.669 Sum_probs=234.4
Q ss_pred ceeecHHHHHHHhcCcccc------CcccccCccEEEEEEECCCCEEEEEEeecCC--CChHHHHHHHHHHHHHHhcCCC
Q 041143 612 TLVISVQVLRKVTQNFAQE------NELGRGGFGTVYKGELEDGTKIAVKRMEAGV--TTTKALDEFQSEIAVLSKVRHR 683 (973)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~------~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~ 683 (973)
...++..++..++++|... +.||+|+||.||+|.. +++.||||++.... ......+.+.+|++++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 4568899999999999887 8999999999999987 48899999986532 2344567899999999999999
Q ss_pred ceeeeeeEEEeCCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEE
Q 041143 684 HLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNIL 763 (973)
Q Consensus 684 niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nil 763 (973)
||+++++++.+.+..++||||+++|+|.+++.... ....++|..++.++.||+.||+||| +++|+||||||+||+
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil 165 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD--GTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANIL 165 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG--GCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEE
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEE
Confidence 99999999999999999999999999999997532 2356899999999999999999999 789999999999999
Q ss_pred ECCCCCEEEeeccccccCCCCCc-ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHH
Q 041143 764 LDDDYRAKVSDFGLVKLAPDGEK-SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRY 842 (973)
Q Consensus 764 l~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~ 842 (973)
++.++.+||+|||+++....... .......||+.|+|||.+.+ .++.++|||||||++|||++|+.||....... .
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~ 242 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ--L 242 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS--B
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH--H
Confidence 99999999999999986544322 22344679999999998754 68999999999999999999999998654322 1
Q ss_pred HHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhh
Q 041143 843 LAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLV 907 (973)
Q Consensus 843 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~ 907 (973)
+..+..........+...+++.+. .........+.+++.+|++.||.+||++.+|++.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 243 LLDIKEEIEDEEKTIEDYIDKKMN--DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp TTHHHHHHHTTSCCHHHHSCSSCS--CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHHHHhhhhhhhhhhhcccccc--ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 122222333333345566666553 344566778999999999999999999999999998874
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=371.83 Aligned_cols=256 Identities=23% Similarity=0.412 Sum_probs=210.7
Q ss_pred hcCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
.++|...+.||+|+||.||+|.. .+|+.||||++...... ..+.+.+|+.++++++||||+++++++..++..++||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc--HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence 46899999999999999999986 56899999998754222 2457889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++|+|.+++.. ..+++.++..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++...
T Consensus 97 e~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (297)
T 3fxz_A 97 EYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (297)
T ss_dssp ECCTTCBHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred ECCCCCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 99999999999865 35899999999999999999999 7899999999999999999999999999998654
Q ss_pred CCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcC
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (973)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........... +. ....
T Consensus 168 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~------~~-------~~~~ 233 (297)
T 3fxz_A 168 PEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL------IA-------TNGT 233 (297)
T ss_dssp STTC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH------HH-------HHCS
T ss_pred Cccc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------HH-------hCCC
Confidence 4332 23456799999999999999999999999999999999999999987654322111 00 0011
Q ss_pred ccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 863 PALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 863 ~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
+.+. ........+.+++.+|++.||++||++.|+++ +++++.
T Consensus 234 ~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~--h~~~~~ 275 (297)
T 3fxz_A 234 PELQ---NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ--HQFLKI 275 (297)
T ss_dssp CCCS---CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT--CGGGGG
T ss_pred CCCC---CccccCHHHHHHHHHHccCChhHCcCHHHHhh--Chhhcc
Confidence 1111 01112244779999999999999999999998 666554
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=370.05 Aligned_cols=261 Identities=25% Similarity=0.404 Sum_probs=213.4
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
++|...+.||+|+||.||+|... +++.||+|++... .....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE 87 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence 57888999999999999999875 5899999988643 56677889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+++|+|.+++... ...+++.++..++.|+++||+||| +++|+||||||+||+++.++.+||+|||+++....
T Consensus 88 ~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 160 (310)
T 3s95_A 88 YIKGGTLRGIIKSM----DSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVD 160 (310)
T ss_dssp CCTTCBHHHHHHHC----CTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred ecCCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence 99999999999652 256899999999999999999999 78999999999999999999999999999986543
Q ss_pred CCcce-------------ecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHH
Q 041143 784 GEKSV-------------VTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRI 850 (973)
Q Consensus 784 ~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 850 (973)
..... .....||+.|+|||++.+..++.++|||||||++|||++|..|+.............
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~----- 235 (310)
T 3s95_A 161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN----- 235 (310)
T ss_dssp -------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC-----
T ss_pred ccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh-----
Confidence 32211 114679999999999999999999999999999999999999987654322110000
Q ss_pred hhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhc
Q 041143 851 KSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKW 910 (973)
Q Consensus 851 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~ 910 (973)
..........+.+. ..+.+++.+|++.||++||++.++++.|+.+.+..
T Consensus 236 --~~~~~~~~~~~~~~---------~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 236 --VRGFLDRYCPPNCP---------PSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp --HHHHHHHTCCTTCC---------TTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --hhccccccCCCCCC---------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 01111111222221 23779999999999999999999999999987754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=365.47 Aligned_cols=266 Identities=24% Similarity=0.386 Sum_probs=210.3
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCC-CChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGV-TTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLV 701 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 701 (973)
.++|+..+.||+|+||.||+|+.. +++.||+|++.... ......+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 368999999999999999999865 68999999986542 3455667899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccC
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA 781 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~ 781 (973)
|||+++|+|.+++... ..+++.++..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++..
T Consensus 90 ~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 161 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH-----GPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL 161 (294)
T ss_dssp EECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC
T ss_pred EeCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCcccc
Confidence 9999999999999652 46899999999999999999999 789999999999999999999999999999866
Q ss_pred CCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhc
Q 041143 782 PDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861 (973)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (973)
............||+.|+|||.+.+..++.++|||||||++|||++|+.||......... ..............+
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~-----~~~~~~~~~~~~~~~ 236 (294)
T 4eqm_A 162 SETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA-----IKHIQDSVPNVTTDV 236 (294)
T ss_dssp -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH-----HHHHSSCCCCHHHHS
T ss_pred ccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH-----HHHhhccCCCcchhc
Confidence 544333344567999999999999999999999999999999999999999876543211 011111001111111
Q ss_pred CccccCCcccHHHHHHHHHHHHHhhccCCCCCC-CHhHHHHHHHHhhhhcC
Q 041143 862 DPALEVNEETFESISIVAELAGHCTAREPYHRP-DMGHVVNVLSPLVEKWR 911 (973)
Q Consensus 862 ~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-s~~~v~~~L~~~~~~~~ 911 (973)
.+ .....+.+++.+|++.||++|| +++++.+.|+.+.....
T Consensus 237 ~~---------~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 237 RK---------DIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR 278 (294)
T ss_dssp CT---------TSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred cc---------CCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence 11 1224578999999999999999 89999998887766433
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=371.82 Aligned_cols=266 Identities=23% Similarity=0.394 Sum_probs=216.2
Q ss_pred eecHHHHHHHhcC----------ccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC
Q 041143 614 VISVQVLRKVTQN----------FAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRH 682 (973)
Q Consensus 614 ~~~~~~~~~~~~~----------~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h 682 (973)
.++.++++.+++. |...+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.++++++|
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCSHHHHHHHHHHHTTCCC
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc--hhHHHHHHHHHHHHHhCCC
Confidence 3566777777654 677789999999999999876 79999999997542 2334678899999999999
Q ss_pred CceeeeeeEEEeCCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcE
Q 041143 683 RHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNI 762 (973)
Q Consensus 683 ~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Ni 762 (973)
|||+++++++...+..++||||+++|+|.+++.. ..+++..+..++.||+.||+||| +.+|+||||||+||
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~------~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NI 172 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ------VRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSI 172 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGE
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHE
Confidence 9999999999999999999999999999998854 46899999999999999999999 78999999999999
Q ss_pred EECCCCCEEEeeccccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHH
Q 041143 763 LLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRY 842 (973)
Q Consensus 763 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~ 842 (973)
+++.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.
T Consensus 173 ll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~-- 249 (321)
T 2c30_A 173 LLTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA-- 249 (321)
T ss_dssp EECTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--
T ss_pred EECCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--
Confidence 999999999999999986544322 23456799999999999999999999999999999999999999986653221
Q ss_pred HHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 843 LAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 843 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
.. .+.....+.+.. .......+.+++.+|++.||++||++.|+++ ++++.+
T Consensus 250 ----~~-------~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~--hp~~~~ 300 (321)
T 2c30_A 250 ----MK-------RLRDSPPPKLKN---SHKVSPVLRDFLERMLVRDPQERATAQELLD--HPFLLQ 300 (321)
T ss_dssp ----HH-------HHHHSSCCCCTT---GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT--SGGGGG
T ss_pred ----HH-------HHhcCCCCCcCc---cccCCHHHHHHHHHHccCChhhCcCHHHHhc--Chhhcc
Confidence 11 111112222211 1112234779999999999999999999998 566554
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=365.75 Aligned_cols=256 Identities=29% Similarity=0.456 Sum_probs=213.1
Q ss_pred cCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEe
Q 041143 625 QNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEY 704 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 704 (973)
++|...+.||+|+||.||+|...+++.||||++...... .+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 578889999999999999999988999999999765333 35689999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCC
Q 041143 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG 784 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~ 784 (973)
+++|+|.+++... ...+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 87 ~~~~~L~~~l~~~----~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 87 MEHGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp CTTCBHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred CCCCcHHHHHHhc----CcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 9999999999652 246899999999999999999999 889999999999999999999999999999866543
Q ss_pred CcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCc
Q 041143 785 EKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDP 863 (973)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (973)
.........||+.|+|||++.+..++.++||||+|+++|||++ |+.||......+.. ..+.. ....
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~------~~~~~-------~~~~ 226 (269)
T 4hcu_A 160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV------EDIST-------GFRL 226 (269)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH------HHHHT-------TCCC
T ss_pred ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHH------HHHhc-------CccC
Confidence 3333344567889999999999999999999999999999999 99999876543211 11111 1111
Q ss_pred cccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 864 ALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 864 ~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
... ......+.+++.+|++.||++||++.|+++.|+++.+
T Consensus 227 ~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 227 YKP-----RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp CCC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCC-----CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 111 1112447899999999999999999999999999876
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=374.96 Aligned_cols=260 Identities=26% Similarity=0.433 Sum_probs=211.2
Q ss_pred hcCccccCcccccCccEEEEEEEC----CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE----DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERL 699 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 699 (973)
.++|...+.||+|+||.||+|.+. .+..||||+++.. ......+.|.+|++++++++||||+++++++.+++..+
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG-YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 367889999999999999999874 3456999999764 34556678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccc
Q 041143 700 LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK 779 (973)
Q Consensus 700 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~ 779 (973)
+||||+++|+|.+++... ...+++.+++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 127 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRTH----DGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp EEEECCTTCBHHHHHHTT----TTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEeeCCCCCcHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCccc
Confidence 999999999999999652 246899999999999999999999 7899999999999999999999999999998
Q ss_pred cCCCCCcc--eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhH
Q 041143 780 LAPDGEKS--VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEK 856 (973)
Q Consensus 780 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (973)
........ ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+.. ..+.
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~------~~~~----- 268 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVI------SSVE----- 268 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH------HHHH-----
T ss_pred ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHH------HHHH-----
Confidence 66543222 2233456788999999999999999999999999999999 99999776543211 1111
Q ss_pred HHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 857 FKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 857 ~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
....... .......+.+++..|++.||++||++.||++.|+.+.+.
T Consensus 269 --~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 269 --EGYRLPA-----PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp --TTCCCCC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred --cCCCCCC-----CCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 1111111 112234578999999999999999999999999999874
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=362.34 Aligned_cols=258 Identities=28% Similarity=0.436 Sum_probs=214.2
Q ss_pred hcCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
.++|...+.||+|+||.||+|+..++..||||+++..... .+++.+|++++.+++||||+++++++.+.+..++|||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS---EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc---HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 3678899999999999999999998889999999765332 3568999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+++|+|.+++... ...+++.+++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 84 ~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 156 (268)
T 3sxs_A 84 YISNGCLLNYLRSH----GKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156 (268)
T ss_dssp CCTTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred ccCCCcHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecch
Confidence 99999999999763 245899999999999999999999 78999999999999999999999999999987665
Q ss_pred CCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcC
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (973)
..........||+.|+|||.+.+..++.++||||||+++|||++ |+.||......+.. ....... ....
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~------~~~~~~~----~~~~ 226 (268)
T 3sxs_A 157 DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV------LKVSQGH----RLYR 226 (268)
T ss_dssp TCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH------HHHHTTC----CCCC
T ss_pred hhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHH------HHHHcCC----CCCC
Confidence 54444444567788999999999899999999999999999999 99999876543221 1111100 0011
Q ss_pred ccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 863 PALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 863 ~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
+. .....+.+++.+|++.||++||++.|+++.|+.+.++
T Consensus 227 ~~--------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 227 PH--------LASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp CT--------TSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred CC--------cChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 11 1123578999999999999999999999999988664
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=382.38 Aligned_cols=259 Identities=25% Similarity=0.460 Sum_probs=201.7
Q ss_pred cCccccCcccccCccEEEEEEEC----CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE----DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLL 700 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 700 (973)
++|...+.||+|+||.||+|++. ++..||||+++.. ......+.|.+|++++++++||||+++++++.+.+..++
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 57899999999999999999865 5778999999764 245566789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecccccc
Q 041143 701 VYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKL 780 (973)
Q Consensus 701 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~ 780 (973)
||||+++|+|.++++.. ...+++.+++.++.||++||+||| +++|+||||||+|||++.++.+||+|||+++.
T Consensus 124 v~e~~~~~sL~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKH----DAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp EEECCTTCBHHHHHHTT----TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEeCCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 99999999999999652 246899999999999999999999 78999999999999999999999999999986
Q ss_pred CCCCCcce--ecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHH
Q 041143 781 APDGEKSV--VTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKF 857 (973)
Q Consensus 781 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (973)
........ .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+.. ..+..
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~------~~i~~----- 265 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI------KAVDE----- 265 (373)
T ss_dssp -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHH------HHHHT-----
T ss_pred cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH------HHHHc-----
Confidence 54432221 122345788999999999999999999999999999998 99999766533211 11110
Q ss_pred HhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 858 KAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 858 ~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
.... .........+.+++.+|++.||++||++.+|++.|+.+.+.
T Consensus 266 --~~~~-----~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 266 --GYRL-----PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp --TEEC-----CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred --CCCC-----CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 0000 01112234588999999999999999999999999999775
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=384.59 Aligned_cols=260 Identities=27% Similarity=0.432 Sum_probs=212.3
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
.++|...+.||+|+||.||+|++. +++.||||+++.. ......+.|.+|++++++++|||||++++++...+..++||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 367888999999999999999886 6899999998754 34455667999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++|+|.++++.. ...+++.+++.++.||++||+||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 192 e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTE----GARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp ECCTTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred EcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 999999999999752 245899999999999999999999 7899999999999999999999999999998654
Q ss_pred CCCccee-cccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhh
Q 041143 783 DGEKSVV-TRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAA 860 (973)
Q Consensus 783 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (973)
+...... ....+++.|+|||.+....++.++|||||||++|||++ |+.||......+.. ..+ ...
T Consensus 265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~---~~~----------~~~ 331 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR---EFV----------EKG 331 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHH---HHH----------HTT
T ss_pred CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHH----------HcC
Confidence 3221111 12235778999999998999999999999999999998 99999876543221 111 000
Q ss_pred cCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 861 IDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 861 ~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
. .+.... .....+.+++.+||+.||++|||+.+|++.|+.+.++
T Consensus 332 ~--~~~~~~---~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 332 G--RLPCPE---LCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp C--CCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred C--CCCCCC---CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 0 011011 1224577999999999999999999999999998764
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=367.16 Aligned_cols=272 Identities=19% Similarity=0.216 Sum_probs=216.2
Q ss_pred cCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 702 (973)
++|...+.||+|+||.||+|+. .+|+.||||++..... .+.+.+|+++++++ +||||+++++++..++..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 6789999999999999999986 5689999999875422 23578999999999 8999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCC-----EEEeeccc
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYR-----AKVSDFGL 777 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~-----~kl~DfGl 777 (973)
||+ +|+|.+++... ...+++.+++.++.||+.||+||| +.+|+||||||+|||++.++. +||+|||+
T Consensus 85 e~~-~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~ 156 (330)
T 2izr_A 85 ELL-GPSLEDLFDLC----DRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFAL 156 (330)
T ss_dssp ECC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTT
T ss_pred EeC-CCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEccc
Confidence 999 99999999753 256899999999999999999999 789999999999999998887 99999999
Q ss_pred cccCCCCCcc------eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHh
Q 041143 778 VKLAPDGEKS------VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIK 851 (973)
Q Consensus 778 a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 851 (973)
++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.......+....
T Consensus 157 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~ 236 (330)
T 2izr_A 157 AKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTK 236 (330)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHH
T ss_pred ceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhh
Confidence 9865433221 1245689999999999999999999999999999999999999998765433222222111110
Q ss_pred hchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCCCCCCCccc
Q 041143 852 SSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPITDESECC 920 (973)
Q Consensus 852 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~~~~~~~~~ 920 (973)
. ....... .. ... .+.+++..|++.||.+||++.+|++.|+.+.++.....+....+
T Consensus 237 ~-------~~~~~~~-~~---~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw 293 (330)
T 2izr_A 237 R-------ATPIEVL-CE---NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDW 293 (330)
T ss_dssp H-------HSCHHHH-TT---TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTT
T ss_pred c-------cCCHHHH-hc---cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccC
Confidence 0 0000000 00 011 58899999999999999999999999999988765544443333
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=365.02 Aligned_cols=274 Identities=22% Similarity=0.341 Sum_probs=207.7
Q ss_pred HhcCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 623 VTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
..++|+..+.||+|+||.||+|+..+|+.||||+++.........+.+.+|++++++++||||+++++++.+++..++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 34789999999999999999999988999999999765444445678899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||++ |+|.+++.. ....+++.++..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 99 e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 99 EFME-KDLKKVLDE----NKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFG 170 (311)
T ss_dssp ECCS-EEHHHHHHT----CTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred cCCC-CCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecC
Confidence 9997 588888754 2245899999999999999999999 7899999999999999999999999999998654
Q ss_pred CCCcceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhch-hH----
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSK-EK---- 856 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~---- 856 (973)
.... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+.. ........... ..
T Consensus 171 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--~~i~~~~~~~~~~~~~~~ 247 (311)
T 3niz_A 171 IPVR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL--PKIFSILGTPNPREWPQV 247 (311)
T ss_dssp SCCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHH--HHHHHHHCCCCTTTSGGG
T ss_pred CCcc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHH--HHHHHHHCCCChHHhhhh
Confidence 3322 2344578999999999876 56899999999999999999999999876543321 11111110000 00
Q ss_pred --HHhhcCccccC-CcccH-----HHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 857 --FKAAIDPALEV-NEETF-----ESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 857 --~~~~~~~~l~~-~~~~~-----~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
.....+..... ..... .....+.+++.+|++.||++|||++|+++ +++++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~f~~ 306 (311)
T 3niz_A 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN--HPYFKD 306 (311)
T ss_dssp TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT--SGGGTT
T ss_pred hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc--Cccccc
Confidence 00000000000 00011 11235789999999999999999999998 666554
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=379.24 Aligned_cols=289 Identities=24% Similarity=0.366 Sum_probs=210.0
Q ss_pred HHHhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeeEEEeCC--
Q 041143 621 RKVTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR-HRHLVSLLGYSIEGN-- 696 (973)
Q Consensus 621 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-- 696 (973)
+...++|...+.||+|+||.||+|.+. +|+.||||++..........+.+.+|+.++.++. ||||+++++++...+
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 456789999999999999999999864 6899999999766556677788899999999997 999999999998654
Q ss_pred eEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecc
Q 041143 697 ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFG 776 (973)
Q Consensus 697 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG 776 (973)
..|+||||++ |+|..++.. ..+++..+..++.||++||+||| +.+|+||||||+|||++.++.+||+|||
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG 154 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRA------NILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFG 154 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHH------TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEecccC-cCHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCc
Confidence 6899999996 699988865 46899999999999999999999 7899999999999999999999999999
Q ss_pred ccccCCCC--------------------CcceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCC
Q 041143 777 LVKLAPDG--------------------EKSVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEE 835 (973)
Q Consensus 777 la~~~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~ 835 (973)
+|+..... .....+..+||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.
T Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 155 LSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp TCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99854321 1122345689999999999886 67899999999999999999999999876
Q ss_pred ChhhHHHHHHHHHHHhhc-hhHHHhhcCc----------------cccCCcccH-------------HHHHHHHHHHHHh
Q 041143 836 RPEESRYLAEWFWRIKSS-KEKFKAAIDP----------------ALEVNEETF-------------ESISIVAELAGHC 885 (973)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----------------~l~~~~~~~-------------~~~~~~~~l~~~c 885 (973)
...+.... .+...... .+.+...-.+ ......... .....+.+|+.+|
T Consensus 235 ~~~~~~~~--i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~ 312 (388)
T 3oz6_A 235 STMNQLER--IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKL 312 (388)
T ss_dssp SHHHHHHH--HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHH
T ss_pred CHHHHHHH--HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHh
Confidence 64332111 11100000 0000000000 000000000 1123578999999
Q ss_pred hccCCCCCCCHhHHHHHHHHhhhhcCCCCCCCcccCCC
Q 041143 886 TAREPYHRPDMGHVVNVLSPLVEKWRPITDESECCSGI 923 (973)
Q Consensus 886 l~~dP~~RPs~~~v~~~L~~~~~~~~~~~~~~~~~~~~ 923 (973)
|+.||++|||+.|+++ ++++..+....+++.+...+
T Consensus 313 L~~dP~~R~t~~e~l~--Hp~~~~~~~~~~~~~~~~~~ 348 (388)
T 3oz6_A 313 LQFNPNKRISANDALK--HPFVSIFHNPNEEPNCDHII 348 (388)
T ss_dssp CCSSGGGSCCHHHHTT--STTTTTTCCGGGCCCCSSCC
T ss_pred hccCcccCCCHHHHhC--CHHHHHhcCCccCCCCCCCC
Confidence 9999999999999999 88887776666555444433
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=364.08 Aligned_cols=258 Identities=26% Similarity=0.414 Sum_probs=210.9
Q ss_pred hcCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
.++|...+.||+|+||.||+|+..++..||||+++..... .+++.+|++++++++||||+++++++.+.+..++|||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC---HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 3678899999999999999999998889999999765333 3568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+++|+|.+++... ...+++.++..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++....
T Consensus 100 ~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 100 YMANGCLLNYLREM----RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp CCTTCBHHHHHHCG----GGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred ccCCCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 99999999999652 245899999999999999999999 78999999999999999999999999999986654
Q ss_pred CCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcC
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (973)
..........||+.|+|||++.+..++.++||||||+++|||++ |+.||......+... .+ .....
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~------~~-------~~~~~ 239 (283)
T 3gen_A 173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE------HI-------AQGLR 239 (283)
T ss_dssp HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH------HH-------HTTCC
T ss_pred cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHH------HH-------hcccC
Confidence 33333334467889999999998999999999999999999998 999998765432211 11 11111
Q ss_pred ccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 863 PALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 863 ~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
.... . .....+.+++.+|++.||++||++.|+++.|+.+.++
T Consensus 240 ~~~~-~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 240 LYRP-H----LASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp CCCC-T----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCC-C----cCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 1111 0 1124578999999999999999999999999988764
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=389.95 Aligned_cols=259 Identities=26% Similarity=0.437 Sum_probs=212.0
Q ss_pred HhcCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 623 VTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
..++|...+.||+|+||.||+|.+.++..||||+++... ...+.|.+|++++++++|||||++++++. .+..++||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~ 261 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT 261 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence 346788899999999999999999888999999997643 23568999999999999999999999986 56789999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++|+|.++++.... ..+++..++.++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 262 e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp CCCTTCBHHHHHHSHHH---HTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred eecCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 99999999999975322 35789999999999999999999 7899999999999999999999999999998664
Q ss_pred CCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhc
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (973)
...........+|..|+|||++....++.++|||||||++|||++ |+.||......+.. . .+. ...
T Consensus 336 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~---~---~i~-------~~~ 402 (454)
T 1qcf_A 336 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI---R---ALE-------RGY 402 (454)
T ss_dssp CHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH---H---HHH-------HTC
T ss_pred CCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHH---H---HHH-------cCC
Confidence 432222233457789999999998999999999999999999999 99999876543221 1 111 111
Q ss_pred CccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 862 DPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 862 ~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
.... +......+.+++.+|++.||++||++.+|++.|+.+...
T Consensus 403 ~~~~-----~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 403 RMPR-----PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp CCCC-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred CCCC-----CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 1100 111234578999999999999999999999999988654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=378.30 Aligned_cols=264 Identities=26% Similarity=0.384 Sum_probs=212.0
Q ss_pred hcCccccCcccccCccEEEEEEEC------CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCe
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE------DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNE 697 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 697 (973)
.++|...+.||+|+||.||+|++. +++.||||+++.. ........+.+|+.++++++|||||++++++.....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 367889999999999999999853 4678999998753 345566789999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCC---CEEE
Q 041143 698 RLLVYEYMPHGALSRHLFRWEKL--QLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDY---RAKV 772 (973)
Q Consensus 698 ~~lV~e~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~---~~kl 772 (973)
.++||||+++|+|.+++...... ....+++.+++.++.||++||+||| +++|+||||||+|||++.++ .+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEE
Confidence 99999999999999999764321 2245899999999999999999999 88999999999999999554 5999
Q ss_pred eeccccccCCC-CCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHH
Q 041143 773 SDFGLVKLAPD-GEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRI 850 (973)
Q Consensus 773 ~DfGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 850 (973)
+|||+++.... ..........||+.|+|||++.+..++.++|||||||++|||++ |+.||......+.. ..+
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~------~~i 299 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL------EFV 299 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH------HHH
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH------HHH
Confidence 99999974321 11122234568999999999999999999999999999999998 99999876543211 111
Q ss_pred hhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 851 KSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 851 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
.. ...... .......+.+++.+||+.||++||++.+|++.|+.+.+.
T Consensus 300 ~~-------~~~~~~-----~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 300 TS-------GGRMDP-----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp HT-------TCCCCC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred Hc-------CCCCCC-----CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 11 000111 111223578999999999999999999999999988764
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=356.96 Aligned_cols=270 Identities=17% Similarity=0.229 Sum_probs=215.5
Q ss_pred hcCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGNERLLV 701 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 701 (973)
.++|...+.||+|+||.||+|.. .+|+.||||++..... .+.+.+|+++++++ +|+|++++++++.+....++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence 36799999999999999999986 5689999999865422 23578899999999 799999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCC-----EEEeecc
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYR-----AKVSDFG 776 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~-----~kl~DfG 776 (973)
|||+ +|+|.+++... ...+++.++..++.||+.||+||| +++|+||||||+||+++.++. +||+|||
T Consensus 85 ~e~~-~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg 156 (298)
T 1csn_A 85 IDLL-GPSLEDLLDLC----GRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 156 (298)
T ss_dssp EECC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred EEec-CCCHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence 9999 99999999752 245899999999999999999999 889999999999999987776 9999999
Q ss_pred ccccCCCCCc------ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHH
Q 041143 777 LVKLAPDGEK------SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRI 850 (973)
Q Consensus 777 la~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 850 (973)
+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (298)
T 1csn_A 157 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 236 (298)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred cccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh
Confidence 9986544322 1234567999999999999999999999999999999999999999875533222222111111
Q ss_pred hhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCCCCCC
Q 041143 851 KSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPITDE 916 (973)
Q Consensus 851 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~~~~~ 916 (973)
.. ....... .+ .....+.+++.+|++.||++||++++|++.|+.+.++.....+.
T Consensus 237 ~~-~~~~~~~-~~---------~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~ 291 (298)
T 1csn_A 237 KQ-STPLREL-CA---------GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDE 291 (298)
T ss_dssp HH-HSCHHHH-TT---------TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCS
T ss_pred cc-CccHHHH-Hh---------hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCC
Confidence 10 0000110 01 11245789999999999999999999999999999876654443
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=368.48 Aligned_cols=253 Identities=26% Similarity=0.345 Sum_probs=206.7
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
++|+..+.||+|+||.||+|+.. +|+.||+|+++.... .....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 67999999999999999999875 689999999864311 1223457889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++|+|..++.. ...+++.++..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 85 E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 85 EYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp ECCTTCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 99999999999865 246899999999999999999999 7899999999999999999999999999998543
Q ss_pred CCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcC
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (973)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+...
T Consensus 157 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~------~~~i~~~--------- 220 (337)
T 1o6l_A 157 SDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL------FELILME--------- 220 (337)
T ss_dssp CTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHC---------
T ss_pred cCC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHH------HHHHHcC---------
Confidence 322 223456899999999999999999999999999999999999999987653221 1111111
Q ss_pred ccccCCcccHHHHHHHHHHHHHhhccCCCCCC-----CHhHHHHHHHHhh
Q 041143 863 PALEVNEETFESISIVAELAGHCTAREPYHRP-----DMGHVVNVLSPLV 907 (973)
Q Consensus 863 ~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~~v~~~L~~~~ 907 (973)
.+.... .....+.+++.+|++.||++|| ++.||++ +++.
T Consensus 221 -~~~~p~---~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~--h~~f 264 (337)
T 1o6l_A 221 -EIRFPR---TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME--HRFF 264 (337)
T ss_dssp -CCCCCT---TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT--SGGG
T ss_pred -CCCCCC---CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc--CCCc
Confidence 111000 1123477999999999999999 8999887 4443
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=373.30 Aligned_cols=268 Identities=28% Similarity=0.436 Sum_probs=214.2
Q ss_pred HHhcCccccCcccccCccEEEEEEEC------CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeC
Q 041143 622 KVTQNFAQENELGRGGFGTVYKGELE------DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEG 695 (973)
Q Consensus 622 ~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 695 (973)
...++|...+.||+|+||.||+|+.. +++.||||+++.. ......+.+.+|++++++++||||+++++++.+.
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 34578999999999999999999874 3478999999764 2455667899999999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhhhhc-------------------cCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeecc
Q 041143 696 NERLLVYEYMPHGALSRHLFRWEKL-------------------QLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRD 756 (973)
Q Consensus 696 ~~~~lV~e~~~~g~L~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~D 756 (973)
+..++||||+++|+|.+++...... ....+++.+++.++.||++||+||| +++|+|||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~D 199 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRD 199 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCC
Confidence 9999999999999999999763211 1256899999999999999999999 78999999
Q ss_pred CCCCcEEECCCCCEEEeeccccccCCCCC-cceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCC
Q 041143 757 LKSSNILLDDDYRAKVSDFGLVKLAPDGE-KSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDE 834 (973)
Q Consensus 757 ikp~Nill~~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~ 834 (973)
|||+||+++.++.+||+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 99999999999999999999997543221 122334568999999999999999999999999999999999 9999987
Q ss_pred CChhhHHHHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcC
Q 041143 835 ERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWR 911 (973)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~ 911 (973)
....+.. ..+... ..+... ......+.+++.+|++.||++||++.+|++.|+++.+++.
T Consensus 280 ~~~~~~~------~~~~~~-------~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 280 MAHEEVI------YYVRDG-------NILACP-----ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp SCHHHHH------HHHHTT-------CCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred CChHHHH------HHHhCC-------CcCCCC-----CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 6533211 111110 000111 1122457899999999999999999999999999987654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=370.44 Aligned_cols=258 Identities=25% Similarity=0.383 Sum_probs=209.6
Q ss_pred HhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCCh----HHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCe
Q 041143 623 VTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTT----KALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNE 697 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 697 (973)
+.++|...+.||+|+||.||+|+.. +|+.||||+++...... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3468999999999999999999875 68999999997643221 134678999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCC----CEEEe
Q 041143 698 RLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDY----RAKVS 773 (973)
Q Consensus 698 ~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~----~~kl~ 773 (973)
.++||||+++|+|.+++.. ...+++..+..++.||+.||+||| +.+|+||||||+||+++.++ .+||+
T Consensus 90 ~~lv~e~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~ 161 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQ-----KESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLI 161 (361)
T ss_dssp EEEEEECCCSCBHHHHHTT-----CSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred EEEEEEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEE
Confidence 9999999999999999854 256899999999999999999999 78999999999999998877 79999
Q ss_pred eccccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhc
Q 041143 774 DFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSS 853 (973)
Q Consensus 774 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 853 (973)
|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. +..+..
T Consensus 162 DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~------~~~i~~- 232 (361)
T 2yab_A 162 DFGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET------LANITA- 232 (361)
T ss_dssp CCSSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHHHHT-
T ss_pred ecCCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHh-
Confidence 999998665432 23456799999999999998999999999999999999999999987653221 111111
Q ss_pred hhHHHhhcCccccCCccc-HHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 854 KEKFKAAIDPALEVNEET-FESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 854 ~~~~~~~~~~~l~~~~~~-~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
......... ......+.+++.+|+..||++||++.|+++ ++++.
T Consensus 233 ---------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~--hp~~~ 277 (361)
T 2yab_A 233 ---------VSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR--HPWIT 277 (361)
T ss_dssp ---------TCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT--STTTS
T ss_pred ---------cCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc--CcCcC
Confidence 111111000 011234779999999999999999999987 55543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=378.74 Aligned_cols=274 Identities=25% Similarity=0.373 Sum_probs=217.3
Q ss_pred cHHHHHHHhcCccccCcccccCccEEEEEEE------CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeee
Q 041143 616 SVQVLRKVTQNFAQENELGRGGFGTVYKGEL------EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSL 688 (973)
Q Consensus 616 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l 688 (973)
.....+...++|...+.||+|+||.||+|++ .+++.||||+++.. ......+.+.+|++++.++ +|||||++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 3444555678999999999999999999974 24678999999764 3445567899999999999 79999999
Q ss_pred eeEEEeCCe-EEEEEEecCCCCHHHHHHhhhhcc----------------------------------------------
Q 041143 689 LGYSIEGNE-RLLVYEYMPHGALSRHLFRWEKLQ---------------------------------------------- 721 (973)
Q Consensus 689 ~~~~~~~~~-~~lV~e~~~~g~L~~~l~~~~~~~---------------------------------------------- 721 (973)
++++.+.+. .++||||+++|+|.++++......
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999988654 899999999999999997643210
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCC-
Q 041143 722 ---------------LKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGE- 785 (973)
Q Consensus 722 ---------------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~- 785 (973)
...+++..++.++.||++||+||| +++|+||||||+|||++.++.+||+|||+++......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 122899999999999999999999 7899999999999999999999999999998554332
Q ss_pred cceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCcc
Q 041143 786 KSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPA 864 (973)
Q Consensus 786 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 864 (973)
........||+.|+|||++.+..++.++|||||||++|||++ |+.||......+.. .. . +.......
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~--~~---~-------~~~~~~~~ 316 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CR---R-------LKEGTRMR 316 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH--HH---H-------HHHTCCCC
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH--HH---H-------HHcCCCCC
Confidence 233445678999999999999999999999999999999998 99999876533211 10 0 01111111
Q ss_pred ccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhc
Q 041143 865 LEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKW 910 (973)
Q Consensus 865 l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~ 910 (973)
.. . .....+.+++.+|++.||++||++.||++.|+.+.+..
T Consensus 317 ~~-~----~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 317 AP-D----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp CC-T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CC-C----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 11 1 11234789999999999999999999999999988753
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=375.66 Aligned_cols=266 Identities=28% Similarity=0.385 Sum_probs=216.6
Q ss_pred hcCccccCcccccCccEEEEEEEC--------CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEe
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE--------DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIE 694 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 694 (973)
.++|...+.||+|+||.||+|+.. .+..||||+++.. ......+.+.+|+++++++ +|||||++++++..
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 468889999999999999999762 2457999999765 3456667899999999999 89999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHHhhhhc-----------cCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEE
Q 041143 695 GNERLLVYEYMPHGALSRHLFRWEKL-----------QLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNIL 763 (973)
Q Consensus 695 ~~~~~lV~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nil 763 (973)
.+..++||||+++|+|.+++...... ....+++.+++.++.||+.||+||| +.+|+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEE
Confidence 99999999999999999999764321 1245899999999999999999999 789999999999999
Q ss_pred ECCCCCEEEeeccccccCCCCCc-ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHH
Q 041143 764 LDDDYRAKVSDFGLVKLAPDGEK-SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESR 841 (973)
Q Consensus 764 l~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~ 841 (973)
++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||......+.
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~- 302 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL- 302 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH-
Confidence 99999999999999986543322 22344568899999999999999999999999999999999 9999987653321
Q ss_pred HHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcC
Q 041143 842 YLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWR 911 (973)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~ 911 (973)
. ..+.. ....... ......+.+++.+|++.||++||++.||++.|+++.....
T Consensus 303 --~---~~~~~-------~~~~~~~-----~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 355 (382)
T 3tt0_A 303 --F---KLLKE-------GHRMDKP-----SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 355 (382)
T ss_dssp --H---HHHHT-------TCCCCCC-----SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred --H---HHHHc-------CCCCCCC-----ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 1 11111 1111111 1122457899999999999999999999999999987543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=391.21 Aligned_cols=258 Identities=26% Similarity=0.435 Sum_probs=213.2
Q ss_pred hcCccccCcccccCccEEEEEEECC-CCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELED-GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
.++|...+.||+|+||.||+|.+.. +..||||+++.... ..++|.+|+++|++++|||||+++++|...+..++||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 295 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc---chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence 3578888999999999999998874 88999999976422 3567999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++|+|.+++... ....+++..++.|+.||++||+||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 296 E~~~~g~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 296 EFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp ECCTTCBHHHHHHHS---CTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred EccCCCCHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceecc
Confidence 999999999999753 2356899999999999999999999 7899999999999999999999999999998765
Q ss_pred CCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhc
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (973)
...........++..|+|||++....++.++|||||||++|||++ |+.||......+.. ..+ ....
T Consensus 370 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~---~~~----------~~~~ 436 (495)
T 1opk_A 370 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY---ELL----------EKDY 436 (495)
T ss_dssp TCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH---HHH----------HTTC
T ss_pred CCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHH---HHH----------HcCC
Confidence 443333344557789999999999999999999999999999999 99999876543221 111 1111
Q ss_pred CccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 862 DPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 862 ~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
.... +......+.+|+.+||+.||++||++.+|++.|+.+.+
T Consensus 437 ~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 437 RMER-----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp CCCC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred CCCC-----CCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 1111 11123457899999999999999999999999988754
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=368.34 Aligned_cols=272 Identities=25% Similarity=0.417 Sum_probs=207.3
Q ss_pred hcCccccCcccccCccEEEEEEE-----CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeC--C
Q 041143 624 TQNFAQENELGRGGFGTVYKGEL-----EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEG--N 696 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~ 696 (973)
.++|+..+.||+|+||.||+|++ .+++.||||++... .....+.+.+|++++++++||||+++++++... .
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 36888999999999999999984 36889999998754 556667899999999999999999999998653 5
Q ss_pred eEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecc
Q 041143 697 ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFG 776 (973)
Q Consensus 697 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG 776 (973)
..++||||+++|+|.+++... ...+++.+++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg 159 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFG 159 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHC----GGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred ceEEEEEeCCCCCHHHHHHhc----ccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCc
Confidence 589999999999999999762 235899999999999999999999 7899999999999999999999999999
Q ss_pred ccccCCCCCc--ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhc-
Q 041143 777 LVKLAPDGEK--SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSS- 853 (973)
Q Consensus 777 la~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~- 853 (973)
+++....... .......|+..|+|||++.+..++.++|||||||++|||++|..|+......... +.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~----~~~~~~~~~ 235 (295)
T 3ugc_A 160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMR----MIGNDKQGQ 235 (295)
T ss_dssp SCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHH----HHCTTCCTH
T ss_pred ccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHh----hhcCccccc
Confidence 9986543322 1223345788899999999999999999999999999999999998643211100 00000000
Q ss_pred --hhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 854 --KEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 854 --~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
.....+.+..... ..........+.+++.+|++.||++||++.||++.|+.+.+.
T Consensus 236 ~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 236 MIVFHLIELLKNNGR-LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hhHHHHHHHHhccCc-CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 0000011111100 011112234588999999999999999999999999998764
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=371.11 Aligned_cols=260 Identities=24% Similarity=0.365 Sum_probs=212.3
Q ss_pred HHhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEE
Q 041143 622 KVTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLL 700 (973)
Q Consensus 622 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 700 (973)
...++|...+.||+|+||.||+|... +|+.||||++..........+.+.+|++++++++|||||++++++.+.+..++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34578999999999999999999875 68999999998765566677889999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCC---CCEEEeeccc
Q 041143 701 VYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDD---YRAKVSDFGL 777 (973)
Q Consensus 701 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~---~~~kl~DfGl 777 (973)
||||+++|+|.+++.. ...+++.++..++.||++||+||| +++|+||||||+|||++.+ +.+||+|||+
T Consensus 106 v~e~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~ 177 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVA-----REFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGL 177 (362)
T ss_dssp EECCCCSCBHHHHHTT-----CSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCc
Confidence 9999999999998864 246899999999999999999999 7899999999999999865 4599999999
Q ss_pred cccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHH
Q 041143 778 VKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKF 857 (973)
Q Consensus 778 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (973)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ...+....
T Consensus 178 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~------~~~i~~~~--- 246 (362)
T 2bdw_A 178 AIEVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL------YAQIKAGA--- 246 (362)
T ss_dssp CBCCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHTC---
T ss_pred ceEecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHHhCC---
Confidence 98665432 23456899999999999998999999999999999999999999987653221 11111110
Q ss_pred HhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 858 KAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 858 ~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
.+. . ..........+.+++.+|++.||++||++.|+++ ++++.
T Consensus 247 ---~~~--~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--hp~~~ 289 (362)
T 2bdw_A 247 ---YDY--P-SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK--VPWIC 289 (362)
T ss_dssp ---CCC--C-TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT--SHHHH
T ss_pred ---CCC--C-cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc--CcccC
Confidence 000 0 0000112245779999999999999999999997 55543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=378.66 Aligned_cols=261 Identities=21% Similarity=0.313 Sum_probs=211.4
Q ss_pred HHhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEE
Q 041143 622 KVTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLL 700 (973)
Q Consensus 622 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 700 (973)
...++|...+.||+|+||.||+|... +|+.||+|++..........+.+.+|++++++++|||||++++++.+.+..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 45678999999999999999999764 68999999998765555667789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEEC---CCCCEEEeeccc
Q 041143 701 VYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLD---DDYRAKVSDFGL 777 (973)
Q Consensus 701 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~---~~~~~kl~DfGl 777 (973)
||||+++|+|.+++.. ...+++..+..++.||+.||+||| +++|+||||||+|||++ .++.+||+|||+
T Consensus 88 v~E~~~gg~L~~~i~~-----~~~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~ 159 (444)
T 3soa_A 88 IFDLVTGGELFEDIVA-----REYYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGL 159 (444)
T ss_dssp EECCCBCCBHHHHHHH-----CSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred EEEeCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCce
Confidence 9999999999999865 256899999999999999999999 78999999999999998 467899999999
Q ss_pred cccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHH
Q 041143 778 VKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKF 857 (973)
Q Consensus 778 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (973)
++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+. ...+......
T Consensus 160 a~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~------~~~i~~~~~~- 231 (444)
T 3soa_A 160 AIEVEGEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL------YQQIKAGAYD- 231 (444)
T ss_dssp CBCCCTTC-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHTCCC-
T ss_pred eEEecCCC-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHH------HHHHHhCCCC-
Confidence 98655432 223456899999999999998999999999999999999999999987653221 1111111000
Q ss_pred HhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 858 KAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 858 ~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
...+.. ......+.+++.+|++.||++||++.|+++ ++++.
T Consensus 232 --~~~~~~------~~~s~~~~~li~~~L~~dP~~Rpta~e~L~--hp~~~ 272 (444)
T 3soa_A 232 --FPSPEW------DTVTPEAKDLINKMLTINPSKRITAAEALK--HPWIS 272 (444)
T ss_dssp --CCTTTT------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH--SCTTH
T ss_pred --CCcccc------ccCCHHHHHHHHHHcCCChhHCCCHHHHhc--Ccccc
Confidence 000110 011245779999999999999999999998 55544
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=366.54 Aligned_cols=264 Identities=28% Similarity=0.409 Sum_probs=215.4
Q ss_pred hcCccccCcccccCccEEEEEEE------CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCe
Q 041143 624 TQNFAQENELGRGGFGTVYKGEL------EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNE 697 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 697 (973)
.++|...+.||+|+||.||+|.. .+++.||||+++.. ......+.+.+|++++++++||||+++++++.+.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 46888999999999999999976 24578999999754 345666789999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhhhhc-------------------cCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCC
Q 041143 698 RLLVYEYMPHGALSRHLFRWEKL-------------------QLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLK 758 (973)
Q Consensus 698 ~~lV~e~~~~g~L~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dik 758 (973)
.++||||+++|+|.+++...... ....+++.+++.++.||++||+||| +++|+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccc
Confidence 99999999999999999764321 1234899999999999999999999 7899999999
Q ss_pred CCcEEECCCCCEEEeeccccccCCCCCcc-eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCC
Q 041143 759 SSNILLDDDYRAKVSDFGLVKLAPDGEKS-VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEER 836 (973)
Q Consensus 759 p~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~ 836 (973)
|+||+++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999865443222 2234467889999999999999999999999999999999 999998765
Q ss_pred hhhHHHHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 837 PEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
....... +. ....+... ......+.+++.+|++.||++||++.||++.|+++.++
T Consensus 258 ~~~~~~~------~~-------~~~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 258 PERLFNL------LK-------TGHRMERP-----DNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp GGGHHHH------HH-------TTCCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHH------hh-------cCCcCCCC-----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 4332111 11 00111111 11224578999999999999999999999999998775
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=362.88 Aligned_cols=265 Identities=22% Similarity=0.383 Sum_probs=204.3
Q ss_pred HhcCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHh--cCCCceeeeeeEEEeC----C
Q 041143 623 VTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSK--VRHRHLVSLLGYSIEG----N 696 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~ 696 (973)
..++|...+.||+|+||.||+|+. +|+.||||++... ..+.+.+|.+++.. ++||||+++++++... .
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~ 79 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence 357899999999999999999988 5899999998542 23456677777776 7999999999997653 4
Q ss_pred eEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhc-----cCCeeeccCCCCcEEECCCCCEE
Q 041143 697 ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLA-----RQTFIHRDLKSSNILLDDDYRAK 771 (973)
Q Consensus 697 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~-----~~~ivH~Dikp~Nill~~~~~~k 771 (973)
..++||||+++|+|.++++. ..+++..++.++.||+.||+|||... +++|+||||||+|||++.++.+|
T Consensus 80 ~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQL------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp EEEEEECCCTTCBHHHHHTT------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEE
T ss_pred eeEEehhhccCCCHHHHHhh------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEE
Confidence 57899999999999999953 46899999999999999999999322 67999999999999999999999
Q ss_pred EeeccccccCCCCCcce---ecccccccCcccccccccC------cCCCchhHHhHHHHHHHHHhC----------CCCC
Q 041143 772 VSDFGLVKLAPDGEKSV---VTRLAGTFGYLAPEYAVMG------KITTKADVFSYGVVLMELLTG----------LAAL 832 (973)
Q Consensus 772 l~DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~S~Gvvl~elltg----------~~p~ 832 (973)
|+|||+++......... .....||+.|+|||++.+. .++.++|||||||++|||++| +.||
T Consensus 154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 99999998544332221 2335799999999999876 556799999999999999999 8888
Q ss_pred CCCChhhHHHHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHh
Q 041143 833 DEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPL 906 (973)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~ 906 (973)
.......... .. ..... ......+.+............+.+++.+|++.||++|||+.||++.|+++
T Consensus 234 ~~~~~~~~~~-~~-~~~~~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 234 YDVVPNDPSF-ED-MRKVV-----CVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTTSCSSCCH-HH-HHHHH-----TTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCCCCcch-hh-hhHHH-----hccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 6543322111 00 01100 00111122221112334567789999999999999999999999999875
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=365.20 Aligned_cols=256 Identities=20% Similarity=0.297 Sum_probs=210.5
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
.++|...+.||+|+||.||+|... +++.||+|.++.. ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 80 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence 478999999999999999999875 5889999998643 344567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECC--CCCEEEeecccccc
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDD--DYRAKVSDFGLVKL 780 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~--~~~~kl~DfGla~~ 780 (973)
||+++|+|.+++.. ....+++.++..++.||+.||+||| +++|+||||||+|||++. ++.+||+|||+++.
T Consensus 81 e~~~g~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~ 153 (321)
T 1tki_A 81 EFISGLDIFERINT----SAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp CCCCCCBHHHHHTS----SSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred EeCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeE
Confidence 99999999999854 2246899999999999999999999 789999999999999987 78999999999987
Q ss_pred CCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhh
Q 041143 781 APDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAA 860 (973)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (973)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. +..+..
T Consensus 154 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~~~i~~-------- 217 (321)
T 1tki_A 154 LKPGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI------IENIMN-------- 217 (321)
T ss_dssp CCTTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHH--------
T ss_pred CCCCC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHH------HHHHHc--------
Confidence 65433 23446799999999999988899999999999999999999999987653221 111111
Q ss_pred cCccccCCccc-HHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 861 IDPALEVNEET-FESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 861 ~~~~l~~~~~~-~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
......... ......+.+++.+|++.||++|||+.|+++ ++++++
T Consensus 218 --~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~--hp~~~~ 263 (321)
T 1tki_A 218 --AEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ--HPWLKQ 263 (321)
T ss_dssp --TCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH--SHHHHS
T ss_pred --CCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc--Chhhcc
Confidence 111100000 011245789999999999999999999999 777664
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=369.03 Aligned_cols=258 Identities=28% Similarity=0.406 Sum_probs=201.8
Q ss_pred cCccccCcccccCccEEEEEEEC-CCC----EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGT----KIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERL 699 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 699 (973)
++|...+.||+|+||.||+|++. +++ +||+|.++.. ......+.+.+|+.++++++||||++++++|.+.. .+
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 57889999999999999999864 344 3588877543 23344578999999999999999999999998754 78
Q ss_pred EEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccc
Q 041143 700 LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK 779 (973)
Q Consensus 700 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~ 779 (973)
+||||+++|+|.+++... ...+++..++.++.||++||+||| +++|+||||||+|||++.++.+||+|||+++
T Consensus 93 ~v~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEEECCTTCBHHHHHHHS----TTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred EEEEecCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCccee
Confidence 999999999999999752 256899999999999999999999 7899999999999999999999999999998
Q ss_pred cCCCCCc-ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHH
Q 041143 780 LAPDGEK-SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKF 857 (973)
Q Consensus 780 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (973)
....... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||......+.....
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~------------- 232 (327)
T 3poz_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL------------- 232 (327)
T ss_dssp HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-------------
T ss_pred EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHH-------------
Confidence 6543322 22334567889999999999999999999999999999999 99999876543321111
Q ss_pred HhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 858 KAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 858 ~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
....... ........+.+++.+|++.||++||++.||++.|+.+.+.
T Consensus 233 ~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 233 EKGERLP-----QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HTTCCCC-----CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred HcCCCCC-----CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 0000000 1111234578999999999999999999999999988653
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=385.38 Aligned_cols=260 Identities=30% Similarity=0.471 Sum_probs=206.9
Q ss_pred hcCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
.++|...+.||+|+||.||+|.+.++..||||+++..... .+.|.+|++++++++||||+++++++.+ +..++|||
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 4678889999999999999999988888999999764322 4578999999999999999999999876 67899999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+++|+|.+++.... ...+++.+++.++.||+.||+||| +++|+||||||+|||+++++.+||+|||+++....
T Consensus 259 ~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 259 YMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp CCTTCBHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred hhcCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 999999999996522 245899999999999999999999 78999999999999999999999999999986554
Q ss_pred CCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcC
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (973)
..........++..|+|||++....++.++|||||||++|||++ |+.||......+.. ..+.. ...
T Consensus 333 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~------~~i~~-------~~~ 399 (452)
T 1fmk_A 333 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL------DQVER-------GYR 399 (452)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH------HHHHT-------TCC
T ss_pred CceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHH------HHHHc-------CCC
Confidence 33333334567889999999999999999999999999999999 99999876543211 11111 011
Q ss_pred ccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcC
Q 041143 863 PALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWR 911 (973)
Q Consensus 863 ~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~ 911 (973)
... +......+.+++.+|++.||++||++.+|++.|+.+.....
T Consensus 400 ~~~-----~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~ 443 (452)
T 1fmk_A 400 MPC-----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443 (452)
T ss_dssp CCC-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred CCC-----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence 111 11223457899999999999999999999999998876543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=367.80 Aligned_cols=265 Identities=27% Similarity=0.426 Sum_probs=198.7
Q ss_pred hcCccccCcccccCccEEEEEEECCC----CEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeE-
Q 041143 624 TQNFAQENELGRGGFGTVYKGELEDG----TKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNER- 698 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~~g----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~- 698 (973)
.++|...+.||+|+||.||+|++... ..||||+++.........+.+.+|++++++++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 46899999999999999999987543 2799999976654556678899999999999999999999999887655
Q ss_pred -----EEEEEecCCCCHHHHHHhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEE
Q 041143 699 -----LLVYEYMPHGALSRHLFRWEKL-QLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKV 772 (973)
Q Consensus 699 -----~lV~e~~~~g~L~~~l~~~~~~-~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl 772 (973)
++||||+++|+|.+++...... ....+++.+++.++.||+.||+||| +++|+||||||+||++++++.+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEEE
Confidence 9999999999999999764322 1225899999999999999999999 789999999999999999999999
Q ss_pred eeccccccCCCCCc-ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHH
Q 041143 773 SDFGLVKLAPDGEK-SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRI 850 (973)
Q Consensus 773 ~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 850 (973)
+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||......+... .+
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~------~~ 252 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN------YL 252 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH------HH
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHH------HH
Confidence 99999986543322 12233457889999999999999999999999999999999 999998765432211 11
Q ss_pred hhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 851 KSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 851 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
.. ..... ........+.+++.+|++.||++||++.++++.|+++.+.
T Consensus 253 ~~-------~~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 253 IG-------GNRLK-----QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp HT-------TCCCC-----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hc-------CCCCC-----CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 10 00000 0111224578999999999999999999999999999875
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=359.18 Aligned_cols=259 Identities=23% Similarity=0.392 Sum_probs=199.7
Q ss_pred hcCccccCcccccCccEEEEEEECC----CCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELED----GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERL 699 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 699 (973)
.++|...+.||+|+||.||+|.... +..||+|+++.. ......+.+.+|+.++++++||||+++++++. ++..+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 4688999999999999999998743 457999998654 34556678999999999999999999999974 56789
Q ss_pred EEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccc
Q 041143 700 LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK 779 (973)
Q Consensus 700 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~ 779 (973)
+||||+++|+|.+++... ...+++.+++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++
T Consensus 92 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVR----KYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp EEEECCTTEEHHHHHHHT----TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEecCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECcccccc
Confidence 999999999999999652 246899999999999999999999 7899999999999999999999999999998
Q ss_pred cCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHH
Q 041143 780 LAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFK 858 (973)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (973)
..............+|+.|+|||++....++.++|||||||++|||++ |+.||......+.. . .+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~---~---~i~~------ 232 (281)
T 1mp8_A 165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---G---RIEN------ 232 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---H---HHHT------
T ss_pred ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHH---H---HHHc------
Confidence 665443333344567889999999998999999999999999999997 99999876543221 1 1111
Q ss_pred hhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 859 AAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 859 ~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
.....+. ......+.+++.+|++.||++||++.|+++.|+.+.++
T Consensus 233 -~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 233 -GERLPMP-----PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp -TCCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCCCCCC-----CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 0001111 11224577999999999999999999999999998764
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=370.32 Aligned_cols=261 Identities=20% Similarity=0.289 Sum_probs=207.7
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCC---CChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGV---TTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERL 699 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 699 (973)
.++|+..+.||+|+||.||+|... +|+.||||++.... ......+.+.+|+++++.++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 467999999999999999999875 68999999985321 11113467899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCC---EEEeecc
Q 041143 700 LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYR---AKVSDFG 776 (973)
Q Consensus 700 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~---~kl~DfG 776 (973)
+||||+++|+|.+++..... ....+++..+..++.||++||+||| +++|+||||||+|||++.++. +||+|||
T Consensus 103 lv~e~~~g~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRAD-AGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEeCCCCCCHHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence 99999999999988876332 2346899999999999999999999 789999999999999986654 9999999
Q ss_pred ccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhH
Q 041143 777 LVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEK 856 (973)
Q Consensus 777 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (973)
+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+. ..+...
T Consensus 179 ~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~---~~i~~~--- 247 (351)
T 3c0i_A 179 VAIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLF---EGIIKG--- 247 (351)
T ss_dssp TCEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHH---HHHHHT---
T ss_pred ceeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHH---HHHHcC---
Confidence 998665432 223456799999999999999999999999999999999999999976421 111 111110
Q ss_pred HHhhcCccccCCccc-HHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 857 FKAAIDPALEVNEET-FESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 857 ~~~~~~~~l~~~~~~-~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
........ ......+.+++.+|++.||++||++.|+++ +++++
T Consensus 248 -------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~--hp~~~ 291 (351)
T 3c0i_A 248 -------KYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN--HPWLK 291 (351)
T ss_dssp -------CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHH
T ss_pred -------CCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc--Chhhc
Confidence 01000000 011245789999999999999999999998 56654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=361.60 Aligned_cols=251 Identities=25% Similarity=0.303 Sum_probs=200.3
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGNERLLV 701 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 701 (973)
.++|+..++||+|+||+||+|++. +|+.||||++............+..|+..+.++ +||||++++++|.+++..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 368999999999999999999886 799999999876655566666677777777666 899999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccC
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA 781 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~ 781 (973)
|||+ +|+|.+++... ...++|..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 136 ~e~~-~~~L~~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAW----GASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207 (311)
T ss_dssp EECC-CCBHHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred Eecc-CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeec
Confidence 9999 78999988653 246999999999999999999999 789999999999999999999999999999865
Q ss_pred CCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhc
Q 041143 782 PDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861 (973)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (973)
.... ......||++|+|||++.+ .++.++|||||||++|||++|..|+...... ..+.. ...
T Consensus 208 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~---------~~~~~------~~~ 269 (311)
T 3p1a_A 208 GTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW---------QQLRQ------GYL 269 (311)
T ss_dssp C--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH---------HHHTT------TCC
T ss_pred ccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH---------HHHhc------cCC
Confidence 4332 2344579999999998875 7999999999999999999997776532110 00110 001
Q ss_pred CccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhh
Q 041143 862 DPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLV 907 (973)
Q Consensus 862 ~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~ 907 (973)
.+.+. ......+.+++.+|++.||++||++.|+++ .+++
T Consensus 270 ~~~~~-----~~~~~~l~~li~~~L~~dP~~Rpt~~ell~--hp~~ 308 (311)
T 3p1a_A 270 PPEFT-----AGLSSELRSVLVMMLEPDPKLRATAEALLA--LPVL 308 (311)
T ss_dssp CHHHH-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT--SGGG
T ss_pred Ccccc-----cCCCHHHHHHHHHHcCCChhhCcCHHHHHh--Cccc
Confidence 11111 112245789999999999999999999998 4444
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=372.05 Aligned_cols=256 Identities=24% Similarity=0.342 Sum_probs=203.2
Q ss_pred HhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCC-CChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeEE
Q 041143 623 VTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGV-TTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGNERL 699 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 699 (973)
..++|+..+.||+|+||.||+|+.. +|+.||||+++... ......+.+.+|.+++..+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3478999999999999999999875 58999999987531 1222345688999999988 6999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccc
Q 041143 700 LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK 779 (973)
Q Consensus 700 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~ 779 (973)
+||||+++|+|..++... ..+++.++..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++
T Consensus 101 lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~ 172 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKS-----RRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK 172 (353)
T ss_dssp EEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEcccccee
Confidence 999999999999999652 45899999999999999999999 7899999999999999999999999999998
Q ss_pred cCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHh
Q 041143 780 LAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKA 859 (973)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (973)
...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+. +..+...
T Consensus 173 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~------~~~i~~~------ 239 (353)
T 3txo_A 173 EGICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL------FEAILND------ 239 (353)
T ss_dssp CSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHC------
T ss_pred ecccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHH------HHHHHcC------
Confidence 543322 234456899999999999999999999999999999999999999987654321 1111111
Q ss_pred hcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCH------hHHHHHHHHhhh
Q 041143 860 AIDPALEVNEETFESISIVAELAGHCTAREPYHRPDM------GHVVNVLSPLVE 908 (973)
Q Consensus 860 ~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~------~~v~~~L~~~~~ 908 (973)
...... .....+.+++.+|++.||++||++ .||++ +++.+
T Consensus 240 ----~~~~p~---~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~--hp~f~ 285 (353)
T 3txo_A 240 ----EVVYPT---WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR--HPFFK 285 (353)
T ss_dssp ----CCCCCT---TSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT--SGGGT
T ss_pred ----CCCCCC---CCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh--CCccc
Confidence 111111 112347799999999999999998 67776 55544
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=357.43 Aligned_cols=275 Identities=20% Similarity=0.285 Sum_probs=208.5
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
++|+..+.||+|+||+||+|+.. +|+.||||+++.........+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57899999999999999999875 68999999998765556666788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+++ ++.+++... ...+++.++..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++....
T Consensus 82 ~~~~-~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 153 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCSE-EHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred cCCC-CHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence 9965 666665431 256899999999999999999999 78999999999999999999999999999986543
Q ss_pred CCcceecccccccCcccccccccCc-CCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhch-hHH---H
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVMGK-ITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSK-EKF---K 858 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~---~ 858 (973)
.. .......||+.|+|||++.+.. ++.++|||||||++|||++|..|+........ .+........... ... .
T Consensus 154 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 154 PV-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CC-SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH-HHHHHHHHHCCCCTTTCTTGG
T ss_pred cc-ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhCCCChhhhhhhc
Confidence 32 2234467899999999998765 89999999999999999999888654432211 1111111110000 000 0
Q ss_pred hhcCc--------cccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcC
Q 041143 859 AAIDP--------ALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWR 911 (973)
Q Consensus 859 ~~~~~--------~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~ 911 (973)
...+. ..............+.+++.+|++.||++|||++|+++ +++.+.+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--hp~f~~~~ 290 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ--HPYFSDFC 290 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGTTC-
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc--CcccccCC
Confidence 00000 00000001112345779999999999999999999998 66666543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=371.51 Aligned_cols=256 Identities=22% Similarity=0.341 Sum_probs=201.7
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGNERLL 700 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 700 (973)
.++|...++||+|+||.||+|+.+ +++.||||+++.... .....+.+.+|..++.++ +|||||++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 368999999999999999999876 578899999975422 233445688999999887 89999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecccccc
Q 041143 701 VYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKL 780 (973)
Q Consensus 701 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~ 780 (973)
||||+++|+|..++... ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++.
T Consensus 131 V~E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~ 202 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202 (396)
T ss_dssp EEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEcCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeee
Confidence 99999999999998752 46899999999999999999999 78999999999999999999999999999985
Q ss_pred CCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHH---HHHHHHHHHhhchhHH
Q 041143 781 APDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESR---YLAEWFWRIKSSKEKF 857 (973)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~ 857 (973)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ........+
T Consensus 203 ~~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i------- 274 (396)
T 4dc2_A 203 GLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI------- 274 (396)
T ss_dssp CCCTT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHH-------
T ss_pred cccCC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHH-------
Confidence 33222 2345578999999999999999999999999999999999999999754322110 000011111
Q ss_pred HhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCH------hHHHH
Q 041143 858 KAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDM------GHVVN 901 (973)
Q Consensus 858 ~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~------~~v~~ 901 (973)
....+.... .....+.+++.+||+.||++||++ .||++
T Consensus 275 ---~~~~~~~p~---~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 275 ---LEKQIRIPR---SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp ---HHCCCCCCT---TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred ---hccccCCCC---cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 111111111 112347799999999999999996 45655
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=366.95 Aligned_cols=259 Identities=24% Similarity=0.375 Sum_probs=205.3
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
.++|+..+.||+|+||.||+|+.. +++.||||++.... .....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccc-ccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 368999999999999999999876 78999999986542 2233467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++|+|.+++.. ...+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 85 e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 156 (323)
T 3tki_A 85 EYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (323)
T ss_dssp ECCTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred EcCCCCcHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceec
Confidence 99999999988753 245899999999999999999999 7899999999999999999999999999998543
Q ss_pred CCC-cceecccccccCcccccccccCcC-CCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhh
Q 041143 783 DGE-KSVVTRLAGTFGYLAPEYAVMGKI-TTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAA 860 (973)
Q Consensus 783 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (973)
... ........||+.|+|||++.+..+ +.++|||||||++|||++|+.||......... ...|. ... ..
T Consensus 157 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~----~~~----~~ 227 (323)
T 3tki_A 157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWK----EKK----TY 227 (323)
T ss_dssp ETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HHHHH----TTC----TT
T ss_pred cCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHHh----ccc----cc
Confidence 222 222345689999999999987776 77899999999999999999999865532211 11111 000 00
Q ss_pred cCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 861 IDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 861 ~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
..+ .......+.+++.+|++.||++||++.|+++ .+++.+
T Consensus 228 ~~~-------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~--h~~~~~ 267 (323)
T 3tki_A 228 LNP-------WKKIDSAPLALLHKILVENPSARITIPDIKK--DRWYNK 267 (323)
T ss_dssp STT-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT--CTTTTC
T ss_pred CCc-------cccCCHHHHHHHHHHccCChhhCcCHHHHhh--Chhhcc
Confidence 011 0112234679999999999999999999998 555543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=369.53 Aligned_cols=279 Identities=15% Similarity=0.202 Sum_probs=210.9
Q ss_pred hcCccccCcccccCccEEEEEEECC------CCEEEEEEeecCCCChHH---------HHHHHHHHHHHHhcCCCceeee
Q 041143 624 TQNFAQENELGRGGFGTVYKGELED------GTKIAVKRMEAGVTTTKA---------LDEFQSEIAVLSKVRHRHLVSL 688 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vavK~~~~~~~~~~~---------~~~~~~E~~~l~~l~h~niv~l 688 (973)
.++|...+.||+|+||.||+|.+.. ++.||||++......... ...+..|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4689999999999999999998764 478999998754211100 0123345566777889999999
Q ss_pred eeEEEeC----CeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEE
Q 041143 689 LGYSIEG----NERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILL 764 (973)
Q Consensus 689 ~~~~~~~----~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill 764 (973)
++++... ...++||||+ +|+|.+++... ...+++.+++.|+.||+.||+||| +++|+||||||+|||+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill 185 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN----AKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEE
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEE
Confidence 9998874 4479999999 99999999652 256999999999999999999999 7899999999999999
Q ss_pred C--CCCCEEEeeccccccCCCCCcc------eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCC
Q 041143 765 D--DDYRAKVSDFGLVKLAPDGEKS------VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEER 836 (973)
Q Consensus 765 ~--~~~~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~ 836 (973)
+ .++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 9 8899999999999855432111 1133569999999999999999999999999999999999999998543
Q ss_pred hhhHHHHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCCCCCC
Q 041143 837 PEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPITDE 916 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~~~~~ 916 (973)
.... ...+..... ...+...+++.+.... ....+.+++..|++.||++||++.+|++.|+.+.+......+.
T Consensus 266 ~~~~--~~~~~~~~~--~~~~~~~~~~~~~~~~----~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~ 337 (364)
T 3op5_A 266 KDPK--YVRDSKIRY--RENIASLMDKCFPAAN----APGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDG 337 (364)
T ss_dssp TCHH--HHHHHHHHH--HHCHHHHHHHHSCTTC----CCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCC
T ss_pred cCHH--HHHHHHHHh--hhhHHHHHHHhccccc----CHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCC
Confidence 2221 111111111 1223333333332111 1245789999999999999999999999999999876655544
Q ss_pred Cc
Q 041143 917 SE 918 (973)
Q Consensus 917 ~~ 918 (973)
..
T Consensus 338 ~~ 339 (364)
T 3op5_A 338 KL 339 (364)
T ss_dssp CC
T ss_pred cc
Confidence 33
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=378.21 Aligned_cols=266 Identities=21% Similarity=0.252 Sum_probs=211.9
Q ss_pred HHHHHHhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeC
Q 041143 618 QVLRKVTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEG 695 (973)
Q Consensus 618 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 695 (973)
..++...++|...+.||+|+||.||+|+.. +++.||+|+++.... .....+.+.+|+.+++.++|||||++++++.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 344455679999999999999999999876 588999999864210 011123478999999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeec
Q 041143 696 NERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDF 775 (973)
Q Consensus 696 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 775 (973)
+..|+||||+++|+|.+++.. ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+||
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~------~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DF 212 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADF 212 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEeCCCCCcHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEecc
Confidence 999999999999999999864 35889999999999999999999 789999999999999999999999999
Q ss_pred cccccCCCCCcceecccccccCcccccccccCc----CCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHh
Q 041143 776 GLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGK----ITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIK 851 (973)
Q Consensus 776 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 851 (973)
|+|+.............+||+.|+|||++.+.. ++.++|||||||++|||++|+.||......+. +..+.
T Consensus 213 G~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------~~~i~ 286 (410)
T 3v8s_A 213 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT------YSKIM 286 (410)
T ss_dssp TTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHH
T ss_pred ceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH------HHHHH
Confidence 999876554444445678999999999997655 88999999999999999999999987654321 11111
Q ss_pred hchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCC--CCCHhHHHHHHHHhhhh
Q 041143 852 SSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYH--RPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 852 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~--RPs~~~v~~~L~~~~~~ 909 (973)
.... ...-+... .....+.+|+.+|++.+|.+ ||++.||++ +++.+.
T Consensus 287 ~~~~---~~~~p~~~------~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~--Hp~f~~ 335 (410)
T 3v8s_A 287 NHKN---SLTFPDDN------DISKEAKNLICAFLTDREVRLGRNGVEEIKR--HLFFKN 335 (410)
T ss_dssp THHH---HCCCCTTC------CCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT--SGGGCC
T ss_pred hccc---cccCCCcc------cccHHHHHHHHHHccChhhhCCCCCHHHHhc--CccccC
Confidence 1110 01111100 11234779999999999988 999999998 777653
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=355.53 Aligned_cols=256 Identities=29% Similarity=0.450 Sum_probs=212.2
Q ss_pred cCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEe
Q 041143 625 QNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEY 704 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 704 (973)
++|...+.||+|+||.||+|...+++.||+|+++..... .+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 578889999999999999999988899999999765332 35789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCC
Q 041143 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG 784 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~ 784 (973)
+++|+|.+++... ...+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 85 MEHGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CTTCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred CCCCcHHHHHhhC----cccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 9999999999652 245899999999999999999999 789999999999999999999999999999865443
Q ss_pred CcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCc
Q 041143 785 EKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDP 863 (973)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (973)
.........|+..|+|||++.+..++.++||||||+++|||++ |+.||......+. ...+.. ....
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------~~~i~~-------~~~~ 224 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV------VEDIST-------GFRL 224 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------HHHHHT-------TCCC
T ss_pred cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH------HHHHhc-------CCcC
Confidence 2222334567889999999998899999999999999999999 8999987653221 111111 1111
Q ss_pred cccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 864 ALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 864 ~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
... ......+.+++.+|++.||++||++.++++.|+.+.+
T Consensus 225 ~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 225 YKP-----RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CCC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCC-----ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 111 0112457899999999999999999999999999876
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=367.60 Aligned_cols=257 Identities=26% Similarity=0.375 Sum_probs=203.8
Q ss_pred cCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC--CceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRH--RHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV~ 702 (973)
++|...+.||+|+||.||+|...+++.||||++..........+.+.+|++++.+++| +||+++++++...+..++||
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 88 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 88 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence 5789999999999999999999889999999998766667777889999999999976 99999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
|| .+|+|.+++.. ...+++.++..++.||+.||+||| +++|+||||||+|||++ ++.+||+|||+++...
T Consensus 89 e~-~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 89 EC-GNIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp CC-CSEEHHHHHHH-----SCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred eC-CCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 94 58899999965 256899999999999999999999 78999999999999997 5789999999998654
Q ss_pred CCCcc-eecccccccCccccccccc-----------CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHH
Q 041143 783 DGEKS-VVTRLAGTFGYLAPEYAVM-----------GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRI 850 (973)
Q Consensus 783 ~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 850 (973)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---------- 228 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---------- 228 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH----------
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH----------
Confidence 43222 2345679999999999865 6788999999999999999999999976432211
Q ss_pred hhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 851 KSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 851 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
.+...+++.... ..+......+.+++.+||+.||.+||++.|+++ +++++.
T Consensus 229 -----~~~~~~~~~~~~-~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~--hp~~~~ 279 (343)
T 3dbq_A 229 -----KLHAIIDPNHEI-EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA--HPYVQI 279 (343)
T ss_dssp -----HHHHHHCTTSCC-CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHHS
T ss_pred -----HHHHHhcCCccc-CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh--Cccccc
Confidence 111222221110 000011235779999999999999999999998 666654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=355.05 Aligned_cols=254 Identities=23% Similarity=0.341 Sum_probs=209.4
Q ss_pred cCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeC--CeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEG--NERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~ 702 (973)
++|...+.||+|+||.||+|++. ++.||||+++.........+.+.+|++++++++||||+++++++.+. +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 67889999999999999999986 88999999987666667778899999999999999999999999887 7789999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCC--eeeccCCCCcEEECCCCCEEEeecccccc
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQT--FIHRDLKSSNILLDDDYRAKVSDFGLVKL 780 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~--ivH~Dikp~Nill~~~~~~kl~DfGla~~ 780 (973)
||+++|+|.+++... ....+++.+++.++.||+.||+||| +++ |+||||||+||+++.++.++|+|||++..
T Consensus 89 e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEG---TNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp ECCTTCBHHHHHHSC---SSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred cccCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceee
Confidence 999999999999752 2236899999999999999999999 677 99999999999999999999999998764
Q ss_pred CCCCCcceecccccccCcccccccccCcCCC---chhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHH
Q 041143 781 APDGEKSVVTRLAGTFGYLAPEYAVMGKITT---KADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKF 857 (973)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (973)
... ....||+.|+|||.+.+..++. ++|||||||++|||++|+.||......+.. ... .
T Consensus 163 ~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~------~ 224 (271)
T 3kmu_A 163 FQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG------MKV------A 224 (271)
T ss_dssp TSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHH------HHH------H
T ss_pred ecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHH------HHH------H
Confidence 322 2346899999999998766555 799999999999999999999876543211 011 1
Q ss_pred HhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 858 KAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 858 ~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
.....+.+. ......+.+++.+|++.||++||++.|+++.|+.+.+
T Consensus 225 ~~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 225 LEGLRPTIP-----PGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HSCCCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred hcCCCCCCC-----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 111111111 1122457899999999999999999999999998754
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=363.51 Aligned_cols=265 Identities=26% Similarity=0.405 Sum_probs=214.8
Q ss_pred hcCccccCcccccCccEEEEEEE------CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCC
Q 041143 624 TQNFAQENELGRGGFGTVYKGEL------EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGN 696 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 696 (973)
.++|...+.||+|+||.||+|++ .+++.||||+++.. ......+.+.+|+++++++ +||||+++++++...+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc-hhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 46788999999999999999975 34678999999754 2345567899999999999 8999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhhhhc-------------cCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEE
Q 041143 697 ERLLVYEYMPHGALSRHLFRWEKL-------------QLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNIL 763 (973)
Q Consensus 697 ~~~lV~e~~~~g~L~~~l~~~~~~-------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nil 763 (973)
..++||||+++|+|.+++...... ....+++.+++.++.||+.||+||| +++|+||||||+||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEE
Confidence 999999999999999999764321 1235899999999999999999999 789999999999999
Q ss_pred ECCCCCEEEeeccccccCCCCCcc-eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHH
Q 041143 764 LDDDYRAKVSDFGLVKLAPDGEKS-VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESR 841 (973)
Q Consensus 764 l~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~ 841 (973)
++.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++ |+.||........
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~- 256 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK- 256 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH-
Confidence 999999999999999865543322 2334567889999999999999999999999999999999 9999976653221
Q ss_pred HHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 842 YLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
... . ......+... ......+.+++.+|++.||.+||++.||++.|+++.++
T Consensus 257 -~~~----~------~~~~~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 257 -FYK----M------IKEGFRMLSP-----EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp -HHH----H------HHHTCCCCCC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHH----H------hccCCCCCCc-----ccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 111 0 1111111111 11224578999999999999999999999999998875
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=359.13 Aligned_cols=259 Identities=27% Similarity=0.438 Sum_probs=216.4
Q ss_pred hcCccccCcccccCccEEEEEEECC-CCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELED-GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
.++|...+.||+|+||.||+|.+.. +..||||+++.. ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC---STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 4678899999999999999998764 788999998753 334567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++|+|.+++... ....+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 89 e~~~~~~L~~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 89 EFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp ECCTTEEHHHHHHHC---CTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred EcCCCCcHHHHHHhc---ccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 999999999999652 2356899999999999999999999 7799999999999999999999999999998766
Q ss_pred CCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhc
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (973)
...........+|+.|+|||++.+..++.++||||||+++|||++ |+.||........... +....
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~-------------~~~~~ 229 (288)
T 3kfa_A 163 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-------------LEKDY 229 (288)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH-------------HHTTC
T ss_pred CCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-------------HhccC
Confidence 554444455667889999999999999999999999999999999 9999987654322110 11111
Q ss_pred CccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 862 DPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 862 ~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
..... ......+.+++.+|++.||++||++.||++.|+.+.++
T Consensus 230 ~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 230 RMERP-----EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp CCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCC-----CCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 11111 11224578999999999999999999999999998775
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=381.69 Aligned_cols=270 Identities=21% Similarity=0.281 Sum_probs=213.8
Q ss_pred HHHHHHHhcCccccCcccccCccEEEEEEECC-CCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeeEEEe
Q 041143 617 VQVLRKVTQNFAQENELGRGGFGTVYKGELED-GTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKVRHRHLVSLLGYSIE 694 (973)
Q Consensus 617 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 694 (973)
...++...++|+..++||+|+||+||+|+... ++.||||+++.... .....+.+.+|+.++..++|||||++++++.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 34445566899999999999999999998864 78899999864210 01112348899999999999999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEee
Q 041143 695 GNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSD 774 (973)
Q Consensus 695 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D 774 (973)
.+..++||||+++|+|.+++... ...+++..+..++.||+.||+||| +.+||||||||+|||++.++.+||+|
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~----~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~D 218 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKF----EDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLAD 218 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECC
T ss_pred CCEEEEEEecCCCCcHHHHHHHc----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcc
Confidence 99999999999999999999652 246899999999999999999999 78999999999999999999999999
Q ss_pred ccccccCCCCCcceecccccccCcccccccc-----cCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHH
Q 041143 775 FGLVKLAPDGEKSVVTRLAGTFGYLAPEYAV-----MGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWR 849 (973)
Q Consensus 775 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 849 (973)
||+|+.............+||+.|+|||++. ...++.++|||||||++|||++|+.||......+.. ..
T Consensus 219 FGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~------~~ 292 (437)
T 4aw2_A 219 FGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY------GK 292 (437)
T ss_dssp CTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HH
T ss_pred hhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHH------Hh
Confidence 9999866555444455578999999999987 567999999999999999999999999876543221 11
Q ss_pred HhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCC--CCCHhHHHHHHHHhhhh
Q 041143 850 IKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYH--RPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 850 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~--RPs~~~v~~~L~~~~~~ 909 (973)
+..... ...-|... ......+.+++.+|+..+|++ ||++.||++ +++.+.
T Consensus 293 i~~~~~---~~~~p~~~-----~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~--Hpff~~ 344 (437)
T 4aw2_A 293 IMNHKE---RFQFPTQV-----TDVSENAKDLIRRLICSREHRLGQNGIEDFKK--HPFFSG 344 (437)
T ss_dssp HHTHHH---HCCCCSSC-----CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT--SGGGTT
T ss_pred hhhccc---cccCCccc-----ccCCHHHHHHHHHHhcccccccCCCCHHHHhC--CCccCC
Confidence 111010 11111110 011234778999999888888 999999998 676653
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=360.72 Aligned_cols=259 Identities=23% Similarity=0.374 Sum_probs=208.6
Q ss_pred HhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCCh----HHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCe
Q 041143 623 VTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTT----KALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNE 697 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 697 (973)
..++|...+.||+|+||.||+|... +|+.||||+++...... ...+.+.+|++++++++||||+++++++.+.+.
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 3467999999999999999999875 58999999987543221 135678999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCC----CEEEe
Q 041143 698 RLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDY----RAKVS 773 (973)
Q Consensus 698 ~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~----~~kl~ 773 (973)
.++||||+++|+|.+++.. ...+++.++..++.||+.||+||| +.+|+||||||+||+++.++ .+||+
T Consensus 89 ~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~ 160 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKII 160 (326)
T ss_dssp EEEEEECCCSCBHHHHHTT-----SSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEEC
T ss_pred EEEEEEcCCCCCHHHHHHh-----cCCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEE
Confidence 9999999999999999854 256899999999999999999999 78999999999999999887 89999
Q ss_pred eccccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhc
Q 041143 774 DFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSS 853 (973)
Q Consensus 774 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 853 (973)
|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ..+...
T Consensus 161 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~------~~~~~~ 232 (326)
T 2y0a_A 161 DFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL------ANVSAV 232 (326)
T ss_dssp CCTTCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH------HHHHHT
T ss_pred ECCCCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH------HHHHhc
Confidence 999998664332 234467999999999999899999999999999999999999999876533211 111100
Q ss_pred hhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 854 KEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 854 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
..... ..........+.+++.+|++.||++|||+.|+++ +++++
T Consensus 233 --------~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~--hp~~~ 276 (326)
T 2y0a_A 233 --------NYEFE-DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ--HPWIK 276 (326)
T ss_dssp --------CCCCC-HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH--STTTS
T ss_pred --------CCCcC-ccccccCCHHHHHHHHHHccCChhhCCCHHHHhc--CCCcc
Confidence 00000 0000011234779999999999999999999998 55543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=359.10 Aligned_cols=271 Identities=21% Similarity=0.321 Sum_probs=204.4
Q ss_pred cCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEe
Q 041143 625 QNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEY 704 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 704 (973)
++|...+.||+|+||.||+|+..+|+.||||+++.........+.+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57899999999999999999988899999999976533333346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCC
Q 041143 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG 784 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~ 784 (973)
+++ +|.+++... ...+++.++..++.||++||+||| +++|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~-~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (288)
T ss_dssp CSE-EHHHHHHTS----TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred cCC-CHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence 975 998888652 246899999999999999999999 789999999999999999999999999999865432
Q ss_pred CcceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhch-hH---HH-
Q 041143 785 EKSVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSK-EK---FK- 858 (973)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~---~~- 858 (973)
. .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+. +........... .. ..
T Consensus 154 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 154 V-RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--LMRIFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTTSTTGGG
T ss_pred c-cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHHCCCChhhchhhhc
Confidence 2 12334578999999999876 4589999999999999999999999987654322 111111110000 00 00
Q ss_pred -hhcCccccCC------cccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 859 -AAIDPALEVN------EETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 859 -~~~~~~l~~~------~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
...++.+... .........+.+++.+|++.||++||++.|+++ +++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~--hp~f~ 285 (288)
T 1ob3_A 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE--HAYFK 285 (288)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT--SGGGG
T ss_pred ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc--Ccchh
Confidence 0011111100 000112245779999999999999999999987 55543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=369.00 Aligned_cols=276 Identities=18% Similarity=0.262 Sum_probs=211.4
Q ss_pred cCccccCccccc--CccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEE
Q 041143 625 QNFAQENELGRG--GFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLV 701 (973)
Q Consensus 625 ~~~~~~~~lG~G--~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 701 (973)
++|+..+.||+| +||.||+|+.. +|+.||||+++.........+.+.+|++++++++|||||++++++.+.+..++|
T Consensus 25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 104 (389)
T 3gni_B 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 104 (389)
T ss_dssp GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence 678999999999 99999999876 689999999987655667778899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccC
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA 781 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~ 781 (973)
|||+++|+|.+++.... ...+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||.+...
T Consensus 105 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 105 TSFMAYGSAKDLICTHF---MDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EECCTTCBHHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEccCCCCHHHHHhhhc---ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 99999999999997532 245899999999999999999999 789999999999999999999999999998643
Q ss_pred CCCCc------ceecccccccCccccccccc--CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhh-
Q 041143 782 PDGEK------SVVTRLAGTFGYLAPEYAVM--GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKS- 852 (973)
Q Consensus 782 ~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~- 852 (973)
..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+... ........
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~~~~~~~~~ 256 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL--EKLNGTVPC 256 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHH--HC-------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHH--HHhcCCCCc
Confidence 22111 11223478999999999987 679999999999999999999999998654332110 00000000
Q ss_pred -------chh-------------HHHhhcC---c-----cccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHH
Q 041143 853 -------SKE-------------KFKAAID---P-----ALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLS 904 (973)
Q Consensus 853 -------~~~-------------~~~~~~~---~-----~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~ 904 (973)
... .....+. + ..............+.+|+.+||+.||++|||+.|+++ +
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~--h 334 (389)
T 3gni_B 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN--H 334 (389)
T ss_dssp -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT--S
T ss_pred cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc--C
Confidence 000 0000000 0 00000011112245889999999999999999999998 6
Q ss_pred Hhhhhc
Q 041143 905 PLVEKW 910 (973)
Q Consensus 905 ~~~~~~ 910 (973)
++++.+
T Consensus 335 p~f~~~ 340 (389)
T 3gni_B 335 SFFKQI 340 (389)
T ss_dssp GGGGGC
T ss_pred HHHHHH
Confidence 666654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=363.44 Aligned_cols=253 Identities=25% Similarity=0.375 Sum_probs=200.3
Q ss_pred HhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC-----
Q 041143 623 VTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGN----- 696 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 696 (973)
..++|+..+.||+|+||.||+|+.. +|+.||||+++... .....+.+.+|++++++++|||||++++++.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 3468999999999999999999886 79999999997543 3445678999999999999999999999987643
Q ss_pred ----------------------------------------------------eEEEEEEecCCCCHHHHHHhhhhccCCC
Q 041143 697 ----------------------------------------------------ERLLVYEYMPHGALSRHLFRWEKLQLKP 724 (973)
Q Consensus 697 ----------------------------------------------------~~~lV~e~~~~g~L~~~l~~~~~~~~~~ 724 (973)
..++||||+++|+|.+++.... ....
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~ 160 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC--SLED 160 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC--SGGG
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc--Cccc
Confidence 2799999999999999997633 2345
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCc-----------ceecccc
Q 041143 725 LSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEK-----------SVVTRLA 793 (973)
Q Consensus 725 l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~-----------~~~~~~~ 793 (973)
.++..++.++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++....... .......
T Consensus 161 ~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T 3qd2_B 161 REHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV 237 (332)
T ss_dssp SCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC
T ss_pred hhhHHHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccC
Confidence 678889999999999999999 78999999999999999999999999999986554321 1223457
Q ss_pred cccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccCCcccHH
Q 041143 794 GTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFE 873 (973)
Q Consensus 794 gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 873 (973)
||+.|+|||++.+..++.++|||||||++|||++|..|+. +.... .... . .. ........
T Consensus 238 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~-----~~~~~---~~~~-------~---~~--~~~~~~~~ 297 (332)
T 3qd2_B 238 GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM-----ERVRI---ITDV-------R---NL--KFPLLFTQ 297 (332)
T ss_dssp -CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHHH---HHHH-------H---TT--CCCHHHHH
T ss_pred CCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh-----HHHHH---HHHh-------h---cc--CCCccccc
Confidence 9999999999999999999999999999999999866532 11110 0000 0 00 10111223
Q ss_pred HHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 874 SISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 874 ~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
....+.+++.+|++.||++||++.|+++
T Consensus 298 ~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 298 KYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred CChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 3345689999999999999999999997
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=360.14 Aligned_cols=251 Identities=27% Similarity=0.409 Sum_probs=206.8
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
++|...+.||+|+||.||+|+.. +|+.||+|+++.... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 67899999999999999999875 689999999864311 1123456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++|+|.+++.. ...+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 86 e~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 86 DYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp CCCCSCBHHHHHHH-----TSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred eCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 99999999999965 246899999999999999999999 8899999999999999999999999999998654
Q ss_pred CCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcC
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (973)
.. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+. +..+...
T Consensus 158 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~i~~~--------- 218 (318)
T 1fot_A 158 DV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT------YEKILNA--------- 218 (318)
T ss_dssp SC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHHC---------
T ss_pred Cc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH------HHHHHhC---------
Confidence 32 2346899999999999999999999999999999999999999987653221 1111111
Q ss_pred ccccCCcccHHHHHHHHHHHHHhhccCCCCCC-----CHhHHHHHHHHhhh
Q 041143 863 PALEVNEETFESISIVAELAGHCTAREPYHRP-----DMGHVVNVLSPLVE 908 (973)
Q Consensus 863 ~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~~v~~~L~~~~~ 908 (973)
.+.... .....+.+++.+|++.||++|| ++.||++ +++++
T Consensus 219 -~~~~p~---~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~--hp~f~ 263 (318)
T 1fot_A 219 -ELRFPP---FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN--HPWFK 263 (318)
T ss_dssp -CCCCCT---TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT--SGGGS
T ss_pred -CCCCCC---CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc--Ccccc
Confidence 111111 1123577999999999999999 8888887 55554
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=354.51 Aligned_cols=259 Identities=27% Similarity=0.440 Sum_probs=212.4
Q ss_pred hcCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
.++|...+.||+|+||.||+|...++..||||+++.... ..+.+.+|++++++++||||+++++++. .+..++|||
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 87 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITE 87 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc---cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEe
Confidence 367889999999999999999998888999999976432 2457899999999999999999999986 456899999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+++|+|.+++.... ...+++.++..++.|++.||+||| +++|+||||||+||++++++.+||+|||+++....
T Consensus 88 ~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 88 YMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp CCTTCBHHHHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCHHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 999999999986522 135899999999999999999999 78999999999999999999999999999987655
Q ss_pred CCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcC
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (973)
..........++..|+|||.+.+..++.++|||||||++|||++ |+.||......+. ...+.. ...
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~------~~~~~~-------~~~ 228 (279)
T 1qpc_A 162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV------IQNLER-------GYR 228 (279)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH------HHHHHT-------TCC
T ss_pred cccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH------HHHHhc-------ccC
Confidence 44333344567889999999998899999999999999999999 9999987653221 111111 111
Q ss_pred ccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhc
Q 041143 863 PALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKW 910 (973)
Q Consensus 863 ~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~ 910 (973)
.... ......+.+++.+|++.||++||++.++++.|+.+....
T Consensus 229 ~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 229 MVRP-----DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp CCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCCc-----ccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 1111 112245789999999999999999999999999987753
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=360.78 Aligned_cols=250 Identities=26% Similarity=0.404 Sum_probs=196.2
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCC------------------------hHHHHHHHHHHHHHHh
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTT------------------------TKALDEFQSEIAVLSK 679 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~------------------------~~~~~~~~~E~~~l~~ 679 (973)
++|...+.||+|+||.||+|+.. +|+.||||++...... ....+.+.+|++++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 68999999999999999999875 6889999998654211 1123568999999999
Q ss_pred cCCCceeeeeeEEEe--CCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccC
Q 041143 680 VRHRHLVSLLGYSIE--GNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDL 757 (973)
Q Consensus 680 l~h~niv~l~~~~~~--~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Di 757 (973)
++||||+++++++.+ .+..++||||+++|+|.+++. ...+++.++..++.||++||+||| +++|+||||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dl 163 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT------LKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDI 163 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC------SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCC
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCC
Confidence 999999999999987 567899999999999976542 357899999999999999999999 789999999
Q ss_pred CCCcEEECCCCCEEEeeccccccCCCCCcceecccccccCcccccccccCc---CCCchhHHhHHHHHHHHHhCCCCCCC
Q 041143 758 KSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGK---ITTKADVFSYGVVLMELLTGLAALDE 834 (973)
Q Consensus 758 kp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~S~Gvvl~elltg~~p~~~ 834 (973)
||+||+++.++.+||+|||+++...... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||..
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CHHHEEECCCCCEEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999998654432 2234567999999999987655 47789999999999999999999986
Q ss_pred CChhhHHHHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 835 ERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
...... ...+... ... .. ........+.+++.+|++.||++||++.||++
T Consensus 243 ~~~~~~------~~~~~~~------~~~--~~---~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 243 ERIMCL------HSKIKSQ------ALE--FP---DQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SSHHHH------HHHHHHC------CCC--CC---SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccHHHH------HHHHhcc------cCC--CC---CccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 543211 1111110 000 00 00112245789999999999999999999986
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=378.94 Aligned_cols=253 Identities=30% Similarity=0.444 Sum_probs=207.3
Q ss_pred hcCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC-eEEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGN-ERLLVY 702 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~ 702 (973)
.++|...+.||+|+||.||+|.+. |+.||||+++... ..+.|.+|++++++++|||||++++++.+.+ ..++||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 467888999999999999999886 7899999997542 3467899999999999999999999988765 789999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++|+|.+++... ....+++..++.++.||++||+||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 267 e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp ECCTTCBHHHHHHHH---CTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 999999999999763 2244789999999999999999999 7899999999999999999999999999998543
Q ss_pred CCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhc
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (973)
.. .....+++.|+|||++.+..++.++|||||||++|||++ |+.||......+.. . .+.. ..
T Consensus 341 ~~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~---~---~i~~-------~~ 403 (450)
T 1k9a_A 341 ST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV---P---RVEK-------GY 403 (450)
T ss_dssp ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH---H---HHHT-------TC
T ss_pred cc----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---H---HHHc-------CC
Confidence 22 122367899999999999999999999999999999998 99999876543221 1 1111 11
Q ss_pred CccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 862 DPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 862 ~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
.... +......+.+++.+||+.||++||++.+|++.|+.+...
T Consensus 404 ~~~~-----p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 404 KMDA-----PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp CCCC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCC-----CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 1111 111234578999999999999999999999999988764
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=357.30 Aligned_cols=262 Identities=29% Similarity=0.517 Sum_probs=200.6
Q ss_pred hcCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
.++|...+.||+|+||.||+|+.. ..||||+++.........+.+.+|++++++++||||+++++++ .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 467899999999999999999875 3599999987766777778899999999999999999999965 4566899999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+++++|.+++... ...+++.+++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 100 ~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 100 WCEGSSLYHHLHAS----ETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp CCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred ecCCCcHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceecccccc
Confidence 99999999998642 256899999999999999999999 78999999999999999999999999999985432
Q ss_pred C-CcceecccccccCcccccccc---cCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHh
Q 041143 784 G-EKSVVTRLAGTFGYLAPEYAV---MGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKA 859 (973)
Q Consensus 784 ~-~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (973)
. .........||+.|+|||++. ...++.++|||||||++|||++|+.||......+. +...+.. .
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~---------~ 241 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIEMVGR---------G 241 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--HHHHHHH---------T
T ss_pred ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--HHHHhcc---------c
Confidence 1 222334567999999999986 56788899999999999999999999987553321 1111110 1
Q ss_pred hcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 860 AIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 860 ~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
...+.+. .........+.+++.+|++.||++||++.|+++.|+++.+
T Consensus 242 ~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 242 SLSPDLS--KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp SCCCCTT--SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ccCcchh--hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 1111111 1111223458899999999999999999999999998764
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=363.81 Aligned_cols=277 Identities=22% Similarity=0.344 Sum_probs=206.7
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC------
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGN------ 696 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 696 (973)
.++|...+.||+|+||.||+|... +|+.||||++..........+.+.+|++++++++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 468999999999999999999874 6899999999766556666788999999999999999999999998653
Q ss_pred eEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecc
Q 041143 697 ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFG 776 (973)
Q Consensus 697 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG 776 (973)
..++||||+ +++|.+++.. ..+++..+..++.||++||+||| +.+|+||||||+||+++.++.+||+|||
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 173 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFG 173 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred eEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeee
Confidence 469999999 8899998864 45899999999999999999999 7899999999999999999999999999
Q ss_pred ccccCCCCCcceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchh
Q 041143 777 LVKLAPDGEKSVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKE 855 (973)
Q Consensus 777 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 855 (973)
+++..... .+...||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+... ..+........
T Consensus 174 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~--~i~~~~g~~~~ 247 (367)
T 1cm8_A 174 LARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLK--EIMKVTGTPPA 247 (367)
T ss_dssp TCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHHHHCCCCH
T ss_pred cccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHhcCCCCH
Confidence 99865432 344679999999999887 679999999999999999999999998765433211 11110000000
Q ss_pred HH---------H---hhcCccc--cCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCCCCCCCc
Q 041143 856 KF---------K---AAIDPAL--EVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPITDESE 918 (973)
Q Consensus 856 ~~---------~---~~~~~~l--~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~~~~~~~ 918 (973)
.+ . ..+.... ............+.+++.+|++.||++|||+.|+++ +++++.+....+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~--hp~f~~~~~~~~~~~ 322 (367)
T 1cm8_A 248 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA--HPYFESLHDTEDEPQ 322 (367)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH--SGGGTTTC------C
T ss_pred HHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc--ChHHHhhcCCccCCC
Confidence 00 0 0000000 000000112345789999999999999999999999 888877665554443
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=357.11 Aligned_cols=276 Identities=24% Similarity=0.335 Sum_probs=208.3
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
.++|...+.||+|+||.||+|+.. +|+.||||++..........+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 368999999999999999999875 5899999998776555666778899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++++|..++.. ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 82 e~~~~~~l~~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 153 (311)
T 4agu_A 82 EYCDHTVLHELDRY-----QRGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLT 153 (311)
T ss_dssp ECCSEEHHHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EeCCCchHHHHHhh-----hcCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhcc
Confidence 99999999888754 255899999999999999999999 7899999999999999999999999999998654
Q ss_pred CCCcceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHH--------HHhhc
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFW--------RIKSS 853 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~ 853 (973)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+......... .....
T Consensus 154 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
T 4agu_A 154 GPSD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232 (311)
T ss_dssp -------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred Cccc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccc
Confidence 3322 2344579999999999876 678999999999999999999999998776543322211100 00000
Q ss_pred hhHHHhhcCccccCCccc-----HHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcC
Q 041143 854 KEKFKAAIDPALEVNEET-----FESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWR 911 (973)
Q Consensus 854 ~~~~~~~~~~~l~~~~~~-----~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~ 911 (973)
.........+... .... ......+.+++.+|++.||++|||++|+++ +++++...
T Consensus 233 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~f~~~~ 292 (311)
T 4agu_A 233 NQYFSGVKIPDPE-DMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH--HPYFENIR 292 (311)
T ss_dssp CGGGTTCCCCCCS-SCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT--SGGGTTCC
T ss_pred ccccccCcCCCcc-ccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc--ChHHHhcc
Confidence 0000000000000 0000 112234789999999999999999999998 67766543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=354.87 Aligned_cols=252 Identities=29% Similarity=0.486 Sum_probs=194.4
Q ss_pred cCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCC--hHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTT--TKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
++|...+.||+|+||.||+|.+. |+.||||+++..... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 67889999999999999999986 889999998654222 223467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCC---eeeccCCCCcEEECC--------CCCEE
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQT---FIHRDLKSSNILLDD--------DYRAK 771 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~---ivH~Dikp~Nill~~--------~~~~k 771 (973)
||+++|+|.+++.. ..+++..+..++.|++.||+||| +++ |+||||||+||+++. ++.+|
T Consensus 86 e~~~~~~L~~~~~~------~~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~k 156 (271)
T 3dtc_A 86 EFARGGPLNRVLSG------KRIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILK 156 (271)
T ss_dssp ECCTTEEHHHHHTS------SCCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEE
T ss_pred EcCCCCCHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceE
Confidence 99999999998843 56899999999999999999999 566 999999999999986 67899
Q ss_pred EeeccccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHh
Q 041143 772 VSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIK 851 (973)
Q Consensus 772 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 851 (973)
|+|||+++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......... ...
T Consensus 157 l~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~------~~~ 227 (271)
T 3dtc_A 157 ITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY------GVA 227 (271)
T ss_dssp ECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH------HHH
T ss_pred EccCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------hhh
Confidence 99999998554322 224579999999999999999999999999999999999999998765332111 011
Q ss_pred hchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHh
Q 041143 852 SSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPL 906 (973)
Q Consensus 852 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~ 906 (973)
. ....... .......+.+++.+|++.||++||++.|+++.|+.+
T Consensus 228 ~------~~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 228 M------NKLALPI-----PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp T------SCCCCCC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred c------CCCCCCC-----CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 0 0011111 111224578999999999999999999999998753
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=370.43 Aligned_cols=257 Identities=25% Similarity=0.363 Sum_probs=204.4
Q ss_pred cCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcC--CCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR--HRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lV~ 702 (973)
.+|...+.||+|+||.||+|...+++.||||++..........+.+.+|++++++++ |||||++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 468999999999999999999888999999999876556677788999999999996 599999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
| +.+|+|.+++.. ...+++.++..++.||+.||+||| +.+|+||||||+|||++ ++.+||+|||+++...
T Consensus 136 E-~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 136 E-CGNIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp E-CCSEEHHHHHHH-----CSSCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred e-cCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 9 568999999975 246889999999999999999999 88999999999999996 5799999999998654
Q ss_pred CCCc-ceecccccccCccccccccc-----------CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHH
Q 041143 783 DGEK-SVVTRLAGTFGYLAPEYAVM-----------GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRI 850 (973)
Q Consensus 783 ~~~~-~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 850 (973)
.... ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||........
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~---------- 275 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---------- 275 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH----------
T ss_pred CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH----------
Confidence 3322 22345679999999999865 4688999999999999999999999976532211
Q ss_pred hhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 851 KSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 851 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
.+..++++...... +......+.+++.+||+.||++||++.||++ +++++.
T Consensus 276 -----~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~ell~--hp~~~~ 326 (390)
T 2zmd_A 276 -----KLHAIIDPNHEIEF-PDIPEKDLQDVLKCCLKRDPKQRISIPELLA--HPYVQI 326 (390)
T ss_dssp -----HHHHHHCTTSCCCC-CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHHS
T ss_pred -----HHHHHhCccccCCC-CccchHHHHHHHHHHcccChhhCCCHHHHhh--CcCccc
Confidence 11122222211000 0001235779999999999999999999998 566653
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=362.18 Aligned_cols=261 Identities=22% Similarity=0.366 Sum_probs=206.1
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCC-CChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGV-TTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGNERLLV 701 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 701 (973)
++|...+.||+|+||.||+|+.+ +++.||||+++... ......+.+.+|..++.++ +|||||++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 67899999999999999999875 58899999997543 3445567789999999988 899999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccC
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA 781 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~ 781 (973)
|||+++|+|.+++... ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~e~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp ECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 9999999999998652 45899999999999999999999 789999999999999999999999999999854
Q ss_pred CCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHH--HHHHHHHHHhhchhHHHh
Q 041143 782 PDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESR--YLAEWFWRIKSSKEKFKA 859 (973)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 859 (973)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ....... ..
T Consensus 161 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~---------~~ 230 (345)
T 3a8x_A 161 LRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF---------QV 230 (345)
T ss_dssp CCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHH---------HH
T ss_pred cCCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHH---------HH
Confidence 3222 2244568999999999999999999999999999999999999999753221110 0000000 11
Q ss_pred hcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCH------hHHHHHHHHhhh
Q 041143 860 AIDPALEVNEETFESISIVAELAGHCTAREPYHRPDM------GHVVNVLSPLVE 908 (973)
Q Consensus 860 ~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~------~~v~~~L~~~~~ 908 (973)
+....+.... .....+.+++.+|++.||++||++ .||++ +++.+
T Consensus 231 i~~~~~~~p~---~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~--hp~f~ 280 (345)
T 3a8x_A 231 ILEKQIRIPR---SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG--HPFFR 280 (345)
T ss_dssp HHHCCCCCCT---TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT--SGGGT
T ss_pred HHcCCCCCCC---CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc--CCccC
Confidence 1111111111 122357799999999999999996 56655 44443
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=356.57 Aligned_cols=259 Identities=29% Similarity=0.489 Sum_probs=201.6
Q ss_pred cCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEe
Q 041143 625 QNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEY 704 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 704 (973)
++|+..+.||+|+||.||+|+.. ++.||||++... ...+.|.+|++++++++||||+++++++.+ ..++||||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~ 80 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY 80 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence 57888999999999999999886 788999998642 345689999999999999999999998873 47999999
Q ss_pred cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCC-EEEeeccccccCCC
Q 041143 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYR-AKVSDFGLVKLAPD 783 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~-~kl~DfGla~~~~~ 783 (973)
+++|+|.+++.... ....+++..++.++.|+++||+|||+...++|+||||||+||+++.++. +||+|||+++....
T Consensus 81 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 81 AEGGSLYNVLHGAE--PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp CTTCBHHHHHHCSS--SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred CCCCCHHHHHhccC--CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 99999999997532 2235789999999999999999999433389999999999999998886 79999999975432
Q ss_pred CCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCc
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDP 863 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (973)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..+.... ...+
T Consensus 159 ~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~----~~~~~~~-------~~~~ 223 (307)
T 2eva_A 159 H----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR----IMWAVHN-------GTRP 223 (307)
T ss_dssp ----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH----HHHHHHT-------TCCC
T ss_pred c----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH----HHHHHhc-------CCCC
Confidence 2 23346999999999999999999999999999999999999999765432211 1111110 0111
Q ss_pred cccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCC
Q 041143 864 ALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRP 912 (973)
Q Consensus 864 ~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~ 912 (973)
... ......+.+++.+|++.||++||++.+|++.|+.+.+.+..
T Consensus 224 ~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 224 PLI-----KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp CCB-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred Ccc-----cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 111 11123577999999999999999999999999999776543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=363.10 Aligned_cols=266 Identities=25% Similarity=0.385 Sum_probs=214.4
Q ss_pred hcCccccCcccccCccEEEEEEEC--------CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEe
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE--------DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIE 694 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 694 (973)
.++|...+.||+|+||.||+|++. ++..||||+++.. ......+.+.+|+++++++ +||||+++++++..
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC-CcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 368899999999999999999863 4678999999754 3455677899999999999 89999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHHhhhhc-----------cCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEE
Q 041143 695 GNERLLVYEYMPHGALSRHLFRWEKL-----------QLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNIL 763 (973)
Q Consensus 695 ~~~~~lV~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nil 763 (973)
.+..++||||+++|+|.+++...... ....+++.+++.++.||+.||+||| +.+|+||||||+||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEE
Confidence 99999999999999999999763321 1235899999999999999999999 789999999999999
Q ss_pred ECCCCCEEEeeccccccCCCCCc-ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHH
Q 041143 764 LDDDYRAKVSDFGLVKLAPDGEK-SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESR 841 (973)
Q Consensus 764 l~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~ 841 (973)
++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+..
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 269 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence 99999999999999986544322 12233467889999999999999999999999999999999 99999876533211
Q ss_pred HHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcC
Q 041143 842 YLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWR 911 (973)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~ 911 (973)
..+. ........ ......+.+++.+|++.||.+||++.||++.|+.+.....
T Consensus 270 ------~~~~-------~~~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 270 ------KLLK-------EGHRMDKP-----ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp ------HHHH-------HTCCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred ------HHHh-------cCCCCCCC-----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 1111 11111111 1122457899999999999999999999999999987543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=367.70 Aligned_cols=266 Identities=24% Similarity=0.393 Sum_probs=209.4
Q ss_pred HhcCccccCcccccCccEEEEEEE------CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeC
Q 041143 623 VTQNFAQENELGRGGFGTVYKGEL------EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEG 695 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 695 (973)
..++|...+.||+|+||.||+|+. .++..||||+++... .....+.+.+|++++.++ +||||+++++++...
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 347899999999999999999986 245689999997542 334456899999999999 899999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhhhhc------------------cCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccC
Q 041143 696 NERLLVYEYMPHGALSRHLFRWEKL------------------QLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDL 757 (973)
Q Consensus 696 ~~~~lV~e~~~~g~L~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Di 757 (973)
+..++||||+++|+|.+++...... ....+++..++.++.||+.||+||| +++|+||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCC
Confidence 9999999999999999999763221 1134899999999999999999999 789999999
Q ss_pred CCCcEEECCCCCEEEeeccccccCCCCC-cceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCC
Q 041143 758 KSSNILLDDDYRAKVSDFGLVKLAPDGE-KSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEE 835 (973)
Q Consensus 758 kp~Nill~~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~ 835 (973)
||+||+++.++.+||+|||+++...... ........||+.|+|||.+.+..++.++|||||||++|||+| |+.||...
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 9999999999999999999998543332 223344568899999999999999999999999999999998 99999876
Q ss_pred ChhhHHHHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 836 RPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
..... ... .. .....+... ......+.+++.+|++.||.+||++.||++.|+.+...
T Consensus 279 ~~~~~--~~~----~~------~~~~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 279 PVDAN--FYK----LI------QNGFKMDQP-----FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp CCSHH--HHH----HH------HTTCCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred CcHHH--HHH----HH------hcCCCCCCC-----CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 53221 111 11 111111111 11224578999999999999999999999999988764
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=374.13 Aligned_cols=273 Identities=21% Similarity=0.285 Sum_probs=207.4
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeC------C
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEG------N 696 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 696 (973)
.++|...+.||+|+||.||+|... +|+.||||++..........+.+.+|+.+++.++|||||++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 478999999999999999999765 688999999986655666778899999999999999999999999754 4
Q ss_pred eEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecc
Q 041143 697 ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFG 776 (973)
Q Consensus 697 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG 776 (973)
..|+||||+++ +|.+.+. ..+++.++..++.||++||+||| +.+|+||||||+|||++.++.+||+|||
T Consensus 141 ~~~lv~E~~~~-~l~~~~~-------~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG 209 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG 209 (464)
T ss_dssp EEEEEEECCSE-EHHHHHT-------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred eEEEEEeCCCC-CHHHHHh-------hcCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEE
Confidence 57999999965 5666553 24889999999999999999999 7899999999999999999999999999
Q ss_pred ccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhh----
Q 041143 777 LVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKS---- 852 (973)
Q Consensus 777 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---- 852 (973)
+|+..... ...+..+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+....+... ..+.....
T Consensus 210 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~--~i~~~lg~p~~~ 285 (464)
T 3ttj_A 210 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN--KVIEQLGTPCPE 285 (464)
T ss_dssp CC-----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHHHHCSCCHH
T ss_pred eeeecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHhcCCCCHH
Confidence 99865432 22455689999999999999999999999999999999999999998766433211 11110000
Q ss_pred ----chhHHHhhcC---------------ccccCC--cccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcC
Q 041143 853 ----SKEKFKAAID---------------PALEVN--EETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWR 911 (973)
Q Consensus 853 ----~~~~~~~~~~---------------~~l~~~--~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~ 911 (973)
........+. ..+... .........+.+|+.+||+.||++|||++|+++ +++++.|.
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~--Hp~~~~~~ 363 (464)
T 3ttj_A 286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ--HPYINVWY 363 (464)
T ss_dssp HHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT--STTTGGGC
T ss_pred HHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc--Chhhhhcc
Confidence 0001111111 110000 011112456889999999999999999999999 88888765
Q ss_pred CC
Q 041143 912 PI 913 (973)
Q Consensus 912 ~~ 913 (973)
.+
T Consensus 364 ~~ 365 (464)
T 3ttj_A 364 DP 365 (464)
T ss_dssp CH
T ss_pred Cc
Confidence 43
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=366.61 Aligned_cols=252 Identities=27% Similarity=0.417 Sum_probs=204.3
Q ss_pred HHhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeE
Q 041143 622 KVTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGNER 698 (973)
Q Consensus 622 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 698 (973)
...++|...+.||+|+||.||+|+.+ +|+.||||+++.... .....+.+..|.+++..+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34578999999999999999999875 588999999965311 112345678899999887 899999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecccc
Q 041143 699 LLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLV 778 (973)
Q Consensus 699 ~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla 778 (973)
++||||+++|+|.+++... ..+++.++..++.||+.||+||| +++|+||||||+|||++.++.+||+|||++
T Consensus 94 ~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a 165 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMC 165 (345)
T ss_dssp EEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhh
Confidence 9999999999999999652 45899999999999999999999 789999999999999999999999999999
Q ss_pred ccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHH
Q 041143 779 KLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFK 858 (973)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (973)
+...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+. +..+....
T Consensus 166 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~------~~~i~~~~---- 234 (345)
T 1xjd_A 166 KENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL------FHSIRMDN---- 234 (345)
T ss_dssp BCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHCC----
T ss_pred hhcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHH------HHHHHhCC----
Confidence 8543322 224457899999999999999999999999999999999999999987654321 11111111
Q ss_pred hhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHh-HHHH
Q 041143 859 AAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMG-HVVN 901 (973)
Q Consensus 859 ~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~-~v~~ 901 (973)
+.+. . .....+.+++.+|++.||++||++. +|.+
T Consensus 235 ----~~~p-~----~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 235 ----PFYP-R----WLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp ----CCCC-T----TSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ----CCCC-c----ccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 1111 0 1123477999999999999999998 6665
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=361.89 Aligned_cols=272 Identities=28% Similarity=0.421 Sum_probs=211.4
Q ss_pred ccccCcccccCccEEEEEEEC-----CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeC--CeEE
Q 041143 627 FAQENELGRGGFGTVYKGELE-----DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEG--NERL 699 (973)
Q Consensus 627 ~~~~~~lG~G~fg~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 699 (973)
|...+.||+|+||.||++.+. +|+.||||+++.. ......+.+.+|++++++++||||+++++++.+. ...+
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 488899999999999998653 5889999999765 3455677899999999999999999999999884 5789
Q ss_pred EEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccc
Q 041143 700 LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK 779 (973)
Q Consensus 700 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~ 779 (973)
+||||+++|+|.+++.. ..+++.+++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 112 lv~e~~~~~~L~~~l~~------~~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPR------HSIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp EEECCCTTCBHHHHGGG------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEecccCCcHHHHHhh------CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCccccc
Confidence 99999999999999854 34899999999999999999999 7899999999999999999999999999998
Q ss_pred cCCCCCcc--eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHH
Q 041143 780 LAPDGEKS--VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKF 857 (973)
Q Consensus 780 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (973)
........ ......||..|+|||++.+..++.++|||||||++|||++|+.||........ ....+...... ...+
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~-~~~~ 260 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIAQGQMT-VLRL 260 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCHHHH-HHHH
T ss_pred cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhcccccchh-HHHH
Confidence 76544322 23345688899999999999999999999999999999999999865321110 00000000000 0011
Q ss_pred HhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcC
Q 041143 858 KAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWR 911 (973)
Q Consensus 858 ~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~ 911 (973)
.+.+..... ..........+.+++.+|++.||++||++.|+++.|+.+.+++.
T Consensus 261 ~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 261 TELLERGER-LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp HHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHHHhcccC-CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 111111111 01111223568899999999999999999999999999988754
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=376.01 Aligned_cols=269 Identities=22% Similarity=0.278 Sum_probs=212.0
Q ss_pred HHHHHHHhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeeEEEe
Q 041143 617 VQVLRKVTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKVRHRHLVSLLGYSIE 694 (973)
Q Consensus 617 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 694 (973)
..+.+...++|+..+.||+|+||.||+|+.+ +|+.||||+++.... .....+.+.+|..++..++||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 3444455689999999999999999999875 689999999864211 11223458899999999999999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEee
Q 041143 695 GNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSD 774 (973)
Q Consensus 695 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D 774 (973)
.+..|+||||+++|+|.+++.+. ...+++..+..++.||+.||+||| +++|+||||||+|||++.++++||+|
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~----~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKF----GERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH----SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECC
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEee
Confidence 99999999999999999999752 246899999999999999999999 78999999999999999999999999
Q ss_pred ccccccCCCCCcceecccccccCcccccccc-------cCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHH
Q 041143 775 FGLVKLAPDGEKSVVTRLAGTFGYLAPEYAV-------MGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWF 847 (973)
Q Consensus 775 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 847 (973)
||+++.............+||+.|+|||++. ...++.++|||||||++|||++|+.||......+. +
T Consensus 206 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~ 279 (412)
T 2vd5_A 206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET------Y 279 (412)
T ss_dssp CTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------H
T ss_pred chhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH------H
Confidence 9999876554433344568999999999987 46789999999999999999999999987654322 1
Q ss_pred HHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCC---CCHhHHHHHHHHhhhh
Q 041143 848 WRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHR---PDMGHVVNVLSPLVEK 909 (973)
Q Consensus 848 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~R---Ps~~~v~~~L~~~~~~ 909 (973)
..+..... ....+... ......+.+++.+|+. +|++| |++.||.+ +++.+.
T Consensus 280 ~~i~~~~~---~~~~p~~~-----~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~--Hpff~~ 333 (412)
T 2vd5_A 280 GKIVHYKE---HLSLPLVD-----EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT--HPFFFG 333 (412)
T ss_dssp HHHHTHHH---HCCCC---------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT--SGGGTT
T ss_pred HHHHhccc---CcCCCccc-----cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc--CCCcCC
Confidence 11111000 00011110 1112457799999999 99998 58999887 666653
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=357.11 Aligned_cols=272 Identities=22% Similarity=0.305 Sum_probs=209.9
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC--eEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGN--ERLLV 701 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV 701 (973)
++|...+.||+|+||.||+|+.. +|+.||||+++... .....+.+.+|++++++++||||+++++++.... ..++|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS-FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG-GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccc-ccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 57889999999999999999876 48999999987532 2233567889999999999999999999998765 77999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEE----CCCCCEEEeeccc
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILL----DDDYRAKVSDFGL 777 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill----~~~~~~kl~DfGl 777 (973)
|||+++|+|.+++..... ...+++.+++.++.||+.||+||| +.+|+||||||+||++ +.++.+||+|||+
T Consensus 88 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp EECCTTCBHHHHHHSGGG--TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred EeCCCCCCHHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 999999999999976322 234899999999999999999999 7899999999999999 7888899999999
Q ss_pred cccCCCCCcceecccccccCcccccccc--------cCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHH
Q 041143 778 VKLAPDGEKSVVTRLAGTFGYLAPEYAV--------MGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWR 849 (973)
Q Consensus 778 a~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 849 (973)
++....... .....||+.|+|||++. +..++.++|||||||++|||++|+.||......... ...+..
T Consensus 163 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~ 238 (319)
T 4euu_A 163 ARELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYK 238 (319)
T ss_dssp CEECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC--HHHHHH
T ss_pred ceecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh--HHHHHH
Confidence 986654332 33457999999999886 578899999999999999999999999754432211 111111
Q ss_pred Hhhchh--HHH---hhcC------cccc-CCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHh
Q 041143 850 IKSSKE--KFK---AAID------PALE-VNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPL 906 (973)
Q Consensus 850 ~~~~~~--~~~---~~~~------~~l~-~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~ 906 (973)
+..... ... .... +.+. ...........+.+++.+|++.||++||+++|+++.....
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred HhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 111000 000 0000 0111 0122345566788999999999999999999999866543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=350.41 Aligned_cols=259 Identities=24% Similarity=0.360 Sum_probs=212.1
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
.++|...+.||+|+||.||+|... +|+.||+|++..........+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 478999999999999999999875 5899999999776556667788999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCC---EEEeeccccc
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYR---AKVSDFGLVK 779 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~---~kl~DfGla~ 779 (973)
||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++. +||+|||++.
T Consensus 85 e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~ 156 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR-----EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI 156 (284)
T ss_dssp CCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred ecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence 999999999988652 45899999999999999999999 789999999999999986655 9999999998
Q ss_pred cCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHh
Q 041143 780 LAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKA 859 (973)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (973)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......... ..+...
T Consensus 157 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~------~~~~~~------ 222 (284)
T 3kk8_A 157 EVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY------AQIKAG------ 222 (284)
T ss_dssp ECCSSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHHT------
T ss_pred EcccCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHH------HHHHhc------
Confidence 665432 234467999999999999999999999999999999999999999876533211 111110
Q ss_pred hcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 860 AIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 860 ~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
...... .........+.+++.+|++.||++||++.|+++ ++++..
T Consensus 223 ~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~--h~~~~~ 267 (284)
T 3kk8_A 223 AYDYPS---PEWDTVTPEAKSLIDSMLTVNPKKRITADQALK--VPWICN 267 (284)
T ss_dssp CCCCCT---TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT--SHHHHS
T ss_pred cccCCc---hhhcccCHHHHHHHHHHcccChhhCCCHHHHhc--CccccC
Confidence 000000 000111244779999999999999999999998 666654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=358.68 Aligned_cols=278 Identities=21% Similarity=0.323 Sum_probs=197.5
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
.++|...+.||+|+||.||+|... +|+.||||+++... .....+.+.+|++++++++||||+++++++..++..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 357889999999999999999865 58999999997542 2223456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccC
Q 041143 703 EYMPHGALSRHLFRWEKL-QLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA 781 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~-~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~ 781 (973)
||++ |+|.+++...... ....+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++..
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 9997 6999998764321 1245899999999999999999999 789999999999999999999999999999865
Q ss_pred CCCCcceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHH-Hh
Q 041143 782 PDGEKSVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKF-KA 859 (973)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 859 (973)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+... ............. ..
T Consensus 159 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~i~~~~~~~~~~~~~~ 235 (317)
T 2pmi_A 159 GIPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLK--LIFDIMGTPNESLWPS 235 (317)
T ss_dssp TSCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HHHHHHCSCCTTTCGG
T ss_pred CCCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH--HHHHHhCCCChhHhhh
Confidence 43221 2334578999999999876 468999999999999999999999998766433211 1111110000000 00
Q ss_pred -----hcCccccC--Ccc---------cHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcC
Q 041143 860 -----AIDPALEV--NEE---------TFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWR 911 (973)
Q Consensus 860 -----~~~~~l~~--~~~---------~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~ 911 (973)
...+.+.. ... .......+.+++.+|++.||++|||+.|+++ ++++.++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~--hp~f~~~~ 301 (317)
T 2pmi_A 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH--HPWFAEYY 301 (317)
T ss_dssp GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT--SGGGGGGC
T ss_pred hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC--Chhhhccc
Confidence 00000000 000 0011235889999999999999999999998 77776544
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=367.75 Aligned_cols=251 Identities=23% Similarity=0.335 Sum_probs=203.0
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCC-CChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGV-TTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
++|...+.||+|+||.||+|+.. +++.||+|++.... ......+.+.+|+++++.++|||||++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 67899999999999999999875 58899999986431 11223467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++|+|..++.. ...+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 95 e~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQ-----NVHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp CCCTTEEHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred ecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 99999999999865 246899999999999999999999 8899999999999999999999999999998664
Q ss_pred CCCcceecccccccCccccccccc---CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHh
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVM---GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKA 859 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (973)
... .....+||+.|+|||++.. ..++.++|||||||++|||++|+.||..........+...+ ...
T Consensus 167 ~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~---~~~------ 235 (384)
T 4fr4_A 167 RET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF---ETT------ 235 (384)
T ss_dssp TTC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH---HHC------
T ss_pred CCC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH---hhc------
Confidence 432 3455789999999999864 45899999999999999999999999865433322221111 110
Q ss_pred hcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCC-HhHHHH
Q 041143 860 AIDPALEVNEETFESISIVAELAGHCTAREPYHRPD-MGHVVN 901 (973)
Q Consensus 860 ~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-~~~v~~ 901 (973)
...+. ......+.+++.+|++.||.+||+ +.+|.+
T Consensus 236 --~~~~p-----~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 236 --VVTYP-----SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp --CCCCC-----TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred --ccCCC-----CcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 00010 111245789999999999999998 666665
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=389.07 Aligned_cols=259 Identities=30% Similarity=0.472 Sum_probs=211.4
Q ss_pred hcCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
.++|...+.||+|+||.||+|.+.++..||||+++..... .++|.+|+++|++++|||||++++++.+ +..++|||
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 4678888999999999999999988888999999765322 4578999999999999999999999876 67899999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+++|+|.+++.... ...+++.+++.|+.||++||+||| +++|+||||||+|||+++++.+||+|||+++....
T Consensus 342 ~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 342 YMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp CCTTEEHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred hhcCCcHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 999999999997532 245899999999999999999999 78999999999999999999999999999986543
Q ss_pred CCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcC
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (973)
..........++..|+|||++....++.++|||||||++|||++ |+.||......+.. ..+.. ...
T Consensus 416 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~------~~i~~-------~~~ 482 (535)
T 2h8h_A 416 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL------DQVER-------GYR 482 (535)
T ss_dssp HHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHH------HHHHT-------TCC
T ss_pred CceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH------HHHHc-------CCC
Confidence 22222233457889999999999999999999999999999999 99999876543211 11111 011
Q ss_pred ccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhc
Q 041143 863 PALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKW 910 (973)
Q Consensus 863 ~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~ 910 (973)
... .......+.+|+.+||+.||++||++.+|++.|+.+....
T Consensus 483 ~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 483 MPC-----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp CCC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred CCC-----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 111 1112345789999999999999999999999999887643
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=360.09 Aligned_cols=269 Identities=25% Similarity=0.400 Sum_probs=206.2
Q ss_pred HHHHHhcCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc--CCCceeeeeeEEEeC-
Q 041143 619 VLRKVTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV--RHRHLVSLLGYSIEG- 695 (973)
Q Consensus 619 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~- 695 (973)
..+...++|...+.||+|+||.||+|+.. |+.||||++... . ...+.+|.+++... +||||+++++++...
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---E--EASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---G--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred cccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---c--cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 33456689999999999999999999887 899999998643 1 23445566666554 899999999999987
Q ss_pred ---CeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccC--------CeeeccCCCCcEEE
Q 041143 696 ---NERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQ--------TFIHRDLKSSNILL 764 (973)
Q Consensus 696 ---~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~--------~ivH~Dikp~Nill 764 (973)
...++||||+++|+|.+++.. ..+++.+++.++.|++.||+||| .. +|+||||||+|||+
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill 175 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKS------TTLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILV 175 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEE
T ss_pred CCCCceEEEEeccCCCcHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEE
Confidence 788999999999999999965 45899999999999999999999 66 99999999999999
Q ss_pred CCCCCEEEeeccccccCCCCCcce---ecccccccCcccccccccCcCCCc------hhHHhHHHHHHHHHhC-------
Q 041143 765 DDDYRAKVSDFGLVKLAPDGEKSV---VTRLAGTFGYLAPEYAVMGKITTK------ADVFSYGVVLMELLTG------- 828 (973)
Q Consensus 765 ~~~~~~kl~DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------~Dv~S~Gvvl~elltg------- 828 (973)
+.++.+||+|||+++......... .....||+.|+|||++.+..++.+ +|||||||++|||++|
T Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~ 255 (337)
T 3mdy_A 176 KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV 255 (337)
T ss_dssp CTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccc
Confidence 999999999999997554332221 224579999999999987766665 9999999999999999
Q ss_pred ---CCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHH
Q 041143 829 ---LAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSP 905 (973)
Q Consensus 829 ---~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~ 905 (973)
+.||.......... .. .... .......+.+............+.+++.+|++.||++||++.||++.|+.
T Consensus 256 ~~~~~p~~~~~~~~~~~-~~-~~~~-----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 328 (337)
T 3mdy_A 256 EEYQLPYHDLVPSDPSY-ED-MREI-----VCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328 (337)
T ss_dssp CCCCCTTTTTSCSSCCH-HH-HHHH-----HTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred ccccccHhhhcCCCCch-hh-hHHH-----HhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHH
Confidence 66665443222110 00 0000 00111122222111223566778999999999999999999999999999
Q ss_pred hhhh
Q 041143 906 LVEK 909 (973)
Q Consensus 906 ~~~~ 909 (973)
+.+.
T Consensus 329 l~~~ 332 (337)
T 3mdy_A 329 MSES 332 (337)
T ss_dssp HHHT
T ss_pred HHhh
Confidence 9774
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=352.27 Aligned_cols=254 Identities=32% Similarity=0.593 Sum_probs=202.6
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHH-----HHHHHHHHHHHhcCCCceeeeeeEEEeCCeE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKAL-----DEFQSEIAVLSKVRHRHLVSLLGYSIEGNER 698 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~-----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 698 (973)
++|...+.||+|+||.||+|++. +++.||||++.......... +.+.+|++++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 67888999999999999999874 78999999986543222211 67899999999999999999999987655
Q ss_pred EEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCC--eeeccCCCCcEEECCCCC-----EE
Q 041143 699 LLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQT--FIHRDLKSSNILLDDDYR-----AK 771 (973)
Q Consensus 699 ~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~--ivH~Dikp~Nill~~~~~-----~k 771 (973)
++||||+++|+|.+++.. ....+++..++.++.|++.||+||| +++ |+||||||+||+++.++. +|
T Consensus 97 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLD----KAHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp EEEEECCTTCBHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred eEEEEecCCCCHHHHHhc----ccCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEE
Confidence 799999999999998864 2356899999999999999999999 777 999999999999988776 99
Q ss_pred EeeccccccCCCCCcceecccccccCccccccc--ccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHH
Q 041143 772 VSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYA--VMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWR 849 (973)
Q Consensus 772 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 849 (973)
|+|||+++.... ......||+.|+|||++ ....++.++|||||||++|||++|+.||............ .
T Consensus 170 l~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~----~ 241 (287)
T 4f0f_A 170 VADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFIN----M 241 (287)
T ss_dssp ECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHH----H
T ss_pred eCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHH----H
Confidence 999999985433 23446799999999998 3556789999999999999999999999866543321111 1
Q ss_pred HhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHh
Q 041143 850 IKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPL 906 (973)
Q Consensus 850 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~ 906 (973)
.. .....+.+. ......+.+++.+|++.||++||++.||++.|+++
T Consensus 242 ~~------~~~~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 242 IR------EEGLRPTIP-----EDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HH------HSCCCCCCC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred Hh------ccCCCCCCC-----cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 10 011111111 11224578999999999999999999999998753
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=358.13 Aligned_cols=267 Identities=27% Similarity=0.404 Sum_probs=205.0
Q ss_pred HhcCccccCcccccCccEEEEEEEC----CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCe-
Q 041143 623 VTQNFAQENELGRGGFGTVYKGELE----DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNE- 697 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~- 697 (973)
..++|...+.||+|+||.||+|... .+..||||+++.........+.+.+|++++++++||||+++++++.+.+.
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 3468889999999999999999764 34589999998665566777889999999999999999999999987553
Q ss_pred ----EEEEEEecCCCCHHHHHHhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEE
Q 041143 698 ----RLLVYEYMPHGALSRHLFRWEK-LQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKV 772 (973)
Q Consensus 698 ----~~lV~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl 772 (973)
.++||||+++|+|.+++..... .....+++.+++.++.||++||+||| +++|+||||||+||+++.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEE
Confidence 4999999999999999865322 23356999999999999999999999 889999999999999999999999
Q ss_pred eeccccccCCCCCc-ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHH
Q 041143 773 SDFGLVKLAPDGEK-SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRI 850 (973)
Q Consensus 773 ~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 850 (973)
+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||......+... ..
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~------~~ 262 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYD------YL 262 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH------HH
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH------HH
Confidence 99999986543321 12233467889999999999999999999999999999999 899998765432211 11
Q ss_pred hhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhc
Q 041143 851 KSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKW 910 (973)
Q Consensus 851 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~ 910 (973)
.. ...+.. .......+.+++.+|++.||.+||++.++++.|+.+.+..
T Consensus 263 ~~-------~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 263 LH-------GHRLKQ-----PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp HT-------TCCCCC-----BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred Hc-------CCCCCC-----CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 10 001111 1112245889999999999999999999999999998754
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=364.27 Aligned_cols=260 Identities=23% Similarity=0.313 Sum_probs=198.0
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
++|...+.||+|+||.||+|+.. +++.||||++...... .+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS---CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc---cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 67999999999999999999876 6899999999764322 2467899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCC--EEEeeccccccC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYR--AKVSDFGLVKLA 781 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~--~kl~DfGla~~~ 781 (973)
|+++|+|.+++.. ...+++..+..++.|++.||+||| +++|+||||||+||+++.++. +||+|||+++..
T Consensus 97 ~~~~~~L~~~l~~-----~~~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 97 YASGGELYERICN-----AGRFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168 (361)
T ss_dssp CCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred eCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence 9999999999865 245899999999999999999999 889999999999999987765 999999999843
Q ss_pred CCCCcceecccccccCcccccccccCcCCCc-hhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhh
Q 041143 782 PDGEKSVVTRLAGTFGYLAPEYAVMGKITTK-ADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAA 860 (973)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (973)
.... ......||+.|+|||++.+..++.+ +|||||||++|||++|+.||........ ....+..+
T Consensus 169 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~~~~---------- 234 (361)
T 3uc3_A 169 VLHS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTIQRI---------- 234 (361)
T ss_dssp --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHHHHH----------
T ss_pred cccC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHHHHH----------
Confidence 3221 2334579999999999988887765 8999999999999999999976543211 11111111
Q ss_pred cCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCC
Q 041143 861 IDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRP 912 (973)
Q Consensus 861 ~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~ 912 (973)
......... .......+.+++.+|++.||++|||+.|+++ ++++.++.+
T Consensus 235 ~~~~~~~~~-~~~~s~~~~~li~~~L~~dP~~Rps~~ell~--hp~f~~~~~ 283 (361)
T 3uc3_A 235 LSVKYSIPD-DIRISPECCHLISRIFVADPATRISIPEIKT--HSWFLKNLP 283 (361)
T ss_dssp HTTCCCCCT-TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT--SHHHHTTCC
T ss_pred hcCCCCCCC-cCCCCHHHHHHHHHHccCChhHCcCHHHHHh--CcchhcCCc
Confidence 111111000 0011245779999999999999999999998 777765443
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=363.60 Aligned_cols=251 Identities=25% Similarity=0.329 Sum_probs=206.6
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
++|...+.||+|+||.||+|+.. +|+.||||+++.... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 67899999999999999999875 689999999864311 1123467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++|+|.+++... ..+++.++..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 121 e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp ECCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred cCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceecc
Confidence 999999999999752 45899999999999999999999 8899999999999999999999999999998654
Q ss_pred CCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcC
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (973)
.. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+. +..+...
T Consensus 193 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~------~~~i~~~--------- 253 (350)
T 1rdq_E 193 GR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI------YEKIVSG--------- 253 (350)
T ss_dssp SC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHC---------
T ss_pred CC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHH------HHHHHcC---------
Confidence 32 2346799999999999999999999999999999999999999987653221 1112111
Q ss_pred ccccCCcccHHHHHHHHHHHHHhhccCCCCCCC-----HhHHHHHHHHhhh
Q 041143 863 PALEVNEETFESISIVAELAGHCTAREPYHRPD-----MGHVVNVLSPLVE 908 (973)
Q Consensus 863 ~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~~v~~~L~~~~~ 908 (973)
.+.... .....+.+++.+|++.||.+||+ +.||++ +++.+
T Consensus 254 -~~~~p~---~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~--h~~f~ 298 (350)
T 1rdq_E 254 -KVRFPS---HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN--HKWFA 298 (350)
T ss_dssp -CCCCCT---TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT--SGGGT
T ss_pred -CCCCCC---CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh--CcCcC
Confidence 111111 11244779999999999999998 888876 55543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=351.72 Aligned_cols=268 Identities=24% Similarity=0.373 Sum_probs=204.7
Q ss_pred cCccccCcccccCccEEEEEEE-CCCCEEEEEEeecC-CCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAG-VTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
++|...+.||+|+||.||+|.. .+|+.||||+++.. .......+.+.+|++++++++||||+++++++...+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 5789999999999999999986 47899999999753 234556778999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++|+|.+++..... ....+++..++.++.||++||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 112 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKK-QKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp ECCCSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred ecCCCCCHHHHHHHhcc-cccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 99999999999976433 2356899999999999999999999 7899999999999999999999999999998654
Q ss_pred CCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcC
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (973)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .....+. ....
T Consensus 188 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~-------~~~~ 255 (310)
T 2wqm_A 188 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY----SLCKKIE-------QCDY 255 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH----HHHHHHH-------TTCS
T ss_pred CCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH----HHHHHhh-------cccC
Confidence 3221 22345789999999999999999999999999999999999999975432111 1111111 1111
Q ss_pred ccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCC
Q 041143 863 PALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRP 912 (973)
Q Consensus 863 ~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~ 912 (973)
+..... .....+.+++.+|++.||++||++.+|++.|+++...+..
T Consensus 256 ~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 256 PPLPSD----HYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp CCCCTT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred CCCccc----ccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 111101 1123578999999999999999999999999999887654
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=366.53 Aligned_cols=270 Identities=15% Similarity=0.214 Sum_probs=210.3
Q ss_pred cCccccCcccccCccEEEEEEECC---------CCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceee--------
Q 041143 625 QNFAQENELGRGGFGTVYKGELED---------GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVS-------- 687 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------- 687 (973)
++|...+.||+|+||.||+|+... ++.||||++... +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 688999999999999999998763 789999998753 35789999999999999988
Q ss_pred -------eeeEEEe-CCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCC
Q 041143 688 -------LLGYSIE-GNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKS 759 (973)
Q Consensus 688 -------l~~~~~~-~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp 759 (973)
+++++.. +...++||||+ +|+|.+++.... ...+++.+++.++.||+.||+||| +++|+||||||
T Consensus 115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp 187 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP---KHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTA 187 (352)
T ss_dssp TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCG
T ss_pred CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC---cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCH
Confidence 6778776 67889999999 999999997632 256899999999999999999999 78999999999
Q ss_pred CcEEECCCC--CEEEeeccccccCCCCCc------ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCC
Q 041143 760 SNILLDDDY--RAKVSDFGLVKLAPDGEK------SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAA 831 (973)
Q Consensus 760 ~Nill~~~~--~~kl~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p 831 (973)
+||+++.++ .+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 188 ~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 267 (352)
T 2jii_A 188 ENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267 (352)
T ss_dssp GGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred HHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 999999998 999999999985543211 112345799999999999999999999999999999999999999
Q ss_pred CCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcC
Q 041143 832 LDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWR 911 (973)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~ 911 (973)
|........ .+......... ......+.... .......+.+++.+|++.||++||++.+|++.|+.+.++..
T Consensus 268 f~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 268 WTNCLPNTE-DIMKQKQKFVD---KPGPFVGPCGH----WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp TGGGTTCHH-HHHHHHHHHHH---SCCCEECTTSC----EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred cccCCcCHH-HHHHHHHhccC---Chhhhhhhccc----cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 986542221 11111111110 00111111100 00112458899999999999999999999999999998766
Q ss_pred CCCCC
Q 041143 912 PITDE 916 (973)
Q Consensus 912 ~~~~~ 916 (973)
...+.
T Consensus 340 ~~~~~ 344 (352)
T 2jii_A 340 VSPYD 344 (352)
T ss_dssp CCTTS
T ss_pred CCcCc
Confidence 54433
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=352.93 Aligned_cols=259 Identities=26% Similarity=0.376 Sum_probs=202.9
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
.++|...+.||+|+||.||+|+.. ++..||+|++.... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR-SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG-CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc-cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 467999999999999999999875 68899999987643 2233567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEE---CCCCCEEEeeccccc
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILL---DDDYRAKVSDFGLVK 779 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill---~~~~~~kl~DfGla~ 779 (973)
||+++|+|.+++...... ...+++..+..++.|+++||+||| +.+|+||||||+||++ +.++.+||+|||+++
T Consensus 100 e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 100 ETCEGGELLERIVSAQAR-GKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp CCCSCCBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EeCCCCcHHHHHHhhhhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 999999999999764332 367999999999999999999999 7899999999999999 456889999999998
Q ss_pred cCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHh
Q 041143 780 LAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKA 859 (973)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (973)
...... ......||+.|+|||++. +.++.++|||||||++|||++|+.||......+... ...
T Consensus 176 ~~~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~------~~~-------- 238 (285)
T 3is5_A 176 LFKSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQ------KAT-------- 238 (285)
T ss_dssp C------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHH--------
T ss_pred ecCCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHh------hhc--------
Confidence 654332 234567999999999875 578999999999999999999999998765432211 000
Q ss_pred hcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 860 AIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 860 ~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
...+..... .......+.+++.+|++.||++||++.||++ +++++
T Consensus 239 ~~~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~--hp~f~ 283 (285)
T 3is5_A 239 YKEPNYAVE--CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH--HEWFK 283 (285)
T ss_dssp HCCCCCCC----CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT--SGGGG
T ss_pred cCCcccccc--cCcCCHHHHHHHHHHccCChhhCcCHHHHhc--CHHhh
Confidence 011111100 0011245779999999999999999999997 55543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=359.23 Aligned_cols=259 Identities=28% Similarity=0.467 Sum_probs=204.5
Q ss_pred cCccccCcccccCccEEEEEEECC-----CCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELED-----GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERL 699 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 699 (973)
.+|...+.||+|+||.||+|.... +..||||+++... .......+.+|++++++++||||+++++++...+..+
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 567778999999999999997653 2359999997542 4555678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccc
Q 041143 700 LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK 779 (973)
Q Consensus 700 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~ 779 (973)
+||||+++|+|.+++... ...+++.+++.++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 123 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 123 IITEYMENGALDKFLREK----DGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp EEEECCTTEEHHHHHHHT----TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred EEEeCCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcch
Confidence 999999999999999652 246899999999999999999999 7899999999999999999999999999998
Q ss_pred cCCCCCcc--eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhH
Q 041143 780 LAPDGEKS--VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEK 856 (973)
Q Consensus 780 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (973)
........ ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+. . ..+..
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~---~---~~~~~---- 265 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV---M---KAIND---- 265 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---H---HHHHT----
T ss_pred hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHH---H---HHHHC----
Confidence 65433221 1223356889999999998999999999999999999999 9999976653221 1 11111
Q ss_pred HHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 857 FKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 857 ~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
...... .......+.+++.+|++.||++||++.+|++.|+.+.+.
T Consensus 266 ---~~~~~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 266 ---GFRLPT-----PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp ---TCCCCC-----CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ---CCcCCC-----cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 001111 111234578999999999999999999999999998874
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=361.90 Aligned_cols=257 Identities=27% Similarity=0.449 Sum_probs=202.6
Q ss_pred cCccccCcccccCccEEEEEEEC-CCC----EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGT----KIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERL 699 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 699 (973)
++|...+.||+|+||.||+|++. +++ +||+|.+.... .....+.+.+|+.++++++||||+++++++. ++..+
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 57888999999999999999864 344 37888775432 2223346788999999999999999999986 45689
Q ss_pred EEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccc
Q 041143 700 LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK 779 (973)
Q Consensus 700 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~ 779 (973)
+||||+++|+|.+++... ...+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 91 ~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 163 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQH----RGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVAD 163 (325)
T ss_dssp EEEECCTTCBSHHHHHSS----GGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred EEEEeCCCCCHHHHHHHc----cccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCccc
Confidence 999999999999999652 246899999999999999999999 7899999999999999999999999999998
Q ss_pred cCCCCCc-ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHH
Q 041143 780 LAPDGEK-SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKF 857 (973)
Q Consensus 780 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (973)
....... .......||..|+|||++.+..++.++|||||||++|||++ |+.||......+..... ...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~------~~~---- 233 (325)
T 3kex_A 164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL------EKG---- 233 (325)
T ss_dssp GSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHH------HTT----
T ss_pred ccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHH------HcC----
Confidence 6654332 23345678889999999999999999999999999999999 99999876543321111 100
Q ss_pred HhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 858 KAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 858 ~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
.....+.. ....+.+++.+|++.||++||++.||++.|+.+.+
T Consensus 234 ~~~~~~~~--------~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 234 ERLAQPQI--------CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp CBCCCCTT--------BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred CCCCCCCc--------CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 00000100 11236689999999999999999999999998865
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=372.87 Aligned_cols=282 Identities=22% Similarity=0.292 Sum_probs=197.3
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeC-----Ce
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEG-----NE 697 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 697 (973)
.++|...+.||+|+||.||+|... +|+.||||++..........+.+.+|++++++++|||||++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 368999999999999999999765 689999999977656667778899999999999999999999998543 56
Q ss_pred EEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccc
Q 041143 698 RLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL 777 (973)
Q Consensus 698 ~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGl 777 (973)
.|+||||+ +|+|.+++.. ...+++..+..++.||++||+||| +.+||||||||+|||++.++.+||+|||+
T Consensus 132 ~~lv~e~~-~~~L~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGl 202 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRT-----PVYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGL 202 (458)
T ss_dssp EEEEECCC-SEEHHHHHHS-----SCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEecc-ccchhhhccc-----CCCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeeccccc
Confidence 89999998 6799988854 256899999999999999999999 78999999999999999999999999999
Q ss_pred cccCCCCCc--------------------------ceecccccccCccccccc-ccCcCCCchhHHhHHHHHHHHHh---
Q 041143 778 VKLAPDGEK--------------------------SVVTRLAGTFGYLAPEYA-VMGKITTKADVFSYGVVLMELLT--- 827 (973)
Q Consensus 778 a~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~S~Gvvl~ellt--- 827 (973)
|+....... ...+..+||+.|+|||++ ....++.++|||||||++|||++
T Consensus 203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~ 282 (458)
T 3rp9_A 203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK 282 (458)
T ss_dssp CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTST
T ss_pred chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcc
Confidence 986542211 123456789999999986 45679999999999999999999
Q ss_pred --------CCCCCCCCChhh-----------------HHHHHHHHHHHhhc--hh--------HHH---hhcCcccc--C
Q 041143 828 --------GLAALDEERPEE-----------------SRYLAEWFWRIKSS--KE--------KFK---AAIDPALE--V 867 (973)
Q Consensus 828 --------g~~p~~~~~~~~-----------------~~~~~~~~~~~~~~--~~--------~~~---~~~~~~l~--~ 867 (973)
|+++|.+..... .......+...... .+ ... ..+..... .
T Consensus 283 ~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (458)
T 3rp9_A 283 ENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDL 362 (458)
T ss_dssp TTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCG
T ss_pred ccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCH
Confidence 666665433100 00000001100000 00 000 00000000 0
Q ss_pred CcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCCCCCC
Q 041143 868 NEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPITDE 916 (973)
Q Consensus 868 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~~~~~ 916 (973)
..........+.+|+.+||+.||++|||+.|+++ +++++.+.....+
T Consensus 363 ~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~--Hp~f~~~~~~~~e 409 (458)
T 3rp9_A 363 AERFPASSADAIHLLKRMLVFNPNKRITINECLA--HPFFKEVRIAEVE 409 (458)
T ss_dssp GGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH--SGGGTTTCCGGGC
T ss_pred HHHCCCCCHHHHHHHHHHhccCccccCCHHHHhc--CHhhhhcCCCccC
Confidence 0000112345789999999999999999999999 8888876544443
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=365.08 Aligned_cols=253 Identities=27% Similarity=0.379 Sum_probs=200.2
Q ss_pred cccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEecC
Q 041143 628 AQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMP 706 (973)
Q Consensus 628 ~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 706 (973)
...+.||+|+||.||+|... +|+.||+|+++.. .....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 169 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR--GMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVD 169 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEccc--ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCC
Confidence 33578999999999999874 6899999999764 44566789999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEE--CCCCCEEEeeccccccCCCC
Q 041143 707 HGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILL--DDDYRAKVSDFGLVKLAPDG 784 (973)
Q Consensus 707 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill--~~~~~~kl~DfGla~~~~~~ 784 (973)
+|+|.+++... ...+++..+..++.||++||+||| +.+|+||||||+|||+ +.++.+||+|||+++.....
T Consensus 170 ~~~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~ 242 (373)
T 2x4f_A 170 GGELFDRIIDE----SYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR 242 (373)
T ss_dssp TCEEHHHHHHT----GGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT
T ss_pred CCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc
Confidence 99999988652 245899999999999999999999 7899999999999999 66789999999999866543
Q ss_pred CcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCcc
Q 041143 785 EKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPA 864 (973)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 864 (973)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+. +..+.... .+.
T Consensus 243 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~------~~~i~~~~------~~~- 307 (373)
T 2x4f_A 243 EK--LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET------LNNILACR------WDL- 307 (373)
T ss_dssp CB--CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHHTC------CCS-
T ss_pred cc--cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhcc------CCC-
Confidence 32 3345799999999999988999999999999999999999999987653321 11111100 000
Q ss_pred ccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 865 LEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 865 l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
. ..........+.+++.+|++.||++||++.|+++ ++++.
T Consensus 308 -~-~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~--hp~~~ 347 (373)
T 2x4f_A 308 -E-DEEFQDISEEAKEFISKLLIKEKSWRISASEALK--HPWLS 347 (373)
T ss_dssp -C-SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH--SHHHH
T ss_pred -C-hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc--CcCcC
Confidence 0 0000112245789999999999999999999998 55554
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=359.56 Aligned_cols=255 Identities=25% Similarity=0.385 Sum_probs=197.4
Q ss_pred hcCccccCcccccCccEEEEEEE----CCCCEEEEEEeecCCC--ChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCe
Q 041143 624 TQNFAQENELGRGGFGTVYKGEL----EDGTKIAVKRMEAGVT--TTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNE 697 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~----~~g~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 697 (973)
.++|...+.||+|+||.||+|+. .+|+.||+|+++.... .......+.+|++++++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 36899999999999999999987 4789999999975422 22345568899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccc
Q 041143 698 RLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL 777 (973)
Q Consensus 698 ~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGl 777 (973)
.++||||+++|+|.+++... ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 167 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE-----GIFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGL 167 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred EEEEEeCCCCCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCc
Confidence 99999999999999999652 45889999999999999999999 78999999999999999999999999999
Q ss_pred cccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHH
Q 041143 778 VKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKF 857 (973)
Q Consensus 778 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (973)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. +..+...
T Consensus 168 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------~~~i~~~---- 236 (327)
T 3a62_A 168 CKESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT------IDKILKC---- 236 (327)
T ss_dssp C-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHT----
T ss_pred ccccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH------HHHHHhC----
Confidence 98543222 223456799999999999999999999999999999999999999987653221 1111111
Q ss_pred HhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCC-----CHhHHHHHHHHhhh
Q 041143 858 KAAIDPALEVNEETFESISIVAELAGHCTAREPYHRP-----DMGHVVNVLSPLVE 908 (973)
Q Consensus 858 ~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~~v~~~L~~~~~ 908 (973)
...... .....+.+++.+|++.||++|| ++.|+++ +++++
T Consensus 237 ------~~~~p~---~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~--hp~f~ 281 (327)
T 3a62_A 237 ------KLNLPP---YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA--HPFFR 281 (327)
T ss_dssp ------CCCCCT---TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH--SGGGS
T ss_pred ------CCCCCC---CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc--CCccc
Confidence 111000 1124577999999999999999 6777777 55554
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=351.53 Aligned_cols=259 Identities=24% Similarity=0.360 Sum_probs=206.4
Q ss_pred hcCccccCcccccCccEEEEEEECC----CCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELED----GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERL 699 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 699 (973)
.++|...+.||+|+||.||+|.+.. +..||||+++.. ......+.+.+|++++++++||||+++++++.+ +..+
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD-CTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTT-SCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccc-cCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 4678899999999999999997643 235999998764 245566789999999999999999999999765 4568
Q ss_pred EEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccc
Q 041143 700 LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK 779 (973)
Q Consensus 700 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~ 779 (973)
+||||+++|+|.+++... ...+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++
T Consensus 89 ~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 161 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERN----KNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSR 161 (281)
T ss_dssp EEEECCTTCBHHHHHHHH----TTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred EEEecCCCCCHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCc
Confidence 999999999999999652 245899999999999999999999 8899999999999999999999999999998
Q ss_pred cCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHH
Q 041143 780 LAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFK 858 (973)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (973)
..............+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+... .+ .
T Consensus 162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~---~~---~------- 228 (281)
T 3cc6_A 162 YIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIG---VL---E------- 228 (281)
T ss_dssp CC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHH---HH---H-------
T ss_pred ccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHH---HH---h-------
Confidence 665443333344567889999999998999999999999999999998 999997655433211 11 0
Q ss_pred hhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 859 AAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 859 ~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
........ ......+.+++.+|++.||++||++.|+++.|+.+.+.
T Consensus 229 ~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 229 KGDRLPKP-----DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp HTCCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCCCCCC-----CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 00000000 01124478999999999999999999999999988764
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=348.05 Aligned_cols=269 Identities=21% Similarity=0.276 Sum_probs=210.2
Q ss_pred hcCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEE-EeCCeEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYS-IEGNERLLV 701 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lV 701 (973)
.++|...+.||+|+||.||+|+. .+|+.||||++...... +.+.+|+++++.++|++++..++++ ...+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence 46899999999999999999986 57899999998754322 3588999999999988877666655 567788999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEE---CCCCCEEEeecccc
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILL---DDDYRAKVSDFGLV 778 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill---~~~~~~kl~DfGla 778 (973)
|||+ +|+|.+++... ...+++.++..++.||+.||+||| +++|+||||||+||++ +.++.+||+|||++
T Consensus 84 ~e~~-~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 155 (296)
T 3uzp_A 84 MELL-GPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp EECC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred EEec-CCCHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCc
Confidence 9999 99999999642 246899999999999999999999 8899999999999999 48899999999999
Q ss_pred ccCCCCCcc------eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhh
Q 041143 779 KLAPDGEKS------VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKS 852 (973)
Q Consensus 779 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 852 (973)
+........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (296)
T 3uzp_A 156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 235 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc
Confidence 865443221 12446799999999999999999999999999999999999999986543221111111111000
Q ss_pred chhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCCCCC
Q 041143 853 SKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPITD 915 (973)
Q Consensus 853 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~~~~ 915 (973)
.... ..+.+. ....+.+++.+|++.||++||++.+|++.|+.+.++.....+
T Consensus 236 -~~~~-~~~~~~---------~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~ 287 (296)
T 3uzp_A 236 -STPI-EVLCKG---------YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD 287 (296)
T ss_dssp -HSCH-HHHTTT---------SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSS
T ss_pred -CCch-HHHHhh---------CCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccc
Confidence 0000 000111 123478999999999999999999999999999887655443
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=350.34 Aligned_cols=269 Identities=21% Similarity=0.277 Sum_probs=206.5
Q ss_pred HHhcCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEE-EeCCeEE
Q 041143 622 KVTQNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYS-IEGNERL 699 (973)
Q Consensus 622 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~ 699 (973)
...++|...+.||+|+||.||+|+. .+++.||||++.... ..+.+.+|+++++.++|++++..++++ ...+..+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc----cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence 3457899999999999999999986 568899999875432 223578899999999988877776665 5677889
Q ss_pred EEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEE---CCCCCEEEeecc
Q 041143 700 LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILL---DDDYRAKVSDFG 776 (973)
Q Consensus 700 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill---~~~~~~kl~DfG 776 (973)
+||||+ +|+|.+++... ...+++.++..++.||+.||+||| +++|+||||||+||++ +.++.+||+|||
T Consensus 82 lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg 153 (296)
T 4hgt_A 82 MVMELL-GPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFG 153 (296)
T ss_dssp EEEECC-CCBHHHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCT
T ss_pred EEEEcc-CCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCc
Confidence 999999 99999998642 246899999999999999999999 7899999999999999 788999999999
Q ss_pred ccccCCCCCc------ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHH
Q 041143 777 LVKLAPDGEK------SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRI 850 (973)
Q Consensus 777 la~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 850 (973)
+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+...
T Consensus 154 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 233 (296)
T 4hgt_A 154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK 233 (296)
T ss_dssp TCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH
T ss_pred cceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcc
Confidence 9986544322 1223467999999999999999999999999999999999999999865433221111111110
Q ss_pred hhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCCC
Q 041143 851 KSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPI 913 (973)
Q Consensus 851 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~~ 913 (973)
.. .... ..+... ....+.+++.+|++.||++||++.+|++.|+.+.++....
T Consensus 234 ~~-~~~~-~~~~~~---------~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~ 285 (296)
T 4hgt_A 234 KM-STPI-EVLCKG---------YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp HH-HSCH-HHHTTT---------SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred cc-cchh-hhhhcc---------CCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCC
Confidence 00 0000 000011 1235789999999999999999999999999998876543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=366.29 Aligned_cols=255 Identities=17% Similarity=0.197 Sum_probs=209.1
Q ss_pred hcCccccCcccccCccEEEEEE------ECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcC---CCceeeeeeEEEe
Q 041143 624 TQNFAQENELGRGGFGTVYKGE------LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR---HRHLVSLLGYSIE 694 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~------~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~ 694 (973)
.++|...+.||+|+||.||+|. ..+++.||||+++.. . ..++.+|++++++++ |+||+++++++..
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--N---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--C---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--C---hhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 4678899999999999999994 456889999998653 2 346788888888887 9999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECC--------
Q 041143 695 GNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDD-------- 766 (973)
Q Consensus 695 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~-------- 766 (973)
.+..++||||+++|+|.+++..........++|..++.|+.||++||+||| +++||||||||+|||++.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCcccc
Confidence 999999999999999999998765555577999999999999999999999 889999999999999998
Q ss_pred ---CCCEEEeeccccccCC-CCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHH
Q 041143 767 ---DYRAKVSDFGLVKLAP-DGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRY 842 (973)
Q Consensus 767 ---~~~~kl~DfGla~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~ 842 (973)
++.+||+|||+|+... ..........+||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--- 292 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--- 292 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE---
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc---
Confidence 8999999999997432 222334556789999999999999999999999999999999999999986432210
Q ss_pred HHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCC-CCHhHHHHHHHHhhhh
Q 041143 843 LAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHR-PDMGHVVNVLSPLVEK 909 (973)
Q Consensus 843 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~R-Ps~~~v~~~L~~~~~~ 909 (973)
.. +...+... . ....+.+++..|++.+|.+| |+++++.+.|+.+.++
T Consensus 293 ------------~~----~~~~~~~~-~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 293 ------------CK----PEGLFRRL-P---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp ------------EE----ECSCCTTC-S---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ------------ee----echhcccc-C---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 00 11111101 1 12346688999999999998 5888899999988875
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=363.46 Aligned_cols=257 Identities=21% Similarity=0.316 Sum_probs=208.3
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
.++|...+.||+|+||.||+|... +|+.||+|++... .......+.+|++++++++||||+++++++.+.+..++||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 127 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 127 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc--chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence 468999999999999999999875 6899999998754 3445567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECC--CCCEEEeecccccc
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDD--DYRAKVSDFGLVKL 780 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~--~~~~kl~DfGla~~ 780 (973)
||+++|+|.+++.. ....+++.++..++.||+.||+||| +++|+||||||+|||++. ++.+||+|||+++.
T Consensus 128 E~~~gg~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~ 200 (387)
T 1kob_A 128 EFLSGGELFDRIAA----EDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATK 200 (387)
T ss_dssp ECCCCCBHHHHTTC----TTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred EcCCCCcHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEeccccee
Confidence 99999999998854 1246899999999999999999999 789999999999999974 47899999999986
Q ss_pred CCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhh
Q 041143 781 APDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAA 860 (973)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (973)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ...+..... .
T Consensus 201 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~------~~~i~~~~~----~ 268 (387)
T 1kob_A 201 LNPDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET------LQNVKRCDW----E 268 (387)
T ss_dssp CCTTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHHHHHCCC----C
T ss_pred cCCCc--ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH------HHHHHhCCC----C
Confidence 65432 23345799999999999999999999999999999999999999987653221 111111000 0
Q ss_pred cCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 861 IDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 861 ~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
+++.. .......+.+++.+|++.||++||++.|+++ +++++
T Consensus 269 ~~~~~-----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~--hp~~~ 309 (387)
T 1kob_A 269 FDEDA-----FSSVSPEAKDFIKNLLQKEPRKRLTVHDALE--HPWLK 309 (387)
T ss_dssp CCSST-----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT--STTTS
T ss_pred CCccc-----cccCCHHHHHHHHHHcCCChhHCcCHHHHhh--Ccccc
Confidence 11110 0112245789999999999999999999998 55543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=358.04 Aligned_cols=255 Identities=23% Similarity=0.363 Sum_probs=196.8
Q ss_pred hcCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCe----
Q 041143 624 TQNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNE---- 697 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 697 (973)
.++|...+.||+|+||.||+|+. .+++.||||+++.... .......+.+|++++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 36899999999999999999986 5689999999976532 34556789999999999999999999999876543
Q ss_pred EEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccc
Q 041143 698 RLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL 777 (973)
Q Consensus 698 ~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGl 777 (973)
.++||||+++|+|.+++... ..+++.++..++.||+.||+||| +++|+||||||+||+++.++.+||+|||+
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 162 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGI 162 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSC
T ss_pred cEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccC
Confidence 49999999999999999652 46899999999999999999999 78999999999999999999999999999
Q ss_pred cccCCCCCc--ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchh
Q 041143 778 VKLAPDGEK--SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKE 855 (973)
Q Consensus 778 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 855 (973)
++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ........
T Consensus 163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~------~~~~~~~~ 236 (311)
T 3ork_A 163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA------YQHVREDP 236 (311)
T ss_dssp C------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHHHHCCC
T ss_pred cccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHhcCCC
Confidence 986543322 1223457999999999999999999999999999999999999999876543211 11111000
Q ss_pred HHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 856 KFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 856 ~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
..+... .......+.+++.+|++.||++||++.++++
T Consensus 237 -----~~~~~~----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 237 -----IPPSAR----HEGLSADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp -----CCHHHH----STTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred -----CCcccc----cCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 000000 0011245779999999999999998777665
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=360.62 Aligned_cols=271 Identities=23% Similarity=0.392 Sum_probs=206.0
Q ss_pred cCccccCcccccCccEEEEEEE-----CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeC--Ce
Q 041143 625 QNFAQENELGRGGFGTVYKGEL-----EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEG--NE 697 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 697 (973)
+.|+..+.||+|+||.||+|++ .+++.||||+++... .....+.+.+|++++++++||||+++++++... ..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 4688889999999999999984 368899999987542 233456789999999999999999999999876 66
Q ss_pred EEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccc
Q 041143 698 RLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL 777 (973)
Q Consensus 698 ~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGl 777 (973)
.++||||+++|+|.+++... ...+++.+++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||+
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKN----KNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHH----TTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred EEEEEEeCCCCcHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECcccc
Confidence 89999999999999999652 245899999999999999999999 78999999999999999999999999999
Q ss_pred cccCCCCCc--ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHh--hc
Q 041143 778 VKLAPDGEK--SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIK--SS 853 (973)
Q Consensus 778 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~ 853 (973)
++....... .......||..|+|||++.+..++.++|||||||++|||++|+.|+....... ........ ..
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~ 248 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALF----LKMIGPTHGQMT 248 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH----HHHHCSCCGGGH
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHH----hhccCCcccccC
Confidence 986654432 22334578899999999999999999999999999999999999864321100 00000000 00
Q ss_pred hhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 854 KEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 854 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
...+...+..... ..........+.+++.+|++.||.+||++.|+++.|+.+++
T Consensus 249 ~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 249 VTRLVNTLKEGKR-LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp HHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred HHHHHHHHhccCC-CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 0000111100000 00111223458899999999999999999999999998753
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=355.50 Aligned_cols=263 Identities=22% Similarity=0.309 Sum_probs=201.4
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLV 701 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 701 (973)
.++|...+.||+|+||.||+|... +++.||||++..... .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 478999999999999999999875 688999999875422 344457899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccC
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA 781 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~ 781 (973)
|||+++++|.+++... ..+++.++..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 113 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ-----GPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASAT 184 (309)
T ss_dssp EECCCCEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred EEecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence 9999999999999752 46899999999999999999999 789999999999999999999999999999865
Q ss_pred CCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhc
Q 041143 782 PDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861 (973)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (973)
............||+.|+|||++.+..++.++||||||+++|||++|+.||....... +.. .+.. ........
T Consensus 185 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~---~~~~-~~~~~~~~ 257 (309)
T 2h34_A 185 TDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV---MGA---HINQ-AIPRPSTV 257 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH---HHH---HHHS-CCCCGGGT
T ss_pred cccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH---HHH---Hhcc-CCCCcccc
Confidence 5443333445679999999999999999999999999999999999999998653221 110 1110 00000011
Q ss_pred CccccCCcccHHHHHHHHHHHHHhhccCCCCCC-CHhHHHHHHHHhhhhc
Q 041143 862 DPALEVNEETFESISIVAELAGHCTAREPYHRP-DMGHVVNVLSPLVEKW 910 (973)
Q Consensus 862 ~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-s~~~v~~~L~~~~~~~ 910 (973)
.+ .....+.+++.+|++.||++|| ++.++++.|+.+....
T Consensus 258 ~~---------~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 258 RP---------GIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp ST---------TCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred CC---------CCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 11 1123477999999999999999 9999999999886643
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=366.70 Aligned_cols=264 Identities=22% Similarity=0.311 Sum_probs=206.8
Q ss_pred HHHhcCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-----CCceeeeeeEEEe
Q 041143 621 RKVTQNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR-----HRHLVSLLGYSIE 694 (973)
Q Consensus 621 ~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~~~~~~ 694 (973)
....++|...+.||+|+||.||+|+. .+++.||||+++. .....+.+..|+++++.++ |||||++++++..
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~ 107 (360)
T 3llt_A 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY 107 (360)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE
T ss_pred eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE
Confidence 34457899999999999999999987 4689999999864 3455667888999999996 9999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECC--------
Q 041143 695 GNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDD-------- 766 (973)
Q Consensus 695 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~-------- 766 (973)
.+..++||||+ +++|.+++.... ...+++.++..++.||+.||+||| +++|+||||||+|||++.
T Consensus 108 ~~~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~~ 180 (360)
T 3llt_A 108 YDHMCLIFEPL-GPSLYEIITRNN---YNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLI 180 (360)
T ss_dssp TTEEEEEECCC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCCEEEE
T ss_pred CCeeEEEEcCC-CCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEcccccccccc
Confidence 99999999999 999999997622 245899999999999999999999 889999999999999975
Q ss_pred -----------------CCCEEEeeccccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCC
Q 041143 767 -----------------DYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGL 829 (973)
Q Consensus 767 -----------------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~ 829 (973)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 256 (360)
T 3llt_A 181 TVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256 (360)
T ss_dssp EEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSS
T ss_pred chhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCC
Confidence 789999999999865432 23467999999999999999999999999999999999999
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhc--hhHHHhhc--------Cc-c----ccCCcccHH---------------HHHHHH
Q 041143 830 AALDEERPEESRYLAEWFWRIKSS--KEKFKAAI--------DP-A----LEVNEETFE---------------SISIVA 879 (973)
Q Consensus 830 ~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~--------~~-~----l~~~~~~~~---------------~~~~~~ 879 (973)
.||......+...... ..... ........ +. . ......... ....+.
T Consensus 257 ~pf~~~~~~~~~~~~~---~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 333 (360)
T 3llt_A 257 LLFRTHEHMEHLAMME---SIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFC 333 (360)
T ss_dssp CSCCCSSHHHHHHHHH---HHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHH
T ss_pred CCCCCCcHHHHHHHHH---HhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHH
Confidence 9998765443221111 11000 00000000 00 0 000000000 014577
Q ss_pred HHHHHhhccCCCCCCCHhHHHH
Q 041143 880 ELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 880 ~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
+++.+||+.||++|||++|+++
T Consensus 334 ~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 334 DFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHhcCChhhCCCHHHHhc
Confidence 9999999999999999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=352.17 Aligned_cols=259 Identities=27% Similarity=0.368 Sum_probs=207.0
Q ss_pred hcCccccC-cccccCccEEEEEEEC---CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEE
Q 041143 624 TQNFAQEN-ELGRGGFGTVYKGELE---DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERL 699 (973)
Q Consensus 624 ~~~~~~~~-~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 699 (973)
.++|...+ .||+|+||.||+|.+. +++.||||+++.........+.+.+|++++++++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 35677777 9999999999999642 467899999976544455577899999999999999999999999 667789
Q ss_pred EEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccc
Q 041143 700 LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK 779 (973)
Q Consensus 700 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~ 779 (973)
+||||+++|+|.+++.. ...+++.++..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 94 lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp EEEECCTTEEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEeCCCCCHHHHHHh-----CcCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 99999999999999965 245899999999999999999999 7899999999999999999999999999998
Q ss_pred cCCCCCcce--ecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhH
Q 041143 780 LAPDGEKSV--VTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEK 856 (973)
Q Consensus 780 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (973)
......... .....||+.|+|||.+.+..++.++||||||+++|||++ |+.||......+.. . .+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~---~~~----- 234 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT---A---MLE----- 234 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH---H---HHH-----
T ss_pred eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH---H---HHH-----
Confidence 665433322 223456789999999998889999999999999999999 99999876543211 1 111
Q ss_pred HHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 857 FKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 857 ~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
....+... ......+.+++.+|++.||++||++.+|++.|+.+...
T Consensus 235 --~~~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 235 --KGERMGCP-----AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp --TTCCCCCC-----TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred --cCCCCCCC-----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 11111111 11234588999999999999999999999999998764
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=357.32 Aligned_cols=254 Identities=26% Similarity=0.433 Sum_probs=205.8
Q ss_pred hcCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLV 701 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 701 (973)
.+.|...+.||+|+||.||+|+. .+|+.||||++..... .....+.+.+|++++++++||||+++++++...+..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 35688999999999999999986 5789999999975432 334457899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccC
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA 781 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~ 781 (973)
|||+. |+|.+++... ...+++.++..++.|+++||+||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 133 ~e~~~-g~l~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 204 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 204 (348)
T ss_dssp EECCS-EEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred EecCC-CCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceec
Confidence 99996 7888887542 256899999999999999999999 789999999999999999999999999999865
Q ss_pred CCCCcceecccccccCcccccccc---cCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHH
Q 041143 782 PDGEKSVVTRLAGTFGYLAPEYAV---MGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFK 858 (973)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (973)
... ....||+.|+|||++. ...++.++|||||||++|||++|+.||........ ...+..
T Consensus 205 ~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~------~~~~~~------ 267 (348)
T 1u5q_A 205 APA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQ------ 267 (348)
T ss_dssp SSB-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHH------
T ss_pred CCC-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHHh------
Confidence 432 3457999999999984 56789999999999999999999999976653221 111111
Q ss_pred hhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 859 AAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 859 ~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
...+...... ....+.+++.+|++.||++||++.++++ +.++..
T Consensus 268 -~~~~~~~~~~----~~~~l~~li~~~l~~dP~~Rps~~~ll~--h~~~~~ 311 (348)
T 1u5q_A 268 -NESPALQSGH----WSEYFRNFVDSCLQKIPQDRPTSEVLLK--HRFVLR 311 (348)
T ss_dssp -SCCCCCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHTT--CHHHHS
T ss_pred -cCCCCCCCCC----CCHHHHHHHHHHcccChhhCcCHHHHhh--Chhhhc
Confidence 1111111111 1234779999999999999999999998 555543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=358.46 Aligned_cols=254 Identities=23% Similarity=0.310 Sum_probs=183.5
Q ss_pred cCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeeEEEeCCeEEEEEEecCC
Q 041143 630 ENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR-HRHLVSLLGYSIEGNERLLVYEYMPH 707 (973)
Q Consensus 630 ~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~ 707 (973)
.+.||+|+||.||+|... +|+.||||++... ....+.+|+++++.++ ||||+++++++.+....++||||+++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~ 90 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG 90 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence 478999999999999875 6899999998643 2356789999999997 99999999999999999999999999
Q ss_pred CCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCC---CEEEeeccccccCCCC
Q 041143 708 GALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDY---RAKVSDFGLVKLAPDG 784 (973)
Q Consensus 708 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~---~~kl~DfGla~~~~~~ 784 (973)
|+|.+++.. ...+++.++..++.||+.||+||| +++|+||||||+||+++.++ .+||+|||+++.....
T Consensus 91 ~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 91 GELFERIKK-----KKHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp CBHHHHHHH-----CSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred CcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 999999965 256899999999999999999999 88999999999999997765 8999999999865443
Q ss_pred CcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhH-HHHHHHHHHHhhchhHHHhhcCc
Q 041143 785 EKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEES-RYLAEWFWRIKSSKEKFKAAIDP 863 (973)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 863 (973)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ....+.. ..+...
T Consensus 163 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~----------~~i~~~ 231 (325)
T 3kn6_A 163 NQ-PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM----------KKIKKG 231 (325)
T ss_dssp ----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHH----------HHHTTT
T ss_pred CC-cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHH----------HHHHcC
Confidence 22 23456789999999999999999999999999999999999999986543211 0111111 111122
Q ss_pred cccCCccc-HHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 864 ALEVNEET-FESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 864 ~l~~~~~~-~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
........ ......+.+++.+|++.||++||++.|+++ +++++.
T Consensus 232 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~--h~w~~~ 276 (325)
T 3kn6_A 232 DFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY--NEWLQD 276 (325)
T ss_dssp CCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT--CGGGCT
T ss_pred CCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc--Chhhcc
Confidence 22111111 122345789999999999999999999987 666654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=350.06 Aligned_cols=260 Identities=26% Similarity=0.384 Sum_probs=210.8
Q ss_pred cCccccC-cccccCccEEEEEEEC---CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEE
Q 041143 625 QNFAQEN-ELGRGGFGTVYKGELE---DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLL 700 (973)
Q Consensus 625 ~~~~~~~-~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 700 (973)
++|...+ .||+|+||.||+|.+. ++..||||+++.. ......+.+.+|++++++++||||+++++++ ..+..++
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 4555655 8999999999999754 5788999999764 3455677899999999999999999999999 5567899
Q ss_pred EEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecccccc
Q 041143 701 VYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKL 780 (973)
Q Consensus 701 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~ 780 (973)
||||+++|+|.+++.. ....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 87 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKA 159 (287)
T ss_dssp EEECCTTEEHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEeCCCCCHHHHHHh----CCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceee
Confidence 9999999999999864 2356899999999999999999999 78999999999999999999999999999986
Q ss_pred CCCCCcce--ecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHH
Q 041143 781 APDGEKSV--VTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKF 857 (973)
Q Consensus 781 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (973)
........ .....||+.|+|||++.+..++.++|||||||++|||++ |+.||......+.. . .+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---~---~i~~----- 228 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM---A---FIEQ----- 228 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH---H---HHHT-----
T ss_pred eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH---H---HHhc-----
Confidence 64433221 223457899999999998899999999999999999999 99999876543211 1 1111
Q ss_pred HhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcC
Q 041143 858 KAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWR 911 (973)
Q Consensus 858 ~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~ 911 (973)
...+... ......+.+++.+|++.||++||++.++++.|+.+.....
T Consensus 229 --~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 275 (287)
T 1u59_A 229 --GKRMECP-----PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275 (287)
T ss_dssp --TCCCCCC-----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred --CCcCCCC-----CCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 0111111 1122457899999999999999999999999999987644
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=362.73 Aligned_cols=265 Identities=27% Similarity=0.388 Sum_probs=212.9
Q ss_pred hcCccccCcccccCccEEEEEEECC------CCEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCC
Q 041143 624 TQNFAQENELGRGGFGTVYKGELED------GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGN 696 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 696 (973)
.++|...+.||+|+||.||+|.... +..||||+++... .....+.+.+|+++++++ +||||+++++++...+
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 4688999999999999999998642 2479999997642 445567899999999999 8999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhhhhc---------cCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCC
Q 041143 697 ERLLVYEYMPHGALSRHLFRWEKL---------QLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDD 767 (973)
Q Consensus 697 ~~~lV~e~~~~g~L~~~l~~~~~~---------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~ 767 (973)
..++||||+++|+|.+++...... ....+++..++.++.||+.||+||| +++|+||||||+||+++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEECCC
Confidence 999999999999999999764321 1245799999999999999999999 7899999999999999999
Q ss_pred CCEEEeeccccccCCCCC-cceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHH
Q 041143 768 YRAKVSDFGLVKLAPDGE-KSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAE 845 (973)
Q Consensus 768 ~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~ 845 (973)
+.+||+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++ |+.||......... ..
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~--~~ 278 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF--YK 278 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH--HH
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH--HH
Confidence 999999999998543322 222334567889999999999999999999999999999999 99999865432211 11
Q ss_pred HHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 846 WFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 846 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
.. ......... ......+.+++.+|++.||.+||++.||++.|+.+.++
T Consensus 279 ----~~------~~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 279 ----LV------KDGYQMAQP-----AFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp ----HH------HHTCCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----HH------hcCCCCCCC-----CCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 00 111111111 01124578999999999999999999999999988764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=362.77 Aligned_cols=251 Identities=24% Similarity=0.325 Sum_probs=203.2
Q ss_pred HhcCccccCcccccCccEEEEEEECC-CCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeEE
Q 041143 623 VTQNFAQENELGRGGFGTVYKGELED-GTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGNERL 699 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 699 (973)
..++|...+.||+|+||.||+|+... |+.||||+++.... .....+.+..|..++..+ +||||+++++++.+.+..|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 34789999999999999999998864 78999999865311 112345688899999988 7999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccc
Q 041143 700 LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK 779 (973)
Q Consensus 700 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~ 779 (973)
+||||+++|+|.+++... ..+++.++..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++
T Consensus 98 lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~ 169 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK 169 (353)
T ss_dssp EEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence 999999999999999652 45899999999999999999999 7899999999999999999999999999998
Q ss_pred cCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHh
Q 041143 780 LAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKA 859 (973)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (973)
...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+. +..+...
T Consensus 170 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~------~~~i~~~------ 236 (353)
T 2i0e_A 170 ENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL------FQSIMEH------ 236 (353)
T ss_dssp CCCCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHC------
T ss_pred ccccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHH------HHHHHhC------
Confidence 543222 223456899999999999999999999999999999999999999987653221 1111111
Q ss_pred hcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCH-----hHHHH
Q 041143 860 AIDPALEVNEETFESISIVAELAGHCTAREPYHRPDM-----GHVVN 901 (973)
Q Consensus 860 ~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~-----~~v~~ 901 (973)
.+.... .....+.+++.+|++.||++||++ .||.+
T Consensus 237 ----~~~~p~---~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 237 ----NVAYPK---SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp ----CCCCCT---TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred ----CCCCCC---CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 111111 112457799999999999999964 66665
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=359.03 Aligned_cols=266 Identities=27% Similarity=0.436 Sum_probs=213.6
Q ss_pred HHhcCccccCcccccCccEEEEEEEC------CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeC
Q 041143 622 KVTQNFAQENELGRGGFGTVYKGELE------DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEG 695 (973)
Q Consensus 622 ~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 695 (973)
...++|...+.||+|+||.||+|... +++.||||++... ........+.+|++++++++||||+++++++.+.
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 34578999999999999999999764 3678999998754 3445566799999999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhhhhc-----cCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCE
Q 041143 696 NERLLVYEYMPHGALSRHLFRWEKL-----QLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRA 770 (973)
Q Consensus 696 ~~~~lV~e~~~~g~L~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~ 770 (973)
+..++||||+++|+|.+++...... ....+++..++.++.||+.||+||| +++|+||||||+||+++.++.+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCE
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCCCeE
Confidence 9999999999999999999764321 1245799999999999999999999 7899999999999999999999
Q ss_pred EEeeccccccCCCCCc-ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHH
Q 041143 771 KVSDFGLVKLAPDGEK-SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFW 848 (973)
Q Consensus 771 kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 848 (973)
||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||......+.. .
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~------~ 251 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL------R 251 (322)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH------H
T ss_pred EECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHH------H
Confidence 9999999985433221 12233467899999999999999999999999999999999 89999876532211 1
Q ss_pred HHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 849 RIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 849 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
.+.. .... .........+.+++.+|++.||++||++.|+++.|+...+.
T Consensus 252 ~~~~----------~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 252 FVME----------GGLL--DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp HHHT----------TCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred HHHc----------CCcC--CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 1111 0000 00111224578999999999999999999999999887653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=364.34 Aligned_cols=253 Identities=25% Similarity=0.378 Sum_probs=204.9
Q ss_pred cCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTT-TKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
++|...+.||+|+||.||+|.. .+|+.||||++...... ....+.+.+|+++++.++||||+++++++...+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 6899999999999999999987 57899999998643111 112346889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+ +|+|.+++... ..+++.++..++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+++...
T Consensus 89 E~~-~g~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 89 EYA-GGELFDYIVEK-----KRMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp CCC-CEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred ECC-CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 999 78999988652 46899999999999999999999 7799999999999999999999999999998655
Q ss_pred CCCcceecccccccCcccccccccCcC-CCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhc
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMGKI-TTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (973)
... .....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||........ ...+.
T Consensus 160 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~----------------~~~i~ 221 (336)
T 3h4j_B 160 DGN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL----------------FKKVN 221 (336)
T ss_dssp TSB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC----------------BCCCC
T ss_pred CCc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH----------------HHHHH
Confidence 432 2344679999999999988776 6899999999999999999999976542211 00111
Q ss_pred CccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 862 DPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 862 ~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
....... ......+.+++.+|++.||.+|||+.|+++ ++++..
T Consensus 222 ~~~~~~p---~~~s~~~~~li~~~L~~dP~~Rpt~~eil~--hp~~~~ 264 (336)
T 3h4j_B 222 SCVYVMP---DFLSPGAQSLIRRMIVADPMQRITIQEIRR--DPWFNV 264 (336)
T ss_dssp SSCCCCC---TTSCHHHHHHHHTTSCSSGGGSCCHHHHTT--CHHHHT
T ss_pred cCCCCCc---ccCCHHHHHHHHHHcCCChhHCcCHHHHHh--Chhhcc
Confidence 1111101 111234779999999999999999999998 666653
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=359.77 Aligned_cols=274 Identities=25% Similarity=0.383 Sum_probs=217.3
Q ss_pred cHHHHHHHhcCccccCcccccCccEEEEEEE------CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeee
Q 041143 616 SVQVLRKVTQNFAQENELGRGGFGTVYKGEL------EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSL 688 (973)
Q Consensus 616 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l 688 (973)
.........++|...+.||+|+||.||+|++ .+++.||||+++.. ......+.+.+|++++.++ +||||+++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC-CCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 3344445568999999999999999999974 34688999999764 3445567899999999999 79999999
Q ss_pred eeEEEeCC-eEEEEEEecCCCCHHHHHHhhhhcc-----------CCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeecc
Q 041143 689 LGYSIEGN-ERLLVYEYMPHGALSRHLFRWEKLQ-----------LKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRD 756 (973)
Q Consensus 689 ~~~~~~~~-~~~lV~e~~~~g~L~~~l~~~~~~~-----------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~D 756 (973)
++++...+ ..++||||+++|+|.+++....... ...+++..+..++.||++||+||| +++|+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCccccc
Confidence 99988755 4899999999999999997633210 123889999999999999999999 78999999
Q ss_pred CCCCcEEECCCCCEEEeeccccccCCCCCc-ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCC
Q 041143 757 LKSSNILLDDDYRAKVSDFGLVKLAPDGEK-SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDE 834 (973)
Q Consensus 757 ikp~Nill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~ 834 (973)
|||+||+++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999986543322 23344568999999999999999999999999999999998 9999976
Q ss_pred CChhhHHHHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhc
Q 041143 835 ERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKW 910 (973)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~ 910 (973)
....+. +.. ... ........ . .....+.+++.+|++.||.+||++.||++.|+.+.+..
T Consensus 254 ~~~~~~--~~~---~~~-------~~~~~~~~-~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 254 VKIDEE--FCR---RLK-------EGTRMRAP-D----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp CCCSHH--HHH---HHH-------HTCCCCCC-T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cchhHH--HHH---Hhc-------cCccCCCC-C----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 553221 111 111 11111111 0 11235789999999999999999999999999998754
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=361.75 Aligned_cols=256 Identities=27% Similarity=0.367 Sum_probs=192.5
Q ss_pred HhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEE
Q 041143 623 VTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLV 701 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 701 (973)
..++|...+.||+|+||.||+|+.. +++.||||+++... ..+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 4578999999999999999999886 57899999997542 345688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECC---CCCEEEeecccc
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDD---DYRAKVSDFGLV 778 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~---~~~~kl~DfGla 778 (973)
|||+++|+|.+++.. ...+++.++..++.||+.||+||| +.+|+||||||+||+++. ++.+||+|||++
T Consensus 127 ~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a 198 (349)
T 2w4o_A 127 LELVTGGELFDRIVE-----KGYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLS 198 (349)
T ss_dssp ECCCCSCBHHHHHTT-----CSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC--
T ss_pred EEeCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccc
Confidence 999999999999864 245899999999999999999999 789999999999999975 889999999999
Q ss_pred ccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHH
Q 041143 779 KLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFK 858 (973)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (973)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ . ...+.....
T Consensus 199 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~---~~~i~~~~~--- 268 (349)
T 2w4o_A 199 KIVEHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--M---FRRILNCEY--- 268 (349)
T ss_dssp ----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--H---HHHHHTTCC---
T ss_pred cccCccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--H---HHHHHhCCC---
Confidence 8654322 23446799999999999999999999999999999999999999976553321 1 111111000
Q ss_pred hhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 859 AAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 859 ~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
....+. .......+.+++.+|++.||++||++.|+++ ++++.
T Consensus 269 ~~~~~~------~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~--hp~~~ 310 (349)
T 2w4o_A 269 YFISPW------WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ--HPWVT 310 (349)
T ss_dssp CCCTTT------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH--STTTT
T ss_pred ccCCch------hhhCCHHHHHHHHHHccCChhhCcCHHHHhc--CcccC
Confidence 000000 0112245789999999999999999999998 55554
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=359.93 Aligned_cols=274 Identities=28% Similarity=0.385 Sum_probs=210.2
Q ss_pred cCccccCcccccCccEEEEEEE-----CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEe--CCe
Q 041143 625 QNFAQENELGRGGFGTVYKGEL-----EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIE--GNE 697 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~ 697 (973)
++|+..+.||+|+||.||+|++ .+++.||||++... .....+.+.+|++++++++||||+++++++.. ...
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence 5788999999999999999984 36889999998754 55666789999999999999999999999874 556
Q ss_pred EEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccc
Q 041143 698 RLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL 777 (973)
Q Consensus 698 ~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGl 777 (973)
.++||||+++|+|.+++.... ..+++.+++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||+
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 173 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHR----ARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGL 173 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred EEEEEeecCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEccccc
Confidence 899999999999999997532 35899999999999999999999 78999999999999999999999999999
Q ss_pred cccCCCCCcc--eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchh
Q 041143 778 VKLAPDGEKS--VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKE 855 (973)
Q Consensus 778 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 855 (973)
++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||........... .+... .....
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~-~~~~~-~~~~~ 251 (327)
T 3lxl_A 174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM-GCERD-VPALS 251 (327)
T ss_dssp CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHC-C-----CCHHH
T ss_pred ceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhc-ccccc-cccHH
Confidence 9866543322 22345688899999999999999999999999999999999999865332110000 00000 00000
Q ss_pred HHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhc
Q 041143 856 KFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKW 910 (973)
Q Consensus 856 ~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~ 910 (973)
.....+..... ..........+.+++.+|++.||++||++.||++.|+.+....
T Consensus 252 ~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 252 RLLELLEEGQR-LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred HHHHHhhcccC-CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 11111111111 0111122345889999999999999999999999999887654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=364.94 Aligned_cols=249 Identities=27% Similarity=0.342 Sum_probs=193.7
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCC-ChHHHHHHHHHHHH-HHhcCCCceeeeeeEEEeCCeEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVT-TTKALDEFQSEIAV-LSKVRHRHLVSLLGYSIEGNERLLV 701 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lV 701 (973)
++|...+.||+|+||.||+|+.+ +++.||||+++.... .....+.+.+|..+ ++.++|||||++++++.+.+..|+|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 67999999999999999999876 588999999975422 23344566777776 4678999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccC
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA 781 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~ 781 (973)
|||+++|+|.+++... ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++..
T Consensus 118 ~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 118 LDYINGGELFYHLQRE-----RCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 9999999999999652 45789999999999999999999 889999999999999999999999999999853
Q ss_pred CCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhc
Q 041143 782 PDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861 (973)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (973)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+. +..+..
T Consensus 190 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~------~~~i~~--------- 253 (373)
T 2r5t_A 190 IEHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM------YDNILN--------- 253 (373)
T ss_dssp BCCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHH------HHHHHH---------
T ss_pred ccCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH------HHHHHh---------
Confidence 3222 234457899999999999999999999999999999999999999987553221 111111
Q ss_pred CccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 862 DPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 862 ~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
..+.... .....+.+++.+|++.||.+||++.+.++
T Consensus 254 -~~~~~~~---~~~~~~~~li~~lL~~dp~~R~~~~~~~~ 289 (373)
T 2r5t_A 254 -KPLQLKP---NITNSARHLLEGLLQKDRTKRLGAKDDFM 289 (373)
T ss_dssp -SCCCCCS---SSCHHHHHHHHHHTCSSGGGSTTTTTTHH
T ss_pred -cccCCCC---CCCHHHHHHHHHHcccCHHhCCCCCCCHH
Confidence 1111111 11234779999999999999999865443
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=362.88 Aligned_cols=270 Identities=22% Similarity=0.271 Sum_probs=206.5
Q ss_pred HHHHhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCC---CChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeC
Q 041143 620 LRKVTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGV---TTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEG 695 (973)
Q Consensus 620 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 695 (973)
+....++|...+.||+|+||.||+|... +++.||+|++.... ......+.+.+|++++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 3567789999999999999999999874 68899999986431 1234567899999999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhhhhc-----------------------------------cCCCCCHHHHHHHHHHHHHH
Q 041143 696 NERLLVYEYMPHGALSRHLFRWEKL-----------------------------------QLKPLSWTRRLSIALDVARG 740 (973)
Q Consensus 696 ~~~~lV~e~~~~g~L~~~l~~~~~~-----------------------------------~~~~l~~~~~~~i~~~ia~g 740 (973)
+..++||||+++|+|.+++...... ....+++..+..++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 9999999999999999988531110 01224567788999999999
Q ss_pred HHHHHhhccCCeeeccCCCCcEEECCCC--CEEEeeccccccCCC---CCcceecccccccCccccccccc--CcCCCch
Q 041143 741 MEYLHCLARQTFIHRDLKSSNILLDDDY--RAKVSDFGLVKLAPD---GEKSVVTRLAGTFGYLAPEYAVM--GKITTKA 813 (973)
Q Consensus 741 l~~LH~~~~~~ivH~Dikp~Nill~~~~--~~kl~DfGla~~~~~---~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~ 813 (973)
|+||| +.+|+||||||+||+++.++ .+||+|||+++.... ..........||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999 78999999999999998776 899999999985432 11222345679999999999875 6789999
Q ss_pred hHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccCC-cccHHHHHHHHHHHHHhhccCCCC
Q 041143 814 DVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVN-EETFESISIVAELAGHCTAREPYH 892 (973)
Q Consensus 814 Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~~~~~l~~~cl~~dP~~ 892 (973)
|||||||++|||++|+.||......+.. ..+.. ...... .........+.+++.+|++.||.+
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~~------~~~~~----------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 321 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADTI------SQVLN----------KKLCFENPNYNVLSPLARDLLSNLLNRNVDE 321 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHH----------CCCCTTSGGGGGSCHHHHHHHHHHSCSCTTT
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHHH------HHHHh----------cccccCCcccccCCHHHHHHHHHHcCCChhH
Confidence 9999999999999999999876543211 11111 111000 011112245779999999999999
Q ss_pred CCCHhHHHHHHHHhhhhc
Q 041143 893 RPDMGHVVNVLSPLVEKW 910 (973)
Q Consensus 893 RPs~~~v~~~L~~~~~~~ 910 (973)
||++.|+++ +++++.+
T Consensus 322 Rps~~~~l~--hp~~~~~ 337 (345)
T 3hko_A 322 RFDAMRALQ--HPWISQF 337 (345)
T ss_dssp SCCHHHHHH--SHHHHTT
T ss_pred CCCHHHHhc--ChhhccC
Confidence 999999998 7776654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=359.37 Aligned_cols=258 Identities=27% Similarity=0.402 Sum_probs=200.9
Q ss_pred cCccccCcccccCccEEEEEEEC-CCC----EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGT----KIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERL 699 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 699 (973)
++|...+.||+|+||.||+|.+. +++ +||+|.+.... .....+.+.+|+.++++++||||+++++++.... .+
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 67899999999999999999864 444 35777775432 3344567899999999999999999999998765 78
Q ss_pred EEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccc
Q 041143 700 LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK 779 (973)
Q Consensus 700 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~ 779 (973)
+||||+++|+|.+++... ...+++..++.++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++
T Consensus 93 ~v~~~~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEECCCSSCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred EEEEecCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence 999999999999999752 246899999999999999999999 7899999999999999999999999999998
Q ss_pred cCCCCCc-ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHH
Q 041143 780 LAPDGEK-SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKF 857 (973)
Q Consensus 780 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (973)
....... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||......+..... .
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~------~------ 233 (327)
T 3lzb_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL------E------ 233 (327)
T ss_dssp --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH------H------
T ss_pred EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH------H------
Confidence 6543222 22233457889999999999999999999999999999999 99999876544321110 0
Q ss_pred HhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 858 KAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 858 ~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
....... .......+.+++.+|++.||++||++.|+++.|+.+.+.
T Consensus 234 -~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 234 -KGERLPQ-----PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -TTCCCCC-----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred -cCCCCCC-----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 0000000 111223578999999999999999999999999998753
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=388.95 Aligned_cols=252 Identities=27% Similarity=0.365 Sum_probs=202.3
Q ss_pred CcccccCccEEEEEEEC---CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEecCC
Q 041143 631 NELGRGGFGTVYKGELE---DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPH 707 (973)
Q Consensus 631 ~~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 707 (973)
+.||+|+||.||+|.+. .++.||||+++.........+++.+|++++++++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999653 46789999998765455556789999999999999999999999864 568999999999
Q ss_pred CCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCc-
Q 041143 708 GALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEK- 786 (973)
Q Consensus 708 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~- 786 (973)
|+|.+++.. ...+++.+++.|+.||+.||+||| +++|+||||||+|||++.++.+||+|||+++.......
T Consensus 454 g~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 454 GPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525 (635)
T ss_dssp EEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred CCHHHHHhh-----CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence 999999964 246899999999999999999999 78999999999999999999999999999986544322
Q ss_pred -ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCcc
Q 041143 787 -SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPA 864 (973)
Q Consensus 787 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 864 (973)
.......||+.|+|||++.+..++.++|||||||++|||++ |+.||......+... .+. ......
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~------~i~-------~~~~~~ 592 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA------MLE-------KGERMG 592 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH------HHH-------TTCCCC
T ss_pred cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH------HHH-------cCCCCC
Confidence 22233457889999999999999999999999999999998 999998766432111 111 111111
Q ss_pred ccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 865 LEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 865 l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
.. ......+.+++..||+.||++||++.+|++.|+.+..+
T Consensus 593 ~p-----~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 593 CP-----AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp CC-----TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CC-----CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 11 11234578999999999999999999999999988764
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=363.08 Aligned_cols=274 Identities=24% Similarity=0.376 Sum_probs=199.4
Q ss_pred cCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHH--HHhcCCCceeeeeeEEEe-----CCe
Q 041143 625 QNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAV--LSKVRHRHLVSLLGYSIE-----GNE 697 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~-----~~~ 697 (973)
++|...+.||+|+||.||+|+. +++.||||++... . ...+..|.++ +..++||||+++++++.. ...
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---N--RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---G--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---c--hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 6889999999999999999987 4899999998643 1 2334444444 445899999999986543 235
Q ss_pred EEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccC---------CeeeccCCCCcEEECCCC
Q 041143 698 RLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQ---------TFIHRDLKSSNILLDDDY 768 (973)
Q Consensus 698 ~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~---------~ivH~Dikp~Nill~~~~ 768 (973)
.++||||+++|+|.+++.. ...++..+..++.||++||+||| +. +|+||||||+|||++.++
T Consensus 87 ~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~ 157 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSL------HTSDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDG 157 (336)
T ss_dssp EEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTS
T ss_pred EEEEEecCCCCcHHHHHhh------cccchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCC
Confidence 6899999999999999965 34589999999999999999999 66 999999999999999999
Q ss_pred CEEEeeccccccCCCCC-------cceecccccccCccccccccc-------CcCCCchhHHhHHHHHHHHHhCCCCCCC
Q 041143 769 RAKVSDFGLVKLAPDGE-------KSVVTRLAGTFGYLAPEYAVM-------GKITTKADVFSYGVVLMELLTGLAALDE 834 (973)
Q Consensus 769 ~~kl~DfGla~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~S~Gvvl~elltg~~p~~~ 834 (973)
.+||+|||+++...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.|+..
T Consensus 158 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~ 237 (336)
T 3g2f_A 158 TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237 (336)
T ss_dssp CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence 99999999998654321 112234579999999999876 4667899999999999999999777643
Q ss_pred CChhhH-HHHHHHHHHHhhchhHHHh-----hcCccccC-CcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhh
Q 041143 835 ERPEES-RYLAEWFWRIKSSKEKFKA-----AIDPALEV-NEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLV 907 (973)
Q Consensus 835 ~~~~~~-~~~~~~~~~~~~~~~~~~~-----~~~~~l~~-~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~ 907 (973)
...... ................... ...+.+.. ..........+.+++.+||+.||++|||++||++.|+.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp TSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 322110 0000000000000000000 11111110 1112234557899999999999999999999999999999
Q ss_pred hhcCCC
Q 041143 908 EKWRPI 913 (973)
Q Consensus 908 ~~~~~~ 913 (973)
..|...
T Consensus 318 ~~~~~~ 323 (336)
T 3g2f_A 318 MIWERN 323 (336)
T ss_dssp HCCCC-
T ss_pred HHHHhc
Confidence 887654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=346.65 Aligned_cols=256 Identities=24% Similarity=0.394 Sum_probs=210.3
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCC-CChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGV-TTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLV 701 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 701 (973)
.++|...+.||+|+||.||+|... +++.||+|++.... ......+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 367889999999999999999876 57899999986542 2345667899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccC
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA 781 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~ 781 (973)
|||+++++|.+++.. ...+++.++..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 94 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 165 (294)
T 2rku_A 94 LELCRRRSLLELHKR-----RKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 165 (294)
T ss_dssp EECCTTCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceec
Confidence 999999999998865 246899999999999999999999 789999999999999999999999999999865
Q ss_pred CCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhc
Q 041143 782 PDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861 (973)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (973)
..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+. ...+..
T Consensus 166 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~--------- 229 (294)
T 2rku_A 166 EYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET------YLRIKK--------- 229 (294)
T ss_dssp CSTTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHT---------
T ss_pred ccCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHhh---------
Confidence 43222 23446799999999999988999999999999999999999999987653221 111111
Q ss_pred CccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 862 DPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 862 ~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
....... .....+.+++.+|++.||++||++.|+++ +.++..
T Consensus 230 -~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~~ll~--~~~~~~ 271 (294)
T 2rku_A 230 -NEYSIPK---HINPVAASLIQKMLQTDPTARPTINELLN--DEFFTS 271 (294)
T ss_dssp -TCCCCCT---TSCHHHHHHHHHHTCSSGGGSCCGGGGGG--SHHHHT
T ss_pred -ccCCCcc---ccCHHHHHHHHHHcccChhhCcCHHHHhh--Chheec
Confidence 1111000 11234779999999999999999999998 566553
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=367.12 Aligned_cols=283 Identities=23% Similarity=0.288 Sum_probs=207.2
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeC-----Ce
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEG-----NE 697 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 697 (973)
.++|...+.||+|+||.||+|... +|+.||||+++.........+.+.+|++++++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468999999999999999999875 578999999987656666778899999999999999999999999876 57
Q ss_pred EEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccc
Q 041143 698 RLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL 777 (973)
Q Consensus 698 ~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGl 777 (973)
.|+||||+. |+|.+++.. ...+++..+..++.||++||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 105 ~~lv~e~~~-~~L~~~~~~-----~~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGl 175 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT-----PIFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGL 175 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS-----SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEecCC-cCHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCC
Confidence 899999985 699998854 256899999999999999999999 78999999999999999999999999999
Q ss_pred cccCCCCCc---------------------ceecccccccCccccccc-ccCcCCCchhHHhHHHHHHHHHhCCCCCC--
Q 041143 778 VKLAPDGEK---------------------SVVTRLAGTFGYLAPEYA-VMGKITTKADVFSYGVVLMELLTGLAALD-- 833 (973)
Q Consensus 778 a~~~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~S~Gvvl~elltg~~p~~-- 833 (973)
|+....... ...+..+||+.|+|||++ ....++.++||||+||++|||++|..||.
T Consensus 176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~ 255 (432)
T 3n9x_A 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255 (432)
T ss_dssp CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSS
T ss_pred cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccc
Confidence 986543221 123567899999999986 46679999999999999999998544443
Q ss_pred ---------CCChh---------------hHHHHHHHHHHHhhc---------hhHHHhhc---CccccCC--cccHHHH
Q 041143 834 ---------EERPE---------------ESRYLAEWFWRIKSS---------KEKFKAAI---DPALEVN--EETFESI 875 (973)
Q Consensus 834 ---------~~~~~---------------~~~~~~~~~~~~~~~---------~~~~~~~~---~~~l~~~--~~~~~~~ 875 (973)
+.... ....+...+...... .......+ ....... .......
T Consensus 256 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 335 (432)
T 3n9x_A 256 PTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSIS 335 (432)
T ss_dssp GGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSC
T ss_pred cccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCC
Confidence 22110 000110000000000 00000000 0000000 0001123
Q ss_pred HHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCCCCCCC
Q 041143 876 SIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPITDES 917 (973)
Q Consensus 876 ~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~~~~~~ 917 (973)
..+.+|+.+||+.||++|||+.|+++ +++++.......+.
T Consensus 336 ~~~~dLl~~mL~~dP~~R~ta~e~L~--Hp~f~~~~~~~~e~ 375 (432)
T 3n9x_A 336 DDGINLLESMLKFNPNKRITIDQALD--HPYLKDVRKKKLEN 375 (432)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHT--CGGGTTTCCTTTC-
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhc--ChhhhhccCcccCc
Confidence 45789999999999999999999999 88888765554443
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=372.61 Aligned_cols=253 Identities=27% Similarity=0.433 Sum_probs=206.9
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
++|...+.||+|+||.||+|+.. +|+.||||++..... .....+.+.+|+++++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 57889999999999999999875 799999999864311 1123457899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++|+|.+++.. ...+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 96 E~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 96 EYVSGGELFDYICK-----NGRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp ECCSSEEHHHHTTS-----SSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred eCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 99999999999854 256899999999999999999999 8899999999999999999999999999998765
Q ss_pred CCCcceecccccccCcccccccccCcC-CCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhc
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMGKI-TTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (973)
... .....+||+.|+|||++.+..+ +.++||||+||++|||++|+.||........ ...+..
T Consensus 168 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~------~~~i~~--------- 230 (476)
T 2y94_A 168 DGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL------FKKICD--------- 230 (476)
T ss_dssp TTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH------HHHHHT---------
T ss_pred ccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH------HHHHhc---------
Confidence 432 2345689999999999988766 6899999999999999999999986553221 111111
Q ss_pred CccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 862 DPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 862 ~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
....... .....+.+++.+|++.||++|||+.||++ +++++
T Consensus 231 -~~~~~p~---~~s~~~~~Li~~~L~~dP~~Rpt~~eil~--hp~~~ 271 (476)
T 2y94_A 231 -GIFYTPQ---YLNPSVISLLKHMLQVDPMKRATIKDIRE--HEWFK 271 (476)
T ss_dssp -TCCCCCT---TCCHHHHHHHHHHTCSSTTTSCCHHHHHT--CHHHH
T ss_pred -CCcCCCc---cCCHHHHHHHHHHcCCCchhCcCHHHHHh--CHHhh
Confidence 1111000 11234779999999999999999999998 55544
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=357.32 Aligned_cols=266 Identities=15% Similarity=0.183 Sum_probs=198.7
Q ss_pred cCccccCcccccCccEEEEEEEC----CCCEEEEEEeecCCCChH---------HHHHHHHHHHHHHhcCCCceeeeeeE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE----DGTKIAVKRMEAGVTTTK---------ALDEFQSEIAVLSKVRHRHLVSLLGY 691 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~ 691 (973)
++|...+.||+|+||.||+|... ++..+|||++........ ....+.+|+..+..++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 67899999999999999999875 578899999875422111 11246678899999999999999999
Q ss_pred EEe----CCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCC
Q 041143 692 SIE----GNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDD 767 (973)
Q Consensus 692 ~~~----~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~ 767 (973)
+.. ....++||||+ +++|.+++... ..+++.+++.++.||+.||+||| +++|+||||||+|||++.+
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQN-----GTFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGG-----GBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESS
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccC
Confidence 988 67889999999 99999998652 36899999999999999999999 7899999999999999988
Q ss_pred C--CEEEeeccccccCCCCCc------ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhh
Q 041143 768 Y--RAKVSDFGLVKLAPDGEK------SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEE 839 (973)
Q Consensus 768 ~--~~kl~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~ 839 (973)
+ .+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 7 999999999985532211 11244679999999999999999999999999999999999999996432221
Q ss_pred HHHHHHHHHHHhh-chhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 840 SRYLAEWFWRIKS-SKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 840 ~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
.. .......... ....+...... . .....+.+++.+|++.||++||++.+|++.|+.+..
T Consensus 268 ~~-~~~~~~~~~~~~~~~~~~~~~~----~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 268 VA-VQTAKTNLLDELPQSVLKWAPS----G----SSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HH-HHHHHHHHHHTTTHHHHHHSCT----T----SCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HH-HHHHHHhhcccccHHHHhhccc----c----ccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 11 1111111100 00111111100 0 112358899999999999999999999999987644
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=345.74 Aligned_cols=256 Identities=23% Similarity=0.351 Sum_probs=206.8
Q ss_pred HhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEE
Q 041143 623 VTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLV 701 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 701 (973)
..++|...+.||+|+||.||+|... ++..||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence 4578999999999999999999876 477899999875422 2356789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEE---CCCCCEEEeecccc
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILL---DDDYRAKVSDFGLV 778 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill---~~~~~~kl~DfGla 778 (973)
|||+++++|.+++.. ...+++.++..++.|++.||+||| +++|+||||||+||++ +.++.+||+|||++
T Consensus 85 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~ 156 (277)
T 3f3z_A 85 MELCTGGELFERVVH-----KRVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLA 156 (277)
T ss_dssp EECCCSCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EeccCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccc
Confidence 999999999998865 245899999999999999999999 8899999999999999 78899999999999
Q ss_pred ccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHH
Q 041143 779 KLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFK 858 (973)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (973)
....... ......||+.|+|||++.+ .++.++||||||+++|||++|+.||......+.. ..+...
T Consensus 157 ~~~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~------~~~~~~----- 222 (277)
T 3f3z_A 157 ARFKPGK--MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVM------LKIREG----- 222 (277)
T ss_dssp EECCTTS--CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHHC-----
T ss_pred eeccCcc--chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHH------HHHHhC-----
Confidence 8654432 2344579999999998765 4899999999999999999999999876533211 111110
Q ss_pred hhcCccccCCcc-cHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 859 AAIDPALEVNEE-TFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 859 ~~~~~~l~~~~~-~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
....... .......+.+++.+|++.||++||++.|+++ ++++++
T Consensus 223 -----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~--h~~~~~ 267 (277)
T 3f3z_A 223 -----TFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE--HEWFEK 267 (277)
T ss_dssp -----CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT--SHHHHH
T ss_pred -----CCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc--CHHHhc
Confidence 0000000 0011245789999999999999999999998 566553
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=364.17 Aligned_cols=260 Identities=29% Similarity=0.452 Sum_probs=198.1
Q ss_pred CccccCcccccCccEEEEEEEC--CC--CEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEe-CCeEEE
Q 041143 626 NFAQENELGRGGFGTVYKGELE--DG--TKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIE-GNERLL 700 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~--~g--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~l 700 (973)
.|...+.||+|+||.||+|++. ++ ..||||.++.. ......++|.+|+.++++++||||++++++|.. ++..++
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 4667789999999999999764 22 36899988653 344566789999999999999999999999765 457799
Q ss_pred EEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecccccc
Q 041143 701 VYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKL 780 (973)
Q Consensus 701 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~ 780 (973)
||||+++|+|.+++.. ....+++.+++.++.||++||+||| +++|+||||||+|||++.++.+||+|||+++.
T Consensus 169 v~e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 241 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARD 241 (373)
T ss_dssp EEECCTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEECCCCCCHHHHHhh----cccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeecccccc
Confidence 9999999999999964 2245789999999999999999999 78999999999999999999999999999985
Q ss_pred CCCCCcc---eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhH
Q 041143 781 APDGEKS---VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEK 856 (973)
Q Consensus 781 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (973)
....... ......+|+.|+|||++.+..++.++|||||||++|||++ |.+||......+... .+....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~------~~~~~~-- 313 (373)
T 3c1x_A 242 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV------YLLQGR-- 313 (373)
T ss_dssp ----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHH------HHHTTC--
T ss_pred ccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHH------HHHcCC--
Confidence 5432211 1233467889999999999999999999999999999999 677887654332111 011100
Q ss_pred HHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcC
Q 041143 857 FKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWR 911 (973)
Q Consensus 857 ~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~ 911 (973)
....+ ......+.+++.+||+.||++||++.|+++.|+.+...+.
T Consensus 314 --~~~~p--------~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 314 --RLLQP--------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp --CCCCC--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred --CCCCC--------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 00011 1122457899999999999999999999999999988654
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=346.49 Aligned_cols=253 Identities=26% Similarity=0.399 Sum_probs=203.1
Q ss_pred CccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEe----CCeEEE
Q 041143 626 NFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIE----GNERLL 700 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l 700 (973)
.|...+.||+|+||.||+|... ++..||+|++..........+.+.+|+.++++++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 4677788999999999999774 57899999998765566777889999999999999999999999875 345799
Q ss_pred EEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCC--eeeccCCCCcEEEC-CCCCEEEeeccc
Q 041143 701 VYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQT--FIHRDLKSSNILLD-DDYRAKVSDFGL 777 (973)
Q Consensus 701 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~--ivH~Dikp~Nill~-~~~~~kl~DfGl 777 (973)
||||+++|+|.+++... ..+++..+..++.||+.||+||| +.+ |+||||||+||+++ .++.+||+|||+
T Consensus 107 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEecCCCCHHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 99999999999999652 45899999999999999999999 667 99999999999998 789999999999
Q ss_pred cccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHH
Q 041143 778 VKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKF 857 (973)
Q Consensus 778 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (973)
+....... .....||+.|+|||++. +.++.++|||||||++|||++|+.||........ .......
T Consensus 179 ~~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-----~~~~~~~----- 244 (290)
T 1t4h_A 179 ATLKRASF---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-----IYRRVTS----- 244 (290)
T ss_dssp GGGCCTTS---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-----HHHHHTT-----
T ss_pred cccccccc---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH-----HHHHHhc-----
Confidence 97554332 23457999999999876 5699999999999999999999999976543221 1111111
Q ss_pred HhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 858 KAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 858 ~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
...+. .........+.+++.+|++.||.+||++.||++ +++++
T Consensus 245 --~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~--h~~f~ 287 (290)
T 1t4h_A 245 --GVKPA----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN--HAFFQ 287 (290)
T ss_dssp --TCCCG----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGC
T ss_pred --cCCcc----ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh--Ccccc
Confidence 01110 001111235789999999999999999999997 44443
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=375.59 Aligned_cols=255 Identities=25% Similarity=0.327 Sum_probs=198.7
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCC-CChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGV-TTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLV 701 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 701 (973)
.++|+..+.||+|+||.||+|+.. +|+.||||+++... ........+.+|+++++.++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 468999999999999999999864 68999999987531 1233456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhcc-CCeeeccCCCCcEEECCCCCEEEeecccccc
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLAR-QTFIHRDLKSSNILLDDDYRAKVSDFGLVKL 780 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~-~~ivH~Dikp~Nill~~~~~~kl~DfGla~~ 780 (973)
|||+++|+|.+++.. ...+++..+..++.||++||+||| + ++|+||||||+|||++.++.+||+|||+++.
T Consensus 227 ~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~ 298 (446)
T 4ejn_A 227 MEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE 298 (446)
T ss_dssp ECCCSSCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred EeeCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCcee
Confidence 999999999999865 246899999999999999999999 5 7999999999999999999999999999985
Q ss_pred CCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhh
Q 041143 781 APDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAA 860 (973)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (973)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..+...
T Consensus 299 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~------~~i~~~------- 364 (446)
T 4ejn_A 299 GIKDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF------ELILME------- 364 (446)
T ss_dssp TCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHHC-------
T ss_pred ccCCC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH------HHHHhC-------
Confidence 43322 2344578999999999999999999999999999999999999999876543211 111111
Q ss_pred cCccccCCcccHHHHHHHHHHHHHhhccCCCCCC-----CHhHHHHHHHHhhh
Q 041143 861 IDPALEVNEETFESISIVAELAGHCTAREPYHRP-----DMGHVVNVLSPLVE 908 (973)
Q Consensus 861 ~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~~v~~~L~~~~~ 908 (973)
...... .....+.+++.+||+.||.+|| ++.|+++ +++++
T Consensus 365 ---~~~~p~---~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~--hp~f~ 409 (446)
T 4ejn_A 365 ---EIRFPR---TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ--HRFFA 409 (446)
T ss_dssp ---CCCCCT---TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT--SGGGT
T ss_pred ---CCCCCc---cCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh--Ccccc
Confidence 111000 1123477999999999999999 9999987 55544
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=362.56 Aligned_cols=276 Identities=22% Similarity=0.351 Sum_probs=197.5
Q ss_pred hcCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeC------C
Q 041143 624 TQNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEG------N 696 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 696 (973)
.++|...+.||+|+||.||+|.. .+|+.||||++..........+.+.+|++++++++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 37899999999999999999976 4689999999976655666778899999999999999999999998754 5
Q ss_pred eEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecc
Q 041143 697 ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFG 776 (973)
Q Consensus 697 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG 776 (973)
..++||||+ +++|.+++.. ..+++..+..++.||++||+||| +.+|+||||||+||+++.++.+||+|||
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG 177 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFG 177 (367)
T ss_dssp CCEEEEECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC--
T ss_pred eEEEEeccc-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeecc
Confidence 679999999 7899988854 46899999999999999999999 7899999999999999999999999999
Q ss_pred ccccCCCCCcceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhch-
Q 041143 777 LVKLAPDGEKSVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSK- 854 (973)
Q Consensus 777 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~- 854 (973)
+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+.... .........
T Consensus 178 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~--i~~~~g~p~~ 251 (367)
T 2fst_X 178 LARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL--ILRLVGTPGA 251 (367)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH--HHHHHCSCCH
T ss_pred cccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHHHhCCCCH
Confidence 99865432 344679999999999886 6789999999999999999999999987664332111 111000000
Q ss_pred --------hHHHhhcCccccCCcccH-----HHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCCCCCCC
Q 041143 855 --------EKFKAAIDPALEVNEETF-----ESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPITDES 917 (973)
Q Consensus 855 --------~~~~~~~~~~l~~~~~~~-----~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~~~~~~ 917 (973)
......+........... .....+.+|+.+|++.||++|||+.|+++ +++++.+..+.+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~--hp~~~~~~~~~~~~ 325 (367)
T 2fst_X 252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA--HAYFAQYHDPDDEP 325 (367)
T ss_dssp HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGTTTCCGGGCC
T ss_pred HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc--ChhhhhccCCCCCC
Confidence 000111100000000011 11245789999999999999999999998 78887766554443
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=385.97 Aligned_cols=253 Identities=26% Similarity=0.379 Sum_probs=201.6
Q ss_pred cccccCccEEEEEEEC---CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEecCCC
Q 041143 632 ELGRGGFGTVYKGELE---DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHG 708 (973)
Q Consensus 632 ~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 708 (973)
.||+|+||.||+|.+. ++..||||+++... .....++|.+|+++|++++|||||+++++|.. +..++||||+++|
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g 420 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGG 420 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTC
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCC
Confidence 7999999999999764 46679999997652 33346789999999999999999999999976 5689999999999
Q ss_pred CHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCcce
Q 041143 709 ALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSV 788 (973)
Q Consensus 709 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 788 (973)
+|.+++... ...+++.++..|+.||++||+||| +++|+||||||+|||++.++.+||+|||+++.........
T Consensus 421 ~L~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 493 (613)
T 2ozo_A 421 PLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY 493 (613)
T ss_dssp BHHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC------
T ss_pred cHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCcee
Confidence 999999642 356899999999999999999999 7899999999999999999999999999998654332221
Q ss_pred --ecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccc
Q 041143 789 --VTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPAL 865 (973)
Q Consensus 789 --~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 865 (973)
.....+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+.. . .+.. .. .+
T Consensus 494 ~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~---~---~i~~-------~~--~~ 558 (613)
T 2ozo_A 494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM---A---FIEQ-------GK--RM 558 (613)
T ss_dssp --------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHH---H---HHHT-------TC--CC
T ss_pred eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH---H---HHHc-------CC--CC
Confidence 122346789999999999999999999999999999998 99999876543321 1 1111 00 01
Q ss_pred cCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcC
Q 041143 866 EVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWR 911 (973)
Q Consensus 866 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~ 911 (973)
. .+......+.+++.+||+.||++||++.+|++.|+.+.....
T Consensus 559 ~---~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~ 601 (613)
T 2ozo_A 559 E---CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 601 (613)
T ss_dssp C---CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred C---CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence 1 011123457899999999999999999999999999877654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=356.74 Aligned_cols=275 Identities=23% Similarity=0.375 Sum_probs=214.4
Q ss_pred HHHHHHHhcCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHh--cCCCceeeeeeEEEe
Q 041143 617 VQVLRKVTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSK--VRHRHLVSLLGYSIE 694 (973)
Q Consensus 617 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~ 694 (973)
....+...++|...+.||+|+||.||+|+.. |+.||||++... ..+.+.+|++++.. ++||||+++++++..
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 3344567789999999999999999999885 899999998542 23567889999987 789999999999988
Q ss_pred CC----eEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhc-----cCCeeeccCCCCcEEEC
Q 041143 695 GN----ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLA-----RQTFIHRDLKSSNILLD 765 (973)
Q Consensus 695 ~~----~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~-----~~~ivH~Dikp~Nill~ 765 (973)
.. ..++||||+++|+|.+++.. ..+++.+++.++.|++.||+|||... +++|+||||||+||+++
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~ 181 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK 181 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEEC
T ss_pred cCCccceeEEEEeecCCCcHHHHHhc------cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEEC
Confidence 76 78999999999999999965 35899999999999999999999321 56899999999999999
Q ss_pred CCCCEEEeeccccccCCCCCcc---eecccccccCcccccccccC------cCCCchhHHhHHHHHHHHHhC--------
Q 041143 766 DDYRAKVSDFGLVKLAPDGEKS---VVTRLAGTFGYLAPEYAVMG------KITTKADVFSYGVVLMELLTG-------- 828 (973)
Q Consensus 766 ~~~~~kl~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~S~Gvvl~elltg-------- 828 (973)
.++.+||+|||+++........ ......||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~ 261 (342)
T 1b6c_B 182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261 (342)
T ss_dssp TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence 9999999999999855443322 22445799999999998765 344689999999999999999
Q ss_pred --CCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHh
Q 041143 829 --LAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPL 906 (973)
Q Consensus 829 --~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~ 906 (973)
+.||......+. ....+..... .....+.+.......+....+.+++.+|++.||++||++.||++.|+.+
T Consensus 262 ~~~~p~~~~~~~~~-~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 262 DYQLPYYDLVPSDP-SVEEMRKVVC------EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp CCCCTTTTTSCSSC-CHHHHHHHHT------TSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccCccccCcCcc-cHHHHHHHHH------HHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 778865432211 1111111111 1112222221112335667789999999999999999999999999999
Q ss_pred hhhc
Q 041143 907 VEKW 910 (973)
Q Consensus 907 ~~~~ 910 (973)
.++.
T Consensus 335 ~~~~ 338 (342)
T 1b6c_B 335 SQQE 338 (342)
T ss_dssp HHTT
T ss_pred HHHh
Confidence 8753
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=352.27 Aligned_cols=251 Identities=24% Similarity=0.411 Sum_probs=201.6
Q ss_pred hcCccccCcccccCccEEEEEEECC-C-------CEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeC
Q 041143 624 TQNFAQENELGRGGFGTVYKGELED-G-------TKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEG 695 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~~-g-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 695 (973)
.++|...+.||+|+||.||+|+... + ..||+|++... .....+.+.+|++++++++||||+++++++.++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG--GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc--cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 3678899999999999999997653 3 47999998654 344557899999999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCC------
Q 041143 696 NERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYR------ 769 (973)
Q Consensus 696 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~------ 769 (973)
+..++||||+++|+|.+++... ...+++..+..++.||+.||+||| +++|+||||||+||+++.++.
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~ 157 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKN----KNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNP 157 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHT----GGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBC
T ss_pred CCCEEEEECCCCCCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCccccccc
Confidence 9999999999999999999762 234899999999999999999999 889999999999999998887
Q ss_pred --EEEeeccccccCCCCCcceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCC-CCCCCChhhHHHHHH
Q 041143 770 --AKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLA-ALDEERPEESRYLAE 845 (973)
Q Consensus 770 --~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~-p~~~~~~~~~~~~~~ 845 (973)
+||+|||+++.... .....||+.|+|||++.+ ..++.++|||||||++|||++|.. |+..........
T Consensus 158 ~~~kl~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~--- 229 (289)
T 4fvq_A 158 PFIKLSDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ--- 229 (289)
T ss_dssp CEEEECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH---
T ss_pred ceeeeccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHH---
Confidence 99999999875432 123468999999999987 778999999999999999999654 444433221110
Q ss_pred HHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 846 WFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 846 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
..... ..+.+.. ...+.+++.+|++.||++||++.|+++.|+++..
T Consensus 230 ----~~~~~----~~~~~~~---------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 230 ----FYEDR----HQLPAPK---------AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp ----HHHTT----CCCCCCS---------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred ----Hhhcc----CCCCCCC---------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 00000 0011111 1236799999999999999999999999988865
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=352.68 Aligned_cols=272 Identities=22% Similarity=0.357 Sum_probs=208.5
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
.++|+..+.||+|+||.||+|+.. +|+.||||++..........+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 368999999999999999999876 4899999999776556666778899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++++|..++.. ...+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 104 e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 175 (331)
T 4aaa_A 104 EFVDHTILDDLELF-----PNGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA 175 (331)
T ss_dssp ECCSEEHHHHHHHS-----TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecCCcchHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence 99999999887643 245899999999999999999999 7899999999999999999999999999998554
Q ss_pred CCCcceecccccccCcccccccccC-cCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHh----------
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMG-KITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIK---------- 851 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~---------- 851 (973)
... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+... .......
T Consensus 176 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 252 (331)
T 4aaa_A 176 APG-EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLY--HIMMCLGNLIPRHQELF 252 (331)
T ss_dssp ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HHHHHHCSCCHHHHHHH
T ss_pred CCc-cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHH--HHHHHhCCCChhhhhHh
Confidence 322 223445799999999998875 78999999999999999999999998766433211 1111000
Q ss_pred hchhHHHhhcCccccCCcc----cHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 852 SSKEKFKAAIDPALEVNEE----TFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 852 ~~~~~~~~~~~~~l~~~~~----~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
...........+.+..... .......+.+++.+|++.||++||++.|+++ +++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~--hp~f~ 311 (331)
T 4aaa_A 253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH--HDFFQ 311 (331)
T ss_dssp HHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG--SHHHH
T ss_pred hhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc--Cchhc
Confidence 0000111111111110000 0112356889999999999999999999998 66655
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=364.86 Aligned_cols=267 Identities=20% Similarity=0.279 Sum_probs=211.1
Q ss_pred hcCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC-CceeeeeeEEEeCCeEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRH-RHLVSLLGYSIEGNERLLV 701 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV 701 (973)
.++|...+.||+|+||.||+|+. .+++.||||++...... +++.+|+++++.++| ++|..+..++.+.+..++|
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv 81 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV 81 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence 46899999999999999999986 56899999988654322 347889999999976 5666777777788899999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEE---CCCCCEEEeecccc
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILL---DDDYRAKVSDFGLV 778 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill---~~~~~~kl~DfGla 778 (973)
|||+ +++|.+++... ...+++.+++.|+.||+.||+||| +++||||||||+|||+ +.++.+||+|||++
T Consensus 82 me~~-g~sL~~ll~~~----~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla 153 (483)
T 3sv0_A 82 MDLL-GPSLEDLFNFC----SRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (483)
T ss_dssp EECC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred EECC-CCCHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcc
Confidence 9999 99999999642 246899999999999999999999 7899999999999999 68899999999999
Q ss_pred ccCCCCCcc------eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhh
Q 041143 779 KLAPDGEKS------VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKS 852 (973)
Q Consensus 779 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 852 (973)
+........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~- 232 (483)
T 3sv0_A 154 KKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK- 232 (483)
T ss_dssp EECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHH-
T ss_pred eeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcc-
Confidence 865443221 1235689999999999999999999999999999999999999998765433322222211111
Q ss_pred chhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCCC
Q 041143 853 SKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPI 913 (973)
Q Consensus 853 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~~ 913 (973)
....+..... .....+.+++..|++.||++||++.+|++.|+.+.+.....
T Consensus 233 ----~~~~~~~l~~------~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~ 283 (483)
T 3sv0_A 233 ----VATSIEALCR------GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQ 283 (483)
T ss_dssp ----HHSCHHHHHT------TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred ----ccccHHHHhc------CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCC
Confidence 1100000000 11245789999999999999999999999999998765433
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=352.40 Aligned_cols=258 Identities=25% Similarity=0.373 Sum_probs=208.7
Q ss_pred HhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCCh----HHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCe
Q 041143 623 VTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTT----KALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNE 697 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 697 (973)
..++|...+.||+|+||.||+|+.. +|+.||||+++...... ...+.+.+|++++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3467999999999999999999875 68999999997543221 135678999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCC----CEEEe
Q 041143 698 RLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDY----RAKVS 773 (973)
Q Consensus 698 ~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~----~~kl~ 773 (973)
.++||||+++|+|.+++.. ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++ .+||+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~ 161 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQ-----KESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLI 161 (321)
T ss_dssp EEEEECCCCSCBHHHHHHT-----CSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred EEEEEEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEc
Confidence 9999999999999999964 246899999999999999999999 78999999999999999887 79999
Q ss_pred eccccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhc
Q 041143 774 DFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSS 853 (973)
Q Consensus 774 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 853 (973)
|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ...+...
T Consensus 162 Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~i~~~ 233 (321)
T 2a2a_A 162 DFGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET------LANITSV 233 (321)
T ss_dssp CCTTCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHHHHTT
T ss_pred cCccceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHHhc
Confidence 999998665432 23445799999999999999999999999999999999999999987653221 1111110
Q ss_pred hhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhh
Q 041143 854 KEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLV 907 (973)
Q Consensus 854 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~ 907 (973)
... .++... ......+.+++.+|++.||++||++.|+++ ++++
T Consensus 234 ~~~----~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~--hp~~ 276 (321)
T 2a2a_A 234 SYD----FDEEFF-----SHTSELAKDFIRKLLVKETRKRLTIQEALR--HPWI 276 (321)
T ss_dssp CCC----CCHHHH-----TTCCHHHHHHHHTTSCSSTTTSCCHHHHHH--STTT
T ss_pred ccc----cChhhh-----cccCHHHHHHHHHHcCCChhhCcCHHHHhc--Cccc
Confidence 000 000000 011234779999999999999999999998 4444
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=354.27 Aligned_cols=263 Identities=31% Similarity=0.480 Sum_probs=207.9
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCE--EEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTK--IAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGNERLL 700 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~--vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 700 (973)
++|...+.||+|+||.||+|+.. +|.. +|||+++.. ......+.+.+|+++++++ +||||+++++++.+.+..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc-cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 67889999999999999999765 4554 499998753 2334456789999999999 89999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhh-----------ccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCC
Q 041143 701 VYEYMPHGALSRHLFRWEK-----------LQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYR 769 (973)
Q Consensus 701 V~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~ 769 (973)
||||+++|+|.+++..... .....+++.+++.++.||+.||+||| +++|+||||||+||+++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCe
Confidence 9999999999999976331 12346899999999999999999999 889999999999999999999
Q ss_pred EEEeeccccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHH
Q 041143 770 AKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFW 848 (973)
Q Consensus 770 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 848 (973)
+||+|||+++..... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||......+. ..
T Consensus 181 ~kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~------~~ 252 (327)
T 1fvr_A 181 AKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL------YE 252 (327)
T ss_dssp EEECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------HH
T ss_pred EEEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH------HH
Confidence 999999999743221 11233457889999999998899999999999999999998 9999987653221 11
Q ss_pred HHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcC
Q 041143 849 RIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWR 911 (973)
Q Consensus 849 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~ 911 (973)
.+ ......... ......+.+++.+|++.||++||++.|+++.|+.+.++..
T Consensus 253 ~~-------~~~~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 253 KL-------PQGYRLEKP-----LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp HG-------GGTCCCCCC-----TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred Hh-------hcCCCCCCC-----CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 11 111111111 1122457899999999999999999999999999987543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=353.62 Aligned_cols=274 Identities=22% Similarity=0.286 Sum_probs=201.6
Q ss_pred HHhcCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCC---ChHHHHHHHHHHHHHHhc---CCCceeeeeeEEEe
Q 041143 622 KVTQNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVT---TTKALDEFQSEIAVLSKV---RHRHLVSLLGYSIE 694 (973)
Q Consensus 622 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~ 694 (973)
...++|+..+.||+|+||.||+|+. .+|+.||||+++.... .......+.+|+++++++ +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 3467999999999999999999986 4689999999864321 111123566777777766 49999999999987
Q ss_pred CC-----eEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCC
Q 041143 695 GN-----ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYR 769 (973)
Q Consensus 695 ~~-----~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~ 769 (973)
.. ..++||||+. |+|.+++... ....+++.++..++.||+.||+||| +++|+||||||+||+++.++.
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~ 158 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKA---PPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGT 158 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTC---CTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSC
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCC
Confidence 65 4789999996 6999999652 2244899999999999999999999 789999999999999999999
Q ss_pred EEEeeccccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHH
Q 041143 770 AKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWR 849 (973)
Q Consensus 770 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 849 (973)
+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ......
T Consensus 159 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~--~~i~~~ 234 (308)
T 3g33_A 159 VKLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL--GKIFDL 234 (308)
T ss_dssp EEECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHH--HHHHHH
T ss_pred EEEeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHH
Confidence 9999999998654322 234568999999999999999999999999999999999999999876543321 111111
Q ss_pred Hhhc-hhHHHh-------hcCccccCC--cccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 850 IKSS-KEKFKA-------AIDPALEVN--EETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 850 ~~~~-~~~~~~-------~~~~~l~~~--~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
.... ...... .+.+..... ....+....+.+++.+|++.||++|||+.|+++ +++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--h~~~~ 301 (308)
T 3g33_A 235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ--HSYLH 301 (308)
T ss_dssp HCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT--STTC-
T ss_pred hCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc--Ccccc
Confidence 1000 000000 000000000 000012245789999999999999999999998 55554
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=356.55 Aligned_cols=263 Identities=27% Similarity=0.382 Sum_probs=210.2
Q ss_pred HHHHHHHhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCC------hHHHHHHHHHHHHHHhc-CCCceeee
Q 041143 617 VQVLRKVTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTT------TKALDEFQSEIAVLSKV-RHRHLVSL 688 (973)
Q Consensus 617 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l-~h~niv~l 688 (973)
........++|...+.||+|+||.||+|++. +|+.||||+++..... ....+.+.+|+.+++++ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 3445566788999999999999999999885 6999999998754321 12245688999999999 79999999
Q ss_pred eeEEEeCCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCC
Q 041143 689 LGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDY 768 (973)
Q Consensus 689 ~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~ 768 (973)
++++...+..++||||+++|+|.+++.. ...+++..+..++.||+.||+||| +.+|+||||||+||+++.++
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~ 237 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTE-----KVALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNM 237 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTC
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCC
Confidence 9999999999999999999999999965 246899999999999999999999 78999999999999999999
Q ss_pred CEEEeeccccccCCCCCcceecccccccCccccccccc------CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHH
Q 041143 769 RAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVM------GKITTKADVFSYGVVLMELLTGLAALDEERPEESRY 842 (973)
Q Consensus 769 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~ 842 (973)
.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........
T Consensus 238 ~ikl~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~- 314 (365)
T 2y7j_A 238 QIRLSDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILML- 314 (365)
T ss_dssp CEEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-
T ss_pred CEEEEecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHH-
Confidence 99999999998655432 2345689999999998863 35889999999999999999999999765432211
Q ss_pred HHHHHHHHhhchhHHHhhcCccccCCccc-HHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhh
Q 041143 843 LAEWFWRIKSSKEKFKAAIDPALEVNEET-FESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLV 907 (973)
Q Consensus 843 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~-~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~ 907 (973)
..+... ........ ......+.+++.+|++.||++||++.|+++ ++++
T Consensus 315 -----~~i~~~----------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~--hp~f 363 (365)
T 2y7j_A 315 -----RMIMEG----------QYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ--HPFF 363 (365)
T ss_dssp -----HHHHHT----------CCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH--SGGG
T ss_pred -----HHHHhC----------CCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc--Cccc
Confidence 111110 00000000 011234789999999999999999999998 4443
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=356.76 Aligned_cols=261 Identities=24% Similarity=0.379 Sum_probs=206.8
Q ss_pred HhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeEEE
Q 041143 623 VTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGNERLL 700 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 700 (973)
..++|...+.||+|+||.||+|..+ +|+.||||+++.... .+.+|++++.++ +||||+++++++.+++..++
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 4578999999999999999999875 588999999976532 245688888888 79999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCC----CCEEEeecc
Q 041143 701 VYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDD----YRAKVSDFG 776 (973)
Q Consensus 701 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~----~~~kl~DfG 776 (973)
||||+++|+|.+++.. ...+++.++..++.||+.||+||| +++|+||||||+|||+.++ +.+||+|||
T Consensus 94 v~E~~~gg~L~~~i~~-----~~~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg 165 (342)
T 2qr7_A 94 VTELMKGGELLDKILR-----QKFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFG 165 (342)
T ss_dssp EECCCCSCBHHHHHHT-----CTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCT
T ss_pred EEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECC
Confidence 9999999999999865 246899999999999999999999 7899999999999998543 359999999
Q ss_pred ccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhH
Q 041143 777 LVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEK 856 (973)
Q Consensus 777 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (973)
+++....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..........+ +..+....
T Consensus 166 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~---~~~i~~~~-- 239 (342)
T 2qr7_A 166 FAKQLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI---LARIGSGK-- 239 (342)
T ss_dssp TCEECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHH---HHHHHHCC--
T ss_pred CcccCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHH---HHHHccCC--
Confidence 9986544322 23456899999999999888899999999999999999999999986432222111 11111111
Q ss_pred HHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCC
Q 041143 857 FKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRP 912 (973)
Q Consensus 857 ~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~ 912 (973)
++ +. ..........+.+++.+|++.||++||++.|+++ ++++..|..
T Consensus 240 ----~~--~~-~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~--hp~~~~~~~ 286 (342)
T 2qr7_A 240 ----FS--LS-GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR--HPWIVHWDQ 286 (342)
T ss_dssp ----CC--CC-STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT--SHHHHTGGG
T ss_pred ----cc--cC-ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc--CCeecCccc
Confidence 00 00 0000112245779999999999999999999998 788876654
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=348.19 Aligned_cols=257 Identities=23% Similarity=0.373 Sum_probs=206.9
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEe--CCeEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIE--GNERLL 700 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 700 (973)
.++|+..+.||+|+||.||+|... +|+.||+|++..........+.+.+|++++++++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 368899999999999999999875 68999999998765566677889999999999999999999998864 567899
Q ss_pred EEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCC-----eeeccCCCCcEEECCCCCEEEeec
Q 041143 701 VYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQT-----FIHRDLKSSNILLDDDYRAKVSDF 775 (973)
Q Consensus 701 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~-----ivH~Dikp~Nill~~~~~~kl~Df 775 (973)
||||+++|+|.+++..... ....+++..++.++.|++.||+||| +.+ |+||||||+||+++.++.+||+||
T Consensus 85 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEECCTTEEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred EEeCCCCCCHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 9999999999999976433 2356899999999999999999999 555 999999999999999999999999
Q ss_pred cccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchh
Q 041143 776 GLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKE 855 (973)
Q Consensus 776 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 855 (973)
|+++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+. .. .+.
T Consensus 161 g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~---~i~---- 229 (279)
T 2w5a_A 161 GLARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL---AG---KIR---- 229 (279)
T ss_dssp CHHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH---HHH----
T ss_pred chheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHH---HH---HHh----
Confidence 99986544321 22345789999999999988999999999999999999999999987653221 11 111
Q ss_pred HHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHH
Q 041143 856 KFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVL 903 (973)
Q Consensus 856 ~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L 903 (973)
....+.+. ......+.+++.+|++.||++||++.||++.+
T Consensus 230 ---~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 230 ---EGKFRRIP-----YRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp ---HTCCCCCC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred ---hcccccCC-----cccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 11111111 11224578999999999999999999999833
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=352.53 Aligned_cols=256 Identities=24% Similarity=0.395 Sum_probs=210.4
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCC-CChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGV-TTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLV 701 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 701 (973)
.++|...+.||+|+||.||+|... +++.||+|++.... ......+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 367889999999999999999876 47899999986542 3445667899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccC
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA 781 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~ 781 (973)
|||+++++|.+++.. ...+++.++..++.||++||+||| +++|+||||||+||+++.++.+||+|||+++..
T Consensus 120 ~e~~~~~~L~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 191 (335)
T 2owb_A 120 LELCRRRSLLELHKR-----RKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 191 (335)
T ss_dssp ECCCTTCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EecCCCCCHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceec
Confidence 999999999998865 246899999999999999999999 789999999999999999999999999999865
Q ss_pred CCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhc
Q 041143 782 PDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861 (973)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (973)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ...+....
T Consensus 192 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~~~~------- 257 (335)
T 2owb_A 192 EYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET------YLRIKKNE------- 257 (335)
T ss_dssp CSTTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHHTC-------
T ss_pred ccCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH------HHHHhcCC-------
Confidence 43222 23446799999999999999999999999999999999999999987653221 11111100
Q ss_pred CccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 862 DPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 862 ~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
..+. . .....+.+++.+|++.||++||++.|+++ +.++..
T Consensus 258 -~~~~--~---~~~~~~~~li~~~l~~dp~~Rps~~ell~--~~~~~~ 297 (335)
T 2owb_A 258 -YSIP--K---HINPVAASLIQKMLQTDPTARPTINELLN--DEFFTS 297 (335)
T ss_dssp -CCCC--T---TSCHHHHHHHHHHTCSSGGGSCCGGGGGG--SHHHHT
T ss_pred -CCCC--c---cCCHHHHHHHHHHccCChhHCcCHHHHhc--CccccC
Confidence 0111 0 11234778999999999999999999998 566554
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=350.17 Aligned_cols=261 Identities=28% Similarity=0.422 Sum_probs=205.3
Q ss_pred cCccccCcccccCccEEEEEEECC----CCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEe-CCeEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELED----GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIE-GNERL 699 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~ 699 (973)
.+|...+.||+|+||.||+|.+.+ +..||||.+... ......+.+.+|++++++++||||+++++++.. ++..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 467888999999999999998643 235899988753 355566789999999999999999999999754 55779
Q ss_pred EEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccc
Q 041143 700 LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK 779 (973)
Q Consensus 700 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~ 779 (973)
+||||+++|+|.+++.. ....+++.++..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++
T Consensus 104 ~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~ 176 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176 (298)
T ss_dssp EEEECCTTCBHHHHHHC----TTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred EEEeCCCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECcccccc
Confidence 99999999999999964 2256799999999999999999999 7899999999999999999999999999998
Q ss_pred cCCCCCc---ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchh
Q 041143 780 LAPDGEK---SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKE 855 (973)
Q Consensus 780 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 855 (973)
....... .......||+.|+|||.+.+..++.++||||||+++|||++ |.+||......+... ....
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~------~~~~--- 247 (298)
T 3f66_A 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV------YLLQ--- 247 (298)
T ss_dssp CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHH------HHHT---
T ss_pred cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHH------HHhc---
Confidence 6543321 12234567889999999999999999999999999999999 566665544322110 0110
Q ss_pred HHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcC
Q 041143 856 KFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWR 911 (973)
Q Consensus 856 ~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~ 911 (973)
....... . .....+.+++.+|++.||++||++.|+++.|+++...+.
T Consensus 248 ----~~~~~~~-~----~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 248 ----GRRLLQP-E----YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp ----TCCCCCC-T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred ----CCCCCCC-c----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 0000000 1 112357899999999999999999999999999987543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=350.86 Aligned_cols=272 Identities=21% Similarity=0.306 Sum_probs=199.1
Q ss_pred cCcccc-CcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeEEEE
Q 041143 625 QNFAQE-NELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGNERLLV 701 (973)
Q Consensus 625 ~~~~~~-~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 701 (973)
+.|.+. +.||+|+||.||+|... +++.||||++.... ....+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 567774 78999999999999864 68999999997642 23346789999999985 799999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCC---EEEeecccc
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYR---AKVSDFGLV 778 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~---~kl~DfGla 778 (973)
|||+++|+|.+++... ..+++.++..++.||+.||+||| +++|+||||||+||+++.++. +||+|||++
T Consensus 90 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~ 161 (316)
T 2ac3_A 90 FEKMRGGSILSHIHKR-----RHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLG 161 (316)
T ss_dssp EECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCC
T ss_pred EEcCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCc
Confidence 9999999999999752 46899999999999999999999 789999999999999998776 999999998
Q ss_pred ccCCCCCc------ceecccccccCccccccccc-----CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHH
Q 041143 779 KLAPDGEK------SVVTRLAGTFGYLAPEYAVM-----GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWF 847 (973)
Q Consensus 779 ~~~~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 847 (973)
+....... .......||+.|+|||++.. ..++.++|||||||++|||++|+.||......+........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 241 (316)
T 2ac3_A 162 SGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA 241 (316)
T ss_dssp C-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----C
T ss_pred cccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccccc
Confidence 75432211 11233569999999999875 56899999999999999999999999865432100000000
Q ss_pred HHHhhchhHHHhhcCccccCCccc-HHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 848 WRIKSSKEKFKAAIDPALEVNEET-FESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 848 ~~~~~~~~~~~~~~~~~l~~~~~~-~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
.... .......+........... ......+.+++.+|++.||++||++.|+++ +++++.
T Consensus 242 ~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~--hp~~~~ 301 (316)
T 2ac3_A 242 CPAC-QNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ--HPWVQG 301 (316)
T ss_dssp CHHH-HHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH--STTCC-
T ss_pred chhH-HHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc--ChhhcC
Confidence 0000 0000011111111111000 011245789999999999999999999998 555553
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=377.83 Aligned_cols=260 Identities=28% Similarity=0.413 Sum_probs=208.2
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLV 701 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 701 (973)
.++|...+.||+|+||.||+|+.. +|+.||||++..... .......+.+|++++++++|||||++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467899999999999999999875 689999999864311 112245688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccC
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA 781 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~ 781 (973)
|||+++|+|.+++... ....+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++..
T Consensus 263 mEy~~gg~L~~~l~~~---~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHM---GQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp ECCCCSCBHHHHHHSS---SSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEcCCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceec
Confidence 9999999999998652 2245899999999999999999999 789999999999999999999999999999876
Q ss_pred CCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhc
Q 041143 782 PDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861 (973)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (973)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .....+.. .
T Consensus 337 ~~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~--~i~~~i~~--------~ 404 (576)
T 2acx_A 337 PEGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE--EVERLVKE--------V 404 (576)
T ss_dssp CTTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHH--HHHHHHHH--------C
T ss_pred ccCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHH--HHHHHhhc--------c
Confidence 5433 2344689999999999999999999999999999999999999998654321110 11111111 0
Q ss_pred CccccCCcccHHHHHHHHHHHHHhhccCCCCCC-----CHhHHHHHHHHhhh
Q 041143 862 DPALEVNEETFESISIVAELAGHCTAREPYHRP-----DMGHVVNVLSPLVE 908 (973)
Q Consensus 862 ~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~~v~~~L~~~~~ 908 (973)
...+. ......+.+++.+|++.||.+|| ++.||++ +++++
T Consensus 405 ~~~~p-----~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~--HpfF~ 449 (576)
T 2acx_A 405 PEEYS-----ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE--HPLFK 449 (576)
T ss_dssp CCCCC-----TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT--SGGGT
T ss_pred cccCC-----ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh--Chhhc
Confidence 11111 11123577999999999999999 7788887 55544
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=355.22 Aligned_cols=264 Identities=26% Similarity=0.393 Sum_probs=207.5
Q ss_pred hcCccccCcccccCccEEEEEEE------CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCe
Q 041143 624 TQNFAQENELGRGGFGTVYKGEL------EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNE 697 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 697 (973)
.++|...+.||+|+||.||+|++ .+++.||||++... .......++.+|+.++++++||||+++++++...+.
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 46889999999999999999974 35778999999643 345566789999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECC---CCCEEE
Q 041143 698 RLLVYEYMPHGALSRHLFRWEKL--QLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDD---DYRAKV 772 (973)
Q Consensus 698 ~~lV~e~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~---~~~~kl 772 (973)
.++||||+++|+|.+++...... ....+++.+++.++.||+.||+||| +.+|+||||||+||+++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEE
Confidence 99999999999999999764321 1245899999999999999999999 789999999999999984 456999
Q ss_pred eeccccccCCCCC-cceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHH
Q 041143 773 SDFGLVKLAPDGE-KSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRI 850 (973)
Q Consensus 773 ~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 850 (973)
+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++ |+.||......+. .. .+
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~---~~ 258 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV---LE---FV 258 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---HH---HH
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHH---HH---HH
Confidence 9999987432221 122234568999999999999999999999999999999998 9999986653221 11 11
Q ss_pred hhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 851 KSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 851 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
.. ...+... ......+.+++.+|++.||.+||++.+|++.|+.+.+.
T Consensus 259 ~~-------~~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 259 TS-------GGRMDPP-----KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp HT-------TCCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hc-------CCCCCCC-----CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 11 0001111 11224578999999999999999999999999988664
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=357.29 Aligned_cols=250 Identities=26% Similarity=0.353 Sum_probs=205.6
Q ss_pred HHhcCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCCh------HHHHHHHHHHHHHHhcCCCceeeeeeEEEe
Q 041143 622 KVTQNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTT------KALDEFQSEIAVLSKVRHRHLVSLLGYSIE 694 (973)
Q Consensus 622 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 694 (973)
...++|...+.||+|+||.||+|+. .+++.||||+++...... ...+.+.+|++++++++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 3457899999999999999999986 468899999997653221 133467789999999999999999999999
Q ss_pred CCeEEEEEEecCCC-CHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEe
Q 041143 695 GNERLLVYEYMPHG-ALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVS 773 (973)
Q Consensus 695 ~~~~~lV~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~ 773 (973)
.+..++||||+.+| +|.+++.. ...+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~ 172 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDR-----HPRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLI 172 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHT-----CCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEEC
T ss_pred CCEEEEEEEeCCCCccHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEe
Confidence 99999999999777 99998865 246899999999999999999999 7899999999999999999999999
Q ss_pred eccccccCCCCCcceecccccccCcccccccccCcC-CCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhh
Q 041143 774 DFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKI-TTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKS 852 (973)
Q Consensus 774 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 852 (973)
|||+++....... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....
T Consensus 173 Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------------- 235 (335)
T 3dls_A 173 DFGSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE--------------- 235 (335)
T ss_dssp CCTTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG---------------
T ss_pred ecccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH---------------
Confidence 9999986654332 334679999999999988877 7899999999999999999999965221
Q ss_pred chhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 853 SKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 853 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
.......+... ....+.+++.+|++.||++||++.|+++ ++++.
T Consensus 236 ---~~~~~~~~~~~-------~~~~l~~li~~~L~~dP~~Rps~~ell~--hp~~~ 279 (335)
T 3dls_A 236 ---TVEAAIHPPYL-------VSKELMSLVSGLLQPVPERRTTLEKLVT--DPWVT 279 (335)
T ss_dssp ---GTTTCCCCSSC-------CCHHHHHHHHHHTCSSGGGSCCHHHHHH--CTTTT
T ss_pred ---HHhhccCCCcc-------cCHHHHHHHHHHccCChhhCcCHHHHhc--Ccccc
Confidence 01111111111 1234789999999999999999999998 55554
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=346.11 Aligned_cols=250 Identities=22% Similarity=0.314 Sum_probs=203.5
Q ss_pred HHhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeEE
Q 041143 622 KVTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGNERL 699 (973)
Q Consensus 622 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 699 (973)
...++|...+.||+|+||.||+|... +++.||||+++...........+.+|+..+.++ +||||+++++++.+.+..+
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~ 87 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML 87 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 34578999999999999999999876 789999999987655566677889999999999 8999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCC------------
Q 041143 700 LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDD------------ 767 (973)
Q Consensus 700 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~------------ 767 (973)
+||||+++|+|.+++...... ...+++.++..++.||+.||+||| +++|+||||||+||+++.+
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~ 163 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRI-MSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDE 163 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC--------------
T ss_pred EEEEecCCCcHHHHHHhhccc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCccccccccc
Confidence 999999999999999764332 256899999999999999999999 7899999999999999844
Q ss_pred -------CCEEEeeccccccCCCCCcceecccccccCcccccccccC-cCCCchhHHhHHHHHHHHHhCCCCCCCCChhh
Q 041143 768 -------YRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMG-KITTKADVFSYGVVLMELLTGLAALDEERPEE 839 (973)
Q Consensus 768 -------~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~ 839 (973)
..+||+|||.++...... ...||+.|+|||++.+. .++.++|||||||++|||++|++++......
T Consensus 164 ~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~- 237 (289)
T 1x8b_A 164 DDWASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW- 237 (289)
T ss_dssp ------CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH-
T ss_pred ccccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH-
Confidence 479999999998665432 23599999999998765 5668999999999999999998876533210
Q ss_pred HHHHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 840 SRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
..+ .....+.+. . .....+.+++.+|++.||++||++.|+++
T Consensus 238 --------~~~-------~~~~~~~~~-~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 238 --------HEI-------RQGRLPRIP-Q----VLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp --------HHH-------HTTCCCCCS-S----CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------HHH-------HcCCCCCCC-c----ccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 001 111111111 0 11245789999999999999999999997
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=357.65 Aligned_cols=271 Identities=20% Similarity=0.282 Sum_probs=202.4
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC------
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGN------ 696 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 696 (973)
.++|...+.||+|+||.||+|... +|+.||||++..........+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 368999999999999999999765 6889999999876556667788999999999999999999999998654
Q ss_pred eEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecc
Q 041143 697 ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFG 776 (973)
Q Consensus 697 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG 776 (973)
..++||||++ |+|.+++. ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||
T Consensus 104 ~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 172 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ-------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG 172 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred ceEEEEEcCC-CCHHHHHh-------hccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEee
Confidence 7899999996 57877774 34889999999999999999999 7899999999999999999999999999
Q ss_pred ccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHh-----
Q 041143 777 LVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIK----- 851 (973)
Q Consensus 777 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~----- 851 (973)
+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... ..+....
T Consensus 173 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~i~~~~~~~~~~ 248 (371)
T 2xrw_A 173 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWN--KVIEQLGTPCPE 248 (371)
T ss_dssp C------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHC-CCCCCHH
T ss_pred cccccccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHHhCCCCHH
Confidence 99865432 12344679999999999999999999999999999999999999998765432111 0000000
Q ss_pred ---hchhHH---------------HhhcCccccC--CcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcC
Q 041143 852 ---SSKEKF---------------KAAIDPALEV--NEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWR 911 (973)
Q Consensus 852 ---~~~~~~---------------~~~~~~~l~~--~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~ 911 (973)
...... ...+...... ..........+.+++.+|++.||++|||++|+++ +++++.|.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~--hp~~~~~~ 326 (371)
T 2xrw_A 249 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ--HPYINVWY 326 (371)
T ss_dssp HHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH--SHHHHTTC
T ss_pred HHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC--Ccchhhhc
Confidence 000000 0001000000 0011223456889999999999999999999999 78777654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=348.94 Aligned_cols=260 Identities=28% Similarity=0.412 Sum_probs=206.0
Q ss_pred CccccCcccccCccEEEEEEECC-C---CEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeE-EE
Q 041143 626 NFAQENELGRGGFGTVYKGELED-G---TKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNER-LL 700 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~~-g---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~l 700 (973)
.|...+.||+|+||.||+|.+.+ + ..||+|++... ......+.+.+|++++++++||||+++++++.+.+.. ++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 45566899999999999997532 2 37999998753 3455677899999999999999999999999876655 99
Q ss_pred EEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecccccc
Q 041143 701 VYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKL 780 (973)
Q Consensus 701 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~ 780 (973)
||||+.+|+|.+++.. ....+++.++..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++.
T Consensus 101 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 173 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRS----PQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARD 173 (298)
T ss_dssp EECCCTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCT
T ss_pred EEecccCCCHHHHHhc----cccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCccc
Confidence 9999999999999965 2356899999999999999999999 78999999999999999999999999999985
Q ss_pred CCCCC---cceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCC-CCCCChhhHHHHHHHHHHHhhchhH
Q 041143 781 APDGE---KSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAA-LDEERPEESRYLAEWFWRIKSSKEK 856 (973)
Q Consensus 781 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (973)
..... ........||+.|+|||.+.+..++.++|||||||++|||++|..| +......+. ...+ .
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~---~~~~---~----- 242 (298)
T 3pls_A 174 ILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL---THFL---A----- 242 (298)
T ss_dssp TTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGH---HHHH---H-----
T ss_pred ccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHH---HHHh---h-----
Confidence 54322 1122345688999999999999999999999999999999995555 444333221 1110 0
Q ss_pred HHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcC
Q 041143 857 FKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWR 911 (973)
Q Consensus 857 ~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~ 911 (973)
........ ......+.+++.+|++.||.+|||+.++++.|+++.+...
T Consensus 243 --~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 243 --QGRRLPQP-----EYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp --TTCCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred --cCCCCCCC-----ccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 00011110 1112457899999999999999999999999999988754
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=364.88 Aligned_cols=275 Identities=22% Similarity=0.305 Sum_probs=212.7
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC--eEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGN--ERLLV 701 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV 701 (973)
++|...+.||+|+||.||+|++. +|+.||||+++... .....+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS-FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG-GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccc-ccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 57889999999999999999876 48999999987532 2233567889999999999999999999998765 67999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEE----CCCCCEEEeeccc
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILL----DDDYRAKVSDFGL 777 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill----~~~~~~kl~DfGl 777 (973)
|||+++|+|.+++..... ...+++..++.++.||+.||+||| +++|+||||||+|||+ +.++.+||+|||+
T Consensus 88 ~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp ECCCTTEEHHHHTTSGGG--TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred EecCCCCCHHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 999999999999975322 234899999999999999999999 7899999999999999 7788899999999
Q ss_pred cccCCCCCcceecccccccCccccccccc--------CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHH
Q 041143 778 VKLAPDGEKSVVTRLAGTFGYLAPEYAVM--------GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWR 849 (973)
Q Consensus 778 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 849 (973)
++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .+.+..
T Consensus 163 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~~~ 238 (396)
T 4eut_A 163 ARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYK 238 (396)
T ss_dssp CEECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HHHHHH
T ss_pred ceEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HHHHHH
Confidence 98664432 2344679999999998865 56788999999999999999999999754322111 111111
Q ss_pred HhhchhH--H---HhhcC------cccc-CCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 850 IKSSKEK--F---KAAID------PALE-VNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 850 ~~~~~~~--~---~~~~~------~~l~-~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
+...... . ..... ..+. ...........+.+++.+|++.||++||++.|+++.++.+.++
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred HhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 1111100 0 00000 0011 0112345666788999999999999999999999999988764
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=346.41 Aligned_cols=255 Identities=26% Similarity=0.442 Sum_probs=205.3
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLV 701 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 701 (973)
.++|...+.||+|+||.||+|... +++.||||++..... .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 478999999999999999999775 577999999864311 111245688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccC
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA 781 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~ 781 (973)
|||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++...
T Consensus 88 ~e~~~~~~l~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp ECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccC
Confidence 9999999999998652 45899999999999999999999 889999999999999999999999999998654
Q ss_pred CCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhc
Q 041143 782 PDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861 (973)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (973)
.... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.. ..+.. .
T Consensus 160 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~--------~ 222 (279)
T 3fdn_A 160 PSSR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY------KRISR--------V 222 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHH--------T
T ss_pred Cccc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHH------HHHHh--------C
Confidence 3322 23457999999999999999999999999999999999999999866533211 11111 0
Q ss_pred CccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhc
Q 041143 862 DPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKW 910 (973)
Q Consensus 862 ~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~ 910 (973)
...+. . .....+.+++.+|++.||++||++.||++ ++++...
T Consensus 223 ~~~~~--~---~~~~~~~~li~~~l~~~p~~Rps~~e~l~--h~~~~~~ 264 (279)
T 3fdn_A 223 EFTFP--D---FVTEGARDLISRLLKHNPSQRPMLREVLE--HPWITAN 264 (279)
T ss_dssp CCCCC--T---TSCHHHHHHHHHHCCSSGGGSCCHHHHHH--CHHHHHH
T ss_pred CCCCC--C---cCCHHHHHHHHHHhccChhhCCCHHHHhh--CccccCC
Confidence 11111 0 11234679999999999999999999999 6776643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=353.78 Aligned_cols=278 Identities=22% Similarity=0.336 Sum_probs=211.2
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeC-----Ce
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEG-----NE 697 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 697 (973)
.++|...+.||+|+||.||+|... +++.||||++... ......+.+.+|++++++++||||+++++++... ..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc-cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 358999999999999999999865 6889999999753 3455567899999999999999999999999765 36
Q ss_pred EEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccc
Q 041143 698 RLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL 777 (973)
Q Consensus 698 ~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGl 777 (973)
.++||||+. |+|.+++.. ..+++.++..++.||+.||+||| +++|+||||||+||+++.++.+||+|||+
T Consensus 105 ~~iv~e~~~-~~L~~~l~~------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 174 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT------QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGL 174 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEcccC-cCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcc
Confidence 899999996 699998864 45899999999999999999999 78999999999999999999999999999
Q ss_pred cccCCCCCcc--eecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhc-
Q 041143 778 VKLAPDGEKS--VVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSS- 853 (973)
Q Consensus 778 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~- 853 (973)
++........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+..... .......
T Consensus 175 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i--~~~~~~~~ 252 (364)
T 3qyz_A 175 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI--LGILGSPS 252 (364)
T ss_dssp CEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHH--HHHHCSCC
T ss_pred eEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHH--HHHhCCCC
Confidence 9865432211 1244689999999998764 45899999999999999999999999876644322111 1000000
Q ss_pred hhHHHhhcC--------ccccCCccc-----HHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCCCCCC
Q 041143 854 KEKFKAAID--------PALEVNEET-----FESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPITDE 916 (973)
Q Consensus 854 ~~~~~~~~~--------~~l~~~~~~-----~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~~~~~ 916 (973)
.+......+ ......... ......+.+++.+|++.||++|||+.|+++ +++++++.....+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--hp~~~~~~~~~~~ 326 (364)
T 3qyz_A 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA--HPYLEQYYDPSDE 326 (364)
T ss_dssp HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SGGGTTTCCGGGS
T ss_pred HHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc--CcchhhccCcccc
Confidence 000000000 000000000 111245789999999999999999999999 8888776544433
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=343.36 Aligned_cols=258 Identities=23% Similarity=0.377 Sum_probs=205.1
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCCh----HHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTT----KALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNER 698 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 698 (973)
.++|...+.||+|+||.||+|+.. +|+.||||+++...... ...+.+.+|++++++++||||+++++++.+.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 467899999999999999999876 68999999987542221 1356789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCC----CEEEee
Q 041143 699 LLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDY----RAKVSD 774 (973)
Q Consensus 699 ~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~----~~kl~D 774 (973)
++||||+++++|.+++.. ...+++.++..++.||+.||+||| +.+|+||||||+||+++.++ .+||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~d 155 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE-----KESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLID 155 (283)
T ss_dssp EEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEEeecCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEe
Confidence 999999999999999965 246899999999999999999999 78999999999999998877 899999
Q ss_pred ccccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhch
Q 041143 775 FGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSK 854 (973)
Q Consensus 775 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 854 (973)
||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.. ..+....
T Consensus 156 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~~~ 227 (283)
T 3bhy_A 156 FGIAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL------TNISAVN 227 (283)
T ss_dssp CTTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHTTC
T ss_pred cccceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHH------HHhHhcc
Confidence 99998654432 233457999999999999899999999999999999999999999876532211 1111100
Q ss_pred hHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 855 EKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 855 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
.. .++.. .......+.+++.+|++.||++||++.|+++ +++++
T Consensus 228 ~~----~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~--h~~~~ 270 (283)
T 3bhy_A 228 YD----FDEEY-----FSNTSELAKDFIRRLLVKDPKRRMTIAQSLE--HSWIK 270 (283)
T ss_dssp CC----CCHHH-----HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH--CHHHH
T ss_pred cC----Ccchh-----cccCCHHHHHHHHHHccCCHhHCcCHHHHHh--CHHHH
Confidence 00 00000 0011235779999999999999999999998 44444
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=346.79 Aligned_cols=253 Identities=30% Similarity=0.443 Sum_probs=200.6
Q ss_pred hcCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeC-CeEEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEG-NERLLVY 702 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lV~ 702 (973)
.++|...+.||+|+||.||+|+.. |+.||||+++.. ...+.+.+|++++++++||||+++++++.+. +..++||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch----hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 368899999999999999999886 889999998754 2346789999999999999999999997654 4689999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++|+|.+++..... ..+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++...
T Consensus 95 e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp CCCTTEEHHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred ecCCCCCHHHHHHhccc---ccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 99999999999976322 34789999999999999999999 7899999999999999999999999999988543
Q ss_pred CCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhc
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (973)
.. .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.. ..+. ...
T Consensus 169 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~------~~~~-------~~~ 231 (278)
T 1byg_A 169 ST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV------PRVE-------KGY 231 (278)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH------HHHT-------TTC
T ss_pred cc----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH------HHHh-------cCC
Confidence 32 123467899999999999999999999999999999998 99999866533211 1111 111
Q ss_pred CccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 862 DPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 862 ~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
..... ......+.+++.+|++.||++||++.|+++.|+.+...
T Consensus 232 ~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 232 KMDAP-----DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp CCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCc-----ccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 11111 11224578999999999999999999999999998664
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=367.91 Aligned_cols=246 Identities=15% Similarity=0.162 Sum_probs=192.6
Q ss_pred hcCccccCcccccCccEEEEEEE-CCCCEEEEEEeecC-CCChHHHHHHHHHH---HHHHhcCCCceeeee-------eE
Q 041143 624 TQNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAG-VTTTKALDEFQSEI---AVLSKVRHRHLVSLL-------GY 691 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~ 691 (973)
.++|...+.||+|+||.||+|+. .+|+.||||++... .......+.+.+|+ +++++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 36788899999999999999986 56999999999743 22344567899999 455556899999998 66
Q ss_pred EEeCC-----------------eEEEEEEecCCCCHHHHHHhhhhccC--CCCCHHHHHHHHHHHHHHHHHHHhhccCCe
Q 041143 692 SIEGN-----------------ERLLVYEYMPHGALSRHLFRWEKLQL--KPLSWTRRLSIALDVARGMEYLHCLARQTF 752 (973)
Q Consensus 692 ~~~~~-----------------~~~lV~e~~~~g~L~~~l~~~~~~~~--~~l~~~~~~~i~~~ia~gl~~LH~~~~~~i 752 (973)
+.+.+ ..++||||+ +|+|.+++........ ..++|..++.|+.||++||+||| +++|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence 65543 278999999 7899999986433221 34557889999999999999999 7899
Q ss_pred eeccCCCCcEEECCCCCEEEeeccccccCCCCCcceecccccccCcccccccccC-----------cCCCchhHHhHHHH
Q 041143 753 IHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMG-----------KITTKADVFSYGVV 821 (973)
Q Consensus 753 vH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~S~Gvv 821 (973)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999986432 3345678 999999999887 89999999999999
Q ss_pred HHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 822 LMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 822 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
+|||++|+.||........ ....... .. . ....+.+++.+||+.||++||++.|+++
T Consensus 303 l~elltg~~Pf~~~~~~~~----------------~~~~~~~-~~--~----~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGG----------------SEWIFRS-CK--N----IPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHSSCCC------CC----------------SGGGGSS-CC--C----CCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHCCCCCcccccccc----------------hhhhhhh-cc--C----CCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 9999999999975432110 1111111 00 1 1234779999999999999999999997
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=356.63 Aligned_cols=273 Identities=19% Similarity=0.283 Sum_probs=197.6
Q ss_pred HHhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEE
Q 041143 622 KVTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLL 700 (973)
Q Consensus 622 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 700 (973)
...++|...+.||+|+||.||+|... +++.||||+++.........+.+.+|++++++++||||+++++++.+.+..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 34578999999999999999999764 68899999997654444556678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEE-----CCCCCEEEeec
Q 041143 701 VYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILL-----DDDYRAKVSDF 775 (973)
Q Consensus 701 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill-----~~~~~~kl~Df 775 (973)
||||++ |+|.+++.. ...+++..+..++.||+.||+||| +++|+||||||+|||+ ++++.+||+||
T Consensus 111 v~e~~~-~~L~~~~~~-----~~~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Df 181 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDK-----NPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDF 181 (329)
T ss_dssp EEECCS-EEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred EEecCC-CCHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcC
Confidence 999997 599999865 245899999999999999999999 7899999999999999 45566999999
Q ss_pred cccccCCCCCcceecccccccCcccccccccC-cCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhch
Q 041143 776 GLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMG-KITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSK 854 (973)
Q Consensus 776 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 854 (973)
|+++...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+. +...+.......
T Consensus 182 g~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~ 258 (329)
T 3gbz_A 182 GLARAFGIPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ--LFKIFEVLGLPD 258 (329)
T ss_dssp THHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCC
T ss_pred CCccccCCcc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH--HHHHHHHhCCCc
Confidence 9998654322 223445789999999999874 489999999999999999999999987654332 111111110000
Q ss_pred h-H------HHhhcCccccCCcccHH------HHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 855 E-K------FKAAIDPALEVNEETFE------SISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 855 ~-~------~~~~~~~~l~~~~~~~~------~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
. . ................. ....+.+++.+|++.||++|||+.|+++ +++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--hp~f~ 323 (329)
T 3gbz_A 259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE--HPYFS 323 (329)
T ss_dssp TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT--SGGGS
T ss_pred hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC--CcccC
Confidence 0 0 00000000000000000 1245789999999999999999999998 65554
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=373.85 Aligned_cols=257 Identities=25% Similarity=0.363 Sum_probs=205.0
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
++|...+.||+|+||.||+|+.. +|+.||||++..... .....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 67888899999999999999875 689999999864311 1122457889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++|+|..++..... ....+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 265 E~~~gg~L~~~l~~~~~-~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDE-DNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp CCCTTCBHHHHHHTSST-TSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EeccCCCHHHHHHHhhc-ccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999976322 2356899999999999999999999 7899999999999999999999999999998665
Q ss_pred CCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcC
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (973)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........ .......+..
T Consensus 341 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~~~~~~~i~~---------- 407 (543)
T 3c4z_A 341 AGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRVLE---------- 407 (543)
T ss_dssp TTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--HHHHHHHHHH----------
T ss_pred CCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--HHHHHHHHhh----------
Confidence 4332 23446899999999999999999999999999999999999999986532111 0111111111
Q ss_pred ccccCCcccHHHHHHHHHHHHHhhccCCCCCCCH-----hHHHH
Q 041143 863 PALEVNEETFESISIVAELAGHCTAREPYHRPDM-----GHVVN 901 (973)
Q Consensus 863 ~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~-----~~v~~ 901 (973)
...... ......+.+++.+|++.||++||++ .+|.+
T Consensus 408 ~~~~~p---~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 408 QAVTYP---DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp CCCCCC---TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred cccCCC---cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 111100 1112457799999999999999976 55654
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=351.51 Aligned_cols=263 Identities=25% Similarity=0.354 Sum_probs=204.6
Q ss_pred hcCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEe----CCeE
Q 041143 624 TQNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIE----GNER 698 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 698 (973)
.++|...+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|++++++++||||+++++++.. ....
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 36899999999999999999987 57899999998654 45667789999999999999999999999873 3467
Q ss_pred EEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecccc
Q 041143 699 LLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLV 778 (973)
Q Consensus 699 ~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla 778 (973)
++||||+++|+|.+++..... ....+++.+++.++.||++||+||| +++|+||||||+||+++.++.+||+|||++
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKD-KGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred EEEEEeCCCCcHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 899999999999999976433 3367999999999999999999999 789999999999999999999999999998
Q ss_pred ccCCCCCcc--------eecccccccCcccccccccCc---CCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHH
Q 041143 779 KLAPDGEKS--------VVTRLAGTFGYLAPEYAVMGK---ITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWF 847 (973)
Q Consensus 779 ~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 847 (973)
+........ ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||........ ....
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~-- 258 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVAL-- 258 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHH--
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhH--
Confidence 754321110 012345799999999987543 78999999999999999999999853111000 0000
Q ss_pred HHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 848 WRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 848 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
. ..... ... ........+.+++.+|++.||.+||++.+|++.|+.+..
T Consensus 259 -~-------~~~~~--~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 259 -A-------VQNQL--SIP---QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp -H-------HHCC----CC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred -H-------hhccC--CCC---ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 0 00000 000 001122458899999999999999999999999987754
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=371.94 Aligned_cols=261 Identities=25% Similarity=0.362 Sum_probs=208.3
Q ss_pred HhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEE
Q 041143 623 VTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLV 701 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 701 (973)
..++|...+.||+|+||.||+|+.. +|+.||||++............+.+|++++++++|||||++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4578999999999999999999875 689999999864322223356789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEEC---CCCCEEEeecccc
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLD---DDYRAKVSDFGLV 778 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~---~~~~~kl~DfGla 778 (973)
|||+++|+|.+++... ..+++.++..++.||+.||+||| +++|+||||||+|||++ .++.+||+|||++
T Consensus 100 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 171 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (486)
T ss_dssp ECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred EEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence 9999999999988652 46899999999999999999999 78999999999999995 4567999999999
Q ss_pred ccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHH
Q 041143 779 KLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFK 858 (973)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (973)
+...... ......||+.|+|||++.+ .++.++||||+||++|||++|+.||......+. ...+....
T Consensus 172 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~~~i~~~~---- 238 (486)
T 3mwu_A 172 TCFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI------LKRVETGK---- 238 (486)
T ss_dssp TTBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHTC----
T ss_pred eECCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhCC----
Confidence 8654432 2345679999999998865 599999999999999999999999987654321 11111100
Q ss_pred hhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcC
Q 041143 859 AAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWR 911 (973)
Q Consensus 859 ~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~ 911 (973)
..... .........+.+++.+|++.||.+|||+.|+++ +++++.+.
T Consensus 239 --~~~~~---~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~--hp~~~~~~ 284 (486)
T 3mwu_A 239 --YAFDL---PQWRTISDDAKDLIRKMLTFHPSLRITATQCLE--HPWIQKYS 284 (486)
T ss_dssp --CCSCS---GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH--CHHHHHTC
T ss_pred --CCCCC---cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc--CHhhccCc
Confidence 00000 000112245779999999999999999999998 77776644
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=353.28 Aligned_cols=272 Identities=20% Similarity=0.307 Sum_probs=206.2
Q ss_pred cCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeC--------
Q 041143 625 QNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEG-------- 695 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------- 695 (973)
++|...+.||+|+||.||+|+. .+|+.||||++............+.+|++++++++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 6899999999999999999987 4789999999866544444455788999999999999999999999873
Q ss_pred CeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeec
Q 041143 696 NERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDF 775 (973)
Q Consensus 696 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 775 (973)
+..++||||++ |+|.+.+... ...+++.++..++.||+.||+||| +++|+||||||+|||++.++.+||+||
T Consensus 97 ~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 97 GSIYLVFDFCE-HDLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp CEEEEEEECCS-EEHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred ceEEEEEeccC-CCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccc
Confidence 46899999996 4787777542 245899999999999999999999 789999999999999999999999999
Q ss_pred cccccCCCCC---cceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHh
Q 041143 776 GLVKLAPDGE---KSVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIK 851 (973)
Q Consensus 776 Gla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 851 (973)
|+++...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+..... ....
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i---~~~~ 245 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI---SQLC 245 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHH
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HHHh
Confidence 9998654221 222345678999999998876 45899999999999999999999999876644322211 1111
Q ss_pred hc-h-hHHHhhcC----ccc---cCC-cccHHH------HHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 852 SS-K-EKFKAAID----PAL---EVN-EETFES------ISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 852 ~~-~-~~~~~~~~----~~l---~~~-~~~~~~------~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
.. . ......-. ..+ ... ....+. ...+.+++.+|++.||++|||++|+++ ++++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--hp~f~~ 317 (351)
T 3mi9_A 246 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN--HDFFWS 317 (351)
T ss_dssp CCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGGS
T ss_pred CCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC--CCCcCC
Confidence 00 0 00000000 000 000 000111 134779999999999999999999998 666653
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=363.09 Aligned_cols=255 Identities=26% Similarity=0.366 Sum_probs=201.8
Q ss_pred hcCccccCcccccCccEEEEEEE----CCCCEEEEEEeecCCC--ChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCC
Q 041143 624 TQNFAQENELGRGGFGTVYKGEL----EDGTKIAVKRMEAGVT--TTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGN 696 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~----~~g~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 696 (973)
.++|...+.||+|+||.||+|+. .+|+.||||+++.... .....+.+.+|+++++++ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36899999999999999999987 3689999999864311 112234577899999999 6999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecc
Q 041143 697 ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFG 776 (973)
Q Consensus 697 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG 776 (973)
..++||||+++|+|.+++... ..+++.++..++.||++||+||| +++|+||||||+|||++.++.+||+|||
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG 204 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFG 204 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred eEEEEeecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCC
Confidence 999999999999999999752 45899999999999999999999 7899999999999999999999999999
Q ss_pred ccccCCCCCcceecccccccCccccccccc--CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhch
Q 041143 777 LVKLAPDGEKSVVTRLAGTFGYLAPEYAVM--GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSK 854 (973)
Q Consensus 777 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 854 (973)
+++..............||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .........
T Consensus 205 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~-- 280 (355)
T 1vzo_A 205 LSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRRILK-- 280 (355)
T ss_dssp EEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHHHHHH--
T ss_pred CCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH--HHHHHHHhc--
Confidence 998655433333445689999999999985 34789999999999999999999999754322111 111111111
Q ss_pred hHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCC-----CHhHHHH
Q 041143 855 EKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRP-----DMGHVVN 901 (973)
Q Consensus 855 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~~v~~ 901 (973)
..+.+. ......+.+++.+|++.||++|| ++.|+++
T Consensus 281 ------~~~~~~-----~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~ 321 (355)
T 1vzo_A 281 ------SEPPYP-----QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 321 (355)
T ss_dssp ------CCCCCC-----TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ------cCCCCC-----cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc
Confidence 011111 11224477999999999999999 8899887
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=361.36 Aligned_cols=256 Identities=22% Similarity=0.268 Sum_probs=193.2
Q ss_pred cCcccc-CcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHh-cCCCceeeeeeEEEe----CCe
Q 041143 625 QNFAQE-NELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSK-VRHRHLVSLLGYSIE----GNE 697 (973)
Q Consensus 625 ~~~~~~-~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~ 697 (973)
++|... +.||+|+||+||+|... +|+.||||+++.. ..+.+|++++.+ .+||||+++++++.. ...
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 456665 68999999999999875 6899999998642 356788888755 589999999999876 556
Q ss_pred EEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECC---CCCEEEee
Q 041143 698 RLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDD---DYRAKVSD 774 (973)
Q Consensus 698 ~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~---~~~~kl~D 774 (973)
.++||||+++|+|.+++... ....+++.++..|+.||+.||+||| +.+|+||||||+|||++. ++.+||+|
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~---~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~D 207 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTD 207 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECC
T ss_pred EEEEEEeCCCCcHHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEe
Confidence 89999999999999999752 2246899999999999999999999 789999999999999998 78999999
Q ss_pred ccccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHH-HHHHHHHHHhhc
Q 041143 775 FGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESR-YLAEWFWRIKSS 853 (973)
Q Consensus 775 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~ 853 (973)
||+++...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ... ..+...
T Consensus 208 FG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~---~~i~~~ 282 (400)
T 1nxk_A 208 FGFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK---TRIRMG 282 (400)
T ss_dssp CTTCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHH---HHHHHT
T ss_pred cccccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHH---HHHHcC
Confidence 99998654322 234568999999999999999999999999999999999999999765432110 000 011100
Q ss_pred hhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 854 KEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 854 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
. .-.+... .......+.+++.+||+.||++||++.||++ +.++..
T Consensus 283 ~-----~~~~~~~----~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~--hp~~~~ 327 (400)
T 1nxk_A 283 Q-----YEFPNPE----WSEVSEEVKMLIRNLLKTEPTQRMTITEFMN--HPWIMQ 327 (400)
T ss_dssp C-----CCCCTTT----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH--SHHHHT
T ss_pred c-----ccCCCcc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhc--CccccC
Confidence 0 0000000 0112245789999999999999999999998 566543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=356.83 Aligned_cols=272 Identities=25% Similarity=0.405 Sum_probs=209.4
Q ss_pred cCccccCcccccCccEEEEEEE-----CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC--e
Q 041143 625 QNFAQENELGRGGFGTVYKGEL-----EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGN--E 697 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~ 697 (973)
++|...+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|++++++++||||+++++++...+ .
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 5788899999999999999984 36889999998754 4556678999999999999999999999987654 6
Q ss_pred EEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccc
Q 041143 698 RLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL 777 (973)
Q Consensus 698 ~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGl 777 (973)
.++||||+++|+|.+++... ...+++.+++.++.||++||+||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGL 191 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHS----TTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred eEEEEECCCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcc
Confidence 79999999999999999752 245899999999999999999999 78999999999999999999999999999
Q ss_pred cccCCCCCcce--ecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhc--
Q 041143 778 VKLAPDGEKSV--VTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSS-- 853 (973)
Q Consensus 778 a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-- 853 (973)
++......... .....++..|+|||.+.+..++.++|||||||++|||++|+.|+......- ..........
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~----~~~~~~~~~~~~ 267 (326)
T 2w1i_A 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF----MRMIGNDKQGQM 267 (326)
T ss_dssp CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHH----HHHHCTTCCTHH
T ss_pred hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHH----HHhhccccchhh
Confidence 98665433221 233457888999999998899999999999999999999999876421100 0000000000
Q ss_pred -hhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhc
Q 041143 854 -KEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKW 910 (973)
Q Consensus 854 -~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~ 910 (973)
...+.+.+..... ..........+.+++.+|++.||++||++.||++.|+.+.++.
T Consensus 268 ~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 268 IVFHLIELLKNNGR-LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp HHHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHhhcCCC-CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 0001111111100 0011122345889999999999999999999999999987653
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=359.02 Aligned_cols=270 Identities=21% Similarity=0.328 Sum_probs=210.1
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
.++|...+.||+|+||.||+|... +|+.||+|+++.. ......+.+.+|++++++++||||+++++++..++..++||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc-cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 357999999999999999999876 6899999999765 34556678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++|+|.+++... ..+++..+..++.|++.||+|||+ .++|+||||||+||+++.++.+||+|||+++...
T Consensus 111 e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 111 EHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp CCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred ECCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH--hCCEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 999999999999652 458999999999999999999993 2389999999999999999999999999987442
Q ss_pred CCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHH---------HHHh--
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWF---------WRIK-- 851 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~---------~~~~-- 851 (973)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+........ ....
T Consensus 184 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3eqc_A 184 DS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260 (360)
T ss_dssp HH---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred cc---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence 21 223457999999999999999999999999999999999999999876543322111000 0000
Q ss_pred ------------------hchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhc
Q 041143 852 ------------------SSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKW 910 (973)
Q Consensus 852 ------------------~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~ 910 (973)
...........+... .......+.+++.+|++.||++|||+.|+++ +++++..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~~~~~ 331 (360)
T 3eqc_A 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLP----SGVFSLEFQDFVNKCLIKNPAERADLKQLMV--HAFIKRS 331 (360)
T ss_dssp -------------CCCHHHHHHHHHHSCCCCCC----TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT--SHHHHHH
T ss_pred CCcccccccCCCCcccchhhhhHHhccCCCCCC----cccccHHHHHHHHHHhhcChhhCCCHHHHhh--ChHhhcc
Confidence 000000000011111 0011235789999999999999999999998 7777653
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=344.84 Aligned_cols=251 Identities=25% Similarity=0.434 Sum_probs=205.2
Q ss_pred HHhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEe------
Q 041143 622 KVTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIE------ 694 (973)
Q Consensus 622 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------ 694 (973)
....+|...+.||+|+||.||+|... +|+.||||+++... +.+.+|++++++++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence 34578999999999999999999886 78999999997542 356789999999999999999998864
Q ss_pred ----------CCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEE
Q 041143 695 ----------GNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILL 764 (973)
Q Consensus 695 ----------~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill 764 (973)
....++||||+++|+|.+++.... ...+++..++.++.||+.||+||| +.+|+||||||+||++
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~ 155 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR---GEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFL 155 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHGG---GSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEE
Confidence 345799999999999999997632 256899999999999999999999 7899999999999999
Q ss_pred CCCCCEEEeeccccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 041143 765 DDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLA 844 (973)
Q Consensus 765 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~ 844 (973)
+.++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|..|+... .
T Consensus 156 ~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~--- 225 (284)
T 2a19_B 156 VDTKQVKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-----S--- 225 (284)
T ss_dssp EETTEEEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----H---
T ss_pred cCCCCEEECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----H---
Confidence 999999999999998655432 223457999999999999999999999999999999999998876311 0
Q ss_pred HHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 845 EWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 845 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
.+..... ...+...+ ...+.+++.+|++.||++||++.|+++.|+.+.+.
T Consensus 226 ~~~~~~~------~~~~~~~~---------~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 226 KFFTDLR------DGIISDIF---------DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp HHHHHHH------TTCCCTTS---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred HHHHHhh------cccccccC---------CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 1111111 01111111 13467999999999999999999999999988664
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=355.36 Aligned_cols=266 Identities=24% Similarity=0.349 Sum_probs=209.6
Q ss_pred HHHHhcCcccc-CcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeeEEEeCC
Q 041143 620 LRKVTQNFAQE-NELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR-HRHLVSLLGYSIEGN 696 (973)
Q Consensus 620 ~~~~~~~~~~~-~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 696 (973)
.+...++|... +.||+|+||.||+|... +|+.||||+++...........+.+|+.++.+++ ||||+++++++.+.+
T Consensus 23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~ 102 (327)
T 3lm5_A 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS 102 (327)
T ss_dssp HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence 35566778877 88999999999999876 5899999999765444445678899999999994 799999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECC---CCCEEEe
Q 041143 697 ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDD---DYRAKVS 773 (973)
Q Consensus 697 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~---~~~~kl~ 773 (973)
..++||||+++|+|.+++.. .....+++.++..++.|++.||+||| +++|+||||||+||+++. ++.+||+
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~ 176 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLP---ELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIV 176 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSS---CC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEEC
T ss_pred eEEEEEEecCCCcHHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEe
Confidence 99999999999999988743 22356899999999999999999999 789999999999999998 7899999
Q ss_pred eccccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhc
Q 041143 774 DFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSS 853 (973)
Q Consensus 774 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 853 (973)
|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .+...
T Consensus 177 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~------~i~~~ 248 (327)
T 3lm5_A 177 DFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYL------NISQV 248 (327)
T ss_dssp CGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHHT
T ss_pred eCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH------HHHhc
Confidence 999998664332 2344679999999999999999999999999999999999999998765432211 11100
Q ss_pred hhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhc
Q 041143 854 KEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKW 910 (973)
Q Consensus 854 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~ 910 (973)
..+... .........+.+++.+|++.||++||++.|+++ +++++.+
T Consensus 249 ------~~~~~~---~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~--h~~~~~~ 294 (327)
T 3lm5_A 249 ------NVDYSE---ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS--HSWLQQW 294 (327)
T ss_dssp ------CCCCCT---TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT--CGGGCCC
T ss_pred ------ccccCc---hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC--CHhhccc
Confidence 000000 001112245779999999999999999999998 6666643
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=371.52 Aligned_cols=258 Identities=24% Similarity=0.368 Sum_probs=202.2
Q ss_pred HhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEE
Q 041143 623 VTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLV 701 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 701 (973)
..++|...+.||+|+||.||+|+.. ++..||||+++.........+.+.+|+++++.++|||||++++++.+....++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3467999999999999999999875 688999999976543333456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCC---CCEEEeecccc
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDD---YRAKVSDFGLV 778 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~---~~~kl~DfGla 778 (973)
|||+++|+|.+++... ..+++..+..++.||+.||+||| +++|+||||||+|||++.. +.+||+|||++
T Consensus 115 ~e~~~~g~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a 186 (494)
T 3lij_A 115 MECYKGGELFDEIIHR-----MKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLS 186 (494)
T ss_dssp EECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence 9999999999988652 45899999999999999999999 7899999999999999764 55999999999
Q ss_pred ccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHH
Q 041143 779 KLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFK 858 (973)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (973)
+...... ......||+.|+|||++. +.++.++||||+||++|||++|+.||......+. ...+......
T Consensus 187 ~~~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~~~i~~~~~~-- 255 (494)
T 3lij_A 187 AVFENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI------LRKVEKGKYT-- 255 (494)
T ss_dssp EECBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHTCCC--
T ss_pred eECCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhCCCC--
Confidence 8654432 234567999999999875 5799999999999999999999999987654321 1111111000
Q ss_pred hhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 859 AAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 859 ~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
...+.. ......+.+++.+|++.||.+|||+.|+++ +++++
T Consensus 256 -~~~~~~------~~~s~~~~~li~~~L~~dp~~R~s~~e~l~--hp~~~ 296 (494)
T 3lij_A 256 -FDSPEW------KNVSEGAKDLIKQMLQFDSQRRISAQQALE--HPWIK 296 (494)
T ss_dssp -CCSGGG------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT--CHHHH
T ss_pred -CCchhc------ccCCHHHHHHHHHHCCCChhhCccHHHHhc--Ccccc
Confidence 000111 112245779999999999999999999987 44443
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=360.22 Aligned_cols=278 Identities=23% Similarity=0.317 Sum_probs=190.9
Q ss_pred HhcCccc-cCcccccCccEEEEEEEC---CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEe--CC
Q 041143 623 VTQNFAQ-ENELGRGGFGTVYKGELE---DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIE--GN 696 (973)
Q Consensus 623 ~~~~~~~-~~~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~ 696 (973)
..+.|.. .++||+|+||.||+|+.. +++.||||++...... +.+.+|++++++++|||||++++++.. ..
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADR 93 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence 3455666 458999999999999865 5788999999754222 357899999999999999999999965 66
Q ss_pred eEEEEEEecCCCCHHHHHHhhhhcc----CCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEE----CCCC
Q 041143 697 ERLLVYEYMPHGALSRHLFRWEKLQ----LKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILL----DDDY 768 (973)
Q Consensus 697 ~~~lV~e~~~~g~L~~~l~~~~~~~----~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill----~~~~ 768 (973)
..++||||++ |+|.+++....... ...+++..+..|+.||+.||+||| +.+|+||||||+|||+ +.++
T Consensus 94 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~ 169 (405)
T 3rgf_A 94 KVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERG 169 (405)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTT
T ss_pred eEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCC
Confidence 8899999995 68888886533221 224899999999999999999999 7899999999999999 7789
Q ss_pred CEEEeeccccccCCCCCc--ceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhh------
Q 041143 769 RAKVSDFGLVKLAPDGEK--SVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEE------ 839 (973)
Q Consensus 769 ~~kl~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~------ 839 (973)
.+||+|||+++....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~ 249 (405)
T 3rgf_A 170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 249 (405)
T ss_dssp CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCC
T ss_pred cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccc
Confidence 999999999986543221 22345689999999999887 458999999999999999999999997654321
Q ss_pred -HHHHHHHHHHHhhchh-------------HHHhhcC-ccccCCcccHH--------HHHHHHHHHHHhhccCCCCCCCH
Q 041143 840 -SRYLAEWFWRIKSSKE-------------KFKAAID-PALEVNEETFE--------SISIVAELAGHCTAREPYHRPDM 896 (973)
Q Consensus 840 -~~~~~~~~~~~~~~~~-------------~~~~~~~-~~l~~~~~~~~--------~~~~~~~l~~~cl~~dP~~RPs~ 896 (973)
...+...+........ .+...+. .... ...... ....+.+|+.+||+.||++|||+
T Consensus 250 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta 328 (405)
T 3rgf_A 250 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYT-NCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS 328 (405)
T ss_dssp CHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGT-TCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCH
T ss_pred hHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCC-cchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCH
Confidence 1111111111100000 0000000 0000 000000 02347799999999999999999
Q ss_pred hHHHHHHHHhhhhcC
Q 041143 897 GHVVNVLSPLVEKWR 911 (973)
Q Consensus 897 ~~v~~~L~~~~~~~~ 911 (973)
.|+++ ++++....
T Consensus 329 ~e~L~--hp~f~~~~ 341 (405)
T 3rgf_A 329 EQAMQ--DPYFLEDP 341 (405)
T ss_dssp HHHHT--SGGGTSSS
T ss_pred HHHhc--ChhhccCC
Confidence 99999 88876543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=356.39 Aligned_cols=272 Identities=23% Similarity=0.338 Sum_probs=201.4
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
++|...+.||+|+||.||+|+.. +++.||||+++... .......+.+|++++++++||||+++++++...+..++|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccc-ccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 57899999999999999999876 68999999986542 12222245679999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|++ |+|.+++... ...+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 152 (324)
T 3mtl_A 81 YLD-KDLKQYLDDC----GNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSI 152 (324)
T ss_dssp CCS-EEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred ccc-cCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence 996 6999988652 246899999999999999999999 78999999999999999999999999999985543
Q ss_pred CCcceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhc---------
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSS--------- 853 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------- 853 (973)
.. .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+... .+......
T Consensus 153 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~ 228 (324)
T 3mtl_A 153 PT-KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLH---FIFRILGTPTEETWPGI 228 (324)
T ss_dssp -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCCCTTTSTTG
T ss_pred Cc-cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHhCCCChHhchhh
Confidence 22 22344578999999999876 568999999999999999999999998776443221 11111100
Q ss_pred --hhHHHhhcCccccCCc---ccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcC
Q 041143 854 --KEKFKAAIDPALEVNE---ETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWR 911 (973)
Q Consensus 854 --~~~~~~~~~~~l~~~~---~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~ 911 (973)
.........+...... ........+.+++.+|++.||++|||+.|+++ ++++..+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--hp~f~~~~ 289 (324)
T 3mtl_A 229 LSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK--HPFFLSLG 289 (324)
T ss_dssp GGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT--SGGGGGGC
T ss_pred hcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc--Chhhhhcc
Confidence 0000011011100000 00011245789999999999999999999998 77766543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=347.64 Aligned_cols=261 Identities=23% Similarity=0.322 Sum_probs=193.3
Q ss_pred hcCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
.++|+..+.||+|+||.||+|+. .+|+.||||+++.........+.+.++...++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 46899999999999999999987 46899999999765444444445555666678889999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccC-CeeeccCCCCcEEECCCCCEEEeeccccccC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQ-TFIHRDLKSSNILLDDDYRAKVSDFGLVKLA 781 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~-~ivH~Dikp~Nill~~~~~~kl~DfGla~~~ 781 (973)
||++ |+|.+++..... ....+++..+..++.|++.||+||| ++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 86 e~~~-~~l~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVID-KGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp ECCS-EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred ehhc-cchHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 9996 599888865333 3367999999999999999999999 65 9999999999999999999999999999865
Q ss_pred CCCCcceecccccccCccccccc----ccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHH
Q 041143 782 PDGEKSVVTRLAGTFGYLAPEYA----VMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKF 857 (973)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (973)
.... ......||+.|+|||++ ....++.++|||||||++|||++|+.||........ .+.. ..
T Consensus 161 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~----~~------ 227 (290)
T 3fme_A 161 VDDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-QLKQ----VV------ 227 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH-HHHH----HH------
T ss_pred cccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH-HHHH----Hh------
Confidence 4432 22334799999999996 566789999999999999999999999976432211 1110 00
Q ss_pred HhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 858 KAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 858 ~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
....+..... .....+.+++.+|++.||++|||+.|+++ +++++.
T Consensus 228 -~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rpt~~e~l~--hp~f~~ 272 (290)
T 3fme_A 228 -EEPSPQLPAD----KFSAEFVDFTSQCLKKNSKERPTYPELMQ--HPFFTL 272 (290)
T ss_dssp -HSCCCCCCTT----TSCHHHHHHHHHHTCSSGGGSCCHHHHTT--SHHHHH
T ss_pred -ccCCCCcccc----cCCHHHHHHHHHHhhcChhhCcCHHHHHh--Cccccc
Confidence 0011111101 12245789999999999999999999998 555543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=344.68 Aligned_cols=257 Identities=24% Similarity=0.408 Sum_probs=206.6
Q ss_pred HhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEE
Q 041143 623 VTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLV 701 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 701 (973)
..++|...+.||+|+||.||+|+.. +|+.||+|+++.. .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKS--PAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecc--cccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 4578999999999999999999875 6899999999754 223345788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEE---CCCCCEEEeecccc
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILL---DDDYRAKVSDFGLV 778 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill---~~~~~~kl~DfGla 778 (973)
|||+++|+|.+++... ..+++.++..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||++
T Consensus 85 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~ 156 (304)
T 2jam_A 85 MQLVSGGELFDRILER-----GVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLS 156 (304)
T ss_dssp ECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTT
T ss_pred EEcCCCccHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcc
Confidence 9999999999998652 45899999999999999999999 7899999999999999 78899999999999
Q ss_pred ccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHH
Q 041143 779 KLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFK 858 (973)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (973)
+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ...+......
T Consensus 157 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~i~~~~~~-- 225 (304)
T 2jam_A 157 KMEQNG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL------FEKIKEGYYE-- 225 (304)
T ss_dssp CCCCCB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHCCCC--
T ss_pred eecCCC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHHcCCCC--
Confidence 754432 22345699999999999999999999999999999999999999986653221 1111111000
Q ss_pred hhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 859 AAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 859 ~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
..... .......+.+++.+|++.||++||++.|+++ +++++.
T Consensus 226 --~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~--h~~~~~ 267 (304)
T 2jam_A 226 --FESPF-----WDDISESAKDFICHLLEKDPNERYTCEKALS--HPWIDG 267 (304)
T ss_dssp --CCTTT-----TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT--SHHHHS
T ss_pred --CCccc-----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc--CccccC
Confidence 00000 0112245789999999999999999999998 666654
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=353.78 Aligned_cols=273 Identities=20% Similarity=0.326 Sum_probs=208.1
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeE----
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNER---- 698 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---- 698 (973)
.++|...+.||+|+||.||+|... +|+.||||++..........+.+.+|+.++++++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 368999999999999999999865 689999999987656666678899999999999999999999999877654
Q ss_pred --EEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecc
Q 041143 699 --LLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFG 776 (973)
Q Consensus 699 --~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG 776 (973)
++||||+. |+|.+++. ..+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||
T Consensus 121 ~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg 189 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG-------MEFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFG 189 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT-------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTT
T ss_pred eEEEEEcccc-ccHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecC
Confidence 99999996 68877662 34899999999999999999999 7899999999999999999999999999
Q ss_pred ccccCCCCCcceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchh
Q 041143 777 LVKLAPDGEKSVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKE 855 (973)
Q Consensus 777 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 855 (973)
+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.. ............
T Consensus 190 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~i~~~~~~~~~ 263 (371)
T 4exu_A 190 LARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL--TQILKVTGVPGT 263 (371)
T ss_dssp CC------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHHHHCCCCH
T ss_pred cccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHHHHhCCCcH
Confidence 99855332 334678999999999887 78999999999999999999999999876543221 111111000000
Q ss_pred HH------------HhhcCccccCC--cccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCCCCC
Q 041143 856 KF------------KAAIDPALEVN--EETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPITD 915 (973)
Q Consensus 856 ~~------------~~~~~~~l~~~--~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~~~~ 915 (973)
.. ...+....... .........+.+++.+|++.||++||++.|+++ +++++.+.....
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~f~~~~~~~~ 335 (371)
T 4exu_A 264 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT--HPFFEPFRDPEE 335 (371)
T ss_dssp HHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT--SGGGTTTCCGGG
T ss_pred HHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc--CcccccCCCccc
Confidence 00 00000000000 000112346889999999999999999999998 788776554433
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=342.26 Aligned_cols=254 Identities=24% Similarity=0.375 Sum_probs=204.9
Q ss_pred HhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEE
Q 041143 623 VTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLV 701 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 701 (973)
..++|+..+.||+|+||.||+|... +++.||||++.... .....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGG-CTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeecc-chhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence 4478999999999999999999875 68999999987542 234457889999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccC
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA 781 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~ 781 (973)
|||+++|+|.+++.. ...+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++...
T Consensus 84 ~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 155 (276)
T 2yex_A 84 LEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVF 155 (276)
T ss_dssp EECCTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEecCCCcHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCcccc
Confidence 999999999988743 246899999999999999999999 789999999999999999999999999999854
Q ss_pred CCCC-cceecccccccCcccccccccCcC-CCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHh
Q 041143 782 PDGE-KSVVTRLAGTFGYLAPEYAVMGKI-TTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKA 859 (973)
Q Consensus 782 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (973)
.... ........||+.|+|||.+.+..+ +.++||||||+++|||++|+.||........ ....|. ....
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~----~~~~---- 226 (276)
T 2yex_A 156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWK----EKKT---- 226 (276)
T ss_dssp EETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHH----TTCT----
T ss_pred CCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhh----hccc----
Confidence 3222 122345679999999999987765 6789999999999999999999986553221 111111 0000
Q ss_pred hcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 860 AIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 860 ~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
...+ .......+.+++.+|++.||++||++.||++
T Consensus 227 ~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 227 YLNP-------WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp TSTT-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCc-------hhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 0000 0011234779999999999999999999987
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=343.60 Aligned_cols=256 Identities=26% Similarity=0.442 Sum_probs=185.6
Q ss_pred hcCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLV 701 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 701 (973)
.++|...+.||+|+||.||+|+. .+|+.||||++..... .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 36799999999999999999987 4789999999864311 111236789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccC
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA 781 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~ 781 (973)
|||+++++|.+++.. ....+++.++..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++...
T Consensus 90 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 162 (278)
T 3cok_A 90 LEMCHNGEMNRYLKN----RVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQL 162 (278)
T ss_dssp EECCTTEEHHHHHHT----CSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EecCCCCcHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeec
Confidence 999999999999864 2256899999999999999999999 789999999999999999999999999999865
Q ss_pred CCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhc
Q 041143 782 PDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861 (973)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (973)
..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+. .....
T Consensus 163 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----------------~~~~~ 225 (278)
T 3cok_A 163 KMPHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT----------------LNKVV 225 (278)
T ss_dssp C-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------------CC
T ss_pred cCCCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH----------------HHHHh
Confidence 43222 12345799999999999988999999999999999999999999976543211 11111
Q ss_pred CccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 862 DPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 862 ~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
........ .....+.+++.+|++.||++||++.++++ ++++.
T Consensus 226 ~~~~~~~~---~~~~~~~~li~~~l~~dp~~Rps~~~~l~--h~~~~ 267 (278)
T 3cok_A 226 LADYEMPS---FLSIEAKDLIHQLLRRNPADRLSLSSVLD--HPFMS 267 (278)
T ss_dssp SSCCCCCT---TSCHHHHHHHHHHSCSSGGGSCCHHHHTT--STTTC
T ss_pred hcccCCcc---ccCHHHHHHHHHHcccCHhhCCCHHHHhc--Ccccc
Confidence 11111111 11235779999999999999999999997 44443
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=343.74 Aligned_cols=254 Identities=26% Similarity=0.458 Sum_probs=209.1
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
+.|...+.||+|+||.||+|... +++.||||++..... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 57889999999999999999764 689999999976532 3345789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+++++|.+++.. ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 101 ~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 101 YLGGGSALDLLEP------GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171 (303)
T ss_dssp CCTTEEHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred eCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCc
Confidence 9999999998853 46899999999999999999999 78999999999999999999999999999986543
Q ss_pred CCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCc
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDP 863 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (973)
.. .......||+.|+|||++.+..++.++||||||+++|||++|+.||.......... .+ .....+
T Consensus 172 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~-------~~~~~~ 237 (303)
T 3a7i_A 172 TQ-IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF------LI-------PKNNPP 237 (303)
T ss_dssp TB-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HH-------HHSCCC
T ss_pred cc-cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHH------Hh-------hcCCCC
Confidence 32 12344679999999999999999999999999999999999999998665432111 11 111111
Q ss_pred cccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 864 ALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 864 ~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
.+. .. ....+.+++.+|++.||++||++.||++ +.++..
T Consensus 238 ~~~-~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~--~~~~~~ 276 (303)
T 3a7i_A 238 TLE-GN----YSKPLKEFVEACLNKEPSFRPTAKELLK--HKFILR 276 (303)
T ss_dssp CCC-SS----CCHHHHHHHHHHCCSSGGGSCCHHHHTT--CHHHHH
T ss_pred CCc-cc----cCHHHHHHHHHHcCCChhhCcCHHHHhh--Chhhhc
Confidence 111 11 1234789999999999999999999998 555443
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=368.90 Aligned_cols=260 Identities=23% Similarity=0.355 Sum_probs=207.0
Q ss_pred HhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCCh-----------HHHHHHHHHHHHHHhcCCCceeeeee
Q 041143 623 VTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTT-----------KALDEFQSEIAVLSKVRHRHLVSLLG 690 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-----------~~~~~~~~E~~~l~~l~h~niv~l~~ 690 (973)
+.++|...+.||+|+||.||+|+.. +++.||||+++...... ...+.+.+|++++++++|||||++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4578999999999999999999875 57899999987542221 23467899999999999999999999
Q ss_pred EEEeCCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCC--
Q 041143 691 YSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDY-- 768 (973)
Q Consensus 691 ~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~-- 768 (973)
++.+....++||||+++|+|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~ 185 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR-----HKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSL 185 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCC
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCC
Confidence 999999999999999999999988652 45899999999999999999999 78999999999999998775
Q ss_pred -CEEEeeccccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHH
Q 041143 769 -RAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWF 847 (973)
Q Consensus 769 -~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 847 (973)
.+||+|||+++...... ......||+.|+|||++. +.++.++||||+||++|||++|+.||......+. +
T Consensus 186 ~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~ 256 (504)
T 3q5i_A 186 LNIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI------I 256 (504)
T ss_dssp SSEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------H
T ss_pred ccEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH------H
Confidence 69999999998665432 234567999999999876 5699999999999999999999999987654321 1
Q ss_pred HHHhhchhHHHhhcCccccCCccc-HHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcC
Q 041143 848 WRIKSSKEKFKAAIDPALEVNEET-FESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWR 911 (973)
Q Consensus 848 ~~~~~~~~~~~~~~~~~l~~~~~~-~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~ 911 (973)
..+... .+...... ......+.+++.+|++.||.+|||+.|+++ +++++++.
T Consensus 257 ~~i~~~----------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~--h~~~~~~~ 309 (504)
T 3q5i_A 257 KKVEKG----------KYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN--SRWIKKYA 309 (504)
T ss_dssp HHHHHC----------CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHHHTC
T ss_pred HHHHcC----------CCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc--CHhhhhch
Confidence 111111 01000000 011245789999999999999999999998 77776644
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=363.60 Aligned_cols=259 Identities=25% Similarity=0.357 Sum_probs=194.1
Q ss_pred HHhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCC------ChHHHHHHHHHHHHHHhcCCCceeeeeeEEEe
Q 041143 622 KVTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVT------TTKALDEFQSEIAVLSKVRHRHLVSLLGYSIE 694 (973)
Q Consensus 622 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 694 (973)
...++|...+.||+|+||.||+|... +++.||||++..... .......+.+|++++++++|||||++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 45689999999999999999999765 589999999865321 1122335889999999999999999999975
Q ss_pred CCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCC---CCEE
Q 041143 695 GNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDD---YRAK 771 (973)
Q Consensus 695 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~---~~~k 771 (973)
.+..++||||+++|+|.+++.. ...+++.++..++.|++.||+||| +++|+||||||+|||++.+ +.+|
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~k 282 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIK 282 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSS-----SCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEE
T ss_pred cCceEEEEEcCCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEE
Confidence 5568999999999999887753 356899999999999999999999 7899999999999999754 4599
Q ss_pred EeeccccccCCCCCcceecccccccCccccccccc---CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHH
Q 041143 772 VSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVM---GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFW 848 (973)
Q Consensus 772 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 848 (973)
|+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ +...
T Consensus 283 l~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~~-- 356 (419)
T 3i6u_A 283 ITDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQ-- 356 (419)
T ss_dssp ECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHHH--
T ss_pred EeecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHHH--
Confidence 9999999866432 23345689999999999863 5678899999999999999999999976543211 1110
Q ss_pred HHhhchhHHHhhcCccccCCcc-cHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 849 RIKSSKEKFKAAIDPALEVNEE-TFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 849 ~~~~~~~~~~~~~~~~l~~~~~-~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
+.. ........ .......+.+++.+|++.||++||++.|+++ +++++
T Consensus 357 -i~~----------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~--hp~~~ 404 (419)
T 3i6u_A 357 -ITS----------GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR--HPWLQ 404 (419)
T ss_dssp -HHT----------TCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH--SGGGC
T ss_pred -Hhc----------CCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC--CcccC
Confidence 000 00000000 0012245789999999999999999999998 55543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=352.20 Aligned_cols=256 Identities=23% Similarity=0.304 Sum_probs=188.9
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeeEEEe--------
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR-HRHLVSLLGYSIE-------- 694 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~-------- 694 (973)
.+|...+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|+.++.++. ||||+++++++..
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 57889999999999999999874 6899999998654 4556678999999999996 9999999999953
Q ss_pred CCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCC--eeeccCCCCcEEECCCCCEEE
Q 041143 695 GNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQT--FIHRDLKSSNILLDDDYRAKV 772 (973)
Q Consensus 695 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~--ivH~Dikp~Nill~~~~~~kl 772 (973)
....++||||+. |+|.+++..... ...+++.+++.++.||+.||+||| ..+ |+||||||+|||++.++.+||
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl 179 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMES--RGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKL 179 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHT--TCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEB
T ss_pred CceEEEEEEecC-CCHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEE
Confidence 335789999995 899999876332 356999999999999999999999 777 999999999999999999999
Q ss_pred eeccccccCCCCCcc-----------eecccccccCccccccc---ccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChh
Q 041143 773 SDFGLVKLAPDGEKS-----------VVTRLAGTFGYLAPEYA---VMGKITTKADVFSYGVVLMELLTGLAALDEERPE 838 (973)
Q Consensus 773 ~DfGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~ 838 (973)
+|||+++........ ......||+.|+|||++ .+..++.++|||||||++|||++|+.||......
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~ 259 (337)
T 3ll6_A 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL 259 (337)
T ss_dssp CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence 999999865433221 11134699999999998 5667889999999999999999999999754321
Q ss_pred hHHHHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 839 ESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
.. . ......... . .....+.+++.+|++.||++||++.|+++.|+.+.+.
T Consensus 260 ~~------~----------~~~~~~~~~-~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 260 RI------V----------NGKYSIPPH-D----TQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp ----------------------CCCCTT-C----CSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred Hh------h----------cCcccCCcc-c----ccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 10 0 000000000 0 0112367899999999999999999999999998765
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=356.92 Aligned_cols=270 Identities=23% Similarity=0.350 Sum_probs=202.5
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeC----C--e
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEG----N--E 697 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----~--~ 697 (973)
.+|...+.||+|+||.||+|++. +|+.||||++.... +.+.+|++++++++|||||++++++... + .
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 46888899999999999999885 58999999986542 1234799999999999999999998642 2 2
Q ss_pred EEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCC-CCEEEeecc
Q 041143 698 RLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDD-YRAKVSDFG 776 (973)
Q Consensus 698 ~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~-~~~kl~DfG 776 (973)
.++||||+++ ++.+.+..... ....+++..+..++.||++||+||| +++|+||||||+|||++.+ +.+||+|||
T Consensus 128 ~~lv~e~~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG 202 (420)
T 1j1b_A 128 LNLVLDYVPE-TVYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFG 202 (420)
T ss_dssp EEEEEECCCE-EHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEeehhcccc-cHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccch
Confidence 5689999965 77776655332 2367999999999999999999999 8899999999999999965 678999999
Q ss_pred ccccCCCCCcceecccccccCcccccccccC-cCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhc-h
Q 041143 777 LVKLAPDGEKSVVTRLAGTFGYLAPEYAVMG-KITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSS-K 854 (973)
Q Consensus 777 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~ 854 (973)
+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+ .+...+...... .
T Consensus 203 ~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~i~~~lg~p~~ 278 (420)
T 1j1b_A 203 SAKQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTR 278 (420)
T ss_dssp TCEECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCSCCH
T ss_pred hhhhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCH
Confidence 9986544322 2346799999999998764 79999999999999999999999998765432 222222211110 1
Q ss_pred hHHHhhcCcccc---C---CcccH------HHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCC
Q 041143 855 EKFKAAIDPALE---V---NEETF------ESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRP 912 (973)
Q Consensus 855 ~~~~~~~~~~l~---~---~~~~~------~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~ 912 (973)
+.+... ++.+. . ....+ .....+.+|+.+||+.||++||++.|+++ +.+++.+..
T Consensus 279 ~~~~~~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~--hp~f~~~~~ 345 (420)
T 1j1b_A 279 EQIREM-NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA--HSFFDELRD 345 (420)
T ss_dssp HHHHHH-CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGGGGGC
T ss_pred HHHHhh-ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC--CHhhccccc
Confidence 111111 11110 0 00011 11246889999999999999999999998 777765543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=341.16 Aligned_cols=254 Identities=27% Similarity=0.437 Sum_probs=198.2
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
++|...+.||+|+||.||+|+.. +|+.||||++..... .....+.+.+|+++++.++||||+++++++...+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 68899999999999999999876 789999999864311 1122457889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++++|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||++....
T Consensus 91 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 91 EYVSGGELFDYICKH-----GRVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp ECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred eccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccC
Confidence 999999999999652 45899999999999999999999 7799999999999999999999999999998654
Q ss_pred CCCcceecccccccCcccccccccCcC-CCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhc
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMGKI-TTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (973)
... ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||........ ...+... .
T Consensus 163 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~~-------~ 227 (276)
T 2h6d_A 163 DGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL------FKKIRGG-------V 227 (276)
T ss_dssp C---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHC-------C
T ss_pred CCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH------HHHhhcC-------c
Confidence 432 2234578999999999987765 5899999999999999999999986543221 1111110 0
Q ss_pred CccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 862 DPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 862 ~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
..+. . .....+.+++.+|++.||++||++.||++ ++++++
T Consensus 228 -~~~~-~----~~~~~l~~li~~~l~~~p~~Rps~~~~l~--h~~~~~ 267 (276)
T 2h6d_A 228 -FYIP-E----YLNRSVATLLMHMLQVDPLKRATIKDIRE--HEWFKQ 267 (276)
T ss_dssp -CCCC-T----TSCHHHHHHHHHHTCSSGGGSCCHHHHHH--SHHHHT
T ss_pred -ccCc-h----hcCHHHHHHHHHHccCChhhCCCHHHHHh--Chhhcc
Confidence 0010 0 11234779999999999999999999998 666654
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=345.20 Aligned_cols=259 Identities=27% Similarity=0.440 Sum_probs=198.2
Q ss_pred cCccccCcccccCccEEEEEEEC--CCC--EEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE--DGT--KIAVKRMEAGVT-TTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERL 699 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~--~g~--~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 699 (973)
++|+..+.||+|+||.||+|++. +++ .||||+++.... .....+.+.+|++++++++||||+++++++.... .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 67899999999999999999753 333 689998865422 3345678999999999999999999999998765 88
Q ss_pred EEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccc
Q 041143 700 LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK 779 (973)
Q Consensus 700 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~ 779 (973)
+||||+++|+|.+++.... ..+++.++..++.|+++||+||| +++|+||||||+||+++.++.+||+|||+++
T Consensus 97 ~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEECCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeEecccCCCHHHHHHhcc----CCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEccccccc
Confidence 9999999999999997532 45899999999999999999999 7899999999999999999999999999998
Q ss_pred cCCCCCcc--eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhH
Q 041143 780 LAPDGEKS--VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEK 856 (973)
Q Consensus 780 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (973)
........ ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+. ...+....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------~~~~~~~~-- 241 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI------LHKIDKEG-- 241 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------HHHHHTSC--
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH------HHHHHccC--
Confidence 66543322 1234567889999999998889999999999999999999 9999987653321 11111100
Q ss_pred HHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 857 FKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 857 ~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
.... ........+.+++.+|++.||++||++.++++.|+++..
T Consensus 242 ------~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 242 ------ERLP---RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp ------CCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred ------CCCC---CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 0000 011123458899999999999999999999999988754
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=370.67 Aligned_cols=261 Identities=23% Similarity=0.340 Sum_probs=211.0
Q ss_pred HhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEE
Q 041143 623 VTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLL 700 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 700 (973)
..++|...+.||+|+||.||+|+.. +|+.||||++..... .....+.+.+|++++++++|||||++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3468999999999999999999876 789999999865422 23345678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEE---CCCCCEEEeeccc
Q 041143 701 VYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILL---DDDYRAKVSDFGL 777 (973)
Q Consensus 701 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill---~~~~~~kl~DfGl 777 (973)
||||+.+|+|.+++.. ...+++..+..++.||+.||+||| +++|+||||||+|||+ +.++.+||+|||+
T Consensus 104 v~e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 175 (484)
T 3nyv_A 104 VGEVYTGGELFDEIIS-----RKRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGL 175 (484)
T ss_dssp EECCCCSCBHHHHHHT-----CSCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred EEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence 9999999999998865 256899999999999999999999 7899999999999999 5678999999999
Q ss_pred cccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHH
Q 041143 778 VKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKF 857 (973)
Q Consensus 778 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (973)
++...... ......||+.|+|||++.+ .++.++||||+||++|||++|+.||......+.. ..+....
T Consensus 176 a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~------~~i~~~~--- 243 (484)
T 3nyv_A 176 STHFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDIL------KKVEKGK--- 243 (484)
T ss_dssp HHHBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHHCC---
T ss_pred eEEccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHH------HHHHcCC---
Confidence 98665433 2344579999999998865 7999999999999999999999999876543211 1111110
Q ss_pred HhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcC
Q 041143 858 KAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWR 911 (973)
Q Consensus 858 ~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~ 911 (973)
..... .........+.+++.+|++.||++|||+.|+++ +++++.+.
T Consensus 244 ---~~~~~---~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~--h~~~~~~~ 289 (484)
T 3nyv_A 244 ---YTFEL---PQWKKVSESAKDLIRKMLTYVPSMRISARDALD--HEWIQTYT 289 (484)
T ss_dssp ---CCCCS---GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT--SHHHHHHT
T ss_pred ---CCCCC---cccccCCHHHHHHHHHHCCCChhHCcCHHHHhh--Chhhcccc
Confidence 00000 000112245779999999999999999999998 77776543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=351.99 Aligned_cols=283 Identities=20% Similarity=0.261 Sum_probs=209.0
Q ss_pred cHHHHHHHhcCccccCcccccCccEEEEEEECCCCEEEEEEeecCCC---------ChHHHHHHHHHHHHHHhcCCCcee
Q 041143 616 SVQVLRKVTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVT---------TTKALDEFQSEIAVLSKVRHRHLV 686 (973)
Q Consensus 616 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~---------~~~~~~~~~~E~~~l~~l~h~niv 686 (973)
...++....++|...+.||+|+||.||+|...+|+.||||++..... .....+.+.+|++++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 45677888899999999999999999999988899999999854322 223357899999999999999999
Q ss_pred eeeeEEEeC-----CeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCc
Q 041143 687 SLLGYSIEG-----NERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSN 761 (973)
Q Consensus 687 ~l~~~~~~~-----~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~N 761 (973)
++++++... ...++||||++ |+|.+++.. ....+++..+..++.||+.||+||| +.+|+||||||+|
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~N 164 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD----QRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGN 164 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGG
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHH
Confidence 999998643 35799999997 688888864 2246899999999999999999999 7899999999999
Q ss_pred EEECCCCCEEEeeccccccCCCCCcceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhH
Q 041143 762 ILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEES 840 (973)
Q Consensus 762 ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~ 840 (973)
|+++.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.
T Consensus 165 Il~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 242 (362)
T 3pg1_A 165 ILLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ 242 (362)
T ss_dssp EEECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred EEEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999999999999999998543322 2344679999999999876 6789999999999999999999999987654332
Q ss_pred HHHHHHHHHHhh---------chhHHHhhcCcccc-CCccc-----HHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHH
Q 041143 841 RYLAEWFWRIKS---------SKEKFKAAIDPALE-VNEET-----FESISIVAELAGHCTAREPYHRPDMGHVVNVLSP 905 (973)
Q Consensus 841 ~~~~~~~~~~~~---------~~~~~~~~~~~~l~-~~~~~-----~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~ 905 (973)
.. ........ ........+...+. ..... ......+.+++.+|++.||++|||+.|+++ ++
T Consensus 243 ~~--~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp 318 (362)
T 3pg1_A 243 LN--KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR--HP 318 (362)
T ss_dssp HH--HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT--SG
T ss_pred HH--HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc--Cc
Confidence 11 11110000 00111111111111 00000 111245789999999999999999999998 77
Q ss_pred hhhhcCC
Q 041143 906 LVEKWRP 912 (973)
Q Consensus 906 ~~~~~~~ 912 (973)
+++.+..
T Consensus 319 ~f~~~~~ 325 (362)
T 3pg1_A 319 YFESLFD 325 (362)
T ss_dssp GGTTTCC
T ss_pred hhhhccC
Confidence 7776543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=353.83 Aligned_cols=272 Identities=21% Similarity=0.309 Sum_probs=202.8
Q ss_pred HHHhcCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeC----
Q 041143 621 RKVTQNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEG---- 695 (973)
Q Consensus 621 ~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---- 695 (973)
+...++|...+.||+|+||.||+|.. .+|+.||||++..... ...+|+++++.++|||||++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 34567899999999999999999976 5789999999875422 234799999999999999999998543
Q ss_pred ----------------------------------CeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHH
Q 041143 696 ----------------------------------NERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGM 741 (973)
Q Consensus 696 ----------------------------------~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl 741 (973)
...++||||++ |+|.+.+...... ...+++..+..++.||++||
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRS-GRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHH
Confidence 23789999997 6998888764332 36799999999999999999
Q ss_pred HHHHhhccCCeeeccCCCCcEEEC-CCCCEEEeeccccccCCCCCcceecccccccCcccccccccC-cCCCchhHHhHH
Q 041143 742 EYLHCLARQTFIHRDLKSSNILLD-DDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMG-KITTKADVFSYG 819 (973)
Q Consensus 742 ~~LH~~~~~~ivH~Dikp~Nill~-~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~G 819 (973)
+||| +.+|+||||||+||+++ .++.+||+|||+++...... ......||+.|+|||++.+. .++.++||||+|
T Consensus 155 ~~LH---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG 229 (383)
T 3eb0_A 155 GFIH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIG 229 (383)
T ss_dssp HHHH---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHH
T ss_pred HHHH---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHH
Confidence 9999 88999999999999998 68999999999998654432 23345789999999998764 589999999999
Q ss_pred HHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhch-hHHHh-------hcCccccCCc----ccHHHHHHHHHHHHHhhc
Q 041143 820 VVLMELLTGLAALDEERPEESRYLAEWFWRIKSSK-EKFKA-------AIDPALEVNE----ETFESISIVAELAGHCTA 887 (973)
Q Consensus 820 vvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-------~~~~~l~~~~----~~~~~~~~~~~l~~~cl~ 887 (973)
|++|||++|+.||......+. +...+....... +.+.. ..-+.+.... ........+.+++.+|++
T Consensus 230 ~il~ell~g~~pf~~~~~~~~--~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 307 (383)
T 3eb0_A 230 CVFGELILGKPLFSGETSIDQ--LVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILR 307 (383)
T ss_dssp HHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCC
T ss_pred HHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHcc
Confidence 999999999999987654332 222111111100 00000 0001110000 000122457899999999
Q ss_pred cCCCCCCCHhHHHHHHHHhhhh
Q 041143 888 REPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 888 ~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
.||++|||+.|+++ +++++.
T Consensus 308 ~dP~~R~t~~e~l~--hp~f~~ 327 (383)
T 3eb0_A 308 YEPDLRINPYEAMA--HPFFDH 327 (383)
T ss_dssp SSGGGSCCHHHHHT--SGGGHH
T ss_pred CChhhCCCHHHHhc--CHHHHH
Confidence 99999999999997 666554
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=356.71 Aligned_cols=268 Identities=22% Similarity=0.299 Sum_probs=207.1
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc------CCCceeeeeeEEEeCC
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV------RHRHLVSLLGYSIEGN 696 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~ 696 (973)
..+|+..+.||+|+||.||+|... +++.||||+++.. ....+.+.+|+++++.+ +|+||+++++++...+
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 467999999999999999999775 5889999999653 44556788899998887 5779999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCC--EEEee
Q 041143 697 ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYR--AKVSD 774 (973)
Q Consensus 697 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~--~kl~D 774 (973)
..++||||+. |+|.+++.... ...+++..+..++.||+.||+||| +++|+||||||+|||++.++. +||+|
T Consensus 173 ~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~D 245 (429)
T 3kvw_A 173 HICMTFELLS-MNLYELIKKNK---FQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVID 245 (429)
T ss_dssp EEEEEECCCC-CBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECC
T ss_pred eEEEEEeccC-CCHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEee
Confidence 9999999995 79999987632 245899999999999999999999 779999999999999999987 99999
Q ss_pred ccccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhch
Q 041143 775 FGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSK 854 (973)
Q Consensus 775 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 854 (973)
||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+. +...+.......
T Consensus 246 FG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~--l~~i~~~~~~p~ 319 (429)
T 3kvw_A 246 FGSSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQ--LACMIELLGMPS 319 (429)
T ss_dssp CTTCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCC
T ss_pred cccceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHcCCCC
Confidence 9999765432 2345799999999999999999999999999999999999999987764332 222111111000
Q ss_pred h-------HHHhhcCccc---------------------------c--CCcccHH------HHHHHHHHHHHhhccCCCC
Q 041143 855 E-------KFKAAIDPAL---------------------------E--VNEETFE------SISIVAELAGHCTAREPYH 892 (973)
Q Consensus 855 ~-------~~~~~~~~~l---------------------------~--~~~~~~~------~~~~~~~l~~~cl~~dP~~ 892 (973)
. .....++..- . ....... ....+.+++.+||+.||++
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~ 399 (429)
T 3kvw_A 320 QKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAV 399 (429)
T ss_dssp HHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTT
T ss_pred HHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhh
Confidence 0 1111111100 0 0000000 0245789999999999999
Q ss_pred CCCHhHHHHHHHHhhhh
Q 041143 893 RPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 893 RPs~~~v~~~L~~~~~~ 909 (973)
|||+.|+++ ++++++
T Consensus 400 Rpta~e~L~--Hpw~~~ 414 (429)
T 3kvw_A 400 RMTPGQALR--HPWLRR 414 (429)
T ss_dssp SCCHHHHHT--STTTC-
T ss_pred CCCHHHHhC--Chhhcc
Confidence 999999998 666654
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=350.74 Aligned_cols=275 Identities=23% Similarity=0.295 Sum_probs=201.5
Q ss_pred HHhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCCh---HHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCe
Q 041143 622 KVTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTT---KALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNE 697 (973)
Q Consensus 622 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 697 (973)
...++|...+.||+|+||.||+|+.. +|+.||||+++...... ...+.+.+|++++++++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999875 58999999986532211 123468899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccc
Q 041143 698 RLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL 777 (973)
Q Consensus 698 ~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGl 777 (973)
.++||||+++ +|..++.. ....+++.++..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 87 ~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGL 158 (346)
T ss_dssp CEEEEECCSE-EHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGG
T ss_pred eEEEEEcCCC-CHHHHHHh----cCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEeccc
Confidence 9999999975 88888754 2246889999999999999999999 78999999999999999999999999999
Q ss_pred cccCCCCCcceecccccccCcccccccccC-cCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhc-hh
Q 041143 778 VKLAPDGEKSVVTRLAGTFGYLAPEYAVMG-KITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSS-KE 855 (973)
Q Consensus 778 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~ 855 (973)
++...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+. +...+...... ..
T Consensus 159 a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~--~~~i~~~~~~~~~~ 235 (346)
T 1ua2_A 159 AKSFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ--LTRIFETLGTPTEE 235 (346)
T ss_dssp GSTTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCTT
T ss_pred ceeccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHcCCCChh
Confidence 98654332 223456799999999998754 588999999999999999999999987654322 11111111000 00
Q ss_pred HHHhhcC--ccccC---Cccc-----HHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 856 KFKAAID--PALEV---NEET-----FESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 856 ~~~~~~~--~~l~~---~~~~-----~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
....... ..... .... ......+.+++.+|++.||++|||+.|+++ ++++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--h~~f~~ 297 (346)
T 1ua2_A 236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK--MKYFSN 297 (346)
T ss_dssp TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT--SGGGTS
T ss_pred hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc--Chhhhc
Confidence 0000000 00000 0000 111246889999999999999999999998 666654
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=381.10 Aligned_cols=251 Identities=24% Similarity=0.326 Sum_probs=204.9
Q ss_pred HhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCC-CChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeEE
Q 041143 623 VTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGV-TTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGNERL 699 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 699 (973)
..++|...+.||+|+||.||+|+.. +++.||||+++... ......+.+..|.+++..+ +||+|+++++++.+.+..|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4578999999999999999999875 58899999987431 1122345678899999987 7999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccc
Q 041143 700 LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK 779 (973)
Q Consensus 700 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~ 779 (973)
+||||+++|+|..++... ..+++.++..++.||+.||+||| +++||||||||+|||++.++.+||+|||+|+
T Consensus 419 lV~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~ 490 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK 490 (674)
T ss_dssp EEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred EEEeCcCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceee
Confidence 999999999999999752 45899999999999999999999 7899999999999999999999999999998
Q ss_pred cCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHh
Q 041143 780 LAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKA 859 (973)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (973)
...... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||......+. +..+.
T Consensus 491 ~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~------~~~i~-------- 555 (674)
T 3pfq_A 491 ENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL------FQSIM-------- 555 (674)
T ss_dssp ECCCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHH--------
T ss_pred ccccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHH------HHHHH--------
Confidence 543322 234557899999999999999999999999999999999999999987654221 11222
Q ss_pred hcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCH-----hHHHH
Q 041143 860 AIDPALEVNEETFESISIVAELAGHCTAREPYHRPDM-----GHVVN 901 (973)
Q Consensus 860 ~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~-----~~v~~ 901 (973)
...+.... .....+.+|+.+||+.||++||++ .||.+
T Consensus 556 --~~~~~~p~---~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 556 --EHNVAYPK---SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp --SSCCCCCT---TSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred --hCCCCCCc---cCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 11111111 122457899999999999999998 56655
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=344.78 Aligned_cols=267 Identities=22% Similarity=0.321 Sum_probs=209.3
Q ss_pred hcCccccCcccccCccEEEEEEE--CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCC------ceeeeeeEEEeC
Q 041143 624 TQNFAQENELGRGGFGTVYKGEL--EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHR------HLVSLLGYSIEG 695 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~~~~~~~ 695 (973)
.++|...+.||+|+||.||+|.. .+|+.||||+++. .....+.+.+|+++++.++|+ +++++++++...
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN---VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS---SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec---CCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 36899999999999999999986 3688999999864 345567889999999998765 499999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECC---------
Q 041143 696 NERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDD--------- 766 (973)
Q Consensus 696 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~--------- 766 (973)
+..++||||+ +++|.+++... ....+++.++..++.||+.||+||| +++|+||||||+||+++.
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~ 162 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKEN---GFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNP 162 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC-
T ss_pred CcEEEEEcCC-CCCHHHHHHhc---CCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCC
Confidence 9999999999 99999999652 2246899999999999999999999 789999999999999987
Q ss_pred ----------CCCEEEeeccccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCC
Q 041143 767 ----------DYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEER 836 (973)
Q Consensus 767 ----------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~ 836 (973)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 238 (339)
T 1z57_A 163 KIKRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238 (339)
T ss_dssp ---CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred ccccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 678999999999865432 234579999999999999999999999999999999999999998766
Q ss_pred hhhHHHHHHHHHHHhhc-hh---------------------------HHHhhcCccccCCcccHHHHHHHHHHHHHhhcc
Q 041143 837 PEESRYLAEWFWRIKSS-KE---------------------------KFKAAIDPALEVNEETFESISIVAELAGHCTAR 888 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~~~-~~---------------------------~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~ 888 (973)
..+...... ..... .. .......+..............+.+++.+|++.
T Consensus 239 ~~~~~~~~~---~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 315 (339)
T 1z57_A 239 SKEHLAMME---RILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEY 315 (339)
T ss_dssp HHHHHHHHH---HHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred hHHHHHHHH---HHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCc
Confidence 443222111 11100 00 000111111111112223456788999999999
Q ss_pred CCCCCCCHhHHHHHHHHhhhh
Q 041143 889 EPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 889 dP~~RPs~~~v~~~L~~~~~~ 909 (973)
||++|||+.||++ +++++.
T Consensus 316 dP~~Rpt~~ell~--hp~f~~ 334 (339)
T 1z57_A 316 DPAKRITLREALK--HPFFDL 334 (339)
T ss_dssp STTTSCCHHHHTT--SGGGGG
T ss_pred CcccccCHHHHhc--CHHHHH
Confidence 9999999999997 555543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=345.31 Aligned_cols=258 Identities=25% Similarity=0.363 Sum_probs=202.7
Q ss_pred hcCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcC--CCceeeeeeEEEeCCeEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR--HRHLVSLLGYSIEGNERLLV 701 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lV 701 (973)
.++|...+.||+|+||.||+|...+++.||||++..........+.+.+|++++.+++ |+||+++++++...+..++|
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 106 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 106 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred cceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence 4679999999999999999999988999999999876556677788999999999997 59999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccC
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA 781 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~ 781 (973)
|| +.+++|.+++.. ...+++.++..++.||++||+||| +.+|+||||||+||++++ +.+||+|||+++..
T Consensus 107 ~e-~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 107 ME-CGNIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQM 176 (313)
T ss_dssp EC-CCSEEHHHHHHH-----CSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCSSSCC-
T ss_pred Ee-cCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeeccccccc
Confidence 99 568999999965 246899999999999999999999 789999999999999965 89999999999865
Q ss_pred CCCCc-ceecccccccCccccccccc-----------CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHH
Q 041143 782 PDGEK-SVVTRLAGTFGYLAPEYAVM-----------GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWR 849 (973)
Q Consensus 782 ~~~~~-~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 849 (973)
..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--------- 247 (313)
T 3cek_A 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--------- 247 (313)
T ss_dssp -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH---------
T ss_pred cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH---------
Confidence 43322 12234579999999999865 4688899999999999999999999976543211
Q ss_pred HhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 850 IKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 850 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
.+...+++..... ........+.+++.+|++.||++||++.|+++ +.+++.
T Consensus 248 ------~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~--h~~~~~ 298 (313)
T 3cek_A 248 ------KLHAIIDPNHEIE-FPDIPEKDLQDVLKCCLKRDPKQRISIPELLA--HPYVQI 298 (313)
T ss_dssp ------HHHHHHCTTSCCC-CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHHC
T ss_pred ------HHHHHHhcccccC-CcccchHHHHHHHHHHccCCcccCcCHHHHhc--CccccC
Confidence 1111122111100 00011245789999999999999999999998 666654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=341.01 Aligned_cols=253 Identities=25% Similarity=0.408 Sum_probs=206.8
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
++|...+.||+|+||.||+|+.. +++.||||++..... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 67899999999999999999876 578899999864311 1112357889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++....
T Consensus 94 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 94 EFAPRGELYKELQKH-----GRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp CCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 999999999999652 45899999999999999999999 8899999999999999999999999999987554
Q ss_pred CCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcC
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (973)
... .....|++.|+|||++.+..++.++||||||+++|||++|+.||......+.. ..+.. .+
T Consensus 166 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~~~--------~~ 228 (284)
T 2vgo_A 166 SLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH------RRIVN--------VD 228 (284)
T ss_dssp SSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHT--------TC
T ss_pred ccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHH------HHHhc--------cc
Confidence 322 23457999999999999999999999999999999999999999866532211 11111 01
Q ss_pred ccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 863 PALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 863 ~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
..+. . .....+.+++.+|++.||.+||++.|+++ +++++.
T Consensus 229 ~~~~--~---~~~~~~~~li~~~l~~~p~~Rps~~~ll~--h~~~~~ 268 (284)
T 2vgo_A 229 LKFP--P---FLSDGSKDLISKLLRYHPPQRLPLKGVME--HPWVKA 268 (284)
T ss_dssp CCCC--T---TSCHHHHHHHHHHSCSSGGGSCCHHHHHT--CHHHHH
T ss_pred cCCC--C---cCCHHHHHHHHHHhhcCHhhCCCHHHHhh--CHHHHh
Confidence 1111 1 11234779999999999999999999998 566553
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=377.58 Aligned_cols=260 Identities=23% Similarity=0.390 Sum_probs=207.3
Q ss_pred HhcCccccCcccccCccEEEEEEECC----CCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeE
Q 041143 623 VTQNFAQENELGRGGFGTVYKGELED----GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNER 698 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 698 (973)
..++|...+.||+|+||.||+|.+.. +..||||+++.. ......+.+.+|+.++++++||||+++++++. ++..
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 465 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 465 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence 34678899999999999999998742 457999998654 34555678999999999999999999999985 4568
Q ss_pred EEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecccc
Q 041143 699 LLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLV 778 (973)
Q Consensus 699 ~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla 778 (973)
++||||+++|+|.+++... ...+++..++.++.||++||+||| +++|+||||||+|||++.++.+||+|||++
T Consensus 466 ~lv~E~~~~g~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVR----KFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp EEEEECCTTCBHHHHHHHT----TTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred EEEEEcCCCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCC
Confidence 9999999999999999652 245899999999999999999999 789999999999999999999999999999
Q ss_pred ccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHH
Q 041143 779 KLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKF 857 (973)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (973)
+..............||+.|+|||++.+..++.++|||||||++|||++ |+.||......+. .. .+..
T Consensus 539 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~---~~---~i~~----- 607 (656)
T 2j0j_A 539 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IG---RIEN----- 607 (656)
T ss_dssp CSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HH---HHHH-----
T ss_pred eecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH---HH---HHHc-----
Confidence 8765544333344567889999999998999999999999999999997 9999987654321 11 1111
Q ss_pred HhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 858 KAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 858 ~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
.....+. ......+.+++.+|++.||++||++.||++.|+.+.+.
T Consensus 608 --~~~~~~~-----~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 608 --GERLPMP-----PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp --TCCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CCCCCCC-----ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 0011111 11224578999999999999999999999999998764
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=345.29 Aligned_cols=273 Identities=21% Similarity=0.317 Sum_probs=200.4
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEE---------
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSI--------- 693 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--------- 693 (973)
.++|...+.||+|+||.||+|... +|+.||||++... .....+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 368899999999999999999876 4899999998754 5566788999999999999999999999874
Q ss_pred -----eCCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEEC-CC
Q 041143 694 -----EGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLD-DD 767 (973)
Q Consensus 694 -----~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~-~~ 767 (973)
+....++||||++ |+|.+++.. ..+++..+..++.||+.||+||| +++|+||||||+||+++ ++
T Consensus 88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~ 157 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYME-TDLANVLEQ------GPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTED 157 (320)
T ss_dssp ---CCSCSEEEEEEECCS-EEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTT
T ss_pred cccccccCceeEEeeccC-CCHHHHhhc------CCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCC
Confidence 3467899999997 699998853 46899999999999999999999 78999999999999997 56
Q ss_pred CCEEEeeccccccCCCCC--cceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 041143 768 YRAKVSDFGLVKLAPDGE--KSVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLA 844 (973)
Q Consensus 768 ~~~kl~DfGla~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~ 844 (973)
+.+||+|||+++...... ........||..|+|||.+.. ..++.++|||||||++|||++|+.||......+...
T Consensus 158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~-- 235 (320)
T 2i6l_A 158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQ-- 235 (320)
T ss_dssp TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--
T ss_pred CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHH--
Confidence 799999999998654321 112234567999999998865 678999999999999999999999998766432211
Q ss_pred HHHHHHhhc-hhHHHh---h--------c-CccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcC
Q 041143 845 EWFWRIKSS-KEKFKA---A--------I-DPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWR 911 (973)
Q Consensus 845 ~~~~~~~~~-~~~~~~---~--------~-~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~ 911 (973)
......... .....+ . . .+..............+.+++.+|++.||++||++.|+++ +++++.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~~~~~~ 313 (320)
T 2i6l_A 236 LILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS--HPYMSIYS 313 (320)
T ss_dssp HHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT--SHHHHTTC
T ss_pred HHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC--Cccccccc
Confidence 111000000 000000 0 0 0000000000112345889999999999999999999998 77776544
Q ss_pred C
Q 041143 912 P 912 (973)
Q Consensus 912 ~ 912 (973)
.
T Consensus 314 ~ 314 (320)
T 2i6l_A 314 F 314 (320)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=350.10 Aligned_cols=274 Identities=20% Similarity=0.332 Sum_probs=207.7
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCe------
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNE------ 697 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------ 697 (973)
++|...+.||+|+||.||+|... +|+.||||++..........+.+.+|+.++++++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 67889999999999999999875 68999999997765566667889999999999999999999999987654
Q ss_pred EEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccc
Q 041143 698 RLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL 777 (973)
Q Consensus 698 ~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGl 777 (973)
.++||||+. |+|.+++. ..+++.++..++.||+.||+||| +++|+||||||+||+++.++.+||+|||+
T Consensus 104 ~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMG-------LKFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CEEEEECCS-EEGGGTTT-------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred EEEEecccc-CCHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999996 68876652 34899999999999999999999 78999999999999999999999999999
Q ss_pred cccCCCCCcceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhH
Q 041143 778 VKLAPDGEKSVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEK 856 (973)
Q Consensus 778 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (973)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.. .............
T Consensus 173 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~--~~i~~~~~~~~~~ 246 (353)
T 3coi_A 173 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL--TQILKVTGVPGTE 246 (353)
T ss_dssp TTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHH--HHHHHHHCBCCHH
T ss_pred ccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHhCCCCHH
Confidence 9854332 234578999999999876 67899999999999999999999999876543221 1111100000000
Q ss_pred H------------HhhcCcc--ccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCCCCCCC
Q 041143 857 F------------KAAIDPA--LEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPITDES 917 (973)
Q Consensus 857 ~------------~~~~~~~--l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~~~~~~ 917 (973)
. ...+... .............+.+++.+|++.||++||++.|+++ +++++.+.....+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~--hp~f~~~~~~~~~~ 319 (353)
T 3coi_A 247 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT--HPFFEPFRDPEEET 319 (353)
T ss_dssp HHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT--SGGGTTTCCGGGCC
T ss_pred HHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc--CcchhhccCccccc
Confidence 0 0000000 0000111122356889999999999999999999998 77777655444433
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=352.31 Aligned_cols=271 Identities=23% Similarity=0.347 Sum_probs=201.8
Q ss_pred cCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCe------E
Q 041143 625 QNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNE------R 698 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~ 698 (973)
.+|...+.||+|+||.||+|+...+..||+|++..... ...+|+++++.++|||||++++++...+. .
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 57889999999999999999998777899998865421 22479999999999999999999975433 7
Q ss_pred EEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEEC-CCCCEEEeeccc
Q 041143 699 LLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLD-DDYRAKVSDFGL 777 (973)
Q Consensus 699 ~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~-~~~~~kl~DfGl 777 (973)
++||||++++ +...+..... ....+++..+..++.||++||+||| +.+|+||||||+|||++ .++.+||+|||+
T Consensus 114 ~lv~e~~~~~-l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~ 188 (394)
T 4e7w_A 114 NLVLEYVPET-VYRASRHYAK-LKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGS 188 (394)
T ss_dssp EEEEECCSEE-HHHHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEeeccCcc-HHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence 8999999764 4444433222 2357899999999999999999999 78999999999999999 799999999999
Q ss_pred cccCCCCCcceecccccccCcccccccccC-cCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhH
Q 041143 778 VKLAPDGEKSVVTRLAGTFGYLAPEYAVMG-KITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEK 856 (973)
Q Consensus 778 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (973)
++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+. +...+.........
T Consensus 189 a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--l~~i~~~~g~p~~~ 264 (394)
T 4e7w_A 189 AKILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ--LVEIIKVLGTPSRE 264 (394)
T ss_dssp CEECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHH
T ss_pred cccccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHH
Confidence 986544332 3346789999999998764 589999999999999999999999987664332 22211111100000
Q ss_pred HHhhcCccc-----cC-CcccH------HHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCC
Q 041143 857 FKAAIDPAL-----EV-NEETF------ESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRP 912 (973)
Q Consensus 857 ~~~~~~~~l-----~~-~~~~~------~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~ 912 (973)
.....++.. .. ..... .....+.+++.+||+.||++||++.|+++ +++++....
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--hp~f~~~~~ 330 (394)
T 4e7w_A 265 QIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC--HPFFDELRT 330 (394)
T ss_dssp HHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT--SGGGSTTTS
T ss_pred HHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc--Chhhhhhcc
Confidence 000011110 00 00000 12246889999999999999999999998 777765443
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=339.05 Aligned_cols=257 Identities=23% Similarity=0.347 Sum_probs=200.5
Q ss_pred CccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEe
Q 041143 626 NFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEY 704 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 704 (973)
+|....+||+|+||.||+|.. .+++.||||++... .....+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 100 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ 100 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC--CC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC--chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence 455566899999999999986 46889999998764 334457799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECC-CCCEEEeeccccccCCC
Q 041143 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDD-DYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~-~~~~kl~DfGla~~~~~ 783 (973)
+++|+|.+++.... ....+++..+..++.||+.||+||| +.+|+||||||+||+++. ++.+||+|||+++....
T Consensus 101 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 101 VPGGSLSALLRSKW--GPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp CSEEEHHHHHHHTT--CCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred CCCCCHHHHHHhhc--cCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 99999999997622 2245678899999999999999999 789999999999999987 89999999999986543
Q ss_pred CCcceecccccccCcccccccccCc--CCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhc
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVMGK--ITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (973)
... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.......... ... .....
T Consensus 176 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~----~~~-------~~~~~ 243 (295)
T 2clq_A 176 INP-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM----FKV-------GMFKV 243 (295)
T ss_dssp ------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHH----HHH-------HHHCC
T ss_pred CCC-cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHH----Hhh-------ccccc
Confidence 221 233457999999999987643 8899999999999999999999997543221110 000 00011
Q ss_pred CccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 862 DPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 862 ~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
.+.+. ......+.+++.+|++.||++||++.|+++ +++++
T Consensus 244 ~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~--~~~~~ 283 (295)
T 2clq_A 244 HPEIP-----ESMSAEAKAFILKCFEPDPDKRACANDLLV--DEFLK 283 (295)
T ss_dssp CCCCC-----TTSCHHHHHHHHHTTCSSTTTSCCHHHHHT--SGGGC
T ss_pred ccccc-----ccCCHHHHHHHHHHccCChhhCCCHHHHhc--Chhhh
Confidence 12211 112245779999999999999999999987 55544
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=354.42 Aligned_cols=261 Identities=22% Similarity=0.387 Sum_probs=202.0
Q ss_pred hcCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
.++|...+.||+|+||.||+|+... .||+|+++.........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 4688999999999999999998864 49999987654344444568889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+++++|.+++.. ....+++.++..++.||+.||+||| +++|+||||||+||+++ ++.+||+|||+++....
T Consensus 110 ~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 110 LCKGRTLYSVVRD----AKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp CCCSEEHHHHTTS----SCCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred cccCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 9999999999854 2246899999999999999999999 78999999999999998 67999999999875432
Q ss_pred C----CcceecccccccCccccccccc---------CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHH
Q 041143 784 G----EKSVVTRLAGTFGYLAPEYAVM---------GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRI 850 (973)
Q Consensus 784 ~----~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 850 (973)
. .........||+.|+|||++.. ..++.++|||||||++|||++|+.||......... ..+
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~ 255 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII------WQM 255 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH------HHH
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHh
Confidence 1 1122234569999999999864 45788999999999999999999999876543211 111
Q ss_pred hhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcC
Q 041143 851 KSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWR 911 (973)
Q Consensus 851 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~ 911 (973)
. ....+...... ....+.+++.+|++.||++||++.+|++.|+.+.++..
T Consensus 256 ~-------~~~~~~~~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~ 305 (319)
T 2y4i_B 256 G-------TGMKPNLSQIG----MGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR 305 (319)
T ss_dssp H-------TTCCCCCCCSS----CCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred c-------cCCCCCCCcCC----CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence 1 11112111000 11237799999999999999999999999999877643
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=338.70 Aligned_cols=263 Identities=25% Similarity=0.359 Sum_probs=210.1
Q ss_pred HHHhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEE
Q 041143 621 RKVTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERL 699 (973)
Q Consensus 621 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 699 (973)
....++|...+.||+|+||.||+|+.. +++.||||++..........+.+.+|++++++++||||+++++++.+.+..+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 455679999999999999999999876 6899999998765444445678899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCC---CCEEEeecc
Q 041143 700 LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDD---YRAKVSDFG 776 (973)
Q Consensus 700 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~---~~~kl~DfG 776 (973)
+||||+++++|.+++... ..+++.++..++.||+.||+||| +.+|+||||||+||+++.+ +.+||+|||
T Consensus 98 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg 169 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFG 169 (287)
T ss_dssp EEECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTT
T ss_pred EEEEccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccC
Confidence 999999999999988652 45899999999999999999999 7899999999999999764 479999999
Q ss_pred ccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhH
Q 041143 777 LVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEK 856 (973)
Q Consensus 777 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (973)
+++....... .....||+.|+|||.+.+ .++.++||||||+++|||++|+.||......+. ...+....
T Consensus 170 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~~~-- 238 (287)
T 2wei_A 170 LSTCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI------LKRVETGK-- 238 (287)
T ss_dssp GGGTBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHCC--
T ss_pred cceeecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH------HHHHHcCC--
Confidence 9986544322 233468999999998765 589999999999999999999999987653321 11111100
Q ss_pred HHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcC
Q 041143 857 FKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWR 911 (973)
Q Consensus 857 ~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~ 911 (973)
...... ........+.+++.+|++.||++||++.|+++ .++++++.
T Consensus 239 ----~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~--hp~~~~~~ 284 (287)
T 2wei_A 239 ----YAFDLP---QWRTISDDAKDLIRKMLTFHPSLRITATQCLE--HPWIQKYS 284 (287)
T ss_dssp ----CCCCSG---GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH--SHHHHHHC
T ss_pred ----CCCCch---hhhhcCHHHHHHHHHHcccChhhCcCHHHHhc--CHHHhccc
Confidence 000000 00111245789999999999999999999998 66666543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=340.16 Aligned_cols=262 Identities=22% Similarity=0.301 Sum_probs=203.2
Q ss_pred HhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCC--ChHHHHHHHHHHHHHHhcCCCceeeeeeEEE--eCCe
Q 041143 623 VTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVT--TTKALDEFQSEIAVLSKVRHRHLVSLLGYSI--EGNE 697 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~ 697 (973)
..++|...+.||+|+||.||+|... +++.||||+++.... .....+.+.+|++++++++||||+++++++. +...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 3578999999999999999999874 688999999864311 1234567999999999999999999999985 4457
Q ss_pred EEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccc
Q 041143 698 RLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL 777 (973)
Q Consensus 698 ~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGl 777 (973)
.++||||+++| |.+++... ....+++..+..++.||++||+||| +++|+||||||+||+++.++.+||+|||+
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~ 155 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSV---PEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGV 155 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHS---TTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEEehhccCC-HHHHHHhC---cccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeecccc
Confidence 89999999876 77777542 2356899999999999999999999 78999999999999999999999999999
Q ss_pred cccCCCC-CcceecccccccCcccccccccCc--CCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhch
Q 041143 778 VKLAPDG-EKSVVTRLAGTFGYLAPEYAVMGK--ITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSK 854 (973)
Q Consensus 778 a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 854 (973)
++..... .........||+.|+|||++.+.. ++.++|||||||++|||++|+.||......+. ...+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~i~~~~ 229 (305)
T 2wtk_C 156 AEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKL------FENIGKGS 229 (305)
T ss_dssp CEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHCC
T ss_pred ccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH------HHHHhcCC
Confidence 9865432 222334567999999999987643 47799999999999999999999987543221 11111100
Q ss_pred hHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCC
Q 041143 855 EKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRP 912 (973)
Q Consensus 855 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~ 912 (973)
..+. . .....+.+++.+|++.||++||++.|+++ +++++...+
T Consensus 230 --------~~~~--~---~~~~~l~~li~~~l~~dp~~Rps~~~ll~--~~~~~~~~~ 272 (305)
T 2wtk_C 230 --------YAIP--G---DCGPPLSDLLKGMLEYEPAKRFSIRQIRQ--HSWFRKKHP 272 (305)
T ss_dssp --------CCCC--S---SSCHHHHHHHHHHTCSSTTTSCCHHHHHH--SHHHHSCCC
T ss_pred --------CCCC--C---ccCHHHHHHHHHHccCChhhCCCHHHHhc--CcccccCCC
Confidence 0111 0 11234779999999999999999999998 677665443
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=344.72 Aligned_cols=259 Identities=25% Similarity=0.356 Sum_probs=198.8
Q ss_pred HHhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCC------ChHHHHHHHHHHHHHHhcCCCceeeeeeEEEe
Q 041143 622 KVTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVT------TTKALDEFQSEIAVLSKVRHRHLVSLLGYSIE 694 (973)
Q Consensus 622 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 694 (973)
...++|...+.||+|+||.||+|... +++.||||++..... .......+.+|++++++++||||+++++++..
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 34578999999999999999999875 578999999865321 11223458899999999999999999999876
Q ss_pred CCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCC---EE
Q 041143 695 GNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYR---AK 771 (973)
Q Consensus 695 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~---~k 771 (973)
.+ .++||||+++|+|.+++.. ...+++..+..++.||+.||+||| +++|+||||||+||+++.++. +|
T Consensus 87 ~~-~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~k 157 (322)
T 2ycf_A 87 ED-YYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIK 157 (322)
T ss_dssp SS-EEEEEECCTTEETHHHHST-----TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEE
T ss_pred Cc-eEEEEecCCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEE
Confidence 54 8999999999999998854 256899999999999999999999 789999999999999987654 99
Q ss_pred EeeccccccCCCCCcceecccccccCcccccccc---cCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHH
Q 041143 772 VSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAV---MGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFW 848 (973)
Q Consensus 772 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 848 (973)
|+|||+++..... .......||+.|+|||++. ...++.++|||||||++|||++|+.||........ +...+.
T Consensus 158 l~Dfg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~ 233 (322)
T 2ycf_A 158 ITDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQIT 233 (322)
T ss_dssp ECCCTTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHHH
T ss_pred EccCccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHHH
Confidence 9999999866432 2233457999999999874 56789999999999999999999999976543211 111111
Q ss_pred HHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhh
Q 041143 849 RIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLV 907 (973)
Q Consensus 849 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~ 907 (973)
..... ..+.. .......+.+++.+|++.||++||++.|+++ ++++
T Consensus 234 ---~~~~~----~~~~~-----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~--h~~~ 278 (322)
T 2ycf_A 234 ---SGKYN----FIPEV-----WAEVSEKALDLVKKLLVVDPKARFTTEEALR--HPWL 278 (322)
T ss_dssp ---HTCCC----CCHHH-----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT--SGGG
T ss_pred ---hCccc----cCchh-----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh--CcCc
Confidence 00000 00000 0011245789999999999999999999987 4443
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=347.79 Aligned_cols=269 Identities=23% Similarity=0.382 Sum_probs=189.7
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
.++|...+.||+|+||.||+|... +++.||||++.... .....+++.+|++++++++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK-CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh-cchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 478999999999999999999764 68999999886542 2334567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccc
Q 041143 703 EYMPHGALSRHLFRWEKL---QLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK 779 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~---~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~ 779 (973)
||+++|+|.+++...... ....+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999999753221 2345899999999999999999999 7899999999999999999999999999998
Q ss_pred cCCCCCc----ceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhch
Q 041143 780 LAPDGEK----SVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSK 854 (973)
Q Consensus 780 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 854 (973)
....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......... .......
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-----~~~~~~~ 244 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM-----LTLQNDP 244 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH-----HHHTSSC
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH-----HHhccCC
Confidence 5543221 12234579999999999875 568999999999999999999999998765433211 0001000
Q ss_pred hHHHh-hcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 855 EKFKA-AIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 855 ~~~~~-~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
..... ..++... ......+.+++.+|++.||.+||++.|+++ +++++
T Consensus 245 ~~~~~~~~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~--h~~~~ 292 (303)
T 2vwi_A 245 PSLETGVQDKEML-----KKYGKSFRKMISLCLQKDPEKRPTAAELLR--HKFFQ 292 (303)
T ss_dssp CCTTC-----CCC-----CCCCHHHHHHHHHHCCSSGGGSCCHHHHHT--STTC-
T ss_pred Cccccccccchhh-----hhhhHHHHHHHHHHccCChhhCcCHHHHhh--Chhhh
Confidence 00000 0001100 011235789999999999999999999998 45544
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=340.04 Aligned_cols=258 Identities=25% Similarity=0.405 Sum_probs=204.2
Q ss_pred HHhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEE
Q 041143 622 KVTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLL 700 (973)
Q Consensus 622 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 700 (973)
...++|...+.||+|+||.||+|... +|+.||||++.... ..+.+.+|++++++++||||+++++++...+..++
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 44578999999999999999999876 58999999997542 23568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecccccc
Q 041143 701 VYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKL 780 (973)
Q Consensus 701 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~ 780 (973)
||||+++|+|.+++... ...+++.++..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||++..
T Consensus 102 v~e~~~~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 174 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLR----NKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQ 174 (314)
T ss_dssp EEECCTTEEHHHHHHHH----TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EeecCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchh
Confidence 99999999999998641 256899999999999999999999 78999999999999999999999999999986
Q ss_pred CCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhh
Q 041143 781 APDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAA 860 (973)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (973)
..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.......... .. ...
T Consensus 175 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~-------~~~ 240 (314)
T 3com_A 175 LTDTM-AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF------MI-------PTN 240 (314)
T ss_dssp CBTTB-SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HH-------HHS
T ss_pred hhhhc-cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH------HH-------hcC
Confidence 54322 12334579999999999999999999999999999999999999998665332111 01 111
Q ss_pred cCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 861 IDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 861 ~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
..+.+.. .......+.+++.+|++.||.+||++.++++ +++++.
T Consensus 241 ~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~--~~~~~~ 284 (314)
T 3com_A 241 PPPTFRK---PELWSDNFTDFVKQCLVKSPEQRATATQLLQ--HPFVRS 284 (314)
T ss_dssp CCCCCSS---GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT--SHHHHT
T ss_pred CCcccCC---cccCCHHHHHHHHHHccCChhhCcCHHHHHh--CHHHhc
Confidence 1111110 0111245789999999999999999999998 566553
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=347.52 Aligned_cols=275 Identities=22% Similarity=0.323 Sum_probs=208.3
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeC-----Ce
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEG-----NE 697 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 697 (973)
.++|...+.||+|+||.||+|+.. +|+.||||++... ........+.+|++++++++||||+++++++... ..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 468999999999999999999875 6889999999653 3455567789999999999999999999998764 67
Q ss_pred EEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccc
Q 041143 698 RLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL 777 (973)
Q Consensus 698 ~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGl 777 (973)
.++||||+. |+|.+++.. ..+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||+
T Consensus 89 ~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST------QMLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGL 158 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEeccC-ccHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEeccc
Confidence 899999996 699988865 46899999999999999999999 78999999999999999999999999999
Q ss_pred cccCCCCCcc---------eecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHH
Q 041143 778 VKLAPDGEKS---------VVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWF 847 (973)
Q Consensus 778 a~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 847 (973)
++........ ......||+.|+|||++.. ..++.++|||||||++|||++|+.||......+.... +
T Consensus 159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~ 235 (353)
T 2b9h_A 159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL---I 235 (353)
T ss_dssp CEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---H
T ss_pred ccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH---H
Confidence 9865432211 1223578999999998764 6789999999999999999999999987654322111 1
Q ss_pred HHHhhc-----------hhHHHhhcCccccCCccc-----HHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcC
Q 041143 848 WRIKSS-----------KEKFKAAIDPALEVNEET-----FESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWR 911 (973)
Q Consensus 848 ~~~~~~-----------~~~~~~~~~~~l~~~~~~-----~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~ 911 (973)
...... .....+.+.......... ......+.+++.+|++.||++||++.|+++ +++++.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~~~~~~ 313 (353)
T 2b9h_A 236 FGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE--HPYLQTYH 313 (353)
T ss_dssp HHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGTTTC
T ss_pred HHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc--CccccccC
Confidence 111000 000000000000000000 112245789999999999999999999998 77777655
Q ss_pred CCC
Q 041143 912 PIT 914 (973)
Q Consensus 912 ~~~ 914 (973)
...
T Consensus 314 ~~~ 316 (353)
T 2b9h_A 314 DPN 316 (353)
T ss_dssp CTT
T ss_pred Ccc
Confidence 443
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=344.74 Aligned_cols=257 Identities=24% Similarity=0.398 Sum_probs=200.4
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
.++|+..+.||+|+||.||+|+.. +|+.||+|++... .....+.+.+|++++++++||||+++++++...+..++||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC--CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 468999999999999999999886 5899999998654 2334567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++|+|.+++... ...+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||++....
T Consensus 96 e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (302)
T 2j7t_A 96 EFCPGGAVDAIMLEL----DRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL 168 (302)
T ss_dssp ECCTTEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHH
T ss_pred EeCCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcccc
Confidence 999999999988652 245899999999999999999999 7899999999999999999999999999875321
Q ss_pred CCCcceecccccccCcccccccc-----cCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHH
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAV-----MGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKF 857 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (973)
.. ........||+.|+|||++. ...++.++|||||||++|||++|+.||........ ...+..
T Consensus 169 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~----- 236 (302)
T 2j7t_A 169 KT-LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLKIAK----- 236 (302)
T ss_dssp HH-HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHH-----
T ss_pred cc-ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH------HHHHhc-----
Confidence 11 01123357999999999883 56789999999999999999999999987654321 111111
Q ss_pred HhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 858 KAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 858 ~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
...+... ........+.+++.+|++.||++||++.|+++ +++++
T Consensus 237 --~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--h~~~~ 280 (302)
T 2j7t_A 237 --SDPPTLL---TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE--HPFVS 280 (302)
T ss_dssp --SCCCCCS---SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT--STTTT
T ss_pred --cCCcccC---CccccCHHHHHHHHHHcccChhhCCCHHHHhc--ChHHh
Confidence 0011110 01111245789999999999999999999987 44444
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=356.69 Aligned_cols=264 Identities=23% Similarity=0.252 Sum_probs=202.5
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcC--------CCceeeeeeEEE-
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR--------HRHLVSLLGYSI- 693 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~- 693 (973)
.++|...+.||+|+||.||+|+.. +++.||||+++. .....+.+.+|++++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS---AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec---CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 368999999999999999999764 688999999964 3455678899999999985 788999999988
Q ss_pred ---eCCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccC-CeeeccCCCCcEEECCCC-
Q 041143 694 ---EGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQ-TFIHRDLKSSNILLDDDY- 768 (973)
Q Consensus 694 ---~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~-~ivH~Dikp~Nill~~~~- 768 (973)
.....++||||+ +|+|.+++... ....+++..+..++.||+.||+||| ++ +|+||||||+|||++.++
T Consensus 113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~ 185 (397)
T 1wak_A 113 SGVNGTHICMVFEVL-GHHLLKWIIKS---NYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQ 185 (397)
T ss_dssp EETTEEEEEEEECCC-CCBHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHH
T ss_pred cCCCCceEEEEEecc-CccHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccch
Confidence 455789999999 67777777542 2256899999999999999999999 66 999999999999999775
Q ss_pred ------------------------------------------------CEEEeeccccccCCCCCcceecccccccCccc
Q 041143 769 ------------------------------------------------RAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLA 800 (973)
Q Consensus 769 ------------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~a 800 (973)
.+||+|||+++..... .....||+.|+|
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~a 261 (397)
T 1wak_A 186 YIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRS 261 (397)
T ss_dssp HHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCC
T ss_pred hhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccC
Confidence 8999999999865432 334579999999
Q ss_pred ccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHH---HHHHHHHHHhhc-hhH-------HHhhcCcc--c--
Q 041143 801 PEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESR---YLAEWFWRIKSS-KEK-------FKAAIDPA--L-- 865 (973)
Q Consensus 801 PE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~---~~~~~~~~~~~~-~~~-------~~~~~~~~--l-- 865 (973)
||++.+..++.++|||||||++|||++|+.||......+.. .....+...... ... ....+... +
T Consensus 262 PE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 341 (397)
T 1wak_A 262 LEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKH 341 (397)
T ss_dssp HHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSS
T ss_pred ChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccc
Confidence 99999999999999999999999999999999865532211 111111111100 000 00000000 0
Q ss_pred --------------cCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 866 --------------EVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 866 --------------~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
............+.+|+.+||+.||++|||+.||++
T Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 342 ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 000123455567889999999999999999999997
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=345.97 Aligned_cols=284 Identities=21% Similarity=0.279 Sum_probs=201.0
Q ss_pred HHHHHhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCe
Q 041143 619 VLRKVTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNE 697 (973)
Q Consensus 619 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 697 (973)
......++|...+.||+|+||.||+|+.. +|+.||||++...... ...+.+|++.++.++||||+++++++...+.
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC---CCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc---cHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 44567789999999999999999999875 6899999998654222 2356778888999999999999999976433
Q ss_pred -------EEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECC-CCC
Q 041143 698 -------RLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDD-DYR 769 (973)
Q Consensus 698 -------~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~-~~~ 769 (973)
.++||||+++ +|...+..... ....+++..+..++.|++.||+|||.. +++|+||||||+|||++. ++.
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYR-RQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTE
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCc
Confidence 7899999975 66555544222 235689999999999999999999943 679999999999999997 899
Q ss_pred EEEeeccccccCCCCCcceecccccccCcccccccccCc-CCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHH
Q 041143 770 AKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGK-ITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFW 848 (973)
Q Consensus 770 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 848 (973)
+||+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||........ +.....
T Consensus 171 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~--~~~~~~ 246 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ--LHEIVR 246 (360)
T ss_dssp EEECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHH
T ss_pred EEEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH--HHHHHH
Confidence 9999999998665432 233457899999999987654 89999999999999999999999987654332 112111
Q ss_pred HHhhchhHHHhhcCcccc------C---------CcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCCC
Q 041143 849 RIKSSKEKFKAAIDPALE------V---------NEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPI 913 (973)
Q Consensus 849 ~~~~~~~~~~~~~~~~l~------~---------~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~~ 913 (973)
............+++... . ..........+.+++.+|++.||++|||+.|+++ +++++.....
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~--hp~f~~~~~~ 324 (360)
T 3e3p_A 247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC--HPYFDELHDP 324 (360)
T ss_dssp HHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT--SGGGGGGGCT
T ss_pred HcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc--CccccccCCc
Confidence 111111111111111100 0 0001113456889999999999999999999998 8888765543
Q ss_pred C
Q 041143 914 T 914 (973)
Q Consensus 914 ~ 914 (973)
.
T Consensus 325 ~ 325 (360)
T 3e3p_A 325 A 325 (360)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=357.38 Aligned_cols=260 Identities=11% Similarity=0.080 Sum_probs=186.8
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc--CCCceeeee-------eEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKV--RHRHLVSLL-------GYSI 693 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~~ 693 (973)
.+|...+.||+|+||.||+|++. +|+.||||+++.... .....+.+.+|+++++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45888999999999999999875 789999999987543 334566788885555444 699988755 4444
Q ss_pred eC-----------------CeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHH------HHHHHHHHHHHHHHHhhccC
Q 041143 694 EG-----------------NERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRR------LSIALDVARGMEYLHCLARQ 750 (973)
Q Consensus 694 ~~-----------------~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~------~~i~~~ia~gl~~LH~~~~~ 750 (973)
.. ...++||||++ |+|.+++.... ..+.+..+ ..++.||++||+||| ++
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~ 213 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD----FVYVFRGDEGILALHILTAQLIRLAANLQ---SK 213 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH----HSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HT
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc----cccchhhhhhhhhHHHHHHHHHHHHHHHH---HC
Confidence 33 33799999998 89999997642 23455666 788899999999999 88
Q ss_pred CeeeccCCCCcEEECCCCCEEEeeccccccCCCCCcceecccccccCccccccccc--CcCCCchhHHhHHHHHHHHHhC
Q 041143 751 TFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVM--GKITTKADVFSYGVVLMELLTG 828 (973)
Q Consensus 751 ~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gvvl~elltg 828 (973)
+|+||||||+|||++.++.+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 9999999999999999999999999999865431 224467799999999987 7799999999999999999999
Q ss_pred CCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 829 LAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 829 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
+.||....+...... . ...........+... ........+.+++.+||+.||++||++.|+++ +++++
T Consensus 290 ~~Pf~~~~~~~~~~~--------~-~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~--hp~f~ 357 (371)
T 3q60_A 290 FLPFGLVTPGIKGSW--------K-RPSLRVPGTDSLAFG-SCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME--TPEFL 357 (371)
T ss_dssp SCSTTBCCTTCTTCC--------C-BCCTTSCCCCSCCCT-TSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT--SHHHH
T ss_pred CCCCCCcCcccccch--------h-hhhhhhccccccchh-hccCCCHHHHHHHHHHcCCChhhCCCHHHHhc--CHHHH
Confidence 999987643211000 0 000000001111100 00122345789999999999999999999987 55544
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=338.15 Aligned_cols=260 Identities=25% Similarity=0.324 Sum_probs=208.1
Q ss_pred HhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCC---C----hHHHHHHHHHHHHHHhcC-CCceeeeeeEEE
Q 041143 623 VTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVT---T----TKALDEFQSEIAVLSKVR-HRHLVSLLGYSI 693 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~----~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 693 (973)
..++|...+.||+|+||.||+|... +|+.||||+++.... . ....+.+.+|++++++++ ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3478999999999999999999875 688999999975421 1 223567889999999995 999999999999
Q ss_pred eCCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEe
Q 041143 694 EGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVS 773 (973)
Q Consensus 694 ~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~ 773 (973)
..+..++||||+++|+|.+++.. ...+++.++..++.||+.||+||| +.+|+||||||+||+++.++.+||+
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~ 166 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTE-----KVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLT 166 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEEC
T ss_pred cCCeEEEEEeccCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEe
Confidence 99999999999999999999965 246899999999999999999999 7899999999999999999999999
Q ss_pred eccccccCCCCCcceecccccccCcccccccc------cCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHH
Q 041143 774 DFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAV------MGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWF 847 (973)
Q Consensus 774 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 847 (973)
|||+++...... ......||+.|+|||++. ...++.++||||||+++|||++|+.||.........
T Consensus 167 dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~------ 238 (298)
T 1phk_A 167 DFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML------ 238 (298)
T ss_dssp CCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------
T ss_pred cccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHH------
Confidence 999998654432 234467999999999885 456889999999999999999999999765532211
Q ss_pred HHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 848 WRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 848 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
..+.... .. .. ..........+.+++.+|++.||++||++.|+++ ++++++
T Consensus 239 ~~~~~~~------~~--~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--h~~~~~ 289 (298)
T 1phk_A 239 RMIMSGN------YQ--FG-SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA--HPFFQQ 289 (298)
T ss_dssp HHHHHTC------CC--CC-TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT--SGGGCT
T ss_pred HHHhcCC------cc--cC-cccccccCHHHHHHHHHHccCCcccCCCHHHHHh--ChHhhh
Confidence 1111100 00 00 0000122345789999999999999999999998 666554
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=345.70 Aligned_cols=274 Identities=22% Similarity=0.346 Sum_probs=204.7
Q ss_pred HhcCccccCcccccCccEEEEEEE--CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc---CCCceeeeeeEEE----
Q 041143 623 VTQNFAQENELGRGGFGTVYKGEL--EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV---RHRHLVSLLGYSI---- 693 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~---- 693 (973)
..++|...+.||+|+||.||+|+. .+|+.||||+++...........+.+|+++++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 447899999999999999999987 4688999999865432222223566777777766 8999999999987
Q ss_pred -eCCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEE
Q 041143 694 -EGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKV 772 (973)
Q Consensus 694 -~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl 772 (973)
.....++||||++ |+|.+++.... ...+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl 161 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKL 161 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC---TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEE
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEE
Confidence 4567899999997 69999997532 245899999999999999999999 789999999999999999999999
Q ss_pred eeccccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhh
Q 041143 773 SDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKS 852 (973)
Q Consensus 773 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 852 (973)
+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. +.........
T Consensus 162 ~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~i~~~~~~ 237 (326)
T 1blx_A 162 ADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ--LGKILDVIGL 237 (326)
T ss_dssp CSCCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCC
T ss_pred ecCcccccccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHHHHcCC
Confidence 999999865432 223446799999999999999999999999999999999999999987654322 1111111000
Q ss_pred c-hhHHHhhcC-cc--cc------CCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 853 S-KEKFKAAID-PA--LE------VNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 853 ~-~~~~~~~~~-~~--l~------~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
. ......... +. +. ...........+.+++.+|++.||++||++.|+++ +++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~--hp~~~~ 302 (326)
T 1blx_A 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS--HPYFQD 302 (326)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT--SGGGTT
T ss_pred CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc--Cccccc
Confidence 0 000000000 00 00 00000112345779999999999999999999997 666554
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=343.07 Aligned_cols=261 Identities=17% Similarity=0.276 Sum_probs=201.9
Q ss_pred cCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeeEEEe--CCeEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR-HRHLVSLLGYSIE--GNERLL 700 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~l 700 (973)
++|+..+.||+|+||.||+|+. .+++.||||+++.. . .+.+.+|++++++++ ||||+++++++.+ ....++
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l 110 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--K---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 110 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--C---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc--c---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence 6789999999999999999976 56899999998643 1 356889999999997 9999999999998 667899
Q ss_pred EEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCC-CEEEeeccccc
Q 041143 701 VYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDY-RAKVSDFGLVK 779 (973)
Q Consensus 701 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~-~~kl~DfGla~ 779 (973)
||||+++++|.+++. .+++.++..++.||+.||+||| +++|+||||||+|||++.++ .+||+|||+++
T Consensus 111 v~e~~~~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~ 179 (330)
T 3nsz_A 111 VFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179 (330)
T ss_dssp EEECCCCCCHHHHGG--------GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEeccCchhHHHHHH--------hCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence 999999999988773 3788999999999999999999 88999999999999999776 89999999998
Q ss_pred cCCCCCcceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHH
Q 041143 780 LAPDGEKSVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFK 858 (973)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (973)
....... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ .+....... . .....
T Consensus 180 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-~l~~~~~~~-~-~~~~~ 254 (330)
T 3nsz_A 180 FYHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVRIAKVL-G-TEDLY 254 (330)
T ss_dssp ECCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH-HHHHHHHHH-C-HHHHH
T ss_pred EcCCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH-HHHHHHHhc-C-Cchhh
Confidence 6544332 344579999999999877 6789999999999999999999999965443211 111111110 0 11111
Q ss_pred hhcC-------ccc---------------cCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 859 AAID-------PAL---------------EVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 859 ~~~~-------~~l---------------~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
+.++ +.+ ............+.+++.+|++.||++|||++|+++ +++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~--hp~f~ 324 (330)
T 3nsz_A 255 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME--HPYFY 324 (330)
T ss_dssp HHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT--SGGGT
T ss_pred hHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc--CccHh
Confidence 1000 000 000001112356889999999999999999999998 66654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=342.13 Aligned_cols=258 Identities=24% Similarity=0.399 Sum_probs=199.8
Q ss_pred HHhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEe-----
Q 041143 622 KVTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIE----- 694 (973)
Q Consensus 622 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----- 694 (973)
...++|...+.||+|+||.||+|+.. +|+.||||++..... ..+.+.+|+.+++++ +||||+++++++..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc---cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence 34578999999999999999999874 689999999875422 235788999999999 79999999999987
Q ss_pred -CCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEe
Q 041143 695 -GNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVS 773 (973)
Q Consensus 695 -~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~ 773 (973)
.+..++||||+++|+|.+++.... ...+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~kl~ 171 (326)
T 2x7f_A 98 MDDQLWLVMEFCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLV 171 (326)
T ss_dssp CCCEEEEEEECCTTEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEEC
T ss_pred ccceEEEEEEcCCCCcHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEEEe
Confidence 467899999999999999997632 256899999999999999999999 7899999999999999999999999
Q ss_pred eccccccCCCCCcceecccccccCcccccccc-----cCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHH
Q 041143 774 DFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAV-----MGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFW 848 (973)
Q Consensus 774 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 848 (973)
|||++....... .......||+.|+|||++. ...++.++|||||||++|||++|+.||..........
T Consensus 172 Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------ 244 (326)
T 2x7f_A 172 DFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF------ 244 (326)
T ss_dssp CCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------
T ss_pred eCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH------
Confidence 999988654322 1233457999999999987 5678999999999999999999999997665432211
Q ss_pred HHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 849 RIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 849 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
.+ .....+.+.... ....+.+++.+|++.||++||++.++++ +++++
T Consensus 245 ~~-------~~~~~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~--hp~~~ 291 (326)
T 2x7f_A 245 LI-------PRNPAPRLKSKK----WSKKFQSFIESCLVKNHSQRPATEQLMK--HPFIR 291 (326)
T ss_dssp HH-------HHSCCCCCSCSC----SCHHHHHHHHHHCCSSGGGSCCHHHHHT--SHHHH
T ss_pred Hh-------hcCccccCCccc----cCHHHHHHHHHHhccChhhCCCHHHHhh--ChHHh
Confidence 01 111111111111 1235789999999999999999999998 56655
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=343.99 Aligned_cols=270 Identities=20% Similarity=0.218 Sum_probs=207.7
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CC-----ceeeeeeEEEeCC
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR-HR-----HLVSLLGYSIEGN 696 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~ 696 (973)
.++|...+.||+|+||.||+|... +++.||||+++. .....+++.+|+++++.++ |+ +|+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN---KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS---SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec---cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 478999999999999999999875 678999999974 3445667888999998885 55 4999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEEC--CCCCEEEee
Q 041143 697 ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLD--DDYRAKVSD 774 (973)
Q Consensus 697 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~--~~~~~kl~D 774 (973)
..++||||++ |+|.+++.... ...+++..+..++.|++.||+|||+. +.+|+||||||+|||++ .++.+||+|
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNTN---FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred ceEEEEecCC-CCHHHHHhhcC---cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 9999999995 69999997632 24589999999999999999999942 47899999999999994 578899999
Q ss_pred ccccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhch
Q 041143 775 FGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSK 854 (973)
Q Consensus 775 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 854 (973)
||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+... ..........
T Consensus 205 FG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~--~i~~~~~~~~ 278 (382)
T 2vx3_A 205 FGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMN--KIVEVLGIPP 278 (382)
T ss_dssp CTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHHHHCSCC
T ss_pred ccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHHhCCCC
Confidence 9999866432 234679999999999999999999999999999999999999998766433211 1111100000
Q ss_pred h-------HHHhhcCcc----c------------------------------------cCCcccHHHHHHHHHHHHHhhc
Q 041143 855 E-------KFKAAIDPA----L------------------------------------EVNEETFESISIVAELAGHCTA 887 (973)
Q Consensus 855 ~-------~~~~~~~~~----l------------------------------------~~~~~~~~~~~~~~~l~~~cl~ 887 (973)
. .....++.. . ........+...+.+|+.+||+
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~ 358 (382)
T 2vx3_A 279 AHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLD 358 (382)
T ss_dssp HHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTC
T ss_pred HHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcC
Confidence 0 001111000 0 0000112334578899999999
Q ss_pred cCCCCCCCHhHHHHHHHHhhhh
Q 041143 888 REPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 888 ~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
.||++|||++|+++ ++++++
T Consensus 359 ~dP~~Rpta~e~L~--hp~f~~ 378 (382)
T 2vx3_A 359 YDPKTRIQPYYALQ--HSFFKK 378 (382)
T ss_dssp SCTTTSCCHHHHTT--SGGGCC
T ss_pred CChhhCCCHHHHhc--Cccccc
Confidence 99999999999998 666554
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=350.89 Aligned_cols=271 Identities=20% Similarity=0.318 Sum_probs=206.8
Q ss_pred hcCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCCh---------------HHHHHHHHHHHHHHhcCCCceeee
Q 041143 624 TQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTT---------------KALDEFQSEIAVLSKVRHRHLVSL 688 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~---------------~~~~~~~~E~~~l~~l~h~niv~l 688 (973)
.++|...+.||+|+||.||+|.. +|+.||||++....... ...+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 36899999999999999999998 89999999986431111 112689999999999999999999
Q ss_pred eeEEEeCCeEEEEEEecCCCCHHHHHHhh---hhccCCCCCHHHHHHHHHHHHHHHHHHHhhcc-CCeeeccCCCCcEEE
Q 041143 689 LGYSIEGNERLLVYEYMPHGALSRHLFRW---EKLQLKPLSWTRRLSIALDVARGMEYLHCLAR-QTFIHRDLKSSNILL 764 (973)
Q Consensus 689 ~~~~~~~~~~~lV~e~~~~g~L~~~l~~~---~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~-~~ivH~Dikp~Nill 764 (973)
++++.+.+..++||||+++|+|.+++... .......+++..+..++.||+.||+||| + ++|+||||||+||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEEE
Confidence 99999999999999999999999883211 1112367899999999999999999999 6 899999999999999
Q ss_pred CCCCCEEEeeccccccCCCCCcceecccccccCcccccccccC-cCCC-chhHHhHHHHHHHHHhCCCCCCCCChhhHHH
Q 041143 765 DDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMG-KITT-KADVFSYGVVLMELLTGLAALDEERPEESRY 842 (973)
Q Consensus 765 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~ 842 (973)
+.++.+||+|||+++..... ......||+.|+|||++.+. .++. ++|||||||++|||++|+.||........
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-- 260 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE-- 260 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH--
T ss_pred cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH--
Confidence 99999999999999865432 34456799999999999877 6666 99999999999999999999986654211
Q ss_pred HHHHHHHHhhchhHHHhh----cCccccC--CcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 843 LAEWFWRIKSSKEKFKAA----IDPALEV--NEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 843 ~~~~~~~~~~~~~~~~~~----~~~~l~~--~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
+ ...+......+... ..+.... ..........+.+++.+|++.||.+||++.|+++ +++++
T Consensus 261 ~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~--hp~f~ 327 (348)
T 2pml_X 261 L---FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK--HEWLA 327 (348)
T ss_dssp H---HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT--SGGGT
T ss_pred H---HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc--Ccccc
Confidence 1 11111110000000 0000000 0000122345789999999999999999999998 55554
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=333.96 Aligned_cols=252 Identities=23% Similarity=0.380 Sum_probs=192.6
Q ss_pred HhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEe-------
Q 041143 623 VTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIE------- 694 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------- 694 (973)
..++|+..+.||+|+||.||+|+.. +|+.||||++.. .....+.+.+|++++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP 80 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE---EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec---cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence 4568999999999999999999874 789999999864 34556789999999999999999999999865
Q ss_pred ------CCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCC
Q 041143 695 ------GNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDY 768 (973)
Q Consensus 695 ------~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~ 768 (973)
.+..++||||+++|+|.+++... ...+++.+++.++.|+++||+||| +++|+||||||+||+++.++
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~ 153 (303)
T 1zy4_A 81 MTAVKKKSTLFIQMEYCENGTLYDLIHSE----NLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESR 153 (303)
T ss_dssp -----CEEEEEEEEECCCSCBHHHHHHHS----CGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTS
T ss_pred hcccccCCceEEEEecCCCCCHHHhhhcc----ccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCC
Confidence 34678999999999999999752 245788999999999999999999 78999999999999999999
Q ss_pred CEEEeeccccccCCCCC-------------cceecccccccCcccccccccC-cCCCchhHHhHHHHHHHHHhCCCCCCC
Q 041143 769 RAKVSDFGLVKLAPDGE-------------KSVVTRLAGTFGYLAPEYAVMG-KITTKADVFSYGVVLMELLTGLAALDE 834 (973)
Q Consensus 769 ~~kl~DfGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~ 834 (973)
.+||+|||+++...... ........||+.|+|||++.+. .++.++|||||||++|||++ ||..
T Consensus 154 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~ 230 (303)
T 1zy4_A 154 NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST 230 (303)
T ss_dssp CEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred CEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC
Confidence 99999999998554221 1122345799999999998754 78999999999999999998 4432
Q ss_pred CChhhHHHHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 835 ERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
. .+.. .....+.... ..+.+.+ .......+.+++.+|++.||.+||++.|+++
T Consensus 231 ~--~~~~---~~~~~~~~~~----~~~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 231 G--MERV---NILKKLRSVS----IEFPPDF-----DDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp H--HHHH---HHHHHHHSTT----CCCCTTC-----CTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred c--hhHH---HHHHhccccc----cccCccc-----cccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 1 1111 1111111100 0111111 1122345779999999999999999999998
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=380.55 Aligned_cols=391 Identities=18% Similarity=0.148 Sum_probs=263.8
Q ss_pred CcCeEEeeCCeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCC-C-CCCCCCccceeeccCCCCCCCCccccC
Q 041143 58 PWPHVFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKL-P-TFSGLSELEFAYLDFNEFDTIPSDFFD 135 (973)
Q Consensus 58 ~w~gv~C~~~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~-~-~~~~l~~L~~L~L~~N~l~~i~~~~f~ 135 (973)
.|..|-+-..+++.|+|++|.|++..+..|.++++|++|+|++|.+.+.+ | .|.++++|++|+|++|+|+.+.+..|.
T Consensus 15 ~L~~vP~lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~ 94 (844)
T 3j0a_A 15 NLTQVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQ 94 (844)
T ss_dssp CSSCCCSSCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSC
T ss_pred CCCCCCCCCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHcc
Confidence 46666663468999999999999999999999999999999999766644 4 699999999999999999999999999
Q ss_pred CCCCccEEEcccCCCCCccCCCCCcc--cccccccCeeecccccccCCcc-hhccCCCCCCeEEccCCcCcccCChhhhh
Q 041143 136 GLSSVRVLALDYNPFNKTFGWSIPDS--LANSVQLTNLSLINCNLVGPLP-DFLGTLPSLAALKLSYNRLSGVIPASFGQ 212 (973)
Q Consensus 136 ~l~~L~~L~Ls~N~l~~~~~~~ip~~--~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 212 (973)
++++|++|+|++|.+++. +|.. +.++++|++|+|++|.+++..+ ..|+++++|++|+|++|++++..+..+..
T Consensus 95 ~l~~L~~L~Ls~n~l~~~----~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~ 170 (844)
T 3j0a_A 95 GLFHLFELRLYFCGLSDA----VLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEP 170 (844)
T ss_dssp SCSSCCCEECTTCCCSSC----CSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHH
T ss_pred CCcccCEeeCcCCCCCcc----cccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHccc
Confidence 999999999999999874 4544 8899999999999999987655 57899999999999999998877776643
Q ss_pred hH---------------------------------HHHHhhccc------------------------------------
Q 041143 213 SL---------------------------------MQILWLNDQ------------------------------------ 223 (973)
Q Consensus 213 ~~---------------------------------~~~~~l~~~------------------------------------ 223 (973)
.. ++.+.+..+
T Consensus 171 l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~ 250 (844)
T 3j0a_A 171 LQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFH 250 (844)
T ss_dssp HHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCS
T ss_pred ccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceeccccccccccccc
Confidence 20 111111111
Q ss_pred ------------------------CCCCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcccccC
Q 041143 224 ------------------------DAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLI 279 (973)
Q Consensus 224 ------------------------~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~ 279 (973)
.+.........|..+++|+.|+|++|++++..|..|..+++|++|+|++|++++..
T Consensus 251 ~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 330 (844)
T 3j0a_A 251 NIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELY 330 (844)
T ss_dssp SSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCC
T ss_pred ccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccC
Confidence 00011111233455566666666666666555666666666666666666666655
Q ss_pred ccccccc-ccCeEEccCCcCcCCCCCCCCCCcccccCcccCCCCCc-c----------------cCC-------------
Q 041143 280 PKSLANM-ELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGI-E----------------CAP------------- 328 (973)
Q Consensus 280 p~~~~~l-~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~-~----------------~~~------------- 328 (973)
|..|..+ +|+.|++++|.+.+..+..+...-.+...++..+.... . ..+
T Consensus 331 ~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~ 410 (844)
T 3j0a_A 331 SSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSE 410 (844)
T ss_dssp SCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCS
T ss_pred HHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccCCCCcchhccCCCCcccccccccccceeeccc
Confidence 6666555 56666666666654444322211111111111110000 0 000
Q ss_pred -------c--chhhhhhccCCCCCCcccCCCCCCC----------------CCCC----CccccccCCCCcccEEecCCC
Q 041143 329 -------D--VNVLLDFLGGVNYPVNLVSQWPGND----------------PCQG----PWLGLSCTSNSKVSIINLPRH 379 (973)
Q Consensus 329 -------~--~~~~~~~l~~l~~~~n~~~~~~~~~----------------~~~~----~~~~~~~~~~~~L~~L~Ls~N 379 (973)
. ....+..+..+++..|.+...+... .... ......+..+++|+.|+|++|
T Consensus 411 N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N 490 (844)
T 3j0a_A 411 NRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHN 490 (844)
T ss_dssp CCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHH
T ss_pred CccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCC
Confidence 0 0001233444444444444322110 0000 011123556788899999999
Q ss_pred cCCCccchhhhCccccceEEccCCccccccCccccCcCCCCeeeCCCCcCCCCCCC-CCcccceeecCCccccCCC
Q 041143 380 NLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLPE-FHDTVKLVIDGNPLLVGGI 454 (973)
Q Consensus 380 ~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~-~~~~~~~~~~~N~~~c~~~ 454 (973)
++++.+|..|.++++|+.|+|++|+|++..|..+. ++|+.|||++|+|++.+|. +..+..+++.+|||.|...
T Consensus 491 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C~c~ 564 (844)
T 3j0a_A 491 YLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECE 564 (844)
T ss_dssp HHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCSSCCEEEEEEECCCCSSS
T ss_pred cccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhCCcCEEEecCCCcccccc
Confidence 99988888899999999999999999876666666 8899999999999998886 4567789999999999754
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=339.99 Aligned_cols=267 Identities=20% Similarity=0.292 Sum_probs=207.0
Q ss_pred hcCccccCcccccCccEEEEEEEC-CC-CEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCc------eeeeeeEEEeC
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DG-TKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRH------LVSLLGYSIEG 695 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~ 695 (973)
.++|...+.||+|+||.||+|... ++ +.||||+++. .....+.+.+|++++++++|++ ++.+++++...
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN---VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc---cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 368999999999999999999875 34 6899999864 3455677889999999997665 99999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEE-----------
Q 041143 696 NERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILL----------- 764 (973)
Q Consensus 696 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill----------- 764 (973)
+..++||||+ +|++.+++... ....+++.++..++.||+.||+||| +++|+||||||+|||+
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~~---~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~ 167 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKEN---NFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNE 167 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECC
T ss_pred CeEEEEEecc-CCChHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecccccccccc
Confidence 9999999999 77887777652 2246899999999999999999999 8899999999999999
Q ss_pred --------CCCCCEEEeeccccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCC
Q 041143 765 --------DDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEER 836 (973)
Q Consensus 765 --------~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~ 836 (973)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (355)
T 2eu9_A 168 HKSCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE 243 (355)
T ss_dssp C-CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 56789999999999865432 234579999999999999999999999999999999999999998766
Q ss_pred hhhHHHHHHHHHHHhhc--hhH--------------------------HHhhcCccccCCcccHHHHHHHHHHHHHhhcc
Q 041143 837 PEESRYLAEWFWRIKSS--KEK--------------------------FKAAIDPALEVNEETFESISIVAELAGHCTAR 888 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~~~--~~~--------------------------~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~ 888 (973)
..+..... ...... ... ......+..............+.+++.+||+.
T Consensus 244 ~~~~~~~~---~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 320 (355)
T 2eu9_A 244 NREHLVMM---EKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEF 320 (355)
T ss_dssp HHHHHHHH---HHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred HHHHHHHH---HHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcC
Confidence 43322111 111100 000 00000000000111123345688999999999
Q ss_pred CCCCCCCHhHHHHHHHHhhhh
Q 041143 889 EPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 889 dP~~RPs~~~v~~~L~~~~~~ 909 (973)
||++|||+.|+++ ++++..
T Consensus 321 dP~~Rpt~~e~l~--hp~f~~ 339 (355)
T 2eu9_A 321 DPAQRITLAEALL--HPFFAG 339 (355)
T ss_dssp STTTSCCHHHHTT--SGGGGG
T ss_pred ChhhCcCHHHHhc--ChhhcC
Confidence 9999999999997 666654
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=343.56 Aligned_cols=260 Identities=25% Similarity=0.364 Sum_probs=184.3
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHH-HHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIA-VLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
++|...+.||+|+||.||+|... +|+.||||+++... ......++..|+. +++.++||||+++++++...+..++||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC-CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc-CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 68889999999999999999875 68999999997653 3344455666666 666789999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccC-CeeeccCCCCcEEECCCCCEEEeeccccccC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQ-TFIHRDLKSSNILLDDDYRAKVSDFGLVKLA 781 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~-~ivH~Dikp~Nill~~~~~~kl~DfGla~~~ 781 (973)
||++ |+|.+++..........+++..+..++.|++.||+||| +. +|+||||||+||+++.++.+||+|||+++..
T Consensus 101 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 9997 58888876543333467899999999999999999999 66 9999999999999999999999999999865
Q ss_pred CCCCcceecccccccCccccccc----ccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHH
Q 041143 782 PDGEKSVVTRLAGTFGYLAPEYA----VMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKF 857 (973)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (973)
.... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||....... ..+
T Consensus 177 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---------------~~~ 239 (327)
T 3aln_A 177 VDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF---------------DQL 239 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------------------
T ss_pred cccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH---------------HHH
Confidence 4332 22334799999999998 46678999999999999999999999997643210 001
Q ss_pred HhhcC---ccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 858 KAAID---PALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 858 ~~~~~---~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
...+. +.+. ..........+.+++.+|++.||++||++.||++ .+++..
T Consensus 240 ~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~--hp~~~~ 291 (327)
T 3aln_A 240 TQVVKGDPPQLS-NSEEREFSPSFINFVNLCLTKDESKRPKYKELLK--HPFILM 291 (327)
T ss_dssp CCCCCSCCCCCC-CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT--SHHHHH
T ss_pred HHHhcCCCCCCC-CcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh--ChHHHH
Confidence 11111 1111 0001112345889999999999999999999998 555543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=352.75 Aligned_cols=253 Identities=26% Similarity=0.332 Sum_probs=188.6
Q ss_pred cCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e 703 (973)
+.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|++++.++ +|||||++++++.+.+..++|||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E 89 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE 89 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence 345566889999999998777778999999998643 234678899999986 89999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccC--CCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCC-------------C
Q 041143 704 YMPHGALSRHLFRWEKLQL--KPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDD-------------Y 768 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~--~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~-------------~ 768 (973)
|+. |+|.+++........ ...++..++.++.||+.||+||| +++|+||||||+|||++.+ +
T Consensus 90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCce
Confidence 995 799999976332211 11244466889999999999999 7899999999999999754 4
Q ss_pred CEEEeeccccccCCCCCcc---eecccccccCccccccccc-------CcCCCchhHHhHHHHHHHHHh-CCCCCCCCCh
Q 041143 769 RAKVSDFGLVKLAPDGEKS---VVTRLAGTFGYLAPEYAVM-------GKITTKADVFSYGVVLMELLT-GLAALDEERP 837 (973)
Q Consensus 769 ~~kl~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~ 837 (973)
.+||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.....
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 8999999999866543322 1234579999999999875 678999999999999999999 9999976543
Q ss_pred hhHHHHHHHHHHHhhchhHHHhhcC-ccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 838 EESRYLAEWFWRIKSSKEKFKAAID-PALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
... . + ...... +... ..........+.+++.+|++.||.+||++.||++
T Consensus 246 ~~~-~-------i------~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 246 RES-N-------I------IRGIFSLDEMK-CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHH-H-------H------HHTCCCCCCCT-TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hHH-H-------H------hcCCCCccccc-ccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 221 0 0 011111 1111 1123345567889999999999999999999987
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=347.10 Aligned_cols=269 Identities=20% Similarity=0.324 Sum_probs=203.0
Q ss_pred cCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-----------CCceeeeeeEE
Q 041143 625 QNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR-----------HRHLVSLLGYS 692 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~ 692 (973)
++|...+.||+|+||.||+|+. .+++.||||++.. .....+.+.+|++++++++ |+||+++++++
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC---CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 5799999999999999999986 4688999999864 3445567889999999886 89999999998
Q ss_pred EeCC----eEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccC-CeeeccCCCCcEEEC--
Q 041143 693 IEGN----ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQ-TFIHRDLKSSNILLD-- 765 (973)
Q Consensus 693 ~~~~----~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~-~ivH~Dikp~Nill~-- 765 (973)
...+ ..++||||+ +++|.+++.... ...+++..+..++.||+.||+||| ++ +|+||||||+|||++
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~ 168 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYE---HRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIV 168 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEE
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhh---ccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEecc
Confidence 8654 689999999 999999997632 245899999999999999999999 76 999999999999994
Q ss_pred ----CCCCEEEeeccccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhh--
Q 041143 766 ----DDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEE-- 839 (973)
Q Consensus 766 ----~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~-- 839 (973)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 169 ~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 244 (373)
T 1q8y_A 169 DSPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244 (373)
T ss_dssp ETTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred CCCcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence 4458999999999865432 234579999999999999999999999999999999999999998654321
Q ss_pred --HHHHHHHHHHHhhchh-------HHHhhcCcc-----c-------------cCCcccHHHHHHHHHHHHHhhccCCCC
Q 041143 840 --SRYLAEWFWRIKSSKE-------KFKAAIDPA-----L-------------EVNEETFESISIVAELAGHCTAREPYH 892 (973)
Q Consensus 840 --~~~~~~~~~~~~~~~~-------~~~~~~~~~-----l-------------~~~~~~~~~~~~~~~l~~~cl~~dP~~ 892 (973)
...+...+........ .....++.. + ............+.+++.+||+.||++
T Consensus 245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 324 (373)
T 1q8y_A 245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 324 (373)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence 1111111111000000 000000000 0 001122455667889999999999999
Q ss_pred CCCHhHHHHHHHHhhhh
Q 041143 893 RPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 893 RPs~~~v~~~L~~~~~~ 909 (973)
|||++||++ +++++.
T Consensus 325 Rpt~~ell~--hp~f~~ 339 (373)
T 1q8y_A 325 RADAGGLVN--HPWLKD 339 (373)
T ss_dssp CBCHHHHHT--CGGGTT
T ss_pred cCCHHHHhh--Chhhhc
Confidence 999999998 666654
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=338.79 Aligned_cols=260 Identities=23% Similarity=0.354 Sum_probs=186.1
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
.++|...+.||+|+||.||+|... +|+.||||++..........+.+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 468899999999999999999875 6899999999865434444445555666788889999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhcc-CCeeeccCCCCcEEECCCCCEEEeeccccccC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLAR-QTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA 781 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~-~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~ 781 (973)
||+ ++.+..+... . ...+++..+..++.||++||+||| + ++|+||||||+||+++.++.+||+|||+++..
T Consensus 104 e~~-~~~~~~l~~~-~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 175 (318)
T 2dyl_A 104 ELM-GTCAEKLKKR-M---QGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRL 175 (318)
T ss_dssp CCC-SEEHHHHHHH-H---TSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred ecc-CCcHHHHHHH-h---ccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence 999 5555544432 1 256899999999999999999999 5 39999999999999999999999999999755
Q ss_pred CCCCcceecccccccCcccccccc-----cCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhH
Q 041143 782 PDGEKSVVTRLAGTFGYLAPEYAV-----MGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEK 856 (973)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (973)
.... ......||+.|+|||++. ...++.++|||||||++|||++|+.||........ . ......
T Consensus 176 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~----~~~~~~---- 244 (318)
T 2dyl_A 176 VDDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE-V----LTKVLQ---- 244 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-H----HHHHHH----
T ss_pred cCCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH-H----HHHHhc----
Confidence 4322 233457999999999984 56788999999999999999999999986432211 0 111111
Q ss_pred HHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhc
Q 041143 857 FKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKW 910 (973)
Q Consensus 857 ~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~ 910 (973)
...+.+... ......+.+++.+|++.||.+||++.||++ +++++.+
T Consensus 245 ---~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--h~~~~~~ 290 (318)
T 2dyl_A 245 ---EEPPLLPGH---MGFSGDFQSFVKDCLTKDHRKRPKYNKLLE--HSFIKRY 290 (318)
T ss_dssp ---SCCCCCCSS---SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT--SHHHHHH
T ss_pred ---cCCCCCCcc---CCCCHHHHHHHHHHccCChhHCcCHHHHhh--CHHHHhc
Confidence 011111100 011235779999999999999999999998 6666554
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=356.32 Aligned_cols=356 Identities=19% Similarity=0.209 Sum_probs=274.7
Q ss_pred CeEEeeCC----------eEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCC--CCCCCCccceeeccCCCCC
Q 041143 60 PHVFCSGN----------RVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP--TFSGLSELEFAYLDFNEFD 127 (973)
Q Consensus 60 ~gv~C~~~----------~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~--~~~~l~~L~~L~L~~N~l~ 127 (973)
..|.|+.. +++.|+|++|.+++..|..|+++++|++|+|++|.+.+.++ .|.++++|++|+|++|+++
T Consensus 13 ~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~ 92 (455)
T 3v47_A 13 YNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL 92 (455)
T ss_dssp TEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTC
T ss_pred cccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccC
Confidence 34889753 58999999999999999999999999999999999986543 6999999999999999999
Q ss_pred CCCccccCCCCCccEEEcccCCCCCccCCCCCcc--cccccccCeeecccccccCCcchh-ccCCCCCCeEEccCCcCcc
Q 041143 128 TIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDS--LANSVQLTNLSLINCNLVGPLPDF-LGTLPSLAALKLSYNRLSG 204 (973)
Q Consensus 128 ~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~--~~~l~~L~~L~L~~N~l~~~~p~~-l~~l~~L~~L~Ls~N~l~~ 204 (973)
.+.+..|.++++|++|+|++|++++. +|.. +..+++|++|+|++|++++..|.. +.++++|++|+|++|++++
T Consensus 93 ~~~~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~ 168 (455)
T 3v47_A 93 QLETGAFNGLANLEVLTLTQCNLDGA----VLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKS 168 (455)
T ss_dssp EECTTTTTTCTTCCEEECTTSCCBTH----HHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSC
T ss_pred ccChhhccCcccCCEEeCCCCCCCcc----ccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccc
Confidence 99999999999999999999999874 3443 889999999999999999887876 8999999999999999998
Q ss_pred cCChhhhhhH-HHHHhhcccCCCCCCCcch--------hhcCCccccEEEccCCccccCCCccccCC---CCCCEEeCcC
Q 041143 205 VIPASFGQSL-MQILWLNDQDAGGMTGPID--------VVAKMVSLTQLWLHGNQFTGSIPEDIGAL---SSLKDLNLNR 272 (973)
Q Consensus 205 ~~p~~~~~~~-~~~~~l~~~~~~~~~~~~~--------~~~~l~~L~~L~L~~N~l~g~~p~~~~~l---~~L~~L~Ls~ 272 (973)
..|..+.... ..+..+....+........ .+..+++|++|+|++|++++.+|..+..+ ++|+.|++++
T Consensus 169 ~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~ 248 (455)
T 3v47_A 169 ICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSN 248 (455)
T ss_dssp CCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTT
T ss_pred cChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeecc
Confidence 8888775421 2223333333332222221 13356789999999999988777776554 5666666666
Q ss_pred Cccccc----------Cccccccc---ccCeEEccCCcCcCCCCCCCCCCcccccCcccCCCCCcccCCcchhhhhhccC
Q 041143 273 NQLVGL----------IPKSLANM---ELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGG 339 (973)
Q Consensus 273 N~l~~~----------~p~~~~~l---~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 339 (973)
|.+.+. .+..+..+ +|+.|++++|.+.+.+|..+. .+..+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~-------------------------~l~~L~~ 303 (455)
T 3v47_A 249 SYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFS-------------------------HFTDLEQ 303 (455)
T ss_dssp CTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTT-------------------------TCTTCCE
T ss_pred ccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcc-------------------------cCCCCCE
Confidence 644432 11222222 477777777777665554321 1223445
Q ss_pred CCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCCCccchhhhCccccceEEccCCccccccCccccCcCCC
Q 041143 340 VNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSL 419 (973)
Q Consensus 340 l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L 419 (973)
+++..|.+...+.. .+..+++|++|+|++|++++..|..|+++++|+.|+|++|+|++..|..|..+++|
T Consensus 304 L~Ls~n~l~~~~~~----------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 373 (455)
T 3v47_A 304 LTLAQNEINKIDDN----------AFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNL 373 (455)
T ss_dssp EECTTSCCCEECTT----------TTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTC
T ss_pred EECCCCcccccChh----------HhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccc
Confidence 55555555443221 34567899999999999999999999999999999999999998889999999999
Q ss_pred CeeeCCCCcCCCCCCC----CCcccceeecCCccccCCC
Q 041143 420 RLLDVSDNNIKPPLPE----FHDTVKLVIDGNPLLVGGI 454 (973)
Q Consensus 420 ~~L~Ls~N~l~g~~p~----~~~~~~~~~~~N~~~c~~~ 454 (973)
++|+|++|+|++.++. +.++..+++.+|++.|..+
T Consensus 374 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 374 KELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp CEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred cEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 9999999999987764 3466779999999998754
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=336.98 Aligned_cols=259 Identities=24% Similarity=0.277 Sum_probs=175.5
Q ss_pred HhcCccccC-cccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEe----CC
Q 041143 623 VTQNFAQEN-ELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIE----GN 696 (973)
Q Consensus 623 ~~~~~~~~~-~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~ 696 (973)
..++|...+ +||+|+||.||+|... +|+.||||++... .... .+....++.++||||+++++++.. ..
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PKAR---QEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HHHH---HHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HHHH---HHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 346788854 6999999999999876 6899999998653 2221 222334566799999999999876 34
Q ss_pred eEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECC---CCCEEEe
Q 041143 697 ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDD---DYRAKVS 773 (973)
Q Consensus 697 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~---~~~~kl~ 773 (973)
..++||||+++|+|.+++... ....+++.++..++.||+.||+||| +++|+||||||+||+++. ++.+||+
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~---~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~ 173 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQER---GDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLT 173 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC----CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred eEEEEEeccCCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEe
Confidence 579999999999999999752 2246899999999999999999999 789999999999999976 4569999
Q ss_pred eccccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhc
Q 041143 774 DFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSS 853 (973)
Q Consensus 774 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 853 (973)
|||+++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .....+..
T Consensus 174 Dfg~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~~~~~~- 247 (336)
T 3fhr_A 174 DFGFAKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP--GMKRRIRL- 247 (336)
T ss_dssp CCTTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------
T ss_pred ccccceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh--hHHHhhhc-
Confidence 99999865432 2234578999999999988899999999999999999999999997654322100 00000000
Q ss_pred hhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 854 KEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 854 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
...-.+. .........+.+++.+|++.||++||++.|+++ ++++.+
T Consensus 248 ----~~~~~~~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~~~~ 293 (336)
T 3fhr_A 248 ----GQYGFPN----PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN--HPWINQ 293 (336)
T ss_dssp -------CCCT----TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH--SHHHHT
T ss_pred ----cccccCc----hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc--Cccccc
Confidence 0000000 000112345789999999999999999999998 666654
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=340.49 Aligned_cols=252 Identities=25% Similarity=0.353 Sum_probs=201.5
Q ss_pred HHHHHhcCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCCh----HHHHHHHHHHHHHHhcC--CCceeeeeeE
Q 041143 619 VLRKVTQNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTT----KALDEFQSEIAVLSKVR--HRHLVSLLGY 691 (973)
Q Consensus 619 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~--h~niv~l~~~ 691 (973)
..+...++|...+.||+|+||.||+|.. .+++.||||+++...... ...+.+.+|+.++++++ |+||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 3344567899999999999999999976 468899999986542221 12245678999999996 5999999999
Q ss_pred EEeCCeEEEEEEecCC-CCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEEC-CCCC
Q 041143 692 SIEGNERLLVYEYMPH-GALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLD-DDYR 769 (973)
Q Consensus 692 ~~~~~~~~lV~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~-~~~~ 769 (973)
+...+..++||||+.+ ++|.+++.. ...+++..+..++.||+.||+||| +.+|+||||||+||+++ +++.
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~ 188 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITE-----RGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGE 188 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTE
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCC
Confidence 9999999999999976 899999865 246899999999999999999999 78999999999999999 7899
Q ss_pred EEEeeccccccCCCCCcceecccccccCcccccccccCcC-CCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHH
Q 041143 770 AKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKI-TTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFW 848 (973)
Q Consensus 770 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 848 (973)
+||+|||+++...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....
T Consensus 189 ~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----------- 254 (320)
T 3a99_A 189 LKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------- 254 (320)
T ss_dssp EEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----------
T ss_pred EEEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-----------
Confidence 9999999998665432 334579999999999887766 6789999999999999999999964210
Q ss_pred HHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 849 RIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 849 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
..... ...... ....+.+++.+|++.||++||++.||++ .++++
T Consensus 255 -~~~~~----~~~~~~---------~~~~~~~li~~~l~~dp~~Rps~~~ll~--hp~~~ 298 (320)
T 3a99_A 255 -IIRGQ----VFFRQR---------VSSECQHLIRWCLALRPSDRPTFEEIQN--HPWMQ 298 (320)
T ss_dssp -HHHCC----CCCSSC---------CCHHHHHHHHHHTCSSGGGSCCHHHHHT--SGGGS
T ss_pred -hhccc----cccccc---------CCHHHHHHHHHHccCChhhCcCHHHHhc--CHhhc
Confidence 00000 001111 1235779999999999999999999987 44444
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=345.43 Aligned_cols=248 Identities=24% Similarity=0.344 Sum_probs=186.7
Q ss_pred cCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e 703 (973)
.+|...+.||+|+||+||.....+|+.||||++..... ..+.+|+++++++ +|||||++++++.+....++|||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 46888899999999997666666799999999865321 2356899999999 79999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECC-----CCCEEEeecccc
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDD-----DYRAKVSDFGLV 778 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~-----~~~~kl~DfGla 778 (973)
|+. |+|.+++.... ....+.++..++.||++||+||| +.+|+||||||+|||++. ...+||+|||++
T Consensus 99 ~~~-g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 99 LCA-ATLQEYVEQKD----FAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp CCS-EEHHHHHHSSS----CCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred CCC-CCHHHHHHhcC----CCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 995 69999996522 23455567889999999999999 789999999999999953 346889999999
Q ss_pred ccCCCCCc--ceecccccccCcccccccc---cCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhh
Q 041143 779 KLAPDGEK--SVVTRLAGTFGYLAPEYAV---MGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKS 852 (973)
Q Consensus 779 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 852 (973)
+....... .......||+.|+|||++. ...++.++|||||||++|||++ |+.||.......... ..
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~-------~~- 242 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI-------LL- 242 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH-------HT-
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH-------Hh-
Confidence 86543321 2234467999999999987 4567889999999999999999 999996543221100 00
Q ss_pred chhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 853 SKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 853 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
. ................+.+++.+|++.||++||++.||++
T Consensus 243 ------~--~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 243 ------G--ACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp ------T--CCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ------c--cCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0 0001101111223345779999999999999999999995
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-37 Score=336.46 Aligned_cols=250 Identities=26% Similarity=0.383 Sum_probs=193.0
Q ss_pred HHHhcCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCCh----HHHHHHHHHHHHHHhc----CCCceeeeeeE
Q 041143 621 RKVTQNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTT----KALDEFQSEIAVLSKV----RHRHLVSLLGY 691 (973)
Q Consensus 621 ~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l----~h~niv~l~~~ 691 (973)
+...++|...+.||+|+||.||+|+. .+++.||||+++...... .....+.+|++++.++ +|+||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 44567899999999999999999976 468899999996542221 2234566799999998 89999999999
Q ss_pred EEeCCeEEEEEEe-cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEEC-CCCC
Q 041143 692 SIEGNERLLVYEY-MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLD-DDYR 769 (973)
Q Consensus 692 ~~~~~~~~lV~e~-~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~-~~~~ 769 (973)
+...+..++|||| +.+++|.+++.. ...+++..++.++.||+.||+||| +.+|+||||||+||+++ .++.
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~ 178 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITE-----KGPLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGC 178 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCe
Confidence 9999999999999 889999999975 245899999999999999999999 77999999999999999 8899
Q ss_pred EEEeeccccccCCCCCcceecccccccCcccccccccCcCC-CchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHH
Q 041143 770 AKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKIT-TKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFW 848 (973)
Q Consensus 770 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 848 (973)
+||+|||+++...... .....||..|+|||++.+..+. .++|||||||++|||++|+.||.....
T Consensus 179 ~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----------- 244 (312)
T 2iwi_A 179 AKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE----------- 244 (312)
T ss_dssp EEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----------
T ss_pred EEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-----------
Confidence 9999999998665432 3446799999999998877664 589999999999999999999964210
Q ss_pred HHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 849 RIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 849 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
... . ..... ......+.+++.+|++.||++||++.|+++ +.+++
T Consensus 245 -~~~------~----~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~e~l~--~~~~~ 288 (312)
T 2iwi_A 245 -ILE------A----ELHFP---AHVSPDCCALIRRCLAPKPSSRPSLEEILL--DPWMQ 288 (312)
T ss_dssp -HHH------T----CCCCC---TTSCHHHHHHHHHHTCSSTTTSCCHHHHHH--STTTC
T ss_pred -Hhh------h----ccCCc---ccCCHHHHHHHHHHccCChhhCcCHHHHhc--Chhhc
Confidence 000 0 00000 011234779999999999999999999998 44444
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=345.54 Aligned_cols=316 Identities=21% Similarity=0.248 Sum_probs=251.0
Q ss_pred CCCCCCC-CCcCeEEeeCC-----------eEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCC-CCCCCCcc
Q 041143 50 GDDPCGP-PPWPHVFCSGN-----------RVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSEL 116 (973)
Q Consensus 50 ~~d~C~~-~~w~gv~C~~~-----------~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L 116 (973)
.+..|.+ ..|..|.|... .++.|+|++|.|++..+..|.++++|++|+|++|.|++..| .|.++++|
T Consensus 3 Cp~~C~C~~~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L 82 (477)
T 2id5_A 3 CPPRCECSAQDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNL 82 (477)
T ss_dssp CSTTCEEETTTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred ccCCCeECCCCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccC
Confidence 3455653 24788999752 57788888888888778888888888888888888888766 68888888
Q ss_pred ceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEE
Q 041143 117 EFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALK 196 (973)
Q Consensus 117 ~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 196 (973)
++|+|++|+|+.+++..|.++++|++|+|++|++++. .|..|.++++|++|+|++|.+++..+..|.++++|++|+
T Consensus 83 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~----~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 158 (477)
T 2id5_A 83 RTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVIL----LDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLT 158 (477)
T ss_dssp CEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEE----CTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEE
T ss_pred CEEECCCCcCCccCcccccCCCCCCEEECCCCccccC----ChhHccccccCCEEECCCCccceeChhhccCCCCCCEEE
Confidence 8888888888888888888888888888888888874 667788888888888888888877788888888888888
Q ss_pred ccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCccc
Q 041143 197 LSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLV 276 (973)
Q Consensus 197 Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~ 276 (973)
|++|++++..+.. |.++++|+.|+|++|.+++..+..|..+++|++|+|++|.+.
T Consensus 159 l~~n~l~~~~~~~-------------------------l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~ 213 (477)
T 2id5_A 159 LEKCNLTSIPTEA-------------------------LSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYL 213 (477)
T ss_dssp EESCCCSSCCHHH-------------------------HTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTC
T ss_pred CCCCcCcccChhH-------------------------hcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccc
Confidence 8888887443333 345888888888888888777778888888888888888777
Q ss_pred ccCccccccc-ccCeEEccCCcCcCCCCCCCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCC
Q 041143 277 GLIPKSLANM-ELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDP 355 (973)
Q Consensus 277 ~~~p~~~~~l-~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~ 355 (973)
+.+|..+... +|+.|+|++|.|++ +|.
T Consensus 214 ~~~~~~~~~~~~L~~L~l~~n~l~~-~~~--------------------------------------------------- 241 (477)
T 2id5_A 214 DTMTPNCLYGLNLTSLSITHCNLTA-VPY--------------------------------------------------- 241 (477)
T ss_dssp CEECTTTTTTCCCSEEEEESSCCCS-CCH---------------------------------------------------
T ss_pred cccCcccccCccccEEECcCCcccc-cCH---------------------------------------------------
Confidence 7666554433 78888888888773 221
Q ss_pred CCCCccccccCCCCcccEEecCCCcCCCccchhhhCccccceEEccCCccccccCccccCcCCCCeeeCCCCcCCCCCCC
Q 041143 356 CQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLPE 435 (973)
Q Consensus 356 ~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~ 435 (973)
..+..+++|+.|+|++|.+.+..+..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++.++.
T Consensus 242 -------~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 314 (477)
T 2id5_A 242 -------LAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEES 314 (477)
T ss_dssp -------HHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGG
T ss_pred -------HHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHh
Confidence 0234567888999999999888888888899999999999999888888899999999999999999887664
Q ss_pred ----CCcccceeecCCccccCC
Q 041143 436 ----FHDTVKLVIDGNPLLVGG 453 (973)
Q Consensus 436 ----~~~~~~~~~~~N~~~c~~ 453 (973)
+.++..+.+.+|||.|..
T Consensus 315 ~~~~l~~L~~L~l~~N~l~c~c 336 (477)
T 2id5_A 315 VFHSVGNLETLILDSNPLACDC 336 (477)
T ss_dssp GBSCGGGCCEEECCSSCEECSG
T ss_pred HcCCCcccCEEEccCCCccCcc
Confidence 345667888999988864
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=354.87 Aligned_cols=272 Identities=24% Similarity=0.371 Sum_probs=204.7
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEe------CC
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIE------GN 696 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~ 696 (973)
.++|...+.||+|+||.||+|... +|+.||||+++.. ......+.+.+|++++++++||||+++++++.. .+
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 368999999999999999999774 6899999998764 345667789999999999999999999998765 66
Q ss_pred eEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCC---EEEe
Q 041143 697 ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYR---AKVS 773 (973)
Q Consensus 697 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~---~kl~ 773 (973)
..++||||+++|+|.+++.... ....+++..+..++.|++.||+||| +.+|+||||||+||+++.++. +||+
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~--~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~ 166 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFE--NCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKII 166 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSS--CTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred eEEEEEEeCCCCCHHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEc
Confidence 7799999999999999997632 2246899999999999999999999 789999999999999997765 9999
Q ss_pred eccccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhc
Q 041143 774 DFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSS 853 (973)
Q Consensus 774 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 853 (973)
|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..|.......
T Consensus 167 DFG~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~~ 239 (676)
T 3qa8_A 167 DLGYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVREK 239 (676)
T ss_dssp SCCCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC--
T ss_pred cccccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhcc
Confidence 999998665432 234568999999999999999999999999999999999999999765321 1111111000
Q ss_pred hh---HHHhhcCccccC-------CcccHHHHHHHHHHHHHhhccCCCCCCCHhH-----HHHHHHHhhh
Q 041143 854 KE---KFKAAIDPALEV-------NEETFESISIVAELAGHCTAREPYHRPDMGH-----VVNVLSPLVE 908 (973)
Q Consensus 854 ~~---~~~~~~~~~l~~-------~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~-----v~~~L~~~~~ 908 (973)
.. .........+.. ..........+.+++..|++.||++||++.| ..+.++.+..
T Consensus 240 ~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 240 SNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp ----CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred cchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 00 000001111100 1112234567889999999999999999988 4555655554
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-35 Score=351.23 Aligned_cols=389 Identities=17% Similarity=0.134 Sum_probs=256.9
Q ss_pred CCCCCC-CCcCeEEeeC-----------CeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCC-CCCCCCccc
Q 041143 51 DDPCGP-PPWPHVFCSG-----------NRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELE 117 (973)
Q Consensus 51 ~d~C~~-~~w~gv~C~~-----------~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~ 117 (973)
.+||.. ..-..|.|++ .+++.|+|++|.+++..+..|.++++|++|+|++|.++++.| .|.++++|+
T Consensus 4 ~~~c~~~~~~~~~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~ 83 (606)
T 3vq2_A 4 LNPCIEVVPNITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLS 83 (606)
T ss_dssp --CCEEEETTTEEECTTSCCSSCCTTSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCC
T ss_pred CCCceecCCCCceEccCCCcccCCCCCCCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcC
Confidence 356652 1124688864 478999999999999988899999999999999999999877 799999999
Q ss_pred eeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeeecccccccC-CcchhccCCCCCCeEE
Q 041143 118 FAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVG-PLPDFLGTLPSLAALK 196 (973)
Q Consensus 118 ~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~ 196 (973)
+|+|++|+|+.+++..|.++++|++|+|++|++++. .+..++++++|++|+|++|.+++ .+|..|+++++|++|+
T Consensus 84 ~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~ 159 (606)
T 3vq2_A 84 NLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASL----ESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVD 159 (606)
T ss_dssp EEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCS----SSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEE
T ss_pred EeECCCCcccccChhhcCCcccCCEEEccCCccccc----cccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEE
Confidence 999999999999999999999999999999999974 44779999999999999999986 5799999999999999
Q ss_pred ccCCcCcccCChhhhhhH-HH--HHhhcccCCCCCC--------------------------------------------
Q 041143 197 LSYNRLSGVIPASFGQSL-MQ--ILWLNDQDAGGMT-------------------------------------------- 229 (973)
Q Consensus 197 Ls~N~l~~~~p~~~~~~~-~~--~~~l~~~~~~~~~-------------------------------------------- 229 (973)
|++|++++..|..+.... ++ +..++...+....
T Consensus 160 Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~ 239 (606)
T 3vq2_A 160 LSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILG 239 (606)
T ss_dssp CCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEE
T ss_pred ccCCcceecChhhhhhhhccccccceeeccCCCcceeCcccccCceeeeeeccCCccchhHHHHHhcccccccccccccc
Confidence 999999988777664311 11 0011111111000
Q ss_pred ------------------------------------Ccch----------------------hhcCCccccEEEccCCcc
Q 041143 230 ------------------------------------GPID----------------------VVAKMVSLTQLWLHGNQF 251 (973)
Q Consensus 230 ------------------------------------~~~~----------------------~~~~l~~L~~L~L~~N~l 251 (973)
+... .+..+++|+.|++++|.+
T Consensus 240 ~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~l~~L~~L~l~~~~~~~l~~l~~~~~L~~L~l~~n~l 319 (606)
T 3vq2_A 240 EFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQL 319 (606)
T ss_dssp CCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGSCGGGTTCSEEEEESCCCCCCCCCCTTCCCSEEEEESCCC
T ss_pred ccccCCcccccChHHhhhhhhccHhheeccccccccccccccccCCCCCEEEecCccchhhhhccccccCCEEEcccccC
Confidence 0000 122222333333333333
Q ss_pred -------------------------------------------ccC--CCccccCCCCCCEEeCcCCcccccCccccccc
Q 041143 252 -------------------------------------------TGS--IPEDIGALSSLKDLNLNRNQLVGLIPKSLANM 286 (973)
Q Consensus 252 -------------------------------------------~g~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 286 (973)
++. +|..+..+++|++|+|++|.+++ +|..+..+
T Consensus 320 ~~lp~~~l~~L~~L~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l 398 (606)
T 3vq2_A 320 KQFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGL 398 (606)
T ss_dssp SSCCCCCCSSCCEEEEESCSSCEECCCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTC
T ss_pred cccccCCCCccceeeccCCcCccchhhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCC
Confidence 322 13333333333333333333332 22333333
Q ss_pred -ccCeEEccCCcCcCCCC-CCCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCccccc
Q 041143 287 -ELDNLVLNNNLLMGPIP-KFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLS 364 (973)
Q Consensus 287 -~L~~L~l~~N~l~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~ 364 (973)
+|+.|++++|.+.+..| ..+...-.+....+...... ...+.....+..+..+++..|.+..- .....
T Consensus 399 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~---------~~~~~ 468 (606)
T 3vq2_A 399 EELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTK-IDFDGIFLGLTSLNTLKMAGNSFKDN---------TLSNV 468 (606)
T ss_dssp TTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCE-ECCTTTTTTCTTCCEEECTTCEEGGG---------EECSC
T ss_pred CCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCC-ccchhhhcCCCCCCEEECCCCcCCCc---------chHHh
Confidence 34444444444444333 11111111111111111000 00111112223344444444443320 11224
Q ss_pred cCCCCcccEEecCCCcCCCccchhhhCccccceEEccCCccccccCccccCcCCCCeeeCCCCcCCCCCCCCC----ccc
Q 041143 365 CTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLPEFH----DTV 440 (973)
Q Consensus 365 ~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~----~~~ 440 (973)
+..+++|+.|+|++|++++.+|..|+++++|+.|+|++|+|++.+|..|..+++|++|||++|+|+..++.+. ++.
T Consensus 469 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~ 548 (606)
T 3vq2_A 469 FANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLA 548 (606)
T ss_dssp CTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCC
T ss_pred hccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCc
Confidence 5678899999999999999999999999999999999999999999999999999999999999996555443 366
Q ss_pred ceeecCCccccCCC
Q 041143 441 KLVIDGNPLLVGGI 454 (973)
Q Consensus 441 ~~~~~~N~~~c~~~ 454 (973)
.+++.+|||.|...
T Consensus 549 ~l~l~~N~~~c~c~ 562 (606)
T 3vq2_A 549 FFNLTNNSVACICE 562 (606)
T ss_dssp EEECCSCCCCCSST
T ss_pred EEEccCCCcccCCc
Confidence 78999999999654
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=359.86 Aligned_cols=241 Identities=21% Similarity=0.340 Sum_probs=195.1
Q ss_pred cCccccCcccccCccEEEEEEEC--CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCe-----
Q 041143 625 QNFAQENELGRGGFGTVYKGELE--DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNE----- 697 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 697 (973)
++|.+.+.||+|+||.||+|.+. +|+.||||++... ......+.+.+|++++++++|||||++++++...+.
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 68999999999999999999875 5899999998653 345566789999999999999999999999987655
Q ss_pred EEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccc
Q 041143 698 RLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL 777 (973)
Q Consensus 698 ~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGl 777 (973)
.|+||||+++++|.+++. ..++|.+++.|+.||+.||+||| +++||||||||+|||++.+ .+||+|||+
T Consensus 159 ~~lv~E~~~g~~L~~~~~-------~~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~ 227 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKG-------QKLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGA 227 (681)
T ss_dssp EEEEEECCCCEECC-----------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred eEEEEEeCCCCcHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEeccc
Confidence 699999999999987763 25899999999999999999999 7899999999999999986 899999999
Q ss_pred cccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHH
Q 041143 778 VKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKF 857 (973)
Q Consensus 778 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (973)
++..... ....||++|+|||++.+. ++.++|||||||++|||++|..|+.......
T Consensus 228 a~~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~------------------ 283 (681)
T 2pzi_A 228 VSRINSF-----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG------------------ 283 (681)
T ss_dssp CEETTCC-----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS------------------
T ss_pred chhcccC-----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc------------------
Confidence 9866442 345799999999988765 4889999999999999999998876422110
Q ss_pred HhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCC-HhHHHHHHHHhhh
Q 041143 858 KAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPD-MGHVVNVLSPLVE 908 (973)
Q Consensus 858 ~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-~~~v~~~L~~~~~ 908 (973)
+............+.+++.+|++.||++||+ +.++.+.|..+..
T Consensus 284 -------~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 284 -------LPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp -------CCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred -------ccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 0001111122245779999999999999995 6666666666543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-35 Score=316.97 Aligned_cols=233 Identities=12% Similarity=0.040 Sum_probs=184.8
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
++|...+.||+|+||.||+|+.. +|+.||||++..... .....+.+.+|+.++.+++||||+++++++.+.+..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 57899999999999999999876 489999999976533 3455678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++++|.+++.. . ....++.+|+.|++.||+||| +++|+||||||+|||++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~------~-~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~------ 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADT------S-PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA------ 174 (286)
T ss_dssp ECCCEEEHHHHHTT------C-CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred EecCCCCHHHHHhc------C-CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc------
Confidence 99999999999843 1 345578899999999999999 8899999999999999999999998543
Q ss_pred CCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcC
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (973)
|++ .++.++|||||||++|||++|+.||.......... .....+.
T Consensus 175 ---------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~-------------~~~~~~~ 219 (286)
T 3uqc_A 175 ---------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA-------------PAERDTA 219 (286)
T ss_dssp ---------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE-------------ECCBCTT
T ss_pred ---------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH-------------HHHHHhc
Confidence 333 36889999999999999999999998765321100 0000000
Q ss_pred ccccC-CcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 863 PALEV-NEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 863 ~~l~~-~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
..... ..........+.+++.+||+.||++| |+.|+++.|+.+...
T Consensus 220 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 220 GQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp SCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred cCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 00000 00001122457899999999999999 999999999988653
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=349.20 Aligned_cols=369 Identities=18% Similarity=0.184 Sum_probs=245.5
Q ss_pred cCeEEeeC-------------CeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCC-CCCCCCccceeeccCC
Q 041143 59 WPHVFCSG-------------NRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFN 124 (973)
Q Consensus 59 w~gv~C~~-------------~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N 124 (973)
|.|+ |+. ..+++|+|++|.+++..|.+|+++++|++|+|++|++++.+| .|.++++|++|+|++|
T Consensus 6 ~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n 84 (549)
T 2z81_A 6 ASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDN 84 (549)
T ss_dssp TTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTS
T ss_pred CCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCC
Confidence 9998 864 279999999999999999999999999999999999999887 7999999999999999
Q ss_pred CCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeeecccccccCCcc-hhccCCCCCCeEEccCCcCc
Q 041143 125 EFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLP-DFLGTLPSLAALKLSYNRLS 203 (973)
Q Consensus 125 ~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~ 203 (973)
+++.+++..|.++++|++|+|++|++++. .+|..+.++++|++|+|++|.+.+.+| ..|.++++|++|+|++|+++
T Consensus 85 ~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~---~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~ 161 (549)
T 2z81_A 85 HLSSLSSSWFGPLSSLKYLNLMGNPYQTL---GVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR 161 (549)
T ss_dssp CCCSCCHHHHTTCTTCCEEECTTCCCSSS---CSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCC
T ss_pred ccCccCHHHhccCCCCcEEECCCCccccc---chhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCccc
Confidence 99999999999999999999999999864 367789999999999999998544554 68999999999999999999
Q ss_pred ccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCc--------------------------------------------
Q 041143 204 GVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMV-------------------------------------------- 239 (973)
Q Consensus 204 ~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~-------------------------------------------- 239 (973)
+.+|..+... ..+..|....+.....+...+..++
T Consensus 162 ~~~~~~l~~l-~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~ 240 (549)
T 2z81_A 162 NYQSQSLKSI-RDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESF 240 (549)
T ss_dssp EECTTTTTTC-SEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHH
T ss_pred ccChhhhhcc-ccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHH
Confidence 8888766431 1111111111111111111112222
Q ss_pred ----------------------------------------------------------------------cccEEEccCC
Q 041143 240 ----------------------------------------------------------------------SLTQLWLHGN 249 (973)
Q Consensus 240 ----------------------------------------------------------------------~L~~L~L~~N 249 (973)
+|+.|++++|
T Consensus 241 ~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n 320 (549)
T 2z81_A 241 NELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENS 320 (549)
T ss_dssp HHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESS
T ss_pred HHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccC
Confidence 2333333333
Q ss_pred ccccCCCccc-cCCCCCCEEeCcCCcccccCcc---ccccc-ccCeEEccCCcCcCCCC--CCCCCCcccccCcccCCCC
Q 041143 250 QFTGSIPEDI-GALSSLKDLNLNRNQLVGLIPK---SLANM-ELDNLVLNNNLLMGPIP--KFKAGNVTYDSNSFCQSEP 322 (973)
Q Consensus 250 ~l~g~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~---~~~~l-~L~~L~l~~N~l~g~~p--~~~~~~~~~~~~~~~~~~~ 322 (973)
+++ .+|..+ ..+++|++|+|++|++++.+|. .+..+ +|+.|++++|+|++..+ ..+...-.+...++...
T Consensus 321 ~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N-- 397 (549)
T 2z81_A 321 KVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRN-- 397 (549)
T ss_dssp CCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTC--
T ss_pred ccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCC--
Confidence 333 333333 2355555555555555544332 13333 45555555555543211 00000000000011000
Q ss_pred CcccCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCCCccchhhhCccccceEEccC
Q 041143 323 GIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGK 402 (973)
Q Consensus 323 ~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 402 (973)
.+...+.....+..+..++++.|.+..+++. ..++|++|+|++|++++.+ ..+++|++|+|++
T Consensus 398 ~l~~lp~~~~~~~~L~~L~Ls~N~l~~l~~~-------------~~~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~ 460 (549)
T 2z81_A 398 TFHPMPDSCQWPEKMRFLNLSSTGIRVVKTC-------------IPQTLEVLDVSNNNLDSFS----LFLPRLQELYISR 460 (549)
T ss_dssp CCCCCCSCCCCCTTCCEEECTTSCCSCCCTT-------------SCTTCSEEECCSSCCSCCC----CCCTTCCEEECCS
T ss_pred CCccCChhhcccccccEEECCCCCcccccch-------------hcCCceEEECCCCChhhhc----ccCChhcEEECCC
Confidence 0001111112223444455555555444322 1247888889988888754 5789999999999
Q ss_pred CccccccCccccCcCCCCeeeCCCCcCCCCCCC----CCcccceeecCCccccCCC
Q 041143 403 NSISGTVPNNFTELKSLRLLDVSDNNIKPPLPE----FHDTVKLVIDGNPLLVGGI 454 (973)
Q Consensus 403 N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~----~~~~~~~~~~~N~~~c~~~ 454 (973)
|+|+ .+|. ...+++|++|||++|+|++.+|. +.++..+++.+|+|.|...
T Consensus 461 N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 461 NKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp SCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred CccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 9998 7887 57899999999999999999885 3456679999999998743
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=334.42 Aligned_cols=245 Identities=16% Similarity=0.138 Sum_probs=182.3
Q ss_pred cCccccCcccccCccEEEEEEE-CCCCEEEEEEeecC-CCChHHHHHHHHHHHHHHhcCC-Cceee--------------
Q 041143 625 QNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAG-VTTTKALDEFQSEIAVLSKVRH-RHLVS-------------- 687 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h-~niv~-------------- 687 (973)
..|...+.||+|+||.||+|++ .+|+.||||+++.. .......+.+.+|+.+++.++| +|...
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 4577788999999999999985 46999999998733 2222335679999999999987 32111
Q ss_pred -e------eeEEEe-----CCeEEEEEEecCCCCHHHHHHhhh--hccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCee
Q 041143 688 -L------LGYSIE-----GNERLLVYEYMPHGALSRHLFRWE--KLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFI 753 (973)
Q Consensus 688 -l------~~~~~~-----~~~~~lV~e~~~~g~L~~~l~~~~--~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~iv 753 (973)
+ ..++.. ....+++|+++ +|+|.+++.... ......+++..++.|+.||++||+||| +++|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcc
Confidence 1 111111 12356777765 789999886432 122356889999999999999999999 88999
Q ss_pred eccCCCCcEEECCCCCEEEeeccccccCCCCCcceecccccccCccccccc----------ccCcCCCchhHHhHHHHHH
Q 041143 754 HRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYA----------VMGKITTKADVFSYGVVLM 823 (973)
Q Consensus 754 H~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dv~S~Gvvl~ 823 (973)
||||||+|||++.++.+||+|||+++..... ....+| +.|+|||++ ....++.++|||||||++|
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 9999999999999999999999999865432 445678 999999999 5566889999999999999
Q ss_pred HHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 824 ELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 824 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
||++|+.||......+. ....+..... ....+.+++.+||+.||++||++.|+++
T Consensus 309 elltg~~Pf~~~~~~~~----------------~~~~~~~~~~-------~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGG----------------SEWIFRSCKN-------IPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHSSCCCCTTGGGSC----------------SGGGGSSCCC-------CCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHCCCCCCCcchhhh----------------HHHHHhhccc-------CCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99999999976542211 1111111111 1245889999999999999999888865
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-34 Score=312.20 Aligned_cols=236 Identities=20% Similarity=0.249 Sum_probs=181.3
Q ss_pred hcCcccc-CcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHH-HhcCCCceeeeeeEEEe----CC
Q 041143 624 TQNFAQE-NELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVL-SKVRHRHLVSLLGYSIE----GN 696 (973)
Q Consensus 624 ~~~~~~~-~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~ 696 (973)
.++|... +.||+|+||.||+|.. .+++.||||+++.. ..+.+|++++ +..+||||+++++++.. ..
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 88 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 88 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence 3567776 7899999999999987 46899999998642 3567899888 55689999999999987 66
Q ss_pred eEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECC---CCCEEEe
Q 041143 697 ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDD---DYRAKVS 773 (973)
Q Consensus 697 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~---~~~~kl~ 773 (973)
..++||||+++|+|.+++... ....+++.++..++.|++.||+||| +++|+||||||+||+++. ++.+||+
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~ 162 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLT 162 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred eEEEEEeecCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEe
Confidence 789999999999999999762 2246899999999999999999999 789999999999999998 7899999
Q ss_pred eccccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhc
Q 041143 774 DFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSS 853 (973)
Q Consensus 774 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 853 (973)
|||+++... +..++.++|||||||++|||++|+.||.........
T Consensus 163 Dfg~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~------------ 207 (299)
T 3m2w_A 163 DFGFAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS------------ 207 (299)
T ss_dssp CCTTCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------------------
T ss_pred ccccccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh------------
Confidence 999986432 235678999999999999999999999765421100
Q ss_pred hhHHHhhcCccccCCcc-cHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 854 KEKFKAAIDPALEVNEE-TFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 854 ~~~~~~~~~~~l~~~~~-~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
................. .......+.+++.+|++.||++||++.|+++ ++++.+
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~--hp~~~~ 262 (299)
T 3m2w_A 208 PGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN--HPWIMQ 262 (299)
T ss_dssp CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHHT
T ss_pred HHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc--Chhhcc
Confidence 00000000011110000 0112345889999999999999999999998 666654
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=345.54 Aligned_cols=381 Identities=16% Similarity=0.156 Sum_probs=236.2
Q ss_pred CeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCC-CCCCCCccceeeccCCCCCCCCccccCCCCCccEEEc
Q 041143 67 NRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLAL 145 (973)
Q Consensus 67 ~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~L 145 (973)
.++++|+|++|.+++..|.+|+++++|++|+|++|.+++..| .|.++++|++|+|++|+|+.+++..|.++++|++|+|
T Consensus 57 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L 136 (606)
T 3t6q_A 57 INLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYL 136 (606)
T ss_dssp TTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEEC
T ss_pred ccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEEC
Confidence 568888888888888778888888888888888888888766 6788888888888888888887777888888888888
Q ss_pred ccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCC--eEEccCCcCcccCChhhhhh----------
Q 041143 146 DYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLA--ALKLSYNRLSGVIPASFGQS---------- 213 (973)
Q Consensus 146 s~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~--~L~Ls~N~l~~~~p~~~~~~---------- 213 (973)
++|++++. .+| .+..+++|++|+|++|.+++..+..|+.+++|+ .|++++|++++..|..+...
T Consensus 137 ~~n~l~~~---~~~-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~ 212 (606)
T 3t6q_A 137 GSNHISSI---KLP-KGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGT 212 (606)
T ss_dssp CSSCCCCC---CCC-TTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEECTTC
T ss_pred CCCccccc---Ccc-cccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCccChhHhhhccccccccCCc
Confidence 88888763 123 333477777777777777766666777777777 67777777665555433210
Q ss_pred ----------------------------------------------------------------HHHHHhhcccCCCCCC
Q 041143 214 ----------------------------------------------------------------LMQILWLNDQDAGGMT 229 (973)
Q Consensus 214 ----------------------------------------------------------------~~~~~~l~~~~~~~~~ 229 (973)
+..+..|+...+.. .
T Consensus 213 ~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l-~ 291 (606)
T 3t6q_A 213 QNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHL-S 291 (606)
T ss_dssp SCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCC-S
T ss_pred hhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCcc-C
Confidence 01111122222222 2
Q ss_pred CcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcccccCccc-cccc-c--------------------
Q 041143 230 GPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKS-LANM-E-------------------- 287 (973)
Q Consensus 230 ~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l-~-------------------- 287 (973)
..+..+.++++|++|+|++|.+++..|..+..+++|++|++++|.+.+.+|.. +..+ +
T Consensus 292 ~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 371 (606)
T 3t6q_A 292 ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQ 371 (606)
T ss_dssp CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTT
T ss_pred CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchh
Confidence 22334555566666666666665544555555555555555555544333322 3333 3
Q ss_pred ------cCeEEccCCcCcCCCCCCCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCCC----
Q 041143 288 ------LDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQ---- 357 (973)
Q Consensus 288 ------L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~---- 357 (973)
|+.|++++|.+.+..|..+...-.+....+.+..............+..+..+++..|.+...+......
T Consensus 372 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 451 (606)
T 3t6q_A 372 LRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPAL 451 (606)
T ss_dssp TTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTC
T ss_pred cccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCC
Confidence 4444444444433333322211111111111111000001111222344555555555544332211000
Q ss_pred -------CCcc------ccccCCCCcccEEecCCCcCCCccchhhhCccccceEEccCCccccccCccccCcCCCCeeeC
Q 041143 358 -------GPWL------GLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDV 424 (973)
Q Consensus 358 -------~~~~------~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L 424 (973)
..+. ...+..+++|++|+|++|++++.+|..|+++++|+.|+|++|+|++..|..|.++++| +|+|
T Consensus 452 ~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L 530 (606)
T 3t6q_A 452 QHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNL 530 (606)
T ss_dssp CEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEEC
T ss_pred CEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEEC
Confidence 0000 1235667889999999999999989999999999999999999999999999999999 9999
Q ss_pred CCCcCCCCCCC----CCcccceeecCCccccCC
Q 041143 425 SDNNIKPPLPE----FHDTVKLVIDGNPLLVGG 453 (973)
Q Consensus 425 s~N~l~g~~p~----~~~~~~~~~~~N~~~c~~ 453 (973)
++|++++.+|. +.++..+++.+|||.|..
T Consensus 531 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 563 (606)
T 3t6q_A 531 ASNHISIILPSLLPILSQQRTINLRQNPLDCTC 563 (606)
T ss_dssp CSSCCCCCCGGGHHHHHTSSEEECTTCCEECSG
T ss_pred cCCcccccCHhhcccCCCCCEEeCCCCCccccC
Confidence 99999988875 356677999999999863
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-34 Score=344.01 Aligned_cols=379 Identities=16% Similarity=0.111 Sum_probs=255.7
Q ss_pred cCeEEeeC-----------CeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCC-CCCCCCccceeeccCCCC
Q 041143 59 WPHVFCSG-----------NRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEF 126 (973)
Q Consensus 59 w~gv~C~~-----------~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l 126 (973)
+..|.|.. ..++.|+|++|.|++..|.+|+++++|++|+|++|.+++..| .|.++++|++|+|++|++
T Consensus 14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 93 (606)
T 3t6q_A 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93 (606)
T ss_dssp TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence 56788864 368999999999999999999999999999999999999877 799999999999999999
Q ss_pred CCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccC
Q 041143 127 DTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVI 206 (973)
Q Consensus 127 ~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~ 206 (973)
+.+++..|.++++|++|+|++|++++. .|..+.++++|++|+|++|++++.....+..+++|++|+|++|++++..
T Consensus 94 ~~~~~~~~~~l~~L~~L~L~~n~i~~l----~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 169 (606)
T 3t6q_A 94 IFMAETALSGPKALKHLFFIQTGISSI----DFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLS 169 (606)
T ss_dssp SEECTTTTSSCTTCCEEECTTSCCSCG----GGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEEC
T ss_pred cccChhhhcccccccEeeccccCcccC----CcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccC
Confidence 999999999999999999999999974 4677899999999999999999855455556999999999999999777
Q ss_pred Chhhhhh-HHHHHhhcccCCCCCCCcchhh-------------------------------------------------c
Q 041143 207 PASFGQS-LMQILWLNDQDAGGMTGPIDVV-------------------------------------------------A 236 (973)
Q Consensus 207 p~~~~~~-~~~~~~l~~~~~~~~~~~~~~~-------------------------------------------------~ 236 (973)
|..+... .++.+.++...+.....++..| .
T Consensus 170 ~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~ 249 (606)
T 3t6q_A 170 KEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFE 249 (606)
T ss_dssp HHHHHTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGG
T ss_pred hhhhhhhcccceeEEecCCCccCccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhc
Confidence 7766541 1221123333332222111111 1
Q ss_pred CCc--cccEEEccCCccccCCCccccCCCCCCEEeCcCCcccccCccccccc-ccCeEEccCCcCcCCCCCCCCCCcccc
Q 041143 237 KMV--SLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGPIPKFKAGNVTYD 313 (973)
Q Consensus 237 ~l~--~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~g~~p~~~~~~~~~~ 313 (973)
++. +|+.|++++|.+++..+..|..+++|++|+|++|+++ .+|..+..+ +|++|++++|.+.+..|..+...-.+.
T Consensus 250 ~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 328 (606)
T 3t6q_A 250 GLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLT 328 (606)
T ss_dssp GGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCS
T ss_pred hhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCC
Confidence 111 4555666666666555555666666666666666665 445555554 566666666665554443222111111
Q ss_pred cCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCCCccchhhhCcc
Q 041143 314 SNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLD 393 (973)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~ 393 (973)
...+.+..............+..+..++++.|.+..... ....+..+++|++|+|++|++.+..|..|.+++
T Consensus 329 ~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~--------~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 400 (606)
T 3t6q_A 329 HLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDC--------CNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECP 400 (606)
T ss_dssp EEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEE--------STTTTTTCTTCCEEECCSCSCEEECTTTTTTCT
T ss_pred EEECCCCCcccccchhhhhccCcCCEEECCCCccccccC--------cchhcccCCCCCEEECCCCcCCcCCHHHhcCCc
Confidence 222222111111111222234455566666665544320 012345667777888888877777777777777
Q ss_pred ccceEEccCCccccccCcc-ccCcCCCCeeeCCCCcCCCCCCC----CCcccceeecCCccc
Q 041143 394 SLIEIRLGKNSISGTVPNN-FTELKSLRLLDVSDNNIKPPLPE----FHDTVKLVIDGNPLL 450 (973)
Q Consensus 394 ~L~~L~L~~N~l~g~~p~~-~~~l~~L~~L~Ls~N~l~g~~p~----~~~~~~~~~~~N~~~ 450 (973)
+|+.|+|++|++++..|.. |..+++|++|+|++|.+++.+|. +.++..+++.+|++.
T Consensus 401 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 462 (606)
T 3t6q_A 401 QLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFP 462 (606)
T ss_dssp TCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCG
T ss_pred cCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCC
Confidence 8888888888777666544 77777788888888877776654 345566777777653
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=349.18 Aligned_cols=324 Identities=27% Similarity=0.314 Sum_probs=190.1
Q ss_pred eEEEEEecccCCcccCCcCccc--ccccceeeccCcccCCCCC-CCCCCCccceeeccCCCCCCCCccccCCCCCccEEE
Q 041143 68 RVTQIQVQNLGLKGPLPQNFNQ--LTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLA 144 (973)
Q Consensus 68 ~v~~L~L~~~~l~g~~~~~~~~--l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~ 144 (973)
.++.|+|++|.++|.+|+.+.. +++|++|+|++|.+++.+| .|.++++|++|+|++|+++...+..|..+++|++|+
T Consensus 369 ~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 448 (768)
T 3rgz_A 369 SLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLK 448 (768)
T ss_dssp TCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEE
T ss_pred CCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEE
Confidence 5666677777776666666655 6666777777777666555 566666677777777766666666666666777777
Q ss_pred cccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccC
Q 041143 145 LDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQD 224 (973)
Q Consensus 145 Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~ 224 (973)
|++|++++. +|..+..+++|++|+|++|++++.+|..+.++++|++|+|++|++++.+|..+.. +.++..|+...
T Consensus 449 L~~n~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~L~~ 523 (768)
T 3rgz_A 449 LWLNMLEGE----IPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGR-LENLAILKLSN 523 (768)
T ss_dssp CCSSCCCSC----CCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGG-CTTCCEEECCS
T ss_pred CCCCcccCc----CCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhc-CCCCCEEECCC
Confidence 777766653 6666666666777777777776666666666777777777777766666665542 11111111112
Q ss_pred CCCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCC--------------------------------------
Q 041143 225 AGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLK-------------------------------------- 266 (973)
Q Consensus 225 ~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~-------------------------------------- 266 (973)
+......+..+.++++|+.|+|++|+++|.+|..+..+..+.
T Consensus 524 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (768)
T 3rgz_A 524 NSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQ 603 (768)
T ss_dssp SCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGG
T ss_pred CcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchh
Confidence 211111222233344444444444444444443332211100
Q ss_pred --------EEeCcCCcccccCccccccc-ccCeEEccCCcCcCCCCCCCCCCcccccCcccCCCCCcccCCcchhhhhhc
Q 041143 267 --------DLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFL 337 (973)
Q Consensus 267 --------~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 337 (973)
.++++.|.+.|.+|..+..+ +|+.|+|++|+++|.+|..+ ..+..+
T Consensus 604 ~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l-------------------------~~l~~L 658 (768)
T 3rgz_A 604 LNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEI-------------------------GSMPYL 658 (768)
T ss_dssp GGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGG-------------------------GGCTTC
T ss_pred hhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHH-------------------------hccccC
Confidence 00111111112222222222 35555555555555555421 112234
Q ss_pred cCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCCCccchhhhCccccceEEccCCccccccCccccCcC
Q 041143 338 GGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELK 417 (973)
Q Consensus 338 ~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~ 417 (973)
..++++.|.+... .+..+..+++|++|||++|+++|.+|..+++++.|++|+|++|+|+|.||.. ..+.
T Consensus 659 ~~L~Ls~N~l~g~----------ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~-~~~~ 727 (768)
T 3rgz_A 659 FILNLGHNDISGS----------IPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM-GQFE 727 (768)
T ss_dssp CEEECCSSCCCSC----------CCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSS-SSGG
T ss_pred CEEeCcCCccCCC----------CChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCc-hhhc
Confidence 4445555444321 1114677889999999999999999999999999999999999999999975 4555
Q ss_pred CCCeeeCCCCc-CCCC
Q 041143 418 SLRLLDVSDNN-IKPP 432 (973)
Q Consensus 418 ~L~~L~Ls~N~-l~g~ 432 (973)
++..+.+.+|. |.|.
T Consensus 728 ~~~~~~~~gN~~Lcg~ 743 (768)
T 3rgz_A 728 TFPPAKFLNNPGLCGY 743 (768)
T ss_dssp GSCGGGGCSCTEEEST
T ss_pred cCCHHHhcCCchhcCC
Confidence 66666777775 5553
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=339.46 Aligned_cols=390 Identities=19% Similarity=0.135 Sum_probs=267.6
Q ss_pred CeEEeeC-----------CeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCC-CCCCCCccceeeccCCCCC
Q 041143 60 PHVFCSG-----------NRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFD 127 (973)
Q Consensus 60 ~gv~C~~-----------~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~ 127 (973)
..|.|.. ..++.|+|++|.|++..+.+|.++++|++|||++|+|+++++ +|.+|++|++|+|++|+|+
T Consensus 34 ~~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~ 113 (635)
T 4g8a_A 34 ITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 113 (635)
T ss_dssp TEEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC
T ss_pred CEEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCC
Confidence 3578964 268999999999998888899999999999999999999888 7999999999999999999
Q ss_pred CCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeeecccccccC-CcchhccCCCCCCeEEccCCcCcccC
Q 041143 128 TIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVG-PLPDFLGTLPSLAALKLSYNRLSGVI 206 (973)
Q Consensus 128 ~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~Ls~N~l~~~~ 206 (973)
.+++.+|.++++|++|+|++|+++++ .+..|+++++|++|+|++|.|++ .+|..++.+++|++|+|++|+|++..
T Consensus 114 ~l~~~~f~~L~~L~~L~Ls~N~l~~l----~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 189 (635)
T 4g8a_A 114 SLALGAFSGLSSLQKLVAVETNLASL----ENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIY 189 (635)
T ss_dssp EECGGGGTTCTTCCEEECTTSCCCCS----TTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEEC
T ss_pred CCCHHHhcCCCCCCEEECCCCcCCCC----ChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccc
Confidence 99999999999999999999999974 44578999999999999999986 46889999999999999999999877
Q ss_pred ChhhhhhH-HHH----HhhcccCCC---------------------------------------------------CCC-
Q 041143 207 PASFGQSL-MQI----LWLNDQDAG---------------------------------------------------GMT- 229 (973)
Q Consensus 207 p~~~~~~~-~~~----~~l~~~~~~---------------------------------------------------~~~- 229 (973)
+..+.... .+. +.+..+... ...
T Consensus 190 ~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~ 269 (635)
T 4g8a_A 190 CTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEK 269 (635)
T ss_dssp GGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSC
T ss_pred cccccchhhhhhhhhhhhcccCcccccCcccccchhhhhhhhhcccccccccchhhcCCccccccccccccccccccccc
Confidence 76653210 000 000000000 000
Q ss_pred -------------------------------------------------CcchhhcCCccccEEEccCCccccCCCc---
Q 041143 230 -------------------------------------------------GPIDVVAKMVSLTQLWLHGNQFTGSIPE--- 257 (973)
Q Consensus 230 -------------------------------------------------~~~~~~~~l~~L~~L~L~~N~l~g~~p~--- 257 (973)
.....+....+|+.|++.+|.+.+..+.
T Consensus 270 ~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~ 349 (635)
T 4g8a_A 270 FDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLK 349 (635)
T ss_dssp CCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCT
T ss_pred ccccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccccccccccccccccchhhhhhhcccccccCcCcccch
Confidence 0001233345567777777766533222
Q ss_pred ----------------cccCCCCCCEEeCcCCccccc--Cccccccc-ccCeEEccCCcCcCCCCCCCCCCcccccCccc
Q 041143 258 ----------------DIGALSSLKDLNLNRNQLVGL--IPKSLANM-ELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFC 318 (973)
Q Consensus 258 ----------------~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l-~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~ 318 (973)
.+..+++|+.|++++|.+... .+..+... +|+.|++..|.+.+..+.+ .....+....+.
T Consensus 350 ~L~~l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~~~~~-~~l~~L~~l~l~ 428 (635)
T 4g8a_A 350 SLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITMSSNF-LGLEQLEHLDFQ 428 (635)
T ss_dssp TCCEEEEESCCSCCBCCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEEECSCC-TTCTTCCEEECT
T ss_pred hhhhcccccccCCCCcccccccccccchhhccccccccccccchhhhhhhhhhhccccccccccccc-cccccccchhhh
Confidence 223567888999998888643 23333222 5666666666554332221 111111111111
Q ss_pred CCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCC---------------CCCCccccccCCCCcccEEecCCCcCCC
Q 041143 319 QSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDP---------------CQGPWLGLSCTSNSKVSIINLPRHNLTG 383 (973)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~---------------~~~~~~~~~~~~~~~L~~L~Ls~N~l~~ 383 (973)
...............+..+..++++.|.+........ ....+....+..+++|++|+|++|++++
T Consensus 429 ~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~ 508 (635)
T 4g8a_A 429 HSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ 508 (635)
T ss_dssp TSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCE
T ss_pred hccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCC
Confidence 0000000000111112222223333333222211100 0001122346778899999999999999
Q ss_pred ccchhhhCccccceEEccCCccccccCccccCcCCCCeeeCCCCcCCCCCCCC-----CcccceeecCCccccCCC
Q 041143 384 TLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLPEF-----HDTVKLVIDGNPLLVGGI 454 (973)
Q Consensus 384 ~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~-----~~~~~~~~~~N~~~c~~~ 454 (973)
.+|..|+++++|++|+|++|+|++..|..|..+++|++|||++|+|++.+|.. .++..+++.+|||.|...
T Consensus 509 l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 509 LSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp ECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred cChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence 99999999999999999999999988999999999999999999999998862 346679999999999753
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=335.14 Aligned_cols=342 Identities=19% Similarity=0.213 Sum_probs=240.7
Q ss_pred CeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCC-CCCCCCccceeeccCCCCCCCCccccCCCCCccEEEc
Q 041143 67 NRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLAL 145 (973)
Q Consensus 67 ~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~L 145 (973)
.+++.|+|++|.+++..+.+|.++++|++|+|++|+|++..| .|.++++|++|+|++|+|+.+|.. .+++|++|+|
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~---~l~~L~~L~L 128 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNISCC---PMASLRHLDL 128 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCEECSC---CCTTCSEEEC
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCccCcc---ccccCCEEEC
Confidence 468888999999988777888999999999999999988766 688889999999999999888876 7889999999
Q ss_pred ccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCC--CeEEccCCcC--cccCChhhhhhHHHHHhhc
Q 041143 146 DYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSL--AALKLSYNRL--SGVIPASFGQSLMQILWLN 221 (973)
Q Consensus 146 s~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L--~~L~Ls~N~l--~~~~p~~~~~~~~~~~~l~ 221 (973)
++|++++. .+|..|+++++|++|+|++|+|++. .+..+++| ++|+|++|++ ++..|..+.....+.+.+.
T Consensus 129 s~N~l~~l---~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~ 202 (562)
T 3a79_B 129 SFNDFDVL---PVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLV 202 (562)
T ss_dssp CSSCCSBC---CCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEE
T ss_pred CCCCcccc---CchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccccccCcccccccCcceEEEE
Confidence 99988864 3567888899999999999988853 34555555 8899999888 7777766543110111111
Q ss_pred ccCCCCCCC-c----------------------------chh---------------------------hcCCccccEEE
Q 041143 222 DQDAGGMTG-P----------------------------IDV---------------------------VAKMVSLTQLW 245 (973)
Q Consensus 222 ~~~~~~~~~-~----------------------------~~~---------------------------~~~l~~L~~L~ 245 (973)
...+..... . ... ....++|++|+
T Consensus 203 l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~ 282 (562)
T 3a79_B 203 FHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLN 282 (562)
T ss_dssp ECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEE
T ss_pred ecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEE
Confidence 111110000 0 000 01123677777
Q ss_pred ccCCccccCCCccc-----------------------------------------------------cCCCCCCEEeCcC
Q 041143 246 LHGNQFTGSIPEDI-----------------------------------------------------GALSSLKDLNLNR 272 (973)
Q Consensus 246 L~~N~l~g~~p~~~-----------------------------------------------------~~l~~L~~L~Ls~ 272 (973)
+++|.++|.+|..+ ..+++|++|+|++
T Consensus 283 l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~l~~L~~L~l~~ 362 (562)
T 3a79_B 283 IYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQ 362 (562)
T ss_dssp EEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCS
T ss_pred EeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCcccccCccCCCCceEEECCC
Confidence 77777777777665 3445555555555
Q ss_pred CcccccCccccccc-ccCeEEccCCcCcCCCCCCCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCC-C
Q 041143 273 NQLVGLIPKSLANM-ELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQ-W 350 (973)
Q Consensus 273 N~l~~~~p~~~~~l-~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~-~ 350 (973)
|++++.+|..+..+ +|+.|++++|++++..+ .+.....+..+..++++.|.+.. +
T Consensus 363 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-----------------------~~~~~~~l~~L~~L~l~~N~l~~~~ 419 (562)
T 3a79_B 363 NVFTDSVFQGCSTLKRLQTLILQRNGLKNFFK-----------------------VALMTKNMSSLETLDVSLNSLNSHA 419 (562)
T ss_dssp SCCCTTTTTTCCSCSSCCEEECCSSCCCBTTH-----------------------HHHTTTTCTTCCEEECTTSCCBSCC
T ss_pred CccccchhhhhcccCCCCEEECCCCCcCCccc-----------------------chhhhcCCCCCCEEECCCCcCCCcc
Confidence 55555555555554 45555555555543110 00111234456777788887766 4
Q ss_pred CCCCCCCCCccccccCCCCcccEEecCCCcCCCccchhhhCccccceEEccCCccccccCccccCcCCCCeeeCCCCcCC
Q 041143 351 PGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIK 430 (973)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~ 430 (973)
+.. .+..+++|+.|+|++|++++.+|..+. ++|+.|+|++|+|+ .+|..+..+++|++|+|++|+|+
T Consensus 420 ~~~----------~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~ 486 (562)
T 3a79_B 420 YDR----------TCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK 486 (562)
T ss_dssp SSC----------CCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC
T ss_pred Chh----------hhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC
Confidence 432 345678999999999999998887665 79999999999999 89988889999999999999999
Q ss_pred CCCCC-C---CcccceeecCCccccCC
Q 041143 431 PPLPE-F---HDTVKLVIDGNPLLVGG 453 (973)
Q Consensus 431 g~~p~-~---~~~~~~~~~~N~~~c~~ 453 (973)
+.++. + .++..+++.+|||.|..
T Consensus 487 ~l~~~~~~~l~~L~~L~l~~N~~~c~c 513 (562)
T 3a79_B 487 SVPDGVFDRLTSLQYIWLHDNPWDCTC 513 (562)
T ss_dssp CCCTTSTTTCTTCCCEECCSCCBCCCH
T ss_pred CCCHHHHhcCCCCCEEEecCCCcCCCc
Confidence 76654 3 45567899999999964
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=336.72 Aligned_cols=378 Identities=17% Similarity=0.184 Sum_probs=250.6
Q ss_pred CeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCC-CCCCCCccceeeccCCCCCCCCccccCCCCCccEEEc
Q 041143 67 NRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLAL 145 (973)
Q Consensus 67 ~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~L 145 (973)
.+++.|+|++|++++..+.+|.++++|++|+|++|++++..+ .|.++++|++|+|++|+++.+++..|.++++|++|+|
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence 368889999999998888889999999999999999998877 6888999999999999999999889999999999999
Q ss_pred ccCCCCCccCCCCCcccccccccCeeecccccccC-CcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHH----Hhh
Q 041143 146 DYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVG-PLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQI----LWL 220 (973)
Q Consensus 146 s~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~----~~l 220 (973)
++|++++. .+..++++++|++|+|++|.+++ .+|..|+++++|++|+|++|++++..|..+.. +.++ ..+
T Consensus 108 ~~n~l~~l----~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~-l~~L~~~~~~L 182 (570)
T 2z63_A 108 VETNLASL----ENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRV-LHQMPLLNLSL 182 (570)
T ss_dssp TTSCCCCS----TTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHH-HHTCTTCCCEE
T ss_pred cccccccC----CCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccc-hhccchhhhhc
Confidence 99998863 22368889999999999999886 46888999999999999999988766665543 1111 111
Q ss_pred cccCCCCC------------------------------------------------------------------------
Q 041143 221 NDQDAGGM------------------------------------------------------------------------ 228 (973)
Q Consensus 221 ~~~~~~~~------------------------------------------------------------------------ 228 (973)
+...+...
T Consensus 183 ~l~~n~l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l 262 (570)
T 2z63_A 183 DLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEF 262 (570)
T ss_dssp ECTTCCCCEECTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEE
T ss_pred ccCCCCceecCHHHhccCcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhh
Confidence 11111100
Q ss_pred ---------CCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcccccCccc-c---------------
Q 041143 229 ---------TGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKS-L--------------- 283 (973)
Q Consensus 229 ---------~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~--------------- 283 (973)
......+..+++|+.|++++|.++ .+|..+..+ +|++|++++|.+.. +|.. +
T Consensus 263 ~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~~-l~~~~l~~L~~L~l~~n~~~~ 339 (570)
T 2z63_A 263 RLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFGQ-FPTLKLKSLKRLTFTSNKGGN 339 (570)
T ss_dssp EEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCSS-CCBCBCSSCCEEEEESCBSCC
T ss_pred hhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCcccc-cCcccccccCEEeCcCCcccc
Confidence 111234556677888888887777 566666555 55555555555542 2211 1
Q ss_pred ----ccc-ccCeEEccCCcCcCCC--CCCCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCC-C
Q 041143 284 ----ANM-ELDNLVLNNNLLMGPI--PKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGND-P 355 (973)
Q Consensus 284 ----~~l-~L~~L~l~~N~l~g~~--p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~-~ 355 (973)
..+ +|+.|++++|.+++.. |..+...-.+....+.+. .+...+.....+..+..+++..|.+...+... .
T Consensus 340 ~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n--~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 417 (570)
T 2z63_A 340 AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFN--GVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVF 417 (570)
T ss_dssp BCCCCBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSC--SEEEEEEEEETCTTCCEEECTTSEEESCTTSCTT
T ss_pred ccccccCCCCCEEeCcCCccCccccccccccccCccCEEECCCC--ccccccccccccCCCCEEEccCCccccccchhhh
Confidence 122 4556666666555332 111000000000011000 00000000111223333344443333221100 0
Q ss_pred -------------CC-CCccccccCCCCcccEEecCCCcCC-CccchhhhCccccceEEccCCccccccCccccCcCCCC
Q 041143 356 -------------CQ-GPWLGLSCTSNSKVSIINLPRHNLT-GTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLR 420 (973)
Q Consensus 356 -------------~~-~~~~~~~~~~~~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~ 420 (973)
+. .......+..+++|++|+|++|.+. +.+|..+..+++|+.|+|++|++++..|..|..+++|+
T Consensus 418 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 497 (570)
T 2z63_A 418 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 497 (570)
T ss_dssp TTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred hcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCC
Confidence 00 0011123566889999999999998 68899999999999999999999988899999999999
Q ss_pred eeeCCCCcCCCCCCC----CCcccceeecCCccccCCC
Q 041143 421 LLDVSDNNIKPPLPE----FHDTVKLVIDGNPLLVGGI 454 (973)
Q Consensus 421 ~L~Ls~N~l~g~~p~----~~~~~~~~~~~N~~~c~~~ 454 (973)
+|+|++|+|++.+|. +.++..+++.+|++.|...
T Consensus 498 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 535 (570)
T 2z63_A 498 VLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535 (570)
T ss_dssp EEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred EEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCc
Confidence 999999999998775 3456678999999998643
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-33 Score=338.92 Aligned_cols=387 Identities=18% Similarity=0.142 Sum_probs=259.9
Q ss_pred CcCeEEeeC-----------CeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCC-CCCCCCccceeeccCCC
Q 041143 58 PWPHVFCSG-----------NRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNE 125 (973)
Q Consensus 58 ~w~gv~C~~-----------~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~ 125 (973)
.+..|.|+. .+++.|+|++|++++..+..|+++++|++|+|++|.+++..| .|.++++|++|+|++|+
T Consensus 5 ~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~ 84 (680)
T 1ziw_A 5 SHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNE 84 (680)
T ss_dssp BSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSC
T ss_pred ECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCc
Confidence 366677764 378999999999998888889999999999999999999887 58899999999999999
Q ss_pred CCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCccc
Q 041143 126 FDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGV 205 (973)
Q Consensus 126 l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 205 (973)
|+.+++..|.++++|++|+|++|++++. .|..|.++++|++|+|++|.+++..|..++++++|++|+|++|++++.
T Consensus 85 l~~l~~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 160 (680)
T 1ziw_A 85 LSQLSDKTFAFCTNLTELHLMSNSIQKI----KNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQAL 160 (680)
T ss_dssp CCCCCTTTTTTCTTCSEEECCSSCCCCC----CSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCB
T ss_pred cCccChhhhccCCCCCEEECCCCccCcc----ChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCccccc
Confidence 9999999999999999999999999874 457899999999999999999999999999999999999999999977
Q ss_pred CChhhhhh-HHHHHhhcccCCCCCCCcchhhcCC---------------------------ccccEEEccCCccccCCCc
Q 041143 206 IPASFGQS-LMQILWLNDQDAGGMTGPIDVVAKM---------------------------VSLTQLWLHGNQFTGSIPE 257 (973)
Q Consensus 206 ~p~~~~~~-~~~~~~l~~~~~~~~~~~~~~~~~l---------------------------~~L~~L~L~~N~l~g~~p~ 257 (973)
.+..+... ...+..|+...+......+..|..+ ++|+.|+|++|.+++..|.
T Consensus 161 ~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~ 240 (680)
T 1ziw_A 161 KSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240 (680)
T ss_dssp CHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTT
T ss_pred CHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChh
Confidence 77665321 1233344444443333333333332 5677888888888888888
Q ss_pred cccCCCC--CCEEeCcCCcccccCccccccc-ccCeEEccCCcCcCCCCCCCCCCcccccCcccCCCCCc----ccCC--
Q 041143 258 DIGALSS--LKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGI----ECAP-- 328 (973)
Q Consensus 258 ~~~~l~~--L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~-- 328 (973)
.|..++. |+.|+|++|++++..|..|..+ +|+.|++++|.+.+..|..+.....+....+....... ...+
T Consensus 241 ~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i 320 (680)
T 1ziw_A 241 TFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKI 320 (680)
T ss_dssp TTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEE
T ss_pred HhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhccccccccccc
Confidence 8887754 8888888888888888888877 78888888888887777654433322222222111000 0000
Q ss_pred --cchhhhhhccCCCCCCcccCCCCCCCCCCCC-ccccc---------------c--CCCCcccEEecCCCcCCCccchh
Q 041143 329 --DVNVLLDFLGGVNYPVNLVSQWPGNDPCQGP-WLGLS---------------C--TSNSKVSIINLPRHNLTGTLSPS 388 (973)
Q Consensus 329 --~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~-~~~~~---------------~--~~~~~L~~L~Ls~N~l~~~~p~~ 388 (973)
.....+..+..+++..|.+...+.......+ ...+. + ...++|+.|+|++|++++..|..
T Consensus 321 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~ 400 (680)
T 1ziw_A 321 DDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDA 400 (680)
T ss_dssp CTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTT
T ss_pred ChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhh
Confidence 0122344566666666666655432111000 00000 0 01134555555555555555555
Q ss_pred hhCccccceEEccCCccccccC-ccccCcCCCCeeeCCCCcCCCCCCC----CCcccceeecCCc
Q 041143 389 IANLDSLIEIRLGKNSISGTVP-NNFTELKSLRLLDVSDNNIKPPLPE----FHDTVKLVIDGNP 448 (973)
Q Consensus 389 ~~~l~~L~~L~L~~N~l~g~~p-~~~~~l~~L~~L~Ls~N~l~g~~p~----~~~~~~~~~~~N~ 448 (973)
|..+++|+.|+|++|++++.+| ..|..+++|++|+|++|++++..+. +..+..+.+.+|.
T Consensus 401 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~ 465 (680)
T 1ziw_A 401 FSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVA 465 (680)
T ss_dssp TTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSC
T ss_pred hhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhcccc
Confidence 5555555555555555555444 3455555555555555555544332 2333444454443
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=322.74 Aligned_cols=246 Identities=16% Similarity=0.187 Sum_probs=184.3
Q ss_pred hcCccccCcccccCccEEEEEEECCCCEEEEEEeecCCC------ChHHHHHHHHHHHHHHhcC---------CCceeee
Q 041143 624 TQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVT------TTKALDEFQSEIAVLSKVR---------HRHLVSL 688 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~---------h~niv~l 688 (973)
.++|...+.||+|+||.||+|+. +|+.||||+++.... .....+.+.+|+++++.++ |||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 36788999999999999999988 589999999975422 2223467889999999886 7777777
Q ss_pred eeEEE-----------------e-------------CCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHH
Q 041143 689 LGYSI-----------------E-------------GNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVA 738 (973)
Q Consensus 689 ~~~~~-----------------~-------------~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia 738 (973)
++++. + .+..++||||+++|++.+.+.+ ..+++.++..++.||+
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHHHH
Confidence 66543 2 6789999999999977665532 4579999999999999
Q ss_pred HHHHHHHhhccCCeeeccCCCCcEEECCCC--------------------CEEEeeccccccCCCCCcceecccccccCc
Q 041143 739 RGMEYLHCLARQTFIHRDLKSSNILLDDDY--------------------RAKVSDFGLVKLAPDGEKSVVTRLAGTFGY 798 (973)
Q Consensus 739 ~gl~~LH~~~~~~ivH~Dikp~Nill~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y 798 (973)
.||+|||+ +++|+||||||+|||++.++ .+||+|||+|+..... ..+||+.|
T Consensus 172 ~aL~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y 243 (336)
T 2vuw_A 172 ASLAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCT
T ss_pred HHHHHHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecc
Confidence 99999992 35899999999999999887 8999999999865432 34799999
Q ss_pred ccccccccCcCCCchhHHhHHHH-HHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHH
Q 041143 799 LAPEYAVMGKITTKADVFSYGVV-LMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISI 877 (973)
Q Consensus 799 ~aPE~~~~~~~~~~~Dv~S~Gvv-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 877 (973)
+|||++.+.. +.++||||+|++ .+++++|..||... .|..... .........+..............
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~---------~~~~~~~--~~~~~~~~~~~~~~~~~~~~~s~~ 311 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV---------LWLHYLT--DKMLKQMTFKTKCNTPAMKQIKRK 311 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH---------HHHHHHH--HHHHHTCCCSSCCCSHHHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch---------hhhhHHH--HhhhhhhccCcccchhhhhhcCHH
Confidence 9999988666 889999998777 78899998887321 1111111 001111111111111223345567
Q ss_pred HHHHHHHhhccCCCCCCCHhHHH-H
Q 041143 878 VAELAGHCTAREPYHRPDMGHVV-N 901 (973)
Q Consensus 878 ~~~l~~~cl~~dP~~RPs~~~v~-~ 901 (973)
+.+++.+||+.| |++|++ +
T Consensus 312 ~~dli~~~L~~d-----sa~e~l~~ 331 (336)
T 2vuw_A 312 IQEFHRTMLNFS-----SATDLLCQ 331 (336)
T ss_dssp HHHHHHHGGGSS-----SHHHHHHH
T ss_pred HHHHHHHHhccC-----CHHHHHhc
Confidence 889999999976 898888 5
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-33 Score=331.46 Aligned_cols=363 Identities=17% Similarity=0.179 Sum_probs=259.6
Q ss_pred CeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCC-CCCCCCccceeeccCCCCCCCCccccCCCCCccEEEc
Q 041143 67 NRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLAL 145 (973)
Q Consensus 67 ~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~L 145 (973)
.+++.|+|++|.+++..|..|.++++|++|+|++|+|++..| .|.++++|++|+|++|+|+.+|.. .+++|++|+|
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~---~l~~L~~L~L 97 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCH---PTVNLKHLDL 97 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCEEECC---CCCCCSEEEC
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceeecCcc---ccCCccEEec
Confidence 578999999999998877889999999999999999999876 789999999999999999988876 7999999999
Q ss_pred ccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCC--CeEEccCCcC--cccCChhhhhhHHHHHhhc
Q 041143 146 DYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSL--AALKLSYNRL--SGVIPASFGQSLMQILWLN 221 (973)
Q Consensus 146 s~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L--~~L~Ls~N~l--~~~~p~~~~~~~~~~~~l~ 221 (973)
++|++++. .+|..|+++++|++|+|++|+|++ ..+..+++| ++|+|++|++ .+..|..+.....+.+.+.
T Consensus 98 ~~N~l~~~---~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~ 171 (520)
T 2z7x_B 98 SFNAFDAL---PICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIV 171 (520)
T ss_dssp CSSCCSSC---CCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEE
T ss_pred cCCccccc---cchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEEE
Confidence 99999874 478899999999999999999985 457777888 9999999999 7777776654111111111
Q ss_pred ccCCCCCC-------------------------------CcchhhcC---------------------------CccccE
Q 041143 222 DQDAGGMT-------------------------------GPIDVVAK---------------------------MVSLTQ 243 (973)
Q Consensus 222 ~~~~~~~~-------------------------------~~~~~~~~---------------------------l~~L~~ 243 (973)
...+.... +....+.. .++|++
T Consensus 172 l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~ 251 (520)
T 2z7x_B 172 FPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWY 251 (520)
T ss_dssp CCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSE
T ss_pred eccCcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccE
Confidence 11111000 00001111 236777
Q ss_pred EEccCCccccCCCccc-----cCCCCCCEEeCcCCcccccCc-cc-------------------------cccc-ccCeE
Q 041143 244 LWLHGNQFTGSIPEDI-----GALSSLKDLNLNRNQLVGLIP-KS-------------------------LANM-ELDNL 291 (973)
Q Consensus 244 L~L~~N~l~g~~p~~~-----~~l~~L~~L~Ls~N~l~~~~p-~~-------------------------~~~l-~L~~L 291 (973)
|+|++|+++|.+|..+ ..+++|+.+++++|.+ .+| .. +..+ +|++|
T Consensus 252 L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L 329 (520)
T 2z7x_B 252 FSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHL 329 (520)
T ss_dssp EEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEE
T ss_pred EEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCccccccchhhCCcccEE
Confidence 7778888887788777 5555555555555554 222 00 1233 57778
Q ss_pred EccCCcCcCCCCCCCCCCcccccCcccCCCCCc-ccCCcchhhhhhccCCCCCCcccCC-CCCCCCCCCCccccccCCCC
Q 041143 292 VLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGI-ECAPDVNVLLDFLGGVNYPVNLVSQ-WPGNDPCQGPWLGLSCTSNS 369 (973)
Q Consensus 292 ~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~l~~~~n~~~~-~~~~~~~~~~~~~~~~~~~~ 369 (973)
++++|.+++.+|..+...-.+....+..+.... ...+.....+..+..++++.|.+.. ++.. .+..++
T Consensus 330 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~----------~~~~l~ 399 (520)
T 2z7x_B 330 DFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKG----------DCSWTK 399 (520)
T ss_dssp ECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGC----------SCCCCT
T ss_pred EeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccc----------hhccCc
Confidence 888888777666654333333333333222111 0111122335567778888887766 4422 345678
Q ss_pred cccEEecCCCcCCCccchhhhCccccceEEccCCccccccCccccCcCCCCeeeCCCCcCCCCCCC-C---Ccccceeec
Q 041143 370 KVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLPE-F---HDTVKLVID 445 (973)
Q Consensus 370 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~-~---~~~~~~~~~ 445 (973)
+|+.|+|++|++++.+|..+. ++|+.|+|++|+|+ .+|..+..+++|++|+|++|+|++.++. + .++..+++.
T Consensus 400 ~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~ 476 (520)
T 2z7x_B 400 SLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLH 476 (520)
T ss_dssp TCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred cCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECc
Confidence 999999999999998887765 79999999999999 8999888999999999999999976554 3 456779999
Q ss_pred CCccccCC
Q 041143 446 GNPLLVGG 453 (973)
Q Consensus 446 ~N~~~c~~ 453 (973)
+||+.|..
T Consensus 477 ~N~~~c~c 484 (520)
T 2z7x_B 477 TNPWDCSC 484 (520)
T ss_dssp SSCBCCCH
T ss_pred CCCCcccC
Confidence 99999964
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-32 Score=333.21 Aligned_cols=385 Identities=20% Similarity=0.180 Sum_probs=295.1
Q ss_pred CeEEEEEecccCCcccCCcCcccccc--cceeeccCcccCCCCC-CCCCCCccceeeccCCCCCCCCccccCCCCCccEE
Q 041143 67 NRVTQIQVQNLGLKGPLPQNFNQLTK--LYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVL 143 (973)
Q Consensus 67 ~~v~~L~L~~~~l~g~~~~~~~~l~~--L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L 143 (973)
..++.|+|++|.+++..|..|.+++. |++|+|++|.+++.++ .|.++++|++|+|++|++..+++..|.++++|++|
T Consensus 222 ~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 301 (680)
T 1ziw_A 222 TSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYL 301 (680)
T ss_dssp SCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEE
T ss_pred ccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEE
Confidence 46889999999999999999999876 9999999999999877 68999999999999999999999999999999999
Q ss_pred EcccCCCCCccC-CCCCc----ccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCccc-CCh-hhhhh-HH
Q 041143 144 ALDYNPFNKTFG-WSIPD----SLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGV-IPA-SFGQS-LM 215 (973)
Q Consensus 144 ~Ls~N~l~~~~~-~~ip~----~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~-~p~-~~~~~-~~ 215 (973)
+|++|...+.+. ..+|. .|..+++|++|+|++|++++..+..|.++++|++|+|++|.+++. ++. .|... ..
T Consensus 302 ~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~ 381 (680)
T 1ziw_A 302 NLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHS 381 (680)
T ss_dssp ECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTS
T ss_pred eccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccC
Confidence 999886654211 02343 778899999999999999998899999999999999999986532 222 22110 11
Q ss_pred HHHhhcccCCCCCCCcchhhcCCccccEEEccCCccccCCC-ccccCCCCCCEEeCcCCcccccCccccccc-ccCeEEc
Q 041143 216 QILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIP-EDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVL 293 (973)
Q Consensus 216 ~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l 293 (973)
.+..|+...+......+..|.++++|+.|+|++|.+++.+| ..|..+++|++|+|++|++.+..+..|..+ +|+.|++
T Consensus 382 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l 461 (680)
T 1ziw_A 382 PLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLML 461 (680)
T ss_dssp CCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEEC
T ss_pred cCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchh
Confidence 33344455555555566788889999999999999987776 678889999999999999988888888777 7888888
Q ss_pred cCCcCc--CCCCCCCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcc
Q 041143 294 NNNLLM--GPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKV 371 (973)
Q Consensus 294 ~~N~l~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L 371 (973)
++|.+. +.+|..+...-.+...++...... ...+.....+..+..++++.|.+..++....... ....+..+++|
T Consensus 462 ~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~--~~~~~~~l~~L 538 (680)
T 1ziw_A 462 RRVALKNVDSSPSPFQPLRNLTILDLSNNNIA-NINDDMLEGLEKLEILDLQHNNLARLWKHANPGG--PIYFLKGLSHL 538 (680)
T ss_dssp TTSCCBCTTCSSCTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTS--CCCTTTTCTTC
T ss_pred ccccccccccCCcccccCCCCCEEECCCCCCC-cCChhhhccccccCEEeCCCCCccccchhhccCC--cchhhcCCCCC
Confidence 888886 456654433323333333322211 1122233445677888888888776533211000 01135678999
Q ss_pred cEEecCCCcCCCccchhhhCccccceEEccCCccccccCccccCcCCCCeeeCCCCcCCCCCCC-----CCcccceeecC
Q 041143 372 SIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLPE-----FHDTVKLVIDG 446 (973)
Q Consensus 372 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~-----~~~~~~~~~~~ 446 (973)
++|+|++|++....+..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++.+|. +.++..+++.+
T Consensus 539 ~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~ 618 (680)
T 1ziw_A 539 HILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRF 618 (680)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTT
T ss_pred CEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccC
Confidence 9999999999966666799999999999999999977777789999999999999999998874 46678899999
Q ss_pred CccccCCC
Q 041143 447 NPLLVGGI 454 (973)
Q Consensus 447 N~~~c~~~ 454 (973)
|||.|...
T Consensus 619 N~~~c~c~ 626 (680)
T 1ziw_A 619 NPFDCTCE 626 (680)
T ss_dssp CCCCBCCC
T ss_pred CCcccCCc
Confidence 99999754
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-33 Score=323.20 Aligned_cols=310 Identities=20% Similarity=0.223 Sum_probs=246.3
Q ss_pred CCeEEEEEecccCCcccC-CcCcccccccceeeccCcccCCCCC-CCCCCCccceeeccCCCCCC--CCccccCCCCCcc
Q 041143 66 GNRVTQIQVQNLGLKGPL-PQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFDT--IPSDFFDGLSSVR 141 (973)
Q Consensus 66 ~~~v~~L~L~~~~l~g~~-~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~--i~~~~f~~l~~L~ 141 (973)
..+++.|+|++|.+.+.+ +..|.++++|++|+|++|.+++..| .|.++++|++|+|++|+++. +....|..+++|+
T Consensus 53 l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~ 132 (455)
T 3v47_A 53 LQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLE 132 (455)
T ss_dssp CTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCC
T ss_pred CccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCC
Confidence 357899999999998666 4568999999999999999998866 78999999999999999987 3445588999999
Q ss_pred EEEcccCCCCCccCCCCCcc-cccccccCeeecccccccCCcchhccCC-------------------------------
Q 041143 142 VLALDYNPFNKTFGWSIPDS-LANSVQLTNLSLINCNLVGPLPDFLGTL------------------------------- 189 (973)
Q Consensus 142 ~L~Ls~N~l~~~~~~~ip~~-~~~l~~L~~L~L~~N~l~~~~p~~l~~l------------------------------- 189 (973)
+|+|++|++++. .|.. +.++++|++|+|++|++++..+..+..+
T Consensus 133 ~L~L~~n~l~~~----~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~ 208 (455)
T 3v47_A 133 MLVLRDNNIKKI----QPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNP 208 (455)
T ss_dssp EEECCSSBCCSC----CCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCT
T ss_pred EEECCCCccCcc----CcccccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccc
Confidence 999999999874 5655 7889999999999999998877766554
Q ss_pred ---CCCCeEEccCCcCcccCChhhhhhH--HHHHhhcccCCCCC----------CCcchhhcC--CccccEEEccCCccc
Q 041143 190 ---PSLAALKLSYNRLSGVIPASFGQSL--MQILWLNDQDAGGM----------TGPIDVVAK--MVSLTQLWLHGNQFT 252 (973)
Q Consensus 190 ---~~L~~L~Ls~N~l~~~~p~~~~~~~--~~~~~l~~~~~~~~----------~~~~~~~~~--l~~L~~L~L~~N~l~ 252 (973)
++|++|+|++|++++.+|..+.... .++..+....+... ......+.. .++|+.|+|++|+++
T Consensus 209 ~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~ 288 (455)
T 3v47_A 209 FKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF 288 (455)
T ss_dssp TTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCC
T ss_pred cccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCcccc
Confidence 6788888888888777776664321 11111221111110 001111222 368999999999999
Q ss_pred cCCCccccCCCCCCEEeCcCCcccccCccccccc-ccCeEEccCCcCcCCCCCCCCCCcccccCcccCCCCCcccCCcch
Q 041143 253 GSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVN 331 (973)
Q Consensus 253 g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (973)
+.+|..|..+++|++|+|++|++++..|..|..+ +|+.|+|++|.+++..|.
T Consensus 289 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~--------------------------- 341 (455)
T 3v47_A 289 ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSR--------------------------- 341 (455)
T ss_dssp EECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGG---------------------------
T ss_pred ccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChh---------------------------
Confidence 8888889999999999999999998888888887 799999999988755443
Q ss_pred hhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCCCccchhhhCccccceEEccCCccccccCc
Q 041143 332 VLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPN 411 (973)
Q Consensus 332 ~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~ 411 (973)
.+..+++|++|+|++|++++..|..|.++++|++|+|++|+|++..+.
T Consensus 342 --------------------------------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 389 (455)
T 3v47_A 342 --------------------------------MFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDG 389 (455)
T ss_dssp --------------------------------GGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred --------------------------------HhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHh
Confidence 234678999999999999999999999999999999999999987777
Q ss_pred cccCcCCCCeeeCCCCcCCCCCCCCCc
Q 041143 412 NFTELKSLRLLDVSDNNIKPPLPEFHD 438 (973)
Q Consensus 412 ~~~~l~~L~~L~Ls~N~l~g~~p~~~~ 438 (973)
.|..+++|+.|+|++|++++..|.+..
T Consensus 390 ~~~~l~~L~~L~l~~N~l~~~~~~~~~ 416 (455)
T 3v47_A 390 IFDRLTSLQKIWLHTNPWDCSCPRIDY 416 (455)
T ss_dssp TTTTCTTCCEEECCSSCBCCCTTTTHH
T ss_pred HhccCCcccEEEccCCCcccCCCcchH
Confidence 889999999999999999999996543
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-32 Score=328.88 Aligned_cols=331 Identities=19% Similarity=0.196 Sum_probs=247.3
Q ss_pred cCCCCCCCCCCCCC-CCcCeEEeeC------------------CeEEEEEecccCCcccCCcCcccccccceeeccCccc
Q 041143 43 LLKWPANGDDPCGP-PPWPHVFCSG------------------NRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKF 103 (973)
Q Consensus 43 l~~w~~~~~d~C~~-~~w~gv~C~~------------------~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l 103 (973)
+.+|.. +.+||.. ..|.++.|+. ..++.|+++++.+++..+..|.++++|++|+|++|.|
T Consensus 9 l~~~~~-~~~C~~~~~~~~c~~~~~~i~~~~~~~~~~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l 87 (597)
T 3oja_B 9 VKPRQP-EYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQI 87 (597)
T ss_dssp --CCCS-EECCCCC--CCSEEECSCEECSSCCCCEESCSSGGGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCC
T ss_pred ccCCCC-CCcCcccCcCceeEecCceecccccccccCcccccCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCC
Confidence 456743 3455532 2477777652 3568889999999876666689999999999999999
Q ss_pred CCCCC-CCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCc-ccccccccCeeecccccccCC
Q 041143 104 NGKLP-TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPD-SLANSVQLTNLSLINCNLVGP 181 (973)
Q Consensus 104 ~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~-~~~~l~~L~~L~L~~N~l~~~ 181 (973)
++.++ .|.++++|++|+|++|.|+.+++..|.++++|++|+|++|+|+. +|. .|.++++|++|+|++|.|++.
T Consensus 88 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-----l~~~~~~~l~~L~~L~Ls~N~l~~~ 162 (597)
T 3oja_B 88 EEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS-----LPRGIFHNTPKLTTLSMSNNNLERI 162 (597)
T ss_dssp CEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-----CCTTTTTTCTTCCEEECCSSCCCBC
T ss_pred CCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCC-----CCHHHhccCCCCCEEEeeCCcCCCC
Confidence 99887 89999999999999999999999999999999999999999996 554 468999999999999999999
Q ss_pred cchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCccccCCCccccC
Q 041143 182 LPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGA 261 (973)
Q Consensus 182 ~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~ 261 (973)
.|..|+++++|++|+|++|++++.....+. .+..|....+... .+...++|+.|++++|.++. +|..+
T Consensus 163 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~----~L~~L~l~~n~l~-----~l~~~~~L~~L~ls~n~l~~-~~~~~-- 230 (597)
T 3oja_B 163 EDDTFQATTSLQNLQLSSNRLTHVDLSLIP----SLFHANVSYNLLS-----TLAIPIAVEELDASHNSINV-VRGPV-- 230 (597)
T ss_dssp CTTTTTTCTTCCEEECTTSCCSBCCGGGCT----TCSEEECCSSCCS-----EEECCTTCSEEECCSSCCCE-EECSC--
T ss_pred ChhhhhcCCcCcEEECcCCCCCCcChhhhh----hhhhhhcccCccc-----cccCCchhheeeccCCcccc-ccccc--
Confidence 999999999999999999999965322221 1111221111111 12234455556666665552 22222
Q ss_pred CCCCCEEeCcCCcccccCccccccc-ccCeEEccCCcCcCCCCCCCCCCcccccCcccCCCCCcccCCcchhhhhhccCC
Q 041143 262 LSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGV 340 (973)
Q Consensus 262 l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 340 (973)
.++|+.|+|++|.+++. ..+..+ +|+.|+|++|.|.+.+|.
T Consensus 231 ~~~L~~L~L~~n~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~------------------------------------ 272 (597)
T 3oja_B 231 NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYH------------------------------------ 272 (597)
T ss_dssp CSCCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESG------------------------------------
T ss_pred CCCCCEEECCCCCCCCC--hhhccCCCCCEEECCCCccCCCCHH------------------------------------
Confidence 14566666666666542 344444 566666666665554443
Q ss_pred CCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCCCccchhhhCccccceEEccCCccccccCccccCcCCCC
Q 041143 341 NYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLR 420 (973)
Q Consensus 341 ~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~ 420 (973)
.+..+++|+.|+|++|.+++ +|..+..+++|+.|+|++|.|+ .+|..+..+++|+
T Consensus 273 -----------------------~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~ 327 (597)
T 3oja_B 273 -----------------------PFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLE 327 (597)
T ss_dssp -----------------------GGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCS
T ss_pred -----------------------HhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCC
Confidence 34567899999999999987 5777888999999999999999 7888899999999
Q ss_pred eeeCCCCcCCCCCC-CCCcccceeecCCccccCCC
Q 041143 421 LLDVSDNNIKPPLP-EFHDTVKLVIDGNPLLVGGI 454 (973)
Q Consensus 421 ~L~Ls~N~l~g~~p-~~~~~~~~~~~~N~~~c~~~ 454 (973)
.|+|++|+|++... .+..+..+++.+|+|.|...
T Consensus 328 ~L~L~~N~l~~~~~~~~~~L~~L~l~~N~~~~~~~ 362 (597)
T 3oja_B 328 NLYLDHNSIVTLKLSTHHTLKNLTLSHNDWDCNSL 362 (597)
T ss_dssp EEECCSSCCCCCCCCTTCCCSEEECCSSCEEHHHH
T ss_pred EEECCCCCCCCcChhhcCCCCEEEeeCCCCCChhH
Confidence 99999999998754 35677889999999998754
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=331.98 Aligned_cols=353 Identities=16% Similarity=0.121 Sum_probs=277.0
Q ss_pred CeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCC-CCCCCCccceeeccCCCCCCCCccccCCCCCccEEEc
Q 041143 67 NRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLAL 145 (973)
Q Consensus 67 ~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~L 145 (973)
.+++.|+|++|.+++..|.+|+++++|++|+|++|.+++..| .|.++++|++|+|++|+++.+++..|.++++|++|+|
T Consensus 56 ~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 135 (606)
T 3vq2_A 56 SELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNV 135 (606)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEEC
T ss_pred ccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeC
Confidence 579999999999999889999999999999999999999877 7999999999999999999999888999999999999
Q ss_pred ccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCC----eEEccCCcCcccCChhhhhhHH------
Q 041143 146 DYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLA----ALKLSYNRLSGVIPASFGQSLM------ 215 (973)
Q Consensus 146 s~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~----~L~Ls~N~l~~~~p~~~~~~~~------ 215 (973)
++|++++. .+|..++++++|++|+|++|++++..+..|+.+++|+ +|++++|++++..+..+....+
T Consensus 136 ~~n~l~~~---~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~ 212 (606)
T 3vq2_A 136 AHNFIHSC---KLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLR 212 (606)
T ss_dssp CSSCCCCC---CCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEE
T ss_pred CCCcccce---echHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcceeCcccccCceeeeeecc
Confidence 99999864 4799999999999999999999988777776655544 5666666665433322210000
Q ss_pred --------------------------------------------------------------------------------
Q 041143 216 -------------------------------------------------------------------------------- 215 (973)
Q Consensus 216 -------------------------------------------------------------------------------- 215 (973)
T Consensus 213 ~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~l~~L~~L~l 292 (606)
T 3vq2_A 213 GNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSL 292 (606)
T ss_dssp SCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGSCGGGTTCSEEEE
T ss_pred CCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccccccCCCCCEEEe
Confidence
Q ss_pred ----------------------------------------------------------HHHhhcccCCCCCCC--cchhh
Q 041143 216 ----------------------------------------------------------QILWLNDQDAGGMTG--PIDVV 235 (973)
Q Consensus 216 ----------------------------------------------------------~~~~l~~~~~~~~~~--~~~~~ 235 (973)
++.+|+...+..... ....+
T Consensus 293 ~~~~~~~l~~l~~~~~L~~L~l~~n~l~~lp~~~l~~L~~L~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~ 372 (606)
T 3vq2_A 293 AGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSD 372 (606)
T ss_dssp ESCCCCCCCCCCTTCCCSEEEEESCCCSSCCCCCCSSCCEEEEESCSSCEECCCCCCTTCCEEECCSSCEEEEEECCHHH
T ss_pred cCccchhhhhccccccCCEEEcccccCcccccCCCCccceeeccCCcCccchhhccCCCCCEEECcCCccCCCcchhhhh
Confidence 000000011111111 14567
Q ss_pred cCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcccccCc-cccccc-ccCeEEccCCcCcCCCCCCCCCCcccc
Q 041143 236 AKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIP-KSLANM-ELDNLVLNNNLLMGPIPKFKAGNVTYD 313 (973)
Q Consensus 236 ~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l-~L~~L~l~~N~l~g~~p~~~~~~~~~~ 313 (973)
..+++|++|+|++|.++ .+|..+..+++|++|++++|++.+..| ..+..+ +|+.|++++|.+.+..|..+...-.+.
T Consensus 373 ~~~~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 451 (606)
T 3vq2_A 373 LGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLN 451 (606)
T ss_dssp HCCSCCCEEECCSCSEE-EECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCC
T ss_pred ccCCcccEeECCCCccc-cchhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCC
Confidence 78899999999999998 477889999999999999999998877 677777 899999999999988887654443444
Q ss_pred cCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCCCccchhhhCcc
Q 041143 314 SNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLD 393 (973)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~ 393 (973)
..++.+........+.....+..+..++++.|.+...+.. .+..+++|+.|+|++|++++.+|..|++++
T Consensus 452 ~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~----------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 521 (606)
T 3vq2_A 452 TLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWG----------VFDTLHRLQLLNMSHNNLLFLDSSHYNQLY 521 (606)
T ss_dssp EEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTT----------TTTTCTTCCEEECCSSCCSCEEGGGTTTCT
T ss_pred EEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChh----------hhcccccCCEEECCCCcCCCcCHHHccCCC
Confidence 3344333221111233444567788888988887765432 356789999999999999999999999999
Q ss_pred ccceEEccCCccccccCccccCcC-CCCeeeCCCCcCCCCCC
Q 041143 394 SLIEIRLGKNSISGTVPNNFTELK-SLRLLDVSDNNIKPPLP 434 (973)
Q Consensus 394 ~L~~L~L~~N~l~g~~p~~~~~l~-~L~~L~Ls~N~l~g~~p 434 (973)
+|+.|+|++|+|+ .+|..+..++ +|++|+|++|++.+..+
T Consensus 522 ~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~ 562 (606)
T 3vq2_A 522 SLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICE 562 (606)
T ss_dssp TCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred cCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCc
Confidence 9999999999999 7888899997 69999999999998766
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-33 Score=335.91 Aligned_cols=340 Identities=20% Similarity=0.257 Sum_probs=270.7
Q ss_pred CCeEEEEEecccCCccc-----------------CCcCcc--cccccceeeccCcccCCCCC-CCCCCCccceeeccCCC
Q 041143 66 GNRVTQIQVQNLGLKGP-----------------LPQNFN--QLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNE 125 (973)
Q Consensus 66 ~~~v~~L~L~~~~l~g~-----------------~~~~~~--~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~ 125 (973)
..+++.|+|++|.++|. +|..++ ++++|++|+|++|++.+.+| .|.++++|++|+|++|+
T Consensus 205 l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~ 284 (636)
T 4eco_A 205 LTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNR 284 (636)
T ss_dssp CTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCT
T ss_pred ccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCC
Confidence 36899999999999996 999999 99999999999999999887 79999999999999998
Q ss_pred -CCC--CCccccCCC------CCccEEEcccCCCCCccCCCCCc--ccccccccCeeecccccccCCcchhccCCCCCCe
Q 041143 126 -FDT--IPSDFFDGL------SSVRVLALDYNPFNKTFGWSIPD--SLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAA 194 (973)
Q Consensus 126 -l~~--i~~~~f~~l------~~L~~L~Ls~N~l~~~~~~~ip~--~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 194 (973)
++. +|. .+..+ ++|++|+|++|+++. +|. .++++++|++|+|++|+++|.+| .|+++++|++
T Consensus 285 ~l~~~~lp~-~~~~L~~~~~l~~L~~L~L~~n~l~~-----ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~ 357 (636)
T 4eco_A 285 GISGEQLKD-DWQALADAPVGEKIQIIYIGYNNLKT-----FPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLAS 357 (636)
T ss_dssp TSCHHHHHH-HHHHHHHSGGGGTCCEEECCSSCCSS-----CCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESE
T ss_pred CCccccchH-HHHhhhccccCCCCCEEECCCCcCCc-----cCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCE
Confidence 885 554 34444 899999999999983 888 89999999999999999998888 8999999999
Q ss_pred EEccCCcCcccCChhhhhhHHH-HHhhcccCCCCCCCcchhhcCC--ccccEEEccCCccccCCCcccc-------CCCC
Q 041143 195 LKLSYNRLSGVIPASFGQSLMQ-ILWLNDQDAGGMTGPIDVVAKM--VSLTQLWLHGNQFTGSIPEDIG-------ALSS 264 (973)
Q Consensus 195 L~Ls~N~l~~~~p~~~~~~~~~-~~~l~~~~~~~~~~~~~~~~~l--~~L~~L~L~~N~l~g~~p~~~~-------~l~~ 264 (973)
|+|++|+++ .+|..+... .. +..|+...+... ..+..+..+ ++|+.|+|++|++++.+|..|. .+++
T Consensus 358 L~L~~N~l~-~lp~~l~~l-~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~ 434 (636)
T 4eco_A 358 LNLAYNQIT-EIPANFCGF-TEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGIN 434 (636)
T ss_dssp EECCSSEEE-ECCTTSEEE-CTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCC
T ss_pred EECCCCccc-cccHhhhhh-cccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCC
Confidence 999999998 888776542 22 444444444433 333455554 4899999999999999998888 8889
Q ss_pred CCEEeCcCCcccccCccccccc-ccCeEEccCCcCcCCCCCCCCCCc--------ccccCcccCCCCCcccCCcchh--h
Q 041143 265 LKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGPIPKFKAGNV--------TYDSNSFCQSEPGIECAPDVNV--L 333 (973)
Q Consensus 265 L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~--~ 333 (973)
|++|+|++|+++...+..+..+ +|+.|+|++|.|+ .+|....... .+...++..+... ..+.... .
T Consensus 435 L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~--~lp~~~~~~~ 511 (636)
T 4eco_A 435 VSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT--KLSDDFRATT 511 (636)
T ss_dssp EEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC--BCCGGGSTTT
T ss_pred CCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCC--ccChhhhhcc
Confidence 9999999999995444445555 7999999999998 6776543322 2333333333222 2333332 5
Q ss_pred hhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEec------CCCcCCCccchhhhCccccceEEccCCcccc
Q 041143 334 LDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINL------PRHNLTGTLSPSIANLDSLIEIRLGKNSISG 407 (973)
Q Consensus 334 ~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~L------s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g 407 (973)
+..+..++++.|.+..+|. .+..+++|+.|+| ++|++.+.+|..++++++|+.|+|++|+| +
T Consensus 512 l~~L~~L~Ls~N~l~~ip~-----------~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~ 579 (636)
T 4eco_A 512 LPYLVGIDLSYNSFSKFPT-----------QPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-R 579 (636)
T ss_dssp CTTCCEEECCSSCCSSCCC-----------GGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-C
T ss_pred CCCcCEEECCCCCCCCcCh-----------hhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-C
Confidence 6678888888888877543 4567899999999 67889999999999999999999999999 6
Q ss_pred ccCccccCcCCCCeeeCCCCcCCCC
Q 041143 408 TVPNNFTELKSLRLLDVSDNNIKPP 432 (973)
Q Consensus 408 ~~p~~~~~l~~L~~L~Ls~N~l~g~ 432 (973)
.+|..+. ++|+.|||++|++...
T Consensus 580 ~ip~~~~--~~L~~L~Ls~N~l~~~ 602 (636)
T 4eco_A 580 KVNEKIT--PNISVLDIKDNPNISI 602 (636)
T ss_dssp BCCSCCC--TTCCEEECCSCTTCEE
T ss_pred ccCHhHh--CcCCEEECcCCCCccc
Confidence 9999877 8999999999987743
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.6e-32 Score=319.47 Aligned_cols=301 Identities=17% Similarity=0.181 Sum_probs=266.9
Q ss_pred CeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCC-CCCCCCccceeeccCCCCCCCCccccCCCCCccEEEc
Q 041143 67 NRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLAL 145 (973)
Q Consensus 67 ~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~L 145 (973)
.+++.|+|++|.+++..|..|.++++|++|+|++|.+++.++ .|.++++|++|+|++|++..+++..|.++++|++|+|
T Consensus 56 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l 135 (477)
T 2id5_A 56 PHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEV 135 (477)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEE
T ss_pred CCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEEC
Confidence 579999999999999999999999999999999999999887 5899999999999999999999999999999999999
Q ss_pred ccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCC
Q 041143 146 DYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDA 225 (973)
Q Consensus 146 s~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~ 225 (973)
++|++++. .+..|.++++|+.|+|++|++++..+..|.++++|+.|+|++|++.+..+..|
T Consensus 136 ~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~--------------- 196 (477)
T 2id5_A 136 GDNDLVYI----SHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSF--------------- 196 (477)
T ss_dssp CCTTCCEE----CTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCS---------------
T ss_pred CCCcccee----ChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhc---------------
Confidence 99999975 67789999999999999999998888889999999999999999997655444
Q ss_pred CCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcccccCccccccc-ccCeEEccCCcCcCCCCC
Q 041143 226 GGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGPIPK 304 (973)
Q Consensus 226 ~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~g~~p~ 304 (973)
..+++|+.|+|++|.+.+.+|..+....+|++|+|++|++++..+..+..+ +|+.|+|++|.|++..+.
T Consensus 197 ----------~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~ 266 (477)
T 2id5_A 197 ----------KRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGS 266 (477)
T ss_dssp ----------CSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTT
T ss_pred ----------ccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChh
Confidence 468999999999999988999888888899999999999997666778887 899999999999854443
Q ss_pred CCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCCCc
Q 041143 305 FKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGT 384 (973)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~ 384 (973)
.+..+++|+.|+|++|++.+.
T Consensus 267 -----------------------------------------------------------~~~~l~~L~~L~L~~n~l~~~ 287 (477)
T 2id5_A 267 -----------------------------------------------------------MLHELLRLQEIQLVGGQLAVV 287 (477)
T ss_dssp -----------------------------------------------------------SCTTCTTCCEEECCSSCCSEE
T ss_pred -----------------------------------------------------------hccccccCCEEECCCCccceE
Confidence 234567899999999999999
Q ss_pred cchhhhCccccceEEccCCccccccCccccCcCCCCeeeCCCCcCCCCCCC--C-CcccceeecCCccccCCCC
Q 041143 385 LSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLPE--F-HDTVKLVIDGNPLLVGGIN 455 (973)
Q Consensus 385 ~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~--~-~~~~~~~~~~N~~~c~~~~ 455 (973)
.|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|++++..+. + .....+.+.++...|..+.
T Consensus 288 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p~ 361 (477)
T 2id5_A 288 EPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATPE 361 (477)
T ss_dssp CTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEESG
T ss_pred CHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccchHhHHhhhhccccCccCceeCCch
Confidence 999999999999999999999987778899999999999999999986542 1 2223356778888887553
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.98 E-value=5.2e-32 Score=308.11 Aligned_cols=309 Identities=20% Similarity=0.214 Sum_probs=232.4
Q ss_pred CeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCC-CCCCCCccceeeccCCCCCCCCccccCCCCCccEEEc
Q 041143 67 NRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLAL 145 (973)
Q Consensus 67 ~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~L 145 (973)
..++.|+++++.++...+..|..+++|++|+|++|.+++..+ .|.++++|++|+|++|+++.+++..|.++++|++|+|
T Consensus 45 ~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 124 (390)
T 3o6n_A 45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 124 (390)
T ss_dssp CCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEEC
Confidence 467889999999986555558999999999999999999887 7999999999999999999999999999999999999
Q ss_pred ccCCCCCccCCCCCcc-cccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccC
Q 041143 146 DYNPFNKTFGWSIPDS-LANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQD 224 (973)
Q Consensus 146 s~N~l~~~~~~~ip~~-~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~ 224 (973)
++|+++. +|.. |.++++|++|+|++|++++..+..|.++++|++|+|++|++++.....+ ..+..+....
T Consensus 125 ~~n~l~~-----l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l----~~L~~L~l~~ 195 (390)
T 3o6n_A 125 ERNDLSS-----LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLI----PSLFHANVSY 195 (390)
T ss_dssp CSSCCCC-----CCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCCGGGC----TTCSEEECCS
T ss_pred CCCccCc-----CCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccccccc----cccceeeccc
Confidence 9999996 5655 6899999999999999998888899999999999999999985422221 1111111111
Q ss_pred CCCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcccccCccccccc-ccCeEEccCCcCcCCCC
Q 041143 225 AGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGPIP 303 (973)
Q Consensus 225 ~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~g~~p 303 (973)
+... .+...++|+.|++++|.++. +|..+ .++|+.|+|++|++++. ..+..+ +|+.|++++|.+++..|
T Consensus 196 n~l~-----~~~~~~~L~~L~l~~n~l~~-~~~~~--~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~ 265 (390)
T 3o6n_A 196 NLLS-----TLAIPIAVEELDASHNSINV-VRGPV--NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMY 265 (390)
T ss_dssp SCCS-----EEECCSSCSEEECCSSCCCE-EECCC--CSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEES
T ss_pred cccc-----ccCCCCcceEEECCCCeeee-ccccc--cccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcCh
Confidence 1111 11223455555555555552 23222 24555555555555542 234443 45555665555554333
Q ss_pred CCCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCCC
Q 041143 304 KFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTG 383 (973)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~ 383 (973)
. .+..+++|+.|+|++|++++
T Consensus 266 ~-----------------------------------------------------------~~~~l~~L~~L~L~~n~l~~ 286 (390)
T 3o6n_A 266 H-----------------------------------------------------------PFVKMQRLERLYISNNRLVA 286 (390)
T ss_dssp G-----------------------------------------------------------GGTTCSSCCEEECCSSCCCE
T ss_pred h-----------------------------------------------------------HccccccCCEEECCCCcCcc
Confidence 2 34567899999999999986
Q ss_pred ccchhhhCccccceEEccCCccccccCccccCcCCCCeeeCCCCcCCCCCC-CCCcccceeecCCccccCCCC
Q 041143 384 TLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLP-EFHDTVKLVIDGNPLLVGGIN 455 (973)
Q Consensus 384 ~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p-~~~~~~~~~~~~N~~~c~~~~ 455 (973)
+|..+..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|+.... .+.++..+++.+|++.|....
T Consensus 287 -~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~L~~L~l~~N~~~~~~~~ 357 (390)
T 3o6n_A 287 -LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLTLSHNDWDCNSLR 357 (390)
T ss_dssp -EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCCCCTTCCCSEEECCSSCEEHHHHH
T ss_pred -cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccceeCchhhccCCEEEcCCCCccchhHH
Confidence 5667788999999999999998 678889999999999999999987643 356778899999999986543
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.4e-32 Score=331.37 Aligned_cols=344 Identities=16% Similarity=0.146 Sum_probs=271.0
Q ss_pred CCcCcccccccceeeccCcccCC------------------CCCCCC--CCCccceeeccCCCCCCCCccccCCCCCccE
Q 041143 83 LPQNFNQLTKLYNLGLQRNKFNG------------------KLPTFS--GLSELEFAYLDFNEFDTIPSDFFDGLSSVRV 142 (973)
Q Consensus 83 ~~~~~~~l~~L~~L~L~~N~l~~------------------~~~~~~--~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~ 142 (973)
+|..|++|++|++|+|++|.|++ +++.+. ++++|++|+|++|++....+..|.++++|++
T Consensus 440 IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~ 519 (876)
T 4ecn_A 440 ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQS 519 (876)
T ss_dssp ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCE
T ss_pred hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCE
Confidence 88899999999999999999999 555666 9999999999999988777788999999999
Q ss_pred EEcccCC-CCC-ccCCCCCccccccc-------ccCeeecccccccCCcch--hccCCCCCCeEEccCCcCcccCChhhh
Q 041143 143 LALDYNP-FNK-TFGWSIPDSLANSV-------QLTNLSLINCNLVGPLPD--FLGTLPSLAALKLSYNRLSGVIPASFG 211 (973)
Q Consensus 143 L~Ls~N~-l~~-~~~~~ip~~~~~l~-------~L~~L~L~~N~l~~~~p~--~l~~l~~L~~L~Ls~N~l~~~~p~~~~ 211 (973)
|+|++|+ +++ . +|..+++++ +|+.|+|++|+|+ .+|. .|+++++|++|+|++|+++ .+| .+.
T Consensus 520 L~Ls~N~~lsg~~----iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~ 592 (876)
T 4ecn_A 520 LNIACNRGISAAQ----LKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFG 592 (876)
T ss_dssp EECTTCTTSCHHH----HHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCC
T ss_pred EECcCCCCccccc----chHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhc
Confidence 9999998 886 4 788888777 9999999999999 8888 9999999999999999999 888 554
Q ss_pred hhHHHHHhhcccCCCCCCCcchhhcCCcc-ccEEEccCCccccCCCccccCCCC--CCEEeCcCCcccccCcccc---cc
Q 041143 212 QSLMQILWLNDQDAGGMTGPIDVVAKMVS-LTQLWLHGNQFTGSIPEDIGALSS--LKDLNLNRNQLVGLIPKSL---AN 285 (973)
Q Consensus 212 ~~~~~~~~l~~~~~~~~~~~~~~~~~l~~-L~~L~L~~N~l~g~~p~~~~~l~~--L~~L~Ls~N~l~~~~p~~~---~~ 285 (973)
. +..+..|....+... ..+..+.++++ |+.|+|++|+|+ .+|..+..++. |+.|+|++|++++.+|... ..
T Consensus 593 ~-L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~ 669 (876)
T 4ecn_A 593 T-NVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDD 669 (876)
T ss_dssp T-TSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTT
T ss_pred C-CCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhcc
Confidence 3 333444444444444 44456888998 999999999999 88988887765 9999999999998776433 22
Q ss_pred ---cccCeEEccCCcCcCCCCCCCC-CCcccccCcccCCCCCcccCCcchh-------hhhhccCCCCCCcccCCCCCCC
Q 041143 286 ---MELDNLVLNNNLLMGPIPKFKA-GNVTYDSNSFCQSEPGIECAPDVNV-------LLDFLGGVNYPVNLVSQWPGND 354 (973)
Q Consensus 286 ---l~L~~L~l~~N~l~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~l~~l~~~~n~~~~~~~~~ 354 (973)
.+|+.|+|++|.|+ .+|..+. ..-.+....+..+... ........ .+..+..++++.|.+..++.
T Consensus 670 ~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~~lp~-- 745 (876)
T 4ecn_A 670 YKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSD-- 745 (876)
T ss_dssp CCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCCCCCG--
T ss_pred ccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCccchH--
Confidence 26999999999998 5664321 1011111222221111 11111111 12378888999998886653
Q ss_pred CCCCCccccccC--CCCcccEEecCCCcCCCccchhhhCccccceEEccC------CccccccCccccCcCCCCeeeCCC
Q 041143 355 PCQGPWLGLSCT--SNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGK------NSISGTVPNNFTELKSLRLLDVSD 426 (973)
Q Consensus 355 ~~~~~~~~~~~~--~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~------N~l~g~~p~~~~~l~~L~~L~Ls~ 426 (973)
.+. .+++|+.|+|++|++++ +|..++++++|+.|+|++ |++.+.+|..|.++++|+.|+|++
T Consensus 746 ---------~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~ 815 (876)
T 4ecn_A 746 ---------DFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGS 815 (876)
T ss_dssp ---------GGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCS
T ss_pred ---------HhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCC
Confidence 233 78899999999999998 799999999999999976 889999999999999999999999
Q ss_pred CcCCCCCCC--CCcccceeecCCcccc
Q 041143 427 NNIKPPLPE--FHDTVKLVIDGNPLLV 451 (973)
Q Consensus 427 N~l~g~~p~--~~~~~~~~~~~N~~~c 451 (973)
|+| +.+|. ..++..+++.+|++..
T Consensus 816 N~L-~~Ip~~l~~~L~~LdLs~N~l~~ 841 (876)
T 4ecn_A 816 NDI-RKVDEKLTPQLYILDIADNPNIS 841 (876)
T ss_dssp SCC-CBCCSCCCSSSCEEECCSCTTCE
T ss_pred CCC-CccCHhhcCCCCEEECCCCCCCc
Confidence 999 67775 3566779999999754
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-31 Score=292.31 Aligned_cols=281 Identities=20% Similarity=0.285 Sum_probs=218.9
Q ss_pred EEEEEecccCCcccCCcCcccccccceeeccCcccCCCCC-CCCCCCccceeeccCCCCCCCCccccCCCCCccEEEccc
Q 041143 69 VTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDY 147 (973)
Q Consensus 69 v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~ 147 (973)
++.+++++++++ .+|..+. ++|++|+|++|+|++.++ .|.++++|++|+|++|+++.+.+..|.++++|++|+|++
T Consensus 33 l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 109 (330)
T 1xku_A 33 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 109 (330)
T ss_dssp TTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCC
Confidence 345566666666 4666554 688999999999998877 688999999999999999999888899999999999999
Q ss_pred CCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcc--cCChhhhhhHHHHHhhcccCC
Q 041143 148 NPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSG--VIPASFGQSLMQILWLNDQDA 225 (973)
Q Consensus 148 N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~--~~p~~~~~~~~~~~~l~~~~~ 225 (973)
|+++. +|..+. ++|++|++++|++++..+..|.++++|++|+|++|+++. ..+..
T Consensus 110 n~l~~-----l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~---------------- 166 (330)
T 1xku_A 110 NQLKE-----LPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGA---------------- 166 (330)
T ss_dssp SCCSB-----CCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTG----------------
T ss_pred CcCCc-----cChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhh----------------
Confidence 99884 666554 689999999999998888889999999999999999863 33433
Q ss_pred CCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcccccCccccccc-ccCeEEccCCcCcCCCCC
Q 041143 226 GGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGPIPK 304 (973)
Q Consensus 226 ~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~g~~p~ 304 (973)
+.++++|++|++++|.++ .+|..+. ++|++|+|++|++++..|..+..+ +|+.|++++|.+++..+.
T Consensus 167 ---------~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~ 234 (330)
T 1xku_A 167 ---------FQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNG 234 (330)
T ss_dssp ---------GGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTT
T ss_pred ---------ccCCCCcCEEECCCCccc-cCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChh
Confidence 346889999999999998 5676654 789999999999998888888887 799999999988765443
Q ss_pred CCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCCCc
Q 041143 305 FKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGT 384 (973)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~ 384 (973)
.+..+++|+.|+|++|+++ .
T Consensus 235 -----------------------------------------------------------~~~~l~~L~~L~L~~N~l~-~ 254 (330)
T 1xku_A 235 -----------------------------------------------------------SLANTPHLRELHLNNNKLV-K 254 (330)
T ss_dssp -----------------------------------------------------------TGGGSTTCCEEECCSSCCS-S
T ss_pred -----------------------------------------------------------hccCCCCCCEEECCCCcCc-c
Confidence 1234567888888888888 7
Q ss_pred cchhhhCccccceEEccCCccccccCccccCc------CCCCeeeCCCCcCCC--CCC-C---CCcccceeecCC
Q 041143 385 LSPSIANLDSLIEIRLGKNSISGTVPNNFTEL------KSLRLLDVSDNNIKP--PLP-E---FHDTVKLVIDGN 447 (973)
Q Consensus 385 ~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l------~~L~~L~Ls~N~l~g--~~p-~---~~~~~~~~~~~N 447 (973)
+|..+..+++|++|+|++|+|++..+..|+.. ..|+.|+|++|.+.. ..| . +..+..+++.+|
T Consensus 255 lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N 329 (330)
T 1xku_A 255 VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329 (330)
T ss_dssp CCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC---
T ss_pred CChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEeccc
Confidence 77788888888888888888887666666543 678888888888863 222 2 344556777766
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.4e-32 Score=298.31 Aligned_cols=276 Identities=16% Similarity=0.219 Sum_probs=167.7
Q ss_pred CCChhHHHHHHHHHhhCC-CCc--cCCCC---CCCCCCCCCCCcCeEEeeC----------CeEEEEEecccCCcccCCc
Q 041143 22 ATDPNDLKILNDFKNGLE-NPE--LLKWP---ANGDDPCGPPPWPHVFCSG----------NRVTQIQVQNLGLKGPLPQ 85 (973)
Q Consensus 22 ~~~~~~~~~l~~~k~~~~-~~~--l~~w~---~~~~d~C~~~~w~gv~C~~----------~~v~~L~L~~~~l~g~~~~ 85 (973)
++..+|..||++||+++. ++. +.+|. ....++|. |.|+.|.. .+|+.|+|++++++ .+|+
T Consensus 23 ~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~---~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~ 98 (328)
T 4fcg_A 23 TALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIET---RTGRALKATADLLEDATQPGRVALELRSVPLP-QFPD 98 (328)
T ss_dssp CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCC---SHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCS
T ss_pred ccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccc---cCCcchhhhHHHHhcccccceeEEEccCCCch-hcCh
Confidence 455689999999999884 432 45673 34577887 99999952 57777788777777 6677
Q ss_pred CcccccccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccc
Q 041143 86 NFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANS 165 (973)
Q Consensus 86 ~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l 165 (973)
.++++++|++|+|++|.|+.++..|.++++|++|+|++|+|+.+|. .|.++++|++|+|++|++.+. +|..+...
T Consensus 99 ~l~~l~~L~~L~L~~n~l~~lp~~~~~l~~L~~L~Ls~n~l~~lp~-~l~~l~~L~~L~L~~n~~~~~----~p~~~~~~ 173 (328)
T 4fcg_A 99 QAFRLSHLQHMTIDAAGLMELPDTMQQFAGLETLTLARNPLRALPA-SIASLNRLRELSIRACPELTE----LPEPLAST 173 (328)
T ss_dssp CGGGGTTCSEEEEESSCCCCCCSCGGGGTTCSEEEEESCCCCCCCG-GGGGCTTCCEEEEEEETTCCC----CCSCSEEE
T ss_pred hhhhCCCCCEEECCCCCccchhHHHhccCCCCEEECCCCccccCcH-HHhcCcCCCEEECCCCCCccc----cChhHhhc
Confidence 7777777777777777777433356666666666666666665433 245555555555555544442 44333220
Q ss_pred cccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEE
Q 041143 166 VQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLW 245 (973)
Q Consensus 166 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~ 245 (973)
..+..|.++++|++|+|++|+++ .+|..+. ++++|++|+
T Consensus 174 ---------------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~-------------------------~l~~L~~L~ 212 (328)
T 4fcg_A 174 ---------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIA-------------------------NLQNLKSLK 212 (328)
T ss_dssp ---------------C-CCCEEESTTCCEEEEEEECCC-CCCGGGG-------------------------GCTTCCEEE
T ss_pred ---------------cchhhhccCCCCCEEECcCCCcC-cchHhhc-------------------------CCCCCCEEE
Confidence 00112333555555555555555 4444432 355555555
Q ss_pred ccCCccccCCCccccCCCCCCEEeCcCCcccccCcccccccccCeEEccCCcCcCCCCCCCCCCcccccCcccCCCCCcc
Q 041143 246 LHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIE 325 (973)
Q Consensus 246 L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~ 325 (973)
|++|+++ .+|..+..+++|++|+|++|++.+.+|..+..
T Consensus 213 L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~---------------------------------------- 251 (328)
T 4fcg_A 213 IRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGG---------------------------------------- 251 (328)
T ss_dssp EESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTC----------------------------------------
T ss_pred ccCCCCC-cCchhhccCCCCCEEECcCCcchhhhHHHhcC----------------------------------------
Confidence 5555555 34445555555555555555555544444333
Q ss_pred cCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCCCccchhhhCccccceEEccCCcc
Q 041143 326 CAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSI 405 (973)
Q Consensus 326 ~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 405 (973)
+++|+.|+|++|++.+.+|..++++++|+.|+|++|++
T Consensus 252 ------------------------------------------l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~ 289 (328)
T 4fcg_A 252 ------------------------------------------RAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVN 289 (328)
T ss_dssp ------------------------------------------CCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTT
T ss_pred ------------------------------------------CCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCc
Confidence 34555555555555566666667777777777777777
Q ss_pred ccccCccccCcCCCCeeeCCCCcCC
Q 041143 406 SGTVPNNFTELKSLRLLDVSDNNIK 430 (973)
Q Consensus 406 ~g~~p~~~~~l~~L~~L~Ls~N~l~ 430 (973)
.+.+|..+.++++|+.++++.|.+.
T Consensus 290 ~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 290 LSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp CCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred hhhccHHHhhccCceEEeCCHHHHH
Confidence 7777777777777777777766554
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=318.19 Aligned_cols=321 Identities=20% Similarity=0.239 Sum_probs=243.0
Q ss_pred eeCCeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCC-ccccCCCCCccE
Q 041143 64 CSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIP-SDFFDGLSSVRV 142 (973)
Q Consensus 64 C~~~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~-~~~f~~l~~L~~ 142 (973)
+...+++.|+|++|.+++..|..|+++++|++|+|++|+|+.+++. .+++|++|+|++|+|+.++ +..|.++++|++
T Consensus 42 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~ 119 (520)
T 2z7x_B 42 LSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKF 119 (520)
T ss_dssp TTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCEEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCE
T ss_pred cccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceeecCcc--ccCCccEEeccCCccccccchhhhccCCcceE
Confidence 3446899999999999999899999999999999999999965445 8999999999999999875 578999999999
Q ss_pred EEcccCCCCCccCCCCCccccccccc--Ceeecccccc--cCCcchhccCCC----------------------------
Q 041143 143 LALDYNPFNKTFGWSIPDSLANSVQL--TNLSLINCNL--VGPLPDFLGTLP---------------------------- 190 (973)
Q Consensus 143 L~Ls~N~l~~~~~~~ip~~~~~l~~L--~~L~L~~N~l--~~~~p~~l~~l~---------------------------- 190 (973)
|+|++|++++. .+..+++| +.|+|++|.+ .+..|..+..+.
T Consensus 120 L~L~~n~l~~~-------~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L 192 (520)
T 2z7x_B 120 LGLSTTHLEKS-------SVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANL 192 (520)
T ss_dssp EEEEESSCCGG-------GGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEE
T ss_pred EEecCcccchh-------hccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccce
Confidence 99999998752 44555555 6666666666 445554444422
Q ss_pred -------------------------------------------------------CCCeEEccCCcCcccCChhhh----
Q 041143 191 -------------------------------------------------------SLAALKLSYNRLSGVIPASFG---- 211 (973)
Q Consensus 191 -------------------------------------------------------~L~~L~Ls~N~l~~~~p~~~~---- 211 (973)
+|++|+|++|+++|.+|..+.
T Consensus 193 ~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~ 272 (520)
T 2z7x_B 193 ELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSG 272 (520)
T ss_dssp EECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCS
T ss_pred eeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhccc
Confidence 566666666666655555441
Q ss_pred -h----------------------hH---HHHHhhcccCCCCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCC
Q 041143 212 -Q----------------------SL---MQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSL 265 (973)
Q Consensus 212 -~----------------------~~---~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L 265 (973)
. .. .++..|....+..... ..+..+++|++|+|++|++++.+|..+..+++|
T Consensus 273 ~~l~~L~~l~l~~n~~~~p~~~~~~~~~~~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L 350 (520)
T 2z7x_B 273 TSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHM--LCPSKISPFLHLDFSNNLLTDTVFENCGHLTEL 350 (520)
T ss_dssp CCCCEEEEEEEEECCCCSCTHHHHHHHHTCCCSEEEEESSCCCCC--CCCSSCCCCCEEECCSSCCCTTTTTTCCCCSSC
T ss_pred ccCceeEeccccccceecchhhhhcccccCceeEEEcCCCccccc--cchhhCCcccEEEeECCccChhhhhhhccCCCC
Confidence 0 00 0122222222222211 112678999999999999998899999999999
Q ss_pred CEEeCcCCcccc--cCccccccc-ccCeEEccCCcCcCCCCCCCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCC
Q 041143 266 KDLNLNRNQLVG--LIPKSLANM-ELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNY 342 (973)
Q Consensus 266 ~~L~Ls~N~l~~--~~p~~~~~l-~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 342 (973)
++|+|++|++++ .+|..+..+ +|+.|++++|.+++.+|..... .+..+..+++
T Consensus 351 ~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~------------------------~l~~L~~L~L 406 (520)
T 2z7x_B 351 ETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCS------------------------WTKSLLSLNM 406 (520)
T ss_dssp CEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCC------------------------CCTTCCEEEC
T ss_pred CEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhc------------------------cCccCCEEEC
Confidence 999999999997 556778887 8999999999999877753111 1234556667
Q ss_pred CCcccCCCCCCCCCCCCccccccCCC-CcccEEecCCCcCCCccchhhhCccccceEEccCCccccccCcc-ccCcCCCC
Q 041143 343 PVNLVSQWPGNDPCQGPWLGLSCTSN-SKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNN-FTELKSLR 420 (973)
Q Consensus 343 ~~n~~~~~~~~~~~~~~~~~~~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~-~~~l~~L~ 420 (973)
+.|.+.... +..+ ++|+.|+|++|+++ .+|..+..+++|+.|+|++|+|+ .+|.. |..+++|+
T Consensus 407 s~N~l~~~~-------------~~~l~~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~ 471 (520)
T 2z7x_B 407 SSNILTDTI-------------FRCLPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQ 471 (520)
T ss_dssp CSSCCCGGG-------------GGSCCTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCC
T ss_pred cCCCCCcch-------------hhhhcccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCccc
Confidence 666654211 1112 68999999999999 88888889999999999999999 57765 99999999
Q ss_pred eeeCCCCcCCCCCC
Q 041143 421 LLDVSDNNIKPPLP 434 (973)
Q Consensus 421 ~L~Ls~N~l~g~~p 434 (973)
+|+|++|++++..+
T Consensus 472 ~L~l~~N~~~c~c~ 485 (520)
T 2z7x_B 472 KIWLHTNPWDCSCP 485 (520)
T ss_dssp EEECCSSCBCCCHH
T ss_pred EEECcCCCCcccCC
Confidence 99999999998765
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.6e-31 Score=292.02 Aligned_cols=281 Identities=21% Similarity=0.311 Sum_probs=210.0
Q ss_pred EEEEEecccCCcccCCcCcccccccceeeccCcccCCCCC-CCCCCCccceeeccCCCCCCCCccccCCCCCccEEEccc
Q 041143 69 VTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDY 147 (973)
Q Consensus 69 v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~ 147 (973)
++.+++++++++ .+|..+. ++|++|+|++|.+++.++ .|.++++|++|+|++|+|+.+++..|.++++|++|+|++
T Consensus 35 l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 111 (332)
T 2ft3_A 35 LRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISK 111 (332)
T ss_dssp TTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCS
T ss_pred CCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCC
Confidence 445666777776 5676664 688999999999988877 688899999999999999998888899999999999999
Q ss_pred CCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcc--cCChhhhhhHHHHHhhcccCC
Q 041143 148 NPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSG--VIPASFGQSLMQILWLNDQDA 225 (973)
Q Consensus 148 N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~--~~p~~~~~~~~~~~~l~~~~~ 225 (973)
|+++. +|..+. ++|++|+|++|++++..+..|.++++|++|+|++|+++. ..|..+
T Consensus 112 n~l~~-----l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~--------------- 169 (332)
T 2ft3_A 112 NHLVE-----IPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAF--------------- 169 (332)
T ss_dssp SCCCS-----CCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSS---------------
T ss_pred CcCCc-----cCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccc---------------
Confidence 99884 666655 789999999999987777788999999999999999863 444433
Q ss_pred CCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcccccCccccccc-ccCeEEccCCcCcCCCCC
Q 041143 226 GGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGPIPK 304 (973)
Q Consensus 226 ~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~g~~p~ 304 (973)
..+ +|++|++++|+++ .+|..+. ++|++|+|++|++++..+..+..+ +|+.|++++|.+++..|.
T Consensus 170 ----------~~l-~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~ 235 (332)
T 2ft3_A 170 ----------DGL-KLNYLRISEAKLT-GIPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENG 235 (332)
T ss_dssp ----------CSC-CCSCCBCCSSBCS-SCCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTT
T ss_pred ----------cCC-ccCEEECcCCCCC-ccCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChh
Confidence 345 7888888888888 4666554 688888888888887777777777 788888888888764443
Q ss_pred CCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCCCc
Q 041143 305 FKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGT 384 (973)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~ 384 (973)
.+..+++|+.|+|++|+++ .
T Consensus 236 -----------------------------------------------------------~~~~l~~L~~L~L~~N~l~-~ 255 (332)
T 2ft3_A 236 -----------------------------------------------------------SLSFLPTLRELHLDNNKLS-R 255 (332)
T ss_dssp -----------------------------------------------------------GGGGCTTCCEEECCSSCCC-B
T ss_pred -----------------------------------------------------------HhhCCCCCCEEECCCCcCe-e
Confidence 1234567788888888887 6
Q ss_pred cchhhhCccccceEEccCCccccccCccccCc------CCCCeeeCCCCcCC--CCCCC----CCcccceeecCCc
Q 041143 385 LSPSIANLDSLIEIRLGKNSISGTVPNNFTEL------KSLRLLDVSDNNIK--PPLPE----FHDTVKLVIDGNP 448 (973)
Q Consensus 385 ~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l------~~L~~L~Ls~N~l~--g~~p~----~~~~~~~~~~~N~ 448 (973)
+|..+..+++|+.|+|++|+|++..+..|..+ ..|+.|+|++|.+. +..|. +..+..+.+.+|.
T Consensus 256 lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 256 VPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp CCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred cChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 77778888888888888888876666666553 56778888888776 33332 3344556666653
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-31 Score=318.57 Aligned_cols=355 Identities=17% Similarity=0.137 Sum_probs=261.3
Q ss_pred CeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCC-CCCCCCccceeeccCCCCCCCCccccCCCCCccEEEc
Q 041143 67 NRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLAL 145 (973)
Q Consensus 67 ~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~L 145 (973)
.+++.|+|++|++++..+..|+++++|++|+|++|.+++.+| .|.++++|++|+|++|+++.++...|.++++|++|+|
T Consensus 52 ~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 131 (570)
T 2z63_A 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131 (570)
T ss_dssp SSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEEC
T ss_pred CCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccccccccccCCCccccccccccEEec
Confidence 579999999999999888899999999999999999999887 7999999999999999999999988999999999999
Q ss_pred ccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCC----CeEEccCCcCcccCChhhhhhH-------
Q 041143 146 DYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSL----AALKLSYNRLSGVIPASFGQSL------- 214 (973)
Q Consensus 146 s~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L----~~L~Ls~N~l~~~~p~~~~~~~------- 214 (973)
++|++++. .+|..++++++|++|++++|++++..+..++.+++| +.|++++|.+++..|..+....
T Consensus 132 ~~n~l~~~---~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~~L~~L~l~ 208 (570)
T 2z63_A 132 AHNLIQSF---KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLR 208 (570)
T ss_dssp CSSCCCCC---CCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEE
T ss_pred CCCcccee---cChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCCceecCHHHhccCcceeEecc
Confidence 99999864 478999999999999999999998888888888888 8889999888766554432100
Q ss_pred -------------------------------------------------------------------------HHHHhhc
Q 041143 215 -------------------------------------------------------------------------MQILWLN 221 (973)
Q Consensus 215 -------------------------------------------------------------------------~~~~~l~ 221 (973)
..+..+.
T Consensus 209 ~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~ 288 (570)
T 2z63_A 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFS 288 (570)
T ss_dssp SCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEE
T ss_pred cccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEE
Confidence 0000111
Q ss_pred ccCCCCCCCcchhh------------------------------------------cCCccccEEEccCCccccCC--Cc
Q 041143 222 DQDAGGMTGPIDVV------------------------------------------AKMVSLTQLWLHGNQFTGSI--PE 257 (973)
Q Consensus 222 ~~~~~~~~~~~~~~------------------------------------------~~l~~L~~L~L~~N~l~g~~--p~ 257 (973)
...+... ..+..+ ..+++|++|+|++|++++.. |.
T Consensus 289 l~~~~l~-~l~~~~~~~~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~ 367 (570)
T 2z63_A 289 LVSVTIE-RVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQ 367 (570)
T ss_dssp EESCEEC-SCCBCCSCCCCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCCCBCTTCCEEECCSSCCBEEEEEEH
T ss_pred ecCccch-hhhhhhccCCccEEeeccCcccccCcccccccCEEeCcCCccccccccccCCCCCEEeCcCCccCccccccc
Confidence 1111100 000111 34566777777777776443 56
Q ss_pred cccCCCCCCEEeCcCCcccccCccccccc-ccCeEEccCCcCcCCCCCC-CCCCcccccCcccCCCCCcccCCcchhhhh
Q 041143 258 DIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGPIPKF-KAGNVTYDSNSFCQSEPGIECAPDVNVLLD 335 (973)
Q Consensus 258 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (973)
.+..+++|++|+|++|.+.+..+. +..+ +|+.|++++|.+.+..|.. +...-.+...++..... ....+.....+.
T Consensus 368 ~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l-~~~~~~~~~~l~ 445 (570)
T 2z63_A 368 SDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT-RVAFNGIFNGLS 445 (570)
T ss_dssp HHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCC-EECCTTTTTTCT
T ss_pred cccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcc-cccchhhhhcCC
Confidence 677777777777777777765444 6665 6888888888877765532 11111111122221111 011112223345
Q ss_pred hccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCCCccchhhhCccccceEEccCCccccccCccccC
Q 041143 336 FLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTE 415 (973)
Q Consensus 336 ~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~ 415 (973)
.+..+++..|.+... .....+..+++|++|+|++|++++..|..|.++++|+.|+|++|+|++..|..|..
T Consensus 446 ~L~~L~l~~n~l~~~---------~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 516 (570)
T 2z63_A 446 SLEVLKMAGNSFQEN---------FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDR 516 (570)
T ss_dssp TCCEEECTTCEEGGG---------EECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTT
T ss_pred cCcEEECcCCcCccc---------cchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhc
Confidence 566667777665420 11124567899999999999999999999999999999999999999988889999
Q ss_pred cCCCCeeeCCCCcCCCCCCCC
Q 041143 416 LKSLRLLDVSDNNIKPPLPEF 436 (973)
Q Consensus 416 l~~L~~L~Ls~N~l~g~~p~~ 436 (973)
+++|+.|+|++|++++..|..
T Consensus 517 l~~L~~L~l~~N~~~~~~~~~ 537 (570)
T 2z63_A 517 LTSLQKIWLHTNPWDCSCPRI 537 (570)
T ss_dssp CTTCCEEECCSSCBCCCTTTT
T ss_pred ccCCcEEEecCCcccCCCcch
Confidence 999999999999999998864
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-31 Score=316.66 Aligned_cols=345 Identities=19% Similarity=0.222 Sum_probs=256.4
Q ss_pred CCeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCCC-CCCCCccceeeccCCCCCCCC-ccccCCCCCccEE
Q 041143 66 GNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPT-FSGLSELEFAYLDFNEFDTIP-SDFFDGLSSVRVL 143 (973)
Q Consensus 66 ~~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~L~~N~l~~i~-~~~f~~l~~L~~L 143 (973)
..++++|+|++|.+++..|.+|+++++|++|+|++|.+++.++. |.++++|++|+|++|+++.++ +..|.++++|++|
T Consensus 49 l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L 128 (549)
T 2z81_A 49 CANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTL 128 (549)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEE
T ss_pred CCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEE
Confidence 35799999999999988888999999999999999999998884 899999999999999998764 4578899999999
Q ss_pred EcccCCCCCccCCCCC-cccccccccCeeecccccccCCcchhccC------------------------CCCCCeEEcc
Q 041143 144 ALDYNPFNKTFGWSIP-DSLANSVQLTNLSLINCNLVGPLPDFLGT------------------------LPSLAALKLS 198 (973)
Q Consensus 144 ~Ls~N~l~~~~~~~ip-~~~~~l~~L~~L~L~~N~l~~~~p~~l~~------------------------l~~L~~L~Ls 198 (973)
+|++|++.+. +| ..+.++++|++|+|++|++++..|..+++ +++|++|+|+
T Consensus 129 ~L~~n~~~~~----~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~ 204 (549)
T 2z81_A 129 RIGNVETFSE----IRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELR 204 (549)
T ss_dssp EEEESSSCCE----ECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEE
T ss_pred ECCCCccccc----cCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEcc
Confidence 9999985442 44 57888889999999999888877776654 5667777777
Q ss_pred CCcCcccC--Chhh-------------------------hhh--------------------------------------
Q 041143 199 YNRLSGVI--PASF-------------------------GQS-------------------------------------- 213 (973)
Q Consensus 199 ~N~l~~~~--p~~~-------------------------~~~-------------------------------------- 213 (973)
+|++++.. |..+ ...
T Consensus 205 ~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~ 284 (549)
T 2z81_A 205 DTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVE 284 (549)
T ss_dssp SCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCC
T ss_pred CCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccc
Confidence 77776531 1000 000
Q ss_pred ------------------------HHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCccccCCCc---cccCCCCCC
Q 041143 214 ------------------------LMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPE---DIGALSSLK 266 (973)
Q Consensus 214 ------------------------~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~---~~~~l~~L~ 266 (973)
..++..+....+.....+...+.++++|++|+|++|++++.+|. .++.+++|+
T Consensus 285 ~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~ 364 (549)
T 2z81_A 285 TVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQ 364 (549)
T ss_dssp EEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCCCCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCC
T ss_pred cccccccccchhhhcccchhhhhhcccceEEEeccCccccCCHHHHhcCccccEEEccCCccccccccchhhhhccccCc
Confidence 00011111112222223334446799999999999999987753 478899999
Q ss_pred EEeCcCCcccccCc--cccccc-ccCeEEccCCcCcCCCCCCCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCC
Q 041143 267 DLNLNRNQLVGLIP--KSLANM-ELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYP 343 (973)
Q Consensus 267 ~L~Ls~N~l~~~~p--~~~~~l-~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 343 (973)
+|+|++|++++..+ ..+..+ +|+.|++++|+|+ .+|..+...-.+...++.++. +...+. .....+..++++
T Consensus 365 ~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~--l~~l~~--~~~~~L~~L~Ls 439 (549)
T 2z81_A 365 TLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTG--IRVVKT--CIPQTLEVLDVS 439 (549)
T ss_dssp EEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSC--CSCCCT--TSCTTCSEEECC
T ss_pred EEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCC--cccccc--hhcCCceEEECC
Confidence 99999999987543 456776 7999999999998 567644332222222332222 111111 112467888899
Q ss_pred CcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCCCccchhhhCccccceEEccCCccccccCccccCcCCCCeee
Q 041143 344 VNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLD 423 (973)
Q Consensus 344 ~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 423 (973)
.|.+..++ ..+++|++|+|++|+++ .+|. ...+++|+.|+|++|+|++.+|..|..+++|+.|+
T Consensus 440 ~N~l~~~~--------------~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 503 (549)
T 2z81_A 440 NNNLDSFS--------------LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIW 503 (549)
T ss_dssp SSCCSCCC--------------CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEE
T ss_pred CCChhhhc--------------ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEE
Confidence 99887753 35789999999999998 6676 57899999999999999999999999999999999
Q ss_pred CCCCcCCCCCCC
Q 041143 424 VSDNNIKPPLPE 435 (973)
Q Consensus 424 Ls~N~l~g~~p~ 435 (973)
|++|++++..|.
T Consensus 504 l~~N~~~~~~~~ 515 (549)
T 2z81_A 504 LHTNPWDCSCPR 515 (549)
T ss_dssp CCSSCBCCCHHH
T ss_pred ecCCCccCCCcc
Confidence 999999998874
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.1e-31 Score=315.36 Aligned_cols=305 Identities=20% Similarity=0.253 Sum_probs=255.2
Q ss_pred CeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCC-CCCCCCccceeeccCCCCCCCCccccCCCCCccEEEc
Q 041143 67 NRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLAL 145 (973)
Q Consensus 67 ~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~L 145 (973)
..++.|+|++|.+++..+..|+++++|++|+|++|.|++.+| .|.++++|++|+|++|.|+.+++..|.++++|++|+|
T Consensus 75 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 154 (597)
T 3oja_B 75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 154 (597)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEe
Confidence 579999999999999888899999999999999999999888 5899999999999999999999999999999999999
Q ss_pred ccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccC-ChhhhhhHHHHHhhcccC
Q 041143 146 DYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVI-PASFGQSLMQILWLNDQD 224 (973)
Q Consensus 146 s~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~-p~~~~~~~~~~~~l~~~~ 224 (973)
++|.+++. .|..|.++++|++|+|++|.|++.. ++.+++|+.|++++|.+++.. |.. + ..|....
T Consensus 155 s~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~l~~~~~-----L--~~L~ls~ 220 (597)
T 3oja_B 155 SNNNLERI----EDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLSTLAIPIA-----V--EELDASH 220 (597)
T ss_dssp CSSCCCBC----CTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCSEEECCTT-----C--SEEECCS
T ss_pred eCCcCCCC----ChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCccccccCCch-----h--heeeccC
Confidence 99999985 6778999999999999999999653 667899999999999998632 221 2 2233333
Q ss_pred CCCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcccccCccccccc-ccCeEEccCCcCcCCCC
Q 041143 225 AGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGPIP 303 (973)
Q Consensus 225 ~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~g~~p 303 (973)
+.....+.. ..++|+.|+|++|.+++ +..+..+++|+.|+|++|.+++.+|..|..+ +|+.|+|++|.|++. |
T Consensus 221 n~l~~~~~~---~~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l-~ 294 (597)
T 3oja_B 221 NSINVVRGP---VNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVAL-N 294 (597)
T ss_dssp SCCCEEECS---CCSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCEE-E
T ss_pred Ccccccccc---cCCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCCC-C
Confidence 332222211 24689999999999996 4789999999999999999999999999988 899999999999852 3
Q ss_pred CCCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCCC
Q 041143 304 KFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTG 383 (973)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~ 383 (973)
. .+..+++|+.|+|++|.+.
T Consensus 295 ~-----------------------------------------------------------~~~~l~~L~~L~Ls~N~l~- 314 (597)
T 3oja_B 295 L-----------------------------------------------------------YGQPIPTLKVLDLSHNHLL- 314 (597)
T ss_dssp C-----------------------------------------------------------SSSCCTTCCEEECCSSCCC-
T ss_pred c-----------------------------------------------------------ccccCCCCcEEECCCCCCC-
Confidence 2 1234678999999999999
Q ss_pred ccchhhhCccccceEEccCCccccccCccccCcCCCCeeeCCCCcCCCCCC--CCCcccceeecCCccccCCC
Q 041143 384 TLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLP--EFHDTVKLVIDGNPLLVGGI 454 (973)
Q Consensus 384 ~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p--~~~~~~~~~~~~N~~~c~~~ 454 (973)
.+|..++.+++|+.|+|++|+|++. | +..+++|+.|+|++|++++... .+..+....+.+|+..|+..
T Consensus 315 ~i~~~~~~l~~L~~L~L~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~C~~~ 384 (597)
T 3oja_B 315 HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKID 384 (597)
T ss_dssp CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHHHHTTTCCTTTBCCCCCCCCTT
T ss_pred ccCcccccCCCCCEEECCCCCCCCc-C--hhhcCCCCEEEeeCCCCCChhHHHHHHHHhhhccccccccCCcc
Confidence 6788899999999999999999854 3 7888999999999999987533 23444555677888888754
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-30 Score=293.75 Aligned_cols=304 Identities=21% Similarity=0.270 Sum_probs=251.8
Q ss_pred CeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCC-CCCCCCccceeeccCCCCCCCCccccCCCCCccEEEc
Q 041143 67 NRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLAL 145 (973)
Q Consensus 67 ~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~L 145 (973)
.+++.|+|++|.+++..+..|.++++|++|+|++|.+++.+| .|.++++|++|+|++|+|+.+++..|.++++|++|+|
T Consensus 69 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 148 (390)
T 3o6n_A 69 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 148 (390)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred ccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEEC
Confidence 579999999999998888899999999999999999999888 5899999999999999999999999999999999999
Q ss_pred ccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCccc-CChhhhhhHHHHHhhcccC
Q 041143 146 DYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGV-IPASFGQSLMQILWLNDQD 224 (973)
Q Consensus 146 s~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~-~p~~~~~~~~~~~~l~~~~ 224 (973)
++|++++. .|..+..+++|++|+|++|++++. .+..+++|++|++++|.+++. .|.. +..|....
T Consensus 149 ~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~~~~~~~-------L~~L~l~~ 214 (390)
T 3o6n_A 149 SNNNLERI----EDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLSTLAIPIA-------VEELDASH 214 (390)
T ss_dssp CSSCCCBC----CTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSEEECCSS-------CSEEECCS
T ss_pred CCCccCcc----ChhhccCCCCCCEEECCCCcCCcc---ccccccccceeecccccccccCCCCc-------ceEEECCC
Confidence 99999974 567799999999999999999964 367789999999999999853 2221 22233333
Q ss_pred CCCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcccccCccccccc-ccCeEEccCCcCcCCCC
Q 041143 225 AGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGPIP 303 (973)
Q Consensus 225 ~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~g~~p 303 (973)
+.....+. ...++|+.|+|++|++++. ..+..+++|++|+|++|.+++..|..|..+ +|+.|+|++|++++. |
T Consensus 215 n~l~~~~~---~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~ 288 (390)
T 3o6n_A 215 NSINVVRG---PVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVAL-N 288 (390)
T ss_dssp SCCCEEEC---CCCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCEE-E
T ss_pred Ceeeeccc---cccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCccc-C
Confidence 33322222 2357999999999999964 589999999999999999999989999888 899999999999752 2
Q ss_pred CCCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCCC
Q 041143 304 KFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTG 383 (973)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~ 383 (973)
. ....+++|+.|+|++|++.
T Consensus 289 ~-----------------------------------------------------------~~~~l~~L~~L~L~~n~l~- 308 (390)
T 3o6n_A 289 L-----------------------------------------------------------YGQPIPTLKVLDLSHNHLL- 308 (390)
T ss_dssp C-----------------------------------------------------------SSSCCTTCCEEECCSSCCC-
T ss_pred c-----------------------------------------------------------ccCCCCCCCEEECCCCcce-
Confidence 1 1234678999999999998
Q ss_pred ccchhhhCccccceEEccCCccccccCccccCcCCCCeeeCCCCcCCCCCC--CCCcccceeecCCccccCC
Q 041143 384 TLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLP--EFHDTVKLVIDGNPLLVGG 453 (973)
Q Consensus 384 ~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p--~~~~~~~~~~~~N~~~c~~ 453 (973)
.+|..+..+++|+.|+|++|+|+. +| +..+++|+.|+|++|++++.-. .+..+....+.+++..|..
T Consensus 309 ~~~~~~~~l~~L~~L~L~~N~i~~-~~--~~~~~~L~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~c~~ 377 (390)
T 3o6n_A 309 HVERNQPQFDRLENLYLDHNSIVT-LK--LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKI 377 (390)
T ss_dssp CCGGGHHHHTTCSEEECCSSCCCC-CC--CCTTCCCSEEECCSSCEEHHHHHHHTTTCCTTTBCCCCSCCCT
T ss_pred ecCccccccCcCCEEECCCCccce-eC--chhhccCCEEEcCCCCccchhHHHHHHHHHhhcccccCceecc
Confidence 567778999999999999999984 44 7889999999999999987532 1344445556777777763
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-29 Score=280.60 Aligned_cols=290 Identities=22% Similarity=0.272 Sum_probs=240.8
Q ss_pred cCCCCCCCCCCCCCCCcCeEEeeC-----------CeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCC-CC
Q 041143 43 LLKWPANGDDPCGPPPWPHVFCSG-----------NRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TF 110 (973)
Q Consensus 43 l~~w~~~~~d~C~~~~w~gv~C~~-----------~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~ 110 (973)
...|....+..|. |.|..+.|+. ..++.|+|++|++++..+..|+++++|++|+|++|.+++..| .|
T Consensus 18 i~~~~~~cp~~c~-c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 96 (330)
T 1xku_A 18 IEPMGPVCPFRCQ-CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAF 96 (330)
T ss_dssp ----CCCCCTTCE-EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTT
T ss_pred cccccCCCCCCCc-CCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHh
Confidence 4456444444453 4599999974 367889999999998888889999999999999999999866 79
Q ss_pred CCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeeecccccccC--CcchhccC
Q 041143 111 SGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVG--PLPDFLGT 188 (973)
Q Consensus 111 ~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~--~~p~~l~~ 188 (973)
.++++|++|+|++|+|+.++...+ ++|++|+|++|++++. .+..+.++++|+.|+|++|.+.. ..+..|.+
T Consensus 97 ~~l~~L~~L~Ls~n~l~~l~~~~~---~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~ 169 (330)
T 1xku_A 97 APLVKLERLYLSKNQLKELPEKMP---KTLQELRVHENEITKV----RKSVFNGLNQMIVVELGTNPLKSSGIENGAFQG 169 (330)
T ss_dssp TTCTTCCEEECCSSCCSBCCSSCC---TTCCEEECCSSCCCBB----CHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGG
T ss_pred cCCCCCCEEECCCCcCCccChhhc---ccccEEECCCCccccc----CHhHhcCCccccEEECCCCcCCccCcChhhccC
Confidence 999999999999999999988765 7899999999999974 45568899999999999999963 77888999
Q ss_pred CCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEE
Q 041143 189 LPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDL 268 (973)
Q Consensus 189 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L 268 (973)
+++|++|++++|+++ .+|..+ .++|++|+|++|++++..|..|..+++|++|
T Consensus 170 l~~L~~L~l~~n~l~-~l~~~~---------------------------~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 221 (330)
T 1xku_A 170 MKKLSYIRIADTNIT-TIPQGL---------------------------PPSLTELHLDGNKITKVDAASLKGLNNLAKL 221 (330)
T ss_dssp CTTCCEEECCSSCCC-SCCSSC---------------------------CTTCSEEECTTSCCCEECTGGGTTCTTCCEE
T ss_pred CCCcCEEECCCCccc-cCCccc---------------------------cccCCEEECCCCcCCccCHHHhcCCCCCCEE
Confidence 999999999999998 456543 3789999999999998888999999999999
Q ss_pred eCcCCcccccCccccccc-ccCeEEccCCcCcCCCCCCCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCccc
Q 041143 269 NLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLV 347 (973)
Q Consensus 269 ~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~ 347 (973)
+|++|++++..+..+..+ +|+.|+|++|.++ .+|.
T Consensus 222 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~------------------------------------------- 257 (330)
T 1xku_A 222 GLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPG------------------------------------------- 257 (330)
T ss_dssp ECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCT-------------------------------------------
T ss_pred ECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCCh-------------------------------------------
Confidence 999999998888888887 8999999999987 4554
Q ss_pred CCCCCCCCCCCCccccccCCCCcccEEecCCCcCCCccchhhhCc------cccceEEccCCcccc--ccCccccCcCCC
Q 041143 348 SQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANL------DSLIEIRLGKNSISG--TVPNNFTELKSL 419 (973)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l------~~L~~L~L~~N~l~g--~~p~~~~~l~~L 419 (973)
.+..+++|++|+|++|++++..+..|... ..|+.|+|++|.+.. ..|..|..+.+|
T Consensus 258 ----------------~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l 321 (330)
T 1xku_A 258 ----------------GLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVR 321 (330)
T ss_dssp ----------------TTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCG
T ss_pred ----------------hhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccce
Confidence 12456789999999999999888877643 778999999999863 566789999999
Q ss_pred CeeeCCCCc
Q 041143 420 RLLDVSDNN 428 (973)
Q Consensus 420 ~~L~Ls~N~ 428 (973)
+.++|++|+
T Consensus 322 ~~l~L~~N~ 330 (330)
T 1xku_A 322 AAVQLGNYK 330 (330)
T ss_dssp GGEEC----
T ss_pred eEEEecccC
Confidence 999999985
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-30 Score=308.46 Aligned_cols=357 Identities=16% Similarity=0.144 Sum_probs=221.9
Q ss_pred EEEEecccCCcccCCcCcccccccceeeccCcccCCCCC-CCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccC
Q 041143 70 TQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYN 148 (973)
Q Consensus 70 ~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N 148 (973)
+.++++++++++ +|..+. ++|++|+|++|.|++.++ .|.++++|++|+|++|+|+.++++.|.++++|++|+|++|
T Consensus 34 ~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 110 (562)
T 3a79_B 34 SMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN 110 (562)
T ss_dssp CEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred cEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence 789999999995 777665 899999999999999887 7999999999999999999999999999999999999999
Q ss_pred CCCCccCCCCCcccccccccCeeecccccccC-CcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCC
Q 041143 149 PFNKTFGWSIPDSLANSVQLTNLSLINCNLVG-PLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGG 227 (973)
Q Consensus 149 ~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~ 227 (973)
+|+. +|.. .+++|++|+|++|++++ .+|..|+++++|++|+|++|++++.....+....++.+.+..+....
T Consensus 111 ~l~~-----lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~L~L~~L~L~~n~l~~ 183 (562)
T 3a79_B 111 RLQN-----ISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHI 183 (562)
T ss_dssp CCCE-----ECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTTTTGGGTTSCEEEEEEEESSCCC
T ss_pred cCCc-----cCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccCchhhhhhceeeEEEeecccccc
Confidence 9995 6766 89999999999999997 45789999999999999999998532222211000112222222100
Q ss_pred CCCcchhhcCCc-cccEEEccCCccccCCCc-cccCCCCCCEEeCcCCc----------------------------ccc
Q 041143 228 MTGPIDVVAKMV-SLTQLWLHGNQFTGSIPE-DIGALSSLKDLNLNRNQ----------------------------LVG 277 (973)
Q Consensus 228 ~~~~~~~~~~l~-~L~~L~L~~N~l~g~~p~-~~~~l~~L~~L~Ls~N~----------------------------l~~ 277 (973)
....+..+..+. ..-.+++++|.+.+.++. .+..+++|+.|++++|+ +.+
T Consensus 184 ~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~ 263 (562)
T 3a79_B 184 KGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTW 263 (562)
T ss_dssp CSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECH
T ss_pred cccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcH
Confidence 111122222211 000122222222222211 11122334444444432 211
Q ss_pred c----CcccccccccCeEEccCCcCcCCCCCCCCC----Ccc---------------------------cccCcccCCCC
Q 041143 278 L----IPKSLANMELDNLVLNNNLLMGPIPKFKAG----NVT---------------------------YDSNSFCQSEP 322 (973)
Q Consensus 278 ~----~p~~~~~l~L~~L~l~~N~l~g~~p~~~~~----~~~---------------------------~~~~~~~~~~~ 322 (973)
. ++..+...+|++|++++|.++|.+|..+.. .+. +....+.+...
T Consensus 264 ~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~ 343 (562)
T 3a79_B 264 KCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPF 343 (562)
T ss_dssp HHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCC
T ss_pred HHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCc
Confidence 1 011111115677777777777777664310 000 00111111100
Q ss_pred CcccCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCCC--ccchhhhCccccceEEc
Q 041143 323 GIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTG--TLSPSIANLDSLIEIRL 400 (973)
Q Consensus 323 ~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L 400 (973)
.. ......+..+..+++..|.+..... ..+..+++|+.|+|++|++++ .+|..++++++|+.|+|
T Consensus 344 --~~-~~~~~~l~~L~~L~l~~n~l~~~~~----------~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l 410 (562)
T 3a79_B 344 --IH-MVCPPSPSSFTFLNFTQNVFTDSVF----------QGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDV 410 (562)
T ss_dssp --CC-CCCCSSCCCCCEEECCSSCCCTTTT----------TTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEEC
T ss_pred --cc-ccCccCCCCceEEECCCCccccchh----------hhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEEC
Confidence 00 0000223455666666666654211 134567778888888888876 34566778888888888
Q ss_pred cCCccccccCc-cccCcCCCCeeeCCCCcCCCCCCCC--CcccceeecCCcc
Q 041143 401 GKNSISGTVPN-NFTELKSLRLLDVSDNNIKPPLPEF--HDTVKLVIDGNPL 449 (973)
Q Consensus 401 ~~N~l~g~~p~-~~~~l~~L~~L~Ls~N~l~g~~p~~--~~~~~~~~~~N~~ 449 (973)
++|+|++.+|. .+..+++|++|+|++|+|++.+|.. .++..+++.+|..
T Consensus 411 ~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~~L~~L~L~~N~l 462 (562)
T 3a79_B 411 SLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRI 462 (562)
T ss_dssp TTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCCTTCSEEECCSSCC
T ss_pred CCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhcCcCCEEECCCCcC
Confidence 88888775554 3677778888888888887766643 3566777777754
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-30 Score=322.55 Aligned_cols=338 Identities=19% Similarity=0.180 Sum_probs=260.3
Q ss_pred EEEecccCCcccCCcCcccccccceeeccCcccCCCCC-CCCCCCccceeeccCC-CCCCCCccccCCCCCccEEEcccC
Q 041143 71 QIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFN-EFDTIPSDFFDGLSSVRVLALDYN 148 (973)
Q Consensus 71 ~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N-~l~~i~~~~f~~l~~L~~L~Ls~N 148 (973)
.++.++++++ .+|. ..++|++|||++|.|++..+ .|.++++|++|+|++| .+..+++..|.++++|++|+|++|
T Consensus 8 ~~dcs~~~L~-~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N 83 (844)
T 3j0a_A 8 IAFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSS 83 (844)
T ss_dssp EEEESCCCSS-CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTC
T ss_pred EEEccCCCCC-CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCC
Confidence 4567777887 4565 45899999999999999877 7999999999999999 556788999999999999999999
Q ss_pred CCCCccCCCCCcccccccccCeeecccccccCCcchh--ccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCC
Q 041143 149 PFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDF--LGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAG 226 (973)
Q Consensus 149 ~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~--l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~ 226 (973)
++.+. .|..|.++++|++|+|++|.+++.+|.. |+++++|++|+|++|++++..+..
T Consensus 84 ~l~~~----~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~----------------- 142 (844)
T 3j0a_A 84 KIYFL----HPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHP----------------- 142 (844)
T ss_dssp CCCEE----CTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCG-----------------
T ss_pred cCccc----CHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccch-----------------
Confidence 99985 7899999999999999999999877665 999999999999999998765532
Q ss_pred CCCCcchhhcCCccccEEEccCCccccCCCccccCC--CCCCEEeCcCCcccccCccccccc-------ccCeEEccCCc
Q 041143 227 GMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGAL--SSLKDLNLNRNQLVGLIPKSLANM-------ELDNLVLNNNL 297 (973)
Q Consensus 227 ~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l--~~L~~L~Ls~N~l~~~~p~~~~~l-------~L~~L~l~~N~ 297 (973)
.|.++++|++|+|++|.+++..|..+..+ ++|+.|+|++|.+.+..|..+..+ .|+.|++++|.
T Consensus 143 -------~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~ 215 (844)
T 3j0a_A 143 -------SFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNG 215 (844)
T ss_dssp -------GGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCC
T ss_pred -------hHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCc
Confidence 13569999999999999998899999887 899999999999998887766543 49999999999
Q ss_pred CcCCCCCCCCCCccc---ccCccc---------CCCCCcccCCcchhh-hhhccCCCCCCcccCCCCCCCCCCCCccccc
Q 041143 298 LMGPIPKFKAGNVTY---DSNSFC---------QSEPGIECAPDVNVL-LDFLGGVNYPVNLVSQWPGNDPCQGPWLGLS 364 (973)
Q Consensus 298 l~g~~p~~~~~~~~~---~~~~~~---------~~~~~~~~~~~~~~~-~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~ 364 (973)
+.+.+|..+...+.. ....+. ..............+ ...+..++++.|.+...+.. .
T Consensus 216 l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~----------~ 285 (844)
T 3j0a_A 216 WTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSR----------V 285 (844)
T ss_dssp SSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSC----------C
T ss_pred CchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChh----------h
Confidence 988877654322111 000000 000000000000011 23466667777766554322 3
Q ss_pred cCCCCcccEEecCCCcCCCccchhhhCccccceEEccCCccccccCccccCcCCCCeeeCCCCcCCCCCCC----CCccc
Q 041143 365 CTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLPE----FHDTV 440 (973)
Q Consensus 365 ~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~----~~~~~ 440 (973)
+..+++|+.|+|++|++.+..|..|.++++|+.|+|++|+|++..|..|..+++|++|+|++|++++..+. +.++.
T Consensus 286 ~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~ 365 (844)
T 3j0a_A 286 FETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQ 365 (844)
T ss_dssp SSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCC
T ss_pred hhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCC
Confidence 55677888888888888888888888888888888888888877788888888888888888888877664 34556
Q ss_pred ceeecCCccc
Q 041143 441 KLVIDGNPLL 450 (973)
Q Consensus 441 ~~~~~~N~~~ 450 (973)
.+.+.+|...
T Consensus 366 ~L~Ls~N~l~ 375 (844)
T 3j0a_A 366 TLDLRDNALT 375 (844)
T ss_dssp EEEEETCCSC
T ss_pred EEECCCCCCC
Confidence 6788887653
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-30 Score=291.24 Aligned_cols=284 Identities=19% Similarity=0.275 Sum_probs=235.2
Q ss_pred CCCCCCCCcCeEEeeCCeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCC-CCCCCCccceeeccCCCCCCC
Q 041143 51 DDPCGPPPWPHVFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFDTI 129 (973)
Q Consensus 51 ~d~C~~~~w~gv~C~~~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i 129 (973)
..+|. |.|+ | ++++++++ .+|..+. ++|++|+|++|++++.++ .|.++++|++|+|++|+|+.+
T Consensus 27 ~~~C~---~~~~-c--------~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~ 91 (353)
T 2z80_A 27 SLSCD---RNGI-C--------KGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTI 91 (353)
T ss_dssp CCEEC---TTSE-E--------ECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEE
T ss_pred CCCCC---CCeE-e--------eCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCcc
Confidence 34565 8887 6 34667777 5677665 589999999999999887 799999999999999999999
Q ss_pred CccccCCCCCccEEEcccCCCCCccCCCCCcc-cccccccCeeecccccccCCcc-hhccCCCCCCeEEccCCc-CcccC
Q 041143 130 PSDFFDGLSSVRVLALDYNPFNKTFGWSIPDS-LANSVQLTNLSLINCNLVGPLP-DFLGTLPSLAALKLSYNR-LSGVI 206 (973)
Q Consensus 130 ~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~-~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~-l~~~~ 206 (973)
++..|.++++|++|+|++|++++ +|.. +.++++|++|+|++|++++..+ ..|.++++|++|+|++|+ +.+..
T Consensus 92 ~~~~~~~l~~L~~L~Ls~n~l~~-----~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~ 166 (353)
T 2z80_A 92 EEDSFSSLGSLEHLDLSYNYLSN-----LSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQ 166 (353)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSS-----CCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEEC
T ss_pred CHhhcCCCCCCCEEECCCCcCCc-----CCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccC
Confidence 99999999999999999999996 5554 8899999999999999996544 489999999999999994 66544
Q ss_pred ChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcccccCccccccc
Q 041143 207 PASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM 286 (973)
Q Consensus 207 p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 286 (973)
+..+ .++++|++|+|++|++++..|..+..+++|++|+|++|+++...+..+..+
T Consensus 167 ~~~~-------------------------~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~ 221 (353)
T 2z80_A 167 RKDF-------------------------AGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVT 221 (353)
T ss_dssp TTTT-------------------------TTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHT
T ss_pred HHHc-------------------------cCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhc
Confidence 5444 469999999999999998889999999999999999999975433344444
Q ss_pred -ccCeEEccCCcCcCCCCCCCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCcccccc
Q 041143 287 -ELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSC 365 (973)
Q Consensus 287 -~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~ 365 (973)
+|+.|++++|.+++..+..+. ..
T Consensus 222 ~~L~~L~L~~n~l~~~~~~~l~--------------------------------------------------------~~ 245 (353)
T 2z80_A 222 SSVECLELRDTDLDTFHFSELS--------------------------------------------------------TG 245 (353)
T ss_dssp TTEEEEEEESCBCTTCCCC-------------------------------------------------------------
T ss_pred ccccEEECCCCccccccccccc--------------------------------------------------------cc
Confidence 799999999999865443110 01
Q ss_pred CCCCcccEEecCCCcCCC----ccchhhhCccccceEEccCCccccccCcc-ccCcCCCCeeeCCCCcCCCCCCCC
Q 041143 366 TSNSKVSIINLPRHNLTG----TLSPSIANLDSLIEIRLGKNSISGTVPNN-FTELKSLRLLDVSDNNIKPPLPEF 436 (973)
Q Consensus 366 ~~~~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~g~~p~~-~~~l~~L~~L~Ls~N~l~g~~p~~ 436 (973)
.....++.++|++|.+.+ .+|..+.++++|+.|+|++|+|+ .+|.. |..+++|++|+|++|++++..|.+
T Consensus 246 ~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~~~~~~l 320 (353)
T 2z80_A 246 ETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 320 (353)
T ss_dssp -CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHHHH
T ss_pred cccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCccCcCCCc
Confidence 123467788888888887 57888999999999999999999 66766 589999999999999999988743
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-29 Score=281.62 Aligned_cols=282 Identities=24% Similarity=0.286 Sum_probs=229.6
Q ss_pred CCCCCCCCCcCeEEeeC-----------CeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCC-CCCCCCccc
Q 041143 50 GDDPCGPPPWPHVFCSG-----------NRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELE 117 (973)
Q Consensus 50 ~~d~C~~~~w~gv~C~~-----------~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~ 117 (973)
.+..|. |.|..+.|+. ..++.|+|++|.+++..+..|.++++|++|+|++|.+++..| .|.++++|+
T Consensus 27 cp~~c~-c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 105 (332)
T 2ft3_A 27 CPFGCH-CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQ 105 (332)
T ss_dssp CCSSCE-EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCC
T ss_pred CCCCCc-ccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCC
Confidence 344442 3588898864 257889999999998878889999999999999999998876 688899999
Q ss_pred eeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeeeccccccc--CCcchhccCCCCCCeE
Q 041143 118 FAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLV--GPLPDFLGTLPSLAAL 195 (973)
Q Consensus 118 ~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~--~~~p~~l~~l~~L~~L 195 (973)
+|+|++|+++.+|...+ ++|++|+|++|+++.. .+..|.++++|+.|+|++|.++ +..+..+..+ +|++|
T Consensus 106 ~L~L~~n~l~~l~~~~~---~~L~~L~l~~n~i~~~----~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L 177 (332)
T 2ft3_A 106 KLYISKNHLVEIPPNLP---SSLVELRIHDNRIRKV----PKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYL 177 (332)
T ss_dssp EEECCSSCCCSCCSSCC---TTCCEEECCSSCCCCC----CSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCC
T ss_pred EEECCCCcCCccCcccc---ccCCEEECCCCccCcc----CHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEE
Confidence 99999999999888766 7899999999999863 3446888999999999999986 4777888888 89999
Q ss_pred EccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcc
Q 041143 196 KLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQL 275 (973)
Q Consensus 196 ~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l 275 (973)
++++|++++ +|..+ .++|++|+|++|.+++..+..|..+++|++|+|++|++
T Consensus 178 ~l~~n~l~~-l~~~~---------------------------~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l 229 (332)
T 2ft3_A 178 RISEAKLTG-IPKDL---------------------------PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQI 229 (332)
T ss_dssp BCCSSBCSS-CCSSS---------------------------CSSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCC
T ss_pred ECcCCCCCc-cCccc---------------------------cCCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcC
Confidence 999999984 55543 36889999999999987778899999999999999999
Q ss_pred cccCccccccc-ccCeEEccCCcCcCCCCCCCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCC
Q 041143 276 VGLIPKSLANM-ELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGND 354 (973)
Q Consensus 276 ~~~~p~~~~~l-~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~ 354 (973)
++..+..+..+ +|+.|++++|.|+ .+|.
T Consensus 230 ~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~-------------------------------------------------- 258 (332)
T 2ft3_A 230 RMIENGSLSFLPTLRELHLDNNKLS-RVPA-------------------------------------------------- 258 (332)
T ss_dssp CCCCTTGGGGCTTCCEEECCSSCCC-BCCT--------------------------------------------------
T ss_pred CcCChhHhhCCCCCCEEECCCCcCe-ecCh--------------------------------------------------
Confidence 98887788877 7999999999887 4554
Q ss_pred CCCCCccccccCCCCcccEEecCCCcCCCccchhhhCc------cccceEEccCCccc--cccCccccCcCCCCeeeCCC
Q 041143 355 PCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANL------DSLIEIRLGKNSIS--GTVPNNFTELKSLRLLDVSD 426 (973)
Q Consensus 355 ~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l------~~L~~L~L~~N~l~--g~~p~~~~~l~~L~~L~Ls~ 426 (973)
.+..+++|+.|+|++|++++..+..|..+ ..|+.|+|++|.+. +..|..|..+++|+.|+|++
T Consensus 259 ---------~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~ 329 (332)
T 2ft3_A 259 ---------GLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGN 329 (332)
T ss_dssp ---------TGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC--
T ss_pred ---------hhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccc
Confidence 12456789999999999998887777654 66889999999887 66778889999999999998
Q ss_pred Cc
Q 041143 427 NN 428 (973)
Q Consensus 427 N~ 428 (973)
|+
T Consensus 330 n~ 331 (332)
T 2ft3_A 330 YK 331 (332)
T ss_dssp --
T ss_pred cc
Confidence 85
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-29 Score=281.24 Aligned_cols=299 Identities=23% Similarity=0.319 Sum_probs=222.2
Q ss_pred CeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcc
Q 041143 67 NRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALD 146 (973)
Q Consensus 67 ~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls 146 (973)
..+++|++++++++. ++ .+..+++|++|+|++|.+++..+ +.++++|++|+|++|+++.++ .|.++++|++|+|+
T Consensus 44 ~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~~~~~-~~~l~~L~~L~L~~n~i~~~~--~~~~l~~L~~L~l~ 118 (347)
T 4fmz_A 44 ESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQITDISP-LSNLVKLTNLYIGTNKITDIS--ALQNLTNLRELYLN 118 (347)
T ss_dssp TTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCG--GGTTCTTCSEEECT
T ss_pred ccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCccccchh-hhcCCcCCEEEccCCcccCch--HHcCCCcCCEEECc
Confidence 578999999999974 33 48999999999999999998766 899999999999999999875 58999999999999
Q ss_pred cCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCC
Q 041143 147 YNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAG 226 (973)
Q Consensus 147 ~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~ 226 (973)
+|++++ ++. +..+++|+.|++++|.....++ .+..+++|++|++++|++.+..+ +
T Consensus 119 ~n~i~~-----~~~-~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~---------------- 173 (347)
T 4fmz_A 119 EDNISD-----ISP-LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--I---------------- 173 (347)
T ss_dssp TSCCCC-----CGG-GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--G----------------
T ss_pred CCcccC-----chh-hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--h----------------
Confidence 999986 444 8899999999999997664444 48999999999999999884433 2
Q ss_pred CCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcccccCccccccc-ccCeEEccCCcCcCCCCCC
Q 041143 227 GMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGPIPKF 305 (973)
Q Consensus 227 ~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~g~~p~~ 305 (973)
..+++|+.|++++|.+++ ++. +..+++|+.|++++|.+.+..+ +..+ +|+.|++++|.+++..+
T Consensus 174 ---------~~l~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~-- 238 (347)
T 4fmz_A 174 ---------ANLTDLYSLSLNYNQIED-ISP-LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP-- 238 (347)
T ss_dssp ---------GGCTTCSEEECTTSCCCC-CGG-GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--
T ss_pred ---------ccCCCCCEEEccCCcccc-ccc-ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--
Confidence 246666677777766663 332 6666666777777666665433 4444 56666666666654222
Q ss_pred CCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCCCcc
Q 041143 306 KAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTL 385 (973)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~ 385 (973)
...+..+..+++..|.+..++ .+..+++|+.|++++|++++.
T Consensus 239 -------------------------~~~l~~L~~L~l~~n~l~~~~------------~~~~l~~L~~L~l~~n~l~~~- 280 (347)
T 4fmz_A 239 -------------------------LANLSQLTWLEIGTNQISDIN------------AVKDLTKLKMLNVGSNQISDI- 280 (347)
T ss_dssp -------------------------GTTCTTCCEEECCSSCCCCCG------------GGTTCTTCCEEECCSSCCCCC-
T ss_pred -------------------------hhcCCCCCEEECCCCccCCCh------------hHhcCCCcCEEEccCCccCCC-
Confidence 011223444455555444431 245677889999999988875
Q ss_pred chhhhCccccceEEccCCccccccCccccCcCCCCeeeCCCCcCCCCCC--CCCcccceeecCCcc
Q 041143 386 SPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLP--EFHDTVKLVIDGNPL 449 (973)
Q Consensus 386 p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p--~~~~~~~~~~~~N~~ 449 (973)
+.+..+++|+.|+|++|++++..|..|..+++|++|+|++|++++.+| .+..+..+++.+|++
T Consensus 281 -~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~N~i 345 (347)
T 4fmz_A 281 -SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKMDSADFANQVI 345 (347)
T ss_dssp -GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGGGGGCTTCSEESSSCC--
T ss_pred -hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccChhhhhccceeehhhhcc
Confidence 458888899999999999988888888889999999999999988776 345566788888874
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.7e-29 Score=291.44 Aligned_cols=318 Identities=23% Similarity=0.318 Sum_probs=184.4
Q ss_pred eEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEccc
Q 041143 68 RVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDY 147 (973)
Q Consensus 68 ~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~ 147 (973)
+++.|+|++|.+++..+ |.++++|++|+|++|.+++..+ +.++++|++|+|++|+++.+++ |.++++|++|+|++
T Consensus 69 ~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~ 143 (466)
T 1o6v_A 69 NLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP-LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSS 143 (466)
T ss_dssp TCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEE
T ss_pred CCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh-hcCCCCCCEEECCCCCCCCChH--HcCCCCCCEEECCC
Confidence 45555555555554322 5555555555555555555444 5555555555555555555543 55555555555555
Q ss_pred CCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCC
Q 041143 148 NPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGG 227 (973)
Q Consensus 148 N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~ 227 (973)
|++.+ ++ .+..+++|+.|+++ |.+.+.. .+.++++|++|+|++|++++. +. +. .+..+..|....+..
T Consensus 144 n~l~~-----~~-~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l~~~-~~-l~-~l~~L~~L~l~~n~l 211 (466)
T 1o6v_A 144 NTISD-----IS-ALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKVSDI-SV-LA-KLTNLESLIATNNQI 211 (466)
T ss_dssp EEECC-----CG-GGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCCCCC-GG-GG-GCTTCSEEECCSSCC
T ss_pred CccCC-----Ch-hhccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcCCCC-hh-hc-cCCCCCEEEecCCcc
Confidence 55553 22 34455555555553 3333222 256666666666666666532 21 21 111222222222221
Q ss_pred CCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcccccCccccccc-ccCeEEccCCcCcCCCCCCC
Q 041143 228 MTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGPIPKFK 306 (973)
Q Consensus 228 ~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~g~~p~~~ 306 (973)
.... .+..+++|+.|+|++|++++ + ..+..+++|++|++++|.+++..+ +..+ +|+.|++++|.+++..+
T Consensus 212 ~~~~--~~~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--- 282 (466)
T 1o6v_A 212 SDIT--PLGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--- 282 (466)
T ss_dssp CCCG--GGGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG---
T ss_pred cccc--cccccCCCCEEECCCCCccc-c-hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc---
Confidence 1111 13445555555555555552 2 244555555555555555554433 3333 45555555555543221
Q ss_pred CCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCCCccc
Q 041143 307 AGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLS 386 (973)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p 386 (973)
...+..+..+++..|.+..++ .+..+++|+.|+|++|++.+..|
T Consensus 283 ------------------------~~~l~~L~~L~L~~n~l~~~~------------~~~~l~~L~~L~L~~n~l~~~~~ 326 (466)
T 1o6v_A 283 ------------------------LAGLTALTNLELNENQLEDIS------------PISNLKNLTYLTLYFNNISDISP 326 (466)
T ss_dssp ------------------------GTTCTTCSEEECCSSCCSCCG------------GGGGCTTCSEEECCSSCCSCCGG
T ss_pred ------------------------ccCCCccCeEEcCCCcccCch------------hhcCCCCCCEEECcCCcCCCchh
Confidence 122345666777777666543 14678899999999999998877
Q ss_pred hhhhCccccceEEccCCccccccCccccCcCCCCeeeCCCCcCCCCCC--CCCcccceeecCCcccc
Q 041143 387 PSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLP--EFHDTVKLVIDGNPLLV 451 (973)
Q Consensus 387 ~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p--~~~~~~~~~~~~N~~~c 451 (973)
+..+++|+.|+|++|++++. ..+..+++|+.|+|++|++++.+| .+..+..+.+.+|++..
T Consensus 327 --~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 327 --VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp --GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGGGTTCTTCCEEECCCEEEEC
T ss_pred --hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccchhhcCCCCCEEeccCCcccC
Confidence 78999999999999999865 578999999999999999999887 23455668899998865
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.6e-29 Score=288.30 Aligned_cols=318 Identities=16% Similarity=0.126 Sum_probs=229.2
Q ss_pred CCeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEc
Q 041143 66 GNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLAL 145 (973)
Q Consensus 66 ~~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~L 145 (973)
..+++.|+|++|++++. | .|+.+++|++|+|++|+|++. | +..+++|++|+|++|+|+.++ |.++++|++|+|
T Consensus 41 l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~-~~~l~~L~~L~Ls~N~l~~~~---~~~l~~L~~L~L 113 (457)
T 3bz5_A 41 LATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D-LSQNTNLTYLACDSNKLTNLD---VTPLTKLTYLNC 113 (457)
T ss_dssp HTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C-CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEEC
T ss_pred cCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c-cccCCCCCEEECcCCCCceee---cCCCCcCCEEEC
Confidence 35799999999999975 4 799999999999999999986 3 889999999999999999985 889999999999
Q ss_pred ccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCC
Q 041143 146 DYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDA 225 (973)
Q Consensus 146 s~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~ 225 (973)
++|++++ +| ++.+++|++|+|++|+|++. + ++++++|++|++++|+..+.++ +.. +.++..|+...+
T Consensus 114 ~~N~l~~-----l~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~~--~~~-l~~L~~L~ls~n 180 (457)
T 3bz5_A 114 DTNKLTK-----LD--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKLD--VTP-QTQLTTLDCSFN 180 (457)
T ss_dssp CSSCCSC-----CC--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCCC--CTT-CTTCCEEECCSS
T ss_pred CCCcCCe-----ec--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCcccccc--ccc-CCcCCEEECCCC
Confidence 9999986 44 88999999999999999974 3 8899999999999996655653 221 222333333333
Q ss_pred CCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcccccCccccccc-ccCeEEccCCcCcCCCCC
Q 041143 226 GGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGPIPK 304 (973)
Q Consensus 226 ~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~g~~p~ 304 (973)
.....+ +..+++|+.|++++|++++. .+..+++|++|+|++|++++ +| +..+ +|+.|++++|.+++..+.
T Consensus 181 ~l~~l~---l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~ 251 (457)
T 3bz5_A 181 KITELD---VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVS 251 (457)
T ss_dssp CCCCCC---CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCT
T ss_pred ccceec---cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHH
Confidence 333222 66788888888888888854 37788888888888888887 45 5555 788888888888865332
Q ss_pred CCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCCCc
Q 041143 305 FKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGT 384 (973)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~ 384 (973)
.+. .+... .+ ....+..+++..|.. ... +.+..+++|+.|+|++|.+.+.
T Consensus 252 ~l~-~L~~L--~l---------------~~n~L~~L~l~~n~~---------~~~---~~~~~l~~L~~L~Ls~n~~l~~ 301 (457)
T 3bz5_A 252 TLS-KLTTL--HC---------------IQTDLLEIDLTHNTQ---------LIY---FQAEGCRKIKELDVTHNTQLYL 301 (457)
T ss_dssp TCT-TCCEE--EC---------------TTCCCSCCCCTTCTT---------CCE---EECTTCTTCCCCCCTTCTTCCE
T ss_pred HCC-CCCEE--ec---------------cCCCCCEEECCCCcc---------CCc---ccccccccCCEEECCCCcccce
Confidence 111 11000 00 001223333333321 111 1235678899999999998888
Q ss_pred cchh--------hhCccccceEEccCCccccccCccccCcCCCCeeeCCCCcCCCCCCCCCcccceeecCCcc
Q 041143 385 LSPS--------IANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLPEFHDTVKLVIDGNPL 449 (973)
Q Consensus 385 ~p~~--------~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~~~~N~~ 449 (973)
+|.. +.++++|+.|+|++|+|++ ++ ++.+++|+.|||++|+|++ ++. +..+.+..|.+
T Consensus 302 l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~-l~--l~~l~~L~~L~l~~N~l~~-l~~---L~~L~l~~n~l 367 (457)
T 3bz5_A 302 LDCQAAGITELDLSQNPKLVYLYLNNTELTE-LD--VSHNTKLKSLSCVNAHIQD-FSS---VGKIPALNNNF 367 (457)
T ss_dssp EECTTCCCSCCCCTTCTTCCEEECTTCCCSC-CC--CTTCTTCSEEECCSSCCCB-CTT---GGGSSGGGTSE
T ss_pred eccCCCcceEechhhcccCCEEECCCCcccc-cc--cccCCcCcEEECCCCCCCC-ccc---cccccccCCcE
Confidence 7753 4556788999999999997 43 8899999999999999988 333 33444444443
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.4e-30 Score=282.83 Aligned_cols=278 Identities=21% Similarity=0.273 Sum_probs=158.5
Q ss_pred CCCCCCCCcCeEEeeCCeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCC-CCCCCCccceeeccCCCCCCC
Q 041143 51 DDPCGPPPWPHVFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFDTI 129 (973)
Q Consensus 51 ~d~C~~~~w~gv~C~~~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i 129 (973)
++.|. |.|.+|.|+..+++ .+|..+. ++|++|+|++|+++..++ .|.++++|++|+|++|+++.+
T Consensus 2 P~~C~-C~~~~l~c~~~~l~-----------~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~ 67 (306)
T 2z66_A 2 PSRCS-CSGTEIRCNSKGLT-----------SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFK 67 (306)
T ss_dssp CTTCE-EETTEEECCSSCCS-----------SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEE
T ss_pred cCCCe-eCCCEEEcCCCCcc-----------cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcc
Confidence 34564 35877777655443 3454332 466666666666665544 255566666666666665543
Q ss_pred C--ccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeeecccccccCCcc-hhccCCCCCCeEEccCCcCcccC
Q 041143 130 P--SDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLP-DFLGTLPSLAALKLSYNRLSGVI 206 (973)
Q Consensus 130 ~--~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~ 206 (973)
. +..+..+++|++|+|++|.++. +|..+..+++|++|+|++|++++..+ ..+..+++|++|+|++|++++..
T Consensus 68 ~~~~~~~~~~~~L~~L~Ls~n~i~~-----l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 142 (306)
T 2z66_A 68 GCCSQSDFGTTSLKYLDLSFNGVIT-----MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAF 142 (306)
T ss_dssp EEEEHHHHSCSCCCEEECCSCSEEE-----EEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECS
T ss_pred cCcccccccccccCEEECCCCcccc-----ChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccc
Confidence 2 2223345555555555555542 34444455555555555555543332 34444555555555555544333
Q ss_pred ChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCcccc-CCCccccCCCCCCEEeCcCCcccccCcccccc
Q 041143 207 PASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTG-SIPEDIGALSSLKDLNLNRNQLVGLIPKSLAN 285 (973)
Q Consensus 207 p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 285 (973)
+..+ .++++|++|+|++|.+++ .+|..+..+++|++|+|++|++++..|..+.
T Consensus 143 ~~~~-------------------------~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~- 196 (306)
T 2z66_A 143 NGIF-------------------------NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN- 196 (306)
T ss_dssp TTTT-------------------------TTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTT-
T ss_pred hhhc-------------------------ccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhc-
Confidence 3322 234445555555554443 2444444444444444444444443333332
Q ss_pred cccCeEEccCCcCcCCCCCCCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCcccccc
Q 041143 286 MELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSC 365 (973)
Q Consensus 286 l~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~ 365 (973)
T Consensus 197 -------------------------------------------------------------------------------- 196 (306)
T 2z66_A 197 -------------------------------------------------------------------------------- 196 (306)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcccEEecCCCcCCCccchhhhCccccceEEccCCccccccCccccCcC-CCCeeeCCCCcCCCCCCC------CCc
Q 041143 366 TSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELK-SLRLLDVSDNNIKPPLPE------FHD 438 (973)
Q Consensus 366 ~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~-~L~~L~Ls~N~l~g~~p~------~~~ 438 (973)
.+++|+.|+|++|++++..+..+..+++|+.|+|++|+|++..|..+..++ +|++|+|++|++++..+. +.+
T Consensus 197 -~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~ 275 (306)
T 2z66_A 197 -SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKD 275 (306)
T ss_dssp -TCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHH
T ss_pred -CCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHh
Confidence 345677777777777777676788888899999999999888888888884 899999999999876431 223
Q ss_pred ccceeecCCccccCCC
Q 041143 439 TVKLVIDGNPLLVGGI 454 (973)
Q Consensus 439 ~~~~~~~~N~~~c~~~ 454 (973)
...+.++.|...|..+
T Consensus 276 ~~~~~~~~~~~~C~~p 291 (306)
T 2z66_A 276 QRQLLVEVERMECATP 291 (306)
T ss_dssp TGGGBSCGGGCBEEES
T ss_pred hhhhhccccccccCCc
Confidence 3345556677777643
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-28 Score=287.30 Aligned_cols=305 Identities=26% Similarity=0.347 Sum_probs=245.6
Q ss_pred CCeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEc
Q 041143 66 GNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLAL 145 (973)
Q Consensus 66 ~~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~L 145 (973)
..+++.|+|++|.+++..+ ++++++|++|+|++|.+++..+ +.++++|++|+|++|+++.++ .+..+++|++|++
T Consensus 89 l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~l 163 (466)
T 1o6v_A 89 LTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP-LKNLTNLNRLELSSNTISDIS--ALSGLTSLQQLSF 163 (466)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG-GTTCTTCSEEEEEEEEECCCG--GGTTCTTCSEEEE
T ss_pred cccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCChH-HcCCCCCCEEECCCCccCCCh--hhccCCcccEeec
Confidence 3579999999999997654 9999999999999999998765 999999999999999999986 3889999999999
Q ss_pred ccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCC
Q 041143 146 DYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDA 225 (973)
Q Consensus 146 s~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~ 225 (973)
+ |.+.+ ++ .+.++++|+.|+|++|.+++. ..+..+++|++|++++|++++..| +. ....+..|....+
T Consensus 164 ~-~~~~~-----~~-~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~-~l~~L~~L~l~~n 231 (466)
T 1o6v_A 164 G-NQVTD-----LK-PLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LG-ILTNLDELSLNGN 231 (466)
T ss_dssp E-ESCCC-----CG-GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GG-GCTTCCEEECCSS
T ss_pred C-CcccC-----ch-hhccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc--cc-ccCCCCEEECCCC
Confidence 6 55554 22 388889999999999998854 348889999999999999987655 21 1223333444433
Q ss_pred CCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcccccCccccccc-ccCeEEccCCcCcCCCCC
Q 041143 226 GGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGPIPK 304 (973)
Q Consensus 226 ~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~g~~p~ 304 (973)
.... ...+..+++|+.|+|++|.+++..| +..+++|++|+|++|++++..+ +..+ +|+.|++++|.+++..|
T Consensus 232 ~l~~--~~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~- 304 (466)
T 1o6v_A 232 QLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP- 304 (466)
T ss_dssp CCCC--CGGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG-
T ss_pred Cccc--chhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh-
Confidence 3322 2467889999999999999996655 8999999999999999997655 6666 89999999999986433
Q ss_pred CCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCCCc
Q 041143 305 FKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGT 384 (973)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~ 384 (973)
...+..+..+++..|.+..++. +..+++|+.|++++|++++.
T Consensus 305 --------------------------~~~l~~L~~L~L~~n~l~~~~~------------~~~l~~L~~L~l~~n~l~~~ 346 (466)
T 1o6v_A 305 --------------------------ISNLKNLTYLTLYFNNISDISP------------VSSLTKLQRLFFYNNKVSDV 346 (466)
T ss_dssp --------------------------GGGCTTCSEEECCSSCCSCCGG------------GGGCTTCCEEECCSSCCCCC
T ss_pred --------------------------hcCCCCCCEEECcCCcCCCchh------------hccCccCCEeECCCCccCCc
Confidence 1123456677777777665531 45788999999999999987
Q ss_pred cchhhhCccccceEEccCCccccccCccccCcCCCCeeeCCCCcCCCCCCCC
Q 041143 385 LSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLPEF 436 (973)
Q Consensus 385 ~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~ 436 (973)
+.+.++++|+.|+|++|++++..| +..+++|+.|+|++|++++.+..+
T Consensus 347 --~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~~p~~~ 394 (466)
T 1o6v_A 347 --SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNY 394 (466)
T ss_dssp --GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEECCCBCC
T ss_pred --hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccCCchhh
Confidence 579999999999999999998887 899999999999999999965543
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-28 Score=273.93 Aligned_cols=282 Identities=23% Similarity=0.305 Sum_probs=217.4
Q ss_pred eCCeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEE
Q 041143 65 SGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLA 144 (973)
Q Consensus 65 ~~~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~ 144 (973)
...+++.|+|++|.+++. ++ |..+++|++|+|++|.++.. +.|.++++|++|+|++|+++.+++ +..+++|++|+
T Consensus 64 ~~~~L~~L~l~~n~i~~~-~~-~~~l~~L~~L~L~~n~i~~~-~~~~~l~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~ 138 (347)
T 4fmz_A 64 YLTNLEYLNLNGNQITDI-SP-LSNLVKLTNLYIGTNKITDI-SALQNLTNLRELYLNEDNISDISP--LANLTKMYSLN 138 (347)
T ss_dssp GCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCC-GGGTTCTTCSEEECTTSCCCCCGG--GTTCTTCCEEE
T ss_pred hcCCccEEEccCCccccc-hh-hhcCCcCCEEEccCCcccCc-hHHcCCCcCCEEECcCCcccCchh--hccCCceeEEE
Confidence 346899999999999864 44 99999999999999999974 679999999999999999999887 89999999999
Q ss_pred cccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccC
Q 041143 145 LDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQD 224 (973)
Q Consensus 145 Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~ 224 (973)
+++|.... .+..+..+++|++|++++|.+.+..+ +..+++|++|++++|++.+..+ +
T Consensus 139 l~~n~~~~-----~~~~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~-------------- 195 (347)
T 4fmz_A 139 LGANHNLS-----DLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--L-------------- 195 (347)
T ss_dssp CTTCTTCC-----CCGGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGG--G--------------
T ss_pred CCCCCCcc-----cccchhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCccccccc--c--------------
Confidence 99997664 34458999999999999999996554 8999999999999999984332 2
Q ss_pred CCCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcccccCccccccc-ccCeEEccCCcCcCCCC
Q 041143 225 AGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGPIP 303 (973)
Q Consensus 225 ~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~g~~p 303 (973)
..+++|+.|++++|.+++..+ +..+++|++|+|++|++++..+ +..+ +|+.|++++|.+++. +
T Consensus 196 -----------~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~ 259 (347)
T 4fmz_A 196 -----------ASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI-N 259 (347)
T ss_dssp -----------GGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC-G
T ss_pred -----------cCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC-h
Confidence 236666666666666664333 6666666666666666665433 4444 566666666666531 1
Q ss_pred CCCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCCC
Q 041143 304 KFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTG 383 (973)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~ 383 (973)
. ...+..+..+++..|.+..++ .+..+++|+.|+|++|++.+
T Consensus 260 ~--------------------------~~~l~~L~~L~l~~n~l~~~~------------~~~~l~~L~~L~L~~n~l~~ 301 (347)
T 4fmz_A 260 A--------------------------VKDLTKLKMLNVGSNQISDIS------------VLNNLSQLNSLFLNNNQLGN 301 (347)
T ss_dssp G--------------------------GTTCTTCCEEECCSSCCCCCG------------GGGGCTTCSEEECCSSCCCG
T ss_pred h--------------------------HhcCCCcCEEEccCCccCCCh------------hhcCCCCCCEEECcCCcCCC
Confidence 1 011223444555555544432 24567899999999999999
Q ss_pred ccchhhhCccccceEEccCCccccccCccccCcCCCCeeeCCCCcCC
Q 041143 384 TLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIK 430 (973)
Q Consensus 384 ~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~ 430 (973)
..|..++.+++|+.|+|++|++++..| +..+++|+.||+++|.|+
T Consensus 302 ~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 302 EDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp GGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred cChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 999999999999999999999997766 899999999999999986
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-28 Score=300.03 Aligned_cols=354 Identities=17% Similarity=0.183 Sum_probs=251.1
Q ss_pred CeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCC-CCCCCCccceeeccCCCCCCCCccccCCCCCccEEEc
Q 041143 67 NRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLAL 145 (973)
Q Consensus 67 ~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~L 145 (973)
.+++.|+|++|+|++..+.+|.+|++|++|+|++|+|++.++ .|.++++|++|+|++|+|+.+++..|.++++|++|+|
T Consensus 76 ~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~L 155 (635)
T 4g8a_A 76 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 155 (635)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEEC
T ss_pred CCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeecc
Confidence 579999999999998888899999999999999999999887 6999999999999999999999999999999999999
Q ss_pred ccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCC----eEEccCCcCcccCChhhhhh--------
Q 041143 146 DYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLA----ALKLSYNRLSGVIPASFGQS-------- 213 (973)
Q Consensus 146 s~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~----~L~Ls~N~l~~~~p~~~~~~-------- 213 (973)
++|+++.. .+|..+..+++|++|+|++|+|++..+..|..+.+++ .++++.|.++...+..+...
T Consensus 156 s~N~l~~~---~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~ 232 (635)
T 4g8a_A 156 AHNLIQSF---KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLR 232 (635)
T ss_dssp CSSCCCCC---CCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEE
T ss_pred ccCccccC---CCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccccchhhhhhhhh
Confidence 99999875 4788999999999999999999988888776655443 57777777654322211000
Q ss_pred -------HH-----------------------------------------------------------------H-----
Q 041143 214 -------LM-----------------------------------------------------------------Q----- 216 (973)
Q Consensus 214 -------~~-----------------------------------------------------------------~----- 216 (973)
.. .
T Consensus 233 ~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~ 312 (635)
T 4g8a_A 233 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFS 312 (635)
T ss_dssp SCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEE
T ss_pred cccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhccccccc
Confidence 00 0
Q ss_pred -----------------HHhhcccCC--CCCC-----------------CcchhhcCCccccEEEccCCcccc--CCCcc
Q 041143 217 -----------------ILWLNDQDA--GGMT-----------------GPIDVVAKMVSLTQLWLHGNQFTG--SIPED 258 (973)
Q Consensus 217 -----------------~~~l~~~~~--~~~~-----------------~~~~~~~~l~~L~~L~L~~N~l~g--~~p~~ 258 (973)
+..|....+ .... .....+..+++|+.|++++|.+.. ..+..
T Consensus 313 ~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~ 392 (635)
T 4g8a_A 313 LVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQS 392 (635)
T ss_dssp EESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBCTTCCEEECCSSCCBEEEECCHH
T ss_pred ccccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCcccccccccccchhhccccccccccccc
Confidence 000000000 0000 001122356788888888887752 23333
Q ss_pred ccC-----------------------CCCCCEEeCcCCcccccCc-cccccc-ccCeEEccCCcCcCCCCCCCCCCcccc
Q 041143 259 IGA-----------------------LSSLKDLNLNRNQLVGLIP-KSLANM-ELDNLVLNNNLLMGPIPKFKAGNVTYD 313 (973)
Q Consensus 259 ~~~-----------------------l~~L~~L~Ls~N~l~~~~p-~~~~~l-~L~~L~l~~N~l~g~~p~~~~~~~~~~ 313 (973)
+.. +++|+.+++++|++....+ ..+..+ ++..++++.|.+.+..|..+...-.+.
T Consensus 393 ~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~ 472 (635)
T 4g8a_A 393 DFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLE 472 (635)
T ss_dssp HHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCC
T ss_pred hhhhhhhhhhhccccccccccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhh
Confidence 334 4444444554444443333 233334 566667777776665555433322222
Q ss_pred cCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCCCccchhhhCcc
Q 041143 314 SNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLD 393 (973)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~ 393 (973)
..++.+........++....+..+..++++.|.+..++.. .+..+++|++|+|++|+|++..|..|.+++
T Consensus 473 ~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~----------~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~ 542 (635)
T 4g8a_A 473 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT----------AFNSLSSLQVLNMSHNNFFSLDTFPYKCLN 542 (635)
T ss_dssp EEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTT----------TTTTCTTCCEEECTTSCCCBCCCGGGTTCT
T ss_pred hhhhhhcccccccCchhhhhccccCEEECCCCccCCcChH----------HHcCCCCCCEEECCCCcCCCCChhHHhCCC
Confidence 2222222111112233334456677888888888776433 467789999999999999999999999999
Q ss_pred ccceEEccCCccccccCccccCc-CCCCeeeCCCCcCCCCC
Q 041143 394 SLIEIRLGKNSISGTVPNNFTEL-KSLRLLDVSDNNIKPPL 433 (973)
Q Consensus 394 ~L~~L~L~~N~l~g~~p~~~~~l-~~L~~L~Ls~N~l~g~~ 433 (973)
+|+.|+|++|+|++..|..|..+ ++|++|+|++|++++.-
T Consensus 543 ~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C 583 (635)
T 4g8a_A 543 SLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTC 583 (635)
T ss_dssp TCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSG
T ss_pred CCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccC
Confidence 99999999999999999999998 68999999999999854
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.96 E-value=5.9e-29 Score=273.35 Aligned_cols=224 Identities=22% Similarity=0.424 Sum_probs=171.9
Q ss_pred CeEEEEEecc-cCCcccCCcCcccccccceeeccCcccCCCCC-CCCCCCccceeeccCCCCCCCCccccCCCCCccEEE
Q 041143 67 NRVTQIQVQN-LGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLA 144 (973)
Q Consensus 67 ~~v~~L~L~~-~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~ 144 (973)
..++.|+|++ |.+.+.+|..|+++++|++|+|++|.+++.+| .|.+ +++|++|+
T Consensus 76 ~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~------------------------l~~L~~L~ 131 (313)
T 1ogq_A 76 PYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQ------------------------IKTLVTLD 131 (313)
T ss_dssp TTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGG------------------------CTTCCEEE
T ss_pred CCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhC------------------------CCCCCEEe
Confidence 4678889985 88998999999999999999888888887665 3444 44555555
Q ss_pred cccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCC-CCCeEEccCCcCcccCChhhhhhHHHHHhhccc
Q 041143 145 LDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLP-SLAALKLSYNRLSGVIPASFGQSLMQILWLNDQ 223 (973)
Q Consensus 145 Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~ 223 (973)
|++|++++. +|..+..+++|++|+|++|++++.+|..+..++ +|++|+|++|++++.+|..+..
T Consensus 132 Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~----------- 196 (313)
T 1ogq_A 132 FSYNALSGT----LPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFAN----------- 196 (313)
T ss_dssp CCSSEEESC----CCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGG-----------
T ss_pred CCCCccCCc----CChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhC-----------
Confidence 555555543 777888889999999999999988898899888 8999999999998888887642
Q ss_pred CCCCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcccccCcccccccccCeEEccCCcCcCCCC
Q 041143 224 DAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMGPIP 303 (973)
Q Consensus 224 ~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~L~~L~l~~N~l~g~~p 303 (973)
+. |+.|+|++|++++.+|..|..+++|+.|+|++|++++.+|. +..
T Consensus 197 --------------l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~------------------ 242 (313)
T 1ogq_A 197 --------------LN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGL------------------ 242 (313)
T ss_dssp --------------CC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCC------------------
T ss_pred --------------Cc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccc------------------
Confidence 54 99999999999988888899999999999999999876654 322
Q ss_pred CCCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCCC
Q 041143 304 KFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTG 383 (973)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~ 383 (973)
+++|++|+|++|++++
T Consensus 243 ----------------------------------------------------------------l~~L~~L~Ls~N~l~~ 258 (313)
T 1ogq_A 243 ----------------------------------------------------------------SKNLNGLDLRNNRIYG 258 (313)
T ss_dssp ----------------------------------------------------------------CTTCCEEECCSSCCEE
T ss_pred ----------------------------------------------------------------cCCCCEEECcCCcccC
Confidence 1245566666666666
Q ss_pred ccchhhhCccccceEEccCCccccccCccccCcCCCCeeeCCCCc
Q 041143 384 TLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNN 428 (973)
Q Consensus 384 ~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~ 428 (973)
.+|..|..+++|+.|+|++|+|+|.+|.. ..+++|+.|++++|+
T Consensus 259 ~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 259 TLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNK 302 (313)
T ss_dssp CCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSS
T ss_pred cCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCC
Confidence 66667777777778888888777777765 666767666665543
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-28 Score=281.53 Aligned_cols=245 Identities=23% Similarity=0.282 Sum_probs=181.3
Q ss_pred EEecccCCcccCCcCcccccccceeeccCcccCCCCC-CCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCC
Q 041143 72 IQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPF 150 (973)
Q Consensus 72 L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l 150 (973)
+++.+.+|+ .+|..+. ++|+.|+|++|+|++..+ .|.++++|++|+|++|+|+.+++..|.++++|++|+|++|+|
T Consensus 48 v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l 124 (440)
T 3zyj_A 48 VICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL 124 (440)
T ss_dssp EECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCC
T ss_pred EEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcC
Confidence 344445555 5676665 688999999999998776 789999999999999999999988899999999999999988
Q ss_pred CCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCC
Q 041143 151 NKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTG 230 (973)
Q Consensus 151 ~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~ 230 (973)
+.. .+..|..+++|++|+|++|+|+...+..|.++++|++|+|++|+..+.++..
T Consensus 125 ~~~----~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~--------------------- 179 (440)
T 3zyj_A 125 TTI----PNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEG--------------------- 179 (440)
T ss_dssp SSC----CTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTT---------------------
T ss_pred Cee----CHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcc---------------------
Confidence 863 3346888888888888888888777778888888888888885544344432
Q ss_pred cchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcccccCcccccccccCeEEccCCcCcCCCCCCCCCCc
Q 041143 231 PIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMGPIPKFKAGNV 310 (973)
Q Consensus 231 ~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~L~~L~l~~N~l~g~~p~~~~~~~ 310 (973)
.|.++++|++|+|++|+++ .+| .+..+++|++|+|++|++++..|..|..+
T Consensus 180 ---~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l------------------------ 230 (440)
T 3zyj_A 180 ---AFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGL------------------------ 230 (440)
T ss_dssp ---TTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTC------------------------
T ss_pred ---hhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccC------------------------
Confidence 2346788888888888887 555 46777777777777777776655555443
Q ss_pred ccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCCCccchhhh
Q 041143 311 TYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIA 390 (973)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~ 390 (973)
++|+.|+|++|++.+..+..|.
T Consensus 231 ----------------------------------------------------------~~L~~L~L~~n~l~~~~~~~~~ 252 (440)
T 3zyj_A 231 ----------------------------------------------------------MHLQKLWMIQSQIQVIERNAFD 252 (440)
T ss_dssp ----------------------------------------------------------TTCCEEECTTCCCCEECTTSST
T ss_pred ----------------------------------------------------------ccCCEEECCCCceeEEChhhhc
Confidence 3455555555555555555667
Q ss_pred CccccceEEccCCccccccCccccCcCCCCeeeCCCCcCCC
Q 041143 391 NLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKP 431 (973)
Q Consensus 391 ~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g 431 (973)
++++|+.|+|++|+|++..+..|..+++|+.|+|++|.+..
T Consensus 253 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C 293 (440)
T 3zyj_A 253 NLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNC 293 (440)
T ss_dssp TCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEEC
T ss_pred CCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccC
Confidence 77777777777777776666667777777777777777654
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-28 Score=280.02 Aligned_cols=316 Identities=17% Similarity=0.122 Sum_probs=242.9
Q ss_pred ccCCcccCCcCcccccccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccC
Q 041143 76 NLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFG 155 (973)
Q Consensus 76 ~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~ 155 (973)
..+..+..+..++++++|++|+|++|.|++. |.+..+++|++|+|++|+|+.++ |..+++|++|+|++|++++
T Consensus 27 ~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~~l~~l~~L~~L~Ls~n~l~~~~---~~~l~~L~~L~Ls~N~l~~--- 99 (457)
T 3bz5_A 27 AFEMQATDTISEEQLATLTSLDCHNSSITDM-TGIEKLTGLTKLICTSNNITTLD---LSQNTNLTYLACDSNKLTN--- 99 (457)
T ss_dssp HTTCCTTSEEEHHHHTTCCEEECCSSCCCCC-TTGGGCTTCSEEECCSSCCSCCC---CTTCTTCSEEECCSSCCSC---
T ss_pred hcCcCcccccChhHcCCCCEEEccCCCcccC-hhhcccCCCCEEEccCCcCCeEc---cccCCCCCEEECcCCCCce---
Confidence 3455566677899999999999999999986 58999999999999999999986 8899999999999999997
Q ss_pred CCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhh
Q 041143 156 WSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVV 235 (973)
Q Consensus 156 ~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 235 (973)
++ ++++++|++|+|++|++++. + ++.+++|++|+|++|++++. + +. .+..+..|....+...... .+
T Consensus 100 --~~--~~~l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l-~--l~-~l~~L~~L~l~~n~~~~~~--~~ 166 (457)
T 3bz5_A 100 --LD--VTPLTKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI-D--VS-HNTQLTELDCHLNKKITKL--DV 166 (457)
T ss_dssp --CC--CTTCTTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC-C--CT-TCTTCCEEECTTCSCCCCC--CC
T ss_pred --ee--cCCCCcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee-c--cc-cCCcCCEEECCCCCccccc--cc
Confidence 43 88999999999999999974 4 89999999999999999974 3 22 1223334444444222222 36
Q ss_pred cCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcccccCccccccc-ccCeEEccCCcCcCCCCCCCCCCccccc
Q 041143 236 AKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGPIPKFKAGNVTYDS 314 (973)
Q Consensus 236 ~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~g~~p~~~~~~~~~~~ 314 (973)
..+++|++|+|++|++++ +| +..+++|+.|++++|++++. .+..+ +|+.|++++|++++ +|-
T Consensus 167 ~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip~---------- 229 (457)
T 3bz5_A 167 TPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-IDV---------- 229 (457)
T ss_dssp TTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CCC----------
T ss_pred ccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cCc----------
Confidence 778999999999999985 55 88889999999999999875 36666 79999999999987 441
Q ss_pred CcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCCCccchhhhCccc
Q 041143 315 NSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDS 394 (973)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~ 394 (973)
..+..+..++++.|.+..++...... +..-.....+|+.|++++|.+.|.+| ++.+++
T Consensus 230 -----------------~~l~~L~~L~l~~N~l~~~~~~~l~~---L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~ 287 (457)
T 3bz5_A 230 -----------------TPLTQLTYFDCSVNPLTELDVSTLSK---LTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRK 287 (457)
T ss_dssp -----------------TTCTTCSEEECCSSCCSCCCCTTCTT---CCEEECTTCCCSCCCCTTCTTCCEEE--CTTCTT
T ss_pred -----------------cccCCCCEEEeeCCcCCCcCHHHCCC---CCEEeccCCCCCEEECCCCccCCccc--cccccc
Confidence 11234566677777777664221111 11001122467888999999999888 578999
Q ss_pred cceEEccCCccccccCcc--------ccCcCCCCeeeCCCCcCCCCC-CCCCcccceeecCCccc
Q 041143 395 LIEIRLGKNSISGTVPNN--------FTELKSLRLLDVSDNNIKPPL-PEFHDTVKLVIDGNPLL 450 (973)
Q Consensus 395 L~~L~L~~N~l~g~~p~~--------~~~l~~L~~L~Ls~N~l~g~~-p~~~~~~~~~~~~N~~~ 450 (973)
|+.|+|++|.+.|.+|.. +..+++|++|+|++|+|+|.. ..+.++..+++.+|.+.
T Consensus 288 L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~l~l~~l~~L~~L~l~~N~l~ 352 (457)
T 3bz5_A 288 IKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTELDVSHNTKLKSLSCVNAHIQ 352 (457)
T ss_dssp CCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCSEEECCSSCCC
T ss_pred CCEEECCCCcccceeccCCCcceEechhhcccCCEEECCCCcccccccccCCcCcEEECCCCCCC
Confidence 999999999988888753 566789999999999999951 13456677899999764
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-28 Score=282.43 Aligned_cols=325 Identities=19% Similarity=0.212 Sum_probs=162.7
Q ss_pred CeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCC-CCCCCCcc-------------ceeeccCCCCCCCCcc
Q 041143 67 NRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSEL-------------EFAYLDFNEFDTIPSD 132 (973)
Q Consensus 67 ~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L-------------~~L~L~~N~l~~i~~~ 132 (973)
.++++|++++|++ |.+|++|++|++|++|+|++|.++|.+| .+.++++| ++|++++|+++.+|..
T Consensus 11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~lp~~ 89 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLPEL 89 (454)
T ss_dssp ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCCCSC
T ss_pred ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccCCCC
Confidence 3566667777776 5667667777777777777777666555 45555443 5555555555554431
Q ss_pred c----------------cCCCCCccEEEcccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEE
Q 041143 133 F----------------FDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALK 196 (973)
Q Consensus 133 ~----------------f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 196 (973)
. -..+++|++|+|++|++++ +|.. .++|++|+|++|++++ +| .|+++++|++|+
T Consensus 90 ~~~L~~L~l~~n~l~~lp~~~~~L~~L~l~~n~l~~-----l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~ 159 (454)
T 1jl5_A 90 PPHLESLVASCNSLTELPELPQSLKSLLVDNNNLKA-----LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIID 159 (454)
T ss_dssp CTTCSEEECCSSCCSSCCCCCTTCCEEECCSSCCSC-----CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEE
T ss_pred cCCCCEEEccCCcCCccccccCCCcEEECCCCccCc-----ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEE
Confidence 0 0012445555555555543 2211 1577888888888875 56 478888888888
Q ss_pred ccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCccc
Q 041143 197 LSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLV 276 (973)
Q Consensus 197 Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~ 276 (973)
+++|++++ +|..+. .+.+|+...+.....+ .+.++++|++|++++|++++ +|... ++|++|++++|.++
T Consensus 160 l~~N~l~~-lp~~~~----~L~~L~L~~n~l~~l~--~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n~l~ 228 (454)
T 1jl5_A 160 VDNNSLKK-LPDLPP----SLEFIAAGNNQLEELP--ELQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGNNILE 228 (454)
T ss_dssp CCSSCCSC-CCCCCT----TCCEEECCSSCCSSCC--CCTTCTTCCEEECCSSCCSS-CCCCC---TTCCEEECCSSCCS
T ss_pred CCCCcCcc-cCCCcc----cccEEECcCCcCCcCc--cccCCCCCCEEECCCCcCCc-CCCCc---CcccEEECcCCcCC
Confidence 88888874 554432 2223333333222222 46677777777777777774 44332 46777777777777
Q ss_pred ccCccccccc-ccCeEEccCCcCcCCCCCCCCCCcc---cccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCC
Q 041143 277 GLIPKSLANM-ELDNLVLNNNLLMGPIPKFKAGNVT---YDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPG 352 (973)
Q Consensus 277 ~~~p~~~~~l-~L~~L~l~~N~l~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~ 352 (973)
.+|. +..+ +|+.|++++|++++ +|... ..+. +..+.+.+ .+. ....+..++++.|.+..++.
T Consensus 229 -~lp~-~~~l~~L~~L~l~~N~l~~-l~~~~-~~L~~L~l~~N~l~~-------l~~---~~~~L~~L~ls~N~l~~l~~ 294 (454)
T 1jl5_A 229 -ELPE-LQNLPFLTTIYADNNLLKT-LPDLP-PSLEALNVRDNYLTD-------LPE---LPQSLTFLDVSENIFSGLSE 294 (454)
T ss_dssp -SCCC-CTTCTTCCEEECCSSCCSS-CCSCC-TTCCEEECCSSCCSC-------CCC---CCTTCCEEECCSSCCSEESC
T ss_pred -cccc-cCCCCCCCEEECCCCcCCc-ccccc-cccCEEECCCCcccc-------cCc---ccCcCCEEECcCCccCcccC
Confidence 4553 5555 67777777777765 33321 1111 11111111 000 01233444444444433221
Q ss_pred CCCCCCCccccccCCCCcccEEecCCCcCCCccchhhhCc-cccceEEccCCccccccCccccCcCCCCeeeCCCCcCCC
Q 041143 353 NDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANL-DSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKP 431 (973)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g 431 (973)
. .++|+.|++++|++.+. + .+ ++|+.|+|++|+|++ +|.. +++|++|+|++|++++
T Consensus 295 ~--------------~~~L~~L~l~~N~l~~i-~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~ 351 (454)
T 1jl5_A 295 L--------------PPNLYYLNASSNEIRSL-C----DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAE 351 (454)
T ss_dssp C--------------CTTCCEEECCSSCCSEE-C----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC
T ss_pred c--------------CCcCCEEECcCCcCCcc-c----CCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCcccc
Confidence 0 13555566666655541 1 22 366677777777664 5543 4666777777777765
Q ss_pred CCCCCCcccceeecCCccc
Q 041143 432 PLPEFHDTVKLVIDGNPLL 450 (973)
Q Consensus 432 ~~p~~~~~~~~~~~~N~~~ 450 (973)
.++.+.++..+++.+|++.
T Consensus 352 lp~~l~~L~~L~L~~N~l~ 370 (454)
T 1jl5_A 352 VPELPQNLKQLHVEYNPLR 370 (454)
T ss_dssp CCCCCTTCCEEECCSSCCS
T ss_pred ccchhhhccEEECCCCCCC
Confidence 4433345555666666654
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.8e-28 Score=281.67 Aligned_cols=244 Identities=23% Similarity=0.267 Sum_probs=182.5
Q ss_pred ecccCCcccCCcCcccccccceeeccCcccCCCCC-CCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCC
Q 041143 74 VQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNK 152 (973)
Q Consensus 74 L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~ 152 (973)
+.+.+++ .+|..+. ++|++|+|++|+|++..+ .|.++++|++|+|++|+|+.+++..|.++++|++|+|++|+|+.
T Consensus 61 c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~ 137 (452)
T 3zyi_A 61 CTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTV 137 (452)
T ss_dssp CCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSB
T ss_pred ECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCc
Confidence 3334444 4666554 688999999999999876 68899999999999999999988889999999999999999886
Q ss_pred ccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcc
Q 041143 153 TFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPI 232 (973)
Q Consensus 153 ~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 232 (973)
. .+..|..+++|++|+|++|+|+...+..|.++++|++|+|++|+..+.++..
T Consensus 138 ~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~----------------------- 190 (452)
T 3zyi_A 138 I----PSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEG----------------------- 190 (452)
T ss_dssp C----CTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTT-----------------------
T ss_pred c----ChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChh-----------------------
Confidence 3 3455788888899999888888777778888888888888885443344432
Q ss_pred hhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcccccCcccccccccCeEEccCCcCcCCCCCCCCCCccc
Q 041143 233 DVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMGPIPKFKAGNVTY 312 (973)
Q Consensus 233 ~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~L~~L~l~~N~l~g~~p~~~~~~~~~ 312 (973)
.|.++++|++|+|++|++++ +| .+..+++|++|+|++|++++..|..|..+
T Consensus 191 -~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-------------------------- 241 (452)
T 3zyi_A 191 -AFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGL-------------------------- 241 (452)
T ss_dssp -TTTTCTTCCEEECTTSCCSS-CC-CCTTCTTCCEEECTTSCCSEECGGGGTTC--------------------------
T ss_pred -hccCCCCCCEEECCCCcccc-cc-cccccccccEEECcCCcCcccCcccccCc--------------------------
Confidence 23467888888888888883 44 47777788888888887776666555543
Q ss_pred ccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCCCccchhhhCc
Q 041143 313 DSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANL 392 (973)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l 392 (973)
++|+.|+|++|++.+..|..|.++
T Consensus 242 --------------------------------------------------------~~L~~L~L~~n~l~~~~~~~~~~l 265 (452)
T 3zyi_A 242 --------------------------------------------------------SSLKKLWVMNSQVSLIERNAFDGL 265 (452)
T ss_dssp --------------------------------------------------------TTCCEEECTTSCCCEECTTTTTTC
T ss_pred --------------------------------------------------------cCCCEEEeCCCcCceECHHHhcCC
Confidence 345555555555555556667777
Q ss_pred cccceEEccCCccccccCccccCcCCCCeeeCCCCcCCCC
Q 041143 393 DSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPP 432 (973)
Q Consensus 393 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ 432 (973)
++|+.|+|++|+|++..+..|..+++|+.|+|++|.+...
T Consensus 266 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~Cd 305 (452)
T 3zyi_A 266 ASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCD 305 (452)
T ss_dssp TTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECS
T ss_pred CCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCC
Confidence 7888888888888766666777788888888888777654
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-30 Score=301.94 Aligned_cols=217 Identities=20% Similarity=0.200 Sum_probs=160.7
Q ss_pred CCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCC
Q 041143 112 GLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPS 191 (973)
Q Consensus 112 ~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 191 (973)
.+++|++|+|++|.|+.+++..|..+++|++|+|++|.+++. .| +..+++|++|+|++|.|++..+ .++
T Consensus 32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~----~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~ 100 (487)
T 3oja_A 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYET----LD--LESLSTLRTLDLNNNYVQELLV-----GPS 100 (487)
T ss_dssp TGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEE----EE--CTTCTTCCEEECCSSEEEEEEE-----CTT
T ss_pred cCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCC----cc--cccCCCCCEEEecCCcCCCCCC-----CCC
Confidence 344677777777777777777777777777777777777653 22 6777777777777777774332 277
Q ss_pred CCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCc
Q 041143 192 LAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLN 271 (973)
Q Consensus 192 L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls 271 (973)
|++|+|++|+|++..+. .+++|+.|+|++|.|++..|..++.+++|++|+|+
T Consensus 101 L~~L~L~~N~l~~~~~~----------------------------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 152 (487)
T 3oja_A 101 IETLHAANNNISRVSCS----------------------------RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLK 152 (487)
T ss_dssp CCEEECCSSCCCCEEEC----------------------------CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECT
T ss_pred cCEEECcCCcCCCCCcc----------------------------ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECC
Confidence 78888888877754332 25677888888888887777777778888888888
Q ss_pred CCcccccCccccc-cc-ccCeEEccCCcCcCCCCCCCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCC
Q 041143 272 RNQLVGLIPKSLA-NM-ELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQ 349 (973)
Q Consensus 272 ~N~l~~~~p~~~~-~l-~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~ 349 (973)
+|.+++.+|..+. .+ +|+.|+|++|.|++..+.
T Consensus 153 ~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~~--------------------------------------------- 187 (487)
T 3oja_A 153 LNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQ--------------------------------------------- 187 (487)
T ss_dssp TSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECC---------------------------------------------
T ss_pred CCCCCCcChHHHhhhCCcccEEecCCCcccccccc---------------------------------------------
Confidence 8888877777665 44 688888888877653211
Q ss_pred CCCCCCCCCCccccccCCCCcccEEecCCCcCCCccchhhhCccccceEEccCCccccccCccccCcCCCCeeeCCCCcC
Q 041143 350 WPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNI 429 (973)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l 429 (973)
..+++|+.|+|++|.+++..| .+..+++|+.|+|++|+|++ +|..+..+++|+.|+|++|.+
T Consensus 188 ----------------~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l 249 (487)
T 3oja_A 188 ----------------VVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGF 249 (487)
T ss_dssp ----------------CCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCB
T ss_pred ----------------ccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCC
Confidence 135678899999999987555 48889999999999999984 788899999999999999988
Q ss_pred C
Q 041143 430 K 430 (973)
Q Consensus 430 ~ 430 (973)
.
T Consensus 250 ~ 250 (487)
T 3oja_A 250 H 250 (487)
T ss_dssp C
T ss_pred c
Confidence 7
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.8e-29 Score=296.68 Aligned_cols=187 Identities=19% Similarity=0.160 Sum_probs=131.5
Q ss_pred cccccCccEEEEEE-ECCCCEEEEEEeecCCC--------ChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeEEEE
Q 041143 632 ELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVT--------TTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGNERLLV 701 (973)
Q Consensus 632 ~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~--------~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 701 (973)
..+.|++|.++.++ .-.|+.+|||++..... .....++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 46677777777653 33588999999965421 123456799999999999 699999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccC
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA 781 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~ 781 (973)
|||++||+|.+++.. ..+++.. +|+.||+.||+|+| ++|||||||||+|||+++++++||+|||+|+..
T Consensus 321 MEyv~G~~L~d~i~~-----~~~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~ 389 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA-----GEEIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTT 389 (569)
T ss_dssp EECCCSEEHHHHHHT-----TCCCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESC
T ss_pred EecCCCCcHHHHHHh-----CCCCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeC
Confidence 999999999999965 2345543 58999999999999 899999999999999999999999999999866
Q ss_pred CCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCC
Q 041143 782 PDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAA 831 (973)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p 831 (973)
..... .....+||++|||||++.+ .+..++|+||+|++++++.++..+
T Consensus 390 ~~~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 390 PQDCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp C---C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCCCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 54322 3445689999999998865 567789999999999888766443
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-27 Score=274.33 Aligned_cols=320 Identities=20% Similarity=0.271 Sum_probs=188.8
Q ss_pred CeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcc
Q 041143 67 NRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALD 146 (973)
Q Consensus 67 ~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls 146 (973)
.+++.|+|++|.+++ +|.. +++|++|+|++|++++... + .++|++|+|++|+++.+| .|.++++|++|+++
T Consensus 91 ~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~l~~-~--~~~L~~L~L~~n~l~~lp--~~~~l~~L~~L~l~ 161 (454)
T 1jl5_A 91 PHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKALSD-L--PPLLEYLGVSNNQLEKLP--ELQNSSFLKIIDVD 161 (454)
T ss_dssp TTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSCCCS-C--CTTCCEEECCSSCCSSCC--CCTTCTTCCEEECC
T ss_pred CCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCcccC-C--CCCCCEEECcCCCCCCCc--ccCCCCCCCEEECC
Confidence 467888888888886 5643 3778888888888887432 1 168999999999999887 38899999999999
Q ss_pred cCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCC
Q 041143 147 YNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAG 226 (973)
Q Consensus 147 ~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~ 226 (973)
+|++++ +|..+ .+|++|+|++|++++ +| .++++++|++|++++|++++ +|.... .+..|....+.
T Consensus 162 ~N~l~~-----lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~~----~L~~L~l~~n~ 226 (454)
T 1jl5_A 162 NNSLKK-----LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLPL----SLESIVAGNNI 226 (454)
T ss_dssp SSCCSC-----CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCCT----TCCEEECCSSC
T ss_pred CCcCcc-----cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCcC----cccEEECcCCc
Confidence 999886 55443 488999999999986 55 58899999999999999985 444321 22333333333
Q ss_pred CCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcccccCcccccccccCeEEccCCcCcC--CCCC
Q 041143 227 GMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMG--PIPK 304 (973)
Q Consensus 227 ~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~L~~L~l~~N~l~g--~~p~ 304 (973)
....+ .+.++++|++|++++|++++ +|.. +++|++|++++|++++ +|..+ .+|+.|++++|.+++ .+|.
T Consensus 227 l~~lp--~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~~--~~L~~L~ls~N~l~~l~~~~~ 297 (454)
T 1jl5_A 227 LEELP--ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPELP--QSLTFLDVSENIFSGLSELPP 297 (454)
T ss_dssp CSSCC--CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCCC--TTCCEEECCSSCCSEESCCCT
T ss_pred CCccc--ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCccc--CcCCEEECcCCccCcccCcCC
Confidence 33222 36778888888888888874 5543 3678888888888876 44433 267888888888876 3332
Q ss_pred CCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCCCc
Q 041143 305 FKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGT 384 (973)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~ 384 (973)
. ...+.+..+.+.+. + .....+..++++.|.+..++.. +++|++|+|++|++++
T Consensus 298 ~-L~~L~l~~N~l~~i-------~---~~~~~L~~L~Ls~N~l~~lp~~--------------~~~L~~L~L~~N~l~~- 351 (454)
T 1jl5_A 298 N-LYYLNASSNEIRSL-------C---DLPPSLEELNVSNNKLIELPAL--------------PPRLERLIASFNHLAE- 351 (454)
T ss_dssp T-CCEEECCSSCCSEE-------C---CCCTTCCEEECCSSCCSCCCCC--------------CTTCCEEECCSSCCSC-
T ss_pred c-CCEEECcCCcCCcc-------c---CCcCcCCEEECCCCcccccccc--------------CCcCCEEECCCCcccc-
Confidence 1 11122222211110 0 1113455556666665554321 3567777777777764
Q ss_pred cchhhhCccccceEEccCCcccc--ccCccccCc-------------CCCCeeeCCCCcCCC--CCCCCCcccceeecCC
Q 041143 385 LSPSIANLDSLIEIRLGKNSISG--TVPNNFTEL-------------KSLRLLDVSDNNIKP--PLPEFHDTVKLVIDGN 447 (973)
Q Consensus 385 ~p~~~~~l~~L~~L~L~~N~l~g--~~p~~~~~l-------------~~L~~L~Ls~N~l~g--~~p~~~~~~~~~~~~N 447 (973)
+|. .+++|+.|+|++|++++ .+|..+..+ ++|+.|||++|+++| .+|. .+..+.+.+|
T Consensus 352 lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~~i~~~~~~L~~L~ls~N~l~~~~~iP~--sl~~L~~~~~ 426 (454)
T 1jl5_A 352 VPE---LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLREFPDIPE--SVEDLRMNSE 426 (454)
T ss_dssp CCC---CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC------------------------------------------
T ss_pred ccc---hhhhccEEECCCCCCCcCCCChHHHHhhhhcccccccccccCcCCEEECCCCcCCccccchh--hHhheeCcCc
Confidence 444 35677777777777776 667776666 667777777777776 4442 2334444444
Q ss_pred ccc
Q 041143 448 PLL 450 (973)
Q Consensus 448 ~~~ 450 (973)
.+.
T Consensus 427 ~~~ 429 (454)
T 1jl5_A 427 RVV 429 (454)
T ss_dssp ---
T ss_pred ccC
Confidence 443
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.5e-28 Score=265.33 Aligned_cols=228 Identities=19% Similarity=0.235 Sum_probs=160.0
Q ss_pred CccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCC
Q 041143 114 SELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLA 193 (973)
Q Consensus 114 ~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~ 193 (973)
++++.|+|++|+|+.+|.. +..+++|++|+|++|.++. +|..++++++|++|+|++|+++ .+|..++++++|+
T Consensus 81 ~~l~~L~L~~n~l~~lp~~-l~~l~~L~~L~L~~n~l~~-----lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~ 153 (328)
T 4fcg_A 81 PGRVALELRSVPLPQFPDQ-AFRLSHLQHMTIDAAGLME-----LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLR 153 (328)
T ss_dssp TTCCEEEEESSCCSSCCSC-GGGGTTCSEEEEESSCCCC-----CCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCC
T ss_pred cceeEEEccCCCchhcChh-hhhCCCCCEEECCCCCccc-----hhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCC
Confidence 3444555555555555444 2335666666666666652 6666777777777777777777 6677777777777
Q ss_pred eEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCC
Q 041143 194 ALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRN 273 (973)
Q Consensus 194 ~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N 273 (973)
+|+|++|++.+.+|..+... .....|.++++|++|+|++|+|+ .+|..+..+++|++|+|++|
T Consensus 154 ~L~L~~n~~~~~~p~~~~~~----------------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N 216 (328)
T 4fcg_A 154 ELSIRACPELTELPEPLAST----------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNS 216 (328)
T ss_dssp EEEEEEETTCCCCCSCSEEE----------------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESS
T ss_pred EEECCCCCCccccChhHhhc----------------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCC
Confidence 77777777776777655310 00122445777777777777777 77777777777777777777
Q ss_pred cccccCcccccccccCeEEccCCcCcCCCCCCCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCC
Q 041143 274 QLVGLIPKSLANMELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGN 353 (973)
Q Consensus 274 ~l~~~~p~~~~~l~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~ 353 (973)
++++ +|..+.
T Consensus 217 ~l~~-l~~~l~--------------------------------------------------------------------- 226 (328)
T 4fcg_A 217 PLSA-LGPAIH--------------------------------------------------------------------- 226 (328)
T ss_dssp CCCC-CCGGGG---------------------------------------------------------------------
T ss_pred CCCc-Cchhhc---------------------------------------------------------------------
Confidence 7774 333333
Q ss_pred CCCCCCccccccCCCCcccEEecCCCcCCCccchhhhCccccceEEccCCccccccCccccCcCCCCeeeCCCCcCCCCC
Q 041143 354 DPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPL 433 (973)
Q Consensus 354 ~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~ 433 (973)
.+++|++|+|++|++.+.+|..++++++|+.|+|++|++.+.+|..+.++++|++|+|++|++.+.+
T Consensus 227 -------------~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~i 293 (328)
T 4fcg_A 227 -------------HLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRL 293 (328)
T ss_dssp -------------GCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCC
T ss_pred -------------cCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhc
Confidence 3456777788888888888889999999999999999999999999999999999999999999999
Q ss_pred CC-CCc---ccceeecCCc
Q 041143 434 PE-FHD---TVKLVIDGNP 448 (973)
Q Consensus 434 p~-~~~---~~~~~~~~N~ 448 (973)
|. +.+ +..+.+..|.
T Consensus 294 P~~l~~L~~L~~l~l~~~~ 312 (328)
T 4fcg_A 294 PSLIAQLPANCIILVPPHL 312 (328)
T ss_dssp CGGGGGSCTTCEEECCGGG
T ss_pred cHHHhhccCceEEeCCHHH
Confidence 85 333 3345555443
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-27 Score=260.07 Aligned_cols=206 Identities=24% Similarity=0.354 Sum_probs=161.1
Q ss_pred EeeCCeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCC-CCCCCCccceeeccCCCCCCCCccccCCCCCcc
Q 041143 63 FCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVR 141 (973)
Q Consensus 63 ~C~~~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~ 141 (973)
.|.....+.+++++++++ .+|..+ .++|++|+|++|.+++.++ .|.++++|++|+|++|+|+.+.+..|.++++|+
T Consensus 7 ~C~~~~~~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 83 (285)
T 1ozn_A 7 VCYNEPKVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83 (285)
T ss_dssp EEECSSSCEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCC
T ss_pred eECCCCCeEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCC
Confidence 376555567788888887 456544 4689999999999998776 588899999999999999988888888899999
Q ss_pred EEEcccCC-CCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhh
Q 041143 142 VLALDYNP-FNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWL 220 (973)
Q Consensus 142 ~L~Ls~N~-l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l 220 (973)
+|+|++|+ +... .|..+..+++|++|+|++|++++..+..|.++++|++|+|++|++++..+..+
T Consensus 84 ~L~l~~n~~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~---------- 149 (285)
T 1ozn_A 84 QLDLSDNAQLRSV----DPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTF---------- 149 (285)
T ss_dssp EEECCSCTTCCCC----CTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT----------
T ss_pred EEeCCCCCCcccc----CHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHh----------
Confidence 99999887 6653 46778888888888888888888778888888888888888888875444333
Q ss_pred cccCCCCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcccccCccccccc-ccCeEEccCCcCc
Q 041143 221 NDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLM 299 (973)
Q Consensus 221 ~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~ 299 (973)
.++++|++|+|++|++++..+..|..+++|++|+|++|.+++..|..+..+ +|+.|++++|.++
T Consensus 150 ---------------~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 214 (285)
T 1ozn_A 150 ---------------RDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS 214 (285)
T ss_dssp ---------------TTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred ---------------ccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCC
Confidence 357888888888888886656668888888888888888887777777665 5666666666665
Q ss_pred C
Q 041143 300 G 300 (973)
Q Consensus 300 g 300 (973)
+
T Consensus 215 ~ 215 (285)
T 1ozn_A 215 A 215 (285)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-28 Score=271.46 Aligned_cols=251 Identities=20% Similarity=0.219 Sum_probs=161.7
Q ss_pred EEeeCCeEEEEEecccCCcccCCcCcccccccceeeccCcccCC-CCCC-CC-------CCCccceeeccCCCCCC-CCc
Q 041143 62 VFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNG-KLPT-FS-------GLSELEFAYLDFNEFDT-IPS 131 (973)
Q Consensus 62 v~C~~~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~-~~~~-~~-------~l~~L~~L~L~~N~l~~-i~~ 131 (973)
+.|...+++.|++++|.+ .+|..+... |+.|+|++|.++. .+|. +. ++++|++|+|++|+|+. +|.
T Consensus 38 ~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 113 (312)
T 1wwl_A 38 LYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPP 113 (312)
T ss_dssp EEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCC
T ss_pred EEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHH
Confidence 556666777777788877 667666655 7778888888743 4442 22 57777777777777774 444
Q ss_pred ccc-CCCCCccEEEcccCCCCCccCCCCCcccccc-----cccCeeecccccccCCcchhccCCCCCCeEEccCCcCccc
Q 041143 132 DFF-DGLSSVRVLALDYNPFNKTFGWSIPDSLANS-----VQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGV 205 (973)
Q Consensus 132 ~~f-~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l-----~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 205 (973)
..| ..+++|++|+|++|++++ +|..+..+ ++|++|+|++|+|++..|..|+++++|++|+|++|++.+.
T Consensus 114 ~~~~~~l~~L~~L~Ls~N~l~~-----~~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 188 (312)
T 1wwl_A 114 PLLEATGPDLNILNLRNVSWAT-----RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGE 188 (312)
T ss_dssp CSSSCCSCCCSEEEEESCBCSS-----SSSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHH
T ss_pred HHHHhcCCCccEEEccCCCCcc-----hhHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcc
Confidence 433 777777777777777775 46666666 7777777777777776667777777777777777776654
Q ss_pred CC--hhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCcccc--CCC-ccccCCCCCCEEeCcCCcccccCc
Q 041143 206 IP--ASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTG--SIP-EDIGALSSLKDLNLNRNQLVGLIP 280 (973)
Q Consensus 206 ~p--~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g--~~p-~~~~~l~~L~~L~Ls~N~l~~~~p 280 (973)
++ ..+ .+.++++|++|+|++|+|++ .++ ..+..+++|++|+|++|++++.+|
T Consensus 189 ~~~~~~~-----------------------~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 245 (312)
T 1wwl_A 189 RGLISAL-----------------------CPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG 245 (312)
T ss_dssp HHHHHHS-----------------------CTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCC
T ss_pred hHHHHHH-----------------------HhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccc
Confidence 21 111 12356677777777777662 122 223455666666666666665443
Q ss_pred c-cccccccCeEEccCCcCcCCCCCCCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCCCCC
Q 041143 281 K-SLANMELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGP 359 (973)
Q Consensus 281 ~-~~~~l~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~ 359 (973)
. .+.
T Consensus 246 ~~~~~--------------------------------------------------------------------------- 250 (312)
T 1wwl_A 246 APSCD--------------------------------------------------------------------------- 250 (312)
T ss_dssp CSCCC---------------------------------------------------------------------------
T ss_pred hhhhh---------------------------------------------------------------------------
Confidence 1 222
Q ss_pred ccccccCCCCcccEEecCCCcCCCccchhhhCccccceEEccCCccccccCccccCcCCCCeeeCCCCcCCC
Q 041143 360 WLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKP 431 (973)
Q Consensus 360 ~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g 431 (973)
.+++|++|+|++|+++ .+|..+. ++|++|+|++|+|++. |. +..+++|++|+|++|+|++
T Consensus 251 -------~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 251 -------WPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp -------CCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred -------hcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 2345566666666665 4555554 6777777777777754 55 7777778888888887765
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-27 Score=267.19 Aligned_cols=274 Identities=18% Similarity=0.198 Sum_probs=228.8
Q ss_pred cccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCe
Q 041143 91 TKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTN 170 (973)
Q Consensus 91 ~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~ 170 (973)
+.....++++|.++.++..+. ++|++|+|++|+|+.+++..|.++++|++|+|++|++++. .|..|.++++|++
T Consensus 31 ~~~~~c~~~~~~l~~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~ 104 (353)
T 2z80_A 31 DRNGICKGSSGSLNSIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTI----EEDSFSSLGSLEH 104 (353)
T ss_dssp CTTSEEECCSTTCSSCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEE----CTTTTTTCTTCCE
T ss_pred CCCeEeeCCCCCccccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCcc----CHhhcCCCCCCCE
Confidence 344457899999998877554 5899999999999999999999999999999999999974 5678999999999
Q ss_pred eecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCC-
Q 041143 171 LSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGN- 249 (973)
Q Consensus 171 L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N- 249 (973)
|+|++|+|++..+..|.++++|++|+|++|+++ .+|.. ..|.++++|++|++++|
T Consensus 105 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~-----------------------~~~~~l~~L~~L~l~~n~ 160 (353)
T 2z80_A 105 LDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGET-----------------------SLFSHLTKLQILRVGNMD 160 (353)
T ss_dssp EECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSS-----------------------CSCTTCTTCCEEEEEESS
T ss_pred EECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCch-----------------------hhhccCCCCcEEECCCCc
Confidence 999999999776677999999999999999998 44430 12356999999999999
Q ss_pred ccccCCCccccCCCCCCEEeCcCCcccccCccccccc-ccCeEEccCCcCcCCCCCCCCCCcccccCcccCCCCCcccCC
Q 041143 250 QFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAP 328 (973)
Q Consensus 250 ~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (973)
.+++..|..|..+++|++|++++|++++..|..+..+ +|++|++++|.+.. +|..
T Consensus 161 ~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~-~~~~----------------------- 216 (353)
T 2z80_A 161 TFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHIL-LLEI----------------------- 216 (353)
T ss_dssp SCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTT-HHHH-----------------------
T ss_pred cccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCcccc-chhh-----------------------
Confidence 5776667889999999999999999999999999988 89999999999852 2210
Q ss_pred cchhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCCCccchhhh---CccccceEEccCCcc
Q 041143 329 DVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIA---NLDSLIEIRLGKNSI 405 (973)
Q Consensus 329 ~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~L~~N~l 405 (973)
.+..+++|+.|+|++|++++..+..+. ....++.++|++|.+
T Consensus 217 -----------------------------------~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l 261 (353)
T 2z80_A 217 -----------------------------------FVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKI 261 (353)
T ss_dssp -----------------------------------HHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBC
T ss_pred -----------------------------------hhhhcccccEEECCCCccccccccccccccccchhhccccccccc
Confidence 112356899999999999987766544 466788899999998
Q ss_pred cc----ccCccccCcCCCCeeeCCCCcCCCCCCC----CCcccceeecCCccccCC
Q 041143 406 SG----TVPNNFTELKSLRLLDVSDNNIKPPLPE----FHDTVKLVIDGNPLLVGG 453 (973)
Q Consensus 406 ~g----~~p~~~~~l~~L~~L~Ls~N~l~g~~p~----~~~~~~~~~~~N~~~c~~ 453 (973)
++ .+|..+..+++|+.|||++|+|+..++. +.++..+++.+|++.|..
T Consensus 262 ~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~ 317 (353)
T 2z80_A 262 TDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 317 (353)
T ss_dssp CHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred cCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcC
Confidence 87 5888899999999999999999966554 345667999999999864
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-26 Score=268.13 Aligned_cols=247 Identities=21% Similarity=0.206 Sum_probs=177.7
Q ss_pred cceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeee
Q 041143 93 LYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLS 172 (973)
Q Consensus 93 L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~ 172 (973)
...++.+++.++.++..+. ++|++|+|++|+|+.+++..|.++++|++|+|++|+|++. .+..|.++++|++|+
T Consensus 56 ~~~v~c~~~~l~~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~----~~~~~~~l~~L~~L~ 129 (452)
T 3zyi_A 56 FSKVVCTRRGLSEVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQI----EVGAFNGLASLNTLE 129 (452)
T ss_dssp SCEEECCSSCCSSCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEE----CTTTTTTCTTCCEEE
T ss_pred CcEEEECCCCcCccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCc----ChhhccCcccCCEEE
Confidence 3457777777776555443 5677777777777777777777777777777777777654 445666777777777
Q ss_pred cccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCC-cc
Q 041143 173 LINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGN-QF 251 (973)
Q Consensus 173 L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N-~l 251 (973)
|++|+|++..+..|.++++|++|+|++|+++...+..| .++++|+.|+|++| .+
T Consensus 130 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-------------------------~~l~~L~~L~l~~~~~l 184 (452)
T 3zyi_A 130 LFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAF-------------------------NRVPSLMRLDLGELKKL 184 (452)
T ss_dssp CCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTT-------------------------TTCTTCCEEECCCCTTC
T ss_pred CCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHH-------------------------hcCCcccEEeCCCCCCc
Confidence 77777776656666677777777777777663333222 34666666666663 33
Q ss_pred ccCCCccccCCCCCCEEeCcCCcccccCcccccccccCeEEccCCcCcCCCCCCCCCCcccccCcccCCCCCcccCCcch
Q 041143 252 TGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVN 331 (973)
Q Consensus 252 ~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (973)
+...+..|..+++|++|+|++|++++. | .
T Consensus 185 ~~i~~~~~~~l~~L~~L~L~~n~l~~~-~-----------------------~--------------------------- 213 (452)
T 3zyi_A 185 EYISEGAFEGLFNLKYLNLGMCNIKDM-P-----------------------N--------------------------- 213 (452)
T ss_dssp CEECTTTTTTCTTCCEEECTTSCCSSC-C-----------------------C---------------------------
T ss_pred cccChhhccCCCCCCEEECCCCccccc-c-----------------------c---------------------------
Confidence 322223456666666666666655532 1 1
Q ss_pred hhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCCCccchhhhCccccceEEccCCccccccCc
Q 041143 332 VLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPN 411 (973)
Q Consensus 332 ~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~ 411 (973)
+..+++|+.|+|++|++++..|..|.++++|+.|+|++|+|++..|.
T Consensus 214 ---------------------------------~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 260 (452)
T 3zyi_A 214 ---------------------------------LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERN 260 (452)
T ss_dssp ---------------------------------CTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTT
T ss_pred ---------------------------------ccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHH
Confidence 12346788999999999999999999999999999999999999999
Q ss_pred cccCcCCCCeeeCCCCcCCCCCCC----CCcccceeecCCccccCCC
Q 041143 412 NFTELKSLRLLDVSDNNIKPPLPE----FHDTVKLVIDGNPLLVGGI 454 (973)
Q Consensus 412 ~~~~l~~L~~L~Ls~N~l~g~~p~----~~~~~~~~~~~N~~~c~~~ 454 (973)
.|..+++|+.|||++|+|++.++. +.++..+++.+|||.|...
T Consensus 261 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~ 307 (452)
T 3zyi_A 261 AFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCD 307 (452)
T ss_dssp TTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTT
T ss_pred HhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCCC
Confidence 999999999999999999988775 3566779999999999753
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.3e-27 Score=279.63 Aligned_cols=282 Identities=23% Similarity=0.321 Sum_probs=221.4
Q ss_pred CCCCCCCCCCCCCCCcCeEE--------eeCCeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCCCCCCCCc
Q 041143 44 LKWPANGDDPCGPPPWPHVF--------CSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSE 115 (973)
Q Consensus 44 ~~w~~~~~d~C~~~~w~gv~--------C~~~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~ 115 (973)
..|.. +.+||. |.|.. |....++.|+|++++|+ .+|..+. ++|++|+|++|+|+.+++ .+++
T Consensus 13 ~~W~~-~~~~~~---~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~~lp~---~l~~ 82 (622)
T 3g06_A 13 SAWRR-AAPAEE---SRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSLPA---LPPE 82 (622)
T ss_dssp HHHHH-TCCGGG---HHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCSCCCC---CCTT
T ss_pred HHHHh-cCCcch---hccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCCCCCC---cCCC
Confidence 34532 456776 86643 44457999999999999 7888776 899999999999997655 6789
Q ss_pred cceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeE
Q 041143 116 LEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAAL 195 (973)
Q Consensus 116 L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 195 (973)
|++|+|++|+|+.+|. .+++|++|+|++|++++ +|. .+++|+.|+|++|+|++ +|.. +++|++|
T Consensus 83 L~~L~Ls~N~l~~lp~----~l~~L~~L~Ls~N~l~~-----l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L 146 (622)
T 3g06_A 83 LRTLEVSGNQLTSLPV----LPPGLLELSIFSNPLTH-----LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQEL 146 (622)
T ss_dssp CCEEEECSCCCSCCCC----CCTTCCEEEECSCCCCC-----CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEE
T ss_pred CCEEEcCCCcCCcCCC----CCCCCCEEECcCCcCCC-----CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEE
Confidence 9999999999999987 78999999999999996 565 56889999999999995 5543 5999999
Q ss_pred EccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcc
Q 041143 196 KLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQL 275 (973)
Q Consensus 196 ~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l 275 (973)
+|++|++++ +|.. +.+|+.|+|++|+|+ .+| ..+++|+.|+|++|+|
T Consensus 147 ~Ls~N~l~~-l~~~----------------------------~~~L~~L~L~~N~l~-~l~---~~~~~L~~L~Ls~N~l 193 (622)
T 3g06_A 147 SVSDNQLAS-LPAL----------------------------PSELCKLWAYNNQLT-SLP---MLPSGLQELSVSDNQL 193 (622)
T ss_dssp ECCSSCCSC-CCCC----------------------------CTTCCEEECCSSCCS-CCC---CCCTTCCEEECCSSCC
T ss_pred ECcCCcCCC-cCCc----------------------------cCCCCEEECCCCCCC-CCc---ccCCCCcEEECCCCCC
Confidence 999999984 4432 467888888888888 466 4467888888888888
Q ss_pred cccCcccccccccCeEEccCCcCcCCCCCCCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCC
Q 041143 276 VGLIPKSLANMELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDP 355 (973)
Q Consensus 276 ~~~~p~~~~~l~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~ 355 (973)
++ +|..+ .+|+.|++++|.|+. +|.. +..+..++++.|.+..++
T Consensus 194 ~~-l~~~~--~~L~~L~L~~N~l~~-l~~~----------------------------~~~L~~L~Ls~N~L~~lp---- 237 (622)
T 3g06_A 194 AS-LPTLP--SELYKLWAYNNRLTS-LPAL----------------------------PSGLKELIVSGNRLTSLP---- 237 (622)
T ss_dssp SC-CCCCC--TTCCEEECCSSCCSS-CCCC----------------------------CTTCCEEECCSSCCSCCC----
T ss_pred CC-CCCcc--chhhEEECcCCcccc-cCCC----------------------------CCCCCEEEccCCccCcCC----
Confidence 85 44332 267888888888763 3321 123455666666666654
Q ss_pred CCCCccccccCCCCcccEEecCCCcCCCccchhhhCccccceEEccCCccccccCccccCcCCCCeeeCCCCcCCCCCCC
Q 041143 356 CQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLPE 435 (973)
Q Consensus 356 ~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~ 435 (973)
..+++|+.|+|++|+|+. +|. .+++|+.|+|++|+|+ .+|..|.++++|+.|+|++|+|++.+|.
T Consensus 238 ----------~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~ 302 (622)
T 3g06_A 238 ----------VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 302 (622)
T ss_dssp ----------CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHH
T ss_pred ----------CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHH
Confidence 234689999999999985 555 6788999999999999 8899999999999999999999988775
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.94 E-value=8.5e-27 Score=255.73 Aligned_cols=249 Identities=19% Similarity=0.209 Sum_probs=188.8
Q ss_pred ceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeeec
Q 041143 94 YNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSL 173 (973)
Q Consensus 94 ~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L 173 (973)
+.++++++.++.++..+. ++|++|+|++|+|+.++..+|.++++|++|+|++|+++... .++..+..+++|++|+|
T Consensus 10 ~~l~c~~~~l~~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~--~~~~~~~~~~~L~~L~L 85 (306)
T 2z66_A 10 TEIRCNSKGLTSVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKG--CCSQSDFGTTSLKYLDL 85 (306)
T ss_dssp TEEECCSSCCSSCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEE--EEEHHHHSCSCCCEEEC
T ss_pred CEEEcCCCCcccCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCccc--CcccccccccccCEEEC
Confidence 457778888877665443 57888888888888888888888888888888888877420 12456667778888888
Q ss_pred ccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCcccc
Q 041143 174 INCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTG 253 (973)
Q Consensus 174 ~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g 253 (973)
++|.++ .+|..+..+++|++|+|++|++++..+.. .+.++++|++|+|++|.+++
T Consensus 86 s~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~------------------------~~~~l~~L~~L~l~~n~l~~ 140 (306)
T 2z66_A 86 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFS------------------------VFLSLRNLIYLDISHTHTRV 140 (306)
T ss_dssp CSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTT------------------------TTTTCTTCCEEECTTSCCEE
T ss_pred CCCccc-cChhhcCCCCCCCEEECCCCcccccccch------------------------hhhhccCCCEEECCCCcCCc
Confidence 888877 45666777888888888888777433311 13457777777777777777
Q ss_pred CCCccccCCCCCCEEeCcCCcccc-cCcccccccccCeEEccCCcCcCCCCCCCCCCcccccCcccCCCCCcccCCcchh
Q 041143 254 SIPEDIGALSSLKDLNLNRNQLVG-LIPKSLANMELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNV 332 (973)
Q Consensus 254 ~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (973)
..|..+..+++|++|+|++|.+++ .+|..+
T Consensus 141 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~------------------------------------------------- 171 (306)
T 2z66_A 141 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIF------------------------------------------------- 171 (306)
T ss_dssp CSTTTTTTCTTCCEEECTTCEEGGGEECSCC-------------------------------------------------
T ss_pred cchhhcccCcCCCEEECCCCccccccchhHH-------------------------------------------------
Confidence 677777777777777777777664 223222
Q ss_pred hhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCCCccchhhhCccccceEEccCCccccccCcc
Q 041143 333 LLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNN 412 (973)
Q Consensus 333 ~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~ 412 (973)
..+++|++|+|++|++++..|..|..+++|+.|+|++|+|++..+..
T Consensus 172 ---------------------------------~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 218 (306)
T 2z66_A 172 ---------------------------------TELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFP 218 (306)
T ss_dssp ---------------------------------TTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGG
T ss_pred ---------------------------------hhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhh
Confidence 23457888888888888888889999999999999999999887878
Q ss_pred ccCcCCCCeeeCCCCcCCCCCCC----C-CcccceeecCCccccCC
Q 041143 413 FTELKSLRLLDVSDNNIKPPLPE----F-HDTVKLVIDGNPLLVGG 453 (973)
Q Consensus 413 ~~~l~~L~~L~Ls~N~l~g~~p~----~-~~~~~~~~~~N~~~c~~ 453 (973)
|..+++|++|||++|++++.+|. + .++..+++.+|++.|..
T Consensus 219 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c 264 (306)
T 2z66_A 219 YKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTC 264 (306)
T ss_dssp GTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSG
T ss_pred ccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeeccc
Confidence 99999999999999999998774 2 35677999999998863
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-26 Score=267.03 Aligned_cols=247 Identities=21% Similarity=0.224 Sum_probs=192.8
Q ss_pred cceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeee
Q 041143 93 LYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLS 172 (973)
Q Consensus 93 L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~ 172 (973)
...++.+++.++.++..+. ++++.|+|++|+|+.+++..|.++++|++|+|++|+|+.. .+..|.++++|++|+
T Consensus 45 ~~~v~c~~~~l~~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i----~~~~~~~l~~L~~L~ 118 (440)
T 3zyj_A 45 FSKVICVRKNLREVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTI----EIGAFNGLANLNTLE 118 (440)
T ss_dssp SCEEECCSCCCSSCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEE----CGGGGTTCSSCCEEE
T ss_pred CCEEEeCCCCcCcCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCcc----ChhhccCCccCCEEE
Confidence 3568888888887766554 6788888888888888888888888888888888888864 446777888888888
Q ss_pred cccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCC-cc
Q 041143 173 LINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGN-QF 251 (973)
Q Consensus 173 L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N-~l 251 (973)
|++|+|+...+..|..+++|++|+|++|+++...+..| .++++|++|+|++| .+
T Consensus 119 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~-------------------------~~l~~L~~L~l~~~~~l 173 (440)
T 3zyj_A 119 LFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAF-------------------------NRIPSLRRLDLGELKRL 173 (440)
T ss_dssp CCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTT-------------------------TTCTTCCEEECCCCTTC
T ss_pred CCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHh-------------------------hhCcccCEeCCCCCCCc
Confidence 88888886666678888888888888888874433333 35777888888774 34
Q ss_pred ccCCCccccCCCCCCEEeCcCCcccccCcccccccccCeEEccCCcCcCCCCCCCCCCcccccCcccCCCCCcccCCcch
Q 041143 252 TGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVN 331 (973)
Q Consensus 252 ~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (973)
+...+..|.++++|++|+|++|+++. +|.
T Consensus 174 ~~i~~~~~~~l~~L~~L~L~~n~l~~-~~~-------------------------------------------------- 202 (440)
T 3zyj_A 174 SYISEGAFEGLSNLRYLNLAMCNLRE-IPN-------------------------------------------------- 202 (440)
T ss_dssp CEECTTTTTTCSSCCEEECTTSCCSS-CCC--------------------------------------------------
T ss_pred ceeCcchhhcccccCeecCCCCcCcc-ccc--------------------------------------------------
Confidence 42333356777777777777776662 221
Q ss_pred hhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCCCccchhhhCccccceEEccCCccccccCc
Q 041143 332 VLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPN 411 (973)
Q Consensus 332 ~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~ 411 (973)
+..+++|+.|+|++|++++..|..|.++++|+.|+|++|+|++..+.
T Consensus 203 ---------------------------------~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 249 (440)
T 3zyj_A 203 ---------------------------------LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERN 249 (440)
T ss_dssp ---------------------------------CTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTT
T ss_pred ---------------------------------cCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChh
Confidence 12345788889999999988899999999999999999999999999
Q ss_pred cccCcCCCCeeeCCCCcCCCCCCC----CCcccceeecCCccccCCC
Q 041143 412 NFTELKSLRLLDVSDNNIKPPLPE----FHDTVKLVIDGNPLLVGGI 454 (973)
Q Consensus 412 ~~~~l~~L~~L~Ls~N~l~g~~p~----~~~~~~~~~~~N~~~c~~~ 454 (973)
.|.++++|+.|||++|+|++.++. +.++..+++.+|||.|...
T Consensus 250 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~ 296 (440)
T 3zyj_A 250 AFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNCD 296 (440)
T ss_dssp SSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSST
T ss_pred hhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCCCC
Confidence 999999999999999999988775 3566779999999999753
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-26 Score=251.22 Aligned_cols=176 Identities=19% Similarity=0.256 Sum_probs=121.1
Q ss_pred ceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeeec
Q 041143 94 YNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSL 173 (973)
Q Consensus 94 ~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L 173 (973)
+.++++++.++.++..+ .++|++|+|++|+|+.+++..|..+++|++|+|++|++++. .|..|.++++|++|+|
T Consensus 14 ~~~~c~~~~l~~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l 87 (285)
T 1ozn_A 14 VTTSCPQQGLQAVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARI----DAAAFTGLALLEQLDL 87 (285)
T ss_dssp CEEECCSSCCSSCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEE----CTTTTTTCTTCCEEEC
T ss_pred eEEEcCcCCcccCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCcccee----CHhhcCCccCCCEEeC
Confidence 56778888777665433 35778888888888877777777777888888887777763 4667777777777777
Q ss_pred cccc-ccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCccc
Q 041143 174 INCN-LVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFT 252 (973)
Q Consensus 174 ~~N~-l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~ 252 (973)
++|. +....+..|..+++|++|+|++|++++..|..+ .++++|++|+|++|+++
T Consensus 88 ~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~-------------------------~~l~~L~~L~l~~n~l~ 142 (285)
T 1ozn_A 88 SDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLF-------------------------RGLAALQYLYLQDNALQ 142 (285)
T ss_dssp CSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTT-------------------------TTCTTCCEEECCSSCCC
T ss_pred CCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHh-------------------------hCCcCCCEEECCCCccc
Confidence 7776 665556777777777777777777775545443 34777777777777777
Q ss_pred cCCCccccCCCCCCEEeCcCCcccccCccccccc-ccCeEEccCCcCcC
Q 041143 253 GSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMG 300 (973)
Q Consensus 253 g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~g 300 (973)
+..+..|..+++|++|+|++|++++..+..+..+ +|+.|++++|.+++
T Consensus 143 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 191 (285)
T 1ozn_A 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191 (285)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred ccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccc
Confidence 5555567777777777777777775544445444 45555555554443
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.3e-28 Score=267.20 Aligned_cols=217 Identities=20% Similarity=0.205 Sum_probs=119.9
Q ss_pred CCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCC
Q 041143 112 GLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPS 191 (973)
Q Consensus 112 ~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 191 (973)
.+++|++|+|++|+|+.+++..|.++++|++|+|++|++++. ++ +..+++|++|+|++|+|++.. ..++
T Consensus 32 ~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~-----~~-~~~l~~L~~L~Ls~n~l~~l~-----~~~~ 100 (317)
T 3o53_A 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYET-----LD-LESLSTLRTLDLNNNYVQELL-----VGPS 100 (317)
T ss_dssp TGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEE-----EE-ETTCTTCCEEECCSSEEEEEE-----ECTT
T ss_pred cCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcc-----hh-hhhcCCCCEEECcCCcccccc-----CCCC
Confidence 344555555555555555555555555555555555555532 11 555555555555555555322 2255
Q ss_pred CCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCc
Q 041143 192 LAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLN 271 (973)
Q Consensus 192 L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls 271 (973)
|++|+|++|++++..+. .+++|++|+|++|++++..|..+..+++|++|+|+
T Consensus 101 L~~L~l~~n~l~~~~~~----------------------------~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls 152 (317)
T 3o53_A 101 IETLHAANNNISRVSCS----------------------------RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLK 152 (317)
T ss_dssp CCEEECCSSCCSEEEEC----------------------------CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECT
T ss_pred cCEEECCCCccCCcCcc----------------------------ccCCCCEEECCCCCCCCccchhhhccCCCCEEECC
Confidence 55666666655533221 13455566666666655445555555566666666
Q ss_pred CCcccccCccccc-cc-ccCeEEccCCcCcCCCCCCCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCC
Q 041143 272 RNQLVGLIPKSLA-NM-ELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQ 349 (973)
Q Consensus 272 ~N~l~~~~p~~~~-~l-~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~ 349 (973)
+|.+++..+..+. .+ +|+.|+|++|.|++. |.
T Consensus 153 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~--------------------------------------------- 186 (317)
T 3o53_A 153 LNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG--------------------------------------------- 186 (317)
T ss_dssp TSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC---------------------------------------------
T ss_pred CCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc---------------------------------------------
Confidence 6666555444443 23 566666666655432 11
Q ss_pred CCCCCCCCCCccccccCCCCcccEEecCCCcCCCccchhhhCccccceEEccCCccccccCccccCcCCCCeeeCCCCcC
Q 041143 350 WPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNI 429 (973)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l 429 (973)
...+++|+.|+|++|++++..+ .+..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|++
T Consensus 187 ---------------~~~l~~L~~L~Ls~N~l~~l~~-~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~ 249 (317)
T 3o53_A 187 ---------------QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGF 249 (317)
T ss_dssp ---------------CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCC
T ss_pred ---------------ccccccCCEEECCCCcCCcchh-hhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCc
Confidence 0123466666666666665433 3666677777777777776 4666666777777777777777
Q ss_pred C
Q 041143 430 K 430 (973)
Q Consensus 430 ~ 430 (973)
+
T Consensus 250 ~ 250 (317)
T 3o53_A 250 H 250 (317)
T ss_dssp B
T ss_pred c
Confidence 6
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-25 Score=240.17 Aligned_cols=216 Identities=26% Similarity=0.370 Sum_probs=191.6
Q ss_pred CCCCCCCCcCeEEeeC-CeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCC-CCCCCCccceeeccCCCCCC
Q 041143 51 DDPCGPPPWPHVFCSG-NRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFDT 128 (973)
Q Consensus 51 ~d~C~~~~w~gv~C~~-~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~ 128 (973)
.|+|. |.|+.|+- ..++.+++++++++ .+|..+. ++|++|+|++|+|++.++ .|.++++|++|+|++|+|+.
T Consensus 2 ~~~C~---~~~~~C~c~~~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 75 (270)
T 2o6q_A 2 EALCK---KDGGVCSCNNNKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT 75 (270)
T ss_dssp CCCBG---GGTCSBEEETTTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSC
T ss_pred CccCC---CCCCCCEeCCCCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCe
Confidence 47887 99999863 45778999999999 5777665 689999999999999887 79999999999999999999
Q ss_pred CCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCCh
Q 041143 129 IPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPA 208 (973)
Q Consensus 129 i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 208 (973)
+++..|.++++|++|+|++|+++.. .+..|..+++|++|+|++|++++..+..|.++++|++|+|++|++++..+.
T Consensus 76 i~~~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~ 151 (270)
T 2o6q_A 76 LPAGIFKELKNLETLWVTDNKLQAL----PIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKG 151 (270)
T ss_dssp CCTTTTSSCTTCCEEECCSSCCCCC----CTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred eChhhhcCCCCCCEEECCCCcCCcC----CHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHh
Confidence 9999999999999999999999974 445678999999999999999998888999999999999999999954443
Q ss_pred hhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcccccCccccccc-c
Q 041143 209 SFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-E 287 (973)
Q Consensus 209 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~ 287 (973)
.| ..+++|+.|+|++|++++..+..|..+++|++|+|++|++++..+..+..+ +
T Consensus 152 ~~-------------------------~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 206 (270)
T 2o6q_A 152 VF-------------------------DKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEK 206 (270)
T ss_dssp TT-------------------------TTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTT
T ss_pred Hc-------------------------cCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccC
Confidence 33 469999999999999997777789999999999999999998777778877 8
Q ss_pred cCeEEccCCcCcCC
Q 041143 288 LDNLVLNNNLLMGP 301 (973)
Q Consensus 288 L~~L~l~~N~l~g~ 301 (973)
|+.|+|++|.+...
T Consensus 207 L~~L~l~~N~~~c~ 220 (270)
T 2o6q_A 207 LKMLQLQENPWDCT 220 (270)
T ss_dssp CCEEECCSSCBCCS
T ss_pred CCEEEecCCCeeCC
Confidence 99999999998743
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.1e-27 Score=258.74 Aligned_cols=249 Identities=22% Similarity=0.272 Sum_probs=187.0
Q ss_pred CCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccc-------cccccCeeecccccccCCcch
Q 041143 112 GLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLA-------NSVQLTNLSLINCNLVGPLPD 184 (973)
Q Consensus 112 ~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~-------~l~~L~~L~L~~N~l~~~~p~ 184 (973)
+.++|++|++++|.+ .+|...... |+.|+|++|++... .+|..+. ++++|++|+|++|++++.+|.
T Consensus 41 ~~~~L~~l~l~~n~l-~~p~~~~~~---L~~L~L~~n~l~~~---~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 113 (312)
T 1wwl_A 41 GGRSLEYLLKRVDTE-ADLGQFTDI---IKSLSLKRLTVRAA---RIPSRILFGALRVLGISGLQELTLENLEVTGTAPP 113 (312)
T ss_dssp EEEECTTHHHHCCTT-CCCHHHHHH---HHHCCCCEEEEEEE---ECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCC
T ss_pred cCCCceeEeeccccc-ccHHHHHHH---HhhcccccccccCC---CcCHHHHHHHHHhcCcCCccEEEccCCcccchhHH
Confidence 344555566666666 555443322 66667777776432 3565555 688899999999999888888
Q ss_pred hc--cCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCccccCCCccccCC
Q 041143 185 FL--GTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGAL 262 (973)
Q Consensus 185 ~l--~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l 262 (973)
.+ ..+++|++|+|++|++++. |..+.... ...+++|++|+|++|++++..|..|..+
T Consensus 114 ~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~--------------------~~~~~~L~~L~L~~N~l~~~~~~~~~~l 172 (312)
T 1wwl_A 114 PLLEATGPDLNILNLRNVSWATR-DAWLAELQ--------------------QWLKPGLKVLSIAQAHSLNFSCEQVRVF 172 (312)
T ss_dssp CSSSCCSCCCSEEEEESCBCSSS-SSHHHHHH--------------------TTCCTTCCEEEEESCSCCCCCTTTCCCC
T ss_pred HHHHhcCCCccEEEccCCCCcch-hHHHHHHH--------------------HhhcCCCcEEEeeCCCCccchHHHhccC
Confidence 76 8899999999999999866 76654300 0013889999999999998777899999
Q ss_pred CCCCEEeCcCCccccc--Ccccc--ccc-ccCeEEccCCcCcCC--CCCCCCCCcccccCcccCCCCCcccCCcchhhhh
Q 041143 263 SSLKDLNLNRNQLVGL--IPKSL--ANM-ELDNLVLNNNLLMGP--IPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLD 335 (973)
Q Consensus 263 ~~L~~L~Ls~N~l~~~--~p~~~--~~l-~L~~L~l~~N~l~g~--~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (973)
++|++|+|++|++.+. .|..+ ..+ +|++|+|++|.|++. ++.
T Consensus 173 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~------------------------------- 221 (312)
T 1wwl_A 173 PALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCS------------------------------- 221 (312)
T ss_dssp SSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHH-------------------------------
T ss_pred CCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHH-------------------------------
Confidence 9999999999998765 23333 555 799999999988731 110
Q ss_pred hccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCCCccc-hhhhCccccceEEccCCccccccCcccc
Q 041143 336 FLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLS-PSIANLDSLIEIRLGKNSISGTVPNNFT 414 (973)
Q Consensus 336 ~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~g~~p~~~~ 414 (973)
..+..+++|+.|+|++|++.+.+| ..+..+++|+.|+|++|+|+ .+|..+.
T Consensus 222 ---------------------------~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~ 273 (312)
T 1wwl_A 222 ---------------------------ALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP 273 (312)
T ss_dssp ---------------------------HHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC
T ss_pred ---------------------------HHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc
Confidence 012345789999999999999886 56778999999999999999 8898887
Q ss_pred CcCCCCeeeCCCCcCCCCCCCC---CcccceeecCCccc
Q 041143 415 ELKSLRLLDVSDNNIKPPLPEF---HDTVKLVIDGNPLL 450 (973)
Q Consensus 415 ~l~~L~~L~Ls~N~l~g~~p~~---~~~~~~~~~~N~~~ 450 (973)
++|++|||++|+|++. |.+ .++..+++.+|++.
T Consensus 274 --~~L~~L~Ls~N~l~~~-p~~~~l~~L~~L~L~~N~l~ 309 (312)
T 1wwl_A 274 --AKLSVLDLSYNRLDRN-PSPDELPQVGNLSLKGNPFL 309 (312)
T ss_dssp --SEEEEEECCSSCCCSC-CCTTTSCEEEEEECTTCTTT
T ss_pred --CCceEEECCCCCCCCC-hhHhhCCCCCEEeccCCCCC
Confidence 8999999999999987 544 45566899999875
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.1e-26 Score=252.34 Aligned_cols=273 Identities=19% Similarity=0.178 Sum_probs=229.1
Q ss_pred EEeeCCeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCC-CCCCCCccceeeccCCCCCCCCccccCCCCCc
Q 041143 62 VFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSV 140 (973)
Q Consensus 62 v~C~~~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L 140 (973)
+...+.++..++++++.+...+...+..+++|++|+|++|+|++.+| .|.++++|++|+|++|+++.+++ |..+++|
T Consensus 5 l~~~g~~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L 82 (317)
T 3o53_A 5 IKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTL 82 (317)
T ss_dssp EEEETTEEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTC
T ss_pred ccCCcCceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCC
Confidence 44455677888888888876666667788899999999999999887 79999999999999999998775 9999999
Q ss_pred cEEEcccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhh
Q 041143 141 RVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWL 220 (973)
Q Consensus 141 ~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l 220 (973)
++|+|++|++++. + .+++|++|++++|+|++..+. .+++|++|+|++|++++..+..+
T Consensus 83 ~~L~Ls~n~l~~l-----~----~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~---------- 140 (317)
T 3o53_A 83 RTLDLNNNYVQEL-----L----VGPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDE---------- 140 (317)
T ss_dssp CEEECCSSEEEEE-----E----ECTTCCEEECCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCT----------
T ss_pred CEEECcCCccccc-----c----CCCCcCEEECCCCccCCcCcc---ccCCCCEEECCCCCCCCccchhh----------
Confidence 9999999999853 3 348999999999999976554 46889999999999997656554
Q ss_pred cccCCCCCCCcchhhcCCccccEEEccCCccccCCCcccc-CCCCCCEEeCcCCcccccCcccccccccCeEEccCCcCc
Q 041143 221 NDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIG-ALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLLM 299 (973)
Q Consensus 221 ~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~L~~L~l~~N~l~ 299 (973)
..+++|++|+|++|.+++..+..+. .+++|++|+|++|++++. +......+|+.|+|++|.|+
T Consensus 141 ---------------~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~l~~L~~L~Ls~N~l~ 204 (317)
T 3o53_A 141 ---------------GCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KGQVVFAKLKTLDLSSNKLA 204 (317)
T ss_dssp ---------------GGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-ECCCCCTTCCEEECCSSCCC
T ss_pred ---------------hccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-ccccccccCCEEECCCCcCC
Confidence 3589999999999999988787774 789999999999999976 33332238999999999998
Q ss_pred CCCCCCCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCC
Q 041143 300 GPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRH 379 (973)
Q Consensus 300 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N 379 (973)
+..+. +..+++|+.|+|++|
T Consensus 205 ~l~~~------------------------------------------------------------~~~l~~L~~L~L~~N 224 (317)
T 3o53_A 205 FMGPE------------------------------------------------------------FQSAAGVTWISLRNN 224 (317)
T ss_dssp EECGG------------------------------------------------------------GGGGTTCSEEECTTS
T ss_pred cchhh------------------------------------------------------------hcccCcccEEECcCC
Confidence 53221 234678999999999
Q ss_pred cCCCccchhhhCccccceEEccCCccc-cccCccccCcCCCCeeeCC-CCcCCCCCCC
Q 041143 380 NLTGTLSPSIANLDSLIEIRLGKNSIS-GTVPNNFTELKSLRLLDVS-DNNIKPPLPE 435 (973)
Q Consensus 380 ~l~~~~p~~~~~l~~L~~L~L~~N~l~-g~~p~~~~~l~~L~~L~Ls-~N~l~g~~p~ 435 (973)
+++ .+|..+..+++|+.|+|++|.++ +.+|..+..+++|+.|+++ .+.++|..|.
T Consensus 225 ~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~ 281 (317)
T 3o53_A 225 KLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281 (317)
T ss_dssp CCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSC
T ss_pred ccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchh
Confidence 999 57888999999999999999998 8899999999999999999 4567775553
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=2e-26 Score=268.61 Aligned_cols=237 Identities=19% Similarity=0.180 Sum_probs=192.7
Q ss_pred ccccccceeeccCcccCCCCC-CCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCccccccc
Q 041143 88 NQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSV 166 (973)
Q Consensus 88 ~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~ 166 (973)
..+++|++|+|++|.|++.+| .|.++++|++|+|++|.|+.+++ |..+++|++|+|++|.|++. | ..+
T Consensus 31 ~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l-----~----~~~ 99 (487)
T 3oja_A 31 QSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQEL-----L----VGP 99 (487)
T ss_dssp TTGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEE-----E----ECT
T ss_pred ccCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCC-----C----CCC
Confidence 344589999999999998776 68889999999999999987665 88899999999999988853 3 237
Q ss_pred ccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEc
Q 041143 167 QLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWL 246 (973)
Q Consensus 167 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L 246 (973)
+|++|+|++|.|++..+. .+++|+.|+|++|++++..|..+. ++++|+.|+|
T Consensus 100 ~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~-------------------------~l~~L~~L~L 151 (487)
T 3oja_A 100 SIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEG-------------------------CRSRVQYLDL 151 (487)
T ss_dssp TCCEEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGG-------------------------GGSSEEEEEC
T ss_pred CcCEEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhc-------------------------CCCCCCEEEC
Confidence 899999999999876554 467899999999999877666553 4889999999
Q ss_pred cCCccccCCCcccc-CCCCCCEEeCcCCcccccCcccccccccCeEEccCCcCcCCCCCCCCCCcccccCcccCCCCCcc
Q 041143 247 HGNQFTGSIPEDIG-ALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIE 325 (973)
Q Consensus 247 ~~N~l~g~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~ 325 (973)
++|.|++.+|..+. .+++|++|+|++|.|++..+ .....+|+.|+|++|.|++..|.
T Consensus 152 s~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~--------------------- 209 (487)
T 3oja_A 152 KLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG-QVVFAKLKTLDLSSNKLAFMGPE--------------------- 209 (487)
T ss_dssp TTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC-CCCCTTCCEEECCSSCCCEECGG---------------------
T ss_pred CCCCCCCcChHHHhhhCCcccEEecCCCccccccc-cccCCCCCEEECCCCCCCCCCHh---------------------
Confidence 99999988888876 78999999999999987632 22222799999999998864332
Q ss_pred cCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCCCccchhhhCccccceEEccCCcc
Q 041143 326 CAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSI 405 (973)
Q Consensus 326 ~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 405 (973)
+..+++|+.|+|++|.+++ +|..++.+++|+.|+|++|.+
T Consensus 210 ---------------------------------------~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l 249 (487)
T 3oja_A 210 ---------------------------------------FQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGF 249 (487)
T ss_dssp ---------------------------------------GGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCB
T ss_pred ---------------------------------------HcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCC
Confidence 2345689999999999996 777899999999999999999
Q ss_pred c-cccCccccCcCCCCeeeCC
Q 041143 406 S-GTVPNNFTELKSLRLLDVS 425 (973)
Q Consensus 406 ~-g~~p~~~~~l~~L~~L~Ls 425 (973)
. +.+|..+..++.|+.|+++
T Consensus 250 ~c~~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 250 HCGTLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp CHHHHHHHHTTCHHHHHHHHH
T ss_pred cCcchHHHHHhCCCCcEEecc
Confidence 8 7888888888888888876
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.8e-26 Score=269.55 Aligned_cols=187 Identities=17% Similarity=0.180 Sum_probs=147.5
Q ss_pred cccCcccccCccEEEEEEECCCCEEEEEEeecCCCChH------HHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEE
Q 041143 628 AQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTK------ALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLV 701 (973)
Q Consensus 628 ~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 701 (973)
...+.||+|+||.||+|... ++.+|+|+......... ..+++.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 34578999999999999554 78899998754322211 235689999999999999999777777788888999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccC
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA 781 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~ 781 (973)
|||+++|+|.+++.. +..++.|+++||+||| +++|+||||||+|||++. ++||+|||+++..
T Consensus 418 mE~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~ 479 (540)
T 3en9_A 418 MSYINGKLAKDVIED-------------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKIS 479 (540)
T ss_dssp EECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred EECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEEC
Confidence 999999999998853 4579999999999999 889999999999999999 9999999999976
Q ss_pred CCCCcce------ecccccccCccccccccc--CcCCCchhHHhHHHHHHHHHhCCCCCC
Q 041143 782 PDGEKSV------VTRLAGTFGYLAPEYAVM--GKITTKADVFSYGVVLMELLTGLAALD 833 (973)
Q Consensus 782 ~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gvvl~elltg~~p~~ 833 (973)
....... .....||+.|||||++.. ..|+.++|+|+..+-..+.+.++.++.
T Consensus 480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 5432211 235689999999999976 668888999999998888887776653
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-24 Score=234.67 Aligned_cols=221 Identities=23% Similarity=0.294 Sum_probs=141.0
Q ss_pred EecccCCcccCCcCcccccccceeeccCcccCCCCC-CCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCC
Q 041143 73 QVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFN 151 (973)
Q Consensus 73 ~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~ 151 (973)
+..+.+++ .+|..+. ++|++|+|++|++++..+ .|.++++|++|+|++|+++.+++..|.++++|++|+|++|+++
T Consensus 13 ~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 89 (276)
T 2z62_A 13 QCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89 (276)
T ss_dssp ECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC
T ss_pred EecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccC
Confidence 33444444 4565553 468888888888888776 6777888888888888887777777777777777777777776
Q ss_pred CccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCccc-CChhhhhhHHHHHhhcccCCCCCCC
Q 041143 152 KTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGV-IPASFGQSLMQILWLNDQDAGGMTG 230 (973)
Q Consensus 152 ~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~-~p~~~~~~~~~~~~l~~~~~~~~~~ 230 (973)
+. .+..|.++++|++|+|++|++++..+..+.++++|++|+|++|++++. +|..+.
T Consensus 90 ~~----~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~------------------- 146 (276)
T 2z62_A 90 SL----ALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS------------------- 146 (276)
T ss_dssp EE----CTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGG-------------------
T ss_pred cc----ChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhc-------------------
Confidence 53 445566666777777777666655555566666666666666666532 344332
Q ss_pred cchhhcCCccccEEEccCCccccCCCccccCCCCCC----EEeCcCCcccccCcccccccccCeEEccCCcCcCCCCCCC
Q 041143 231 PIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLK----DLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMGPIPKFK 306 (973)
Q Consensus 231 ~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~----~L~Ls~N~l~~~~p~~~~~l~L~~L~l~~N~l~g~~p~~~ 306 (973)
++++|++|+|++|++++..+..+..+++|+ +|++++|.+++..+..+..
T Consensus 147 ------~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~--------------------- 199 (276)
T 2z62_A 147 ------NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE--------------------- 199 (276)
T ss_dssp ------GCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCS---------------------
T ss_pred ------cCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccCC---------------------
Confidence 355566666666655544444454444444 4444444444333322222
Q ss_pred CCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCCCccc
Q 041143 307 AGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLS 386 (973)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p 386 (973)
.+|+.|+|++|++++..+
T Consensus 200 --------------------------------------------------------------~~L~~L~L~~n~l~~~~~ 217 (276)
T 2z62_A 200 --------------------------------------------------------------IRLKELALDTNQLKSVPD 217 (276)
T ss_dssp --------------------------------------------------------------CCEEEEECCSSCCSCCCT
T ss_pred --------------------------------------------------------------CcccEEECCCCceeecCH
Confidence 256667777777777777
Q ss_pred hhhhCccccceEEccCCccccc
Q 041143 387 PSIANLDSLIEIRLGKNSISGT 408 (973)
Q Consensus 387 ~~~~~l~~L~~L~L~~N~l~g~ 408 (973)
..|.++++|+.|+|++|.+++.
T Consensus 218 ~~~~~l~~L~~L~l~~N~~~c~ 239 (276)
T 2z62_A 218 GIFDRLTSLQKIWLHTNPWDCS 239 (276)
T ss_dssp TTTTTCCSCCEEECCSSCBCCC
T ss_pred hHhcccccccEEEccCCccccc
Confidence 7778888888888888888753
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.7e-24 Score=231.92 Aligned_cols=231 Identities=17% Similarity=0.187 Sum_probs=172.9
Q ss_pred eeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeeecc
Q 041143 95 NLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLI 174 (973)
Q Consensus 95 ~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~ 174 (973)
.++..+.+++.++..+. ++|++|+|++|+|+.+++..|.++++|++|+|++|++++. .+..|.++++|++|+|+
T Consensus 11 ~~~c~~~~l~~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~L~ 84 (276)
T 2z62_A 11 TYQCMELNFYKIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTI----EDGAYQSLSHLSTLILT 84 (276)
T ss_dssp EEECTTSCCSSCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEE----CTTTTTTCTTCCEEECT
T ss_pred eEEecCCCccccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCcc----CHHHccCCcCCCEEECC
Confidence 45666677766655443 4688888888888888887888888888888888888763 44567788888888888
Q ss_pred cccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCccccC
Q 041143 175 NCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGS 254 (973)
Q Consensus 175 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~ 254 (973)
+|++++..+..|.++++|++|+|++|++++..+..+ .++++|++|+|++|++++.
T Consensus 85 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~-------------------------~~l~~L~~L~l~~n~l~~~ 139 (276)
T 2z62_A 85 GNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPI-------------------------GHLKTLKELNVAHNLIQSF 139 (276)
T ss_dssp TCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCC-------------------------TTCTTCCEEECCSSCCCCC
T ss_pred CCccCccChhhhcCCccccEEECCCCCccccCchhc-------------------------ccCCCCCEEECcCCcccee
Confidence 888887777778888888888888888875444333 3577888888888888753
Q ss_pred -CCccccCCCCCCEEeCcCCcccccCccccccc-ccCeEEccCCcCcCCCCCCCCCCcccccCcccCCCCCcccCCcchh
Q 041143 255 -IPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNV 332 (973)
Q Consensus 255 -~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (973)
+|..|..+++|++|+|++|++++..+..+..+ +|+
T Consensus 140 ~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~------------------------------------------- 176 (276)
T 2z62_A 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMP------------------------------------------- 176 (276)
T ss_dssp CCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCT-------------------------------------------
T ss_pred cCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhcc-------------------------------------------
Confidence 57788888888888888888876655555443 222
Q ss_pred hhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCccc-EEecCCCcCCCccchhhhCccccceEEccCCccccccCc
Q 041143 333 LLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVS-IINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPN 411 (973)
Q Consensus 333 ~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~ 411 (973)
.|. .|+|++|.+.+..+..+.. .+|+.|+|++|+|++..+.
T Consensus 177 -------------------------------------~l~l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~ 218 (276)
T 2z62_A 177 -------------------------------------LLNLSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDG 218 (276)
T ss_dssp -------------------------------------TCCEEEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTT
T ss_pred -------------------------------------ccceeeecCCCcccccCccccCC-CcccEEECCCCceeecCHh
Confidence 222 5666666666555554544 4899999999999977777
Q ss_pred cccCcCCCCeeeCCCCcCCCCCCCCC
Q 041143 412 NFTELKSLRLLDVSDNNIKPPLPEFH 437 (973)
Q Consensus 412 ~~~~l~~L~~L~Ls~N~l~g~~p~~~ 437 (973)
.|..+++|+.|+|++|++++..|.+.
T Consensus 219 ~~~~l~~L~~L~l~~N~~~c~c~~l~ 244 (276)
T 2z62_A 219 IFDRLTSLQKIWLHTNPWDCSCPRID 244 (276)
T ss_dssp TTTTCCSCCEEECCSSCBCCCTTTTH
T ss_pred HhcccccccEEEccCCcccccCCchH
Confidence 78999999999999999999887543
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.91 E-value=3.5e-27 Score=274.80 Aligned_cols=229 Identities=21% Similarity=0.227 Sum_probs=110.4
Q ss_pred CeEEEEEecccCCcc----cCCcCcccccccceeeccCcccCCCCC-C-CCCCC----ccceeeccCCCCCCC----Ccc
Q 041143 67 NRVTQIQVQNLGLKG----PLPQNFNQLTKLYNLGLQRNKFNGKLP-T-FSGLS----ELEFAYLDFNEFDTI----PSD 132 (973)
Q Consensus 67 ~~v~~L~L~~~~l~g----~~~~~~~~l~~L~~L~L~~N~l~~~~~-~-~~~l~----~L~~L~L~~N~l~~i----~~~ 132 (973)
.+++.|+|++|++++ .++..+..+++|++|+|++|.++...+ . +..++ +|++|+|++|+|+.. .+.
T Consensus 28 ~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~ 107 (461)
T 1z7x_W 28 QQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSS 107 (461)
T ss_dssp TTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred CCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHH
Confidence 345666666666653 234455556666666666666654322 1 12233 466666666666632 244
Q ss_pred ccCCCCCccEEEcccCCCCCccCCCCCcccc-----cccccCeeecccccccCC----cchhccCCCCCCeEEccCCcCc
Q 041143 133 FFDGLSSVRVLALDYNPFNKTFGWSIPDSLA-----NSVQLTNLSLINCNLVGP----LPDFLGTLPSLAALKLSYNRLS 203 (973)
Q Consensus 133 ~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~-----~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~ 203 (973)
.|..+++|++|+|++|+++.. .+..+. .+++|++|+|++|++++. ++..+..+++|++|+|++|+++
T Consensus 108 ~l~~~~~L~~L~Ls~n~i~~~----~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~ 183 (461)
T 1z7x_W 108 TLRTLPTLQELHLSDNLLGDA----GLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN 183 (461)
T ss_dssp HTTSCTTCCEEECCSSBCHHH----HHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCH
T ss_pred HHccCCceeEEECCCCcCchH----HHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcc
Confidence 566666666666666665532 111121 134566666666666642 2444555666666666666665
Q ss_pred ccCChhhhhhHH----HHHhhcccCCCCCCC----cchhhcCCccccEEEccCCccccCC-----CccccCCCCCCEEeC
Q 041143 204 GVIPASFGQSLM----QILWLNDQDAGGMTG----PIDVVAKMVSLTQLWLHGNQFTGSI-----PEDIGALSSLKDLNL 270 (973)
Q Consensus 204 ~~~p~~~~~~~~----~~~~l~~~~~~~~~~----~~~~~~~l~~L~~L~L~~N~l~g~~-----p~~~~~l~~L~~L~L 270 (973)
...+..+...+. ++..|+...+..... ....+..+++|++|+|++|.+++.. +..+..+++|++|+|
T Consensus 184 ~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L 263 (461)
T 1z7x_W 184 EAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWI 263 (461)
T ss_dssp HHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEEC
T ss_pred hHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEEC
Confidence 443333332111 222222222222211 1223334455555555555544321 111223445555555
Q ss_pred cCCccccc----Cccccccc-ccCeEEccCCcCc
Q 041143 271 NRNQLVGL----IPKSLANM-ELDNLVLNNNLLM 299 (973)
Q Consensus 271 s~N~l~~~----~p~~~~~l-~L~~L~l~~N~l~ 299 (973)
++|.++.. ++..+..+ +|+.|++++|.+.
T Consensus 264 ~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~ 297 (461)
T 1z7x_W 264 WECGITAKGCGDLCRVLRAKESLKELSLAGNELG 297 (461)
T ss_dssp TTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCH
T ss_pred cCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCc
Confidence 55555432 23333333 4555555555543
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.91 E-value=3.9e-23 Score=245.67 Aligned_cols=257 Identities=21% Similarity=0.247 Sum_probs=208.0
Q ss_pred ccccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccC
Q 041143 90 LTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLT 169 (973)
Q Consensus 90 l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~ 169 (973)
..+++.|++++|.|+.++..+. ++|++|+|++|+|+.+|. .+++|++|+|++|+|+. +|. .+++|+
T Consensus 39 ~~~l~~L~ls~n~L~~lp~~l~--~~L~~L~L~~N~l~~lp~----~l~~L~~L~Ls~N~l~~-----lp~---~l~~L~ 104 (622)
T 3g06_A 39 NNGNAVLNVGESGLTTLPDCLP--AHITTLVIPDNNLTSLPA----LPPELRTLEVSGNQLTS-----LPV---LPPGLL 104 (622)
T ss_dssp HHCCCEEECCSSCCSCCCSCCC--TTCSEEEECSCCCSCCCC----CCTTCCEEEECSCCCSC-----CCC---CCTTCC
T ss_pred CCCCcEEEecCCCcCccChhhC--CCCcEEEecCCCCCCCCC----cCCCCCEEEcCCCcCCc-----CCC---CCCCCC
Confidence 3468999999999997665565 899999999999999987 57999999999999995 666 678999
Q ss_pred eeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCC
Q 041143 170 NLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGN 249 (973)
Q Consensus 170 ~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N 249 (973)
+|+|++|+|++ +|. .+++|++|+|++|+|++ +|. .+++|++|+|++|
T Consensus 105 ~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~----------------------------~l~~L~~L~Ls~N 151 (622)
T 3g06_A 105 ELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPV----------------------------LPPGLQELSVSDN 151 (622)
T ss_dssp EEEECSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCC----------------------------CCTTCCEEECCSS
T ss_pred EEECcCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCC----------------------------CCCCCCEEECcCC
Confidence 99999999996 444 67899999999999984 553 2579999999999
Q ss_pred ccccCCCccccCCCCCCEEeCcCCcccccCcccccccccCeEEccCCcCcCCCCCCCCCCcccccCcccCCCCCcccCCc
Q 041143 250 QFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPD 329 (973)
Q Consensus 250 ~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (973)
+|+ .+|. .+++|+.|+|++|+|++ +|..+ .+|+.|++++|.|++ +|..
T Consensus 152 ~l~-~l~~---~~~~L~~L~L~~N~l~~-l~~~~--~~L~~L~Ls~N~l~~-l~~~------------------------ 199 (622)
T 3g06_A 152 QLA-SLPA---LPSELCKLWAYNNQLTS-LPMLP--SGLQELSVSDNQLAS-LPTL------------------------ 199 (622)
T ss_dssp CCS-CCCC---CCTTCCEEECCSSCCSC-CCCCC--TTCCEEECCSSCCSC-CCCC------------------------
T ss_pred cCC-CcCC---ccCCCCEEECCCCCCCC-CcccC--CCCcEEECCCCCCCC-CCCc------------------------
Confidence 999 4564 34789999999999996 55222 279999999999985 4431
Q ss_pred chhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCCCccchhhhCccccceEEccCCcccccc
Q 041143 330 VNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTV 409 (973)
Q Consensus 330 ~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~ 409 (973)
+..+..+++..|.+..++. .+++|+.|+|++|++++ +| ..+++|+.|+|++|+|+ .+
T Consensus 200 ----~~~L~~L~L~~N~l~~l~~--------------~~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~l 256 (622)
T 3g06_A 200 ----PSELYKLWAYNNRLTSLPA--------------LPSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SL 256 (622)
T ss_dssp ----CTTCCEEECCSSCCSSCCC--------------CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CC
T ss_pred ----cchhhEEECcCCcccccCC--------------CCCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cC
Confidence 1235556677777776653 23689999999999997 55 56789999999999999 67
Q ss_pred CccccCcCCCCeeeCCCCcCCCCCCCC---CcccceeecCCcccc
Q 041143 410 PNNFTELKSLRLLDVSDNNIKPPLPEF---HDTVKLVIDGNPLLV 451 (973)
Q Consensus 410 p~~~~~l~~L~~L~Ls~N~l~g~~p~~---~~~~~~~~~~N~~~c 451 (973)
|. .+++|+.|+|++|+|+..++.+ .++..+++.+|++..
T Consensus 257 p~---~~~~L~~L~Ls~N~L~~lp~~l~~l~~L~~L~L~~N~l~~ 298 (622)
T 3g06_A 257 PM---LPSGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPLSE 298 (622)
T ss_dssp CC---CCTTCCEEECCSSCCCSCCGGGGGSCTTCEEECCSCCCCH
T ss_pred Cc---ccccCcEEeCCCCCCCcCCHHHhhccccCEEEecCCCCCC
Confidence 76 6789999999999999554433 456678999999754
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.4e-24 Score=231.66 Aligned_cols=223 Identities=23% Similarity=0.250 Sum_probs=129.5
Q ss_pred ccccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccC
Q 041143 90 LTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLT 169 (973)
Q Consensus 90 l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~ 169 (973)
+.++..+++..+.+.... .+..+++|+.|++++|.++.++. +..+++|++|+|++|++++ + ..+..+++|+
T Consensus 18 ~~~l~~l~l~~~~~~~~~-~~~~l~~L~~L~l~~~~i~~~~~--l~~l~~L~~L~l~~n~l~~-----~-~~l~~l~~L~ 88 (272)
T 3rfs_A 18 FAETIKANLKKKSVTDAV-TQNELNSIDQIIANNSDIKSVQG--IQYLPNVRYLALGGNKLHD-----I-SALKELTNLT 88 (272)
T ss_dssp HHHHHHHHHTCSCTTSEE-CHHHHTTCCEEECTTSCCCCCTT--GGGCTTCCEEECTTSCCCC-----C-GGGTTCTTCC
T ss_pred HHHHHHHHhcCccccccc-ccccccceeeeeeCCCCcccccc--cccCCCCcEEECCCCCCCC-----c-hhhcCCCCCC
Confidence 345555666666655432 24445666666666666665542 5556666666666666553 2 2455556666
Q ss_pred eeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCC
Q 041143 170 NLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGN 249 (973)
Q Consensus 170 ~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N 249 (973)
+|+|++|.+++..+..|.++++|++|+|++|++++..+..+ .++++|++|+|++|
T Consensus 89 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-------------------------~~l~~L~~L~L~~n 143 (272)
T 3rfs_A 89 YLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVF-------------------------DKLTNLTYLNLAHN 143 (272)
T ss_dssp EEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTT-------------------------TTCTTCCEEECCSS
T ss_pred EEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHh-------------------------ccCCCCCEEECCCC
Confidence 66666666665555555666666666666666654333322 23555666666666
Q ss_pred ccccCCCccccCCCCCCEEeCcCCcccccCcccccccccCeEEccCCcCcCCCCCCCCCCcccccCcccCCCCCcccCCc
Q 041143 250 QFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPD 329 (973)
Q Consensus 250 ~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (973)
++++..+..|..+++|++|+|++|++++..+..+..
T Consensus 144 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~-------------------------------------------- 179 (272)
T 3rfs_A 144 QLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDK-------------------------------------------- 179 (272)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTT--------------------------------------------
T ss_pred ccCccCHHHhccCccCCEEECCCCCcCccCHHHhcC--------------------------------------------
Confidence 655444444555555666665555555444333333
Q ss_pred chhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCCCccchhhhCccccceEEccCCcccccc
Q 041143 330 VNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTV 409 (973)
Q Consensus 330 ~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~ 409 (973)
+++|+.|+|++|++.+..+..++.+++|+.|+|++|.+.+.
T Consensus 180 --------------------------------------l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~- 220 (272)
T 3rfs_A 180 --------------------------------------LTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT- 220 (272)
T ss_dssp --------------------------------------CTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-
T ss_pred --------------------------------------CccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-
Confidence 34555566666666655555666777777777777776643
Q ss_pred CccccCcCCCCeeeCCCCcCCCCCCC
Q 041143 410 PNNFTELKSLRLLDVSDNNIKPPLPE 435 (973)
Q Consensus 410 p~~~~~l~~L~~L~Ls~N~l~g~~p~ 435 (973)
+++|+.|+++.|+++|.+|.
T Consensus 221 ------~~~l~~l~~~~n~~~g~ip~ 240 (272)
T 3rfs_A 221 ------CPGIRYLSEWINKHSGVVRN 240 (272)
T ss_dssp ------TTTTHHHHHHHHHTGGGBBC
T ss_pred ------CcHHHHHHHHHHhCCCcccC
Confidence 44677777777777777775
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.91 E-value=2.5e-26 Score=267.58 Aligned_cols=328 Identities=17% Similarity=0.138 Sum_probs=197.4
Q ss_pred CeEEEEEecccCCcccCCcCcc-ccc----ccceeeccCcccCC----CCC-CCCCCCccceeeccCCCCCCCCcc----
Q 041143 67 NRVTQIQVQNLGLKGPLPQNFN-QLT----KLYNLGLQRNKFNG----KLP-TFSGLSELEFAYLDFNEFDTIPSD---- 132 (973)
Q Consensus 67 ~~v~~L~L~~~~l~g~~~~~~~-~l~----~L~~L~L~~N~l~~----~~~-~~~~l~~L~~L~L~~N~l~~i~~~---- 132 (973)
.++++|+|++|.+++..+..+. .+. +|++|+|++|.++. .++ .+..+++|++|+|++|+++.....
T Consensus 56 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~ 135 (461)
T 1z7x_W 56 PALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCE 135 (461)
T ss_dssp TTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHH
T ss_pred CCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHH
Confidence 3455566666555543332222 233 45666666665553 122 455555666666666655432211
Q ss_pred -ccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeeecccccccCCcchhcc-----CCCCCCeEEccCCcCccc-
Q 041143 133 -FFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLG-----TLPSLAALKLSYNRLSGV- 205 (973)
Q Consensus 133 -~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~-----~l~~L~~L~Ls~N~l~~~- 205 (973)
.+..+++|++|+|++|+++......++..+..+++|++|+|++|.++...+..+. .+++|++|+|++|++++.
T Consensus 136 ~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~ 215 (461)
T 1z7x_W 136 GLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDN 215 (461)
T ss_dssp HHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTH
T ss_pred HHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHH
Confidence 1223445666666666555431112334444555555666655555533333222 244555555555555532
Q ss_pred ---CChhhhhhHHHHHhhcccCCCCCCCc-----chhhcCCccccEEEccCCccccC----CCccccCCCCCCEEeCcCC
Q 041143 206 ---IPASFGQSLMQILWLNDQDAGGMTGP-----IDVVAKMVSLTQLWLHGNQFTGS----IPEDIGALSSLKDLNLNRN 273 (973)
Q Consensus 206 ---~p~~~~~~~~~~~~l~~~~~~~~~~~-----~~~~~~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~Ls~N 273 (973)
++..+. ....+..|+...+...... ...+..+++|++|+|++|.+++. ++..+..+++|++|+|++|
T Consensus 216 ~~~l~~~l~-~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n 294 (461)
T 1z7x_W 216 CRDLCGIVA-SKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGN 294 (461)
T ss_dssp HHHHHHHHH-HCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTC
T ss_pred HHHHHHHHH-hCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCC
Confidence 122211 1111222222222211111 12233589999999999999964 6788888999999999999
Q ss_pred cccccCccccccc------ccCeEEccCCcCcCCCCCCCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCccc
Q 041143 274 QLVGLIPKSLANM------ELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLV 347 (973)
Q Consensus 274 ~l~~~~p~~~~~l------~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~ 347 (973)
.+++..+..+... +|+.|++++|.+++..... +
T Consensus 295 ~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~---------------------------l-------------- 333 (461)
T 1z7x_W 295 ELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSH---------------------------F-------------- 333 (461)
T ss_dssp CCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHH---------------------------H--------------
T ss_pred CCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHH---------------------------H--------------
Confidence 9987655555432 7999999999987532110 0
Q ss_pred CCCCCCCCCCCCccccccCCCCcccEEecCCCcCCCccchhhhC-----ccccceEEccCCcccc----ccCccccCcCC
Q 041143 348 SQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIAN-----LDSLIEIRLGKNSISG----TVPNNFTELKS 418 (973)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~L~~N~l~g----~~p~~~~~l~~ 418 (973)
...+..+++|+.|+|++|.+++..+..+.. .++|+.|+|++|+|++ .+|..+..+++
T Consensus 334 --------------~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~ 399 (461)
T 1z7x_W 334 --------------SSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHS 399 (461)
T ss_dssp --------------HHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCC
T ss_pred --------------HHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCC
Confidence 001234578999999999999887776654 6799999999999996 88999999999
Q ss_pred CCeeeCCCCcCCCC--------CCC-CCcccceeecCCccc
Q 041143 419 LRLLDVSDNNIKPP--------LPE-FHDTVKLVIDGNPLL 450 (973)
Q Consensus 419 L~~L~Ls~N~l~g~--------~p~-~~~~~~~~~~~N~~~ 450 (973)
|++|||++|++++. +|. ...+..+.+.++.+.
T Consensus 400 L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~ 440 (461)
T 1z7x_W 400 LRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 440 (461)
T ss_dssp CCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCC
T ss_pred ccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccC
Confidence 99999999999864 232 234666777776654
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.90 E-value=7.3e-24 Score=227.83 Aligned_cols=181 Identities=22% Similarity=0.272 Sum_probs=117.1
Q ss_pred CcccccccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccc
Q 041143 86 NFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANS 165 (973)
Q Consensus 86 ~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l 165 (973)
.+..+++|+.|++++|.++. ++.+..+++|++|+|++|+++.++ .+..+++|++|+|++|++++. .+..+.++
T Consensus 36 ~~~~l~~L~~L~l~~~~i~~-~~~l~~l~~L~~L~l~~n~l~~~~--~l~~l~~L~~L~L~~n~l~~~----~~~~~~~l 108 (272)
T 3rfs_A 36 TQNELNSIDQIIANNSDIKS-VQGIQYLPNVRYLALGGNKLHDIS--ALKELTNLTYLILTGNQLQSL----PNGVFDKL 108 (272)
T ss_dssp CHHHHTTCCEEECTTSCCCC-CTTGGGCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECTTSCCCCC----CTTTTTTC
T ss_pred ccccccceeeeeeCCCCccc-ccccccCCCCcEEECCCCCCCCch--hhcCCCCCCEEECCCCccCcc----ChhHhcCC
Confidence 34566667777777776664 344666677777777777776653 466777777777777777653 34445667
Q ss_pred cccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEE
Q 041143 166 VQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLW 245 (973)
Q Consensus 166 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~ 245 (973)
++|++|+|++|++++..+..|.++++|++|+|++|++++..+..+ .++++|+.|+
T Consensus 109 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-------------------------~~l~~L~~L~ 163 (272)
T 3rfs_A 109 TNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVF-------------------------DKLTNLTELD 163 (272)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT-------------------------TTCTTCCEEE
T ss_pred cCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHh-------------------------ccCccCCEEE
Confidence 777777777777776666667777777777777777764444333 3467777777
Q ss_pred ccCCccccCCCccccCCCCCCEEeCcCCcccccCccccccc-ccCeEEccCCcC
Q 041143 246 LHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLL 298 (973)
Q Consensus 246 L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l 298 (973)
|++|++++..+..|..+++|++|+|++|++++..+..+..+ +|+.|++++|.+
T Consensus 164 l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~ 217 (272)
T 3rfs_A 164 LSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPW 217 (272)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCB
T ss_pred CCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCc
Confidence 77777776666666777777777777777776655555544 444444444444
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.90 E-value=6.9e-24 Score=225.16 Aligned_cols=192 Identities=23% Similarity=0.311 Sum_probs=169.9
Q ss_pred CCCCCCCcCeEEeeCCeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCC-CCCCCCccceeeccCCCCCCCC
Q 041143 52 DPCGPPPWPHVFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFDTIP 130 (973)
Q Consensus 52 d~C~~~~w~gv~C~~~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~ 130 (973)
+||. |.|+.|.. ..+.+++++++++ .+|..+. ++|+.|+|++|.+++..+ .|.++++|++|+|++|+|+.++
T Consensus 3 ~Cp~---~~gC~C~~-~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 75 (251)
T 3m19_A 3 TCET---VTGCTCNE-GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLS 75 (251)
T ss_dssp -CHH---HHSSEEEG-GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCC
T ss_pred cCCC---CCceEcCC-CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccC
Confidence 4555 99999963 3457899999998 6777665 689999999999999888 6999999999999999999999
Q ss_pred ccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhh
Q 041143 131 SDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASF 210 (973)
Q Consensus 131 ~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~ 210 (973)
+..|.++++|++|+|++|++++. .+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|
T Consensus 76 ~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 151 (251)
T 3m19_A 76 AGVFDDLTELGTLGLANNQLASL----PLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAF 151 (251)
T ss_dssp TTTTTTCTTCCEEECTTSCCCCC----CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT
T ss_pred HhHhccCCcCCEEECCCCccccc----ChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHc
Confidence 99999999999999999999974 55678899999999999999998888889999999999999999996555444
Q ss_pred hhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcccccC
Q 041143 211 GQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLI 279 (973)
Q Consensus 211 ~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~ 279 (973)
.++++|++|+|++|+|++..+..|..+++|++|+|++|.+.+..
T Consensus 152 -------------------------~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~ 195 (251)
T 3m19_A 152 -------------------------DKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCSR 195 (251)
T ss_dssp -------------------------TTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTTS
T ss_pred -------------------------CcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCCc
Confidence 46899999999999999877888999999999999999998763
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.2e-22 Score=219.97 Aligned_cols=178 Identities=26% Similarity=0.226 Sum_probs=109.3
Q ss_pred ccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEc
Q 041143 167 QLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWL 246 (973)
Q Consensus 167 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L 246 (973)
+|+.|+|++|+|++..+..|.++++|++|+|++|+|++..+. ..+++|++|+|
T Consensus 32 ~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~---------------------------~~l~~L~~L~L 84 (290)
T 1p9a_G 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD---------------------------GTLPVLGTLDL 84 (290)
T ss_dssp TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC---------------------------SCCTTCCEEEC
T ss_pred CCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC---------------------------CCCCcCCEEEC
Confidence 455555555555555555555555555555555555532111 13555666666
Q ss_pred cCCccccCCCccccCCCCCCEEeCcCCcccccCccccccc-ccCeEEccCCcCcCCCCCCCCCCcccccCcccCCCCCcc
Q 041143 247 HGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIE 325 (973)
Q Consensus 247 ~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~ 325 (973)
++|+|+ .+|..+..+++|++|+|++|+|++..+..|..+ +|+.|+|++|+|++..+.
T Consensus 85 s~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~--------------------- 142 (290)
T 1p9a_G 85 SHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPG--------------------- 142 (290)
T ss_dssp CSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTT---------------------
T ss_pred CCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChh---------------------
Confidence 666665 555555566666666666666665555555555 555555555555532221
Q ss_pred cCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCCCccchhhhCccccceEEccCCcc
Q 041143 326 CAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSI 405 (973)
Q Consensus 326 ~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 405 (973)
.+..+++|+.|+|++|++++..+..|..+++|+.|+|++|+|
T Consensus 143 --------------------------------------~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l 184 (290)
T 1p9a_G 143 --------------------------------------LLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL 184 (290)
T ss_dssp --------------------------------------TTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCC
T ss_pred --------------------------------------hcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcC
Confidence 112345677777777777766666677788888888888888
Q ss_pred ccccCccccCcCCCCeeeCCCCcCCCC
Q 041143 406 SGTVPNNFTELKSLRLLDVSDNNIKPP 432 (973)
Q Consensus 406 ~g~~p~~~~~l~~L~~L~Ls~N~l~g~ 432 (973)
+ .+|..+..+.+|+.|+|++|.+...
T Consensus 185 ~-~ip~~~~~~~~L~~l~L~~Np~~C~ 210 (290)
T 1p9a_G 185 Y-TIPKGFFGSHLLPFAFLHGNPWLCN 210 (290)
T ss_dssp C-CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred C-ccChhhcccccCCeEEeCCCCccCc
Confidence 8 7788888888888888888877654
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-23 Score=230.71 Aligned_cols=58 Identities=21% Similarity=0.284 Sum_probs=42.9
Q ss_pred CcccEEecCCCcCCCccchhhhCccccceEEccCCccccccCccccCcCCCCeeeCCCCcCCC
Q 041143 369 SKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKP 431 (973)
Q Consensus 369 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g 431 (973)
++|++|+|++|+++ .+|..+. ++|+.|+|++|+|++. |. +..+++|+.|+|++|+|+.
T Consensus 251 ~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 251 SALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp TTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred CcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence 46777777777777 5565553 6888888888888853 43 6778888888888888864
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.9e-22 Score=215.10 Aligned_cols=207 Identities=20% Similarity=0.259 Sum_probs=133.8
Q ss_pred ccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCe
Q 041143 115 ELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAA 194 (973)
Q Consensus 115 ~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 194 (973)
+++.+++++|+++.+|.... ++|++|+|++|+++.. .+..|.++++|++|+|++|+|+...+..|.++++|++
T Consensus 17 ~~~~l~~~~~~l~~ip~~~~---~~l~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~ 89 (270)
T 2o6q_A 17 NKNSVDCSSKKLTAIPSNIP---ADTKKLDLQSNKLSSL----PSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLET 89 (270)
T ss_dssp TTTEEECTTSCCSSCCSCCC---TTCSEEECCSSCCSCC----CTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCE
T ss_pred CCCEEEccCCCCCccCCCCC---CCCCEEECcCCCCCee----CHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCE
Confidence 46677777777777765432 4566666666666652 2335666666666666666666555555566666666
Q ss_pred EEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCc
Q 041143 195 LKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQ 274 (973)
Q Consensus 195 L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~ 274 (973)
|+|++|++++..+..| .++++|++|+|++|++++..+..|..+++|++|+|++|+
T Consensus 90 L~l~~n~l~~~~~~~~-------------------------~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 144 (270)
T 2o6q_A 90 LWVTDNKLQALPIGVF-------------------------DQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNE 144 (270)
T ss_dssp EECCSSCCCCCCTTTT-------------------------TTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EECCCCcCCcCCHhHc-------------------------ccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCc
Confidence 6666666653332222 345666666666666665555555666666666666665
Q ss_pred ccccCcccccccccCeEEccCCcCcCCCCCCCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCC
Q 041143 275 LVGLIPKSLANMELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGND 354 (973)
Q Consensus 275 l~~~~p~~~~~l~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~ 354 (973)
+++..+..|.
T Consensus 145 l~~~~~~~~~---------------------------------------------------------------------- 154 (270)
T 2o6q_A 145 LQSLPKGVFD---------------------------------------------------------------------- 154 (270)
T ss_dssp CCCCCTTTTT----------------------------------------------------------------------
T ss_pred CCccCHhHcc----------------------------------------------------------------------
Confidence 5543333333
Q ss_pred CCCCCccccccCCCCcccEEecCCCcCCCccchhhhCccccceEEccCCccccccCccccCcCCCCeeeCCCCcCCCCCC
Q 041143 355 PCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLP 434 (973)
Q Consensus 355 ~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p 434 (973)
.+++|+.|+|++|++++..+..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|.+.+..+
T Consensus 155 ------------~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 155 ------------KLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN 222 (270)
T ss_dssp ------------TCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred ------------CCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence 34566666777777766666678888889999999999987666678889999999999998877654
Q ss_pred C
Q 041143 435 E 435 (973)
Q Consensus 435 ~ 435 (973)
.
T Consensus 223 ~ 223 (270)
T 2o6q_A 223 G 223 (270)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.3e-23 Score=219.51 Aligned_cols=213 Identities=17% Similarity=0.243 Sum_probs=160.7
Q ss_pred CCCCCCCCCcCe--EEeeC--------CeEEEEEecccCCcccCCcCcccccccceeeccCcc-cCCCCC-CCCCCCccc
Q 041143 50 GDDPCGPPPWPH--VFCSG--------NRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNK-FNGKLP-TFSGLSELE 117 (973)
Q Consensus 50 ~~d~C~~~~w~g--v~C~~--------~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~-l~~~~~-~~~~l~~L~ 117 (973)
.++.|.+..|.. |.|.. ..++.|+|++|++++..+..|.++++|++|+|++|+ ++++.+ .|.++++|+
T Consensus 4 cp~~C~C~~~~~~~v~c~~l~~ip~~~~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~ 83 (239)
T 2xwt_C 4 SSPPCECHQEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVT 83 (239)
T ss_dssp CSSSCSEEECSTTEEEECSCSSCCCCCTTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCC
T ss_pred CCCCCeeCCCCcceeEccCccccCCCCCcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCc
Confidence 345666433343 55853 467888888888887777788888888888888886 777766 688888888
Q ss_pred eeeccC-CCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccC---eeecccc-cccCCcchhccCCCCC
Q 041143 118 FAYLDF-NEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLT---NLSLINC-NLVGPLPDFLGTLPSL 192 (973)
Q Consensus 118 ~L~L~~-N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~---~L~L~~N-~l~~~~p~~l~~l~~L 192 (973)
+|+|++ |+|+.+++..|.++++|++|+|++|++++ +|. +..+++|+ +|+|++| ++++..+..|.++++|
T Consensus 84 ~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-----lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L 157 (239)
T 2xwt_C 84 HIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-----FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNE 157 (239)
T ss_dssp EEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-----CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSS
T ss_pred EEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-----ccc-cccccccccccEEECCCCcchhhcCcccccchhcc
Confidence 888887 88888888888888888888888888885 565 77777777 8888888 8887666778888888
Q ss_pred C-eEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCc-cccCCCccccCC-CCCCEEe
Q 041143 193 A-ALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQ-FTGSIPEDIGAL-SSLKDLN 269 (973)
Q Consensus 193 ~-~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~-l~g~~p~~~~~l-~~L~~L~ 269 (973)
+ +|+|++|+++ .+|... |.. ++|+.|+|++|+ +++..+..|..+ ++|+.|+
T Consensus 158 ~~~L~l~~n~l~-~i~~~~------------------------~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~ 211 (239)
T 2xwt_C 158 TLTLKLYNNGFT-SVQGYA------------------------FNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLD 211 (239)
T ss_dssp EEEEECCSCCCC-EECTTT------------------------TTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEE
T ss_pred eeEEEcCCCCCc-ccCHhh------------------------cCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEE
Confidence 8 8888888887 555433 223 688888888884 886556778888 8888888
Q ss_pred CcCCcccccCcccccccccCeEEccCC
Q 041143 270 LNRNQLVGLIPKSLANMELDNLVLNNN 296 (973)
Q Consensus 270 Ls~N~l~~~~p~~~~~l~L~~L~l~~N 296 (973)
|++|++++..+..+. +|+.|+++++
T Consensus 212 l~~N~l~~l~~~~~~--~L~~L~l~~~ 236 (239)
T 2xwt_C 212 VSQTSVTALPSKGLE--HLKELIARNT 236 (239)
T ss_dssp CTTCCCCCCCCTTCT--TCSEEECTTC
T ss_pred CCCCccccCChhHhc--cCceeeccCc
Confidence 888888855444222 6777877765
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-22 Score=219.90 Aligned_cols=158 Identities=22% Similarity=0.305 Sum_probs=77.2
Q ss_pred cccccccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCccccccc
Q 041143 87 FNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSV 166 (973)
Q Consensus 87 ~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~ 166 (973)
++++++|++|++++|.++.+++.+. ++|++|+|++|+|+.+++..|.++++|++|+|++|+|++. +.. ..++
T Consensus 6 ~~~l~~l~~l~~~~~~l~~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-----~~~-~~l~ 77 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLTALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-----QVD-GTLP 77 (290)
T ss_dssp EECSTTCCEEECTTSCCSSCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-----ECC-SCCT
T ss_pred ccccCCccEEECCCCCCCcCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcc-----cCC-CCCC
Confidence 3445555555555555554444332 3455555555555555555555555555555555555532 211 4445
Q ss_pred ccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEc
Q 041143 167 QLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWL 246 (973)
Q Consensus 167 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L 246 (973)
+|++|+|++|+|+ .+|..+..+++|++|+|++|+|++..|..| .++++|++|+|
T Consensus 78 ~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~-------------------------~~l~~L~~L~L 131 (290)
T 1p9a_G 78 VLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGAL-------------------------RGLGELQELYL 131 (290)
T ss_dssp TCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTT-------------------------TTCTTCCEEEC
T ss_pred cCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHH-------------------------cCCCCCCEEEC
Confidence 5555555555554 344444555555555555555543332222 23445555555
Q ss_pred cCCccccCCCccccCCCCCCEEeCcCCccccc
Q 041143 247 HGNQFTGSIPEDIGALSSLKDLNLNRNQLVGL 278 (973)
Q Consensus 247 ~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~ 278 (973)
++|+|++..+..|..+++|+.|+|++|+|++.
T Consensus 132 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l 163 (290)
T 1p9a_G 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLTEL 163 (290)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECTTSCCSCC
T ss_pred CCCCCCccChhhcccccCCCEEECCCCcCCcc
Confidence 55555543334444455555555555555433
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.7e-24 Score=243.07 Aligned_cols=63 Identities=21% Similarity=0.312 Sum_probs=40.0
Q ss_pred cccEEecCCCcCCCccch----hhhCccccceEEccCCcccc-------ccCccccCcCCCCeeeCCCCcCCCC
Q 041143 370 KVSIINLPRHNLTGTLSP----SIANLDSLIEIRLGKNSISG-------TVPNNFTELKSLRLLDVSDNNIKPP 432 (973)
Q Consensus 370 ~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~L~~N~l~g-------~~p~~~~~l~~L~~L~Ls~N~l~g~ 432 (973)
+|+.|+|++|.+++..+. .+..+++|+.|+|++|.+.+ .++..+..+++|+.|||++|++.+.
T Consensus 226 ~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~ 299 (362)
T 3goz_A 226 HVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS 299 (362)
T ss_dssp TCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred CceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCc
Confidence 566666666666665442 23455677777777777332 2344566777777777777777655
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.88 E-value=2.1e-24 Score=240.06 Aligned_cols=207 Identities=17% Similarity=0.252 Sum_probs=149.0
Q ss_pred CcCeEEeeCCeEEEEEecccCCcccCCcCcccc--cccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCC-Ccccc
Q 041143 58 PWPHVFCSGNRVTQIQVQNLGLKGPLPQNFNQL--TKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTI-PSDFF 134 (973)
Q Consensus 58 ~w~gv~C~~~~v~~L~L~~~~l~g~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i-~~~~f 134 (973)
.|.++.|+...++.|+++++.+. +..+..+ ++|+.|++++|.+++.++.+..+++|++|+|++|.++.. .+..+
T Consensus 38 ~W~~~~~~~~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~~~ 114 (336)
T 2ast_B 38 RWYRLASDESLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGIL 114 (336)
T ss_dssp HHHHHHTCSTTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHH
T ss_pred HHHHHhcCchhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHHHHHH
Confidence 39999887767889999998887 4667777 899999999999999888877888899999888887753 44557
Q ss_pred CCCCCccEEEcccCCCCCccCCCCCcccccccccCeeecccc-cccC-CcchhccCCCCCCeEEccCC-cCccc-CChhh
Q 041143 135 DGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINC-NLVG-PLPDFLGTLPSLAALKLSYN-RLSGV-IPASF 210 (973)
Q Consensus 135 ~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N-~l~~-~~p~~l~~l~~L~~L~Ls~N-~l~~~-~p~~~ 210 (973)
..+++|++|+|++|++++. ++..++.+++|++|+|++| .+++ .++..+.++++|++|+|++| .+++. ++..+
T Consensus 115 ~~~~~L~~L~L~~~~l~~~----~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~ 190 (336)
T 2ast_B 115 SQCSKLQNLSLEGLRLSDP----IVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAV 190 (336)
T ss_dssp TTBCCCSEEECTTCBCCHH----HHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHH
T ss_pred hhCCCCCEEeCcCcccCHH----HHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHH
Confidence 7778888888888877653 5666777777777887777 5664 25666777777777777777 77643 23222
Q ss_pred hhhHHHHHhhcccCCCCCCCcchhhcCCc-cccEEEccCC--ccc-cCCCccccCCCCCCEEeCcCCc-ccccCcccccc
Q 041143 211 GQSLMQILWLNDQDAGGMTGPIDVVAKMV-SLTQLWLHGN--QFT-GSIPEDIGALSSLKDLNLNRNQ-LVGLIPKSLAN 285 (973)
Q Consensus 211 ~~~~~~~~~l~~~~~~~~~~~~~~~~~l~-~L~~L~L~~N--~l~-g~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~ 285 (973)
..++ +|++|+|++| .++ +.+|..+..+++|++|+|++|. +++..+..+..
T Consensus 191 -------------------------~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~ 245 (336)
T 2ast_B 191 -------------------------AHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQ 245 (336)
T ss_dssp -------------------------HHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGG
T ss_pred -------------------------HhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhC
Confidence 3466 7777777777 444 3456666677777777777777 55555555554
Q ss_pred c-ccCeEEccCC
Q 041143 286 M-ELDNLVLNNN 296 (973)
Q Consensus 286 l-~L~~L~l~~N 296 (973)
+ +|+.|++++|
T Consensus 246 l~~L~~L~l~~~ 257 (336)
T 2ast_B 246 LNYLQHLSLSRC 257 (336)
T ss_dssp CTTCCEEECTTC
T ss_pred CCCCCEeeCCCC
Confidence 4 4555555555
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.88 E-value=2.2e-24 Score=244.69 Aligned_cols=201 Identities=20% Similarity=0.248 Sum_probs=134.9
Q ss_pred ccccccCeeecccccccC----CcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCC
Q 041143 163 ANSVQLTNLSLINCNLVG----PLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKM 238 (973)
Q Consensus 163 ~~l~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l 238 (973)
..+++|++|+|++|.|++ .++..+..+++|++|+|++|.+++..+..+...+..+..... -...
T Consensus 91 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~------------~~~~ 158 (386)
T 2ca6_A 91 LKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKK------------AKNA 158 (386)
T ss_dssp TTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHH------------HHTC
T ss_pred hhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhh------------cccC
Confidence 566777777777777775 366677777777777777777764444444321111000000 0011
Q ss_pred ccccEEEccCCccc-cCCC---ccccCCCCCCEEeCcCCccc--c---cCccccccc-ccCeEEccCCcCc----CCCCC
Q 041143 239 VSLTQLWLHGNQFT-GSIP---EDIGALSSLKDLNLNRNQLV--G---LIPKSLANM-ELDNLVLNNNLLM----GPIPK 304 (973)
Q Consensus 239 ~~L~~L~L~~N~l~-g~~p---~~~~~l~~L~~L~Ls~N~l~--~---~~p~~~~~l-~L~~L~l~~N~l~----g~~p~ 304 (973)
++|++|+|++|+++ +.+| ..+..+++|++|+|++|+++ | .++..+..+ +|+.|+|++|.|+ +.+|.
T Consensus 159 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~ 238 (386)
T 2ca6_A 159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 238 (386)
T ss_dssp CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred CCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHH
Confidence 67777777777776 3444 45667777888888887776 2 233355555 6777888777775 22221
Q ss_pred CCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCCCc
Q 041143 305 FKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGT 384 (973)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~ 384 (973)
.+..+++|+.|+|++|.+++.
T Consensus 239 -----------------------------------------------------------~l~~~~~L~~L~L~~n~i~~~ 259 (386)
T 2ca6_A 239 -----------------------------------------------------------ALKSWPNLRELGLNDCLLSAR 259 (386)
T ss_dssp -----------------------------------------------------------HGGGCTTCCEEECTTCCCCHH
T ss_pred -----------------------------------------------------------HHccCCCcCEEECCCCCCchh
Confidence 123456788888888888876
Q ss_pred ----cchhhhC--ccccceEEccCCcccc----ccCccc-cCcCCCCeeeCCCCcCCCCCC
Q 041143 385 ----LSPSIAN--LDSLIEIRLGKNSISG----TVPNNF-TELKSLRLLDVSDNNIKPPLP 434 (973)
Q Consensus 385 ----~p~~~~~--l~~L~~L~L~~N~l~g----~~p~~~-~~l~~L~~L~Ls~N~l~g~~p 434 (973)
++..+.. +++|+.|+|++|.|++ .+|..+ .++++|++|+|++|++++..+
T Consensus 260 ~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 260 GAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp HHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred hHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 6667744 8999999999999997 588887 668999999999999998765
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.2e-22 Score=223.03 Aligned_cols=205 Identities=19% Similarity=0.204 Sum_probs=169.5
Q ss_pred eEEEEEecccCCcccCCcCc--ccccccceeeccCcccCCCCC-----CCCCCCccceeeccCCCCCCCCccccCCCCCc
Q 041143 68 RVTQIQVQNLGLKGPLPQNF--NQLTKLYNLGLQRNKFNGKLP-----TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSV 140 (973)
Q Consensus 68 ~v~~L~L~~~~l~g~~~~~~--~~l~~L~~L~L~~N~l~~~~~-----~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L 140 (973)
++++|+|++|++++..|..+ .++++|++|+|++|.+++..+ .+..+++|++|+|++|+|..+++..|..+++|
T Consensus 92 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L 171 (310)
T 4glp_A 92 RLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPAL 171 (310)
T ss_dssp CCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTC
T ss_pred ceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCC
Confidence 49999999999999999988 999999999999999998655 24579999999999999999999999999999
Q ss_pred cEEEcccCCCCCccCCCCCcccccccccCeeecccccccCCcch----hccCCCCCCeEEccCCcCcccCChhhhhhHHH
Q 041143 141 RVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPD----FLGTLPSLAALKLSYNRLSGVIPASFGQSLMQ 216 (973)
Q Consensus 141 ~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~----~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~ 216 (973)
++|+|++|++.+..+...+..+..+++|++|+|++|+|+ .++. .++++++|++|+|++|++++.+|..+..
T Consensus 172 ~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~---- 246 (310)
T 4glp_A 172 TSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPR---- 246 (310)
T ss_dssp CEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSS----
T ss_pred CEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHh----
Confidence 999999999865211012334478899999999999997 3333 3578899999999999999887776532
Q ss_pred HHhhcccCCCCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcccccCccccccc-ccCeEEccC
Q 041143 217 ILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNN 295 (973)
Q Consensus 217 ~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~ 295 (973)
+..+++|++|+|++|+|+ .+|..+. ++|++|+|++|+|++. |. +..+ +|+.|+|++
T Consensus 247 ------------------~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~ 303 (310)
T 4glp_A 247 ------------------CMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDG 303 (310)
T ss_dssp ------------------CCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSS
T ss_pred ------------------ccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcC
Confidence 223479999999999999 7888775 7999999999999974 33 4555 799999999
Q ss_pred CcCcC
Q 041143 296 NLLMG 300 (973)
Q Consensus 296 N~l~g 300 (973)
|+|+.
T Consensus 304 N~l~~ 308 (310)
T 4glp_A 304 NPFLV 308 (310)
T ss_dssp TTTSC
T ss_pred CCCCC
Confidence 99874
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.3e-22 Score=218.41 Aligned_cols=151 Identities=16% Similarity=0.080 Sum_probs=120.5
Q ss_pred HHHhcCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCCh----------------HHHHHHHHHHHHHHhcCCCc
Q 041143 621 RKVTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTT----------------KALDEFQSEIAVLSKVRHRH 684 (973)
Q Consensus 621 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~----------------~~~~~~~~E~~~l~~l~h~n 684 (973)
......|...+.||+|+||.||+|...+|+.||||+++...... .....+.+|++++++++ |
T Consensus 86 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~ 163 (282)
T 1zar_A 86 VRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G 163 (282)
T ss_dssp HHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T
T ss_pred HhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C
Confidence 33345666779999999999999998779999999986432111 24567899999999999 5
Q ss_pred eeeeeeEEEeCCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEE
Q 041143 685 LVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILL 764 (973)
Q Consensus 685 iv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill 764 (973)
+++.+++.. +..++||||+++|+|.+ +. ......++.||++||+||| +.+|+||||||+|||+
T Consensus 164 -~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~-----------~~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl 226 (282)
T 1zar_A 164 -LAVPKVYAW-EGNAVLMELIDAKELYR-VR-----------VENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLV 226 (282)
T ss_dssp -SSSCCEEEE-ETTEEEEECCCCEEGGG-CC-----------CSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEE
T ss_pred -CCcCeEEec-cceEEEEEecCCCcHHH-cc-----------hhhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEE
Confidence 677765544 55699999999999976 31 1234579999999999999 8899999999999999
Q ss_pred CCCCCEEEeeccccccCCCCCcceecccccccCcccccccc
Q 041143 765 DDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAV 805 (973)
Q Consensus 765 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~ 805 (973)
+ ++.+||+|||+|+. +..|+|||++.
T Consensus 227 ~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 227 S-EEGIWIIDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp E-TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred E-CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence 9 99999999999863 34578999874
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.87 E-value=3.5e-22 Score=205.49 Aligned_cols=186 Identities=24% Similarity=0.358 Sum_probs=153.8
Q ss_pred CCCCCCCCcCeEEeeCCeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCC-CCCCCCccceeeccCCCCCCC
Q 041143 51 DDPCGPPPWPHVFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFDTI 129 (973)
Q Consensus 51 ~d~C~~~~w~gv~C~~~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i 129 (973)
++.|. |.|.+|.|+...++ .+|..+ .++|++|+|++|++++.++ .|.++++|++|+|++|+|+.+
T Consensus 2 p~~C~-C~~~~v~c~~~~l~-----------~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 67 (208)
T 2o6s_A 2 PSRCS-CSGTTVECYSQGRT-----------SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSL 67 (208)
T ss_dssp CTTCE-EETTEEECCSSCCS-----------SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCC
T ss_pred cCCCE-ECCCEEEecCCCcc-----------CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCcc
Confidence 34564 45999999765443 344443 4589999999999998777 478899999999999999999
Q ss_pred CccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChh
Q 041143 130 PSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPAS 209 (973)
Q Consensus 130 ~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~ 209 (973)
++..|..+++|++|+|++|++++. .+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|++++..+..
T Consensus 68 ~~~~~~~l~~L~~L~Ls~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 143 (208)
T 2o6s_A 68 PNGVFNKLTSLTYLNLSTNQLQSL----PNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGV 143 (208)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCCC----CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTT
T ss_pred ChhhcCCCCCcCEEECCCCcCCcc----CHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHH
Confidence 999999999999999999999963 4455789999999999999999877778899999999999999998554433
Q ss_pred hhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcccccCccccccc
Q 041143 210 FGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM 286 (973)
Q Consensus 210 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 286 (973)
+ ..+++|+.|+|++|.+.+. +++|++|+++.|+++|.+|..++.+
T Consensus 144 ~-------------------------~~l~~L~~L~l~~N~~~~~-------~~~l~~L~~~~n~~~g~ip~~~~~l 188 (208)
T 2o6s_A 144 F-------------------------DRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGSV 188 (208)
T ss_dssp T-------------------------TTCTTCCEEECCSCCBCCC-------TTTTHHHHHHHHHCTTTBBCTTSSB
T ss_pred h-------------------------ccCCCccEEEecCCCeecC-------CCCHHHHHHHHHhCCceeeccCccc
Confidence 3 4589999999999988754 4589999999999999999988876
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=6.8e-22 Score=208.16 Aligned_cols=84 Identities=21% Similarity=0.284 Sum_probs=45.2
Q ss_pred ccceeeccCcccCCCCC-CCCCCCccceeeccCCC-CCCCCccccCCCCCccEEEccc-CCCCCccCCCCCccccccccc
Q 041143 92 KLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNE-FDTIPSDFFDGLSSVRVLALDY-NPFNKTFGWSIPDSLANSVQL 168 (973)
Q Consensus 92 ~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~-l~~i~~~~f~~l~~L~~L~Ls~-N~l~~~~~~~ip~~~~~l~~L 168 (973)
+|++|+|++|+|+++++ .|.++++|++|+|++|+ ++.+++..|.++++|++|+|++ |+++.. .+..|.++++|
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i----~~~~f~~l~~L 107 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYI----DPDALKELPLL 107 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEE----CTTSEECCTTC
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEc----CHHHhCCCCCC
Confidence 56666666666666555 45556666666666664 5555555555555555555555 555432 22334444444
Q ss_pred Ceeeccccccc
Q 041143 169 TNLSLINCNLV 179 (973)
Q Consensus 169 ~~L~L~~N~l~ 179 (973)
++|+|++|+++
T Consensus 108 ~~L~l~~n~l~ 118 (239)
T 2xwt_C 108 KFLGIFNTGLK 118 (239)
T ss_dssp CEEEEEEECCC
T ss_pred CEEeCCCCCCc
Confidence 44444444444
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.87 E-value=1.4e-21 Score=213.88 Aligned_cols=35 Identities=17% Similarity=0.348 Sum_probs=15.2
Q ss_pred cccEEecCCCcCCCccchhhhCccccceEEccCCccc
Q 041143 370 KVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSIS 406 (973)
Q Consensus 370 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 406 (973)
+|+.|+|++|++.+..+ +..+++|+.|+|++|+++
T Consensus 196 ~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~ 230 (308)
T 1h6u_A 196 NLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTIT 230 (308)
T ss_dssp TCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEE
T ss_pred CCCEEEccCCccCcccc--ccCCCCCCEEEccCCeee
Confidence 33444444444433332 444444555555555444
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.86 E-value=3.8e-21 Score=203.97 Aligned_cols=181 Identities=22% Similarity=0.283 Sum_probs=163.0
Q ss_pred cccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCe
Q 041143 91 TKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTN 170 (973)
Q Consensus 91 ~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~ 170 (973)
...++++++++.++.+++.+. ++|+.|+|++|+|+.+++..|.++++|++|+|++|+|++. .+..|..+++|++
T Consensus 14 ~~~~~l~~~~~~l~~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~ 87 (251)
T 3m19_A 14 EGKKEVDCQGKSLDSVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTL----SAGVFDDLTELGT 87 (251)
T ss_dssp GGGTEEECTTCCCSSCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCC----CTTTTTTCTTCCE
T ss_pred CCCeEEecCCCCccccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCcc----CHhHhccCCcCCE
Confidence 457889999999998777665 6899999999999999999999999999999999999985 6677899999999
Q ss_pred eecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCc
Q 041143 171 LSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQ 250 (973)
Q Consensus 171 L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~ 250 (973)
|+|++|+|++..+..|..+++|++|+|++|+|++..+..| .++++|++|+|++|+
T Consensus 88 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-------------------------~~l~~L~~L~Ls~N~ 142 (251)
T 3m19_A 88 LGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVF-------------------------DRLTKLKELRLNTNQ 142 (251)
T ss_dssp EECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT-------------------------TTCTTCCEEECCSSC
T ss_pred EECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHh-------------------------ccCCcccEEECcCCc
Confidence 9999999998888899999999999999999995554443 469999999999999
Q ss_pred cccCCCccccCCCCCCEEeCcCCcccccCccccccc-ccCeEEccCCcCcCCC
Q 041143 251 FTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGPI 302 (973)
Q Consensus 251 l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~g~~ 302 (973)
|++..+..|..+++|++|+|++|+|++..+..+..+ +|+.|+|++|.+.+..
T Consensus 143 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~ 195 (251)
T 3m19_A 143 LQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCSR 195 (251)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTTS
T ss_pred CCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCCc
Confidence 997777789999999999999999998888888888 8999999999998653
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.86 E-value=9.6e-24 Score=239.42 Aligned_cols=270 Identities=19% Similarity=0.196 Sum_probs=204.8
Q ss_pred cCCcCcccccccceeeccCcccCCCCC-----CCCCCCccceeeccCCCCCCCC----ccc------cCCCCCccEEEcc
Q 041143 82 PLPQNFNQLTKLYNLGLQRNKFNGKLP-----TFSGLSELEFAYLDFNEFDTIP----SDF------FDGLSSVRVLALD 146 (973)
Q Consensus 82 ~~~~~~~~l~~L~~L~L~~N~l~~~~~-----~~~~l~~L~~L~L~~N~l~~i~----~~~------f~~l~~L~~L~Ls 146 (973)
.++..+..+++|++|+|++|.|+...+ .|..+++|++|+|++|.+..+. ... |..+++|++|+|+
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls 102 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 102 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence 566778899999999999999988533 4788999999999998776443 222 4789999999999
Q ss_pred cCCCCCccCCCCCcccccccccCeeecccccccCCcchh----ccCC---------CCCCeEEccCCcCc-ccCChhhhh
Q 041143 147 YNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDF----LGTL---------PSLAALKLSYNRLS-GVIPASFGQ 212 (973)
Q Consensus 147 ~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~----l~~l---------~~L~~L~Ls~N~l~-~~~p~~~~~ 212 (973)
+|+++......+|..+..+++|++|+|++|.|+...+.. +..+ ++|++|+|++|+++ +.++. +.
T Consensus 103 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~-l~- 180 (386)
T 2ca6_A 103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKE-WA- 180 (386)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHH-HH-
T ss_pred CCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHH-HH-
Confidence 999987322236778899999999999999997544444 4344 99999999999997 33332 21
Q ss_pred hHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCccc--c---CCCccccCCCCCCEEeCcCCccc----ccCcccc
Q 041143 213 SLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFT--G---SIPEDIGALSSLKDLNLNRNQLV----GLIPKSL 283 (973)
Q Consensus 213 ~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~--g---~~p~~~~~l~~L~~L~Ls~N~l~----~~~p~~~ 283 (973)
..+..+++|++|+|++|+|+ | .+|..+..+++|++|+|++|.++ +.+|..+
T Consensus 181 --------------------~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l 240 (386)
T 2ca6_A 181 --------------------KTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIAL 240 (386)
T ss_dssp --------------------HHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHG
T ss_pred --------------------HHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHH
Confidence 22456889999999999998 3 34558899999999999999996 5677788
Q ss_pred ccc-ccCeEEccCCcCcCCCCCCCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCccc
Q 041143 284 ANM-ELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLG 362 (973)
Q Consensus 284 ~~l-~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~ 362 (973)
..+ +|+.|+|++|.|++..... +...+
T Consensus 241 ~~~~~L~~L~L~~n~i~~~~~~~---------------------------l~~~l------------------------- 268 (386)
T 2ca6_A 241 KSWPNLRELGLNDCLLSARGAAA---------------------------VVDAF------------------------- 268 (386)
T ss_dssp GGCTTCCEEECTTCCCCHHHHHH---------------------------HHHHH-------------------------
T ss_pred ccCCCcCEEECCCCCCchhhHHH---------------------------HHHHH-------------------------
Confidence 777 8999999999987531110 00000
Q ss_pred cccCCCCcccEEecCCCcCCC----ccchhh-hCccccceEEccCCccccccC--ccc-cCcCCCCeeeCCC
Q 041143 363 LSCTSNSKVSIINLPRHNLTG----TLSPSI-ANLDSLIEIRLGKNSISGTVP--NNF-TELKSLRLLDVSD 426 (973)
Q Consensus 363 ~~~~~~~~L~~L~Ls~N~l~~----~~p~~~-~~l~~L~~L~L~~N~l~g~~p--~~~-~~l~~L~~L~Ls~ 426 (973)
....+++|+.|+|++|.+++ .+|..+ .++++|+.|+|++|++++..+ ..+ ..++.++.+++..
T Consensus 269 -~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~~~~~l~~~l~~~~~~~l~~ 339 (386)
T 2ca6_A 269 -SKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDE 339 (386)
T ss_dssp -HTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSHHHHHHHHHHHHHTCCEECC
T ss_pred -hhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchhHHHHHHHHhhhcCcchhhh
Confidence 11236789999999999999 588887 779999999999999997664 333 2345555555543
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.85 E-value=3.6e-21 Score=210.57 Aligned_cols=190 Identities=24% Similarity=0.369 Sum_probs=167.9
Q ss_pred CeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcc
Q 041143 67 NRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALD 146 (973)
Q Consensus 67 ~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls 146 (973)
.+++.|++++++++. ++ .+..+++|++|+|++|.+++..+ +.++++|++|+|++|+++.++ .|..+++|++|+|+
T Consensus 41 ~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~-~~~l~~L~~L~L~~n~l~~~~--~~~~l~~L~~L~l~ 115 (308)
T 1h6u_A 41 DGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP-LKNLTKITELELSGNPLKNVS--AIAGLQSIKTLDLT 115 (308)
T ss_dssp HTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG-GTTCCSCCEEECCSCCCSCCG--GGTTCTTCCEEECT
T ss_pred CCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh-HccCCCCCEEEccCCcCCCch--hhcCCCCCCEEECC
Confidence 479999999999985 44 79999999999999999998777 999999999999999999985 58999999999999
Q ss_pred cCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCC
Q 041143 147 YNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAG 226 (973)
Q Consensus 147 ~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~ 226 (973)
+|++++ ++ .+..+++|++|+|++|++++..+ +..+++|++|+|++|++++..+ +
T Consensus 116 ~n~l~~-----~~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l---------------- 169 (308)
T 1h6u_A 116 STQITD-----VT-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--L---------------- 169 (308)
T ss_dssp TSCCCC-----CG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--G----------------
T ss_pred CCCCCC-----ch-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--h----------------
Confidence 999996 44 48999999999999999997554 8999999999999999985322 3
Q ss_pred CCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcccccCccccccc-ccCeEEccCCcCcC
Q 041143 227 GMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMG 300 (973)
Q Consensus 227 ~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~g 300 (973)
.++++|+.|+|++|++++..+ +..+++|++|+|++|++++..+ +..+ +|+.|++++|.+++
T Consensus 170 ---------~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 170 ---------ANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp ---------TTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred ---------cCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeec
Confidence 468999999999999995443 8999999999999999997653 6666 89999999999985
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.85 E-value=7.6e-23 Score=229.66 Aligned_cols=253 Identities=21% Similarity=0.247 Sum_probs=153.0
Q ss_pred eeccCcccCCCCCCCCCC-CccceeeccCCCCCCCCc----cccCCCC-CccEEEcccCCCCCccCCCCCcccccc----
Q 041143 96 LGLQRNKFNGKLPTFSGL-SELEFAYLDFNEFDTIPS----DFFDGLS-SVRVLALDYNPFNKTFGWSIPDSLANS---- 165 (973)
Q Consensus 96 L~L~~N~l~~~~~~~~~l-~~L~~L~L~~N~l~~i~~----~~f~~l~-~L~~L~Ls~N~l~~~~~~~ip~~~~~l---- 165 (973)
++|++|.+++.+|.+... ++|++|+|++|+|+.++. ..|..++ +|++|+|++|++++. .+..+..+
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~----~~~~l~~~l~~~ 78 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFK----NSDELVQILAAI 78 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGS----CHHHHHHHHHTS
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHH----HHHHHHHHHhcc
Confidence 456666666666644333 336667777666666665 5566666 666666666666653 33444443
Q ss_pred -cccCeeecccccccCCcchhcc----CC-CCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCC-
Q 041143 166 -VQLTNLSLINCNLVGPLPDFLG----TL-PSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKM- 238 (973)
Q Consensus 166 -~~L~~L~L~~N~l~~~~p~~l~----~l-~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l- 238 (973)
++|++|+|++|.|++..+..+. .+ ++|++|+|++|++++..+..+.. .+..+
T Consensus 79 ~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~---------------------~l~~~~ 137 (362)
T 3goz_A 79 PANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQ---------------------AFSNLP 137 (362)
T ss_dssp CTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH---------------------HHTTSC
T ss_pred CCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHH---------------------HHHhCC
Confidence 6666666666666655544332 33 66666666666666444444321 12232
Q ss_pred ccccEEEccCCccccCC----CccccCCC-CCCEEeCcCCcccccCcccccccccCeEEccCCcCcCCCCCCCCCCcccc
Q 041143 239 VSLTQLWLHGNQFTGSI----PEDIGALS-SLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMGPIPKFKAGNVTYD 313 (973)
Q Consensus 239 ~~L~~L~L~~N~l~g~~----p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~L~~L~l~~N~l~g~~p~~~~~~~~~~ 313 (973)
++|++|+|++|+|++.. +..+..++ +|++|+|++|++++..+..+...
T Consensus 138 ~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~--------------------------- 190 (362)
T 3goz_A 138 ASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKF--------------------------- 190 (362)
T ss_dssp TTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHH---------------------------
T ss_pred CceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHH---------------------------
Confidence 46666666666666432 22333443 56666666666655444333221
Q ss_pred cCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCC-CcccEEecCCCcCCCc----cchh
Q 041143 314 SNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSN-SKVSIINLPRHNLTGT----LSPS 388 (973)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~-~~L~~L~Ls~N~l~~~----~p~~ 388 (973)
+..+ ++|+.|+|++|.+++. ++..
T Consensus 191 ---------------------------------------------------l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~ 219 (362)
T 3goz_A 191 ---------------------------------------------------LASIPASVTSLDLSANLLGLKSYAELAYI 219 (362)
T ss_dssp ---------------------------------------------------HHTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ---------------------------------------------------HHhCCCCCCEEECCCCCCChhHHHHHHHH
Confidence 0112 2566777777777663 5556
Q ss_pred hhC-ccccceEEccCCccccccC----ccccCcCCCCeeeCCCCcCCCC-----------CCCCCcccceeecCCcccc
Q 041143 389 IAN-LDSLIEIRLGKNSISGTVP----NNFTELKSLRLLDVSDNNIKPP-----------LPEFHDTVKLVIDGNPLLV 451 (973)
Q Consensus 389 ~~~-l~~L~~L~L~~N~l~g~~p----~~~~~l~~L~~L~Ls~N~l~g~-----------~p~~~~~~~~~~~~N~~~c 451 (973)
+.. .++|+.|+|++|+|++..+ ..+..+++|+.|+|++|.+.+. .+.+..+..+++.+|++..
T Consensus 220 l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~ 298 (362)
T 3goz_A 220 FSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHP 298 (362)
T ss_dssp HHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCG
T ss_pred HhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCC
Confidence 666 4599999999999986544 4457789999999999996543 3445566778999998643
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.85 E-value=2.2e-21 Score=216.51 Aligned_cols=193 Identities=19% Similarity=0.183 Sum_probs=110.6
Q ss_pred ecccCCcccCCcCcccccccceeeccCcccCCCCC-CCCCCCccceeeccCCCCC-CCCccccCCCCCccE-EEcccCCC
Q 041143 74 VQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFD-TIPSDFFDGLSSVRV-LALDYNPF 150 (973)
Q Consensus 74 L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~-~i~~~~f~~l~~L~~-L~Ls~N~l 150 (973)
.++++|+ .+|..+ .++|++|+|++|+|+.+++ .|.++++|++|+|++|++. .++..+|.++++|++ +.++.|++
T Consensus 16 C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l 92 (350)
T 4ay9_X 16 CQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNL 92 (350)
T ss_dssp EESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTC
T ss_pred ecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcc
Confidence 3444454 566655 2567788888888877666 5777777777777777764 466667777766554 45556666
Q ss_pred CCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccC-CcCcccCChhhhhhHHHHHhhcccCCCCCC
Q 041143 151 NKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSY-NRLSGVIPASFGQSLMQILWLNDQDAGGMT 229 (973)
Q Consensus 151 ~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~-N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~ 229 (973)
+.+ .|..|..+++|++|++++|+|+...+..+....++..|++.+ |++....+..|
T Consensus 93 ~~l----~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f------------------- 149 (350)
T 4ay9_X 93 LYI----NPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSF------------------- 149 (350)
T ss_dssp CEE----CTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSS-------------------
T ss_pred ccc----CchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccch-------------------
Confidence 653 345566666667777766666655555555555666666644 34442222222
Q ss_pred CcchhhcCC-ccccEEEccCCccccCCCccccCCCCCCEEeCcC-CcccccCccccccc-ccCeEEccCCcCc
Q 041143 230 GPIDVVAKM-VSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNR-NQLVGLIPKSLANM-ELDNLVLNNNLLM 299 (973)
Q Consensus 230 ~~~~~~~~l-~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l-~L~~L~l~~N~l~ 299 (973)
..+ ..|+.|+|++|+|+ .+|.......+|+.|++++ |.++...+..|..+ +|+.|+|++|+|+
T Consensus 150 ------~~~~~~l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~ 215 (350)
T 4ay9_X 150 ------VGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH 215 (350)
T ss_dssp ------TTSBSSCEEEECCSSCCC-EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCC
T ss_pred ------hhcchhhhhhcccccccc-CCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcC
Confidence 122 24555666666665 3444444445566666553 34443333344444 4555555555554
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.85 E-value=2.4e-21 Score=216.32 Aligned_cols=178 Identities=17% Similarity=0.158 Sum_probs=98.7
Q ss_pred eeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCC-cccccccccCe-ee
Q 041143 95 NLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIP-DSLANSVQLTN-LS 172 (973)
Q Consensus 95 ~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip-~~~~~l~~L~~-L~ 172 (973)
.++.++|+++.++..+ .++|++|+|++|+|+.|++++|.++++|++|+|++|++.+. +| ..|.++++|+. +.
T Consensus 13 ~v~C~~~~Lt~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~----i~~~~f~~L~~l~~~l~ 86 (350)
T 4ay9_X 13 VFLCQESKVTEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEV----IEADVFSNLPKLHEIRI 86 (350)
T ss_dssp EEEEESTTCCSCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCE----ECTTSBCSCTTCCEEEE
T ss_pred EEEecCCCCCccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCc----cChhHhhcchhhhhhhc
Confidence 4566666666554433 24566666666666666666666666666666666666543 33 34555655543 44
Q ss_pred cccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccC-Ccc
Q 041143 173 LINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHG-NQF 251 (973)
Q Consensus 173 L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~-N~l 251 (973)
+++|+|+...|..|.++++|++|++++|+++...+..+ ....++..|++.+ |++
T Consensus 87 ~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~-------------------------~~~~~l~~l~l~~~~~i 141 (350)
T 4ay9_X 87 EKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHK-------------------------IHSLQKVLLDIQDNINI 141 (350)
T ss_dssp EEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTT-------------------------CCBSSCEEEEEESCTTC
T ss_pred ccCCcccccCchhhhhccccccccccccccccCCchhh-------------------------cccchhhhhhhcccccc
Confidence 55566665556666666666666666666663333222 1344555666643 445
Q ss_pred ccCCCccccCCC-CCCEEeCcCCcccccCcccccccccCeEEccCCcCcCCCC
Q 041143 252 TGSIPEDIGALS-SLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMGPIP 303 (973)
Q Consensus 252 ~g~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~L~~L~l~~N~l~g~~p 303 (973)
+...+..|..+. .++.|+|++|+|+...+..|...+|+.|++.+|+..+.+|
T Consensus 142 ~~l~~~~f~~~~~~l~~L~L~~N~i~~i~~~~f~~~~L~~l~l~~~n~l~~i~ 194 (350)
T 4ay9_X 142 HTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELP 194 (350)
T ss_dssp CEECTTSSTTSBSSCEEEECCSSCCCEECTTSSTTEEEEEEECTTCTTCCCCC
T ss_pred ccccccchhhcchhhhhhccccccccCCChhhccccchhHHhhccCCcccCCC
Confidence 533334455443 4566666666666544444544466666665433333333
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.85 E-value=1.3e-22 Score=225.48 Aligned_cols=251 Identities=16% Similarity=0.168 Sum_probs=194.5
Q ss_pred ccceeeccCcccCCCCCCCCCC--CccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccC
Q 041143 92 KLYNLGLQRNKFNGKLPTFSGL--SELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLT 169 (973)
Q Consensus 92 ~L~~L~L~~N~l~~~~~~~~~l--~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~ 169 (973)
.++.|++++|.+.. ..+..+ ++++.|++++|.+...++..+ .+++|++|+|++|.+++. .++..+..+++|+
T Consensus 48 ~~~~l~l~~~~~~~--~~~~~~~~~~l~~L~l~~n~l~~~~~~~~-~~~~L~~L~L~~~~l~~~---~~~~~~~~~~~L~ 121 (336)
T 2ast_B 48 LWQTLDLTGKNLHP--DVTGRLLSQGVIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEVS---TLHGILSQCSKLQ 121 (336)
T ss_dssp TSSEEECTTCBCCH--HHHHHHHHTTCSEEECTTCEECSCCCSCC-CCBCCCEEECTTCEECHH---HHHHHHTTBCCCS
T ss_pred hheeeccccccCCH--HHHHhhhhccceEEEcCCccccccchhhc-cCCCCCEEEccCCCcCHH---HHHHHHhhCCCCC
Confidence 47889999998872 245555 889999999999998887744 689999999999988753 2677788999999
Q ss_pred eeecccccccCCcchhccCCCCCCeEEccCC-cCccc-CChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEcc
Q 041143 170 NLSLINCNLVGPLPDFLGTLPSLAALKLSYN-RLSGV-IPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLH 247 (973)
Q Consensus 170 ~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N-~l~~~-~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~ 247 (973)
+|+|++|.+++..+..++.+++|++|+|++| .+++. ++..+ .++++|++|+|+
T Consensus 122 ~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~-------------------------~~~~~L~~L~l~ 176 (336)
T 2ast_B 122 NLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLL-------------------------SSCSRLDELNLS 176 (336)
T ss_dssp EEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHH-------------------------HHCTTCCEEECC
T ss_pred EEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHH-------------------------hcCCCCCEEcCC
Confidence 9999999999888889999999999999999 67642 33333 358999999999
Q ss_pred CC-ccccC-CCccccCCC-CCCEEeCcCC--ccc-ccCccccccc-ccCeEEccCCc-CcCCCCCCCCCCcccccCcccC
Q 041143 248 GN-QFTGS-IPEDIGALS-SLKDLNLNRN--QLV-GLIPKSLANM-ELDNLVLNNNL-LMGPIPKFKAGNVTYDSNSFCQ 319 (973)
Q Consensus 248 ~N-~l~g~-~p~~~~~l~-~L~~L~Ls~N--~l~-~~~p~~~~~l-~L~~L~l~~N~-l~g~~p~~~~~~~~~~~~~~~~ 319 (973)
+| .+++. ++..+..++ +|++|+|++| .++ +.+|..+..+ +|+.|++++|. +++..+.
T Consensus 177 ~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~--------------- 241 (336)
T 2ast_B 177 WCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQ--------------- 241 (336)
T ss_dssp CCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGG---------------
T ss_pred CCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHH---------------
Confidence 99 99865 677788999 9999999999 555 4556666666 79999999998 5544332
Q ss_pred CCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCc-CCCccchhhhCccccceE
Q 041143 320 SEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHN-LTGTLSPSIANLDSLIEI 398 (973)
Q Consensus 320 ~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L 398 (973)
.+..+++|+.|+|++|. +.......++++++|+.|
T Consensus 242 --------------------------------------------~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L 277 (336)
T 2ast_B 242 --------------------------------------------EFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTL 277 (336)
T ss_dssp --------------------------------------------GGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEE
T ss_pred --------------------------------------------HHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEE
Confidence 22345789999999985 333333368889999999
Q ss_pred EccCCccccccCccccCc-CCCCeeeCCCCcCCCCCCCC
Q 041143 399 RLGKNSISGTVPNNFTEL-KSLRLLDVSDNNIKPPLPEF 436 (973)
Q Consensus 399 ~L~~N~l~g~~p~~~~~l-~~L~~L~Ls~N~l~g~~p~~ 436 (973)
+|++| ++ ...+..+ .+|..|++++|+|++..|..
T Consensus 278 ~l~~~-i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~~ 312 (336)
T 2ast_B 278 QVFGI-VP---DGTLQLLKEALPHLQINCSHFTTIARPT 312 (336)
T ss_dssp ECTTS-SC---TTCHHHHHHHSTTSEESCCCSCCTTCSS
T ss_pred eccCc-cC---HHHHHHHHhhCcceEEecccCccccCCc
Confidence 99988 33 2234455 34788889999999887753
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.85 E-value=8.4e-22 Score=231.21 Aligned_cols=205 Identities=23% Similarity=0.323 Sum_probs=172.1
Q ss_pred cCCCCCCCCCCCCCC--CcCeE-EeeCCeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCCCCCCCCcccee
Q 041143 43 LLKWPANGDDPCGPP--PWPHV-FCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFA 119 (973)
Q Consensus 43 l~~w~~~~~d~C~~~--~w~gv-~C~~~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L 119 (973)
+.+|.. +.+||... .|.|+ .|..++++.|+|++|+|++ +|..+. ++|++|+|++|+|+.++ ..+++|++|
T Consensus 33 l~~W~~-~~~~~~~~~~~~~~l~~C~~~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~~ip---~~l~~L~~L 105 (571)
T 3cvr_A 33 WDKWEK-QALPGENRNEAVSLLKECLINQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALISLP---ELPASLEYL 105 (571)
T ss_dssp HHHHHT-TCCTTCCHHHHHHHHHHHHHTTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCSCCC---CCCTTCCEE
T ss_pred HHHHhc-cCCccccccchhhhccccccCCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCcccc---cccCCCCEE
Confidence 345643 46788421 39999 7987899999999999997 787664 89999999999999644 568999999
Q ss_pred eccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccC
Q 041143 120 YLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSY 199 (973)
Q Consensus 120 ~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~ 199 (973)
+|++|+|+.+|. |.+ +|++|+|++|+|++ +|. .+++|+.|+|++|+|++ +|. .+++|++|+|++
T Consensus 106 ~Ls~N~l~~ip~--l~~--~L~~L~Ls~N~l~~-----lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~ 169 (571)
T 3cvr_A 106 DACDNRLSTLPE--LPA--SLKHLDVDNNQLTM-----LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRN 169 (571)
T ss_dssp ECCSSCCSCCCC--CCT--TCCEEECCSSCCSC-----CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCS
T ss_pred EccCCCCCCcch--hhc--CCCEEECCCCcCCC-----CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCC
Confidence 999999999887 554 99999999999997 666 68999999999999996 665 689999999999
Q ss_pred CcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCC-------CEEeCcC
Q 041143 200 NRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSL-------KDLNLNR 272 (973)
Q Consensus 200 N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L-------~~L~Ls~ 272 (973)
|+|++ +|. + .++|+.|+|++|+|+ .+|. |.. +| +.|+|++
T Consensus 170 N~L~~-lp~-l---------------------------~~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~ 216 (571)
T 3cvr_A 170 NQLTF-LPE-L---------------------------PESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRE 216 (571)
T ss_dssp SCCSC-CCC-C---------------------------CTTCCEEECCSSCCS-SCCC-CC----------CCEEEECCS
T ss_pred CCCCC-cch-h---------------------------hCCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCC
Confidence 99995 665 4 278999999999999 7887 665 77 9999999
Q ss_pred CcccccCccccccc-ccCeEEccCCcCcCCCCC
Q 041143 273 NQLVGLIPKSLANM-ELDNLVLNNNLLMGPIPK 304 (973)
Q Consensus 273 N~l~~~~p~~~~~l-~L~~L~l~~N~l~g~~p~ 304 (973)
|+|+ .+|..+..+ +|+.|+|++|.|++.+|.
T Consensus 217 N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~ 248 (571)
T 3cvr_A 217 NRIT-HIPENILSLDPTCTIILEDNPLSSRIRE 248 (571)
T ss_dssp SCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHH
T ss_pred Ccce-ecCHHHhcCCCCCEEEeeCCcCCCcCHH
Confidence 9999 477777767 899999999999988776
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.85 E-value=2.6e-21 Score=226.97 Aligned_cols=48 Identities=17% Similarity=0.284 Sum_probs=36.3
Q ss_pred cccEEecCCCcCCCccchhhhCccccceEEccCCccccccCccccCcCC
Q 041143 370 KVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKS 418 (973)
Q Consensus 370 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~ 418 (973)
.|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.+|..|..+..
T Consensus 208 ~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 255 (571)
T 3cvr_A 208 TEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA 255 (571)
T ss_dssp CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred cceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence 4577777777777 46777777888888888888888888877777654
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.85 E-value=2.8e-22 Score=244.34 Aligned_cols=226 Identities=21% Similarity=0.191 Sum_probs=133.8
Q ss_pred CChhHHHHHHHHHhhCCCCc---cCCCCCCCCCCCCCCCcCeEEeeCCeEEEEEecccCCcccCCcCcccccccceeecc
Q 041143 23 TDPNDLKILNDFKNGLENPE---LLKWPANGDDPCGPPPWPHVFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQ 99 (973)
Q Consensus 23 ~~~~~~~~l~~~k~~~~~~~---l~~w~~~~~d~C~~~~w~gv~C~~~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~ 99 (973)
....+.++|+++..+...+. ...|.......+. |.++.++..+++.|+|.++++... +. ..|+.|+|+
T Consensus 129 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~s~~~~~~l~L~~n~~~~~-~~-----~~l~~l~Ls 199 (727)
T 4b8c_D 129 LVDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGT---ATNSAVSTPLTPKIELFANGKDEA-NQ-----ALLQHKKLS 199 (727)
T ss_dssp ---CCCHHHHHHHHHHHHHHTTC---------------------------------------------------------
T ss_pred ccccchhhhhhhhhhcccccCcccCCCcCCCCcccc---CCCceecCCccceEEeeCCCCCcc-hh-----hHhhcCccC
Confidence 34457888999987763221 2345433333343 999999999999999999998862 33 346667788
Q ss_pred CcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeeeccccccc
Q 041143 100 RNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLV 179 (973)
Q Consensus 100 ~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~ 179 (973)
+|.|.+ +++..|++. +++..|..+++|+.|+|++|++.. +|..+.++++|++|+|++|.|+
T Consensus 200 ~~~i~~-------------~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~~-----l~~~~~~l~~L~~L~Ls~N~l~ 260 (727)
T 4b8c_D 200 QYSIDE-------------DDDIENRMV-MPKDSKYDDQLWHALDLSNLQIFN-----ISANIFKYDFLTRLYLNGNSLT 260 (727)
T ss_dssp ------------------------------------CCCCCCEEECTTSCCSC-----CCGGGGGCCSCSCCBCTTSCCS
T ss_pred cccccC-------------cccccccee-cChhhhccCCCCcEEECCCCCCCC-----CChhhcCCCCCCEEEeeCCcCc
Confidence 777664 345566666 667788999999999999999984 7888889999999999999999
Q ss_pred CCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCccccCCCccc
Q 041143 180 GPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDI 259 (973)
Q Consensus 180 ~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~ 259 (973)
.+|..|++|++|++|+|++|+|+ .+|..|. ++++|++|+|++|.|+ .+|..|
T Consensus 261 -~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~-------------------------~l~~L~~L~L~~N~l~-~lp~~~ 312 (727)
T 4b8c_D 261 -ELPAEIKNLSNLRVLDLSHNRLT-SLPAELG-------------------------SCFQLKYFYFFDNMVT-TLPWEF 312 (727)
T ss_dssp -CCCGGGGGGTTCCEEECTTSCCS-SCCSSGG-------------------------GGTTCSEEECCSSCCC-CCCSST
T ss_pred -ccChhhhCCCCCCEEeCcCCcCC-ccChhhc-------------------------CCCCCCEEECCCCCCC-ccChhh
Confidence 88999999999999999999999 7787764 5899999999999998 889999
Q ss_pred cCCCCCCEEeCcCCcccccCccccccc--ccCeEEccCCcCcCCCCC
Q 041143 260 GALSSLKDLNLNRNQLVGLIPKSLANM--ELDNLVLNNNLLMGPIPK 304 (973)
Q Consensus 260 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l--~L~~L~l~~N~l~g~~p~ 304 (973)
+.+++|++|+|++|.|++.+|..+... .+..|+|++|.++|.+|.
T Consensus 313 ~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~ 359 (727)
T 4b8c_D 313 GNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH 359 (727)
T ss_dssp TSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_pred hcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc
Confidence 999999999999999999999988765 344578999999888775
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.82 E-value=3.5e-20 Score=190.53 Aligned_cols=176 Identities=21% Similarity=0.203 Sum_probs=146.0
Q ss_pred ceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeeec
Q 041143 94 YNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSL 173 (973)
Q Consensus 94 ~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L 173 (973)
+.++++++.++..+..+ .++|++|+|++|+|+.+++..|.++++|++|+|++|++++. .+..|..+++|++|+|
T Consensus 10 ~~v~c~~~~l~~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~L 83 (208)
T 2o6s_A 10 TTVECYSQGRTSVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSL----PNGVFNKLTSLTYLNL 83 (208)
T ss_dssp TEEECCSSCCSSCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCC----CTTTTTTCTTCCEEEC
T ss_pred CEEEecCCCccCCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCcc----ChhhcCCCCCcCEEEC
Confidence 46778888888766544 35899999999999999999999999999999999999863 3445788999999999
Q ss_pred ccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCcccc
Q 041143 174 INCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTG 253 (973)
Q Consensus 174 ~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g 253 (973)
++|+|++..+..|.++++|++|+|++|++++..+..+ .++++|++|+|++|++++
T Consensus 84 s~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-------------------------~~l~~L~~L~l~~N~l~~ 138 (208)
T 2o6s_A 84 STNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVF-------------------------DKLTQLKDLRLYQNQLKS 138 (208)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT-------------------------TTCTTCCEEECCSSCCSC
T ss_pred CCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHh-------------------------ccCCcCCEEECCCCccce
Confidence 9999997777778999999999999999985554433 458899999999999997
Q ss_pred CCCccccCCCCCCEEeCcCCcccccCcccccccccCeEEccCCcCcCCCCCCC
Q 041143 254 SIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMGPIPKFK 306 (973)
Q Consensus 254 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~L~~L~l~~N~l~g~~p~~~ 306 (973)
..+..|..+++|++|+|++|.+.+..| +|+.|+++.|.++|.+|..+
T Consensus 139 ~~~~~~~~l~~L~~L~l~~N~~~~~~~------~l~~L~~~~n~~~g~ip~~~ 185 (208)
T 2o6s_A 139 VPDGVFDRLTSLQYIWLHDNPWDCTCP------GIRYLSEWINKHSGVVRNSA 185 (208)
T ss_dssp CCTTTTTTCTTCCEEECCSCCBCCCTT------TTHHHHHHHHHCTTTBBCTT
T ss_pred eCHHHhccCCCccEEEecCCCeecCCC------CHHHHHHHHHhCCceeeccC
Confidence 666678889999999999998876543 57788899999999999754
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.80 E-value=2.1e-19 Score=187.43 Aligned_cols=160 Identities=27% Similarity=0.403 Sum_probs=131.9
Q ss_pred CCCCCCCCCcCeEEeeCCeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCC-CCCCCCccceeeccCCCCCC
Q 041143 50 GDDPCGPPPWPHVFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFDT 128 (973)
Q Consensus 50 ~~d~C~~~~w~gv~C~~~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~ 128 (973)
+.+.|. |.+|.|+..+++ .+|..+. ++|++|+|++|.|++..| .|.++++|++|+|++|+|+.
T Consensus 15 ~~~~Cs---~~~v~c~~~~l~-----------~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~ 78 (229)
T 3e6j_A 15 SQCSCS---GTTVDCRSKRHA-----------SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA 78 (229)
T ss_dssp TTCEEE---TTEEECTTSCCS-----------SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred CCCEEe---CCEeEccCCCcC-----------ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCC
Confidence 567787 999999876553 4555443 889999999999999877 68899999999999999999
Q ss_pred CCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCCh
Q 041143 129 IPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPA 208 (973)
Q Consensus 129 i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 208 (973)
+++..|.++++|++|+|++|+|++. .+..|..+++|++|+|++|+|+ .+|..+..+++|++|+|++|+|++..+.
T Consensus 79 i~~~~~~~l~~L~~L~Ls~N~l~~l----~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~ 153 (229)
T 3e6j_A 79 LPVGVFDSLTQLTVLDLGTNQLTVL----PSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHG 153 (229)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCCCC----CTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTT
T ss_pred cChhhcccCCCcCEEECCCCcCCcc----ChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHH
Confidence 9999999999999999999999864 4455788999999999999998 7788889999999999999999855443
Q ss_pred hhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCccccCC
Q 041143 209 SFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSI 255 (973)
Q Consensus 209 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~ 255 (973)
.| ..+++|+.|+|++|.+....
T Consensus 154 ~~-------------------------~~l~~L~~L~l~~N~~~c~c 175 (229)
T 3e6j_A 154 AF-------------------------DRLSSLTHAYLFGNPWDCEC 175 (229)
T ss_dssp TT-------------------------TTCTTCCEEECTTSCBCTTB
T ss_pred HH-------------------------hCCCCCCEEEeeCCCccCCc
Confidence 33 45788888888888877543
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.79 E-value=4.2e-19 Score=183.87 Aligned_cols=149 Identities=23% Similarity=0.339 Sum_probs=126.4
Q ss_pred EEecccCCcccCCcCcccccccceeeccCcccCCCCC-CCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCC
Q 041143 72 IQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPF 150 (973)
Q Consensus 72 L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l 150 (973)
+++++++++ .+|..+. ++|+.|+|++|+|+++++ .|.++++|++|+|++|+|+.+.+..|.++++|++|+|++|+|
T Consensus 16 v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l 92 (220)
T 2v9t_B 16 VDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKI 92 (220)
T ss_dssp EECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCC
T ss_pred EEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcC
Confidence 345555565 5666654 689999999999999887 789999999999999999999999999999999999999999
Q ss_pred CCccCCCCCc-ccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCC
Q 041143 151 NKTFGWSIPD-SLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMT 229 (973)
Q Consensus 151 ~~~~~~~ip~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~ 229 (973)
+. +|. .|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|
T Consensus 93 ~~-----l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~------------------- 148 (220)
T 2v9t_B 93 TE-----LPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTF------------------- 148 (220)
T ss_dssp CC-----CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTT-------------------
T ss_pred Cc-----cCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHH-------------------
Confidence 96 454 46889999999999999999889999999999999999999996655544
Q ss_pred CcchhhcCCccccEEEccCCcccc
Q 041143 230 GPIDVVAKMVSLTQLWLHGNQFTG 253 (973)
Q Consensus 230 ~~~~~~~~l~~L~~L~L~~N~l~g 253 (973)
..+++|+.|+|++|.+..
T Consensus 149 ------~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 149 ------SPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp ------TTCTTCCEEECCSSCEEC
T ss_pred ------hCCCCCCEEEeCCCCcCC
Confidence 358889999999988863
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.79 E-value=6.3e-21 Score=229.36 Aligned_cols=333 Identities=12% Similarity=0.028 Sum_probs=179.2
Q ss_pred CeEEEEEecccCCccc----CCcCcccccccceeeccCcccCCCC----C-CCCCCCccceeeccCCCCCCCCccccCCC
Q 041143 67 NRVTQIQVQNLGLKGP----LPQNFNQLTKLYNLGLQRNKFNGKL----P-TFSGLSELEFAYLDFNEFDTIPSDFFDGL 137 (973)
Q Consensus 67 ~~v~~L~L~~~~l~g~----~~~~~~~l~~L~~L~L~~N~l~~~~----~-~~~~l~~L~~L~L~~N~l~~i~~~~f~~l 137 (973)
..+++|+|++|.+++. ++..+.++++|++|+|++|.+++.. + .+.++++|++|+|++|.+..++ ..+..+
T Consensus 164 ~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~l~-~~~~~~ 242 (592)
T 3ogk_B 164 RKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELV-GFFKAA 242 (592)
T ss_dssp TTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGGGH-HHHHHC
T ss_pred CCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHHHH-HHHhhh
Confidence 5788899998888765 3445567888999999988887432 2 3566888999999888887765 556777
Q ss_pred CCccEEEcccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHH
Q 041143 138 SSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQI 217 (973)
Q Consensus 138 ~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~ 217 (973)
++|++|+++.+..... ....+..+..+++|+.|+++++.. +.+|..+..+++|++|+|++|.+++.....+.....++
T Consensus 243 ~~L~~L~l~~~~~~~~-~~~~~~~l~~~~~L~~L~l~~~~~-~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L 320 (592)
T 3ogk_B 243 ANLEEFCGGSLNEDIG-MPEKYMNLVFPRKLCRLGLSYMGP-NEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNL 320 (592)
T ss_dssp TTCCEEEECBCCCCTT-CTTSSSCCCCCTTCCEEEETTCCT-TTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTC
T ss_pred hHHHhhcccccccccc-hHHHHHHhhccccccccCccccch-hHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCC
Confidence 7777777764322100 011233444444555555544322 23444444455555555555554322221111111111
Q ss_pred HhhcccCCCCCC-CcchhhcCCccccEEEcc-----------CCccccCC-CccccCCCCCCEEeCcCCcccccCccccc
Q 041143 218 LWLNDQDAGGMT-GPIDVVAKMVSLTQLWLH-----------GNQFTGSI-PEDIGALSSLKDLNLNRNQLVGLIPKSLA 284 (973)
Q Consensus 218 ~~l~~~~~~~~~-~~~~~~~~l~~L~~L~L~-----------~N~l~g~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 284 (973)
..|... +.... +....+..+++|++|+|+ .|.+++.. +..+..+++|++|+++.|++++..+..+.
T Consensus 321 ~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~ 399 (592)
T 3ogk_B 321 EVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIG 399 (592)
T ss_dssp CEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHH
T ss_pred CEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHH
Confidence 111111 00000 011222446777777777 25555332 22234467777777777777766555554
Q ss_pred c-c-ccCeEEcc----CCcCcCCCCCCCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCC--cccCCCCCCCCC
Q 041143 285 N-M-ELDNLVLN----NNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPV--NLVSQWPGNDPC 356 (973)
Q Consensus 285 ~-l-~L~~L~l~----~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~--n~~~~~~~~~~~ 356 (973)
. + +|+.|+++ .|.+++.... .+.......+..+..++++. +.+..-
T Consensus 400 ~~~~~L~~L~l~~~~~~n~l~~~p~~--------------------~~~~~~~~~~~~L~~L~L~~~~~~l~~~------ 453 (592)
T 3ogk_B 400 TYLKNLCDFRLVLLDREERITDLPLD--------------------NGVRSLLIGCKKLRRFAFYLRQGGLTDL------ 453 (592)
T ss_dssp HHCCSCCEEEEEECSCCSCCSSCCCH--------------------HHHHHHHHHCTTCCEEEEECCGGGCCHH------
T ss_pred hhCCCCcEEEEeecCCCccccCchHH--------------------HHHHHHHHhCCCCCEEEEecCCCCccHH------
Confidence 4 3 57777775 4555432000 00000000011122222210 000000
Q ss_pred CCCccccccCCCCcccEEecCCCcCCC-ccchhhhCccccceEEccCCccccc-cCccccCcCCCCeeeCCCCcCCCC
Q 041143 357 QGPWLGLSCTSNSKVSIINLPRHNLTG-TLSPSIANLDSLIEIRLGKNSISGT-VPNNFTELKSLRLLDVSDNNIKPP 432 (973)
Q Consensus 357 ~~~~~~~~~~~~~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~g~-~p~~~~~l~~L~~L~Ls~N~l~g~ 432 (973)
........+++|+.|+|++|++++ .++..+..+++|++|+|++|.|++. ++..+..+++|++|+|++|+++..
T Consensus 454 ---~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~ 528 (592)
T 3ogk_B 454 ---GLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMT 528 (592)
T ss_dssp ---HHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred ---HHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence 000001235678888888888887 4455567888888888888888754 344456788888888888888764
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.79 E-value=7.7e-19 Score=208.54 Aligned_cols=184 Identities=23% Similarity=0.360 Sum_probs=131.1
Q ss_pred EecccCCcccCCcCcccccccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCC
Q 041143 73 QVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNK 152 (973)
Q Consensus 73 ~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~ 152 (973)
.|..+.+.+.+ .+..|++|+.|+|++|.|... +.|..+++|+.|+|++|+|+.+++ |..+++|+.|+|++|+|++
T Consensus 27 ~l~~~~i~~~~--~~~~L~~L~~L~l~~n~i~~l-~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~ 101 (605)
T 1m9s_A 27 NLKKKSVTDAV--TQNELNSIDQIIANNSDIKSV-QGIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD 101 (605)
T ss_dssp HTTCSCTTSEE--CHHHHTTCCCCBCTTCCCCCC-TTGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC
T ss_pred hccCCCccccc--chhcCCCCCEEECcCCCCCCC-hHHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC
Confidence 34444444332 256677778888888877764 457777888888888888877776 7778888888888887775
Q ss_pred ccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcc
Q 041143 153 TFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPI 232 (973)
Q Consensus 153 ~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 232 (973)
+| .+..+++|+.|+|++|+|++. ..+..+++|+.|+|++|+|++. ..
T Consensus 102 -----l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~----------------------- 148 (605)
T 1m9s_A 102 -----LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TV----------------------- 148 (605)
T ss_dssp -----CT-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GG-----------------------
T ss_pred -----Ch-hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hh-----------------------
Confidence 33 677778888888888887753 3577788888888888887743 22
Q ss_pred hhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcccccCccccccc-ccCeEEccCCcCcC
Q 041143 233 DVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMG 300 (973)
Q Consensus 233 ~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~g 300 (973)
+..+++|+.|+|++|+|++..| +..+++|+.|+|++|+|++. | .+..+ +|+.|+|++|.+.+
T Consensus 149 --l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~L~~N~l~~ 211 (605)
T 1m9s_A 149 --LSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLN 211 (605)
T ss_dssp --GGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEECCSEEEEC
T ss_pred --hcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEccCCcCcC
Confidence 3457788888888888876555 77788888888888888764 3 45555 68888888887764
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.78 E-value=8e-19 Score=190.15 Aligned_cols=170 Identities=25% Similarity=0.376 Sum_probs=84.3
Q ss_pred ccccccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccc
Q 041143 88 NQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQ 167 (973)
Q Consensus 88 ~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~ 167 (973)
..+++|+.|++++|.++.. +.+..+++|++|+|++|+++.+++ |..+++|++|+|++|++++ +| .+..+++
T Consensus 43 ~~l~~L~~L~l~~~~i~~~-~~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-----~~-~l~~l~~ 113 (291)
T 1h6t_A 43 NELNSIDQIIANNSDIKSV-QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-----LS-SLKDLKK 113 (291)
T ss_dssp HHHHTCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-----GG-GGTTCTT
T ss_pred hhcCcccEEEccCCCcccC-hhHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-----Ch-hhccCCC
Confidence 3445555555555555443 334445555555555555555444 4555555555555555543 22 2455555
Q ss_pred cCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEcc
Q 041143 168 LTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLH 247 (973)
Q Consensus 168 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~ 247 (973)
|++|+|++|++++. ..+..+++|++|+|++|++++. .. +..+++|++|+|+
T Consensus 114 L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~-------------------------l~~l~~L~~L~L~ 164 (291)
T 1h6t_A 114 LKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TV-------------------------LSRLTKLDTLSLE 164 (291)
T ss_dssp CCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GG-------------------------GGGCTTCSEEECC
T ss_pred CCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hh-------------------------hccCCCCCEEEcc
Confidence 55555555555532 2355555555555555555432 11 2235555555555
Q ss_pred CCccccCCCccccCCCCCCEEeCcCCcccccCccccccc-ccCeEEccCCcCc
Q 041143 248 GNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLM 299 (973)
Q Consensus 248 ~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~ 299 (973)
+|++++..| +..+++|+.|+|++|.+++. + .+..+ +|+.|++++|.++
T Consensus 165 ~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~ 213 (291)
T 1h6t_A 165 DNQISDIVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECL 213 (291)
T ss_dssp SSCCCCCGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEE
T ss_pred CCccccchh--hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCccc
Confidence 555553332 55555555555555555532 2 23333 4555555555554
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=7.2e-19 Score=182.07 Aligned_cols=126 Identities=21% Similarity=0.245 Sum_probs=68.8
Q ss_pred EEEecccCCcccCCcCcccccccceeeccCcccCCCCC--CCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccC
Q 041143 71 QIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP--TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYN 148 (973)
Q Consensus 71 ~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~--~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N 148 (973)
.|++++++++ .+|..+. ..+++|+|++|+|++.++ .|.++++|++|+|++|+|+.+++..|.++++|++|+|++|
T Consensus 15 ~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 5666677776 3566553 345677777777777654 2566666666666666666666555555555555555555
Q ss_pred CCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCc
Q 041143 149 PFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLS 203 (973)
Q Consensus 149 ~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 203 (973)
+|++. .+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|+
T Consensus 92 ~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 142 (220)
T 2v70_A 92 RLENV----QHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT 142 (220)
T ss_dssp CCCCC----CGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCC
T ss_pred ccCcc----CHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCC
Confidence 55542 2223444444444444444444444444444444444444444444
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.78 E-value=7.8e-19 Score=190.26 Aligned_cols=172 Identities=27% Similarity=0.404 Sum_probs=153.0
Q ss_pred CeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcc
Q 041143 67 NRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALD 146 (973)
Q Consensus 67 ~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls 146 (973)
.+++.|++++|+++.. +.+..+++|++|+|++|++++..+ +.++++|++|+|++|+++.++. |..+++|++|+|+
T Consensus 46 ~~L~~L~l~~~~i~~~--~~~~~l~~L~~L~L~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~ 120 (291)
T 1h6t_A 46 NSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDIKP-LANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLE 120 (291)
T ss_dssp HTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCGGG--GTTCTTCCEEECT
T ss_pred CcccEEEccCCCcccC--hhHhcCCCCCEEEccCCccCCCcc-cccCCCCCEEECCCCcCCCChh--hccCCCCCEEECC
Confidence 4789999999999854 459999999999999999999777 9999999999999999999764 8999999999999
Q ss_pred cCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCC
Q 041143 147 YNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAG 226 (973)
Q Consensus 147 ~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~ 226 (973)
+|++++ + +.+..+++|+.|+|++|++++. ..+..+++|++|+|++|++++..| +
T Consensus 121 ~n~i~~-----~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l---------------- 174 (291)
T 1h6t_A 121 HNGISD-----I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--L---------------- 174 (291)
T ss_dssp TSCCCC-----C-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--G----------------
T ss_pred CCcCCC-----C-hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--h----------------
Confidence 999996 3 5789999999999999999975 679999999999999999986543 3
Q ss_pred CCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcccccCc
Q 041143 227 GMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIP 280 (973)
Q Consensus 227 ~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p 280 (973)
..+++|+.|+|++|.|++ +| .+..+++|+.|+|++|.++....
T Consensus 175 ---------~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~~~~~ 217 (291)
T 1h6t_A 175 ---------AGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLNKPI 217 (291)
T ss_dssp ---------TTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEECCCE
T ss_pred ---------cCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCcccCCcc
Confidence 369999999999999995 55 49999999999999999986433
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=1e-18 Score=180.98 Aligned_cols=154 Identities=23% Similarity=0.282 Sum_probs=138.2
Q ss_pred CCCCCCCCCcCeEEeeCC-----------eEEEEEecccCCcccCC-cCcccccccceeeccCcccCCCCC-CCCCCCcc
Q 041143 50 GDDPCGPPPWPHVFCSGN-----------RVTQIQVQNLGLKGPLP-QNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSEL 116 (973)
Q Consensus 50 ~~d~C~~~~w~gv~C~~~-----------~v~~L~L~~~~l~g~~~-~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L 116 (973)
.++.|. |.|..+.|++. .++.|+|++|+|++..+ ..|.++++|++|+|++|.|+++.+ .|.++++|
T Consensus 5 CP~~C~-C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L 83 (220)
T 2v70_A 5 CPEKCR-CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGV 83 (220)
T ss_dssp CCTTCE-EETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTC
T ss_pred CCCCCE-ECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCC
Confidence 355565 46999999752 47789999999998765 458999999999999999999888 79999999
Q ss_pred ceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEE
Q 041143 117 EFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALK 196 (973)
Q Consensus 117 ~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 196 (973)
++|+|++|+|+.+++..|.++++|++|+|++|+|++. .|..|..+++|++|+|++|+|++..|..|..+++|++|+
T Consensus 84 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 159 (220)
T 2v70_A 84 NEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCV----GNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLN 159 (220)
T ss_dssp CEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCB----CTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEE
T ss_pred CEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeE----CHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEE
Confidence 9999999999999999999999999999999999985 678899999999999999999998899999999999999
Q ss_pred ccCCcCcccCCh
Q 041143 197 LSYNRLSGVIPA 208 (973)
Q Consensus 197 Ls~N~l~~~~p~ 208 (973)
|++|.+.+..+-
T Consensus 160 L~~N~l~c~c~l 171 (220)
T 2v70_A 160 LLANPFNCNCYL 171 (220)
T ss_dssp CCSCCEECSGGG
T ss_pred ecCcCCcCCCch
Confidence 999999876553
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.78 E-value=4.8e-19 Score=198.46 Aligned_cols=177 Identities=23% Similarity=0.218 Sum_probs=120.0
Q ss_pred EEEecccCCcccCCcCcccccccceeeccCcccCCCCC-CCC-CCCccceeeccCCCCCCCCccccCCCCCccEEEcccC
Q 041143 71 QIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFS-GLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYN 148 (973)
Q Consensus 71 ~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~-~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N 148 (973)
.+++++++|+ .+|..+. ..|+.|+|++|+|++..+ .|. ++++|++|+|++|+|+.+++..|.++++|++|+|++|
T Consensus 22 ~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 98 (361)
T 2xot_A 22 ILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN 98 (361)
T ss_dssp EEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCC
Confidence 4677777777 4676554 357888888888888777 465 7888888888888888888888888888888888888
Q ss_pred CCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCC
Q 041143 149 PFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGM 228 (973)
Q Consensus 149 ~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~ 228 (973)
+|+.. .+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++ +|..+..
T Consensus 99 ~l~~~----~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~-l~~~~~~---------------- 157 (361)
T 2xot_A 99 HLHTL----DEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISR-FPVELIK---------------- 157 (361)
T ss_dssp CCCEE----CTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCS-CCGGGTC----------------
T ss_pred cCCcC----CHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCe-eCHHHhc----------------
Confidence 88763 34457777777777777777777667777777777777777777773 4433210
Q ss_pred CCcchhhcCCccccEEEccCCccccCCCccccCCCC--CCEEeCcCCccc
Q 041143 229 TGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSS--LKDLNLNRNQLV 276 (973)
Q Consensus 229 ~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~--L~~L~Ls~N~l~ 276 (973)
.+..+++|+.|+|++|+|++..+..+..+++ |+.|+|++|.+.
T Consensus 158 -----~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 158 -----DGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp ---------CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred -----CcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCcc
Confidence 0123566666666666666433344555554 255555555554
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.78 E-value=1.2e-18 Score=180.36 Aligned_cols=153 Identities=18% Similarity=0.252 Sum_probs=130.6
Q ss_pred ceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeeec
Q 041143 94 YNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSL 173 (973)
Q Consensus 94 ~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L 173 (973)
+.+++++|.++.++..+. ++|+.|+|++|+|+.+++..|..+++|++|+|++|+|++. .|..|.++++|++|+|
T Consensus 14 ~~v~c~~~~l~~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~----~~~~~~~l~~L~~L~L 87 (220)
T 2v9t_B 14 NIVDCRGKGLTEIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISEL----APDAFQGLRSLNSLVL 87 (220)
T ss_dssp TEEECTTSCCSSCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEE----CTTTTTTCSSCCEEEC
T ss_pred CEEEcCCCCcCcCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCc----CHHHhhCCcCCCEEEC
Confidence 468899999998766554 6899999999999999998999999999999999999875 6788899999999999
Q ss_pred ccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCcccc
Q 041143 174 INCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTG 253 (973)
Q Consensus 174 ~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g 253 (973)
++|+|+...+..|.++++|++|+|++|+|++..|..| .++++|++|+|++|+|++
T Consensus 88 s~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~-------------------------~~l~~L~~L~L~~N~l~~ 142 (220)
T 2v9t_B 88 YGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAF-------------------------QDLHNLNLLSLYDNKLQT 142 (220)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT-------------------------TTCTTCCEEECCSSCCSC
T ss_pred CCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHc-------------------------CCCCCCCEEECCCCcCCE
Confidence 9999997767778889999999999999987666654 358889999999999997
Q ss_pred CCCccccCCCCCCEEeCcCCcccc
Q 041143 254 SIPEDIGALSSLKDLNLNRNQLVG 277 (973)
Q Consensus 254 ~~p~~~~~l~~L~~L~Ls~N~l~~ 277 (973)
..+..|..+++|++|+|++|.+..
T Consensus 143 ~~~~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 143 IAKGTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp CCTTTTTTCTTCCEEECCSSCEEC
T ss_pred ECHHHHhCCCCCCEEEeCCCCcCC
Confidence 777778888999999999998875
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.77 E-value=2.9e-21 Score=232.29 Aligned_cols=348 Identities=14% Similarity=0.027 Sum_probs=241.8
Q ss_pred eEEEEEecccC-Ccc-cCCcCcccccccceeeccCcccCCCC----C-CCCCCCccceeeccCCCCCCCCcc----ccCC
Q 041143 68 RVTQIQVQNLG-LKG-PLPQNFNQLTKLYNLGLQRNKFNGKL----P-TFSGLSELEFAYLDFNEFDTIPSD----FFDG 136 (973)
Q Consensus 68 ~v~~L~L~~~~-l~g-~~~~~~~~l~~L~~L~L~~N~l~~~~----~-~~~~l~~L~~L~L~~N~l~~i~~~----~f~~ 136 (973)
++++|+|+++. ++. .++..+.++++|++|+|++|.+++.. + .+.++++|++|+|++|.++.+... .+.+
T Consensus 139 ~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~ 218 (592)
T 3ogk_B 139 DLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARN 218 (592)
T ss_dssp GCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHH
T ss_pred cCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhh
Confidence 49999999876 221 12233458899999999999998763 2 245689999999999999866543 3567
Q ss_pred CCCccEEEcccCCCCCccCCCCCcccccccccCeeeccccccc---CCcchhccCCCCCCeEEccCCcCcccCChhhhhh
Q 041143 137 LSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLV---GPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQS 213 (973)
Q Consensus 137 l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~---~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 213 (973)
+++|++|+|++|.+.+ +|..+.++++|+.|+++++... +..+..+..+++|+.|+++++... .+|..+. .
T Consensus 219 ~~~L~~L~L~~~~~~~-----l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~-~ 291 (592)
T 3ogk_B 219 CRSLVSVKVGDFEILE-----LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFP-F 291 (592)
T ss_dssp CTTCCEEECSSCBGGG-----GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGG-G
T ss_pred CCCCcEEeccCccHHH-----HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchh-HHHHHHh-h
Confidence 8999999999999986 6788999999999999875433 345567888999999999987543 5565443 2
Q ss_pred HHHHHhhcccCCCCCCCcc-hhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCc-----------CCcccccCcc
Q 041143 214 LMQILWLNDQDAGGMTGPI-DVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLN-----------RNQLVGLIPK 281 (973)
Q Consensus 214 ~~~~~~l~~~~~~~~~~~~-~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls-----------~N~l~~~~p~ 281 (973)
..++.+|+...+....... ..+.++++|+.|+|++|...+.++..+..+++|++|+|+ .|.+++....
T Consensus 292 ~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~ 371 (592)
T 3ogk_B 292 AAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLI 371 (592)
T ss_dssp GGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHH
T ss_pred cCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHH
Confidence 3455556665555322222 446889999999999443344455555778999999999 4677754333
Q ss_pred c-cccc-ccCeEEccCCcCcCCCCCCCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCC----CcccCCCCCCCC
Q 041143 282 S-LANM-ELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYP----VNLVSQWPGNDP 355 (973)
Q Consensus 282 ~-~~~l-~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~----~n~~~~~~~~~~ 355 (973)
. ...+ +|++|+++.|.+++..+..+. .....+..+++. .|.+...+...
T Consensus 372 ~l~~~~~~L~~L~l~~~~l~~~~~~~l~------------------------~~~~~L~~L~l~~~~~~n~l~~~p~~~- 426 (592)
T 3ogk_B 372 ALAQGCQELEYMAVYVSDITNESLESIG------------------------TYLKNLCDFRLVLLDREERITDLPLDN- 426 (592)
T ss_dssp HHHHHCTTCSEEEEEESCCCHHHHHHHH------------------------HHCCSCCEEEEEECSCCSCCSSCCCHH-
T ss_pred HHHhhCccCeEEEeecCCccHHHHHHHH------------------------hhCCCCcEEEEeecCCCccccCchHHH-
Confidence 3 2334 799999999999864432110 001123333332 22332221100
Q ss_pred CCCCccccccCCCCcccEEecCCC--cCCCccchhhhC-ccccceEEccCCcccc-ccCccccCcCCCCeeeCCCCcCCC
Q 041143 356 CQGPWLGLSCTSNSKVSIINLPRH--NLTGTLSPSIAN-LDSLIEIRLGKNSISG-TVPNNFTELKSLRLLDVSDNNIKP 431 (973)
Q Consensus 356 ~~~~~~~~~~~~~~~L~~L~Ls~N--~l~~~~p~~~~~-l~~L~~L~L~~N~l~g-~~p~~~~~l~~L~~L~Ls~N~l~g 431 (973)
-....+..+++|+.|+|+.+ .+++..+..++. +++|+.|+|++|++++ .++..+..+++|+.|+|++|+|++
T Consensus 427 ----~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~ 502 (592)
T 3ogk_B 427 ----GVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSE 502 (592)
T ss_dssp ----HHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBH
T ss_pred ----HHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcH
Confidence 00111345789999999854 478777777654 8999999999999987 456667889999999999999875
Q ss_pred C-CC----CCCcccceeecCCcccc
Q 041143 432 P-LP----EFHDTVKLVIDGNPLLV 451 (973)
Q Consensus 432 ~-~p----~~~~~~~~~~~~N~~~c 451 (973)
. ++ .+.++..+++.+|....
T Consensus 503 ~~~~~~~~~l~~L~~L~ls~n~it~ 527 (592)
T 3ogk_B 503 RAIAAAVTKLPSLRYLWVQGYRASM 527 (592)
T ss_dssp HHHHHHHHHCSSCCEEEEESCBCCT
T ss_pred HHHHHHHHhcCccCeeECcCCcCCH
Confidence 4 23 25677889999998543
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.77 E-value=1.1e-18 Score=195.35 Aligned_cols=174 Identities=24% Similarity=0.281 Sum_probs=151.2
Q ss_pred ceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccC-CCCCccEEEcccCCCCCccCCCCCcccccccccCeee
Q 041143 94 YNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFD-GLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLS 172 (973)
Q Consensus 94 ~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~-~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~ 172 (973)
+.+++++|+|+.++..+. +.++.|+|++|+|+.+++..|. ++++|++|+|++|+|+++ .+..|.++++|++|+
T Consensus 21 ~~l~c~~~~l~~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i----~~~~~~~l~~L~~L~ 94 (361)
T 2xot_A 21 NILSCSKQQLPNVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFI----SSEAFVPVPNLRYLD 94 (361)
T ss_dssp TEEECCSSCCSSCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEE----CTTTTTTCTTCCEEE
T ss_pred CEEEeCCCCcCccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCcc----ChhhccCCCCCCEEE
Confidence 579999999998766554 4589999999999999999998 999999999999999974 456799999999999
Q ss_pred cccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCccc
Q 041143 173 LINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFT 252 (973)
Q Consensus 173 L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~ 252 (973)
|++|+|++..+..|.++++|++|+|++|+|++..|..| .++++|+.|+|++|+|+
T Consensus 95 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~-------------------------~~l~~L~~L~L~~N~l~ 149 (361)
T 2xot_A 95 LSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAF-------------------------EDMAQLQKLYLSQNQIS 149 (361)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTT-------------------------TTCTTCCEEECCSSCCC
T ss_pred CCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHh-------------------------CCcccCCEEECCCCcCC
Confidence 99999998888889999999999999999997766655 46999999999999999
Q ss_pred cCCCcc-c---cCCCCCCEEeCcCCcccccCccccccc---ccCeEEccCCcCc
Q 041143 253 GSIPED-I---GALSSLKDLNLNRNQLVGLIPKSLANM---ELDNLVLNNNLLM 299 (973)
Q Consensus 253 g~~p~~-~---~~l~~L~~L~Ls~N~l~~~~p~~~~~l---~L~~L~l~~N~l~ 299 (973)
+ +|.. | ..+++|+.|+|++|+|++..+..+..+ .++.|+|++|.+.
T Consensus 150 ~-l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 150 R-FPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp S-CCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred e-eCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCcc
Confidence 5 5554 4 579999999999999998776777766 2689999999986
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.76 E-value=2e-18 Score=204.90 Aligned_cols=177 Identities=25% Similarity=0.397 Sum_probs=156.0
Q ss_pred CeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcc
Q 041143 67 NRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALD 146 (973)
Q Consensus 67 ~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls 146 (973)
..++.|+|+++++.. ++ .|..|++|+.|+|++|.|++.++ +..+++|+.|+|++|+|+.++ .|..+++|++|+|+
T Consensus 43 ~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~l~~l~--~l~~l~~L~~L~Ls 117 (605)
T 1m9s_A 43 NSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP-LTNLKNLGWLFLDENKIKDLS--SLKDLKKLKSLSLE 117 (605)
T ss_dssp TTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG-GGGCTTCCEEECCSSCCCCCT--TSTTCTTCCEEECT
T ss_pred CCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh-hccCCCCCEEECcCCCCCCCh--hhccCCCCCEEEec
Confidence 578899999999985 33 69999999999999999999776 999999999999999999986 58999999999999
Q ss_pred cCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCC
Q 041143 147 YNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAG 226 (973)
Q Consensus 147 ~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~ 226 (973)
+|+|++ + +.+..+++|+.|+|++|+|++. ..|..+++|+.|+|++|+|++..| +
T Consensus 118 ~N~l~~-----l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l---------------- 171 (605)
T 1m9s_A 118 HNGISD-----I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--L---------------- 171 (605)
T ss_dssp TSCCCC-----C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--G----------------
T ss_pred CCCCCC-----C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--h----------------
Confidence 999996 3 4689999999999999999975 679999999999999999996655 3
Q ss_pred CCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcccccCcccccc
Q 041143 227 GMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLAN 285 (973)
Q Consensus 227 ~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 285 (973)
..+++|+.|+|++|+|++ + ..+..+++|+.|+|++|.+.+.....+..
T Consensus 172 ---------~~l~~L~~L~Ls~N~i~~-l-~~l~~l~~L~~L~L~~N~l~~~p~~~~~~ 219 (605)
T 1m9s_A 172 ---------AGLTKLQNLYLSKNHISD-L-RALAGLKNLDVLELFSQECLNKPINHQSN 219 (605)
T ss_dssp ---------TTCTTCCEEECCSSCCCB-C-GGGTTCTTCSEEECCSEEEECCCCCCCSS
T ss_pred ---------ccCCCCCEEECcCCCCCC-C-hHHccCCCCCEEEccCCcCcCCccccccc
Confidence 359999999999999996 4 46999999999999999999764444443
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.76 E-value=8.3e-18 Score=175.29 Aligned_cols=155 Identities=21% Similarity=0.222 Sum_probs=127.9
Q ss_pred ceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeeec
Q 041143 94 YNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSL 173 (973)
Q Consensus 94 ~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L 173 (973)
+.++++++.++.++..+. ++|++|+|++|+|+.+++..|.++++|++|+|++|+|+.. .+..|..+++|++|+|
T Consensus 22 ~~v~c~~~~l~~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i----~~~~~~~l~~L~~L~L 95 (229)
T 3e6j_A 22 TTVDCRSKRHASVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGAL----PVGVFDSLTQLTVLDL 95 (229)
T ss_dssp TEEECTTSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC----CTTTTTTCTTCCEEEC
T ss_pred CEeEccCCCcCccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCc----ChhhcccCCCcCEEEC
Confidence 446777888887666443 7899999999999999888899999999999999999763 3345688999999999
Q ss_pred ccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCcccc
Q 041143 174 INCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTG 253 (973)
Q Consensus 174 ~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g 253 (973)
++|+|++..+..|..+++|++|+|++|+|+ .+|..+. ++++|++|+|++|+|++
T Consensus 96 s~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~-------------------------~l~~L~~L~L~~N~l~~ 149 (229)
T 3e6j_A 96 GTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIE-------------------------RLTHLTHLALDQNQLKS 149 (229)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGG-------------------------GCTTCSEEECCSSCCCC
T ss_pred CCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccc-------------------------cCCCCCEEECCCCcCCc
Confidence 999999877778889999999999999998 6676653 48889999999999986
Q ss_pred CCCccccCCCCCCEEeCcCCcccccCc
Q 041143 254 SIPEDIGALSSLKDLNLNRNQLVGLIP 280 (973)
Q Consensus 254 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p 280 (973)
..+..|..+++|+.|+|++|.+.+..+
T Consensus 150 ~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 150 IPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp CCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred cCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 666778888999999999998886543
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.75 E-value=5.2e-18 Score=172.51 Aligned_cols=154 Identities=16% Similarity=0.141 Sum_probs=94.8
Q ss_pred cccccccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCccccccc
Q 041143 87 FNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSV 166 (973)
Q Consensus 87 ~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~ 166 (973)
...+++|+.|+|++|.++..+ .+..+++|++|+|++|.++.++ .|..+++|++|+|++|++++. .+..+..++
T Consensus 40 ~~~l~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~l~~n~l~~~----~~~~l~~l~ 112 (197)
T 4ezg_A 40 EAQMNSLTYITLANINVTDLT-GIEYAHNIKDLTINNIHATNYN--PISGLSNLERLRIMGKDVTSD----KIPNLSGLT 112 (197)
T ss_dssp HHHHHTCCEEEEESSCCSCCT-TGGGCTTCSEEEEESCCCSCCG--GGTTCTTCCEEEEECTTCBGG----GSCCCTTCT
T ss_pred hhhcCCccEEeccCCCccChH-HHhcCCCCCEEEccCCCCCcch--hhhcCCCCCEEEeECCccCcc----cChhhcCCC
Confidence 355666666666666666433 5666666666666666665543 466666666666666666653 455666666
Q ss_pred ccCeeecccccccCCcchhccCCCCCCeEEccCCc-CcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEE
Q 041143 167 QLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNR-LSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLW 245 (973)
Q Consensus 167 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~-l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~ 245 (973)
+|++|+|++|++++..+..++.+++|++|+|++|+ ++ .+| . +.++++|++|+
T Consensus 113 ~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~-------------------------l~~l~~L~~L~ 165 (197)
T 4ezg_A 113 SLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-P-------------------------LKTLPELKSLN 165 (197)
T ss_dssp TCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-G-------------------------GGGCSSCCEEE
T ss_pred CCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-h-------------------------hcCCCCCCEEE
Confidence 67777777776666666666666777777777666 43 333 1 23466666677
Q ss_pred ccCCccccCCCccccCCCCCCEEeCcCCccc
Q 041143 246 LHGNQFTGSIPEDIGALSSLKDLNLNRNQLV 276 (973)
Q Consensus 246 L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~ 276 (973)
|++|++++ ++ .+..+++|++|++++|++.
T Consensus 166 l~~n~i~~-~~-~l~~l~~L~~L~l~~N~i~ 194 (197)
T 4ezg_A 166 IQFDGVHD-YR-GIEDFPKLNQLYAFSQTIG 194 (197)
T ss_dssp CTTBCCCC-CT-TGGGCSSCCEEEECBC---
T ss_pred CCCCCCcC-hH-HhccCCCCCEEEeeCcccC
Confidence 76666663 33 5666666666666666665
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=2.1e-18 Score=183.30 Aligned_cols=139 Identities=20% Similarity=0.196 Sum_probs=106.3
Q ss_pred ccccCcccccCccEEEEEEE-CCCCE--EEEEEeecCCCCh----------------------HHHHHHHHHHHHHHhcC
Q 041143 627 FAQENELGRGGFGTVYKGEL-EDGTK--IAVKRMEAGVTTT----------------------KALDEFQSEIAVLSKVR 681 (973)
Q Consensus 627 ~~~~~~lG~G~fg~Vy~~~~-~~g~~--vavK~~~~~~~~~----------------------~~~~~~~~E~~~l~~l~ 681 (973)
|...+.||+|+||.||+|.. .+|+. ||||+++...... .....+.+|++++.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999988 67989 9999875431110 11236889999999998
Q ss_pred CCce--eeeeeEEEeCCeEEEEEEecCC-C----CHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeee
Q 041143 682 HRHL--VSLLGYSIEGNERLLVYEYMPH-G----ALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIH 754 (973)
Q Consensus 682 h~ni--v~l~~~~~~~~~~~lV~e~~~~-g----~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH 754 (973)
|+++ ..++++ +..++||||+.+ | +|.++... .++..+..++.|++.||.|||. ..+|+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~--~~givH 194 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQ--EAELVH 194 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHH--TSCEEC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHH--HCCEEe
Confidence 8764 333432 356899999942 4 66654321 2345677899999999999993 569999
Q ss_pred ccCCCCcEEECCCCCEEEeeccccccC
Q 041143 755 RDLKSSNILLDDDYRAKVSDFGLVKLA 781 (973)
Q Consensus 755 ~Dikp~Nill~~~~~~kl~DfGla~~~ 781 (973)
|||||+|||++. .++|+|||+|...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 9999999999754
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=7.3e-18 Score=179.60 Aligned_cols=167 Identities=18% Similarity=0.244 Sum_probs=102.2
Q ss_pred EEEEEecccCCcccCCcCcccccccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccC
Q 041143 69 VTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYN 148 (973)
Q Consensus 69 v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N 148 (973)
++.++|.++++++.. .+..+++|++|+|++|.|+... .+..+++|++|+|++|+|+.+++ |.++++|++|+|++|
T Consensus 21 l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N 95 (263)
T 1xeu_A 21 AVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQSLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRN 95 (263)
T ss_dssp HHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCCCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSS
T ss_pred HHHHHhcCCCccccc--chhhcCcCcEEECcCCCcccch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCC
Confidence 334455555555332 4666666777777776666543 56666667777777777666665 666667777777777
Q ss_pred CCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCC
Q 041143 149 PFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGM 228 (973)
Q Consensus 149 ~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~ 228 (973)
++++ +|... . ++|+.|+|++|+|++. ..+..+++|++|+|++|++++. + .
T Consensus 96 ~l~~-----l~~~~-~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~------------------- 145 (263)
T 1xeu_A 96 RLKN-----LNGIP-S-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-M------------------- 145 (263)
T ss_dssp CCSC-----CTTCC-C-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-G-------------------
T ss_pred ccCC-----cCccc-c-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-H-------------------
Confidence 6664 33222 2 6666667777666642 2466666667777766666632 2 1
Q ss_pred CCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCccccc
Q 041143 229 TGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGL 278 (973)
Q Consensus 229 ~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~ 278 (973)
+..+++|+.|+|++|++++. ..+..+++|+.|+|++|.+++.
T Consensus 146 ------l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 146 ------LGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp ------GGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred ------HccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence 23466666666666666644 4566666666666666666654
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.73 E-value=1.8e-20 Score=225.52 Aligned_cols=349 Identities=13% Similarity=0.116 Sum_probs=207.4
Q ss_pred CCeEEEEEecccCCcccCCcCcc-cccccceeeccCc-ccCCC-CCC-CCCCCccceeeccCCCCCCCCcccc----CCC
Q 041143 66 GNRVTQIQVQNLGLKGPLPQNFN-QLTKLYNLGLQRN-KFNGK-LPT-FSGLSELEFAYLDFNEFDTIPSDFF----DGL 137 (973)
Q Consensus 66 ~~~v~~L~L~~~~l~g~~~~~~~-~l~~L~~L~L~~N-~l~~~-~~~-~~~l~~L~~L~L~~N~l~~i~~~~f----~~l 137 (973)
..++++|+|+++.+++..+..+. .+++|++|+|++| .++.. ++. +.++++|++|+|++|.++......+ ..+
T Consensus 104 ~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~ 183 (594)
T 2p1m_B 104 YTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTY 183 (594)
T ss_dssp CTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTC
T ss_pred CCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcC
Confidence 35799999999999887777775 7899999999998 55542 333 4478999999999999887655444 367
Q ss_pred CCccEEEcccCC--CCCccCCCCCcccccccccCeeecccc-cccCCcchhccCCCCCCeEEccCCc-------------
Q 041143 138 SSVRVLALDYNP--FNKTFGWSIPDSLANSVQLTNLSLINC-NLVGPLPDFLGTLPSLAALKLSYNR------------- 201 (973)
Q Consensus 138 ~~L~~L~Ls~N~--l~~~~~~~ip~~~~~l~~L~~L~L~~N-~l~~~~p~~l~~l~~L~~L~Ls~N~------------- 201 (973)
++|++|+|++|. ++.. .++..+.++++|++|+|++| .+.+ ++..+.++++|++|+++.+.
T Consensus 184 ~~L~~L~l~~~~~~~~~~---~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~ 259 (594)
T 2p1m_B 184 TSLVSLNISCLASEVSFS---ALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSGLSV 259 (594)
T ss_dssp CCCCEEECTTCCSCCCHH---HHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHH
T ss_pred CcCcEEEecccCCcCCHH---HHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHHHHH
Confidence 799999999987 2211 12223345689999999988 4444 67777777778887765542
Q ss_pred -------------CcccCChhhhh---hHHHHHhhcccCCCCCCC-cchhhcCCccccEEEccCCccccC-CCccccCCC
Q 041143 202 -------------LSGVIPASFGQ---SLMQILWLNDQDAGGMTG-PIDVVAKMVSLTQLWLHGNQFTGS-IPEDIGALS 263 (973)
Q Consensus 202 -------------l~~~~p~~~~~---~~~~~~~l~~~~~~~~~~-~~~~~~~l~~L~~L~L~~N~l~g~-~p~~~~~l~ 263 (973)
+.......+.. ...++..|+...+..... ....+.++++|+.|+|++| ++.. ++.....++
T Consensus 260 ~l~~~~~L~~Ls~~~~~~~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~ 338 (594)
T 2p1m_B 260 ALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCK 338 (594)
T ss_dssp HHHTCTTCCEEECCBTCCGGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCT
T ss_pred HHhcCCCcccccCCcccchhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCC
Confidence 11111111111 123334444444442211 1233567899999999988 4422 233334578
Q ss_pred CCCEEeC---------cCCcccccCcccccc-c-ccCeEEccCCcCcCCCCCCCCCCcccccCcccCCCCCcccCCcchh
Q 041143 264 SLKDLNL---------NRNQLVGLIPKSLAN-M-ELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNV 332 (973)
Q Consensus 264 ~L~~L~L---------s~N~l~~~~p~~~~~-l-~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (973)
+|++|+| +.|.+++.....+.. + +|+.|++..|.+++..+..+. .
T Consensus 339 ~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~------------------------~ 394 (594)
T 2p1m_B 339 DLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIA------------------------R 394 (594)
T ss_dssp TCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHH------------------------H
T ss_pred CCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHH------------------------h
Confidence 8999988 345665443333332 3 688888888888753322100 0
Q ss_pred hhhhccCCCCC--C----cccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCCCccchhhhC-ccccceEEccCCcc
Q 041143 333 LLDFLGGVNYP--V----NLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIAN-LDSLIEIRLGKNSI 405 (973)
Q Consensus 333 ~~~~l~~l~~~--~----n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~L~~N~l 405 (973)
.+..+..+++. . +.+...+.. .-....+..+++|+.|+|++ .+++..+..++. +++|+.|+|++|.+
T Consensus 395 ~~~~L~~L~L~~~~~~~~~~l~~~~~~-----~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i 468 (594)
T 2p1m_B 395 NRPNMTRFRLCIIEPKAPDYLTLEPLD-----IGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGD 468 (594)
T ss_dssp HCTTCCEEEEEESSTTCCCTTTCCCTH-----HHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCS
T ss_pred hCCCcceeEeecccCCCcccccCCchh-----hHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCC
Confidence 01112222222 0 111111000 00000123456777777766 666666666655 67777777777777
Q ss_pred ccccCccc-cCcCCCCeeeCCCCcCCCCCC-----CCCcccceeecCCcc
Q 041143 406 SGTVPNNF-TELKSLRLLDVSDNNIKPPLP-----EFHDTVKLVIDGNPL 449 (973)
Q Consensus 406 ~g~~p~~~-~~l~~L~~L~Ls~N~l~g~~p-----~~~~~~~~~~~~N~~ 449 (973)
++..+..+ ..+++|+.|+|++|.+++... .+.++..+++.+|+.
T Consensus 469 ~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~ 518 (594)
T 2p1m_B 469 SDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSV 518 (594)
T ss_dssp SHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCC
T ss_pred cHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCC
Confidence 66555444 557777777777777753322 244566677777654
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.72 E-value=5.2e-18 Score=180.74 Aligned_cols=170 Identities=19% Similarity=0.247 Sum_probs=148.6
Q ss_pred cccccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCccccccccc
Q 041143 89 QLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQL 168 (973)
Q Consensus 89 ~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L 168 (973)
++.+++.|+|++|.+++.. .+..+++|++|+|++|+|+.++ .+..+++|++|+|++|+|++ ++. +..+++|
T Consensus 17 ~l~~l~~l~l~~~~i~~~~-~~~~l~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~L~~N~i~~-----~~~-l~~l~~L 87 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDLV-SQKELSGVQNFNGDNSNIQSLA--GMQFFTNLKELHLSHNQISD-----LSP-LKDLTKL 87 (263)
T ss_dssp HHHHHHHHHHTCSCTTSEE-CHHHHTTCSEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCC-----CGG-GTTCSSC
T ss_pred HHHHHHHHHhcCCCccccc-chhhcCcCcEEECcCCCcccch--HHhhCCCCCEEECCCCccCC-----Chh-hccCCCC
Confidence 6788899999999999766 6888999999999999999987 58899999999999999997 455 9999999
Q ss_pred CeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccC
Q 041143 169 TNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHG 248 (973)
Q Consensus 169 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~ 248 (973)
++|+|++|+|++ +|. +.. ++|++|+|++|++++. + . +.++++|+.|+|++
T Consensus 88 ~~L~L~~N~l~~-l~~-~~~-~~L~~L~L~~N~l~~~-~-~-------------------------l~~l~~L~~L~Ls~ 137 (263)
T 1xeu_A 88 EELSVNRNRLKN-LNG-IPS-ACLSRLFLDNNELRDT-D-S-------------------------LIHLKNLEILSIRN 137 (263)
T ss_dssp CEEECCSSCCSC-CTT-CCC-SSCCEEECCSSCCSBS-G-G-------------------------GTTCTTCCEEECTT
T ss_pred CEEECCCCccCC-cCc-ccc-CcccEEEccCCccCCC-h-h-------------------------hcCcccccEEECCC
Confidence 999999999996 443 333 9999999999999853 3 2 34699999999999
Q ss_pred CccccCCCccccCCCCCCEEeCcCCcccccCccccccc-ccCeEEccCCcCcCC
Q 041143 249 NQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGP 301 (973)
Q Consensus 249 N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~g~ 301 (973)
|+|++. + .+..+++|+.|+|++|++++. ..+..+ +|+.|++++|.+.+.
T Consensus 138 N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 138 NKLKSI-V-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp SCCCBC-G-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred CcCCCC-h-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence 999954 4 799999999999999999976 667776 899999999999865
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=3.5e-19 Score=210.24 Aligned_cols=203 Identities=17% Similarity=0.155 Sum_probs=131.1
Q ss_pred CCCCCccEEEcccCCCCCccCCCCCcccccccccCeeeccccc-------------ccCCcchhccCCCCCCeEE-ccCC
Q 041143 135 DGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCN-------------LVGPLPDFLGTLPSLAALK-LSYN 200 (973)
Q Consensus 135 ~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~-------------l~~~~p~~l~~l~~L~~L~-Ls~N 200 (973)
..+++|+.|+|++|+++. +|..++++++|+.|++++|. +.+.+|..++++++|+.|+ ++.|
T Consensus 346 ~~~~~L~~L~Ls~n~L~~-----Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n 420 (567)
T 1dce_A 346 ATDEQLFRCELSVEKSTV-----LQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAA 420 (567)
T ss_dssp STTTTSSSCCCCHHHHHH-----HHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHH
T ss_pred ccCccceeccCChhhHHh-----hHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhc
Confidence 567788888888888873 78888888888888887765 4566777777777887777 6666
Q ss_pred cCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcccccCc
Q 041143 201 RLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIP 280 (973)
Q Consensus 201 ~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p 280 (973)
.+. .++... +..+... .+ ....|+.|+|++|+|++ +|. |+.+++|+.|+|++|+|+ .+|
T Consensus 421 ~~~-~L~~l~---------l~~n~i~-------~l-~~~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp 479 (567)
T 1dce_A 421 YLD-DLRSKF---------LLENSVL-------KM-EYADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALP 479 (567)
T ss_dssp HHH-HHHHHH---------HHHHHHH-------HH-HHTTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCC
T ss_pred ccc-hhhhhh---------hhccccc-------cc-CccCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccc
Confidence 554 111111 1000000 00 01247778888888874 665 788888888888888887 667
Q ss_pred cccccc-ccCeEEccCCcCcCCCCCCCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCCCCC
Q 041143 281 KSLANM-ELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGP 359 (973)
Q Consensus 281 ~~~~~l-~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~ 359 (973)
..+..+ +|+.|+|++|.|++ +|.
T Consensus 480 ~~~~~l~~L~~L~Ls~N~l~~-lp~------------------------------------------------------- 503 (567)
T 1dce_A 480 PALAALRCLEVLQASDNALEN-VDG------------------------------------------------------- 503 (567)
T ss_dssp GGGGGCTTCCEEECCSSCCCC-CGG-------------------------------------------------------
T ss_pred hhhhcCCCCCEEECCCCCCCC-Ccc-------------------------------------------------------
Confidence 777766 67777777777764 331
Q ss_pred ccccccCCCCcccEEecCCCcCCCcc-chhhhCccccceEEccCCccccccCcc---ccCcCCCCeeeC
Q 041143 360 WLGLSCTSNSKVSIINLPRHNLTGTL-SPSIANLDSLIEIRLGKNSISGTVPNN---FTELKSLRLLDV 424 (973)
Q Consensus 360 ~~~~~~~~~~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~g~~p~~---~~~l~~L~~L~L 424 (973)
+..+++|+.|+|++|+|++.+ |..|+.+++|+.|+|++|+|++..|.. +..+++|+.|||
T Consensus 504 -----l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 504 -----VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp -----GTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred -----cCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 234456666666666666665 666666666666777666666544322 233566666654
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=8e-20 Score=215.73 Aligned_cols=203 Identities=18% Similarity=0.190 Sum_probs=128.6
Q ss_pred ccccccceeeccCcccCCCCCCCCCCCccceeeccCCC-------------CCCCCccccCCCCCccEEE-cccCCCCCc
Q 041143 88 NQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNE-------------FDTIPSDFFDGLSSVRVLA-LDYNPFNKT 153 (973)
Q Consensus 88 ~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~-------------l~~i~~~~f~~l~~L~~L~-Ls~N~l~~~ 153 (973)
..+++|+.|+|++|.|+.+++.+.++++|+.|++++|. +...++..+.++++|+.|+ ++.|.+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~-- 423 (567)
T 1dce_A 346 ATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD-- 423 (567)
T ss_dssp STTTTSSSCCCCHHHHHHHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH--
T ss_pred ccCccceeccCChhhHHhhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc--
Confidence 55677778888888877665577777778777776664 2333344444445555444 3333221
Q ss_pred cCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcch
Q 041143 154 FGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPID 233 (973)
Q Consensus 154 ~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 233 (973)
.|..+.+++|.|+...+ ..|+.|+|++|+|++ +|. +.
T Consensus 424 -------------~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~---------------------- 460 (567)
T 1dce_A 424 -------------DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LE---------------------- 460 (567)
T ss_dssp -------------HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GG----------------------
T ss_pred -------------hhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-cc----------------------
Confidence 22223333344442111 247777777777774 454 42
Q ss_pred hhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcccccCccccccc-ccCeEEccCCcCcCCC-CCCCCCCcc
Q 041143 234 VVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGPI-PKFKAGNVT 311 (973)
Q Consensus 234 ~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~g~~-p~~~~~~~~ 311 (973)
++++|+.|+|++|+|+ .+|..|+.+++|+.|+|++|+|++ +| .+..+ +|+.|+|++|.|++.. |.
T Consensus 461 ---~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~------- 527 (567)
T 1dce_A 461 ---QLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQ------- 527 (567)
T ss_dssp ---GGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTG-------
T ss_pred ---ccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcH-------
Confidence 4777777888877777 777777777778888888887776 45 66666 6777788777777654 43
Q ss_pred cccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCCCccch---h
Q 041143 312 YDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSP---S 388 (973)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~---~ 388 (973)
.+..+++|+.|+|++|.+++.+|. .
T Consensus 528 ----------------------------------------------------~l~~l~~L~~L~L~~N~l~~~~~~~~~l 555 (567)
T 1dce_A 528 ----------------------------------------------------PLVSCPRLVLLNLQGNSLCQEEGIQERL 555 (567)
T ss_dssp ----------------------------------------------------GGGGCTTCCEEECTTSGGGGSSSCTTHH
T ss_pred ----------------------------------------------------HHhcCCCCCEEEecCCcCCCCccHHHHH
Confidence 234566777888888888776553 2
Q ss_pred hhCccccceEEc
Q 041143 389 IANLDSLIEIRL 400 (973)
Q Consensus 389 ~~~l~~L~~L~L 400 (973)
+..+++|+.|+|
T Consensus 556 ~~~lp~L~~L~l 567 (567)
T 1dce_A 556 AEMLPSVSSILT 567 (567)
T ss_dssp HHHCTTCSEEEC
T ss_pred HHHCcccCccCC
Confidence 445778888764
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.71 E-value=2.7e-17 Score=167.20 Aligned_cols=155 Identities=16% Similarity=0.198 Sum_probs=133.9
Q ss_pred CCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccC
Q 041143 109 TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGT 188 (973)
Q Consensus 109 ~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~ 188 (973)
....+++|++|+|++|.|+.++ .+..+++|++|+|++|.++. +..+..+++|++|+|++|++++..+..|+.
T Consensus 39 ~~~~l~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~l~~n~~~~------~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~ 110 (197)
T 4ezg_A 39 TEAQMNSLTYITLANINVTDLT--GIEYAHNIKDLTINNIHATN------YNPISGLSNLERLRIMGKDVTSDKIPNLSG 110 (197)
T ss_dssp BHHHHHTCCEEEEESSCCSCCT--TGGGCTTCSEEEEESCCCSC------CGGGTTCTTCCEEEEECTTCBGGGSCCCTT
T ss_pred ChhhcCCccEEeccCCCccChH--HHhcCCCCCEEEccCCCCCc------chhhhcCCCCCEEEeECCccCcccChhhcC
Confidence 4467889999999999999888 48999999999999997773 458899999999999999999888999999
Q ss_pred CCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCc-cccCCCccccCCCCCCE
Q 041143 189 LPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQ-FTGSIPEDIGALSSLKD 267 (973)
Q Consensus 189 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~-l~g~~p~~~~~l~~L~~ 267 (973)
+++|++|+|++|++++..|..+ ..+++|++|+|++|. ++ .+| .+..+++|++
T Consensus 111 l~~L~~L~Ls~n~i~~~~~~~l-------------------------~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~ 163 (197)
T 4ezg_A 111 LTSLTLLDISHSAHDDSILTKI-------------------------NTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKS 163 (197)
T ss_dssp CTTCCEEECCSSBCBGGGHHHH-------------------------TTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCE
T ss_pred CCCCCEEEecCCccCcHhHHHH-------------------------hhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCE
Confidence 9999999999999997666655 469999999999998 66 666 7999999999
Q ss_pred EeCcCCcccccCccccccc-ccCeEEccCCcCcC
Q 041143 268 LNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMG 300 (973)
Q Consensus 268 L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~g 300 (973)
|+|++|++++. + .+..+ +|+.|++++|++.+
T Consensus 164 L~l~~n~i~~~-~-~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 164 LNIQFDGVHDY-R-GIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp EECTTBCCCCC-T-TGGGCSSCCEEEECBC----
T ss_pred EECCCCCCcCh-H-HhccCCCCCEEEeeCcccCC
Confidence 99999999964 3 66666 79999999999864
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.70 E-value=2.3e-17 Score=166.80 Aligned_cols=133 Identities=23% Similarity=0.299 Sum_probs=117.6
Q ss_pred EEEEecccCCcccCCcCcccccccceeeccCcccCCCCCC--CCCCCccceeeccCCCCCCCCccccCCCCCccEEEccc
Q 041143 70 TQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPT--FSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDY 147 (973)
Q Consensus 70 ~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~~--~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~ 147 (973)
+.|++++++++ .+|..+.. +|++|+|++|+|++.++. |.++++|++|+|++|+|+.+++..|.++++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 45677777775 67776654 899999999999998874 89999999999999999999999999999999999999
Q ss_pred CCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChh
Q 041143 148 NPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPAS 209 (973)
Q Consensus 148 N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~ 209 (973)
|+|++. .+..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+++..+..
T Consensus 88 N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~ 145 (192)
T 1w8a_A 88 NKIKEI----SNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA 145 (192)
T ss_dssp CCCCEE----CSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGH
T ss_pred CcCCcc----CHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcch
Confidence 999985 5667899999999999999999999999999999999999999999876643
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.70 E-value=2.5e-19 Score=215.49 Aligned_cols=327 Identities=12% Similarity=0.068 Sum_probs=189.3
Q ss_pred CeEEEEEeccc-CCccc-CCcCcccccccceeeccCcccCCCCC----C-CCCCCccceeeccCCCCCCCCcccc----C
Q 041143 67 NRVTQIQVQNL-GLKGP-LPQNFNQLTKLYNLGLQRNKFNGKLP----T-FSGLSELEFAYLDFNEFDTIPSDFF----D 135 (973)
Q Consensus 67 ~~v~~L~L~~~-~l~g~-~~~~~~~l~~L~~L~L~~N~l~~~~~----~-~~~l~~L~~L~L~~N~l~~i~~~~f----~ 135 (973)
.++++|+|.+| .++.. ++..+.++++|++|+|++|.+++..+ . ...+++|++|+|++|. ..+....+ .
T Consensus 130 ~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~-~~~~~~~l~~l~~ 208 (594)
T 2p1m_B 130 KNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLA-SEVSFSALERLVT 208 (594)
T ss_dssp TTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCC-SCCCHHHHHHHHH
T ss_pred CCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccC-CcCCHHHHHHHHH
Confidence 57999999988 56543 44445689999999999999887543 2 3367899999999997 44444433 3
Q ss_pred CCCCccEEEcccCCCCCccCCCCCcccccccccCeeeccccc--------------------------cc----CCcchh
Q 041143 136 GLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCN--------------------------LV----GPLPDF 185 (973)
Q Consensus 136 ~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~--------------------------l~----~~~p~~ 185 (973)
.+++|++|+|++|.... .++..+..+++|+.|++..+. +. +.++..
T Consensus 209 ~~~~L~~L~L~~~~~~~----~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~~~~L~~Ls~~~~~~~~~l~~~ 284 (594)
T 2p1m_B 209 RCPNLKSLKLNRAVPLE----KLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAV 284 (594)
T ss_dssp HCTTCCEEECCTTSCHH----HHHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHTCTTCCEEECCBTCCGGGGGGG
T ss_pred hCCCCcEEecCCCCcHH----HHHHHHhcCCcceEcccccccCccchhhHHHHHHHHhcCCCcccccCCcccchhhHHHH
Confidence 46899999999882211 144445555555555543331 11 112333
Q ss_pred ccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcc-hhhcCCccccEEEcc---------CCccccCC
Q 041143 186 LGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPI-DVVAKMVSLTQLWLH---------GNQFTGSI 255 (973)
Q Consensus 186 l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~-~~~~~l~~L~~L~L~---------~N~l~g~~ 255 (973)
+..+++|++|+|++|.+++.....+.....++..|....+ ...... .....+++|+.|+|. .|.+++..
T Consensus 285 ~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~ 363 (594)
T 2p1m_B 285 YSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQG 363 (594)
T ss_dssp HHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHH
T ss_pred HHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHH
Confidence 3355666666666666553322221111122222222222 111111 122347788888873 34555433
Q ss_pred Ccccc-CCCCCCEEeCcCCcccccCcccccc-c-ccCeEEcc--C----CcCcCCCCCCCCCCcccccCcccCCCCCccc
Q 041143 256 PEDIG-ALSSLKDLNLNRNQLVGLIPKSLAN-M-ELDNLVLN--N----NLLMGPIPKFKAGNVTYDSNSFCQSEPGIEC 326 (973)
Q Consensus 256 p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~-l-~L~~L~l~--~----N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 326 (973)
...+. .+++|++|+++.|.+++..+..+.. + +|+.|+++ + |.+++.... ..
T Consensus 364 l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~--------------------~~ 423 (594)
T 2p1m_B 364 LVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLD--------------------IG 423 (594)
T ss_dssp HHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTH--------------------HH
T ss_pred HHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchh--------------------hH
Confidence 33333 3778888888888887665555542 3 68888887 3 333311000 00
Q ss_pred CCcchhhhhhccCCCCCCcccCCCCCCCCCCCCccccccC-CCCcccEEecCCCcCCCccchhh-hCccccceEEccCCc
Q 041143 327 APDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCT-SNSKVSIINLPRHNLTGTLSPSI-ANLDSLIEIRLGKNS 404 (973)
Q Consensus 327 ~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~-~~~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~L~~N~ 404 (973)
..........+..+++.. .+..- -. ..+. .+++|+.|+|++|.+++..+..+ ..+++|+.|+|++|.
T Consensus 424 ~~~l~~~~~~L~~L~L~~-~l~~~---------~~-~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~ 492 (594)
T 2p1m_B 424 FGAIVEHCKDLRRLSLSG-LLTDK---------VF-EYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCP 492 (594)
T ss_dssp HHHHHHHCTTCCEEECCS-SCCHH---------HH-HHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCS
T ss_pred HHHHHhhCCCccEEeecC-cccHH---------HH-HHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCC
Confidence 000001112233333322 00000 00 0011 26789999999999988777666 779999999999999
Q ss_pred cccccCc-cccCcCCCCeeeCCCCcCC
Q 041143 405 ISGTVPN-NFTELKSLRLLDVSDNNIK 430 (973)
Q Consensus 405 l~g~~p~-~~~~l~~L~~L~Ls~N~l~ 430 (973)
+++.... .+..+++|+.|+|++|+++
T Consensus 493 ~~~~~~~~~~~~l~~L~~L~l~~~~~~ 519 (594)
T 2p1m_B 493 FGDKALLANASKLETMRSLWMSSCSVS 519 (594)
T ss_dssp CCHHHHHHTGGGGGGSSEEEEESSCCB
T ss_pred CcHHHHHHHHHhCCCCCEEeeeCCCCC
Confidence 9765554 4456899999999999984
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.67 E-value=1.2e-16 Score=161.66 Aligned_cols=132 Identities=23% Similarity=0.249 Sum_probs=96.4
Q ss_pred ceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCc-ccccccccCeeecccccccCCcchhccCCCCCCeE
Q 041143 117 EFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPD-SLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAAL 195 (973)
Q Consensus 117 ~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 195 (973)
+.|++++|+|+.+|...+. +|++|+|++|+|++. .+. .|..+++|++|+|++|+|++..|..|.++++|++|
T Consensus 11 ~~l~~s~~~l~~ip~~~~~---~l~~L~l~~n~i~~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 83 (192)
T 1w8a_A 11 TTVDCTGRGLKEIPRDIPL---HTTELLLNDNELGRI----SSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQEL 83 (192)
T ss_dssp TEEECTTSCCSSCCSCCCT---TCSEEECCSCCCCSB----CCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEE
T ss_pred CEEEcCCCCcCcCccCCCC---CCCEEECCCCcCCcc----CCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEE
Confidence 4566666666666655433 677777777777653 222 37777888888888888887777788888888888
Q ss_pred EccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcc
Q 041143 196 KLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQL 275 (973)
Q Consensus 196 ~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l 275 (973)
+|++|+|++..+..| .++++|++|+|++|+|++..|..|..+++|++|+|++|.+
T Consensus 84 ~Ls~N~l~~~~~~~~-------------------------~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 138 (192)
T 1w8a_A 84 QLGENKIKEISNKMF-------------------------LGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPF 138 (192)
T ss_dssp ECCSCCCCEECSSSS-------------------------TTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCB
T ss_pred ECCCCcCCccCHHHh-------------------------cCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCc
Confidence 888888876665544 3577888888888888877788888888888888888888
Q ss_pred cccCc
Q 041143 276 VGLIP 280 (973)
Q Consensus 276 ~~~~p 280 (973)
.+..+
T Consensus 139 ~c~c~ 143 (192)
T 1w8a_A 139 NCNCH 143 (192)
T ss_dssp CCSGG
T ss_pred cCcCc
Confidence 87654
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.67 E-value=8.1e-17 Score=196.18 Aligned_cols=194 Identities=18% Similarity=0.173 Sum_probs=123.0
Q ss_pred EEEEEecccCCcccCCcCcccccccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccC
Q 041143 69 VTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYN 148 (973)
Q Consensus 69 v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N 148 (973)
+..+++..+.+. ..+..|..++.|+.|+|++|.|..+++.+.++++|++|+|++|+|+.+|. .|.+|++|++|+|++|
T Consensus 203 i~~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~~l~~~~~~l~~L~~L~Ls~N~l~~lp~-~~~~l~~L~~L~Ls~N 280 (727)
T 4b8c_D 203 IDEDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIFNISANIFKYDFLTRLYLNGNSLTELPA-EIKNLSNLRVLDLSHN 280 (727)
T ss_dssp --------------------CCCCCCEEECTTSCCSCCCGGGGGCCSCSCCBCTTSCCSCCCG-GGGGGTTCCEEECTTS
T ss_pred ccCcccccccee-cChhhhccCCCCcEEECCCCCCCCCChhhcCCCCCCEEEeeCCcCcccCh-hhhCCCCCCEEeCcCC
Confidence 333344444444 45788999999999999999999776677899999999999999998874 5799999999999999
Q ss_pred CCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCC
Q 041143 149 PFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGM 228 (973)
Q Consensus 149 ~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~ 228 (973)
+|+. +|..|++|++|++|+|++|.|+ .+|..|++|++|++|+|++|+|++.+|..+......
T Consensus 281 ~l~~-----lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~------------ 342 (727)
T 4b8c_D 281 RLTS-----LPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVT------------ 342 (727)
T ss_dssp CCSS-----CCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHH------------
T ss_pred cCCc-----cChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchh------------
Confidence 9994 8999999999999999999998 778889999999999999999999999887542211
Q ss_pred CCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCC--------cccccCccccccc-ccCeEEccCCcCc
Q 041143 229 TGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRN--------QLVGLIPKSLANM-ELDNLVLNNNLLM 299 (973)
Q Consensus 229 ~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N--------~l~~~~p~~~~~l-~L~~L~l~~N~l~ 299 (973)
+..|+|++|.++|.+|.. |..|++++| .|.+..+..+..+ .+....++.|.+.
T Consensus 343 ------------~~~l~l~~N~l~~~~p~~------l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~ 404 (727)
T 4b8c_D 343 ------------GLIFYLRDNRPEIPLPHE------RRFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLC 404 (727)
T ss_dssp ------------HHHHHHHHCCCCCCCCCC-----------------------------------------------CCC
T ss_pred ------------hhHHhhccCcccCcCccc------cceeEeecccccccccCCccccccchhhcccccceeeeeccccc
Confidence 122567777777777643 444555555 3333333333333 3555667777765
Q ss_pred C
Q 041143 300 G 300 (973)
Q Consensus 300 g 300 (973)
+
T Consensus 405 ~ 405 (727)
T 4b8c_D 405 Q 405 (727)
T ss_dssp G
T ss_pred c
Confidence 4
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.66 E-value=2.5e-16 Score=157.11 Aligned_cols=138 Identities=22% Similarity=0.314 Sum_probs=117.2
Q ss_pred CCCCCCCcCeEEeeCCeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCC-CCCCCCccceeeccCCCCCCCC
Q 041143 52 DPCGPPPWPHVFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFDTIP 130 (973)
Q Consensus 52 d~C~~~~w~gv~C~~~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~ 130 (973)
+.|. |.|.+|.|+..++ + .+|..+ .++|++|+|++|++++.++ .|.++++|++|+|++|+|+.++
T Consensus 3 ~~C~-C~~~~l~~~~~~l----------~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 68 (177)
T 2o6r_A 3 SRCS-CSGTEIRCNSKGL----------T-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLP 68 (177)
T ss_dssp TTCE-EETTEEECCSSCC----------S-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCC
T ss_pred CCCE-eCCCEEEecCCCC----------c-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeC
Confidence 4564 3577777765544 3 345443 3689999999999998877 5789999999999999999999
Q ss_pred ccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCC
Q 041143 131 SDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIP 207 (973)
Q Consensus 131 ~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 207 (973)
+..|..+++|++|+|++|+|++. .+..+..+++|++|+|++|+|++..+..|..+++|++|+|++|++.+..|
T Consensus 69 ~~~~~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 69 DGVFDKLTKLTILYLHENKLQSL----PNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp TTTTTTCTTCCEEECCSSCCCCC----CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred hhHccCCCccCEEECCCCCcccc----CHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 99999999999999999999974 44567899999999999999998777778999999999999999997765
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.64 E-value=2.4e-16 Score=155.71 Aligned_cols=137 Identities=19% Similarity=0.161 Sum_probs=123.4
Q ss_pred CeEEEEEecccCCc-ccCCcCcccccccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEc
Q 041143 67 NRVTQIQVQNLGLK-GPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLAL 145 (973)
Q Consensus 67 ~~v~~L~L~~~~l~-g~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~L 145 (973)
..++.|+|++|+++ +.+|..+..+++|++|+|++|.|++. +.|..+++|++|+|++|+++...+..+..+++|++|+|
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 102 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNL 102 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEEC
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEec
Confidence 46899999999998 88999999999999999999999988 88999999999999999999977788888999999999
Q ss_pred ccCCCCCccCCCCCcccccccccCeeecccccccCCcc---hhccCCCCCCeEEccCCcCcccCCh
Q 041143 146 DYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLP---DFLGTLPSLAALKLSYNRLSGVIPA 208 (973)
Q Consensus 146 s~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p---~~l~~l~~L~~L~Ls~N~l~~~~p~ 208 (973)
++|++++. ..+..+..+++|+.|+|++|.+++..+ ..+..+++|++|++++|.+. .+|.
T Consensus 103 s~N~l~~~---~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~ 164 (168)
T 2ell_A 103 SGNKLKDI---STLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPD 164 (168)
T ss_dssp BSSSCCSS---GGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCS
T ss_pred cCCccCcc---hhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hccc
Confidence 99999973 122788999999999999999997666 58999999999999999997 5554
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.63 E-value=1.1e-15 Score=154.46 Aligned_cols=130 Identities=23% Similarity=0.280 Sum_probs=115.6
Q ss_pred EEEecccCCcccCCcCcccccccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCC
Q 041143 71 QIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPF 150 (973)
Q Consensus 71 ~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l 150 (973)
.+++++++|+ .+|..+. ++|++|+|++|.|+.++..|.++++|++|+|++|+|+.+++..|.++++|++|+|++|+|
T Consensus 14 ~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l 90 (193)
T 2wfh_A 14 VVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL 90 (193)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCCEEECCSSCCCSCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCchhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCcc
Confidence 4667777777 5676654 689999999999997766899999999999999999999999999999999999999999
Q ss_pred CCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCC
Q 041143 151 NKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIP 207 (973)
Q Consensus 151 ~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 207 (973)
++. .|..|..+++|++|+|++|+|+...+..|..+++|++|+|++|.+.....
T Consensus 91 ~~i----~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~ 143 (193)
T 2wfh_A 91 RCI----PPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCN 143 (193)
T ss_dssp CBC----CTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred CEe----CHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCc
Confidence 985 56689999999999999999998777789999999999999999986443
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.62 E-value=6.7e-16 Score=169.63 Aligned_cols=139 Identities=15% Similarity=0.134 Sum_probs=100.9
Q ss_pred CccccCcccccCccEEEEEEECCCCEEEEEEeecCCCC---------------hH-----HHHHHHHHHHHHHhcCCCce
Q 041143 626 NFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTT---------------TK-----ALDEFQSEIAVLSKVRHRHL 685 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~---------------~~-----~~~~~~~E~~~l~~l~h~ni 685 (973)
-|.+.+.||+|+||.||+|...+|+.||||+++..... .. ......+|...|.++.+..+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 38899999999999999999999999999987532110 00 01123457777777755544
Q ss_pred eeeeeEEEeCCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEEC
Q 041143 686 VSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLD 765 (973)
Q Consensus 686 v~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~ 765 (973)
....-+... ..+|||||++++.|.++. .......++.|++.+|.||| +.+||||||||.|||++
T Consensus 176 ~vp~p~~~~--~~~LVME~i~G~~L~~l~-----------~~~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~ 239 (397)
T 4gyi_A 176 PVPEPIAQS--RHTIVMSLVDALPMRQVS-----------SVPDPASLYADLIALILRLA---KHGLIHGDFNEFNILIR 239 (397)
T ss_dssp SCCCEEEEE--TTEEEEECCSCEEGGGCC-----------CCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE
T ss_pred CCCeeeecc--CceEEEEecCCccHhhhc-----------ccHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEe
Confidence 322222222 237999999998875332 11234578899999999999 78999999999999998
Q ss_pred CCC----------CEEEeecccccc
Q 041143 766 DDY----------RAKVSDFGLVKL 780 (973)
Q Consensus 766 ~~~----------~~kl~DfGla~~ 780 (973)
+++ .+.|+||+-+..
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCCcccccccccceEEEEeCCccc
Confidence 876 389999997654
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.61 E-value=1.8e-15 Score=149.37 Aligned_cols=108 Identities=22% Similarity=0.172 Sum_probs=68.9
Q ss_pred ccccceeeccCcccC-CCCC-CCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccc
Q 041143 90 LTKLYNLGLQRNKFN-GKLP-TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQ 167 (973)
Q Consensus 90 l~~L~~L~L~~N~l~-~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~ 167 (973)
.++|++|+|++|.++ +.+| .+..+++|++|+|++|+|+.+ ..|..+++|++|+|++|++++. +|..+..+++
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~ 96 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGG----LDMLAEKLPN 96 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSC----CCHHHHHCTT
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchH----HHHHHhhCCC
Confidence 366777777777777 4444 456677777777777777766 5566666666666666666653 4555555666
Q ss_pred cCeeecccccccCCc-chhccCCCCCCeEEccCCcCc
Q 041143 168 LTNLSLINCNLVGPL-PDFLGTLPSLAALKLSYNRLS 203 (973)
Q Consensus 168 L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~Ls~N~l~ 203 (973)
|++|+|++|+|++.. +..+..+++|++|+|++|+++
T Consensus 97 L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~ 133 (168)
T 2ell_A 97 LTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT 133 (168)
T ss_dssp CCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGG
T ss_pred CCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCc
Confidence 666666666666432 245666666666666666665
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.61 E-value=3.3e-15 Score=150.87 Aligned_cols=129 Identities=29% Similarity=0.352 Sum_probs=95.9
Q ss_pred ceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEE
Q 041143 117 EFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALK 196 (973)
Q Consensus 117 ~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 196 (973)
+.+++++|+|+.+|...+ ++|++|+|++|+|+. +|..|.++++|+.|+|++|+|++..+..|.++++|++|+
T Consensus 13 ~~l~~~~~~l~~ip~~~~---~~l~~L~L~~n~i~~-----ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ 84 (193)
T 2wfh_A 13 TVVRCSNKGLKVLPKGIP---RDVTELYLDGNQFTL-----VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLI 84 (193)
T ss_dssp TEEECTTSCCSSCCSCCC---TTCCEEECCSSCCCS-----CCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CEEEcCCCCCCcCCCCCC---CCCCEEECCCCcCch-----hHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEE
Confidence 456666666666665543 467777777777773 677778888888888888888877777788888888888
Q ss_pred ccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCccc
Q 041143 197 LSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLV 276 (973)
Q Consensus 197 Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~ 276 (973)
|++|+|++..|..| .++++|++|+|++|+|++..+..|..+++|+.|+|++|.+.
T Consensus 85 Ls~N~l~~i~~~~f-------------------------~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 85 LSYNRLRCIPPRTF-------------------------DGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CCSSCCCBCCTTTT-------------------------TTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CCCCccCEeCHHHh-------------------------CCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 88888886555444 35788888888888888555556788888888888888887
Q ss_pred cc
Q 041143 277 GL 278 (973)
Q Consensus 277 ~~ 278 (973)
..
T Consensus 140 C~ 141 (193)
T 2wfh_A 140 CD 141 (193)
T ss_dssp CS
T ss_pred cC
Confidence 43
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.60 E-value=5.1e-16 Score=171.49 Aligned_cols=102 Identities=16% Similarity=0.175 Sum_probs=74.8
Q ss_pred CCCCCEEeCcCCcccccCccccccc-ccCeEEccCCcCcCCCCCCCCCCcccccCcccCCCCCcccCCcchhhhhhccCC
Q 041143 262 LSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGV 340 (973)
Q Consensus 262 l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 340 (973)
+++|+.|+|++|+++...+..|.++ +|+.|+|.+| ++ .|+..
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~-~I~~~----------------------------------- 267 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LK-TIGQR----------------------------------- 267 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CC-EECTT-----------------------------------
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cc-eehHH-----------------------------------
Confidence 6777777777777776666677776 6777777776 43 22221
Q ss_pred CCCCcccCCCCCCCCCCCCccccccCCCCccc-EEecCCCcCCCccchhhhCccccceEEccCCccccccCccccCcCCC
Q 041143 341 NYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVS-IINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSL 419 (973)
Q Consensus 341 ~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L 419 (973)
.|..+.+|+ .|+|++ .+....+..|.++++|+.|+|++|+++..-+..|.++++|
T Consensus 268 -----------------------aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L 323 (329)
T 3sb4_A 268 -----------------------VFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPS 323 (329)
T ss_dssp -----------------------TTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCC
T ss_pred -----------------------HhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcch
Confidence 234556777 888877 6776677788999999999999999987777789999999
Q ss_pred CeeeC
Q 041143 420 RLLDV 424 (973)
Q Consensus 420 ~~L~L 424 (973)
+.|+.
T Consensus 324 ~~ly~ 328 (329)
T 3sb4_A 324 KLIYK 328 (329)
T ss_dssp CEEEC
T ss_pred hhhcc
Confidence 88864
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.60 E-value=6.6e-16 Score=149.20 Aligned_cols=129 Identities=19% Similarity=0.177 Sum_probs=105.9
Q ss_pred CeEEEEEecccCCc-ccCCcCcccccccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEc
Q 041143 67 NRVTQIQVQNLGLK-GPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLAL 145 (973)
Q Consensus 67 ~~v~~L~L~~~~l~-g~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~L 145 (973)
.+++.|++++|+++ +.+|..+..+++|++|+|++|.+++. +.+.++++|++|+|++|+|+...+..+..+++|++|+|
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l 95 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL 95 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEEC
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEEC
Confidence 46788888888888 78888888888999999999888887 77888888899999988888866677778888888888
Q ss_pred ccCCCCCccCCCCCcccccccccCeeecccccccCCcc---hhccCCCCCCeEEccC
Q 041143 146 DYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLP---DFLGTLPSLAALKLSY 199 (973)
Q Consensus 146 s~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p---~~l~~l~~L~~L~Ls~ 199 (973)
++|++++. ..+..+..+++|++|+|++|.+++..+ ..+..+++|++|++++
T Consensus 96 s~N~i~~~---~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 96 SGNKIKDL---STIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp TTSCCCSH---HHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CCCcCCCh---HHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 88888863 123678888888888888888887665 5788888888888764
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.58 E-value=9.3e-15 Score=145.59 Aligned_cols=132 Identities=23% Similarity=0.244 Sum_probs=78.1
Q ss_pred ceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEE
Q 041143 117 EFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALK 196 (973)
Q Consensus 117 ~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 196 (973)
+.+++++|+++.+|...+ ++|++|+|++|++++. .+..|..+++|++|+|++|+|++..+..|.++++|++|+
T Consensus 10 ~~l~~~~~~l~~~p~~~~---~~l~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 82 (177)
T 2o6r_A 10 TEIRCNSKGLTSVPTGIP---SSATRLELESNKLQSL----PHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILY 82 (177)
T ss_dssp TEEECCSSCCSSCCTTCC---TTCSEEECCSSCCCCC----CTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CEEEecCCCCccCCCCCC---CCCcEEEeCCCcccEe----CHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEE
Confidence 345555555555553322 4555555555555542 223445566666666666666655555566667777777
Q ss_pred ccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCccc
Q 041143 197 LSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLV 276 (973)
Q Consensus 197 Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~ 276 (973)
|++|+|++..+..+ .++++|++|+|++|+|++..+..+..+++|++|+|++|.+.
T Consensus 83 l~~N~l~~~~~~~~-------------------------~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 137 (177)
T 2o6r_A 83 LHENKLQSLPNGVF-------------------------DKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 137 (177)
T ss_dssp CCSSCCCCCCTTTT-------------------------TTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred CCCCCccccCHHHh-------------------------hCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCee
Confidence 77777664433332 34667777777777777544444566777777777777777
Q ss_pred ccCc
Q 041143 277 GLIP 280 (973)
Q Consensus 277 ~~~p 280 (973)
+..|
T Consensus 138 ~~~~ 141 (177)
T 2o6r_A 138 CSCP 141 (177)
T ss_dssp CCHH
T ss_pred ccCc
Confidence 6544
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.57 E-value=5.1e-15 Score=142.90 Aligned_cols=132 Identities=21% Similarity=0.159 Sum_probs=112.0
Q ss_pred cccccceeeccCcccC-CCCC-CCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCccccccc
Q 041143 89 QLTKLYNLGLQRNKFN-GKLP-TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSV 166 (973)
Q Consensus 89 ~l~~L~~L~L~~N~l~-~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~ 166 (973)
..++|+.|++++|.++ +.+| .+..+++|++|+|++|+|+.+ ..|..+++|++|+|++|++++. +|..+..++
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~----~~~~~~~l~ 88 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGG----LEVLAEKCP 88 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSC----THHHHHHCT
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccch----HHHHhhhCC
Confidence 3578999999999999 5555 679999999999999999998 7799999999999999999974 777888899
Q ss_pred ccCeeecccccccCC-cchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEE
Q 041143 167 QLTNLSLINCNLVGP-LPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLW 245 (973)
Q Consensus 167 ~L~~L~L~~N~l~~~-~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~ 245 (973)
+|++|+|++|.+++. .+..+..+++|++|+|++|++++..+-.. ..+..+++|+.|+
T Consensus 89 ~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~----------------------~~~~~l~~L~~L~ 146 (149)
T 2je0_A 89 NLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRE----------------------NVFKLLPQLTYLD 146 (149)
T ss_dssp TCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHH----------------------HHHHHCTTCCEET
T ss_pred CCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHH----------------------HHHHHCCCccccc
Confidence 999999999999974 44889999999999999999996544100 1134589999999
Q ss_pred ccC
Q 041143 246 LHG 248 (973)
Q Consensus 246 L~~ 248 (973)
+++
T Consensus 147 l~d 149 (149)
T 2je0_A 147 GYD 149 (149)
T ss_dssp TBC
T ss_pred CCC
Confidence 864
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.52 E-value=1.9e-16 Score=161.08 Aligned_cols=107 Identities=22% Similarity=0.326 Sum_probs=57.3
Q ss_pred ccccccceeeccCcccCCCCC-------CCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCc
Q 041143 88 NQLTKLYNLGLQRNKFNGKLP-------TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPD 160 (973)
Q Consensus 88 ~~l~~L~~L~L~~N~l~~~~~-------~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~ 160 (973)
.....++.++|+.|.+++..| .|..+++|++|+|++|+|+.++ .|.++++|++|+|++|+++. +|.
T Consensus 15 ~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~l~--~~~~l~~L~~L~l~~n~l~~-----l~~ 87 (198)
T 1ds9_A 15 EERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKIS--SLSGMENLRILSLGRNLIKK-----IEN 87 (198)
T ss_dssp HHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESCCC--CHHHHTTCCEEEEEEEEECS-----CSS
T ss_pred HhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcccc--ccccCCCCCEEECCCCCccc-----ccc
Confidence 344555555666666655444 2444555555555555555544 44555555555555555552 455
Q ss_pred ccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCc
Q 041143 161 SLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLS 203 (973)
Q Consensus 161 ~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 203 (973)
.+..+++|++|+|++|+|++ +| .+..+++|++|+|++|+++
T Consensus 88 ~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~ 128 (198)
T 1ds9_A 88 LDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKIT 128 (198)
T ss_dssp HHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECC
T ss_pred hhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCC
Confidence 55555555555555555553 33 3555555555555555555
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.52 E-value=8.5e-15 Score=145.70 Aligned_cols=128 Identities=16% Similarity=0.233 Sum_probs=114.5
Q ss_pred CeEEEEEecccCCcccCCcCccccc-ccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEc
Q 041143 67 NRVTQIQVQNLGLKGPLPQNFNQLT-KLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLAL 145 (973)
Q Consensus 67 ~~v~~L~L~~~~l~g~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~L 145 (973)
..++.|+|++|+++. ++ .+..+. +|++|+|++|.|++. +.|.++++|++|+|++|+|+.+++..|..+++|++|+|
T Consensus 19 ~~L~~L~l~~n~l~~-i~-~~~~~~~~L~~L~Ls~N~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 95 (176)
T 1a9n_A 19 VRDRELDLRGYKIPV-IE-NLGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELIL 95 (176)
T ss_dssp TSCEEEECTTSCCCS-CC-CGGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEEC
T ss_pred CCceEEEeeCCCCch-hH-HhhhcCCCCCEEECCCCCCCcc-cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEEC
Confidence 468999999999995 44 466665 999999999999987 78999999999999999999999998899999999999
Q ss_pred ccCCCCCccCCCCCc--ccccccccCeeecccccccCCcch----hccCCCCCCeEEccCCcCc
Q 041143 146 DYNPFNKTFGWSIPD--SLANSVQLTNLSLINCNLVGPLPD----FLGTLPSLAALKLSYNRLS 203 (973)
Q Consensus 146 s~N~l~~~~~~~ip~--~~~~l~~L~~L~L~~N~l~~~~p~----~l~~l~~L~~L~Ls~N~l~ 203 (973)
++|+|+. +|. .+..+++|+.|+|++|.++. +|. .+..+++|++||+++|.+.
T Consensus 96 ~~N~i~~-----~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 96 TNNSLVE-----LGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CSCCCCC-----GGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CCCcCCc-----chhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCHH
Confidence 9999975 666 78999999999999999984 555 4899999999999999876
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.52 E-value=1.7e-14 Score=143.60 Aligned_cols=137 Identities=21% Similarity=0.181 Sum_probs=115.7
Q ss_pred cCcccccccceeeccCcccCCCCCCCCCCC-ccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcc-c
Q 041143 85 QNFNQLTKLYNLGLQRNKFNGKLPTFSGLS-ELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDS-L 162 (973)
Q Consensus 85 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~-~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~-~ 162 (973)
+.+.++.+|+.|+|++|+++.. +.+..+. +|++|+|++|+|+.+ ..|..+++|++|+|++|+|++ +|.. +
T Consensus 13 ~~~~~~~~L~~L~l~~n~l~~i-~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~-----~~~~~~ 84 (176)
T 1a9n_A 13 AQYTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICR-----IGEGLD 84 (176)
T ss_dssp CEEECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCE-----ECSCHH
T ss_pred HhcCCcCCceEEEeeCCCCchh-HHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccc-----cCcchh
Confidence 4577889999999999999975 6666655 999999999999998 579999999999999999996 5544 5
Q ss_pred ccccccCeeecccccccCCcch--hccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCcc
Q 041143 163 ANSVQLTNLSLINCNLVGPLPD--FLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVS 240 (973)
Q Consensus 163 ~~l~~L~~L~L~~N~l~~~~p~--~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~ 240 (973)
..+++|++|+|++|+|+ .+|. .+..+++|++|+|++|+++ .+|..-. ..+..+++
T Consensus 85 ~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~---------------------~~~~~l~~ 141 (176)
T 1a9n_A 85 QALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRL---------------------YVIYKVPQ 141 (176)
T ss_dssp HHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHH---------------------HHHHHCTT
T ss_pred hcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHH---------------------HHHHHCCc
Confidence 89999999999999997 5665 8999999999999999998 5555310 12346899
Q ss_pred ccEEEccCCccc
Q 041143 241 LTQLWLHGNQFT 252 (973)
Q Consensus 241 L~~L~L~~N~l~ 252 (973)
|+.|++++|.+.
T Consensus 142 L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 142 VRVLDFQKVKLK 153 (176)
T ss_dssp CSEETTEECCHH
T ss_pred cceeCCCcCCHH
Confidence 999999999876
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.51 E-value=1.8e-16 Score=161.14 Aligned_cols=161 Identities=22% Similarity=0.274 Sum_probs=131.0
Q ss_pred CeEEEEEecccCCcccCCc------CcccccccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCc
Q 041143 67 NRVTQIQVQNLGLKGPLPQ------NFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSV 140 (973)
Q Consensus 67 ~~v~~L~L~~~~l~g~~~~------~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L 140 (973)
.+|+.++++.+.+.|.+|. .|..+++|++|+|++|.|++. |.+.++++|++|+|++|+|+.++. .+..+++|
T Consensus 18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~l-~~~~~l~~L~~L~l~~n~l~~l~~-~~~~~~~L 95 (198)
T 1ds9_A 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKI-SSLSGMENLRILSLGRNLIKKIEN-LDAVADTL 95 (198)
T ss_dssp TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESCC-CCHHHHTTCCEEEEEEEEECSCSS-HHHHHHHC
T ss_pred ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCccc-cccccCCCCCEEECCCCCcccccc-hhhcCCcC
Confidence 4567777788888888776 899999999999999999995 489999999999999999998875 57778999
Q ss_pred cEEEcccCCCCCccCCCCCcccccccccCeeecccccccCCcc-hhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHh
Q 041143 141 RVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLP-DFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILW 219 (973)
Q Consensus 141 ~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~ 219 (973)
++|+|++|++++ +| .+..+++|++|+|++|+|++..+ ..+..+++|++|+|++|++++.+|..-...
T Consensus 96 ~~L~L~~N~l~~-----l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~------ 163 (198)
T 1ds9_A 96 EELWISYNQIAS-----LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATS------ 163 (198)
T ss_dssp SEEEEEEEECCC-----HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHH------
T ss_pred CEEECcCCcCCc-----CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchH------
Confidence 999999999996 45 68999999999999999995433 579999999999999999987766420000
Q ss_pred hcccCCCCCCCcchhhcCCccccEEEccCCccc
Q 041143 220 LNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFT 252 (973)
Q Consensus 220 l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~ 252 (973)
......+..+++|+.|| +|.++
T Consensus 164 ---------~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 164 ---------EYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp ---------HHHHHHHHHCSSCSEEC--CGGGT
T ss_pred ---------HHHHHHHHhCCCcEEEC--CcccC
Confidence 00112345689999887 77776
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.47 E-value=5.9e-13 Score=150.10 Aligned_cols=242 Identities=11% Similarity=0.124 Sum_probs=141.2
Q ss_pred cccceeeccCcccCCCCC-CCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccC
Q 041143 91 TKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLT 169 (973)
Q Consensus 91 ~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~ 169 (973)
..++.+.+.+ .++.+.. +|.+. +|+.+.|..| ++.|...+|.+. +|+.+.|.. .++.+ -...|.++++|+
T Consensus 113 ~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I----~~~aF~~c~~L~ 183 (401)
T 4fdw_A 113 KGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQL----KEDIFYYCYNLK 183 (401)
T ss_dssp SSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEE----CSSTTTTCTTCC
T ss_pred CCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEe----hHHHhhCcccCC
Confidence 4555555543 3444433 56654 5777776655 666777777663 577777764 44432 234566677777
Q ss_pred eeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCC
Q 041143 170 NLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGN 249 (973)
Q Consensus 170 ~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N 249 (973)
.++|.+|+++......|. ..+|+.+.|..| ++ .++. .+|.++++|+.|+|..|
T Consensus 184 ~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~-~I~~------------------------~aF~~~~~L~~l~l~~~ 236 (401)
T 4fdw_A 184 KADLSKTKITKLPASTFV-YAGIEEVLLPVT-LK-EIGS------------------------QAFLKTSQLKTIEIPEN 236 (401)
T ss_dssp EEECTTSCCSEECTTTTT-TCCCSEEECCTT-CC-EECT------------------------TTTTTCTTCCCEECCTT
T ss_pred eeecCCCcceEechhhEe-ecccCEEEeCCc-hh-eehh------------------------hHhhCCCCCCEEecCCC
Confidence 777777776644444454 466777776633 44 2222 23445666777777654
Q ss_pred ccccCCCccccCCCCCCEEeCcCCcccccCccccccc-ccCeEEccCCcCcC----CCCCCCCCCcccccCcccCCCCCc
Q 041143 250 QFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMG----PIPKFKAGNVTYDSNSFCQSEPGI 324 (973)
Q Consensus 250 ~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~g----~~p~~~~~~~~~~~~~~~~~~~~~ 324 (973)
++..-..+|.+ .+|+.++| .|.++......|.++ +|+.+++.+|.+.. .++.
T Consensus 237 -l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~-------------------- 293 (401)
T 4fdw_A 237 -VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHP-------------------- 293 (401)
T ss_dssp -CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECT--------------------
T ss_pred -ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECH--------------------
Confidence 44233344544 56777776 344554555566665 67777776665541 0111
Q ss_pred ccCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCCCccchhhhCccccceEEccCCc
Q 041143 325 ECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNS 404 (973)
Q Consensus 325 ~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 404 (973)
-.+..+.+|+.++|. |.+.......|.++.+|+.|+|.+|
T Consensus 294 --------------------------------------~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~- 333 (401)
T 4fdw_A 294 --------------------------------------YCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN- 333 (401)
T ss_dssp --------------------------------------TTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-
T ss_pred --------------------------------------HHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-
Confidence 023445667777777 3466555666777777777777544
Q ss_pred cccccCccccCcCCCCeeeCCCCcCCCC
Q 041143 405 ISGTVPNNFTELKSLRLLDVSDNNIKPP 432 (973)
Q Consensus 405 l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ 432 (973)
++..-+..|.++ +|+.|++++|.+...
T Consensus 334 l~~I~~~aF~~~-~L~~l~l~~n~~~~l 360 (401)
T 4fdw_A 334 VTQINFSAFNNT-GIKEVKVEGTTPPQV 360 (401)
T ss_dssp CCEECTTSSSSS-CCCEEEECCSSCCBC
T ss_pred ccEEcHHhCCCC-CCCEEEEcCCCCccc
Confidence 554556677777 777777777766543
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.46 E-value=9.6e-14 Score=153.16 Aligned_cols=259 Identities=14% Similarity=0.052 Sum_probs=174.5
Q ss_pred CeEEEEEecccCCc--ccCCcCcccccccceeeccCcccCCCCCCCCC--------CCccceeeccCCCCCCCCccccCC
Q 041143 67 NRVTQIQVQNLGLK--GPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSG--------LSELEFAYLDFNEFDTIPSDFFDG 136 (973)
Q Consensus 67 ~~v~~L~L~~~~l~--g~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~--------l~~L~~L~L~~N~l~~i~~~~f~~ 136 (973)
.+++.|+|++|.+. ......+ +.++.+.+..|.|.. -.|.+ +++|+.|+|.+ +++.|+..+|.+
T Consensus 49 ~~L~~LdLs~n~i~~~~~~~~~~---~~~~~~~~~~~~I~~--~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~ 122 (329)
T 3sb4_A 49 PSLKVLDISNAEIKMYSGKAGTY---PNGKFYIYMANFVPA--YAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKG 122 (329)
T ss_dssp TTCCEEEEEEEEECCEEESSSSS---GGGCCEEECTTEECT--TTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTT
T ss_pred ccCeEEecCcceeEEecCccccc---cccccccccccccCH--HHhcccccccccccCCCcEEECCc-cccchhHHHhhc
Confidence 46899999999987 3332223 235666666664321 15777 99999999998 899999999999
Q ss_pred CCCccEEEcccCCCCCccCCCCCcccccccccCeeecccccc----cCCcchhccCCCCCC-eEEccCCcCcccCChhhh
Q 041143 137 LSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNL----VGPLPDFLGTLPSLA-ALKLSYNRLSGVIPASFG 211 (973)
Q Consensus 137 l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l----~~~~p~~l~~l~~L~-~L~Ls~N~l~~~~p~~~~ 211 (973)
+++|+.|+|++|.+..+ -+..|..+.++..|.+..+.. .......|.++.+|+ .+.+.... .++..+.
T Consensus 123 ~~~L~~l~l~~n~i~~i----~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~---~l~~~~~ 195 (329)
T 3sb4_A 123 CDNLKICQIRKKTAPNL----LPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMG---KLEDEIM 195 (329)
T ss_dssp CTTCCEEEBCCSSCCEE----CTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTC---CHHHHHH
T ss_pred CcccceEEcCCCCcccc----chhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCC---cHHHHHh
Confidence 99999999999988864 456777777787777766432 223344566666666 44443321 2222221
Q ss_pred hhHHHHH---hhcccCCCCCCCcchh-hcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcccccCccccccc-
Q 041143 212 QSLMQIL---WLNDQDAGGMTGPIDV-VAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM- 286 (973)
Q Consensus 212 ~~~~~~~---~l~~~~~~~~~~~~~~-~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l- 286 (973)
....... .+..... ........ ...+++|+.|+|++|+++...+..|.++++|+.|+|.+| ++...+..|.++
T Consensus 196 ~~~~~~~~~~~l~~~~~-l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~ 273 (329)
T 3sb4_A 196 KAGLQPRDINFLTIEGK-LDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCG 273 (329)
T ss_dssp HTTCCGGGCSEEEEEEC-CCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCT
T ss_pred hcccCccccceEEEeee-ecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCCh
Confidence 1000000 0000000 00000011 123789999999999999555667999999999999998 887777889988
Q ss_pred ccC-eEEccCCcCcCCCCCCCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCcccccc
Q 041143 287 ELD-NLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSC 365 (973)
Q Consensus 287 ~L~-~L~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~ 365 (973)
+|+ .|++.+ .++...+. .|
T Consensus 274 ~L~~~l~l~~-~l~~I~~~-----------------------------------------------------------aF 293 (329)
T 3sb4_A 274 RLAGTLELPA-SVTAIEFG-----------------------------------------------------------AF 293 (329)
T ss_dssp TCCEEEEECT-TCCEECTT-----------------------------------------------------------TT
T ss_pred hccEEEEEcc-cceEEchh-----------------------------------------------------------hh
Confidence 699 999987 55422111 34
Q ss_pred CCCCcccEEecCCCcCCCccchhhhCccccceEEc
Q 041143 366 TSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRL 400 (973)
Q Consensus 366 ~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 400 (973)
..+.+|+.|+|+.|++....+..|.++++|+.|+.
T Consensus 294 ~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 294 MGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp TTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred hCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 56789999999999999999999999999999874
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.45 E-value=2.8e-13 Score=133.66 Aligned_cols=89 Identities=25% Similarity=0.247 Sum_probs=49.5
Q ss_pred ccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCe
Q 041143 115 ELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAA 194 (973)
Q Consensus 115 ~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 194 (973)
+|++|+|++|+|+.+++..|.++++|++|+|++|+|+++ .+..|.++++|++|+|++|+|++..+..|.++++|++
T Consensus 31 ~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l----~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 106 (170)
T 3g39_A 31 TTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVL----PAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTH 106 (170)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCC----CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred CCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCcc----ChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCE
Confidence 344444444444444444444455555555555555432 2233455566666666666666555556777777777
Q ss_pred EEccCCcCcccCC
Q 041143 195 LKLSYNRLSGVIP 207 (973)
Q Consensus 195 L~Ls~N~l~~~~p 207 (973)
|+|++|+++...+
T Consensus 107 L~L~~N~~~c~c~ 119 (170)
T 3g39_A 107 IWLLNNPWDCACS 119 (170)
T ss_dssp EECCSSCBCTTBG
T ss_pred EEeCCCCCCCCch
Confidence 7777777775443
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.42 E-value=5.4e-13 Score=131.58 Aligned_cols=106 Identities=25% Similarity=0.319 Sum_probs=93.5
Q ss_pred EEEEecccCCcccCCcCcccccccceeeccCcccCCCCC-CCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccC
Q 041143 70 TQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYN 148 (973)
Q Consensus 70 ~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N 148 (973)
+.|++++++|+ .+|..+. ++|++|+|++|+|++..| .|.++++|++|+|++|+|+.+++..|.++++|++|+|++|
T Consensus 12 ~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 45677788887 4776664 899999999999999977 6999999999999999999999999999999999999999
Q ss_pred CCCCccCCCCCcccccccccCeeecccccccCCc
Q 041143 149 PFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPL 182 (973)
Q Consensus 149 ~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~ 182 (973)
+|++. .+..|..+++|++|+|++|.++...
T Consensus 89 ~l~~~----~~~~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 89 QLKSI----PRGAFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp CCCCC----CTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred ccCEe----CHHHhcCCCCCCEEEeCCCCCCCCc
Confidence 99974 4456899999999999999998543
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.41 E-value=7.3e-13 Score=131.13 Aligned_cols=104 Identities=28% Similarity=0.363 Sum_probs=60.1
Q ss_pred EEEEecccCCcccCCcCcccccccceeeccCcccCCCCC-CCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccC
Q 041143 70 TQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYN 148 (973)
Q Consensus 70 ~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N 148 (973)
+.+++++++++ .+|..+. ++|++|+|++|+|++.+| .|.++++|++|+|++|+|+.+++..|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~-------------- 77 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVF-------------- 77 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT--------------
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHh--------------
Confidence 45666666664 4555443 555666666666555544 34555555555555555555444444
Q ss_pred CCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcc
Q 041143 149 PFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSG 204 (973)
Q Consensus 149 ~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 204 (973)
.++++|++|+|++|+|++..+..|..+++|++|+|++|++..
T Consensus 78 --------------~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~c 119 (174)
T 2r9u_A 78 --------------DKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNNPWDC 119 (174)
T ss_dssp --------------TTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCBCT
T ss_pred --------------CCcchhhEEECCCCccceeCHHHhccccCCCEEEeCCCCccc
Confidence 455555555555555554444556677777777777777763
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.40 E-value=8.3e-13 Score=130.70 Aligned_cols=101 Identities=25% Similarity=0.359 Sum_probs=89.7
Q ss_pred CCCCCCCCcCeEEeeC-----------CeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCC-CCCCCCccce
Q 041143 51 DDPCGPPPWPHVFCSG-----------NRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEF 118 (973)
Q Consensus 51 ~d~C~~~~w~gv~C~~-----------~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~ 118 (973)
+..|. |.+..+.|++ ..++.|+|++|.|++..|..|.++++|++|+|++|+|+++++ .|.++++|++
T Consensus 7 P~~C~-C~~~~l~~~~n~l~~iP~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~ 85 (174)
T 2r9u_A 7 PSQCS-CDQTLVNCQNIRLASVPAGIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQ 85 (174)
T ss_dssp CTTSE-ECSSEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred CCCCE-ECCcEEEeCCCCCCccCCCcCCCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhE
Confidence 34454 3467788864 368899999999999999999999999999999999999887 4789999999
Q ss_pred eeccCCCCCCCCccccCCCCCccEEEcccCCCCC
Q 041143 119 AYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNK 152 (973)
Q Consensus 119 L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~ 152 (973)
|+|++|+|+.+++..|..+++|++|+|++|++..
T Consensus 86 L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~c 119 (174)
T 2r9u_A 86 LDLNDNHLKSIPRGAFDNLKSLTHIYLYNNPWDC 119 (174)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCSEEECCSSCBCT
T ss_pred EECCCCccceeCHHHhccccCCCEEEeCCCCccc
Confidence 9999999999999999999999999999999885
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.38 E-value=4.7e-12 Score=142.69 Aligned_cols=261 Identities=13% Similarity=0.159 Sum_probs=197.8
Q ss_pred EEEEEecccCCcccCCcCcccccccceeeccCcccCCCCC-CCCCCCccceeeccCCCCCCCCccccCCCCCccEEEccc
Q 041143 69 VTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDY 147 (973)
Q Consensus 69 v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~ 147 (973)
++.+.+.+ +++.+-..+|.+. +|+.++|.+| ++.+.. +|.+. +|+.+.|.. .++.|...+|.++.+|+.++|++
T Consensus 115 l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~ 189 (401)
T 4fdw_A 115 YNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSK 189 (401)
T ss_dssp CSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEECTT
T ss_pred ccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeecCC
Confidence 33444433 4555556678874 8999999877 776665 78884 799999986 89999999999999999999999
Q ss_pred CCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCC
Q 041143 148 NPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGG 227 (973)
Q Consensus 148 N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~ 227 (973)
|+++. ++.....+.+|+.+.|.++ ++.+....|.++++|+.|+|..| ++ .++.
T Consensus 190 n~l~~-----I~~~aF~~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~-~I~~------------------- 242 (401)
T 4fdw_A 190 TKITK-----LPASTFVYAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VS-TIGQ------------------- 242 (401)
T ss_dssp SCCSE-----ECTTTTTTCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CC-EECT-------------------
T ss_pred CcceE-----echhhEeecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-cc-Cccc-------------------
Confidence 99996 5655555799999999854 77677889999999999999875 44 3332
Q ss_pred CCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCccc-----ccCccccccc-ccCeEEccCCcCcCC
Q 041143 228 MTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLV-----GLIPKSLANM-ELDNLVLNNNLLMGP 301 (973)
Q Consensus 228 ~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l-~L~~L~l~~N~l~g~ 301 (973)
.+|.+ .+|+.+.|. |.++..-...|.++++|+.+++.+|.+. ...+..|.++ +|+.++|.++ ++ .
T Consensus 243 -----~aF~~-~~L~~i~lp-~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~~-i~-~ 313 (401)
T 4fdw_A 243 -----EAFRE-SGITTVKLP-NGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPES-IR-I 313 (401)
T ss_dssp -----TTTTT-CCCSEEEEE-TTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCTT-CC-E
T ss_pred -----ccccc-CCccEEEeC-CCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCCc-eE-E
Confidence 22344 688999994 5566455778899999999999888775 3455677777 7888888743 43 1
Q ss_pred CCCCCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcC
Q 041143 302 IPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNL 381 (973)
Q Consensus 302 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l 381 (973)
++.. .+..+.+|+.|+|..| +
T Consensus 314 I~~~----------------------------------------------------------aF~~c~~L~~l~lp~~-l 334 (401)
T 4fdw_A 314 LGQG----------------------------------------------------------LLGGNRKVTQLTIPAN-V 334 (401)
T ss_dssp ECTT----------------------------------------------------------TTTTCCSCCEEEECTT-C
T ss_pred Ehhh----------------------------------------------------------hhcCCCCccEEEECcc-c
Confidence 2210 2345678899999655 7
Q ss_pred CCccchhhhCccccceEEccCCccccccCccccCcC-CCCeeeCCCCcCC
Q 041143 382 TGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELK-SLRLLDVSDNNIK 430 (973)
Q Consensus 382 ~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~-~L~~L~Ls~N~l~ 430 (973)
...-...|.++ +|+.|++.+|.+....+..|..++ +++.|.+..|.+.
T Consensus 335 ~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 335 TQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp CEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred cEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence 76667789999 999999999998866677888885 7889998887653
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.27 E-value=4.3e-14 Score=157.83 Aligned_cols=189 Identities=20% Similarity=0.150 Sum_probs=116.6
Q ss_pred ccccceeeccCcccCCCCC-C----CC-CCCccceeeccCCCCCCCCcc-ccCCCCCccEEEcccCCCCCccCCCCCccc
Q 041143 90 LTKLYNLGLQRNKFNGKLP-T----FS-GLSELEFAYLDFNEFDTIPSD-FFDGLSSVRVLALDYNPFNKTFGWSIPDSL 162 (973)
Q Consensus 90 l~~L~~L~L~~N~l~~~~~-~----~~-~l~~L~~L~L~~N~l~~i~~~-~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~ 162 (973)
+++|+.|+|++|.|+.... . +. ..++|++|+|++|.|+..... .+..+++|++|+|++|+|+......+...+
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L 150 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL 150 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence 3567777777777765322 1 22 235777778877777643222 223456788888888887653111111222
Q ss_pred -ccccccCeeecccccccC----CcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcC
Q 041143 163 -ANSVQLTNLSLINCNLVG----PLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAK 237 (973)
Q Consensus 163 -~~l~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 237 (973)
...++|+.|+|++|.|+. .++..+..+++|++|+|++|+|+......+. ..+..
T Consensus 151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~---------------------~~L~~ 209 (372)
T 3un9_A 151 LHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLA---------------------AQLDR 209 (372)
T ss_dssp HSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHH---------------------HHGGG
T ss_pred HhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHH---------------------HHHhc
Confidence 235678888888888864 3445567788899999999988743222222 23445
Q ss_pred CccccEEEccCCccccC----CCccccCCCCCCEEeCcCCcccccCccccccc---c---cCeEE--ccCCcCc
Q 041143 238 MVSLTQLWLHGNQFTGS----IPEDIGALSSLKDLNLNRNQLVGLIPKSLANM---E---LDNLV--LNNNLLM 299 (973)
Q Consensus 238 l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l---~---L~~L~--l~~N~l~ 299 (973)
.++|+.|+|++|.|++. ++..+...++|++|+|++|.|+......+..+ . ++.+. +..|.+.
T Consensus 210 ~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~~~~~~~~L~~l~~ll~~~~~~ 283 (372)
T 3un9_A 210 NRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVS 283 (372)
T ss_dssp CSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHHHHCC------CEEECCCC----CH
T ss_pred CCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHHHHHhcCCCccchhhHhhhcCCccC
Confidence 67889999999988753 34455567889999999998886655555433 2 55555 5566554
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.25 E-value=7.4e-12 Score=139.19 Aligned_cols=108 Identities=20% Similarity=0.177 Sum_probs=62.5
Q ss_pred CcCeEEeeCCeEEEEEecccCCcccCCcCcccccccceeeccC-cccCCCCC-CCCCCCccceeeccCCCCCCCCccccC
Q 041143 58 PWPHVFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQR-NKFNGKLP-TFSGLSELEFAYLDFNEFDTIPSDFFD 135 (973)
Q Consensus 58 ~w~gv~C~~~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~-N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~f~ 135 (973)
.|..|.|++. |+|+ .+|. |..+++|++|+|++ |.|+++++ .|.+|++|++|+|++|+|+.+++.+|.
T Consensus 9 ~~~~v~~~~~---------n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~ 77 (347)
T 2ifg_A 9 GSSGLRCTRD---------GALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFH 77 (347)
T ss_dssp SSSCEECCSS---------CCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGG
T ss_pred cCCEEEcCCC---------CCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhc
Confidence 3766666542 1444 3666 77777777777774 77766655 456666666666666666555555555
Q ss_pred CCCCccEEEcccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCccc
Q 041143 136 GLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGV 205 (973)
Q Consensus 136 ~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 205 (973)
+|++|++|+|++| +|++..+..|..++ |+.|+|.+|+|...
T Consensus 78 ~l~~L~~L~l~~N----------------------------~l~~~~~~~~~~~~-L~~l~l~~N~~~c~ 118 (347)
T 2ifg_A 78 FTPRLSRLNLSFN----------------------------ALESLSWKTVQGLS-LQELVLSGNPLHCS 118 (347)
T ss_dssp SCSCCCEEECCSS----------------------------CCSCCCSTTTCSCC-CCEEECCSSCCCCC
T ss_pred CCcCCCEEeCCCC----------------------------ccceeCHHHcccCC-ceEEEeeCCCccCC
Confidence 5555555555555 44443344444444 66777777776643
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.22 E-value=1.8e-11 Score=135.99 Aligned_cols=88 Identities=19% Similarity=0.235 Sum_probs=70.3
Q ss_pred eeeccCC-CCCCCCccccCCCCCccEEEccc-CCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeE
Q 041143 118 FAYLDFN-EFDTIPSDFFDGLSSVRVLALDY-NPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAAL 195 (973)
Q Consensus 118 ~L~L~~N-~l~~i~~~~f~~l~~L~~L~Ls~-N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 195 (973)
.++++++ +|+.||. |..+++|++|+|++ |+|+++ .+..|.+|++|+.|+|++|+|++..|..|.+|++|++|
T Consensus 12 ~v~~~~~n~l~~ip~--l~~~~~L~~L~l~~~n~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L 85 (347)
T 2ifg_A 12 GLRCTRDGALDSLHH--LPGAENLTELYIENQQHLQHL----ELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRL 85 (347)
T ss_dssp CEECCSSCCCTTTTT--SCSCSCCSEEECCSCSSCCEE----CGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEE
T ss_pred EEEcCCCCCCCccCC--CCCCCCeeEEEccCCCCCCCc----ChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEE
Confidence 4566666 6777776 77777788888875 877763 44678888999999999999998889999999999999
Q ss_pred EccCCcCcccCChhhh
Q 041143 196 KLSYNRLSGVIPASFG 211 (973)
Q Consensus 196 ~Ls~N~l~~~~p~~~~ 211 (973)
+|++|+|++..+..|.
T Consensus 86 ~l~~N~l~~~~~~~~~ 101 (347)
T 2ifg_A 86 NLSFNALESLSWKTVQ 101 (347)
T ss_dssp ECCSSCCSCCCSTTTC
T ss_pred eCCCCccceeCHHHcc
Confidence 9999999965555553
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.22 E-value=3e-11 Score=128.48 Aligned_cols=147 Identities=16% Similarity=0.130 Sum_probs=114.2
Q ss_pred HHHHhcCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeeEEEeCCeE
Q 041143 620 LRKVTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR-HRHLVSLLGYSIEGNER 698 (973)
Q Consensus 620 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 698 (973)
++.....|.....++.|+++.||++... ++.+++|+...... .....+.+|+++++.+. |..+.++++++...+..
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~ 85 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCce
Confidence 3455578888888999999999999765 68899999864211 11235889999999985 67788999999998899
Q ss_pred EEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhc------------------------------
Q 041143 699 LLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLA------------------------------ 748 (973)
Q Consensus 699 ~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~------------------------------ 748 (973)
|+||||++|.+|.+.+. +......++.+++++|+.||...
T Consensus 86 ~lv~e~i~G~~l~~~~~----------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T 3tm0_A 86 NLLMSEADGVLCSEEYE----------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp EEEEECCSSEEHHHHCC----------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSG
T ss_pred EEEEEecCCeehhhccC----------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccc
Confidence 99999999999876521 11234478899999999999610
Q ss_pred --------------------------cCCeeeccCCCCcEEECCCCCEEEeeccccc
Q 041143 749 --------------------------RQTFIHRDLKSSNILLDDDYRAKVSDFGLVK 779 (973)
Q Consensus 749 --------------------------~~~ivH~Dikp~Nill~~~~~~kl~DfGla~ 779 (973)
...++|+|++|.||+++++..+.|+||+.+.
T Consensus 156 ~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1458999999999999876667799998764
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.21 E-value=6e-13 Score=148.55 Aligned_cols=164 Identities=20% Similarity=0.141 Sum_probs=123.2
Q ss_pred CCccceeeccCCCCCCCCccccC-----CCCCccEEEcccCCCCCccCCCCCcccccccccCeeecccccccCCcchhc-
Q 041143 113 LSELEFAYLDFNEFDTIPSDFFD-----GLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFL- 186 (973)
Q Consensus 113 l~~L~~L~L~~N~l~~i~~~~f~-----~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l- 186 (973)
++.|+.|+|++|.|+......|. ..++|++|+|++|.++.. .+......+++|+.|+|++|+|+......+
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~---~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~ 147 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPA---GLRTLLPVFLRARKLGLQLNSLGPEACKDLR 147 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHH---HHHHTHHHHHTEEEEECCSSCCCHHHHHHHH
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHH---HHHHHHHHHHhccHhhcCCCCCCHHHHHHHH
Confidence 46799999999999865544433 337999999999998753 122223457789999999999985444444
Q ss_pred ----cCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCccccC----CCcc
Q 041143 187 ----GTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGS----IPED 258 (973)
Q Consensus 187 ----~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~----~p~~ 258 (973)
...++|++|+|++|.|+......+. ..+..+++|++|+|++|.|++. ++..
T Consensus 148 ~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~---------------------~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~ 206 (372)
T 3un9_A 148 DLLLHDQCQITTLRLSNNPLTAAGVAVLM---------------------EGLAGNTSVTHLSLLHTGLGDEGLELLAAQ 206 (372)
T ss_dssp HHHHSTTCCCCEEECCSSCCHHHHHHHHH---------------------HHHHTCSSCCEEECTTSSCHHHHHHHHHHH
T ss_pred HHHHhcCCccceeeCCCCCCChHHHHHHH---------------------HHHhcCCCcCEEeCCCCCCCcHHHHHHHHH
Confidence 3578999999999999743333332 2345688999999999999853 3566
Q ss_pred ccCCCCCCEEeCcCCcccccCccccc----cc-ccCeEEccCCcCcC
Q 041143 259 IGALSSLKDLNLNRNQLVGLIPKSLA----NM-ELDNLVLNNNLLMG 300 (973)
Q Consensus 259 ~~~l~~L~~L~Ls~N~l~~~~p~~~~----~l-~L~~L~l~~N~l~g 300 (973)
+...++|++|+|++|.|+......+. .. +|++|+|++|.|++
T Consensus 207 L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~ 253 (372)
T 3un9_A 207 LDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSS 253 (372)
T ss_dssp GGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCH
T ss_pred HhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCH
Confidence 78889999999999999865433333 22 79999999999874
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.12 E-value=6.3e-11 Score=125.80 Aligned_cols=136 Identities=21% Similarity=0.193 Sum_probs=99.2
Q ss_pred CccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCc--eeeeeeEEEeCCeEEEEEE
Q 041143 626 NFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRH--LVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lV~e 703 (973)
.+....+.+.|..+.||++...+|+.+++|+.... ....+.+|+++++.+.+.+ +.+++++...++..++|||
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 34433333456669999998877888999987543 1235788999999986545 4568888888788999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhc-----------------------------------
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLA----------------------------------- 748 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~----------------------------------- 748 (973)
|++|.+|. ... . ....++.++++.|..||...
T Consensus 96 ~i~G~~l~--~~~--------~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 96 EVPGQDLL--SSH--------L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp CCSSEETT--TSC--------C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred ecCCcccC--cCc--------C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 99998884 110 1 12356777788888888431
Q ss_pred --------------------cCCeeeccCCCCcEEECCCCCEEEeeccccc
Q 041143 749 --------------------RQTFIHRDLKSSNILLDDDYRAKVSDFGLVK 779 (973)
Q Consensus 749 --------------------~~~ivH~Dikp~Nill~~~~~~kl~DfGla~ 779 (973)
...++|+|++|.||++++++.+.|+|||.+.
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1239999999999999887667799999765
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.10 E-value=6.9e-10 Score=125.44 Aligned_cols=294 Identities=14% Similarity=0.094 Sum_probs=150.0
Q ss_pred CCcCcccccccceeeccCcccCCCCC-CCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCC-----
Q 041143 83 LPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGW----- 156 (973)
Q Consensus 83 ~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~----- 156 (973)
-..+|.++++|+.+.|.. .++.+.. +|.++++|+.++|..+ ++.|...+|.++.+|+.+.+..+- ..+...
T Consensus 63 g~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~l-~~i~~~aF~~~ 139 (394)
T 4fs7_A 63 GYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLML-KSIGVEAFKGC 139 (394)
T ss_dssp CTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTTC-CEECTTTTTTC
T ss_pred HHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCce-eeecceeeecc
Confidence 344566666666666643 2444433 5666666666666533 555555666666555555543321 000000
Q ss_pred ------------C-CCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhccc
Q 041143 157 ------------S-IPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQ 223 (973)
Q Consensus 157 ------------~-ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~ 223 (973)
. -...|.++++|+.+.+.++. .......|.++.+|+.+++..| ++......|.. ...+..+...
T Consensus 140 ~~~~~~~~~~~~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~-~~~L~~i~~~ 216 (394)
T 4fs7_A 140 DFKEITIPEGVTVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAE-CILLENMEFP 216 (394)
T ss_dssp CCSEEECCTTCCEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTT-CTTCCBCCCC
T ss_pred cccccccCccccccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhcc-ccccceeecC
Confidence 0 12356677788888886553 3255567777888888877766 33222222211 1111111111
Q ss_pred CCCCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcccccCccccccc-ccCeEEccCCcCcCCC
Q 041143 224 DAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGPI 302 (973)
Q Consensus 224 ~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~g~~ 302 (973)
... .. ..+.+....+|+.+.+..+. +..-...|..+.+|+.+.+..+... .....|... .++.+.+..+.+.
T Consensus 217 ~~~-~~-i~~~~~~~~~l~~i~ip~~~-~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~--- 289 (394)
T 4fs7_A 217 NSL-YY-LGDFALSKTGVKNIIIPDSF-TELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP--- 289 (394)
T ss_dssp TTC-CE-ECTTTTTTCCCCEEEECTTC-CEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---
T ss_pred CCc-eE-eehhhcccCCCceEEECCCc-eecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeec---
Confidence 110 00 11222334677777776543 3233456777778888887766443 334455544 4555555444321
Q ss_pred CCCCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCC
Q 041143 303 PKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLT 382 (973)
Q Consensus 303 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~ 382 (973)
... |.+ ...+..+.++.+ +..++. ..+.++.+|+.++|..+ +.
T Consensus 290 -~~~----------F~~--------------~~~L~~i~l~~~-i~~I~~----------~aF~~c~~L~~i~lp~~-v~ 332 (394)
T 4fs7_A 290 -EKT----------FYG--------------CSSLTEVKLLDS-VKFIGE----------EAFESCTSLVSIDLPYL-VE 332 (394)
T ss_dssp -TTT----------TTT--------------CTTCCEEEECTT-CCEECT----------TTTTTCTTCCEECCCTT-CC
T ss_pred -ccc----------ccc--------------cccccccccccc-cceech----------hhhcCCCCCCEEEeCCc-cc
Confidence 100 000 001111111111 111111 13455667777777643 55
Q ss_pred CccchhhhCccccceEEccCCccccccCccccCcCCCCeeeCCCC
Q 041143 383 GTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDN 427 (973)
Q Consensus 383 ~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N 427 (973)
..-...|.++.+|+.++|..| ++-.-..+|.++.+|+.++|..|
T Consensus 333 ~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 333 EIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR 376 (394)
T ss_dssp EECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred EEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence 555667888888888888766 65455567888888888887654
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=98.95 E-value=8.3e-09 Score=116.50 Aligned_cols=292 Identities=13% Similarity=0.068 Sum_probs=185.0
Q ss_pred ccCCCCC-CCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeeeccccc---
Q 041143 102 KFNGKLP-TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCN--- 177 (973)
Q Consensus 102 ~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~--- 177 (973)
.++.+.. +|.++.+|+.+.|.. .++.|...+|.++++|+.++|..+ ++.+ -...|.++.+|+.+.+..+-
T Consensus 58 ~VtsIg~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I----~~~aF~~c~~L~~i~~p~~l~~i 131 (394)
T 4fs7_A 58 DVVSIGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMI----GRCTFSGCYALKSILLPLMLKSI 131 (394)
T ss_dssp EEEEECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEE----CTTTTTTCTTCCCCCCCTTCCEE
T ss_pred eEeEhHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEc----cchhhcccccchhhcccCceeee
Confidence 3555544 799999999999974 599999999999999999999865 5432 23467777777777665431
Q ss_pred ------------------ccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCc
Q 041143 178 ------------------LVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMV 239 (973)
Q Consensus 178 ------------------l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~ 239 (973)
+.......|.++++|+.+.+.++..+ .....|. ....+..+... .+.......+|.++.
T Consensus 132 ~~~aF~~~~~~~~~~~~~~~~i~~~aF~~c~~L~~i~l~~~~~~-I~~~~F~-~c~~L~~i~l~-~~~~~I~~~~F~~~~ 208 (394)
T 4fs7_A 132 GVEAFKGCDFKEITIPEGVTVIGDEAFATCESLEYVSLPDSMET-LHNGLFS-GCGKLKSIKLP-RNLKIIRDYCFAECI 208 (394)
T ss_dssp CTTTTTTCCCSEEECCTTCCEECTTTTTTCTTCCEEECCTTCCE-ECTTTTT-TCTTCCBCCCC-TTCCEECTTTTTTCT
T ss_pred cceeeecccccccccCccccccchhhhcccCCCcEEecCCccce-ecccccc-CCCCceEEEcC-CCceEeCchhhcccc
Confidence 11123457889999999999876432 3333332 11222222221 123344557889999
Q ss_pred cccEEEccCCccccCCCccccCCCCCCEEeCcCCcccccCccccccc-ccCeEEccCCcCcCCCCCCCCCCcccccCccc
Q 041143 240 SLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFC 318 (973)
Q Consensus 240 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~ 318 (973)
.|+.+.+..+... +........+|+.+.+..+ ++......|... .++.+.+..+... +.... |.
T Consensus 209 ~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~--i~~~~----------F~ 273 (394)
T 4fs7_A 209 LLENMEFPNSLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR--IGGSL----------FY 273 (394)
T ss_dssp TCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE--ECSCT----------TT
T ss_pred ccceeecCCCceE--eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcce--eeccc----------cc
Confidence 9999999887654 4455566688999998644 343444556555 7888888777543 11110 00
Q ss_pred CCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCCCccchhhhCccccceE
Q 041143 319 QSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEI 398 (973)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 398 (973)
.. ..+..+....+.+.. ..+..+.+|+.+.+..+ +.......|.++.+|+.+
T Consensus 274 ~~--------------~~l~~~~~~~~~i~~-------------~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i 325 (394)
T 4fs7_A 274 NC--------------SGLKKVIYGSVIVPE-------------KTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSI 325 (394)
T ss_dssp TC--------------TTCCEEEECSSEECT-------------TTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEE
T ss_pred cc--------------cccceeccCceeecc-------------ccccccccccccccccc-cceechhhhcCCCCCCEE
Confidence 00 001111111111111 13456678899998765 666667789999999999
Q ss_pred EccCCccccccCccccCcCCCCeeeCCCCcCCCCCC-CC---CcccceeecCC
Q 041143 399 RLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLP-EF---HDTVKLVIDGN 447 (973)
Q Consensus 399 ~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p-~~---~~~~~~~~~~N 447 (973)
+|.++ ++-.-..+|.++.+|+.++|..| ++..-. .| .++..+.+..|
T Consensus 326 ~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 326 DLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR 376 (394)
T ss_dssp CCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred EeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence 99755 76555788999999999999877 543222 22 34455555443
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.94 E-value=2.5e-09 Score=119.20 Aligned_cols=143 Identities=13% Similarity=0.205 Sum_probs=106.3
Q ss_pred ccCcccccCccEEEEEEECCCCEEEEEEee--cCCCChHHHHHHHHHHHHHHhcC--CCceeeeeeEEEeC---CeEEEE
Q 041143 629 QENELGRGGFGTVYKGELEDGTKIAVKRME--AGVTTTKALDEFQSEIAVLSKVR--HRHLVSLLGYSIEG---NERLLV 701 (973)
Q Consensus 629 ~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~--~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lV 701 (973)
..+.|+.|.++.||+....+ ..+++|+.. ... .......+.+|+++++.+. +..+.++++++.+. +..++|
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~-~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSK-LLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCC-CCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 45678999999999998764 678888765 321 1123457889999999997 45578889888776 457999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhc---------------------------------
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLA--------------------------------- 748 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~--------------------------------- 748 (973)
|||++|..+.+. ....++..++..++.++++.|+.||...
T Consensus 120 me~v~G~~l~~~-------~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 120 MEFVSGRVLWDQ-------SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp EECCCCBCCCCT-------TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred EEecCCeecCCC-------ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 999998777421 1134677888899999999999999620
Q ss_pred ----------------------cCCeeeccCCCCcEEECCCCC--EEEeecccccc
Q 041143 749 ----------------------RQTFIHRDLKSSNILLDDDYR--AKVSDFGLVKL 780 (973)
Q Consensus 749 ----------------------~~~ivH~Dikp~Nill~~~~~--~kl~DfGla~~ 780 (973)
...++|+|+++.||+++.++. +.|+||+.+..
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999997753 68999998864
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.93 E-value=2.4e-10 Score=126.37 Aligned_cols=202 Identities=14% Similarity=0.163 Sum_probs=133.7
Q ss_pred CeEEEEEecccCCcc-c-------CCcCcccccccceeeccCcccCC---------CCC-CCCCCCccceeeccCCCCCC
Q 041143 67 NRVTQIQVQNLGLKG-P-------LPQNFNQLTKLYNLGLQRNKFNG---------KLP-TFSGLSELEFAYLDFNEFDT 128 (973)
Q Consensus 67 ~~v~~L~L~~~~l~g-~-------~~~~~~~l~~L~~L~L~~N~l~~---------~~~-~~~~l~~L~~L~L~~N~l~~ 128 (973)
.+|+.|.+...++.| . +..++..+++|+.|.+..+.... .+. .+..+++|+.|+|++|.-..
T Consensus 107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l~ 186 (362)
T 2ra8_A 107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLS 186 (362)
T ss_dssp GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTCB
T ss_pred hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCce
Confidence 468888888776653 2 23456778999999997764321 122 34667899999998874223
Q ss_pred CCccccCCCCCccEEEcccCCCCCccCCCCCcccc--cccccCeeeccc--ccccCC-----cchhc--cCCCCCCeEEc
Q 041143 129 IPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLA--NSVQLTNLSLIN--CNLVGP-----LPDFL--GTLPSLAALKL 197 (973)
Q Consensus 129 i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~--~l~~L~~L~L~~--N~l~~~-----~p~~l--~~l~~L~~L~L 197 (973)
+++ +. +++|+.|+|..|.+... ....+. .+++|+.|+|+. |...+. +...+ ..+++|++|+|
T Consensus 187 l~~--~~-~~~L~~L~L~~~~l~~~----~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L 259 (362)
T 2ra8_A 187 IGK--KP-RPNLKSLEIISGGLPDS----VVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGI 259 (362)
T ss_dssp CCS--CB-CTTCSEEEEECSBCCHH----HHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEE
T ss_pred ecc--cc-CCCCcEEEEecCCCChH----HHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeC
Confidence 333 33 88999999998887642 222333 688999999863 232211 11223 35789999999
Q ss_pred cCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCccccC----CCccccCCCCCCEEeCcCC
Q 041143 198 SYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGS----IPEDIGALSSLKDLNLNRN 273 (973)
Q Consensus 198 s~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~Ls~N 273 (973)
.+|.+....+..+.. ...+++|++|+|+.|.|++. ++..+..+++|+.|+|++|
T Consensus 260 ~~~~i~~~~~~~la~----------------------a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n 317 (362)
T 2ra8_A 260 VDAEEQNVVVEMFLE----------------------SDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYN 317 (362)
T ss_dssp ESCTTHHHHHHHHHH----------------------CSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSB
T ss_pred CCCCCchHHHHHHHh----------------------CccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCC
Confidence 999987544333321 01378999999999999864 3444456789999999999
Q ss_pred cccccCcccccccccCeEEccCCc
Q 041143 274 QLVGLIPKSLANMELDNLVLNNNL 297 (973)
Q Consensus 274 ~l~~~~p~~~~~l~L~~L~l~~N~ 297 (973)
.++...-..+...-...+++++|+
T Consensus 318 ~i~d~~~~~l~~alg~~~~~~~~~ 341 (362)
T 2ra8_A 318 YLSDEMKKELQKSLPMKIDVSDSQ 341 (362)
T ss_dssp BCCHHHHHHHHHHCCSEEECCSBC
T ss_pred cCCHHHHHHHHHHcCCEEEecCCc
Confidence 888554444443113568888876
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.87 E-value=1.4e-09 Score=118.26 Aligned_cols=186 Identities=16% Similarity=0.222 Sum_probs=121.0
Q ss_pred cCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCc--eeeeeeEEEeCC---eEEEEEE
Q 041143 630 ENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR-HRH--LVSLLGYSIEGN---ERLLVYE 703 (973)
Q Consensus 630 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lV~e 703 (973)
.+.++.|.+..||+.. ..+++|+.. .......+.+|.++++.+. +.. +.+++.++...+ ..|+|||
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~----~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~ 96 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPK----HSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT 96 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEES----SHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred eEecCCCCcceEEEEC----CEEEEEecC----CcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence 4568999999999863 568888753 2344567899999999884 333 334444443333 3489999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhc-----------------------------------
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLA----------------------------------- 748 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~----------------------------------- 748 (973)
|++|..+..... ..++..++..++.++++.++.||...
T Consensus 97 ~i~G~~l~~~~~-------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (304)
T 3sg8_A 97 KIKGVPLTPLLL-------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQ 169 (304)
T ss_dssp CCCCEECCHHHH-------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHH
T ss_pred ccCCeECCcccc-------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCccc
Confidence 999988865332 23566777788888888888888510
Q ss_pred --------------------cCCeeeccCCCCcEEECC--CCCEEEeeccccccCCCCCccee-------------cccc
Q 041143 749 --------------------RQTFIHRDLKSSNILLDD--DYRAKVSDFGLVKLAPDGEKSVV-------------TRLA 793 (973)
Q Consensus 749 --------------------~~~ivH~Dikp~Nill~~--~~~~kl~DfGla~~~~~~~~~~~-------------~~~~ 793 (973)
...++|+|++|.||++++ +..+.|+||+.+........-.. ..+.
T Consensus 170 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l 249 (304)
T 3sg8_A 170 MKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKIL 249 (304)
T ss_dssp HHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHH
T ss_pred HHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHH
Confidence 135899999999999998 55688999998864322110000 0000
Q ss_pred cccCccc-ccccccCcCCCchhHHhHHHHHHHHHhCCCCC
Q 041143 794 GTFGYLA-PEYAVMGKITTKADVFSYGVVLMELLTGLAAL 832 (973)
Q Consensus 794 gt~~y~a-PE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~ 832 (973)
..+++.. |+.... .....+.|++|+++|++.+|+.+|
T Consensus 250 ~~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 250 NHYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 1111122 222111 122368999999999999997654
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.79 E-value=1.1e-07 Score=107.17 Aligned_cols=124 Identities=15% Similarity=0.123 Sum_probs=86.3
Q ss_pred eEEEEEecccCCcccCCcCcccccccceeeccCcc---cCCCCC-CCCCCCccceeeccCCCCCCCCccccCCCCCccEE
Q 041143 68 RVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNK---FNGKLP-TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVL 143 (973)
Q Consensus 68 ~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~---l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L 143 (973)
.++++.+.+ +++.+-..+|.++++|+.+.+..|. ++.+.. +|.++.+|+.+.+..+ ++.|...+|.++.+|+.+
T Consensus 65 ~L~sI~iP~-svt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c~~L~~i 142 (394)
T 4gt6_A 65 VLTSVQIPD-TVTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHHCEELDTV 142 (394)
T ss_dssp CCCEEEECT-TCCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTTCTTCCEE
T ss_pred cCEEEEECC-CeeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhhhcccccc
Confidence 377787765 4776777889999999999998875 555444 7888999998888654 788888899999999999
Q ss_pred EcccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCC
Q 041143 144 ALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYN 200 (973)
Q Consensus 144 ~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N 200 (973)
.+..+. ..+ -...|..+.+|+.+.+.++ ++..-...|.+ .+|+.+.+..+
T Consensus 143 ~lp~~~-~~I----~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~ 192 (394)
T 4gt6_A 143 TIPEGV-TSV----ADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAK 192 (394)
T ss_dssp ECCTTC-CEE----CTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTT
T ss_pred ccccee-eee----cccceecccccccccccce-eeEeccccccc-cceeEEEECCc
Confidence 987543 321 2345667777877777654 33233334433 45666655443
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.77 E-value=1.7e-07 Score=105.80 Aligned_cols=299 Identities=11% Similarity=0.142 Sum_probs=169.2
Q ss_pred CcccCCcCcccc-cccceeeccCcccCCCCC-CCCCCCccceeeccCCC---CCCCCccccCCCCCccEEEcccCCCCCc
Q 041143 79 LKGPLPQNFNQL-TKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNE---FDTIPSDFFDGLSSVRVLALDYNPFNKT 153 (973)
Q Consensus 79 l~g~~~~~~~~l-~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~---l~~i~~~~f~~l~~L~~L~Ls~N~l~~~ 153 (973)
++.+-..+|.+. ..|+.+.+-.+ ++.+.. +|.++++|+.+.+..|. ++.|...+|.++.+|+.+.+..+ ++.+
T Consensus 51 Vt~Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I 128 (394)
T 4gt6_A 51 VSKIGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEI 128 (394)
T ss_dssp EEEECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEE
T ss_pred eeEcCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-ccee
Confidence 344456778887 46999999754 776655 89999999999998874 88899999999999999988766 4432
Q ss_pred cCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcch
Q 041143 154 FGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPID 233 (973)
Q Consensus 154 ~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 233 (973)
-...|..+.+|+.+.+..+ +.......|.++.+|+.+.+..+ ++..-...|.... +..+... .........
T Consensus 129 ----~~~aF~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~~~--l~~i~ip-~~~~~i~~~ 199 (394)
T 4gt6_A 129 ----DSEAFHHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTGTA--LTQIHIP-AKVTRIGTN 199 (394)
T ss_dssp ----CTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCC--CSEEEEC-TTCCEECTT
T ss_pred ----hhhhhhhhcccccccccce-eeeecccceecccccccccccce-eeEeccccccccc--eeEEEEC-Ccccccccc
Confidence 2357788999999999764 44466778999999999999766 4423333332211 1111111 112222345
Q ss_pred hhcCCccccEEEccCCccccCCCcccc--------------CCCCCCEEeCcCCcccccCccccccc-ccCeEEccCCcC
Q 041143 234 VVAKMVSLTQLWLHGNQFTGSIPEDIG--------------ALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLL 298 (973)
Q Consensus 234 ~~~~l~~L~~L~L~~N~l~g~~p~~~~--------------~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l 298 (973)
+|.++.+|.......+... .+...+. ....+..+.+. +.++......|.+. .|+.+.+.++..
T Consensus 200 af~~c~~l~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~~ 277 (394)
T 4gt6_A 200 AFSECFALSTITSDSESYP-AIDNVLYEKSANGDYALIRYPSQREDPAFKIP-NGVARIETHAFDSCAYLASVKMPDSVV 277 (394)
T ss_dssp TTTTCTTCCEEEECCSSSC-BSSSCEEEECTTSCEEEEECCTTCCCSEEECC-TTEEEECTTTTTTCSSCCEEECCTTCC
T ss_pred hhhhccccceecccccccc-cccceeecccccccccccccccccccceEEcC-CcceEcccceeeecccccEEecccccc
Confidence 6777777777776655443 1111111 11222333322 12222223344443 455555544332
Q ss_pred cCCCCCCCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCC
Q 041143 299 MGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPR 378 (973)
Q Consensus 299 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~ 378 (973)
. +.... |.+ ...|..+.++. .+..++.. .|..+.+|+.++|..
T Consensus 278 ~--I~~~a----------F~~--------------c~~L~~i~l~~-~i~~I~~~----------aF~~c~~L~~i~lp~ 320 (394)
T 4gt6_A 278 S--IGTGA----------FMN--------------CPALQDIEFSS-RITELPES----------VFAGCISLKSIDIPE 320 (394)
T ss_dssp E--ECTTT----------TTT--------------CTTCCEEECCT-TCCEECTT----------TTTTCTTCCEEECCT
T ss_pred e--ecCcc----------ccc--------------ccccccccCCC-cccccCce----------eecCCCCcCEEEeCC
Confidence 1 11100 000 00011111110 11111111 244556677777764
Q ss_pred CcCCCccchhhhCccccceEEccCCccccccCccccCcCCCCeeeCCCCcC
Q 041143 379 HNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNI 429 (973)
Q Consensus 379 N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l 429 (973)
+ ++......|.++.+|+.+.|..+ ++-.-..+|.++.+|+.+++.+|..
T Consensus 321 ~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~ 369 (394)
T 4gt6_A 321 G-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRS 369 (394)
T ss_dssp T-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHH
T ss_pred c-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCcee
Confidence 3 55455566777777777777544 5534455677777777777776643
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.75 E-value=1.4e-10 Score=121.51 Aligned_cols=144 Identities=15% Similarity=0.106 Sum_probs=102.5
Q ss_pred cCeEEeeCC--eEEEEEecc---cCCcccCC-cCcccccccceeeccCcccCCCCC--CCCCCCccce--eeccCCCCCC
Q 041143 59 WPHVFCSGN--RVTQIQVQN---LGLKGPLP-QNFNQLTKLYNLGLQRNKFNGKLP--TFSGLSELEF--AYLDFNEFDT 128 (973)
Q Consensus 59 w~gv~C~~~--~v~~L~L~~---~~l~g~~~-~~~~~l~~L~~L~L~~N~l~~~~~--~~~~l~~L~~--L~L~~N~l~~ 128 (973)
|.|+.|+.. +|+.+...+ ..+.+.+. ..+..|.. .|...+|..++.++ .|...+.|+. ++++.|+...
T Consensus 80 ~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~~~~ 157 (267)
T 3rw6_A 80 VNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRSC 157 (267)
T ss_dssp TTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTSHHH
T ss_pred cCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCCHHHH
Confidence 999999754 776665544 33444444 23344443 45666676666554 4777777877 7888886554
Q ss_pred CC---ccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCC--CCCeEEccCCcCc
Q 041143 129 IP---SDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLP--SLAALKLSYNRLS 203 (973)
Q Consensus 129 i~---~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~--~L~~L~Ls~N~l~ 203 (973)
++ .-...++++|+.|+|++|+|+++. .+|..+..+++|+.|+|++|+|++. ..+..++ +|++|+|++|.+.
T Consensus 158 ~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~--~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~ 233 (267)
T 3rw6_A 158 MAATLRIIEENIPELLSLNLSNNRLYRLD--DMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLC 233 (267)
T ss_dssp HHHHHHHHHHHCTTCCEEECTTSCCCCCG--GGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTG
T ss_pred HHHHHHHHHhhCCCCCEEECCCCCCCCCc--cchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCc
Confidence 33 222357899999999999999742 2567778999999999999999965 3344444 9999999999999
Q ss_pred ccCCh
Q 041143 204 GVIPA 208 (973)
Q Consensus 204 ~~~p~ 208 (973)
+.+|.
T Consensus 234 ~~~~~ 238 (267)
T 3rw6_A 234 DTFRD 238 (267)
T ss_dssp GGCSS
T ss_pred cccCc
Confidence 87774
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.65 E-value=4.4e-09 Score=116.15 Aligned_cols=183 Identities=11% Similarity=0.100 Sum_probs=122.4
Q ss_pred CeEEEEEecccCCc---------ccCCcCcccccccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCcccc--C
Q 041143 67 NRVTQIQVQNLGLK---------GPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFF--D 135 (973)
Q Consensus 67 ~~v~~L~L~~~~l~---------g~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f--~ 135 (973)
.+++.|.+.+.... +.+...+..+++|+.|+|++|.-. .++.+. +++|++|+|..+.+..-....+ .
T Consensus 139 ~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~~~-~~~L~~L~L~~~~l~~~~l~~l~~~ 216 (362)
T 2ra8_A 139 AHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGKKP-RPNLKSLEIISGGLPDSVVEDILGS 216 (362)
T ss_dssp TTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCSCB-CTTCSEEEEECSBCCHHHHHHHHHS
T ss_pred chhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eecccc-CCCCcEEEEecCCCChHHHHHHHHc
Confidence 57888888654331 234455678899999999988311 233343 8999999999988764332233 3
Q ss_pred CCCCccEEEccc--CCCCCcc-CCCCCccc--ccccccCeeecccccccCCcchhcc---CCCCCCeEEccCCcCcccCC
Q 041143 136 GLSSVRVLALDY--NPFNKTF-GWSIPDSL--ANSVQLTNLSLINCNLVGPLPDFLG---TLPSLAALKLSYNRLSGVIP 207 (973)
Q Consensus 136 ~l~~L~~L~Ls~--N~l~~~~-~~~ip~~~--~~l~~L~~L~L~~N~l~~~~p~~l~---~l~~L~~L~Ls~N~l~~~~p 207 (973)
.+++|+.|+|+. |...+.. ...+...+ ..+++|++|+|.+|.+....+..+. .+++|++|+|+.|.|.+...
T Consensus 217 ~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~ 296 (362)
T 2ra8_A 217 DLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGA 296 (362)
T ss_dssp BCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHH
T ss_pred cCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHH
Confidence 789999999964 3222110 00122223 2578999999999999854444443 58899999999999986544
Q ss_pred hhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCccccCCCccccC-CCCCCEEeCcCCc
Q 041143 208 ASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGA-LSSLKDLNLNRNQ 274 (973)
Q Consensus 208 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~-l~~L~~L~Ls~N~ 274 (973)
..+.. .+.++++|+.|+|++|.|+...-..+.. + ...++++.|+
T Consensus 297 ~~L~~---------------------~L~~l~~L~~L~L~~n~i~d~~~~~l~~al--g~~~~~~~~~ 341 (362)
T 2ra8_A 297 RLLLD---------------------HVDKIKHLKFINMKYNYLSDEMKKELQKSL--PMKIDVSDSQ 341 (362)
T ss_dssp HHHHT---------------------THHHHTTCSEEECCSBBCCHHHHHHHHHHC--CSEEECCSBC
T ss_pred HHHHh---------------------hcccCCcceEEECCCCcCCHHHHHHHHHHc--CCEEEecCCc
Confidence 43321 1234789999999999998544444443 2 4678999887
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.57 E-value=8e-07 Score=99.59 Aligned_cols=285 Identities=12% Similarity=0.107 Sum_probs=146.4
Q ss_pred eEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCC-CCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcc
Q 041143 68 RVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALD 146 (973)
Q Consensus 68 ~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls 146 (973)
.++++.+. .+++.+-..+|.++++|+.++|..+ ++.+.. +|.++ +|+.+.+. +.++.|...+|.+. +|+.+.+.
T Consensus 47 ~i~~v~ip-~~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~-~~l~~I~~~aF~~~-~L~~i~lp 121 (379)
T 4h09_A 47 RISEVRVN-SGITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGM-ERVKKFGDYVFQGT-DLDDFEFP 121 (379)
T ss_dssp GCSEEEEC-TTEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEEC-TTCCEECTTTTTTC-CCSEEECC
T ss_pred CCEEEEeC-CCccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECC-ceeeEeccceeccC-CcccccCC
Confidence 45555554 2455555566777777777777543 554444 56665 56666665 34666777777664 67777776
Q ss_pred cCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhc-----
Q 041143 147 YNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLN----- 221 (973)
Q Consensus 147 ~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~----- 221 (973)
.+... +........+|+.+.+..+ ++......|.++.+|+.+.+..+.........+...........
T Consensus 122 ~~~~~------i~~~~F~~~~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (379)
T 4h09_A 122 GATTE------IGNYIFYNSSVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAK 194 (379)
T ss_dssp TTCCE------ECTTTTTTCCCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTC
T ss_pred Ccccc------ccccccccceeeeeeccce-eeccccchhcccccccccccccccceeecccceecccccceeccccccc
Confidence 54222 2222222235555555443 33344556777778887777665543211111000000000000
Q ss_pred -----ccCCCCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcccccCccccccc-ccCeEEccC
Q 041143 222 -----DQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNN 295 (973)
Q Consensus 222 -----~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~ 295 (973)
............++....+|+.+.+..+ ++......|.++.+|+.+.+..+ ++......|.+. +|+.+.+..
T Consensus 195 ~~~~~~~~~~~~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~ 272 (379)
T 4h09_A 195 TGTEFTIPSTVKTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYA 272 (379)
T ss_dssp CCSEEECCTTCCEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECC
T ss_pred cccccccccceeEEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhccccccc
Confidence 0000000111123334444555554433 22122334445555555555433 332333333333 344444432
Q ss_pred CcCcCCCCCCCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEe
Q 041143 296 NLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIIN 375 (973)
Q Consensus 296 N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ 375 (973)
+ +. .++. ..+..+.+|+.+.
T Consensus 273 ~-i~-~i~~----------------------------------------------------------~aF~~c~~L~~i~ 292 (379)
T 4h09_A 273 K-VK-TVPY----------------------------------------------------------LLCSGCSNLTKVV 292 (379)
T ss_dssp C-CS-EECT----------------------------------------------------------TTTTTCTTCCEEE
T ss_pred c-ce-eccc----------------------------------------------------------ccccccccccccc
Confidence 2 11 0000 1244566788888
Q ss_pred cCCCcCCCccchhhhCccccceEEccCCccccccCccccCcCCCCeeeCCCC
Q 041143 376 LPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDN 427 (973)
Q Consensus 376 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N 427 (973)
+.++.+...-...|.++.+|+.+.|..+ ++-.-..+|.++.+|+.+.|..|
T Consensus 293 l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~ 343 (379)
T 4h09_A 293 MDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS 343 (379)
T ss_dssp ECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT
T ss_pred ccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc
Confidence 8888777777778888888888888654 65444567888888888887654
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.52 E-value=1.1e-08 Score=101.97 Aligned_cols=70 Identities=13% Similarity=0.140 Sum_probs=30.9
Q ss_pred cCCCCCccEEEcccC-CCCCccCCCCCcccccccccCeeecccccccC----CcchhccCCCCCCeEEccCCcCc
Q 041143 134 FDGLSSVRVLALDYN-PFNKTFGWSIPDSLANSVQLTNLSLINCNLVG----PLPDFLGTLPSLAALKLSYNRLS 203 (973)
Q Consensus 134 f~~l~~L~~L~Ls~N-~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~Ls~N~l~ 203 (973)
+...++|++|+|++| .|.......+...+...++|++|+|++|+|.. .+...+...++|++|+|++|.|.
T Consensus 32 l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~ 106 (185)
T 1io0_A 32 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 106 (185)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred HhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCC
Confidence 334444555555554 44422111122333344455555555555542 12233344455555555555554
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.49 E-value=1.4e-08 Score=101.20 Aligned_cols=71 Identities=17% Similarity=0.208 Sum_probs=38.1
Q ss_pred CCCCCccEEEcccCCCCCccCCCCCcccccccccCeeecccccccCC----cchhccCCCCCCeEEc--cCCcCccc
Q 041143 135 DGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGP----LPDFLGTLPSLAALKL--SYNRLSGV 205 (973)
Q Consensus 135 ~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L--s~N~l~~~ 205 (973)
...++|++|+|++|+|.......+...+...+.|++|+|++|.|... +...+...++|++|+| ++|.|...
T Consensus 62 ~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~ 138 (185)
T 1io0_A 62 KTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNN 138 (185)
T ss_dssp TTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHH
T ss_pred HhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHH
Confidence 33445555555555554321112333444555666666666666532 3445556666777777 66776643
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=4e-06 Score=89.02 Aligned_cols=134 Identities=16% Similarity=0.181 Sum_probs=96.2
Q ss_pred cccccCcc-EEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeeEEEeCCeEEEEEEecCCC
Q 041143 632 ELGRGGFG-TVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR-HRHLVSLLGYSIEGNERLLVYEYMPHG 708 (973)
Q Consensus 632 ~lG~G~fg-~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~g 708 (973)
.+..|..| .||+.... ++..+.+|+-.. .....+.+|.+.|+.+. +--+.++++++.+.+..++|||+++|.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 34556555 69988765 456788887643 23457889999999884 333667899999999999999999998
Q ss_pred CHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhc----------------------------------------
Q 041143 709 ALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLA---------------------------------------- 748 (973)
Q Consensus 709 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~---------------------------------------- 748 (973)
++.+.... .......++.++++.|..||...
T Consensus 106 ~~~~~~~~---------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 106 TAFQVLEE---------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp EHHHHHHH---------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred cccccccC---------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 88765432 11223446666667777776410
Q ss_pred ---------------cCCeeeccCCCCcEEECCCCCEEEeeccccc
Q 041143 749 ---------------RQTFIHRDLKSSNILLDDDYRAKVSDFGLVK 779 (973)
Q Consensus 749 ---------------~~~ivH~Dikp~Nill~~~~~~kl~DfGla~ 779 (973)
...++|+|+.+.||+++.++.+-|+||+.+.
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1137899999999999988777899998765
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.29 E-value=8.2e-08 Score=100.41 Aligned_cols=104 Identities=17% Similarity=0.190 Sum_probs=80.2
Q ss_pred cccccccce--eeccCcccCCC---CC-CCCCCCccceeeccCCCCCCCCc--cccCCCCCccEEEcccCCCCCccCCCC
Q 041143 87 FNQLTKLYN--LGLQRNKFNGK---LP-TFSGLSELEFAYLDFNEFDTIPS--DFFDGLSSVRVLALDYNPFNKTFGWSI 158 (973)
Q Consensus 87 ~~~l~~L~~--L~L~~N~l~~~---~~-~~~~l~~L~~L~L~~N~l~~i~~--~~f~~l~~L~~L~Ls~N~l~~~~~~~i 158 (973)
|...+.|+. ++++.|..... ++ ...++++|+.|+|++|+|+.++. ..+..+++|+.|+|++|+|++.
T Consensus 137 l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~----- 211 (267)
T 3rw6_A 137 LRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE----- 211 (267)
T ss_dssp GGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG-----
T ss_pred cCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc-----
Confidence 666667776 77888854332 22 22568899999999999998764 5677899999999999999974
Q ss_pred Cccccccc--ccCeeecccccccCCcc-------hhccCCCCCCeEE
Q 041143 159 PDSLANSV--QLTNLSLINCNLVGPLP-------DFLGTLPSLAALK 196 (973)
Q Consensus 159 p~~~~~l~--~L~~L~L~~N~l~~~~p-------~~l~~l~~L~~L~ 196 (973)
..+..+. +|++|+|++|.+.+.+| ..+..+++|+.||
T Consensus 212 -~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 212 -RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp -GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred -hhhhhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 3445555 99999999999997665 3478899999887
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.27 E-value=5.5e-06 Score=89.60 Aligned_cols=136 Identities=18% Similarity=0.184 Sum_probs=91.8
Q ss_pred cCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCC---ceeeeeeEEE-eCCeEEEEEEec
Q 041143 630 ENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHR---HLVSLLGYSI-EGNERLLVYEYM 705 (973)
Q Consensus 630 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lV~e~~ 705 (973)
.+.++.|....||+. |..++||+-. .......+.+|.++|+.+.+. .+.+++.++. ..+..++||||+
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i 95 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV 95 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence 345788888899998 5678888742 334556889999999999753 3556666664 345678999999
Q ss_pred CCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhh--------------------------------------
Q 041143 706 PHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCL-------------------------------------- 747 (973)
Q Consensus 706 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~-------------------------------------- 747 (973)
+|..+..... ..++..++..++.++++.|+.||..
T Consensus 96 ~G~~l~~~~~-------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~ 168 (306)
T 3tdw_A 96 QGQILGEDGM-------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL 168 (306)
T ss_dssp CSEECHHHHH-------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred CCeECchhhh-------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence 9988865321 1123333444444444444444421
Q ss_pred -------------------ccCCeeeccCCCCcEEECC---CCC-EEEeecccccc
Q 041143 748 -------------------ARQTFIHRDLKSSNILLDD---DYR-AKVSDFGLVKL 780 (973)
Q Consensus 748 -------------------~~~~ivH~Dikp~Nill~~---~~~-~kl~DfGla~~ 780 (973)
....++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1345799999999999997 455 48999997763
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.08 E-value=9.2e-05 Score=82.65 Aligned_cols=267 Identities=9% Similarity=0.108 Sum_probs=144.9
Q ss_pred cCcccccccceeeccCcccCCCCC-CCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccc
Q 041143 85 QNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLA 163 (973)
Q Consensus 85 ~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~ 163 (973)
+.+....+|+.+.+.. .++.+.. +|.++.+|+.+.|.. .++.|...+|.+. +|+.+.+..+ ++. +.....
T Consensus 40 ~~~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~-~v~~Ig~~aF~~c-~l~~i~~~~~-l~~-----I~~~aF 110 (379)
T 4h09_A 40 PWYKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAS-TVTSIGDGAFADT-KLQSYTGMER-VKK-----FGDYVF 110 (379)
T ss_dssp TTGGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECT-TCCEECTTTTTTC-CCCEEEECTT-CCE-----ECTTTT
T ss_pred cccccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCC-cceEechhhhcCC-CCceEECCce-eeE-----ecccee
Confidence 4466677888888864 4665555 799999999999974 4888888999887 6777777654 442 343333
Q ss_pred cccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccE
Q 041143 164 NSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQ 243 (973)
Q Consensus 164 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~ 243 (973)
...+|+.+.+.++ ++......|.+. +|+.+.+..+ ++..... +|.++.+|+.
T Consensus 111 ~~~~L~~i~lp~~-~~~i~~~~F~~~-~l~~~~~~~~-v~~i~~~-------------------------~f~~~~~l~~ 162 (379)
T 4h09_A 111 QGTDLDDFEFPGA-TTEIGNYIFYNS-SVKRIVIPKS-VTTIKDG-------------------------IGYKAENLEK 162 (379)
T ss_dssp TTCCCSEEECCTT-CCEECTTTTTTC-CCCEEEECTT-CCEECSC-------------------------TTTTCTTCCE
T ss_pred ccCCcccccCCCc-cccccccccccc-eeeeeeccce-eeccccc-------------------------hhcccccccc
Confidence 3457888888765 332334455544 5666655443 2212222 2334555555
Q ss_pred EEccCCcccc------------CCCccccCCCCCCEEeCcCCcccccCccccccc-ccCeEEccCCcCcCCCCCCCCCCc
Q 041143 244 LWLHGNQFTG------------SIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGPIPKFKAGNV 310 (973)
Q Consensus 244 L~L~~N~l~g------------~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~g~~p~~~~~~~ 310 (973)
+.+..+.... .....+.....+..+.+..+.-. .....+... .|+.+.+..+.-. ++..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~~~~--i~~~----- 234 (379)
T 4h09_A 163 IEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSGVTT--LGDG----- 234 (379)
T ss_dssp EEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTTCCE--ECTT-----
T ss_pred cccccccceeecccceecccccceeccccccccccccccccceeE-EeecccccccccceeeeccceeE--Eccc-----
Confidence 5554433210 11122333334444443322211 112222222 3444444332110 0000
Q ss_pred ccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCCCccchhhh
Q 041143 311 TYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIA 390 (973)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~ 390 (973)
.|.+ ...+..+.++.+ +..+.. ..+....+|+.+.+..+ +.......|.
T Consensus 235 -----~f~~--------------~~~L~~i~lp~~-v~~I~~----------~aF~~~~~l~~i~l~~~-i~~i~~~aF~ 283 (379)
T 4h09_A 235 -----AFYG--------------MKALDEIAIPKN-VTSIGS----------FLLQNCTALKTLNFYAK-VKTVPYLLCS 283 (379)
T ss_dssp -----TTTT--------------CSSCCEEEECTT-CCEECT----------TTTTTCTTCCEEEECCC-CSEECTTTTT
T ss_pred -----cccC--------------CccceEEEcCCC-ccEeCc----------cccceeehhcccccccc-ceeccccccc
Confidence 0000 000111111111 111110 12345567888888654 5555566789
Q ss_pred CccccceEEccCCccccccCccccCcCCCCeeeCCCC
Q 041143 391 NLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDN 427 (973)
Q Consensus 391 ~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N 427 (973)
++.+|+.+.+.+|.++-.-...|.++.+|+.++|..|
T Consensus 284 ~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~ 320 (379)
T 4h09_A 284 GCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA 320 (379)
T ss_dssp TCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT
T ss_pred cccccccccccccccceehhhhhcCCCCCCEEEcCcc
Confidence 9999999999999888666788999999999999754
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.91 E-value=9.9e-05 Score=81.08 Aligned_cols=142 Identities=18% Similarity=0.217 Sum_probs=81.2
Q ss_pred CcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-----CCceeeee-e--EEEeCCeEEEEE
Q 041143 631 NELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR-----HRHLVSLL-G--YSIEGNERLLVY 702 (973)
Q Consensus 631 ~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~-~--~~~~~~~~~lV~ 702 (973)
+.|+.|..+.||+....+| .+++|+.... . ..+..|.++++.+. .|.++... | +....+..++||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~---~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~ 110 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP---E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY 110 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC---H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC---H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence 4466677899999987655 5889987642 2 23344555555542 24433311 1 223466789999
Q ss_pred EecCCCCHH--------------HHHHhhhhcc--C-------CCCCHHHHH----------------------------
Q 041143 703 EYMPHGALS--------------RHLFRWEKLQ--L-------KPLSWTRRL---------------------------- 731 (973)
Q Consensus 703 e~~~~g~L~--------------~~l~~~~~~~--~-------~~l~~~~~~---------------------------- 731 (973)
||++|..+. ..+|.....- . ..-.|....
T Consensus 111 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 190 (346)
T 2q83_A 111 DWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ 190 (346)
T ss_dssp ECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred EeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence 999986542 1223211100 0 012343211
Q ss_pred ---HHHHHHHHHHHHHHh----------hccCCeeeccCCCCcEEECCCCCEEEeeccccc
Q 041143 732 ---SIALDVARGMEYLHC----------LARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK 779 (973)
Q Consensus 732 ---~i~~~ia~gl~~LH~----------~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~ 779 (973)
.+...+.+++++|+. .....++|+|+++.||+++.++.+.|+||+.+.
T Consensus 191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 011223445666653 125789999999999999888899999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.86 E-value=1.1e-05 Score=89.40 Aligned_cols=82 Identities=10% Similarity=0.048 Sum_probs=54.4
Q ss_pred cCcc-cccCccEEEEEEEC-------CCCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcC-C--CceeeeeeEEEeC--
Q 041143 630 ENEL-GRGGFGTVYKGELE-------DGTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKVR-H--RHLVSLLGYSIEG-- 695 (973)
Q Consensus 630 ~~~l-G~G~fg~Vy~~~~~-------~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~-- 695 (973)
.+.| +.|....+|+.... +++.+++|+-..... .......+.+|+++++.+. + -.+.++++++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88889999998764 266788887543210 0001135678888888884 3 3466788877655
Q ss_pred -CeEEEEEEecCCCCHH
Q 041143 696 -NERLLVYEYMPHGALS 711 (973)
Q Consensus 696 -~~~~lV~e~~~~g~L~ 711 (973)
+..++||||++|..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3568999999886543
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.82 E-value=5.6e-05 Score=85.00 Aligned_cols=77 Identities=18% Similarity=0.214 Sum_probs=49.8
Q ss_pred cCcccccCccEEEEEEEC-CCCEEEEEEeecCCC--Ch---HHHHHHHHHHHHHHhcCC--Ccee-eeeeEEEeCCeEEE
Q 041143 630 ENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVT--TT---KALDEFQSEIAVLSKVRH--RHLV-SLLGYSIEGNERLL 700 (973)
Q Consensus 630 ~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~---~~~~~~~~E~~~l~~l~h--~niv-~l~~~~~~~~~~~l 700 (973)
.+.||.|.++.||++... +++.++||....... .. ...+++..|.++++.+.. +..+ +++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457899999999999764 468899998653211 00 112456789999888742 4444 55543 4455689
Q ss_pred EEEecCCC
Q 041143 701 VYEYMPHG 708 (973)
Q Consensus 701 V~e~~~~g 708 (973)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.71 E-value=5.7e-05 Score=85.61 Aligned_cols=77 Identities=18% Similarity=0.220 Sum_probs=49.1
Q ss_pred cCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCcceeccccc--ccCcccccccccCc---CCCchhHHhHHHHHH
Q 041143 749 RQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAG--TFGYLAPEYAVMGK---ITTKADVFSYGVVLM 823 (973)
Q Consensus 749 ~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~---~~~~~Dv~S~Gvvl~ 823 (973)
...++|+|+++.||+++.++ ++|+||+.+......... ....+ ...|.+|+...... -....++......+|
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl--a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI--GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH--HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH--HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 67899999999999999876 999999988754321110 01111 23466766553211 112345667888888
Q ss_pred HHHhC
Q 041143 824 ELLTG 828 (973)
Q Consensus 824 elltg 828 (973)
+.+.+
T Consensus 308 ~~y~~ 312 (420)
T 2pyw_A 308 NLFNK 312 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 88775
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.61 E-value=1.1e-05 Score=79.72 Aligned_cols=69 Identities=22% Similarity=0.262 Sum_probs=33.5
Q ss_pred CCCCccEEEcccC-CCCCccCCCCCcccccccccCeeecccccccC----CcchhccCCCCCCeEEccCCcCcc
Q 041143 136 GLSSVRVLALDYN-PFNKTFGWSIPDSLANSVQLTNLSLINCNLVG----PLPDFLGTLPSLAALKLSYNRLSG 204 (973)
Q Consensus 136 ~l~~L~~L~Ls~N-~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~ 204 (973)
+-+.|++|+|++| +|.......+...+...+.|+.|+|++|+|.. .+...+..-+.|++|+|++|.|..
T Consensus 39 ~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~ 112 (197)
T 1pgv_A 39 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTP 112 (197)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCH
T ss_pred cCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCH
Confidence 3344555555543 44321111233344445556666666666552 233344455566666666666653
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.56 E-value=1.5e-05 Score=78.57 Aligned_cols=68 Identities=13% Similarity=0.065 Sum_probs=42.1
Q ss_pred cCCCCCccEEEcccCCCCCccCCCCCcccccccccCeeecccccccC----CcchhccCCCCCCeEEccCCc
Q 041143 134 FDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVG----PLPDFLGTLPSLAALKLSYNR 201 (973)
Q Consensus 134 f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~Ls~N~ 201 (973)
+..-..|+.|+|++|+|.......+...+...+.|+.|+|++|.|.. .+...+..-+.|++|+|++|.
T Consensus 66 L~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~ 137 (197)
T 1pgv_A 66 ACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQR 137 (197)
T ss_dssp HTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCS
T ss_pred HhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCc
Confidence 44455666666666666544333455566666777777777777763 233455566678888887653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.48 E-value=0.0013 Score=70.65 Aligned_cols=141 Identities=17% Similarity=0.194 Sum_probs=93.1
Q ss_pred ccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcC---CCceeeeeeEEEeCCeEEEEEEec
Q 041143 629 QENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR---HRHLVSLLGYSIEGNERLLVYEYM 705 (973)
Q Consensus 629 ~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV~e~~ 705 (973)
..+.|+.|.+..+|+.... +..++||+.... ....+.+|.+.|+.+. ...+.++++++...+..++||||+
T Consensus 40 ~~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDE-VQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp EEEEECCSSSSEEEEEESS-SCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred eeEEeCCccceeeeEEEEC-CCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence 3467899999999999864 678889986532 2457889999998884 356788898888888899999999
Q ss_pred CCCCHH--------H---HHHhhhh---ccC--------------CCCCHHHHH---HHHH--H--------------HH
Q 041143 706 PHGALS--------R---HLFRWEK---LQL--------------KPLSWTRRL---SIAL--D--------------VA 738 (973)
Q Consensus 706 ~~g~L~--------~---~l~~~~~---~~~--------------~~l~~~~~~---~i~~--~--------------ia 738 (973)
++..+. + .||.... .+. -.-+|.... ++.. + ++
T Consensus 114 ~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~ 193 (312)
T 3jr1_A 114 NKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIV 193 (312)
T ss_dssp CCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHH
T ss_pred cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHH
Confidence 987652 1 2333211 000 012565332 1111 1 11
Q ss_pred HH-HHHHHh-hccCCeeeccCCCCcEEECCCCCEEEeecc
Q 041143 739 RG-MEYLHC-LARQTFIHRDLKSSNILLDDDYRAKVSDFG 776 (973)
Q Consensus 739 ~g-l~~LH~-~~~~~ivH~Dikp~Nill~~~~~~kl~DfG 776 (973)
.. ...|.. ...+.++|+|+.+.|++++.++ +.|.||.
T Consensus 194 ~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 194 QIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 11 123321 1256799999999999999887 8899974
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.42 E-value=7.7e-05 Score=72.13 Aligned_cols=85 Identities=16% Similarity=0.130 Sum_probs=59.0
Q ss_pred ccceeeccCCCCCCCCccccCCCCCccEEEcccCC-CCCccCCCCCcccccc----cccCeeeccccc-ccCCcchhccC
Q 041143 115 ELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNP-FNKTFGWSIPDSLANS----VQLTNLSLINCN-LVGPLPDFLGT 188 (973)
Q Consensus 115 ~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~-l~~~~~~~ip~~~~~l----~~L~~L~L~~N~-l~~~~p~~l~~ 188 (973)
+|+.|||+++.|+...-..+.++++|+.|+|++|. |+.. --..++.+ ++|++|+|++|. |+..--..+..
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~----gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~ 137 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDG----CLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHH 137 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHH----HHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGG
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHH----HHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhc
Confidence 56666666666665555556778888888888874 5542 11233432 469999999984 87655556788
Q ss_pred CCCCCeEEccCCc-Cc
Q 041143 189 LPSLAALKLSYNR-LS 203 (973)
Q Consensus 189 l~~L~~L~Ls~N~-l~ 203 (973)
+++|++|+|+++. ++
T Consensus 138 ~~~L~~L~L~~c~~It 153 (176)
T 3e4g_A 138 FRNLKYLFLSDLPGVK 153 (176)
T ss_dssp CTTCCEEEEESCTTCC
T ss_pred CCCCCEEECCCCCCCC
Confidence 9999999999986 44
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00038 Score=74.28 Aligned_cols=80 Identities=23% Similarity=0.302 Sum_probs=56.8
Q ss_pred cCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCC---ceeeeeeEEEeCCeEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHR---HLVSLLGYSIEGNERLLV 701 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~~~~lV 701 (973)
......+.+|.|..+.||+.+..||+.|.||+-..... .....|.+|.+.|+.+.-. -+.+++++ + ..++|
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv 88 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAP--ALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLA 88 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCC--CCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCc--chhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEE
Confidence 34556678999999999999999999999998654321 1123578899999988421 23445543 2 24799
Q ss_pred EEecCCCCH
Q 041143 702 YEYMPHGAL 710 (973)
Q Consensus 702 ~e~~~~g~L 710 (973)
|||++++..
T Consensus 89 ~e~l~~~~~ 97 (288)
T 3f7w_A 89 MEWVDERPP 97 (288)
T ss_dssp EECCCCCCC
T ss_pred EEeecccCC
Confidence 999987654
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.30 E-value=0.0001 Score=71.22 Aligned_cols=84 Identities=11% Similarity=0.077 Sum_probs=51.6
Q ss_pred cccCeeecccccccCCcchhccCCCCCCeEEccCCc-CcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCC----cc
Q 041143 166 VQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNR-LSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKM----VS 240 (973)
Q Consensus 166 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~-l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l----~~ 240 (973)
-+|+.|||+++.|+..--..+.++++|++|+|++|. ++..-=. .++.+ ++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~-------------------------~L~~~~~~~~~ 115 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLE-------------------------RLSQLENLQKS 115 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHH-------------------------HHHTCHHHHHH
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHH-------------------------HHHhcccccCC
Confidence 356777777776665444556677777777777774 5421111 12222 46
Q ss_pred ccEEEccCCc-cccCCCccccCCCCCCEEeCcCCc
Q 041143 241 LTQLWLHGNQ-FTGSIPEDIGALSSLKDLNLNRNQ 274 (973)
Q Consensus 241 L~~L~L~~N~-l~g~~p~~~~~l~~L~~L~Ls~N~ 274 (973)
|++|+|++|. ||..--..+.++++|++|+|+++.
T Consensus 116 L~~L~Ls~C~~ITD~Gl~~L~~~~~L~~L~L~~c~ 150 (176)
T 3e4g_A 116 MLEMEIISCGNVTDKGIIALHHFRNLKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCTTCCHHHHHHGGGCTTCCEEEEESCT
T ss_pred CCEEEcCCCCcCCHHHHHHHhcCCCCCEEECCCCC
Confidence 7788887763 664444456677778888877764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.27 E-value=0.0012 Score=71.69 Aligned_cols=160 Identities=12% Similarity=0.149 Sum_probs=89.8
Q ss_pred ecHHHHHHHhcCccc-----cCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCc--eee
Q 041143 615 ISVQVLRKVTQNFAQ-----ENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRH--LVS 687 (973)
Q Consensus 615 ~~~~~~~~~~~~~~~-----~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~ 687 (973)
++.+++......|.. .+.|+.|....+|+....+| .+++|+.... ...+.+..|+++++.+.... +.+
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~----~~~~~l~~e~~~l~~L~~~g~~vP~ 81 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR----VEKNDLPFFLGLMQHLAAKGLSCPL 81 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC----CCHHHHHHHHHHHHHHHHCCCCCCc
Confidence 445666666666754 23466788889999987766 5788887542 11234566888877764212 233
Q ss_pred eeeE------EEeCCeEEEEEEecCCCCHHH--------------HHHhhhh-ccCC------CCCHHHHHH--------
Q 041143 688 LLGY------SIEGNERLLVYEYMPHGALSR--------------HLFRWEK-LQLK------PLSWTRRLS-------- 732 (973)
Q Consensus 688 l~~~------~~~~~~~~lV~e~~~~g~L~~--------------~l~~~~~-~~~~------~l~~~~~~~-------- 732 (973)
++.. ....+..++||||++|..+.. .+|.... .... ...|.....
T Consensus 82 ~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~ 161 (322)
T 2ppq_A 82 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 161 (322)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred ccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHh
Confidence 3321 123456789999998854311 1222110 0000 012332111
Q ss_pred ----HHHHHHHHHHHHHhh----ccCCeeeccCCCCcEEECCCCCEEEeeccccc
Q 041143 733 ----IALDVARGMEYLHCL----ARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK 779 (973)
Q Consensus 733 ----i~~~ia~gl~~LH~~----~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~ 779 (973)
+...+.+.+++++.. ....++|+|+++.||+++.+..+.|+||+.+.
T Consensus 162 ~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 162 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 111244456666532 13579999999999999987666899998664
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.19 E-value=0.0012 Score=71.90 Aligned_cols=144 Identities=15% Similarity=0.111 Sum_probs=74.7
Q ss_pred CcccccCccE-EEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-C-CceeeeeeEEEeCCeEEEEEEecCC
Q 041143 631 NELGRGGFGT-VYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR-H-RHLVSLLGYSIEGNERLLVYEYMPH 707 (973)
Q Consensus 631 ~~lG~G~fg~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h-~niv~l~~~~~~~~~~~lV~e~~~~ 707 (973)
+.|+.|+... +|+....+|..+++|...... .+.+..|+++++.+. + -.+.+++.+..+.+ ++|||++.+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~-----~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~ 96 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE-----GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGD 96 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTT-----TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCS
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCC-----CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCC
Confidence 4565565554 667766446777777643321 023456777777664 2 23455666643333 789999977
Q ss_pred CCHHHHHHhhhh------------------c---cCCCCCHHHHH--------------------HHHHHHHHHHHHHHh
Q 041143 708 GALSRHLFRWEK------------------L---QLKPLSWTRRL--------------------SIALDVARGMEYLHC 746 (973)
Q Consensus 708 g~L~~~l~~~~~------------------~---~~~~l~~~~~~--------------------~i~~~ia~gl~~LH~ 746 (973)
..+.+++..... . ....++..... .....+.+.++.+..
T Consensus 97 ~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~ 176 (333)
T 3csv_A 97 ALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILS 176 (333)
T ss_dssp CBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHH
T ss_pred cchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHH
Confidence 777655432100 0 00111111000 000111122233311
Q ss_pred ---hccCCeeeccCCCCcEEECCC----CCEEEeeccccccC
Q 041143 747 ---LARQTFIHRDLKSSNILLDDD----YRAKVSDFGLVKLA 781 (973)
Q Consensus 747 ---~~~~~ivH~Dikp~Nill~~~----~~~kl~DfGla~~~ 781 (973)
.....++|+|+.+.||+++.+ +.+.|+||+.+...
T Consensus 177 ~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 177 AQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred hcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 124579999999999999875 67999999987643
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0065 Score=65.92 Aligned_cols=159 Identities=11% Similarity=0.065 Sum_probs=88.8
Q ss_pred cHHHHHHHhcCccc-----cCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCC--ceeee
Q 041143 616 SVQVLRKVTQNFAQ-----ENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHR--HLVSL 688 (973)
Q Consensus 616 ~~~~~~~~~~~~~~-----~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l 688 (973)
+.+.+..+.+.|.. ...++ |....||+....+|+.+++|+....... .+.+..|..+++.+... .+.++
T Consensus 12 ~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~---~~~~~~E~~~~~~L~~~g~~vp~~ 87 (328)
T 1zyl_A 12 HPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAP 87 (328)
T ss_dssp CHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCC
T ss_pred CHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCCC---HHHHHHHHHHHHHHHHcCCeecce
Confidence 33444444444432 23466 8888999988777878999988643222 24566788888877422 23444
Q ss_pred eeE-----EEeCCeEEEEEEecCCCCHH-----H---------HHHhhhhc----cCCCCCHHHH----HHH--------
Q 041143 689 LGY-----SIEGNERLLVYEYMPHGALS-----R---------HLFRWEKL----QLKPLSWTRR----LSI-------- 733 (973)
Q Consensus 689 ~~~-----~~~~~~~~lV~e~~~~g~L~-----~---------~l~~~~~~----~~~~l~~~~~----~~i-------- 733 (973)
+.. ....+..++||||++|..+. . .+|..... .....++... ..+
T Consensus 88 ~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 167 (328)
T 1zyl_A 88 VAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIP 167 (328)
T ss_dssp CCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSC
T ss_pred eecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCC
Confidence 442 22345668899999875432 1 12221110 0011222211 000
Q ss_pred -------HHHHHHHHHHHHhh----ccCCeeeccCCCCcEEECCCCCEEEeecccccc
Q 041143 734 -------ALDVARGMEYLHCL----ARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKL 780 (973)
Q Consensus 734 -------~~~ia~gl~~LH~~----~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~ 780 (973)
...+.+.++.+... ....++|+|+++.||+++ + .+.|+||+.+..
T Consensus 168 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 168 SGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp TTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 11111223333221 245689999999999999 4 899999987653
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0012 Score=70.74 Aligned_cols=71 Identities=11% Similarity=0.133 Sum_probs=44.1
Q ss_pred cCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCce-eeeeeEEEeCCeEEEEEEec-CC
Q 041143 630 ENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHL-VSLLGYSIEGNERLLVYEYM-PH 707 (973)
Q Consensus 630 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~~-~~ 707 (973)
.+.|+.|....+|+. +.+++|+-.... .......+|+.+++.+....+ .+++++ +.+.-++|+||+ ++
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g 92 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGT---EEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGA 92 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCc---cceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCC
Confidence 567888999999998 458888765321 111123568888877743233 355544 344457899999 65
Q ss_pred CCH
Q 041143 708 GAL 710 (973)
Q Consensus 708 g~L 710 (973)
.++
T Consensus 93 ~~l 95 (301)
T 3dxq_A 93 QTM 95 (301)
T ss_dssp EEC
T ss_pred ccC
Confidence 444
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.97 E-value=0.00092 Score=61.55 Aligned_cols=37 Identities=24% Similarity=0.438 Sum_probs=31.7
Q ss_pred ccceeeccCCCCCCCCccccCCCCCccEEEcccCCCC
Q 041143 115 ELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFN 151 (973)
Q Consensus 115 ~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~ 151 (973)
+|++|+|++|+|+.|+.++|..+++|++|+|++|.+.
T Consensus 32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 5788888888888888888888999999999998775
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.61 E-value=0.0059 Score=67.33 Aligned_cols=142 Identities=18% Similarity=0.191 Sum_probs=80.7
Q ss_pred CcccccCccEEEEEEEC--------CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeeEEEeCCeEEEE
Q 041143 631 NELGRGGFGTVYKGELE--------DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR-HRHLVSLLGYSIEGNERLLV 701 (973)
Q Consensus 631 ~~lG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV 701 (973)
+.|..|-...+|++... +++.+.+|+-... ......+.+|.++++.+. +.-..++++++.+ .+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~---~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v 128 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI---LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL 128 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc---cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence 45666888889999875 2478888875221 112345668999998884 3333566666543 299
Q ss_pred EEecCCCCHHH--------------H---HHhhhhccCCCCC--HHHHHHHHHHHH-------------------HHHHH
Q 041143 702 YEYMPHGALSR--------------H---LFRWEKLQLKPLS--WTRRLSIALDVA-------------------RGMEY 743 (973)
Q Consensus 702 ~e~~~~g~L~~--------------~---l~~~~~~~~~~l~--~~~~~~i~~~ia-------------------~gl~~ 743 (973)
|||++|..|.. . ||.....-.+... |.+..++..++. +.+..
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 99998855421 1 1211110011222 344444443332 12333
Q ss_pred HHhh-----ccCCeeeccCCCCcEEECCC----CCEEEeeccccc
Q 041143 744 LHCL-----ARQTFIHRDLKSSNILLDDD----YRAKVSDFGLVK 779 (973)
Q Consensus 744 LH~~-----~~~~ivH~Dikp~Nill~~~----~~~kl~DfGla~ 779 (973)
|... ....++|+|+.+.||+++.+ +.+.|+||..+.
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 3321 13468999999999999876 789999998765
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.55 E-value=0.0028 Score=58.28 Aligned_cols=38 Identities=32% Similarity=0.391 Sum_probs=31.8
Q ss_pred ccCeeecccccccCCcchhccCCCCCCeEEccCCcCcc
Q 041143 167 QLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSG 204 (973)
Q Consensus 167 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 204 (973)
+|+.|+|++|+|+...+..|..+++|+.|+|++|.+.-
T Consensus 32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~C 69 (130)
T 3rfe_A 32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRC 69 (130)
T ss_dssp TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBC
T ss_pred CCCEEECCCCcCCccChhhhhhccccCEEEecCCCeec
Confidence 57888888888887777788889999999999998863
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.39 E-value=0.014 Score=65.72 Aligned_cols=73 Identities=19% Similarity=0.253 Sum_probs=48.9
Q ss_pred cCcccccCccEEEEEEECC--------CCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCce-eeeeeEEEeCCeEEE
Q 041143 630 ENELGRGGFGTVYKGELED--------GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHL-VSLLGYSIEGNERLL 700 (973)
Q Consensus 630 ~~~lG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~l 700 (973)
.+.|+.|....||++...+ ++.+.+|+.... .. .+.+.+|..+++.+...++ .++++.+.+ .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~ 149 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 149 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence 4567888889999998753 578888887431 11 1345579999888853333 566665432 38
Q ss_pred EEEecCCCCH
Q 041143 701 VYEYMPHGAL 710 (973)
Q Consensus 701 V~e~~~~g~L 710 (973)
||||++|.++
T Consensus 150 v~e~l~G~~l 159 (429)
T 1nw1_A 150 LEEYIPSRPL 159 (429)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeCCccc
Confidence 9999986343
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.35 E-value=0.0042 Score=68.74 Aligned_cols=73 Identities=15% Similarity=0.143 Sum_probs=43.4
Q ss_pred CcccccCccEEEEEEECC---------CCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCc-eeeeeeEEEeCCeEEE
Q 041143 631 NELGRGGFGTVYKGELED---------GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRH-LVSLLGYSIEGNERLL 700 (973)
Q Consensus 631 ~~lG~G~fg~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~l 700 (973)
+.|+.|..-.+|+....+ ++.+++|+.... .........|.++++.+.... ..++++.. . -++
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~---~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~ 111 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKH---VDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGR 111 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTT---GGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCC---ccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcE
Confidence 457778888999998764 267888876432 111112367888888875333 33666543 2 268
Q ss_pred EEEecCCCCH
Q 041143 701 VYEYMPHGAL 710 (973)
Q Consensus 701 V~e~~~~g~L 710 (973)
||||++|..+
T Consensus 112 v~e~i~G~~l 121 (369)
T 3c5i_A 112 IEEWLYGDPL 121 (369)
T ss_dssp EEECCCSEEC
T ss_pred EEEEecCCcC
Confidence 9999987543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.26 E-value=0.014 Score=66.13 Aligned_cols=74 Identities=12% Similarity=0.056 Sum_probs=47.1
Q ss_pred cCcccccCccEEEEEEECC-CCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCce-eeeeeEEEeCCeEEEEEEecCC
Q 041143 630 ENELGRGGFGTVYKGELED-GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHL-VSLLGYSIEGNERLLVYEYMPH 707 (973)
Q Consensus 630 ~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~~~~ 707 (973)
.+.|+.|-...+|++...+ +..+.+|+....... .-...+|..+++.+...++ .++++++. + .+||||++|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~---~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G 185 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE---IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDG 185 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS---CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCS
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh---hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCC
Confidence 3567888889999998875 477888876432111 0112579999999865445 46676652 2 259999987
Q ss_pred CCH
Q 041143 708 GAL 710 (973)
Q Consensus 708 g~L 710 (973)
..|
T Consensus 186 ~~l 188 (458)
T 2qg7_A 186 YAL 188 (458)
T ss_dssp EEC
T ss_pred ccC
Confidence 444
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.03 E-value=0.057 Score=58.70 Aligned_cols=67 Identities=6% Similarity=0.089 Sum_probs=43.4
Q ss_pred ccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcC---CCceeeeeeE------EEeCCeEEEEEEec
Q 041143 635 RGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR---HRHLVSLLGY------SIEGNERLLVYEYM 705 (973)
Q Consensus 635 ~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~------~~~~~~~~lV~e~~ 705 (973)
.|....||+....+| .+++|+...... ..|+++++.+. -+.+.+.+.. ....+..++||||+
T Consensus 33 ~g~~N~vy~v~~~~g-~~vLK~~~~~~~--------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i 103 (339)
T 3i1a_A 33 ADTNAFAYQADSESK-SYFIKLKYGYHD--------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFI 103 (339)
T ss_dssp SCSSCEEEEEECSSC-EEEEEEEECSSC--------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECC
T ss_pred CccccceEEEEeCCC-CEEEEEecCccc--------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEecc
Confidence 333679999988777 899998765421 34666666552 2224444432 23356779999999
Q ss_pred CCCCH
Q 041143 706 PHGAL 710 (973)
Q Consensus 706 ~~g~L 710 (973)
+|..+
T Consensus 104 ~G~~~ 108 (339)
T 3i1a_A 104 HAPNG 108 (339)
T ss_dssp CCCBT
T ss_pred CCCcC
Confidence 98765
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.46 E-value=0.15 Score=50.45 Aligned_cols=104 Identities=13% Similarity=0.088 Sum_probs=66.7
Q ss_pred CCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCc
Q 041143 707 HGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEK 786 (973)
Q Consensus 707 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~ 786 (973)
.-+|.+.|..+ ..++++.+++.++.|.+++|.-+-. +..-..+=+-|..|++..+|.|.+.+ +.+.
T Consensus 32 ~vSL~eIL~~~----~~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------- 97 (229)
T 2yle_A 32 ALSLEEILRLY----NQPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------- 97 (229)
T ss_dssp EEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C----------
T ss_pred cccHHHHHHHc----CCCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc-------
Confidence 34799999763 3789999999999999999877621 11111333457899999999988764 1111
Q ss_pred ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCC
Q 041143 787 SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAA 831 (973)
Q Consensus 787 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p 831 (973)
.....+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus 98 ------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ---------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0123466888653 3456788999999999998864333
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.04 E-value=0.13 Score=57.50 Aligned_cols=74 Identities=8% Similarity=0.064 Sum_probs=47.1
Q ss_pred cCcccccCccEEEEEEECC--------CCEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeeEEEeCCeEEE
Q 041143 630 ENELGRGGFGTVYKGELED--------GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR-HRHLVSLLGYSIEGNERLL 700 (973)
Q Consensus 630 ~~~lG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 700 (973)
.+.+..|-...+|+....+ ++.+.+|+.... . ...-+..+|.++++.+. +.-..++++.+ . -++
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~--t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~ 147 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKH--V-GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGR 147 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCC--C--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCC--c-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCE
Confidence 3567778888999998763 578888875332 1 11112357888888874 32234555433 2 278
Q ss_pred EEEecCCCCH
Q 041143 701 VYEYMPHGAL 710 (973)
Q Consensus 701 V~e~~~~g~L 710 (973)
||||++|..|
T Consensus 148 I~efI~G~~l 157 (424)
T 3mes_A 148 IEEFIDGEPL 157 (424)
T ss_dssp EEECCCSEEC
T ss_pred EEEEeCCccC
Confidence 9999998653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=87.77 E-value=1.6 Score=48.28 Aligned_cols=28 Identities=32% Similarity=0.541 Sum_probs=24.1
Q ss_pred eeeccCCCCcEEE------CCCCCEEEeeccccc
Q 041143 752 FIHRDLKSSNILL------DDDYRAKVSDFGLVK 779 (973)
Q Consensus 752 ivH~Dikp~Nill------~~~~~~kl~DfGla~ 779 (973)
++|+|+.+.||++ +++..++++||.+|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 5799999999999 456789999998775
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=86.29 E-value=0.1 Score=59.17 Aligned_cols=63 Identities=6% Similarity=0.096 Sum_probs=18.3
Q ss_pred ccCcccccCccEEEEEEECC-CCEEEE------EEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEe
Q 041143 629 QENELGRGGFGTVYKGELED-GTKIAV------KRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIE 694 (973)
Q Consensus 629 ~~~~lG~G~fg~Vy~~~~~~-g~~vav------K~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 694 (973)
..+.|| ||.||+|.+.. ..+||| |..+......+....|.+|..+++..+|||+++.+++...
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 345666 99999998764 367888 7776544444555678899999999999999999887653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 973 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-68 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-65 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-64 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-62 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-60 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-60 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-60 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-60 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-60 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-60 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-59 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-59 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-58 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-58 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-58 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-58 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-57 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-57 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-56 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-56 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-56 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-55 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-54 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-54 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-54 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-53 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-53 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-52 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-52 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-51 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-50 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-49 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-49 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-47 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-47 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-47 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-46 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-45 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-45 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-44 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-44 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-44 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-43 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-43 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-42 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-42 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-41 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-40 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-40 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-39 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 9e-39 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-36 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-35 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-28 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-25 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-16 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-11 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-22 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 7e-12 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-15 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-05 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-06 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 9e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 9e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.003 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-06 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 6e-06 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 9e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 2e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.001 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.004 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (582), Expect = 1e-68
Identities = 75/287 (26%), Positives = 126/287 (43%), Gaps = 27/287 (9%)
Query: 626 NFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHL 685
+G G FGTVYKG+ +AVK + T + L F++E+ VL K RH ++
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 66
Query: 686 VSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLH 745
+ +GYS + +V ++ +L HL E + + IA A+GM+YLH
Sbjct: 67 LLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIET----KFEMIKLIDIARQTAQGMDYLH 121
Query: 746 CLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKS-VVTRLAGTFGYLAPEYA 804
++ IHRDLKS+NI L +D K+ DFGL + S +L+G+ ++APE
Sbjct: 122 A---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 805 VM---GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861
M + ++DV+++G+VL EL+TG + P + + +
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTG------QLPYSNINNRDQIIFMVGRGYLSPDLS 232
Query: 862 DPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908
+ + L C ++ RP ++ + L
Sbjct: 233 KVRSNCPKA-------MKRLMAECLKKKRDERPLFPQILASIELLAR 272
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (558), Expect = 1e-65
Identities = 78/283 (27%), Positives = 126/283 (44%), Gaps = 27/283 (9%)
Query: 626 NFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHL 685
E+G G FG V+ G + K+A+K + G + + +F E V+ K+ H L
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKL 62
Query: 686 VSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLH 745
V L G +E LV+E+M HG LS +L L + L + LDV GM YL
Sbjct: 63 VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF----AAETLLGMCLDVCEGMAYLE 118
Query: 746 CLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAV 805
IHRDL + N L+ ++ KVSDFG+ + D + + T + +PE
Sbjct: 119 E---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 175
Query: 806 MGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPAL 865
+ ++K+DV+S+GV++ E+ + + P E+R +E I + + P L
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSE-----GKIPYENRSNSEVVEDISTGFRLY----KPRL 226
Query: 866 EVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908
V ++ HC P RP ++ L+ + E
Sbjct: 227 ASTH--------VYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 2e-64
Identities = 73/282 (25%), Positives = 124/282 (43%), Gaps = 27/282 (9%)
Query: 625 QNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRH 684
+ LG G FG V+ G TK+AVK ++ G + + D F +E ++ +++H+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQR 69
Query: 685 LVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYL 744
LV L + ++ EYM +G+L L L+ + L +A +A GM ++
Sbjct: 70 LVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFI 125
Query: 745 HCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYA 804
+ +IHRDL+++NIL+ D K++DFGL +L D E + + APE
Sbjct: 126 E---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 182
Query: 805 VMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPA 864
G T K+DV+S+G++L E++T P E ++ +
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTH-----GRIPYPGMTNPEVIQNLERGYRMVRPD---- 233
Query: 865 LEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPL 906
EE + +L C P RP ++ +VL
Sbjct: 234 -NCPEE-------LYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 4e-62
Identities = 69/279 (24%), Positives = 117/279 (41%), Gaps = 27/279 (9%)
Query: 625 QNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRH 684
++ ELG G FG V G+ +A+K ++ G + + DEF E V+ + H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG---SMSEDEFIEEAKVMMNLSHEK 60
Query: 685 LVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYL 744
LV L G + ++ EYM +G L +L + L + DV MEYL
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH----RFQTQQLLEMCKDVCEAMEYL 116
Query: 745 HCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYA 804
+ F+HRDL + N L++D KVSDFGL + D E + + PE
Sbjct: 117 ES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL 173
Query: 805 VMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPA 864
+ K ++K+D++++GV++ E+ + + P E +E I + P
Sbjct: 174 MYSKFSSKSDIWAFGVLMWEIYSL-----GKMPYERFTNSETAEHIAQGLRLY----RPH 224
Query: 865 LEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVL 903
L + V + C + RP +++ +
Sbjct: 225 LASEK--------VYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 1e-60
Identities = 63/301 (20%), Positives = 123/301 (40%), Gaps = 33/301 (10%)
Query: 630 ENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLL 689
+ +G+G FG V++G+ G ++AVK + + ++EI +RH +++ +
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFI 63
Query: 690 GYSIEGN----ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLH 745
+ N + LV +Y HG+L +L R ++ + +AL A G+ +LH
Sbjct: 64 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLH 117
Query: 746 -----CLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSV---VTRLAGTFG 797
+ HRDLKS NIL+ + ++D GL ++ GT
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177
Query: 798 YLAPEY------AVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIK 851
Y+APE + +AD+++ G+V E+ ++ + +
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR-CSIGGIHEDYQLPYYDLVPSDP 236
Query: 852 SSKEKFKA----AIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLV 907
S +E K + P + ++ E++ ++A++ C R + LS L
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296
Query: 908 E 908
+
Sbjct: 297 Q 297
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 1e-60
Identities = 80/281 (28%), Positives = 124/281 (44%), Gaps = 35/281 (12%)
Query: 625 QNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRH 684
+ +G+G FG V G+ G K+AVK ++ F +E +V++++RH +
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIK----NDATAQAFLAEASVMTQLRHSN 61
Query: 685 LVSLLGYSIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEY 743
LV LLG +E L +V EYM G+L +L + L L +LDV MEY
Sbjct: 62 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEY 118
Query: 744 LHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEY 803
L F+HRDL + N+L+ +D AKVSDFGL K A + + + APE
Sbjct: 119 LE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK----LPVKWTAPEA 171
Query: 804 AVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSS-KEKFKAAID 862
K +TK+DV+S+G++L E+ + P L + R++ K
Sbjct: 172 LREKKFSTKSDVWSFGILLWEIYSF-----GRVPYPRIPLKDVVPRVEKGYKMDAPDGCP 226
Query: 863 PALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVL 903
PA+ E+ +C + RP + L
Sbjct: 227 PAV-------------YEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 1e-60
Identities = 80/288 (27%), Positives = 130/288 (45%), Gaps = 27/288 (9%)
Query: 625 QNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRH 684
++ E +LG+G FG V+ G T++A+K ++ G T + + F E V+ K+RH
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG---TMSPEAFLQEAQVMKKLRHEK 73
Query: 685 LVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYL 744
LV L + +V EYM G+L L K L + + +A +A GM Y+
Sbjct: 74 LVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYV 129
Query: 745 HCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYA 804
++HRDL+++NIL+ ++ KV+DFGL +L D E + + APE A
Sbjct: 130 ER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 186
Query: 805 VMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPA 864
+ G+ T K+DV+S+G++L EL T P E +++
Sbjct: 187 LYGRFTIKSDVWSFGILLTELTTK-----GRVPYPGMVNREVLDQVERGYR--------- 232
Query: 865 LEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRP 912
+ E ES + +L C +EP RP ++ L P
Sbjct: 233 MPCPPECPES---LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 1e-60
Identities = 89/320 (27%), Positives = 143/320 (44%), Gaps = 42/320 (13%)
Query: 626 NFAQENELGRGGFGTVYKGELEDG---TKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-R 681
+ ++ +G G FG V K ++ A+KRM+ + +F E+ VL K+
Sbjct: 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGH 69
Query: 682 HRHLVSLLGYSIEGNERLLVYEYMPHGALSRHL-----------FRWEKLQLKPLSWTRR 730
H ++++LLG L EY PHG L L F LS +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 731 LSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVT 790
L A DVARGM+YL ++ FIHRDL + NIL+ ++Y AK++DFGL + K +
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 186
Query: 791 RLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRI 850
R ++A E TT +DV+SYGV+L E+++ P AE + ++
Sbjct: 187 R--LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL-----GGTPYCGMTCAELYEKL 239
Query: 851 KSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKW 910
++ L ++E V +L C +PY RP ++ L+ ++E+
Sbjct: 240 PQGYR-----LEKPLNCDDE-------VYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287
Query: 911 RPITD----ESECCSGIDYS 926
+ + E +GID S
Sbjct: 288 KTYVNTTLYEKFTYAGIDCS 307
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 206 bits (525), Expect = 2e-60
Identities = 72/306 (23%), Positives = 132/306 (43%), Gaps = 42/306 (13%)
Query: 620 LRKVTQNFAQE---------NELGRGGFGTVYKGEL----EDGTKIAVKRMEAGVTTTKA 666
+ + FA+E +G G FG V G L + +A+K +++G T K
Sbjct: 12 PNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE-KQ 70
Query: 667 LDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLS 726
+F SE +++ + H +++ L G + +++ E+M +G L + + +
Sbjct: 71 RRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENG----SLDSFLRQNDGQFT 126
Query: 727 WTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEK 786
+ + + +A GM+YL ++HRDL + NIL++ + KVSDFGL + D
Sbjct: 127 VIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 787 SVVTRLA----GTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRY 842
A + APE K T+ +DV+SYG+V+ E+++ ERP
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSY-----GERPYWDMT 238
Query: 843 LAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNV 902
+ I+ + P ++ + +L C ++ HRP G +VN
Sbjct: 239 NQDVINAIEQDYR-----LPPPMDCPSA-------LHQLMLDCWQKDRNHRPKFGQIVNT 286
Query: 903 LSPLVE 908
L ++
Sbjct: 287 LDKMIR 292
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 2e-60
Identities = 69/296 (23%), Positives = 123/296 (41%), Gaps = 36/296 (12%)
Query: 629 QENELGRGGFGTVYKGELED---GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHL 685
++ ELG G FGTV KG + +AVK ++ DE +E V+ ++ + ++
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 686 VSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLH 745
V ++G E +LV E G L+++L + + + + + V+ GM+YL
Sbjct: 71 VRMIGI-CEAESWMLVMEMAELGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLE 124
Query: 746 CLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTR--LAGTFGYLAPEY 803
F+HRDL + N+LL + AK+SDFGL K E + + APE
Sbjct: 125 E---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 181
Query: 804 AVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKE-KFKAAID 862
K ++K+DV+S+GV++ E + ++P +E ++ + A
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFS-----YGQKPYRGMKGSEVTAMLEKGERMGCPAGCP 236
Query: 863 PALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPITDESE 918
+ +L C + +RP V L + + +E
Sbjct: 237 REM-------------YDLMNLCWTYDVENRPGFAAVELRLRNY---YYDVVNEGH 276
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 2e-59
Identities = 70/279 (25%), Positives = 112/279 (40%), Gaps = 32/279 (11%)
Query: 625 QNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRM-EAGVTTTKALDEFQSEIAVLSKVRH 682
++F LG+G FG VY + +A+K + +A + + + E+ + S +RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 683 RHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGME 742
+++ L GY + L+ EY P G + R L + R + ++A +
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-----SKFDEQRTATYITELANALS 120
Query: 743 YLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPE 802
Y H + IHRD+K N+LL K++DFG AP + T L GT YL PE
Sbjct: 121 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDYLPPE 174
Query: 803 YAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862
K D++S GV+ E L G + P E+ E + RI + F +
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVG------KPPFEANTYQETYKRISRVEFTFPDFVT 228
Query: 863 PALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901
+L P RP + V+
Sbjct: 229 EGA-------------RDLISRLLKHNPSQRPMLREVLE 254
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 7e-59
Identities = 70/279 (25%), Positives = 120/279 (43%), Gaps = 31/279 (11%)
Query: 630 ENELGRGGFGTVYKGEL---EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLV 686
+ ELG G FG+V +G + +A+K ++ G T +E E ++ ++ + ++V
Sbjct: 14 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIV 72
Query: 687 SLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHC 746
L+G + +LV E G L + L + + + + V+ GM+YL
Sbjct: 73 RLIGV-CQAEALMLVMEMAGGGPLHKFLVGKRE----EIPVSNVAELLHQVSMGMKYLEE 127
Query: 747 LARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLA--GTFGYLAPEYA 804
+ F+HRDL + N+LL + + AK+SDFGL K + R A + APE
Sbjct: 128 ---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 184
Query: 805 VMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPA 864
K ++++DV+SYGV + E L+ ++P + E I+ K
Sbjct: 185 NFRKFSSRSDVWSYGVTMWEALSY-----GQKPYKKMKGPEVMAFIEQGKR--------- 230
Query: 865 LEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVL 903
+E E + L C + RPD V +
Sbjct: 231 MECPPECPPE---LYALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 201 bits (511), Expect = 1e-58
Identities = 76/309 (24%), Positives = 126/309 (40%), Gaps = 47/309 (15%)
Query: 626 NFAQENELGRGGFGTVYKGEL------EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSK 679
N ++G G FG V++ E T +AVK ++ + +FQ E A++++
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAE 72
Query: 680 VRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLF-------------------RWEKL 720
+ ++V LLG G L++EYM +G L+ L R
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 721 QLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKL 780
PLS +L IA VA GM YL + F+HRDL + N L+ ++ K++DFGL +
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 781 APDGEKSVV-TRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEE 839
+ A ++ PE + TT++DV++YGVVL E+ + +P
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY-----GLQPYY 244
Query: 840 SRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHV 899
E + ++ L E + L C ++ P RP +
Sbjct: 245 GMAHEEVIYYVRDGNI---------LACPENCPLE---LYNLMRLCWSKLPADRPSFCSI 292
Query: 900 VNVLSPLVE 908
+L + E
Sbjct: 293 HRILQRMCE 301
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 200 bits (509), Expect = 2e-58
Identities = 78/294 (26%), Positives = 135/294 (45%), Gaps = 28/294 (9%)
Query: 626 NFAQENELGRGGFGTVYKGELED-GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRH 684
+ +++LG G +G VY+G + +AVK ++ T ++EF E AV+ +++H +
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPN 74
Query: 685 LVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYL 744
LV LLG ++ E+M +G L +L + + +S L +A ++ MEYL
Sbjct: 75 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYL 131
Query: 745 HCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYA 804
++ FIHRDL + N L+ +++ KV+DFGL +L + + APE
Sbjct: 132 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 188
Query: 805 VMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPA 864
K + K+DV+++GV+L E+ T P L++ + ++ D
Sbjct: 189 AYNKFSIKSDVWAFGVLLWEIATY-----GMSPYPGIDLSQVYELLEK---------DYR 234
Query: 865 LEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPITDESE 918
+E E E V EL C P RP + + ++ I+DE E
Sbjct: 235 MERPEGCPEK---VYELMRACWQWNPSDRPSFAEIHQAFETMFQE-SSISDEVE 284
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 3e-58
Identities = 57/291 (19%), Positives = 110/291 (37%), Gaps = 12/291 (4%)
Query: 620 LRKVTQNFAQENELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLS 678
+ +F + +ELG G G V+K G +A K + + ++ E+ VL
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLH 59
Query: 679 KVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVA 738
+ ++V G E + E+M G+L + L + + +++ V
Sbjct: 60 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVI 114
Query: 739 RGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGY 798
+G+ YL + +HRD+K SNIL++ K+ DFG+ D S+ GT Y
Sbjct: 115 KGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRSY 169
Query: 799 LAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFK 858
++PE + ++D++S G+ L+E+ G + +E + +++ +
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 229
Query: 859 AAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909
+ + EP + G V K
Sbjct: 230 PRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNK 280
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 6e-58
Identities = 69/281 (24%), Positives = 116/281 (41%), Gaps = 38/281 (13%)
Query: 630 ENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSL 688
+ E+GRG F TVYKG E ++A ++ T F+ E +L ++H ++V
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 689 LGY---SIEGNERL-LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYL 744
+++G + + LV E M G L +L R+ K + S + +G+++L
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFL 128
Query: 745 HCLARQTFIHRDLKSSNILLDD-DYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEY 803
H IHRDLK NI + K+ D GL L S + GT ++APE
Sbjct: 129 HTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA---SFAKAVIGTPEFMAPEM 184
Query: 804 AVMGKITTKADVFSYGVVLMELLTGLAALDEERP-EESRYLAEWFWRIKSSK--EKFKAA 860
K DV+++G+ ++E+ T E P E + A+ + R+ S F
Sbjct: 185 -YEEKYDESVDVYAFGMCMLEMATS------EYPYSECQNAAQIYRRVTSGVKPASFDKV 237
Query: 861 IDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901
P + E+ C + R + ++N
Sbjct: 238 AIPEV-------------KEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 2e-57
Identities = 75/297 (25%), Positives = 125/297 (42%), Gaps = 35/297 (11%)
Query: 622 KVTQNFAQENELGRGGFGTVYKGELED----GTKIAVKRMEAGVTTTKALDEFQSEIAVL 677
+ +F +GRG FG VY G L D AVK + +T + +F +E ++
Sbjct: 26 SLIVHF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIM 82
Query: 678 SKVRHRHLVSLLGYSIEG-NERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALD 736
H +++SLLG + L+V YM HG L + + + + + L
Sbjct: 83 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHG----DLRNFIRNETHNPTVKDLIGFGLQ 138
Query: 737 VARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGE---KSVVTRLA 793
VA+GM++L + F+HRDL + N +LD+ + KV+DFGL + D E T
Sbjct: 139 VAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 195
Query: 794 GTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSS 853
++A E K TTK+DV+S+GV+L EL+T P + +
Sbjct: 196 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR-----GAPPYPDVNTFDITVYLLQG 250
Query: 854 KEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKW 910
+ P + + E+ C + RP +V+ +S + +
Sbjct: 251 RRLL----QPEYCPDP--------LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 196 bits (500), Expect = 7e-57
Identities = 67/300 (22%), Positives = 113/300 (37%), Gaps = 37/300 (12%)
Query: 624 TQNFAQENELGRGGFGTVYKGE-LEDGTKIAVKRME-AGVTTTKALDEFQSEIAVLSKVR 681
+ F+ E+G G FG VY + + +A+K+M +G + + + E+ L K+R
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 682 HRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGM 741
H + + G + + LV EY A KPL ++ +G+
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-----KPLQEVEIAAVTHGALQGL 128
Query: 742 EYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAP 801
YLH IHRD+K+ NILL + K+ DFG + GT ++AP
Sbjct: 129 AYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----NSFVGTPYWMAP 180
Query: 802 EYAV---MGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFK 858
E + G+ K DV+S G+ +EL + P + + I ++
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAER------KPPLFNMNAMSALYHIAQNESPA- 233
Query: 859 AAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPITDESE 918
+ +E C + P RP ++ V + RP T +
Sbjct: 234 ---LQSGHWSEY-------FRNFVDSCLQKIPQDRPTSEVLLK--HRFVLRERPPTVIMD 281
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 1e-56
Identities = 75/291 (25%), Positives = 131/291 (45%), Gaps = 32/291 (10%)
Query: 625 QNFAQENELGRGGFGTVYKGELEDGT-----KIAVKRMEAGVTTTKALDEFQSEIAVLSK 679
++ +G G FG VYKG L+ + +A+K ++AG T K +F E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQ 65
Query: 680 VRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVAR 739
H +++ L G + +++ EYM +GAL + L + S + + + +A
Sbjct: 66 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG----EFSVLQLVGMLRGIAA 121
Query: 740 GMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLA--GTFG 797
GM+YL ++HRDL + NIL++ + KVSDFGL ++ D ++ T
Sbjct: 122 GMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 798 YLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKF 857
+ APE K T+ +DV+S+G+V+ E++T ERP E I
Sbjct: 179 WTAPEAISYRKFTSASDVWSFGIVMWEVMTY-----GERPYWELSNHEVMKAINDGFR-- 231
Query: 858 KAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908
L + + + +L C +E RP +V++L L+
Sbjct: 232 -------LPTPMDCPSA---IYQLMMQCWQQERARRPKFADIVSILDKLIR 272
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 1e-56
Identities = 62/282 (21%), Positives = 107/282 (37%), Gaps = 27/282 (9%)
Query: 626 NFAQENELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRH 684
++ +G G +G K DG + K ++ G T SE+ +L +++H +
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 685 LVSLLGYSIEGNERLL--VYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGME 742
+V I+ L V EY G L+ + + K + + L L + + ++
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALK 123
Query: 743 YLH--CLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLA 800
H T +HRDLK +N+ LD K+ DFGL ++ S GT Y++
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT-SFAKAFVGTPYYMS 182
Query: 801 PEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSK-EKFKA 859
PE K+D++S G +L EL P + E +I+ K +
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCAL------MPPFTAFSQKELAGKIREGKFRRIPY 236
Query: 860 AIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901
L E+ + YHRP + ++
Sbjct: 237 RYSDEL-------------NEIITRMLNLKDYHRPSVEEILE 265
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 3e-56
Identities = 71/304 (23%), Positives = 122/304 (40%), Gaps = 46/304 (15%)
Query: 626 NFAQENELGRGGFGTVYKGELED------GTKIAVKRMEAGVTTTKALDEFQSEIAVLSK 679
N LG G FG V ++AVK ++ + + SE+ ++++
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK-ADSSEREALMSELKMMTQ 96
Query: 680 V-RHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFR------------------WEKL 720
+ H ++V+LLG L++EY +G L +L E+
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 721 QLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKL 780
L L++ L A VA+GME+L ++ +HRDL + N+L+ K+ DFGL +
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 781 APDGEKSVV-TRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEE 839
VV ++APE G T K+DV+SYG++L E+ + P
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL-----GVNPYP 268
Query: 840 SRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHV 899
+ F+++ + K D EE + + C A + RP ++
Sbjct: 269 GIPVDANFYKLIQNGFKM----DQPFYATEE-------IYIIMQSCWAFDSRKRPSFPNL 317
Query: 900 VNVL 903
+ L
Sbjct: 318 TSFL 321
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 3e-55
Identities = 63/280 (22%), Positives = 102/280 (36%), Gaps = 28/280 (10%)
Query: 625 QNFAQENELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHR 683
+++ LG G +G V +AVK ++ + + EI + + H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNHE 63
Query: 684 HLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEY 743
++V G+ EGN + L EY G L + + + G+ Y
Sbjct: 64 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVY 118
Query: 744 LHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK-LAPDGEKSVVTRLAGTFGYLAPE 802
LH HRD+K N+LLD+ K+SDFGL + + ++ ++ GT Y+APE
Sbjct: 119 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175
Query: 803 YAVMGKI-TTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861
+ DV+S G+VL +L G D+ Y W+ K + I
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---WKEKKTYLNPWKKI 232
Query: 862 DPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901
D A L P R + +
Sbjct: 233 DSAPL-------------ALLHKILVENPSARITIPDIKK 259
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (482), Expect = 1e-54
Identities = 72/301 (23%), Positives = 119/301 (39%), Gaps = 41/301 (13%)
Query: 630 ENELGRGGFGTVYKGEL------EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RH 682
LG G FG V + + +AVK ++ + SE+ VLS + H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNH 86
Query: 683 RHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQL-------------KPLSWTR 729
++V+LLG G L++ EY +G L L R + L
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 730 RLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVV 789
LS + VA+GM +L + IHRDL + NILL K+ DFGL + + VV
Sbjct: 147 LLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 790 -TRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFW 848
++APE T ++DV+SYG+ L EL + ++ P + F+
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-----SKFY 258
Query: 849 RIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908
++ + + P E + ++ C +P RP +V ++ +
Sbjct: 259 KMIKEGFRM---LSPEHAPAE--------MYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307
Query: 909 K 909
+
Sbjct: 308 E 308
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 5e-54
Identities = 61/292 (20%), Positives = 114/292 (39%), Gaps = 32/292 (10%)
Query: 625 QNFAQENELGRGGFGTVYKGEL----EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV 680
+ +G G FG V++G +A+K + T+ ++F E + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQF 65
Query: 681 RHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARG 740
H H+V L+G E ++ E G L L + L + A ++
Sbjct: 66 DHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKY----SLDLASLILYAYQLSTA 120
Query: 741 MEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLA 800
+ YL + F+HRD+ + N+L+ + K+ DFGL + D ++ ++A
Sbjct: 121 LAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 177
Query: 801 PEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKE-KFKA 859
PE + T+ +DV+ +GV + E+L +P + + RI++ +
Sbjct: 178 PESINFRRFTSASDVWMFGVCMWEILMH-----GVKPFQGVKNNDVIGRIENGERLPMPP 232
Query: 860 AIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWR 911
P L L C A +P RP + LS ++E+ +
Sbjct: 233 NCPPTL-------------YSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 271
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 8e-54
Identities = 65/272 (23%), Positives = 105/272 (38%), Gaps = 32/272 (11%)
Query: 631 NELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLL 689
ELG G FG VYK + E A K ++ + + L+++ EI +L+ H ++V LL
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVID--TKSEEELEDYMVEIDILASCDHPNIVKLL 75
Query: 690 GYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLAR 749
N ++ E+ GA+ + E+ PL+ ++ + + YLH
Sbjct: 76 DAFYYENNLWILIEFCAGGAVDAVMLELER----PLTESQIQVVCKQTLDALNYLH---D 128
Query: 750 QTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVM--- 806
IHRDLK+ NIL D K++DFG+ + GT ++APE +
Sbjct: 129 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR-RDSFIGTPYWMAPEVVMCETS 187
Query: 807 --GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPA 864
KADV+S G+ L+E+ E P +I S+ P
Sbjct: 188 KDRPYDYKADVWSLGITLIEMAEI------EPPHHELNPMRVLLKIAKSE-------PPT 234
Query: 865 LEVNEETFESISIVAELAGHCTAREPYHRPDM 896
L + + C + R
Sbjct: 235 LAQPSRWSSNF---KDFLKKCLEKNVDARWTT 263
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 1e-53
Identities = 72/298 (24%), Positives = 132/298 (44%), Gaps = 33/298 (11%)
Query: 625 QNFAQENELGRGGFGTVYKGEL------EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLS 678
+ ELG+G FG VY+G E T++A+K + + + EF +E +V+
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMK 78
Query: 679 KVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQ-----LKPLSWTRRLSI 733
+ H+V LLG +G L++ E M G L +L L P S ++ + +
Sbjct: 79 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138
Query: 734 ALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVV-TRL 792
A ++A G + L F+HRDL + N ++ +D+ K+ DFG+ + + + +
Sbjct: 139 AGEIADG---MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 195
Query: 793 AGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKS 852
+++PE G TT +DV+S+GVVL E+ T AE ++ S
Sbjct: 196 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATL---------------AEQPYQGLS 240
Query: 853 SKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKW 910
+++ + ++ L + ++ EL C P RP +++ + +E
Sbjct: 241 NEQVLRFVMEGGLLDKPDNCP--DMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 296
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 3e-53
Identities = 69/286 (24%), Positives = 115/286 (40%), Gaps = 31/286 (10%)
Query: 625 QNFAQENELGRGGFGTVYKGELE----DGTKIAVKRMEAGVTTT-KALDEFQSEIAVLSK 679
++ +LG G FG V +GE + +AVK ++ V + +A+D+F E+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 680 VRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVAR 739
+ HR+L+ L G + ++ V E P G L + A+ VA
Sbjct: 68 LDHRNLIRLYGVVLTPPMKM-VTELAPLG----SLLDRLRKHQGHFLLGTLSRYAVQVAE 122
Query: 740 GMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVV--TRLAGTFG 797
GM YL + FIHRDL + N+LL K+ DFGL++ P + V F
Sbjct: 123 GMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
Query: 798 YLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKF 857
+ APE + +D + +GV L E+ T + P ++ +I E+
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFTY-----GQEPWIGLNGSQILHKIDKEGERL 234
Query: 858 KAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVL 903
D + + + C A +P RP + + L
Sbjct: 235 PRPEDCPQD-----------IYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 6e-52
Identities = 71/300 (23%), Positives = 123/300 (41%), Gaps = 34/300 (11%)
Query: 617 VQVLRKVTQNFAQENELGRGGFGTVYKGEL-----EDGTKIAVKRMEAGVTTTKALDEFQ 671
+++L++ F + LG G FGTVYKG + +A+K + T+ KA E
Sbjct: 3 LRILKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEIL 59
Query: 672 SEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRL 731
E V++ V + H+ LLG + +L + + MP G L + + + L
Sbjct: 60 DEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFG----CLLDYVREHKDNIGSQYLL 114
Query: 732 SIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVT- 790
+ + +A+GM YL + +HRDL + N+L+ K++DFGL KL EK
Sbjct: 115 NWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 171
Query: 791 RLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRI 850
++A E + T ++DV+SYGV + EL+T +P + +E +
Sbjct: 172 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTF-----GSKPYDGIPASEISSIL 226
Query: 851 KSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKW 910
+ + L V + C + RP ++ S +
Sbjct: 227 EKGER---------LPQPPICTID---VYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 274
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 9e-52
Identities = 59/293 (20%), Positives = 109/293 (37%), Gaps = 30/293 (10%)
Query: 621 RKVTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRME-AGVTTTKALDEFQSEIAVLS 678
+K ++F LG G F TV EL + A+K +E + + E V+S
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 679 KVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVA 738
++ H V L + + Y +G L +++ + T ++
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-----GSFDETCTRFYTAEIV 118
Query: 739 RGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKL-APDGEKSVVTRLAGTFG 797
+EYLH + IHRDLK NILL++D +++DFG K+ +P+ +++ GT
Sbjct: 119 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 175
Query: 798 YLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKF 857
Y++PE +D+++ G ++ +L+ G P + F +I + F
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAG------LPPFRAGNEYLIFQKIIKLEYDF 229
Query: 858 KAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKW 910
P +L + R + +
Sbjct: 230 PEKFFPKA-------------RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 269
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 3e-51
Identities = 59/287 (20%), Positives = 123/287 (42%), Gaps = 29/287 (10%)
Query: 616 SVQVLRKVTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEI 674
S+ + + + + ++G+G GTVY ++ G ++A+++M + + +EI
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEI 68
Query: 675 AVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIA 734
V+ + ++ ++V+ L + G+E +V EY+ G+L+ + + + ++
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVC 122
Query: 735 LDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAG 794
+ + +E+LH IHRD+KS NILL D K++DFG E+S + + G
Sbjct: 123 RECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI-TPEQSKRSTMVG 178
Query: 795 TFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSK 854
T ++APE K D++S G++ +E++ G E P + YL + +
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL---IATNGTPE 235
Query: 855 EKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901
+ + + C + R ++
Sbjct: 236 LQNPEKLSAIFR-------------DFLNRCLDMDVEKRGSAKELLQ 269
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 2e-50
Identities = 74/303 (24%), Positives = 117/303 (38%), Gaps = 40/303 (13%)
Query: 626 NFAQENELGRGGFGTVYKG------ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSK 679
LGRG FG V + + +AVK ++ G T SE+ +L
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-SEHRALMSELKILIH 72
Query: 680 VRHRHLVSLLGYSI--EGNERLLVYEYMPHGALSRHLFR-----------WEKLQLKPLS 726
+ H V L + G +++ E+ G LS +L E L L+
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 727 WTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK-LAPDGE 785
+ + VA+GME+L + IHRDL + NILL + K+ DFGL + + D +
Sbjct: 133 LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 786 KSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAE 845
++APE T ++DV+S+GV+L E+ + P + E
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL-----GASPYPGVKIDE 244
Query: 846 WFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSP 905
F R + +A P E + + C EP RP +V L
Sbjct: 245 EFCRRLKEGTRMRA---PDYTTPE--------MYQTMLDCWHGEPSQRPTFSELVEHLGN 293
Query: 906 LVE 908
L++
Sbjct: 294 LLQ 296
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 1e-49
Identities = 78/304 (25%), Positives = 123/304 (40%), Gaps = 42/304 (13%)
Query: 626 NFAQENELGRGGFGTVYKGEL--------EDGTKIAVKRMEAGVTTTKALDEFQSEIAVL 677
LG G FG V E TK+AVK +++ T K L + SE+ ++
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEMEMM 72
Query: 678 SKV-RHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQL-----------KPL 725
+ +H+++++LLG + ++ EY G L +L L + L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 726 SWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGE 785
S +S A VARGMEYL + IHRDL + N+L+ +D K++DFGL + +
Sbjct: 133 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 786 KSVVTRL-AGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLA 844
T ++APE T ++DV+S+GV+L E+ T P +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL-----GGSPYPGVPVE 244
Query: 845 EWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLS 904
E F +K +D E + + C P RP +V L
Sbjct: 245 ELFKLLKEGHR-----MDKPSNCTNE-------LYMMMRDCWHAVPSQRPTFKQLVEDLD 292
Query: 905 PLVE 908
+V
Sbjct: 293 RIVA 296
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 176 bits (447), Expect = 3e-49
Identities = 75/339 (22%), Positives = 126/339 (37%), Gaps = 41/339 (12%)
Query: 623 VTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR 681
V ++ ELG G FG V++ E G A K + + K + + EI +S +R
Sbjct: 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK--ETVRKEIQTMSVLR 81
Query: 682 HRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGM 741
H LV+L + NE +++YE+M G L + + +S + V +G+
Sbjct: 82 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD----EHNKMSEDEAVEYMRQVCKGL 137
Query: 742 EYLHCLARQTFIHRDLKSSNILL--DDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYL 799
++H ++H DLK NI+ K+ DFGL + VT GT +
Sbjct: 138 CHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFA 192
Query: 800 APEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKA 859
APE A + D++S GV+ LL+G P E +KS
Sbjct: 193 APEVAEGKPVGYYTDMWSVGVLSYILLSG------LSPFGGENDDETLRNVKSCDWNMD- 245
Query: 860 AIDPALEVNEETFESISIVA-ELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPITDESE 918
+ F IS + +P R + + P + +S+
Sbjct: 246 ---------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE--HPWLTPGNAPGRDSQ 294
Query: 919 CCSGIDYSLPLPQMLKVWQEAESKEISYPNLEDSKGSIP 957
+P + K+ ++K ++P G I
Sbjct: 295 --------IPSSRYTKIRDSIKTKYDAWPEPLPPLGRIS 325
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 170 bits (432), Expect = 3e-47
Identities = 60/280 (21%), Positives = 110/280 (39%), Gaps = 31/280 (11%)
Query: 621 RKVTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSK 679
V + ELG G FG V++ E G K + K ++EI+++++
Sbjct: 25 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK--YTVKNEISIMNQ 82
Query: 680 VRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVAR 739
+ H L++L + E +L+ E++ G L + + +S ++
Sbjct: 83 LHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA----EDYKMSEAEVINYMRQACE 138
Query: 740 GMEYLHCLARQTFIHRDLKSSNILLD--DDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFG 797
G++++H + +H D+K NI+ + K+ DFGL E VT T
Sbjct: 139 GLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAE 193
Query: 798 YLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKF 857
+ APE + D+++ GV+ LL+G P E +K +F
Sbjct: 194 FAAPEIVDREPVGFYTDMWAIGVLGYVLLSG------LSPFAGEDDLETLQNVKRCDWEF 247
Query: 858 KAAIDPALEVNEETFESISIVA-ELAGHCTAREPYHRPDM 896
+E+ F S+S A + + +EP R +
Sbjct: 248 ----------DEDAFSSVSPEAKDFIKNLLQKEPRKRLTV 277
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 167 bits (424), Expect = 4e-47
Identities = 61/273 (22%), Positives = 105/273 (38%), Gaps = 31/273 (11%)
Query: 630 ENELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTK-ALDEFQSEIAVLSKVRHRHLVS 687
LG GG V+ L +AVK + A + F+ E + + H +V+
Sbjct: 12 GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 71
Query: 688 LLGYSIE----GNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEY 743
+ G +V EY+ L + P++ R + + D + + +
Sbjct: 72 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNF 126
Query: 744 LHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVV--TRLAGTFGYLAP 801
H + IHRD+K +NI++ KV DFG+ + D SV + GT YL+P
Sbjct: 127 SH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 802 EYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861
E A + ++DV+S G VL E+LTG E P ++ +A
Sbjct: 184 EQARGDSVDARSDVYSLGCVLYEVLTG------EPPFTGDSPVSVAYQHVREDPIPPSAR 237
Query: 862 DPALEVNEETFESISIVAELAGHCTAREPYHRP 894
++ + + + A+ P +R
Sbjct: 238 HE--GLSAD-------LDAVVLKALAKNPENRY 261
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 167 bits (423), Expect = 6e-47
Identities = 69/287 (24%), Positives = 106/287 (36%), Gaps = 40/287 (13%)
Query: 625 QNFAQENELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDE-------FQSEIAV 676
+N+ + LGRG V + + AVK ++ + + +E E+ +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 677 LSKVR-HRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIAL 735
L KV H +++ L LV++ M G L +L LS I
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMR 117
Query: 736 DVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGT 795
+ + LH + +HRDLK NILLDDD K++DFG GEK + GT
Sbjct: 118 ALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGT 172
Query: 796 FGYLAPEYA------VMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWR 849
YLAPE + D++S GV++ LL G P R
Sbjct: 173 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG------SPPFWHRKQMLMLRM 226
Query: 850 IKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDM 896
I S +F + + ++ V +L +P R
Sbjct: 227 IMSGNYQFGSPEWD--DYSDT-------VKDLVSRFLVVQPQKRYTA 264
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (419), Expect = 5e-46
Identities = 64/278 (23%), Positives = 109/278 (39%), Gaps = 30/278 (10%)
Query: 623 VTQNFAQENELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR 681
+ + + LG G F V E +A+K + K ++EIAVL K++
Sbjct: 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK-EGSMENEIAVLHKIK 65
Query: 682 HRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGM 741
H ++V+L G L+ + + G L + + + V +
Sbjct: 66 HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK-----GFYTERDASRLIFQVLDAV 120
Query: 742 EYLHCLARQTFIHRDLKSSNILL---DDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGY 798
+YLH +HRDLK N+L D+D + +SDFGL K+ G + GT GY
Sbjct: 121 KYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL--STACGTPGY 175
Query: 799 LAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFK 858
+APE + D +S GV+ LL G P A+ F +I ++ +F
Sbjct: 176 VAPEVLAQKPYSKAVDCWSIGVIAYILLCG------YPPFYDENDAKLFEQILKAEYEFD 229
Query: 859 AAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDM 896
+ ++++ + H ++P R
Sbjct: 230 SPYWD--DISDS-------AKDFIRHLMEKDPEKRFTC 258
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 163 bits (414), Expect = 2e-45
Identities = 52/307 (16%), Positives = 106/307 (34%), Gaps = 36/307 (11%)
Query: 623 VTQNFAQENELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR 681
V ++ +G G FG +++G L + ++A+K + + E +
Sbjct: 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR----RSDAPQLRDEYRTYKLLA 58
Query: 682 HR-HLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARG 740
+ ++ + EG +LV + + L + S A +
Sbjct: 59 GCTGIPNVYYFGQEGLHNVLVIDLLGPSL-----EDLLDLCGRKFSVKTVAMAAKQMLAR 113
Query: 741 MEYLHCLARQTFIHRDLKSSNILLDDDYR-----AKVSDFGLVKLAPDGEKSVVTR---- 791
++ +H ++ ++RD+K N L+ V DFG+VK D
Sbjct: 114 VQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 170
Query: 792 --LAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWR 849
L+GT Y++ + + + + D+ + G V M L G + + + R
Sbjct: 171 KNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT---NKQKYER 227
Query: 850 IKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909
I K+ P E+ E + + PD ++ + S ++E+
Sbjct: 228 IGEKKQST-----PLRELCAGFPEEF---YKYMHYARNLAFDATPDYDYLQGLFSKVLER 279
Query: 910 WRPITDE 916
DE
Sbjct: 280 LNTTEDE 286
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 164 bits (416), Expect = 2e-45
Identities = 64/272 (23%), Positives = 112/272 (41%), Gaps = 33/272 (12%)
Query: 625 QNFAQENELGRGGFGTVYKGE-LEDGTKIAVKRME-AGVTTTKALDEFQSEIAVLSKVRH 682
Q+F LG G FG V+ +G A+K ++ V K ++ E +LS V H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 683 RHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGME 742
++ + G + + ++ +Y+ G L L + + A +V +E
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS-----QRFPNPVAKFYAAEVCLALE 118
Query: 743 YLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPE 802
YLH + I+RDLK NILLD + K++DFG K PD ++ GT Y+APE
Sbjct: 119 YLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC----GTPDYIAPE 171
Query: 803 YAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862
D +S+G+++ E+L G P + + +I +++ +F +
Sbjct: 172 VVSTKPYNKSIDWWSFGILIYEMLAG------YTPFYDSNTMKTYEKILNAELRFPPFFN 225
Query: 863 PALEVNEETFESISIVAELAGHCTAREPYHRP 894
++ +L R+ R
Sbjct: 226 EDVK-------------DLLSRLITRDLSQRL 244
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 162 bits (411), Expect = 4e-45
Identities = 57/300 (19%), Positives = 99/300 (33%), Gaps = 36/300 (12%)
Query: 622 KVTQNFAQENELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV 680
+V + ++G G FG +Y G + G ++A+K + E + +
Sbjct: 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLE----CVKTKHPQLHIESKIYKMM 59
Query: 681 RHRHLVSLLGYSI-EGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVAR 739
+ + + + EG+ ++V E + L + S L +A +
Sbjct: 60 QGGVGIPTIRWCGAEGDYNVMVMELLGPS-----LEDLFNFCSRKFSLKTVLLLADQMIS 114
Query: 740 GMEYLHCLARQTFIHRDLKSSNIL---LDDDYRAKVSDFGLVKLAPDGEKSVV------T 790
+EY+H + FIHRD+K N L + DFGL K D
Sbjct: 115 RIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 171
Query: 791 RLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRI 850
L GT Y + + + + + D+ S G VLM G + R E
Sbjct: 172 NLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK 231
Query: 851 KSSKEKFKAAIDPALEVNEETFESISI-VAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909
K S E + A C + +PD ++ + L +
Sbjct: 232 KMS------------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 2e-44
Identities = 65/339 (19%), Positives = 126/339 (37%), Gaps = 25/339 (7%)
Query: 623 VTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR 681
V + + +G G +G V + + ++A+K++ EI +L + R
Sbjct: 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISP-FEHQTYCQRTLREIKILLRFR 64
Query: 682 HRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGM 741
H +++ + + Y+ + L++ L+ + LS + RG+
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKL--LKTQHLSNDHICYFLYQILRGL 122
Query: 742 EYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKS--VVTRLAGTFGYL 799
+Y+H +HRDLK SN+LL+ K+ DFGL ++A +T T Y
Sbjct: 123 KYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 179
Query: 800 APEYAVMGKITT-KADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFK 858
APE + K T D++S G +L E+L+ + + S ++
Sbjct: 180 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239
Query: 859 AAIDPALEVN-----------EETFESISIVA-ELAGHCTAREPYHRPDMGHVVNVLSPL 906
A F + A +L P+ R ++ + P
Sbjct: 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA--HPY 297
Query: 907 VEKWRPITDESECCSGIDYSLPLPQMLK-VWQEAESKEI 944
+E++ +DE + + + L + K +E +E
Sbjct: 298 LEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEET 336
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 162 bits (410), Expect = 3e-44
Identities = 63/275 (22%), Positives = 109/275 (39%), Gaps = 33/275 (12%)
Query: 626 NFAQENELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEF----QSEIAVLSKV 680
+F+ +GRGGFG VY + G A+K ++ K + + ++++S
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 681 RHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARG 740
+V + ++ + + M G L HL + S A ++ G
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILG 119
Query: 741 MEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLA 800
+E++H + ++RDLK +NILLD+ ++SD G LA D K GT GY+A
Sbjct: 120 LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLG---LACDFSKKKPHASVGTHGYMA 173
Query: 801 PEYAVMGK-ITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKA 859
PE G + AD FS G +L +LL G + + + ++ + + +
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV---ELPD 230
Query: 860 AIDPALEVNEETFESISIVAELAGHCTAREPYHRP 894
+ P L L R+ R
Sbjct: 231 SFSPELR-------------SLLEGLLQRDVNRRL 252
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 6e-44
Identities = 56/269 (20%), Positives = 104/269 (38%), Gaps = 32/269 (11%)
Query: 632 ELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLG 690
+LGRG FG V++ E K ++ T + EI++L+ RHR+++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV---LVKKEISILNIARHRNILHLHE 68
Query: 691 YSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQ 750
E ++++E++ + + L+ +S V +++LH
Sbjct: 69 SFESMEELVMIFEFISGLDIFERI----NTSAFELNEREIVSYVHQVCEALQFLH---SH 121
Query: 751 TFIHRDLKSSNILLD--DDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGK 808
H D++ NI+ K+ +FG + G+ L Y APE
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYAPEVHQHDV 179
Query: 809 ITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVN 868
++T D++S G ++ LL+G P + + I +++ F +
Sbjct: 180 VSTATDMWSLGTLVYVLLSG------INPFLAETNQQIIENIMNAEYTF----------D 223
Query: 869 EETFESISIVA-ELAGHCTAREPYHRPDM 896
EE F+ ISI A + +E R
Sbjct: 224 EEAFKEISIEAMDFVDRLLVKERKSRMTA 252
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 1e-43
Identities = 68/275 (24%), Positives = 109/275 (39%), Gaps = 31/275 (11%)
Query: 625 QNFAQENELGRGGFGTVYKGE-LEDGTKIAVKRME-AGVTTTKALDEFQSEIAVLSKV-R 681
++F LG+G FG V+ E + A+K ++ V ++ E VLS
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 682 HRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGM 741
H L + V EY+ G L H+ +R A ++ G+
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS-----CHKFDLSRATFYAAEIILGL 116
Query: 742 EYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAP 801
++LH + ++RDLK NILLD D K++DFG+ K G+ GT Y+AP
Sbjct: 117 QFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT-NTFCGTPDYIAP 172
Query: 802 EYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861
E + K D +S+GV+L E+L G + P + E F I+ + +
Sbjct: 173 EILLGQKYNHSVDWWSFGVLLYEMLIG------QSPFHGQDEEELFHSIRMDNPFYPRWL 226
Query: 862 DPALEVNEETFESISIVAELAGHCTAREPYHRPDM 896
+ + +L REP R +
Sbjct: 227 EKEAK-------------DLLVKLFVREPEKRLGV 248
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 2e-43
Identities = 54/289 (18%), Positives = 99/289 (34%), Gaps = 19/289 (6%)
Query: 622 KVTQNFAQENELGRGGFGTVYKGE--LEDGTKIAVKRMEAGVTTTKALDEFQSEIAV--- 676
+ Q + E+G G +G V+K G +A+KR+ E+AV
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 677 LSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSR-HLFRWEKLQLKPLSWTRRLSIAL 735
L H ++V L + + + +K+ + +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 736 DVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGT 795
+ RG+++LH +HRDLK NIL+ + K++DFGL ++ +T + T
Sbjct: 124 QLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVVVT 178
Query: 796 FGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKE 855
Y APE + T D++S G + E+ + + ++
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 856 KFKAAIDPALEVN-------EETFESISIVA-ELAGHCTAREPYHRPDM 896
+ P + E+ I + +L C P R
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 287
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 154 bits (389), Expect = 2e-42
Identities = 51/276 (18%), Positives = 96/276 (34%), Gaps = 18/276 (6%)
Query: 631 NELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLG 690
++G G +G VYK + G A+K++ EI++L +++H ++V L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 691 YSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQ 750
+LV+E++ L S L + G+ Y H +
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCE-----GGLESVTAKSFLLQLLNGIAYCH---DR 119
Query: 751 TFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKIT 810
+HRDLK N+L++ + K++DFGL + + + + K +
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179
Query: 811 TKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVN-- 868
T D++S G + E++ G + +SK P + N
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239
Query: 869 -------EETFESISIVA-ELAGHCTAREPYHRPDM 896
E + + +L +P R
Sbjct: 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA 275
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 3e-42
Identities = 67/289 (23%), Positives = 116/289 (40%), Gaps = 45/289 (15%)
Query: 627 FAQEN---------ELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTK----ALDEFQS 672
F QEN ELG G F V K E G + A K ++ T + + ++ +
Sbjct: 3 FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 673 EIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLS 732
E+++L +++H ++++L + +L+ E + G L L + L+
Sbjct: 63 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-----ESLTEEEATE 117
Query: 733 IALDVARGMEYLHCLARQTFIHRDLKSSNILLDDD----YRAKVSDFGLVKLAPDGEKSV 788
+ G+ YLH H DLK NI+L D R K+ DFGL G +
Sbjct: 118 FLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF- 173
Query: 789 VTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFW 848
+ GT ++APE + +AD++S GV+ LL+G P E
Sbjct: 174 -KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------ASPFLGDTKQETLA 226
Query: 849 RIKSSKEKFKAAIDPALEVNEETFESISIVA-ELAGHCTAREPYHRPDM 896
+ + +F+ +E F + S +A + ++P R +
Sbjct: 227 NVSAVNYEFE----------DEYFSNTSALAKDFIRRLLVKDPKKRMTI 265
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 3e-42
Identities = 52/282 (18%), Positives = 103/282 (36%), Gaps = 18/282 (6%)
Query: 626 NFAQENELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRH 684
NF + ++G G +G VYK G +A+K++ T EI++L ++ H +
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 685 LVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYL 744
+V LL N+ LV+E++ + S + +G+ +
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALT----GIPLPLIKSYLFQLLQGLAFC 118
Query: 745 HCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYA 804
H +HRDLK N+L++ + K++DFGL + ++ + +
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 805 VMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYL--------AEWFWRIKSSKEK 856
+T D++S G + E++T A + + + E W +S
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 857 FKAAIDPALEVN-EETFESISIVA-ELAGHCTAREPYHRPDM 896
+K + + + + L +P R
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 277
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 6e-41
Identities = 62/280 (22%), Positives = 105/280 (37%), Gaps = 23/280 (8%)
Query: 631 NELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTK---ALDEFQSEIAVLSKVRHRHLV 686
+ LG G F TVYK +A+K+++ G + EI +L ++ H +++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 687 SLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHC 746
LL + LV+++M L+ + + L +G+EYLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLH- 117
Query: 747 LARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVM 806
+ +HRDLK +N+LLD++ K++DFGL K ++ T T Y APE
Sbjct: 118 --QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA-YTHQVVTRWYRAPELLFG 174
Query: 807 GK-ITTKADVFSYGVVLMELLTGLAALDEERPEESRYL--------AEWFWRIKSSKEKF 857
+ D+++ G +L ELL + L + + E W S +
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234
Query: 858 KAAIDPALEVNEETFESISIVA-ELAGHCTAREPYHRPDM 896
F + +L P R
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA 274
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 2e-40
Identities = 70/279 (25%), Positives = 106/279 (37%), Gaps = 31/279 (11%)
Query: 622 KVT-QNFAQENELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTK-ALDEFQSEIAVLS 678
KVT +F LG+G FG V G A+K + V K + +E VL
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 679 KVRHRHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVA 738
RH L +L + V EY G L HL R + + R ++
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE-----RVFTEERARFYGAEIV 115
Query: 739 RGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGY 798
+EYLH + ++RD+K N++LD D K++DFGL K + + + GT Y
Sbjct: 116 SALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKTFCGTPEY 171
Query: 799 LAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFK 858
LAPE D + GVV+ E++ G P ++ F I + +F
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCG------RLPFYNQDHERLFELILMEEIRFP 225
Query: 859 AAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMG 897
+ P + L ++P R G
Sbjct: 226 RTLSPEAK-------------SLLAGLLKKDPKQRLGGG 251
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 3e-40
Identities = 62/322 (19%), Positives = 111/322 (34%), Gaps = 42/322 (13%)
Query: 633 LGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLG 690
LG G G V + K A+K + + + + E+ + + + H+V ++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIVD 72
Query: 691 Y----SIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHC 746
L+V E + G L + + + + I + ++YLH
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRI---QDRGDQAFTEREASEIMKSIGEAIQYLH- 128
Query: 747 LARQTFIHRDLKSSNILLD---DDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEY 803
HRD+K N+L + K++DFG K T Y+APE
Sbjct: 129 --SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC--YTPYYVAPEV 184
Query: 804 AVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDP 863
K D++S GV++ LL G RI+ + +F
Sbjct: 185 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA--ISPGMKTRIRMGQYEFPNPEWS 242
Query: 864 ALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPITDESECCSGI 923
EV+EE V L + EP R + +N P + + + +
Sbjct: 243 --EVSEE-------VKMLIRNLLKTEPTQRMTITEFMN--HPWIMQSTKVPQTP-----L 286
Query: 924 DYSLPLPQMLKVWQEAESKEIS 945
S L + + W++ + + S
Sbjct: 287 HTSRVLKEDKERWEDVKEEMTS 308
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 2e-39
Identities = 66/295 (22%), Positives = 103/295 (34%), Gaps = 32/295 (10%)
Query: 621 RKVTQNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSK 679
R ++ +G G FG VY+ +L + G +A+K++ + E+ ++ K
Sbjct: 16 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL------QDKRFKNRELQIMRK 69
Query: 680 VRHRHLVSLLGYSIEGNER------LLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSI 733
+ H ++V L + E+ LV +Y+P Q L
Sbjct: 70 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ--TLPVIYVKLY 127
Query: 734 ALDVARGMEYLHCLARQTFIHRDLKSSNILLDDD-YRAKVSDFGLVKLAPDGEKSVVTRL 792
+ R + Y+H HRD+K N+LLD D K+ DFG K GE +V
Sbjct: 128 MYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-- 182
Query: 793 AGTFGYLAPEYAVMG-KITTKADVFSYGVVLMELLTGLAALDEERPEESRYL-------- 843
+ Y APE T+ DV+S G VL ELL G + +
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 242
Query: 844 -AEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVA-ELAGHCTAREPYHRPDM 896
E + + +FK A + A L P R
Sbjct: 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP 297
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 2e-39
Identities = 61/279 (21%), Positives = 100/279 (35%), Gaps = 44/279 (15%)
Query: 632 ELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKA----LDEFQSEIAVLSKVRHRH-- 684
LG GGFG+VY G + D +A+K +E + E+ +L KV
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 685 LVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYL 744
++ LL + + +L+ E + L S V + +
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFIT----ERGALQEELARSFFWQVLEAVRHC 126
Query: 745 HCLARQTFIHRDLKSSNILLD-DDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEY 803
H +HRD+K NIL+D + K+ DFG L D +V T GT Y PE+
Sbjct: 127 HN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDFDGTRVYSPPEW 180
Query: 804 AVMGKITTK-ADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862
+ + A V+S G++L +++ G + + I + F+ +
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVS 228
Query: 863 PALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901
+ L C A P RP + N
Sbjct: 229 SECQ-------------HLIRWCLALRPSDRPTFEEIQN 254
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 9e-39
Identities = 50/300 (16%), Positives = 103/300 (34%), Gaps = 22/300 (7%)
Query: 625 QNFAQENELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHR 683
Q + + ++G G +GTV+K + E +A+KR+ EI +L +++H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 684 HLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEY 743
++V L + LV+E+ L S + +G+ +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN-----GDLDPEIVKSFLFQLLKGLGF 116
Query: 744 LHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEY 803
H + +HRDLK N+L++ + K+++FGL + + + +
Sbjct: 117 CHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173
Query: 804 AVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRY----------LAEWFWRIKSS 853
+T D++S G + EL L + + E + +
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 854 KEKFKAAIDPALEVNEETFESISIVA-ELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRP 912
+ + PA ++ +L + P R + P + P
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ--HPYFSDFCP 291
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 4e-38
Identities = 75/343 (21%), Positives = 130/343 (37%), Gaps = 36/343 (10%)
Query: 622 KVTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV 680
+V + +G G +G V + G K+A+K++ + E+ +L +
Sbjct: 15 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 74
Query: 681 RHRHLVSLLGYSIEGN------ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIA 734
RH +++ LL + LV +M G L + + L R +
Sbjct: 75 RHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKH-----EKLGEDRIQFLV 127
Query: 735 LDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAG 794
+ +G+ Y+H IHRDLK N+ +++D K+ DFGL + A S +T
Sbjct: 128 YQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA----DSEMTGYVV 180
Query: 795 TFGYLAPEYAV-MGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYL---------A 844
T Y APE + + T D++S G ++ E++TG + A
Sbjct: 181 TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 240
Query: 845 EWFWRIKSSKEKFKAAIDPALEVNE--ETFESISIVA-ELAGHCTAREPYHRPDMGHVVN 901
E+ R++S + K P LE + + S +A L + R G +
Sbjct: 241 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
Query: 902 VLSPLVEKWRPITDESECCSGIDYSLPLPQMLKVWQEAESKEI 944
P E DE + D + + L W+ KE+
Sbjct: 301 --HPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEV 341
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 6e-37
Identities = 56/292 (19%), Positives = 109/292 (37%), Gaps = 34/292 (11%)
Query: 631 NELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLL 689
++G+G FG V+K + G K+A+K++ EI +L ++H ++V+L+
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 690 G--------YSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGM 741
Y+ LV+++ H K LS +R+ L +
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKF---TLSEIKRVMQML-----L 127
Query: 742 EYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKS---VVTRLAGTFGY 798
L+ + R +HRD+K++N+L+ D K++DFGL + + S T T Y
Sbjct: 128 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187
Query: 799 LAPEYAVMGK-ITTKADVFSYGVVLMELLTGLAALDEERPEESRYL---------AEWFW 848
PE + + D++ G ++ E+ T + + L E +
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247
Query: 849 RIKSSKEKFKAAIDPALEVNEETFESISIVAELA----GHCTAREPYHRPDM 896
+ + + K + + + + A +P R D
Sbjct: 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 299
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 139 bits (352), Expect = 1e-36
Identities = 63/265 (23%), Positives = 101/265 (38%), Gaps = 33/265 (12%)
Query: 632 ELGRGGFGTVYKGE-LEDGTKIAVKRME-AGVTTTKALDEFQSEIAVLSKVRHRHLVSLL 689
LG G FG V + E G A+K ++ V K ++ +E +L V LV L
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 690 GYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLAR 749
+ + +V EY+ G + HL R + S A + EYLH
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFYAAQIVLTFEYLH---S 159
Query: 750 QTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKI 809
I+RDLK N+L+D +V+DFG K ++ GT LAPE +
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC----GTPEALAPEIILSKGY 215
Query: 810 TTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNE 869
D ++ GV++ E+ G P + + + +I S K +F + L+
Sbjct: 216 NKAVDWWALGVLIYEMAAG------YPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK--- 266
Query: 870 ETFESISIVAELAGHCTAREPYHRP 894
+L + + R
Sbjct: 267 ----------DLLRNLLQVDLTKRF 281
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 3e-35
Identities = 63/331 (19%), Positives = 109/331 (32%), Gaps = 45/331 (13%)
Query: 623 VTQNFAQENELGRGGFGTVYKG-ELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR 681
V + + +G G G V + +A+K++ E+ ++ V
Sbjct: 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 74
Query: 682 HRHLVSLLGYSI------EGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIAL 735
H++++SLL E + LV E M R +
Sbjct: 75 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL--------DHERMSYLLY 126
Query: 736 DVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGT 795
+ G+++LH IHRDLK SNI++ D K+ DFGL + A T T
Sbjct: 127 QMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVT 181
Query: 796 FGYLAPEYAVMGKITTKADVFSYGVVLMELLTG----------------LAALDEERPEE 839
Y APE + D++S G ++ E++ + L PE
Sbjct: 182 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241
Query: 840 SRYLAEWFWRIKSSKEKFKAAIDPAL------EVNEETFESISIVA-ELAGHCTAREPYH 892
+ L ++ K+ P L + E + + A +L +P
Sbjct: 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301
Query: 893 RPDMGHVVNVLSPLVEKWRPITDESECCSGI 923
R + + P + W + I
Sbjct: 302 RISVDDALQ--HPYINVWYDPAEVEAPPPQI 330
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 5e-34
Identities = 68/283 (24%), Positives = 111/283 (39%), Gaps = 32/283 (11%)
Query: 625 QNFAQENELGRGGFGTVYKGEL----EDGTKIAVKRM--EAGVTTTKALDEFQSEIAVLS 678
+NF LG G +G V+ + G A+K + V K + ++E VL
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 679 KVRHR-HLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDV 737
+R LV+L + L+ +Y+ G L HL + + + ++
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEI 138
Query: 738 ARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFG 797
+E+LH + I+RD+K NILLD + ++DFGL K E GT
Sbjct: 139 VLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 195
Query: 798 YLAPEYAVMGK--ITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKE 855
Y+AP+ G D +S GV++ ELLTG + + + S AE RI S+
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRILKSEP 253
Query: 856 KFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGH 898
+ + + +L ++P R G
Sbjct: 254 PYPQEMSALAK-------------DLIQRLLMKDPKKRLGCGP 283
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 124 bits (313), Expect = 8e-32
Identities = 37/209 (17%), Positives = 89/209 (42%), Gaps = 24/209 (11%)
Query: 626 NFAQENELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR-HR 683
++ +LGRG + V++ + + K+ VK ++ + + EI +L +R
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-----PVKKKKIKREIKILENLRGGP 90
Query: 684 HLVSLLGYSIEGNERL--LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGM 741
++++L + R LV+E++ + + + L+ ++ + +
Sbjct: 91 NIITLADIVKDPVSRTPALVFEHVNNTDFKQL--------YQTLTDYDIRFYMYEILKAL 142
Query: 742 EYLHCLARQTFIHRDLKSSNILLD-DDYRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLA 800
+Y H +HRD+K N+++D + + ++ D+GL + G++ + +
Sbjct: 143 DYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKG 197
Query: 801 PEYAV-MGKITTKADVFSYGVVLMELLTG 828
PE V D++S G +L ++
Sbjct: 198 PELLVDYQMYDYSLDMWSLGCMLASMIFR 226
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 6e-31
Identities = 60/342 (17%), Positives = 121/342 (35%), Gaps = 34/342 (9%)
Query: 622 KVTQNFAQENELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV 680
+V + + + +G G +G+V + G ++AVK++ + E+ +L +
Sbjct: 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 681 RHRHLVSLLGY-----SIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIAL 735
+H +++ LL S+E + + ++ GA ++ + +KL +
Sbjct: 75 KHENVIGLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLT-----DDHVQFLIY 128
Query: 736 DVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKSVVTRLAGT 795
+ RG++Y+H IHRDLK SN+ +++D K+ DFG LA + + +A
Sbjct: 129 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFG---LARHTDDEMTGYVATR 182
Query: 796 FGYLAPEYAVMGKITTKADVFSYGVVLMELLTG------------LAALDEERPEESRYL 843
+ D++S G ++ ELLTG L + L
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 242
Query: 844 AEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVL 903
+ + P + + + +L + R +
Sbjct: 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA-- 300
Query: 904 SPLVEKWRPITDESECCSGIDYSLPLPQMLK-VWQEAESKEI 944
++ DE D S +L W+ E+
Sbjct: 301 HAYFAQYHDPDDEP-VADPYDQSFESRDLLIDEWKSLTYDEV 341
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 114 bits (286), Expect = 4e-28
Identities = 46/235 (19%), Positives = 89/235 (37%), Gaps = 19/235 (8%)
Query: 630 ENELGRGGFGTVYKGE-LEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRH------ 682
+LG G F TV+ + + + T +A+K + T+A + EI +L +V
Sbjct: 18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA---AEDEIKLLQRVNDADNTKE 74
Query: 683 -----RHLVSLLGYSIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDV 737
H++ LL + + + L +K + + + I+ +
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 738 ARGMEYLHCLARQTFIHRDLKSSNILLD-DDYRAKVSDFGLVKLA-PDGEKSVVTRLAGT 795
G++Y+H R IH D+K N+L++ D + + L T T
Sbjct: 135 LLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 192
Query: 796 FGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRI 850
Y +PE + AD++S ++ EL+TG + + + +I
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 105 bits (261), Expect = 3e-25
Identities = 69/313 (22%), Positives = 116/313 (37%), Gaps = 37/313 (11%)
Query: 24 DPNDLKILNDFKNGLENPELLKWPANGDDPCGPPPWPHVFCSGN----RVTQIQVQNLGL 79
+P D + L K L NP L D C W V C + RV + + L L
Sbjct: 4 NPQDKQALLQIKKDLGNPTTLSSWLPTTDCC-NRTWLGVLCDTDTQTYRVNNLDLSGLNL 62
Query: 80 KG--PLPQNFNQLTKL--YNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFD 135
P+P + L L +G N P + L++L + Y+ DF
Sbjct: 63 PKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS 122
Query: 136 GLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAA- 194
+ ++ L YN + ++P S+++ L ++ + G +PD G+ L
Sbjct: 123 QIKTLVTLDFSYNALS----GTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTS 178
Query: 195 LKLSYNRLSGVIPASFGQSLMQIL---------------------WLNDQDAGGMTGPID 233
+ +S NRL+G IP +F + + + +
Sbjct: 179 MTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG 238
Query: 234 VVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKS--LANMELDNL 291
V +L L L N+ G++P+ + L L LN++ N L G IP+ L ++
Sbjct: 239 KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAY 298
Query: 292 VLNNNLLMGPIPK 304
N L P+P
Sbjct: 299 ANNKCLCGSPLPA 311
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 77.9 bits (190), Expect = 6e-16
Identities = 52/282 (18%), Positives = 99/282 (35%), Gaps = 22/282 (7%)
Query: 160 DSLANSVQLTNLSLINCNLVG--PLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQI 217
D+ + ++ NL L NL P+P L LP L L + L Q+
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103
Query: 218 LWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVG 277
+L D ++++ +L L N +G++P I +L +L + + N++ G
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163
Query: 278 LIPKSLA---NMELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLL 334
IP S + + N L P F N+ + S E
Sbjct: 164 AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASV-------- 215
Query: 335 DFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDS 394
+ + +Q + + ++ ++L + + GTL + L
Sbjct: 216 ------LFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKF 269
Query: 395 LIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNI--KPPLP 434
L + + N++ G +P L+ + ++N PLP
Sbjct: 270 LHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSPLP 310
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 64.0 bits (154), Expect = 2e-11
Identities = 31/110 (28%), Positives = 50/110 (45%), Gaps = 7/110 (6%)
Query: 326 CAP-DVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNS---KVSIINLPRHNL 381
C P D LL + P L S P D C WLG+ C +++ +V+ ++L NL
Sbjct: 3 CNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNL 62
Query: 382 TG--TLSPSIANLDSLIEIRLGKN-SISGTVPNNFTELKSLRLLDVSDNN 428
+ S+ANL L + +G ++ G +P +L L L ++ N
Sbjct: 63 PKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTN 112
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 93.7 bits (232), Expect = 2e-22
Identities = 24/159 (15%), Positives = 47/159 (29%), Gaps = 28/159 (17%)
Query: 631 NELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKAL--------DEFQSEIAVLSKVRH 682
+G G V+ E + VK + G T+ K + F ++
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 683 RHLVSLLGYSI----EGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVA 738
R L L G ++ ++ E + L R + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPD------------EVLDMIL 113
Query: 739 RGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL 777
+ + + +H DL N+L+ + + DF
Sbjct: 114 EEVAKFY---HRGIVHGDLSQYNVLV-SEEGIWIIDFPQ 148
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 77.4 bits (189), Expect = 8e-16
Identities = 48/322 (14%), Positives = 94/322 (29%), Gaps = 53/322 (16%)
Query: 115 ELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLI 174
L + +P D +L L N + N L L LI
Sbjct: 11 HLRVVQCSDLGLEKVPKDLP---PDTALLDLQNNKITEI----KDGDFKNLKNLHTLILI 63
Query: 175 NCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDV 234
N + P L L L LS N+L + +Q L +++ + + +
Sbjct: 64 NNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKT--LQELRVHENEITKVRKSVFN 121
Query: 235 VAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLN 294
+ + +L + + +G + L + + + + + L L L+
Sbjct: 122 GLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPS--LTELHLD 179
Query: 295 NNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGND 354
N + G L+ L + N +S
Sbjct: 180 GNKITKVDAASLKG-------------------------LNNLAKLGLSFNSISAVDNGS 214
Query: 355 PCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNF- 413
P L +N+K+ + +A+ + + L N+IS N+F
Sbjct: 215 LANTPHLRELHLNNNKLVKVP-----------GGLADHKYIQVVYLHNNNISAIGSNDFC 263
Query: 414 -----TELKSLRLLDVSDNNIK 430
T+ S + + N ++
Sbjct: 264 PPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 65.1 bits (157), Expect = 7e-12
Identities = 38/199 (19%), Positives = 69/199 (34%), Gaps = 16/199 (8%)
Query: 240 SLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLL 298
L L N+ T D L +L L L N++ + P + A + +L+ L L+ N L
Sbjct: 32 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 91
Query: 299 MGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQG 358
+P+ + + + + + + P+ G
Sbjct: 92 KE-LPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENG------ 144
Query: 359 PWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKS 418
+ K+S I + N+T T+ + SL E+ L N I+ + L +
Sbjct: 145 -----AFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNN 196
Query: 419 LRLLDVSDNNIKPPLPEFH 437
L L +S N+I
Sbjct: 197 LAKLGLSFNSISAVDNGSL 215
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 41.6 bits (96), Expect = 3e-04
Identities = 21/103 (20%), Positives = 36/103 (34%), Gaps = 10/103 (9%)
Query: 355 PCQGPWLGLSCTSNSKVSI----------INLPRHNLTGTLSPSIANLDSLIEIRLGKNS 404
CQ + C+ + ++L + +T NL +L + L N
Sbjct: 7 RCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNK 66
Query: 405 ISGTVPNNFTELKSLRLLDVSDNNIKPPLPEFHDTVKLVIDGN 447
IS P F L L L +S N +K + T++ +
Sbjct: 67 ISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHE 109
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 75.0 bits (183), Expect = 8e-15
Identities = 45/254 (17%), Positives = 76/254 (29%), Gaps = 45/254 (17%)
Query: 44 LKWPANGDDPCGPPPWPHVFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKF 103
L D V + + N + P T L L L N+
Sbjct: 174 LTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQL 231
Query: 104 NGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLA 163
+ T + L+ L L N+ + GL+ + L L N +I
Sbjct: 232 KD-IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQI-----SNISPLAG 283
Query: 164 NSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQ 223
+ N L L L L +N +S + P
Sbjct: 284 LTALTNLELNENQLEDISPISNLKNLTYL---TLYFNNISDISP---------------- 324
Query: 224 DAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSL 283
V+ + L +L+ N+ + + L+++ L+ NQ+ L P L
Sbjct: 325 -----------VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--L 369
Query: 284 ANME-LDNLVLNNN 296
AN+ + L LN+
Sbjct: 370 ANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 74.3 bits (181), Expect = 1e-14
Identities = 54/390 (13%), Positives = 117/390 (30%), Gaps = 41/390 (10%)
Query: 69 VTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDT 128
+ + + + Q L ++ L R + L+ L N+
Sbjct: 24 KMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDGVEYLNNLTQINFSNNQLTD 80
Query: 129 IPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDS--LANSVQLTNLSLINCNLVGPLPDFL 186
I L+ + + ++ N + + + + L
Sbjct: 81 ITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLE 138
Query: 187 GTLPSLAALKLSYNRLSGVIPASFGQSLMQIL------WLNDQDAGGMTGPIDVVAKMVS 240
+ +++ + S + Q + I V+AK+ +
Sbjct: 139 LSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTN 198
Query: 241 LTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANME-LDNLVLNNNLLM 299
L L NQ + P I ++L +L+LN NQL +LA++ L +L L NN +
Sbjct: 199 LESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQIS 254
Query: 300 GPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGP 359
P +T Q + ++ L +
Sbjct: 255 NLAPLSGLTKLTELKLGANQ-----------------ISNISPLAGLTALTNLELNENQL 297
Query: 360 WLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSL 419
++ ++ + L +N++ +++L L + N +S ++ L ++
Sbjct: 298 EDISPISNLKNLTYLTLYFNNISD--ISPVSSLTKLQRLFFANNKVSD--VSSLANLTNI 353
Query: 420 RLLDVSDNNIK--PPLPEFHDTVKLVIDGN 447
L N I PL +L ++
Sbjct: 354 NWLSAGHNQISDLTPLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 73.5 bits (179), Expect = 3e-14
Identities = 67/369 (18%), Positives = 127/369 (34%), Gaps = 37/369 (10%)
Query: 67 NRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEF 126
++VT +Q LG+K L L + N+ + L++L ++ N+
Sbjct: 44 DQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTD-ITPLKNLTKLVDILMNNNQI 100
Query: 127 DTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPD--------SLANSVQLTNLSLINCNL 178
I + L + ++++ L+ L+ +
Sbjct: 101 ADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLS 160
Query: 179 VGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKM 238
G L L +L L+ + V S L + L + ++ + +
Sbjct: 161 FGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATN-NQISDITPLG-IL 218
Query: 239 VSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLL 298
+L +L L+GNQ + +L++L DL+L NQ+ L P S +L L L N +
Sbjct: 219 TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLS-GLTKLTELKLGANQI 275
Query: 299 MGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQG 358
P +T + Q E + N+ L N +S
Sbjct: 276 SNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYF-----NNISDIS------- 323
Query: 359 PWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKS 418
+S +K+ + + ++ S+ANL ++ + G N IS P L
Sbjct: 324 -----PVSSLTKLQRLFFANNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTR 374
Query: 419 LRLLDVSDN 427
+ L ++D
Sbjct: 375 ITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 45.4 bits (106), Expect = 2e-05
Identities = 37/236 (15%), Positives = 77/236 (32%), Gaps = 11/236 (4%)
Query: 217 ILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLV 276
L + +T + + +T L SI + + L++L +N + NQL
Sbjct: 26 KTVLGKTN---VTDTVSQ-TDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQLT 79
Query: 277 GLIP-KSLANMELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLD 335
+ P K+L + + N + P+ N+ ++ ++N L
Sbjct: 80 DITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLEL 139
Query: 336 FLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSL 395
++ L G + + ++ L + + +A L +L
Sbjct: 140 SSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNL 199
Query: 396 IEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIK--PPLPEFHDTVKLVIDGNPL 449
+ N IS P +L L ++ N +K L + L + N +
Sbjct: 200 ESLIATNNQISDITPLGIL--TNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQI 253
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 43.8 bits (102), Expect = 7e-05
Identities = 48/305 (15%), Positives = 91/305 (29%), Gaps = 30/305 (9%)
Query: 167 QLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAG 226
Q+T L + D + L +L + S N+L+ + P L+ IL N+Q A
Sbjct: 45 QVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIAD 102
Query: 227 GMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM 286
++L + ++ S ++ + L+
Sbjct: 103 ITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFG 162
Query: 287 ELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNL 346
+ L + N D + + N + D
Sbjct: 163 NQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILTNLD 222
Query: 347 VSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSIS 406
GN L S + ++ ++L + ++ ++ L L E++LG N IS
Sbjct: 223 ELSLNGNQLKDIGTLA----SLTNLTDLDLANNQISN--LAPLSGLTKLTELKLGANQIS 276
Query: 407 GTVP--------------------NNFTELKSLRLLDVSDNNIK--PPLPEFHDTVKLVI 444
P + + LK+L L + NNI P+ +L
Sbjct: 277 NISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFF 336
Query: 445 DGNPL 449
N +
Sbjct: 337 ANNKV 341
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.3 bits (129), Expect = 2e-08
Identities = 35/208 (16%), Positives = 60/208 (28%), Gaps = 15/208 (7%)
Query: 231 PIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELD 289
PI V+K+ S ++ T ++P D+ L+L+ N L +L L
Sbjct: 2 PICEVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLT 58
Query: 290 NLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIE---------CAPDVNVLLDFLGGV 340
L L+ L + S Q + L L
Sbjct: 59 QLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLG 118
Query: 341 NYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSP-SIANLDSLIEIR 399
Q + L + + +N L + L++L +
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 400 LGKNSISGTVPNNFTELKSLRLLDVSDN 427
L +NS+ T+P F L + N
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.8 bits (112), Expect = 2e-06
Identities = 37/216 (17%), Positives = 58/216 (26%), Gaps = 23/216 (10%)
Query: 61 HVFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFA 119
V C +T + P + + T L L N T + L
Sbjct: 14 EVNCDKRNLTAL-----------PPDLPKDTT--ILHLSENLLYTFSLATLMPYTRLT-- 58
Query: 120 YLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLV 179
L+ + + L L + S+P LT L + L
Sbjct: 59 QLNLDRAELTKLQVDGTLPV-----LGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLT 113
Query: 180 GPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMV 239
L L L L L N L + P + + P ++ +
Sbjct: 114 SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANN-NLTELPAGLLNGLE 172
Query: 240 SLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQL 275
+L L L N +IP+ L L+ N
Sbjct: 173 NLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.0 bits (110), Expect = 5e-06
Identities = 31/183 (16%), Positives = 49/183 (26%), Gaps = 8/183 (4%)
Query: 114 SELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSL 173
+ +L N T + + L LD K L N
Sbjct: 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQ 90
Query: 174 INCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPID 233
L LP +S+NRL+ + + + P
Sbjct: 91 SLPLLGQTLPALTVL-------DVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPP-G 142
Query: 234 VVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLVL 293
++ L +L L N T + L +L L L N L + + L L
Sbjct: 143 LLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFL 202
Query: 294 NNN 296
+ N
Sbjct: 203 HGN 205
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.7 bits (127), Expect = 4e-08
Identities = 42/310 (13%), Positives = 86/310 (27%), Gaps = 47/310 (15%)
Query: 120 YLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLV 179
+P ++ + + L N + S LT L L + L
Sbjct: 17 SCPQQGLQAVPVGIP---AASQRIFLHGNRISH----VPAASFRACRNLTILWLHSNVLA 69
Query: 180 GPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMV 239
L L L LS N + + L ++ L+ G + +
Sbjct: 70 RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLA 129
Query: 240 SLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANME-LDNLVLNNNLL 298
+L L+L N + L +L L L+ N++ + ++ + LD L+L+ N +
Sbjct: 130 ALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRV 189
Query: 299 MGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQG 358
P ++F + N
Sbjct: 190 AHVHP-----------HAFRDLGRLMTLYLFAN------------------------NLS 214
Query: 359 PWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKS 418
+ + + L + + L + R + + ++P L
Sbjct: 215 ALPTEALAPLRALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVPCSLPQR---LAG 270
Query: 419 LRLLDVSDNN 428
L ++ N+
Sbjct: 271 RDLKRLAAND 280
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 51.6 bits (122), Expect = 1e-07
Identities = 39/194 (20%), Positives = 71/194 (36%), Gaps = 8/194 (4%)
Query: 236 AKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGL-IPKSLANMELDNLVLN 294
A + +T L G T +I E + L++L L L NQ+ L K+L + L N
Sbjct: 38 ADLDGITTLSAFGTGVT-TI-EGVQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGN 95
Query: 295 NNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGN- 353
+ I ++ +++ + ++ VL L + L
Sbjct: 96 PLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQY 155
Query: 354 -DPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNN 412
L+ +N N +SP +A+L +LIE+ L N IS P
Sbjct: 156 LSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-LASLPNLIEVHLKNNQISDVSP-- 212
Query: 413 FTELKSLRLLDVSD 426
+L ++ +++
Sbjct: 213 LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 48.1 bits (113), Expect = 1e-06
Identities = 38/243 (15%), Positives = 67/243 (27%), Gaps = 25/243 (10%)
Query: 56 PPPWPHVFCSGN--RVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGL 113
P +F +I + + Q L + L + L
Sbjct: 6 PTAINVIFPDPALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEGVQYL 62
Query: 114 SELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSL 173
+ L L N+ + L+ + L L NP + S+ +
Sbjct: 63 NNLIGLELKDNQITDLA--PLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQIT 120
Query: 174 INCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPID 233
L G L + + P+
Sbjct: 121 DVTPLAGLSNLQ----------VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPL- 169
Query: 234 VVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANME-LDNLV 292
A + LT L N+ + P + +L +L +++L NQ+ + P LAN L +
Sbjct: 170 --ANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVT 223
Query: 293 LNN 295
L N
Sbjct: 224 LTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 44.6 bits (104), Expect = 2e-05
Identities = 31/212 (14%), Positives = 65/212 (30%), Gaps = 15/212 (7%)
Query: 231 PIDVV---AKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM- 286
I+V+ + + ++ + T ++ + L + L+ + + + + +
Sbjct: 8 AINVIFPDPALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLN 63
Query: 287 ELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNL 346
L L L +N + P +T S + A ++ L
Sbjct: 64 NLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVT 123
Query: 347 VSQWPGNDPC---QGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKN 403
N + ++ L N + +ANL L ++ N
Sbjct: 124 PLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDN 183
Query: 404 SISGTVPNNFTELKSLRLLDVSDNNIK--PPL 433
IS P L +L + + +N I PL
Sbjct: 184 KISDISP--LASLPNLIEVHLKNNQISDVSPL 213
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 1e-04
Identities = 21/77 (27%), Positives = 33/77 (42%), Gaps = 3/77 (3%)
Query: 147 YNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVI 206
S LAN +LT L + + P L +LP+L + L N++S V
Sbjct: 154 QYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVS 211
Query: 207 PASFGQSLMQILWLNDQ 223
P + +L I+ L +Q
Sbjct: 212 PLANTSNL-FIVTLTNQ 227
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 49.3 bits (117), Expect = 1e-07
Identities = 28/109 (25%), Positives = 45/109 (41%), Gaps = 7/109 (6%)
Query: 171 LSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTG 230
L L + +L L L + L LS+NRL + PA +++L +D
Sbjct: 3 LHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDN----ALE 56
Query: 231 PIDVVAKMVSLTQLWLHGNQFTG-SIPEDIGALSSLKDLNLNRNQLVGL 278
+D VA + L +L L N+ + + + + L LNL N L
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.3 bits (104), Expect = 6e-06
Identities = 21/115 (18%), Positives = 39/115 (33%), Gaps = 8/115 (6%)
Query: 84 PQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVL 143
+ QL + +L L N+ P + L LE N + + ++ L
Sbjct: 13 LCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVANL--PRLQEL 70
Query: 144 ALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGP---LPDFLGTLPSLAAL 195
L N + L + +L L+L +L LPS++++
Sbjct: 71 LLCNNRLQ---QSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.2 bits (96), Expect = 7e-05
Identities = 25/111 (22%), Positives = 33/111 (29%), Gaps = 9/111 (8%)
Query: 96 LGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFG 155
L L L L + L N L+++R L + N
Sbjct: 3 LHLAHKDLT-VLCHLEQLLLVTHLDLSHNRL----RALPPALAALRCLEVLQASDNA--- 54
Query: 156 WSIPDSLANSVQLTNLSLINCNLVG-PLPDFLGTLPSLAALKLSYNRLSGV 205
D +AN +L L L N L L + P L L L N L
Sbjct: 55 LENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 39.7 bits (92), Expect = 2e-04
Identities = 25/125 (20%), Positives = 39/125 (31%), Gaps = 10/125 (8%)
Query: 141 RVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYN 200
RVL L + ++ L + +T+L L + L P L L L+ S N
Sbjct: 1 RVLHLAHKDL------TVLCHLEQLLLVTHLDLSHNRLRALPPAL-AALRCLEVLQASDN 53
Query: 201 RLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIG 260
+ +Q L L + I + L L L GN
Sbjct: 54 A-LENVDGVANLPRLQELLLCNNRLQQS-AAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQE 110
Query: 261 ALSSL 265
L+ +
Sbjct: 111 RLAEM 115
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.3 bits (121), Expect = 2e-07
Identities = 37/261 (14%), Positives = 64/261 (24%), Gaps = 30/261 (11%)
Query: 169 TNLSLINCNLVGPLPDFLGTLPS--LAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAG 226
L L NL PD G L S + A + + + + F +Q + L++
Sbjct: 3 QTLDLTGKNL---HPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIE 59
Query: 227 GMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM 286
+ ++++ L L L G + + I + S+L LNL+
Sbjct: 60 V-STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLS 118
Query: 287 ELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNL 346
L N + + N +
Sbjct: 119 SCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRK------------NLQKSD 166
Query: 347 VSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSIS 406
+S P + N LS S I
Sbjct: 167 LSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLS------------RCYDII 214
Query: 407 GTVPNNFTELKSLRLLDVSDN 427
E+ +L+ L V
Sbjct: 215 PETLLELGEIPTLKTLQVFGI 235
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 50.6 bits (119), Expect = 5e-07
Identities = 22/120 (18%), Positives = 38/120 (31%), Gaps = 35/120 (29%)
Query: 173 LINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPI 232
+ PSL L +S N+L +PA
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPP--------------------- 304
Query: 233 DVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGL--IPKSLANMELDN 290
L +L N +PE +LK L++ N L IP+S+ ++ +++
Sbjct: 305 -------RLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLREFPDIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.1 bits (97), Expect = 2e-04
Identities = 15/61 (24%), Positives = 24/61 (39%), Gaps = 7/61 (11%)
Query: 238 MVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNL 297
SL +L + N+ +P L+ L + N L +P+ N L L + N
Sbjct: 283 PPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLAE-VPELPQN--LKQLHVEYNP 335
Query: 298 L 298
L
Sbjct: 336 L 336
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.2 bits (92), Expect = 9e-04
Identities = 22/105 (20%), Positives = 34/105 (32%), Gaps = 37/105 (35%)
Query: 167 QLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAG 226
L L++ N L+ LP P L L S+N L+ +P
Sbjct: 285 SLEELNVSNNKLIE-LPALP---PRLERLIASFNHLAE-VPELPQ--------------- 324
Query: 227 GMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLN 271
+L QL + N P+ S++DL +N
Sbjct: 325 -------------NLKQLHVEYNPLR-EFPD---IPESVEDLRMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.2 bits (92), Expect = 9e-04
Identities = 16/82 (19%), Positives = 31/82 (37%), Gaps = 10/82 (12%)
Query: 219 WLNDQDAGGMTGPIDVVAKMV-----SLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRN 273
W + G V+++ +L L+ + S+PE L+ L + N
Sbjct: 13 WERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPELPP---HLESLVASCN 68
Query: 274 QLVGLIPKSLANMELDNLVLNN 295
L L P+ +++ + NN
Sbjct: 69 SLTEL-PELPQSLKSLLVDNNN 89
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 38.3 bits (87), Expect = 0.003
Identities = 41/312 (13%), Positives = 86/312 (27%), Gaps = 13/312 (4%)
Query: 138 SSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKL 197
L L+ + S+P+ + L +L +CN + LP+ +L SL
Sbjct: 38 RQAHELELNNLGLS-----SLPELPPH---LESLVA-SCNSLTELPELPQSLKSLLVDNN 88
Query: 198 SYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPE 257
+ LS + P + + + + SL +L
Sbjct: 89 NLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAG 148
Query: 258 DIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMGPIPKFKAGNVTYDSNSF 317
+ + NL + SL + L L + + I + +
Sbjct: 149 NNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTT 208
Query: 318 CQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLP 377
++ + V + S++
Sbjct: 209 IYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYY 268
Query: 378 RHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLPEFH 437
+ + + SL E+ + N + +P L+ L S N++
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLIA---SFNHLAEVPELPQ 324
Query: 438 DTVKLVIDGNPL 449
+ +L ++ NPL
Sbjct: 325 NLKQLHVEYNPL 336
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 48.5 bits (114), Expect = 1e-06
Identities = 30/189 (15%), Positives = 64/189 (33%), Gaps = 10/189 (5%)
Query: 241 LTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANME-LDNLVLNNNLLM 299
+ L T ++ ++ L+S+ + N + + + + + + L LN N L
Sbjct: 26 TIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLT 81
Query: 300 GP--IPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQ 357
+ K + + + ++ + L G++ LV
Sbjct: 82 DIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYL 141
Query: 358 GPWLGLSCTSNSKVSIINLPRHNLTGTLS-PSIANLDSLIEIRLGKNSISGTVPNNFTEL 416
G T S+++ ++ +A L L + L KN IS L
Sbjct: 142 GNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD--LRALAGL 199
Query: 417 KSLRLLDVS 425
K+L +L++
Sbjct: 200 KNLDVLELF 208
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.4 bits (108), Expect = 6e-06
Identities = 31/240 (12%), Positives = 58/240 (24%), Gaps = 16/240 (6%)
Query: 59 WPHVFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELE 117
C ++VT+I P + L K FSG +LE
Sbjct: 10 NRVFLCQESKVTEI-----------PSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLE 56
Query: 118 FAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCN 177
+ N+ + N + ++Q +S
Sbjct: 57 KIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLIS-NTGI 115
Query: 178 LVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAK 237
P + +L + + + SF + + L G
Sbjct: 116 KHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNG 175
Query: 238 MVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNN 296
N + S L+++R ++ L L N+ +L N
Sbjct: 176 TQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.6 bits (98), Expect = 1e-04
Identities = 18/212 (8%), Positives = 50/212 (23%), Gaps = 18/212 (8%)
Query: 240 SLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-------ELDNLV 292
+ +L + L+ + +++N ++ +I + + ++
Sbjct: 30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 89
Query: 293 LNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPG 352
+ SN+ + P + + +L + +
Sbjct: 90 NLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFV 149
Query: 353 NDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPS-----------IANLDSLIEIRLG 401
+ L L+ ++ L + + +
Sbjct: 150 GLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDIS 209
Query: 402 KNSISGTVPNNFTELKSLRLLDVSDNNIKPPL 433
+ I LK LR + P L
Sbjct: 210 RTRIHSLPSYGLENLKKLRARSTYNLKKLPTL 241
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.1 bits (89), Expect = 0.001
Identities = 21/209 (10%), Positives = 52/209 (24%), Gaps = 21/209 (10%)
Query: 240 SLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM---ELDNLVLNNN 296
S ++ T IP D+ + +L +L + + + E + N+
Sbjct: 9 SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65
Query: 297 LLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVS-------- 348
L + F ++ + L + + +
Sbjct: 66 LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 125
Query: 349 -------QWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLG 401
N + + I+ L ++ + + +
Sbjct: 126 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSD 185
Query: 402 KNSISGTVPNNFTELKSLRLLDVSDNNIK 430
N++ + F +LD+S I
Sbjct: 186 NNNLEELPNDVFHGASGPVILDISRTRIH 214
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (109), Expect = 9e-06
Identities = 23/124 (18%), Positives = 35/124 (28%), Gaps = 24/124 (19%)
Query: 147 YNPFNKTFGWSIPDSLANSVQLTNLSLINCNL----VGPLPDFLGTLPSLAALKLSYNRL 202
+ L L L +C++ L L SL L LS N L
Sbjct: 350 NRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCL 409
Query: 203 SGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGAL 262
+S+ Q L L QL L+ ++ + + + AL
Sbjct: 410 GDAGILQLVESVRQPGCL--------------------LEQLVLYDIYWSEEMEDRLQAL 449
Query: 263 SSLK 266
K
Sbjct: 450 EKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 2e-05
Identities = 17/80 (21%), Positives = 26/80 (32%), Gaps = 7/80 (8%)
Query: 139 SVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNL----VGPLPDFLGTLPSLAA 194
++ L + + + L Q + L +C L + L P+LA
Sbjct: 3 DIQSLDIQCEELSDA---RWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 59
Query: 195 LKLSYNRLSGVIPASFGQSL 214
L L N L V Q L
Sbjct: 60 LNLRSNELGDVGVHCVLQGL 79
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 2e-05
Identities = 22/101 (21%), Positives = 35/101 (34%), Gaps = 10/101 (9%)
Query: 215 MQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTG----SIPEDIGALSSLKDLNL 270
+QI +DAG + L LWL + S+ + A SL++L+L
Sbjct: 345 LQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDL 404
Query: 271 NRNQLVGLIPKSLANM------ELDNLVLNNNLLMGPIPKF 305
+ N L L L+ LVL + +
Sbjct: 405 SNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDR 445
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 1e-04
Identities = 17/106 (16%), Positives = 27/106 (25%), Gaps = 26/106 (24%)
Query: 190 PSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGN 249
L L L+ +S +S +L SL +L L N
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATL---------------------LANHSLRELDLSNN 407
Query: 250 QFTGSIPEDIGA-----LSSLKDLNLNRNQLVGLIPKSLANMELDN 290
+ + L+ L L + L +E D
Sbjct: 408 CLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 8e-04
Identities = 14/91 (15%), Positives = 30/91 (32%), Gaps = 1/91 (1%)
Query: 115 ELEFAYLDFNEF-DTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSL 173
+++ + E D ++ L +V+ LD + I +L + L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 174 INCNLVGPLPDFLGTLPSLAALKLSYNRLSG 204
+ L + + K+ L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.002
Identities = 10/62 (16%), Positives = 23/62 (37%), Gaps = 4/62 (6%)
Query: 229 TGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGA----LSSLKDLNLNRNQLVGLIPKSLA 284
+++ + + L T + +DI + +L +LNL N+L + +
Sbjct: 17 ARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVL 76
Query: 285 NM 286
Sbjct: 77 QG 78
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 43.3 bits (100), Expect = 9e-05
Identities = 34/295 (11%), Positives = 73/295 (24%), Gaps = 22/295 (7%)
Query: 157 SIPDSLANSVQLTNLSLINCNL----VGPLPDFLGTLPSLAALKLSYN---RLSGVIP-- 207
S+ L + + L + L + + + L + S R+ IP
Sbjct: 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEA 81
Query: 208 -ASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLK 266
Q+L++ L+ ++ +
Sbjct: 82 LRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKI 141
Query: 267 DLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIEC 326
L + + + N K ++ + GI
Sbjct: 142 ARALQELAVNKKAKNAPPLRSIIC-GRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRP 200
Query: 327 APDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLS 386
++LL+ L L Q L ++ S + + L L+ +
Sbjct: 201 EGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGA 260
Query: 387 PSIAN------LDSLIEIRLGKNSISGTVPNNFTE-----LKSLRLLDVSDNNIK 430
++ + L +RL N I + L L+++ N
Sbjct: 261 AAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.2 bits (95), Expect = 2e-04
Identities = 31/197 (15%), Positives = 61/197 (30%), Gaps = 12/197 (6%)
Query: 231 PIDVV---AKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM- 286
PI+ + + + L T ++ + L + L +R + + + +
Sbjct: 7 PINQIFTDTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLN 62
Query: 287 ELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNL 346
L + +NN L P + + Q A N+ L
Sbjct: 63 NLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDID 122
Query: 347 VSQWPGN---DPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKN 403
+ N + + S+ L + T +ANL +L + + N
Sbjct: 123 PLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSN 182
Query: 404 SISG-TVPNNFTELKSL 419
+S +V T L+SL
Sbjct: 183 KVSDISVLAKLTNLESL 199
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.6 bits (94), Expect = 2e-04
Identities = 24/152 (15%), Positives = 45/152 (29%), Gaps = 8/152 (5%)
Query: 157 SIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQ 216
+ ++ + +L L L L + + + +
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELL 68
Query: 217 ILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLV 276
L L++ + +V K +L L L GN+ D L++L L+ N L
Sbjct: 69 SLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128
Query: 277 GLIPKSLANME-----LDNL-VLNNNLLMGPI 302
+ L L+ + L PI
Sbjct: 129 DTFRDQSTYISAIRERFPKLLRLDGHELPPPI 160
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (88), Expect = 0.001
Identities = 11/44 (25%), Positives = 15/44 (34%), Gaps = 1/44 (2%)
Query: 386 SPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNI 429
+ N E+ L I + N L +D SDN I
Sbjct: 11 AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI 53
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.8 bits (84), Expect = 0.004
Identities = 13/68 (19%), Positives = 23/68 (33%), Gaps = 2/68 (2%)
Query: 238 MVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNL 297
V +L L G + I L ++ + N++ L L L++NNN
Sbjct: 17 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP-LLRRLKTLLVNNNR 74
Query: 298 LMGPIPKF 305
+
Sbjct: 75 ICRIGEGL 82
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 973 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.97 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.93 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.93 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.89 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.89 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.88 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.88 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.78 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.77 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.74 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.73 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.72 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.71 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.71 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.71 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.69 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.68 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.68 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.57 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.51 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.5 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.49 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.48 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.48 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.47 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.42 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.4 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.33 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.33 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.32 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.31 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.31 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.43 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.32 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.3 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.87 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.85 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.74 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.28 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.27 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.1 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.72 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.88 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.29 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-50 Score=430.31 Aligned_cols=262 Identities=28% Similarity=0.500 Sum_probs=207.9
Q ss_pred hcCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
.++|...+.||+|+||+||+|+.+ ..||||+++.........+.|.+|++++++++|||||++++++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 367889999999999999999875 369999998665566777899999999999999999999998764 56899999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+++|+|.++++.. ...++|.+++.|+.|||+||+||| +++||||||||+|||++.++.+||+|||+|+....
T Consensus 84 y~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 84 WCEGSSLYHHLHII----ETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp CCCEEEHHHHHHTS----CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred cCCCCCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 99999999999652 246899999999999999999999 78999999999999999999999999999986543
Q ss_pred CC-cceecccccccCccccccccc---CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHh
Q 041143 784 GE-KSVVTRLAGTFGYLAPEYAVM---GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKA 859 (973)
Q Consensus 784 ~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (973)
.. ........||+.|||||++.+ ..|+.++|||||||++|||+||+.||.+........ ..+. ..
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~--~~~~---------~~ 225 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII--FMVG---------RG 225 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH--HHHH---------HT
T ss_pred cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHH--HHHh---------cC
Confidence 22 233456789999999999864 358899999999999999999999998765432211 1011 11
Q ss_pred hcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 860 AIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 860 ~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
...+.+. .........+.+++.+||+.||++||||+||++.|+.+.+
T Consensus 226 ~~~p~~~--~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 226 YLSPDLS--KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp SCCCCGG--GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCcch--hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1122111 1111123457899999999999999999999999998865
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=429.35 Aligned_cols=256 Identities=29% Similarity=0.478 Sum_probs=200.4
Q ss_pred cCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEe
Q 041143 625 QNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEY 704 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 704 (973)
++|+..+.||+|+||+||+|++.+++.||||+++..... .++|.+|++++++++|||||+++|+|.+.+..++||||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc---HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 468888999999999999999998999999999764332 35799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCC
Q 041143 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG 784 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~ 784 (973)
+++|+|.+++... ...++|..++.|+.|||+||+||| +++|+||||||+|||+++++.+||+|||+++.....
T Consensus 82 ~~~g~L~~~l~~~----~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 154 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 154 (263)
T ss_dssp CTTCBHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred cCCCcHHHHhhcc----ccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCC
Confidence 9999999998652 256899999999999999999999 789999999999999999999999999999876554
Q ss_pred CcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhC-CCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCc
Q 041143 785 EKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTG-LAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDP 863 (973)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (973)
.........||+.|+|||++.+..|+.++|||||||++|||+|+ ++|+......+ +.. .+... .....|
T Consensus 155 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~---~~~---~i~~~----~~~~~p 224 (263)
T d1sm2a_ 155 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVE---DISTG----FRLYKP 224 (263)
T ss_dssp ----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH---HHH---HHHHT----CCCCCC
T ss_pred CceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH---HHH---HHHhc----CCCCCc
Confidence 44444556799999999999999999999999999999999995 55555433221 111 11110 001111
Q ss_pred cccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 864 ALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 864 ~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
. ....++.+++.+||+.||++||||+||++.|+++.+
T Consensus 225 ~--------~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 225 R--------LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp T--------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred c--------ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 1 112457899999999999999999999999998865
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-50 Score=426.11 Aligned_cols=258 Identities=27% Similarity=0.444 Sum_probs=210.6
Q ss_pred hcCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
.++|+..+.||+|+||.||+|++++++.||||+++.... ..+.|.+|++++++++|||||+++|++.+ +..++|||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E 87 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC---CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEE
Confidence 367888999999999999999999889999999976432 24579999999999999999999998765 56799999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+++|+|.+++..... ..++|.++++|+.|||+||+||| +++|+||||||+|||+++++.+||+|||+|+...+
T Consensus 88 y~~~g~L~~~~~~~~~---~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 88 YMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (272)
T ss_dssp CCTTCBHHHHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred eCCCCcHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccC
Confidence 9999999998765322 45899999999999999999999 78999999999999999999999999999997766
Q ss_pred CCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCc
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDP 863 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (973)
..........||+.|+|||++.++.++.++|||||||++|||+||..|+....... .+.. .+. ....+
T Consensus 162 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~--~~~~---~i~-------~~~~~ 229 (272)
T d1qpca_ 162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQ---NLE-------RGYRM 229 (272)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHH---HHH-------TTCCC
T ss_pred CccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH--HHHH---HHH-------hcCCC
Confidence 55555556789999999999999999999999999999999999665554332211 1111 111 11111
Q ss_pred cccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 864 ALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 864 ~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
... . .....+.+|+.+||+.||++||||+||++.|+.+..
T Consensus 230 ~~p-~----~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 230 VRP-D----NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp CCC-T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCc-c----cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 111 1 122457899999999999999999999999998764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7e-50 Score=429.78 Aligned_cols=259 Identities=26% Similarity=0.402 Sum_probs=213.3
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
.++|+..+.||+|+||+||+|++. +|+.||||+++.... ..++|.+|+++|++++|||||+++|+|.+++..++||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc---hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 357888899999999999999876 588999999975432 3457999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++|+|.+++... ....++|..+..|+.|||+||+||| +++|+||||||+|||+++++.+||+|||+|+...
T Consensus 93 E~~~~g~l~~~l~~~---~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 93 EFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 166 (287)
T ss_dssp ECCTTCBHHHHHHHS---CTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred ecccCcchHHHhhhc---cccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecC
Confidence 999999999999652 2357899999999999999999999 7899999999999999999999999999999776
Q ss_pred CCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcC
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (973)
...........||+.|+|||++.+..|+.++|||||||++|||++|..|+........ +...+ .....
T Consensus 167 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~--~~~~i----------~~~~~ 234 (287)
T d1opja_ 167 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYELL----------EKDYR 234 (287)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHH----------HTTCC
T ss_pred CCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH--HHHHH----------hcCCC
Confidence 5555555556789999999999999999999999999999999997776644332211 11111 11111
Q ss_pred ccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 863 PALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 863 ~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
+... ......+.+|+.+||+.||++||||+||++.|+.+.+
T Consensus 235 ~~~~-----~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 235 MERP-----EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp CCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred CCCC-----ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1111 1122457899999999999999999999999988765
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.9e-49 Score=429.10 Aligned_cols=259 Identities=27% Similarity=0.472 Sum_probs=201.7
Q ss_pred cCccccCcccccCccEEEEEEECC-C---CEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELED-G---TKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLL 700 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~-g---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 700 (973)
++|+..++||+|+||+||+|+++. | ..||||++... ......++|.+|+++|++++|||||+++|+|.+++..++
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 457778899999999999998752 3 25889988654 345666789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecccccc
Q 041143 701 VYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKL 780 (973)
Q Consensus 701 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~ 780 (973)
||||+++|+|.+++... ...++|.+++.++.|||+||+||| +++|+||||||+|||++.++++||+|||+|+.
T Consensus 105 v~Ey~~~g~L~~~~~~~----~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 177 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQN----DGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177 (299)
T ss_dssp EEECCTTEEHHHHHHTT----TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEecCCCcceeeeccc----cCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceE
Confidence 99999999999988652 246899999999999999999999 78999999999999999999999999999986
Q ss_pred CCCCCcce----ecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchh
Q 041143 781 APDGEKSV----VTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKE 855 (973)
Q Consensus 781 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 855 (973)
........ .....||+.|||||++.++.++.++|||||||++|||+| |+.||......+. .. .+..
T Consensus 178 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~---~~---~i~~--- 248 (299)
T d1jpaa_ 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV---IN---AIEQ--- 248 (299)
T ss_dssp ------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HH---HHHT---
T ss_pred ccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHH---HH---HHHc---
Confidence 54432211 122468999999999999999999999999999999998 8999987654321 11 1111
Q ss_pred HHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 856 KFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 856 ~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
.. .+. .+......+.+|+.+||+.||++||||+||++.|+++++.
T Consensus 249 ----~~--~~~---~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 249 ----DY--RLP---PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp ----TC--CCC---CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ----CC--CCC---CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 01 111 1112234578999999999999999999999999998763
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-49 Score=422.29 Aligned_cols=254 Identities=24% Similarity=0.408 Sum_probs=209.7
Q ss_pred cCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
++|+..+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|++++++++|||||++++++.+.+..|+|||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC--hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 4799999999999999999986 4699999999875422 234678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+++|+|.+++.+ ..+++.++..++.||+.||+||| +++|+||||||+|||++.++++||+|||+|+....
T Consensus 98 y~~gg~L~~~~~~------~~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~ 168 (293)
T d1yhwa1 98 YLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (293)
T ss_dssp CCTTCBHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ecCCCcHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence 9999999988754 46899999999999999999999 78999999999999999999999999999986644
Q ss_pred CCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCc
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDP 863 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (973)
.. ......+||+.|+|||++.+..|+.++||||+||++|||++|+.||......+... .+.. .-.+
T Consensus 169 ~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~------~~~~-------~~~~ 234 (293)
T d1yhwa1 169 EQ-SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY------LIAT-------NGTP 234 (293)
T ss_dssp TT-CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHH-------HCSC
T ss_pred cc-ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHH------HHHh-------CCCC
Confidence 33 23455689999999999999999999999999999999999999998765432211 1110 0011
Q ss_pred cccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 864 ALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 864 ~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
.+.. .......+.+++.+||+.||++|||+.|+++ +++++
T Consensus 235 ~~~~---~~~~s~~~~~li~~~L~~dP~~R~s~~eil~--Hp~~~ 274 (293)
T d1yhwa1 235 ELQN---PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ--HQFLK 274 (293)
T ss_dssp CCSS---GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT--CGGGG
T ss_pred CCCC---cccCCHHHHHHHHHHccCChhHCcCHHHHhc--CHhhC
Confidence 1110 1111245779999999999999999999987 66665
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-49 Score=418.18 Aligned_cols=252 Identities=27% Similarity=0.465 Sum_probs=208.6
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCC-CChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGV-TTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
++|+..+.||+|+||+||+|+.+ +|+.||||++.... ......+.+.+|++++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57899999999999999999875 68999999986431 11223467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++|+|.+++.. ...+++.++..++.||++||+||| +++||||||||+|||++.++.+||+|||+|+...
T Consensus 86 Ey~~~g~L~~~l~~-----~~~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~ 157 (263)
T d2j4za1 86 EYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 157 (263)
T ss_dssp ECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC
T ss_pred eecCCCcHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecC
Confidence 99999999999965 246899999999999999999999 7899999999999999999999999999998665
Q ss_pred CCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcC
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (973)
... .....||+.|||||++.+..|+.++|||||||++|||++|+.||......+. ...+..
T Consensus 158 ~~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------~~~i~~---------- 218 (263)
T d2j4za1 158 SSR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET------YKRISR---------- 218 (263)
T ss_dssp CCC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHT----------
T ss_pred CCc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHH------HHHHHc----------
Confidence 432 3456899999999999999999999999999999999999999987654321 111111
Q ss_pred ccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 863 PALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 863 ~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
....... .....+.+++.+|++.||++|||++||++ ++++.
T Consensus 219 ~~~~~p~---~~s~~~~~li~~~L~~dp~~R~t~~eil~--hp~~~ 259 (263)
T d2j4za1 219 VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREVLE--HPWIT 259 (263)
T ss_dssp TCCCCCT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHT--CHHHH
T ss_pred CCCCCCc---cCCHHHHHHHHHHccCCHhHCcCHHHHHc--CcCcC
Confidence 1111111 11234779999999999999999999987 55543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-49 Score=421.03 Aligned_cols=257 Identities=23% Similarity=0.352 Sum_probs=198.8
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEe--CCeEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIE--GNERLLV 701 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV 701 (973)
++|+..+.||+|+||+||+|+.+ +|+.||||+++.........+.+.+|++++++++|||||++++++.+ .+..|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 67999999999999999999875 68999999998765566677889999999999999999999999875 4567999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhc--cCCeeeccCCCCcEEECCCCCEEEeeccccc
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLA--RQTFIHRDLKSSNILLDDDYRAKVSDFGLVK 779 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~--~~~ivH~Dikp~Nill~~~~~~kl~DfGla~ 779 (973)
|||+++|+|.+++.+.... ...+++..++.++.||+.||+|||+.. ..+||||||||+|||++.++.+||+|||+|+
T Consensus 84 mEy~~~g~L~~~i~~~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 84 MEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EECCTTEEHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EecCCCCcHHHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 9999999999999764433 367999999999999999999999531 2459999999999999999999999999999
Q ss_pred cCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHh
Q 041143 780 LAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKA 859 (973)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (973)
...... ......+||+.|||||++.+..|+.++|||||||++|||+||+.||......+. . ..+..
T Consensus 163 ~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~---~---~~i~~------- 228 (269)
T d2java1 163 ILNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL---A---GKIRE------- 228 (269)
T ss_dssp HC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---H---HHHHH-------
T ss_pred ecccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHH---H---HHHHc-------
Confidence 765432 233457899999999999999999999999999999999999999987654321 1 11111
Q ss_pred hcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 860 AIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 860 ~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
.-.+.+. . .....+.+++.+||+.||.+|||+.|+++
T Consensus 229 ~~~~~~~-~----~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 229 GKFRRIP-Y----RYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp TCCCCCC-T----TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCCC-c----ccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 0011111 0 11235789999999999999999999986
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=422.28 Aligned_cols=257 Identities=24% Similarity=0.362 Sum_probs=204.7
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
++|+..+.||+|+||+||+|+.. +|+.||||++.... .....+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhh-cchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 57999999999999999999875 68999999997542 23344678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+++|+|.+++.. ...+++.++..++.||+.||+||| +++|+||||||+|||+++++.+||+|||+|+....
T Consensus 84 y~~gg~L~~~l~~-----~~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~ 155 (271)
T d1nvra_ 84 YCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRY 155 (271)
T ss_dssp CCTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred ccCCCcHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeecc
Confidence 9999999998853 356899999999999999999999 78999999999999999999999999999986543
Q ss_pred CC-cceecccccccCcccccccccCcC-CCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhc
Q 041143 784 GE-KSVVTRLAGTFGYLAPEYAVMGKI-TTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861 (973)
Q Consensus 784 ~~-~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (973)
.. ....+..+||+.|||||++.+..+ +.++||||+||++|||++|+.||.......... ....... ...
T Consensus 156 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~-----~~~~~~~----~~~ 226 (271)
T d1nvra_ 156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-----SDWKEKK----TYL 226 (271)
T ss_dssp TTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH-----HHHHTTC----TTS
T ss_pred CCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH-----HHHhcCC----CCC
Confidence 32 223455789999999999988776 578999999999999999999997654322111 0011000 000
Q ss_pred CccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 862 DPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 862 ~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
.+ .......+.+|+.+||+.||++|||++||++ +++++
T Consensus 227 ~~-------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~--hpwf~ 264 (271)
T d1nvra_ 227 NP-------WKKIDSAPLALLHKILVENPSARITIPDIKK--DRWYN 264 (271)
T ss_dssp TT-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT--CTTTT
T ss_pred Cc-------cccCCHHHHHHHHHHcCCChhHCcCHHHHhc--CHhhC
Confidence 00 0011234678999999999999999999987 45543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-49 Score=414.70 Aligned_cols=253 Identities=26% Similarity=0.409 Sum_probs=212.6
Q ss_pred cCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEe
Q 041143 625 QNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEY 704 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 704 (973)
++|+..+.||+|+||+||+|++++++.||||+++..... .++|.+|++++++++|||||+++|+|.+.+..++||||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~---~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC---HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC---HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 578899999999999999999998889999999865332 35799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCC
Q 041143 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG 784 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~ 784 (973)
+++|+|..++... ...+++..+++++.|||+||+||| +++|+||||||+||++++++.+||+|||+++.....
T Consensus 81 ~~~g~l~~~~~~~----~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 153 (258)
T d1k2pa_ 81 MANGCLLNYLREM----RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 153 (258)
T ss_dssp CTTEEHHHHHHSG----GGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred cCCCcHHHhhhcc----ccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCC
Confidence 9999999997652 256899999999999999999999 789999999999999999999999999999866555
Q ss_pred CcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCc
Q 041143 785 EKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDP 863 (973)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 863 (973)
.........||+.|+|||++.+..++.|+|||||||++|||+| |+.||......+.. ..+.. ...+
T Consensus 154 ~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~------~~i~~-------~~~~ 220 (258)
T d1k2pa_ 154 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA------EHIAQ-------GLRL 220 (258)
T ss_dssp SCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH------HHHHT-------TCCC
T ss_pred CceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHH------HHHHh-------CCCC
Confidence 4444555679999999999999999999999999999999998 89999877643221 11111 1111
Q ss_pred cccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHH
Q 041143 864 ALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSP 905 (973)
Q Consensus 864 ~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~ 905 (973)
.. . ......+.+++.+||+.||++|||++||++.|..
T Consensus 221 ~~--p---~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 221 YR--P---HLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CC--C---TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CC--c---ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 11 0 1122457899999999999999999999998753
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=417.67 Aligned_cols=251 Identities=27% Similarity=0.366 Sum_probs=201.2
Q ss_pred CcccccCccEEEEEEECC---CCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEecCC
Q 041143 631 NELGRGGFGTVYKGELED---GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYMPH 707 (973)
Q Consensus 631 ~~lG~G~fg~Vy~~~~~~---g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 707 (973)
++||+|+||+||+|.+++ ++.||||+++.........++|.+|+++|++++|||||+++|+|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 569999999999997643 4689999997655555667789999999999999999999999865 567899999999
Q ss_pred CCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCCcc
Q 041143 708 GALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGEKS 787 (973)
Q Consensus 708 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~~~ 787 (973)
|+|.++++. ...++|.+++.++.|||+||+||| +++||||||||+|||++.++.+||+|||+|+........
T Consensus 92 g~L~~~l~~-----~~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 92 GPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163 (277)
T ss_dssp EEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred CcHHHHHhh-----ccCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence 999999865 256899999999999999999999 789999999999999999999999999999865543332
Q ss_pred e--ecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCcc
Q 041143 788 V--VTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPA 864 (973)
Q Consensus 788 ~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 864 (973)
. .....||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+....+. .. .+.. ...+.
T Consensus 164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~---~~---~i~~-------~~~~~ 230 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV---TA---MLEK-------GERMG 230 (277)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HH---HHHT-------TCCCC
T ss_pred cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHH---HH---HHHc-------CCCCC
Confidence 2 234579999999999999999999999999999999998 8999987654321 11 1111 01111
Q ss_pred ccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 865 LEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 865 l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
.. ......+.+|+.+||+.||++||||++|++.|+.+..
T Consensus 231 ~p-----~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 231 CP-----AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp CC-----TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CC-----cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 11 1122457799999999999999999999999987654
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-48 Score=411.85 Aligned_cols=246 Identities=27% Similarity=0.417 Sum_probs=198.3
Q ss_pred cccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEe----CCeEEEEE
Q 041143 628 AQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIE----GNERLLVY 702 (973)
Q Consensus 628 ~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~ 702 (973)
+..++||+|+||+||+|++. +++.||+|++..........+.|.+|+++|++++|||||++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45567999999999999875 68899999997765566667889999999999999999999999875 34578999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCC--eeeccCCCCcEEEC-CCCCEEEeeccccc
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQT--FIHRDLKSSNILLD-DDYRAKVSDFGLVK 779 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~--ivH~Dikp~Nill~-~~~~~kl~DfGla~ 779 (973)
||+++|+|.+++.+. ..+++.++..++.||++||+||| +++ |+||||||+|||++ +++.+||+|||+|+
T Consensus 92 E~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp ECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred eCCCCCcHHHHHhcc-----ccccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence 999999999999652 46899999999999999999999 666 99999999999996 57899999999998
Q ss_pred cCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHh
Q 041143 780 LAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKA 859 (973)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (973)
..... .....+||+.|||||++.+ .++.++|||||||++|||++|+.||........ + ...+..
T Consensus 164 ~~~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~--~---~~~i~~------- 227 (270)
T d1t4ha_ 164 LKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--I---YRRVTS------- 227 (270)
T ss_dssp GCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--H---HHHHTT-------
T ss_pred eccCC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH--H---HHHHHc-------
Confidence 65432 2345689999999998865 699999999999999999999999976543221 1 111111
Q ss_pred hcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 860 AIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 860 ~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
...+. .........+.+++.+||+.||++|||++|+++
T Consensus 228 ~~~~~----~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 228 GVKPA----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp TCCCG----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCc----ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 01110 001111234779999999999999999999987
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=417.81 Aligned_cols=259 Identities=27% Similarity=0.456 Sum_probs=202.9
Q ss_pred cCccccCcccccCccEEEEEEECCC-----CEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELEDG-----TKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERL 699 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~g-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 699 (973)
+.|+..++||+|+||.||+|.++.. ..||||+++.. .......+|.+|++++++++|||||+++|++.+.+..+
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc-cChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 4678889999999999999987532 36999999754 34555678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccc
Q 041143 700 LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK 779 (973)
Q Consensus 700 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~ 779 (973)
+||||+.+|++.+++.. ....++|.+++.++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+
T Consensus 86 ~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 86 IITEYMENGALDKFLRE----KDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSR 158 (283)
T ss_dssp EEEECCTTEEHHHHHHH----TTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred EEEEecccCcchhhhhc----ccccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhh
Confidence 99999999999988754 2356899999999999999999999 7899999999999999999999999999998
Q ss_pred cCCCCCc--ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHH
Q 041143 780 LAPDGEK--SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKF 857 (973)
Q Consensus 780 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (973)
....... .......||+.|+|||++.++.++.++|||||||++|||++|..|+........ +.. .+.
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~--~~~---~i~------ 227 (283)
T d1mqba_ 159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--VMK---AIN------ 227 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHH---HHH------
T ss_pred cccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH--HHH---HHh------
Confidence 6544322 222345689999999999999999999999999999999997666544332211 111 111
Q ss_pred HhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 858 KAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 858 ~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
....+... ......+.+|+.+||+.||++||+|.||++.|+++++
T Consensus 228 -~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 228 -DGFRLPTP-----MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp -TTCCCCCC-----TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -ccCCCCCc-----hhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 11111111 1223457899999999999999999999999999876
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=416.51 Aligned_cols=258 Identities=26% Similarity=0.374 Sum_probs=208.7
Q ss_pred cCccccCc-ccccCccEEEEEEEC---CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEE
Q 041143 625 QNFAQENE-LGRGGFGTVYKGELE---DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLL 700 (973)
Q Consensus 625 ~~~~~~~~-lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 700 (973)
++|...+. ||+|+||.||+|.++ ++..||||+++.. ......++|.+|+++|++++|||||+++|+|.+ +..++
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 45666664 999999999999764 3557999999764 345567889999999999999999999999865 56899
Q ss_pred EEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecccccc
Q 041143 701 VYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKL 780 (973)
Q Consensus 701 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~ 780 (973)
||||+++|+|.+++.. ....+++.++..++.|||+||+||| +++|+||||||+|||++.++.+||+|||+|+.
T Consensus 86 vmE~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKA 158 (285)
T ss_dssp EEECCTTEEHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEeCCCCcHHHHhhc----cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhc
Confidence 9999999999998854 2256899999999999999999999 78999999999999999999999999999996
Q ss_pred CCCCCcc--eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHH
Q 041143 781 APDGEKS--VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKF 857 (973)
Q Consensus 781 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (973)
....... ......||+.|+|||++..+.++.++|||||||++|||+| |+.||......+. . ..+..
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~---~---~~i~~----- 227 (285)
T d1u59a_ 159 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV---M---AFIEQ----- 227 (285)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH---H---HHHHT-----
T ss_pred ccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHH---H---HHHHc-----
Confidence 6543322 2234578999999999999999999999999999999998 9999987654321 1 11111
Q ss_pred HhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 858 KAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 858 ~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
...+... ......+.+|+.+||+.||++||+|.+|++.|+.....
T Consensus 228 --~~~~~~p-----~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 228 --GKRMECP-----PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp --TCCCCCC-----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CCCCCCC-----CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 1111111 11224577999999999999999999999999877653
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=416.20 Aligned_cols=258 Identities=29% Similarity=0.466 Sum_probs=203.4
Q ss_pred cCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEe
Q 041143 625 QNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEY 704 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 704 (973)
++|++.+.||+|+||.||+|++++++.||||+++..... .+.|.+|+.++++++|||||+++|+|.+ +..++||||
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey 92 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 92 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC---HHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEe
Confidence 678999999999999999999998889999999765332 3579999999999999999999999854 568999999
Q ss_pred cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCC
Q 041143 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG 784 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~ 784 (973)
+++|+|..++.... ...++|.+++.|+.|||+||+||| +++|+||||||+|||+++++++||+|||+|+.....
T Consensus 93 ~~~g~l~~~~~~~~---~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 93 MSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp CTTCBHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred cCCCchhhhhhhcc---cccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCC
Confidence 99999999887632 246899999999999999999999 789999999999999999999999999999876555
Q ss_pred CcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcCcc
Q 041143 785 EKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAIDPA 864 (973)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 864 (973)
.........||+.|+|||++..+.++.++|||||||++|||++|..|+........ +..+ +.. ...+.
T Consensus 167 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~--~~~~---i~~-------~~~~~ 234 (285)
T d1fmka3 167 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQ---VER-------GYRMP 234 (285)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHH---HHT-------TCCCC
T ss_pred CceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH--HHHH---HHh-------cCCCC
Confidence 44445556799999999999999999999999999999999997666544332211 1111 111 11111
Q ss_pred ccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 865 LEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 865 l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
.. ......+.+++.+||+.||++||+|++|+++|+.+...
T Consensus 235 ~~-----~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 235 CP-----PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp CC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CC-----cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 11 11224578999999999999999999999999887654
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=418.09 Aligned_cols=255 Identities=26% Similarity=0.388 Sum_probs=207.3
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
+.|+..+.||+|+||+||+|+.. +|+.||||+++.. .....+.+.+|++++++++|||||++++++.+.+..++|||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 46888999999999999999875 6899999999754 34445678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+++|+|.+++.+. ...+++.++..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+....
T Consensus 90 y~~~g~L~~~~~~~----~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~ 162 (288)
T d2jfla1 90 FCAGGAVDAVMLEL----ERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 162 (288)
T ss_dssp CCTTEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred cCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCC
Confidence 99999999988652 256899999999999999999999 78999999999999999999999999999975432
Q ss_pred CCcceecccccccCcccccccc-----cCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHH
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAV-----MGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFK 858 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (973)
. ........||+.|+|||++. ...|+.++|||||||++|||+||+.||......+.. ..+...
T Consensus 163 ~-~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~------~~i~~~----- 230 (288)
T d2jfla1 163 T-IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL------LKIAKS----- 230 (288)
T ss_dssp H-HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH------HHHHHS-----
T ss_pred C-cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHH------HHHHcC-----
Confidence 1 11234568999999999984 456899999999999999999999999876543321 111110
Q ss_pred hhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhh
Q 041143 859 AAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLV 907 (973)
Q Consensus 859 ~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~ 907 (973)
-.+.+. ........+.+|+.+||+.||++|||++|+++ ++++
T Consensus 231 --~~~~~~---~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~--hp~~ 272 (288)
T d2jfla1 231 --EPPTLA---QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ--HPFV 272 (288)
T ss_dssp --CCCCCS---SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT--SGGG
T ss_pred --CCCCCC---ccccCCHHHHHHHHHHccCChhHCcCHHHHhc--Cccc
Confidence 011111 11112245789999999999999999999987 4444
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-48 Score=424.38 Aligned_cols=260 Identities=25% Similarity=0.412 Sum_probs=205.6
Q ss_pred hcCccccCcccccCccEEEEEEECC-C-----CEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCC
Q 041143 624 TQNFAQENELGRGGFGTVYKGELED-G-----TKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGN 696 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~~-g-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 696 (973)
.++|+..+.||+|+||+||+|++.. + ..||||++.... .......+.+|+.++.++ +|||||++++++.+.+
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 3678899999999999999998643 2 369999986542 334456789999999998 8999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhhhh------------------ccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCC
Q 041143 697 ERLLVYEYMPHGALSRHLFRWEK------------------LQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLK 758 (973)
Q Consensus 697 ~~~lV~e~~~~g~L~~~l~~~~~------------------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dik 758 (973)
..++||||+++|+|.++++..+. .....++|..++.|+.||++||+||| +++|||||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCS
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCc
Confidence 99999999999999999976332 11245899999999999999999999 7899999999
Q ss_pred CCcEEECCCCCEEEeeccccccCCCCCc-ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCC
Q 041143 759 SSNILLDDDYRAKVSDFGLVKLAPDGEK-SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEER 836 (973)
Q Consensus 759 p~Nill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~ 836 (973)
|+|||++.++.+||+|||+|+....... .......||+.|||||++.++.++.++|||||||++|||+| |+.||.+..
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999985543332 23445678999999999999999999999999999999998 899998654
Q ss_pred hhhHHHHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHH
Q 041143 837 PEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLS 904 (973)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~ 904 (973)
.... +. .+.. ....+... ......+.+|+.+||+.||++||||+||++.|.
T Consensus 272 ~~~~--~~----~~~~------~~~~~~~p-----~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 272 VDAN--FY----KLIQ------NGFKMDQP-----FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CSHH--HH----HHHH------TTCCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHH--HH----HHHh------cCCCCCCC-----CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 3321 11 1111 11111111 112245789999999999999999999999884
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-48 Score=423.77 Aligned_cols=269 Identities=22% Similarity=0.345 Sum_probs=209.4
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
.++|+..+.||+|+||+||+|+.. +|+.||+|+++... .....+.+.+|+.+|++++|||||+++++|.+.+..++||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 468999999999999999999874 68999999997653 3444578999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++|+|.+++.+. ..+++..+..++.|+++||+|||+ .++|+||||||+|||++.++++||+|||+|+...
T Consensus 84 Ey~~gg~L~~~l~~~-----~~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp ECCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EcCCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 999999999999752 458999999999999999999993 2489999999999999999999999999998543
Q ss_pred CCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHH-HHHHh--------hc
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEW-FWRIK--------SS 853 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~-~~~~~--------~~ 853 (973)
+. .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||......+....... ..... ..
T Consensus 157 ~~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
T d1s9ja_ 157 DS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233 (322)
T ss_dssp HH---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred CC---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence 21 23456899999999999999999999999999999999999999987654322111000 00000 00
Q ss_pred -----------------hhHHHhhc---CccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 854 -----------------KEKFKAAI---DPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 854 -----------------~~~~~~~~---~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
........ .+.+... .....+.+++.+||+.||++|||++|+++ ++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~s~~~~dli~~~L~~dP~~R~ta~e~L~--Hpf~~~ 303 (322)
T d1s9ja_ 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSG----VFSLEFQDFVNKCLIKNPAERADLKQLMV--HAFIKR 303 (322)
T ss_dssp ------------CCCCHHHHHHHHHTSCCCCCCBT----TBCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHHH
T ss_pred cccccccccccccchhHHHHHhhhhccCCccCccc----cCCHHHHHHHHHHcCCChhHCcCHHHHhh--CHhhCc
Confidence 00000000 0111100 01235789999999999999999999998 666654
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-48 Score=416.58 Aligned_cols=250 Identities=22% Similarity=0.340 Sum_probs=203.7
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCC-CChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGV-TTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
++|+..+.||+|+||+||+|+.. +|+.||||+++... ......+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999874 68999999986431 11223467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++|+|.+++.. ...+++..+..++.|++.||+||| +++||||||||+|||+++++.+||+|||+|+...
T Consensus 88 Ey~~gg~L~~~~~~-----~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 159 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 159 (288)
T ss_dssp CCCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EccCCCCHHHhhhc-----cCCCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecc
Confidence 99999999998865 256899999999999999999999 8899999999999999999999999999998664
Q ss_pred CCC-cceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhc
Q 041143 783 DGE-KSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861 (973)
Q Consensus 783 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (973)
... .......+||+.|+|||++.+..|+.++||||+||++|||++|+.||......+. ...+...
T Consensus 160 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~------~~~i~~~-------- 225 (288)
T d1uu3a_ 160 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI------FQKIIKL-------- 225 (288)
T ss_dssp ----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHTT--------
T ss_pred cCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHH------HHHHHcC--------
Confidence 332 2334456899999999999999999999999999999999999999987653321 1111111
Q ss_pred CccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHH
Q 041143 862 DPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVN 901 (973)
Q Consensus 862 ~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~ 901 (973)
.+.... .....+.+|+.+||+.||++|||++|+++
T Consensus 226 --~~~~p~---~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 226 --EYDFPE---KFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp --CCCCCT---TCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred --CCCCCc---cCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 111111 11234779999999999999999999865
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-47 Score=416.38 Aligned_cols=253 Identities=26% Similarity=0.420 Sum_probs=207.1
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
+.|+..+.||+|+||+||+|+.. +|+.||||+++.... .....+.+.+|+++|++++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 45899999999999999999864 688999999976533 3445677999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++|+|..++.. ...+++.++..++.||+.||+||| +++||||||||+|||++.++++||+|||+|+...
T Consensus 95 E~~~~g~l~~~~~~-----~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH-----KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (309)
T ss_dssp ECCSEEHHHHHHHH-----TSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred EecCCCchHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccC
Confidence 99999999766543 256899999999999999999999 8899999999999999999999999999998654
Q ss_pred CCCcceecccccccCccccccccc---CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHh
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVM---GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKA 859 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 859 (973)
. .....||+.|||||++.+ +.|+.++|||||||++|||++|+.||......+. +..+..
T Consensus 167 ~-----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~------~~~i~~------- 228 (309)
T d1u5ra_ 167 P-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQ------- 228 (309)
T ss_dssp S-----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHH-------
T ss_pred C-----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH------HHHHHh-------
Confidence 3 234579999999999864 4689999999999999999999999986653321 111111
Q ss_pred hcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 860 AIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 860 ~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
...+.+... .....+.+++.+||+.||++|||++|+++ ++++.+
T Consensus 229 ~~~~~~~~~----~~s~~~~~li~~~L~~dP~~Rpt~~ell~--Hp~~~~ 272 (309)
T d1u5ra_ 229 NESPALQSG----HWSEYFRNFVDSCLQKIPQDRPTSEVLLK--HRFVLR 272 (309)
T ss_dssp SCCCCCSCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHTT--CHHHHS
T ss_pred CCCCCCCCC----CCCHHHHHHHHHHCcCChhHCcCHHHHHh--CHHhcC
Confidence 111111111 11235789999999999999999999988 666654
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.9e-47 Score=412.76 Aligned_cols=258 Identities=24% Similarity=0.368 Sum_probs=194.0
Q ss_pred HhcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEE
Q 041143 623 VTQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLV 701 (973)
Q Consensus 623 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 701 (973)
+.+.|+..+.||+|+||+||+|+.. +|+.||||++..... ....+.+.+|++++++++|||||++++++.+++..|+|
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL-EGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHh-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 3467999999999999999999875 689999999975432 22345688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEEC---CCCCEEEeecccc
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLD---DDYRAKVSDFGLV 778 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~---~~~~~kl~DfGla 778 (973)
|||+++|+|.+++.. ...+++.++..++.||+.||+||| +++|+||||||+|||+. +++.+||+|||+|
T Consensus 86 mE~~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a 157 (307)
T d1a06a_ 86 MQLVSGGELFDRIVE-----KGFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLS 157 (307)
T ss_dssp ECCCCSCBHHHHHHT-----CSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC---
T ss_pred EeccCCCcHHHhhhc-----ccCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEecccee
Confidence 999999999999964 256899999999999999999999 88999999999999994 5789999999999
Q ss_pred ccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHH
Q 041143 779 KLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFK 858 (973)
Q Consensus 779 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (973)
+...... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||......+. . ..+......
T Consensus 158 ~~~~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~---~---~~i~~~~~~-- 227 (307)
T d1a06a_ 158 KMEDPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL---F---EQILKAEYE-- 227 (307)
T ss_dssp -----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---H---HHHHTTCCC--
T ss_pred EEccCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHH---H---HHHhccCCC--
Confidence 8654332 23456899999999999999999999999999999999999999987654321 1 111111100
Q ss_pred hhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 859 AAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 859 ~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
.+.. ........+.+++.+|++.||++|||++|+++ +++++
T Consensus 228 --~~~~-----~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~--hp~~~ 268 (307)
T d1a06a_ 228 --FDSP-----YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ--HPWIA 268 (307)
T ss_dssp --CCTT-----TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH--STTTT
T ss_pred --CCCc-----cccCCCHHHHHHHHHHccCCHhHCcCHHHHhc--CHhhC
Confidence 0000 00112245789999999999999999999988 55554
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-47 Score=416.05 Aligned_cols=267 Identities=28% Similarity=0.419 Sum_probs=214.1
Q ss_pred HHHHhcCccccCcccccCccEEEEEEEC------CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEE
Q 041143 620 LRKVTQNFAQENELGRGGFGTVYKGELE------DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSI 693 (973)
Q Consensus 620 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 693 (973)
++...++|+..+.||+|+||+||+|+.+ +++.||||+++.. ......++|.+|++++++++||||++++++|.
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh-cChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 4445678999999999999999999864 3578999998754 34556678999999999999999999999999
Q ss_pred eCCeEEEEEEecCCCCHHHHHHhhhh-------------------ccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeee
Q 041143 694 EGNERLLVYEYMPHGALSRHLFRWEK-------------------LQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIH 754 (973)
Q Consensus 694 ~~~~~~lV~e~~~~g~L~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH 754 (973)
..+..++||||+++|+|.++++.... .....++|.+++.|+.|+|.||+||| +++|||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEe
Confidence 99999999999999999999975321 11235899999999999999999999 889999
Q ss_pred ccCCCCcEEECCCCCEEEeeccccccCCCCC-cceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCC-CCC
Q 041143 755 RDLKSSNILLDDDYRAKVSDFGLVKLAPDGE-KSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGL-AAL 832 (973)
Q Consensus 755 ~Dikp~Nill~~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~-~p~ 832 (973)
|||||+|||++.++.+||+|||+|+...... ....+...||+.|+|||++.+..|+.++|||||||++|||++|. +||
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 9999999999999999999999998543322 22334567999999999999999999999999999999999995 567
Q ss_pred CCCChhhHHHHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 833 DEERPEESRYLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
......+.. ..+... -.+... ......+.+|+.+||+.||++||||.||+++|+++.+
T Consensus 244 ~~~~~~e~~------~~v~~~-------~~~~~p-----~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 244 YGMAHEEVI------YYVRDG-------NILACP-----ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp TTSCHHHHH------HHHHTT-------CCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCCCHHHHH------HHHHcC-------CCCCCC-----ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 765543221 111110 001111 1122457899999999999999999999999998753
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=9.5e-47 Score=415.72 Aligned_cols=258 Identities=24% Similarity=0.366 Sum_probs=211.7
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
.++|++.+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 102 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 102 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc--chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 468999999999999999999874 6899999999754 4555678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEEC--CCCCEEEeecccccc
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLD--DDYRAKVSDFGLVKL 780 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~--~~~~~kl~DfGla~~ 780 (973)
||+++|+|.+++.. ....+++.++..|+.||+.||+||| +++||||||||+|||++ .++.+||+|||+|+.
T Consensus 103 E~~~gg~L~~~l~~----~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~ 175 (350)
T d1koaa2 103 EFMSGGELFEKVAD----EHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 175 (350)
T ss_dssp CCCCSCBHHHHHTC----TTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EcCCCCCHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchhee
Confidence 99999999999854 1246899999999999999999999 88999999999999996 468899999999987
Q ss_pred CCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhh
Q 041143 781 APDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAA 860 (973)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (973)
..... ......||+.|||||++.+..|+.++||||+||++|||++|+.||.+....+. +..+.......
T Consensus 176 ~~~~~--~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------~~~i~~~~~~~--- 244 (350)
T d1koaa2 176 LDPKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET------LRNVKSCDWNM--- 244 (350)
T ss_dssp CCTTS--CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHTCCCS---
T ss_pred ccccc--ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH------HHHHHhCCCCC---
Confidence 65433 23456899999999999999999999999999999999999999987654321 11121111000
Q ss_pred cCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 861 IDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 861 ~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
+.. ........+.+++.+||+.||++|||++|+++ ++++..
T Consensus 245 -~~~-----~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~--hp~~~~ 285 (350)
T d1koaa2 245 -DDS-----AFSGISEDGKDFIRKLLLADPNTRMTIHQALE--HPWLTP 285 (350)
T ss_dssp -CCG-----GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH--STTTSC
T ss_pred -Ccc-----cccCCCHHHHHHHHHHccCChhHCcCHHHHhc--CcccCC
Confidence 000 00111235779999999999999999999998 666554
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-47 Score=404.55 Aligned_cols=259 Identities=23% Similarity=0.392 Sum_probs=200.5
Q ss_pred hcCccccCcccccCccEEEEEEECC----CCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELED----GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERL 699 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 699 (973)
.++|+..+.||+|+||.||+|++.. +..||||+++.. ......+.|.+|++++++++|||||+++|++. .+..+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence 3678899999999999999998642 356889988653 34556678999999999999999999999986 46789
Q ss_pred EEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccc
Q 041143 700 LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK 779 (973)
Q Consensus 700 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~ 779 (973)
+||||+++|+|.+++... ...+++.+++.++.||++||+||| +++|+||||||+||+++.++.+||+|||+|+
T Consensus 84 iv~E~~~~g~l~~~~~~~----~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVR----KYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp EEEECCTTEEHHHHHHHT----TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEEeccCCcHHhhhhcc----CCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhhe
Confidence 999999999999987652 356899999999999999999999 8899999999999999999999999999998
Q ss_pred cCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHH
Q 041143 780 LAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFK 858 (973)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (973)
..............||+.|+|||++.+..++.++|||||||++|||+| |+.||......+.. . .+...
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~---~---~i~~~----- 225 (273)
T d1mp8a_ 157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---G---RIENG----- 225 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---H---HHHTT-----
T ss_pred eccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHH---H---HHHcC-----
Confidence 765544444556678999999999999999999999999999999998 89999877654321 1 11110
Q ss_pred hhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 859 AAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 859 ~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
..+... ......+.+|+.+||+.||++|||+.||++.|+.+.++
T Consensus 226 --~~~~~~-----~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 226 --ERLPMP-----PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp --CCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CCCCCC-----CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 011111 11224578999999999999999999999999988764
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-47 Score=401.30 Aligned_cols=251 Identities=30% Similarity=0.452 Sum_probs=199.9
Q ss_pred cCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeC-CeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEG-NERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lV~e 703 (973)
++|+..+.||+|+||.||+|+++ |++||||+++.. ...+.|.+|++++++++|||||+++|+|.+. +..++|||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 56888899999999999999986 789999999653 2346789999999999999999999999754 56799999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+++|+|.++++.... ..++|..+++|+.|||.||+||| +++|+||||||+|||++.++.+||+|||+++....
T Consensus 82 y~~~g~L~~~l~~~~~---~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 82 YMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp CCTTEEHHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred ccCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCC
Confidence 9999999999976322 45899999999999999999999 78999999999999999999999999999986533
Q ss_pred CCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcC
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (973)
. .....+|..|+|||++.++.++.++|||||||++|||+| |+.||......+. ..++ . ....
T Consensus 156 ~----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~---~~~i---~-------~~~~ 218 (262)
T d1byga_ 156 T----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPRV---E-------KGYK 218 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---HHHH---T-------TTCC
T ss_pred C----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHH---HHHH---H-------cCCC
Confidence 2 233468999999999999999999999999999999998 6888876544322 1111 1 1111
Q ss_pred ccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 863 PALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 863 ~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
+.+. . .....+.+|+.+||+.||.+||||.||+++|+.+..
T Consensus 219 ~~~~--~---~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 219 MDAP--D---GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp CCCC--T---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCC--c---cCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 1111 1 122457799999999999999999999999998754
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-46 Score=403.66 Aligned_cols=258 Identities=22% Similarity=0.366 Sum_probs=209.8
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCC----hHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTT----TKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNER 698 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 698 (973)
.++|+..+.||+|+||+||+|+.. +|+.||||+++..... ....+.+.+|+++|++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 468999999999999999999874 6899999998654221 12357899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCC----CEEEee
Q 041143 699 LLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDY----RAKVSD 774 (973)
Q Consensus 699 ~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~----~~kl~D 774 (973)
++||||+++|+|.+++... ..+++.++..++.||+.||+||| +++|+||||||+|||++.++ .+|++|
T Consensus 89 ~iv~E~~~gg~L~~~i~~~-----~~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~D 160 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIID 160 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEcCCCccccchhccc-----cccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecc
Confidence 9999999999999999652 46899999999999999999999 88999999999999998776 499999
Q ss_pred ccccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhch
Q 041143 775 FGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSK 854 (973)
Q Consensus 775 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 854 (973)
||+|+...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+. ...+....
T Consensus 161 fG~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~------~~~i~~~~ 232 (293)
T d1jksa_ 161 FGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET------LANVSAVN 232 (293)
T ss_dssp CTTCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHTTC
T ss_pred hhhhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH------HHHHHhcC
Confidence 99998765433 23456799999999999999999999999999999999999999987654321 11111111
Q ss_pred hHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 855 EKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 855 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
........ ......+.+++.+||+.||++|||++|+++ +++++
T Consensus 233 ~~~~~~~~---------~~~s~~~~~li~~~L~~dP~~R~s~~eil~--hp~~~ 275 (293)
T d1jksa_ 233 YEFEDEYF---------SNTSALAKDFIRRLLVKDPKKRMTIQDSLQ--HPWIK 275 (293)
T ss_dssp CCCCHHHH---------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH--STTTC
T ss_pred CCCCchhc---------CCCCHHHHHHHHHHccCChhHCcCHHHHhc--CcccC
Confidence 00000000 011234779999999999999999999987 55554
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.8e-46 Score=410.39 Aligned_cols=257 Identities=21% Similarity=0.318 Sum_probs=210.6
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
.++|+..+.||+|+||.||+|+.. +|+.||||+++.. .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 105 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 105 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc--chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 357999999999999999999874 6999999999764 3445667899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEEC--CCCCEEEeecccccc
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLD--DDYRAKVSDFGLVKL 780 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~--~~~~~kl~DfGla~~ 780 (973)
||+++|+|.+++.. ....+++.++..|+.||+.||+||| +++||||||||+|||++ .++.+||+|||+|+.
T Consensus 106 E~~~gg~L~~~~~~----~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~ 178 (352)
T d1koba_ 106 EFLSGGELFDRIAA----EDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATK 178 (352)
T ss_dssp ECCCCCBHHHHTTC----TTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred EcCCCChHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeeccccee
Confidence 99999999887754 2246899999999999999999999 88999999999999998 578999999999997
Q ss_pred CCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhh
Q 041143 781 APDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAA 860 (973)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (973)
..... ......||+.|+|||++.+..|+.++||||+||++|||+||+.||.+....+. +..+......
T Consensus 179 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~i~~~~~~---- 246 (352)
T d1koba_ 179 LNPDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET------LQNVKRCDWE---- 246 (352)
T ss_dssp CCTTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHHHHHCCCC----
T ss_pred cCCCC--ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhCCCC----
Confidence 65433 23456799999999999999999999999999999999999999987654321 1111111100
Q ss_pred cCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 861 IDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 861 ~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
..... .......+.+|+.+||+.||.+|||+.|+++ +++++
T Consensus 247 ~~~~~-----~~~~s~~~~~li~~~L~~dp~~R~s~~eil~--Hp~~~ 287 (352)
T d1koba_ 247 FDEDA-----FSSVSPEAKDFIKNLLQKEPRKRLTVHDALE--HPWLK 287 (352)
T ss_dssp CCSST-----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT--STTTS
T ss_pred CCccc-----ccCCCHHHHHHHHHHccCChhHCcCHHHHhc--CHhhC
Confidence 01100 0112235779999999999999999999987 55554
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=409.73 Aligned_cols=258 Identities=28% Similarity=0.411 Sum_probs=203.3
Q ss_pred cCccccCcccccCccEEEEEEEC-CCC----EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGT----KIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERL 699 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 699 (973)
.+|+..++||+|+||+||+|.+. +|+ +||||+++.. ...+..++|.+|++++++++|||||+++|+|.++ ..+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~ 86 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 86 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Cee
Confidence 46899999999999999999864 343 6899988654 2344567899999999999999999999999865 567
Q ss_pred EEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccc
Q 041143 700 LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK 779 (973)
Q Consensus 700 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~ 779 (973)
+||||+.+|+|.+++.. ....+++..+++++.|||+||+||| +++||||||||+|||++.++.+||+|||+|+
T Consensus 87 ~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~ 159 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAK 159 (317)
T ss_dssp EEEECCTTCBHHHHHHH----TSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred EEEEeccCCcccccccc----cccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccce
Confidence 88999999999998865 2357899999999999999999999 7899999999999999999999999999999
Q ss_pred cCCCCCcc-eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhHH
Q 041143 780 LAPDGEKS-VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEKF 857 (973)
Q Consensus 780 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (973)
........ ......||+.|+|||++.++.|+.++|||||||++|||+| |+.||+.....+.... + .
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~---i---~------ 227 (317)
T d1xkka_ 160 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---L---E------ 227 (317)
T ss_dssp HTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHH---H---H------
T ss_pred ecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHH---H---H------
Confidence 65543322 2344578999999999999999999999999999999998 7899887654332111 1 1
Q ss_pred HhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 858 KAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 858 ~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
....+.. +......+.+|+.+||+.||++|||+.||++.|..+.+.
T Consensus 228 -~~~~~~~-----p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 228 -KGERLPQ-----PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp -HTCCCCC-----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -cCCCCCC-----CcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 1011111 111224578999999999999999999999999887653
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=8.7e-46 Score=397.17 Aligned_cols=261 Identities=22% Similarity=0.321 Sum_probs=203.7
Q ss_pred hcCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC----e
Q 041143 624 TQNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGN----E 697 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~ 697 (973)
.++|++.+.||+|+||.||+|+. .+|+.||||+++.... .....+.|.+|++++++++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 36799999999999999999986 4789999999976533 4455678999999999999999999999998654 3
Q ss_pred EEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccc
Q 041143 698 RLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL 777 (973)
Q Consensus 698 ~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGl 777 (973)
.|+||||+++|+|.+++.. ...+++.++..++.||+.||+||| +++|+||||||+|||++.++..+++|||.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~-----~~~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~ 157 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGI 157 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTT
T ss_pred EEEEEECCCCCEehhhhcc-----cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhh
Confidence 7899999999999998865 246899999999999999999999 88999999999999999999999999999
Q ss_pred cccCCCCC--cceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchh
Q 041143 778 VKLAPDGE--KSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKE 855 (973)
Q Consensus 778 a~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 855 (973)
++...... .......+||+.|+|||++.+..++.++|||||||++|||+||+.||......+. +..+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~~~~~~~ 231 (277)
T d1o6ya_ 158 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDP 231 (277)
T ss_dssp CEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHCCC
T ss_pred hhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH------HHHHHhcCC
Confidence 87543322 2234456899999999999999999999999999999999999999987654321 111111111
Q ss_pred HHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCC-CHhHHHHHHHHhh
Q 041143 856 KFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRP-DMGHVVNVLSPLV 907 (973)
Q Consensus 856 ~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-s~~~v~~~L~~~~ 907 (973)
.......+. ....+.+++.+|++.||++|| +++++.+.|.++.
T Consensus 232 ~~~~~~~~~---------~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 232 IPPSARHEG---------LSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CCGGGTSSS---------CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCCchhccC---------CCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 111111111 124577999999999999999 8999988887653
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=407.25 Aligned_cols=270 Identities=23% Similarity=0.350 Sum_probs=204.1
Q ss_pred cCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC----eEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGN----ERLL 700 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~l 700 (973)
++|...+.||+|+||.||+|+++ |+.||||+++.. ......++.|+..+.+++|||||+++++|.+.+ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 56778889999999999999875 889999998643 222222334555556789999999999998754 5789
Q ss_pred EEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhh-----ccCCeeeccCCCCcEEECCCCCEEEeec
Q 041143 701 VYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCL-----ARQTFIHRDLKSSNILLDDDYRAKVSDF 775 (973)
Q Consensus 701 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~-----~~~~ivH~Dikp~Nill~~~~~~kl~Df 775 (973)
||||+++|+|.+++++ ..++|.++++++.|+|.||+|||+. .+++||||||||+|||++.++.+||+||
T Consensus 79 v~Ey~~~g~L~~~l~~------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF 152 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEecccCCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence 9999999999999975 4689999999999999999999953 2479999999999999999999999999
Q ss_pred cccccCCCCCcc---eecccccccCcccccccccC------cCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHH----
Q 041143 776 GLVKLAPDGEKS---VVTRLAGTFGYLAPEYAVMG------KITTKADVFSYGVVLMELLTGLAALDEERPEESRY---- 842 (973)
Q Consensus 776 Gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~---- 842 (973)
|+++........ ......||+.|+|||++... .++.|+|||||||++|||+||..|+..........
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~ 232 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcc
Confidence 999865443322 23456899999999998754 36779999999999999999998875433211000
Q ss_pred ----HHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 843 ----LAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 843 ----~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
....... .......+|.+.......+....+.+|+.+||+.||++||||.||++.|+++.++
T Consensus 233 ~~~~~~~~~~~-----~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 233 PSDPSVEEMRK-----VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CSSCCHHHHHH-----HHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccchHHHHHH-----HHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 0011111 1111222333322222345667788999999999999999999999999998765
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.5e-46 Score=405.08 Aligned_cols=251 Identities=27% Similarity=0.419 Sum_probs=207.4
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
++|+..+.||+|+||+||+|+.+ +|+.||||+++.... .....+.+.+|+.++++++|||||++++++.+.+..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57999999999999999999874 699999999864311 1223567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++|+|..++.. ...+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+...
T Consensus 84 E~~~gg~l~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~ 155 (316)
T d1fota_ 84 DYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP 155 (316)
T ss_dssp CCCCSCBHHHHHHH-----TSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred eecCCccccccccc-----cccccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEec
Confidence 99999999988865 245788899999999999999999 8899999999999999999999999999998765
Q ss_pred CCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcC
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (973)
+. ....+||+.|||||++.+..|+.++||||+||++|||++|+.||......+. ...+...... +.
T Consensus 156 ~~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------~~~i~~~~~~----~p 221 (316)
T d1fota_ 156 DV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT------YEKILNAELR----FP 221 (316)
T ss_dssp SC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHHCCCC----CC
T ss_pred cc----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH------HHHHHcCCCC----CC
Confidence 42 2356899999999999999999999999999999999999999987654322 1112111110 11
Q ss_pred ccccCCcccHHHHHHHHHHHHHhhccCCCCCC-----CHhHHHHHHHHhhh
Q 041143 863 PALEVNEETFESISIVAELAGHCTAREPYHRP-----DMGHVVNVLSPLVE 908 (973)
Q Consensus 863 ~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~~v~~~L~~~~~ 908 (973)
+. ....+.+++.+|++.||.+|| +++|+++ +++++
T Consensus 222 ~~---------~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~--Hp~f~ 261 (316)
T d1fota_ 222 PF---------FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN--HPWFK 261 (316)
T ss_dssp TT---------SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT--SGGGS
T ss_pred CC---------CCHHHHHHHHHHhhhCHHhccccchhhHHHHHc--Ccccc
Confidence 11 123477999999999999996 8899887 55554
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-46 Score=406.20 Aligned_cols=249 Identities=26% Similarity=0.338 Sum_probs=205.8
Q ss_pred cCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVT-TTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
++|+..+.||+|+||.||+|+. .+|+.||||+++.... .....+.+.+|+.+|++++|||||++++++.+.+..|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 6799999999999999999987 4799999999964311 1223567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+++|+|.+++.. ...+++..+..++.||+.||+||| +++||||||||+|||++++|.+||+|||+|+...
T Consensus 85 ey~~gg~L~~~~~~-----~~~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 85 EYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp ECCTTCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eccCCCchhhhhhc-----ccCCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccc
Confidence 99999999999875 246888999999999999999999 8899999999999999999999999999998654
Q ss_pred CCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcC
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (973)
... ......+||+.|+|||++.+..|+.++||||+||++|||++|+.||......+. +..+.....
T Consensus 157 ~~~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~------~~~i~~~~~------- 222 (337)
T d1o6la_ 157 SDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL------FELILMEEI------- 222 (337)
T ss_dssp CTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHCCC-------
T ss_pred cCC-cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH------HHHHhcCCC-------
Confidence 322 234557899999999999999999999999999999999999999987664321 111211111
Q ss_pred ccccCCcccHHHHHHHHHHHHHhhccCCCCCCC-----HhHHHH
Q 041143 863 PALEVNEETFESISIVAELAGHCTAREPYHRPD-----MGHVVN 901 (973)
Q Consensus 863 ~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~~v~~ 901 (973)
.+. . .....+.+|+.+||+.||.+||+ +.|+++
T Consensus 223 -~~p--~---~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 -RFP--R---TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -CCC--T---TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -CCC--c---cCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 111 1 11234679999999999999995 677776
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-46 Score=398.51 Aligned_cols=257 Identities=26% Similarity=0.433 Sum_probs=197.0
Q ss_pred cCccccCcccccCccEEEEEEEC--CC--CEEEEEEeecCC-CChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE--DG--TKIAVKRMEAGV-TTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERL 699 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~--~g--~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 699 (973)
++|+..+.||+|+||.||+|+.. ++ ..||||+++... ...+..++|.+|++++++++|||||+++|+|.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 57889999999999999999764 23 368999986542 234456789999999999999999999999976 4678
Q ss_pred EEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccc
Q 041143 700 LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK 779 (973)
Q Consensus 700 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~ 779 (973)
+||||+++|++.+++... ...+++..++.++.|||+||+||| +++|+||||||+||+++.++++||+|||+++
T Consensus 87 lv~e~~~~~~l~~~~~~~----~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH----QGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp EEEECCTTCBHHHHHHHH----GGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeeeecCcchhhhhhcc----cCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhh
Confidence 999999999999988652 246899999999999999999999 7899999999999999999999999999999
Q ss_pred cCCCCCcc--eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHHHHHhhchhH
Q 041143 780 LAPDGEKS--VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRYLAEWFWRIKSSKEK 856 (973)
Q Consensus 780 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (973)
........ ......||..|+|||++.+..++.++|||||||++|||+| |+.||......+. .. .+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~---~~---~i~~~~-- 231 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI---LH---KIDKEG-- 231 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HH---HHHTSC--
T ss_pred hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH---HH---HHHhCC--
Confidence 66443322 2234568899999999999999999999999999999998 8999987654322 11 111110
Q ss_pred HHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHh
Q 041143 857 FKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPL 906 (973)
Q Consensus 857 ~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~ 906 (973)
..+ . ........+.+|+.+||+.||++||||.||++.|++.
T Consensus 232 ----~~~--~---~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 232 ----ERL--P---RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ----CCC--C---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCC--C---CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 011 1 0111224578999999999999999999999988764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-46 Score=404.30 Aligned_cols=265 Identities=26% Similarity=0.383 Sum_probs=202.0
Q ss_pred hcCccccCcccccCccEEEEEEEC------CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeC-
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE------DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEG- 695 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~- 695 (973)
.++|+..+.||+|+||.||+|++. +++.||||+++.. ......+.+.+|+.++.++ +|+|||.+++++.+.
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccc-cCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence 478999999999999999999863 3468999998754 2445567788898888887 689999999998765
Q ss_pred CeEEEEEEecCCCCHHHHHHhhhhc-----------cCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEE
Q 041143 696 NERLLVYEYMPHGALSRHLFRWEKL-----------QLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILL 764 (973)
Q Consensus 696 ~~~~lV~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill 764 (973)
...++||||+++|+|.++++..... ....++|.+++.++.||++||+||| +++||||||||+|||+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NILl 167 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILL 167 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccceeE
Confidence 4679999999999999999764321 1245899999999999999999999 8899999999999999
Q ss_pred CCCCCEEEeeccccccCCCCCc-ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCC-CCCCCCChhhHHH
Q 041143 765 DDDYRAKVSDFGLVKLAPDGEK-SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGL-AALDEERPEESRY 842 (973)
Q Consensus 765 ~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~-~p~~~~~~~~~~~ 842 (973)
++++.+||+|||+|+....... .......||+.|+|||++.+..++.++|||||||++|||+||. .||......+.
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~-- 245 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-- 245 (299)
T ss_dssp CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH--
T ss_pred CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH--
Confidence 9999999999999986543332 2334568999999999999999999999999999999999974 57765443221
Q ss_pred HHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 843 LAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 843 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
+. .. +.....+... . .....+.+++.+||+.||++|||++||++.|+.+++.
T Consensus 246 ~~----~~------~~~~~~~~~~--~---~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 246 FC----RR------LKEGTRMRAP--D---YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp HH----HH------HHHTCCCCCC--T---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HH----HH------HhcCCCCCCC--c---cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 11 11 1111111111 1 1123578999999999999999999999999998764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-46 Score=403.42 Aligned_cols=263 Identities=30% Similarity=0.456 Sum_probs=207.4
Q ss_pred cCccccCcccccCccEEEEEEECC-CC--EEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCCeEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELED-GT--KIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGNERLL 700 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~-g~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 700 (973)
++|+..++||+|+||.||+|++++ |. .||||+++... .....+.|.+|+++|.++ +|||||+++|+|.+++..++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 678888999999999999998753 44 47888876432 334556899999999999 79999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhh-----------hccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCC
Q 041143 701 VYEYMPHGALSRHLFRWE-----------KLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYR 769 (973)
Q Consensus 701 V~e~~~~g~L~~~l~~~~-----------~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~ 769 (973)
||||+++|+|.++++... ......++|.++.+++.|||+||.||| +++|+||||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGC
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCc
Confidence 999999999999997532 123467999999999999999999999 789999999999999999999
Q ss_pred EEEeeccccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCC-CCCCCChhhHHHHHHHHH
Q 041143 770 AKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLA-ALDEERPEESRYLAEWFW 848 (973)
Q Consensus 770 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~-p~~~~~~~~~~~~~~~~~ 848 (973)
+||+|||+|+....... .....||..|+|||.+..+.++.++|||||||++|||++|.. ||......+. . .
T Consensus 166 ~kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~---~---~ 237 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---Y---E 237 (309)
T ss_dssp EEECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---H---H
T ss_pred eEEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHH---H---H
Confidence 99999999985543221 234568999999999999999999999999999999999764 6765543221 1 1
Q ss_pred HHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcC
Q 041143 849 RIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWR 911 (973)
Q Consensus 849 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~ 911 (973)
.+. +...+... ......+.+|+.+||+.||++||||+||++.|++++++..
T Consensus 238 ~i~-------~~~~~~~~-----~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 238 KLP-------QGYRLEKP-----LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp HGG-------GTCCCCCC-----TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred HHH-------hcCCCCCC-----ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence 111 11111111 1122458899999999999999999999999999987543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.6e-45 Score=391.14 Aligned_cols=257 Identities=26% Similarity=0.321 Sum_probs=208.1
Q ss_pred cCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCC-------hHHHHHHHHHHHHHHhcC-CCceeeeeeEEEeC
Q 041143 625 QNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTT-------TKALDEFQSEIAVLSKVR-HRHLVSLLGYSIEG 695 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 695 (973)
++|+..+.||+|+||+||+|+. .+|+.||||+++..... ....+.+.+|+.++++++ |||||++++++.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6899999999999999999987 46899999998754322 123456889999999997 99999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeec
Q 041143 696 NERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDF 775 (973)
Q Consensus 696 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 775 (973)
+..|+||||+++|+|.+++.. ...+++.++..++.||++||+||| +++|+||||||+|||++.++.+||+||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DF 154 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE-----KVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDF 154 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred cceEEEEEcCCCchHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccc
Confidence 999999999999999999965 246899999999999999999999 789999999999999999999999999
Q ss_pred cccccCCCCCcceecccccccCccccccccc------CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHH
Q 041143 776 GLVKLAPDGEKSVVTRLAGTFGYLAPEYAVM------GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWR 849 (973)
Q Consensus 776 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 849 (973)
|+++...... ..+...||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+.. ..
T Consensus 155 G~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~------~~ 226 (277)
T d1phka_ 155 GFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML------RM 226 (277)
T ss_dssp TTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HH
T ss_pred hheeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHH------HH
Confidence 9998765433 2345689999999999863 34788999999999999999999999876543221 11
Q ss_pred HhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 850 IKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 850 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
+...... ...+ ........+.+++.+||+.||++||++.||++ +++++
T Consensus 227 i~~~~~~---~~~~------~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~--h~~~~ 274 (277)
T d1phka_ 227 IMSGNYQ---FGSP------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA--HPFFQ 274 (277)
T ss_dssp HHHTCCC---CCTT------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT--SGGGC
T ss_pred HHhCCCC---CCCc------ccccCCHHHHHHHHHHccCChhHCcCHHHHHc--CHHHH
Confidence 1111100 0000 01112245789999999999999999999987 55554
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-46 Score=403.63 Aligned_cols=265 Identities=26% Similarity=0.400 Sum_probs=213.2
Q ss_pred hcCccccCcccccCccEEEEEEE------CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeCC
Q 041143 624 TQNFAQENELGRGGFGTVYKGEL------EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEGN 696 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 696 (973)
.++|+..+.||+|+||.||+|++ .+++.||||+++.. ........|.+|+.+++++ +|||||+++|+|.+.+
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcc-cCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 36788889999999999999975 24578999999764 3455567899999999999 6999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhhhh-------------ccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEE
Q 041143 697 ERLLVYEYMPHGALSRHLFRWEK-------------LQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNIL 763 (973)
Q Consensus 697 ~~~lV~e~~~~g~L~~~l~~~~~-------------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nil 763 (973)
..++||||+++|+|.++++.... .....+++..+..++.|||+||+||| +++||||||||+||+
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl 177 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNIL 177 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccccccccc
Confidence 99999999999999999976432 12246899999999999999999999 889999999999999
Q ss_pred ECCCCCEEEeeccccccCCCCCc-ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHH
Q 041143 764 LDDDYRAKVSDFGLVKLAPDGEK-SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESR 841 (973)
Q Consensus 764 l~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~ 841 (973)
++.++.+|++|||+++....... .......||+.|+|||++.++.++.++|||||||++|||+| |++|+......+.
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~- 256 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK- 256 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-
T ss_pred ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH-
Confidence 99999999999999996654433 33445689999999999999999999999999999999999 5555554433221
Q ss_pred HHHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 842 YLAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
+.. +. ..-..+... ......+.+|+.+||+.||++||||.||+++|++.+..
T Consensus 257 -~~~----~i------~~~~~~~~~-----~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 257 -FYK----MI------KEGFRMLSP-----EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp -HHH----HH------HHTCCCCCC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHH----HH------hcCCCCCCc-----ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 111 11 111111111 11224588999999999999999999999999987764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=400.37 Aligned_cols=262 Identities=29% Similarity=0.405 Sum_probs=208.0
Q ss_pred cCccccCcccccCccEEEEEEECC--------CCEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEeC
Q 041143 625 QNFAQENELGRGGFGTVYKGELED--------GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIEG 695 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 695 (973)
++|...+.||+|+||.||+|+... +..||||+++.. .......++.+|...+.++ +|||||+++++|.++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcc-cChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 678888999999999999997532 347999999765 3455667899999999988 899999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhhhh-----------ccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEE
Q 041143 696 NERLLVYEYMPHGALSRHLFRWEK-----------LQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILL 764 (973)
Q Consensus 696 ~~~~lV~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill 764 (973)
+..++||||+++|+|.+++..... .....+++.+++.++.|||.||+||| +++||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceee
Confidence 999999999999999999976321 12356899999999999999999999 8899999999999999
Q ss_pred CCCCCEEEeeccccccCCCCC-cceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHh-CCCCCCCCChhhHHH
Q 041143 765 DDDYRAKVSDFGLVKLAPDGE-KSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLT-GLAALDEERPEESRY 842 (973)
Q Consensus 765 ~~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~ellt-g~~p~~~~~~~~~~~ 842 (973)
+.++.+||+|||+++...... ........||+.|+|||++.++.|+.++|||||||++|||++ |+.||......+.
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~-- 246 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL-- 246 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH--
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH--
Confidence 999999999999998554332 223455679999999999999999999999999999999998 6888876654321
Q ss_pred HHHHHHHHhhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 843 LAEWFWRIKSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 843 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
... + .....+... ......+.+|+.+|++.||++|||+.||++.|++++.
T Consensus 247 -~~~---i-------~~~~~~~~p-----~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 247 -FKL---L-------KEGHRMDKP-----SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp -HHH---H-------HTTCCCCCC-----SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHH---H-------HcCCCCCCC-----ccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 111 1 111111111 1122457899999999999999999999999998865
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-45 Score=397.39 Aligned_cols=257 Identities=29% Similarity=0.426 Sum_probs=204.7
Q ss_pred cCcccccCccEEEEEEECCC----CEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEe-CCeEEEEEEe
Q 041143 630 ENELGRGGFGTVYKGELEDG----TKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIE-GNERLLVYEY 704 (973)
Q Consensus 630 ~~~lG~G~fg~Vy~~~~~~g----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~e~ 704 (973)
.++||+|+||+||+|++.++ ..||||+++.. ......++|.+|++++++++|||||+++|++.+ +...++||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 46799999999999987542 25899998753 456667889999999999999999999999886 4588999999
Q ss_pred cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCC
Q 041143 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG 784 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~ 784 (973)
+++|+|.++++. .....++..+++++.|+|+||.||| +++|+||||||+|||+++++.+||+|||+++.....
T Consensus 111 ~~~g~l~~~~~~----~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 111 MKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp CTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred eecCchhhhhcc----ccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 999999998865 2345788999999999999999999 889999999999999999999999999999865443
Q ss_pred Ccc---eecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhc
Q 041143 785 EKS---VVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861 (973)
Q Consensus 785 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (973)
... ......||+.|+|||++....++.++||||||+++|||+||+.||...... ..+.. .+..+.
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~---~i~~g~------- 251 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITV---YLLQGR------- 251 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHH---HHHTTC-------
T ss_pred ccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHHH---HHHcCC-------
Confidence 222 223457899999999999999999999999999999999988887653321 11111 111110
Q ss_pred CccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcC
Q 041143 862 DPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWR 911 (973)
Q Consensus 862 ~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~ 911 (973)
.+.. .. .....+.+|+.+||+.||++||+|.||++.|+++.+.+.
T Consensus 252 ~~~~--p~---~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~ 296 (311)
T d1r0pa_ 252 RLLQ--PE---YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296 (311)
T ss_dssp CCCC--CT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred CCCC--cc---cCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhh
Confidence 1111 11 112457899999999999999999999999999987644
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=400.16 Aligned_cols=263 Identities=27% Similarity=0.447 Sum_probs=212.9
Q ss_pred hcCccccCcccccCccEEEEEEEC------CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCe
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE------DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNE 697 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 697 (973)
.++|...+.||+|+||.||+|.+. +++.||||+++.. ........|.+|++++++++|||||+++|+|...+.
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~-~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 97 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 97 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc-cChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence 368888999999999999999763 3578999999754 355666789999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhhhh-----ccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEE
Q 041143 698 RLLVYEYMPHGALSRHLFRWEK-----LQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKV 772 (973)
Q Consensus 698 ~~lV~e~~~~g~L~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl 772 (973)
.++||||+++|+|.++++.... .....++|..+.+++.|+|+||.||| +++|+||||||+|||+++++++||
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEE
T ss_pred eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEE
Confidence 9999999999999999976432 12235799999999999999999999 789999999999999999999999
Q ss_pred eeccccccCCCCCc-ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCC-CCCCCCChhhHHHHHHHHHHH
Q 041143 773 SDFGLVKLAPDGEK-SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGL-AALDEERPEESRYLAEWFWRI 850 (973)
Q Consensus 773 ~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~ 850 (973)
+|||+|+....... .......||+.|+|||.+.+..++.++|||||||++|||+||. .||......+. ...+
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~------~~~i 248 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV------LRFV 248 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH------HHHH
T ss_pred eecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHH------HHHH
Confidence 99999986543322 2234457899999999999999999999999999999999985 66765543221 1111
Q ss_pred hhchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 851 KSSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 851 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
. +.... ..+......+.+++.+||+.||++||||.||++.|++.++
T Consensus 249 ~----------~~~~~--~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 249 M----------EGGLL--DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp H----------TTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred H----------hCCCC--CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1 11100 0001122458899999999999999999999999987755
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.8e-45 Score=403.26 Aligned_cols=251 Identities=25% Similarity=0.330 Sum_probs=207.0
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCC-CChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGV-TTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
++|+..+.||+|+||.||+|+.+ +|+.||||++.... ......+.+.+|+++|+.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999875 69999999986431 11223467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCC
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAP 782 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~ 782 (973)
||+.+|+|..++... ..+++.++..++.||+.||+||| +++||||||||+|||++.++.+||+|||+|+...
T Consensus 121 e~~~~g~l~~~l~~~-----~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~ 192 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp ECCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred ccccccchhhhHhhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeecc
Confidence 999999999998652 46899999999999999999999 8899999999999999999999999999998764
Q ss_pred CCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhcC
Q 041143 783 DGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAID 862 (973)
Q Consensus 783 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (973)
.. .....||+.|||||++.+..++.++|||||||++|||+||+.||........ ...+....
T Consensus 193 ~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------~~~i~~~~-------- 254 (350)
T d1rdqe_ 193 GR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI------YEKIVSGK-------- 254 (350)
T ss_dssp SC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHCC--------
T ss_pred cc----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHH------HHHHhcCC--------
Confidence 32 2346899999999999999999999999999999999999999987653221 11121111
Q ss_pred ccccCCcccHHHHHHHHHHHHHhhccCCCCCC-----CHhHHHHHHHHhhh
Q 041143 863 PALEVNEETFESISIVAELAGHCTAREPYHRP-----DMGHVVNVLSPLVE 908 (973)
Q Consensus 863 ~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~~v~~~L~~~~~ 908 (973)
+... . .....+.+++.+||+.||.+|+ +++|+++ +++.+
T Consensus 255 ~~~p--~---~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~--Hp~f~ 298 (350)
T d1rdqe_ 255 VRFP--S---HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN--HKWFA 298 (350)
T ss_dssp CCCC--T---TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT--SGGGT
T ss_pred CCCC--c---cCCHHHHHHHHHHhhhCHHhccccccccHHHHHc--Ccccc
Confidence 0110 0 1123477999999999999994 8899887 55543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=394.77 Aligned_cols=256 Identities=19% Similarity=0.287 Sum_probs=208.5
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEE
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 702 (973)
.++|.+.+.||+|+||+||+|... +|+.||||+++.. ......+.+|+++|++++|||||++++++.+.+..|+||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvm 80 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 478999999999999999999875 6889999999754 233456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCC--CCEEEeecccccc
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDD--YRAKVSDFGLVKL 780 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~--~~~kl~DfGla~~ 780 (973)
||+++|+|.+++.. ....+++.++..++.||+.||+||| +++|+||||||+|||++.+ ..+||+|||+++.
T Consensus 81 E~~~gg~L~~~i~~----~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~ 153 (321)
T d1tkia_ 81 EFISGLDIFERINT----SAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp CCCCCCBHHHHHTS----SSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred ecCCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhc
Confidence 99999999999864 1246899999999999999999999 8899999999999999854 5899999999986
Q ss_pred CCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhh
Q 041143 781 APDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAA 860 (973)
Q Consensus 781 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (973)
..... ......||+.|+|||...+..|+.++||||+||++|||++|+.||......+. +..+......+...
T Consensus 154 ~~~~~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~------~~~i~~~~~~~~~~ 225 (321)
T d1tkia_ 154 LKPGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI------IENIMNAEYTFDEE 225 (321)
T ss_dssp CCTTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHHTCCCCCHH
T ss_pred cccCC--cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhCCCCCChh
Confidence 64432 23446799999999999999999999999999999999999999987654321 11111111000000
Q ss_pred cCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 861 IDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 861 ~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
..+ .....+.+++.+|++.||++|||+.|+++ +++++
T Consensus 226 ~~~---------~~s~~~~~li~~~L~~dp~~R~s~~eil~--hp~~~ 262 (321)
T d1tkia_ 226 AFK---------EISIEAMDFVDRLLVKERKSRMTASEALQ--HPWLK 262 (321)
T ss_dssp HHT---------TSCHHHHHHHHTTSCSSGGGSCCHHHHHH--SHHHH
T ss_pred hcc---------CCCHHHHHHHHHHccCChhHCcCHHHHhc--CHhhc
Confidence 000 11234779999999999999999999998 56654
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-45 Score=398.29 Aligned_cols=249 Identities=28% Similarity=0.426 Sum_probs=202.3
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCC-CChHHHHHHHHHHHHHH-hcCCCceeeeeeEEEeCCeEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGV-TTTKALDEFQSEIAVLS-KVRHRHLVSLLGYSIEGNERLLV 701 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lV 701 (973)
++|...+.||+|+||+||+|+.. +|+.||||+++... ......+.+..|..++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999875 68999999996431 11223445677777765 68999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccC
Q 041143 702 YEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLA 781 (973)
Q Consensus 702 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~ 781 (973)
|||+++|+|.+++... ..+++.++..++.||+.||+||| +++|+||||||+|||+++++.+||+|||+|+..
T Consensus 82 mEy~~~g~L~~~i~~~-----~~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~ 153 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 153 (320)
T ss_dssp EECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EeecCCCcHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhc
Confidence 9999999999999752 45788999999999999999999 789999999999999999999999999999855
Q ss_pred CCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHHhhc
Q 041143 782 PDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFKAAI 861 (973)
Q Consensus 782 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (973)
.... ...+...||+.|+|||++.+..|+.++||||+||++|||++|+.||.+....+. ...+...
T Consensus 154 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~------~~~i~~~-------- 218 (320)
T d1xjda_ 154 MLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL------FHSIRMD-------- 218 (320)
T ss_dssp CCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHC--------
T ss_pred cccc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHH------HHHHHcC--------
Confidence 4332 234456899999999999999999999999999999999999999987654321 1111111
Q ss_pred CccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHh-HHHH
Q 041143 862 DPALEVNEETFESISIVAELAGHCTAREPYHRPDMG-HVVN 901 (973)
Q Consensus 862 ~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~-~v~~ 901 (973)
.+.+. . .....+.+|+.+||+.||++||++. |+++
T Consensus 219 ~~~~p--~---~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 219 NPFYP--R---WLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CCCCC--T---TSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCCCC--c---cCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 11111 0 1123477999999999999999996 6765
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=9.8e-45 Score=402.21 Aligned_cols=255 Identities=24% Similarity=0.332 Sum_probs=200.9
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCC----ChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVT----TTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERL 699 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 699 (973)
++|++.+.||+|+||.||+|+.. +|+.||||++..... ..........|+++++.++|||||++++++.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57999999999999999999875 699999999853211 1111222334466777788999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccc
Q 041143 700 LVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK 779 (973)
Q Consensus 700 lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~ 779 (973)
+||||+++|+|.+++.. ...+++..+..++.||+.||+||| +++||||||||+|||++.++.+||+|||+|+
T Consensus 84 ivmE~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ-----HGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp EEECCCCSCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred EEEEecCCCcHHHHHHh-----cccccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceee
Confidence 99999999999999965 245789999999999999999999 8899999999999999999999999999998
Q ss_pred cCCCCCcceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHHH
Q 041143 780 LAPDGEKSVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKFK 858 (973)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (973)
...... ....+||+.|+|||++.. ..|+.++|||||||++|||+||+.||......+...+. .
T Consensus 156 ~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~-------------~ 219 (364)
T d1omwa3 156 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-------------R 219 (364)
T ss_dssp ECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH-------------H
T ss_pred ecCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------------H
Confidence 665432 344689999999999875 56899999999999999999999999875543321111 1
Q ss_pred hhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCC-----HhHHHHHHHHhhh
Q 041143 859 AAIDPALEVNEETFESISIVAELAGHCTAREPYHRPD-----MGHVVNVLSPLVE 908 (973)
Q Consensus 859 ~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~~v~~~L~~~~~ 908 (973)
........... .....+.+++.+||+.||++||+ ++|+++ +++++
T Consensus 220 ~~~~~~~~~~~---~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~--Hp~f~ 269 (364)
T d1omwa3 220 MTLTMAVELPD---SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE--SPFFR 269 (364)
T ss_dssp HSSSCCCCCCS---SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT--SGGGT
T ss_pred hcccCCCCCCC---CCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc--Ccccc
Confidence 11111111111 11234779999999999999999 577776 55544
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-44 Score=395.35 Aligned_cols=257 Identities=21% Similarity=0.246 Sum_probs=201.9
Q ss_pred hcCccccC-cccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeeEEEe----CC
Q 041143 624 TQNFAQEN-ELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV-RHRHLVSLLGYSIE----GN 696 (973)
Q Consensus 624 ~~~~~~~~-~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~ 696 (973)
.++|.+.. .||+|+||+||+|+. .+|+.||||+++.. +.+.+|++++.++ +|||||++++++.+ ..
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 46788764 699999999999986 56899999999743 3577899987665 89999999999875 35
Q ss_pred eEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECC---CCCEEEe
Q 041143 697 ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDD---DYRAKVS 773 (973)
Q Consensus 697 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~---~~~~kl~ 773 (973)
..|+|||||+||+|.+++... ....+++.++..|+.||+.||+||| +++|+||||||+|||+++ ++.+||+
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~---~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~ 156 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLT 156 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSC---SCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred EEEEEEECCCCCcHHHHHHhc---CCCCcCHHHHHHHHHHHHHHHHHHH---HcCCcccccccccccccccccccccccc
Confidence 679999999999999999652 2356999999999999999999999 889999999999999985 4679999
Q ss_pred eccccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhc
Q 041143 774 DFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSS 853 (973)
Q Consensus 774 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 853 (973)
|||+|+...... .....+||+.|+|||++.+..|+.++|||||||++|||+||+.||.+........ .
T Consensus 157 DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~--~-------- 224 (335)
T d2ozaa1 157 DFGFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP--G-------- 224 (335)
T ss_dssp CCTTCEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------------
T ss_pred ccceeeeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH--H--------
Confidence 999998665433 2345689999999999999999999999999999999999999997654322100 0
Q ss_pred hhHHHhhcCccccCCccc-HHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 854 KEKFKAAIDPALEVNEET-FESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 854 ~~~~~~~~~~~l~~~~~~-~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
....+........... ......+.+|+.+|++.||++|||+.|+++ ++++.+
T Consensus 225 --~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~--hp~~~~ 277 (335)
T d2ozaa1 225 --MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN--HPWIMQ 277 (335)
T ss_dssp -----CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH--SHHHHT
T ss_pred --HHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc--CHHhhC
Confidence 0011111111111111 122346889999999999999999999988 565543
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-44 Score=390.16 Aligned_cols=273 Identities=23% Similarity=0.368 Sum_probs=204.4
Q ss_pred cCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
++|+..+.||+|+||+||+|+. .+|+.||||+++.........+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5899999999999999999987 569999999997653333445689999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+.+ ++..++.. .....+++.++..++.||+.||+||| +++||||||||+|||++.++.+||+|||+|+....
T Consensus 82 ~~~~-~~~~~~~~---~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~ 154 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDA---SALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 154 (298)
T ss_dssp CCSE-EHHHHHHH---TTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred ecCC-chhhhhhh---hcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccC
Confidence 9965 45455533 12356999999999999999999999 88999999999999999999999999999986544
Q ss_pred CCcceecccccccCcccccccccCc-CCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchhHH-Hh--
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVMGK-ITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKEKF-KA-- 859 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-- 859 (973)
.. .......||+.|+|||.+.... ++.++||||+||++|||++|+.||......+. +...........+.. ..
T Consensus 155 ~~-~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~ 231 (298)
T d1gz8a_ 155 PV-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFRTLGTPDEVVWPGVT 231 (298)
T ss_dssp CS-BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTTSTTGG
T ss_pred Cc-ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH--HHHHHHhcCCCchhhccccc
Confidence 32 2344467999999999877655 57899999999999999999999987654332 111111110000000 00
Q ss_pred -hcC--ccc-cCCcccH-----HHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 860 -AID--PAL-EVNEETF-----ESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 860 -~~~--~~l-~~~~~~~-----~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
..+ ... ....... .....+.+++.+|++.||++|||+.|+++ +++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~--H~ff~~ 288 (298)
T d1gz8a_ 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQD 288 (298)
T ss_dssp GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT--SGGGTT
T ss_pred cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC--CHhhcc
Confidence 000 000 0000110 11245789999999999999999999998 666654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-44 Score=391.56 Aligned_cols=265 Identities=22% Similarity=0.278 Sum_probs=197.6
Q ss_pred cCcccccCccEEEEEEEC-CCCEEEEEEeecCCCCh---HHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEec
Q 041143 630 ENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTT---KALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEYM 705 (973)
Q Consensus 630 ~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 705 (973)
+++||+|+||+||+|+.. +|+.||||+++...... ...+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 568999999999999875 68999999986542221 12346889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCCC
Q 041143 706 PHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDGE 785 (973)
Q Consensus 706 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~~ 785 (973)
.++++..+.. ....+++.++..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+......
T Consensus 83 ~~~~~~~~~~-----~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 83 ETDLEVIIKD-----NSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp SEEHHHHHTT-----CCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred cchHHhhhhh-----cccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCc
Confidence 8887665442 2356888999999999999999999 8899999999999999999999999999998655433
Q ss_pred cceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhc--hhHHHhhcC
Q 041143 786 KSVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSS--KEKFKAAID 862 (973)
Q Consensus 786 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 862 (973)
. .....+||+.|+|||++.. ..|+.++||||+||++|||++|+.||......+... . +...... .........
T Consensus 155 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~--~-i~~~~~~~~~~~~~~~~~ 230 (299)
T d1ua2a_ 155 R-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLT--R-IFETLGTPTEEQWPDMCS 230 (299)
T ss_dssp C-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--H-HHHHHCCCCTTTSSSTTS
T ss_pred c-cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHH--H-HHHhcCCCChhhccchhc
Confidence 2 2334679999999999865 457999999999999999999999998766433211 1 1111000 000000000
Q ss_pred ----cccc-CCcccH-----HHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 863 ----PALE-VNEETF-----ESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 863 ----~~l~-~~~~~~-----~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
.... ...... .....+.+|+.+|++.||++|||++|+++ +++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~--Hp~f~ 284 (299)
T d1ua2a_ 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK--MKYFS 284 (299)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT--SGGGT
T ss_pred cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC--CHhhC
Confidence 0000 000011 11245889999999999999999999987 66654
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.7e-44 Score=385.94 Aligned_cols=271 Identities=20% Similarity=0.302 Sum_probs=204.7
Q ss_pred cCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEEe
Q 041143 625 QNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYEY 704 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 704 (973)
++|+..+.||+|+||+||+|++++|+.||||+++.........+.+.+|+.+|++++|||||++++++...+..++||||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 68999999999999999999999999999999976544444457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCCC
Q 041143 705 MPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPDG 784 (973)
Q Consensus 705 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~~ 784 (973)
+.++.+..+... ...+++.++..++.||+.||+||| +.+||||||||+|||++.++.+|++|||.|......
T Consensus 82 ~~~~~~~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 82 LDQDLKKLLDVC-----EGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp CSEEHHHHHHTS-----TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred ehhhhHHHHHhh-----cCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 987777665532 356899999999999999999999 789999999999999999999999999999865433
Q ss_pred CcceecccccccCcccccccccC-cCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhch-hH---HHh
Q 041143 785 EKSVVTRLAGTFGYLAPEYAVMG-KITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSK-EK---FKA 859 (973)
Q Consensus 785 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~---~~~ 859 (973)
.. ......|++.|+|||.+.+. .++.++||||+||++|||++|+.||.+....+.. ........... .. ...
T Consensus 154 ~~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~--~~i~~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 154 VR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL--MRIFRILGTPNSKNWPNVTE 230 (286)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHHHHCCCCTTTSTTGGG
T ss_pred cc-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHH--HHHHHhhCCCChhhccchhh
Confidence 22 23345689999999998754 5689999999999999999999999876543321 11111100000 00 000
Q ss_pred h--cCccccC------CcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 860 A--IDPALEV------NEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 860 ~--~~~~l~~------~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
. .+..... ..........+.+++.+||+.||++|||++|+++ +++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~--Hp~f~ 285 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE--HAYFK 285 (286)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT--SGGGG
T ss_pred hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc--CcccC
Confidence 0 0000000 0000111235779999999999999999999986 45543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=385.51 Aligned_cols=246 Identities=26% Similarity=0.365 Sum_probs=198.6
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCCh----HHHHHHHHHHHHHHhcC--CCceeeeeeEEEeCCe
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTT----KALDEFQSEIAVLSKVR--HRHLVSLLGYSIEGNE 697 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~ 697 (973)
++|++.+.||+|+||+||+|+.. +|+.||||+++...... ....++.+|+.++++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57999999999999999999874 68999999986432111 11234678999999996 8999999999999999
Q ss_pred EEEEEEecCC-CCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECC-CCCEEEeec
Q 041143 698 RLLVYEYMPH-GALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDD-DYRAKVSDF 775 (973)
Q Consensus 698 ~~lV~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~-~~~~kl~Df 775 (973)
.++||||+.+ +++.+++.. ...+++.++..++.||++||+||| +++|+||||||+|||++. ++.+||+||
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~-----~~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITE-----RGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred EEEEEEeccCcchHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECcc
Confidence 9999999976 677777754 256899999999999999999999 889999999999999985 479999999
Q ss_pred cccccCCCCCcceecccccccCcccccccccCcC-CCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhch
Q 041143 776 GLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKI-TTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSK 854 (973)
Q Consensus 776 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 854 (973)
|+|+..... ..+...||+.|+|||++.+..+ +.++||||+||++|||++|+.||..... +....
T Consensus 156 G~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------------i~~~~ 220 (273)
T d1xwsa_ 156 GSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQ 220 (273)
T ss_dssp TTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------HHHCC
T ss_pred ccceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------------Hhhcc
Confidence 999865433 2345789999999999987765 5678999999999999999999964210 11100
Q ss_pred hHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 855 EKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 855 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
..+.+.+ ...+.+++.+|++.||++|||++|+++ +++++
T Consensus 221 ----~~~~~~~---------s~~~~~li~~~L~~dp~~R~s~~eil~--hp~~~ 259 (273)
T d1xwsa_ 221 ----VFFRQRV---------SSECQHLIRWCLALRPSDRPTFEEIQN--HPWMQ 259 (273)
T ss_dssp ----CCCSSCC---------CHHHHHHHHHHTCSSGGGSCCHHHHHT--SGGGS
T ss_pred ----cCCCCCC---------CHHHHHHHHHHccCCHhHCcCHHHHhc--CHhhC
Confidence 0111111 134779999999999999999999987 55554
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=386.67 Aligned_cols=273 Identities=21% Similarity=0.297 Sum_probs=202.0
Q ss_pred hcCccccCcccccCccEEEEEEEC-C-CCEEEEEEeecCCCChHHHHHHHHHHHHHHhc---CCCceeeeeeEEEe----
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-D-GTKIAVKRMEAGVTTTKALDEFQSEIAVLSKV---RHRHLVSLLGYSIE---- 694 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~-g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~---- 694 (973)
.++|+..+.||+|+||+||+|++. + ++.||||+++...........+.+|+.+++.+ +|||||++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 368999999999999999999873 4 56799999865433333334566777777665 79999999999864
Q ss_pred -CCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEe
Q 041143 695 -GNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVS 773 (973)
Q Consensus 695 -~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~ 773 (973)
....++||||+.+|++...... ....+++..+..++.||+.||+||| +++||||||||+|||++.++.+||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~----~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~ 158 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV----PEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLA 158 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS----CTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCceEEEEEEeccCCchhhhhhc----cCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeec
Confidence 2467899999988777544432 3356899999999999999999999 8899999999999999999999999
Q ss_pred eccccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhc
Q 041143 774 DFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSS 853 (973)
Q Consensus 774 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 853 (973)
|||+++..... .......||+.|+|||++.+..|+.++||||+||++|||++|+.||......+..... .......
T Consensus 159 dfg~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i--~~~~~~~ 234 (305)
T d1blxa_ 159 DFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI--LDVIGLP 234 (305)
T ss_dssp SCCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--HHHHCCC
T ss_pred chhhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHH--HHhhCCC
Confidence 99998854432 2345568999999999999999999999999999999999999999877644321111 1110000
Q ss_pred -hhHHHh-------hcCcccc--CCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhh
Q 041143 854 -KEKFKA-------AIDPALE--VNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEK 909 (973)
Q Consensus 854 -~~~~~~-------~~~~~l~--~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~ 909 (973)
...... ....... ...........+.+|+.+||+.||++|||++|+++ +++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~--Hpff~~ 298 (305)
T d1blxa_ 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS--HPYFQD 298 (305)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT--SGGGTT
T ss_pred chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc--ChhhcC
Confidence 000000 0000000 00000111235678999999999999999999998 666654
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=385.71 Aligned_cols=275 Identities=21% Similarity=0.335 Sum_probs=204.3
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC------
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGN------ 696 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 696 (973)
.++|+..+.||+|+||+||+|.+. +|+.||||+++.........+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999874 6999999999876666677788999999999999999999999998654
Q ss_pred eEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecc
Q 041143 697 ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFG 776 (973)
Q Consensus 697 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG 776 (973)
+.++||||+ +++|..+.+. ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+|++|||
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg 166 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFG 166 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred eEEEEEecc-cccHHHHHHh------ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhccccccccccccc
Confidence 469999999 6678776643 56899999999999999999999 8899999999999999999999999999
Q ss_pred ccccCCCCCcceecccccccCcccccccccC-cCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchh
Q 041143 777 LVKLAPDGEKSVVTRLAGTFGYLAPEYAVMG-KITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKE 855 (973)
Q Consensus 777 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 855 (973)
+|+..... .+...||+.|+|||++.+. .++.++||||+||++|||++|+.||......+...... ........
T Consensus 167 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~--~~~~~~~~ 240 (346)
T d1cm8a_ 167 LARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM--KVTGTPPA 240 (346)
T ss_dssp TCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HHHCCCCH
T ss_pred ceeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHH--hccCCCcH
Confidence 99865432 3456799999999998764 56899999999999999999999998775433211111 10000000
Q ss_pred ------------HHHhhcCccccCC---cccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCCCCCCC
Q 041143 856 ------------KFKAAIDPALEVN---EETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPITDES 917 (973)
Q Consensus 856 ------------~~~~~~~~~l~~~---~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~~~~~~ 917 (973)
.....+. ..... .........+.+|+.+||+.||++|||++|+++ +++++.....++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~--Hp~f~~~~~~~~~~ 314 (346)
T d1cm8a_ 241 EFVQRLQSDEAKNYMKGLP-ELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA--HPYFESLHDTEDEP 314 (346)
T ss_dssp HHHHTCSCHHHHHHHHHSC-CCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH--SGGGTTTC------
T ss_pred HHHhhhcchhhhhhhccCC-cccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc--ChhhCcCCCccccc
Confidence 0000000 00000 000011234679999999999999999999998 77777655544443
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.3e-41 Score=367.02 Aligned_cols=271 Identities=17% Similarity=0.228 Sum_probs=213.0
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC-CceeeeeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRH-RHLVSLLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~ 702 (973)
++|.+.+.||+|+||+||+|++. +|+.||||++...... +.+.+|++.++.++| +|++.+++++..+...++||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 68999999999999999999865 6889999998654222 346789999999965 89999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECC-----CCCEEEeeccc
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDD-----DYRAKVSDFGL 777 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~-----~~~~kl~DfGl 777 (973)
||+ +|+|.+++... ...+++.++..++.|++.||+||| +++|+||||||+|||++. ++.+||+|||+
T Consensus 81 e~~-~~~l~~~~~~~----~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~ 152 (293)
T d1csna_ 81 DLL-GPSLEDLLDLC----GRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 152 (293)
T ss_dssp ECC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred Eec-CCCHHHHHHhh----ccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccce
Confidence 999 78999988652 246899999999999999999999 899999999999999974 57899999999
Q ss_pred cccCCCCCc------ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHh
Q 041143 778 VKLAPDGEK------SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIK 851 (973)
Q Consensus 778 a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 851 (973)
|+...+... ......+||+.|||||.+.+..++.++|||||||++|||+||+.||..............+....
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~ 232 (293)
T d1csna_ 153 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK 232 (293)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred eEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhcc
Confidence 986543221 12334689999999999999999999999999999999999999998655433222111111111
Q ss_pred hchhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCCCCCCCc
Q 041143 852 SSKEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPITDESE 918 (973)
Q Consensus 852 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~~~~~~~ 918 (973)
. .....+. .+. ...++.+++..|++.+|++||+++.+.+.|+++.++.....++..
T Consensus 233 ~-~~~~~~l-~~~---------~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~ 288 (293)
T d1csna_ 233 Q-STPLREL-CAG---------FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENF 288 (293)
T ss_dssp H-HSCHHHH-TTT---------SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCC
T ss_pred C-CCChHHh-cCC---------CCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCC
Confidence 0 0001111 111 123477899999999999999999999999999887665554433
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-42 Score=378.40 Aligned_cols=281 Identities=21% Similarity=0.300 Sum_probs=206.0
Q ss_pred hcCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCC----eE
Q 041143 624 TQNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGN----ER 698 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~ 698 (973)
..+|+..+.||+|+||+||+|+. .+|+.||||+++.. ......+.+.+|+++|++++|||||++++++.... ..
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehh-cChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 35799999999999999999976 57999999999753 24556678999999999999999999999987643 33
Q ss_pred EEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecccc
Q 041143 699 LLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLV 778 (973)
Q Consensus 699 ~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla 778 (973)
+++++|+.+|+|.+++.. ..+++..+..++.||++||+||| +++||||||||+|||++.++.+||+|||+|
T Consensus 86 ~~l~~~~~~g~L~~~l~~------~~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a 156 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT------QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLA 156 (345)
T ss_dssp EEEEEECCCEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeecCCchhhhhhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCce
Confidence 555667779999999864 46899999999999999999999 889999999999999999999999999999
Q ss_pred ccCCCCCc--ceecccccccCcccccccc-cCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhch-
Q 041143 779 KLAPDGEK--SVVTRLAGTFGYLAPEYAV-MGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSK- 854 (973)
Q Consensus 779 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~- 854 (973)
+....... ......+||+.|+|||++. ...++.++||||+||++|||++|+.||......+...............
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (345)
T d1pmea_ 157 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236 (345)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred eeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhh
Confidence 85543221 1234467999999999985 4567899999999999999999999998776443222111110000000
Q ss_pred ------hHHHhhcCccccCCcccH-----HHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCCCCCC
Q 041143 855 ------EKFKAAIDPALEVNEETF-----ESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPITDE 916 (973)
Q Consensus 855 ------~~~~~~~~~~l~~~~~~~-----~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~~~~~ 916 (973)
.................. ....++.+++.+|++.||++|||+.|+++ ++++++.....+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~--hpf~~~~~~~~~~ 307 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA--HPYLEQYYDPSDE 307 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT--SGGGTTTCCGGGS
T ss_pred hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc--CHhhccCCCCccC
Confidence 000000000000000011 11135789999999999999999999998 6776655444333
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-42 Score=376.51 Aligned_cols=271 Identities=19% Similarity=0.299 Sum_probs=200.9
Q ss_pred cCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeC--------
Q 041143 625 QNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEG-------- 695 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------- 695 (973)
++|+..+.||+|+||+||+|++ .+|+.||||++..........+++.+|+++|++++||||+++++++...
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 6899999999999999999987 4799999999866544445566789999999999999999999998653
Q ss_pred CeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeec
Q 041143 696 NERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDF 775 (973)
Q Consensus 696 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 775 (973)
+..++||||+.++.+..+.. ....++...+..++.||+.||+||| +++|+||||||+|||++.++.+||+||
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~-----~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSN-----VLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTC-----TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCC
T ss_pred ceEEEEEeccCCCccchhhh-----cccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeec
Confidence 45789999998877654432 2356888999999999999999999 889999999999999999999999999
Q ss_pred cccccCCCCCc---ceecccccccCcccccccccC-cCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHh
Q 041143 776 GLVKLAPDGEK---SVVTRLAGTFGYLAPEYAVMG-KITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIK 851 (973)
Q Consensus 776 Gla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 851 (973)
|+++....... ......+||+.|+|||++.+. .++.++||||+||++|||++|+.||......+...... ...
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~---~~~ 238 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS---QLC 238 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---HHH
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHH---Hhc
Confidence 99985543221 122335799999999998765 68999999999999999999999998765433322111 111
Q ss_pred hc-hhHH---------HhhcCccccCCcccHH------HHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 852 SS-KEKF---------KAAIDPALEVNEETFE------SISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 852 ~~-~~~~---------~~~~~~~l~~~~~~~~------~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
.. .... ...+...........+ ....+.+|+.+||+.||++|||++|+++ +++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~--Hpff~ 309 (318)
T d3blha1 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN--HDFFW 309 (318)
T ss_dssp CCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH--SGGGS
T ss_pred CCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc--Chhhc
Confidence 00 0000 0000000000000111 1234678999999999999999999998 77765
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.7e-41 Score=366.62 Aligned_cols=263 Identities=21% Similarity=0.271 Sum_probs=199.3
Q ss_pred cCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceee-eeeEEEeCCeEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVS-LLGYSIEGNERLLVY 702 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~lV~ 702 (973)
++|+..+.||+|+||.||+|++ .+|+.||||++...... +++..|+++++.++|+|+|. +.+++.+.+..++||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 5799999999999999999987 46899999998754222 35788999999998776554 455567788899999
Q ss_pred EecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECC---CCCEEEeeccccc
Q 041143 703 EYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDD---DYRAKVSDFGLVK 779 (973)
Q Consensus 703 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~---~~~~kl~DfGla~ 779 (973)
||+ +|++...+.. ....+++..+..++.|++.||+||| +++||||||||+|||++. +..+||+|||+|+
T Consensus 83 e~~-~~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~ 154 (299)
T d1ckia_ 83 ELL-GPSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154 (299)
T ss_dssp ECC-CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred EEc-CCchhhhhhh----ccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcce
Confidence 999 6677666643 2356899999999999999999999 889999999999999864 5679999999998
Q ss_pred cCCCCCc------ceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhc
Q 041143 780 LAPDGEK------SVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSS 853 (973)
Q Consensus 780 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 853 (973)
...+... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||....................
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~- 233 (299)
T d1ckia_ 155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM- 233 (299)
T ss_dssp ECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH-
T ss_pred eccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccC-
Confidence 6544322 123456899999999999999999999999999999999999999987654332221111110000
Q ss_pred hhHHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhc
Q 041143 854 KEKFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKW 910 (973)
Q Consensus 854 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~ 910 (973)
...... +.+. ....+.+++..|++.+|++||+++++.+.|+.+..+.
T Consensus 234 ~~~~~~-~~~~---------~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 234 STPIEV-LCKG---------YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp HSCHHH-HTTT---------SCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred CCChhH-hccC---------CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 000000 0111 1234779999999999999999999999999886643
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-42 Score=371.24 Aligned_cols=274 Identities=19% Similarity=0.277 Sum_probs=211.1
Q ss_pred cCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeCCeEEEEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEGNERLLVYE 703 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 703 (973)
++|+..+.||+|+||+||+|++. +|+.||||+++.........+++.+|+.++++++|||||++++++.+.+..++|||
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 58999999999999999999874 78999999998765566677889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccccccCCC
Q 041143 704 YMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGLVKLAPD 783 (973)
Q Consensus 704 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~~~~~ 783 (973)
|+.+++|..++.. .+.+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||.|+....
T Consensus 82 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~ 153 (292)
T d1unla_ 82 FCDQDLKKYFDSC-----NGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCSEEHHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ecccccccccccc-----ccccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccC
Confidence 9999998877754 356789999999999999999999 78999999999999999999999999999986654
Q ss_pred CCcceecccccccCcccccccccCc-CCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhch--h-----
Q 041143 784 GEKSVVTRLAGTFGYLAPEYAVMGK-ITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSK--E----- 855 (973)
Q Consensus 784 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~----- 855 (973)
... ......+++.|+|||++.... ++.++||||+||++|||++|+.||........ ....+....... .
T Consensus 154 ~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 230 (292)
T d1unla_ 154 PVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEEQWPSM 230 (292)
T ss_dssp CCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCTTTCTTG
T ss_pred CCc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHH--HHHHHHhhcCCCChhhhhhh
Confidence 332 233456788999999887655 68999999999999999999999754433221 111111111100 0
Q ss_pred -HHHhhcC-ccc----cCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcC
Q 041143 856 -KFKAAID-PAL----EVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWR 911 (973)
Q Consensus 856 -~~~~~~~-~~l----~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~ 911 (973)
......+ +.. ............+.+|+.+|++.||.+|||++||++ +++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~--Hp~f~~~~ 290 (292)
T d1unla_ 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ--HPYFSDFC 290 (292)
T ss_dssp GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT--SGGGSSCS
T ss_pred hhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc--ChhhcCCC
Confidence 0000000 000 000011112245779999999999999999999988 66666544
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-41 Score=373.71 Aligned_cols=269 Identities=23% Similarity=0.320 Sum_probs=199.0
Q ss_pred CccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeC------CeE
Q 041143 626 NFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEG------NER 698 (973)
Q Consensus 626 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~ 698 (973)
+|...++||+|+||+||+|++. +|+.||||+++.... .+.+|+++|++++|||||++++++... ...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 5778899999999999999875 689999999976422 234799999999999999999998653 246
Q ss_pred EEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCC-CEEEeeccc
Q 041143 699 LLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDY-RAKVSDFGL 777 (973)
Q Consensus 699 ~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~-~~kl~DfGl 777 (973)
++||||+++|.+. .+.... .....+++.++..++.||+.||+||| +++|+||||||+|||++.++ .+||+|||+
T Consensus 95 ~lv~Ey~~~~~~~-~l~~~~-~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~ 169 (350)
T d1q5ka_ 95 NLVLDYVPETVYR-VARHYS-RAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGS 169 (350)
T ss_dssp EEEEECCSEEHHH-HHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred EEEEeccCCccHH-HHHhhh-hccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccc
Confidence 8999999765444 443322 23357999999999999999999999 89999999999999999775 899999999
Q ss_pred cccCCCCCcceecccccccCccccccccc-CcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhc-hh
Q 041143 778 VKLAPDGEKSVVTRLAGTFGYLAPEYAVM-GKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSS-KE 855 (973)
Q Consensus 778 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~ 855 (973)
++...... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+. +...+...... ..
T Consensus 170 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~--l~~i~~~~g~~~~~ 245 (350)
T d1q5ka_ 170 AKQLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIKVLGTPTRE 245 (350)
T ss_dssp CEECCTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH--HHHHHHHHCCCCHH
T ss_pred hhhccCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH--HHHHHHHhCCChHH
Confidence 98664432 2344689999999998875 5789999999999999999999999987654332 11111111000 01
Q ss_pred HHHhhc----C---ccccCC----cccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcC
Q 041143 856 KFKAAI----D---PALEVN----EETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWR 911 (973)
Q Consensus 856 ~~~~~~----~---~~l~~~----~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~ 911 (973)
...... + +..... .........+.+|+.+||+.||++|||+.|+++ ++++++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~--Hp~f~~~~ 310 (350)
T d1q5ka_ 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA--HSFFDELR 310 (350)
T ss_dssp HHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGGGGG
T ss_pred hhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc--CHhhcccc
Confidence 111110 0 000000 000112235789999999999999999999998 66666543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-41 Score=373.44 Aligned_cols=271 Identities=20% Similarity=0.273 Sum_probs=201.2
Q ss_pred hcCccccCcccccCccEEEEEEEC-CCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEe------CC
Q 041143 624 TQNFAQENELGRGGFGTVYKGELE-DGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIE------GN 696 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~ 696 (973)
.++|+..++||+|+||+||+|++. +|+.||||+++.........+++.+|+.++++++|||||++++++.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 368999999999999999999875 69999999998776666777789999999999999999999999864 36
Q ss_pred eEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeecc
Q 041143 697 ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFG 776 (973)
Q Consensus 697 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG 776 (973)
..|+||||+.++.+ +.++ ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+|++|||
T Consensus 96 ~~~iv~Ey~~~~l~-~~~~-------~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~ 164 (355)
T d2b1pa1 96 DVYLVMELMDANLC-QVIQ-------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_dssp EEEEEEECCSEEHH-HHHT-------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred eeEEEEeccchHHH-Hhhh-------cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechh
Confidence 78999999966544 4442 45789999999999999999999 8899999999999999999999999999
Q ss_pred ccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHh-----
Q 041143 777 LVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIK----- 851 (973)
Q Consensus 777 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~----- 851 (973)
+++...... ..+...||+.|+|||++.+..++.++||||+||++|||++|+.||.+.......... .....
T Consensus 165 ~~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i--~~~~~~~~~~ 240 (355)
T d2b1pa1 165 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV--IEQLGTPCPE 240 (355)
T ss_dssp C-----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HHHHCCCCHH
T ss_pred hhhcccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHH--HHhccCCCHH
Confidence 988554432 334567999999999999999999999999999999999999999866533221110 00000
Q ss_pred ---hchhHHH---------------hhcCcccc-C-CcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcC
Q 041143 852 ---SSKEKFK---------------AAIDPALE-V-NEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWR 911 (973)
Q Consensus 852 ---~~~~~~~---------------~~~~~~l~-~-~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~ 911 (973)
....... ..+..... . ..........+.+|+.+|++.||++|||++||++ +++++.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~--Hpw~~~~~ 318 (355)
T d2b1pa1 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ--HPYINVWY 318 (355)
T ss_dssp HHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT--STTTGGGC
T ss_pred HHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc--CcccCCCC
Confidence 0000111 11111110 0 1112233456889999999999999999999999 88887654
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=5.1e-41 Score=367.68 Aligned_cols=291 Identities=24% Similarity=0.478 Sum_probs=208.4
Q ss_pred CCChhHHHHHHHHHhhCCCCc-cCCCCCCCCCCCCCCCcCeEEeeC----CeEEEEEecccCCcc--cCCcCcccccccc
Q 041143 22 ATDPNDLKILNDFKNGLENPE-LLKWPANGDDPCGPPPWPHVFCSG----NRVTQIQVQNLGLKG--PLPQNFNQLTKLY 94 (973)
Q Consensus 22 ~~~~~~~~~l~~~k~~~~~~~-l~~w~~~~~d~C~~~~w~gv~C~~----~~v~~L~L~~~~l~g--~~~~~~~~l~~L~ 94 (973)
-|.++|++||++||+++.+|. +.+|+. +.|||. +.|.||.|+. .||+.|+|++++++| .+|++|++|++|+
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~~~l~sW~~-~~d~C~-~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~ 79 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNPTTLSSWLP-TTDCCN-RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN 79 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCT-TSCTTT-TCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCS
T ss_pred CCCHHHHHHHHHHHHHCCCCCcCCCCCC-CCCCCC-CcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCcccc
Confidence 488999999999999999886 788964 689995 3499999975 379999999999998 5899999999999
Q ss_pred eeeccC-cccCCCCC-CCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeee
Q 041143 95 NLGLQR-NKFNGKLP-TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLS 172 (973)
Q Consensus 95 ~L~L~~-N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~ 172 (973)
+|+|++ |+++|.+| .|.+|++|++|+|++|+|..+++..+..+.+|+++++++|++.+. +|..+.+++.|+.++
T Consensus 80 ~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~----~p~~l~~l~~L~~l~ 155 (313)
T d1ogqa_ 80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGT----LPPSISSLPNLVGIT 155 (313)
T ss_dssp EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESC----CCGGGGGCTTCCEEE
T ss_pred ccccccccccccccccccccccccchhhhccccccccccccccchhhhccccccccccccc----CchhhccCcccceee
Confidence 999996 89998777 688888888888888888777766666666666666666666653 666666666666666
Q ss_pred cccccccCCcchhccCCCCC-CeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCcc
Q 041143 173 LINCNLVGPLPDFLGTLPSL-AALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQF 251 (973)
Q Consensus 173 L~~N~l~~~~p~~l~~l~~L-~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l 251 (973)
+++|.+++.+|..+..+.++ +.+++++|++++..|..+.. + .+..+++++|.+
T Consensus 156 l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~-------------------------l-~~~~l~l~~~~~ 209 (313)
T d1ogqa_ 156 FDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFAN-------------------------L-NLAFVDLSRNML 209 (313)
T ss_dssp CCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGG-------------------------C-CCSEEECCSSEE
T ss_pred ccccccccccccccccccccccccccccccccccccccccc-------------------------c-cccccccccccc
Confidence 66666666666666665554 55666666666555554421 2 233456666666
Q ss_pred ccCCCccccCCCCCCEEeCcCCcccccCcccccccccCeEEccCCcCcCCCCCCCCCCcccccCcccCCCCCcccCCcch
Q 041143 252 TGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVN 331 (973)
Q Consensus 252 ~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (973)
.|.+|..+..+++|+.|++++|.+.+.+|. +
T Consensus 210 ~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~-~------------------------------------------------ 240 (313)
T d1ogqa_ 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLGK-V------------------------------------------------ 240 (313)
T ss_dssp EECCGGGCCTTSCCSEEECCSSEECCBGGG-C------------------------------------------------
T ss_pred cccccccccccccccccccccccccccccc-c------------------------------------------------
Confidence 656665555555666666555555543321 1
Q ss_pred hhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCCCccchhhhCccccceEEccCCccccccCc
Q 041143 332 VLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPN 411 (973)
Q Consensus 332 ~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~ 411 (973)
..+++|+.|+|++|+++|.+|..|+++++|++|+|++|+|+|.+|.
T Consensus 241 ----------------------------------~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~ 286 (313)
T d1ogqa_ 241 ----------------------------------GLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286 (313)
T ss_dssp ----------------------------------CCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC
T ss_pred ----------------------------------ccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC
Confidence 1234566677777777777777777888888888888888877774
Q ss_pred cccCcCCCCeeeCCCCc
Q 041143 412 NFTELKSLRLLDVSDNN 428 (973)
Q Consensus 412 ~~~~l~~L~~L~Ls~N~ 428 (973)
++++++|+.+++++|+
T Consensus 287 -~~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 287 -GGNLQRFDVSAYANNK 302 (313)
T ss_dssp -STTGGGSCGGGTCSSS
T ss_pred -cccCCCCCHHHhCCCc
Confidence 5677777777777665
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-40 Score=370.22 Aligned_cols=276 Identities=20% Similarity=0.318 Sum_probs=209.0
Q ss_pred hcCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeeEEEeC-----Ce
Q 041143 624 TQNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHLVSLLGYSIEG-----NE 697 (973)
Q Consensus 624 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 697 (973)
.++|+..+.||+|+||+||+|+. .+|+.||||+++.........+++.+|++++++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46899999999999999999986 4799999999987666666777899999999999999999999998643 34
Q ss_pred EEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccc
Q 041143 698 RLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL 777 (973)
Q Consensus 698 ~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGl 777 (973)
.++||||+.+|+|.+++.. +.+++.++..++.||+.||+||| +++|+||||||+|||++.++.+|++|||+
T Consensus 97 ~~~i~~~~~gg~L~~~~~~------~~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~ 167 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGL 167 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC--
T ss_pred eEEEEEeecCCchhhhccc------ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccch
Confidence 5677788889999998854 46899999999999999999999 88999999999999999999999999999
Q ss_pred cccCCCCCcceecccccccCcccccccccC-cCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchh-
Q 041143 778 VKLAPDGEKSVVTRLAGTFGYLAPEYAVMG-KITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKE- 855 (973)
Q Consensus 778 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~- 855 (973)
+..... ......||+.|+|||...+. .++.++||||+||++|||++|+.||.+........... ........
T Consensus 168 a~~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~--~~~~~~~~~ 241 (348)
T d2gfsa1 168 ARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL--RLVGTPGAE 241 (348)
T ss_dssp --CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH--HHHCCCCHH
T ss_pred hcccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH--HhcCCCChH
Confidence 875432 23446799999999987765 46889999999999999999999998765433221111 00000000
Q ss_pred --------HHHhhcCccccCCcccH-----HHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhhhcCCCCCC
Q 041143 856 --------KFKAAIDPALEVNEETF-----ESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVEKWRPITDE 916 (973)
Q Consensus 856 --------~~~~~~~~~l~~~~~~~-----~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~~~~~~~~~ 916 (973)
................. .....+.+|+.+||+.||++|||++|+++ +++++++..+.++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~--Hp~f~~~~~~~~~ 313 (348)
T d2gfsa1 242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA--HAYFAQYHDPDDE 313 (348)
T ss_dssp HHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGTTTCCTTSC
T ss_pred HhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc--CHhhCCCCCCccC
Confidence 00000100000000010 11235779999999999999999999998 7888876655444
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-41 Score=369.25 Aligned_cols=259 Identities=25% Similarity=0.352 Sum_probs=203.1
Q ss_pred cCccccCcccccCccEEEEEEEC----CCCEEEEEEeecCC--CChHHHHHHHHHHHHHHhcCC-CceeeeeeEEEeCCe
Q 041143 625 QNFAQENELGRGGFGTVYKGELE----DGTKIAVKRMEAGV--TTTKALDEFQSEIAVLSKVRH-RHLVSLLGYSIEGNE 697 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~ 697 (973)
++|+..+.||+|+||+||+|+.. +|+.||||+++... ......+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999752 47899999985431 112234568899999999966 899999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEEEeeccc
Q 041143 698 RLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAKVSDFGL 777 (973)
Q Consensus 698 ~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfGl 777 (973)
.++||||+.+|+|.+++... ..+.......++.||+.||+||| +++|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~-----~~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~ 175 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGL 175 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eeeeeecccccHHHHHHHhc-----ccccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccc
Confidence 99999999999999998762 34677888999999999999999 88999999999999999999999999999
Q ss_pred cccCCCCCcceecccccccCcccccccccC--cCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHHHHHhhchh
Q 041143 778 VKLAPDGEKSVVTRLAGTFGYLAPEYAVMG--KITTKADVFSYGVVLMELLTGLAALDEERPEESRYLAEWFWRIKSSKE 855 (973)
Q Consensus 778 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 855 (973)
|+..............|++.|+|||.+.+. .++.++||||+||+||||++|+.||......+..... ......
T Consensus 176 a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i--~~~~~~--- 250 (322)
T d1vzoa_ 176 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI--SRRILK--- 250 (322)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH--HHHHHH---
T ss_pred hhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHhccc---
Confidence 987655444445557899999999998754 4688999999999999999999999766543221110 010000
Q ss_pred HHHhhcCccccCCcccHHHHHHHHHHHHHhhccCCCCCCC-----HhHHHHHHHHhhh
Q 041143 856 KFKAAIDPALEVNEETFESISIVAELAGHCTAREPYHRPD-----MGHVVNVLSPLVE 908 (973)
Q Consensus 856 ~~~~~~~~~l~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~~v~~~L~~~~~ 908 (973)
..+.+. ......+.+++.+|++.||++||+ ++|+++ +++++
T Consensus 251 -----~~~~~~-----~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~--Hpff~ 296 (322)
T d1vzoa_ 251 -----SEPPYP-----QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE--HLFFQ 296 (322)
T ss_dssp -----CCCCCC-----TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT--SGGGT
T ss_pred -----CCCCCc-----ccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc--CHhhc
Confidence 011111 112345789999999999999995 677776 45543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.5e-40 Score=361.32 Aligned_cols=264 Identities=16% Similarity=0.271 Sum_probs=198.6
Q ss_pred cCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeeEEEeC--CeEEE
Q 041143 625 QNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR-HRHLVSLLGYSIEG--NERLL 700 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~l 700 (973)
++|++.++||+|+||+||+|+. .+|+.||||+++.. . .+++.+|+++|++++ ||||+++++++... ...++
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--K---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS--C---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH--H---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence 5799999999999999999987 46899999998653 1 356889999999995 99999999998853 56899
Q ss_pred EEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCC-CEEEeeccccc
Q 041143 701 VYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDY-RAKVSDFGLVK 779 (973)
Q Consensus 701 V~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~-~~kl~DfGla~ 779 (973)
||||+.+|+|..+. +.+++.++..++.||+.||+||| +++|+||||||+|||++.++ .+||+|||+|+
T Consensus 110 v~e~~~~~~L~~~~--------~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~ 178 (328)
T d3bqca1 110 VFEHVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 178 (328)
T ss_dssp EEECCCSCBGGGTT--------TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred EEeecCCCcHHHHh--------cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccce
Confidence 99999999986542 45899999999999999999999 88999999999999998654 69999999998
Q ss_pred cCCCCCcceecccccccCcccccccccC-cCCCchhHHhHHHHHHHHHhCCCCCCCCChhhHHHH--H---------HHH
Q 041143 780 LAPDGEKSVVTRLAGTFGYLAPEYAVMG-KITTKADVFSYGVVLMELLTGLAALDEERPEESRYL--A---------EWF 847 (973)
Q Consensus 780 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~~~~~--~---------~~~ 847 (973)
...... ......||+.|+|||.+.+. .++.++||||+||++|||++|+.||........... . .|.
T Consensus 179 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~ 256 (328)
T d3bqca1 179 FYHPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 256 (328)
T ss_dssp ECCTTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHH
T ss_pred eccCCC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhh
Confidence 665432 23456799999999998765 479999999999999999999999976653321110 0 000
Q ss_pred HHHhhc-hhHHHhhcCccc-------cCCcccHHHHHHHHHHHHHhhccCCCCCCCHhHHHHHHHHhhh
Q 041143 848 WRIKSS-KEKFKAAIDPAL-------EVNEETFESISIVAELAGHCTAREPYHRPDMGHVVNVLSPLVE 908 (973)
Q Consensus 848 ~~~~~~-~~~~~~~~~~~l-------~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~~v~~~L~~~~~ 908 (973)
...... ...+........ ............+.+|+.+||+.||++|||++|+++ +++.+
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~--Hp~F~ 323 (328)
T d3bqca1 257 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME--HPYFY 323 (328)
T ss_dssp HHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGT
T ss_pred hhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc--CcccC
Confidence 000000 000011110000 000001112235789999999999999999999998 55544
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.9e-35 Score=330.27 Aligned_cols=271 Identities=20% Similarity=0.284 Sum_probs=196.4
Q ss_pred cCccccCcccccCccEEEEEEE-CCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-----------CCceeeeeeEE
Q 041143 625 QNFAQENELGRGGFGTVYKGEL-EDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR-----------HRHLVSLLGYS 692 (973)
Q Consensus 625 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~ 692 (973)
.+|+++++||+|+||+||+|+. .+|+.||||+++.. ....+.+.+|++++++++ |+|||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 3589999999999999999987 47999999999753 344567889999988875 57899999987
Q ss_pred Ee--CCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCC--
Q 041143 693 IE--GNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDY-- 768 (973)
Q Consensus 693 ~~--~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~-- 768 (973)
.. ....++||+++..+........ ......+++..+..++.||+.||+|||+ ..+|+||||||+|||++.++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~ 165 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIK--KYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSP 165 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHH--HTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETT
T ss_pred eeccccceeeeeeecccccccccccc--cccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcc
Confidence 64 4566778887766654444332 2234668899999999999999999993 37999999999999998664
Q ss_pred ----CEEEeeccccccCCCCCcceecccccccCcccccccccCcCCCchhHHhHHHHHHHHHhCCCCCCCCChhh----H
Q 041143 769 ----RAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVMGKITTKADVFSYGVVLMELLTGLAALDEERPEE----S 840 (973)
Q Consensus 769 ----~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~elltg~~p~~~~~~~~----~ 840 (973)
.+|++|||.++..... ....+||+.|+|||++....++.++||||+||+++||++|+.||....... .
T Consensus 166 ~~~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~ 241 (362)
T d1q8ya_ 166 ENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241 (362)
T ss_dssp TTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred cccceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchh
Confidence 3999999999855432 234679999999999999999999999999999999999999997543221 1
Q ss_pred HHHHHHHHHHhhc-hhH------HHhhcCc-----ccc-------------CCcccHHHHHHHHHHHHHhhccCCCCCCC
Q 041143 841 RYLAEWFWRIKSS-KEK------FKAAIDP-----ALE-------------VNEETFESISIVAELAGHCTAREPYHRPD 895 (973)
Q Consensus 841 ~~~~~~~~~~~~~-~~~------~~~~~~~-----~l~-------------~~~~~~~~~~~~~~l~~~cl~~dP~~RPs 895 (973)
..+...+...... ... .....+. .+. ...........+.+|+.+|++.||++|||
T Consensus 242 ~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt 321 (362)
T d1q8ya_ 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 321 (362)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC
Confidence 1122211111000 000 0111110 000 01112345567889999999999999999
Q ss_pred HhHHHHHHHHhhh
Q 041143 896 MGHVVNVLSPLVE 908 (973)
Q Consensus 896 ~~~v~~~L~~~~~ 908 (973)
++|+++ +++++
T Consensus 322 a~e~L~--Hp~f~ 332 (362)
T d1q8ya_ 322 AGGLVN--HPWLK 332 (362)
T ss_dssp HHHHHT--CGGGT
T ss_pred HHHHhc--CcccC
Confidence 999998 77666
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.97 E-value=1.3e-30 Score=284.40 Aligned_cols=232 Identities=31% Similarity=0.494 Sum_probs=200.9
Q ss_pred ccCCCCCccEEEccc-CCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhh
Q 041143 133 FFDGLSSVRVLALDY-NPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFG 211 (973)
Q Consensus 133 ~f~~l~~L~~L~Ls~-N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~ 211 (973)
.+.+|++|++|+|++ |++++. +|..|+++++|++|+|++|+|.+..+..+..+.+|+++++++|++.+.+|..+.
T Consensus 71 ~l~~L~~L~~L~Ls~~N~l~g~----iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~ 146 (313)
T d1ogqa_ 71 SLANLPYLNFLYIGGINNLVGP----IPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSIS 146 (313)
T ss_dssp GGGGCTTCSEEEEEEETTEESC----CCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGG
T ss_pred HHhcCccccccccccccccccc----cccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhc
Confidence 356677777777765 677764 888899999999999999999988888899999999999999999888887764
Q ss_pred hhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCC-CEEeCcCCcccccCcccccccccCe
Q 041143 212 QSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSL-KDLNLNRNQLVGLIPKSLANMELDN 290 (973)
Q Consensus 212 ~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L-~~L~Ls~N~l~~~~p~~~~~l~L~~ 290 (973)
++++|+.+++++|.++|.+|..+..+.++ +.+++++|++++..|..+..+....
T Consensus 147 -------------------------~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~ 201 (313)
T d1ogqa_ 147 -------------------------SLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAF 201 (313)
T ss_dssp -------------------------GCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSE
T ss_pred -------------------------cCcccceeecccccccccccccccccccccccccccccccccccccccccccccc
Confidence 48899999999999999999999888876 8899999999999999998888888
Q ss_pred EEccCCcCcCCCCCCCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCc
Q 041143 291 LVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSK 370 (973)
Q Consensus 291 L~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (973)
+++++|.+.|.+|.. +..+++
T Consensus 202 l~l~~~~~~~~~~~~-----------------------------------------------------------~~~~~~ 222 (313)
T d1ogqa_ 202 VDLSRNMLEGDASVL-----------------------------------------------------------FGSDKN 222 (313)
T ss_dssp EECCSSEEEECCGGG-----------------------------------------------------------CCTTSC
T ss_pred ccccccccccccccc-----------------------------------------------------------cccccc
Confidence 999999988877752 234578
Q ss_pred ccEEecCCCcCCCccchhhhCccccceEEccCCccccccCccccCcCCCCeeeCCCCcCCCCCCCCCcc---cceeecCC
Q 041143 371 VSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPLPEFHDT---VKLVIDGN 447 (973)
Q Consensus 371 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~---~~~~~~~N 447 (973)
|+.+++++|.+.+.+| .++.+++|+.|+|++|+|+|.+|..|+++++|++|||++|+|+|.+|++.++ ..+.+.+|
T Consensus 223 l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N 301 (313)
T d1ogqa_ 223 TQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANN 301 (313)
T ss_dssp CSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSS
T ss_pred cccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCC
Confidence 9999999999998876 6899999999999999999999999999999999999999999999986544 45779999
Q ss_pred ccccCC
Q 041143 448 PLLVGG 453 (973)
Q Consensus 448 ~~~c~~ 453 (973)
+.+||.
T Consensus 302 ~~l~g~ 307 (313)
T d1ogqa_ 302 KCLCGS 307 (313)
T ss_dssp SEEEST
T ss_pred ccccCC
Confidence 999985
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=4.5e-25 Score=239.18 Aligned_cols=204 Identities=22% Similarity=0.287 Sum_probs=158.7
Q ss_pred CCCCCCCCcCeEEeeCCeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCC-CCCCCCccceeeccCCCCCCC
Q 041143 51 DDPCGPPPWPHVFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFDTI 129 (973)
Q Consensus 51 ~d~C~~~~w~gv~C~~~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i 129 (973)
+-.|. |.|.+|.|++.+ ++ .+|..+. ++|++|+|++|+|+.+++ .|.++++|++|++++|.+..+
T Consensus 5 p~~c~-c~~~~~~C~~~~----------L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i 70 (305)
T d1xkua_ 5 PFRCQ-CHLRVVQCSDLG----------LE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKI 70 (305)
T ss_dssp CTTCE-EETTEEECTTSC----------CC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCB
T ss_pred CCCCE-ecCCEEEecCCC----------CC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhcccccccccccccccccc
Confidence 33464 457777776544 44 5677664 689999999999999887 699999999999999999999
Q ss_pred CccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChh
Q 041143 130 PSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPAS 209 (973)
Q Consensus 130 ~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~ 209 (973)
++..|.++++|++|+|++|+++. +|..+ ...|..|++.+|.+.+..+..+.....+..++...|.......
T Consensus 71 ~~~~f~~l~~L~~L~l~~n~l~~-----l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~-- 141 (305)
T d1xkua_ 71 SPGAFAPLVKLERLYLSKNQLKE-----LPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI-- 141 (305)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSB-----CCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGB--
T ss_pred chhhhhCCCccCEecccCCccCc-----Cccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCC--
Confidence 99999999999999999999985 56544 3578899999999998777788888899999998887642211
Q ss_pred hhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcccccCccccccc-cc
Q 041143 210 FGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-EL 288 (973)
Q Consensus 210 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L 288 (973)
....+..+++|+.+++++|.++ .+|..+ +++|+.|++++|.+++..+..|..+ .+
T Consensus 142 ---------------------~~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l 197 (305)
T d1xkua_ 142 ---------------------ENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNL 197 (305)
T ss_dssp ---------------------CTTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTC
T ss_pred ---------------------CccccccccccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhccccc
Confidence 1123456888999999999888 566554 5788888998888888777777666 56
Q ss_pred CeEEccCCcCcCC
Q 041143 289 DNLVLNNNLLMGP 301 (973)
Q Consensus 289 ~~L~l~~N~l~g~ 301 (973)
+.|++++|.+.+.
T Consensus 198 ~~L~~s~n~l~~~ 210 (305)
T d1xkua_ 198 AKLGLSFNSISAV 210 (305)
T ss_dssp CEEECCSSCCCEE
T ss_pred ccccccccccccc
Confidence 7777777766643
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=1.4e-25 Score=240.31 Aligned_cols=274 Identities=20% Similarity=0.290 Sum_probs=206.6
Q ss_pred EeeCCeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCC-CCCCCCccceeeccCCCCCCCCccccCCCCCcc
Q 041143 63 FCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVR 141 (973)
Q Consensus 63 ~C~~~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~ 141 (973)
.|....-..+++++++++ .+|..+. +.+++|+|++|+|+++++ .|.++++|++|++++|+|..++...+.++..++
T Consensus 7 ~C~~~~~~~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~ 83 (284)
T d1ozna_ 7 VCYNEPKVTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83 (284)
T ss_dssp EEECSSSCEEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCC
T ss_pred EEcCCCCeEEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccc
Confidence 465433344566777777 6676654 578999999999998877 699999999999999999999999999999999
Q ss_pred EEEcc-cCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhh
Q 041143 142 VLALD-YNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWL 220 (973)
Q Consensus 142 ~L~Ls-~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l 220 (973)
.++.. .|.++.. .+..|.++++|++|+|++|.+....+..+..+++|+.+++++|+|++..+..|
T Consensus 84 ~l~~~~~~~~~~l----~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f---------- 149 (284)
T d1ozna_ 84 QLDLSDNAQLRSV----DPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTF---------- 149 (284)
T ss_dssp EEECCSCTTCCCC----CTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT----------
T ss_pred ccccccccccccc----cchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHh----------
Confidence 98765 5556553 46778889999999999999987778888889999999999999985544444
Q ss_pred cccCCCCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcccccCccccccc-ccCeEEccCCcCc
Q 041143 221 NDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLM 299 (973)
Q Consensus 221 ~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~ 299 (973)
..+++|+.|+|++|+|++..+..|..+++|+.|++++|++++..|..|..+ +|++|++++|.+.
T Consensus 150 ---------------~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~ 214 (284)
T d1ozna_ 150 ---------------RDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS 214 (284)
T ss_dssp ---------------TTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred ---------------ccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccc
Confidence 457889999999999987778888889999999999999998888888877 6888888888877
Q ss_pred CCCCCCCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCC
Q 041143 300 GPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRH 379 (973)
Q Consensus 300 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N 379 (973)
+..|. .+..+.+|++|+|++|
T Consensus 215 ~~~~~-----------------------------------------------------------~~~~~~~L~~L~l~~N 235 (284)
T d1ozna_ 215 ALPTE-----------------------------------------------------------ALAPLRALQYLRLNDN 235 (284)
T ss_dssp CCCHH-----------------------------------------------------------HHTTCTTCCEEECCSS
T ss_pred ccccc-----------------------------------------------------------ccccccccCEEEecCC
Confidence 54432 1234556777777777
Q ss_pred cCCCccchhhhCccccceEEccCCccccccCccccCcCCCCeeeCCCCcCCC
Q 041143 380 NLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKP 431 (973)
Q Consensus 380 ~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g 431 (973)
.+...-+.. .-...++.+....+++....|..+.+ +..++|+.|+|+|
T Consensus 236 ~l~C~C~~~-~l~~~l~~~~~~~~~~~C~~p~~l~g---~~l~~l~~~~l~g 283 (284)
T d1ozna_ 236 PWVCDCRAR-PLWAWLQKFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQG 283 (284)
T ss_dssp CEECSGGGH-HHHHHHHHCCSEECCCBEEESGGGTT---CBGGGSCGGGSCC
T ss_pred CCCCCccch-HHHHHHHhCcCCCCceEeCCchHHcC---CccccCCHHHCCC
Confidence 777554321 12234556666667777666766553 4556677777666
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.93 E-value=9.9e-25 Score=244.72 Aligned_cols=296 Identities=23% Similarity=0.363 Sum_probs=205.2
Q ss_pred CeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcc
Q 041143 67 NRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALD 146 (973)
Q Consensus 67 ~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls 146 (973)
..+++|++++++|+. + +.+..|++|++|||++|+|++.. .|.++++|++|+|++|+|..+++ +.++++|+.|+++
T Consensus 44 ~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l~-~l~~L~~L~~L~L~~n~i~~i~~--l~~l~~L~~L~~~ 118 (384)
T d2omza2 44 DQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDIT-PLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLF 118 (384)
T ss_dssp TTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECC
T ss_pred CCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCCc-cccCCcccccccccccccccccc--ccccccccccccc
Confidence 579999999999985 3 56899999999999999999865 49999999999999999998875 8899999999999
Q ss_pred cCCCCCccCCCCCcccccccccCeeecccccccC-----------------------------------------Ccchh
Q 041143 147 YNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVG-----------------------------------------PLPDF 185 (973)
Q Consensus 147 ~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~-----------------------------------------~~p~~ 185 (973)
+|.+++.. .......+..+....|.+.. .....
T Consensus 119 ~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (384)
T d2omza2 119 NNQITDID------PLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV 192 (384)
T ss_dssp SSCCCCCG------GGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGG
T ss_pred cccccccc------cccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccccccccc
Confidence 99998642 12223333344433333321 12234
Q ss_pred ccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCC
Q 041143 186 LGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSL 265 (973)
Q Consensus 186 l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L 265 (973)
+..+++++.|++++|.+++..|. ..+++|+.|++++|+++. + ..+..+++|
T Consensus 193 ~~~l~~~~~l~l~~n~i~~~~~~---------------------------~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L 243 (384)
T d2omza2 193 LAKLTNLESLIATNNQISDITPL---------------------------GILTNLDELSLNGNQLKD-I-GTLASLTNL 243 (384)
T ss_dssp GGGCTTCSEEECCSSCCCCCGGG---------------------------GGCTTCCEEECCSSCCCC-C-GGGGGCTTC
T ss_pred cccccccceeeccCCccCCCCcc---------------------------cccCCCCEEECCCCCCCC-c-chhhccccc
Confidence 55566677777777776644332 235677777777777763 3 356677777
Q ss_pred CEEeCcCCcccccCccccccc-ccCeEEccCCcCcCCCCCCCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCC
Q 041143 266 KDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPV 344 (973)
Q Consensus 266 ~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~ 344 (973)
+.|++++|.+++..+ +..+ +|+.|++++|.+++..+-.. +..+..+....
T Consensus 244 ~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~~~~---------------------------~~~l~~l~~~~ 294 (384)
T d2omza2 244 TDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAG---------------------------LTALTNLELNE 294 (384)
T ss_dssp SEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGGGTT---------------------------CTTCSEEECCS
T ss_pred chhccccCccCCCCc--ccccccCCEeeccCcccCCCCcccc---------------------------ccccccccccc
Confidence 777777777775433 4444 67777777777764332100 01111122222
Q ss_pred cccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCCCccchhhhCccccceEEccCCccccccCccccCcCCCCeeeC
Q 041143 345 NLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDV 424 (973)
Q Consensus 345 n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L 424 (973)
|.+..+. .+..+.+++.|+|++|++++..+ +..+++|++|+|++|+|++ ++ .|.++++|++|+|
T Consensus 295 n~l~~~~------------~~~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l 358 (384)
T d2omza2 295 NQLEDIS------------PISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSA 358 (384)
T ss_dssp SCCSCCG------------GGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEEC
T ss_pred ccccccc------------ccchhcccCeEECCCCCCCCCcc--cccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEEC
Confidence 2222211 24556789999999999998643 8889999999999999984 44 6899999999999
Q ss_pred CCCcCCCCCC--CCCcccceeecCC
Q 041143 425 SDNNIKPPLP--EFHDTVKLVIDGN 447 (973)
Q Consensus 425 s~N~l~g~~p--~~~~~~~~~~~~N 447 (973)
++|+|++.+| .+.++..|++++|
T Consensus 359 ~~N~l~~l~~l~~l~~L~~L~L~~N 383 (384)
T d2omza2 359 GHNQISDLTPLANLTRITQLGLNDQ 383 (384)
T ss_dssp CSSCCCBCGGGTTCTTCSEEECCCE
T ss_pred CCCcCCCChhhccCCCCCEeeCCCC
Confidence 9999998765 2445666788776
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.92 E-value=6.5e-24 Score=229.96 Aligned_cols=267 Identities=20% Similarity=0.247 Sum_probs=220.5
Q ss_pred ccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCee
Q 041143 92 KLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNL 171 (973)
Q Consensus 92 ~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L 171 (973)
.++.+|.++++++.+|+.+. +++++|+|++|+|+.+++..|.++++|++|++++|++... .|..|.++++|++|
T Consensus 11 ~~~~~~C~~~~L~~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i----~~~~f~~l~~L~~L 84 (305)
T d1xkua_ 11 HLRVVQCSDLGLEKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKI----SPGAFAPLVKLERL 84 (305)
T ss_dssp ETTEEECTTSCCCSCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCB----CTTTTTTCTTCCEE
T ss_pred cCCEEEecCCCCCccCCCCC--CCCCEEECcCCcCCCcChhHhhcccccccccccccccccc----chhhhhCCCccCEe
Confidence 56778999999998877664 6899999999999999999999999999999999999974 57789999999999
Q ss_pred ecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCcc
Q 041143 172 SLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQF 251 (973)
Q Consensus 172 ~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l 251 (973)
+|++|+|+. +|.. ....|..|++++|.+.+..+..+ .....+..++...|..
T Consensus 85 ~l~~n~l~~-l~~~--~~~~l~~L~~~~n~l~~l~~~~~-------------------------~~~~~~~~l~~~~n~~ 136 (305)
T d1xkua_ 85 YLSKNQLKE-LPEK--MPKTLQELRVHENEITKVRKSVF-------------------------NGLNQMIVVELGTNPL 136 (305)
T ss_dssp ECCSSCCSB-CCSS--CCTTCCEEECCSSCCCBBCHHHH-------------------------TTCTTCCEEECCSSCC
T ss_pred cccCCccCc-Cccc--hhhhhhhhhccccchhhhhhhhh-------------------------hccccccccccccccc
Confidence 999999994 5543 34689999999999985444333 3467788899888854
Q ss_pred c--cCCCccccCCCCCCEEeCcCCcccccCcccccccccCeEEccCCcCcCCCCCCCCCCcccccCcccCCCCCcccCCc
Q 041143 252 T--GSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANMELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPD 329 (973)
Q Consensus 252 ~--g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (973)
. +..+..+..+++|+.+++++|.+.. +|..+. -+|+.|++++|.+.+..+.
T Consensus 137 ~~~~~~~~~~~~l~~L~~l~l~~n~l~~-l~~~~~-~~L~~L~l~~n~~~~~~~~------------------------- 189 (305)
T d1xkua_ 137 KSSGIENGAFQGMKKLSYIRIADTNITT-IPQGLP-PSLTELHLDGNKITKVDAA------------------------- 189 (305)
T ss_dssp CGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSSCC-TTCSEEECTTSCCCEECTG-------------------------
T ss_pred cccCCCccccccccccCccccccCCccc-cCcccC-CccCEEECCCCcCCCCChh-------------------------
Confidence 3 3456778899999999999999984 444331 2799999999998865543
Q ss_pred chhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCCCccchhhhCccccceEEccCCcccccc
Q 041143 330 VNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTV 409 (973)
Q Consensus 330 ~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~ 409 (973)
.+..++.+++|++++|++.+..+..+.++++|++|+|++|+|+ .+
T Consensus 190 ----------------------------------~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~l 234 (305)
T d1xkua_ 190 ----------------------------------SLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KV 234 (305)
T ss_dssp ----------------------------------GGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SC
T ss_pred ----------------------------------Hhhccccccccccccccccccccccccccccceeeeccccccc-cc
Confidence 2345678999999999999999999999999999999999998 78
Q ss_pred CccccCcCCCCeeeCCCCcCCCCCCC----------CCcccceeecCCccccCCC
Q 041143 410 PNNFTELKSLRLLDVSDNNIKPPLPE----------FHDTVKLVIDGNPLLVGGI 454 (973)
Q Consensus 410 p~~~~~l~~L~~L~Ls~N~l~g~~p~----------~~~~~~~~~~~N~~~c~~~ 454 (973)
|..|..+++|++|+|++|+|+..... ..++..+.+++|||.+..+
T Consensus 235 p~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~ 289 (305)
T d1xkua_ 235 PGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEI 289 (305)
T ss_dssp CTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGS
T ss_pred ccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccCcC
Confidence 99999999999999999999975332 2445668999999987543
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=2.2e-23 Score=223.10 Aligned_cols=180 Identities=19% Similarity=0.272 Sum_probs=133.3
Q ss_pred ceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeeec
Q 041143 94 YNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSL 173 (973)
Q Consensus 94 ~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L 173 (973)
..++.++++++.++..+. +.+++|+|++|+|+.+++..|.++++|++|++++|++..+ .+..+..+..++.++.
T Consensus 14 ~~v~c~~~~L~~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i----~~~~~~~~~~~~~l~~ 87 (284)
T d1ozna_ 14 VTTSCPQQGLQAVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARI----DAAAFTGLALLEQLDL 87 (284)
T ss_dssp CEEECCSSCCSSCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEE----CTTTTTTCTTCCEEEC
T ss_pred eEEEcCCCCCCccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccc----cccccccccccccccc
Confidence 346777878876644443 5678888888888888888888888888888888888875 4556667777888765
Q ss_pred c-cccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCccc
Q 041143 174 I-NCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFT 252 (973)
Q Consensus 174 ~-~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~ 252 (973)
. .|.++...+..|.++++|++|+|++|.+....+..+ ..+.+|+.+++++|+|+
T Consensus 88 ~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~-------------------------~~~~~L~~l~l~~N~l~ 142 (284)
T d1ozna_ 88 SDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLF-------------------------RGLAALQYLYLQDNALQ 142 (284)
T ss_dssp CSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTT-------------------------TTCTTCCEEECCSSCCC
T ss_pred ccccccccccchhhcccccCCEEecCCccccccccccc-------------------------chhcccchhhhcccccc
Confidence 4 566776667788888888888888888874444333 34778888888888888
Q ss_pred cCCCccccCCCCCCEEeCcCCcccccCccccccc-ccCeEEccCCcCcCCCCC
Q 041143 253 GSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGPIPK 304 (973)
Q Consensus 253 g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~g~~p~ 304 (973)
+..+..|..+++|+.|+|++|+|++..+..|.++ +|+.+++++|++++..|.
T Consensus 143 ~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~ 195 (284)
T d1ozna_ 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPH 195 (284)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred ccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChh
Confidence 6666777788888888888888887767677666 566666666666654443
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.89 E-value=2.1e-22 Score=225.43 Aligned_cols=281 Identities=28% Similarity=0.339 Sum_probs=202.0
Q ss_pred CCeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEc
Q 041143 66 GNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLAL 145 (973)
Q Consensus 66 ~~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~L 145 (973)
..++++|+|++|+|++. + .|++|++|++|+|++|.|.+.. .+.++++|+.|++++|.++.+... .....+..+..
T Consensus 65 L~nL~~L~Ls~N~l~~l-~-~l~~L~~L~~L~L~~n~i~~i~-~l~~l~~L~~L~~~~~~~~~~~~~--~~~~~~~~~~~ 139 (384)
T d2omza2 65 LNNLTQINFSNNQLTDI-T-PLKNLTKLVDILMNNNQIADIT-PLANLTNLTGLTLFNNQITDIDPL--KNLTNLNRLEL 139 (384)
T ss_dssp CTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCCCCGGG--TTCTTCSEEEE
T ss_pred CCCCCEEeCcCCcCCCC-c-cccCCccccccccccccccccc-cccccccccccccccccccccccc--ccccccccccc
Confidence 35799999999999964 3 3999999999999999999754 589999999999999999876643 33445555555
Q ss_pred ccCCCCCccC-------------------------------------CCCCcccccccccCeeecccccccCCcchhccC
Q 041143 146 DYNPFNKTFG-------------------------------------WSIPDSLANSVQLTNLSLINCNLVGPLPDFLGT 188 (973)
Q Consensus 146 s~N~l~~~~~-------------------------------------~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~ 188 (973)
..|.+..... ......+..+++++.|++++|.+++..| +..
T Consensus 140 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~ 217 (384)
T d2omza2 140 SSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITP--LGI 217 (384)
T ss_dssp EEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGG--GGG
T ss_pred ccccccccccccccccccccccccccchhhhhccccccccccccccccccccccccccccceeeccCCccCCCCc--ccc
Confidence 4444322100 0123456777888999999999887654 466
Q ss_pred CCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEE
Q 041143 189 LPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDL 268 (973)
Q Consensus 189 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L 268 (973)
+++|++|++++|+++. ++ .+ ..+++|+.|++++|.+++.. .+..+++|++|
T Consensus 218 ~~~L~~L~l~~n~l~~-~~-~l-------------------------~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L 268 (384)
T d2omza2 218 LTNLDELSLNGNQLKD-IG-TL-------------------------ASLTNLTDLDLANNQISNLA--PLSGLTKLTEL 268 (384)
T ss_dssp CTTCCEEECCSSCCCC-CG-GG-------------------------GGCTTCSEEECCSSCCCCCG--GGTTCTTCSEE
T ss_pred cCCCCEEECCCCCCCC-cc-hh-------------------------hcccccchhccccCccCCCC--cccccccCCEe
Confidence 7889999999998873 32 22 34677777777777777543 36677777777
Q ss_pred eCcCCcccccCccccccc-ccCeEEccCCcCcCCCCCCCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCccc
Q 041143 269 NLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLV 347 (973)
Q Consensus 269 ~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~ 347 (973)
++++|++++..+ +..+ .+..+++++|.+++... ...+..+..++++.|.+
T Consensus 269 ~l~~~~l~~~~~--~~~~~~l~~l~~~~n~l~~~~~---------------------------~~~~~~l~~L~ls~n~l 319 (384)
T d2omza2 269 KLGANQISNISP--LAGLTALTNLELNENQLEDISP---------------------------ISNLKNLTYLTLYFNNI 319 (384)
T ss_dssp ECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG---------------------------GGGCTTCSEEECCSSCC
T ss_pred eccCcccCCCCc--cccccccccccccccccccccc---------------------------cchhcccCeEECCCCCC
Confidence 777777775432 3333 67777777777664211 01122233445555554
Q ss_pred CCCCCCCCCCCCccccccCCCCcccEEecCCCcCCCccchhhhCccccceEEccCCccccccCccccCcCCCCeeeCCCC
Q 041143 348 SQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDN 427 (973)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N 427 (973)
..++ .+..+++|++|+|++|++++ ++ .++++++|++|+|++|+|++..| +.++++|+.|+|++|
T Consensus 320 ~~l~------------~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 320 SDIS------------PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp SCCG------------GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CCCc------------ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 4432 24567899999999999986 34 69999999999999999997655 899999999999998
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=1.2e-22 Score=214.78 Aligned_cols=197 Identities=23% Similarity=0.192 Sum_probs=173.5
Q ss_pred CeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCC-CCCCCCccceeeccCCCCCCCCccccCCCCCccEEEc
Q 041143 67 NRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP-TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLAL 145 (973)
Q Consensus 67 ~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~L 145 (973)
.+..++++++++|+ .+|+.|. ++|++|+|++|+|+++++ .|.++++|++|+|++|+|+.++. +..+++|++|+|
T Consensus 10 ~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~~--~~~l~~L~~L~L 84 (266)
T d1p9ag_ 10 ASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--DGTLPVLGTLDL 84 (266)
T ss_dssp TTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC--CSCCTTCCEEEC
T ss_pred CCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccccc--cccccccccccc
Confidence 34556788999998 5787775 579999999999999876 69999999999999999998874 578999999999
Q ss_pred ccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCC
Q 041143 146 DYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDA 225 (973)
Q Consensus 146 s~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~ 225 (973)
++|+++. ++..+..+++|+.|++++|.+....+..+..+.+|++|++++|.++...+..
T Consensus 85 s~N~l~~-----~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~---------------- 143 (266)
T d1p9ag_ 85 SHNQLQS-----LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGL---------------- 143 (266)
T ss_dssp CSSCCSS-----CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTT----------------
T ss_pred ccccccc-----cccccccccccccccccccccceeeccccccccccccccccccccceecccc----------------
Confidence 9999986 6788999999999999999999888889999999999999999998544433
Q ss_pred CCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcccccCccccccc-ccCeEEccCCcCc
Q 041143 226 GGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLM 299 (973)
Q Consensus 226 ~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~ 299 (973)
+..+++|+.|++++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+ +|+.|+|++|.+.
T Consensus 144 ---------~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 144 ---------LTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp ---------TTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred ---------ccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence 346899999999999999888888999999999999999999 677766666 8999999999875
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=3e-23 Score=207.59 Aligned_cols=166 Identities=16% Similarity=0.144 Sum_probs=122.9
Q ss_pred cccCcccccCccEEEEEEECCCCEEEEEEeecCCCC----------------hHHHHHHHHHHHHHHhcCCCceeeeeeE
Q 041143 628 AQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTT----------------TKALDEFQSEIAVLSKVRHRHLVSLLGY 691 (973)
Q Consensus 628 ~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~----------------~~~~~~~~~E~~~l~~l~h~niv~l~~~ 691 (973)
.+.+.||+|+||.||+|+..+|+.||||+++..... ......+.+|+..+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 456889999999999999999999999987532111 0112345678999999999999988765
Q ss_pred EEeCCeEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhccCCeeeccCCCCcEEECCCCCEE
Q 041143 692 SIEGNERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLARQTFIHRDLKSSNILLDDDYRAK 771 (973)
Q Consensus 692 ~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dikp~Nill~~~~~~k 771 (973)
. ..++||||++++.+. .++......++.|++++++||| +++|+||||||+|||++++ .++
T Consensus 83 ~----~~~lvme~~~~~~~~------------~l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~ 142 (191)
T d1zara2 83 E----GNAVLMELIDAKELY------------RVRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIW 142 (191)
T ss_dssp E----TTEEEEECCCCEEGG------------GCCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEE
T ss_pred c----CCEEEEEeecccccc------------chhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEE
Confidence 3 237999999875542 2444556789999999999999 7899999999999999965 489
Q ss_pred EeeccccccCCCCCcceecccccccCcccc------cccccCcCCCchhHHhHHHHHH
Q 041143 772 VSDFGLVKLAPDGEKSVVTRLAGTFGYLAP------EYAVMGKITTKADVFSYGVVLM 823 (973)
Q Consensus 772 l~DfGla~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~~Dv~S~Gvvl~ 823 (973)
|+|||.|+........ .|... | ...+.|..++|+||..--+.
T Consensus 143 liDFG~a~~~~~~~~~---------~~l~rd~~~~~~-~f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 143 IIDFPQSVEVGEEGWR---------EILERDVRNIIT-YFSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp ECCCTTCEETTSTTHH---------HHHHHHHHHHHH-HHHHHHCCCCCHHHHHHHHH
T ss_pred EEECCCcccCCCCCcH---------HHHHHHHHHHHH-HHcCCCCCcccHHHHHHHHh
Confidence 9999999865433211 11111 1 12467889999999765443
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=5.1e-22 Score=209.95 Aligned_cols=177 Identities=26% Similarity=0.232 Sum_probs=119.3
Q ss_pred ccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEc
Q 041143 167 QLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWL 246 (973)
Q Consensus 167 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L 246 (973)
+|++|+|++|+|++..+..|.++++|++|+|++|+|+ .+|. ++.+++|++|+|
T Consensus 32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~--------------------------~~~l~~L~~L~L 84 (266)
T d1p9ag_ 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV--------------------------DGTLPVLGTLDL 84 (266)
T ss_dssp TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEEC--------------------------CSCCTTCCEEEC
T ss_pred CCCEEECcCCcCCCcCHHHhhcccccccccccccccc-cccc--------------------------cccccccccccc
Confidence 4566666666666555556666666666666666665 2221 123666666777
Q ss_pred cCCccccCCCccccCCCCCCEEeCcCCcccccCccccccc-ccCeEEccCCcCcCCCCCCCCCCcccccCcccCCCCCcc
Q 041143 247 HGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIE 325 (973)
Q Consensus 247 ~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~ 325 (973)
++|+++ .++..+..+++|++|++++|.+....+..+..+ ++..|++++|.++...+.
T Consensus 85 s~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~--------------------- 142 (266)
T d1p9ag_ 85 SHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPG--------------------- 142 (266)
T ss_dssp CSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTT---------------------
T ss_pred cccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccc---------------------
Confidence 777666 445566666777777777777666555555554 566666666666533222
Q ss_pred cCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCCCccchhhhCccccceEEccCCcc
Q 041143 326 CAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGTLSPSIANLDSLIEIRLGKNSI 405 (973)
Q Consensus 326 ~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 405 (973)
.+..+++|+.|++++|++++..+..|..+++|++|+|++|+|
T Consensus 143 --------------------------------------~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L 184 (266)
T d1p9ag_ 143 --------------------------------------LLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL 184 (266)
T ss_dssp --------------------------------------TTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCC
T ss_pred --------------------------------------cccccccchhcccccccccccCccccccccccceeecccCCC
Confidence 123355777888888888877777888888888888888888
Q ss_pred ccccCccccCcCCCCeeeCCCCcCCC
Q 041143 406 SGTVPNNFTELKSLRLLDVSDNNIKP 431 (973)
Q Consensus 406 ~g~~p~~~~~l~~L~~L~Ls~N~l~g 431 (973)
+ .+|..+..+++|+.|+|++|.+..
T Consensus 185 ~-~lp~~~~~~~~L~~L~L~~Np~~C 209 (266)
T d1p9ag_ 185 Y-TIPKGFFGSHLLPFAFLHGNPWLC 209 (266)
T ss_dssp C-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred c-ccChhHCCCCCCCEEEecCCCCCC
Confidence 8 788888888888888888776654
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.78 E-value=1.5e-17 Score=182.86 Aligned_cols=115 Identities=23% Similarity=0.283 Sum_probs=82.2
Q ss_pred CeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcc
Q 041143 67 NRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALD 146 (973)
Q Consensus 67 ~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls 146 (973)
.++++|+|++++|+ .+|+. +++|++|+|++|+|+.++.. +.+|+.|++++|+++.++. -.+.|++|+|+
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~~lp~~---~~~L~~L~l~~n~l~~l~~----lp~~L~~L~L~ 106 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLTELPEL---PQSLKSLLVDNNNLKALSD----LPPLLEYLGVS 106 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCSSCCCC---CTTCCEEECCSSCCSCCCS----CCTTCCEEECC
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCcccccc---hhhhhhhhhhhcccchhhh----hcccccccccc
Confidence 46788999999997 56753 46888999999999865433 4578888999999887763 12468999999
Q ss_pred cCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcC
Q 041143 147 YNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRL 202 (973)
Q Consensus 147 ~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 202 (973)
+|.+.. +|. ++.+++|+.|++++|.+..... ....+..|.+.++..
T Consensus 107 ~n~l~~-----lp~-~~~l~~L~~L~l~~~~~~~~~~----~~~~l~~l~~~~~~~ 152 (353)
T d1jl5a_ 107 NNQLEK-----LPE-LQNSSFLKIIDVDNNSLKKLPD----LPPSLEFIAAGNNQL 152 (353)
T ss_dssp SSCCSS-----CCC-CTTCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCC
T ss_pred cccccc-----ccc-hhhhccceeecccccccccccc----ccccccchhhccccc
Confidence 999885 564 6788899999998888764322 133444455444443
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.77 E-value=1.5e-19 Score=180.48 Aligned_cols=172 Identities=20% Similarity=0.252 Sum_probs=138.7
Q ss_pred EEEecccCCcccCCcCcccccccceeeccCcccCCCCC--CCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccC
Q 041143 71 QIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP--TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYN 148 (973)
Q Consensus 71 ~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~--~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N 148 (973)
++++++++|+ .+|..+. +++++|+|++|+|++.++ .|.++++|++|+|++|++..+++..|..+++|++|+|++|
T Consensus 12 ~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence 3456666776 6777664 789999999999987554 6899999999999999999999999999999999999999
Q ss_pred CCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCC
Q 041143 149 PFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGM 228 (973)
Q Consensus 149 ~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~ 228 (973)
+|+.+ .|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|.+.......+..
T Consensus 89 ~l~~l----~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~---------------- 148 (192)
T d1w8aa_ 89 KIKEI----SNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFA---------------- 148 (192)
T ss_dssp CCCEE----CSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHH----------------
T ss_pred ccccc----CHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHh----------------
Confidence 99975 5667899999999999999999888899999999999999999998654433321
Q ss_pred CCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCccccc
Q 041143 229 TGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGL 278 (973)
Q Consensus 229 ~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~ 278 (973)
..|+.+.+..|.++...|..+ .+++.++|+.|.|...
T Consensus 149 ----------~~l~~~~l~~~~~~c~~p~~l---~~~~l~~L~~n~l~C~ 185 (192)
T d1w8aa_ 149 ----------EWLRKKSLNGGAARCGAPSKV---RDVQIKDLPHSEFKCS 185 (192)
T ss_dssp ----------HHHHHHCCSGGGCBBCSSTTT---TTSBGGGSCTTTCCCC
T ss_pred ----------hhhhhhcccCCCeEeCCChhh---cCCEeeecCHhhCcCC
Confidence 123344556677776666544 4566778888887643
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.74 E-value=9.7e-18 Score=172.18 Aligned_cols=150 Identities=21% Similarity=0.259 Sum_probs=106.3
Q ss_pred ccccccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccc
Q 041143 88 NQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQ 167 (973)
Q Consensus 88 ~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~ 167 (973)
..|+++..++++.+++++.. .+..+.+|++|++.+|+|+.+. .+..+++|++|+|++|++++. + .+..+++
T Consensus 16 ~~l~~~~~~~l~~~~~~d~~-~~~~l~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~ls~n~i~~~-----~-~l~~l~~ 86 (227)
T d1h6ua2 16 PALANAIKIAAGKSNVTDTV-TQADLDGITTLSAFGTGVTTIE--GVQYLNNLIGLELKDNQITDL-----A-PLKNLTK 86 (227)
T ss_dssp HHHHHHHHHHTTCSSTTSEE-CHHHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCC-----G-GGTTCCS
T ss_pred HHHHHHHHHHhCCCCcCCcC-CHHHcCCcCEEECCCCCCCcch--hHhcCCCCcEeecCCceeecc-----c-ccccccc
Confidence 34455556677777777643 4556677788888888887773 377788888888888887753 2 3777888
Q ss_pred cCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEcc
Q 041143 168 LTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLH 247 (973)
Q Consensus 168 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~ 247 (973)
|++|++++|.++. ++ .+..+++|++|++++|+..+..+ +...+.+..+.++
T Consensus 87 l~~l~~~~n~~~~-i~-~l~~l~~L~~l~l~~~~~~~~~~---------------------------~~~~~~~~~l~~~ 137 (227)
T d1h6ua2 87 ITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITDVTP---------------------------LAGLSNLQVLYLD 137 (227)
T ss_dssp CCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCCCGG---------------------------GTTCTTCCEEECC
T ss_pred ccccccccccccc-cc-cccccccccccccccccccccch---------------------------hccccchhhhhch
Confidence 8888888888773 33 47788888888888887764322 2346778888888
Q ss_pred CCccccCCCccccCCCCCCEEeCcCCcccc
Q 041143 248 GNQFTGSIPEDIGALSSLKDLNLNRNQLVG 277 (973)
Q Consensus 248 ~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~ 277 (973)
++.+.... .+..+++|+.|++++|.+.+
T Consensus 138 ~~~~~~~~--~~~~~~~L~~L~l~~n~~~~ 165 (227)
T d1h6ua2 138 LNQITNIS--PLAGLTNLQYLSIGNAQVSD 165 (227)
T ss_dssp SSCCCCCG--GGGGCTTCCEEECCSSCCCC
T ss_pred hhhhchhh--hhcccccccccccccccccc
Confidence 88877433 46777888888888887764
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.73 E-value=8.3e-18 Score=174.67 Aligned_cols=138 Identities=15% Similarity=0.141 Sum_probs=74.3
Q ss_pred cceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeeeccc-ccccCCcchhccCCCCCCe
Q 041143 116 LEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLIN-CNLVGPLPDFLGTLPSLAA 194 (973)
Q Consensus 116 L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~-N~l~~~~p~~l~~l~~L~~ 194 (973)
+++|+|++|+|+.++..+|.++++|++|+|++|.+...+ -+..|.+++++++|.+.. |++....+..|.++++|++
T Consensus 31 l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i---~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~ 107 (242)
T d1xwdc1 31 AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI---EADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQY 107 (242)
T ss_dssp CSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEE---CSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCE
T ss_pred CCEEECcCCcCCccChhHhhccchhhhhhhcccccccee---eccccccccccccccccccccccccccccccccccccc
Confidence 344444444444444445555555555555555554320 123455566666666543 4565555666777777777
Q ss_pred EEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCccccCCCccccCCC-CCCEEeCcCC
Q 041143 195 LKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALS-SLKDLNLNRN 273 (973)
Q Consensus 195 L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~-~L~~L~Ls~N 273 (973)
|++++|++....+..+ +..+..|..+..+++.+....+..|..++ .++.|++++|
T Consensus 108 l~l~~~~l~~~~~~~~------------------------~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n 163 (242)
T d1xwdc1 108 LLISNTGIKHLPDVHK------------------------IHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKN 163 (242)
T ss_dssp EEEESCCCCSCCCCTT------------------------TCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSS
T ss_pred cccchhhhcccccccc------------------------cccccccccccccccccccccccccccccccceeeecccc
Confidence 7777777753222111 22355566666666666644444555443 5666666666
Q ss_pred cccccCc
Q 041143 274 QLVGLIP 280 (973)
Q Consensus 274 ~l~~~~p 280 (973)
+++...+
T Consensus 164 ~l~~i~~ 170 (242)
T d1xwdc1 164 GIQEIHN 170 (242)
T ss_dssp CCCEECT
T ss_pred ccccccc
Confidence 6664433
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.72 E-value=1.7e-16 Score=174.23 Aligned_cols=179 Identities=22% Similarity=0.279 Sum_probs=115.5
Q ss_pred cccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCe
Q 041143 91 TKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTN 170 (973)
Q Consensus 91 ~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~ 170 (973)
.+|++|||++|.++..++ .+++|++|+|++|+|+.+|.. +.+|+.|++++|+++. ++. + .+.|++
T Consensus 38 ~~l~~LdLs~~~L~~lp~---~~~~L~~L~Ls~N~l~~lp~~----~~~L~~L~l~~n~l~~-----l~~-l--p~~L~~ 102 (353)
T d1jl5a_ 38 RQAHELELNNLGLSSLPE---LPPHLESLVASCNSLTELPEL----PQSLKSLLVDNNNLKA-----LSD-L--PPLLEY 102 (353)
T ss_dssp HTCSEEECTTSCCSCCCS---CCTTCSEEECCSSCCSSCCCC----CTTCCEEECCSSCCSC-----CCS-C--CTTCCE
T ss_pred cCCCEEEeCCCCCCCCCC---CCCCCCEEECCCCCCcccccc----hhhhhhhhhhhcccch-----hhh-h--cccccc
Confidence 468999999999997543 257899999999999999853 5789999999999985 332 1 146999
Q ss_pred eecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCc
Q 041143 171 LSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQ 250 (973)
Q Consensus 171 L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~ 250 (973)
|+|++|.+. .+|. ++.+++|++|++++|.+... +..... +..+...... ......+..++.++.|++++|.
T Consensus 103 L~L~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~-~~~~~~----l~~l~~~~~~--~~~~~~l~~l~~l~~L~l~~n~ 173 (353)
T d1jl5a_ 103 LGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKL-PDLPPS----LEFIAAGNNQ--LEELPELQNLPFLTAIYADNNS 173 (353)
T ss_dssp EECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSCC-CCCCTT----CCEEECCSSC--CSSCCCCTTCTTCCEEECCSSC
T ss_pred ccccccccc-cccc-hhhhccceeecccccccccc-cccccc----ccchhhcccc--ccccccccccccceeccccccc
Confidence 999999998 4564 68899999999999999844 322211 1111111111 1122345667888888888888
Q ss_pred cccCCCccccCCCCCCEEeCcCCcccccCccccccc-ccCeEEccCCcCc
Q 041143 251 FTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNNNLLM 299 (973)
Q Consensus 251 l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~N~l~ 299 (973)
+.. ++... ...+.+.++++.+. .++. +..+ .|+.+++++|...
T Consensus 174 ~~~-~~~~~---~~~~~l~~~~~~~~-~~~~-~~~l~~L~~l~l~~n~~~ 217 (353)
T d1jl5a_ 174 LKK-LPDLP---LSLESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLK 217 (353)
T ss_dssp CSS-CCCCC---TTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCS
T ss_pred ccc-ccccc---cccccccccccccc-cccc-cccccccccccccccccc
Confidence 763 22211 12334444444333 2222 2222 4555555555543
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.71 E-value=7.7e-18 Score=167.86 Aligned_cols=157 Identities=22% Similarity=0.203 Sum_probs=99.4
Q ss_pred ceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEE
Q 041143 117 EFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALK 196 (973)
Q Consensus 117 ~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 196 (973)
+.+++++|+++.||.+.+ +++++|+|++|+|+.. ..+..|.++++|+.|+|++|++....+..|..+++|++|+
T Consensus 11 ~~v~Cs~~~L~~iP~~lp---~~l~~L~Ls~N~i~~~---~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~ 84 (192)
T d1w8aa_ 11 TTVDCTGRGLKEIPRDIP---LHTTELLLNDNELGRI---SSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQ 84 (192)
T ss_dssp TEEECTTSCCSSCCSCCC---TTCSEEECCSCCCCSB---CCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred CEEEEeCCCcCccCCCCC---CCCCEEEeCCCCCccc---ccccccCCCceEeeeeccccccccccccccccccccceee
Confidence 355666666666665543 4566677777776643 1244566777777777777777777777777777777777
Q ss_pred ccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCccc
Q 041143 197 LSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLV 276 (973)
Q Consensus 197 Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~ 276 (973)
|++|+|+...|..| .++++|++|+|++|+|++..|..|..+++|++|+|++|.+.
T Consensus 85 Ls~N~l~~l~~~~F-------------------------~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~ 139 (192)
T d1w8aa_ 85 LGENKIKEISNKMF-------------------------LGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139 (192)
T ss_dssp CCSCCCCEECSSSS-------------------------TTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred eccccccccCHHHH-------------------------hCCCcccccccCCccccccCHHHhcCCcccccccccccccc
Confidence 77777775444433 35777777777777777666667777777777887777776
Q ss_pred ccCcccccccccCeEEccCCcCcCCCCC
Q 041143 277 GLIPKSLANMELDNLVLNNNLLMGPIPK 304 (973)
Q Consensus 277 ~~~p~~~~~l~L~~L~l~~N~l~g~~p~ 304 (973)
......+-...++.+.+..|.++...|.
T Consensus 140 ~~~~~~~~~~~l~~~~l~~~~~~c~~p~ 167 (192)
T d1w8aa_ 140 CNCHLAWFAEWLRKKSLNGGAARCGAPS 167 (192)
T ss_dssp CSGGGHHHHHHHHHHCCSGGGCBBCSST
T ss_pred cccchHHHhhhhhhhcccCCCeEeCCCh
Confidence 5432221111344445555665544443
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.71 E-value=6.7e-17 Score=165.78 Aligned_cols=185 Identities=24% Similarity=0.353 Sum_probs=154.6
Q ss_pred CeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcc
Q 041143 67 NRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALD 146 (973)
Q Consensus 67 ~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls 146 (973)
..++.|++.+++|+. + +.|.++++|++|+|++|.+++..+ +.++++|++|++++|.++.++ .|.++++|++|+++
T Consensus 41 ~~L~~L~l~~~~i~~-l-~~l~~l~~L~~L~ls~n~i~~~~~-l~~l~~l~~l~~~~n~~~~i~--~l~~l~~L~~l~l~ 115 (227)
T d1h6ua2 41 DGITTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQITDLAP-LKNLTKITELELSGNPLKNVS--AIAGLQSIKTLDLT 115 (227)
T ss_dssp HTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG-GTTCCSCCEEECCSCCCSCCG--GGTTCTTCCEEECT
T ss_pred CCcCEEECCCCCCCc-c-hhHhcCCCCcEeecCCceeecccc-ccccccccccccccccccccc--cccccccccccccc
Confidence 478999999999985 4 469999999999999999987654 889999999999999999875 47899999999999
Q ss_pred cCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCC
Q 041143 147 YNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAG 226 (973)
Q Consensus 147 ~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~ 226 (973)
+|.+.+. ..+...+.++.+.++++.+.... .+.++++|++|++++|+++...+
T Consensus 116 ~~~~~~~------~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~~~------------------- 168 (227)
T d1h6ua2 116 STQITDV------TPLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDLTP------------------- 168 (227)
T ss_dssp TSCCCCC------GGGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCCGG-------------------
T ss_pred ccccccc------chhccccchhhhhchhhhhchhh--hhccccccccccccccccccchh-------------------
Confidence 9988753 45677888999999999987543 47788999999999999873321
Q ss_pred CCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcCCcccccCccccccc-ccCeEEccC
Q 041143 227 GMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLNN 295 (973)
Q Consensus 227 ~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~~ 295 (973)
+.++++|+.|+|++|++++ ++ .+..+++|++|+|++|++++..| +.++ +|+.|++++
T Consensus 169 --------l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 169 --------LANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226 (227)
T ss_dssp --------GTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEE
T ss_pred --------hcccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCCCCcc--cccCCCCCEEEeeC
Confidence 3468999999999999995 44 48999999999999999996543 6676 799999874
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.71 E-value=3.8e-17 Score=165.21 Aligned_cols=163 Identities=25% Similarity=0.369 Sum_probs=82.1
Q ss_pred ccccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccC
Q 041143 90 LTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLT 169 (973)
Q Consensus 90 l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~ 169 (973)
|.+|++|++++|.++... .+..+++|++|+|++|+|+.+++ +..+++|++|++++|++++ +| .+..+++|+
T Consensus 45 L~~L~~L~l~~~~i~~l~-~l~~l~~L~~L~L~~n~i~~l~~--~~~l~~L~~L~l~~n~i~~-----l~-~l~~l~~L~ 115 (210)
T d1h6ta2 45 LNSIDQIIANNSDIKSVQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-----LS-SLKDLKKLK 115 (210)
T ss_dssp HHTCCEEECTTSCCCCCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-----GG-GGTTCTTCC
T ss_pred hcCccEEECcCCCCCCch-hHhhCCCCCEEeCCCccccCccc--cccCccccccccccccccc-----cc-ccccccccc
Confidence 445555555555555432 34445555555555555555442 3455555555555555553 22 355555555
Q ss_pred eeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCC
Q 041143 170 NLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGN 249 (973)
Q Consensus 170 ~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N 249 (973)
.|++++|.+.. + ..+..+++|+.+++++|.+++.. . +..+++|+.+++++|
T Consensus 116 ~L~l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~~~--~-------------------------~~~l~~L~~l~l~~n 166 (210)
T d1h6ta2 116 SLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDIT--V-------------------------LSRLTKLDTLSLEDN 166 (210)
T ss_dssp EEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCCG--G-------------------------GGGCTTCSEEECCSS
T ss_pred ccccccccccc-c-ccccccccccccccccccccccc--c-------------------------ccccccccccccccc
Confidence 55555555542 1 23555555555555555554211 1 123555555555555
Q ss_pred ccccCCCccccCCCCCCEEeCcCCcccccCccccccc-ccCeEEcc
Q 041143 250 QFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVLN 294 (973)
Q Consensus 250 ~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l~ 294 (973)
++++ ++ .+.++++|+.|+|++|+++. +| .+..+ +|++|+|+
T Consensus 167 ~l~~-i~-~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 167 QISD-IV-PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELF 208 (210)
T ss_dssp CCCC-CG-GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEE
T ss_pred cccc-cc-cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEcc
Confidence 5553 22 25555555555555555553 22 34444 45555554
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=4.5e-17 Score=164.68 Aligned_cols=164 Identities=26% Similarity=0.376 Sum_probs=142.3
Q ss_pred CeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcc
Q 041143 67 NRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALD 146 (973)
Q Consensus 67 ~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls 146 (973)
..++.|++++++++.. + .+..+++|++|+|++|+|++.. .+.++++|++|++++|+|+.++ .+.++++|+.|+++
T Consensus 46 ~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~l~-~~~~l~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~l~ 120 (210)
T d1h6ta2 46 NSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIK-PLANLKNLGWLFLDENKVKDLS--SLKDLKKLKSLSLE 120 (210)
T ss_dssp HTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCCCGG--GGTTCTTCCEEECT
T ss_pred cCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccCcc-ccccCccccccccccccccccc--cccccccccccccc
Confidence 3688999999999854 3 4899999999999999999854 5788999999999999999986 48899999999999
Q ss_pred cCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCC
Q 041143 147 YNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAG 226 (973)
Q Consensus 147 ~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~ 226 (973)
+|.+.. + ..+..+++|+.+++++|.+++ +..+..+++|+++++++|++++. +.
T Consensus 121 ~~~~~~-----~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i-~~------------------ 173 (210)
T d1h6ta2 121 HNGISD-----I-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDI-VP------------------ 173 (210)
T ss_dssp TSCCCC-----C-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCC-GG------------------
T ss_pred cccccc-----c-ccccccccccccccccccccc--ccccccccccccccccccccccc-cc------------------
Confidence 999874 3 478899999999999999985 34678899999999999999843 32
Q ss_pred CCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEEeCcC
Q 041143 227 GMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDLNLNR 272 (973)
Q Consensus 227 ~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~ 272 (973)
++++++|+.|+|++|+|+ .+| .+..+++|++|+|++
T Consensus 174 --------l~~l~~L~~L~Ls~N~i~-~l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 174 --------LAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp --------GTTCTTCCEEECCSSCCC-BCG-GGTTCTTCSEEEEEE
T ss_pred --------ccCCCCCCEEECCCCCCC-CCh-hhcCCCCCCEEEccC
Confidence 346999999999999999 565 699999999999974
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.69 E-value=3.1e-17 Score=170.27 Aligned_cols=196 Identities=14% Similarity=0.114 Sum_probs=87.6
Q ss_pred EEEEEecccCCcccCCcCcccccccceeeccCcccCCCCC--CCCCCCccceeecc-CCCCCCCCccccCCCCCccEEEc
Q 041143 69 VTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLP--TFSGLSELEFAYLD-FNEFDTIPSDFFDGLSSVRVLAL 145 (973)
Q Consensus 69 v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~--~~~~l~~L~~L~L~-~N~l~~i~~~~f~~l~~L~~L~L 145 (973)
+++|+|++|.|+...+.+|.++++|++|+|++|.+...++ .|.+++++++|.+. .|++..+++..|.++++|++|++
T Consensus 31 l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l 110 (242)
T d1xwdc1 31 AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLI 110 (242)
T ss_dssp CSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEE
T ss_pred CCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccccccccccccccccccccc
Confidence 4444444444443333344444444444444444443222 34444444444433 23444444444444444444444
Q ss_pred ccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCC-CCCeEEccCCcCcccCChhhhhhHHHHHhhcccC
Q 041143 146 DYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLP-SLAALKLSYNRLSGVIPASFGQSLMQILWLNDQD 224 (973)
Q Consensus 146 s~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~ 224 (973)
++|++... .....+..+..|..+...++.+....+..|..++ .++.|++++|+++...+.
T Consensus 111 ~~~~l~~~---~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~---------------- 171 (242)
T d1xwdc1 111 SNTGIKHL---PDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNC---------------- 171 (242)
T ss_dssp ESCCCCSC---CCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTT----------------
T ss_pred chhhhccc---ccccccccccccccccccccccccccccccccccccceeeecccccccccccc----------------
Confidence 44444421 0111222233333333344444433333333332 344444444444422211
Q ss_pred CCCCCCcchhhcCCccccE-EEccCCccccCCCccccCCCCCCEEeCcCCcccccCccccccc-ccCeEEc
Q 041143 225 AGGMTGPIDVVAKMVSLTQ-LWLHGNQFTGSIPEDIGALSSLKDLNLNRNQLVGLIPKSLANM-ELDNLVL 293 (973)
Q Consensus 225 ~~~~~~~~~~~~~l~~L~~-L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~l 293 (973)
.| ...++.. +++++|+|+...+..|..+++|++|+|++|+|+...+..|.++ +|+.+++
T Consensus 172 ---------~~-~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~ 232 (242)
T d1xwdc1 172 ---------AF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232 (242)
T ss_dssp ---------TT-TTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSE
T ss_pred ---------cc-cchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcC
Confidence 12 2334333 3456666763323346667777777777777775544455555 4555444
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.68 E-value=1.6e-16 Score=159.04 Aligned_cols=104 Identities=26% Similarity=0.324 Sum_probs=48.9
Q ss_pred cccccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCccccccccc
Q 041143 89 QLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQL 168 (973)
Q Consensus 89 ~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L 168 (973)
.+.+|++|++++|.++.. +.+..+++|++|+|++|+|+.+++ |.++++|++|++++|.+.. ++ .+.+++.|
T Consensus 38 ~l~~l~~L~l~~~~i~~l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~-----~~-~l~~l~~L 108 (199)
T d2omxa2 38 DLDQVTTLQADRLGIKSI-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-----IT-PLANLTNL 108 (199)
T ss_dssp HHTTCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-----CG-GGTTCTTC
T ss_pred HhcCCCEEECCCCCCCCc-cccccCCCcCcCccccccccCccc--ccCCccccccccccccccc-----cc-cccccccc
Confidence 344444455555444432 234444455555555555544433 4455555555555554442 22 24445555
Q ss_pred CeeecccccccCCcchhccCCCCCCeEEccCCcCc
Q 041143 169 TNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLS 203 (973)
Q Consensus 169 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 203 (973)
+.|++++|.+... ..+..+++|+.|++++|++.
T Consensus 109 ~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~ 141 (199)
T d2omxa2 109 TGLTLFNNQITDI--DPLKNLTNLNRLELSSNTIS 141 (199)
T ss_dssp SEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCC
T ss_pred ccccccccccccc--cccchhhhhHHhhhhhhhhc
Confidence 5555555544432 12444555555555555544
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.68 E-value=1.8e-16 Score=158.77 Aligned_cols=160 Identities=24% Similarity=0.407 Sum_probs=138.2
Q ss_pred CeEEEEEecccCCcccCCcCcccccccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcc
Q 041143 67 NRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALD 146 (973)
Q Consensus 67 ~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls 146 (973)
.+++.|++++++++. + +.+..+++|++|+|++|+|++..+ +.++++|++|++++|.+..++. |.++++|+.|+++
T Consensus 40 ~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~-l~~l~~L~~L~l~~n~~~~~~~--l~~l~~L~~L~l~ 114 (199)
T d2omxa2 40 DQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLF 114 (199)
T ss_dssp TTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEECC
T ss_pred cCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc-ccCCcccccccccccccccccc--ccccccccccccc
Confidence 578899999999984 3 458999999999999999998655 9999999999999999999874 8899999999999
Q ss_pred cCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCC
Q 041143 147 YNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAG 226 (973)
Q Consensus 147 ~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~ 226 (973)
+|.+... ..+..+++|+.|++++|++.. ++ .+..+++|++|++.+|++++. +.
T Consensus 115 ~~~~~~~------~~~~~l~~L~~L~l~~n~l~~-~~-~l~~~~~L~~L~l~~n~l~~l-~~------------------ 167 (199)
T d2omxa2 115 NNQITDI------DPLKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLNFSSNQVTDL-KP------------------ 167 (199)
T ss_dssp SSCCCCC------GGGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCC-GG------------------
T ss_pred ccccccc------cccchhhhhHHhhhhhhhhcc-cc-cccccccccccccccccccCC-cc------------------
Confidence 9998853 458889999999999999984 33 589999999999999999843 21
Q ss_pred CCCCcchhhcCCccccEEEccCCccccCCCccccCCCCCCEE
Q 041143 227 GMTGPIDVVAKMVSLTQLWLHGNQFTGSIPEDIGALSSLKDL 268 (973)
Q Consensus 227 ~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L 268 (973)
+.++++|++|+|++|++++ ++ .+..+++|++|
T Consensus 168 --------l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 168 --------LANLTTLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp --------GTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred --------ccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 3469999999999999984 54 58889999876
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.57 E-value=3e-17 Score=187.36 Aligned_cols=112 Identities=13% Similarity=0.085 Sum_probs=81.4
Q ss_pred eEEEEEecccCCcccC-CcCcccccccceeeccCcccCCC----CC-CCCCCCccceeeccCCCCCCCC-----ccccCC
Q 041143 68 RVTQIQVQNLGLKGPL-PQNFNQLTKLYNLGLQRNKFNGK----LP-TFSGLSELEFAYLDFNEFDTIP-----SDFFDG 136 (973)
Q Consensus 68 ~v~~L~L~~~~l~g~~-~~~~~~l~~L~~L~L~~N~l~~~----~~-~~~~l~~L~~L~L~~N~l~~i~-----~~~f~~ 136 (973)
+|++||++++++++.. ..-+..+++|+.|+|++|.|+.. +. .+..+++|++|+|++|+|+... ......
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 5889999999998632 34467788899999999988742 22 4677889999999999886322 111223
Q ss_pred CCCccEEEcccCCCCCccCCCCCcccccccccCeeeccccccc
Q 041143 137 LSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLV 179 (973)
Q Consensus 137 l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~ 179 (973)
..+|++|+|++|+++......++..+..+++|++|+|++|.|+
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccch
Confidence 4579999999999876422234566778889999999998875
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.51 E-value=1.9e-15 Score=165.49 Aligned_cols=265 Identities=16% Similarity=0.141 Sum_probs=140.2
Q ss_pred CcCcccccccceeeccCcccCCCC-----CCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCC
Q 041143 84 PQNFNQLTKLYNLGLQRNKFNGKL-----PTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSI 158 (973)
Q Consensus 84 ~~~~~~l~~L~~L~L~~N~l~~~~-----~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~i 158 (973)
...+.+.+.|+.|+|++|.|+..- ..+...++|+.|+++++.+..+....... ...+
T Consensus 24 ~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~------------------~~~l 85 (344)
T d2ca6a1 24 FAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEA------------------LRLL 85 (344)
T ss_dssp SHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHH------------------HHHH
T ss_pred HHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchH------------------HHHH
Confidence 344566667777777777665421 13444555555555554443222110000 0001
Q ss_pred CcccccccccCeeecccccccCC----cchhccCCCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchh
Q 041143 159 PDSLANSVQLTNLSLINCNLVGP----LPDFLGTLPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDV 234 (973)
Q Consensus 159 p~~~~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 234 (973)
...+..+++|+.|+|++|.++.. +...+...++|++|+|++|.+.......++..+... .. ...
T Consensus 86 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~-~~-----------~~~ 153 (344)
T d2ca6a1 86 LQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQEL-AV-----------NKK 153 (344)
T ss_dssp HHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHH-HH-----------HHH
T ss_pred HHHHhhCCCcccccccccccccccccchhhhhcccccchheeccccccccccccccccccccc-cc-----------ccc
Confidence 22334455666666666666543 333444566777777777766532222222111100 00 001
Q ss_pred hcCCccccEEEccCCccccC----CCccccCCCCCCEEeCcCCccccc-----Cccccccc-ccCeEEccCCcCcCCCCC
Q 041143 235 VAKMVSLTQLWLHGNQFTGS----IPEDIGALSSLKDLNLNRNQLVGL-----IPKSLANM-ELDNLVLNNNLLMGPIPK 304 (973)
Q Consensus 235 ~~~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~~~-----~p~~~~~l-~L~~L~l~~N~l~g~~p~ 304 (973)
....+.|+.|++++|.++.. +...+...+.|++|+|++|+++.. +...+... +|+.|+|++|.++.....
T Consensus 154 ~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~ 233 (344)
T d2ca6a1 154 AKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSS 233 (344)
T ss_dssp HHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHH
T ss_pred cccCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccc
Confidence 12355677777777766522 223345566777777777776532 12223333 577777777766421100
Q ss_pred CCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccCCCCCCCCCCCCccccccCCCCcccEEecCCCcCCCc
Q 041143 305 FKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVSQWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGT 384 (973)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~ 384 (973)
.+. ..+..+++|+.|+|++|.+++.
T Consensus 234 ---------------------------~L~----------------------------~~l~~~~~L~~L~Ls~n~i~~~ 258 (344)
T d2ca6a1 234 ---------------------------ALA----------------------------IALKSWPNLRELGLNDCLLSAR 258 (344)
T ss_dssp ---------------------------HHH----------------------------HHGGGCTTCCEEECTTCCCCHH
T ss_pred ---------------------------ccc----------------------------ccccccccchhhhhhcCccCch
Confidence 000 0123446778888888888765
Q ss_pred cchhh----hC--ccccceEEccCCccccc----cCcccc-CcCCCCeeeCCCCcCCCCC
Q 041143 385 LSPSI----AN--LDSLIEIRLGKNSISGT----VPNNFT-ELKSLRLLDVSDNNIKPPL 433 (973)
Q Consensus 385 ~p~~~----~~--l~~L~~L~L~~N~l~g~----~p~~~~-~l~~L~~L~Ls~N~l~g~~ 433 (973)
....+ .. ...|++|+|++|+|+.. +...+. ++++|+.|+|++|++....
T Consensus 259 g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~~~ 318 (344)
T d2ca6a1 259 GAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 318 (344)
T ss_dssp HHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred hhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCCcc
Confidence 44433 22 35688999999988643 233342 5678999999999997543
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.50 E-value=1.3e-14 Score=139.18 Aligned_cols=86 Identities=19% Similarity=0.144 Sum_probs=37.6
Q ss_pred CCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCC
Q 041143 111 SGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLP 190 (973)
Q Consensus 111 ~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 190 (973)
.++.+|++|+|++|+|+.|+ ..+..+++|+.|+|++|+|+. + +.+..+++|++|+|++|+|+...+..+..++
T Consensus 15 ~n~~~lr~L~L~~n~I~~i~-~~~~~l~~L~~L~Ls~N~i~~-----l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~ 87 (162)
T d1a9na_ 15 TNAVRDRELDLRGYKIPVIE-NLGATLDQFDAIDFSDNEIRK-----L-DGFPLLRRLKTLLVNNNRICRIGEGLDQALP 87 (162)
T ss_dssp ECTTSCEEEECTTSCCCSCC-CGGGGTTCCSEEECCSSCCCE-----E-CCCCCCSSCCEEECCSSCCCEECSCHHHHCT
T ss_pred cCcCcCcEEECCCCCCCccC-ccccccccCCEEECCCCCCCc-----c-CCcccCcchhhhhcccccccCCCcccccccc
Confidence 33334444444444444442 233344444444444444442 2 1244444444444444444433333344445
Q ss_pred CCCeEEccCCcCc
Q 041143 191 SLAALKLSYNRLS 203 (973)
Q Consensus 191 ~L~~L~Ls~N~l~ 203 (973)
+|++|+|++|+|+
T Consensus 88 ~L~~L~L~~N~i~ 100 (162)
T d1a9na_ 88 DLTELILTNNSLV 100 (162)
T ss_dssp TCCEEECCSCCCC
T ss_pred ccccceecccccc
Confidence 5555555555444
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.49 E-value=2.6e-14 Score=137.04 Aligned_cols=115 Identities=22% Similarity=0.157 Sum_probs=94.5
Q ss_pred cCcccccccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCc-ccc
Q 041143 85 QNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPD-SLA 163 (973)
Q Consensus 85 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~-~~~ 163 (973)
+.|.+...|++|||++|+|+.+...+..+++|++|+|++|+|+.++ .|..+++|++|+|++|+++. ++. .+.
T Consensus 12 ~~~~n~~~lr~L~L~~n~I~~i~~~~~~l~~L~~L~Ls~N~i~~l~--~~~~l~~L~~L~ls~N~i~~-----l~~~~~~ 84 (162)
T d1a9na_ 12 AQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLD--GFPLLRRLKTLLVNNNRICR-----IGEGLDQ 84 (162)
T ss_dssp CEEECTTSCEEEECTTSCCCSCCCGGGGTTCCSEEECCSSCCCEEC--CCCCCSSCCEEECCSSCCCE-----ECSCHHH
T ss_pred HhccCcCcCcEEECCCCCCCccCccccccccCCEEECCCCCCCccC--CcccCcchhhhhcccccccC-----CCccccc
Confidence 4467888899999999999987555677899999999999999884 48889999999999999986 444 456
Q ss_pred cccccCeeecccccccCCcc-hhccCCCCCCeEEccCCcCcccCC
Q 041143 164 NSVQLTNLSLINCNLVGPLP-DFLGTLPSLAALKLSYNRLSGVIP 207 (973)
Q Consensus 164 ~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~p 207 (973)
.+++|+.|+|++|+|+.... ..+..+++|++|++++|.++ ..|
T Consensus 85 ~l~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~-~~~ 128 (162)
T d1a9na_ 85 ALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKK 128 (162)
T ss_dssp HCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GST
T ss_pred cccccccceeccccccccccccccccccccchhhcCCCccc-ccc
Confidence 78999999999999984322 46888999999999999987 444
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.48 E-value=1.3e-16 Score=182.06 Aligned_cols=114 Identities=25% Similarity=0.285 Sum_probs=86.4
Q ss_pred cccceeeccCcccCCCC--CCCCCCCccceeeccCCCCCCCC----ccccCCCCCccEEEcccCCCCCccCCCCCcccc-
Q 041143 91 TKLYNLGLQRNKFNGKL--PTFSGLSELEFAYLDFNEFDTIP----SDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLA- 163 (973)
Q Consensus 91 ~~L~~L~L~~N~l~~~~--~~~~~l~~L~~L~L~~N~l~~i~----~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~- 163 (973)
.+|++||++.|++++.. .-+..+++|+.|+|++|.|+... ..++..+++|++|||++|+|+......+...+.
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 36899999999999842 23566889999999999987422 344678999999999999986421001222332
Q ss_pred cccccCeeecccccccCC----cchhccCCCCCCeEEccCCcCcc
Q 041143 164 NSVQLTNLSLINCNLVGP----LPDFLGTLPSLAALKLSYNRLSG 204 (973)
Q Consensus 164 ~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~ 204 (973)
...+|++|+|++|+|+.. ++..+..+++|++|+|++|+++.
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred CCCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence 235799999999999753 45678889999999999999864
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.48 E-value=6e-14 Score=127.71 Aligned_cols=101 Identities=21% Similarity=0.268 Sum_probs=53.5
Q ss_pred EEecccCCcccCCcCcccccccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCC
Q 041143 72 IQVQNLGLKGPLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFN 151 (973)
Q Consensus 72 L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~ 151 (973)
|+|++|+|+ .++ .++++++|++|||++|.|+..++.|..+++|++|++++|+|+.++ .|..+++|++|++++|+|+
T Consensus 3 L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~~lp~~~~~l~~L~~L~l~~N~i~~l~--~~~~l~~L~~L~l~~N~i~ 78 (124)
T d1dcea3 3 LHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD--GVANLPRLQELLLCNNRLQ 78 (124)
T ss_dssp EECTTSCCS-SCC-CGGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCCCG--GGTTCSSCCEEECCSSCCC
T ss_pred EEcCCCCCC-CCc-ccccCCCCCEEECCCCccCcchhhhhhhhcccccccccccccccC--ccccccccCeEECCCCccC
Confidence 555556555 222 355555566666666655554445555555555555555555553 2555555555555555555
Q ss_pred CccCCCCCcccccccccCeeeccccccc
Q 041143 152 KTFGWSIPDSLANSVQLTNLSLINCNLV 179 (973)
Q Consensus 152 ~~~~~~ip~~~~~l~~L~~L~L~~N~l~ 179 (973)
.. .....+..+++|+.|+|++|.++
T Consensus 79 ~~---~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 79 QS---AAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp SS---STTGGGGGCTTCCEEECTTSGGG
T ss_pred CC---CCchhhcCCCCCCEEECCCCcCC
Confidence 32 11134455555555555555554
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.47 E-value=9.8e-14 Score=126.27 Aligned_cols=102 Identities=24% Similarity=0.245 Sum_probs=50.0
Q ss_pred ceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeeec
Q 041143 94 YNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSL 173 (973)
Q Consensus 94 ~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L 173 (973)
|.|||++|+|+.. +.+.++++|++|+|++|+|+.+|+ .|..+++|++|++++|+|+. +| .+..+++|++|++
T Consensus 1 R~L~Ls~n~l~~l-~~l~~l~~L~~L~ls~N~l~~lp~-~~~~l~~L~~L~l~~N~i~~-----l~-~~~~l~~L~~L~l 72 (124)
T d1dcea3 1 RVLHLAHKDLTVL-CHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALEN-----VD-GVANLPRLQELLL 72 (124)
T ss_dssp SEEECTTSCCSSC-CCGGGGTTCCEEECCSSCCCCCCG-GGGGCTTCCEEECCSSCCCC-----CG-GGTTCSSCCEEEC
T ss_pred CEEEcCCCCCCCC-cccccCCCCCEEECCCCccCcchh-hhhhhhcccccccccccccc-----cC-ccccccccCeEEC
Confidence 3455666666533 335555555555555555555543 24445555555555555543 22 3444555555555
Q ss_pred ccccccCCc-chhccCCCCCCeEEccCCcCc
Q 041143 174 INCNLVGPL-PDFLGTLPSLAALKLSYNRLS 203 (973)
Q Consensus 174 ~~N~l~~~~-p~~l~~l~~L~~L~Ls~N~l~ 203 (973)
++|+|+... ...+..+++|++|+|++|+++
T Consensus 73 ~~N~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 73 CNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CSSCCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred CCCccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 555554321 123444455555555555544
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.42 E-value=3.4e-14 Score=150.35 Aligned_cols=63 Identities=11% Similarity=0.090 Sum_probs=36.4
Q ss_pred CCcccEEecCC-CcCCCccchhhhCccccceEEccCCccccccCccccCcCCCCeeeCCCCcCCCCC
Q 041143 368 NSKVSIINLPR-HNLTGTLSPSIANLDSLIEIRLGKNSISGTVPNNFTELKSLRLLDVSDNNIKPPL 433 (973)
Q Consensus 368 ~~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~ 433 (973)
+++|++|+|++ +.+++.....++++++|+.|+++++--.+.++.-...+++ |++..++++...
T Consensus 199 ~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~~~d~~l~~l~~~lp~---L~i~~~~ls~~~ 262 (284)
T d2astb2 199 LNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPH---LQINCSHFTTIA 262 (284)
T ss_dssp CTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTSSCTTCHHHHHHHSTT---SEESCCCSCCTT
T ss_pred cCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCCCCHHHHHHHHHhCcc---ccccCccCCCCC
Confidence 45667777776 4566666666777778888888776222222222233444 445667777653
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.40 E-value=3.3e-14 Score=150.44 Aligned_cols=60 Identities=17% Similarity=0.180 Sum_probs=46.0
Q ss_pred CCcccEEecCCC-cCCCccchhhhCccccceEEccCC-ccccccCccccCcCCCCeeeCCCC
Q 041143 368 NSKVSIINLPRH-NLTGTLSPSIANLDSLIEIRLGKN-SISGTVPNNFTELKSLRLLDVSDN 427 (973)
Q Consensus 368 ~~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N-~l~g~~p~~~~~l~~L~~L~Ls~N 427 (973)
+++|+.|+|++| .+++.....+.++++|++|+|+++ .|+......++++++|+.|+++++
T Consensus 174 ~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 174 CPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp CTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred cccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 456777777764 466677777888888888888884 677776777888888888888876
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.33 E-value=9.4e-13 Score=125.04 Aligned_cols=86 Identities=23% Similarity=0.226 Sum_probs=42.4
Q ss_pred CCccceeeccCC-CCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccCCCC
Q 041143 113 LSELEFAYLDFN-EFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGTLPS 191 (973)
Q Consensus 113 l~~L~~L~L~~N-~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 191 (973)
+++|++|+|++| .|+.+++.+|.++++|+.|+|++|+|+.+ .+..|..+++|++|+|++|+|+...+..|..+ +
T Consensus 30 l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i----~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~~-~ 104 (156)
T d2ifga3 30 AENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFV----APDAFHFTPRLSRLNLSFNALESLSWKTVQGL-S 104 (156)
T ss_dssp CSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEE----CTTGGGSCSCCCEEECCSSCCSCCCSTTTCSC-C
T ss_pred ccccCeeecCCCccccccCchhhccccccCcceeeccccCCc----ccccccccccccceeccCCCCcccChhhhccc-c
Confidence 334444444332 24444444444455555555555554432 23445555555555555555553333334333 5
Q ss_pred CCeEEccCCcCc
Q 041143 192 LAALKLSYNRLS 203 (973)
Q Consensus 192 L~~L~Ls~N~l~ 203 (973)
|++|+|++|.+.
T Consensus 105 l~~L~L~~Np~~ 116 (156)
T d2ifga3 105 LQELVLSGNPLH 116 (156)
T ss_dssp CCEEECCSSCCC
T ss_pred ccccccCCCccc
Confidence 777777777764
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.33 E-value=3.2e-14 Score=141.38 Aligned_cols=119 Identities=21% Similarity=0.235 Sum_probs=101.5
Q ss_pred cCCcCcccccccceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcc
Q 041143 82 PLPQNFNQLTKLYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDS 161 (973)
Q Consensus 82 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~ 161 (973)
.++.+|..|++|++|+|++|+|+.+ +.|.++++|++|+|++|+|+.++. .+..+++|++|++++|+++. + +.
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~~i-~~l~~l~~L~~L~Ls~N~i~~i~~-~~~~~~~L~~L~l~~N~i~~-----l-~~ 110 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIEKI-SSLSGMENLRILSLGRNLIKKIEN-LDAVADTLEELWISYNQIAS-----L-SG 110 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEESCC-CCHHHHTTCCEEECCEEEECSCSS-HHHHHHHCCEEECSEEECCC-----H-HH
T ss_pred hhhhHHhcccccceeECcccCCCCc-ccccCCccccChhhcccccccccc-cccccccccccccccccccc-----c-cc
Confidence 4566799999999999999999965 568999999999999999999873 45566789999999999995 3 46
Q ss_pred cccccccCeeecccccccCCcc-hhccCCCCCCeEEccCCcCcccCCh
Q 041143 162 LANSVQLTNLSLINCNLVGPLP-DFLGTLPSLAALKLSYNRLSGVIPA 208 (973)
Q Consensus 162 ~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~p~ 208 (973)
+..+++|+.|+|++|+|+.... ..|..+++|++|+|++|++....+.
T Consensus 111 ~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~ 158 (198)
T d1m9la_ 111 IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp HHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCT
T ss_pred ccccccccccccccchhccccccccccCCCccceeecCCCccccCccc
Confidence 8899999999999999985322 4789999999999999998755443
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.32 E-value=2.2e-14 Score=142.54 Aligned_cols=128 Identities=27% Similarity=0.355 Sum_probs=83.1
Q ss_pred CCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeeecccccccCCcchhccC
Q 041143 109 TFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGPLPDFLGT 188 (973)
Q Consensus 109 ~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~l~~ 188 (973)
.+..+++|++|+|++|+|+.++ .|.++++|++|+|++|+|+. +|..+..+++|+.|++++|+|+. + ..+..
T Consensus 43 sl~~L~~L~~L~Ls~n~I~~i~--~l~~l~~L~~L~Ls~N~i~~-----i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~ 113 (198)
T d1m9la_ 43 TLSTLKACKHLALSTNNIEKIS--SLSGMENLRILSLGRNLIKK-----IENLDAVADTLEELWISYNQIAS-L-SGIEK 113 (198)
T ss_dssp HHHHTTTCCEEECSEEEESCCC--CHHHHTTCCEEECCEEEECS-----CSSHHHHHHHCCEEECSEEECCC-H-HHHHH
T ss_pred HHhcccccceeECcccCCCCcc--cccCCccccChhhccccccc-----ccccccccccccccccccccccc-c-ccccc
Confidence 4666777888888888887774 36777777777777777764 55555556677777777777774 3 34667
Q ss_pred CCCCCeEEccCCcCcccCChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCccccCCCcc----------
Q 041143 189 LPSLAALKLSYNRLSGVIPASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPED---------- 258 (973)
Q Consensus 189 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~---------- 258 (973)
+++|++|+|++|+|+.. +. + ..+..+++|+.|+|++|.+....+..
T Consensus 114 l~~L~~L~L~~N~i~~~-~~-~----------------------~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~v 169 (198)
T d1m9la_ 114 LVNLRVLYMSNNKITNW-GE-I----------------------DKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEV 169 (198)
T ss_dssp HHHSSEEEESEEECCCH-HH-H----------------------HHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHH
T ss_pred cccccccccccchhccc-cc-c----------------------ccccCCCccceeecCCCccccCcccccchhhHHHHH
Confidence 77777777777777622 21 0 12345777777777777765433321
Q ss_pred ccCCCCCCEEe
Q 041143 259 IGALSSLKDLN 269 (973)
Q Consensus 259 ~~~l~~L~~L~ 269 (973)
+..+++|+.||
T Consensus 170 i~~lp~L~~LD 180 (198)
T d1m9la_ 170 VKRLPNLKKLD 180 (198)
T ss_dssp HHHCSSCCEES
T ss_pred HHHCCCcCEeC
Confidence 44566666665
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.31 E-value=7.9e-14 Score=152.27 Aligned_cols=239 Identities=18% Similarity=0.174 Sum_probs=149.9
Q ss_pred CCCccEEEcccCCCCCccCCCCCcccccccccCeeecccccccC----------CcchhccCCCCCCeEEccCCcCcccC
Q 041143 137 LSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVG----------PLPDFLGTLPSLAALKLSYNRLSGVI 206 (973)
Q Consensus 137 l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~----------~~p~~l~~l~~L~~L~Ls~N~l~~~~ 206 (973)
...|+.|+|++|.|.......+...+..+++|+.|+++++.+.. .+...+...++|+.|+|++|.++...
T Consensus 30 ~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~ 109 (344)
T d2ca6a1 30 DDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTA 109 (344)
T ss_dssp CSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTT
T ss_pred CCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccccccccccc
Confidence 44444444444444321111122234444555555555543321 13345667889999999999987543
Q ss_pred ChhhhhhHHHHHhhcccCCCCCCCcchhhcCCccccEEEccCCccccCCCcc-------------ccCCCCCCEEeCcCC
Q 041143 207 PASFGQSLMQILWLNDQDAGGMTGPIDVVAKMVSLTQLWLHGNQFTGSIPED-------------IGALSSLKDLNLNRN 273 (973)
Q Consensus 207 p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~-------------~~~l~~L~~L~Ls~N 273 (973)
...+. ..+...++|++|++++|.++..-... ....+.|+.|++++|
T Consensus 110 ~~~l~---------------------~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n 168 (344)
T d2ca6a1 110 QEPLI---------------------DFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRN 168 (344)
T ss_dssp HHHHH---------------------HHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSS
T ss_pred ccchh---------------------hhhcccccchheecccccccccccccccccccccccccccccCcccceeecccc
Confidence 33332 22345789999999999886221111 135678999999999
Q ss_pred cccccCccccc----cc-ccCeEEccCCcCcCCCCCCCCCCcccccCcccCCCCCcccCCcchhhhhhccCCCCCCcccC
Q 041143 274 QLVGLIPKSLA----NM-ELDNLVLNNNLLMGPIPKFKAGNVTYDSNSFCQSEPGIECAPDVNVLLDFLGGVNYPVNLVS 348 (973)
Q Consensus 274 ~l~~~~p~~~~----~l-~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~n~~~ 348 (973)
.++...-..+. .. .|+.|+|++|.|...... .
T Consensus 169 ~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~---------------------------~---------------- 205 (344)
T d2ca6a1 169 RLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIE---------------------------H---------------- 205 (344)
T ss_dssp CCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHH---------------------------H----------------
T ss_pred cccccccccccchhhhhhhhcccccccccccccccc---------------------------c----------------
Confidence 98754333332 22 699999999988631100 0
Q ss_pred CCCCCCCCCCCccccccCCCCcccEEecCCCcCCCc----cchhhhCccccceEEccCCccccccCccc----cC--cCC
Q 041143 349 QWPGNDPCQGPWLGLSCTSNSKVSIINLPRHNLTGT----LSPSIANLDSLIEIRLGKNSISGTVPNNF----TE--LKS 418 (973)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~g~~p~~~----~~--l~~ 418 (973)
++...+..+++|+.|+|++|.++.. +...+...+.|++|+|++|.|++.-...+ .. .+.
T Consensus 206 -----------~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~ 274 (344)
T d2ca6a1 206 -----------LLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIG 274 (344)
T ss_dssp -----------HHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCC
T ss_pred -----------chhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCC
Confidence 0000123567899999999998754 55667789999999999999986533333 33 367
Q ss_pred CCeeeCCCCcCCCCC----C-----CCCcccceeecCCccc
Q 041143 419 LRLLDVSDNNIKPPL----P-----EFHDTVKLVIDGNPLL 450 (973)
Q Consensus 419 L~~L~Ls~N~l~g~~----p-----~~~~~~~~~~~~N~~~ 450 (973)
|++|||++|+|+..- . ...++..+.++||.+.
T Consensus 275 L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 275 LQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp CCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred CCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence 999999999987421 1 1345677899999874
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.31 E-value=2.8e-12 Score=121.67 Aligned_cols=113 Identities=17% Similarity=0.211 Sum_probs=93.3
Q ss_pred CCCCCCCCcCeEEeeCCeEEEEEecccCCcccCCcCcccccccceeeccCc-ccCCCCC-CCCCCCccceeeccCCCCCC
Q 041143 51 DDPCGPPPWPHVFCSGNRVTQIQVQNLGLKGPLPQNFNQLTKLYNLGLQRN-KFNGKLP-TFSGLSELEFAYLDFNEFDT 128 (973)
Q Consensus 51 ~d~C~~~~w~gv~C~~~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~L~~N-~l~~~~~-~~~~l~~L~~L~L~~N~l~~ 128 (973)
++.|.++.+.+|.|.... +. ..|..+..+++|++|+|++| .|+.+.+ .|.++++|+.|+|++|+|+.
T Consensus 2 P~~C~c~~~~~l~c~~~~----------~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~ 70 (156)
T d2ifga3 2 PDACCPHGSSGLRCTRDG----------AL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRF 70 (156)
T ss_dssp CSSSCCSSSSCEECCSSC----------CC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCE
T ss_pred cCCCCcCCCCeEEecCCC----------Cc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCC
Confidence 345655556777775443 33 56778889999999999866 5888766 79999999999999999999
Q ss_pred CCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeeeccccccc
Q 041143 129 IPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLV 179 (973)
Q Consensus 129 i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~ 179 (973)
|++.+|.++++|++|+|++|+|+. +|.......+|+.|+|++|.+.
T Consensus 71 i~~~~f~~l~~L~~L~Ls~N~l~~-----l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 71 VAPDAFHFTPRLSRLNLSFNALES-----LSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp ECTTGGGSCSCCCEEECCSSCCSC-----CCSTTTCSCCCCEEECCSSCCC
T ss_pred cccccccccccccceeccCCCCcc-----cChhhhccccccccccCCCccc
Confidence 999999999999999999999995 6666555568999999999885
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.43 E-value=1.1e-08 Score=96.97 Aligned_cols=110 Identities=15% Similarity=0.027 Sum_probs=72.1
Q ss_pred cceeeccCcccCCCCCCCCCCCccceeeccCCCCCCCCccccCCCCCccEEEcccCCCCCccCCCCCcccccccccCeee
Q 041143 93 LYNLGLQRNKFNGKLPTFSGLSELEFAYLDFNEFDTIPSDFFDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLS 172 (973)
Q Consensus 93 L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~ 172 (973)
.+.||++++... +.+..+..+..+++.+|.+..+ ..++..+++|++|+|++|+|+..- .++..+..+++|+.|+
T Consensus 24 ~~~Ldls~l~~~---~~l~~~~~~~~l~~~~~~~~~l-~~~~~~~~~L~~L~Ls~N~i~~l~--~~~~~~~~l~~L~~L~ 97 (162)
T d1koha1 24 QQALDLKGLRSD---PDLVAQNIDVVLNRRSSMAATL-RIIEENIPELLSLNLSNNRLYRLD--DMSSIVQKAPNLKILN 97 (162)
T ss_dssp SCCBCCCCCSSC---TTTTTTTCCCCTTSHHHHHHHH-HHHHHHCTTCCCCCCCSSCCCCCS--GGGTHHHHSTTCCCCC
T ss_pred hCeeecccCCCC---chhhhccchhhcchhhhHhhhh-HHHHHhCCCCCEeeCCCccccCCc--hhHHHHhhCCcccccc
Confidence 445666554422 2334444444455544443332 344567888888888888888641 1345677889999999
Q ss_pred cccccccCCcchhccCCCCCCeEEccCCcCcccCCh
Q 041143 173 LINCNLVGPLPDFLGTLPSLAALKLSYNRLSGVIPA 208 (973)
Q Consensus 173 L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 208 (973)
|++|.|+...+-.+....+|+.|+|++|.++.....
T Consensus 98 Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~ 133 (162)
T d1koha1 98 LSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRD 133 (162)
T ss_dssp CTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSS
T ss_pred cccCccccchhhhhhhccccceeecCCCCcCcCccc
Confidence 999999965444455566899999999999865543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.32 E-value=9.1e-07 Score=90.98 Aligned_cols=149 Identities=16% Similarity=0.121 Sum_probs=100.2
Q ss_pred HHHHHHhcCccccCcccccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeeEEEeCC
Q 041143 618 QVLRKVTQNFAQENELGRGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR-HRHLVSLLGYSIEGN 696 (973)
Q Consensus 618 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 696 (973)
.+++...+.|+..+..+-++.+.||+.... +..+.+|+..... ......+.+|...+..+. +--+.++++++..++
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~--~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~ 83 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRY--KGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDG 83 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGG--TTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETT
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCc--ccchhhHHHHHHHHHHHhccCCCCcEEEEEecCC
Confidence 355666678877766554555789998654 5667888775431 112235678888888774 333567788888888
Q ss_pred eEEEEEEecCCCCHHHHHHhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhhc----------------------------
Q 041143 697 ERLLVYEYMPHGALSRHLFRWEKLQLKPLSWTRRLSIALDVARGMEYLHCLA---------------------------- 748 (973)
Q Consensus 697 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~---------------------------- 748 (973)
..++||++++|..+.+.... ......++.++++.++.||+..
T Consensus 84 ~~~lv~~~l~G~~~~~~~~~----------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (263)
T d1j7la_ 84 WSNLLMSEADGVLCSEEYED----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADV 153 (263)
T ss_dssp EEEEEEECCSSEEHHHHTTT----------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCC
T ss_pred ceEEEEEecccccccccccc----------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhh
Confidence 99999999999887543211 1112234555555556665310
Q ss_pred ----------------------------cCCeeeccCCCCcEEECCCCCEEEeeccccc
Q 041143 749 ----------------------------RQTFIHRDLKSSNILLDDDYRAKVSDFGLVK 779 (973)
Q Consensus 749 ----------------------------~~~ivH~Dikp~Nill~~~~~~kl~DfGla~ 779 (973)
...++|+|+.|.||++++++..-|.||+.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 154 DCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1237899999999999987767799998765
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.30 E-value=4.2e-08 Score=92.96 Aligned_cols=41 Identities=32% Similarity=0.371 Sum_probs=22.1
Q ss_pred ccccccCeeecccccccCC--cchhccCCCCCCeEEccCCcCc
Q 041143 163 ANSVQLTNLSLINCNLVGP--LPDFLGTLPSLAALKLSYNRLS 203 (973)
Q Consensus 163 ~~l~~L~~L~L~~N~l~~~--~p~~l~~l~~L~~L~Ls~N~l~ 203 (973)
..+++|++|+|++|+|+.. ++..+..+++|+.|+|++|+|+
T Consensus 62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~ 104 (162)
T d1koha1 62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK 104 (162)
T ss_dssp HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC
T ss_pred HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc
Confidence 4455566666666655532 2233445555566666666555
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.87 E-value=1.8e-05 Score=80.37 Aligned_cols=73 Identities=23% Similarity=0.230 Sum_probs=53.0
Q ss_pred ccccCc-cEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC--CceeeeeeEEEeCCeEEEEEEecCCCC
Q 041143 633 LGRGGF-GTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRH--RHLVSLLGYSIEGNERLLVYEYMPHGA 709 (973)
Q Consensus 633 lG~G~f-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV~e~~~~g~ 709 (973)
+..|.. +.||+....++..+.+|.-.... ...+.+|.+.++.+.. -.+.++++++.+++..++||||++|-+
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~-----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccC-----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence 444553 67999998888888999765432 1246778888887743 335667888888888999999998865
Q ss_pred H
Q 041143 710 L 710 (973)
Q Consensus 710 L 710 (973)
+
T Consensus 93 ~ 93 (255)
T d1nd4a_ 93 L 93 (255)
T ss_dssp T
T ss_pred c
Confidence 5
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.85 E-value=2.3e-06 Score=80.94 Aligned_cols=42 Identities=31% Similarity=0.412 Sum_probs=20.8
Q ss_pred cccccccCeeecccccccC----CcchhccCCCCCCeEEccCCcCc
Q 041143 162 LANSVQLTNLSLINCNLVG----PLPDFLGTLPSLAALKLSYNRLS 203 (973)
Q Consensus 162 ~~~l~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~Ls~N~l~ 203 (973)
+...+.|++|+|++|.+.. .+...+...+.|++|+|++|.++
T Consensus 40 L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~ 85 (167)
T d1pgva_ 40 ACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 85 (167)
T ss_dssp HTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred HhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcc
Confidence 3344455555555555542 22233444455566666666555
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.74 E-value=4.1e-06 Score=79.22 Aligned_cols=70 Identities=14% Similarity=0.068 Sum_probs=45.8
Q ss_pred cCCCCCccEEEcccCCCCCccCCCCCcccccccccCeeecccccccCC----cchhccCCCCCCeEEccCCcCc
Q 041143 134 FDGLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVGP----LPDFLGTLPSLAALKLSYNRLS 203 (973)
Q Consensus 134 f~~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~ 203 (973)
+...+.|++|+|++|.+.......+...+...+.|+.|+|++|.|+.. +-..+...++|++|+|++|++.
T Consensus 40 L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 40 ACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSC
T ss_pred HhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCC
Confidence 445556666666666665432223445566677788888888887742 3345667788888888888765
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.28 E-value=0.00032 Score=75.71 Aligned_cols=77 Identities=16% Similarity=0.196 Sum_probs=48.3
Q ss_pred CcccccCccEEEEEEECC-CCEEEEEEeecCC-----CChHHHHHHHHHHHHHHhcC-C--CceeeeeeEEEeCCeEEEE
Q 041143 631 NELGRGGFGTVYKGELED-GTKIAVKRMEAGV-----TTTKALDEFQSEIAVLSKVR-H--RHLVSLLGYSIEGNERLLV 701 (973)
Q Consensus 631 ~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~-----~~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~lV 701 (973)
+.||.|....||++...+ ++.++||.-.... ......++...|.+.++.+. + ..+.+++.+ +.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 468999999999998754 6789999643211 00112234566888887662 3 334555544 45566899
Q ss_pred EEecCCCC
Q 041143 702 YEYMPHGA 709 (973)
Q Consensus 702 ~e~~~~g~ 709 (973)
|||+++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997754
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.27 E-value=1.7e-05 Score=74.76 Aligned_cols=42 Identities=21% Similarity=0.350 Sum_probs=20.4
Q ss_pred cccccccCeeecccccccCC----cchhccCCCCCCeEEccCCcCc
Q 041143 162 LANSVQLTNLSLINCNLVGP----LPDFLGTLPSLAALKLSYNRLS 203 (973)
Q Consensus 162 ~~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~ 203 (973)
+...++|+.|+|++|.++.. +...+...++|+.|++++|.+.
T Consensus 42 l~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~ 87 (166)
T d1io0a_ 42 LKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 87 (166)
T ss_dssp HTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred HhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence 33445555555555555421 2223344455555555555554
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.10 E-value=3.1e-05 Score=72.87 Aligned_cols=68 Identities=18% Similarity=0.223 Sum_probs=33.1
Q ss_pred CCCCccEEEcccCCCCCccCCCCCcccccccccCeeecccccccC----CcchhccCCCCCCeEEc--cCCcCc
Q 041143 136 GLSSVRVLALDYNPFNKTFGWSIPDSLANSVQLTNLSLINCNLVG----PLPDFLGTLPSLAALKL--SYNRLS 203 (973)
Q Consensus 136 ~l~~L~~L~Ls~N~l~~~~~~~ip~~~~~l~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~L--s~N~l~ 203 (973)
..++|++|+|++|.++......+...+...+.|+.|++++|.+.. .+...+...++|+.++| ++|++.
T Consensus 44 ~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~ 117 (166)
T d1io0a_ 44 TNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLG 117 (166)
T ss_dssp TCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred cCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCc
Confidence 444555555555554432111233344455566666666666542 12334555666665444 344554
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.72 E-value=0.0029 Score=65.99 Aligned_cols=137 Identities=12% Similarity=0.097 Sum_probs=78.4
Q ss_pred cEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCce--eeee-----eEEEeCCeEEEEEEecCCCCHH
Q 041143 639 GTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRHRHL--VSLL-----GYSIEGNERLLVYEYMPHGALS 711 (973)
Q Consensus 639 g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~-----~~~~~~~~~~lV~e~~~~g~L~ 711 (973)
=.||+++.++|+.+++|+.+....+ .+++..|.+.+..+....+ +..+ ......+..+.|++|++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCC---HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 4799999999999999987654333 3457788888888742222 1111 1233456778999999763321
Q ss_pred -----H---------HHHhhhh----ccCCCCCH-------------------HHHHHHHHHHHHHHHHHHh----hccC
Q 041143 712 -----R---------HLFRWEK----LQLKPLSW-------------------TRRLSIALDVARGMEYLHC----LARQ 750 (973)
Q Consensus 712 -----~---------~l~~~~~----~~~~~l~~-------------------~~~~~i~~~ia~gl~~LH~----~~~~ 750 (973)
. .+|.... ......++ ..+..+...+.+.++.+.. ....
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence 1 1111100 00111111 1111222223333334432 1245
Q ss_pred CeeeccCCCCcEEECCCCCEEEeecccccc
Q 041143 751 TFIHRDLKSSNILLDDDYRAKVSDFGLVKL 780 (973)
Q Consensus 751 ~ivH~Dikp~Nill~~~~~~kl~DfGla~~ 780 (973)
++||+|+.+.|||++++ ..++||+-+..
T Consensus 193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eeecCCCCcccEEEeCC--ceEEechhccc
Confidence 78999999999999754 45899987753
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.88 E-value=0.015 Score=60.09 Aligned_cols=160 Identities=10% Similarity=0.010 Sum_probs=86.2
Q ss_pred ecHHHHHHHhcCccccCccc-----ccCccEEEEEEECCCCEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC-----Cc
Q 041143 615 ISVQVLRKVTQNFAQENELG-----RGGFGTVYKGELEDGTKIAVKRMEAGVTTTKALDEFQSEIAVLSKVRH-----RH 684 (973)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~lG-----~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-----~n 684 (973)
++.++++....+|...+... .|---+.|+.+..+|+ +++|+..... ..+++..|++++..+.. |.
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~----~~~~l~~~~~~l~~L~~~g~pvp~ 77 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPL 77 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC----CHHHHHHHHHHHHhhhhccccccc
Confidence 45678888889997755443 4545678999887665 8888875431 12345567777777642 22
Q ss_pred eeeee-e--EEEeCCeEEEEEEecCCCCHHH--------------HHHhhhhc-c---------------------CCCC
Q 041143 685 LVSLL-G--YSIEGNERLLVYEYMPHGALSR--------------HLFRWEKL-Q---------------------LKPL 725 (973)
Q Consensus 685 iv~l~-~--~~~~~~~~~lV~e~~~~g~L~~--------------~l~~~~~~-~---------------------~~~l 725 (973)
.+... | +.........++.++.+..... .++..... . ....
T Consensus 78 pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (316)
T d2ppqa1 78 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 157 (316)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred cceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhh
Confidence 22111 0 1223455677788776633211 11110000 0 0000
Q ss_pred CHHHHHHHHHHHHHHHHHHHh-hccCCeeeccCCCCcEEECCCCCEEEeeccccc
Q 041143 726 SWTRRLSIALDVARGMEYLHC-LARQTFIHRDLKSSNILLDDDYRAKVSDFGLVK 779 (973)
Q Consensus 726 ~~~~~~~i~~~ia~gl~~LH~-~~~~~ivH~Dikp~Nill~~~~~~kl~DfGla~ 779 (973)
........+..+...+...+. ....++||+|+.+.||+++.+...-|.||+.+.
T Consensus 158 ~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 158 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 111112222222333333321 125679999999999999998877899999764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.29 E-value=0.018 Score=61.61 Aligned_cols=73 Identities=15% Similarity=0.169 Sum_probs=47.2
Q ss_pred cCcccccCccEEEEEEECCC--------CEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeeEEEeCCeEEE
Q 041143 630 ENELGRGGFGTVYKGELEDG--------TKIAVKRMEAGVTTTKALDEFQSEIAVLSKVR-HRHLVSLLGYSIEGNERLL 700 (973)
Q Consensus 630 ~~~lG~G~fg~Vy~~~~~~g--------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 700 (973)
++.|+.|-.=.+|++...++ +.|.+++.- .... . ....+|..+++.+. +.-..++++++.+ .+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~--~-idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~ 118 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPET--E-SHLVAESVIFTLLSERHLGPKLYGIFSG----GR 118 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCC--H-HHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccch--h-hHHHHHHHHHHHHHhCCCCCeEEEEcCC----ce
Confidence 35677788889999987543 456665543 2222 2 24567999988885 4333477777643 68
Q ss_pred EEEecCCCCH
Q 041143 701 VYEYMPHGAL 710 (973)
Q Consensus 701 V~e~~~~g~L 710 (973)
||||++|-.+
T Consensus 119 I~efi~g~~l 128 (395)
T d1nw1a_ 119 LEEYIPSRPL 128 (395)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeccccC
Confidence 9999987544
|